<SEC-DOCUMENT>0000790526-20-000007.txt : 20201109
<SEC-HEADER>0000790526-20-000007.hdr.sgml : 20201109
<ACCEPTANCE-DATETIME>20201109162423
ACCESSION NUMBER:		0000790526-20-000007
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		55
CONFORMED PERIOD OF REPORT:	20200930
FILED AS OF DATE:		20201109
DATE AS OF CHANGE:		20201109

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			RadNet, Inc.
		CENTRAL INDEX KEY:			0000790526
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		IRS NUMBER:				133326724
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33307
		FILM NUMBER:		201298050

	BUSINESS ADDRESS:	
		STREET 1:		1510 COTNER AVE
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90025
		BUSINESS PHONE:		3104787808

	MAIL ADDRESS:	
		STREET 1:		1510 COTNER AVE
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90025

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PRIMEDEX HEALTH SYSTEMS INC
		DATE OF NAME CHANGE:	19930518

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CCC FRANCHISING CORP
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>rdnt-20200930.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2020 Workiva--><!--r:57afb805-d064-496f-ad72-af37e545924d,g:a8620cad-346c-45d4-8ba0-be03bf014f2b,d:ffc0b59705bf4cff936f619293b1a306--><html xmlns="http://www.w3.org/1999/xhtml" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:rdnt="http://www.radnet.com/20200930" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:srt="http://fasb.org/srt/2019-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>rdnt-20200930</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80L2ZyYWc6NjkxMmEyMDg1OGEwNDM2OWFmNTgzOTgwNGMyYjFkNTIvdGFibGU6YmUwYzM0OTViNWM2NGVhNGFjYWI1MzA5NWE1OGFiNmMvdGFibGVyYW5nZTpiZTBjMzQ5NWI1YzY0ZWE0YWNhYjUzMDk1YTU4YWI2Y18xLTEtMS0xLTA_ece6089e-27d7-4059-9077-c1e9a763b9d4">0000790526</ix:nonNumeric><ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80L2ZyYWc6NjkxMmEyMDg1OGEwNDM2OWFmNTgzOTgwNGMyYjFkNTIvdGFibGU6YmUwYzM0OTViNWM2NGVhNGFjYWI1MzA5NWE1OGFiNmMvdGFibGVyYW5nZTpiZTBjMzQ5NWI1YzY0ZWE0YWNhYjUzMDk1YTU4YWI2Y18yLTEtMS0xLTA_3c426677-05e7-4e3d-8a1f-adad7a40fa13">false</ix:nonNumeric><ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" format="ixt:datemonthday" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80L2ZyYWc6NjkxMmEyMDg1OGEwNDM2OWFmNTgzOTgwNGMyYjFkNTIvdGFibGU6YmUwYzM0OTViNWM2NGVhNGFjYWI1MzA5NWE1OGFiNmMvdGFibGVyYW5nZTpiZTBjMzQ5NWI1YzY0ZWE0YWNhYjUzMDk1YTU4YWI2Y18zLTEtMS0xLTA_64193899-1025-4ba7-8b2b-3dedefed8d8c">12/31</ix:nonNumeric><ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80L2ZyYWc6NjkxMmEyMDg1OGEwNDM2OWFmNTgzOTgwNGMyYjFkNTIvdGFibGU6YmUwYzM0OTViNWM2NGVhNGFjYWI1MzA5NWE1OGFiNmMvdGFibGVyYW5nZTpiZTBjMzQ5NWI1YzY0ZWE0YWNhYjUzMDk1YTU4YWI2Y180LTEtMS0xLTA_a6773483-7631-4c67-81ed-ae3f59489d42">Q3</ix:nonNumeric><ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80L2ZyYWc6NjkxMmEyMDg1OGEwNDM2OWFmNTgzOTgwNGMyYjFkNTIvdGFibGU6YmUwYzM0OTViNWM2NGVhNGFjYWI1MzA5NWE1OGFiNmMvdGFibGVyYW5nZTpiZTBjMzQ5NWI1YzY0ZWE0YWNhYjUzMDk1YTU4YWI2Y181LTEtMS0xLTA_5dca5a91-6c89-4973-b50d-df709aaa9c88">2020</ix:nonNumeric><ix:nonNumeric contextRef="ib32f550e8d5d42f69af46e7e6c5dedd0_D20200101-20200930" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMTY2Mzg_7bbe4cad-8aac-4d51-9911-a759df597876">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="ib32f550e8d5d42f69af46e7e6c5dedd0_D20200101-20200930" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMTY2NTg_8014eae6-0e25-46ab-80ed-ec3b42b893fd">P5Y</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="rdnt-20200930.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i60bc3d6fa03048149fc05435bef6c409_I20201105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-11-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i4a9fe0209e954a06aca8cad30d601c73_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0096f14793b40c99c3a08b6a4ac8010_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe98f272e55f41dd878edf32fc7653a3_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ee478ac62b2402380d60e1df30d2970_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i058de6765e1e47449153067fb1e94bc6_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CapitationArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia03c585e05f349bd894ed447f40ca3fc_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CapitationArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife4b7517ca2542439322f6bb062453a3_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CapitationArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i202db1f71dbd487f9b8bf67552d7ead3_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CapitationArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ae3d85b0b824473a80ccd4a4708aba0_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ae0e1753b584266bd033c7378cf877e_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94f2d48724ea46b3aa0a89c46fcb12f8_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d04f49cdfcc40eb9852bb1986ae7007_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb96d5b718234c88935d8f52fbbbf3f6_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">rdnt:StockholdersEquityDeficitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91203f5108484c309c7a4260b22ee742_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2376698dad8742228ddb9d35b6913ee4_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c20b6a988b44e36a260b09593425753_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5fd6699fb85d4180a93c8a06313ec3e6_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4961d9edd85f4cd7b2f81b0166beb6fa_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09bf6bb1e62e463c8657ba3f07a2376b_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c7faff739fa454eacddcea55ed701ca_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">rdnt:StockholdersEquityDeficitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i555980525511438faed4ba009d6f37b0_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90d9b7dfff1842639dab833ff5ec3886_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief71dd6a90be46dd80cc9cdc74b1b643_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6a10831dcf34a89b6122ba9bb78bea5_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6c25823a7a04a639911e6f404f10a57_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b82209eab2648ec9c1833dbc1c0b1db_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69ba183096574a37a4b5b0ca97c5a51f_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i693f4b2418da466e9e6ad9dad2ab2b32_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">rdnt:StockholdersEquityDeficitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0c660ddab0648f28f0f4288a933f163_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03b809d756f245699c9daa49222191fe_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if75788edb86f41d092529d110d74bf6b_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89e4fdcc70e84e32bb0c67373df7c420_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04d33784ad9449e99e9c45a3134d5d9c_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15c0b6b3069e42be8f76b29a49821089_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">rdnt:StockholdersEquityDeficitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46b89b31f76140d281b073abfb16009e_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77ea6f08b3b34bc687923c35ae708d67_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f84ecccfa2c445b87e09865cedb5674_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide24663efeeb41099f7c5f224f6bc5d7_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e3e0e81d2f34922abfd07a4e2eaad7b_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">rdnt:StockholdersEquityDeficitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0e02291004444ac9e7381725f9d033f_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42768d703fd64d3cb22b5badf8ab7fa5_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8831da9d7f5d4f6fb802e218f7740494_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic034acb0117040d6afe7d976972fa479_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0747908eb36543a89df88a2d9e1cd35b_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e1094d35d014fd3a95b14bc592059f5_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0f76e06105741279da7c3328d1d487a_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd2c608cacd0477aa45970e7d954f191_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">rdnt:StockholdersEquityDeficitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d9baeb9e126447b98c2cf732d7b12b4_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i799130036d73414da02bb032ba102c39_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4d77a0476814e54bf880ea51ec53067_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07e00b3689c84e6a9310fc4102bb4b43_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73519d6ef869432190c131a957d0509a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic04fc01f723141e58a3d30372eb006ea_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b58c81a32474a7dad91e48ea01781b6_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">rdnt:StockholdersEquityDeficitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icfb4354e13e748e5a050d331bc69d1a3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7d38396af1648f3a9c78d6c8c94147c_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3743b37848a340a097d285381b700385_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7fda9262fb95476a816ecc3cad434f3c_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77d674128a5b4732a239eb275df36879_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6912bfccd4a448a292e8ea776b60d181_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">rdnt:StockholdersEquityDeficitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idfbed43c89ad4ebfa5f48f8e5bb8a6f9_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id643d75beaf84a40a839ec6515ad926a_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04b4ca98d99646caa1edf8c9b4cb072e_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e1e45a341fa4faa80a854e436e843dc_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6fd92e65f41647c28809f9a7ea4bfa83_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i705ee60e173d4b72997f9e6d827ceed9_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb755bfe39e64168aac8fb85840caa13_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8702613a07bc43e49e4a5a9dc8474851_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">rdnt:StockholdersEquityDeficitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i990f6dad8c174377a290cf37479ca637_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9799a383a2814cafbb89d610347f767d_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i040549d733b84e41865f935d6710183a_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0d67703fcc549f58c3bb54805e151a1_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4644861e9ece4360bab418f1b9fef51a_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">rdnt:StockholdersEquityDeficitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id349387901e24032a2736f786cf5a404_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a16c2751a89418ca779969dd77a5344_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34391a7bab5d4dc58cabd25c59a6d33e_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if4d28a9eeb2a4c71935db70483100dcc_D20200601-20200601"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-01</xbrli:startDate><xbrli:endDate>2020-06-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ef5f4569a454da5b5b38254fa362064_I20200601"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibdf5ae03b0ed462b8db002f00aaa9eb3_D20190801-20190801"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:NulogixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-01</xbrli:startDate><xbrli:endDate>2019-08-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i9c76df6e41e74111ace2b21a4181efad_I20190801"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:NulogixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03857062bad24956a20685e95d06b5f4_I20180412"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-04-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id84f65c6811e410281f7a3f3cee987b2_I20190301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:VenturaCountyImagingGroupLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09d00c2072a64166aae3435ab4296e8b_D20190227-20190227"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableInterestEntitiesByClassificationOfEntityAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HudsonValleyRadiologyAssociatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-02-27</xbrli:startDate><xbrli:endDate>2019-02-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iada1780824384c7aa307e03c01df38f3_I20190227"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableInterestEntitiesByClassificationOfEntityAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HudsonValleyRadiologyAssociatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-02-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="center"><xbrli:measure>rdnt:Center</xbrli:measure></xbrli:unit><xbrli:context id="ic0ea34f7e0b34c6cb8b791288d9c8ac5_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:BeverlyRadiologyMedicalGroupIIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a57a87a6da342959e454a8c3d0ad301_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:BeverlyRadiologyMedicalGroupIIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">rdnt:BoardMemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47fc5bf332c0415ca58f64dd07a99d47_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a3dff9af20d4d0898edd8b68ba20037_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie01b35e6814e4aa2a06cc5668ed2166b_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:ScriptSenderLlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24364a0cec3f4ac4a7f4537560711888_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CommercialInsurance1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if8be3197ba81441aab9f7bdfa36dd45b_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CommercialInsurance1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic05adfe570c7418c8583caa2e3756087_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CommercialInsurance1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if079f62201f649a19398e263e6bb723c_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CommercialInsurance1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic506a388c6254f67851aedb7d7e51a7c_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicare1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d59877f74b84a14b84be572617b45e4_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicare1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa7ae55f8352482ab21ec0d1d7641820_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicare1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82a5ccc725d2482e9b6e4b8be5a837c2_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicare1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id2804457ff9c4979ab5dea362493dfa8_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicaid1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibbd32a5208b04ee3af351b7e413a9606_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicaid1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb0bcbdd5fb649f5a3eba1e57ea2bbdb_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicaid1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i510758bcd5d0485a8ea0f178b65d230b_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicaid1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1ccd693101546e9948d833ef3206f25_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:WorkersCompensationPersonalInjury1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6fc9ace2676a462f9ebb5cde7964d542_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:WorkersCompensationPersonalInjury1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia51cd72af487490cb9a1c49464f21473_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:WorkersCompensationPersonalInjury1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f5a0223f69441b2ac8a10d4c658efa4_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:WorkersCompensationPersonalInjury1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i959dcd70aa414905a86891687e922d26_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCarePatientServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36a7f7a656c54a7a93f09e843a05e4dc_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCarePatientServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f798c18497b4449804b907ac22474ac_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCarePatientServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d5a8b020d4846f2be96b5b9d725d28a_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCarePatientServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2de4a1d7e34f4c979e8ee54471682d8a_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCareManagementServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i467bef824abe4dc791d4fb7875ad8839_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCareManagementServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0daed54cf994635a1e3a709aa285693_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCareManagementServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id54012c7cfa84d7182be4c74e1c06f71_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCareManagementServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35e7f0afe7a540a99ebbf34af2e3756a_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:TeleradiologyandSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63e61bbfa0be4d13b84f9d661bb940ba_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:TeleradiologyandSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c1f6bb93c3c4ac6aba73e2eb120728c_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:TeleradiologyandSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i521d126ad2134cb19713cd8598e5062b_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:TeleradiologyandSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d60555cdf4c455083bcb664a31aa0e9_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b1f63bb36be4d77bc8acab605869faa_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5744e3fc1fd54fb286b8e45bdced2585_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d13380e9b574e229bc4acfa7bd99b00_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1da458a1f30e42a280a85b687626d8c9_D20200401-20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f412c4a4bc94dc6bdf4cf62ede09d62_D20200501-20200531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-01</xbrli:startDate><xbrli:endDate>2020-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd0727e676b44495b92424a21cfd803d_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:PaycheckProtectionProgramLoansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03664eb4b82e43e8b82d1e6f730f020d_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie19ca44258f54d33b5e7d6546bae1a8d_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rdnt:PropertyAndEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e5c92bdeee343cfa400ee011058ca0f_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rdnt:PropertyAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9851e7fbb9b4406b9d2a6222679efb4d_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6887d928dca440bbe9351ea5442a009_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i812d1f3338f848fbb0cae71405a11682_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:OlneyOpenMRILLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b47417b06a54e549d7dc88a99fac34c_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MRIatWoodbridgeLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib71e54b77f294940bda2035bdb641b80_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AZTechMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i027fbe622cb740e796aa36dc1f00b42e_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rdnt:RestatedPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib32f550e8d5d42f69af46e7e6c5dedd0_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73cdb78ce3cb47cf9c32f71cc3b685a7_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="numberofagreement"><xbrli:measure>rdnt:numberOfAgreement</xbrli:measure></xbrli:unit><xbrli:context id="i658e0bcb8f99489086788f33b3dd88c1_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:Caps2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91802bf2d66e48f8b03dbae52a216767_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditDerivativesByContractTypeAxis">rdnt:September2020CapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:Caps2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc736fa25bf945e0a7f00b0f62403cd4_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditDerivativesByContractTypeAxis">rdnt:October2020CapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:Caps2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4052e92e79fc4969969e1b1a1bdef340_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">rdnt:Caps2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a7deb3c96cc42bcaa935bd270ffd41b_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ae781a9e9de432895fcc55db7b0b610_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e0459768a414e26a0829c4867e4d0d0_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f380d5dd68c48e19e7b1642f1ddc90a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i042c5a0cd0164e16bee1a9405ebde456_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b5787978e97447bb1142eeeaa5ad186_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib707578bfbd243ac8417cc2b7cbfd5e7_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5dc9976fcf3a4031bb4bd9fd7345be68_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditDerivativesByContractTypeAxis">rdnt:October2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91b5b54bcf7a4da796a36d934ff39258_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditDerivativesByContractTypeAxis">rdnt:October2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia060340684bb4943a12a873d70c71339_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62e737b9da50433792d2421c47ccf0cc_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifcd8f19b217b413699a01d86bc9952fd_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPS1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3910f866882c4e5bb053c720b008b7b3_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPS1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77a7a48de64144dbbdb67e5d5e1fd55d_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57991304d22244b4afe63c7cf8852d25_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0cef0dd9679a4974b78ae9d5a40855d5_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59e1973e89c2415998dcf8ff7e0ecc39_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3da5fe50e89470eab1ee1a1f974a635_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie82dec00a8604d95a2968bee33120c7b_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i431f25720da34567b5a173bf4a73fe62_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i889543454acf49acbccb8ebd9c38f86a_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia396b2b61c8e4b9abc54299a4a1c0633_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia385deaca17344c6a8f1436288ae4840_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01ce6999cc2b4bf9b84083975db56a53_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b463d8a36cc4c62adba03e5d8291e67_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c840428ea464162be7bc72c9f034b71_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c5e95d255df47498c382ead963f4c96_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0824895d6334dfe9da358f2324b7091_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f6dd49d77474e6fb6ccf417ecec63d2_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48d3b990dba24f0cb0d02544b0cf7fa6_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4387d0038f9941debbb302baf4924da2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5fd69436b804acfb68af2e47702c383_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59307cb2dd2b47f9a6120f81576277c0_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i00f4787a196b415f81d3165cb90e703b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67bcd77704ee456ab79b13a06de53338_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa429bfca5a2467c87c67ff821d458bd_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e9fd1b586d44e85871ade2eab7bb3ed_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ided14c36476d4cab94bd8241ae0fc540_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3feb945275b44b0fb63b73ab2bc8752d_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89984b2070bb46b08c4541ec8ad418d4_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4a7827c18a1422ea8ef8558bf7be6c6_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3612bace1a1a42f99fbd311811c270f5_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i032df92579e74d6c8afec1017d9cb9c5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e87b2da11c74056a77487fc8c5830e4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a05e3ae8a634224aa7d2a7d85315360_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66da6813d35d464786a99b7d5141ed64_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i505d1abebd8447a787b012d89a5eacb7_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1abfe8394b234eb5bbad4195a9ec0e60_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0cbd1734b449470db208d75670176435_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i601cf4edf4274dc1b781ef5ce684831c_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id452ca96882e4a38a4bc8cd85bf9878b_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0b2de2326bf4699aba943152bce409a_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ace966e50834326892e2ead3a754d4f_I20170324"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:MedicVisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-03-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i918ce2e8fa4a4e8e9a15abd08285dd07_D20170324-20170324"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:MedicVisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-03-24</xbrli:startDate><xbrli:endDate>2017-03-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5e9eca7800545f5913ba28234bb8765_D20180301-20180301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:MedicVisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-03-01</xbrli:startDate><xbrli:endDate>2018-03-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a31e32cd3854ea7a79489c93300ee4d_I20180301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:MedicVisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-03-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaad66b5ea72843f5b39b9301e19778be_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:MedicVisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i936ffb40dcb9477e990698614800d7df_D20180201-20180201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:TurnerImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-02-01</xbrli:startDate><xbrli:endDate>2018-02-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4d616de0e5248008f9d7307398420b2_I20190101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:TurnerImagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f1bfde7a34b4cdcbac1a70f78d72a80_I20191011"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:TurnerImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-10-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8efe47b9b214f68a5239a62a1642eb8_D20191105-20191105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:WhiteRabbit.aiInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-05</xbrli:startDate><xbrli:endDate>2019-11-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic70d35efa82941bba6027c1e3fda60f0_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:WhiteRabbit.aiInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="joint_venture"><xbrli:measure>rdnt:joint_venture</xbrli:measure></xbrli:unit><xbrli:context id="icab535e9b02f4e88a0372c47d217e396_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:GlendaleAdvancedImagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">rdnt:JointVentureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:DignityHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id982434e749e47d18d3f11f2943eee32_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:GlendaleAdvancedImagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">rdnt:JointVentureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:DignityHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01a109385ece4d30a97550263c32b101_D20200801-20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:SantaMonicaImagingGroupLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a8c4e00f17d4b9db8412be7b503be4e_I20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:SantaMonicaImagingGroupLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i162b6e4a9b024569bbd2a742fbb7e2df_D20200831-20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:AssetAcquisitionAxis">rdnt:AZTechMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-31</xbrli:startDate><xbrli:endDate>2020-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88ab08c169fd45579b828ee84aa3fbe2_I20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:AssetAcquisitionAxis">rdnt:AZTechMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91654ea5e0e647c0ba9d259407ee064a_D20200601-20200601"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-01</xbrli:startDate><xbrli:endDate>2020-06-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8973a0068cd845ef97762ff48f7c1a82_I20200601"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if82d035b351345f5a975f117243ce1cd_D20200302-20200302"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:AssetAcquisitionAxis">rdnt:MRIatWoodbridgeLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-02</xbrli:startDate><xbrli:endDate>2020-03-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc8791aabe8a4ca798528207f763624d_I20200302"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:AssetAcquisitionAxis">rdnt:MRIatWoodbridgeLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5716180cf92431199e9568b6e00f780_D20200102-20200102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:AssetAcquisitionAxis">rdnt:OlneyOpenMRILLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-02</xbrli:startDate><xbrli:endDate>2020-01-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6cbda2807f6f4c2388609f72bced8aa2_I20200102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:AssetAcquisitionAxis">rdnt:OlneyOpenMRILLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-01-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e52cfe398fa4efabaa39a7aee14b01c_D20200601-20200601"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">rdnt:ImagingOnCallMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-01</xbrli:startDate><xbrli:endDate>2020-06-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2afc665ece974620b3ccc8ebbf0e35c7_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2fe2d4283d9e45e4ad2946e8fa2b5dad_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71fd7722d0aa4607b2773ebefd280d93_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if476d02b586946bfaa11a0d8851b0dc2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21f621247677495cadc7f88b6433f851_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:PaycheckProtectionProgramLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5ca3ff1c3f84af0b0834ea2b962f872_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:PaycheckProtectionProgramLoansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic35d04f7e5d145f491a377cf89ff8da0_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9a34455b88e496f99f11135df67cea7_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a84159a6d674db38efa7bbccb1be3e3_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:FirstLienTermLoansAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b01a556be2b4c8ab3308ab426b040ab_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementEighthAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf61ff95dda14ecdb11e6615b7e7633a_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42e0febe792a4db09dfe882d336f96bd_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iafc255d1386a4de3bf178436d2562022_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:SunTrustMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9d01a93b2904f61b4796d8a81410b9e_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:SunTrustMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i843b248c0d484e4c80e2fdd2f502195c_D20160701-20160701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-07-01</xbrli:startDate><xbrli:endDate>2016-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b15ecede84f41abb4d034630198d257_D20160701-20160701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-07-01</xbrli:startDate><xbrli:endDate>2016-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9aab2f0d56d34189a074316bda4c4b67_D20160701-20160701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-07-01</xbrli:startDate><xbrli:endDate>2016-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic02a9a741f3842eea3e3a5a7eb322904_D20160701-20160701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-07-01</xbrli:startDate><xbrli:endDate>2016-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b849e478e084b868c575f20c8653b78_D20160701-20160701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-07-01</xbrli:startDate><xbrli:endDate>2016-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8684bb7afe064ac9983fbd954121786d_D20160701-20160701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-07-01</xbrli:startDate><xbrli:endDate>2016-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1a02d97b28646ba996e0c7e95b82bdd_D20160701-20160701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-07-01</xbrli:startDate><xbrli:endDate>2016-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i437bbb2e361f476fa45f34fff448bb87_D20160701-20160701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-07-01</xbrli:startDate><xbrli:endDate>2016-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82c3ce35d9e9413e9de0e1feba63291d_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6eb5d73b46ce44f6be703ba3df195553_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icbbf618e1bfe4a609b2387b2599710eb_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36ad65e4b32d4d83a34c87cef93670a7_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88ef47c29fec45228c446b6058e13c36_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5c31aa95d9342c4ba31e43e8ecb8e1f_I20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb9718af7bcb4577b02afe00cd03dadd_D20180831-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-31</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i640e0341ae9546acb37a3b43ce1eba05_D20180831-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-31</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c9e317de1694916936baac47457baad_D20180831-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-31</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ffaf7ff24bc4ca493fd2b08c7ff3a25_I20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f5089184ad64416acfb6e9f45e20056_D20180831-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-31</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e66507e91084592ad6ec96e2082905e_D20180831-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-31</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2a7f7080321422c81221d552960c25c_D20180831-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-31</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26e31c72794a4556a79b247236f494e6_I20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f63a8341b184981a270daf0995422d2_D20180831-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-31</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a2cdf61ca404c6b9eaecf77fe17e670_D20180831-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-31</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i213ea2bff4394c6288e6955b70cfbd38_D20180831-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-31</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b253bd7f2ce411085bd510025d25d34_I20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d4647b913524ddf926d5badbccce1c9_D20180831-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-31</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e02d8d2117c46f3b37af31ddd457d1b_D20180831-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-31</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a4736e633334391ba86255660511b78_D20180831-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-31</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id619046e0cd648adbb423bb179acab8e_I20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae42d0b5f76b4c879b3f0f43f04b1aed_D20180831-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-31</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7de0702b16e423a8f2781f8ef6aa693_D20180831-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-31</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9129b65b01747c292ade5e736c79ab6_D20180831-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-31</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a832ef6cbe04ce4bb0e0da41889582d_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if922a8b092874f639caee5acc1fd1a61_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:SunTrustMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id655214ccff949e495e113e479f89eba_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:SunTrustMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5fdeeaa617f45bc8b5b2de98d538da7_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34109ecc091e412a9dbd8651e8bb4f2e_I20170822"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-08-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i978f7eac6654400d951615a49c92ee12_I20190418"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-04-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8cca9d99b9324bd1b781038f68dc4e2f_I20190418"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:FirstLienCreditAgreementSeventhAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-04-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5b7a6ac8167458194c44af4ba48c5bd_D20190418-20190418"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:FirstLienCreditAgreementSeventhAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-18</xbrli:startDate><xbrli:endDate>2019-04-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i965d7b0c650248aeb676ce27ef4835ab_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:PaycheckProtectionProgramLoansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="loan"><xbrli:measure>rdnt:loan</xbrli:measure></xbrli:unit><xbrli:context id="ib55973caf29b407cacf26e47cab62a42_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rdnt:RestatedPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if47fff6cbf3149a0a1f38edce2abc129_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rdnt:RestatedPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d158c180c134e64a61a649a0dff7314_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaab629f0885047bfac5042b54e4cf7b0_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b5d964821bf467daf58020889b187c2_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i656e4333bc494b37a20f965c8618f1d0_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb572eb0a62c470bb17e387648d4f17f_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic88e676c8ae54e949cbc0e057a2855a7_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e4ebdf884e14af1b77318c2bc533fa7_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icff8e20d84f241cd8104a1116305268a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8741d0f710974ec5a70b0b546a43e7fb_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iced7ee1846d8433483d7f50dbea0a847_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icfc15acb74684a52b57e605b24afd3db_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24073316903a4b80852ce62f50a13e5f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id598685e49ce4cde89846d1481b70e13_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic62bac0609a645d1a910b8ba6cb946fb_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:FutureServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8bcd128fbffd44eca246f153070892ca_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rdnt:RestatedPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic97e88dc3d0b400f82757dbc8ca7b075_I20201101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentsInAndAdvancesToAffiliatesCategorizationAxis">us-gaap:InvestmentsInMajorityOwnedSubsidiariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f2ef1f8cedb41f48a20163cf23ac25f_I20201101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:SimiValleyHospitalAndHealthServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentsInAndAdvancesToAffiliatesCategorizationAxis">us-gaap:InvestmentsInMajorityOwnedSubsidiariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-01</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="iffc0b59705bf4cff936f619293b1a306_1"></div><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington D.C. 20549</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xL2ZyYWc6NDU4OTU2OGJlZDFkNDIxZTkwYmQ2ZTRmYzZmYmFjZjgvdGV4dHJlZ2lvbjo0NTg5NTY4YmVkMWQ0MjFlOTBiZDZlNGZjNmZiYWNmOF8yMTc2_7da13e44-9ead-41f6-be52-6d2adabc89ee">10-Q</ix:nonNumeric> </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Mark One)</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" format="ixt-sec:boolballotbox" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xL2ZyYWc6NDU4OTU2OGJlZDFkNDIxZTkwYmQ2ZTRmYzZmYmFjZjgvdGV4dHJlZ2lvbjo0NTg5NTY4YmVkMWQ0MjFlOTBiZDZlNGZjNmZiYWNmOF8yMTgx_f01004cf-7118-4bcd-aeff-3f31fce2aea2">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xL2ZyYWc6NDU4OTU2OGJlZDFkNDIxZTkwYmQ2ZTRmYzZmYmFjZjgvdGV4dHJlZ2lvbjo0NTg5NTY4YmVkMWQ0MjFlOTBiZDZlNGZjNmZiYWNmOF8yMjM_13177161-1f90-491c-89db-2a4ed0d417b8">September 30, 2020</ix:nonNumeric> </span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">OR</span></div><div style="margin-bottom:10pt;margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xL2ZyYWc6NDU4OTU2OGJlZDFkNDIxZTkwYmQ2ZTRmYzZmYmFjZjgvdGV4dHJlZ2lvbjo0NTg5NTY4YmVkMWQ0MjFlOTBiZDZlNGZjNmZiYWNmOF8yMTgy_d2236016-db19-420f-a455-f92551ff2595">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-bottom:10pt;margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the transition period from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number <ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xL2ZyYWc6NDU4OTU2OGJlZDFkNDIxZTkwYmQ2ZTRmYzZmYmFjZjgvdGV4dHJlZ2lvbjo0NTg5NTY4YmVkMWQ0MjFlOTBiZDZlNGZjNmZiYWNmOF8yMTc3_e319d1aa-3131-4ec2-b4f6-ba6b1b0e451e">001-33307</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xL2ZyYWc6NDU4OTU2OGJlZDFkNDIxZTkwYmQ2ZTRmYzZmYmFjZjgvdGV4dHJlZ2lvbjo0NTg5NTY4YmVkMWQ0MjFlOTBiZDZlNGZjNmZiYWNmOF8yMTgz_27641702-962b-443e-943f-c23e22a05e75">RadNet, Inc.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in charter)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:87.865%"><tr><td style="width:1.0%"></td><td style="width:26.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.322%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xL2ZyYWc6NDU4OTU2OGJlZDFkNDIxZTkwYmQ2ZTRmYzZmYmFjZjgvdGFibGU6YjdhMGI4YWE3YjE5NGQyZTlmZGJjYWVkMDFjYzI4MjYvdGFibGVyYW5nZTpiN2EwYjhhYTdiMTk0ZDJlOWZkYmNhZWQwMWNjMjgyNl8wLTAtMS0xLTA_c03f8aca-8de6-4ab3-92dd-f4286c1be23d">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xL2ZyYWc6NDU4OTU2OGJlZDFkNDIxZTkwYmQ2ZTRmYzZmYmFjZjgvdGFibGU6YjdhMGI4YWE3YjE5NGQyZTlmZGJjYWVkMDFjYzI4MjYvdGFibGVyYW5nZTpiN2EwYjhhYTdiMTk0ZDJlOWZkYmNhZWQwMWNjMjgyNl8wLTItMS0xLTA_d47a68c1-36b7-4d06-a560-af0dbdd1ccdc">13-3326724</ix:nonNumeric></span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xL2ZyYWc6NDU4OTU2OGJlZDFkNDIxZTkwYmQ2ZTRmYzZmYmFjZjgvdGFibGU6YjdhMGI4YWE3YjE5NGQyZTlmZGJjYWVkMDFjYzI4MjYvdGFibGVyYW5nZTpiN2EwYjhhYTdiMTk0ZDJlOWZkYmNhZWQwMWNjMjgyNl8zLTAtMS0xLTA_f89828d5-44bf-49bb-b87e-aea228ef7c04">1510 Cotner Avenue</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xL2ZyYWc6NDU4OTU2OGJlZDFkNDIxZTkwYmQ2ZTRmYzZmYmFjZjgvdGFibGU6YjdhMGI4YWE3YjE5NGQyZTlmZGJjYWVkMDFjYzI4MjYvdGFibGVyYW5nZTpiN2EwYjhhYTdiMTk0ZDJlOWZkYmNhZWQwMWNjMjgyNl80LTAtMS0xLTA_c95c52eb-f312-4a15-a238-ec38804990e2">Los Angeles,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xL2ZyYWc6NDU4OTU2OGJlZDFkNDIxZTkwYmQ2ZTRmYzZmYmFjZjgvdGFibGU6YjdhMGI4YWE3YjE5NGQyZTlmZGJjYWVkMDFjYzI4MjYvdGFibGVyYW5nZTpiN2EwYjhhYTdiMTk0ZDJlOWZkYmNhZWQwMWNjMjgyNl80LTEtMS0xLTA_3f0cc4c8-bbb8-4159-8f1b-1da1972d2db8">California</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xL2ZyYWc6NDU4OTU2OGJlZDFkNDIxZTkwYmQ2ZTRmYzZmYmFjZjgvdGFibGU6YjdhMGI4YWE3YjE5NGQyZTlmZGJjYWVkMDFjYzI4MjYvdGFibGVyYW5nZTpiN2EwYjhhYTdiMTk0ZDJlOWZkYmNhZWQwMWNjMjgyNl80LTItMS0xLTA_165051f6-5ac8-4370-877d-2ba2badafca9">90025</ix:nonNumeric></span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xL2ZyYWc6NDU4OTU2OGJlZDFkNDIxZTkwYmQ2ZTRmYzZmYmFjZjgvdGV4dHJlZ2lvbjo0NTg5NTY4YmVkMWQ0MjFlOTBiZDZlNGZjNmZiYWNmOF8yMTg0_ad299a2d-7736-462c-bb84-bbc187585d13">310</ix:nonNumeric>) <ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xL2ZyYWc6NDU4OTU2OGJlZDFkNDIxZTkwYmQ2ZTRmYzZmYmFjZjgvdGV4dHJlZ2lvbjo0NTg5NTY4YmVkMWQ0MjFlOTBiZDZlNGZjNmZiYWNmOF8yMTc4_0be551ff-2ded-4ecf-9b47-621af6c8bbce">478-7808</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-bottom:10pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities and Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. <ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xL2ZyYWc6NDU4OTU2OGJlZDFkNDIxZTkwYmQ2ZTRmYzZmYmFjZjgvdGV4dHJlZ2lvbjo0NTg5NTY4YmVkMWQ0MjFlOTBiZDZlNGZjNmZiYWNmOF8yMTg1_7b0c4840-3ea2-4556-86a6-7f3672f49599">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:10pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).&#160;<ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xL2ZyYWc6NDU4OTU2OGJlZDFkNDIxZTkwYmQ2ZTRmYzZmYmFjZjgvdGV4dHJlZ2lvbjo0NTg5NTY4YmVkMWQ0MjFlOTBiZDZlNGZjNmZiYWNmOF8yMTc5_c455263e-04af-452b-bc33-8ae10d411e0b">Yes</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer&#8221;, &#8220;smaller reporting company&#8221;, and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act. (Check one)</span></div><div style="margin-bottom:15pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.256%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.159%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Large accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xL2ZyYWc6NDU4OTU2OGJlZDFkNDIxZTkwYmQ2ZTRmYzZmYmFjZjgvdGFibGU6ODliOWY1ZDlkZjAxNGJmYzljYjkyZTAyZDg2MTlhMTIvdGFibGVyYW5nZTo4OWI5ZjVkOWRmMDE0YmZjOWNiOTJlMDJkODYxOWExMl8wLTItMS0xLTA_6999d642-d5f3-42e7-851d-c88066282f8c">Accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xL2ZyYWc6NDU4OTU2OGJlZDFkNDIxZTkwYmQ2ZTRmYzZmYmFjZjgvdGFibGU6ODliOWY1ZDlkZjAxNGJmYzljYjkyZTAyZDg2MTlhMTIvdGFibGVyYW5nZTo4OWI5ZjVkOWRmMDE0YmZjOWNiOTJlMDJkODYxOWExMl8xLTMtMS0xLTA_b1483c75-c593-4735-b2cb-6232b28be048">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xL2ZyYWc6NDU4OTU2OGJlZDFkNDIxZTkwYmQ2ZTRmYzZmYmFjZjgvdGFibGU6ODliOWY1ZDlkZjAxNGJmYzljYjkyZTAyZDg2MTlhMTIvdGFibGVyYW5nZTo4OWI5ZjVkOWRmMDE0YmZjOWNiOTJlMDJkODYxOWExMl8yLTEtMS0xLTA_530a3d55-fdb8-4259-862d-0912b0900633">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="margin-bottom:10pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#160;&#9744;</span></div><div style="margin-bottom:10pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act)&#160;Yes </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xL2ZyYWc6NDU4OTU2OGJlZDFkNDIxZTkwYmQ2ZTRmYzZmYmFjZjgvdGV4dHJlZ2lvbjo0NTg5NTY4YmVkMWQ0MjFlOTBiZDZlNGZjNmZiYWNmOF8yMTgw_c5b8f839-972d-4755-8499-b1acbf054609">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-bottom:15pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.162%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.405%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.162%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.405%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.166%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Class Title</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading Symbol</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Registered Exchange</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xL2ZyYWc6NDU4OTU2OGJlZDFkNDIxZTkwYmQ2ZTRmYzZmYmFjZjgvdGFibGU6NjA5ODkzNWYzMTcxNGE1NWIxYTA5ZjhmOTE2MGZiMjIvdGFibGVyYW5nZTo2MDk4OTM1ZjMxNzE0YTU1YjFhMDlmOGY5MTYwZmIyMl8xLTAtMS0xLTA_4c79e57f-1cdb-43bd-9c37-6e7eb3d16ec4">Common Stock</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xL2ZyYWc6NDU4OTU2OGJlZDFkNDIxZTkwYmQ2ZTRmYzZmYmFjZjgvdGFibGU6NjA5ODkzNWYzMTcxNGE1NWIxYTA5ZjhmOTE2MGZiMjIvdGFibGVyYW5nZTo2MDk4OTM1ZjMxNzE0YTU1YjFhMDlmOGY5MTYwZmIyMl8xLTItMS0xLTA_103aa28b-67aa-4cd1-94be-581d7857b280">RDNT</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xL2ZyYWc6NDU4OTU2OGJlZDFkNDIxZTkwYmQ2ZTRmYzZmYmFjZjgvdGFibGU6NjA5ODkzNWYzMTcxNGE1NWIxYTA5ZjhmOTE2MGZiMjIvdGFibGVyYW5nZTo2MDk4OTM1ZjMxNzE0YTU1YjFhMDlmOGY5MTYwZmIyMl8xLTQtMS0xLTA_1a0c78f5-66b9-4f14-b4ae-3de7f275347e">NASDAQ</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:10pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of shares of the registrant&#8217;s common stock outstanding on November&#160;5, 2020 was <ix:nonFraction unitRef="shares" contextRef="i60bc3d6fa03048149fc05435bef6c409_I20201105" decimals="INF" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xL2ZyYWc6NDU4OTU2OGJlZDFkNDIxZTkwYmQ2ZTRmYzZmYmFjZjgvdGV4dHJlZ2lvbjo0NTg5NTY4YmVkMWQ0MjFlOTBiZDZlNGZjNmZiYWNmOF8yMTY3_1d5709a0-986c-44c5-a40c-818d2cd48cf6">51,636,099</ix:nonFraction> shares.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="iffc0b59705bf4cff936f619293b1a306_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_25">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RADNET, INC.</span></div><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:91.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.368%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Page</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_10">PART I &#8211; FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_10">1</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_13">ITEM 1. Condensed Consolidated Financial Statements (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_13">1</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_16">Condensed Consolidated Balance Sheets at </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_16">September</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_16"> 30, 2020 and December 31, 2019</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_16">1</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_22">Condensed Consolidated Statements of Operations for the Three and </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_22">Nine</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_22"> Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_22">September</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_22"> 30, 2020 and 2019</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_22">2</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_25">Condensed Consolidated Statements of Comprehensive</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_25"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_25">Income (Loss)</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_25"> for the Three and </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_25">Nine</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_25"> Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_25">September</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_25"> 30, 2020 and 2019</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_25">3</a></span></div><div style="text-align:center"><span><br/></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_28">Condensed Consolidated Statement of Stockholders' Equity for the Three Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_28">September</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_28"> 30, 2020 and 2019</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_28">4</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_31">Condensed Consolidated Statement of Stockholders&#8217; Equity for the </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_31">Nine</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_31"> Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_31">September</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_31"> 30, 2020 and 2019</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_31">5</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_34">Condensed Consolidated Statements of Cash Flows for the </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_34">Nine</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_34"> Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_34">September</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_34"> 30, 2020 and 2019</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_34">7</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_37">Notes to Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_37">10</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_67">ITEM 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_67">27</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_91">ITEM 3. Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_91">46</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_94">ITEM 4. Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_94">46</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_97">PART II &#8211; OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_97">48</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_100">ITEM 1.&#160;&#160;Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_100">48</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_103">ITEM 1A.&#160;&#160;Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_106">48</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_106">ITEM 2.&#160;&#160;Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_109">48</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_109">ITEM 3.&#160;&#160;Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_109">48</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_112">ITEM 4.&#160;&#160;Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_112">48</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_115">ITEM 5.&#160;&#160;Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_115">48</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">ITEM 6.&#160;&#160;Exhibits</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_118">49</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_121">SIGNATURES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_121">50</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i</span></div></div></div><div id="iffc0b59705bf4cff936f619293b1a306_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_25">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I - FINANCIAL INFORMATION</span></div><div id="iffc0b59705bf4cff936f619293b1a306_13"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1 &#8211; Financial Statements</span></div><div id="iffc0b59705bf4cff936f619293b1a306_16"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RADNET, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(IN THOUSANDS EXCEPT SHARE AND PER SHARE DATA)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:74.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr style="height:18pt"><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2019</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CURRENT ASSETS</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Cash and cash equivalents</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfNC0xLTEtMS0w_5f353ba9-8514-467a-9f4d-ec4fe6e85e70">89,739</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfNC0zLTEtMS0w_ca770016-e80f-419a-b5d0-f50536d51baa">40,165</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfNS0xLTEtMS0w_24a05d98-7e44-41ca-9d26-20d95110a39b">137,411</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfNS0zLTEtMS0w_849fae01-4fc9-4788-a322-241aaaab0585">154,763</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Due from affiliates</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="-3" name="us-gaap:DueFromRelatedPartiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfNi0xLTEtMS0w_edd410bc-7851-4d3f-a8bf-58e411a726dc">424</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DueFromRelatedPartiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfNi0zLTEtMS0w_e78fbfe1-76a3-4e37-b0b7-773d3ef84246">1,242</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfNy0xLTEtMS0w_0fd86245-5f2d-45dc-9300-e119ec31b965">31,482</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfNy0zLTEtMS0w_cb2d87d9-4f38-451a-865b-8b69b675fc82">45,004</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total current assets </span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfOS0xLTEtMS0w_d288acbd-0a02-4250-a453-651751bdf10e">259,056</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfOS0zLTEtMS0w_a3b791c2-1d32-4798-aa28-c577641ebf29">241,174</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PROPERTY, EQUIPMENT AND RIGHT-OF-USE ASSETS</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Property and equipment, net</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMTEtMS0xLTEtMA_301219ff-63c8-4734-bfd9-66e7a0e91707">361,950</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMTEtMy0xLTEtMA_11dabb61-2f58-4708-bba1-31715eb9aafc">367,795</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMTItMS0xLTEtMA_c2219aa9-9b26-4133-878e-adb50f18876c">451,613</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMTItMy0xLTEtMA_70dbc591-5687-4b7a-b416-16f5ad39aa2d">445,477</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total property, equipment and right-of-use assets</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="-3" format="ixt:numdotdecimal" name="rdnt:PropertyPlantandEquipmentNetIncludingRightofUseAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMTMtMS0xLTEtMA_81e75e78-4d72-4686-a22e-398f570752cf">813,563</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231" decimals="-3" format="ixt:numdotdecimal" name="rdnt:PropertyPlantandEquipmentNetIncludingRightofUseAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMTMtMy0xLTEtMA_3db50396-74e7-455b-a59a-afee069dc35a">813,272</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OTHER ASSETS</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Goodwill</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMTUtMS0xLTEtMA_30d16c41-4c1a-4a7f-b4c2-2839f915d93c">470,685</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMTUtMy0xLTEtMA_da99798a-ce81-4c90-9b36-20783c9cf975">441,973</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Other intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMTYtMS0xLTEtMA_a0f821a7-2c65-4ccb-b00b-580293ac35ab">57,152</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMTYtMy0xLTEtMA_0c1da3ce-fad1-48d2-8289-372f34381227">42,994</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Deferred financing costs</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsNoncurrentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMTctMS0xLTEtMA_ccafbb7a-6c7d-4906-a2f7-a4eefa8d32d2">1,944</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsNoncurrentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMTctMy0xLTEtMA_cc56835b-31cd-4c76-9ebd-9a448c228644">1,559</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Investment in joint ventures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMTgtMS0xLTEtMA_34fb13bd-ced8-40af-891d-050f7e346332">35,571</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMTgtMy0xLTEtMA_803c5ef4-fcde-41bf-9be0-f36edaf671d7">34,470</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Deferred tax assets, net of current portion</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMTktMS0xLTEtMA_ee3f49f7-3336-4266-83b9-4e1576de1aeb">42,188</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMTktMy0xLTEtMA_00c5c341-2620-4bed-9e85-5243cc8a286e">34,548</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Deposits and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepositsAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMjAtMS0xLTEtMA_0c67edc3-30e1-4978-bc2c-20b1f366d60b">37,707</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepositsAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMjAtMy0xLTEtMA_dc2d846a-5741-48d8-80fa-9ca354f87a21">36,996</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total assets</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMjEtMS0xLTEtMA_2d5dd518-129c-4b7e-a057-a3a52dfc3a50">1,717,866</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMjEtMy0xLTEtMA_3bfa8545-e735-49dc-9bf7-ed13d9ea414b">1,646,986</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES AND EQUITY</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CURRENT LIABILITIES</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Accounts payable, accrued expenses and other</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMjQtMS0xLTEtMA_82b6fec2-7c33-4774-a5d8-2ca55fc7b550">205,701</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMjQtMy0xLTEtMA_8ffd0560-e4c3-4431-8df2-323ff4587e16">207,585</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Due to affiliates</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DueToAffiliateCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMjUtMS0xLTEtMA_490e2b01-5bd0-47b4-816c-b599733b42a1">12,287</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DueToAffiliateCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMjUtMy0xLTEtMA_9f376949-5622-4111-8b0c-05b9f2dcbd9f">14,347</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMjYtMS0xLTEtMA_b8a6e4ae-299a-4216-b4a9-6efa4db0d35f">45,846</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMjYtMy0xLTEtMA_ec692343-c9e8-4ea7-9662-9a2d5cb4de18">1,316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Current finance lease liability</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMjctMS0xLTEtMA_b05546b3-f15f-4aaf-a282-2671aeec584f">3,041</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMjctMy0xLTEtMA_8eea5c4c-095f-4099-b42c-4d7354d7dfcf">3,283</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Current operating lease liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMjgtMS0xLTEtMA_4cbf253b-ab11-4f69-8a6c-cb215a7ca813">67,449</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMjgtMy0xLTEtMA_1a99202f-25ba-4659-92be-aabda04d249b">61,206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Current portion of notes payable</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NotesPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMjktMS0xLTEtMA_9b366fab-b732-407b-819b-2440c0143bf0">39,463</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NotesPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMjktMy0xLTEtMA_5a6c51fe-0a76-43f8-87bf-0b0f200cdfc6">39,691</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMzAtMS0xLTEtMA_ab121f88-311c-42f3-b16a-173a046cc998">373,787</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMzAtMy0xLTEtMA_69fbe095-190b-45a2-9271-810697319a8a">327,428</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LONG-TERM LIABILITIES</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Long-term finance lease liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMzItMS0xLTEtMA_ac7ace82-d27d-4c44-be3b-acb2720244d4">1,108</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMzItMy0xLTEtMA_332a9f0e-f7d8-4918-9075-2d13414ab982">3,264</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Long-term operating lease liability</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMzMtMS0xLTEtMA_379b6616-5b09-4068-a6ca-10ed480d9d37">428,233</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMzMtMy0xLTEtMA_4387cfc0-71e2-41eb-824c-5b0c7411cca4">420,922</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Notes payable, net of current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermNotesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMzQtMS0xLTEtMA_627ada95-050b-4c0c-8a73-6a1a427de53e">627,179</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermNotesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMzQtMy0xLTEtMA_940f869b-0ec3-43fd-83ff-e2c7f2d08675">652,704</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Other non-current liabilities</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMzUtMS0xLTEtMA_2eff0916-1ed0-4baa-995a-5fde15949ffa">41,438</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMzUtMy0xLTEtMA_47b0b307-9a47-4076-8aa6-081e36d6a1f9">9,529</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMzYtMS0xLTEtMA_72e7a110-1cb7-41ec-8991-a2e051e4c622">1,471,745</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMzYtMy0xLTEtMA_45bfd864-aa9c-4879-b1d8-ac8851b2e381">1,413,847</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EQUITY</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock - $<ix:nonFraction unitRef="usdPerShare" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjgzNmUxZTI5ZTlmNDRiMDg5ZjdlNmU2NzM5ZTUzMDc0XzE2NDkyNjc0NDE4NTE_1cf549c9-b986-45ec-89b0-779e266bccc2"><ix:nonFraction unitRef="usdPerShare" contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjgzNmUxZTI5ZTlmNDRiMDg5ZjdlNmU2NzM5ZTUzMDc0XzE2NDkyNjc0NDE4NTE_d7b11d97-9e19-4101-b3f5-93b69f46513f">0.0001</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjgzNmUxZTI5ZTlmNDRiMDg5ZjdlNmU2NzM5ZTUzMDc0XzE2NDkyNjc0NDE4NjU_a0fd9169-e8a5-4a58-b663-d50e155f35ae"><ix:nonFraction unitRef="shares" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjgzNmUxZTI5ZTlmNDRiMDg5ZjdlNmU2NzM5ZTUzMDc0XzE2NDkyNjc0NDE4NjU_a16e6018-41d2-4a55-b8c2-1926dc9adc51">200,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjgzNmUxZTI5ZTlmNDRiMDg5ZjdlNmU2NzM5ZTUzMDc0XzE2NDkyNjc0NDE4Nzg_f1ce8da0-ee7a-417c-ae21-c98e6522a249"><ix:nonFraction unitRef="shares" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjgzNmUxZTI5ZTlmNDRiMDg5ZjdlNmU2NzM5ZTUzMDc0XzE2NDkyNjc0NDE4Nzg_f6167a0a-93aa-44fc-80f5-6fa143ba9e45">51,596,098</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjgzNmUxZTI5ZTlmNDRiMDg5ZjdlNmU2NzM5ZTUzMDc0XzE2NDkyNjc0NDE4OTE_5bd94392-321a-4fb8-8c73-71a913882030"><ix:nonFraction unitRef="shares" contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjgzNmUxZTI5ZTlmNDRiMDg5ZjdlNmU2NzM5ZTUzMDc0XzE2NDkyNjc0NDE4OTE_d9d0399c-d436-4e4a-abea-10fbfada97e5">50,314,328</ix:nonFraction></ix:nonFraction> shares issued and outstanding at September 30, 2020 and December 31, 2019, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMzgtMS0xLTEtMA_a87cebd9-842a-45a3-b9bf-0f0b5d7b4555">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMzgtMy0xLTEtMA_10310590-4ef0-4e51-98d2-5615c8238e53">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Additional paid-in-capital</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMzktMS0xLTEtMA_50e1214d-ca20-49b1-b3b4-bb24fb0a8d1a">306,079</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMzktMy0xLTEtMA_97dd333e-7149-471e-8db3-d36ecb0a776e">262,865</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfNDAtMS0xLTEtMA_d239722e-b850-4c38-a0c4-8732283ba591">24,923</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfNDAtMy0xLTEtMA_a52298ab-4ada-400f-99da-8f60dc4655c0">8,026</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Accumulated deficit</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfNDEtMS0xLTEtMA_d3e606ff-5b66-4e14-b75f-1759e12e7edd">123,956</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfNDEtMy0xLTEtMA_7de832d0-805e-4d02-b399-ba620708b865">103,159</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total RadNet, Inc.'s stockholders' equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfNDItMS0xLTEtMA_de0a55ee-143e-4486-9623-d9cb70bd945a">157,205</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfNDItMy0xLTEtMA_69602399-05df-4059-b5b9-b9876f98e75c">151,685</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MinorityInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfNDMtMS0xLTEtMA_fa0a360e-15d9-4011-a34c-ef4ab58e75f8">88,916</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MinorityInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfNDMtMy0xLTEtMA_e4dff2e5-c371-4592-b7a1-2163ebe40716">81,454</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfNDQtMS0xLTEtMA_57cc05f3-b212-4f1c-ba5b-5ea05fa6f0b4">246,121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfNDQtMy0xLTEtMA_91851a4d-44fd-4d29-b249-3d3f4536b09f">233,139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total liabilities and equity</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfNDUtMS0xLTEtMA_c12045e4-db0a-4e33-8610-59782eef2117">1,717,866</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfNDUtMy0xLTEtMA_b5070292-36e5-489c-ae33-860a27807e1e">1,646,986</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these financial statements.</span></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_25">Table of Contents</a></span></div></div><div style="text-align:center"><span><br/></span></div><div id="iffc0b59705bf4cff936f619293b1a306_22"></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RADNET, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(IN THOUSANDS EXCEPT SHARE AND PER SHARE DATA)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:49.779%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.632%"></td><td style="width:0.1%"></td></tr><tr style="height:21pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">REVENUE</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Service fee revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a9fe0209e954a06aca8cad30d601c73_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMy0xLTEtMS0w_bf7c07a4-ea88-4e61-adf2-a35dc43f2b12">256,730</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0096f14793b40c99c3a08b6a4ac8010_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMy0zLTEtMS0w_6b3b181f-379f-4d50-b43d-4de3e1000707">261,908</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe98f272e55f41dd878edf32fc7653a3_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMy01LTEtMS0w_3c971745-2afe-457c-b74a-f38450e2f7ab">660,760</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ee478ac62b2402380d60e1df30d2970_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMy03LTEtMS0w_3fa174eb-b945-4301-8fbf-c22044cea28f">762,751</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Revenue under capitation arrangements</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i058de6765e1e47449153067fb1e94bc6_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfNC0xLTEtMS0w_dfa3ff63-2d21-40be-9ae6-5dffa017ce3c">35,046</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia03c585e05f349bd894ed447f40ca3fc_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfNC0zLTEtMS0w_005451df-c13b-44da-8577-4c24dd46fc06">30,784</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4b7517ca2542439322f6bb062453a3_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfNC01LTEtMS0w_42ec0ae6-cb2e-4037-891a-73067a333fb1">103,145</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i202db1f71dbd487f9b8bf67552d7ead3_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfNC03LTEtMS0w_0af072d2-bf4a-48b5-ad87-6ecb7706ce81">90,587</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 47.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total service revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfNS0xLTEtMS0w_e613f6ae-321f-43ab-969e-1a75edc8aa9f">291,776</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfNS0zLTEtMS0w_5ad7a3be-7a76-42aa-9d3b-ab64423a2533">292,692</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfNS01LTEtMS0w_ac3800f8-0651-4f57-a3fc-14c7162bcbe4">763,905</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfNS03LTEtMS0w_e00a046e-2cde-4666-bb5b-27d445f7a02c">853,338</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Provider relief funding</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930" decimals="-3" name="us-gaap:RevenueNotFromContractWithCustomer" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfNi0xLTEtMS0w_8fa5796e-0ad9-4c80-8dac-9fa817cdf381">221</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueNotFromContractWithCustomer" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfNi0zLTEtMS0w_8d539efe-46a4-43ad-b08f-f5aef1e2e828">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueNotFromContractWithCustomer" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfNi01LTEtMS0w_8589f83e-b5d6-4ade-9db5-42a25e1fd899">25,696</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueNotFromContractWithCustomer" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfNi03LTEtMS0w_de286ba6-2464-4c38-8ad8-f29bcb7954d2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OPERATING EXPENSES</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Cost of operations, excluding depreciation and amortization</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingCostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfOC0xLTEtMS0w_8b79b9d0-639c-49ca-8fbf-8e6bca787e0e">246,462</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingCostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfOC0zLTEtMS0w_0416bc00-e27b-4563-b131-e17903403878">254,383</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingCostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfOC01LTEtMS0w_288f5480-df2d-4555-b3e7-20392e33a4c0">708,095</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingCostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfOC03LTEtMS0w_62d263d5-a1de-4bf8-82af-800961e2fd10">743,997</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfOS0xLTEtMS0w_816665b0-fe25-4c58-973b-7830c8262965">21,247</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfOS0zLTEtMS0w_90d7f1b0-30f6-4b5a-8cad-972f3340758b">20,490</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfOS01LTEtMS0w_3ec21319-1072-4263-9357-3298bfb4bf1c">64,536</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfOS03LTEtMS0w_2556e07d-6691-452b-aab4-e840b8527034">60,193</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Loss on sale and disposal of equipment and other</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:GainLossOnDispositionOfAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTAtMS0xLTEtMA_6319ee86-6c10-4105-ab16-9a93eaba4715">342</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930" decimals="-3" sign="-" name="us-gaap:GainLossOnDispositionOfAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTAtMy0xLTEtMA_d37c67d8-b147-4ac6-9b80-6ff54b5d814a">917</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:GainLossOnDispositionOfAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTAtNS0xLTEtMA_271bf9b2-b88d-4b11-885c-8377878c1852">543</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossOnDispositionOfAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTAtNy0xLTEtMA_30e525f3-67b4-462c-93b0-f6cab5276daf">1,990</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Severance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930" decimals="-3" name="us-gaap:SeveranceCosts1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTEtMS0xLTEtMA_d516c725-ea83-4258-be78-39ec2c9e4667">571</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930" decimals="-3" name="us-gaap:SeveranceCosts1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTEtMy0xLTEtMA_9ee31284-65b3-4dfc-b832-90effa54477b">52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SeveranceCosts1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTEtNS0xLTEtMA_59287cc2-f6f9-49a8-a439-49024ee73fd3">1,647</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SeveranceCosts1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTEtNy0xLTEtMA_fcdb29c0-efe3-4ef5-ba74-e4b20dd98b29">1,054</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 47.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTItMS0xLTEtMA_a04da6d6-300f-46ce-b572-2a0c36adff1e">268,622</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTItMy0xLTEtMA_974b8585-9c9a-4652-be1a-86ac9b84afae">275,842</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTItNS0xLTEtMA_661c27a7-aa60-47c7-8201-78db7f11b7d6">774,821</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTItNy0xLTEtMA_17f02b40-ac82-4b62-a2e4-7956358c2e60">807,234</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">INCOME FROM OPERATIONS</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTMtMS0xLTEtMA_a57c9582-b0e9-462f-9bc9-79b2c26fa153">23,375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTMtMy0xLTEtMA_7de55257-35f7-4a5e-90af-af1ad4311b67">16,850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTMtNS0xLTEtMA_125dc9bc-7228-45be-922f-dafb725be285">14,780</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTMtNy0xLTEtMA_0346588e-a6ab-44b7-a798-d67c4e9573a7">46,104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OTHER INCOME AND EXPENSES</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Interest expense</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTYtMS0xLTEtMA_1e238834-e3df-4eb3-a36a-e2ef950a6df9">11,061</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTYtMy0xLTEtMA_a3bfd9ef-26ae-47e1-93ac-1fd6202b63e6">11,895</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTYtNS0xLTEtMA_13ed0a78-e993-4d71-ac9e-c3a7f11270f0">33,443</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTYtNy0xLTEtMA_715d5131-1984-4764-b93c-01c9a5d17a5d">36,589</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Equity in earnings of joint ventures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTctMS0xLTEtMA_2257e000-2c46-41dd-aaf9-96df105a7414">2,276</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTctMy0xLTEtMA_8e810eba-8154-4a73-a506-28310e9bee50">1,955</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTctNS0xLTEtMA_151f10d1-7751-4396-b21c-0bb91028ffab">5,176</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTctNy0xLTEtMA_97ad5160-c775-4c6a-8b84-8389ab0566b9">6,072</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Non-cash change in fair value of interest rate hedge</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTgtMS0xLTEtMA_707b291d-9c1a-4e43-894a-f89546d6d142">679</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTgtMy0xLTEtMA_8786e49e-8676-47b2-8bfd-6d7ce2bc6468">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTgtNS0xLTEtMA_b2bab0a0-0e3c-47cf-a3b6-0b9af138480b">4,523</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTgtNy0xLTEtMA_123b3c8d-530d-4b82-83de-539f0564243c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Other (income) expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTktMS0xLTEtMA_18c9bbac-4e7f-4b9e-b05b-b5596f102841">139</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTktMy0xLTEtMA_7ddebe63-0d71-43ec-af4a-f454a5e2b7a2">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTktNS0xLTEtMA_455b8503-9e17-41c6-8016-e9c03fac582b">247</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTktNy0xLTEtMA_1947c2df-e2a4-426c-80fd-8102298d8532">1,271</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 42.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other expenses</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjAtMS0xLTEtMA_7a3eba80-a35c-4a31-9198-916bc636d24f">9,325</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjAtMy0xLTEtMA_757cb3e9-3f63-4e5b-bcc7-d52d0c22b8e5">9,942</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjAtNS0xLTEtMA_3d5cfaf3-636a-4c8e-9925-1aa9628bc408">32,543</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjAtNy0xLTEtMA_ec96d7da-09c7-46ce-9a89-1ab9247d490a">31,788</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">INCOME (LOSS) BEFORE INCOME TAXES</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjEtMS0xLTEtMA_f67fc565-ec2e-466b-9252-24c1a634bfc1">14,050</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjEtMy0xLTEtMA_d0bfb3a8-c3d1-4d20-bce7-e37c620a158b">6,908</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjEtNS0xLTEtMA_f85e8ac5-1efd-4fea-b96e-482397d4cfb8">17,763</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjEtNy0xLTEtMA_b8d3ec2d-e375-49f0-a9b5-528746a21d02">14,316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;(Provision for) benefit from income taxes</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjItMS0xLTEtMA_8ed2e573-259a-4c95-b777-a20fa3689af5">3,825</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjItMy0xLTEtMA_db94617e-efc9-43db-82c0-ac71db079dca">1,816</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjItNS0xLTEtMA_e42bf3b2-118e-4655-b172-585910a7d431">5,029</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjItNy0xLTEtMA_6456f652-16ce-411c-a778-3069d4a56393">3,556</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NET INCOME (LOSS)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjMtMS0xLTEtMA_d4e2d3e9-03c5-4d7a-889e-c8bb3e5780c1">10,225</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjMtMy0xLTEtMA_16efd2e6-3ffe-4fe4-a795-c771c6f58c08">5,092</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjMtNS0xLTEtMA_c8b52fb1-563c-43ca-a5fa-2d51809a800f">12,734</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjMtNy0xLTEtMA_2a9b76bf-8182-46b9-9e09-850a43e9a65d">10,760</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjQtMS0xLTEtMA_f9f1024e-6236-4e44-8713-c42c46bfd0f4">4,069</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjQtMy0xLTEtMA_52598eec-4c6b-4409-ab86-5716744340c8">1,897</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjQtNS0xLTEtMA_71f30af9-fc6b-4d62-8a02-04a32708493c">8,063</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjQtNy0xLTEtMA_7d987a0b-85c4-4e9b-ab9d-27f027a7bd06">6,400</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NET INCOME (LOSS) ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjUtMS0xLTEtMA_014bf2e0-e508-4597-bf31-7c0a42f49bc1">6,156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjUtMy0xLTEtMA_159d80ba-38d4-4787-987d-97e3b6b46bb6">3,195</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjUtNS0xLTEtMA_4416fedb-1495-492f-8f02-96f2f28f1e65">20,797</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjUtNy0xLTEtMA_a66c4737-1f86-4e95-b7a4-9885d3daee7e">4,360</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjctMS0xLTEtMA_74e5e306-a7d7-448d-a800-5d53a7d8b6c1">0.12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjctMy0xLTEtMA_83979e64-7c50-44ab-934f-0a791b5fb475">0.06</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjctNS0xLTEtMA_4796f212-f4ba-45c7-bb85-682144204fc5">0.41</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjctNy0xLTEtMA_6386cd3e-a9ef-4ce1-96e8-8141ff729ed7">0.09</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjktMS0xLTEtMA_8933812f-32cc-4927-bcd5-a6d2bd93097d">0.12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjktMy0xLTEtMA_c067caa6-dcf2-4558-a8fc-663556df9670">0.06</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjktNS0xLTEtMA_a5039b3b-b306-4680-840f-19ac611f28db">0.41</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjktNy0xLTEtMA_0b05b82e-253d-44dc-8191-9996c0f05dc4">0.09</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">WEIGHTED AVERAGE SHARES OUTSTANDING</span></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMzEtMS0xLTEtMA_00e42a2f-60de-4a39-9d05-ec99e6d3214b">51,358,603</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMzEtMy0xLTEtMA_347064ee-95b1-4ce0-9669-935e85cbf922">49,807,460</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMzEtNS0xLTEtMA_b9b4425e-5d3e-480c-aeb9-6b5882ee8ed8">50,746,380</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMzEtNy0xLTEtMA_598e2aba-4b1c-4090-b2ea-fc4615603baf">49,597,138</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMzItMS0xLTEtMA_10b5a331-afa2-4cbb-bb55-12c501f6fb4f">51,955,815</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMzItMy0xLTEtMA_171e71c5-1881-461c-a749-8a19cfc05f4e">50,360,360</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMzItNS0xLTEtMA_e7494d89-4f16-42b9-ac00-ae402f43f029">50,746,380</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMzItNy0xLTEtMA_15fb4d85-de88-4d3e-b9b0-71200bd09738">50,113,306</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="iffc0b59705bf4cff936f619293b1a306_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_25">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RADNET, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(IN THOUSANDS)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:54.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.472%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.622%"></td><td style="width:0.1%"></td></tr><tr style="height:21pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NET INCOME (LOSS)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yNS9mcmFnOjhkYmIzODA2YzViMzRhMjk5NzE1Y2UyNGYxMjIwZWQ2L3RhYmxlOmMzYmFiNmUyMDI2OTRhYjI4NzQyNWMwYjc1MWE0NDZmL3RhYmxlcmFuZ2U6YzNiYWI2ZTIwMjY5NGFiMjg3NDI1YzBiNzUxYTQ0NmZfMi0xLTEtMS0w_1ee845fc-bcc9-484f-ba28-f9b6893b2bad">10,225</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yNS9mcmFnOjhkYmIzODA2YzViMzRhMjk5NzE1Y2UyNGYxMjIwZWQ2L3RhYmxlOmMzYmFiNmUyMDI2OTRhYjI4NzQyNWMwYjc1MWE0NDZmL3RhYmxlcmFuZ2U6YzNiYWI2ZTIwMjY5NGFiMjg3NDI1YzBiNzUxYTQ0NmZfMi0zLTEtMS0w_c2acc063-f58a-445e-ab12-98615d2f4b18">5,092</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yNS9mcmFnOjhkYmIzODA2YzViMzRhMjk5NzE1Y2UyNGYxMjIwZWQ2L3RhYmxlOmMzYmFiNmUyMDI2OTRhYjI4NzQyNWMwYjc1MWE0NDZmL3RhYmxlcmFuZ2U6YzNiYWI2ZTIwMjY5NGFiMjg3NDI1YzBiNzUxYTQ0NmZfMi01LTEtMS0w_60aa02b8-eb25-425c-813d-f2c2ffacb072">12,734</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yNS9mcmFnOjhkYmIzODA2YzViMzRhMjk5NzE1Y2UyNGYxMjIwZWQ2L3RhYmxlOmMzYmFiNmUyMDI2OTRhYjI4NzQyNWMwYjc1MWE0NDZmL3RhYmxlcmFuZ2U6YzNiYWI2ZTIwMjY5NGFiMjg3NDI1YzBiNzUxYTQ0NmZfMi03LTEtMS0w_5fd06429-463f-4f8f-8b70-6b16b32763a8">10,760</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Foreign currency translation adjustments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yNS9mcmFnOjhkYmIzODA2YzViMzRhMjk5NzE1Y2UyNGYxMjIwZWQ2L3RhYmxlOmMzYmFiNmUyMDI2OTRhYjI4NzQyNWMwYjc1MWE0NDZmL3RhYmxlcmFuZ2U6YzNiYWI2ZTIwMjY5NGFiMjg3NDI1YzBiNzUxYTQ0NmZfMy0xLTEtMS0w_10d4c400-6a6f-4931-813e-0396b6930123">11</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yNS9mcmFnOjhkYmIzODA2YzViMzRhMjk5NzE1Y2UyNGYxMjIwZWQ2L3RhYmxlOmMzYmFiNmUyMDI2OTRhYjI4NzQyNWMwYjc1MWE0NDZmL3RhYmxlcmFuZ2U6YzNiYWI2ZTIwMjY5NGFiMjg3NDI1YzBiNzUxYTQ0NmZfMy0zLTEtMS0w_43106a0b-8d88-4973-80c8-19b456d95603">23</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yNS9mcmFnOjhkYmIzODA2YzViMzRhMjk5NzE1Y2UyNGYxMjIwZWQ2L3RhYmxlOmMzYmFiNmUyMDI2OTRhYjI4NzQyNWMwYjc1MWE0NDZmL3RhYmxlcmFuZ2U6YzNiYWI2ZTIwMjY5NGFiMjg3NDI1YzBiNzUxYTQ0NmZfMy01LTEtMS0w_5cc25002-957b-4032-884a-12954a2c6863">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yNS9mcmFnOjhkYmIzODA2YzViMzRhMjk5NzE1Y2UyNGYxMjIwZWQ2L3RhYmxlOmMzYmFiNmUyMDI2OTRhYjI4NzQyNWMwYjc1MWE0NDZmL3RhYmxlcmFuZ2U6YzNiYWI2ZTIwMjY5NGFiMjg3NDI1YzBiNzUxYTQ0NmZfMy03LTEtMS0w_ce473d23-d0fd-4735-bfd0-e219c5482f50">28</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Change in fair value of cash flow hedge, net of taxes</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yNS9mcmFnOjhkYmIzODA2YzViMzRhMjk5NzE1Y2UyNGYxMjIwZWQ2L3RhYmxlOmMzYmFiNmUyMDI2OTRhYjI4NzQyNWMwYjc1MWE0NDZmL3RhYmxlcmFuZ2U6YzNiYWI2ZTIwMjY5NGFiMjg3NDI1YzBiNzUxYTQ0NmZfNC0xLTEtMS0w_9c9c2c7b-f2d3-48d2-9dbd-36c5cf366866">195</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yNS9mcmFnOjhkYmIzODA2YzViMzRhMjk5NzE1Y2UyNGYxMjIwZWQ2L3RhYmxlOmMzYmFiNmUyMDI2OTRhYjI4NzQyNWMwYjc1MWE0NDZmL3RhYmxlcmFuZ2U6YzNiYWI2ZTIwMjY5NGFiMjg3NDI1YzBiNzUxYTQ0NmZfNC0zLTEtMS0w_ef235ad4-267f-4a4a-bae9-23041b48f274">5,283</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yNS9mcmFnOjhkYmIzODA2YzViMzRhMjk5NzE1Y2UyNGYxMjIwZWQ2L3RhYmxlOmMzYmFiNmUyMDI2OTRhYjI4NzQyNWMwYjc1MWE0NDZmL3RhYmxlcmFuZ2U6YzNiYWI2ZTIwMjY5NGFiMjg3NDI1YzBiNzUxYTQ0NmZfNC01LTEtMS0w_75783a3c-134f-4b45-935d-3508ca6695e4">18,764</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yNS9mcmFnOjhkYmIzODA2YzViMzRhMjk5NzE1Y2UyNGYxMjIwZWQ2L3RhYmxlOmMzYmFiNmUyMDI2OTRhYjI4NzQyNWMwYjc1MWE0NDZmL3RhYmxlcmFuZ2U6YzNiYWI2ZTIwMjY5NGFiMjg3NDI1YzBiNzUxYTQ0NmZfNC03LTEtMS0w_8fb1e305-b7f9-41e7-a178-c354566f1120">14,481</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Change in fair value of cash flow hedge from prior periods reclassified to earnings, net of taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yNS9mcmFnOjhkYmIzODA2YzViMzRhMjk5NzE1Y2UyNGYxMjIwZWQ2L3RhYmxlOmMzYmFiNmUyMDI2OTRhYjI4NzQyNWMwYjc1MWE0NDZmL3RhYmxlcmFuZ2U6YzNiYWI2ZTIwMjY5NGFiMjg3NDI1YzBiNzUxYTQ0NmZfNS0xLTEtMS0w_29dcc640-62dd-4d0c-b7cc-2cfd922f8024">969</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yNS9mcmFnOjhkYmIzODA2YzViMzRhMjk5NzE1Y2UyNGYxMjIwZWQ2L3RhYmxlOmMzYmFiNmUyMDI2OTRhYjI4NzQyNWMwYjc1MWE0NDZmL3RhYmxlcmFuZ2U6YzNiYWI2ZTIwMjY5NGFiMjg3NDI1YzBiNzUxYTQ0NmZfNS0zLTEtMS0w_a0d614cd-cc2a-4964-a2d1-fd1a0b9725b7">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yNS9mcmFnOjhkYmIzODA2YzViMzRhMjk5NzE1Y2UyNGYxMjIwZWQ2L3RhYmxlOmMzYmFiNmUyMDI2OTRhYjI4NzQyNWMwYjc1MWE0NDZmL3RhYmxlcmFuZ2U6YzNiYWI2ZTIwMjY5NGFiMjg3NDI1YzBiNzUxYTQ0NmZfNS01LTEtMS0w_c9f976db-1c80-4e46-982b-7142dfb8bb4d">1,861</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yNS9mcmFnOjhkYmIzODA2YzViMzRhMjk5NzE1Y2UyNGYxMjIwZWQ2L3RhYmxlOmMzYmFiNmUyMDI2OTRhYjI4NzQyNWMwYjc1MWE0NDZmL3RhYmxlcmFuZ2U6YzNiYWI2ZTIwMjY5NGFiMjg3NDI1YzBiNzUxYTQ0NmZfNS03LTEtMS0w_49ddf1a2-ea1b-47f4-931a-5ec4d0358f1c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">COMPREHENSIVE INCOME (LOSS)</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yNS9mcmFnOjhkYmIzODA2YzViMzRhMjk5NzE1Y2UyNGYxMjIwZWQ2L3RhYmxlOmMzYmFiNmUyMDI2OTRhYjI4NzQyNWMwYjc1MWE0NDZmL3RhYmxlcmFuZ2U6YzNiYWI2ZTIwMjY5NGFiMjg3NDI1YzBiNzUxYTQ0NmZfNi0xLTEtMS0w_d85a4c79-e6d5-409c-b804-675a7e22df42">11,400</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yNS9mcmFnOjhkYmIzODA2YzViMzRhMjk5NzE1Y2UyNGYxMjIwZWQ2L3RhYmxlOmMzYmFiNmUyMDI2OTRhYjI4NzQyNWMwYjc1MWE0NDZmL3RhYmxlcmFuZ2U6YzNiYWI2ZTIwMjY5NGFiMjg3NDI1YzBiNzUxYTQ0NmZfNi0zLTEtMS0w_55025a09-7716-426c-affc-a58e7a02acea">214</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yNS9mcmFnOjhkYmIzODA2YzViMzRhMjk5NzE1Y2UyNGYxMjIwZWQ2L3RhYmxlOmMzYmFiNmUyMDI2OTRhYjI4NzQyNWMwYjc1MWE0NDZmL3RhYmxlcmFuZ2U6YzNiYWI2ZTIwMjY5NGFiMjg3NDI1YzBiNzUxYTQ0NmZfNi01LTEtMS0w_67355c6c-be6a-4ac3-bae1-fb5f7806d1ce">29,631</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yNS9mcmFnOjhkYmIzODA2YzViMzRhMjk5NzE1Y2UyNGYxMjIwZWQ2L3RhYmxlOmMzYmFiNmUyMDI2OTRhYjI4NzQyNWMwYjc1MWE0NDZmL3RhYmxlcmFuZ2U6YzNiYWI2ZTIwMjY5NGFiMjg3NDI1YzBiNzUxYTQ0NmZfNi03LTEtMS0w_2a424c08-f0ad-4cba-b7e7-7c2494512b19">3,749</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Less comprehensive income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yNS9mcmFnOjhkYmIzODA2YzViMzRhMjk5NzE1Y2UyNGYxMjIwZWQ2L3RhYmxlOmMzYmFiNmUyMDI2OTRhYjI4NzQyNWMwYjc1MWE0NDZmL3RhYmxlcmFuZ2U6YzNiYWI2ZTIwMjY5NGFiMjg3NDI1YzBiNzUxYTQ0NmZfNy0xLTEtMS0w_07d0559e-9458-47fc-801d-2f3e4f74bd61">4,069</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yNS9mcmFnOjhkYmIzODA2YzViMzRhMjk5NzE1Y2UyNGYxMjIwZWQ2L3RhYmxlOmMzYmFiNmUyMDI2OTRhYjI4NzQyNWMwYjc1MWE0NDZmL3RhYmxlcmFuZ2U6YzNiYWI2ZTIwMjY5NGFiMjg3NDI1YzBiNzUxYTQ0NmZfNy0zLTEtMS0w_282e2baa-6117-4962-be07-599d1edc17b9">1,897</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yNS9mcmFnOjhkYmIzODA2YzViMzRhMjk5NzE1Y2UyNGYxMjIwZWQ2L3RhYmxlOmMzYmFiNmUyMDI2OTRhYjI4NzQyNWMwYjc1MWE0NDZmL3RhYmxlcmFuZ2U6YzNiYWI2ZTIwMjY5NGFiMjg3NDI1YzBiNzUxYTQ0NmZfNy01LTEtMS0w_f0c1a53e-c3c3-44e7-b56f-b35732ea9c59">8,063</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yNS9mcmFnOjhkYmIzODA2YzViMzRhMjk5NzE1Y2UyNGYxMjIwZWQ2L3RhYmxlOmMzYmFiNmUyMDI2OTRhYjI4NzQyNWMwYjc1MWE0NDZmL3RhYmxlcmFuZ2U6YzNiYWI2ZTIwMjY5NGFiMjg3NDI1YzBiNzUxYTQ0NmZfNy03LTEtMS0w_894cdfe9-fda1-48d6-a6ff-1d4ecefb3948">6,400</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">COMPREHENSIVE INCOME (LOSS) ATTRIBUTABLE TO</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">RADNET, INC. COMMON STOCKHOLDERS</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yNS9mcmFnOjhkYmIzODA2YzViMzRhMjk5NzE1Y2UyNGYxMjIwZWQ2L3RhYmxlOmMzYmFiNmUyMDI2OTRhYjI4NzQyNWMwYjc1MWE0NDZmL3RhYmxlcmFuZ2U6YzNiYWI2ZTIwMjY5NGFiMjg3NDI1YzBiNzUxYTQ0NmZfOS0xLTEtMS0w_4ee4ef1f-659f-4793-a983-1ff44d9a1d83">7,331</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yNS9mcmFnOjhkYmIzODA2YzViMzRhMjk5NzE1Y2UyNGYxMjIwZWQ2L3RhYmxlOmMzYmFiNmUyMDI2OTRhYjI4NzQyNWMwYjc1MWE0NDZmL3RhYmxlcmFuZ2U6YzNiYWI2ZTIwMjY5NGFiMjg3NDI1YzBiNzUxYTQ0NmZfOS0zLTEtMS0w_a522dc44-3aa9-469e-9b35-bd67d30a2d31">2,111</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yNS9mcmFnOjhkYmIzODA2YzViMzRhMjk5NzE1Y2UyNGYxMjIwZWQ2L3RhYmxlOmMzYmFiNmUyMDI2OTRhYjI4NzQyNWMwYjc1MWE0NDZmL3RhYmxlcmFuZ2U6YzNiYWI2ZTIwMjY5NGFiMjg3NDI1YzBiNzUxYTQ0NmZfOS01LTEtMS0w_73e77fcb-c7b7-4720-99f5-400f04a77b29">37,694</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yNS9mcmFnOjhkYmIzODA2YzViMzRhMjk5NzE1Y2UyNGYxMjIwZWQ2L3RhYmxlOmMzYmFiNmUyMDI2OTRhYjI4NzQyNWMwYjc1MWE0NDZmL3RhYmxlcmFuZ2U6YzNiYWI2ZTIwMjY5NGFiMjg3NDI1YzBiNzUxYTQ0NmZfOS03LTEtMS0w_95247d53-9a4f-4a19-ae4b-c594a5458a68">10,149</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these financial statements.</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="iffc0b59705bf4cff936f619293b1a306_28"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_25">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RADNET, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(IN THOUSANDS EXCEPT SHARE DATA)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes in the Company&#8217;s consolidated stockholders' equity, including noncontrolling interest, during the three months ended September&#160;30, 2020 and September&#160;30, 2019.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.458%"><tr><td style="width:1.0%"></td><td style="width:28.606%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.454%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.781%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.843%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.843%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.149%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.888%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-In<br/>Capital</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other<br/>Comprehensive<br/>Income (Loss)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Radnet, Inc.'s<br/>Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling<br/>Interests</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Equity</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">BALANCE - July 1, 2020</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4ae3d85b0b824473a80ccd4a4708aba0_I20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMi0xLTEtMS0w_361f7021-6d71-4bb8-8962-3ef4ffab9494">51,554,760</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ae3d85b0b824473a80ccd4a4708aba0_I20200630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMi0zLTEtMS0w_57736c72-2ad4-4fcd-b89f-70843ef2a41e">5</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ae0e1753b584266bd033c7378cf877e_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMi01LTEtMS0w_d2899dac-76cf-49ad-be24-94e4a28e93ed">304,012</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94f2d48724ea46b3aa0a89c46fcb12f8_I20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMi03LTEtMS0w_85468d08-a223-403c-9236-1524a0048324">26,098</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d04f49cdfcc40eb9852bb1986ae7007_I20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMi05LTEtMS0w_3281fefb-c4ca-4215-9929-4d33d97a4166">130,111</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb96d5b718234c88935d8f52fbbbf3f6_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMi0xMS0xLTEtMA_47bbee85-bf2c-4e38-b396-42c80d68d0c7">147,808</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91203f5108484c309c7a4260b22ee742_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMi0xMy0xLTEtMA_fd5538c5-e5f1-4b59-88bf-2fec2b787b55">85,448</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2376698dad8742228ddb9d35b6913ee4_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMi0xNS0xLTEtMA_989c372d-5eb6-45b6-b630-fa3303f78995">233,256</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under the equity compensation plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8c20b6a988b44e36a260b09593425753_D20200701-20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfNS0xLTEtMS0w_1a047034-2192-4277-b6a1-49292829059b">37,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfNS0xNS0xLTEtMA_dd7ba91a-70a7-4883-8e37-8ae16a86d2e9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under the DeepHealth equity compensation plan</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5fd6699fb85d4180a93c8a06313ec3e6_D20200701-20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfNi0xLTEtMS01MDA_8d98dced-faa3-43ce-b3c7-414494393dbe">4,338</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4961d9edd85f4cd7b2f81b0166beb6fa_D20200701-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfNi0xNS0xLTEtNTA1_e52eaf1c-bda0-4d95-8de5-2f41ff439711">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09bf6bb1e62e463c8657ba3f07a2376b_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfNi01LTEtMS0w_65b895f1-282c-48fa-a030-8aece1da1155">2,067</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c7faff739fa454eacddcea55ed701ca_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfNi0xMS0xLTEtMA_bc555cec-7944-4949-94c7-4c3f3bf8a4a9">2,067</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfNi0xNS0xLTEtMA_11a6f9f4-2635-4d99-acf4-74b1dc2c811c">2,067</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions paid to noncontrolling interests</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i555980525511438faed4ba009d6f37b0_D20200701-20200930" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMTItMTMtMS0xLTA_76c8628c-3f00-44a2-afaf-83c68bd7a21b">601</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMTItMTUtMS0xLTA_01e858f7-8c5e-4e01-827f-c80b9a9281d3">601</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in cumulative foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90d9b7dfff1842639dab833ff5ec3886_D20200701-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMTUtNy0xLTEtMA_8c60086b-6a25-4a10-ab47-906f065f0876">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c7faff739fa454eacddcea55ed701ca_D20200701-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMTUtMTEtMS0xLTA_3bf42d59-d9ee-4e8a-9a12-ab25c2811736">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMTUtMTUtMS0xLTA_2cf30451-2459-4e5e-9908-aeef86df210a">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in fair value of cash flow hedge, net of taxes</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90d9b7dfff1842639dab833ff5ec3886_D20200701-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMTYtNy0xLTEtMA_0797c19b-012d-4af7-b620-3774b2ac6c01">195</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c7faff739fa454eacddcea55ed701ca_D20200701-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMTYtMTEtMS0xLTA_772491c1-bb7b-4d6f-aed4-d24ba6dad1c9">195</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMTYtMTUtMS0xLTA_c1013b6c-a9b1-496a-9652-caf2b5711502">195</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in fair value of cash flow hedge from prior periods reclassified to earnings, net of taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90d9b7dfff1842639dab833ff5ec3886_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMTctNy0xLTEtMA_adb54dda-2c7d-4ee6-b313-85c6561377e4">969</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c7faff739fa454eacddcea55ed701ca_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMTctMTEtMS0xLTA_c51dde4a-6a18-4d16-a6d2-fd35548b4b8f">969</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMTctMTUtMS0xLTA_e5197ecb-fdf5-46b1-9760-b00efd036295">969</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief71dd6a90be46dd80cc9cdc74b1b643_D20200701-20200930" decimals="-3" name="us-gaap:StockholdersEquityOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMTgtOS0xLTEtMA_82ff8e61-918b-4bb0-9467-fbb1fdd0c09c">1</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c7faff739fa454eacddcea55ed701ca_D20200701-20200930" decimals="-3" name="us-gaap:StockholdersEquityOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMTgtMTEtMS0xLTA_21538563-3557-4fbb-9222-a505d8903aa4">1</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930" decimals="-3" name="us-gaap:StockholdersEquityOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMTgtMTUtMS0xLTA_c05aaef5-d216-48a5-9d42-015f7852d30d">1</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief71dd6a90be46dd80cc9cdc74b1b643_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMTktOS0xLTEtMA_ccd77e50-a958-48f5-b0e2-b49ed008e28f">6,156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c7faff739fa454eacddcea55ed701ca_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMTktMTEtMS0xLTA_5ae4e6a8-c8df-4184-8fba-4751197e37b1">6,156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i555980525511438faed4ba009d6f37b0_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMTktMTMtMS0xLTA_e5138e8e-0edd-4b71-a012-fa471f5798d8">4,069</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMTktMTUtMS0xLTA_2e69c766-5ba7-408a-b8a4-1354576bfdc5">10,225</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">BALANCE-SEPTEMBER 30, 2020</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia6a10831dcf34a89b6122ba9bb78bea5_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMjAtMS0xLTEtMA_518fc2cd-714e-4820-83e7-a626d07cc8ad">51,596,098</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6a10831dcf34a89b6122ba9bb78bea5_I20200930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMjAtMy0xLTEtMA_6f3c65cb-6877-4ace-a460-4943739ab930">5</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6c25823a7a04a639911e6f404f10a57_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMjAtNS0xLTEtMA_7ea2975f-5e47-489f-83bf-7e18839fdfad">306,079</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b82209eab2648ec9c1833dbc1c0b1db_I20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMjAtNy0xLTEtMA_61df93ae-2012-4f5b-a3b5-6263333c8d38">24,923</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69ba183096574a37a4b5b0ca97c5a51f_I20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMjAtOS0xLTEtMA_40a641f1-bfd6-48e8-88f5-658990835c05">123,956</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i693f4b2418da466e9e6ad9dad2ab2b32_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMjAtMTEtMS0xLTA_415fa0d0-32ea-4262-81c2-eb0b084e14d3">157,205</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0c660ddab0648f28f0f4288a933f163_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMjAtMTMtMS0xLTA_4581fd15-6bb6-47a5-be3c-f55b93e1697d">88,916</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMjAtMTUtMS0xLTA_e4dba09e-81bd-4b1e-9ae6-8b2231d5f574">246,121</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">BALANCE - July 1, 2019</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i03b809d756f245699c9daa49222191fe_I20190630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMjItMS0xLTEtMA_c1a83963-ca5d-4c62-aea2-36b3a5fb44b5">50,127,234</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03b809d756f245699c9daa49222191fe_I20190630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMjItMy0xLTEtMA_7cc03034-adc9-4f7d-85af-7717111b7054">5</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if75788edb86f41d092529d110d74bf6b_I20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMjItNS0xLTEtMA_70935b5f-ac46-41c7-84d1-60d27a4e1a3e">257,607</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i89e4fdcc70e84e32bb0c67373df7c420_I20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMjItNy0xLTEtMA_399d2c56-559a-4284-962d-fdd9e3a7f133">6,942</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04d33784ad9449e99e9c45a3134d5d9c_I20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMjItOS0xLTEtMA_65244594-3356-48eb-a837-7fa85da0b267">116,752</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15c0b6b3069e42be8f76b29a49821089_I20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMjItMTEtMS0xLTA_45e0d667-1c29-4a0b-a662-421cad327837">133,918</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46b89b31f76140d281b073abfb16009e_I20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMjItMTMtMS0xLTA_1b666555-e950-4319-b55b-0bd80adae366">78,512</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77ea6f08b3b34bc687923c35ae708d67_I20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMjItMTUtMS0xLTA_e38e7d0a-b3b4-48af-8ba6-f0a69e7436de">212,430</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under the equity compensation plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9f84ecccfa2c445b87e09865cedb5674_D20190701-20190930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMjQtMS0xLTEtMA_b32725bc-c225-424b-a134-ea69ba4da9ee">25,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMjQtMTUtMS0xLTA_47bea64f-fdbc-4087-b429-fdc997b30df4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide24663efeeb41099f7c5f224f6bc5d7_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMjUtNS0xLTEtMA_abb51d5b-ae20-4b52-a1e8-034c95a66efe">1,356</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e3e0e81d2f34922abfd07a4e2eaad7b_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMjUtMTEtMS0xLTA_3549bfd5-1500-4179-a31e-8942075fe0e4">1,356</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMjUtMTUtMS0xLTA_c826f7fb-0d0a-4dca-ad07-6fc6aeee2d17">1,356</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock for purchase of membership interest in HVRA</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9f84ecccfa2c445b87e09865cedb5674_D20190701-20190930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMjYtMS0xLTEtMA_4cba6037-c6b8-4ae3-9488-d9173f845690">101,902</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide24663efeeb41099f7c5f224f6bc5d7_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMjYtNS0xLTEtMA_7fbceb0f-085a-4f32-b9ff-6719b9b15c4a">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e3e0e81d2f34922abfd07a4e2eaad7b_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMjYtMTEtMS0xLTA_0f64aeb1-4663-4a62-99ca-528304c0204b">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMjYtMTUtMS0xLTA_f1924214-eb82-4e5f-b039-c4fd52bdfa2b">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in cumulative foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id0e02291004444ac9e7381725f9d033f_D20190701-20190930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMzItNy0xLTEtMA_a188df8f-1d7c-4407-b84f-5cbac8063baf">23</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4e3e0e81d2f34922abfd07a4e2eaad7b_D20190701-20190930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMzItMTEtMS0xLTA_44c443de-68ea-4721-9207-7e14ff80c0cc">23</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMzItMTUtMS0xLTA_93dacc1e-6d62-4986-84e6-0cf06b20801a">23</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in fair value cash flow hedge, net of taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id0e02291004444ac9e7381725f9d033f_D20190701-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMzMtNy0xLTEtMA_1dfdb44d-c6ba-45b2-98f2-e7ade08a5536">5,283</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4e3e0e81d2f34922abfd07a4e2eaad7b_D20190701-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMzMtMTEtMS0xLTA_cd1ef074-5b02-4172-81b4-67c5e772376e">5,283</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMzMtMTUtMS0xLTA_c04a18d1-669d-4f6e-ae9e-3ffbd577bb04">5,283</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id0e02291004444ac9e7381725f9d033f_D20190701-20190930" decimals="-3" name="us-gaap:StockholdersEquityOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMzQtNy0xLTEtMA_d13d18a1-74b0-40d0-9577-8e72f23836c4">2</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42768d703fd64d3cb22b5badf8ab7fa5_D20190701-20190930" decimals="-3" sign="-" name="us-gaap:StockholdersEquityOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMzQtOS0xLTEtMA_dd74dc15-f444-4543-8120-0f3df5bdf60c">2</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:StockholdersEquityOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMzQtMTUtMS0xLTA_a7cd5d72-35d3-4477-88a7-da9f4496b04a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42768d703fd64d3cb22b5badf8ab7fa5_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMzUtOS0xLTEtMA_3017148f-cbdf-40df-bb77-82c0012e657b">3,195</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e3e0e81d2f34922abfd07a4e2eaad7b_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMzUtMTEtMS0xLTA_0dd6ab2d-9315-4d39-8a5e-3d1d757352fe">3,195</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8831da9d7f5d4f6fb802e218f7740494_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMzUtMTMtMS0xLTA_bc5fad7e-95f3-4f53-a64a-b29f961e19a0">1,897</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMzUtMTUtMS0xLTA_75324686-5430-456a-92c2-55ebdc25f9b5">5,092</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">BALANCE-SEPTEMBER 30, 2019</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic034acb0117040d6afe7d976972fa479_I20190930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMzYtMS0xLTEtMA_1238e860-9def-4079-a825-67fa60e491c4">50,254,136</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic034acb0117040d6afe7d976972fa479_I20190930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMzYtMy0xLTEtMA_30c9aee5-9522-4981-b017-e558a51b39eb">5</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0747908eb36543a89df88a2d9e1cd35b_I20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMzYtNS0xLTEtMA_5306cc59-16c0-48a8-8fc9-7430e35dbb1c">260,463</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e1094d35d014fd3a95b14bc592059f5_I20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMzYtNy0xLTEtMA_f3cde724-2b6f-42b5-bebf-f43e8b3b1027">12,250</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie0f76e06105741279da7c3328d1d487a_I20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMzYtOS0xLTEtMA_b7d5b08e-9c99-4069-b0f7-898992573183">113,555</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd2c608cacd0477aa45970e7d954f191_I20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMzYtMTEtMS0xLTA_5c6975a3-1f53-489c-a682-a289434f9379">134,663</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d9baeb9e126447b98c2cf732d7b12b4_I20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMzYtMTMtMS0xLTA_2672f534-370b-4b13-8f20-941b8c67d9bd">80,409</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i799130036d73414da02bb032ba102c39_I20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMzYtMTUtMS0xLTA_f92407f1-4262-47d2-8aea-a95a20b855fd">215,072</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="iffc0b59705bf4cff936f619293b1a306_31"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_25">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RADNET, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(IN THOUSANDS EXCEPT SHARE DATA)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes in the Company&#8217;s consolidated stockholders' equity, including noncontrolling interest, during the nine months ended September&#160;30, 2020 and September&#160;30, 2019.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_25">Table of Contents</a></span></div></div><div style="margin-bottom:5pt;margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.458%"><tr><td style="width:1.0%"></td><td style="width:28.606%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.454%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.781%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.843%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.843%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.149%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.888%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-In<br/>Capital</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other<br/>Comprehensive<br/>Income (Loss)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Radnet, Inc.'s<br/>Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling<br/>Interests</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Equity</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">BALANCE - January 1, 2020</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id4d77a0476814e54bf880ea51ec53067_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMi0xLTEtMS0w_2839a5a6-d47b-4249-8e41-3b7caf937ec9">50,314,328</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4d77a0476814e54bf880ea51ec53067_I20191231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMi0zLTEtMS0w_3a4f6a99-9cd3-4424-bb0a-36f193835dad">5</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07e00b3689c84e6a9310fc4102bb4b43_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMi01LTEtMS0w_ab2fbc0b-4303-4931-a78c-6f57fb231a13">262,865</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73519d6ef869432190c131a957d0509a_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMi03LTEtMS0w_03b6751d-7e21-4b27-b7f3-ef7de139c266">8,026</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic04fc01f723141e58a3d30372eb006ea_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMi05LTEtMS0w_48aa1b67-94cf-41c6-979a-a3d7316c1ea5">103,159</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b58c81a32474a7dad91e48ea01781b6_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMi0xMS0xLTEtMA_513becae-8403-4d9f-96c6-15e44302c0b1">151,685</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfb4354e13e748e5a050d331bc69d1a3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMi0xMy0xLTEtMA_868db6d7-72a2-4937-b312-28badfba9127">81,454</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMi0xNS0xLTEtMA_1a6f9bee-8834-481c-b445-bfefa714cdef">233,139</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under the equity compensation plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if7d38396af1648f3a9c78d6c8c94147c_D20200101-20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfNS0xLTEtMS0w_9ef0179a-8246-4747-810d-ca0fbb64b5eb">453,817</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfNS0xNS0xLTEtMA_eb7fa7da-d337-411e-8a65-fb3c258d85de">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under the DeepHealth equity compensation plan</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3743b37848a340a097d285381b700385_D20200101-20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfNi0xLTEtMS0zMTkw_8629753e-9538-42da-844c-9e3c55e37cdf">4,338</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fda9262fb95476a816ecc3cad434f3c_D20200101-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfNi0xNS0xLTEtMzE5Mw_c11815f5-ed87-4918-99ff-2716cef0ccb1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77d674128a5b4732a239eb275df36879_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfNi01LTEtMS0w_6e31dcc6-129b-4e09-8c3e-86d1f1727abb">10,203</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6912bfccd4a448a292e8ea776b60d181_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfNi0xMS0xLTEtMA_78efe909-0ea8-442d-a812-d1b5b0558213">10,203</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfNi0xNS0xLTEtMA_87748de5-eb9e-4985-b970-5479a2c16145">10,203</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock for sale of unregistered securities for the DeepHealth acquisition</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if7d38396af1648f3a9c78d6c8c94147c_D20200101-20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfOC0xLTEtMS0w_955dbbd9-8d67-4e91-abeb-4b2b94f22624">823,615</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77d674128a5b4732a239eb275df36879_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfOC01LTEtMS0w_47bdc091-a7e3-45eb-910a-81a72c43618a">33,011</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6912bfccd4a448a292e8ea776b60d181_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfOC0xMS0xLTEtMA_036f400c-2dbe-446e-be67-a74bc0d5b9d4">33,011</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfOC0xNS0xLTEtMA_a2a17bb0-9789-49c5-af61-f02d13dbb37b">33,011</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions paid to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idfbed43c89ad4ebfa5f48f8e5bb8a6f9_D20200101-20200930" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMTItMTMtMS0xLTA_08385c1e-d0ec-4cdc-b4ac-d7536eeb1510">601</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMTItMTUtMS0xLTA_33acd66f-1d2a-4fc1-9bd9-c409f0f5661b">601</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in cumulative foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id643d75beaf84a40a839ec6515ad926a_D20200101-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMTUtNy0xLTEtMA_d397b0d8-2d92-4f82-8105-134f93b34581">6</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6912bfccd4a448a292e8ea776b60d181_D20200101-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMTUtMTEtMS0xLTA_5809c63b-8e33-48c3-b674-528b2e743e53">6</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMTUtMTUtMS0xLTA_fc2f7c4a-ca92-4bb0-bd7e-10986392cb57">6</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in fair value cash flow hedge, net of taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id643d75beaf84a40a839ec6515ad926a_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMTYtNy0xLTEtMA_4caa1237-a966-4dbc-bdb5-0a78d99c4cf3">18,764</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6912bfccd4a448a292e8ea776b60d181_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMTYtMTEtMS0xLTA_8fb48740-3308-427e-bed9-a4d988fc0555">18,764</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMTYtMTUtMS0xLTA_ba3532c1-dcb4-4e2a-8053-bf926e22c8c3">18,764</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in fair value of cash flow hedge from prior periods reclassified to earnings, net of taxes</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id643d75beaf84a40a839ec6515ad926a_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMTctNy0xLTEtMA_166d3469-7b6f-4a05-86a4-cbf9cb5296f6">1,861</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6912bfccd4a448a292e8ea776b60d181_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMTctMTEtMS0xLTA_e0634d48-2827-4d7e-843a-eacde09b734d">1,861</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMTctMTUtMS0xLTA_b49eb5b6-4148-4f4e-8e69-00e120fa9188">1,861</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04b4ca98d99646caa1edf8c9b4cb072e_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMTktOS0xLTEtMA_843ebf79-d626-4d29-8b2b-8c220daca91b">20,797</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6912bfccd4a448a292e8ea776b60d181_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMTktMTEtMS0xLTA_3fc15a02-128e-4c1f-ba9b-2af9c889c5f8">20,797</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfbed43c89ad4ebfa5f48f8e5bb8a6f9_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMTktMTMtMS0xLTA_c494931c-c345-4d96-9d5b-a14f9b53e5cc">8,063</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMTktMTUtMS0xLTA_85944d0b-e3c5-4d29-9f79-b7c8db610686">12,734</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">BALANCE-SEPTEMBER 30, 2020</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia6a10831dcf34a89b6122ba9bb78bea5_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjAtMS0xLTEtMA_de49ea27-861a-4270-acd5-c78d8de0ec1a">51,596,098</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6a10831dcf34a89b6122ba9bb78bea5_I20200930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjAtMy0xLTEtMA_bb24b695-fdf5-44af-a8aa-ad10f3ade48f">5</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6c25823a7a04a639911e6f404f10a57_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjAtNS0xLTEtMA_396b1200-aaf6-4adb-8941-62b4963ae176">306,079</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b82209eab2648ec9c1833dbc1c0b1db_I20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjAtNy0xLTEtMA_1dae844a-e2e4-428b-bd95-74471d994361">24,923</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69ba183096574a37a4b5b0ca97c5a51f_I20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjAtOS0xLTEtMA_ed68b5dc-b491-42ce-8aa2-91dc4887de61">123,956</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i693f4b2418da466e9e6ad9dad2ab2b32_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjAtMTEtMS0xLTA_aad732f9-b629-4712-a692-97b75bf432a9">157,205</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0c660ddab0648f28f0f4288a933f163_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjAtMTMtMS0xLTA_79649471-242b-4a5b-98c6-cc645c623f43">88,916</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjAtMTUtMS0xLTA_41fedeee-1e14-4563-8f07-d442b7886705">246,121</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">BALANCE - January 1, 2019</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3e1e45a341fa4faa80a854e436e843dc_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjItMS0xLTEtMA_c940d892-bbbf-49e3-b92e-2cdb2e04b162">48,977,485</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e1e45a341fa4faa80a854e436e843dc_I20181231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjItMy0xLTEtMA_1f367f65-a246-4ff8-b881-e00209dfa188">5</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fd92e65f41647c28809f9a7ea4bfa83_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjItNS0xLTEtMA_62241e25-7487-4acf-aa97-52c6799e469c">242,835</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i705ee60e173d4b72997f9e6d827ceed9_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjItNy0xLTEtMA_a4b4bf39-418e-4849-a74b-a0eb2f17bb46">2,259</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icb755bfe39e64168aac8fb85840caa13_I20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjItOS0xLTEtMA_0bee8621-c642-4ac5-b0b9-787aa5a6bc12">117,915</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8702613a07bc43e49e4a5a9dc8474851_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjItMTEtMS0xLTA_ad5de01e-3cbb-4d4a-ab0e-4849731621d3">127,184</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i990f6dad8c174377a290cf37479ca637_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjItMTMtMS0xLTA_d33adfae-ad89-4ab7-8ec4-0e66291c92fe">73,069</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9799a383a2814cafbb89d610347f767d_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjItMTUtMS0xLTA_39d5d21d-3f4c-46b3-bb8d-fb7f6d255d1e">200,253</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock upon exercise of options</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i040549d733b84e41865f935d6710183a_D20190101-20190930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjMtMS0xLTEtMA_07a2005b-f5d7-4b23-806e-5aa25f74bf4d">10,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0d67703fcc549f58c3bb54805e151a1_D20190101-20190930" decimals="-3" name="rdnt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjMtNS0xLTEtMA_83ea1a3d-ec9b-426d-b953-41e5a3973b10">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4644861e9ece4360bab418f1b9fef51a_D20190101-20190930" decimals="-3" name="rdnt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjMtMTEtMS0xLTA_38e9ea3e-cc19-49a0-bf3c-c62cbadfd2fc">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" name="rdnt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjMtMTUtMS0xLTA_e22a8fc9-2aa5-4e68-a9e1-72e822e11558">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under the equity compensation plan</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i040549d733b84e41865f935d6710183a_D20190101-20190930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjQtMS0xLTEtMA_063a5bc6-1932-48c8-80c3-6473612b1d82">726,042</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjQtMTUtMS0xLTA_75ff0d5d-9d1f-4510-8c5c-ef75928cd49d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0d67703fcc549f58c3bb54805e151a1_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjUtNS0xLTEtMA_aaed3148-4337-4613-942f-05025ebfb3f0">6,993</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4644861e9ece4360bab418f1b9fef51a_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjUtMTEtMS0xLTA_13c0c5f9-a933-4489-aed7-cdedd59d74d6">6,993</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjUtMTUtMS0xLTA_8eb2cb66-d10b-47e2-8f7b-0212532c8ac5">6,993</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock for purchase of membership interest in HVRA</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i040549d733b84e41865f935d6710183a_D20190101-20190930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjctMS0xLTEtMA_21a139c1-af97-446c-8d76-c8e3456f5ce0">440,207</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0d67703fcc549f58c3bb54805e151a1_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjctNS0xLTEtMA_2a355522-abca-4cdd-a671-e05d8d0e8477">6,000</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4644861e9ece4360bab418f1b9fef51a_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjctMTEtMS0xLTA_4399e86b-1ed8-4510-91e2-37aa2818d9a4">6,000</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjctMTUtMS0xLTA_731675eb-6e5c-4fac-a0cb-11904bf0d233">6,000</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Forfeiture of restricted stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i040549d733b84e41865f935d6710183a_D20190101-20190930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjgtMS0xLTEtMA_c19d98c3-11ad-434c-8fa2-89d3034db147">1,500</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia0d67703fcc549f58c3bb54805e151a1_D20190101-20190930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjgtNS0xLTEtMA_2505198e-153e-44f7-8255-e358b7090388">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4644861e9ece4360bab418f1b9fef51a_D20190101-20190930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjgtMTEtMS0xLTA_b797f87b-461b-45e9-9491-45eedd5b2dd8">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjgtMTUtMS0xLTA_a7ff8d5c-af09-4115-8fd9-fecaf6aae7e7">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sale of noncontrolling interests, net of taxes</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0d67703fcc549f58c3bb54805e151a1_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjktNS0xLTEtMA_eebd5265-2931-4b7a-8e53-8327f90d2bb9">3,090</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4644861e9ece4360bab418f1b9fef51a_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjktMTEtMS0xLTA_d41b7fa5-1610-4818-a8e0-d4cef33dee24">3,090</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id349387901e24032a2736f786cf5a404_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjktMTMtMS0xLTA_702a91ff-e477-4c9d-b925-ec89545064df">2,008</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjktMTUtMS0xLTA_fbb7bd9e-b6b0-4a44-9cb7-5d7a4a4e43c1">5,098</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id349387901e24032a2736f786cf5a404_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMzItMTMtMS0xLTA_4d8444a6-3e2c-45ec-bd42-58e3a333eeaa">1,818</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMzItMTUtMS0xLTA_ee5cc559-6d16-4de6-9a64-9cda1fffc81f">1,818</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contribution from noncontrolling partner</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id349387901e24032a2736f786cf5a404_D20190101-20190930" decimals="-3" name="rdnt:ContributionsFromNoncontrollingInterests" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMzMtMTMtMS0xLTA_2495f7ff-c8b3-48fa-b930-b46662b4a7eb">750</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" name="rdnt:ContributionsFromNoncontrollingInterests" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMzMtMTUtMS0xLTA_0441d09c-0e4f-4836-a5df-3083f2853dbf">750</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock for purchase of Nulogix</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i040549d733b84e41865f935d6710183a_D20190101-20190930" decimals="INF" format="ixt:numdotdecimal" name="rdnt:StockIssuedDuringPeriodSharesIssuedForReturnOfCapital" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMzUtMS0xLTEtNzM3_74ed00b7-a87a-484c-9b9a-a2114e88dc0b">101,902</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0d67703fcc549f58c3bb54805e151a1_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="rdnt:StockIssuedDuringPeriodValueIssuedForReturnOfCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMzUtNS0xLTEtNzM3_809ad8f2-db1a-4ef4-8f5e-29feacc0b3e0">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4644861e9ece4360bab418f1b9fef51a_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="rdnt:StockIssuedDuringPeriodValueIssuedForReturnOfCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMzUtMTEtMS0xLTczNw_af666c4a-ccea-46d6-b66c-ce1a2a155a72">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="rdnt:StockIssuedDuringPeriodValueIssuedForReturnOfCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMzUtMTUtMS0xLTczNw_d67fc421-4b28-45f0-b997-8c489da87795">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in cumulative foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2a16c2751a89418ca779969dd77a5344_D20190101-20190930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMzQtNy0xLTEtMA_25e71b15-ba4a-4ec3-b78e-3c82d7a2a1a7">28</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4644861e9ece4360bab418f1b9fef51a_D20190101-20190930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMzQtMTEtMS0xLTA_5a49b6bc-f3f6-4501-9e94-0df21e550cac">28</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMzQtMTUtMS0xLTA_8c855121-d868-45bc-bedc-03effcdd3e6d">28</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in fair value cash flow hedge, net of taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2a16c2751a89418ca779969dd77a5344_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMzUtNy0xLTEtMA_42ee1956-5b91-4318-a7f9-a95c925d21db">14,481</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4644861e9ece4360bab418f1b9fef51a_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMzUtMTEtMS0xLTA_dd47fd6a-e2eb-4adf-b6f4-a19156bf5669">14,481</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMzUtMTUtMS0xLTA_f2437781-600a-4e62-a231-d8a503886579">14,481</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34391a7bab5d4dc58cabd25c59a6d33e_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMzYtOS0xLTEtMA_c603efd1-8ad0-49ba-a7fd-820002b7508b">4,360</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4644861e9ece4360bab418f1b9fef51a_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMzYtMTEtMS0xLTA_80dfd6d5-fc19-461b-bee8-eff639e09820">4,360</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id349387901e24032a2736f786cf5a404_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMzYtMTMtMS0xLTA_f0c4fcd8-0c94-4295-bac5-1308d69a4cd4">6,400</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMzYtMTUtMS0xLTA_b6f5e7da-622d-4ad3-9b4a-9c292af8ed06">10,760</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">BALANCE-SEPTEMBER 30, 2019</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic034acb0117040d6afe7d976972fa479_I20190930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMzctMS0xLTEtMA_f2195a07-10b1-4042-bc1f-82509eb9952f">50,254,136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic034acb0117040d6afe7d976972fa479_I20190930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMzctMy0xLTEtMA_b6599ea1-2e38-4c35-9af8-07423996fe86">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0747908eb36543a89df88a2d9e1cd35b_I20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMzctNS0xLTEtMA_26708b4a-a600-4439-8b25-fb43f0802b5c">260,463</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e1094d35d014fd3a95b14bc592059f5_I20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMzctNy0xLTEtMA_82cb4840-2e60-46b2-a1dc-4fe8a5bb9dc4">12,250</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie0f76e06105741279da7c3328d1d487a_I20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMzctOS0xLTEtMA_5ab9e0fa-5c8a-4ba9-a4ad-bf5359e87f2d">113,555</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd2c608cacd0477aa45970e7d954f191_I20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMzctMTEtMS0xLTA_723deec5-5a91-46c9-9bdc-722861006661">134,663</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d9baeb9e126447b98c2cf732d7b12b4_I20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMzctMTMtMS0xLTA_61fdf170-63e2-486b-bc33-ce3b87afcb03">80,409</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i799130036d73414da02bb032ba102c39_I20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMzctMTUtMS0xLTA_25057c1a-9468-49f5-83e3-6955eb4183c6">215,072</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these financial statements.</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="iffc0b59705bf4cff936f619293b1a306_34"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_25">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RADNET, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(IN THOUSANDS)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:74.119%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.218%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CASH FLOWS FROM OPERATING ACTIVITIES</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMy0xLTEtMS0w_69a77182-e352-4f57-9161-066e32c45ac5">12,734</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMy0zLTEtMS0w_5b34f3ab-49f9-4b01-80ee-bc71fd4a320a">10,760</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net (loss) income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfNS0xLTEtMS0w_7bb81ab4-1ec1-43a0-a3fb-13e95756b879">64,536</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfNS0zLTEtMS0w_a95f8ec9-3325-4360-8de9-6b5e00a124ea">60,193</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="rdnt:OperatingLeaseRightofUseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfNi0xLTEtMS0w_ab751fd4-768d-486b-b8fd-542efaffe32e">50,769</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="rdnt:OperatingLeaseRightofUseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfNi0zLTEtMS0w_0136ee01-e237-416a-a591-01ca3646a8c3">49,948</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity in earnings of joint ventures, net of dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfNy0xLTEtMS0w_882752ef-b30b-480d-bc5f-e99968c6fac8">530</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfNy0zLTEtMS0w_811e24c3-0ecf-4bd4-967a-e477513fac25">2,148</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of deferred financing costs and loan discount</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfOS0xLTEtMS0w_62c6dd1f-dc32-4c0a-a06e-614aaa88b486">3,266</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfOS0zLTEtMS0w_f7b4fd5a-652e-4ee6-a4f8-f5ccc06098b1">3,103</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on sale and disposal of equipment and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:GainLossOnDispositionOfAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMTAtMS0xLTEtMA_d7bc7f30-627a-4122-8b40-99fb4f8edf54">543</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossOnDispositionOfAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMTAtMy0xLTEtMA_ab395f23-d9ab-40a9-bf28-bb62584dc86c">1,990</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of cash flow hedge</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfDeferredHedgeGains" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMTEtMS0xLTEtMA_00a2cf0c-585a-40e5-8c0a-ec5b85d85019">2,204</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:AmortizationOfDeferredHedgeGains" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMTEtMy0xLTEtMA_7030ec83-7dd3-449f-8d23-573c62e2d8bb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash change in fair value of interest rate hedge</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMTItMS0xLTEtMA_2d8098ba-5df5-46c7-afad-0b12e3a4c7a4">4,523</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMTItMy0xLTEtMA_3ef1777a-123d-48f0-9f15-2fb02dade425">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMTMtMS0xLTEtMA_e48786d3-9905-4bbb-8818-cb8bc2ce55cb">10,144</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMTMtMy0xLTEtMA_bf41de8d-5a0e-46de-b817-83c89cab3566">6,963</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-cash items included in cost of operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" format="ixt:zerodash" name="rdnt:IncreaseDecreaseInOtherNoncashItem" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMTQtMS0xLTEtMA_25a8c6c4-0f9f-4cae-9c4b-55516ac4d84c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" name="rdnt:IncreaseDecreaseInOtherNoncashItem" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMTQtMy0xLTEtMA_29f10235-d574-4ebf-a9c7-6f64c2adbaac">559</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration</span></div></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMTUtMS0xLTEtMA_b405381b-21db-4a54-939c-be10c1ae16a1">145</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMTUtMy0xLTEtMA_03b04b55-1fe3-4614-9057-cf42de56d24a">1,749</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMTctMS0xLTEtMA_1d65bdd0-8abb-47a0-8e9c-84027dadbdea">17,380</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMTctMy0xLTEtMA_50c4ccb5-b6d4-4526-a847-81c2f3d4c66b">3,467</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherCurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMTgtMS0xLTEtMA_974a37a5-6d4b-4ecb-8f99-ed71193278a1">13,522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherCurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMTgtMy0xLTEtMA_84033711-aa32-4375-a7d8-95e80746db94">1,569</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMTktMS0xLTEtMA_492812b9-0587-476b-b6bb-be28d2016152">700</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMTktMy0xLTEtMA_7259c005-6f36-475a-b5cf-28090c9f0a20">5,770</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMjAtMS0xLTEtMA_134249c8-fb5b-4600-b771-27fec69245a2">7,640</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMjAtMy0xLTEtMA_e13e90ed-d98c-4923-a894-924d45d0e4c9">4,230</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="rdnt:IncreaseDecreaseinOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMjEtMS0xLTEtMA_05bc311c-0ff0-45d0-80fa-8560b49dc1e8">43,351</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="rdnt:IncreaseDecreaseinOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMjEtMy0xLTEtMA_0d05b0d1-797c-4127-baf6-6b4e5653bfc3">49,721</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMjItMS0xLTEtMA_88343077-5007-4690-b069-f188e0f1354b">44,530</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMjItMy0xLTEtMA_3e0d0965-01fe-485b-8c7c-39a8d7de54a8">490</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable, accrued expenses and other</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMjMtMS0xLTEtMA_3afb419a-96f3-4bad-b4d3-c60f05cde695">22,966</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMjMtMy0xLTEtMA_be45dbf5-beff-452a-a97f-21224325241c">19,349</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMjQtMS0xLTEtMA_ab176ccd-2608-4944-894a-30831278439e">170,343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMjQtMy0xLTEtMA_03a9d0a7-431a-4054-a5f9-8a3b41cc5459">82,603</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CASH FLOWS FROM INVESTING ACTIVITIES</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of imaging facilities and other acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBuildings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMjYtMS0xLTEtMA_0b2b089e-b450-4724-b32a-ff0215eaea4d">10,125</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBuildings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMjYtMy0xLTEtMA_71f35349-bf55-4176-a850-8934c95baaa5">27,150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity investments at fair value</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMjctMS0xLTEtMA_c4fd638f-2029-43b4-acf3-8bca6263d3e5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" name="us-gaap:PaymentsToAcquireInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMjctMy0xLTEtMA_0470b081-30f5-46cc-93ca-29430ac9f19f">143</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMjgtMS0xLTEtMA_7042848c-3f55-46be-9861-32ffcabb763e">77,303</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMjgtMy0xLTEtMA_1ee0001b-6a54-4bc9-938b-d46723ced11a">68,269</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from sale of equipment</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMjktMS0xLTEtMA_bb44cb05-8ccf-4b8f-b660-080405ff625b">779</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMjktMy0xLTEtMA_4ca7bcc0-a7fc-4f60-a715-78ea602a81fd">760</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from the sale of equity interests in a joint venture</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromDivestitureOfInterestInJointVenture" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMzAtMS0xLTEtMA_b226d7a1-3d3f-4235-b994-833506e9ba48">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" name="us-gaap:ProceedsFromDivestitureOfInterestInJointVenture" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMzAtMy0xLTEtMA_c2541a04-42df-41d5-9a8e-9ea4bb6d8b8a">132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nulogix return of capital</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMzEtMS0xLTEtMA_adaae8ae-10eb-41f9-b109-9586afcaf1d1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" name="us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMzEtMy0xLTEtMA_3d02847a-11d3-4f59-a7ca-54707efac2f0">792</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity contributions in existing and purchase of interest in joint ventures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="rdnt:PaymentstoAcquireInterestinJointVentureAndContributionsToExistingJointVenture" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMzItMS0xLTEtMA_3760a546-40a9-4640-adae-422369c77563">1,631</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" name="rdnt:PaymentstoAcquireInterestinJointVentureAndContributionsToExistingJointVenture" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMzItMy0xLTEtMA_af5e3238-6691-4bcc-968b-632e0b7022a0">103</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 29.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMzMtMS0xLTEtMA_416a9827-30d8-45d7-8a7f-17d06ddbe035">88,280</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMzMtMy0xLTEtMA_c05f368d-6281-4349-8b9d-fe88f572bb1c">93,981</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CASH FLOWS FROM FINANCING ACTIVITIES</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal payments on notes and leases payable</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMzUtMS0xLTEtMA_5e35c614-cd83-4196-aefb-c6e16f2227d5">2,704</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMzUtMy0xLTEtMA_c9be21c6-bfe6-4143-adbd-1e5dea4d60ea">4,778</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments on term loan debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMzYtMS0xLTEtMA_36de482c-14ab-4c29-906f-5fcd89d61894">32,472</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMzYtMy0xLTEtMA_84952f91-ee07-44ed-8a10-8d5da145e93d">29,918</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional deferred finance costs on revolving loan amendment</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMzctMS0xLTEtNzUw_7a6fc05b-a997-404c-8f7d-30ff186c9db7">741</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMzctMy0xLTEtNzUw_55db0abf-688b-4014-9534-0aac47aefcb0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from debt issuance, net of issuing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromIssuanceOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMzctMS0xLTEtMA_5bf9ca87-8a35-4ae6-b405-8161ce9ffbe9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMzctMy0xLTEtMA_c6c40593-23a1-45d4-85a2-3bf4c2ed9bd6">97,144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from Payment Protection Program</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="rdnt:ProceedsFromGovernmentAssistance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMzgtMS0xLTEtMA_1a472b0f-def2-4123-98ce-de1d9d06ccb1">4,023</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" format="ixt:zerodash" name="rdnt:ProceedsFromGovernmentAssistance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMzgtMy0xLTEtMA_ca8c9899-1129-40d9-a8ab-48e60109c019">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Distributions paid to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" name="us-gaap:PaymentsToMinorityShareholders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMzktMS0xLTEtMA_7b092b2f-fbd7-483c-94e9-4a19a079d29a">601</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToMinorityShareholders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMzktMy0xLTEtMA_43cbbaf2-85f3-4ed6-8e88-681c4cf0f396">1,818</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from sale of noncontrolling interest</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfNDAtMS0xLTEtMA_6cd7dd6b-7c2d-472e-a8a7-71c29fd9ebb3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfNDAtMy0xLTEtMA_0e98684e-6a61-4c33-809b-476442fd203a">5,275</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contribution from noncontrolling partner</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromContributedCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfNDEtMS0xLTEtMA_41a4eae2-ab25-4352-b956-7a6835f4a4e1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" name="us-gaap:ProceedsFromContributedCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfNDEtMy0xLTEtMA_406a21a9-eb17-4e2c-9dcd-6ba7c1d7698e">750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from revolving credit facility</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromLinesOfCredit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfNDItMS0xLTEtMA_38efee3e-56c9-438b-ba6b-943a4f11a3ac">250,900</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromLinesOfCredit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfNDItMy0xLTEtMA_983911d9-8266-4b3a-831e-6c460acdeabd">251,200</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments on revolving credit facility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLinesOfCredit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfNDQtMS0xLTEtMA_ce890b51-019f-47a0-98b7-7b1e9e8ce50c">250,900</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLinesOfCredit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfNDQtMy0xLTEtMA_a8c8ad88-3717-4fbf-abe5-f76f1e535bf4">279,200</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from issuance of common stock upon exercise of options</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfNDUtMS0xLTEtMA_30d7d8e9-fad8-4cfe-a518-bd977cd14d00">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfNDUtMy0xLTEtMA_c7a6949b-ecfd-40b9-9ba3-c2d4e867be71">50</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash (used in) provided by financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfNDYtMS0xLTEtMA_f029f79e-0656-4f8a-9a45-71d9a8b4d5db">32,495</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfNDYtMy0xLTEtMA_5b8a4a62-2adf-45f9-ac0e-0c6cfa9e0447">38,705</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">EFFECT OF EXCHANGE RATE CHANGES ON CASH</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfNDctMS0xLTEtMA_ccb010f3-937e-4225-87f5-ae79795030e1">6</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfNDctMy0xLTEtMA_f3171b87-652e-4f18-baad-8ff47618875f">28</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">NET INCREASE IN CASH AND CASH EQUIVALENTS</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfNDgtMS0xLTEtMA_88b259fe-6caa-4beb-bd93-5ba1f5feb27f">49,574</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfNDgtMy0xLTEtMA_e6baeace-408d-4290-83ad-b3656cb8283a">27,299</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CASH AND CASH EQUIVALENTS, beginning of period</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfNDktMS0xLTEtMA_bd0f19d6-ea94-438a-abf2-ff940c832155">40,165</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9799a383a2814cafbb89d610347f767d_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfNDktMy0xLTEtMA_4f863037-c3a3-4e81-9ffd-f7497c94ef8d">10,389</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CASH AND CASH EQUIVALENTS, end of period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfNTAtMS0xLTEtMA_f1581002-97d5-477f-ba52-67f0f47900dc">89,739</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i799130036d73414da02bb032ba102c39_I20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfNTAtMy0xLTEtMA_0262a5eb-b01c-4730-95b6-316102c50dd7">37,688</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid during the period for interest</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfNTMtMS0xLTEtMA_d4f6181a-cdf4-4d59-8d15-500fd65f1385">31,210</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfNTMtMy0xLTEtMA_8b65202c-4abc-46d3-aec6-c75ab36d53e2">36,058</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_25">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_25">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RADNET, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (CONTINUED)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="margin-bottom:10pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Supplemental Schedule of Non-Cash Investing and Financing Activities</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We acquired equipment and certain leasehold improvements for approximately $<ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-5" format="ixt:numdotdecimal" name="rdnt:EquipmentAcquiredAndLeaseholdImprovements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RleHRyZWdpb246MzY1ZDNlNDkwYjg0NDcwMzhkNzYyYzRkM2E5MTIwNDhfNDMz_516951df-43b4-4fe4-a806-f67ae4ab5312">28.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-5" format="ixt:numdotdecimal" name="rdnt:EquipmentAcquiredAndLeaseholdImprovements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RleHRyZWdpb246MzY1ZDNlNDkwYjg0NDcwMzhkNzYyYzRkM2E5MTIwNDhfNDQw_c39766e1-7c62-4cdd-87c9-2947f2ffaad0">14.1</ix:nonFraction> million during the nine months ended September&#160;30, 2020 and 2019, respectively, which were not paid for as of September&#160;30, 2020 and 2019</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> respectively. The offsetting amounts due were recorded in our condensed consolidated balance sheet under accounts payable, accrued expenses and other.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 1, 2020, we completed our stock purchase of DeepHealth, Inc. by issuing <ix:nonFraction unitRef="shares" contextRef="if4d28a9eeb2a4c71935db70483100dcc_D20200601-20200601" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RleHRyZWdpb246MzY1ZDNlNDkwYjg0NDcwMzhkNzYyYzRkM2E5MTIwNDhfNzY3_26f99d4e-a140-4433-9de2-c8e4f4189a73">823,615</ix:nonFraction> shares of our common stock to purchase all of DeepHealth's shares and share equivalents. The shares were ascribed a value of $<ix:nonFraction unitRef="usd" contextRef="i6ef5f4569a454da5b5b38254fa362064_I20200601" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RleHRyZWdpb246MzY1ZDNlNDkwYjg0NDcwMzhkNzYyYzRkM2E5MTIwNDhfODk2_8f518295-bbdb-4b0c-a199-2d73a37792dc">13.9</ix:nonFraction> million. </span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 1, 2019 we issued RadNet common stock in the amount of $<ix:nonFraction unitRef="usd" contextRef="ibdf5ae03b0ed462b8db002f00aaa9eb3_D20190801-20190801" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RleHRyZWdpb246MzY1ZDNlNDkwYjg0NDcwMzhkNzYyYzRkM2E5MTIwNDhfMjE5OTAyMzI1ODk2Mg_6cfac5cb-4f20-4472-96d6-a3b209d232f4">1.5</ix:nonFraction> million to acquire <ix:nonFraction unitRef="number" contextRef="i9c76df6e41e74111ace2b21a4181efad_I20190801" decimals="INF" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RleHRyZWdpb246MzY1ZDNlNDkwYjg0NDcwMzhkNzYyYzRkM2E5MTIwNDhfMjE5OTAyMzI1ODk3Nw_03354130-080d-4e98-a02d-7fa31d91c294">75</ix:nonFraction>% controlling interest in our formerly <ix:nonFraction unitRef="number" contextRef="i03857062bad24956a20685e95d06b5f4_I20180412" decimals="INF" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RleHRyZWdpb246MzY1ZDNlNDkwYjg0NDcwMzhkNzYyYzRkM2E5MTIwNDhfMjE5OTAyMzI1OTAxOA_c2676a9c-d507-41d8-bb8a-e03f0ca552a8">25</ix:nonFraction>% owned joint venture Nulogix.  See Note 2, Significant Accounting Policies, for further information.</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We transferred approximately $<ix:nonFraction unitRef="usd" contextRef="id84f65c6811e410281f7a3f3cee987b2_I20190301" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RleHRyZWdpb246MzY1ZDNlNDkwYjg0NDcwMzhkNzYyYzRkM2E5MTIwNDhfMTA5MA_310f1c30-02f4-48bb-a37f-29612eba9392">4.3</ix:nonFraction> million in net assets to our new joint venture, Ventura County Imaging Group, LLC in March 2019.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 27, 2019, we issued </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i09d00c2072a64166aae3435ab4296e8b_D20190227-20190227" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RleHRyZWdpb246MzY1ZDNlNDkwYjg0NDcwMzhkNzYyYzRkM2E5MTIwNDhfMTIxNA_da3af1fa-d9cf-4b93-8413-fb393c9c03a8">440,207</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shares of our common stock to the sellers of Hudson Valley Radiology Associates, P.L.L.C. ("HVRA") which permitted our variable interest entity, Lenox Hill Radiology and Medical Imaging Associates, P.C., to complete its purchase of the membership interest of HVRA. The shares were ascribed a value of $<ix:nonFraction unitRef="usd" contextRef="iada1780824384c7aa307e03c01df38f3_I20190227" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RleHRyZWdpb246MzY1ZDNlNDkwYjg0NDcwMzhkNzYyYzRkM2E5MTIwNDhfMTUxOA_fb530c47-f480-48d3-8a9b-89b66147b81e">6.0</ix:nonFraction> million.</span></div><div><span><br/></span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><div id="iffc0b59705bf4cff936f619293b1a306_37"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_25">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RADNET, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div id="iffc0b59705bf4cff936f619293b1a306_40"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 1 &#8211; <ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" name="us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80MC9mcmFnOjBiOGNlMjE4ODI5NzQ5OGQ5MmY5NTNiNDc2MzY5OWQ2L3RleHRyZWdpb246MGI4Y2UyMTg4Mjk3NDk4ZDkyZjk1M2I0NzYzNjk5ZDZfOTA2NA_a50c1f8f-93f6-4457-bff8-a751b1aa9663" continuedAt="i0dfcf8bb99774828a74ed688e5957c18" escape="true">NATURE OF BUSINESS AND BASIS OF PRESENTATION</ix:nonNumeric></span></div><ix:continuation id="i0dfcf8bb99774828a74ed688e5957c18" continuedAt="i3f4baf00c1cf493f9898646d59047136"><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a national provider of freestanding, fixed-site outpatient diagnostic imaging services with operations in seven U.S. states. At September&#160;30, 2020, we operated, directly or indirectly through joint ventures with hospitals, <ix:nonFraction unitRef="center" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="INF" name="rdnt:NumberOfCenters" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80MC9mcmFnOjBiOGNlMjE4ODI5NzQ5OGQ5MmY5NTNiNDc2MzY5OWQ2L3RleHRyZWdpb246MGI4Y2UyMTg4Mjk3NDk4ZDkyZjk1M2I0NzYzNjk5ZDZfMjcw_273a801f-d01f-4f3a-8c9b-ac9770cdc125">334</ix:nonFraction> centers located in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Our centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Our services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. The vast majority of our centers offer multi-modality imaging services. Our multi-modality strategy diversifies revenue streams, reduces exposure to reimbursement changes and provides patients and referring physicians the convenience of a single location to serve the needs of multiple procedures. In addition to our imaging services, we design and develop software applications, Artificial Intelligence tools and other computerized systems for the diagnostic imaging industry. Our operations comprise a single segment for financial reporting purposes.</span></div><div style="text-align:right;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the accounts of RadNet, Inc as well as its subsidiaries in which RadNet has a controlling financial interest. The consolidated financial statements also include certain variable interest entities in which we are the primary beneficiary (as described in more detail below). All material intercompany transactions and balances have been eliminated upon consolidation.  All of these affiliated entities are referred to collectively as &#8220;RadNet&#8221;, &#8220;we&#8221;, &#8220;us&#8221;, &#8220;our&#8221; or the &#8220;Company&#8221; in this report.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounting regulations stipulate that generally any entity with a) insufficient equity to finance its activities without additional subordinated financial support provided by any parties, or b) equity holders that, as a group, lack the characteristics which evidence a controlling financial interest, is considered a Variable Interest Entity (&#8220;VIE&#8221;). We consolidate all VIEs in which we are the primary beneficiary. We determine whether we are the primary beneficiary of a VIE through a qualitative analysis that identifies which variable interest holder has the controlling financial interest in the VIE. The variable interest holder who has both of the following has the controlling financial interest and is the primary beneficiary: (1) the power to direct the activities of the VIE that most significantly impact the VIE&#8217;s economic performance and (2) the obligation to absorb losses of, or the right to receive benefits from, the VIE that could potentially be significant to the VIE. In performing our analysis, we consider all relevant facts and circumstances, including: the design and activities of the VIE, the terms of the contracts the VIE has entered into, the nature of the VIE&#8217;s variable interests issued and how they were negotiated with or marketed to potential investors, and which parties participated significantly in the design or redesign of the entity.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIEs that we consolidate as the primary beneficiary consist of professional corporations which are owned or controlled by individuals within our senior management, namely Howard G. Berger, M.D., our President and Chief Executive Officer, and John V. Crues, III, M.D., RadNet's Medical Director, both of whom are members of our Board of Directors.  Dr. Berger owns, indirectly, <ix:nonFraction unitRef="number" contextRef="ic0ea34f7e0b34c6cb8b791288d9c8ac5_I20200930" decimals="INF" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80MC9mcmFnOjBiOGNlMjE4ODI5NzQ5OGQ5MmY5NTNiNDc2MzY5OWQ2L3RleHRyZWdpb246MGI4Y2UyMTg4Mjk3NDk4ZDkyZjk1M2I0NzYzNjk5ZDZfMzU2Mw_a614c427-532e-460d-8d63-2cf282f39f06">99</ix:nonFraction>% of the equity interests in Beverly Radiology Medical Group III (BRMG) and a controlling interest in two professional corporations in New York City.  BRMG is responsible for the professional medical services at nearly all of our facilities located in California.  Dr. Crues owns six professional corporations which provide medical services in Delaware, Maryland, New Jersey and New York.  Additionally, Dr. Crues is a <ix:nonFraction unitRef="number" contextRef="i6a57a87a6da342959e454a8c3d0ad301_I20200930" decimals="INF" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80MC9mcmFnOjBiOGNlMjE4ODI5NzQ5OGQ5MmY5NTNiNDc2MzY5OWQ2L3RleHRyZWdpb246MGI4Y2UyMTg4Mjk3NDk4ZDkyZjk1M2I0NzYzNjk5ZDZfMzk4Mw_4ab3c313-596f-4aba-9c32-6677664a9797">1</ix:nonFraction>% owner of BRMG.  These VIEs are collectively referred to as the consolidated medical group ("the Group").</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RadNet provides non-medical, technical and administrative services to the Group for which it receives a management fee, pursuant to the related management agreements. Through the management agreements we have exclusive authority over all non-medical decision making related to the ongoing business operations and we determine the annual budget. The Group has insignificant operating assets and liabilities, and de minimis equity. Through management agreements with us, substantially all cash flows of the Group after expenses, including professional salaries, are transferred to us. We consolidate the revenue and expenses, assets and liabilities of the Group.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Group on a combined basis recognized $<ix:nonFraction unitRef="usd" contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80MC9mcmFnOjBiOGNlMjE4ODI5NzQ5OGQ5MmY5NTNiNDc2MzY5OWQ2L3RleHRyZWdpb246MGI4Y2UyMTg4Mjk3NDk4ZDkyZjk1M2I0NzYzNjk5ZDZfNDc5NA_22f5706b-d409-4aa1-9329-04f0d9c7822b">38.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80MC9mcmFnOjBiOGNlMjE4ODI5NzQ5OGQ5MmY5NTNiNDc2MzY5OWQ2L3RleHRyZWdpb246MGI4Y2UyMTg4Mjk3NDk4ZDkyZjk1M2I0NzYzNjk5ZDZfNDgwMQ_ce7ea826-23e5-477e-865b-2331b943dc8b">40.6</ix:nonFraction> million of revenue, net of management services fees to RadNet, for the three months ended September&#160;30, 2020 and 2019, respectively and $<ix:nonFraction unitRef="usd" contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80MC9mcmFnOjBiOGNlMjE4ODI5NzQ5OGQ5MmY5NTNiNDc2MzY5OWQ2L3RleHRyZWdpb246MGI4Y2UyMTg4Mjk3NDk4ZDkyZjk1M2I0NzYzNjk5ZDZfNDkxNA_b5940aff-f8e3-4ca8-8a42-848857161b25">38.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80MC9mcmFnOjBiOGNlMjE4ODI5NzQ5OGQ5MmY5NTNiNDc2MzY5OWQ2L3RleHRyZWdpb246MGI4Y2UyMTg4Mjk3NDk4ZDkyZjk1M2I0NzYzNjk5ZDZfNDkyMQ_031bba07-d32b-4fe2-af06-0369ccc9231d">40.6</ix:nonFraction> million of operating expenses for the three months ended September&#160;30, 2020 and 2019, respectively.  RadNet recognized $<ix:nonFraction unitRef="usd" contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80MC9mcmFnOjBiOGNlMjE4ODI5NzQ5OGQ5MmY5NTNiNDc2MzY5OWQ2L3RleHRyZWdpb246MGI4Y2UyMTg4Mjk3NDk4ZDkyZjk1M2I0NzYzNjk5ZDZfNTAxNw_e05d3d10-e749-4d18-a300-b4dd0b8e829a">169.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80MC9mcmFnOjBiOGNlMjE4ODI5NzQ5OGQ5MmY5NTNiNDc2MzY5OWQ2L3RleHRyZWdpb246MGI4Y2UyMTg4Mjk3NDk4ZDkyZjk1M2I0NzYzNjk5ZDZfNTAyNA_d07c39f1-9643-428d-9198-2302272fa980">154.5</ix:nonFraction> million of total billed net service fee revenue for the three months ended September&#160;30, 2020, and 2019, respectively, for management services provided to the Group relating primarily to the technical portion of billed revenue.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Group on a combined basis recognized $<ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80MC9mcmFnOjBiOGNlMjE4ODI5NzQ5OGQ5MmY5NTNiNDc2MzY5OWQ2L3RleHRyZWdpb246MGI4Y2UyMTg4Mjk3NDk4ZDkyZjk1M2I0NzYzNjk5ZDZfNTI3MQ_1fee2352-abcd-4696-812a-67167221e4a1">104.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80MC9mcmFnOjBiOGNlMjE4ODI5NzQ5OGQ5MmY5NTNiNDc2MzY5OWQ2L3RleHRyZWdpb246MGI4Y2UyMTg4Mjk3NDk4ZDkyZjk1M2I0NzYzNjk5ZDZfNTI3OA_6a23629e-6921-45ed-a667-d27bae984071">116.9</ix:nonFraction> million of revenue, net of management services fees to RadNet, for the nine months ended September&#160;30, 2020 and 2019, respectively and $<ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80MC9mcmFnOjBiOGNlMjE4ODI5NzQ5OGQ5MmY5NTNiNDc2MzY5OWQ2L3RleHRyZWdpb246MGI4Y2UyMTg4Mjk3NDk4ZDkyZjk1M2I0NzYzNjk5ZDZfNTM4OQ_6d87e2e7-67bb-41ba-9cc0-1d5cf74d5fae">104.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80MC9mcmFnOjBiOGNlMjE4ODI5NzQ5OGQ5MmY5NTNiNDc2MzY5OWQ2L3RleHRyZWdpb246MGI4Y2UyMTg4Mjk3NDk4ZDkyZjk1M2I0NzYzNjk5ZDZfNTM5Ng_c1081b85-b88b-4022-8b96-341ebf450539">116.9</ix:nonFraction> million of operating expenses for the nine months ended September&#160;30, 2020 and 2019, respectively.  RadNet recognized $<ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80MC9mcmFnOjBiOGNlMjE4ODI5NzQ5OGQ5MmY5NTNiNDc2MzY5OWQ2L3RleHRyZWdpb246MGI4Y2UyMTg4Mjk3NDk4ZDkyZjk1M2I0NzYzNjk5ZDZfNTQ5MA_69070ae7-bfc1-41df-a51c-c94f0cab138e">433.3</ix:nonFraction> million </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_7">Table of Contents</a></span></div></div><ix:continuation id="i3f4baf00c1cf493f9898646d59047136"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $<ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80MC9mcmFnOjBiOGNlMjE4ODI5NzQ5OGQ5MmY5NTNiNDc2MzY5OWQ2L3RleHRyZWdpb246MGI4Y2UyMTg4Mjk3NDk4ZDkyZjk1M2I0NzYzNjk5ZDZfNTQ5Nw_0e7da238-e01a-497a-b0f5-21c2e14471ba">456.1</ix:nonFraction> million of total billed net service fee revenue for the nine months ended September&#160;30, 2020, and 2019, respectively, for management services provided to the Group relating primarily to the technical portion of billed revenue.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cash flows of the Group are included in the accompanying condensed consolidated statements of cash flows. All intercompany balances and transactions have been eliminated in consolidation. In our condensed consolidated balance sheets at September&#160;30, 2020 and December&#160;31, 2019, we have included approximately $<ix:nonFraction unitRef="usd" contextRef="i47fc5bf332c0415ca58f64dd07a99d47_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80MC9mcmFnOjBiOGNlMjE4ODI5NzQ5OGQ5MmY5NTNiNDc2MzY5OWQ2L3RleHRyZWdpb246MGI4Y2UyMTg4Mjk3NDk4ZDkyZjk1M2I0NzYzNjk5ZDZfNTk4Mw_89313dba-2cd3-4b68-b733-19269de82227">84.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i4a3dff9af20d4d0898edd8b68ba20037_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80MC9mcmFnOjBiOGNlMjE4ODI5NzQ5OGQ5MmY5NTNiNDc2MzY5OWQ2L3RleHRyZWdpb246MGI4Y2UyMTg4Mjk3NDk4ZDkyZjk1M2I0NzYzNjk5ZDZfNTk5MA_07b98322-7fcb-4e2f-b644-387934523ae7">100.3</ix:nonFraction> million, respectively, of accounts receivable and approximately $<ix:nonFraction unitRef="usd" contextRef="i47fc5bf332c0415ca58f64dd07a99d47_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80MC9mcmFnOjBiOGNlMjE4ODI5NzQ5OGQ5MmY5NTNiNDc2MzY5OWQ2L3RleHRyZWdpb246MGI4Y2UyMTg4Mjk3NDk4ZDkyZjk1M2I0NzYzNjk5ZDZfNjA0OQ_e4b0858c-25ea-40db-b31d-a62724e105ea">10.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i4a3dff9af20d4d0898edd8b68ba20037_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80MC9mcmFnOjBiOGNlMjE4ODI5NzQ5OGQ5MmY5NTNiNDc2MzY5OWQ2L3RleHRyZWdpb246MGI4Y2UyMTg4Mjk3NDk4ZDkyZjk1M2I0NzYzNjk5ZDZfNjA1Ng_3fa4928e-74b2-4324-8977-582b60a45170">7.0</ix:nonFraction> million of accounts payable and accrued liabilities related to the Group, respectively.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The creditors of the Group do not have recourse to our general credit and there are no other arrangements that could expose us to losses on their behalf. However, RadNet may be required to provide financial support to cover any operating expenses in excess of operating revenues.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also own a <ix:nonFraction unitRef="number" contextRef="ie01b35e6814e4aa2a06cc5668ed2166b_I20200930" decimals="INF" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80MC9mcmFnOjBiOGNlMjE4ODI5NzQ5OGQ5MmY5NTNiNDc2MzY5OWQ2L3RleHRyZWdpb246MGI4Y2UyMTg4Mjk3NDk4ZDkyZjk1M2I0NzYzNjk5ZDZfNjQzNQ_fe5a378e-81e1-402e-b02c-09c9e37f9361">49</ix:nonFraction>% economic interest in ScriptSender, LLC, which provides secure data transmission services of medical information. Through a management agreement, RadNet provides management and accounting services and receives an agreed upon fee. ScriptSender, LLC is dependent on the Company to finance its own activities, and as such we determined that it is a VIE but we are not a primary beneficiary since we do not have the power to direct the activities of the entity that most significantly impact the entity&#8217;s economic performance.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At all of our centers not serviced by the Group we have entered into long-term contracts (typically up to 40 years) with independent radiology groups to provide physician services at those centers. These radiology practices provide professional services, including supervision and interpretation of diagnostic imaging procedures, in our diagnostic imaging centers. The radiology practices maintain full control over the provision of professional services. Under these arrangements, in addition to obtaining technical fees for the use of our diagnostic imaging equipment and the provision of technical services, we provide management services and receive a fee based on the value of the services we provide.  We own the diagnostic imaging equipment and, therefore, receive 100% of the technical reimbursements associated with imaging procedures. The radiology practice groups retain the professional reimbursements associated with imaging procedures after deducting management service fees paid to us and we have no economic controlling interest in these radiology practices as such, the financial results of these practices are not consolidated in our financial statements.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X and, therefore, do not include all information and footnotes necessary for conformity with U.S. generally accepted accounting principles for complete financial statements; however, in the opinion of our management, all adjustments consisting of normal recurring adjustments necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods ended September&#160;30, 2020 and 2019 have been made. The results of operations for any interim period are not necessarily indicative of the results for a full year. These interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes thereto contained in our annual report on Form 10-K for the year ended December&#160;31, 2019.</span></div></ix:continuation><div id="iffc0b59705bf4cff936f619293b1a306_43"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 2 - <ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMzAxMDg_512490a0-33a0-4b88-9ec8-50df8899b8f0" continuedAt="i78c109a0d6a24bf0a89f916914eae4f5" escape="true">SIGNIFICANT ACCOUNTING POLICIES</ix:nonNumeric></span></div><ix:continuation id="i78c109a0d6a24bf0a89f916914eae4f5" continuedAt="i2e2068413db74c67ba6d66a09de96cef"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the period covered in this report, there have been no material changes to the significant accounting policies we use and have explained, in our annual report on Form 10-K for the fiscal year ended December&#160;31, 2019. The information below is intended only to supplement the disclosure in our annual report on Form 10-K for the fiscal year ended December&#160;31, 2019.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" name="us-gaap:RevenueRecognitionPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMzAwODQ_11573ce6-265f-479f-908e-c25cfa3f4dce" continuedAt="i00ceac7d77c94d2c93e5a5026121b22b" escape="true">REVENUES  - Our revenues generally relate to net patient fees&#160;received from various payors and patients themselves under contracts in which our performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period when our obligations to provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payor (Medicare, Medicaid, managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed care health plans and commercial insurance companies) the third-party payors. The payment arrangements with third-party payors for the services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_25">Table of Contents</a></span></div></div><ix:continuation id="i2e2068413db74c67ba6d66a09de96cef" continuedAt="i9e8fecc97cce4315b5e5bd07f8a6e6d4"><ix:continuation id="i00ceac7d77c94d2c93e5a5026121b22b" continuedAt="i9cba3eece08342c5836121abafb6e052"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As it relates to the Group, this service fee revenue includes payments for both the professional medical interpretation revenue recognized by them as well as the payment for all other aspects related to our providing the imaging services, for which we earn management fees. As it relates to others centers, this service fee revenue is earned through providing the use of our diagnostic imaging equipment and the provision of technical services as well as providing administration services such as clerical and administrative personnel, bookkeeping and accounting services, billing and collection, provision of medical and office supplies, secretarial, reception and transcription services, maintenance of medical records, and advertising, marketing and promotional activities.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues are based upon the estimated amounts we expect to be entitled to receive from patients and third-party payors. Estimates of contractual allowances under managed care and commercial insurance plans are based upon the payment terms specified in the related contractual agreements. Revenues related to uninsured patients and copayment and deductible amounts for patients who have health care coverage may have discounts applied (uninsured discounts and contractual discounts). We also record estimated implicit price concessions (based primarily on historical collection experience) related to uninsured accounts to record self-pay revenues at the estimated amounts we expect to collect.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under capitation arrangements with various health plans, we earn a per-enrollee amount each month for making available diagnostic imaging services to all plan enrollees under the capitation arrangement. Revenue under capitation arrangements is recognized in the period in which we are obligated to provide services to plan enrollees under contracts with various health plans.</span></div><ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" name="us-gaap:ScheduleOfPrincipalTransactionsRevenueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMzAwNjU_23b2d368-6b72-46b9-8089-3dfd347431ab" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our total service revenues during the three and nine  months ended September&#160;30, 2020 and 2019 are presented in the table below based on an allocation of the estimated transaction price with the patient between the primary patient classification of insurance coverage (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:49.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.734%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.734%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.734%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.738%"></td><td style="width:0.1%"></td></tr><tr style="height:21pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial insurance</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24364a0cec3f4ac4a7f4537560711888_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfMi0xLTEtMS0w_749345bf-7d95-499b-aea6-8acaa922c565">160,524</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8be3197ba81441aab9f7bdfa36dd45b_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfMi0zLTEtMS0w_06bad616-2c34-4064-a06f-706baec605a7">163,152</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05adfe570c7418c8583caa2e3756087_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfMi01LTEtMS0w_18439939-65c7-4a1b-a473-90b8c40d6960">412,415</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if079f62201f649a19398e263e6bb723c_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfMi03LTEtMS0w_43fb14e2-5876-4595-9070-e0e115d05dca">475,064</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic506a388c6254f67851aedb7d7e51a7c_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfMy0xLTEtMS0w_00186e8a-3278-4742-ab2e-c2a8a962cdbd">62,704</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d59877f74b84a14b84be572617b45e4_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfMy0zLTEtMS0w_9c060b45-cb81-4468-bcb2-7ebc4ea47410">61,599</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa7ae55f8352482ab21ec0d1d7641820_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfMy01LTEtMS0w_b58bd8e1-59fd-463f-aeb4-7d0b11ee2246">154,847</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82a5ccc725d2482e9b6e4b8be5a837c2_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfMy03LTEtMS0w_2d308bf0-d610-432e-b94e-51b911dbbd60">175,825</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2804457ff9c4979ab5dea362493dfa8_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfNC0xLTEtMS0w_81e11255-bb43-4de0-b687-eb6471b35d2c">7,098</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbd32a5208b04ee3af351b7e413a9606_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfNC0zLTEtMS0w_01d363a8-8487-4ac6-908a-5009b06523ed">7,128</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb0bcbdd5fb649f5a3eba1e57ea2bbdb_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfNC01LTEtMS0w_5784b2b8-be85-4285-8e0a-42823a34850e">18,072</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i510758bcd5d0485a8ea0f178b65d230b_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfNC03LTEtMS0w_e05f593e-4c53-44ad-9f6e-b8079265ba1e">21,564</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Workers' compensation/personal injury</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1ccd693101546e9948d833ef3206f25_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfNS0xLTEtMS0w_354f24c2-e3ea-414c-9a16-e70afda953eb">7,183</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fc9ace2676a462f9ebb5cde7964d542_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfNS0zLTEtMS0w_5c28aaee-57db-4559-b4d2-dd8ace51c6ec">10,865</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia51cd72af487490cb9a1c49464f21473_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfNS01LTEtMS0w_f6e5c1bc-e72e-4dbb-839b-b37ff97e4b2d">25,705</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f5a0223f69441b2ac8a10d4c658efa4_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfNS03LTEtMS0w_bb2b0ba3-1b5d-4afe-8e86-e3e2f6ad712b">32,950</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other patient revenue</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i959dcd70aa414905a86891687e922d26_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfNi0xLTEtMS0w_868ce93b-09d6-41fa-88a9-b926ad13690d">8,328</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36a7f7a656c54a7a93f09e843a05e4dc_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfNi0zLTEtMS0w_e4bb6cc2-eb77-448c-b200-5d4acb4071bb">6,085</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f798c18497b4449804b907ac22474ac_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfNi01LTEtMS0w_a07cd7c3-debe-44d3-80d4-cdb57f46a104">17,211</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d5a8b020d4846f2be96b5b9d725d28a_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfNi03LTEtMS0w_4c6ac13d-7cd3-45be-b38c-620d87280dd0">17,947</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management fee revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2de4a1d7e34f4c979e8ee54471682d8a_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfNy0xLTEtMS0w_9b77ca64-667e-4b46-9cce-6404c2830fa6">2,675</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i467bef824abe4dc791d4fb7875ad8839_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfNy0zLTEtMS0w_676d0506-b5a1-4533-bf2b-b25f3711de6e">1,792</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0daed54cf994635a1e3a709aa285693_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfNy01LTEtMS0w_53c4f0e4-37c3-4aaa-b31a-95568daacf9c">8,574</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id54012c7cfa84d7182be4c74e1c06f71_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfNy03LTEtMS0w_b26224cb-b814-4987-8561-978c16369afb">5,662</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Teleradiology and Software revenue</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35e7f0afe7a540a99ebbf34af2e3756a_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfOC0xLTEtMS0w_7295d326-351a-4dbb-b628-f30e947264b8">2,349</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63e61bbfa0be4d13b84f9d661bb940ba_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfOC0zLTEtMS0w_1be2b034-3f8a-4d7e-b8cd-1a056eb6f0a5">4,412</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c1f6bb93c3c4ac6aba73e2eb120728c_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfOC01LTEtMS0w_c2f75451-6d1d-4809-a09b-df2e331c6a75">8,319</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i521d126ad2134cb19713cd8598e5062b_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfOC03LTEtMS0w_6a1b7f73-8c15-4c2b-8b68-06dc07fbc23b">12,861</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d60555cdf4c455083bcb664a31aa0e9_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfOS0xLTEtMS0w_f32baa9e-015d-4fad-a19d-a4c72db0fd54">5,869</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b1f63bb36be4d77bc8acab605869faa_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfOS0zLTEtMS0w_f650691f-b29c-41fe-9f80-8b4a0c03eb9d">6,875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5744e3fc1fd54fb286b8e45bdced2585_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfOS01LTEtMS0w_b6612280-7a84-48b2-b0fe-8de09a93c80a">15,617</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d13380e9b574e229bc4acfa7bd99b00_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfOS03LTEtMS0w_593f170e-4d0a-4e01-b56e-0144e03a6942">20,878</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service fee revenue</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a9fe0209e954a06aca8cad30d601c73_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfMTAtMS0xLTEtMA_0b5d3e1b-c9b7-4d92-a5d1-9b8af6627503">256,730</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0096f14793b40c99c3a08b6a4ac8010_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfMTAtMy0xLTEtMA_9124e623-3d9b-43ae-8298-e67a0ebe2657">261,908</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe98f272e55f41dd878edf32fc7653a3_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfMTAtNS0xLTEtMA_8dd1f625-6a66-48aa-ac9b-5abe5f2337f8">660,760</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ee478ac62b2402380d60e1df30d2970_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfMTAtNy0xLTEtMA_9c47e0b1-d897-47b2-8bda-5951a9bf6e85">762,751</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue under capitation arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i058de6765e1e47449153067fb1e94bc6_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfMTEtMS0xLTEtMA_e10a3c08-ed64-44a2-95c4-17f3407a8498">35,046</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia03c585e05f349bd894ed447f40ca3fc_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfMTEtMy0xLTEtMA_b995b6c3-6720-4e76-b2e0-94bfe3ca29da">30,784</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4b7517ca2542439322f6bb062453a3_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfMTEtNS0xLTEtMA_241d695d-b60a-4a96-b0b6-27a3f085518c">103,145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i202db1f71dbd487f9b8bf67552d7ead3_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfMTEtNy0xLTEtMA_0e3d3a2a-b982-4fdf-981a-a738ae168e51">90,587</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total service revenue</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfMTItMS0xLTEtMA_2bb274c8-fbc6-4919-955e-67c2ce85f0e8">291,776</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfMTItMy0xLTEtMA_a27114fd-b589-4940-b312-f589c19b731e">292,692</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfMTItNS0xLTEtMA_1ddef44d-b899-4a20-abe6-169c94fa18c8">763,905</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfMTItNy0xLTEtMA_a74153ef-f5aa-44e8-b7fa-8da39f00e23e">853,338</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">COVID-19 PANDEMIC AND CARES ACT FUNDING -  On March 11, 2020 the World Health Organization (WHO) designated COVID-19 as a global pandemic.  Patient volumes and the related revenues for our services were significantly impacted during the latter portion of the first quarter through the middle of the third quarter of 2020 as a result of federal, state and local government mandated restrictions requiring many people to remain at home and forced the closure of or limitations on certain businesses, as well as suspended elective procedures by health care facilities.  Many of these restrictions have been eased or completely lifted across the states the Company operates in however, we are unable to predict the future impact of the pandemic on our operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the nine months ended September 30, 2020, we received $<ix:nonFraction unitRef="usd" contextRef="i1da458a1f30e42a280a85b687626d8c9_D20200401-20200430" decimals="-5" format="ixt:numdotdecimal" name="rdnt:AdvanceMedicarePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjE5OTAyMzMwNDIwOA_85b786b1-cb4a-4fa7-8946-fb06e62daf36">39.4</ix:nonFraction> million of accelerated Medicare payments, $<ix:nonFraction unitRef="usd" contextRef="i9f412c4a4bc94dc6bdf4cf62ede09d62_D20200501-20200531" decimals="-5" format="ixt:numdotdecimal" name="rdnt:ProceedsReceivedFromInsurance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjE5OTAyMzMwNDI1MQ_71b5e3f7-772d-40ab-9513-05f6981cc8fa">5.0</ix:nonFraction> million from Blue Cross, $<ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueNotFromContractWithCustomer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjE5OTAyMzMwNDI4OQ_35ca4f68-1233-4a41-b0ec-d35d0df2f243">25.7</ix:nonFraction> million from the general distribution and $<ix:nonFraction unitRef="usd" contextRef="icd0727e676b44495b92424a21cfd803d_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjE5OTAyMzMwNDMwNw_bf55d90a-c502-4cbb-92d8-f316a5a03cc4">4.0</ix:nonFraction> million from the Paycheck Protection Program established through the Coronavirus Aid, Relief and Economic Security (&#8220;CARES&#8221;) Act.  The accelerated Medicare payments are recorded under the caption &#8220; Deferred Revenue&#8220;  in our condensed consolidated balance sheet and will be repaid beginning in 2021.  The general distribution funds were accounted for as government grants and recognized as other revenue, once reasonable assurance that the applicable terms and conditions required to retain the funds were met, under the caption &#8220;Provider relief funding&#8221; in our condensed Consolidated Statements of Operations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the three months ended September 30, 2020, the Department of Health and Human Services significantly changed the measurement of Provider Relief Funds that providers are able to retain.  We received approximately $<ix:nonFraction unitRef="usd" contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueNotFromContractWithCustomer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjE5OTAyMzMwNDEzNg_309274a4-e247-4d98-9fad-4dc5b4cd15db">0.2</ix:nonFraction> million in </span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_25">Table of Contents</a></span></div></div><ix:continuation id="i9e8fecc97cce4315b5e5bd07f8a6e6d4" continuedAt="ic3841e6833c7472c9d56f850cb6d5b48"><ix:continuation id="i9cba3eece08342c5836121abafb6e052" continuedAt="iac9f5e758abc420daefba9960502cef0"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">funding and based on our assessment of the likelihood of meeting the applicable terms and conditions of the general distribution we continue to recognized the funds received as other revenue.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The CARES Act also providers for a payment deferral of the employer portion of Social Security tax incurred during the pandemic, allowing half of such payroll taxes to be deferred until December 2021 and the remaining half until December 2022.  At September 30, 2020, the Company had deferred $<ix:nonFraction unitRef="usd" contextRef="i03664eb4b82e43e8b82d1e6f730f020d_I20200930" decimals="-5" format="ixt:numdotdecimal" name="rdnt:SocialSecurityTaxEmployerDeferralCARESAct" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjE5OTAyMzMwNzg3NA_6202d977-6f82-4041-a214-4771fc90d7ba">10.8</ix:nonFraction> million of Social Security taxes.  These payment deferrals are recorded as payroll tax liability under the caption &#8220;Accounts payable, accrued expenses and other&#8221; in our condensed consolidated balance sheet.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="iac9f5e758abc420daefba9960502cef0">We believe the extent of the COVID-19 pandemic&#8217;s impact on our operating results and financial condition has been and will continue to be driven by many factors, most of which are beyond our control and ability to forecast.  Such factors include, but are not limited to, the scope and duration of stay-at-home practices, business closures  and restrictions, suspensions of elective procedures and continued decline in procedure volumes for an indeterminable length of time and incremental expenses required for supplies and personal protective equipment.  Because of these uncertainties, we cannot estimate the length or impact of the pandemic on our business.  If we incur declines in cash flows and results of operations, such declines could have an impact on the inputs and assumptions used in significant accounting estimates, including implicit prices concessions related to uninsured patient  accounts, and potential impairment of goodwill and long-lived assets.  During the third quarter of 2020, procedure volumes increased and have had a positive impact on our patient revenue.  However, the impact of COVID-19 in future periods may vary and could adversely impact our results of operations.</ix:continuation>  </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMzAwODU_cc51f6f4-6cdc-4bcb-ba3b-ddce8f4b4348" escape="true">RECLASSIFICATION &#8211;We have reclassified certain amounts previously classified as held for sale related to property and equipment and goodwill to conform to our 2020 presentation.</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" name="us-gaap:ReceivablesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMzAxMDE_d44661a5-3283-4079-926d-115d200d2776" escape="true">ACCOUNTS RECEIVABLE - Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. Services are generally provided pursuant to one-year contracts with healthcare providers. We continuously monitor collections from our payors and maintain an allowance for bad debts based upon specific payor collection issues that we have identified and our historical experience.  In regards to the credit loss standard, we have concluded that the historical credit loss experienced across our receivable portfolio is materially similar to any current expected credit losses estimated under the Current Expected Credit Loss ("CECL") model.</ix:nonNumeric></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2018 and 2019 we entered into factoring agreements with various institutions and sold certain accounts receivable under non-recourse agreements in exchange for notes receivables from the buyers. These transactions are accounted for as a reduction in accounts receivable as the agreements transfer effective control over and risk related to the receivables to the buyers. Proceeds on notes receivables are reflected as operating activities on our statement of cash flows and on our balance sheet as prepaid expenses and other current assets for the current portion and deposits and other for the long term portion. At September&#160;30, 2020 we have&#160;$<ix:nonFraction unitRef="usd" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="-5" format="ixt:numdotdecimal" name="rdnt:ContractsReceivableFactoringReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfNzAyMQ_11e74568-dfd1-43ef-aac9-4297568e9bc9">20.4</ix:nonFraction> million remaining to be collected on these agreements. We do not utilize factoring arrangements as an integral part of our financing for working capital.  To employ the CECL model for the notes receivable, we assess the party's ability to pay upfront at the inception of the notes receivable and subsequently by reviewing their financial statements annually and reassessing any insolvency risk on a periodic basis.  In the event of a significant past due balance, as the sold receivables were already revalued and recorded at net realizable value, we can mitigate the expected credit loss by offsetting any collections from the underlying factored receivables and not remitting that to the counter party.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMzAwNzA_4b25cc81-d691-4a3c-ab56-6b471dea3823" escape="true">DEFERRED REVENUE - As noted above, in April of 2020, we received approximately $<ix:nonFraction unitRef="usd" contextRef="i1da458a1f30e42a280a85b687626d8c9_D20200401-20200430" decimals="-5" format="ixt:numdotdecimal" name="rdnt:AdvanceMedicarePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfNzk4MQ_85b786b1-cb4a-4fa7-8946-fb06e62daf36">39.4</ix:nonFraction> million in advanced Medicare payments from the Centers for Medicare and Medicaid Services ("CMS") as part of the expanded Accelerated and Advance Payment Program under the Coronavirus Aid, Relief, and Economic Security (CARES) Act.  As these payments are required to be repaid to CMS beginning 120 days after their receipt through offsets from new Medicare claims over a three month period, we have recorded amounts received to deferred revenue which will be amortized as Medicare reimbursements are earned.  In addition, in May of 2020 we received $<ix:nonFraction unitRef="usd" contextRef="i9f412c4a4bc94dc6bdf4cf62ede09d62_D20200501-20200531" decimals="-5" format="ixt:numdotdecimal" name="rdnt:ProceedsReceivedFromInsurance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfODUyNg_71b5e3f7-772d-40ab-9513-05f6981cc8fa">5.0</ix:nonFraction> million in advance payments from an insurance carrier with similar repayment terms as the CMS.</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" name="us-gaap:DeferredChargesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMzAwNzg_72b2bd65-42c1-4e95-8075-34c797c1799a" escape="true">DEFERRED FINANCING COSTS - Costs of financing are deferred and amortized using the effective interest rate method. Deferred financing costs, net of accumulated amortization, were $<ix:nonFraction unitRef="usd" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfODc5NQ_33b98e8a-7bea-4b28-9145-9f46addae7bf">1.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfODgwMg_37231beb-608c-47fe-a475-f25f20775250">1.6</ix:nonFraction> million, as of September&#160;30, 2020 and December&#160;31, 2019, respectively and related to our Barclays line of credit.  See Note 5, Credit Facilities and Notes Payable for more information.</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMzAxMDM_c89df241-34c9-4dc7-a6f2-0f91e0ada578" escape="true">PROPERTY AND EQUIPMENT - Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation of property and equipment is performed using the straight-line method over the estimated useful lives of the assets acquired, which range from <ix:nonNumeric contextRef="ie19ca44258f54d33b5e7d6546bae1a8d_D20200101-20200930" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfOTQyNQ_f5244de6-4f32-475f-b398-51fe7bd729b0">3</ix:nonNumeric> to <ix:nonNumeric contextRef="i1e5c92bdeee343cfa400ee011058ca0f_D20200101-20200930" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfOTQzMQ_8c097f2c-e7b2-42e7-bceb-543452c8b2bd">15</ix:nonNumeric> years. Leasehold improvements are amortized at the lesser of lease term or their estimated useful lives, which range from <ix:nonNumeric contextRef="i9851e7fbb9b4406b9d2a6222679efb4d_D20200101-20200930" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfOTU1MA_dbea741d-fefa-4a71-b189-6b4eac46edfb">3</ix:nonNumeric> to <ix:nonNumeric contextRef="ie6887d928dca440bbe9351ea5442a009_D20200101-20200930" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfOTU1Ng_484faceb-8f08-4f5a-b261-4ee53dbb4fe8">15</ix:nonNumeric> years. Maintenance and repairs are charged to expense as incurred.</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_25">Table of Contents</a></span></div></div><ix:continuation id="ic3841e6833c7472c9d56f850cb6d5b48" continuedAt="ibd4ec6d11dbd408ebb4b42fe3432e0a1"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" name="us-gaap:BusinessCombinationsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMzAxMTQ_3dd52393-e9e6-4fb4-9988-1274e33ea264" escape="true">BUSINESS COMBINATION  -  When the qualifications for business combination accounting treatment are met, it requires us to recognize separately from goodwill the assets acquired and the liabilities assumed at their acquisition date fair values. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities assumed. While we use our best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, we record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to our consolidated statements of operations.</ix:nonNumeric></span></div><ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" name="us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMzAwOTM_1e12bc2a-8228-4767-b071-94a71ef3d3a8" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GOODWILL AND INDEFINITE LIVED INTANGIBLES - Goodwill at September&#160;30, 2020 totaled $<ix:nonFraction unitRef="usd" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMTA3Njg_4cc4a8f0-93da-4a6d-96d9-66133c41c18b">470.7</ix:nonFraction> million.  Indefinite lived intangible assets at September&#160;30, 2020 were $<ix:nonFraction unitRef="usd" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMTA4MTk_36aa7966-d02d-40d9-8819-329f2d8bdf4f">11.3</ix:nonFraction> million.  Goodwill and Indefinite Lived Intangibles are recorded as a result of business combinations. When we determine the carrying value of reporting unit exceeds its fair value an impairment charge would be recognized and should not exceed the total amount of goodwill allocated to that reporting unit.  We tested goodwill and indefinite lived intangibles for impairment on October 1, 2019, noting no impairment.  In addition to the annual impairment test, we regularly assess if an event has occurred which would require interim impairment testing.  We considered the current and expected future economic and market conditions surrounding the novel strain of coronavirus ("COVID-19") pandemic and did not identify an indication of goodwill impairment being more likely than not through September&#160;30, 2020.  <ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" name="us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMzAwNzY_d48c4690-a36f-481e-98ad-e01803b1c5fd" continuedAt="i5eb3834a06634318bd495afe0b33fc95" escape="true">Activity in goodwill for the nine months ended September&#160;30, 2020 is provided below (in thousands):</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt"><ix:continuation id="i5eb3834a06634318bd495afe0b33fc95"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:87.186%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjIzNmE0NWEzMDNhYjQwYzA4NWNhZGU4NTZiZTcwM2VkL3RhYmxlcmFuZ2U6MjM2YTQ1YTMwM2FiNDBjMDg1Y2FkZTg1NmJlNzAzZWRfMC0xLTEtMS0w_5c137729-dc6e-4d64-869f-e9ee2febdbde">441,973</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired through the acquisition of Olney Open MRI, LLC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i812d1f3338f848fbb0cae71405a11682_D20200101-20200930" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjIzNmE0NWEzMDNhYjQwYzA4NWNhZGU4NTZiZTcwM2VkL3RhYmxlcmFuZ2U6MjM2YTQ1YTMwM2FiNDBjMDg1Y2FkZTg1NmJlNzAzZWRfMS0xLTEtMS0w_071cec59-9adb-4c9f-aa6a-9e767ecc539e">601</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired through the acquisition of MRI at Woodbridge, LLC</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b47417b06a54e549d7dc88a99fac34c_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjIzNmE0NWEzMDNhYjQwYzA4NWNhZGU4NTZiZTcwM2VkL3RhYmxlcmFuZ2U6MjM2YTQ1YTMwM2FiNDBjMDg1Y2FkZTg1NmJlNzAzZWRfMi0xLTEtMS0w_1fb4a4a8-afdf-420b-8456-2f7e980de6ad">1,833</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired through the acquisition of DeepHealth, Inc.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fda9262fb95476a816ecc3cad434f3c_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjIzNmE0NWEzMDNhYjQwYzA4NWNhZGU4NTZiZTcwM2VkL3RhYmxlcmFuZ2U6MjM2YTQ1YTMwM2FiNDBjMDg1Y2FkZTg1NmJlNzAzZWRfMy0xLTEtMS0w_f209bc65-4a3d-4c00-9912-e51761164eb1">23,396</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired through the acquisition of AZ-Tech Radiology &amp; Open MRI, LLC</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71e54b77f294940bda2035bdb641b80_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjIzNmE0NWEzMDNhYjQwYzA4NWNhZGU4NTZiZTcwM2VkL3RhYmxlcmFuZ2U6MjM2YTQ1YTMwM2FiNDBjMDg1Y2FkZTg1NmJlNzAzZWRfNC0xLTEtMS0yNzQ_2c4458fc-7ee6-4136-9b3d-bb5f9d8a760a">2,882</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjIzNmE0NWEzMDNhYjQwYzA4NWNhZGU4NTZiZTcwM2VkL3RhYmxlcmFuZ2U6MjM2YTQ1YTMwM2FiNDBjMDg1Y2FkZTg1NmJlNzAzZWRfMTMtMS0xLTEtMA_6e7ca319-6307-4734-9606-f258adfaa846">470,685</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:nonNumeric><ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMzAwOTk_215fb02f-4681-4dad-9087-87e3c80787e5" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">INCOME TAXES -  Income tax expense is computed using an asset and liability method and using expected annual effective tax rates. Under this method, deferred income tax assets and liabilities result from temporary differences in the financial reporting bases and the income tax reporting bases of assets and liabilities. The measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefit that, based on available evidence, is not expected to be realized. When it appears more likely than not that deferred taxes will not be realized, a valuation allowance is recorded to reduce the deferred tax asset to its estimated realizable value. For net deferred tax assets we consider estimates of future taxable income in determining whether our net deferred tax assets are more likely than not to be realized. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded an income tax expense of $<ix:nonFraction unitRef="usd" contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMTI1NjY_466ef77b-fe20-4f62-8454-f9b457e5f1c4">3.8</ix:nonFraction> million, or an effective tax rate of <ix:nonFraction unitRef="number" contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMTI1OTg_17072476-1ebc-4eb2-8b25-7cfcacb90cbb">27.2</ix:nonFraction>%, for the three months ended September 30, 2020 compared to an income tax expense of $<ix:nonFraction unitRef="usd" contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMTI2NTA_eb29a957-8ea0-4597-8450-bce4092fc375">1.8</ix:nonFraction> million, or an effective tax rate of <ix:nonFraction unitRef="number" contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMTI2ODI_fadcdb90-5828-4a7c-90e4-46ff75ce2651">26.3</ix:nonFraction>% for the three months ended September 30, 2019. We recorded an income tax benefit of $<ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMTI3MzQ_16f1142b-957d-4638-b215-b77f7eca1653">5.0</ix:nonFraction> million, or an effective tax rate of <ix:nonFraction unitRef="number" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMTI3NjY_c07c2812-4193-49eb-9b19-e11d1b6fc301">28.3</ix:nonFraction>%, for the nine months ended September 30, 2020 compared to an income tax expense of $<ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMTI4MTg_db5ce7ec-adf4-44c6-ad8f-13adb744279b">3.6</ix:nonFraction> million , or an effective tax rate of <ix:nonFraction unitRef="number" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMTI4NTE_70f4546a-8bd1-41f0-ba9a-4f1f03022da1">24.8</ix:nonFraction>% for the nine months ended September 30, 2019.The income tax rates for the three and nine months ended September&#160;30, 2020 diverge from the federal statutory rate due to (i) noncontrolling interests due to the controlled partnerships; (ii) effects of state income taxes; and (iii) excess tax benefits attributable to share-based compensation.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe no significant changes in the unrecognized tax benefits will occur within the next 12 months.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 27, 2020, the President of the United States signed into law the Coronavirus Aid, Relief, and Economic Security Act ("CARES Act"). The CARES Act, among other things, includes certain income tax provisions for individuals and corporations; however, these benefits do not impact the Company&#8217;s current tax provision.</span></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" name="us-gaap:LesseeLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMzAwODY_1ca83f9b-55bb-4845-8a54-901416f9e188" continuedAt="i064bf0f7569f47bb96b381add77fa33d" escape="true">LEASES - We determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (&#8220;ROU&#8221;) assets, current operating lease liabilities, and long term operating lease liability in our consolidated balance sheets. Finance leases are included in property and equipment, current finance lease liability, and long-term finance lease liability in our consolidated balance sheets.&#160;&#160;ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. We use the implicit rate when readily determinable.  We include options to extend a lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term.  For a contract in which we are a lessee that contains fixed </ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_25">Table of Contents</a></span></div></div><ix:continuation id="ibd4ec6d11dbd408ebb4b42fe3432e0a1" continuedAt="ieca5e6b01dfa422cb378f0ad5d37d38e"><div style="margin-top:10pt;text-align:justify"><ix:continuation id="i064bf0f7569f47bb96b381add77fa33d"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">payments for both lease and non-lease components, we have elected to account for the components as a single lease component, as permitted. For finance leases, interest expense on the lease liability is recognized using the effective interest method and amortization of the ROU asset is recognized on a straight-line basis over the shorter of the estimated useful life of the asset or the lease term.  </span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ROU assets are</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> tested for impairment if circumstances suggest that the carrying amount may not be recoverable.  Our ROU assets consist of facility and equipment assets on operating leases.  No events have occurred such as fire, flood, or other acts which have impaired the integrity of our ROU assets in 2020.  Our facility leases require us to maintain insurance policies which would cover major damage to our facilities.  We maintain business interruption insurance to cover loss of business due to a facility becoming non-operational under certain circumstances.  Our equipment leases are covered by warranty and service contracts which cover repairs and provide regular maintenance to keep the equipment in functioning order.</span></ix:continuation></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" name="us-gaap:CompensationRelatedCostsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMzAwNjY_21c18807-1d7f-4798-a425-f5f0ee4540e4" escape="true">EQUITY BASED COMPENSATION &#8211; We have one long-term incentive plan that we adopted in 2006 and which we first amended and restated as of April 20, 2015, and again on March 9, 2017 (the &#8220;Restated Plan&#8221;). The Restated Plan was approved by our stockholders at our annual stockholders meeting on June 8, 2017. We have reserved <ix:nonFraction unitRef="shares" contextRef="i027fbe622cb740e796aa36dc1f00b42e_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMTYzMDQ_24016147-e26d-46b8-9ae8-dce3d0958d11">14,000,000</ix:nonFraction> shares of common stock for issuance under the Restated Plan which can be issued in the form of options, stock awards, stock appreciation rights, stock units, and cash awards.  Stock options generally vest over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMTY2Mzg_7bbe4cad-8aac-4d51-9911-a759df597876">three</span> to <ix:nonNumeric contextRef="i73cdb78ce3cb47cf9c32f71cc3b685a7_D20200101-20200930" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMTY2NDQ_e3594fff-204d-4088-8d77-992371e3fe6d">five years</ix:nonNumeric> and expire <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMTY2NTg_8014eae6-0e25-46ab-80ed-ec3b42b893fd">five</span> to <ix:nonNumeric contextRef="i73cdb78ce3cb47cf9c32f71cc3b685a7_D20200101-20200930" format="ixt-sec:durwordsen" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMTY2NjQ_bb4d0088-3737-409b-94f6-929ec4dab1c7">ten years</ix:nonNumeric> from date of grant.  We determine the compensation expense for each stock option award using the Black Scholes, or similar valuation model.  Those models require that our management make certain estimates concerning risk free interest rates and volatility in the trading price of our common stock. The compensation expense recognized for all equity-based awards is recognized over the awards&#8217; service periods. Equity-based compensation is classified in operating expenses within the same line item as the majority of the cash compensation paid to employees.  In connection with our acquisition of DeepHealth Inc. on June 1, 2020, we assumed the DeepHealth, Inc. 2017 Stock Incentive Plan, including outstanding options awards that can be exercised for our common stock.  No additional awards will be granted under the DeepHealth, Inc. 2017 Equity Incentive Plan.  See Note 4, Facility Acquisitions and Note 6, Stock-Based Compensation, for more information.</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMzAwODc_ce20e728-b3c2-41a7-be62-1655a2d16069" escape="true">COMPREHENSIVE INCOME (LOSS) - ASC 220 establishes rules for reporting and displaying comprehensive income or loss and its components. Our unrealized gains or losses on foreign currency translation adjustments, interest rate cap and swap agreements are included in comprehensive loss and are included in the consolidated statements of comprehensive income (loss) for the three and nine months ended September&#160;30, 2020 and 2019</ix:nonNumeric>.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMzAxMDc_4c10446d-b582-408c-91bf-b46069cd5168" escape="true">COMMITMENTS AND CONTINGENCIES - We are party to various legal proceedings, claims, and regulatory, tax or government inquiries and investigations that arise in the ordinary course of business. With respect to these matters, we evaluate the developments on a regular basis and accrue a liability when we believe a loss is probable and the amount can be reasonably estimated. Based on current information, we do not believe that reasonably possible or probable losses associated with pending legal proceedings would either individually or in the aggregate, have a material adverse effect on our business and consolidated financial statements. However, the outcome of these matters is inherently uncertain. Therefore, if one or more of these matters were resolved against us for amounts in excess of management's expectations, our results of operations and financial condition, including in a particular reporting period in which any such outcome becomes probable and estimable, could be materially adversely affected.</ix:nonNumeric></span></div><ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMzAwODA_70b49a30-f8ab-422b-a7e8-44ca7e9abd9d" continuedAt="i5c1f492354b5490987a17a3c212af7fe" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DERIVATIVE INSTRUMENTS</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2016 CAPS</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2016, we entered into <ix:nonFraction unitRef="numberofagreement" contextRef="i658e0bcb8f99489086788f33b3dd88c1_I20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DerivativeAssetNumberOfInstrumentsHeld" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMTY0OTI2NzQ5NDI1Mg_0ed97b0f-78f3-4f40-b3f9-305cebe87396">two</ix:nonFraction> forward interest rate cap agreements ("2016 Caps"). The 2016 Caps will mature in September and October 2020. The 2016 Caps had notional amounts of $<ix:nonFraction unitRef="usd" contextRef="i91802bf2d66e48f8b03dbae52a216767_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssetNotionalAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMTg5NzM_e5ee2b0c-d0b4-456f-9e63-b25b9307912e">150,000,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="idc736fa25bf945e0a7f00b0f62403cd4_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssetNotionalAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMTg5ODA_facc8c68-2250-40ad-a335-9caae719fa51">350,000,000</ix:nonFraction>, respectively. Under these arrangements, the Company purchased a cap on 3 month LIBOR at <ix:nonFraction unitRef="number" contextRef="i4052e92e79fc4969969e1b1a1bdef340_I20200930" decimals="INF" name="us-gaap:DerivativeBasisSpreadOnVariableRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMTkwNzI_45d5e20d-a568-4ae3-a629-51a5b2ec625d">2.0</ix:nonFraction>%. We incurred a $<ix:nonFraction unitRef="usd" contextRef="i658e0bcb8f99489086788f33b3dd88c1_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMTkwOTA_6c7cebed-a334-4b15-b0c7-2eaad47f6178">5.3</ix:nonFraction> million premium to enter into the 2016 Caps which is being accrued over the life of the agreements.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At inception, we designated our 2016 Caps as cash flow hedges of floating-rate borrowings. In accordance with accounting guidance, derivatives that have been designated and qualify as cash flow hedging instruments are reported at fair value. The gain or loss of the hedge (i.e. change in fair value) is reported as a component of comprehensive loss in the consolidated statement of equity since such hedge has been determined to be effective.  See Fair Value Measurements section below for the fair value of the 2016 Caps at September&#160;30, 2020.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" name="us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMzAxMTM_55cc9c5f-4627-4440-b2ad-1bf698376a2c" continuedAt="i0a5853dfe25e48e3bc4a02706b5db3ab" escape="true">A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive loss of the 2016 Caps is as follows (amounts in thousands):</ix:nonNumeric></span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_25">Table of Contents</a></span></div></div><ix:continuation id="ieca5e6b01dfa422cb378f0ad5d37d38e" continuedAt="i3d628c8257fd4ca883c04ca0e21e28a8"><ix:continuation id="i5c1f492354b5490987a17a3c212af7fe" continuedAt="i6df7af94096c405a8a8dd3f09f87c375"><ix:continuation id="i0a5853dfe25e48e3bc4a02706b5db3ab" continuedAt="i03540386ca6f45c886bb1d716ed9bec1"><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:42.512%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.108%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.650%"></td><td style="width:0.1%"></td></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Account</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">July 1, 2020 Balance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of comprehensive gain recognized on derivative net of taxes</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020 Balance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Other Comprehensive Loss, net of taxes</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6a7deb3c96cc42bcaa935bd270ffd41b_I20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmRmYzIxMzUxMzE4NDQ4ODdhNTNkYTQ1OWI3ZmZjZWFhL3RhYmxlcmFuZ2U6ZGZjMjEzNTEzMTg0NDg4N2E1M2RhNDU5YjdmZmNlYWFfMi0yLTEtMS0w_62705f99-c54c-4ac2-88a1-22911d02a8c8">1,409</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ae781a9e9de432895fcc55db7b0b610_D20200701-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmRmYzIxMzUxMzE4NDQ4ODdhNTNkYTQ1OWI3ZmZjZWFhL3RhYmxlcmFuZ2U6ZGZjMjEzNTEzMTg0NDg4N2E1M2RhNDU5YjdmZmNlYWFfMi00LTEtMS0w_b4d3a814-4ce1-420f-8ba1-b7560c7a1911">195</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e0459768a414e26a0829c4867e4d0d0_I20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmRmYzIxMzUxMzE4NDQ4ODdhNTNkYTQ1OWI3ZmZjZWFhL3RhYmxlcmFuZ2U6ZGZjMjEzNTEzMTg0NDg4N2E1M2RhNDU5YjdmZmNlYWFfMi02LTEtMS0w_80f39cb0-c64a-4381-a8e1-d1581a29c907">1,214</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities and Equity</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:42.512%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.108%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.650%"></td><td style="width:0.1%"></td></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the nine months ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Account</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1, 2020 Balance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of comprehensive gain recognized on derivative net of taxes</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020 Balance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Other Comprehensive Loss, net of taxes</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f380d5dd68c48e19e7b1642f1ddc90a_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjgxYzk4NTA3Y2ExNDRlZTQ5MTkxY2FmYTFjOWQ3Y2U2L3RhYmxlcmFuZ2U6ODFjOTg1MDdjYTE0NGVlNDkxOTFjYWZhMWM5ZDdjZTZfMi0yLTEtMS0w_f7ed630f-50ae-4979-815b-af6ffa77c40f">1,877</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i042c5a0cd0164e16bee1a9405ebde456_D20200101-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjgxYzk4NTA3Y2ExNDRlZTQ5MTkxY2FmYTFjOWQ3Y2U2L3RhYmxlcmFuZ2U6ODFjOTg1MDdjYTE0NGVlNDkxOTFjYWZhMWM5ZDdjZTZfMi00LTEtMS0w_6668d130-f074-4c7e-817f-90a21b1fd029">663</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e0459768a414e26a0829c4867e4d0d0_I20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjgxYzk4NTA3Y2ExNDRlZTQ5MTkxY2FmYTFjOWQ3Y2U2L3RhYmxlcmFuZ2U6ODFjOTg1MDdjYTE0NGVlNDkxOTFjYWZhMWM5ZDdjZTZfMi02LTEtMS0w_0ee3276c-99e5-4ca1-9bb3-6f5f1a0ce0ff">1,214</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities and Equity</span></td></tr></table></div></ix:continuation><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2019 SWAPS</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2019, we entered into <ix:nonFraction unitRef="numberofagreement" contextRef="i1b5787978e97447bb1142eeeaa5ad186_I20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DerivativeAssetNumberOfInstrumentsHeld" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMTY0OTI2NzQ5NDI2MQ_f8cbe8cf-ebb5-474d-b637-d7067ad00bc5">four</ix:nonFraction> forward interest rate agreements ("2019 Swaps").  The 2019 Swaps have total notional amounts of $<ix:nonFraction unitRef="usd" contextRef="ib707578bfbd243ac8417cc2b7cbfd5e7_I20190630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssetNotionalAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjAwNDk_61647e11-1777-4f58-9734-d4e1c8d097da">500,000,000</ix:nonFraction>, consisting of two agreements of $<ix:nonFraction unitRef="usd" contextRef="i5dc9976fcf3a4031bb4bd9fd7345be68_I20190630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssetNotionalAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjAwODU_d8cb9032-ec01-43cc-8366-6edb322d63b2">50,000,000</ix:nonFraction> each and two agreements of  $<ix:nonFraction unitRef="usd" contextRef="i91b5b54bcf7a4da796a36d934ff39258_I20190630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssetNotionalAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjAxMTY_9b01ed96-7838-4eb1-9fee-a1654347cc54">200,000,000</ix:nonFraction> each.   The 2019 Swaps will secure a constant interest rate associated with portions of our variable rate bank debt and have an effective date of October 13, 2020. They will mature in October 2023 for the smaller notional and October 2025 for the larger notional. Under these arrangements, we arranged the 2019 Swaps with locked in 1 month LIBOR rates at <ix:nonFraction unitRef="number" contextRef="ia060340684bb4943a12a873d70c71339_I20190630" decimals="INF" name="us-gaap:DerivativeBasisSpreadOnVariableRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjA0NzQ_05fe54af-ce36-4bff-97ca-cbbd55b2d33a">1.96</ix:nonFraction>% for the $<ix:nonFraction unitRef="usd" contextRef="i62e737b9da50433792d2421c47ccf0cc_I20190630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssetNotionalAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjA0ODU_0d898c97-8b64-48a1-b40a-8c43eb1d3302">100,000,000</ix:nonFraction> notional and at <ix:nonFraction unitRef="number" contextRef="ifcd8f19b217b413699a01d86bc9952fd_I20190630" decimals="INF" name="us-gaap:DerivativeBasisSpreadOnVariableRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjA1MDQ_ac5a360a-3390-4de3-894c-3f388b5feb5e">2.05</ix:nonFraction>%  for the $<ix:nonFraction unitRef="usd" contextRef="i3910f866882c4e5bb053c720b008b7b3_I20190630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssetNotionalAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjA1MTY_efde62ce-dbac-4601-ab83-d5e80aeeea12">400,000,000</ix:nonFraction> notional.  As of the effective date, we will be liable for premium payments if interest rates decline below arranged rates, but will receive interest payments if rates remain above the arranged rates.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At inception, we designated our 2019 Swaps as cash flow hedges of floating-rate borrowings. In accordance with accounting guidance, derivatives that have been designated and qualify as cash flow hedging instruments are reported at fair value. The gain or loss on the effective portion of the hedge (i.e. change in fair value) is reported as a component of comprehensive loss in the consolidated statement of equity.  The remaining gain or loss, if any, is recognized currently in earnings.  As a result of the economic impact of the coronavirus pandemic, which precipitated a reduction in interest rates , the cash flows for both our $<ix:nonFraction unitRef="usd" contextRef="i3910f866882c4e5bb053c720b008b7b3_I20190630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssetNotionalAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjEzNDk_efde62ce-dbac-4601-ab83-d5e80aeeea12">400,000,000</ix:nonFraction> notional interest rate swap contract locked in at <ix:nonFraction unitRef="number" contextRef="ifcd8f19b217b413699a01d86bc9952fd_I20190630" decimals="INF" name="us-gaap:DerivativeBasisSpreadOnVariableRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjE0MDI_ac5a360a-3390-4de3-894c-3f388b5feb5e">2.05</ix:nonFraction>% due October 2025 and our $<ix:nonFraction unitRef="usd" contextRef="i62e737b9da50433792d2421c47ccf0cc_I20190630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssetNotionalAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjc0ODc3OTA5OTYxNg_0d898c97-8b64-48a1-b40a-8c43eb1d3302">100,000,000</ix:nonFraction> notional interest rate swap contract locked in at <ix:nonFraction unitRef="number" contextRef="ia060340684bb4943a12a873d70c71339_I20190630" decimals="INF" name="us-gaap:DerivativeBasisSpreadOnVariableRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjc0ODc3OTA5OTYzMw_05fe54af-ce36-4bff-97ca-cbbd55b2d33a">1.96</ix:nonFraction>% do not match the cash flows for our First Lien Term Loans and so we have determined that they are not currently effective as cash flow hedges. Accordingly, all changes in their fair value after April 1, 2020 for the $<ix:nonFraction unitRef="usd" contextRef="i3910f866882c4e5bb053c720b008b7b3_I20190630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssetNotionalAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjc0ODc3OTA5OTY1OA_efde62ce-dbac-4601-ab83-d5e80aeeea12">400,000,000</ix:nonFraction> notional and after July 1, 2020 for the $<ix:nonFraction unitRef="usd" contextRef="i62e737b9da50433792d2421c47ccf0cc_I20190630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssetNotionalAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjc0ODc3OTA5OTcxMA_0d898c97-8b64-48a1-b40a-8c43eb1d3302">100,000,000</ix:nonFraction> notional will be recognized in earnings.&#160;As of July 1, 2020, the total change in fair value relating to swaps included in other comprehensive income was approximately $<ix:nonFraction unitRef="usd" contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjE4MDg_0425efbf-b478-4151-a032-b744aed93b57">24.4</ix:nonFraction> million, net of taxes.  This amount will be amortized to interest expense through October 2025 at approximately $<ix:nonFraction unitRef="usd" contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930" decimals="-5" format="ixt:numdotdecimal" name="rdnt:MonthlyAmortizationOfDeferredHedgeGains" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjE5MDE_438eeb22-06d6-4357-b6a1-561cb9cdc36c">0.4</ix:nonFraction> million per month.</span></div><ix:continuation id="i03540386ca6f45c886bb1d716ed9bec1" continuedAt="ic0836c555e594a5b9034e5bcf1a1d245"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive loss of the 2019 swaps which remain ineffective is as follows (amounts in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.660%"><tr><td style="width:1.0%"></td><td style="width:36.624%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.548%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.229%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.548%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.217%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.548%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.528%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.548%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.528%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.548%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.534%"></td><td style="width:0.1%"></td></tr><tr><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Account</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">July 1, 2020 Balance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of comprehensive loss recognized on derivative net of taxes</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of loss reclassified out of accumulated OCI into income (prior period effective portion), net of taxes</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020 Balance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Other Comprehensive Loss, net of taxes</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i77a7a48de64144dbbdb67e5d5e1fd55d_I20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmQ3M2NjZWQwNTZiZTQ1NzM5OGQ3YTRiMjNhM2Q1ZWIxL3RhYmxlcmFuZ2U6ZDczY2NlZDA1NmJlNDU3Mzk4ZDdhNGIyM2EzZDVlYjFfMi0yLTEtMS0w_4021d72f-6cd0-4688-9d75-cb06bb7eda77">24,406</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57991304d22244b4afe63c7cf8852d25_D20200701-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmQ3M2NjZWQwNTZiZTQ1NzM5OGQ3YTRiMjNhM2Q1ZWIxL3RhYmxlcmFuZ2U6ZDczY2NlZDA1NmJlNDU3Mzk4ZDdhNGIyM2EzZDVlYjFfMi00LTEtMS0w_74b8ab5a-48b4-47f1-8392-796cd3254964">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57991304d22244b4afe63c7cf8852d25_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmQ3M2NjZWQwNTZiZTQ1NzM5OGQ3YTRiMjNhM2Q1ZWIxL3RhYmxlcmFuZ2U6ZDczY2NlZDA1NmJlNDU3Mzk4ZDdhNGIyM2EzZDVlYjFfMi02LTEtMS0w_0d8a0b4b-5154-4b1d-8a31-670d4e433d05">969</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cef0dd9679a4974b78ae9d5a40855d5_I20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmQ3M2NjZWQwNTZiZTQ1NzM5OGQ3YTRiMjNhM2Q1ZWIxL3RhYmxlcmFuZ2U6ZDczY2NlZDA1NmJlNDU3Mzk4ZDdhNGIyM2EzZDVlYjFfMi04LTEtMS0w_d62ebc58-be46-47bf-955d-38224194cdaa">23,437</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities and Equity</span></td></tr></table></div></ix:continuation></ix:continuation></ix:continuation><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_25">Table of Contents</a></span></div></div><ix:continuation id="i3d628c8257fd4ca883c04ca0e21e28a8" continuedAt="i88f4dd9eae4e453e8f10f0e9c2bd61b6"><ix:continuation id="i6df7af94096c405a8a8dd3f09f87c375"><ix:continuation id="ic0836c555e594a5b9034e5bcf1a1d245"><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.052%"><tr><td style="width:1.0%"></td><td style="width:35.886%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.561%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.561%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.490%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.561%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.561%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.706%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.561%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.709%"></td><td style="width:0.1%"></td></tr><tr><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the nine months ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Account</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1, 2020 Balance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of comprehensive loss recognized on derivative net of taxes</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of loss reclassified out of accumulated OCI into income (prior period effective portion), net of taxes</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020 Balance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Other Comprehensive Loss, net of taxes</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i59e1973e89c2415998dcf8ff7e0ecc39_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmIyNzM0MGM5YjRiMjQ0Yzk5YTk2MDI2ZTRiZGJlOWI5L3RhYmxlcmFuZ2U6YjI3MzQwYzliNGIyNDRjOTlhOTYwMjZlNGJkYmU5YjlfMi0yLTEtMS0w_6469c34c-5bcc-4892-b5ae-5a82597174ca">5,870</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if3da5fe50e89470eab1ee1a1f974a635_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmIyNzM0MGM5YjRiMjQ0Yzk5YTk2MDI2ZTRiZGJlOWI5L3RhYmxlcmFuZ2U6YjI3MzQwYzliNGIyNDRjOTlhOTYwMjZlNGJkYmU5YjlfMi00LTEtMS0w_630577bf-290f-4286-a9f5-3c16da050287">19,428</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3da5fe50e89470eab1ee1a1f974a635_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmIyNzM0MGM5YjRiMjQ0Yzk5YTk2MDI2ZTRiZGJlOWI5L3RhYmxlcmFuZ2U6YjI3MzQwYzliNGIyNDRjOTlhOTYwMjZlNGJkYmU5YjlfMi02LTEtMS0w_334a3d90-83d8-4ef8-bef9-0f7642fddbe4">1,861</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cef0dd9679a4974b78ae9d5a40855d5_I20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmIyNzM0MGM5YjRiMjQ0Yzk5YTk2MDI2ZTRiZGJlOWI5L3RhYmxlcmFuZ2U6YjI3MzQwYzliNGIyNDRjOTlhOTYwMjZlNGJkYmU5YjlfMi04LTEtMS0w_20132c76-b8e3-4f07-ae24-b3bc82557980">23,437</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities and Equity</span></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A tabular presentation of the effect of derivative instruments on our statement of operations of the 2019 Swaps for the Swaps that became ineffective during the third quarter is as follows (amounts in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.345%"><tr><td style="width:1.0%"></td><td style="width:23.027%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.109%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.109%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.109%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.114%"></td><td style="width:0.1%"></td></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ineffective interest rate swap</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of loss recognized in income on derivative (current period ineffective portion)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of  loss recognized in Income on derivative (current period ineffective portion)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of loss reclassified from accumulated OCI into income (prior period effective portion)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of gain (Loss) reclassified from accumulated OCI into income (prior period effective portion)</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie82dec00a8604d95a2968bee33120c7b_D20200701-20200930" decimals="-3" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjQ4ZTY1MTEzMDYxZjRkMTVhN2Q4MjUzYTc4ZDk3NmNkL3RhYmxlcmFuZ2U6NDhlNjUxMTMwNjFmNGQxNWE3ZDgyNTNhNzhkOTc2Y2RfMi0yLTEtMS0w_adb0c28c-6f83-460d-99cb-6f10a17013b2">679</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense)</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i431f25720da34567b5a173bf4a73fe62_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjQ4ZTY1MTEzMDYxZjRkMTVhN2Q4MjUzYTc4ZDk3NmNkL3RhYmxlcmFuZ2U6NDhlNjUxMTMwNjFmNGQxNWE3ZDgyNTNhNzhkOTc2Y2RfMi02LTEtMS0w_8be53258-6248-4e98-a3f8-30694adc24cb">1,312</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity and Interest Expense</span></td></tr></table></div></ix:continuation></ix:continuation><div style="margin-bottom:6pt;margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.345%"><tr><td style="width:1.0%"></td><td style="width:23.027%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.109%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.109%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.109%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.114%"></td><td style="width:0.1%"></td></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the nine months ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ineffective interest rate swap</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of loss recognized in income on derivative (current period ineffective portion)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of  loss recognized in Income on derivative (current period ineffective portion)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of loss reclassified from accumulated OCI into income (prior period effective portion)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of gain (Loss) reclassified from accumulated OCI into income (prior period effective portion)</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i889543454acf49acbccb8ebd9c38f86a_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjAyNzU0MzBmZmQzMzRhNTNhYzIxYjE1NTMyOTFkZDJiL3RhYmxlcmFuZ2U6MDI3NTQzMGZmZDMzNGE1M2FjMjFiMTU1MzI5MWRkMmJfMi0yLTEtMS02NjU_cb2c6e4d-2cea-4a25-afa6-8aaa606ed7d4">4,523</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense)</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia396b2b61c8e4b9abc54299a4a1c0633_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjAyNzU0MzBmZmQzMzRhNTNhYzIxYjE1NTMyOTFkZDJiL3RhYmxlcmFuZ2U6MDI3NTQzMGZmZDMzNGE1M2FjMjFiMTU1MzI5MWRkMmJfMi02LTEtMS02Njk_930e5e2b-4e16-4e2c-a1c5-a2ce21dcd5b7">2,204</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity and Interest Expense</span></td></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Fair Value Measurements section below for the fair value of the 2016 caps and 2019 swaps at September&#160;30, 2020.</span></div><ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMzAwNzM_98af7f22-3473-4bb7-b70b-aec23f4f0353" continuedAt="ic18de92ea7434f77b49d392d679f6d11" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FAIR VALUE MEASUREMENTS &#8211; Assets and liabilities subject to fair value measurements are required to be disclosed within a fair value hierarchy. The fair value hierarchy ranks the quality and reliability of inputs used to determine fair value. Accordingly, assets and liabilities carried at, or permitted to be carried at, fair value are classified within the fair value hierarchy in one of the following categories based on the lowest level input that is significant to a fair value measurement:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;1&#8212;Fair value is determined by using unadjusted quoted prices that are available in active markets for identical assets and liabilities.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;2&#8212;Fair value is determined by using inputs other than Level&#160;1 quoted prices that are directly or indirectly observable. Inputs can include quoted prices for similar assets and liabilities in active markets or quoted prices for identical assets and liabilities in inactive markets. Related inputs can also include those used in valuation or other pricing models such as interest rates and yield curves that can be corroborated by observable market data.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;3&#8212;Fair value is determined by using inputs that are unobservable and not corroborated by market data. Use of these inputs involves significant and subjective judgment.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Derivatives:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" name="us-gaap:FairValueByBalanceSheetGroupingTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMzAwODE_b5720022-69a2-4163-89c5-df52d77c4cf4" continuedAt="i55fa48ccc56c4f08b521488c77307e3a" escape="true">The tables below summarize the estimated fair values of certain of our financial assets that are subject to fair value measurements, and the classification of these assets on our condensed consolidated balance sheets, as follows (in thousands):</ix:nonNumeric></span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_25">Table of Contents</a></span></div></div><ix:continuation id="i88f4dd9eae4e453e8f10f0e9c2bd61b6" continuedAt="i2fc7072271ce4500be3359675b67a3f3"><ix:continuation id="ic18de92ea7434f77b49d392d679f6d11"><ix:continuation id="i55fa48ccc56c4f08b521488c77307e3a" continuedAt="i904c4c76d04542f78ebd580b1e7238ed"><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:49.779%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.632%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 30, 2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current and long term liabilities</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2016 caps - Interest Rate Contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia385deaca17344c6a8f1436288ae4840_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:AccruedLiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjI1ZGE0ZTdlYmUxNjRmNmE4ZTZlMDVlMDA2YTJiZjQ4L3RhYmxlcmFuZ2U6MjVkYTRlN2ViZTE2NGY2YThlNmUwNWUwMDZhMmJmNDhfMy0xLTEtMS0w_7a7e5ab0-198d-48bc-8ea7-3a48bfa55c4d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01ce6999cc2b4bf9b84083975db56a53_I20200930" decimals="-3" name="us-gaap:AccruedLiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjI1ZGE0ZTdlYmUxNjRmNmE4ZTZlMDVlMDA2YTJiZjQ4L3RhYmxlcmFuZ2U6MjVkYTRlN2ViZTE2NGY2YThlNmUwNWUwMDZhMmJmNDhfMy0zLTEtMS0w_44f56c43-36ae-4ee6-9ea4-138584a81192">182</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b463d8a36cc4c62adba03e5d8291e67_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:AccruedLiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjI1ZGE0ZTdlYmUxNjRmNmE4ZTZlMDVlMDA2YTJiZjQ4L3RhYmxlcmFuZ2U6MjVkYTRlN2ViZTE2NGY2YThlNmUwNWUwMDZhMmJmNDhfMy01LTEtMS0w_8ced4af4-c406-4403-a6a1-953714379694">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c840428ea464162be7bc72c9f034b71_I20200930" decimals="-3" name="us-gaap:AccruedLiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjI1ZGE0ZTdlYmUxNjRmNmE4ZTZlMDVlMDA2YTJiZjQ4L3RhYmxlcmFuZ2U6MjVkYTRlN2ViZTE2NGY2YThlNmUwNWUwMDZhMmJmNDhfMy03LTEtMS0w_9e5d73ad-01c5-4632-8ac9-e18186c18b99">182</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 swaps - Interest Rate Contracts</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c5e95d255df47498c382ead963f4c96_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:AccruedLiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjI1ZGE0ZTdlYmUxNjRmNmE4ZTZlMDVlMDA2YTJiZjQ4L3RhYmxlcmFuZ2U6MjVkYTRlN2ViZTE2NGY2YThlNmUwNWUwMDZhMmJmNDhfNC0xLTEtMS0w_200e5b0c-7e60-4e23-a58e-542a33ba5f3c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0824895d6334dfe9da358f2324b7091_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjI1ZGE0ZTdlYmUxNjRmNmE4ZTZlMDVlMDA2YTJiZjQ4L3RhYmxlcmFuZ2U6MjVkYTRlN2ViZTE2NGY2YThlNmUwNWUwMDZhMmJmNDhfNC0zLTEtMS0w_c8b6489b-f8cc-47e3-a760-1fcbba43f30c">39,983</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f6dd49d77474e6fb6ccf417ecec63d2_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:AccruedLiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjI1ZGE0ZTdlYmUxNjRmNmE4ZTZlMDVlMDA2YTJiZjQ4L3RhYmxlcmFuZ2U6MjVkYTRlN2ViZTE2NGY2YThlNmUwNWUwMDZhMmJmNDhfNC01LTEtMS0w_6631c192-dbf2-44a8-9103-ad441209a242">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48d3b990dba24f0cb0d02544b0cf7fa6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjI1ZGE0ZTdlYmUxNjRmNmE4ZTZlMDVlMDA2YTJiZjQ4L3RhYmxlcmFuZ2U6MjVkYTRlN2ViZTE2NGY2YThlNmUwNWUwMDZhMmJmNDhfNC03LTEtMS0w_3ebbc569-6434-47f7-8a7d-78d64654dd7c">39,983</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:49.779%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.632%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2019</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current and long term liabilities</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2016 caps - Interest Rate Contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4387d0038f9941debbb302baf4924da2_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AccruedLiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmMxNDZkNjk5MzI3NDQ3ZGZhN2M5MzkzYjVjZDg3YTJmL3RhYmxlcmFuZ2U6YzE0NmQ2OTkzMjc0NDdkZmE3YzkzOTNiNWNkODdhMmZfMy0xLTEtMS0w_6dc96fd2-6a53-49e7-ae9a-82eb0f3e9d84">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5fd69436b804acfb68af2e47702c383_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmMxNDZkNjk5MzI3NDQ3ZGZhN2M5MzkzYjVjZDg3YTJmL3RhYmxlcmFuZ2U6YzE0NmQ2OTkzMjc0NDdkZmE3YzkzOTNiNWNkODdhMmZfMy0zLTEtMS0w_88e624a7-eff7-4af8-927f-93258fe2eed6">1,081</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59307cb2dd2b47f9a6120f81576277c0_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AccruedLiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmMxNDZkNjk5MzI3NDQ3ZGZhN2M5MzkzYjVjZDg3YTJmL3RhYmxlcmFuZ2U6YzE0NmQ2OTkzMjc0NDdkZmE3YzkzOTNiNWNkODdhMmZfMy01LTEtMS0w_a0712184-8efa-4fe2-b971-610f2343178c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00f4787a196b415f81d3165cb90e703b_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmMxNDZkNjk5MzI3NDQ3ZGZhN2M5MzkzYjVjZDg3YTJmL3RhYmxlcmFuZ2U6YzE0NmQ2OTkzMjc0NDdkZmE3YzkzOTNiNWNkODdhMmZfMy03LTEtMS0w_7ea91455-0218-4c99-bcc0-d47de85f82e2">1,081</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 swaps - Interest Rate Contracts</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67bcd77704ee456ab79b13a06de53338_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AccruedLiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmMxNDZkNjk5MzI3NDQ3ZGZhN2M5MzkzYjVjZDg3YTJmL3RhYmxlcmFuZ2U6YzE0NmQ2OTkzMjc0NDdkZmE3YzkzOTNiNWNkODdhMmZfNC0xLTEtMS0w_7d8691a4-a8cb-4540-88d2-671e4d651f27">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa429bfca5a2467c87c67ff821d458bd_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmMxNDZkNjk5MzI3NDQ3ZGZhN2M5MzkzYjVjZDg3YTJmL3RhYmxlcmFuZ2U6YzE0NmQ2OTkzMjc0NDdkZmE3YzkzOTNiNWNkODdhMmZfNC0zLTEtMS0w_f8aa5d6a-09e9-40a1-b0e4-2473ef5dd9d0">9,477</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e9fd1b586d44e85871ade2eab7bb3ed_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AccruedLiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmMxNDZkNjk5MzI3NDQ3ZGZhN2M5MzkzYjVjZDg3YTJmL3RhYmxlcmFuZ2U6YzE0NmQ2OTkzMjc0NDdkZmE3YzkzOTNiNWNkODdhMmZfNC01LTEtMS0w_86018a33-f27d-46fb-b17d-1c46cfbe1cf8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ided14c36476d4cab94bd8241ae0fc540_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmMxNDZkNjk5MzI3NDQ3ZGZhN2M5MzkzYjVjZDg3YTJmL3RhYmxlcmFuZ2U6YzE0NmQ2OTkzMjc0NDdkZmE3YzkzOTNiNWNkODdhMmZfNC03LTEtMS0w_b29074ee-cf88-4d05-8fe1-048a8c13b53a">9,477</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of these contracts was determined using Level 2 inputs. More specifically, the fair value was determined by calculating the value of the difference between the fixed interest rate of the interest rate swaps and the counterparty&#8217;s forward LIBOR curve. The forward LIBOR curve is readily available in the public markets or can be derived from information available in the public markets.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Long Term Debt:</span></div><ix:continuation id="i904c4c76d04542f78ebd580b1e7238ed"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the estimated fair value compared to our face value of our long-term debt as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:37.225%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.651%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 30, 2020</span></td></tr><tr style="height:21pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Face Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Lien Term Loans and SunTrust Term Loan</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3feb945275b44b0fb63b73ab2bc8752d_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:DebtInstrumentFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjc2NzliODhiMmIyNzQxNmRhYjY5MTE0NTEyMzlhZTg4L3RhYmxlcmFuZ2U6NzY3OWI4OGIyYjI3NDE2ZGFiNjkxMTQ1MTIzOWFlODhfMi0xLTEtMS0w_8d648de9-79a9-49ee-bed9-ccee813e3420">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89984b2070bb46b08c4541ec8ad418d4_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjc2NzliODhiMmIyNzQxNmRhYjY5MTE0NTEyMzlhZTg4L3RhYmxlcmFuZ2U6NzY3OWI4OGIyYjI3NDE2ZGFiNjkxMTQ1MTIzOWFlODhfMi0zLTEtMS0w_0a9aecf3-3b17-4d46-bc78-6a0782f7020d">663,140</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4a7827c18a1422ea8ef8558bf7be6c6_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:DebtInstrumentFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjc2NzliODhiMmIyNzQxNmRhYjY5MTE0NTEyMzlhZTg4L3RhYmxlcmFuZ2U6NzY3OWI4OGIyYjI3NDE2ZGFiNjkxMTQ1MTIzOWFlODhfMi01LTEtMS0w_b418e1ed-1dce-45a6-af3d-6034d4d6a433">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3612bace1a1a42f99fbd311811c270f5_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjc2NzliODhiMmIyNzQxNmRhYjY5MTE0NTEyMzlhZTg4L3RhYmxlcmFuZ2U6NzY3OWI4OGIyYjI3NDE2ZGFiNjkxMTQ1MTIzOWFlODhfMi03LTEtMS0w_1213ea59-a1c1-4dae-afd0-62b93622705d">663,140</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjc2NzliODhiMmIyNzQxNmRhYjY5MTE0NTEyMzlhZTg4L3RhYmxlcmFuZ2U6NzY3OWI4OGIyYjI3NDE2ZGFiNjkxMTQ1MTIzOWFlODhfMi05LTEtMS0w_cddceed9-9be3-49d4-8827-1bc4acf09b1d">673,227</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:37.225%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.651%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2019</span></td></tr><tr style="height:21pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Face Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Lien Term Loans and SunTrust Term Loan</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i032df92579e74d6c8afec1017d9cb9c5_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjlhYjA1MTJjOTcyYTQyZTg4YTljMTdjZGRhZmVlMWJjL3RhYmxlcmFuZ2U6OWFiMDUxMmM5NzJhNDJlODhhOWMxN2NkZGFmZWUxYmNfMi0xLTEtMS0w_3603a9f9-26b6-4e5f-8981-d0fbc8ca2186">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e87b2da11c74056a77487fc8c5830e4_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjlhYjA1MTJjOTcyYTQyZTg4YTljMTdjZGRhZmVlMWJjL3RhYmxlcmFuZ2U6OWFiMDUxMmM5NzJhNDJlODhhOWMxN2NkZGFmZWUxYmNfMi0zLTEtMS0w_fdea8d67-ff25-405a-8825-825ade6e2971">708,948</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a05e3ae8a634224aa7d2a7d85315360_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjlhYjA1MTJjOTcyYTQyZTg4YTljMTdjZGRhZmVlMWJjL3RhYmxlcmFuZ2U6OWFiMDUxMmM5NzJhNDJlODhhOWMxN2NkZGFmZWUxYmNfMi01LTEtMS0w_415ffc15-48db-45d6-b202-bcee8033158f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66da6813d35d464786a99b7d5141ed64_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjlhYjA1MTJjOTcyYTQyZTg4YTljMTdjZGRhZmVlMWJjL3RhYmxlcmFuZ2U6OWFiMDUxMmM5NzJhNDJlODhhOWMxN2NkZGFmZWUxYmNfMi03LTEtMS0w_8dd60e27-2839-4bf7-bd34-66126789d050">708,948</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjlhYjA1MTJjOTcyYTQyZTg4YTljMTdjZGRhZmVlMWJjL3RhYmxlcmFuZ2U6OWFiMDUxMmM5NzJhNDJlODhhOWMxN2NkZGFmZWUxYmNfMi05LTEtMS0w_49d68e62-00bf-4c39-96d0-f63acdc88f29">705,699</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2020 and at December&#160;31, 2019 our Barclays revolving credit facility had <ix:nonFraction unitRef="usd" contextRef="i505d1abebd8447a787b012d89a5eacb7_I20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LineOfCredit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjQ1ODk_ce915ed4-5066-48a2-9d85-91d3e27ef2ea"><ix:nonFraction unitRef="usd" contextRef="i1abfe8394b234eb5bbad4195a9ec0e60_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LineOfCredit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjQ1ODk_d37250a6-14b6-40fd-a41d-319131f9dbb0">no</ix:nonFraction></ix:nonFraction> balance outstanding. Our SunTrust revolving credit facility relating to our consolidated subsidiary NJIN, had <ix:nonFraction unitRef="usd" contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LineOfCredit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjQ3MDI_b2908313-4f0b-4d88-9973-76fff55a7ccc"><ix:nonFraction unitRef="usd" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LineOfCredit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjQ3MDI_ed2e6f78-cc1c-454b-8c60-3a1507f99766">no</ix:nonFraction></ix:nonFraction> principal amount outstanding at September&#160;30, 2020 and at December&#160;31, 2019.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of our long-term debt, which is discussed in Note 5, was determined using Level 2 inputs primarily related to comparable market prices.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider the carrying amounts of cash and cash equivalents, receivables, other current assets, current liabilities and other notes payables to approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization or payment. Additionally, we consider the carrying amount of our finance lease obligations to approximate their fair value because the weighted average interest rate used to formulate the carrying amounts approximates current market rates.</span></div></ix:continuation><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMzAwODk_92668d0b-27d3-488f-b7f8-3d6b63272786" continuedAt="i5641b3e41fe54ffbbc3852bbdfd42ca7" escape="true">EARNINGS PER SHARE - <ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMzAwOTY_27312cb2-2e9e-487f-b2ec-1fe85e2fe11f" continuedAt="i5b08cef6760d49bb9c9b2d40649e424e" escape="true">Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):</ix:nonNumeric></ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_25">Table of Contents</a></span></div></div><ix:continuation id="i2fc7072271ce4500be3359675b67a3f3" continuedAt="ie4be09f6899e452ba48477a2b273ecd8"><div style="margin-bottom:5pt;margin-top:5pt"><ix:continuation id="i5641b3e41fe54ffbbc3852bbdfd42ca7"><ix:continuation id="i5b08cef6760d49bb9c9b2d40649e424e"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.538%"><tr><td style="width:1.0%"></td><td style="width:51.570%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.175%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.175%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.175%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.182%"></td><td style="width:0.1%"></td></tr><tr style="height:21pt"><td colspan="3" rowspan="2" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="9" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to RadNet, Inc.'s common stockholders</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfMi0xLTEtMS0w_aab4274d-f5d0-43ea-a7fc-bb640e83b4e5">6,156</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfMi0zLTEtMS0w_cef91780-76f2-48da-aac5-b84ed329848e">3,195</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfMi01LTEtMS0w_3dcd7c3c-88c8-4377-9592-3ceb36d5b771">20,797</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfMi03LTEtMS0w_01a1c9f0-83fe-4c49-a16a-8becef50066f">4,360</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfNS0xLTEtMS0w_5afd4340-a201-4b81-933a-e0db5866bb4d">51,358,603</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfNS0zLTEtMS0w_1bb35a89-a95a-4687-a103-8a83aaad91a0">49,807,460</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfNS01LTEtMS0w_2de0a369-8ab7-42e8-a88c-6a036d0f78b7">50,746,380</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfNS03LTEtMS0w_a2a8489e-ce03-4a23-becc-628c6c5e8cc3">49,597,138</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net income (loss) per share attributable to RadNet, Inc.'s common stockholders</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfNi0xLTEtMS0w_ffcfa344-d756-473a-8550-584c132ef8ac">0.12</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfNi0zLTEtMS0w_844445c3-151c-46f0-91ee-f442b36cf857">0.06</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfNi01LTEtMS0w_b7fb826d-b44a-400d-bd58-ca72c53741dc">0.41</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfNi03LTEtMS0w_f8321951-7722-4578-8b36-385a9f36dab4">0.09</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfOS0xLTEtMS0w_19f6e0fa-1502-4de8-a4e7-4c30a018f8ef">51,358,603</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfOS0zLTEtMS0w_14f24c32-95cc-456b-8af6-6cd1cb688e5c">49,807,460</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfOS01LTEtMS0w_c5ef5584-25ca-42b3-9ed3-6424627e2cf7">50,746,380</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfOS03LTEtMS0w_20b81c60-36a7-46f6-803b-390c0d30b0f3">49,597,138</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add nonvested restricted stock subject only to service vesting</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesRestrictedStock" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfMTAtMS0xLTEtMA_9ab109c6-f576-4992-9d7e-dfcf4888a3ba">120,605</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesRestrictedStock" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfMTAtMy0xLTEtMA_86daffc6-a35f-4524-a5df-c1c8392db5b1">200,567</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"><ix:nonFraction unitRef="shares" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" xsi:nil="true" name="us-gaap:WeightedAverageNumberOfSharesRestrictedStock" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfMTAtNS0xLTEtMA_735b0cfc-3960-4a64-8e7b-a2dcfb5209d4"></ix:nonFraction></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesRestrictedStock" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfMTAtNy0xLTEtMA_9c5e1e52-0d79-41e3-935e-6c7659ee5cf2">191,375</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add additional shares issuable upon exercise of stock options and warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfMTEtMS0xLTEtMA_5127393a-2e51-4476-adf9-0eaef7b5f8eb">476,607</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfMTEtMy0xLTEtMA_c37f3fab-a0a1-4574-9884-ac707a1af144">352,333</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="shares" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" xsi:nil="true" name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfMTEtNS0xLTEtMA_4dcdec81-2bf0-4d05-a6fd-704416e5a4a3"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfMTEtNy0xLTEtMA_558b662f-ba6d-499a-a974-6ddcc18cb44d">324,793</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares used in calculating diluted net income per share</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfMTItMS0xLTEtMA_e4523f25-8267-401f-bb25-3018913c2109">51,955,815</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfMTItMy0xLTEtMA_fa78b836-74d9-4452-8270-ca657b05c95f">50,360,360</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfMTItNS0xLTEtMA_490c9097-eac8-4a3b-87ac-d81a80006783">50,746,380</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfMTItNy0xLTEtMA_7725edfd-8676-4197-bfc2-064c881444b4">50,113,306</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net income (loss) per share attributable to RadNet, Inc.'s common stockholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfMTMtMS0xLTEtMA_5e282904-1b35-4574-96d0-3fb63531948b">0.12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfMTMtMy0xLTEtMA_30aaef04-c432-4232-965f-5690682fac13">0.06</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfMTMtNS0xLTEtMA_1a2cf55b-4625-4026-bb72-1eb02b64e3b8">0.41</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfMTMtNy0xLTEtMA_58a8ce36-8438-423c-beda-7d08a9bd6af5">0.09</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and non vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested restricted stock subject to service vesting</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0cbd1734b449470db208d75670176435_D20200701-20200930" decimals="0" format="ixt:zerodash" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfMTUtMS0xLTEtMjg2MA_57098a07-cc2e-4d96-ada3-95a1e685c418">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i601cf4edf4274dc1b781ef5ce684831c_D20190701-20190930" decimals="0" format="ixt:zerodash" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfMTUtMy0xLTEtMjg2MA_c699466b-81cb-43cf-a786-db9bbd41eff3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id452ca96882e4a38a4bc8cd85bf9878b_D20200101-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfMTUtNS0xLTEtMjg2MA_45dea0f4-4467-4510-b8eb-ae3f7d82b251">331,659</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic0b2de2326bf4699aba943152bce409a_D20190101-20190930" decimals="0" format="ixt:zerodash" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfMTUtNy0xLTEtMjg2MA_7c5e569d-9a65-4a3d-a171-c2a293f7dfe4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issuable upon the exercise of stock options:</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfMTYtMS0xLTEtMTE2Mw_be0a6c45-8f10-470e-877a-d14655247ca1">48,948</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930" decimals="0" format="ixt:zerodash" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfMTYtMy0xLTEtMTE2Ng_304efb0f-a225-4b98-a781-c620237fa23d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfMTYtNS0xLTEtMTE2OQ_30f838f3-c656-4297-b011-81d057e77961">933,370</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="0" format="ixt:zerodash" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfMTYtNy0xLTEtMTE2OQ_0e24607a-d647-410e-99ba-204bd4f81549">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></ix:continuation></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" name="us-gaap:EquityMethodInvestmentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMzAwNjg_3fd31538-c36f-4560-a45d-f806f91085f1" escape="true">EQUITY INVESTMENTS AT FAIR VALUE&#8211;Accounting guidance requires entities to measure equity investments at fair value, with any changes in fair value recognized in net income. If there is no readily determinable fair value, the guidance allows entities the ability to measure investments at cost, adjusted for observable price changes and impairments, with changes recognized in net income.</ix:nonNumeric> </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2020, we have three equity investments for which a fair value is not readily determinable and therefore the total amounts invested are recognized at cost as follows:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medic Vision Imaging Solutions Ltd., based in Israel, specializes in software packages that provide compliant radiation dose structured reporting and enhanced images from reduced dose CT scans.  On March 24, 2017, we acquired an initial <ix:nonFraction unitRef="number" contextRef="i2ace966e50834326892e2ead3a754d4f_I20170324" decimals="INF" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjY2MTM_83b1578a-315f-40da-92fc-52a88c5d4d2a">12.5</ix:nonFraction>% equity interest in Medic Vision for $<ix:nonFraction unitRef="usd" contextRef="i918ce2e8fa4a4e8e9a15abd08285dd07_D20170324-20170324" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjY2NTI_a302c4a3-8926-465a-b09f-5bc7ab16aa03">1.0</ix:nonFraction> million. We also received an option to exercise warrants to acquire up to an additional <ix:nonFraction unitRef="number" contextRef="i2ace966e50834326892e2ead3a754d4f_I20170324" decimals="INF" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjY3MzU_a96e5b83-6f5c-4e16-bf27-33f6b3dc89ab">12.5</ix:nonFraction>% equity interest for $<ix:nonFraction unitRef="usd" contextRef="i2ace966e50834326892e2ead3a754d4f_I20170324" decimals="-5" format="ixt:numdotdecimal" name="rdnt:EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjY3NTg_deb1a1d6-669c-4718-93e1-e13e7d5b526f">1.4</ix:nonFraction> million within one year from the initial share purchase date, if exercised in full. On March 1, 2018 we exercised our warrant in part and acquired an additional <ix:nonFraction unitRef="number" contextRef="ib5e9eca7800545f5913ba28234bb8765_D20180301-20180301" decimals="INF" name="rdnt:EquityMethodInvestmentsOwnershipInterestPercentageAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjY5MTQ_c0711009-9096-4a4f-b3ad-a1a279ada9f9">1.96</ix:nonFraction>% for $<ix:nonFraction unitRef="usd" contextRef="ib5e9eca7800545f5913ba28234bb8765_D20180301-20180301" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjY5MjE_f3daff03-fbd5-4ed7-b006-5d4470370f81">0.2</ix:nonFraction> million. Our initial equity interest has been diluted to <ix:nonFraction unitRef="number" contextRef="ib5e9eca7800545f5913ba28234bb8765_D20180301-20180301" decimals="INF" name="rdnt:EquityMethodInvestmentInitialOwnershipPercentageAfterDilution" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjY5NzM_b7688d51-8bcf-465a-8d8e-e6ede66c73b3">12.25</ix:nonFraction>% and our total equity investment stands at <ix:nonFraction unitRef="number" contextRef="i9a31e32cd3854ea7a79489c93300ee4d_I20180301" decimals="INF" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjcwMTg_5b8e0afe-918f-4762-917a-a41cad0ffb68">14.21</ix:nonFraction>%.  In accordance with accounting guidance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as we exercise no significant influence over Medic Vision&#8217;s operations, the investment is recorded at its cost of $<ix:nonFraction unitRef="usd" contextRef="iaad66b5ea72843f5b39b9301e19778be_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentAggregateCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjcxNzY_012f0ebf-305d-40eb-aeb9-396882c7c69a">1.2</ix:nonFraction> million, given that the fair value is not readily determinable. No observable price changes or impairment in our investment was identified as of September&#160;30, 2020.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Turner Imaging Systems, based in Utah, develops and markets portable X-ray imaging systems that provide a user the ability to acquire X-ray images wherever and whenever they are needed. On February 1, 2018, we purchased <ix:nonFraction unitRef="shares" contextRef="i936ffb40dcb9477e990698614800d7df_D20180201-20180201" decimals="-5" format="ixt:numdotdecimal" name="rdnt:EquityMethodInvestmentSharesPurchased" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjc1Mjg_d4e9d68d-bdf6-4efc-87f7-6cf079707519">2.1</ix:nonFraction> million preferred shares in Turner Imaging Systems for $<ix:nonFraction unitRef="usd" contextRef="i936ffb40dcb9477e990698614800d7df_D20180201-20180201" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjc1Nzg_fc129543-dd52-4987-bfe9-c5fd8df2aac6">2.0</ix:nonFraction> million. On January 1, 2019 we funded a convertible promissory note in the amount of $<ix:nonFraction unitRef="usd" contextRef="ic4d616de0e5248008f9d7307398420b2_I20190101" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjc2NTg_0196580e-5368-4ccd-bf65-128c2f4a0651">0.1</ix:nonFraction> million that converted to additional <ix:nonFraction unitRef="shares" contextRef="i9f1bfde7a34b4cdcbac1a70f78d72a80_I20191011" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjc2OTA_19a312ff-2ee4-4921-ac4a-12135fdbd9e7">80,000</ix:nonFraction> shares December 21, 2019.  No observable price changes impairment in our investment was identified as of September&#160;30, 2020.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_25">Table of Contents</a></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="ie4be09f6899e452ba48477a2b273ecd8" continuedAt="ic29297c976f447999eb83202e8806ccf"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WhiteRabbit.ai Inc., based in California, is currently developing an artificial intelligence suite which aims to improve the speed and accuracy of cancer detection in radiology and improve patient care. On November 5, 2019 we acquired an equity interest in the company for $<ix:nonFraction unitRef="usd" contextRef="id8efe47b9b214f68a5239a62a1642eb8_D20191105-20191105" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjgwNzI_59ad9c7e-27cf-4da6-8a59-a2e1aa11ef26">1.0</ix:nonFraction> million and also loaned the company $<ix:nonFraction unitRef="usd" contextRef="id8efe47b9b214f68a5239a62a1642eb8_D20191105-20191105" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsToFundLongtermLoansToRelatedParties" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjgxMDM_bfce4b36-cd5f-4a71-bd07-4fb1b899dcb7">2.5</ix:nonFraction> million, the principal of which is due November 2022.  To leverage their artificial intelligence expertise, we entered into a software subscription service contract to assist our radiology work flow and advanced them $<ix:nonFraction unitRef="usd" contextRef="ic70d35efa82941bba6027c1e3fda60f0_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjgzMTU_f5326225-b6bc-4b40-8b6e-d443c7c717e9">4.0</ix:nonFraction> million for future software subscription fees that is recorded as a prepaid expense in Prepaid and Other Current assets in our consolidated balance sheets.  No observable price changes or impairment in our investment or the loan receivable was identified as of September&#160;30, 2020.</span></div><ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" name="us-gaap:InvestmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMzAwNzQ_c6626745-462f-47cb-9075-36460019eb74" continuedAt="i138c0338de7d43a39db5edd6f11e74f8" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">INVESTMENT IN JOINT VENTURES &#8211; We have </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="joint_venture" contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231" decimals="INF" name="rdnt:NumberofUnconsolidatedJointVentures" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjg1ODY_a96fb1e6-0691-465a-a97b-993649ba98a5">12</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> unconsolidated joint ventures with ownership interests ranging from <ix:nonFraction unitRef="number" contextRef="icab535e9b02f4e88a0372c47d217e396_D20190101-20190331" decimals="INF" name="us-gaap:VariableInterestEntityOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjg2NTc_049bb281-e7a5-435e-b969-2e068e6e8229">35</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="id982434e749e47d18d3f11f2943eee32_D20190101-20190331" decimals="INF" name="us-gaap:VariableInterestEntityOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjg2NjM_3349f1a4-42aa-4eb3-9b81-442adf950dbb">55</ix:nonFraction>%. These joint ventures represent partnerships with hospitals, health systems or radiology practices and were formed for the purpose of owning and operating diagnostic imaging centers. Professional services at the joint venture diagnostic imaging centers are performed by contracted radiology practices or a radiology practice that participates in the joint venture.&#160;Our investment in these joint ventures is accounted for under the equity method, since RadNet does not have a controlling financial interest in such ventures. We evaluate our investment in joint ventures, including cost in excess of book value (equity method goodwill) for impairment whenever indicators of impairment exist. No indicators of impairment existed as of September&#160;30, 2020.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Joint venture investment contribution</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the month of August 2020, we made additional cash contributions to our Santa Monica Imaging Group, LLC partnership in the amount of $<ix:nonFraction unitRef="usd" contextRef="i01a109385ece4d30a97550263c32b101_D20200801-20200831" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireInterestInJointVenture" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjE5OTAyMzI4Njg2OQ_bffd2e8d-ea1e-46ac-b83f-0e50a85a8ba9">1.6</ix:nonFraction> million in support of its expanded operations.  We maintain our <ix:nonFraction unitRef="number" contextRef="i6a8c4e00f17d4b9db8412be7b503be4e_I20200831" decimals="INF" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjE5OTAyMzI4NjkzMA_70ca573b-da4d-4c80-97a8-abbb4537bbf3">35</ix:nonFraction>% economic interest in the partnership.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Joint venture investment and financial information</span></div><ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" name="us-gaap:EquityMethodInvestmentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMzAwNjk_eb841f2e-900e-42de-a5cb-03ec22f0222b" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of our investment in joint ventures during the nine months ended September 30, 2020 (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:87.186%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjNiZDEwNzRkMjEwNjQzYTU4OGY0ZjUwMDczNDE4YTgwL3RhYmxlcmFuZ2U6M2JkMTA3NGQyMTA2NDNhNTg4ZjRmNTAwNzM0MThhODBfMC0xLTEtMS0w_a92a2df4-02af-49ad-b681-b75e1e9bfa52">34,470</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings in these joint ventures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjNiZDEwNzRkMjEwNjQzYTU4OGY0ZjUwMDczNDE4YTgwL3RhYmxlcmFuZ2U6M2JkMTA3NGQyMTA2NDNhNTg4ZjRmNTAwNzM0MThhODBfMS0xLTEtMS0w_d86a0dac-719f-449c-8d7d-ef0d2769ec42">5,176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution of earnings</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentDividendsOrDistributions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjNiZDEwNzRkMjEwNjQzYTU4OGY0ZjUwMDczNDE4YTgwL3RhYmxlcmFuZ2U6M2JkMTA3NGQyMTA2NDNhNTg4ZjRmNTAwNzM0MThhODBfMi0xLTEtMS0w_fe158c35-dc07-41e4-a570-8d46e3dd90ad">5,706</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity contributions in existing joint ventures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="rdnt:EquityContributionsInJointVentures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjNiZDEwNzRkMjEwNjQzYTU4OGY0ZjUwMDczNDE4YTgwL3RhYmxlcmFuZ2U6M2JkMTA3NGQyMTA2NDNhNTg4ZjRmNTAwNzM0MThhODBfNi0xLTEtMS0w_517ab8ed-80ca-416e-a15f-a6d79d2659b2">1,631</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2020</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjNiZDEwNzRkMjEwNjQzYTU4OGY0ZjUwMDczNDE4YTgwL3RhYmxlcmFuZ2U6M2JkMTA3NGQyMTA2NDNhNTg4ZjRmNTAwNzM0MThhODBfNy0xLTEtMS0w_8f23bfc9-e95e-4a05-ac3e-51d64e9ff18f">35,571</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We charged management service fees from the centers underlying these joint ventures of approximately $<ix:nonFraction unitRef="usd" contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930" decimals="-5" format="ixt:numdotdecimal" name="rdnt:ManagementServiceFees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjk2NTY_d7994e5c-d7e6-4204-8ecf-f87e1747e6c6">2.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930" decimals="-5" format="ixt:numdotdecimal" name="rdnt:ManagementServiceFees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjk2NjM_5b3176ba-a5dd-4b02-8deb-d72d247492c0">1.8</ix:nonFraction> million for the three months ended September&#160;30, 2020 and 2019, respectively, and $<ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-5" format="ixt:numdotdecimal" name="rdnt:ManagementServiceFees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjk3MjI_bb8248bf-c23b-4a5f-bb6e-fbf5313fad5c">8.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-5" format="ixt:numdotdecimal" name="rdnt:ManagementServiceFees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjk3Mjk_446ad0a0-5090-455f-8b16-9437259eed23">7.8</ix:nonFraction> million for the nine months ended September&#160;30, 2020 and 2019, respectively.  We eliminate any unrealized portion of our management service fees with our equity in earnings of joint ventures.</span></div><ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" name="rdnt:JointVentureInvestmentAndFinancialInformationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMTY0OTI2NzQ5MTQyNw_45d6fd78-cc38-4530-a460-1adccbf74251" continuedAt="i154156bc9f154cdcaca3bcdd49990128" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of key balance sheet data for these joint ventures as of September&#160;30, 2020 and December&#160;31, 2019 and income statement data for the nine months ended September 30, 2020 and 2019 (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:74.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance Sheet Data:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmZmZDI3OTUyYmJmNDRjYTJiMGZhYjgwOGIyMzI1N2IyL3RhYmxlcmFuZ2U6ZmZkMjc5NTJiYmY0NGNhMmIwZmFiODA4YjIzMjU3YjJfMS0xLTEtMS0w_7ffede8f-28b2-4b46-86fc-27dbdecaa564">26,618</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmZmZDI3OTUyYmJmNDRjYTJiMGZhYjgwOGIyMzI1N2IyL3RhYmxlcmFuZ2U6ZmZkMjc5NTJiYmY0NGNhMmIwZmFiODA4YjIzMjU3YjJfMS0zLTEtMS0w_812d46f7-c1c5-4601-a6f1-967fc13ee7fc">27,427</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentSummarizedFinancialInformationAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmZmZDI3OTUyYmJmNDRjYTJiMGZhYjgwOGIyMzI1N2IyL3RhYmxlcmFuZ2U6ZmZkMjc5NTJiYmY0NGNhMmIwZmFiODA4YjIzMjU3YjJfMi0xLTEtMS0w_b649e66b-1708-4117-8a39-8c5b1f954796">70,576</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentSummarizedFinancialInformationAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmZmZDI3OTUyYmJmNDRjYTJiMGZhYjgwOGIyMzI1N2IyL3RhYmxlcmFuZ2U6ZmZkMjc5NTJiYmY0NGNhMmIwZmFiODA4YjIzMjU3YjJfMi0zLTEtMS0w_fa0b3756-1542-4f1a-87b1-2ec6945e8029">61,037</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmZmZDI3OTUyYmJmNDRjYTJiMGZhYjgwOGIyMzI1N2IyL3RhYmxlcmFuZ2U6ZmZkMjc5NTJiYmY0NGNhMmIwZmFiODA4YjIzMjU3YjJfMy0xLTEtMS0w_bf6cecd2-6c96-43e4-89ac-c71fd34a9109">10,487</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmZmZDI3OTUyYmJmNDRjYTJiMGZhYjgwOGIyMzI1N2IyL3RhYmxlcmFuZ2U6ZmZkMjc5NTJiYmY0NGNhMmIwZmFiODA4YjIzMjU3YjJfMy0zLTEtMS0w_5a757bf1-a83a-4295-9f30-c5a536ea30fe">9,217</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentSummarizedFinancialInformationLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmZmZDI3OTUyYmJmNDRjYTJiMGZhYjgwOGIyMzI1N2IyL3RhYmxlcmFuZ2U6ZmZkMjc5NTJiYmY0NGNhMmIwZmFiODA4YjIzMjU3YjJfNC0xLTEtMS0w_abcf0462-277a-49e3-af65-2e6fa150c699">22,751</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentSummarizedFinancialInformationLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmZmZDI3OTUyYmJmNDRjYTJiMGZhYjgwOGIyMzI1N2IyL3RhYmxlcmFuZ2U6ZmZkMjc5NTJiYmY0NGNhMmIwZmFiODA4YjIzMjU3YjJfNC0zLTEtMS0w_ba4ad2bb-9f85-416e-910c-648164acc1ae">18,872</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net assets</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentAggregateCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmZmZDI3OTUyYmJmNDRjYTJiMGZhYjgwOGIyMzI1N2IyL3RhYmxlcmFuZ2U6ZmZkMjc5NTJiYmY0NGNhMmIwZmFiODA4YjIzMjU3YjJfNS0xLTEtMS0w_01a6a06e-e947-43ed-8d29-043d9008e1cb">63,956</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentAggregateCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmZmZDI3OTUyYmJmNDRjYTJiMGZhYjgwOGIyMzI1N2IyL3RhYmxlcmFuZ2U6ZmZkMjc5NTJiYmY0NGNhMmIwZmFiODA4YjIzMjU3YjJfNS0zLTEtMS0w_3ba7a77b-86b0-4c29-9e1d-3ebbe1bae0dc">60,375</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Book value of RadNet joint venture interests</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmZmZDI3OTUyYmJmNDRjYTJiMGZhYjgwOGIyMzI1N2IyL3RhYmxlcmFuZ2U6ZmZkMjc5NTJiYmY0NGNhMmIwZmFiODA4YjIzMjU3YjJfNy0xLTEtMS0w_700e07e3-bf03-49d4-9881-a3af0adcf7d6">29,121</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmZmZDI3OTUyYmJmNDRjYTJiMGZhYjgwOGIyMzI1N2IyL3RhYmxlcmFuZ2U6ZmZkMjc5NTJiYmY0NGNhMmIwZmFiODA4YjIzMjU3YjJfNy0zLTEtMS0w_1f0cea5e-4af2-4cc1-a68b-860d1d69f35a">28,001</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost in excess of book value of acquired joint venture interests and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentUnderlyingEquityInNetAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmZmZDI3OTUyYmJmNDRjYTJiMGZhYjgwOGIyMzI1N2IyL3RhYmxlcmFuZ2U6ZmZkMjc5NTJiYmY0NGNhMmIwZmFiODA4YjIzMjU3YjJfOC0xLTEtMS0w_3b5b3134-5f60-48ff-bb70-713871532e7b">6,450</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentUnderlyingEquityInNetAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmZmZDI3OTUyYmJmNDRjYTJiMGZhYjgwOGIyMzI1N2IyL3RhYmxlcmFuZ2U6ZmZkMjc5NTJiYmY0NGNhMmIwZmFiODA4YjIzMjU3YjJfOC0zLTEtMS0w_9dcf7954-3f3d-43f2-a01c-77e4b0d821ef">6,469</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total value of Radnet joint venture interests</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmZmZDI3OTUyYmJmNDRjYTJiMGZhYjgwOGIyMzI1N2IyL3RhYmxlcmFuZ2U6ZmZkMjc5NTJiYmY0NGNhMmIwZmFiODA4YjIzMjU3YjJfOS0xLTEtMS0w_69e23675-41c6-4698-ae8d-d92532c8c818">35,571</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmZmZDI3OTUyYmJmNDRjYTJiMGZhYjgwOGIyMzI1N2IyL3RhYmxlcmFuZ2U6ZmZkMjc5NTJiYmY0NGNhMmIwZmFiODA4YjIzMjU3YjJfOS0zLTEtMS0w_0bc9d949-6523-4d08-a3c1-98255885426b">34,470</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total book value of other joint venture partner interests</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="-3" format="ixt:numdotdecimal" name="rdnt:TotalBookValueOfOtherJointVenturePartnerInterests" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmZmZDI3OTUyYmJmNDRjYTJiMGZhYjgwOGIyMzI1N2IyL3RhYmxlcmFuZ2U6ZmZkMjc5NTJiYmY0NGNhMmIwZmFiODA4YjIzMjU3YjJfMTEtMS0xLTEtMA_47872d6e-6188-4641-a766-559bf9a9877e">34,835</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231" decimals="-3" format="ixt:numdotdecimal" name="rdnt:TotalBookValueOfOtherJointVenturePartnerInterests" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmZmZDI3OTUyYmJmNDRjYTJiMGZhYjgwOGIyMzI1N2IyL3RhYmxlcmFuZ2U6ZmZkMjc5NTJiYmY0NGNhMmIwZmFiODA4YjIzMjU3YjJfMTEtMy0xLTEtMA_33aad731-e979-467c-b000-3d8243beb9e6">32,374</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_25">Table of Contents</a></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><ix:continuation id="ic29297c976f447999eb83202e8806ccf"><ix:continuation id="i138c0338de7d43a39db5edd6f11e74f8"><ix:continuation id="i154156bc9f154cdcaca3bcdd49990128"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:74.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income statement data for the nine months ended September 30,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentSummarizedFinancialInformationRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjliZjM5ZjFjNWU0ZDQ2ZTRhNDExYzU3YjE1MmFiZDcxL3RhYmxlcmFuZ2U6OWJmMzlmMWM1ZTRkNDZlNGE0MTFjNTdiMTUyYWJkNzFfMS0xLTEtMS0w_98fb453d-c617-4d79-998a-91dcc45c4f53">78,988</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentSummarizedFinancialInformationRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjliZjM5ZjFjNWU0ZDQ2ZTRhNDExYzU3YjE1MmFiZDcxL3RhYmxlcmFuZ2U6OWJmMzlmMWM1ZTRkNDZlNGE0MTFjNTdiMTUyYWJkNzFfMS0zLTEtMS0w_3f017519-fcad-4d5d-92d3-664d916b341f">80,115</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjliZjM5ZjFjNWU0ZDQ2ZTRhNDExYzU3YjE1MmFiZDcxL3RhYmxlcmFuZ2U6OWJmMzlmMWM1ZTRkNDZlNGE0MTFjNTdiMTUyYWJkNzFfMi0xLTEtMS0w_abb4e8dc-2bcd-4894-9447-cf581505c36a">13,651</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjliZjM5ZjFjNWU0ZDQ2ZTRhNDExYzU3YjE1MmFiZDcxL3RhYmxlcmFuZ2U6OWJmMzlmMWM1ZTRkNDZlNGE0MTFjNTdiMTUyYWJkNzFfMi0zLTEtMS0w_5ef1e269-96ba-4ff8-a66a-02e064122a48">13,718</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation></ix:continuation></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="iffc0b59705bf4cff936f619293b1a306_49"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 3 &#8211; <ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" name="us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80OS9mcmFnOjQyN2NmNjUzZDg3ZDRkZjVhNGJhMmQzNjA5M2YxNGQ5L3RleHRyZWdpb246NDI3Y2Y2NTNkODdkNGRmNWE0YmEyZDM2MDkzZjE0ZDlfNDI5Mg_7f89e230-48d9-40aa-a8b8-42980a02ca03" continuedAt="ic44a0b13acd84a4da4711df421b66e00" escape="true"><ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80OS9mcmFnOjQyN2NmNjUzZDg3ZDRkZjVhNGJhMmQzNjA5M2YxNGQ5L3RleHRyZWdpb246NDI3Y2Y2NTNkODdkNGRmNWE0YmEyZDM2MDkzZjE0ZDlfNDI5Mw_85c6488a-be7f-4a44-ab24-100ca5f814e1" continuedAt="i2d78b4b551cf4dda93a197b10defefae" escape="true">RECENT ACCOUNTING AND REPORTING STANDARDS</ix:nonNumeric></ix:nonNumeric></span></div><div style="margin-top:10pt"><span><br/></span></div><ix:continuation id="ic44a0b13acd84a4da4711df421b66e00"><ix:continuation id="i2d78b4b551cf4dda93a197b10defefae"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting standards adopted</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASU No. 2016-13 ("ASU 2016-13), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  ASU 2016-13 replaces the incurred loss methodology previously utilized for valuing financial instruments with an expected loss methodology that is referred to as the current expected credit loss (CECL) methodology.  We prospectively adopted the standard on January 1, 2020 and the adoption did not have a material impact to the condensed consolidated financial statements, resulting in no adjustments to our prior year earnings.  See the Accounts Receivable section to Note 2 for further information on our allowances for credit losses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU No. 2018-15 (&#8220;ASU 2018-15&#8221;),&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles-Goodwill and Other-Internal-Use Software.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;ASU 2018-15 aligns the requirements for deferring implementation costs incurred in a cloud computing arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. This ASU is effective in the first quarter of 2020 with early adoption permitted and can be applied either retrospectively or prospectively to all implementation costs incurred after the date of adoption. The adoption of this standard did not have a material impact on our condensed consolidated balance sheet.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU 2020-03 ("ASU 2020-03"),&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Codification Improvements to Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The amendments in this update represent changes to clarify or improve the codification and correct unintended application. ASU 2020-03 was effective immediately upon issuance and its adoption did not have a material impact on our financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU No. 2018-13 ("ASU 2018-13"),&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disclosure Framework &#8211; Changes to the Disclosure Requirements for Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This standard removes, modifies and adds certain disclosures related to recurring and nonrecurring fair value measurements. We adopted ASC 2018-13 effective January 1, 2020 and it had no effect on our disclosures.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting standards not yet adopted</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12 ("ASU 2019-12"), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740).  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASU 2019-12 removes certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. It also clarifies and simplifies other areas of the standard. ASU 2019-12 will be effective beginning in the first quarter of 2021. Early adoption is permitted. Certain amendments in this update must be applied on a prospective basis, certain amendments must be applied on a retrospective basis, and certain amendments must be applied on a modified retrospective basis through a cumulative-effect adjustment to retained earnings/(deficit) in the period of adoption. We are currently evaluating the impact this ASU will have on our financial statements and related disclosures as well as the timing of adoption.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the FASB issued ASU 2020-01 ("ASU 2020-01"), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments&#8212;Equity Securities (Topic 321), Investments&#8212;Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">clarifying the interaction between accounting standards related to equity securities, equity method investments, and certain derivatives. ASU 2020-01 is effective for fiscal years beginning after December 15, 2020. We do not expect the adoption of this guidance will have a material impact on our financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU 2020-04 ("ASU 2020-04"),&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848), Facilitation of the Effects of Reference Rate Reform on Financial Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. ASU 2020-04 provides optional expedients and exceptions for applying generally accepted accounting principles to certain contract modifications and hedging relationships that reference London Inter-bank Offered Rate (LIBOR) or another reference rate expected to be discontinued. The guidance is effective upon issuance and generally can be applied through December 31, 2022. We are currently evaluating the potential impact of ASU 2020-04 on our financial statements.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_25">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div id="iffc0b59705bf4cff936f619293b1a306_52"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> NOTE 4 &#8211; <ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" name="us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMzU0Mw_3aa25ea7-9268-4484-8e89-cf2b83c379d1" continuedAt="i7957c1f0ab0e41518337bfba9bdac2a4" escape="true">FACILITY ACQUISITIONS AND DISPOSITIONS</ix:nonNumeric></span></div><ix:continuation id="i7957c1f0ab0e41518337bfba9bdac2a4"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions:</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 31, 2020 we completed our acquisition of certain assets of AZ-Tech Radiology &amp; Open MRI, LLC, consisting of <ix:nonFraction unitRef="center" contextRef="i162b6e4a9b024569bbd2a742fbb7e2df_D20200831-20200831" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfBusinessesAcquired" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMjE5OTAyMzI2MDU0Mw_e4d2b8d0-be59-4f82-8d44-0c4b8954a4d2">eight</ix:nonFraction> multi-modality imaging centers located in the Phoenix, Arizona area for purchase consideration of $<ix:nonFraction unitRef="usd" contextRef="i162b6e4a9b024569bbd2a742fbb7e2df_D20200831-20200831" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMjc0ODc3OTA3MzgzOQ_d9ca8ed1-4f43-48f2-ace7-099785e60c1b">5.5</ix:nonFraction> million.  We made a preliminary fair value determination of the acquired assets and assumed liabilities and approximately $<ix:nonFraction unitRef="usd" contextRef="i88ab08c169fd45579b828ee84aa3fbe2_I20200831" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMjc0ODc3OTA3NDI0Mw_4432e8b6-8a66-4f19-b0ab-967640ce2f25">2.5</ix:nonFraction> million in property and equipment, $<ix:nonFraction unitRef="usd" contextRef="i88ab08c169fd45579b828ee84aa3fbe2_I20200831" decimals="-5" format="ixt:numdotdecimal" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMjc0ODc3OTA3NDI1MA_c9da0d12-093a-431d-bdab-545b7d8ae146">7.6</ix:nonFraction> million in right-of-use assets, $<ix:nonFraction unitRef="usd" contextRef="i88ab08c169fd45579b828ee84aa3fbe2_I20200831" decimals="-5" format="ixt:numdotdecimal" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMjc0ODc3OTA3NDM5Mg_6e561829-1337-44f9-acc7-ee9d15bf3546">0.1</ix:nonFraction> million in other assets, $<ix:nonFraction unitRef="usd" contextRef="i88ab08c169fd45579b828ee84aa3fbe2_I20200831" decimals="-5" format="ixt:numdotdecimal" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMjc0ODc3OTA3NDI3Mw_e67070d8-827f-4872-a43c-504275ebdc34">7.6</ix:nonFraction> million in operating lease liabilities, and $<ix:nonFraction unitRef="usd" contextRef="i88ab08c169fd45579b828ee84aa3fbe2_I20200831" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMjc0ODc3OTA3NDI3Nw_7d8729bd-2f55-4f6b-92e7-87b6745e1af9">2.9</ix:nonFraction> million in goodwill were recorded.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 1, 2020, we completed our acquisition of all the equity interests of DeepHealth Inc., ("DeepHealth") an artificial intelligence and machine learning company in an all stock purchase.  As initial purchase consideration, we issued <ix:nonFraction unitRef="shares" contextRef="i91654ea5e0e647c0ba9d259407ee064a_D20200601-20200601" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMzA2_9c437481-77c1-4a0d-8ce9-6fdd5cd6faf6">915,132</ix:nonFraction> shares at $<ix:nonFraction unitRef="usdPerShare" contextRef="i8973a0068cd845ef97762ff48f7c1a82_I20200601" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMzE5_f87fc610-549d-415a-8b54-65aa71e38c72">16.93</ix:nonFraction> per share (<ix:nonFraction unitRef="shares" contextRef="i91654ea5e0e647c0ba9d259407ee064a_D20200601-20200601" decimals="INF" format="ixt:numdotdecimal" name="rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMzMz_34a032e6-2a0e-46e1-aa2b-9d6799552d27">823,615</ix:nonFraction> issued at execution, with up to <ix:nonFraction unitRef="shares" contextRef="i91654ea5e0e647c0ba9d259407ee064a_D20200601-20200601" decimals="INF" format="ixt:numdotdecimal" name="rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMzY4_e75d492c-8d76-4af2-abc2-c52124cffded">91,517</ix:nonFraction> shares to be issued <ix:nonNumeric contextRef="i91654ea5e0e647c0ba9d259407ee064a_D20200601-20200601" format="ixt-sec:durmonth" name="rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMzkx_7bae248b-49bf-466b-b3d2-56ad13866fb5">18</ix:nonNumeric> months after acquisition subject to adjustment for any indemnification claims).  The transaction was accounted for as an acquisition of a business and total purchase consideration determined to be approximately $<ix:nonFraction unitRef="usd" contextRef="i91654ea5e0e647c0ba9d259407ee064a_D20200601-20200601" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfNTk4_64fcb1d8-06ea-43d3-86ae-d97f0e6a86ce">34.6</ix:nonFraction> million including i) <ix:nonFraction unitRef="shares" contextRef="i91654ea5e0e647c0ba9d259407ee064a_D20200601-20200601" decimals="INF" format="ixt:numdotdecimal" name="rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfNjE0_34a032e6-2a0e-46e1-aa2b-9d6799552d27">823,615</ix:nonFraction> shares issued on the date of closing with fair value of $<ix:nonFraction unitRef="usd" contextRef="i91654ea5e0e647c0ba9d259407ee064a_D20200601-20200601" decimals="-5" format="ixt:numdotdecimal" name="rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfNjcz_c694fc78-5919-4fa2-b201-804f992b8a90">13.9</ix:nonFraction> million, ii) a liability of <ix:nonFraction unitRef="shares" contextRef="i91654ea5e0e647c0ba9d259407ee064a_D20200601-20200601" decimals="INF" format="ixt:numdotdecimal" name="rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfNjk2_e75d492c-8d76-4af2-abc2-c52124cffded">91,517</ix:nonFraction> shares with a fair value of $<ix:nonFraction unitRef="usd" contextRef="i91654ea5e0e647c0ba9d259407ee064a_D20200601-20200601" decimals="-5" format="ixt:numdotdecimal" name="rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfNzI3_5fd105e3-1849-470f-978e-947986647767">1.5</ix:nonFraction> million to be issued <ix:nonNumeric contextRef="i91654ea5e0e647c0ba9d259407ee064a_D20200601-20200601" format="ixt-sec:durmonth" name="rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfNzQz_7bae248b-49bf-466b-b3d2-56ad13866fb5">18</ix:nonNumeric> months after acquisition subject to adjustment for any indemnification claims and will be marked to market in subsequent periods, iii) replacement awards attributable to pre-combination service issued to DeepHealth option holders with allocated fair value of $<ix:nonFraction unitRef="usd" contextRef="i91654ea5e0e647c0ba9d259407ee064a_D20200601-20200601" decimals="-5" format="ixt:numdotdecimal" name="rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfOTk4_247dca6d-4d5a-4d40-a737-c158a3602369">2.0</ix:nonFraction> million, iv) acquisition date fair value of contingent consideration of $<ix:nonFraction unitRef="usd" contextRef="i8973a0068cd845ef97762ff48f7c1a82_I20200601" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EquityIssuedInBusinessCombinationFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMTA2NQ_cc952993-b671-4118-a516-55d740b40032">17.0</ix:nonFraction> million and v) $<ix:nonFraction unitRef="usd" contextRef="i8973a0068cd845ef97762ff48f7c1a82_I20200601" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMTA3NQ_8f52ab6c-6e4c-48f5-824c-e82f38375bc8">0.1</ix:nonFraction> million in closing costs reimbursed to the seller.  The fair values of replacement awards attributable to pre-combination service and contingent consideration are recorded in additional paid in capital upon closing of the transaction. For the contingent consideration, there are three arrangements that will be settled in a fixed number of shares upon achievement of three individual specific milestones which are mutually exclusive of each other, with <ix:nonFraction unitRef="shares" contextRef="i91654ea5e0e647c0ba9d259407ee064a_D20200601-20200601" decimals="INF" format="ixt:numdotdecimal" name="rdnt:BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMTUyMw_b59bb3f0-bd29-46d7-a0df-7659c4adbc83">390,789</ix:nonFraction>, <ix:nonFraction unitRef="shares" contextRef="i91654ea5e0e647c0ba9d259407ee064a_D20200601-20200601" decimals="INF" format="ixt:numdotdecimal" name="rdnt:BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMTUyNw_9b6edb8c-e376-4472-bf26-c75343b3f3f1">586,184</ix:nonFraction>, and <ix:nonFraction unitRef="shares" contextRef="i91654ea5e0e647c0ba9d259407ee064a_D20200601-20200601" decimals="INF" format="ixt:numdotdecimal" name="rdnt:BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMTUzNQ_67f2b1d9-b305-40b4-aec0-0fa8beb70d84">195,393</ix:nonFraction> shares, respectively, issuable for each milestone arrangement. The fair value of the contingent consideration was estimated at the date of acquisition based on our share price and estimated probability of the achievement of the respective milestones.  We preliminarily recorded $<ix:nonFraction unitRef="usd" contextRef="i8973a0068cd845ef97762ff48f7c1a82_I20200601" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMTgxNg_54cfaf94-8cf4-409b-b44b-8bd822e6266c">0.1</ix:nonFraction> million in current assets, $<ix:nonFraction unitRef="usd" contextRef="i8973a0068cd845ef97762ff48f7c1a82_I20200601" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMTgzOA_a765954f-433d-41d8-b9e9-d006c02be522">3.5</ix:nonFraction> million in deferred tax liabilities, $<ix:nonFraction unitRef="usd" contextRef="i8973a0068cd845ef97762ff48f7c1a82_I20200601" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMTg3MA_3d9a5d27-0e4f-4d7f-8101-9e66fda11e3a">14.8</ix:nonFraction> million in intangible assets, primarily in-process research and development ("IPR&amp;D'), and $<ix:nonFraction unitRef="usd" contextRef="i8973a0068cd845ef97762ff48f7c1a82_I20200601" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMTk1Ng_7f5b87a3-800c-489e-9a53-c7c69ed45484">23.4</ix:nonFraction> million in goodwill. The goodwill is primarily attributable to expected post-acquisition synergies from integrating DeepHealth&#8217;s assembled workforce and IPR&amp;D technologies. The fair values of the identifiable intangible assets related to IPR&amp;D were determined by the income method and the assets will not be amortized until completion. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 2, 2020 our consolidated subsidiary New Jersey Imaging Networks ("NJIN") completed the acquisition of certain assets of MRI at Woodbridge, LLC consisting of a single multi-modality imaging center located in Avenel, New Jersey for cash consideration of $<ix:nonFraction unitRef="usd" contextRef="if82d035b351345f5a975f117243ce1cd_D20200302-20200302" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMjU1MQ_774ffb70-a349-45ba-bd15-9ede7f3742c3">2.6</ix:nonFraction> million.  NJIN made a fair value determination of the acquired assets and assumed liabilities and approximately $<ix:nonFraction unitRef="usd" contextRef="icc8791aabe8a4ca798528207f763624d_I20200302" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMjY1OA_2ad68bb6-5a4a-480b-a473-abfc4976b0a5">0.5</ix:nonFraction> million in property and equipment, $<ix:nonFraction unitRef="usd" contextRef="icc8791aabe8a4ca798528207f763624d_I20200302" decimals="-5" format="ixt:numdotdecimal" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMjY4OA_16fc645a-4182-438e-a61d-ce7a25639868">1.1</ix:nonFraction> million in right-of-use assets, $<ix:nonFraction unitRef="usd" contextRef="icc8791aabe8a4ca798528207f763624d_I20200302" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMjcxNQ_77143b2b-1019-410d-9a49-c440e48e78f8">0.3</ix:nonFraction> million in intangible assets, $<ix:nonFraction unitRef="usd" contextRef="icc8791aabe8a4ca798528207f763624d_I20200302" decimals="-5" format="ixt:numdotdecimal" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMjc0MA_b2e468ed-ef44-42c1-bbbd-482e1f489530">1.1</ix:nonFraction> million in operating lease liabilities, $<ix:nonFraction unitRef="usd" contextRef="icc8791aabe8a4ca798528207f763624d_I20200302" decimals="-5" format="ixt:numdotdecimal" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFinanceLeaseLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMjc3NQ_2f608064-b46f-425b-b2d8-8ef42cd4cb76">0.1</ix:nonFraction> million in finance lease liabilities, and $<ix:nonFraction unitRef="usd" contextRef="icc8791aabe8a4ca798528207f763624d_I20200302" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMjgxMg_880010ce-a5d5-4e38-b5ee-958e292dde75">1.8</ix:nonFraction> million in goodwill were recorded.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On January 2, 2020 we completed our acquisition of certain assets of Olney Open MRI, LLC, consisting of a single multi-modality imaging center located in Columbia, Maryland for cash consideration of $<ix:nonFraction unitRef="usd" contextRef="ib5716180cf92431199e9568b6e00f780_D20200102-20200102" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMzA0Mw_3252d3ed-d08f-4346-b412-ebd623e15c62">1.8</ix:nonFraction> million.  We have made a fair value determination of the acquired assets and assumed liabilities and approximately $<ix:nonFraction unitRef="usd" contextRef="i6cbda2807f6f4c2388609f72bced8aa2_I20200102" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMzE1Mw_8b2c1062-c3c4-4190-938c-22689990c497">0.8</ix:nonFraction> million in property and equipment, $<ix:nonFraction unitRef="usd" contextRef="i6cbda2807f6f4c2388609f72bced8aa2_I20200102" decimals="-5" format="ixt:numdotdecimal" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMzE4Mw_b72fcaf2-ef04-4853-8bae-8b049a569ba7">1.3</ix:nonFraction> million in right-of-use assets, $<ix:nonFraction unitRef="usd" contextRef="i6cbda2807f6f4c2388609f72bced8aa2_I20200102" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMzIxMA_8215fb83-261b-462d-815c-cfb9c33e19f8">0.3</ix:nonFraction> million in intangible assets, $<ix:nonFraction unitRef="usd" contextRef="i6cbda2807f6f4c2388609f72bced8aa2_I20200102" decimals="-5" format="ixt:numdotdecimal" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMzIzNQ_92b62de1-2dbc-4e86-8378-aa036f019324">1.3</ix:nonFraction> million in operating lease liabilities and $<ix:nonFraction unitRef="usd" contextRef="i6cbda2807f6f4c2388609f72bced8aa2_I20200102" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMzI3Mw_75e083d7-fd15-4bc0-8319-bfc4dd187b47">0.6</ix:nonFraction> million  in goodwill were recorded.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dispositions:</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 1, 2020 we completed our sale of certain assets of our Imaging On Call subsidiary to RadVantage P.C. (an unrelated corporation) for approximately $<ix:nonFraction unitRef="usd" contextRef="i6e52cfe398fa4efabaa39a7aee14b01c_D20200601-20200601" decimals="-2" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromDivestitureOfInterestInJointVenture" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMzQ3Mg_18651465-a360-4ed3-ba6e-bf0430de0066">1.0</ix:nonFraction> thousand.  With this transaction, we have exited the teleradiology business.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><div id="iffc0b59705bf4cff936f619293b1a306_55"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_25">Table of Contents</a></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 5 &#8211; <ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" name="us-gaap:DebtAndCapitalLeasesDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMTAxMDM_4c2628b6-b15d-4618-b5c7-4d5615033dd7" continuedAt="i7e62af63d2a24a2eb1977d925cfa8c54" escape="true">CREDIT FACILITIES AND NOTES PAYABLE</ix:nonNumeric></span></div><ix:continuation id="i7e62af63d2a24a2eb1977d925cfa8c54" continuedAt="i3de721688b424c09a82810ebf121154a"><ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMTAwOTk_fde67d44-14e8-4696-8eca-1cc655d75d95" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2020 and December&#160;31, 2019 our debt obligations consisted of the following (in thousands):</span></div><div style="margin-bottom:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.953%"><tr><td style="width:1.0%"></td><td style="width:74.273%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.840%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.841%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="12" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Lien Term Loans collateralized by RadNet's tangible and intangible assets</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2afc665ece974620b3ccc8ebbf0e35c7_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOjU1MzNmYWMwMWI4NDQ1NWY5MGM0ZjVmMjA5ZWY2NWNjL3RhYmxlcmFuZ2U6NTUzM2ZhYzAxYjg0NDU1ZjkwYzRmNWYyMDllZjY1Y2NfMi0xLTEtMS0w_b04fd261-7707-41af-900e-4771ba0d8183">620,727</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fe2d4283d9e45e4ad2946e8fa2b5dad_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOjU1MzNmYWMwMWI4NDQ1NWY5MGM0ZjVmMjA5ZWY2NWNjL3RhYmxlcmFuZ2U6NTUzM2ZhYzAxYjg0NDU1ZjkwYzRmNWYyMDllZjY1Y2NfMi0zLTEtMS0w_a66e80d9-0844-4419-a64e-0c827af13d38">649,824</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounts on First Lien Term Loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2afc665ece974620b3ccc8ebbf0e35c7_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOjU1MzNmYWMwMWI4NDQ1NWY5MGM0ZjVmMjA5ZWY2NWNjL3RhYmxlcmFuZ2U6NTUzM2ZhYzAxYjg0NDU1ZjkwYzRmNWYyMDllZjY1Y2NfMy0xLTEtMS0w_10e2e41c-4181-44e3-8096-f9482bfd69bf">10,669</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fe2d4283d9e45e4ad2946e8fa2b5dad_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOjU1MzNmYWMwMWI4NDQ1NWY5MGM0ZjVmMjA5ZWY2NWNjL3RhYmxlcmFuZ2U6NTUzM2ZhYzAxYjg0NDU1ZjkwYzRmNWYyMDllZjY1Y2NfMy0zLTEtMS0w_f1636cf4-8219-4205-8606-6b2cd121b24f">13,579</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SunTrust Term Loan Agreement collateralized by NJIN's tangible and intangible assets</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71fd7722d0aa4607b2773ebefd280d93_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOjU1MzNmYWMwMWI4NDQ1NWY5MGM0ZjVmMjA5ZWY2NWNjL3RhYmxlcmFuZ2U6NTUzM2ZhYzAxYjg0NDU1ZjkwYzRmNWYyMDllZjY1Y2NfNC0xLTEtMS0w_f7dc9d13-45c3-4601-9d4b-c9f7cba6b693">52,500</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if476d02b586946bfaa11a0d8851b0dc2_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOjU1MzNmYWMwMWI4NDQ1NWY5MGM0ZjVmMjA5ZWY2NWNjL3RhYmxlcmFuZ2U6NTUzM2ZhYzAxYjg0NDU1ZjkwYzRmNWYyMDllZjY1Y2NfNC0zLTEtMS0w_6fd0dd92-3d0f-47fb-8a06-9a7e62ffa589">55,875</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paycheck Protection Program loans at <ix:nonFraction unitRef="number" contextRef="i21f621247677495cadc7f88b6433f851_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOjU1MzNmYWMwMWI4NDQ1NWY5MGM0ZjVmMjA5ZWY2NWNjL3RhYmxlcmFuZ2U6NTUzM2ZhYzAxYjg0NDU1ZjkwYzRmNWYyMDllZjY1Y2NfNS0wLTEtMS0wL3RleHRyZWdpb246NTJhYTJiMzM5ZmRjNDQ3N2ExZmRlZmYzMzQ2ZGY3ZmNfMTIwOTQ2Mjc5MDU1OTY_eddaad40-49d4-4767-a292-7603579c8194">1</ix:nonFraction>% due April 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5ca3ff1c3f84af0b0834ea2b962f872_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOjU1MzNmYWMwMWI4NDQ1NWY5MGM0ZjVmMjA5ZWY2NWNjL3RhYmxlcmFuZ2U6NTUzM2ZhYzAxYjg0NDU1ZjkwYzRmNWYyMDllZjY1Y2NfNS0xLTEtMS0w_45d8cd93-391a-4a2c-aec0-4afcc86a19e2">4,037</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment note payable at <ix:nonFraction unitRef="number" contextRef="ic35d04f7e5d145f491a377cf89ff8da0_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOjU1MzNmYWMwMWI4NDQ1NWY5MGM0ZjVmMjA5ZWY2NWNjL3RhYmxlcmFuZ2U6NTUzM2ZhYzAxYjg0NDU1ZjkwYzRmNWYyMDllZjY1Y2NfNy0wLTEtMS0wL3RleHRyZWdpb246Nzg4NzA2MWJlOWZhNGM2NjkxN2M1MDdmODE5N2NmODZfMTIwOTQ2Mjc5MDU2Mjk_84aab597-bbc7-4ac0-a68e-302ddaa6bed2">4.6</ix:nonFraction>%, due through 2020, collateralized by medical equipment</span></div></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="-3" name="us-gaap:LongTermLoansPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOjU1MzNmYWMwMWI4NDQ1NWY5MGM0ZjVmMjA5ZWY2NWNjL3RhYmxlcmFuZ2U6NTUzM2ZhYzAxYjg0NDU1ZjkwYzRmNWYyMDllZjY1Y2NfNy0xLTEtMS0w_d69941d5-290b-41e8-a4ac-0e37b327541b">47</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231" decimals="-3" name="us-gaap:LongTermLoansPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOjU1MzNmYWMwMWI4NDQ1NWY5MGM0ZjVmMjA5ZWY2NWNjL3RhYmxlcmFuZ2U6NTUzM2ZhYzAxYjg0NDU1ZjkwYzRmNWYyMDllZjY1Y2NfNy0zLTEtMS0w_2f360ed8-f05b-4acb-be50-81f39de7ebda">275</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt obligations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="-3" format="ixt:numdotdecimal" name="rdnt:LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOjU1MzNmYWMwMWI4NDQ1NWY5MGM0ZjVmMjA5ZWY2NWNjL3RhYmxlcmFuZ2U6NTUzM2ZhYzAxYjg0NDU1ZjkwYzRmNWYyMDllZjY1Y2NfOC0xLTEtMS0w_94154eb1-14b7-4ba5-87d7-98b016b032f5">666,642</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231" decimals="-3" format="ixt:numdotdecimal" name="rdnt:LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOjU1MzNmYWMwMWI4NDQ1NWY5MGM0ZjVmMjA5ZWY2NWNjL3RhYmxlcmFuZ2U6NTUzM2ZhYzAxYjg0NDU1ZjkwYzRmNWYyMDllZjY1Y2NfOC0zLTEtMS0w_aefb3df0-9f80-48db-9105-aeb58d10ca40">692,395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="-3" format="ixt:numdotdecimal" name="rdnt:LongtermDebtShorttermDebtandCapitalLeaseObligationsCurrentMaturities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOjU1MzNmYWMwMWI4NDQ1NWY5MGM0ZjVmMjA5ZWY2NWNjL3RhYmxlcmFuZ2U6NTUzM2ZhYzAxYjg0NDU1ZjkwYzRmNWYyMDllZjY1Y2NfOS0xLTEtMS0w_3a2ac04d-d633-4c13-bee3-7d461866786a">39,463</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231" decimals="-3" format="ixt:numdotdecimal" name="rdnt:LongtermDebtShorttermDebtandCapitalLeaseObligationsCurrentMaturities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOjU1MzNmYWMwMWI4NDQ1NWY5MGM0ZjVmMjA5ZWY2NWNjL3RhYmxlcmFuZ2U6NTUzM2ZhYzAxYjg0NDU1ZjkwYzRmNWYyMDllZjY1Y2NfOS0zLTEtMS0w_15a54079-1704-4727-ad7b-232cd1aea9a2">39,691</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long term portion debt obligations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="-3" format="ixt:numdotdecimal" name="rdnt:LongtermDebtShorttermDebtandCapitalLeaseObligationsExcludingCurrentMaturities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOjU1MzNmYWMwMWI4NDQ1NWY5MGM0ZjVmMjA5ZWY2NWNjL3RhYmxlcmFuZ2U6NTUzM2ZhYzAxYjg0NDU1ZjkwYzRmNWYyMDllZjY1Y2NfMTAtMS0xLTEtMA_e81e2224-f9e9-46cf-9bd2-12a4d39ba464">627,179</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231" decimals="-3" format="ixt:numdotdecimal" name="rdnt:LongtermDebtShorttermDebtandCapitalLeaseObligationsExcludingCurrentMaturities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOjU1MzNmYWMwMWI4NDQ1NWY5MGM0ZjVmMjA5ZWY2NWNjL3RhYmxlcmFuZ2U6NTUzM2ZhYzAxYjg0NDU1ZjkwYzRmNWYyMDllZjY1Y2NfMTAtMy0xLTEtMA_2d8c9fcb-28d3-40b9-9d59-3a45fe192be0">652,704</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMTIwOTQ2Mjc5NTQ1OTc_6594dc1c-68e1-49e9-a0e8-4b40d40d48b4" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in our condensed consolidated balance sheets at September&#160;30, 2020 are $<ix:nonFraction unitRef="usd" contextRef="i2afc665ece974620b3ccc8ebbf0e35c7_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMjE5OTAyMzMwMTMzNQ_d2b34795-378e-447a-a448-c6144f69d9d1">620.7</ix:nonFraction> million of First Lien Term Loans and $<ix:nonFraction unitRef="usd" contextRef="i71fd7722d0aa4607b2773ebefd280d93_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMjE5OTAyMzMwMTM2OA_baeb50b2-80b9-4a9a-81e1-cb35eea40c98">52.5</ix:nonFraction> million of SunTrust Term Loan debt for a combined total of $<ix:nonFraction unitRef="usd" contextRef="ia9a34455b88e496f99f11135df67cea7_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMjE5OTAyMzMwMTQyMw_73dadce3-c8f2-433c-adc8-0c324ac06fb1">673.2</ix:nonFraction> million of total term loan debt (exclusive of unamortized discounts of  $<ix:nonFraction unitRef="usd" contextRef="i0a84159a6d674db38efa7bbccb1be3e3_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMjE5OTAyMzMwMTQ5MQ_62629c21-6714-4a75-8d4c-8cd8cc364886">10.7</ix:nonFraction> million) in thousands: </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:61.748%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.794%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.794%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.796%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Face Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Discount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Carrying<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Lien Term Loans</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2afc665ece974620b3ccc8ebbf0e35c7_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmUyNDEwM2ExOTUzOTQ1MmU5MWI5NDJhNTcyM2Q1MTRjL3RhYmxlcmFuZ2U6ZTI0MTAzYTE5NTM5NDUyZTkxYjk0MmE1NzIzZDUxNGNfMS0xLTEtMS0xNzU1_bbb8f098-bf0f-4540-bb18-9225124ed63b">620,727</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2afc665ece974620b3ccc8ebbf0e35c7_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmUyNDEwM2ExOTUzOTQ1MmU5MWI5NDJhNTcyM2Q1MTRjL3RhYmxlcmFuZ2U6ZTI0MTAzYTE5NTM5NDUyZTkxYjk0MmE1NzIzZDUxNGNfMS0zLTEtMS0xNzU1_4c6c3cc1-4d8a-49e7-8046-a72772868eaf">10,669</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2afc665ece974620b3ccc8ebbf0e35c7_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmUyNDEwM2ExOTUzOTQ1MmU5MWI5NDJhNTcyM2Q1MTRjL3RhYmxlcmFuZ2U6ZTI0MTAzYTE5NTM5NDUyZTkxYjk0MmE1NzIzZDUxNGNfMS01LTEtMS0xNzU1_cf8742cf-f4ff-4551-baec-c71a12958113">610,058</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SunTrust Term Loan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71fd7722d0aa4607b2773ebefd280d93_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmUyNDEwM2ExOTUzOTQ1MmU5MWI5NDJhNTcyM2Q1MTRjL3RhYmxlcmFuZ2U6ZTI0MTAzYTE5NTM5NDUyZTkxYjk0MmE1NzIzZDUxNGNfMi0xLTEtMS0xNzU1_174bbb40-dab3-428d-b38a-5706cd8bd3ad">52,500</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71fd7722d0aa4607b2773ebefd280d93_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmUyNDEwM2ExOTUzOTQ1MmU5MWI5NDJhNTcyM2Q1MTRjL3RhYmxlcmFuZ2U6ZTI0MTAzYTE5NTM5NDUyZTkxYjk0MmE1NzIzZDUxNGNfMi0zLTEtMS0xNzU1_423e001c-99f4-4af2-b962-4e2b356b83b6">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71fd7722d0aa4607b2773ebefd280d93_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmUyNDEwM2ExOTUzOTQ1MmU5MWI5NDJhNTcyM2Q1MTRjL3RhYmxlcmFuZ2U6ZTI0MTAzYTE5NTM5NDUyZTkxYjk0MmE1NzIzZDUxNGNfMi01LTEtMS0xNzU1_2ff0186e-33fd-4150-b09d-694539fd6461">52,500</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Term Loans</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9a34455b88e496f99f11135df67cea7_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmUyNDEwM2ExOTUzOTQ1MmU5MWI5NDJhNTcyM2Q1MTRjL3RhYmxlcmFuZ2U6ZTI0MTAzYTE5NTM5NDUyZTkxYjk0MmE1NzIzZDUxNGNfMy0xLTEtMS0xNzU1_e6d8b119-ce36-4edf-8ff0-a142a99fff00">673,227</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9a34455b88e496f99f11135df67cea7_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmUyNDEwM2ExOTUzOTQ1MmU5MWI5NDJhNTcyM2Q1MTRjL3RhYmxlcmFuZ2U6ZTI0MTAzYTE5NTM5NDUyZTkxYjk0MmE1NzIzZDUxNGNfMy0zLTEtMS0xNzU1_9badcd65-198e-435b-a83e-a99df9a234bc">10,669</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9a34455b88e496f99f11135df67cea7_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmUyNDEwM2ExOTUzOTQ1MmU5MWI5NDJhNTcyM2Q1MTRjL3RhYmxlcmFuZ2U6ZTI0MTAzYTE5NTM5NDUyZTkxYjk0MmE1NzIzZDUxNGNfMy01LTEtMS0xNzU1_02919b8f-38ef-4efc-96f7-b97c297d6b0f">662,558</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had <ix:nonFraction unitRef="usd" contextRef="i505d1abebd8447a787b012d89a5eacb7_I20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LineOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMjE5OTAyMzMwMTUyMA_ce915ed4-5066-48a2-9d85-91d3e27ef2ea"><ix:nonFraction unitRef="usd" contextRef="i1abfe8394b234eb5bbad4195a9ec0e60_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LineOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMjE5OTAyMzMwMTUyMA_d37250a6-14b6-40fd-a41d-319131f9dbb0">no</ix:nonFraction></ix:nonFraction> balance under our $<ix:nonFraction unitRef="usd" contextRef="i2b01a556be2b4c8ab3308ab426b040ab_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMjE5OTAyMzMwMTU0Mg_c1927e52-0cbd-4fc6-94db-913922b29452">195.0</ix:nonFraction> million Barclays Revolving Credit Facility at September&#160;30, 2020 and have reserved $<ix:nonFraction unitRef="usd" contextRef="iaf61ff95dda14ecdb11e6615b7e7633a_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LettersOfCreditOutstandingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMjE5OTAyMzMwMTYyMA_69f54b30-4726-4f1f-a6aa-df31bb53bdf7">6.3</ix:nonFraction> million for certain letters of credit. The remaining $<ix:nonFraction unitRef="usd" contextRef="i42e0febe792a4db09dfe882d336f96bd_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMjE5OTAyMzMwMTY2OQ_2de1aa67-7a45-4c85-9f39-582b0f92066d">188.7</ix:nonFraction> million of our Barclays Revolving Credit Facility was available to draw upon as of September&#160;30, 2020.  We had <ix:nonFraction unitRef="usd" contextRef="iafc255d1386a4de3bf178436d2562022_I20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LineOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMjE5OTAyMzMwMTc2MQ_3ad43d87-4254-4b9c-b29c-a97718dc37dc">no</ix:nonFraction> balance under our $<ix:nonFraction unitRef="usd" contextRef="ib9d01a93b2904f61b4796d8a81410b9e_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMjE5OTAyMzMwMTc4Mw_51da22f1-0fb4-454f-94ca-890e4b34f6d9">30.0</ix:nonFraction> million SunTrust Revolving Credit Facility related to our consolidated subsidiary NJIN at September&#160;30, 2020.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Senior Secured Credit Facilities</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Barclays Credit Facilities:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2020, (a) our Barclays credit facilities were comprised of one tranche of term loans (&#8220;First Lien Term Loans&#8221;) and a revolving credit facility of $<ix:nonFraction unitRef="usd" contextRef="i2b01a556be2b4c8ab3308ab426b040ab_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMzA4_c1927e52-0cbd-4fc6-94db-913922b29452">195.0</ix:nonFraction> million (the &#8220;Barclays Revolving Credit Facility&#8221;) and (b) our SunTrust credit facilities, which relate to our consolidated subsidiary NJIN, were comprised of one term loan (the "SunTrust Term Loan") and a revolving credit facility of $<ix:nonFraction unitRef="usd" contextRef="ib9d01a93b2904f61b4796d8a81410b9e_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfNzE3_51da22f1-0fb4-454f-94ca-890e4b34f6d9">30.0</ix:nonFraction> million (the "SunTrust Revolving Credit Facility").</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2020, we were in compliance with all covenants under our credit facilities.  Deferred financing costs at September&#160;30, 2020, net of accumulated amortization, was $<ix:nonFraction unitRef="usd" contextRef="iaf61ff95dda14ecdb11e6615b7e7633a_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMTAxMw_5a169cae-3897-44d7-9663-1f867187dbdc">1.9</ix:nonFraction> million and is specifically related to our Barclays Revolving Credit Facility.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" name="rdnt:ScheduleOfLeverageRatioTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMTAxMDU_331f653f-9875-407c-9b7f-0b9dba746026" continuedAt="id11f7d2c4c33491ebf9e399fda34734e" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our First Lien Term Loans bear interest at either an Adjusted Eurodollar Rate or a Base Rate, plus an applicable margin according to the following schedule:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:89.181%"><tr><td style="width:1.0%"></td><td style="width:31.850%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.508%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">First Lien Leverage Ratio</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Eurodollar Rate Spread</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Base Rate Spread</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&gt; 5.50x</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i843b248c0d484e4c80e2fdd2f502195c_D20160701-20160701" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOjNmYmE5ZjYwZWRjYzQ4NDM4N2UwZTRjZmE2MzE4YzBhL3RhYmxlcmFuZ2U6M2ZiYTlmNjBlZGNjNDg0Mzg3ZTBlNGNmYTYzMThjMGFfMS0xLTEtMS0w_17b2a799-27c7-43fd-ab5f-cf7d7a6faee3">4.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1b15ecede84f41abb4d034630198d257_D20160701-20160701" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOjNmYmE5ZjYwZWRjYzQ4NDM4N2UwZTRjZmE2MzE4YzBhL3RhYmxlcmFuZ2U6M2ZiYTlmNjBlZGNjNDg0Mzg3ZTBlNGNmYTYzMThjMGFfMS0yLTEtMS0w_9a50e751-a6fc-4b2f-a346-fe6c680a0e61">3.50</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&gt; 4.00x but &#8804; 5.50x</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9aab2f0d56d34189a074316bda4c4b67_D20160701-20160701" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOjNmYmE5ZjYwZWRjYzQ4NDM4N2UwZTRjZmE2MzE4YzBhL3RhYmxlcmFuZ2U6M2ZiYTlmNjBlZGNjNDg0Mzg3ZTBlNGNmYTYzMThjMGFfMi0xLTEtMS0w_af662e66-3f31-4cbc-bdcd-2144aa463e7f">3.75</ix:nonFraction>%</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic02a9a741f3842eea3e3a5a7eb322904_D20160701-20160701" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOjNmYmE5ZjYwZWRjYzQ4NDM4N2UwZTRjZmE2MzE4YzBhL3RhYmxlcmFuZ2U6M2ZiYTlmNjBlZGNjNDg0Mzg3ZTBlNGNmYTYzMThjMGFfMi0yLTEtMS0w_a8b55502-cb5e-4391-929e-16fae0e9ec21">2.75</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&gt;3.50x but &#8804; 4.00x</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0b849e478e084b868c575f20c8653b78_D20160701-20160701" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOjNmYmE5ZjYwZWRjYzQ4NDM4N2UwZTRjZmE2MzE4YzBhL3RhYmxlcmFuZ2U6M2ZiYTlmNjBlZGNjNDg0Mzg3ZTBlNGNmYTYzMThjMGFfMy0xLTEtMS0w_9bf57efc-46c3-4783-9a0e-d5f301a2b177">3.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8684bb7afe064ac9983fbd954121786d_D20160701-20160701" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOjNmYmE5ZjYwZWRjYzQ4NDM4N2UwZTRjZmE2MzE4YzBhL3RhYmxlcmFuZ2U6M2ZiYTlmNjBlZGNjNDg0Mzg3ZTBlNGNmYTYzMThjMGFfMy0yLTEtMS0w_0a52f936-cd83-40c2-9874-0b4c3367ff9a">2.50</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8804; 3.50x</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib1a02d97b28646ba996e0c7e95b82bdd_D20160701-20160701" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOjNmYmE5ZjYwZWRjYzQ4NDM4N2UwZTRjZmE2MzE4YzBhL3RhYmxlcmFuZ2U6M2ZiYTlmNjBlZGNjNDg0Mzg3ZTBlNGNmYTYzMThjMGFfNC0xLTEtMS0w_c9e11312-a338-4863-b333-cc19174aedaa">3.25</ix:nonFraction>%</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i437bbb2e361f476fa45f34fff448bb87_D20160701-20160701" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOjNmYmE5ZjYwZWRjYzQ4NDM4N2UwZTRjZmE2MzE4YzBhL3RhYmxlcmFuZ2U6M2ZiYTlmNjBlZGNjNDg0Mzg3ZTBlNGNmYTYzMThjMGFfNC0yLTEtMS0w_6aac9446-7c14-431a-b6cb-0464464ed95c">2.25</ix:nonFraction>%</span></td></tr></table></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2020 the effective Adjusted Eurodollar Rate and the Base Rate for the First Lien Term Loans was <ix:nonFraction unitRef="number" contextRef="i82c3ce35d9e9413e9de0e1feba63291d_I20200930" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfNDg4Mw_dd98d292-91dd-476f-b623-bfeac401bf16">1.00</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i6eb5d73b46ce44f6be703ba3df195553_I20200930" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfNDg5MA_f0d64618-9a92-4276-80e4-6fa9d8f36aaa">3.25</ix:nonFraction>%, respectively and the applicable margin for Adjusted Eurodollar Rate and Base Rate borrowings was <ix:nonFraction unitRef="number" contextRef="icbbf618e1bfe4a609b2387b2599710eb_D20200101-20200930" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfNDk5MQ_a9c70cc3-f9dd-4967-ad1d-8234c1f73d07">3.75</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i36ad65e4b32d4d83a34c87cef93670a7_D20200101-20200930" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfNDk5OA_c2acbfab-8165-4b73-aff2-8e1c88028f3b">2.75</ix:nonFraction>%, respectively. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_25">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:continuation id="i3de721688b424c09a82810ebf121154a" continuedAt="iec65ec7e71d44b4cb2ae5959e753db2c"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The First Lien Credit Agreement provides for quarterly payments of principal under the First Lien Term Loans in the amount of approximately $<ix:nonFraction unitRef="usd" contextRef="i88ef47c29fec45228c446b6058e13c36_D20200101-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMjE5OTAyMzMwNDE5Ng_1ebeaf77-b1df-49e3-9439-8a3fc2e9f6f2">9.7</ix:nonFraction> million.  The  First Lien Term Loans will mature on July 21, 2023 unless otherwise accelerated under the terms of the First Lien Credit Agreement.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">SunTrust Credit Facilities:</span></div><div style="margin-top:1pt;text-align:justify;text-indent:36pt"><span><br/></span></div><ix:continuation id="id11f7d2c4c33491ebf9e399fda34734e"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our SunTrust Term Loan bears interest at either an Adjusted Eurodollar Rate or a Base Rate, plus an applicable margin according to the following schedule:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:93.859%"><tr><td style="width:1.0%"></td><td style="width:8.713%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.576%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.099%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.099%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.347%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pricing Level</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Leverage Ratio</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Applicable Margin for Eurodollar Loans</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Applicable Margin for Base Rate Loans</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Applicable Margin for Letter of Credit Fees</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Applicable Percentage for Commitment Fee</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than or equal to <ix:nonFraction unitRef="number" contextRef="ia5c31aa95d9342c4ba31e43e8ecb8e1f_I20180831" decimals="INF" name="rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmI5NDhmMjIwMDhmZDQ2MjU5MTJiNzU0NjJkMDcwNGMzL3RhYmxlcmFuZ2U6Yjk0OGYyMjAwOGZkNDYyNTkxMmI3NTQ2MmQwNzA0YzNfMS0xLTEtMS0zMDMxL3RleHRyZWdpb246NmJiOTRiMzUyYjQ1NDE0MTkxNWJkYjJiODI0ZTA4MmVfMTY0OTI2NzQ0MTcwNg_f9625a03-eb52-4c90-a331-b325e5d29d64">3.00</ix:nonFraction>:1.00</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icb9718af7bcb4577b02afe00cd03dadd_D20180831-20180831" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmI5NDhmMjIwMDhmZDQ2MjU5MTJiNzU0NjJkMDcwNGMzL3RhYmxlcmFuZ2U6Yjk0OGYyMjAwOGZkNDYyNTkxMmI3NTQ2MmQwNzA0YzNfMS0yLTEtMS0zMDU4L3RleHRyZWdpb246MDJmYTQ1NzA1YTk0NDFhNzgxNGJhZjIwZDczY2UxYTBfMTY0OTI2NzQ0MTY5Nw_ca3eab2d-1fd1-4692-93af-ca58747ae244">2.75</ix:nonFraction>%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i640e0341ae9546acb37a3b43ce1eba05_D20180831-20180831" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmI5NDhmMjIwMDhmZDQ2MjU5MTJiNzU0NjJkMDcwNGMzL3RhYmxlcmFuZ2U6Yjk0OGYyMjAwOGZkNDYyNTkxMmI3NTQ2MmQwNzA0YzNfMS0zLTEtMS0zMDU1L3RleHRyZWdpb246Nzk2MmZmMDNkNTgzNGQ2YThkYzRhZDU4YmIyZGU0NmVfMTY0OTI2NzQ0MTY4OQ_aa82a150-d5d3-4ea9-b6bc-dff04d49b0bd">1.75</ix:nonFraction>%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5c9e317de1694916936baac47457baad_D20180831-20180831" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmI5NDhmMjIwMDhmZDQ2MjU5MTJiNzU0NjJkMDcwNGMzL3RhYmxlcmFuZ2U6Yjk0OGYyMjAwOGZkNDYyNTkxMmI3NTQ2MmQwNzA0YzNfMS00LTEtMS0zMDY0L3RleHRyZWdpb246ZDdkODZmN2M5MTA3NDIyNmFmYzk5YjNiYTIyMjYxN2JfMTY0OTI2NzQ0MTY5Nw_5b11239a-b6f2-4056-840f-afb1d434b563">2.75</ix:nonFraction>%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5c9e317de1694916936baac47457baad_D20180831-20180831" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmI5NDhmMjIwMDhmZDQ2MjU5MTJiNzU0NjJkMDcwNGMzL3RhYmxlcmFuZ2U6Yjk0OGYyMjAwOGZkNDYyNTkxMmI3NTQ2MmQwNzA0YzNfMS01LTEtMS0zMDYxL3RleHRyZWdpb246MTc3MDRjMjg3NWY2NDdiNzk1YmRiMWMzMTVhNjdjODlfMTY0OTI2NzQ0MTY4OQ_ba960594-88a8-4bf4-9556-0cb0b594dd5a">0.45</ix:nonFraction>%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">II</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than <ix:nonFraction unitRef="number" contextRef="i5ffaf7ff24bc4ca493fd2b08c7ff3a25_I20180831" decimals="INF" name="rdnt:DebtInstrumentCovenantLeverageRatioMaximum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmI5NDhmMjIwMDhmZDQ2MjU5MTJiNzU0NjJkMDcwNGMzL3RhYmxlcmFuZ2U6Yjk0OGYyMjAwOGZkNDYyNTkxMmI3NTQ2MmQwNzA0YzNfMi0xLTEtMS0zMDM0L3RleHRyZWdpb246MDA0NzFiNzhiOWYxNDk5NThjZmU5MTliNjM1YjYyNmJfMTY0OTI2NzQ0MTczNw_bf2875b6-2dd3-48a6-91ca-40f695723b61">3.00</ix:nonFraction>:1.00 but greater than or equal to <ix:nonFraction unitRef="number" contextRef="i5ffaf7ff24bc4ca493fd2b08c7ff3a25_I20180831" decimals="INF" name="rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmI5NDhmMjIwMDhmZDQ2MjU5MTJiNzU0NjJkMDcwNGMzL3RhYmxlcmFuZ2U6Yjk0OGYyMjAwOGZkNDYyNTkxMmI3NTQ2MmQwNzA0YzNfMi0xLTEtMS0zMDM0L3RleHRyZWdpb246MDA0NzFiNzhiOWYxNDk5NThjZmU5MTliNjM1YjYyNmJfMTY0OTI2NzQ0MTczMA_b7cfc392-211f-4102-8336-2f8d2fced6e2">2.50</ix:nonFraction>:1.00</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2f5089184ad64416acfb6e9f45e20056_D20180831-20180831" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmI5NDhmMjIwMDhmZDQ2MjU5MTJiNzU0NjJkMDcwNGMzL3RhYmxlcmFuZ2U6Yjk0OGYyMjAwOGZkNDYyNTkxMmI3NTQ2MmQwNzA0YzNfMi0yLTEtMS0zMDc2L3RleHRyZWdpb246NGU1MTFmZmRjNjNlNDMwOWFmODg2Y2VjODA5NWVhZDdfMTY0OTI2NzQ0MTY4OQ_b7ddcf8b-0704-47cf-bf7f-6690c9980073">2.25</ix:nonFraction>%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0e66507e91084592ad6ec96e2082905e_D20180831-20180831" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmI5NDhmMjIwMDhmZDQ2MjU5MTJiNzU0NjJkMDcwNGMzL3RhYmxlcmFuZ2U6Yjk0OGYyMjAwOGZkNDYyNTkxMmI3NTQ2MmQwNzA0YzNfMi0zLTEtMS0zMDcwL3RleHRyZWdpb246YzkyZGVmMTZlN2RiNDdjODllNzZhNTk5YzRmOTI5MThfMTY0OTI2NzQ0MTY4OQ_544e8427-e2e3-4d10-835d-785e50bf591e">1.25</ix:nonFraction>%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie2a7f7080321422c81221d552960c25c_D20180831-20180831" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmI5NDhmMjIwMDhmZDQ2MjU5MTJiNzU0NjJkMDcwNGMzL3RhYmxlcmFuZ2U6Yjk0OGYyMjAwOGZkNDYyNTkxMmI3NTQ2MmQwNzA0YzNfMi00LTEtMS0zMDczL3RleHRyZWdpb246NTFjOGMwNDg5NDE2NDJlNGFiNTU5NGFjZTYyNGI0ZjVfMTY0OTI2NzQ0MTY5Nw_1d0c4faa-0194-4d2c-86e4-cdf7c6889a98">2.25</ix:nonFraction>%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie2a7f7080321422c81221d552960c25c_D20180831-20180831" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmI5NDhmMjIwMDhmZDQ2MjU5MTJiNzU0NjJkMDcwNGMzL3RhYmxlcmFuZ2U6Yjk0OGYyMjAwOGZkNDYyNTkxMmI3NTQ2MmQwNzA0YzNfMi01LTEtMS0zMDY3L3RleHRyZWdpb246NTIyYjdiMmZkMDdhNGVkYWEwMDlhZWQ4MjU3Y2I2ZjNfMTY0OTI2NzQ0MTY4OQ_12e66f6d-c286-4e60-85d0-0401d6634b5f">0.40</ix:nonFraction>%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">III</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt;padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than <ix:nonFraction unitRef="number" contextRef="i26e31c72794a4556a79b247236f494e6_I20180831" decimals="INF" name="rdnt:DebtInstrumentCovenantLeverageRatioMaximum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmI5NDhmMjIwMDhmZDQ2MjU5MTJiNzU0NjJkMDcwNGMzL3RhYmxlcmFuZ2U6Yjk0OGYyMjAwOGZkNDYyNTkxMmI3NTQ2MmQwNzA0YzNfMy0xLTEtMS0zMDQwL3RleHRyZWdpb246MjA2ODAzNTQ4OWEyNGY0ZGE4ZjNjNDkxZjFhMzcwNTFfMTY0OTI2NzQ0MTc0Nw_6771ebe2-aefa-4b06-ae94-5fb9c7864bce">2.50</ix:nonFraction>:1.00 but greater than or equal to</span></div><div style="margin-top:2.9pt;padding-left:4.5pt;padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i26e31c72794a4556a79b247236f494e6_I20180831" decimals="INF" name="rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmI5NDhmMjIwMDhmZDQ2MjU5MTJiNzU0NjJkMDcwNGMzL3RhYmxlcmFuZ2U6Yjk0OGYyMjAwOGZkNDYyNTkxMmI3NTQ2MmQwNzA0YzNfMy0xLTEtMS0zMDQwL3RleHRyZWdpb246MjA2ODAzNTQ4OWEyNGY0ZGE4ZjNjNDkxZjFhMzcwNTFfMTY0OTI2NzQ0MTczOA_cb4a9dfa-088b-4e87-9b25-5518e05c0795">2.00</ix:nonFraction>:1.00</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5f63a8341b184981a270daf0995422d2_D20180831-20180831" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmI5NDhmMjIwMDhmZDQ2MjU5MTJiNzU0NjJkMDcwNGMzL3RhYmxlcmFuZ2U6Yjk0OGYyMjAwOGZkNDYyNTkxMmI3NTQ2MmQwNzA0YzNfMy0yLTEtMS0zMDg4L3RleHRyZWdpb246NzU2YjFkZGVjZDJkNGU3ZWE1ZWFkMzM3NzU4NmY2MjhfMTY0OTI2NzQ0MTY4OQ_bce5eb7f-a520-43ad-8784-68f6d466b21c">2.00</ix:nonFraction>%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5a2cdf61ca404c6b9eaecf77fe17e670_D20180831-20180831" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmI5NDhmMjIwMDhmZDQ2MjU5MTJiNzU0NjJkMDcwNGMzL3RhYmxlcmFuZ2U6Yjk0OGYyMjAwOGZkNDYyNTkxMmI3NTQ2MmQwNzA0YzNfMy0zLTEtMS0zMDk3L3RleHRyZWdpb246NjcwODJhOTg5YWY3NDE5OTgxODczNjg0OGQzM2ZjZDFfMTY0OTI2NzQ0MTY4OQ_097966c6-9a93-47a4-a76d-cca73161b93b">1.00</ix:nonFraction>%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i213ea2bff4394c6288e6955b70cfbd38_D20180831-20180831" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmI5NDhmMjIwMDhmZDQ2MjU5MTJiNzU0NjJkMDcwNGMzL3RhYmxlcmFuZ2U6Yjk0OGYyMjAwOGZkNDYyNTkxMmI3NTQ2MmQwNzA0YzNfMy00LTEtMS0zMTAwL3RleHRyZWdpb246YTgyNjkwNzQ4NjliNGQzOTg3ZGRlM2NlZWNhMjBkNGZfMTY0OTI2NzQ0MTY5Nw_e0371de2-937a-461c-ba26-cf5e9bdf4539">2.00</ix:nonFraction>%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i213ea2bff4394c6288e6955b70cfbd38_D20180831-20180831" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmI5NDhmMjIwMDhmZDQ2MjU5MTJiNzU0NjJkMDcwNGMzL3RhYmxlcmFuZ2U6Yjk0OGYyMjAwOGZkNDYyNTkxMmI3NTQ2MmQwNzA0YzNfMy01LTEtMS0zMDgyL3RleHRyZWdpb246MDI1Nzk5MWQ3YjFkNDk3Yzg3M2UwN2UwYjVlOGJiN2NfMTY0OTI2NzQ0MTY5Nw_fc8c8d97-b69a-4424-ba7f-732fb20ab463">0.35</ix:nonFraction>%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IV</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than <ix:nonFraction unitRef="number" contextRef="i0b253bd7f2ce411085bd510025d25d34_I20180831" decimals="INF" name="rdnt:DebtInstrumentCovenantLeverageRatioMaximum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmI5NDhmMjIwMDhmZDQ2MjU5MTJiNzU0NjJkMDcwNGMzL3RhYmxlcmFuZ2U6Yjk0OGYyMjAwOGZkNDYyNTkxMmI3NTQ2MmQwNzA0YzNfNC0xLTEtMS0zMDM3L3RleHRyZWdpb246ZDM3MWExMTk4ZmIzNDRlN2EzZDY2NjQ3MzhiMWZjZDVfMTY0OTI2NzQ0MTczNw_e28f4de4-0221-417f-947e-2587dc785c7f">2.00</ix:nonFraction>:1.00 but greater than or equal to <ix:nonFraction unitRef="number" contextRef="i0b253bd7f2ce411085bd510025d25d34_I20180831" decimals="INF" name="rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmI5NDhmMjIwMDhmZDQ2MjU5MTJiNzU0NjJkMDcwNGMzL3RhYmxlcmFuZ2U6Yjk0OGYyMjAwOGZkNDYyNTkxMmI3NTQ2MmQwNzA0YzNfNC0xLTEtMS0zMDM3L3RleHRyZWdpb246ZDM3MWExMTk4ZmIzNDRlN2EzZDY2NjQ3MzhiMWZjZDVfMTY0OTI2NzQ0MTczMA_401bdd6c-f8ad-457b-8c2f-60269068de23">1.50</ix:nonFraction>:1.00</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0d4647b913524ddf926d5badbccce1c9_D20180831-20180831" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmI5NDhmMjIwMDhmZDQ2MjU5MTJiNzU0NjJkMDcwNGMzL3RhYmxlcmFuZ2U6Yjk0OGYyMjAwOGZkNDYyNTkxMmI3NTQ2MmQwNzA0YzNfNC0yLTEtMS0zMDkxL3RleHRyZWdpb246ZmE0YjRjZmFhZmUyNGY5YzgzZWU0NjI0ZGFiNWE5YWFfMTY0OTI2NzQ0MTY4OQ_39c33df9-5d6b-48a0-ac5b-29b9e49c3d61">1.75</ix:nonFraction>%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0e02d8d2117c46f3b37af31ddd457d1b_D20180831-20180831" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmI5NDhmMjIwMDhmZDQ2MjU5MTJiNzU0NjJkMDcwNGMzL3RhYmxlcmFuZ2U6Yjk0OGYyMjAwOGZkNDYyNTkxMmI3NTQ2MmQwNzA0YzNfNC0zLTEtMS0zMTA2L3RleHRyZWdpb246YjJmMTYzZGFmNmEyNGFiYWI4ZTkyY2FiMTQ3NmU1YmZfMTY0OTI2NzQ0MTY4OQ_b88ae1d1-2d01-400f-a937-1a0ddc4af1ca">0.75</ix:nonFraction>%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0a4736e633334391ba86255660511b78_D20180831-20180831" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmI5NDhmMjIwMDhmZDQ2MjU5MTJiNzU0NjJkMDcwNGMzL3RhYmxlcmFuZ2U6Yjk0OGYyMjAwOGZkNDYyNTkxMmI3NTQ2MmQwNzA0YzNfNC00LTEtMS0zMTA5L3RleHRyZWdpb246NWE0Y2ZkYjI0OGQzNGEzNWEyOWI5YjUyMzg1MWVhZGNfMTY0OTI2NzQ0MTY4OQ_d8109db9-a528-45a5-ac9f-27b116bcd69e">1.75</ix:nonFraction>%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0a4736e633334391ba86255660511b78_D20180831-20180831" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmI5NDhmMjIwMDhmZDQ2MjU5MTJiNzU0NjJkMDcwNGMzL3RhYmxlcmFuZ2U6Yjk0OGYyMjAwOGZkNDYyNTkxMmI3NTQ2MmQwNzA0YzNfNC01LTEtMS0zMDc5L3RleHRyZWdpb246ZmI1OGMzY2JlYWY5NDBkNTkyYmFiYzk4MWU1ODNmNmFfMTY0OTI2NzQ0MTY4OQ_bae33007-5c74-4de8-aa9a-6a0e7ef62eea">0.30</ix:nonFraction>%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">V</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than <ix:nonFraction unitRef="number" contextRef="id619046e0cd648adbb423bb179acab8e_I20180831" decimals="INF" name="rdnt:DebtInstrumentCovenantLeverageRatioMaximum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmI5NDhmMjIwMDhmZDQ2MjU5MTJiNzU0NjJkMDcwNGMzL3RhYmxlcmFuZ2U6Yjk0OGYyMjAwOGZkNDYyNTkxMmI3NTQ2MmQwNzA0YzNfNS0xLTEtMS0zMDUyL3RleHRyZWdpb246YjhmNGFjODM3ODVjNDJjNzk4N2FiNGExMWM5MmEyZDlfMTY0OTI2NzQ0MTY5MQ_45090367-23fb-46a3-a462-95e2399ccbb2">1.50</ix:nonFraction>:1.00</span></div></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iae42d0b5f76b4c879b3f0f43f04b1aed_D20180831-20180831" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmI5NDhmMjIwMDhmZDQ2MjU5MTJiNzU0NjJkMDcwNGMzL3RhYmxlcmFuZ2U6Yjk0OGYyMjAwOGZkNDYyNTkxMmI3NTQ2MmQwNzA0YzNfNS0yLTEtMS0zMDk0L3RleHRyZWdpb246OTEyYmM0NGVkNDgwNDQxOWIyYjUwNjA5NjVlNmU2ODZfMTY0OTI2NzQ0MTY4OQ_9dedfec1-d23d-4245-8781-261bc65d7340">1.50</ix:nonFraction>%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic7de0702b16e423a8f2781f8ef6aa693_D20180831-20180831" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmI5NDhmMjIwMDhmZDQ2MjU5MTJiNzU0NjJkMDcwNGMzL3RhYmxlcmFuZ2U6Yjk0OGYyMjAwOGZkNDYyNTkxMmI3NTQ2MmQwNzA0YzNfNS0zLTEtMS0zMTAzL3RleHRyZWdpb246YmYwZjQyMzg0YjAxNGFmNzg2MjNjMmUyZTU1ZTk3YzVfMTY0OTI2NzQ0MTY4OQ_de7f24c3-6531-4098-94d3-140e1fd5aa12">0.50</ix:nonFraction>%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia9129b65b01747c292ade5e736c79ab6_D20180831-20180831" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmI5NDhmMjIwMDhmZDQ2MjU5MTJiNzU0NjJkMDcwNGMzL3RhYmxlcmFuZ2U6Yjk0OGYyMjAwOGZkNDYyNTkxMmI3NTQ2MmQwNzA0YzNfNS00LTEtMS0zMTEyL3RleHRyZWdpb246ZGI4OGRjNzU2MGFmNDM5NzkyYTA5Y2RjNTVhZTAxMTRfMTY0OTI2NzQ0MTY4OQ_9a0c9b30-ffbb-43ab-8f78-12944e65cbb2">1.50</ix:nonFraction>%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia9129b65b01747c292ade5e736c79ab6_D20180831-20180831" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmI5NDhmMjIwMDhmZDQ2MjU5MTJiNzU0NjJkMDcwNGMzL3RhYmxlcmFuZ2U6Yjk0OGYyMjAwOGZkNDYyNTkxMmI3NTQ2MmQwNzA0YzNfNS01LTEtMS0zMDg1L3RleHRyZWdpb246NjZiYzNmMTRkMjk1NDA3ZThjYzQ4NGU1MDkzMGE0Y2NfMTY0OTI2NzQ0MTY5Nw_13476861-b073-4aa6-9b90-723de842f457">0.30</ix:nonFraction>%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr></table></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The loans and other obligations outstanding under the SunTrust Restated Credit Agreement currently bear applicable margin and fees based on Pricing Level III described above.  The loans outstanding under the SunTrust Restated Credit Agreement currently bear interest based on a three month Eurodollar election of <ix:nonFraction unitRef="number" contextRef="i3a832ef6cbe04ce4bb0e0da41889582d_D20200101-20200930" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMjE5OTAyMzI4MjA0OA_d735acef-b3ce-412b-b81b-9579d3f60b60">2.00</ix:nonFraction>%, plus the applicable margin.  </span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:31.5pt"><span><br/></span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The scheduled amortization of the SunTrust Term Loan began December 31, 2018 with quarterly payments of $<ix:nonFraction unitRef="usd" contextRef="if922a8b092874f639caee5acc1fd1a61_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMjE5OTAyMzMwNDU4Ng_655c00c6-2a50-4a04-a639-675761e44d7e">0.8</ix:nonFraction> million, representing annual amortization equal to <ix:nonFraction unitRef="number" contextRef="if922a8b092874f639caee5acc1fd1a61_D20180101-20181231" decimals="INF" name="rdnt:DebtInstrumentPeriodicPaymentPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMjE5OTAyMzMwNDU3MQ_431ea55e-9f4c-44ec-b964-93e380735850">5.00</ix:nonFraction>% of the original principal amount of the SunTrust Term Loan. At scheduled intervals, the quarterly amortization increases by $<ix:nonFraction unitRef="usd" contextRef="id655214ccff949e495e113e479f89eba_I20181231" decimals="-5" format="ixt:numdotdecimal" name="rdnt:DebtInstrumentPeriodicPaymentTermsAmortizationIncrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMjE5OTAyMzMwNDYwNA_215cad6d-091f-47f1-90f0-f487fee8e761">0.4</ix:nonFraction> million, with the remaining balance to be paid at maturity.  The SunTrust Term Loan will mature on August 1, 2023 unless otherwise accelerated under the terms of the SunTrust credit facility.</span></div><div><span><br/></span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:31.5pt"><span><br/></span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Revolving Credit Facilities</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Barclays Revolving Credit Facility</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revolving loans borrowed under the Barclays Revolving Credit Facility bear interest at either an Adjusted Eurodollar Rate or a Base Rate plus an applicable margin.  Rates of the applicable margin for borrowing under the Revolving Credit Facility also change depending on our leverage ratio and are the same rates as noted in the schedule above for First Lien Term Loans. As of September&#160;30, 2020, the effective interest rate payable on revolving loans was <ix:nonFraction unitRef="number" contextRef="iaf61ff95dda14ecdb11e6615b7e7633a_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMzI5ODUzNDkxMjQxOA_713207f6-4d46-4d44-b314-d7101fc3e8a4">6.00</ix:nonFraction>%.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Letters of credit issued under the Barclays Revolving Credit Facility, letter of credit fees accrue at the applicable margin of Adjusted Eurodollar Rate, currently <ix:nonFraction unitRef="number" contextRef="icbbf618e1bfe4a609b2387b2599710eb_D20200101-20200930" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMzI5ODUzNDkxMjYwMw_a9c70cc3-f9dd-4967-ad1d-8234c1f73d07">3.75</ix:nonFraction>% , and fronting fees accrue at <ix:nonFraction unitRef="number" contextRef="if5fdeeaa617f45bc8b5b2de98d538da7_D20200101-20200930" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMzI5ODUzNDkxMjYzNw_2455857a-c428-4e64-8d8c-45d0ba3ecc65">0.25</ix:nonFraction>% per annum, in each case on the average aggregate daily maximum amount available to be drawn under all letters of credit issued under the First Lien Credit Agreement. In addition, a commitment fee of <ix:nonFraction unitRef="number" contextRef="if5fdeeaa617f45bc8b5b2de98d538da7_D20200101-20200930" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMzI5ODUzNDkxMjgzOQ_2810d711-c6cf-4660-9a26-6a6d6d28e17f">0.50</ix:nonFraction>% per annum accrues on the unused revolver commitments under the Revolving Credit Facility.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Barclays Revolving Credit Facility will terminate on the earliest to occur of July 1, 2023 or its earlier termination to specific events of default pursuant to the First Lien Credit Agreement.</span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_25">Table of Contents</a></span></div></div><ix:continuation id="iec65ec7e71d44b4cb2ae5959e753db2c" continuedAt="i48a4fc14ebc94cbf9141a473d64fc874"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Barclays Revolving Credit Facility was amended in August 2020 to add $<ix:nonFraction unitRef="usd" contextRef="i2b01a556be2b4c8ab3308ab426b040ab_I20200930" decimals="INF" format="ixt:numdotdecimal" name="rdnt:LineofCreditFacilityIncreaseBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMzI5ODUzNDkxNTEwMA_55612a07-02e2-4010-8ef5-56cc9d2366e7">57.5</ix:nonFraction> million of revolving commitments and extend the maximum borrowing capacity to $<ix:nonFraction unitRef="usd" contextRef="i2b01a556be2b4c8ab3308ab426b040ab_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMzI5ODUzNDkxNTE3NA_c1927e52-0cbd-4fc6-94db-913922b29452">195.0</ix:nonFraction> million.  Total issue costs added in relation to the eighth amendment amounted to approximately $<ix:nonFraction unitRef="usd" contextRef="i2b01a556be2b4c8ab3308ab426b040ab_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMzI5ODUzNDkxNTI2Ng_8930bab3-7fee-42b4-9d06-0f5f04adadff">0.7</ix:nonFraction> million and was capitalized as deferred financing costs and will be amortized over the remaining term of the agreement.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">SunTrust Revolving Credit Facility</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our SunTrust Revolving Credit Facility is available to NJIN for funding requirements, with an available borrowing limit of $<ix:nonFraction unitRef="usd" contextRef="ib9d01a93b2904f61b4796d8a81410b9e_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMzI5ODUzNDkxOTUxMQ_51da22f1-0fb4-454f-94ca-890e4b34f6d9">30.0</ix:nonFraction> million.  Revolving loan borrowed under the SunTrust Revolving Credit Facility bear interest at either an Adjusted Eurodollar Rate or a Base Rate plus an applicable margin.  Rates of the applicable margin for borrowing under the Revolving Credit Facility also change depending on our leverage ration and are the same rates noted in the schedule above for the SunTrust Term Loan. The SunTrust Revolving Credit Facility terminates on August 31, 2023 unless all amounts outstanding otherwise have been declared or have automatically become due and payable (whether by acceleration or otherwise). NJIN has not borrowed against the revolving credit line.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Recent Amendments to credit facilities:</span></div><div style="margin-top:10pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Barclays Credit Facilities:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 28, 2020, RadNet, Inc. entered into Amendment No. 8, Consent and Incremental Joinder Agreement to Credit and Guaranty Agreement "the Eighth Amendment".  The Eighth Amendment amends the First Lien Credit Agreement to add $<ix:nonFraction unitRef="usd" contextRef="i2b01a556be2b4c8ab3308ab426b040ab_I20200930" decimals="INF" format="ixt:numdotdecimal" name="rdnt:LineofCreditFacilityIncreaseBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMjE5OTAyMzI4MjM2OA_55612a07-02e2-4010-8ef5-56cc9d2366e7">57.5</ix:nonFraction> million of revolving commitments to the Barclays Revolving Credit Facility extending the maximum borrowing capacity under the revolving credit facility to $<ix:nonFraction unitRef="usd" contextRef="i2b01a556be2b4c8ab3308ab426b040ab_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMjE5OTAyMzI4MjUxOQ_c1927e52-0cbd-4fc6-94db-913922b29452">195.0</ix:nonFraction> million while leaving the maturity date of July 1, 2023 unchanged.  Total issue costs added in relation to the Eighth Amendment amounted to approximately $<ix:nonFraction unitRef="usd" contextRef="i2b01a556be2b4c8ab3308ab426b040ab_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMjE5OTAyMzI4MjY2OQ_8930bab3-7fee-42b4-9d06-0f5f04adadff">0.7</ix:nonFraction> million and was capitalized as deferred financing costs and will be amortized over the remaining term of the agreement.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 18, 2019 we entered into the following two amendments to the First Lien Credit Agreement: (i) Amendment No. 6, Consent and Incremental Joinder Agreement to Credit and Guaranty Agreement (the &#8220;Sixth Amendment&#8221;); and (ii) Amendment No. 7 to Credit and Guaranty Agreement (the &#8220;Seventh Amendment&#8221;).  The Sixth Amendment amended the First Lien Credit Agreement to issue $<ix:nonFraction unitRef="usd" contextRef="i34109ecc091e412a9dbd8651e8bb4f2e_I20170822" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMjE5OTAyMzI4MzI3Mg_d737b96f-58ab-42ea-ac84-7ee28b64c744">100.0</ix:nonFraction> million in incremental First Lien Term Loans and to add an additional $<ix:nonFraction unitRef="usd" contextRef="i978f7eac6654400d951615a49c92ee12_I20190418" decimals="INF" format="ixt:numdotdecimal" name="rdnt:LineofCreditFacilityIncreaseBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMjE5OTAyMzI4MzMzOA_a6f0e736-fee4-47cb-920a-06296807602f">20.0</ix:nonFraction> million of revolving commitments to the Barclay's Revolving Credit Facility.  The Seventh Amendment amended the First Lien Credit Agreement to extend the maturity date of the Barclays Revolving Credit Facility by an additional two years to July 1, 2023, unless sooner terminated in accordance with the terms of the First Lien Credit Agreement.  Total issue costs added in relation to the Sixth and Seventh amendments in 2019 amounted to approximately $<ix:nonFraction unitRef="usd" contextRef="i8cca9d99b9324bd1b781038f68dc4e2f_I20190418" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMjE5OTAyMzI4Mzc2Ng_9c2ca9da-7ab6-41ca-8aeb-ce29a2e1520e">4.4</ix:nonFraction> million. Of this amount, $<ix:nonFraction unitRef="usd" contextRef="i8cca9d99b9324bd1b781038f68dc4e2f_I20190418" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscountCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMjE5OTAyMzI4Mzc4Nw_e1ea3946-3ae5-4122-9444-12c15cd68812">2.1</ix:nonFraction> million was identified and capitalized as discount on debt, $<ix:nonFraction unitRef="usd" contextRef="i8cca9d99b9324bd1b781038f68dc4e2f_I20190418" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMjE5OTAyMzI4Mzg0Mw_959db7c4-eb5a-4cd0-a7c6-75f1551c2b6a">0.7</ix:nonFraction> million was capitalized as deferred financing costs, and $<ix:nonFraction unitRef="usd" contextRef="ib5b7a6ac8167458194c44af4ba48c5bd_D20190418-20190418" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfDeferredCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMjE5OTAyMzI4Mzg5Ng_3190007c-3690-4ef1-b179-a10ee7b4e0d6">1.6</ix:nonFraction> million was expensed. Amounts capitalized will be amortized over the remaining term of the agreement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:10pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Paycheck Protection Program</span></div></ix:continuation><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i48a4fc14ebc94cbf9141a473d64fc874">The Paycheck Protection Program (PPP) includes funds available for loans to small business and Medicare providers to support operations during the COVID-19 pandemic. The funds are administered by the Small Business Administration (SBA), through approved lenders and do not require collateral or personal guarantees.  We received our loans based on being a Medicare provider. The terms and conditions for participation require entities to certify that economic uncertainty related to the COVID-19 pandemic makes the loan necessary to support their current operations, and that they will use the funds to retain workers (e.g., by paying salaries, providing paid sick/medical leave and health insurance benefits) and pay certain debts (mortgage obligations) and expenses (e.g. rent, utilities, telephone).  The loans have a <ix:nonFraction unitRef="number" contextRef="icd0727e676b44495b92424a21cfd803d_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMjE5OTAyMzI3MTQxOQ_3c2d6232-3f78-409b-836f-f8d161aa9c6b">1.0</ix:nonFraction>% fixed interest rate and are due in <ix:nonNumeric contextRef="i965d7b0c650248aeb676ce27ef4835ab_D20200101-20200930" format="ixt-sec:duryear" name="us-gaap:DebtInstrumentTerm" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMjE5OTAyMzI3MTQ1OA_6caa1905-3e82-4b6b-be68-88efacda9ee5">2</ix:nonNumeric> years. Initial repayments have been deferred for six months.  The loans are eligible for forgiveness subject to salary limitations and employee retention levels. Certain of our consolidated subsidiaries received <ix:nonFraction unitRef="loan" contextRef="i965d7b0c650248aeb676ce27ef4835ab_D20200101-20200930" decimals="INF" format="ixt-sec:numwordsen" name="rdnt:DebtInstrumentNumberofLoansReceived" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMjE5OTAyMzI3MTY2OA_b493ec2f-f73c-491d-a499-e081c1a71c30">four</ix:nonFraction> loans totaling $<ix:nonFraction unitRef="usd" contextRef="icd0727e676b44495b92424a21cfd803d_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMjE5OTAyMzI3MTY4Nw_bf55d90a-c502-4cbb-92d8-f316a5a03cc4">4.0</ix:nonFraction> million.  We have accounted for the funds received as debt and recorded a liability for the full amount of proceeds received.  Interest will be accrued over the term of the loans.  If we meet the eligibility requirements for forgiveness the amounts forgiven will be recognized in the income statement as a gain on loan extinguishment in accordance with accounting guidance.</ix:continuation> </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div id="iffc0b59705bf4cff936f619293b1a306_61"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 6 &#8211; <ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RleHRyZWdpb246NjYzNDIxNWY0ZWM0NGI4OTg5ZDVkMDk4MGZhYmM4MTdfMzM0Nw_52697d85-c6c4-43b7-a258-1938b2414788" continuedAt="i5c1268f5ae504272a8463adf791a59fc" escape="true">STOCK-BASED COMPENSATION</ix:nonNumeric></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:continuation id="i5c1268f5ae504272a8463adf791a59fc" continuedAt="i36cb32c8fc044930b0a6eb13f6df5cd0">Stock Incentive Plans</ix:continuation></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_25">Table of Contents</a></span></div></div><ix:continuation id="i36cb32c8fc044930b0a6eb13f6df5cd0" continuedAt="i1aa54b20f1df4ed6bea6a0aafab51a92"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have one long-term equity incentive plan which we refer to as the 2006 Equity Incentive Plan, which we first amended and restated as of April 20, 2015 and again on March 9, 2017 (the "Restated Plan&#8221;). The Restated Plan was approved by our stockholders at our annual stockholders meeting on June 8, 2017. We have reserved for issuance under the Restated Plan <ix:nonFraction unitRef="shares" contextRef="i027fbe622cb740e796aa36dc1f00b42e_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RleHRyZWdpb246NjYzNDIxNWY0ZWM0NGI4OTg5ZDVkMDk4MGZhYmM4MTdfNDIy_5f8e318f-7622-4dc2-b132-df8b54eb7362">14,000,000</ix:nonFraction> shares of common stock. We can issue options (incentive and non-qualified), stock awards, stock appreciation rights, stock units and cash awards under the Restated Plan.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Options</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain options granted under the Restated Plan to employees are intended to qualify as incentive stock options under existing tax regulations. Stock options generally vest over <ix:nonNumeric contextRef="ib55973caf29b407cacf26e47cab62a42_D20200101-20200930" format="ixt-sec:duryear" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RleHRyZWdpb246NjYzNDIxNWY0ZWM0NGI4OTg5ZDVkMDk4MGZhYmM4MTdfNzgx_8a0de3f8-81b3-439a-97ba-309505f3aec6">3</ix:nonNumeric> to <ix:nonNumeric contextRef="if47fff6cbf3149a0a1f38edce2abc129_D20200101-20200930" format="ixt-sec:duryear" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RleHRyZWdpb246NjYzNDIxNWY0ZWM0NGI4OTg5ZDVkMDk4MGZhYmM4MTdfNzg3_b7bf8c58-0824-444e-b815-ecb8808920f2">5</ix:nonNumeric> years and expire <ix:nonNumeric contextRef="ib55973caf29b407cacf26e47cab62a42_D20200101-20200930" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RleHRyZWdpb246NjYzNDIxNWY0ZWM0NGI4OTg5ZDVkMDk4MGZhYmM4MTdfODA3_f7518132-06bc-4043-b8c9-ce49da188bdb">5</ix:nonNumeric> to <ix:nonNumeric contextRef="if47fff6cbf3149a0a1f38edce2abc129_D20200101-20200930" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RleHRyZWdpb246NjYzNDIxNWY0ZWM0NGI4OTg5ZDVkMDk4MGZhYmM4MTdfODEz_e2865cfa-67fc-4c46-8fd4-4e9be81a0746">10</ix:nonNumeric> years from the date of grant.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2020, we had outstanding options to acquire <ix:nonFraction unitRef="shares" contextRef="i3d158c180c134e64a61a649a0dff7314_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RleHRyZWdpb246NjYzNDIxNWY0ZWM0NGI4OTg5ZDVkMDk4MGZhYmM4MTdfODk0_db11e330-2764-439f-88dd-a53955ac31e9">527,899</ix:nonFraction> shares of our common stock, of which options to acquire <ix:nonFraction unitRef="shares" contextRef="i3d158c180c134e64a61a649a0dff7314_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RleHRyZWdpb246NjYzNDIxNWY0ZWM0NGI4OTg5ZDVkMDk4MGZhYmM4MTdfOTUz_ada91c4b-bb21-44e0-b069-ade7479658d0">298,863</ix:nonFraction> shares were exercisable. <ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RleHRyZWdpb246NjYzNDIxNWY0ZWM0NGI4OTg5ZDVkMDk4MGZhYmM4MTdfMzM0OQ_0e8cdf64-8a3c-4080-b9a3-6bbe51e5c718" continuedAt="ica57cccaa00d412f97a782ce7a3bf7ce" escape="true">The following summarizes all of our option transactions for the nine months ended September&#160;30, 2020:</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt"><ix:continuation id="ica57cccaa00d412f97a782ce7a3bf7ce" continuedAt="i78f8dc22df2544938be66c4a6477e1ef"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:48.973%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.650%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outstanding Options<br/>Under the 2006 Plan</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise price<br/>Per Common Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining<br/>Contractual Life<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2019</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaab629f0885047bfac5042b54e4cf7b0_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RhYmxlOmUyZTE1ZWI2NWZjYjRlMzg4MzliYWQwNTBmZjM5ZTZkL3RhYmxlcmFuZ2U6ZTJlMTVlYjY1ZmNiNGUzODgzOWJhZDA1MGZmMzllNmRfMS0yLTEtMS0w_3b11629b-ee23-4ebd-9f4e-46302798e01d">478,951</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iaab629f0885047bfac5042b54e4cf7b0_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RhYmxlOmUyZTE1ZWI2NWZjYjRlMzg4MzliYWQwNTBmZjM5ZTZkL3RhYmxlcmFuZ2U6ZTJlMTVlYjY1ZmNiNGUzODgzOWJhZDA1MGZmMzllNmRfMS00LTEtMS0w_4f52061f-b3e0-446e-939c-886de5526c1a">8.21</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4b5d964821bf467daf58020889b187c2_D20200101-20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RhYmxlOmUyZTE1ZWI2NWZjYjRlMzg4MzliYWQwNTBmZjM5ZTZkL3RhYmxlcmFuZ2U6ZTJlMTVlYjY1ZmNiNGUzODgzOWJhZDA1MGZmMzllNmRfMi0yLTEtMS0w_384fcc27-dd13-43a6-8c95-5d0935c900c3">48,948</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4b5d964821bf467daf58020889b187c2_D20200101-20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RhYmxlOmUyZTE1ZWI2NWZjYjRlMzg4MzliYWQwNTBmZjM5ZTZkL3RhYmxlcmFuZ2U6ZTJlMTVlYjY1ZmNiNGUzODgzOWJhZDA1MGZmMzllNmRfMi00LTEtMS0w_ab93a480-110a-42ff-afc5-518b0dd5c0b7">20.43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, September 30, 2020</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3d158c180c134e64a61a649a0dff7314_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RhYmxlOmUyZTE1ZWI2NWZjYjRlMzg4MzliYWQwNTBmZjM5ZTZkL3RhYmxlcmFuZ2U6ZTJlMTVlYjY1ZmNiNGUzODgzOWJhZDA1MGZmMzllNmRfNS0yLTEtMS0w_d1a81745-431f-4a9c-a7e9-4e56a48c7c19">527,899</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3d158c180c134e64a61a649a0dff7314_I20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RhYmxlOmUyZTE1ZWI2NWZjYjRlMzg4MzliYWQwNTBmZjM5ZTZkL3RhYmxlcmFuZ2U6ZTJlMTVlYjY1ZmNiNGUzODgzOWJhZDA1MGZmMzllNmRfNS00LTEtMS0w_3ef9a32f-645a-4d70-b2e2-62f50de778fa">9.34</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4b5d964821bf467daf58020889b187c2_D20200101-20200930" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RhYmxlOmUyZTE1ZWI2NWZjYjRlMzg4MzliYWQwNTBmZjM5ZTZkL3RhYmxlcmFuZ2U6ZTJlMTVlYjY1ZmNiNGUzODgzOWJhZDA1MGZmMzllNmRfNS02LTEtMS0w_4c8c9982-21d3-4f82-974c-59f6a6b91aae">6.59</ix:nonNumeric></span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d158c180c134e64a61a649a0dff7314_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RhYmxlOmUyZTE1ZWI2NWZjYjRlMzg4MzliYWQwNTBmZjM5ZTZkL3RhYmxlcmFuZ2U6ZTJlMTVlYjY1ZmNiNGUzODgzOWJhZDA1MGZmMzllNmRfNS04LTEtMS0w_b3f2b534-3741-421a-bb1c-c4c210313d25">3,419,956</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at September 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3d158c180c134e64a61a649a0dff7314_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RhYmxlOmUyZTE1ZWI2NWZjYjRlMzg4MzliYWQwNTBmZjM5ZTZkL3RhYmxlcmFuZ2U6ZTJlMTVlYjY1ZmNiNGUzODgzOWJhZDA1MGZmMzllNmRfNi0yLTEtMS0w_844b3585-8c95-41f8-9649-4f84bcf19379">298,863</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3d158c180c134e64a61a649a0dff7314_I20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RhYmxlOmUyZTE1ZWI2NWZjYjRlMzg4MzliYWQwNTBmZjM5ZTZkL3RhYmxlcmFuZ2U6ZTJlMTVlYjY1ZmNiNGUzODgzOWJhZDA1MGZmMzllNmRfNi00LTEtMS0w_a8857e76-81b9-49c3-b9ca-9d4a16a25615">7.48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4b5d964821bf467daf58020889b187c2_D20200101-20200930" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RhYmxlOmUyZTE1ZWI2NWZjYjRlMzg4MzliYWQwNTBmZjM5ZTZkL3RhYmxlcmFuZ2U6ZTJlMTVlYjY1ZmNiNGUzODgzOWJhZDA1MGZmMzllNmRfNi02LTEtMS0w_2b809666-c793-48eb-be2d-1996d199e436">5.85</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d158c180c134e64a61a649a0dff7314_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RhYmxlOmUyZTE1ZWI2NWZjYjRlMzg4MzliYWQwNTBmZjM5ZTZkL3RhYmxlcmFuZ2U6ZTJlMTVlYjY1ZmNiNGUzODgzOWJhZDA1MGZmMzllNmRfNi04LTEtMS0w_c0aadbf9-6efa-4853-9537-31e0f2f7b894">2,353,438</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aggregate intrinsic value in the table above represents the total pretax intrinsic value (the difference between our closing stock price on September&#160;30, 2020 and the exercise price, multiplied by the number of in-the-money options as applicable) that would have been received by the holder had all holders exercised their options on September&#160;30, 2020. <ix:nonFraction unitRef="shares" contextRef="i4b5d964821bf467daf58020889b187c2_D20200101-20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RleHRyZWdpb246NjYzNDIxNWY0ZWM0NGI4OTg5ZDVkMDk4MGZhYmM4MTdfMTM4OQ_19011ff6-b720-4e31-a1e0-3dd6fa62c1d0">No</ix:nonFraction> options were exercised during the nine months ended September&#160;30, 2020.  As of September&#160;30, 2020, total unrecognized stock-based compensation expense related to non-vested employee awards was $<ix:nonFraction unitRef="usd" contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RleHRyZWdpb246NjYzNDIxNWY0ZWM0NGI4OTg5ZDVkMDk4MGZhYmM4MTdfMTU1MQ_5048312d-ef11-4a27-a215-2485c790d285">0.7</ix:nonFraction> million which is expected to be recognized over a weighted average period of approximately <ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RleHRyZWdpb246NjYzNDIxNWY0ZWM0NGI4OTg5ZDVkMDk4MGZhYmM4MTdfMTYzNw_e2f88608-c420-43bf-a31b-3900833ce21a">1.68</ix:nonNumeric> years.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:174%">DeepHealth Options</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of fiscal 2020, in connection with the completion of the DeepHealth acquisition, we granted&#160;<ix:nonFraction unitRef="shares" contextRef="i656e4333bc494b37a20f965c8618f1d0_D20200701-20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RleHRyZWdpb246NjYzNDIxNWY0ZWM0NGI4OTg5ZDVkMDk4MGZhYmM4MTdfMTc3OA_eeaec566-5ad1-4898-80ca-45e3e5752acf">412,434</ix:nonFraction>&#160;options at a grant date fair value of $<ix:nonFraction unitRef="usdPerShare" contextRef="ifb572eb0a62c470bb17e387648d4f17f_D20200701-20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RleHRyZWdpb246NjYzNDIxNWY0ZWM0NGI4OTg5ZDVkMDk4MGZhYmM4MTdfMTgxOQ_912a60c9-91a8-45a1-a047-ee07e3d8a0b7">16.93</ix:nonFraction>&#160;per share unit to DeepHealth employees in replacement of their stock options that were outstanding as of the closing date.  As of September&#160;30, 2020, total unrecognized stock based compensation expense related to non-vested DeepHealth options was approximately $<ix:nonFraction unitRef="usd" contextRef="ic88e676c8ae54e949cbc0e057a2855a7_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RleHRyZWdpb246NjYzNDIxNWY0ZWM0NGI4OTg5ZDVkMDk4MGZhYmM4MTdfMjA2Nw_11211331-4b41-4be6-a380-7f291a5950aa">4.3</ix:nonFraction> million which is expected to be recognized over a weighted average period of approximately <ix:nonNumeric contextRef="i1e4ebdf884e14af1b77318c2bc533fa7_D20200101-20200930" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RleHRyZWdpb246NjYzNDIxNWY0ZWM0NGI4OTg5ZDVkMDk4MGZhYmM4MTdfMjE1MA_0dc3f0b6-fe9c-4774-a3c1-921f87d31454">2.53</ix:nonNumeric> years.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="i78f8dc22df2544938be66c4a6477e1ef"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.836%"><tr><td style="width:1.0%"></td><td style="width:48.506%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.587%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.711%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.587%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.711%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.587%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.711%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.587%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.713%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outstanding Options<br/>Under the Deep Health Plan</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise price<br/>Per Common Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining<br/>Contractual Life<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2019</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icff8e20d84f241cd8104a1116305268a_I20191231" decimals="INF" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RhYmxlOmY4OTBhY2YxZGFjNDQ1YmI5MDgyNTczMjIyMWE1ODU1L3RhYmxlcmFuZ2U6Zjg5MGFjZjFkYWM0NDViYjkwODI1NzMyMjIxYTU4NTVfMS0yLTEtMS0w_c6227968-8cfe-4686-88ca-bad9e39d9c9e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted, June 1, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8741d0f710974ec5a70b0b546a43e7fb_D20200101-20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RhYmxlOmY4OTBhY2YxZGFjNDQ1YmI5MDgyNTczMjIyMWE1ODU1L3RhYmxlcmFuZ2U6Zjg5MGFjZjFkYWM0NDViYjkwODI1NzMyMjIxYTU4NTVfMi0yLTEtMS0w_4d552b85-a420-444d-940f-2bbc5a07617a">412,434</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i8741d0f710974ec5a70b0b546a43e7fb_D20200101-20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RhYmxlOmY4OTBhY2YxZGFjNDQ1YmI5MDgyNTczMjIyMWE1ODU1L3RhYmxlcmFuZ2U6Zjg5MGFjZjFkYWM0NDViYjkwODI1NzMyMjIxYTU4NTVfMy0yLTEtMS0w_73fbd1a0-556c-469b-b33c-362a423d927c">6,963</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, September 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iced7ee1846d8433483d7f50dbea0a847_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RhYmxlOmY4OTBhY2YxZGFjNDQ1YmI5MDgyNTczMjIyMWE1ODU1L3RhYmxlcmFuZ2U6Zjg5MGFjZjFkYWM0NDViYjkwODI1NzMyMjIxYTU4NTVfNC0yLTEtMS0w_18047243-eb2d-4b9e-9d7e-8c13066c19c4">405,471</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8741d0f710974ec5a70b0b546a43e7fb_D20200101-20200930" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RhYmxlOmY4OTBhY2YxZGFjNDQ1YmI5MDgyNTczMjIyMWE1ODU1L3RhYmxlcmFuZ2U6Zjg5MGFjZjFkYWM0NDViYjkwODI1NzMyMjIxYTU4NTVfNC02LTEtMS0w_0c64641e-3155-4fc1-8bb7-a26c77f8ffd4">8.65</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iced7ee1846d8433483d7f50dbea0a847_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RhYmxlOmY4OTBhY2YxZGFjNDQ1YmI5MDgyNTczMjIyMWE1ODU1L3RhYmxlcmFuZ2U6Zjg5MGFjZjFkYWM0NDViYjkwODI1NzMyMjIxYTU4NTVfNC04LTEtMS0w_9f01eb71-74e8-403c-a8c2-bfb04df025e1">6,223,980</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at September 30, 2020</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iced7ee1846d8433483d7f50dbea0a847_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RhYmxlOmY4OTBhY2YxZGFjNDQ1YmI5MDgyNTczMjIyMWE1ODU1L3RhYmxlcmFuZ2U6Zjg5MGFjZjFkYWM0NDViYjkwODI1NzMyMjIxYTU4NTVfNS0yLTEtMS0w_f942ecee-4d13-4d60-92f7-6eb48445d63c">24,211</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8741d0f710974ec5a70b0b546a43e7fb_D20200101-20200930" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RhYmxlOmY4OTBhY2YxZGFjNDQ1YmI5MDgyNTczMjIyMWE1ODU1L3RhYmxlcmFuZ2U6Zjg5MGFjZjFkYWM0NDViYjkwODI1NzMyMjIxYTU4NTVfNS02LTEtMS0w_99e25334-1175-4cdc-9dd1-3e494c3656fa">8.65</ix:nonNumeric></span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iced7ee1846d8433483d7f50dbea0a847_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RhYmxlOmY4OTBhY2YxZGFjNDQ1YmI5MDgyNTczMjIyMWE1ODU1L3RhYmxlcmFuZ2U6Zjg5MGFjZjFkYWM0NDViYjkwODI1NzMyMjIxYTU4NTVfNS04LTEtMS0w_29f9a19d-a01b-45d2-bb8e-72bdc2f22550">371,639</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Awards</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Restated Plan permits the award of restricted stock awards (&#8220;RSA&#8217;s&#8221;). As of September&#160;30, 2020, we have issued a total of <ix:nonFraction unitRef="shares" contextRef="icfc15acb74684a52b57e605b24afd3db_I20200930" decimals="INF" format="ixt:numdotdecimal" name="rdnt:AwardsIssuedToDate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RleHRyZWdpb246NjYzNDIxNWY0ZWM0NGI4OTg5ZDVkMDk4MGZhYmM4MTdfMjI5MA_07729ceb-c09f-40c8-9f78-bd59fb93fc01">6,551,872</ix:nonFraction> RSA&#8217;s of which <ix:nonFraction unitRef="shares" contextRef="icfc15acb74684a52b57e605b24afd3db_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RleHRyZWdpb246NjYzNDIxNWY0ZWM0NGI4OTg5ZDVkMDk4MGZhYmM4MTdfMjMwOA_faa8f1fa-036c-4128-9202-e7d46c71e9cb">331,659</ix:nonFraction> were unvested at September&#160;30, 2020. <ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" name="us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RleHRyZWdpb246NjYzNDIxNWY0ZWM0NGI4OTg5ZDVkMDk4MGZhYmM4MTdfMzM1Mg_fb7e70f1-64d7-4960-a0bf-23151bd43395" continuedAt="i4bdb341580f44c1f8dd2237e14af7c20" escape="true">The following summarizes all unvested RSA&#8217;s activities during the nine months ended September&#160;30, 2020:</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_25">Table of Contents</a></span></div></div><ix:continuation id="i1aa54b20f1df4ed6bea6a0aafab51a92"><div style="margin-bottom:5pt;margin-top:5pt"><ix:continuation id="i4bdb341580f44c1f8dd2237e14af7c20"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">RSA's</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Remaining<br/>Contractual<br/>Term (Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSA's unvested at December 31, 2019</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i24073316903a4b80852ce62f50a13e5f_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RhYmxlOmEzZmFjMDA4ZWY3ODQwODY4ZGRjNWZlZDc2MmFmYTkxL3RhYmxlcmFuZ2U6YTNmYWMwMDhlZjc4NDA4NjhkZGM1ZmVkNzYyYWZhOTFfMS0xLTEtMS0w_fe3bd0fe-630c-478d-8bbe-dcf91aa795f8">387,934</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i24073316903a4b80852ce62f50a13e5f_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RhYmxlOmEzZmFjMDA4ZWY3ODQwODY4ZGRjNWZlZDc2MmFmYTkxL3RhYmxlcmFuZ2U6YTNmYWMwMDhlZjc4NDA4NjhkZGM1ZmVkNzYyYWZhOTFfMS01LTEtMS0w_b796a1e5-c551-4164-981c-2cf31dd9eb92">11.61</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes during the period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id598685e49ce4cde89846d1481b70e13_D20200101-20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RhYmxlOmEzZmFjMDA4ZWY3ODQwODY4ZGRjNWZlZDc2MmFmYTkxL3RhYmxlcmFuZ2U6YTNmYWMwMDhlZjc4NDA4NjhkZGM1ZmVkNzYyYWZhOTFfMy0xLTEtMS0w_46be57a3-599e-42a6-8f4b-f631395dcdb1">457,596</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id598685e49ce4cde89846d1481b70e13_D20200101-20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RhYmxlOmEzZmFjMDA4ZWY3ODQwODY4ZGRjNWZlZDc2MmFmYTkxL3RhYmxlcmFuZ2U6YTNmYWMwMDhlZjc4NDA4NjhkZGM1ZmVkNzYyYWZhOTFfMy01LTEtMS0w_52bb503f-d697-4fd1-8a34-eaeed52fc7c2">19.66</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="id598685e49ce4cde89846d1481b70e13_D20200101-20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RhYmxlOmEzZmFjMDA4ZWY3ODQwODY4ZGRjNWZlZDc2MmFmYTkxL3RhYmxlcmFuZ2U6YTNmYWMwMDhlZjc4NDA4NjhkZGM1ZmVkNzYyYWZhOTFfNC0xLTEtMS0w_eaa9debe-de52-4681-807f-7c945865a77a">513,871</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id598685e49ce4cde89846d1481b70e13_D20200101-20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RhYmxlOmEzZmFjMDA4ZWY3ODQwODY4ZGRjNWZlZDc2MmFmYTkxL3RhYmxlcmFuZ2U6YTNmYWMwMDhlZjc4NDA4NjhkZGM1ZmVkNzYyYWZhOTFfNC01LTEtMS0w_d00fea39-37a9-46f1-bc64-c0db080a9910">15.47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSA's unvested at September 30, 2020</span></td><td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icfc15acb74684a52b57e605b24afd3db_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RhYmxlOmEzZmFjMDA4ZWY3ODQwODY4ZGRjNWZlZDc2MmFmYTkxL3RhYmxlcmFuZ2U6YTNmYWMwMDhlZjc4NDA4NjhkZGM1ZmVkNzYyYWZhOTFfNi0xLTEtMS0w_5102b564-8e67-4d13-8bee-78847c325384">331,659</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id598685e49ce4cde89846d1481b70e13_D20200101-20200930" format="ixt-sec:duryear" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RhYmxlOmEzZmFjMDA4ZWY3ODQwODY4ZGRjNWZlZDc2MmFmYTkxL3RhYmxlcmFuZ2U6YTNmYWMwMDhlZjc4NDA4NjhkZGM1ZmVkNzYyYWZhOTFfNi0zLTEtMS0w_5f887e63-9b97-462b-afbc-436af0725264">1.11</ix:nonNumeric></span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="icfc15acb74684a52b57e605b24afd3db_I20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RhYmxlOmEzZmFjMDA4ZWY3ODQwODY4ZGRjNWZlZDc2MmFmYTkxL3RhYmxlcmFuZ2U6YTNmYWMwMDhlZjc4NDA4NjhkZGM1ZmVkNzYyYWZhOTFfNi01LTEtMS0w_f1b7de60-13db-40f2-a04d-850602d56e26">16.67</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine the fair value of all RSA&#8217;s based on the closing price of our common stock on the award date.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other stock bonus awards</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Restated Plan also permits the award of stock bonuses not subject to any future service period. These awards are valued and expensed based on the closing price of our common stock on the date of award. During the nine months ended September&#160;30, 2020 awards totaling <ix:nonFraction unitRef="shares" contextRef="ic62bac0609a645d1a910b8ba6cb946fb_D20200101-20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RleHRyZWdpb246NjYzNDIxNWY0ZWM0NGI4OTg5ZDVkMDk4MGZhYmM4MTdfMjgwNA_96f0217b-92dc-45aa-b84d-f27aee52d0af">26,078</ix:nonFraction> shares were granted.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Plan summary</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In summary, of the <ix:nonFraction unitRef="shares" contextRef="i027fbe622cb740e796aa36dc1f00b42e_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RleHRyZWdpb246NjYzNDIxNWY0ZWM0NGI4OTg5ZDVkMDk4MGZhYmM4MTdfMjg2MA_5f8e318f-7622-4dc2-b132-df8b54eb7362">14,000,000</ix:nonFraction> shares of common stock reserved for issuance under the Restated Plan, at September&#160;30, 2020, we had issued <ix:nonFraction unitRef="shares" contextRef="i027fbe622cb740e796aa36dc1f00b42e_I20200930" decimals="INF" format="ixt:numdotdecimal" name="rdnt:AwardsIssuedToDate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RleHRyZWdpb246NjYzNDIxNWY0ZWM0NGI4OTg5ZDVkMDk4MGZhYmM4MTdfMjk1NA_ccf3d29b-0337-4f9e-844e-fa9209bc5b33">15,384,316</ix:nonFraction> total shares between options, RSA&#8217;s and other stock awards. With options canceled and RSA&#8217;s forfeited amounting to <ix:nonFraction unitRef="shares" contextRef="i8bcd128fbffd44eca246f153070892ca_D20200101-20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RleHRyZWdpb246NjYzNDIxNWY0ZWM0NGI4OTg5ZDVkMDk4MGZhYmM4MTdfMzA3Mg_f47e8ba8-ebba-424f-b6d4-08ce26ab5711">3,281,040</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i8bcd128fbffd44eca246f153070892ca_D20200101-20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RleHRyZWdpb246NjYzNDIxNWY0ZWM0NGI4OTg5ZDVkMDk4MGZhYmM4MTdfMzA3OQ_593ab79b-4e67-4a15-b712-0e160d939f58">61,703</ix:nonFraction> shares, respectively, there remain <ix:nonFraction unitRef="shares" contextRef="i027fbe622cb740e796aa36dc1f00b42e_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RleHRyZWdpb246NjYzNDIxNWY0ZWM0NGI4OTg5ZDVkMDk4MGZhYmM4MTdfMzExNw_4165eae9-c4ea-4375-8a97-4a18d040a240">1,958,427</ix:nonFraction> shares available under the Restated Plan for future issuance.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The DeepHealth options were issued outside of the Restated Plan and are a direct result of our acquisition and not included in the share count of the Restated Plan.</span></div></ix:continuation><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div id="iffc0b59705bf4cff936f619293b1a306_64"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 7 &#8211; <ix:nonNumeric contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930" name="us-gaap:SubsequentEventsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82NC9mcmFnOjJkYmIxMWQwN2I5MDRmMDI5NjhiZmM2ZmFkNTZhZDNiL3RleHRyZWdpb246MmRiYjExZDA3YjkwNGYwMjk2OGJmYzZmYWQ1NmFkM2JfODY3_d12d1ee5-032c-41b9-add7-7bc98fa4771c" continuedAt="ida5909e5c6c949e2ad23d82a1f2592b6" escape="true">SUBSEQUENT EVENTS</ix:nonNumeric></span></div><ix:continuation id="ida5909e5c6c949e2ad23d82a1f2592b6"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Formation of majority owned subsidiary</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2020 we formed in conjunction with Simi Valley Hospital and Health Services ("Simi Adventist") the Simi Valley Imaging Group, LLC (&#8220;SVIG&#8221;), consisting of <ix:nonFraction unitRef="center" contextRef="ic97e88dc3d0b400f82757dbc8ca7b075_I20201101" decimals="INF" format="ixt-sec:numwordsen" name="rdnt:NumberOfAssetsAcquired" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82NC9mcmFnOjJkYmIxMWQwN2I5MDRmMDI5NjhiZmM2ZmFkNTZhZDNiL3RleHRyZWdpb246MmRiYjExZDA3YjkwNGYwMjk2OGJmYzZmYWQ1NmFkM2JfMTY0OTI2NzQ0ODc1NA_310b88b4-fc0a-4270-b71e-fcc40f638c99">three</ix:nonFraction> multi-modality imaging centers located in Simi Valley, CA.  RadNet will hold a <ix:nonFraction unitRef="number" contextRef="ic97e88dc3d0b400f82757dbc8ca7b075_I20201101" decimals="INF" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82NC9mcmFnOjJkYmIxMWQwN2I5MDRmMDI5NjhiZmM2ZmFkNTZhZDNiL3RleHRyZWdpb246MmRiYjExZDA3YjkwNGYwMjk2OGJmYzZmYWQ1NmFkM2JfMjc0ODc3OTA3NjM0NA_77cc7f47-e3bc-4714-b955-97ae137e67d4">60</ix:nonFraction>% economic interest in SVIG and Simi Adventist will have the remaining  <ix:nonFraction unitRef="number" contextRef="i1f2ef1f8cedb41f48a20163cf23ac25f_I20201101" decimals="INF" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82NC9mcmFnOjJkYmIxMWQwN2I5MDRmMDI5NjhiZmM2ZmFkNTZhZDNiL3RleHRyZWdpb246MmRiYjExZDA3YjkwNGYwMjk2OGJmYzZmYWQ1NmFkM2JfMjc0ODc3OTA3NjQxOQ_04bd8f46-0434-4740-936c-175b1c763be2">40</ix:nonFraction>% interest.</span></div></ix:continuation><div id="iffc0b59705bf4cff936f619293b1a306_67"></div><div style="margin-bottom:10pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2.&#160;&#160;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">You should read the following discussion and analysis of our financial condition and results of operations in conjunction with our unaudited condensed consolidated financial statements and notes thereto included in Part I, Item 1 of this Quarterly Report on Form 10-Q and with our audited consolidated financial statements and notes thereto for the year ended December 31, 2019 included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2019 filed with the U.S. Securities and Exchange Commission (SEC) on March 11, 2020.</span></div><div id="iffc0b59705bf4cff936f619293b1a306_70"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Forward-Looking Statements</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This quarterly report on Form 10-Q contains &#8220;forward-looking statements&#8221; within the meaning of Section 27A of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;) and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements reflect current views about future events and are based on our currently available financial, economic and competitive data and on current business plans. Actual events or results may differ materially depending on risks and uncertainties that may affect our operations, markets, services, prices and other factors.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some cases, you can identify forward-looking statements by terminology such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;predict,&#8221; &#8220;potential,&#8221; &#8220;continue,&#8221; &#8220;assumption&#8221; or the negative of these terms or other comparable terminology. Forward-looking statements in this current report include, among others, statements we make regarding</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_7">Table of Contents</a></span></div></div><div style="margin-top:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"> our ability to successfully integrate new operations, to our business and the anticipated benefits to be derived from our investments, acquisitions, and joint ventures;</span></div><div style="margin-top:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">anticipated trends in our revenues, operating expenses and liquidity and cash flows, including our financial guidance and anticipated effects of cost-savings efforts;</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the ongoing impact of the COVID-19 pandemic on our business, suppliers, payors, customers, referral sources, partners, patients and employees, including (i) government&#8217;s unprecedented action regarding existing and potential restrictions and/or obligations related to citizen and business activity to contain the virus; (ii) the consequences of an economic downturn resulting from the impacts of COVID-19 and the possibility of a global economic recession; (iii) the impact of the volume of canceled or rescheduled procedures, whether as a result of government action or patient choice; (iv) measures we are taking to respond to the COVID-19 pandemic, including changes to business practices; (v) the impact of government and administrative regulation, guidance and appropriations; (vi) changes in our revenues due to declining patient procedure volumes, changes in payor mix; (vii) potential increased expenses or workforce disruptions related to our employees that could lead to unavailability of key personnel; (viii) workforce disruptions related to our key partners, suppliers, vendors and others we do business with; (ix) the impact of return to work orders in certain states in which we operate; and (x) increased credit and collectability risks; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our future liquidity and our continuing ability to service and remain in compliance with applicable debt covenants or refinance our current indebtedness.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward-looking statements are not guarantees of future performance and our actual results may differ significantly from the results discussed in the forward-looking statements. Factors that might cause such differences include, but are not limited to, the factors included in &#8220;Risk Factors,&#8221; in our annual report on Form 10-K for the fiscal year ended December 31, 2019 and quarterly report on form 10Q for the quarters ended March 31, and June 30, 2020, or supplemented by the information in Part II&#8211; Item 1A below. You should consider the inherent limitations on, and risks associated with, forward-looking statements and not unduly rely on the accuracy of predictions contained in such forward-looking statements.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These forward-looking statements speak only as of the date when they are made. We assume no obligation to revise or update any forward-looking statements for any reason, except as required by law.</span></div><div id="iffc0b59705bf4cff936f619293b1a306_73"></div><div style="margin-top:10pt"><span><br/></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a leading national provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States based on number of locations and annual imaging revenue. At September&#160;30, 2020, we operated, directly or indirectly through joint ventures with hospitals, 334 centers located in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York.  Our centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders and may reduce unnecessary invasive procedures, often reducing the cost and amount of care for patients.  Our services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. In addition to our imaging services, we own and operate a number of technology businesses that are complementary to our imaging business. Our subsidiary eRAD, Inc., develops and sells computerized systems for the diagnostic imaging industry, which provide the technology to distribute, display, store and retrieve digital images.  Over 2019 and 2020 we have made a number of investments in Artificial Intelligence (AI) with our purchases of Nulogix and DeepHealth, combined with our investment in Whiterabbit.ai and our collaborative arrangement with Hologic.  Our current AI focus is to develop solutions in machine learning to assist radiologists and other clinicians in interpreting images and improving patient care, initially in the field of mammography.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We derive substantially all of our revenue, directly or indirectly, from fees charged for the diagnostic imaging services performed at our facilities. The following table shows our facilities in operation and revenues for the nine months ended September&#160;30, 2020 and September&#160;30, 2019:</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_25">Table of Contents</a></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.836%"><tr><td style="width:1.0%"></td><td style="width:74.490%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.711%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.587%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.712%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Facilities in operation</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues (millions)</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">763.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">853.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue is derived from a diverse mix of payors, including private payors, managed care capitated payors and government payors. We believe our payor diversity mitigates our exposure to possible unfavorable reimbursement trends within any one payor class. In addition, our experience with capitation arrangements over the last several years has provided us with the expertise to manage utilization and pricing effectively, resulting in a predictable stream of revenue. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s total service revenue during the three and nine months ended September&#160;30, 2020 and 2019 are presented in the table below based on an allocation of the estimated transaction price with the patient between the primary patient classification of insurance coverage (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.321%"><tr><td style="width:1.0%"></td><td style="width:52.120%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.169%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.176%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.169%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial insurance</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,524&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,152&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412,415&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475,064&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,704&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154,847&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175,825&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,098&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,128&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,072&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,564&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Workers' compensation/personal injury</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,865&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,950&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other patient revenue</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,328&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,085&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,211&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,947&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management fee revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,675&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,792&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,574&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,662&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Teleradiology and Software revenue</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,349&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,412&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,319&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,861&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,869&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,617&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,878&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service fee revenue</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256,730&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261,908&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">660,760&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">762,751&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue under capitation arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,784&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,587&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total service revenue</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291,776&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292,692&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">763,905&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">853,338&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We typically experience some seasonality to our revenue stream. During the first quarter of each year we generally experience the lowest volumes of procedures and the lowest level of revenue for any quarter during the year. It is common for inclement weather to result in patient appointment cancellations and, in some cases, imaging center closures. Second, in recent years, we have observed greater participation in high deductible health plans by patients.&#160; As these high deductibles reset in January for most of these patients, we have observed that patients utilize medical services less during the first quarter, when&#160;securing medical care&#160;will result in significant out-of-pocket expenditures.</span></div><div id="iffc0b59705bf4cff936f619293b1a306_76"></div><div style="margin-top:10pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Developments</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The discussion below of our results centers on our performance in the third quarter ending September 30, 2020.  As discussed in our Form 8-K filed on April 3, 2020, the overall impact of the coronavirus pandemic on RadNet&#8217;s business has had and could continue to have a material impact on our operating results, cash flows and financial position. The magnitude of the impact will ultimately depend on the duration and extent of the COVID-19 pandemic and the impact of governmental actions and patient behavior in response to the pandemic, which remains ongoing.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As as result of the pandemic we began experiencing reduced procedure volumes in mid-March which intensified through the early part of the second quarter of 2020.  As economic activity has begun to ramp-up, our procedure volumes have returned to our pre-COVID-19 pace, from a low of 28% pre-COVID-19 volumes experienced in April 2020.  Our experience has shown that lost imaging slots in one quarter are not made up within that period or in subsequent quarters.  We continue to adapt our operations in response to the pandemic where needed and implemented several cost-saving measures such as concentrating patient traffic to larger imaging centers, negotiating payment terms with vendors and landlords, adjusting staff levels and telecommuting.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_25">Table of Contents</a></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity Investments, Acquisitions and Dispositions, and Joint Venture Activity</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have developed our medical imaging business through a combination of organic growth, equity investments, acquisitions and joint venture formations. The information below updates our activity of such matters contained in our annual report on Form 10-K for the year ended December 31, 2019.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Investments</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2020, we have three equity investments for which a fair value is not readily determinable and therefore the total amounts invested are recognized at cost as follows</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medic Vision Imaging Solutions Ltd., based in Israel, specializes in software packages that provide compliant radiation dose structured reporting and enhanced images from reduced dose CT scans.  On March 24, 2017, we acquired an initial 12.5% equity interest in Medic Vision for $1.0 million. We also received an option to exercise warrants to acquire up to an additional 12.5% equity interest for $1.4 million within one year from the initial share purchase date, if exercised in full. On March 1, 2018 we exercised our warrant in part and acquired an additional 1.96% for $0.2 million. Our initial equity interest has been diluted to 12.25% and our total equity investment stands at 14.21%.  In accordance with accounting guidance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as we exercise no significant influence over Medic Vision&#8217;s operations, the investment is recorded at its cost of $1.2 million, given that the fair value is not readily determinable. No observable price changes or impairment in our investment was identified as of September&#160;30, 2020.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Turner Imaging Systems, based in Utah, develops and markets portable X-ray imaging systems that provide a user the ability to acquire X-ray images wherever and whenever they are needed. On February 1, 2018, we purchased 2.1 million preferred shares in Turner Imaging Systems for $2.0 million. On January 1, 2019 we funded a convertible promissory note in the amount of $0.1 million that converted to additional 80,000 shares December 21, 2019.  No observable price changes or impairment in our investment was identified as of September&#160;30, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WhiteRabbit.ai Inc., based in California, is currently developing an artificial intelligence suite which aims to improve the speed and accuracy of cancer detection in radiology and improve patient care. On November 5, 2019 we acquired an equity interest in the company for $1.0 million and also loaned the company $2.5 million, the principal of which is due November 2022.  To leverage their artificial intelligence expertise, we entered into a software subscription service contract to assist our radiology work flow and advanced them $4.0 million for future software subscription fees that is recorded as a prepaid expense in Prepaid and Other Current assets in our consolidated balance sheets.  No observable price changes or impairment in our investment or the loan receivable was identified as of September&#160;30, 2020.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Facility acquisitions</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 31, 2020 we completed our acquisition of certain assets of AZ-Tech Radiology &amp; Open MRI, LLC, consisting of eight multi-modality imaging centers located in the Phoenix, Arizona area for purchase consideration of $5.5 million.  We made a preliminary fair value determination of the acquired assets and assumed liabilities and approximately $2.5 million in property and equipment, $7.6 million in right-of-use assets, $0.1 million in other assets, $7.6 million in operating lease liabilities, and $2.9 million in goodwill were recorded.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 1, 2020, we completed our acquisition of all the equity interests of DeepHealth Inc., ("DeepHealth") an artificial intelligence and machine learning company in an all stock purchase.  As initial purchase consideration, we issued 915,132 shares at $16.93 per share (823,615 issued at execution, with up to 91,517 shares to be issued 18 months after acquisition subject to adjustment for any indemnification claims).  The transaction was accounted for as an acquisition of a business and total purchase consideration determined to be approximately $34.6 million including i) 823,615 shares issued on the date of closing with fair value of $13.9 million, ii) a liability of 91,517 shares with a fair value of $1.5 million to be issued 18 months after acquisition subject to adjustment for any indemnification claims and will be marked to market in subsequent periods, iii) replacement awards attributable to pre-combination service issued to DeepHealth option holders with allocated fair value of $2.0 million, iv) acquisition date fair value of contingent consideration of $17.0 million and v) $0.1 million in closing costs reimbursed to the seller.  The fair values of replacement awards attributable to pre-combination service and contingent consideration are recorded in additional paid in capital upon closing of the transaction. For the contingent consideration, there are three arrangements that will be settled in a fixed number of shares upon achievement of three individual specific milestones which are mutually exclusive of each other, with 390,789, 586,184, and 195,393 shares, respectively, issuable for each milestone arrangement. The fair value of the contingent consideration was estimated at the date of acquisition based on our share price and estimated probability of the achievement of the respective milestones.  We preliminarily recorded $0.1 million in current assets, $3.5 million in deferred tax liabilities, $14.8 million in intangible assets, primarily in-process research and </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_25">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">development ("IPR&amp;D'), and $23.4 million in goodwill. The goodwill is primarily attributable to expected post-acquisition synergies from integrating DeepHealth&#8217;s assembled workforce and IPR&amp;D technologies. The fair values of the identifiable intangible assets related to IPR&amp;D were determined by the income method and the assets will not be amortized until completion. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 2, 2020 our consolidated subsidiary New Jersey Imaging Networks ("NJIN") completed the acquisition of certain assets of MRI at Woodbridge, LLC consisting of a single multi-modality imaging center located in Avenel, New Jersey for consideration of $2.6 million.  NJIN made a fair value determination of the acquired assets and assumed liabilities and approximately $0.5 million in property and equipment, $1.1 million in right-of-use assets, $0.3 million in intangible assets, $1.1 million in operating lease liabilities, $0.1 million in finance lease liabilities, and $1.8 million in goodwill were recorded.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On January 2, 2020 we completed our acquisition of certain assets of Olney Open MRI, LLC, consisting of a single multi-modality imaging center located in Columbia, Maryland for consideration of $1.8 million.  We have made a fair value determination of the acquired assets and assumed liabilities and approximately $0.8 million in property and equipment, $1.3 million in right-of-use assets, $0.3 million in intangible assets, $1.3 million in operating lease liabilities and $0.6 million  in goodwill were recorded.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dispositions:</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 1, 2020 we completed our sale of certain assets of our Imaging On Call subsidiary to RadVantage P.C. (an unrelated corporation) for approximately $1.0 thousand.  With this transaction, we have exited the teleradiology business.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Joint venture investment contribution</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the month of August 2020, we made additional cash contributions to our Santa Monica Imaging Group, LLC partnership in the amount of $1.6 million in support of its expanded operations.  We maintain our 35% economic interest in the partnership.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Joint Venture Activity</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of our investment in joint ventures during the nine months ended September 30, 2020 (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:87.186%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,470&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings in these joint ventures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,176&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2020</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,571&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We charged management service fees from the centers underlying these joint ventures of approximately $2.7 million and $1.8 million for the three months ended September&#160;30, 2020 and 2019, respectively. and $8.6 million and $7.8 million for the nine months ended September&#160;30, 2020 and 2019, respectively.  We eliminate any unrealized portion of our management service fees with our equity in earnings of joint ventures.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_25">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of key balance sheet data for these joint ventures as of September&#160;30, 2020 and December&#160;31, 2019 and income statement data for the nine months ended September 30, 2020 and 2019 (in thousands):</span></div><div style="margin-bottom:15pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:70.349%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance Sheet Data:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,618&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,427&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,576&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,037&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,487)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,217)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,751)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,872)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net assets</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,956&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,375&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Book value of RadNet joint venture interests</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,121&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,001&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost in excess of book value of acquired joint venture interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,450&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,469&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total value of Radnet joint venture interests</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,571&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,470&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total book value of other joint venture partner interests</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,835&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,374&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income statement data for the nine months ended September 30,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,988&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,115&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,651&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,718&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div id="iffc0b59705bf4cff936f619293b1a306_79"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Securities and Exchange Commission defines critical accounting estimates as those that are both most important to the portrayal of a company&#8217;s financial condition and results of operations and require management&#8217;s most difficult, subjective or complex judgment, often as a result of the need to make estimates about the effect of matters that are inherently uncertain and may change in subsequent periods.&#160;In Note 2 to our consolidated financial statements in this quarterly report and in our annual report on Form 10-K for the year ended December&#160;31, 2019, we discuss our significant accounting policies, including those that do not require management to make difficult, subjective or complex judgments or estimates. The most significant areas involving management&#8217;s judgments and estimates are described below.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenues</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues generally relate to net patient fees&#160;received from various payors and patients themselves under contracts in which our performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period when our obligations to provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payor (Medicare, Medicaid, managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed care health plans and commercial insurance companies) the third-party payors. The payment arrangements with third-party payors for the services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As it relates to the Group, this service fee revenue includes payments for both the professional medical interpretation revenue recognized by them as well as the payment for all other aspects related to our providing the imaging services, for which we earn management fees. As it relates to other centers, this service fee revenue is earned through providing the use of our diagnostic imaging equipment and the provision of technical services as well as providing administration services such as clerical and administrative personnel, bookkeeping and accounting services, billing and collection, provision of medical and office supplies, secretarial, reception and transcription services, maintenance of medical records, and advertising, marketing and promotional activities.&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_25">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues are based upon the estimated amounts we expect to be entitled to receive from patients and third-party payors. Estimates of contractual allowances under managed care and commercial insurance plans are based upon historical collection experience of the payments received from such payors in accordance with the underlying contractual agreements. Revenues related to uninsured patients and copayment and deductible amounts for patients who have health care coverage may have price concessions applied. We also record estimated implicit price concessions (based primarily on historical collection experience) related to uninsured accounts to record self-pay revenues at the estimated amounts we expect to collect.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under capitation arrangements with various health plans, we earn a per-enrollee amount each month for making available diagnostic imaging services to all plan enrollees under the capitation arrangement. Revenue under capitation arrangements is recognized in the period in which we are obligated to provide services to plan enrollees under contracts with various health plans.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provider Relief Fund (COVID-19 Stimulus Funding)</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Provider Relief Fund offers government assistance to eligible providers throughout the healthcare system in support of certain expenses or lost revenue attributable to the coronavirus pandemic. In the third quarter of 2020, we received approximately $0.2 million in funding and for nine months ended September 30, 2020 we have received funding of $25.7 million. Generally, the department of Health and Human Services ("HHS") does not intend to recoup funds as long as a provider's lost revenue and increased expenses exceed the amount of provider relief funding one has received. HHS reserves the right to audit Relief Fund recipients in the future to ensure that this requirement is met and collect any Relief Fund amounts that were made in error or exceed lost revenue or increased expenses due to the pandemic. Failure to comply with the terms and conditions may be grounds for recoupment.  During the quarter ended September 30, 2020, we continued to evaluate our operating results and gave consideration to the updated reporting guidelines issued in September by the U.S. Department of Health and Human Services that significantly changed the measurement of Provider Relief Fund distributions providers are able to retain. Based on our assessment recognition of the revenue previously recognized remained appropriate.  </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients.&#160;Services are generally provided pursuant to one-year contracts with healthcare providers. Receivables generally are collected within industry norms for third-party payors.&#160;We continuously monitor collections from our payors and maintain an allowance for bad debts based upon specific payor collection issues that we have identified and our historical experience.  In regards to the credit loss standard, our expectation is that the historical credit loss experienced across our receivable portfolio is materially similar to any current expected credit losses that would be estimated under the CECL model.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense is computed using an asset and liability method and using expected annual effective tax rates. Under this method, deferred income tax assets and liabilities result from temporary differences in the financial reporting bases and the income tax reporting bases of assets and liabilities. The measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefit that, based on available evidence, is not expected to be realized. When it appears more likely than not that deferred taxes will not be realized, a valuation allowance is recorded to reduce the deferred tax asset to its estimated realizable value. For net deferred tax assets we consider estimates of future taxable income, including tax planning strategies, in determining whether our net deferred tax assets are more likely than not to be realized.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Revenue</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April of 2020, we received approximately $39.4 million in advanced Medicare payments from the Centers for Medicare and Medicaid Services ("CMS") as part of the expanded Accelerated and Advance Payment Program under the Coronavirus Aid, Relief, and Economic Security (CARES) Act.  As these payments are required to be repaid to CMS beginning 120 days after their receipt through  offsets from new Medicare claims over a three month period, we have recorded amounts received to deferred revenue which will be amortized as Medicare reimbursements are earned.  In addition, in May of 2020 we received $5.0 million in advance payments from an insurance carrier with similar repayment terms as the CMS.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation of property and equipment is performed using the straight-line method over the estimated useful lives of the assets acquired, which range </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_25">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">from 3 to 15 years. Leasehold improvements are amortized at the lesser of lease term or their estimated useful lives, which range from 3 to 15 years. Maintenance and repairs are charged to expense as incurred.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business Combination</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate all purchases under the framework in ASU No. 2017-01 (&#8220;ASU 2017-01&#8221;),&#160;Clarifying the Definition of a Business. Once the purchase has been determined to be the acquisition of a business, we are required to recognize separately from goodwill the assets acquired and the liabilities assumed at their acquisition date fair values. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities assumed. While we use our best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, we record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to our consolidated statements of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and Indefinite Lived Intangibles</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill at September&#160;30, 2020 totaled $470.7 million.  Indefinite Lived Intangible Assets at September&#160;30, 2020 were $11.3 million and are associated with the value of certain trade name intangibles.  Goodwill and trade name intangibles are recorded as a result of business combinations.  When we determine the carrying value of a reporting unit exceeds its fair value an impairment charge would be recognized and should not exceed the total amount of goodwill allocated to that reporting unit.  We tested goodwill for impairment on October 1, 2019. In addition to the annual impairment test, we regularly assess if an event has occurred which would require interim impairment testing.  We considered the current and expected future economic and market conditions surrounding the novel strain of coronavirus ("COVID-19") pandemic and did not identify an indication of goodwill impairment being more likely than not through September&#160;30, 2020.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Lived Assets</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate our long-lived assets (property and equipment) and intangibles, other than goodwill, for impairment whenever indicators of impairment exist. To evaluate the long-lived assets our management estimates the undiscounted future cash flows expected to be derived from the asset. The accounting standards require that if the sum of the undiscounted expected future cash flows from a long-lived asset or definite-lived intangible is less than the carrying value of that asset, an asset impairment charge must be recognized. The amount of the impairment charge is calculated as the excess of the asset&#8217;s carrying value over its fair value, which generally represents the discounted future cash flows from that asset or in the case of assets we expect to sell, at fair value less costs to sell. No indicators of impairment were identified with respect to our long-lived assets as of September&#160;30, 2020.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Depreciation and Amortization of Long-Lived Assets</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We depreciate our long-lived assets over their estimated economic useful lives with the exception of leasehold improvements where we use the shorter of the assets useful lives or the lease term of the facility for which these assets are associated. We estimate the economic useful lives of assets, other than leasehold improvements, to be between 3 and 15 years depending on the type of asset.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (&#8220;ROU&#8221;) assets, current operating lease liabilities, and long term operating lease liability in our consolidated balance sheets. Finance leases are included in property and equipment, current finance lease liability, and long-term finance lease liability in our consolidated balance sheets.&#160;&#160;ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. We use the implicit rate when readily determinable.  We include options to extend a lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term.  For a contract in which we are a lessee that contains fixed payments for both lease and non-lease components, we have elected to account for the components as a single lease component, as permitted. For finance leases, interest expense on the lease liability is recognized using the effective interest method and amortization of the ROU asset is recognized on a straight-line basis over the shorter of the estimated useful life of the asset or the lease term. </span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ROU assets </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_25">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">are</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> tested for impairment if circumstances suggest that the carrying amount may not be recoverable.  Our ROU assets consist of facility and equipment assets on operating leases.  No events have occurred such as fire, flood, or other acts which have impaired the integrity of our ROU assets in 2020.  Our facility leases require us to maintain insurance policies which would cover major damage to our facilities.  We maintain business interruption insurance to cover loss of business due to a facility becoming non-operational under certain circumstances.  Our equipment leases are covered by warranty and service contracts which cover repairs and provide regular maintenance to keep the equipment in functioning order.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Based Compensation</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have one long-term incentive plan that we adopted in 2006 and which we first amended and restated as of April 20, 2015, and again on March 9, 2017 (the &#8220;Restated Plan&#8221;). The Restated Plan was approved by our stockholders at our annual stockholders meeting on June 8, 2017. We have reserved 14,000,000 shares of common stock for issuance under the Restated Plan which can be issued in the form of options, stock awards, stock appreciation rights, and cash awards.  Stock options generally vest over three to five years and expire five to ten years from date of grant.  We determine the compensation expense for each stock option award using the Black Scholes, or similar valuation model.  Those models require that our management make certain estimates concerning risk free interest rates and volatility in the trading price of our common stock. The compensation expense recognized for all equity-based awards is recognized over the awards&#8217; service periods. Equity-based compensation is classified in operating expenses within the same line item as the majority of the cash compensation paid to employees.  In connection with our acquisition of DeepHealth Inc. on June 1, 2020, we assumed the DeepHealth, Inc. 2017 Stock Incentive Plan, including outstanding options awards that can be exercised for our common stock.  No additional awards will be granted under the DeepHealth, Inc. 2017 Equity Incentive Plan.  See Note 4, Facility Acquisitions and Note 6, Stock-Based Compensation, for more information.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commitments and Contingencies</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are party to various legal proceedings, claims, and regulatory, tax or government inquiries and investigations that arise in the ordinary course of business. With respect to these matters, we evaluate the developments on a regular basis and accrue a liability when we believe a loss is probable and the amount can be reasonably estimated. Based on current information, we do not believe that reasonably possible or probable losses associated with pending legal proceedings would either individually or in the aggregate, have a material adverse effect on our business and consolidated financial statements. However, the outcome of these matters is inherently uncertain. Therefore, if one or more of these matters were resolved against us for amounts in excess of management's expectations, our results of operations and financial condition, including in a particular reporting period in which any such outcome becomes probable and estimable, could be materially adversely affected.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div id="iffc0b59705bf4cff936f619293b1a306_82"></div><div style="margin-bottom:10pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Standards</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 3, Recent Accounting and Reporting Standards to the financial statements included in this report or further information.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><div id="iffc0b59705bf4cff936f619293b1a306_85"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_25">Table of Contents</a></span></div></div><div style="margin-bottom:10pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth, for the three and nine months ended September&#160;30, 2020 and 2019, the percentage that certain items in the statements of operations bears to total service revenue, inclusive of revenue under capitation contracts.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RADNET, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(IN THOUSANDS EXCEPT SHARE DATA)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:49.779%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.632%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">REVENUE</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Service fee revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Revenue under capitation arrangements</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.0&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.5&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 42.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total service revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Provider relief funding</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OPERATING EXPENSES</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Cost of operations, excluding depreciation and amortization</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.5&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.9&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.7&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.2&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Loss on sale and disposal of equipment and other</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Severance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 47.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.1&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.2&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.4&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.6&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">INCOME FROM OPERATIONS</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OTHER INCOME AND EXPENSES</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Equity in earnings of joint ventures</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Non-cash change in fair value of interest rate hedge</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Other (income) expenses</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 42.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">INCOME (LOSS) BEFORE INCOME TAXES</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;(Provision for) benefit from income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NET INCOME (LOSS)</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-1.7&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NET INCOME (LOSS) ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have developed our medical imaging business through a combination of organic growth, equity investments, acquisitions and joint venture formations.  We have segregated some of our information to demonstrate which is attributable to centers that were in operation through the entirety of the comparison period, and which is attributable to those that were acquired or disposed of during the period.  The discussion below shows a breakdown and analysis of revenue and expenses for the three and nine months ended September&#160;30, 2020 and 2019 for our operations at a total company and same center level. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Three Months Ended September 30, 2020 Compared to the Three Months Ended September 30, 2019 </span></div><div style="margin-bottom:10pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Total Revenue inclusive of Provider Relief funding for 2020</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_25">Table of Contents</a></span></div></div><div style="margin-bottom:15pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.760%"><tr><td style="width:1.0%"></td><td style="width:39.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.777%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="12" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ Increase/(Decrease)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenue</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$291,997</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$292,692</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(695)</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Same Center Revenue</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$288,919</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$288,700</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$219</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1%</span></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our nationwide operations were affected by the COVID-19 pandemic starting mid March 2020 and has resulted in an approximate 5% decrease in same center procedural volumes compared to the same period last year.  Same Center Revenue however remained flat due to a 14% rise in revenue under capitation arrangements stemming from a combination of rate increases, plan membership growth and higher copays.  This comparison excludes revenue contributions from centers that were acquired or divested subsequent to July&#160;1, 2019. For the three months ended September 30, 2020, net service fee revenue from centers that were acquired or divested subsequent to July&#160;1, 2019 and excluded from the above comparison was $3.1 million. For the three months ended September 30, 2019, net service fee revenue from centers that were acquired or divested subsequent to July&#160;1, 2019 and excluded from the above comparison was $4.0 million.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Expenses</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating expenses for the three months ended September 30, 2020 decreased approximately $7.2 million, or 2.6%, from $275.8 million for the three months ended September 30, 2019 to $268.6 million for the three months ended September 30, 2020. The following table sets forth a breakdown of our cost of operations and total operating expenses for the three months ended September&#160;30, 2020 and 2019 (in thousands):&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.836%"><tr><td style="width:1.0%"></td><td style="width:74.490%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.711%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.587%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.712%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salaries and professional reading fees, excluding stock-based compensation</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,970&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,757&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,067&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and equipment rental</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,703&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,850&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical supplies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,498&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expenses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">*</span></div></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,225&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,082&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246,463&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254,383&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,247&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,490&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Gain) loss on sale and disposal of equipment</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">917&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268,623&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275,842&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Includes billing fees, office supplies, repairs and maintenance, insurance, business tax and license, outside services, telecom, utilities, marketing, travel and other expenses.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Salaries and professional reading fees, excluding stock-based compensation and severance</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.614%"><tr><td style="width:1.0%"></td><td style="width:39.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.810%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="12" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salaries and Professional Fees</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ Increase/(Decrease)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Salaries</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$149,970</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$160,757</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(10,787)</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.7)%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Same Center Salaries</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$146,698</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$158,270</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(11,572)</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.3)%</span></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in salaries expense was a result of staff furloughs and salary reductions initiated in response to the COVID-19 pandemic. During this time, we have reengineered our workflow to improve efficiency and make workforce adjustments as necessary resulting in reductions to payroll overall.  This comparison excludes expenses from centers that were acquired or divested subsequent to July&#160;1, 2019. For the three months ended September 30, 2020, salaries and professional reading fees from centers that were acquired or divested subsequent to July&#160;1, 2019 and excluded from the above comparison was $3.3 million. For the three months ended September 30, 2019, salaries and professional reading fees from centers that were acquired or divested subsequent to July&#160;1, 2019 and excluded from the above comparison was approximately $2.5 million.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_25">Table of Contents</a></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-based compensation</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation increased $0.7 million, or 49.7% to approximately $2.1 million for the three months ended September 30, 2020 compared to $1.4 million for three months ended September 30, 2019. This increase was driven by the higher fair value of RSA&#8217;s awarded and vested in the third quarter of 2020 as compared to RSA&#8217;s awarded and vested in the prior year&#8217;s third quarter.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Building and equipment rental</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.614%"><tr><td style="width:1.0%"></td><td style="width:39.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.810%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="12" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building &amp; Equipment Rental</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ Increase/(Decrease)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$26,703</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$26,850</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(147)</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Same Center </span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$25,839</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$25,968</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(129)</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)%</span></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This comparison excludes expenses from centers that were acquired or divested subsequent to July&#160;1, 2019. For the three months ended September 30, 2020, building and equipment rental expenses from centers that were acquired or divested subsequent to July&#160;1, 2019 and excluded from the above comparison was $0.9 million. For the three months ended September 30, 2019, building and equipment rental expenses from centers that were acquired or divested subsequent to July&#160;1, 2019 and excluded from the above comparison was approximately $0.9 million.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medical supplies</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.614%"><tr><td style="width:1.0%"></td><td style="width:39.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.810%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="12" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Supplies Expense</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ Increase/(Decrease)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$12,498</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$12,313</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$185</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Same Center</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$12,374</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$12,143</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$231</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9%</span></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical supplies expense remained essentially flat compared to the same period in the prior year, with the nominal increase related to securing personal protective equipment for center staff.  This comparison excludes expenses from centers that were acquired or divested subsequent to July&#160;1, 2019. For the three months ended September 30, 2020, medical supplies expenses from centers that were acquired or divested subsequent to July&#160;1, 2019 and excluded from the above comparison was $0.1 million. For the three months ended September 30, 2019, medical supplies expense from centers that were acquired or divested subsequent to July&#160;1, 2019 and excluded from the above comparison was $0.2 million.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other operating expenses</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.760%"><tr><td style="width:1.0%"></td><td style="width:39.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.777%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="12" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Operating Expenses</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ Increase/(Decrease)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$55,225</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$53,082</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,142</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Same Center</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$54,053</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$52,165</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,888</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The rise in other operating expenses resulted from seasonal utilities usage and outside services, offset by reductions in insurance charges and other expenses. This comparison excludes expenses from centers that were acquired or divested subsequent to July&#160;1, 2019. For the three months ended September 30, 2020, other operating expense from centers that were acquired or divested subsequent July&#160;1, 2019 and excluded from the above comparison was $1.2 million. For the three months ended September 30, 2019, other operating expense from centers that were acquired or divested subsequent to July&#160;1, 2019 was $0.9 million.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Depreciation and amortization</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.760%"><tr><td style="width:1.0%"></td><td style="width:39.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.777%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="12" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation &amp; Amortization</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ Increase/(Decrease)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$21,247</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$20,490</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$758</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Same Center</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$20,505</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$19,912</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$593</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0%</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_25">Table of Contents</a></span></div></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in same center depreciation and amortization is primarily due to additional equipment and leasehold improvements placed in service in the third quarter in 2020 over the third quarter in 2019.  This comparison excludes expenses from centers that were acquired or divested subsequent to July&#160;1, 2019. For the three months ended September 30, 2020, depreciation expense from centers that were acquired or divested subsequent to July&#160;1, 2019 and excluded from the above comparison was $0.7 million. For the three months ended September 30, 2019, depreciation and amortization from centers that were acquired or divested subsequent to July&#160;1, 2019 and excluded from the above comparison was $0.6 million.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Loss on sale and disposal of equipment and other</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded losses on the disposal of equipment and other items of approximately $0.3 million for the three months ended September 30, 2020 and approximately $0.9 million for the three months ended September 30, 2019.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-cash change in fair value of interest rate hedge</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded expense of $0.7 million for the ineffective portion of our 2019 Swaps for the three months ended September 30, 2020.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other (income) expenses</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded other income of approximately $0.1 million for the three months ended September 30, 2020 and other expenses of approximately $0.0 million for the three months ended September 30, 2019 related to refinancing of our term loan debt and legal contingency charges.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Severance Costs</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We incurred severance expenses of $0.6 million for the three months ended September 30, 2020 and $0.1 million for the three months ended September 30, 2019.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest expense</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:73.684%"><tr><td style="width:1.0%"></td><td style="width:41.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.188%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="12" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ Increase/(Decrease)</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Interest Expense</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$11,061</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$11,895</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest related to derivatives*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,603</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(288)</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest payable on debt obligations**</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$9,458</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$12,183</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(2,725)</span></td><td colspan="2" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.4)</span></td><td style="background-color:#eeeeee;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest related to amortization***</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,103</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,081</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted Interest Expense</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$8,355</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$11,102</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(2,747)</span></td><td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.7)</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:10pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*    Includes interest on 2016 caps and 2019 swaps not related to debt obligations.</span></div><div style="margin-top:10pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">**  Includes interest related to on our term loans, revolving credit line, notes, finance leases, and other</span></div><div style="margin-top:10pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">***Includes combined noncash amortization of deferred loan costs and discount on issuance of debt.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excluding interest expense for derivatives and amortization for the three months ended September 30, 2020 compared to the three months ended September 30, 2019, interest expense decreased $2.7 million, or 24.7%.  The reduction in interest expense corresponds to lowered variable LIBOR and Prime interest rates paid on our term loan and revolving debt in reaction to market conditions surrounding COVID-19.  See &#8220;Liquidity and Capital Resources&#8221; below for more details on our credit facilities.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity in earnings from unconsolidated joint ventures</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September 30, 2020 we recognized equity in earnings from unconsolidated joint ventures in the amount of $2.3 million and for three months ended September 30, 2019 we recognized equity in earnings from unconsolidated joint ventures of $2.0 million, an increase of $0.3 million or 16.4% and was related to improved procedure volumes specifically at our joint venture sites located within hospital campuses.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income tax provision</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_25">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded an income tax provision of $3.8 million, or an effective tax rate of 27.2%, for the three months ended September 30, 2020 compared to an income tax provision of $1.8 million, or an effective tax rate of 26.3% for the three months ended September 30, 2019. The income tax rates for the three and nine months ended September&#160;30, 2020 diverge from the federal statutory rate due to (i) noncontrolling interests due to the controlled partnerships; (ii) effects of state income taxes; and (iii) excess tax benefits attributable to share-based compensation.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nine Months Ended September 30, 2020 Compared to the Nine Months Ended September 30, 2019 </span></div><div style="margin-bottom:10pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Total Revenue inclusive of Provider Relief funding for 2020</span></div><div style="margin-bottom:15pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.760%"><tr><td style="width:1.0%"></td><td style="width:39.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.777%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="12" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ Increase/(Decrease)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenue</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$789,601</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$853,338</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(63,737)</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.5)%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Same Center Revenue</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$750,358</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$817,492</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(67,134)</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.2)%</span></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our procedure volumes were affected by the COVID-19 pandemic, which has precipitated an approximate 17% decrease in same center procedural volumes year over year.  Mitigating the income decline is $25.7 million received in Provider Relief funding, which, per the official designation of  the program, was used to offset lost revenues.  This comparison excludes revenue contributions from centers that were acquired or divested subsequent to January&#160;1, 2019. For the nine months ended September 30, 2020, net service fee revenue from centers that were acquired or divested subsequent to January&#160;1, 2019 and excluded from the above comparison was $39.2 million. For the nine months ended September 30, 2019, net service fee revenue from centers that were acquired or divested subsequent to January&#160;1, 2019 and excluded from the above comparison was $35.8 million.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Expenses</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating expenses for the nine months ended September 30, 2020 decreased approximately $32.4 million, or 4.0%, from $807.2 million for the nine months ended September 30, 2020 to $774.8 million for the nine months ended September 30, 2019. The following table sets forth a breakdown of our cost of operations and total operating expenses for the nine months ended September&#160;30, 2020 and 2019 (in thousands):&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.836%"><tr><td style="width:1.0%"></td><td style="width:74.490%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.711%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.587%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.712%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salaries and professional reading fees, excluding stock-based compensation</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">429,292&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">471,792&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,964&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and equipment rental</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,148&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,017&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical supplies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,812&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,713&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expenses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">*</span></div></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154,700&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152,512&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">708,096&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743,998&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,536&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on sale and disposal of equipment</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">543&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,990&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,647&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,054&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">774,822&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">807,235&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Includes billing fees, office supplies, repairs and maintenance, insurance, business tax and license, outside services, telecom, utilities, marketing, travel and other expenses.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Salaries and professional reading fees, excluding stock-based compensation and severance</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_25">Table of Contents</a></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.614%"><tr><td style="width:1.0%"></td><td style="width:39.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.810%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="12" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salaries and Professional Fees</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ Increase/(Decrease)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Salaries</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$429,292</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$471,792</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(42,501)</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.0)%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Same Center Salaries</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$409,010</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$451,738</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(42,728)</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.5)%</span></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in salaries expense was a result of staff furloughs and salary reductions initiated in response to the COVID-19 crisis.  As noted in our quarterly explanation above, our review of operational workflows has provided greater efficiencies and resulted in payroll reductions.  Additionally certain of our subsidiaries have accepted approximately $4.0 million in loans from the Paycheck Protection Program (PPP) and the funds were used to pay program approved payroll expenses to both maintain and rehire furloughed employees.  This comparison excludes expenses from centers that were acquired or divested subsequent to January&#160;1, 2019. For the nine months ended September 30, 2020, salaries and professional reading fees from centers that were acquired or divested subsequent to January&#160;1, 2019 and excluded from the above comparison was $20.3 million. For the nine months ended September 30, 2019, salaries and professional reading fees from centers that were acquired or divested subsequent to January&#160;1, 2019 and excluded from the above comparison was approximately $20.1 million.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-based compensation</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation increased $3.2 million, or 45.7% to approximately $10.1 million for the nine months ended September 30, 2020 compared to $7.0 million for nine months ended September 30, 2019. This increase was driven by the higher fair value of RSA&#8217;s awarded and vested in the nine months of 2020 as compared to RSA&#8217;s awarded and vested in the prior year&#8217;s same period.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Building and equipment rental</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.614%"><tr><td style="width:1.0%"></td><td style="width:39.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.810%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="12" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building &amp; Equipment Rental</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ Increase/(Decrease)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$80,148</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$79,017</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,131</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Same Center </span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$74,705</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$74,485</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$219</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3%</span></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This comparison excludes expenses from centers that were acquired or divested subsequent to January&#160;1, 2019. For the nine months ended September 30, 2020, building and equipment rental expenses from centers that were acquired or divested subsequent to January&#160;1, 2019 and excluded from the above comparison was $5.4 million. For the nine months ended September 30, 2019, building and equipment rental expenses from centers that were acquired or divested subsequent to January&#160;1, 2019 and excluded from the above comparison was approximately $4.5 million.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medical supplies</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.614%"><tr><td style="width:1.0%"></td><td style="width:39.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.810%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="12" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Supplies Expense</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ Increase/(Decrease)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$33,812</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$33,713</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$99</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Same Center</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$31,155</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$30,971</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$184</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6%</span></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Year over year medical supplies expense remained relatively flat due to varying factors.  The first quarter noted a 21% same store increase stemming from securing personal protective equipment and procurement of specialized imaging agents, while in the second quarter, a 25% same store expense reduction was correlated to lower procedural volumes.  In the third quarter we consumed medical supplies ordered in prior periods to meet patient demands. The cumulative effect of these factors has resulted in the year over year stability of medical supplies expense.  This comparison excludes expenses from centers that were acquired or divested subsequent to January&#160;1, 2019. For the nine months ended September 30, 2020, medical supplies expenses from centers that were acquired or divested subsequent to April 1, 2018 and excluded from the above comparison was $2.7 million. For the nine months ended September 30, 2019, medical supplies expense from centers that were acquired or divested subsequent to January&#160;1, 2019 and excluded from the above comparison was $2.7 million.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other operating expenses</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_25">Table of Contents</a></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.760%"><tr><td style="width:1.0%"></td><td style="width:39.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.777%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="12" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Operating Expenses</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ Increase/(Decrease)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$154,700</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$152,512</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,188</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Same Center</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$148,358</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$146,397</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,962</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This comparison excludes expenses from centers that were acquired or divested subsequent to January&#160;1, 2019. For the nine months ended September 30, 2020, other operating expense from centers that were acquired or divested subsequent January&#160;1, 2019 and excluded from the above comparison was $6.3 million. For the nine months ended September 30, 2019, other operating expense from centers that were acquired or divested subsequent to January&#160;1, 2019 was $6.1 million.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Depreciation and amortization</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.760%"><tr><td style="width:1.0%"></td><td style="width:39.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.777%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="12" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation &amp; Amortization</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ Increase/(Decrease)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$64,536</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$60,193</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4,343</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Same Center</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$60,923</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$57,086</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3,837</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7%</span></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in same center depreciation and amortization is primarily due to additional equipment and leasehold improvements placed in service in the nine months of 2020 over the same period in 2019.  This comparison excludes expenses from centers that were acquired or divested subsequent to January&#160;1, 2019. For the nine months ended September 30, 2020, depreciation expense from centers that were acquired or divested subsequent to January&#160;1, 2019 and excluded from the above comparison was $3.6 million. For the nine months ended September 30, 2019, depreciation and amortization from centers that were acquired or divested subsequent to January&#160;1, 2019 and excluded from the above comparison was $3.1 million.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Loss on sale and disposal of equipment and other</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded losses on the disposal of equipment and other items of approximately $0.5 million for the nine months ended September 30, 2020 and approximately $2.0 million for the nine months ended September 30, 2019.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-cash change in fair value of interest rate hedge</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded expense of $4.5 million for the ineffective portion of our 2019 Swaps for the nine months ended September 30, 2020.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other (income) expenses</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded other income of approximately $0.2 million for the nine months ended September 30, 2020 and other expenses of approximately $1.3 million for the nine months ended September 30, 2019  related to refinancing of our term loan debt and legal contingency charges.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Severance Costs</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We incurred severance expenses of $1.6 million for the nine months ended September 30, 2020 and $1.1 million for the nine months ended September 30, 2019.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_25">Table of Contents</a></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest expense</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:73.684%"><tr><td style="width:1.0%"></td><td style="width:41.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.188%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="12" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ Increase/(Decrease)</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Interest Expense</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$33,443</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$36,589</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest related to derivatives*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3,152</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(1,182)</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest payable on debt obligations**</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$30,291</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$37,771</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(7,480)</span></td><td colspan="2" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.8)</span></td><td style="background-color:#eeeeee;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest related to amortization***</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3,266</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3,103</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted Interest Expense</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$27,025</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$34,668</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(7,643)</span></td><td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.0)</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:10pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*    Includes interest on 2016 caps and 2019 swaps not related to debt obligations.</span></div><div style="margin-top:10pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">**  Includes interest related to our term loans, revolving credit line, notes, finance leases, and other</span></div><div style="margin-top:10pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">***Includes combined noncash amortization of deferred loan costs and discount on issuance of debt.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excluding interest expense for derivatives and amortization for the nine months ended September 30, 2020 compared to the nine months ended September 30, 2019, interest expense decreased $7.6 million, or 22.0%.  The reduction in interest expense corresponds to lowered variable LIBOR and Prime interest rates paid on our term loan and revolving debt in reaction to market conditions surrounding COVID-19.  See &#8220;Liquidity and Capital Resources&#8221; below for more details on our credit facilities.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity in earnings from unconsolidated joint ventures</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September 30, 2020 we recognized equity in earnings from unconsolidated joint ventures in the amount of $5.2 million and for nine months ended September 30, 2019 we recognized equity in earnings from unconsolidated joint ventures of $6.1 million, an decrease of $0.9 million or 14.8%, related to market conditions stemming from the COVID-19 pandemic.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income tax benefit</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded an income tax benefit of $5.0 million, or an effective tax rate of 28.3%, for the nine months ended September 30, 2020 compared to an income tax provision of $3.6 million , or an effective tax rate of 24.8% for the nine months ended September 30, 2019. The income tax rates for the three and nine months ended September&#160;30, 2020 diverge from the federal statutory rate due to (i) noncontrolling interests due to the controlled partnerships; (ii) effects of state income taxes; and (iii) excess tax benefits attributable to share-based compensation.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adjusted EBITDA</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use both GAAP and non-GAAP metrics to measure our financial results.  We believe that, in addition to GAAP metrics, these non-GAAP metrics assist us in measuring our cash generated from operations and ability to service our debt obligations. We believe this information is useful to investors and other interested parties because we are highly leveraged and our non-GAAP metrics remove non-cash and certain other charges that occur in the affected period and provide a basis for measuring the Company's financial condition against other quarters.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One non-GAAP measure we believe assists us is Adjusted EBITDA. We define Adjusted EBITDA as earnings before interest, taxes, depreciation and amortization, each from continuing operations and excluding losses or gains on the disposal of equipment, other income or loss, loss on debt extinguishment, bargain purchase gains and non-cash equity compensation. Adjusted EBITDA includes equity earnings in unconsolidated operations and subtracts allocations of earnings to noncontrolling interests in subsidiaries, and is adjusted for non-cash or extraordinary and one-time events taking place during the period.  We have not made specific adjustments to our calculation of Adjusted EBITDA in response to COVID 19.  Our net income reflected below includes the effect of the $25 million in other revenue received under the Provider Relief Fund.  We have treated the PPP loans as debt, and accordingly will be liable for an interest charge related to those loans which will be included in interest expense, although the loans may ultimately be forgiven.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted EBITDA is a non-GAAP financial measure used as an analytical indicator by us and the healthcare industry to assess business performance, and is a measure of leverage capacity and ability to service debt.&#160;Adjusted EBITDA should not be considered a measure of financial performance under GAAP, and the items excluded from Adjusted EBITDA should not be considered in isolation or as alternatives to net income, cash flows generated by operating, investing or financing activities or </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_25">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">other financial statement data presented in the consolidated financial statements as an indicator of financial performance or liquidity. As Adjusted EBITDA is not a measurement determined in accordance with GAAP and is therefore susceptible to varying methods of calculation, this metric, as presented, may not be comparable to other similarly titled measures of other companies.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted EBITDA is most comparable to the GAAP financial measure, net income (loss) attributable to RadNet, Inc. common stockholders. The following is a reconciliation of GAAP net income (loss) attributable to RadNet, Inc. common stockholders to Adjusted EBITDA for the three and nine months ended September&#160;30, 2020 and 2019, respectively.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:44.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.860%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.302%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.860%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.862%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to RadNet, Inc. common stockholders</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,156&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,195&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,797)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,360&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for (benefit from) income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,825&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,816&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,029)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,557&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,061&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,895&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,443&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,589&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,647&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,054&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,247&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,490&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,536&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,193&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash employee stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,067&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,964&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on sale and disposal of equipment and other</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">917&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">543&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,989&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash change in fair value of interest rate hedge</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,523&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expenses</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(139)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(247)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,271&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 29.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">45,809</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">40,996</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">88,763</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">117,225</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-36pt"><span><br/></span></div><div id="iffc0b59705bf4cff936f619293b1a306_88"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of key balance sheet data as of September&#160;30, 2020 and December&#160;31, 2019 and income statement data for the nine months ended September&#160;30, 2020 and 2019 (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.690%"><tr><td style="width:1.0%"></td><td style="width:68.773%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.676%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.588%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.463%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance Sheet Data:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,739&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,165&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,411&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154,763&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Working capital (exclusive of current operating lease liabilities)</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47,282)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,048)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders' equity</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246,121&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233,139&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.982%"><tr><td style="width:1.0%"></td><td style="width:68.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.950%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.586%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.410%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income statement data for the nine months ended September 30,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenue</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">763,905&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">853,338&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income attributable to RadNet common stockholders</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,797)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,360&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in a capital intensive, high fixed-cost industry that requires significant amounts of capital to fund operations.&#160;In addition to operations, we require a significant amount of capital for the initial start-up and development of new diagnostic imaging facilities, the acquisition of additional facilities and new diagnostic imaging equipment.&#160;Because our cash flows from operations have been insufficient to fund all of these capital requirements, we have depended on the availability of financing under credit arrangements with third parties.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As noted in our forward looking statements, the COVID 19 pandemic has resulted in a reduction of procedure volumes and corresponding operating revenues. We are uncertain of the duration and ultimate severity of its effects.  Although we are undertaking measures to reduce operating expenses and have received government stimulus funding, we may continue to experience operating losses.  We have credit available from our current credit facilities and borrowing under those facilities is subject to continued compliance with lending covenants.  We currently meet those requirements, but substantial and sustained operating losses could impact our ability to borrow under those facilities.  If we are not able to meet such requirements, we may </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_25">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">be required to seek additional financing and there can be no assurance that we will be able to obtain financing from other sources on terms acceptable to us, if at all.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On a continuing basis, we also consider various transactions to increase shareholder value and enhance our business results, including acquisitions, divestitures and joint ventures. These types of transactions may result in future cash proceeds or payments but the general timing, size or success of any acquisition, divestiture or joint venture effort and the related potential capital commitments cannot be predicted. We expect to fund any future acquisitions primarily with cash flow from operations and borrowings, including borrowing from amounts available under our senior secured credit facilities or through new equity or debt issuances.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and our subsidiaries or affiliates may from time to time, in our sole discretion, purchase, repay, redeem or retire any of our outstanding debt or equity securities in privately negotiated or open market transactions, by tender offer or otherwise.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Sources and Uses of Cash</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes key components of our sources and uses of cash for the nine months ended September 30, 2020 and 2019:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:90.497%"><tr><td style="width:1.0%"></td><td style="width:66.589%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.408%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.092%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.411%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash Flow Data</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash provided by operating activities</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170,343&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,603&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash used in investing activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88,280)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93,981)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash (used in) provided by financing activities</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32,495)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,705&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash provided by operating activities for the nine  months ended September&#160;30, 2020 was $170.3 million and $82.6 million for the nine months ended September 30, 2019. Our cash provided by operating activities was benefited by the reciept of $39.4 million in CMS advances recorded as deferred revenue.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash used in investing activities for the nine months ended September&#160;30, 2020, included purchases of property and equipment for approximately $77.3 million and the acquisition of imaging and software business assets for $10.1 million.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash used in financing activities for the nine months ended September&#160;30, 2020, was due to principal payments on our term loans and equipment debt obligations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2018 and 2019 we entered into factoring agreements with various institutions and sold certain accounts receivable under non-recourse agreements. These transactions are accounted for as a reduction in accounts receivable as the agreements transfer effective control over and risk related to the receivables to the buyers. Payments on the associated notes receivables will be reflected as operating activities on our statement of cash flows and on our balance sheet as prepaid expenses and other current assets for the current portion and deposits and other for the long term portion. At September&#160;30, 2020 we have&#160;$20.4 million, net of discount, remaining to be collected on these agreements. We do not utilize factoring arrangements as an integral part of our financing for working capital.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Senior Secured Credit Facilities</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain secured credit facilities with Barclays Bank PLC and with SunTrust.  The Barclays credit facilities are comprised of first lien term loans and a revolving credit facility.  On August 28, 2020 we amended the Barclays credit facilities to increase the amount available under the revolving line of credit to $195.0 million.  The SunTrust credit facilities are comprised of a term loan and a revolving credit facility of $30.0 million. As of September&#160;30, 2020, we were in compliance with all covenants under our credit facilities.  Deferred financing costs at September&#160;30, 2020, net of accumulated amortization, was $1.9 million and is specifically related to our Barclays revolving credit facility.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in our condensed consolidated balance sheets at September&#160;30, 2020 are $673.2 million of total term loan debt (exclusive of unamortized discounts of  $10.7 million) in thousands: </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_25">Table of Contents</a></span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.543%"><tr><td style="width:1.0%"></td><td style="width:58.931%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.696%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.589%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.696%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.589%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.699%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Face Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Discount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Carrying<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Lien Term Loans</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">620,727&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,669)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610,058&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SunTrust Term Loan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,500&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,500&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Term Loans</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">673,227&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,669)</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662,558&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2020, we had no borrowings under our Barclays or SunTrust revolving credit facilities.  After reserves for outstanding letters of credit of $6.3 million on our Barclays Revolving Credit Facility, we have $188.7 million available for borrowing and $30.0 million available under our SunTrust revolving credit facility.  For more information on our secured credit facilities see Note 5 to our condensed consolidated financial statements in this quarterly report.  </span></div><div id="iffc0b59705bf4cff936f619293b1a306_91"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3.&#160;&#160;Quantitative and Qualitative Disclosures about Market Risk</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Exchange Risk:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We receive payment for our services exclusively in United States dollars. As a result, our financial results are unlikely to be affected by factors such as changes in foreign currency, exchange rates or weak economic conditions in foreign markets.</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain research and development facilities in Prince Edward Island, Canada and Budapest, Hungary for which expenses are paid in the local currency. Accordingly, we do have currency risk resulting from fluctuations between such local currency and the United States Dollar. At the present time, we do not have any foreign currency exchange contracts to mitigate this risk. At September&#160;30, 2020, a hypothetical 1% decline in the currency exchange rates between the U.S. dollar against the Canadian dollar and the Hungarian Forint would have resulted in an annual increase of approximately $27,500 in operating expenses.</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Sensitivity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: We pay interest on various types of debt instruments to our suppliers and lending institutions. The agreements entail either fixed or variable interest rates.&#160; Instruments which have fixed rates are mainly leases on radiology equipment. Variable rate interest obligations relate primarily to amounts borrowed under our outstanding credit facilities.&#160;Accordingly, our interest expense and consequently, our earnings, are affected by changes in short term interest rates. However due to our purchase of caps, described below, the effects of interest rate changes are limited.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2020, we had $620.7 million outstanding subject to an adjusted Eurodollar election on First Lien Term Loans. We can elect Eurodollar or Base Rate (Prime) interest rate options on amounts outstanding under the First Lien Term Loans.  To mitigate interest rate risk sensitivity, in the fourth quarter of 2016 we entered into two forward interest rate cap agreements (the &#8220;2016 Caps&#8221;) which were designated at inception as cash flow hedges of future cash interest payments. The 2016 Caps are designed to provide a hedge against interest rate increases. Under these arrangements, we purchased a cap on 3 month LIBOR at 2.0%. At September&#160;30, 2020, our effective 6 month LIBOR was 1.00%. A hypothetical 1% increase in the adjusted Eurodollar rates under the First Lien Credit Agreement over the current Eurodollar rate would result in an increase of $6.2 million in annual interest expense and a corresponding decrease in income before taxes. See Note 2, Significant Accounting Policies, for further information.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2020, we had $52.5 million outstanding subject to an adjusted Eurodollar election on the SunTrust Restated Credit Agreement. We can elect Eurodollar or Base Rate (Prime) interest rate options on amounts outstanding under the SunTrust Restated Credit Agreement.  At September&#160;30, 2020, our effective LIBOR rate plus applicable margin was 2.31%.  A hypothetical 1% increase in the adjusted Eurodollar rates under the SunTrust Restated Credit Agreement would result in an increase of approximately $0.5 million in annual interest expense and a corresponding decrease in income before taxes.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2019, we entered into four forward interest rate agreements ("2019 Swaps").  The 2019 Swaps have total notional amounts of $500,000,000, consisting of two agreements of $50,000,000 each and two agreements of  $200,000,000 each.   The 2019 Swaps will secure a constant interest rate associated with portions of our variable rate bank debt and have an effective date of October 13, 2020. They will mature in October 2023 for the smaller notional and October 2025 for the larger notional. Under these arrangements, we arranged the 2019 Swaps with locked in 1 month LIBOR rates at 1.96% for the $100,000,000 notional and at 2.05%  for the $400,000,000 notional.  As of the effective date, we will be liable for premium payments if interest rates decline below arranged rates, but will receive interest payments if rates remain above the arranged rates.</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-indent:36pt"><span><br/></span></div><div id="iffc0b59705bf4cff936f619293b1a306_94"></div><div style="margin-bottom:10pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Controls and Procedures</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_25">Table of Contents</a></span></div></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain controls and procedures designed to ensure that we are able to collect the information we are required to disclose in the reports we file with the SEC, and to process, summarize and disclose this information within the time periods specified in the rules of the SEC. Our management, with the participation of our Chief Executive Officer and our Chief Financial Officer, has conducted an evaluation of the design and operation of our &#8220;disclosure controls and procedures&#8221; as defined in Rule 13a-15(e) and 15d-15(e) under the Exchange Act. Based on this evaluation, our Chief Executive Officer and our Chief Financial Officer have concluded that our disclosure controls and procedures are effective as of the end of the period covered by this report  for the purposes set forth above.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There has</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> been no change in our internal control over financial reporting during three months ended September 30, 2020 that has materially affected, or is reasonably likely to materially affect, our internal controls over financial reporting.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><div id="iffc0b59705bf4cff936f619293b1a306_97"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II &#8211; OTHER INFORMATION</span></div><div style="text-align:center"><span><br/></span></div><div id="iffc0b59705bf4cff936f619293b1a306_100"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1.&#160;&#160;Legal Proceedings</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are engaged from time to time in the defense of lawsuits arising out of the ordinary course and conduct of our business. We do not believe that the outcome of any of our current litigation will have a material adverse impact on our business, financial condition and results of operations. However, we could be subsequently named as a defendant in other lawsuits that could adversely affect us.</span></div><div><span><br/></span></div><div id="iffc0b59705bf4cff936f619293b1a306_103"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1A.&#160;&#160;Risk Factors</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For information about the risks and uncertainties related to our business, please see the risk factors described in our annual report on Form 10-K for the year ended December 31, 2019 and our quarterly report on Form 10-Q for the quarters ended March 31 and June 30, 2020. The risks described in our Form 10-K and Form 10-Q are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div id="iffc0b59705bf4cff936f619293b1a306_106"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2.&#160;&#160;Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-top:10pt;text-indent:36pt"><span><br/></span></div><div id="iffc0b59705bf4cff936f619293b1a306_109"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3.&#160;&#160;Defaults Upon Senior Securities</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="iffc0b59705bf4cff936f619293b1a306_112"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4.&#160;&#160;Mine Safety Disclosures</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="iffc0b59705bf4cff936f619293b1a306_115"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 5.&#160;&#160;Other Information</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><div id="iffc0b59705bf4cff936f619293b1a306_118"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_7">Table of Contents</a></span></div></div><div style="-sec-extract:summary;margin-bottom:10pt;margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX TO EXHIBITS</span></div><div style="margin-bottom:15pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.285%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.974%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.17</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000168316820002941/radnet_ex1001.htm">Amendment No. 8, Consent and Incremental Joinder Agreement to Credit and Guaranty Agreement</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="q32020exhibit311.htm">Certification of Howard G. Berger, M.D. pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="q32020exhibit312.htm">Certification of Mark D. Stolper pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="q32020exhibit321.htm">Certification of Howard G. Berger, M.D. pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. *</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="q32020exhibit322.htm">Certification of Mark D. Stolper pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. *</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following financial information from RadNet, Inc.'s Quarterly Report on Form 10-Q for the quarter ended September 30, 2020 formatted in Inline XBRL (Extensible Business Reporting Language) includes: (i) the Condensed Consolidated Balance Sheets, (ii) the Condensed Consolidated Statements of Operations, (iii) the Condensed Consolidated Statements of Comprehensive Loss, (iv) the Condensed Consolidated Statements of Changes in Stockholders Equity, (v) the Condensed Consolidated Statements of Cash Flows, and (vi) Notes to the Condensed Consolidated Financial Statements.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;This certification is being furnished solely to accompany this report pursuant to 18 U.S.C. 1350, and is not being filed for purposes of Section 18 of the Exchange Act and is not to be incorporated by reference into any filing of the registrant, whether made before or after the date hereof, regardless of any general incorporation language in such filing.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><div id="iffc0b59705bf4cff936f619293b1a306_121"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iffc0b59705bf4cff936f619293b1a306_25">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:46.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.435%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RADNET, INC.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Registrant)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: November 9, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Howard G. Berger, M.D.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Howard G. Berger, M.D., President and Chief Executive Officer<br/>(Principal Executive Officer)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: November 9, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Mark D. Stolper</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark D. Stolper, Chief Financial Officer<br/>(Principal Financial and Accounting Officer)</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>q32020exhibit311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i6c7bb1290f3f4d2bb083d983e76f2098_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right;text-indent:198pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Howard G. Berger, M.D., certify that&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;I have reviewed this report on Form 10-Q of RadNet, Inc.&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:1.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:0.1%"></td><td style="width:2.732%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:1.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">c.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:1.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">d.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:0.1%"></td><td style="width:2.732%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:0.1%"></td><td style="width:2.732%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated&#58; November&#160;9, 2020 </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;Howard G. Berger, M.D.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Howard G. Berger, M.D.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">President, Chief Executive Officer and Chairman of the Board of Directors</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>q32020exhibit312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="ia7a554d3cc7b4e10835aba11429e08f1_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Mark D. Stolper, certify that&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;I have reviewed this report on Form 10-Q of RadNet, Inc.&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">have&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:1.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:0.1%"></td><td style="width:2.732%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:0.1%"></td><td style="width:2.732%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">c.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:1.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">d.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:1.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.387%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated&#58; November&#160;9, 2020 </font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;Mark D. Stolper</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Mark D. Stolper</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Executive Vice President</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">and Chief Financial Officer</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>q32020exhibit321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i8765b89b96f044ada41e0bb897348c20_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of RadNet, Inc. (the &#8220;Company&#8221;) on Form 10-Q for the quarterly period ended September 30, 2020, as filed with the Securities and Exchange Commission on November 9, 2020 (the &#8220;Report&#8221;), I, Howard G. Berger, M.D., Chairman of the Board of Directors and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of, and for the periods presented in the Report.</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;Howard G. Berger, M.D.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Howard G. Berger, M.D.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman, President and Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 9, 2020</font></td></tr></table></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section 906 has been provided to the Company and will be furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>q32020exhibit322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i081daed38c2241ea99aded492f929382_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of RadNet, Inc. (the &#8220;Company&#8221;) on Form 10-Q for the quarterly period ended September 30, 2020, as filed with the Securities and Exchange Commission on November 9, 2020 (the &#8220;Report&#8221;), I, Mark D. Stolper, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div><font><br></font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of, and for the periods presented in the Report.</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;Mark D. Stolper</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark D. Stolper</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 9, 2020</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section 906 has been provided to the Company and will be furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>rdnt-20200930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:57afb805-d064-496f-ad72-af37e545924d,g:a8620cad-346c-45d4-8ba0-be03bf014f2b-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:rdnt="http://www.radnet.com/20200930" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:num="http://www.xbrl.org/dtr/type/numeric" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.radnet.com/20200930">
  <xs:import namespace="http://fasb.org/srt/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rdnt-20200930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rdnt-20200930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rdnt-20200930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rdnt-20200930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.radnet.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited" roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited">
        <link:definition>1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical" roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical">
        <link:definition>1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited" roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited">
        <link:definition>1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited" roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited">
        <link:definition>1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited" roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited">
        <link:definition>1005006 - Statement - CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited">
        <link:definition>1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NATUREOFBUSINESSANDBASISOFPRESENTATION" roleURI="http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATION">
        <link:definition>2101101 - Disclosure - NATURE OF BUSINESS AND BASIS OF PRESENTATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NATUREOFBUSINESSDetailsNarrative" roleURI="http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative">
        <link:definition>2402401 - Disclosure - NATURE OF BUSINESS (Details Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SIGNIFICANTACCOUNTINGPOLICIES" roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIES">
        <link:definition>2103102 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SIGNIFICANTACCOUNTINGPOLICIESPolicies" roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies">
        <link:definition>2204201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SIGNIFICANTACCOUNTINGPOLICIESTables" roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables">
        <link:definition>2305301 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SIGNIFICANTACCOUNTINGPOLICIESDetailsRevenue" roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsRevenue">
        <link:definition>2406402 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details - Revenue)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative" roleURI="http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative">
        <link:definition>2407403 - Disclosure - SUMMARY OF ACCOUNTING POLICIES (Details Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SIGNIFICANTACCOUNTINGPOLICIESDetailsGoodwill" roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGoodwill">
        <link:definition>2408404 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details - Goodwill)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SIGNIFICANTACCOUNTINGPOLICIESDetailsGainonDerivative" roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGainonDerivative">
        <link:definition>2409405 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details - Gain on Derivative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFACCOUNTINGPOLICIESDetailsFairValueMeasurements" roleURI="http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsFairValueMeasurements">
        <link:definition>2410406 - Disclosure - SUMMARY OF ACCOUNTING POLICIES (Details - Fair Value Measurements)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFACCOUNTINGPOLICIESDetailsEarningsPerShare" roleURI="http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsEarningsPerShare">
        <link:definition>2411407 - Disclosure - SUMMARY OF ACCOUNTING POLICIES (Details - Earnings Per Share)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFACCOUNTINGPOLICIESDetailsInvestmentinJointVentures" roleURI="http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsInvestmentinJointVentures">
        <link:definition>2412408 - Disclosure - SUMMARY OF ACCOUNTING POLICIES (Details - Investment in Joint Ventures)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures" roleURI="http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures">
        <link:definition>2413409 - Disclosure - SUMMARY OF ACCOUNTING POLICIES (Details - Key Financial Data on Joint Ventures)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RECENTACCOUNTINGANDREPORTINGSTANDARDS" roleURI="http://www.radnet.com/role/RECENTACCOUNTINGANDREPORTINGSTANDARDS">
        <link:definition>2114103 - Disclosure - RECENT ACCOUNTING AND REPORTING STANDARDS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FACILITYACQUISITIONSANDDISPOSITIONS" roleURI="http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONS">
        <link:definition>2115104 - Disclosure - FACILITY ACQUISITIONS AND DISPOSITIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FACILITYACQUISITIONSANDDISPOSITIONSDetailsNarrative" roleURI="http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONSDetailsNarrative">
        <link:definition>2416410 - Disclosure - FACILITY ACQUISITIONS AND DISPOSITIONS (Details Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CREDITFACILITYANDNOTESPAYABLE" roleURI="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLE">
        <link:definition>2117105 - Disclosure - CREDIT FACILITY AND NOTES PAYABLE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CREDITFACILITYANDNOTESPAYABLETables" roleURI="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLETables">
        <link:definition>2318302 - Disclosure - CREDIT FACILITY AND NOTES PAYABLE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt" roleURI="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt">
        <link:definition>2419411 - Disclosure - CREDIT FACILITY AND NOTES PAYABLE (Details - Schedule of debt)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CREDITFACILITYANDNOTESPAYABLEDetailsNarrative" roleURI="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative">
        <link:definition>2420412 - Disclosure - CREDIT FACILITY AND NOTES PAYABLE (Details Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CREDITFACILITYANDNOTESPAYABLEDetailsTermLoans" roleURI="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsTermLoans">
        <link:definition>2421413 - Disclosure - CREDIT FACILITY AND NOTES PAYABLE (Details - Term Loans)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio" roleURI="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio">
        <link:definition>2422414 - Disclosure - CREDIT FACILITY AND NOTES PAYABLE (Details - Margin Spread Based on Leverage Ratio)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument" roleURI="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument">
        <link:definition>2423415 - Disclosure - CREDIT FACILITY AND NOTES PAYABLE (Details - Margin Spread Based on Leverage Ratio, Debt Instrument)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATION" roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATION">
        <link:definition>2124106 - Disclosure - STOCK-BASED COMPENSATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONTables" roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables">
        <link:definition>2325303 - Disclosure - STOCK-BASED COMPENSATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONDetailsNarrative" roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative">
        <link:definition>2426416 - Disclosure - STOCK-BASED COMPENSATION (Details Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants" roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants">
        <link:definition>2427417 - Disclosure - STOCK-BASED COMPENSATION (Details-Outstanding options and warrants)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONDetailsRSUs" roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs">
        <link:definition>2428418 - Disclosure - STOCK-BASED COMPENSATION (Details - RSU's)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUBSEQUENTEVENTS" roleURI="http://www.radnet.com/role/SUBSEQUENTEVENTS">
        <link:definition>2129107 - Disclosure - SUBSEQUENT EVENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUBSEQUENTEVENTSDetails" roleURI="http://www.radnet.com/role/SUBSEQUENTEVENTSDetails">
        <link:definition>2430419 - Disclosure - SUBSEQUENT EVENTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="rdnt_StockIssuedDuringPeriodValueIssuedForReturnOfCapital" abstract="false" name="StockIssuedDuringPeriodValueIssuedForReturnOfCapital" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_FirstLienTermLoanMember" abstract="false" name="FirstLienTermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_LeverageRatioDomain" abstract="true" name="LeverageRatioDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_RestatedPlanMember" abstract="false" name="RestatedPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_EquityContributionsInJointVentures" abstract="false" name="EquityContributionsInJointVentures" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_LeverageRatioTwoMember" abstract="true" name="LeverageRatioTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets" abstract="false" name="PropertyPlantandEquipmentNetIncludingRightofUseAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_StockIssuedDuringPeriodSharesIssuedForReturnOfCapital" abstract="false" name="StockIssuedDuringPeriodSharesIssuedForReturnOfCapital" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="rdnt_LeverageRatioThreeMember" abstract="true" name="LeverageRatioThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_HealthCareManagementServiceMember" abstract="true" name="HealthCareManagementServiceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares" abstract="false" name="BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="rdnt_LeverageRatioFourMember" abstract="true" name="LeverageRatioFourMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_WeightedAverageRemainingContractualLife" abstract="true" name="WeightedAverageRemainingContractualLife" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_AdvanceMedicarePayments" abstract="false" name="AdvanceMedicarePayments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_EquipmentAcquiredAndLeaseholdImprovements" abstract="false" name="EquipmentAcquiredAndLeaseholdImprovements" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsCurrentMaturities" abstract="false" name="LongtermDebtShorttermDebtandCapitalLeaseObligationsCurrentMaturities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFinanceLeaseLiabilities" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFinanceLeaseLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_A2019SWAPSMember" abstract="true" name="A2019SWAPSMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution" abstract="false" name="BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="rdnt_CommercialInsurance1Member" abstract="true" name="CommercialInsurance1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares" abstract="false" name="BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="rdnt_FirstLienCreditAgreementEighthAmendmentMember" abstract="true" name="FirstLienCreditAgreementEighthAmendmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_BeverlyRadiologyMedicalGroupIIIMember" abstract="true" name="BeverlyRadiologyMedicalGroupIIIMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_NumberOfAssetsAcquired" abstract="false" name="NumberOfAssetsAcquired" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum" abstract="false" name="DebtInstrumentCovenantLiquidityRatioRequiredMinimum" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="rdnt_FutureServiceMember" abstract="true" name="FutureServiceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_LeverageRatioAxis" abstract="true" name="LeverageRatioAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_A2019SWAPS1Member" abstract="true" name="A2019SWAPS1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_PaycheckProtectionProgramLoansMember" abstract="true" name="PaycheckProtectionProgramLoansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_SantaMonicaImagingGroupLLCMember" abstract="true" name="SantaMonicaImagingGroupLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_AssetAcquisitionDomain" abstract="true" name="AssetAcquisitionDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_ContributionsFromNoncontrollingInterests" abstract="false" name="ContributionsFromNoncontrollingInterests" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution" abstract="false" name="BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="rdnt_PaymentstoAcquireInterestinJointVentureAndContributionsToExistingJointVenture" abstract="false" name="PaymentstoAcquireInterestinJointVentureAndContributionsToExistingJointVenture" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_VenturaCountyImagingGroupLLCMember" abstract="true" name="VenturaCountyImagingGroupLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_DignityHealthMember" abstract="true" name="DignityHealthMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward" abstract="true" name="InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution" abstract="false" name="BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_BoardMemberMember" abstract="true" name="BoardMemberMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_Caps2016Member" abstract="false" name="Caps2016Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_October2023Member" abstract="true" name="October2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_EquityMethodInvestmentSharesPurchased" abstract="false" name="EquityMethodInvestmentSharesPurchased" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="rdnt_WhiteRabbit.aiInc.Member" abstract="true" name="WhiteRabbit.aiInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_PricingLevelIIMember" abstract="true" name="PricingLevelIIMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_AggregateIntrinsicValue" abstract="true" name="AggregateIntrinsicValue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_AZTechMember" abstract="true" name="AZTechMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsExcludingCurrentMaturities" abstract="false" name="LongtermDebtShorttermDebtandCapitalLeaseObligationsExcludingCurrentMaturities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_DebtInstrumentCovenantLeverageRatioMaximum" abstract="false" name="DebtInstrumentCovenantLeverageRatioMaximum" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="rdnt_OperatingLeaseRightofUseAssetAmortization" abstract="false" name="OperatingLeaseRightofUseAssetAmortization" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_ProceedsReceivedFromInsurance" abstract="false" name="ProceedsReceivedFromInsurance" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" abstract="false" name="ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_TurnerImagingMember" abstract="false" name="TurnerImagingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_SocialSecurityTaxEmployerDeferralCARESAct" abstract="false" name="SocialSecurityTaxEmployerDeferralCARESAct" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_BarclaysMember" abstract="true" name="BarclaysMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_ManagementServiceFees" abstract="false" name="ManagementServiceFees" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_RestatedAgreementMember" abstract="true" name="RestatedAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_September2020CapMember" abstract="false" name="September2020CapMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired" abstract="false" name="EquityMethodInvestmentsOwnershipInterestPercentageAcquired" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="rdnt_OlneyOpenMRILLCMember" abstract="true" name="OlneyOpenMRILLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_PricingLevelIVMember" abstract="true" name="PricingLevelIVMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_TeleradiologyandSoftwareMember" abstract="true" name="TeleradiologyandSoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_COVID19PandemicMember" abstract="true" name="COVID19PandemicMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution" abstract="false" name="EquityMethodInvestmentInitialOwnershipPercentageAfterDilution" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="rdnt_SimiValleyHospitalAndHealthServicesMember" abstract="true" name="SimiValleyHospitalAndHealthServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_SunTrustMember" abstract="true" name="SunTrustMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_ScheduleOfLeverageRatioTableTextBlock" abstract="false" name="ScheduleOfLeverageRatioTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm" abstract="false" name="BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="rdnt_PricingLevelIIIMember" abstract="true" name="PricingLevelIIIMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_NulogixMember" abstract="true" name="NulogixMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_MRIatWoodbridgeLLCMember" abstract="true" name="MRIatWoodbridgeLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease" abstract="false" name="DebtInstrumentPeriodicPaymentTermsAmortizationIncrease" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_FirstLienCreditAgreementSeventhAmendmentMember" abstract="true" name="FirstLienCreditAgreementSeventhAmendmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_DebtInstrumentNumberofLoansReceived" abstract="false" name="DebtInstrumentNumberofLoansReceived" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="rdnt_PricingLevelIMember" abstract="true" name="PricingLevelIMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_HealthCarePatientServiceOtherMember" abstract="true" name="HealthCarePatientServiceOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_AwardsIssuedToDate" abstract="false" name="AwardsIssuedToDate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock" abstract="false" name="JointVentureInvestmentAndFinancialInformationTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="rdnt_JointVentureMember" abstract="true" name="JointVentureMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_GlendaleAdvancedImagingMember" abstract="true" name="GlendaleAdvancedImagingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_ImagingOnCallMember" abstract="true" name="ImagingOnCallMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_StockholdersEquityDeficitMember" abstract="false" name="StockholdersEquityDeficitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_LineofCreditFacilityIncreaseBorrowingCapacity" abstract="false" name="LineofCreditFacilityIncreaseBorrowingCapacity" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution" abstract="false" name="BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_IncreaseDecreaseInOtherNoncashItem" abstract="false" name="IncreaseDecreaseInOtherNoncashItem" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_ScriptSenderLlcMember" abstract="false" name="ScriptSenderLlcMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_TotalBookValueOfOtherJointVenturePartnerInterests" abstract="false" name="TotalBookValueOfOtherJointVenturePartnerInterests" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_IncreaseDecreaseinOperatingLeaseLiability" abstract="false" name="IncreaseDecreaseinOperatingLeaseLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_Medicaid1Member" abstract="true" name="Medicaid1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards" abstract="false" name="BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_DebtInstrumentPeriodicPaymentPercent" abstract="false" name="DebtInstrumentPeriodicPaymentPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares" abstract="false" name="BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="rdnt_AssetAcquisitionAxis" abstract="true" name="AssetAcquisitionAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_PropertyAndEquipmentMember" abstract="false" name="PropertyAndEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_FirstLienCreditAgreementMember" abstract="true" name="FirstLienCreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_KeyFinancialDataForJointVenturesAbstract" abstract="true" name="KeyFinancialDataForJointVenturesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_HudsonValleyRadiologyAssociatesMember" abstract="true" name="HudsonValleyRadiologyAssociatesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_FirstLienCreditAgreementSixthAmendmentMember" abstract="true" name="FirstLienCreditAgreementSixthAmendmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_ProceedsFromGovernmentAssistance" abstract="false" name="ProceedsFromGovernmentAssistance" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_October2020CapMember" abstract="false" name="October2020CapMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_TermLoanMember" abstract="true" name="TermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_FirstLienTermLoansAMember" abstract="false" name="FirstLienTermLoansAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_CapitationArrangementsMember" abstract="true" name="CapitationArrangementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_MedicVisionMember" abstract="false" name="MedicVisionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_NumberOfCenters" abstract="false" name="NumberOfCenters" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities" abstract="false" name="LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_PricingLevelVMember" abstract="true" name="PricingLevelVMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_MonthlyAmortizationOfDeferredHedgeGains" abstract="false" name="MonthlyAmortizationOfDeferredHedgeGains" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_October2025Member" abstract="true" name="October2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_DeepHealthIncMember" abstract="true" name="DeepHealthIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment" abstract="false" name="EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_Medicare1Member" abstract="true" name="Medicare1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_LeverageRatioOneMember" abstract="true" name="LeverageRatioOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_ContractsReceivableFactoringReceivable" abstract="false" name="ContractsReceivableFactoringReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_NumberofUnconsolidatedJointVentures" abstract="false" name="NumberofUnconsolidatedJointVentures" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="rdnt_WorkersCompensationPersonalInjury1Member" abstract="true" name="WorkersCompensationPersonalInjury1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_DeepHealthInc.Member" abstract="true" name="DeepHealthInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>rdnt-20200930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:57afb805-d064-496f-ad72-af37e545924d,g:a8620cad-346c-45d4-8ba0-be03bf014f2b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.radnet.com/role/CoverPage" xlink:type="simple" xlink:href="rdnt-20200930.xsd#CoverPage"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/CoverPage" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited" xlink:type="simple" xlink:href="rdnt-20200930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_e142e84a-8d1e-406f-b2dc-63f426cb6398" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_4babd9f2-b418-4a5b-b5cb-1faf05345bca" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_e142e84a-8d1e-406f-b2dc-63f426cb6398" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_4babd9f2-b418-4a5b-b5cb-1faf05345bca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToAffiliateCurrent_18857e32-e18e-427d-b0c9-32551c251f33" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DueToAffiliateCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_e142e84a-8d1e-406f-b2dc-63f426cb6398" xlink:to="loc_us-gaap_DueToAffiliateCurrent_18857e32-e18e-427d-b0c9-32551c251f33" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenue_235bc1e8-ec94-4c81-911a-b96b5b942691" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredRevenue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_e142e84a-8d1e-406f-b2dc-63f426cb6398" xlink:to="loc_us-gaap_DeferredRevenue_235bc1e8-ec94-4c81-911a-b96b5b942691" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_d9b44d82-4725-4e74-886f-ce8425ad5855" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_e142e84a-8d1e-406f-b2dc-63f426cb6398" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_d9b44d82-4725-4e74-886f-ce8425ad5855" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_cbc4e2ac-191a-4fc5-9b38-0b55ea2110e8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_e142e84a-8d1e-406f-b2dc-63f426cb6398" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_cbc4e2ac-191a-4fc5-9b38-0b55ea2110e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent_302b446a-d84f-42ee-9581-6a230d8341f2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NotesPayableCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_e142e84a-8d1e-406f-b2dc-63f426cb6398" xlink:to="loc_us-gaap_NotesPayableCurrent_302b446a-d84f-42ee-9581-6a230d8341f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_adfea38d-893a-4651-ae21-d1728c1008c7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_4f3921e3-7243-4708-bb22-8cdd3872eebd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_adfea38d-893a-4651-ae21-d1728c1008c7" xlink:to="loc_us-gaap_StockholdersEquity_4f3921e3-7243-4708-bb22-8cdd3872eebd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_610577e4-a1f8-44ae-849b-e948b163ed08" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_adfea38d-893a-4651-ae21-d1728c1008c7" xlink:to="loc_us-gaap_MinorityInterest_610577e4-a1f8-44ae-849b-e948b163ed08" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_abaffdb2-ecd1-46cc-816c-1fce43cbc408" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b39c7d00-93f5-4f0d-8ad5-e79bc659437e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_abaffdb2-ecd1-46cc-816c-1fce43cbc408" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b39c7d00-93f5-4f0d-8ad5-e79bc659437e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_7cd0982c-6330-4290-b3b0-cecef57123b6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_abaffdb2-ecd1-46cc-816c-1fce43cbc408" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_7cd0982c-6330-4290-b3b0-cecef57123b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueFromRelatedPartiesCurrent_1b3d70ed-c1be-4c42-94db-98fdfe240141" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DueFromRelatedPartiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_abaffdb2-ecd1-46cc-816c-1fce43cbc408" xlink:to="loc_us-gaap_DueFromRelatedPartiesCurrent_1b3d70ed-c1be-4c42-94db-98fdfe240141" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_5e0ee396-9dec-498e-86f1-ebf2b4959bdc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_abaffdb2-ecd1-46cc-816c-1fce43cbc408" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_5e0ee396-9dec-498e-86f1-ebf2b4959bdc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets_34f32fa4-9c85-4e88-81bf-762208218d54" xlink:href="rdnt-20200930.xsd#rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_c2eff553-a96f-40e8-be48-324252aacd7b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets_34f32fa4-9c85-4e88-81bf-762208218d54" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_c2eff553-a96f-40e8-be48-324252aacd7b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_2ee82f47-db66-48a6-807e-34f9d11aa090" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets_34f32fa4-9c85-4e88-81bf-762208218d54" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_2ee82f47-db66-48a6-807e-34f9d11aa090" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_724b1894-e63b-4ac3-9c50-0e04b2ed1424" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_f9b7cec7-c388-4271-951d-81235c998396" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_724b1894-e63b-4ac3-9c50-0e04b2ed1424" xlink:to="loc_us-gaap_CommonStockValue_f9b7cec7-c388-4271-951d-81235c998396" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_403dc2e0-0c41-47b3-902a-efa3b832c0b7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_724b1894-e63b-4ac3-9c50-0e04b2ed1424" xlink:to="loc_us-gaap_AdditionalPaidInCapital_403dc2e0-0c41-47b3-902a-efa3b832c0b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b6576e97-81df-49dd-9ae8-d48a88eba91a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_724b1894-e63b-4ac3-9c50-0e04b2ed1424" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b6576e97-81df-49dd-9ae8-d48a88eba91a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_076a2945-90c1-483b-88a0-4a617ff37407" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_724b1894-e63b-4ac3-9c50-0e04b2ed1424" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_076a2945-90c1-483b-88a0-4a617ff37407" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_55ac8e94-4d4f-488c-a60a-1959b2bbb4dc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_6f034035-c37b-4500-85b4-354c706baa65" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_55ac8e94-4d4f-488c-a60a-1959b2bbb4dc" xlink:to="loc_us-gaap_Goodwill_6f034035-c37b-4500-85b4-354c706baa65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_5ca4b8b8-a3a7-46c4-ac27-5064d65b2401" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_55ac8e94-4d4f-488c-a60a-1959b2bbb4dc" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_5ca4b8b8-a3a7-46c4-ac27-5064d65b2401" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_e958ae33-9a6f-436e-a4a3-2cb347eb38bb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_55ac8e94-4d4f-488c-a60a-1959b2bbb4dc" xlink:to="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_e958ae33-9a6f-436e-a4a3-2cb347eb38bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_266ccaa9-f360-454d-941f-c23df2ee6fef" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_55ac8e94-4d4f-488c-a60a-1959b2bbb4dc" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_266ccaa9-f360-454d-941f-c23df2ee6fef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_876f7bfd-a527-4f51-aa57-40a7c8266b9e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_55ac8e94-4d4f-488c-a60a-1959b2bbb4dc" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_876f7bfd-a527-4f51-aa57-40a7c8266b9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsAssets_86776a2a-bdd2-4802-aed8-a939cf59a8c3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DepositsAssets"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_55ac8e94-4d4f-488c-a60a-1959b2bbb4dc" xlink:to="loc_us-gaap_DepositsAssets_86776a2a-bdd2-4802-aed8-a939cf59a8c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets_f94150eb-c1d1-4f30-8b15-61a6fa7fe2a5" xlink:href="rdnt-20200930.xsd#rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_55ac8e94-4d4f-488c-a60a-1959b2bbb4dc" xlink:to="loc_rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets_f94150eb-c1d1-4f30-8b15-61a6fa7fe2a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_54e82a62-64b5-413f-a9af-051e92dc9c05" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_55ac8e94-4d4f-488c-a60a-1959b2bbb4dc" xlink:to="loc_us-gaap_AssetsCurrent_54e82a62-64b5-413f-a9af-051e92dc9c05" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_4c56cb15-4c32-44bf-bbde-bcd663a54383" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_8d9eeb31-d08d-4c11-b9c5-3afb8b8d043f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_4c56cb15-4c32-44bf-bbde-bcd663a54383" xlink:to="loc_us-gaap_Liabilities_8d9eeb31-d08d-4c11-b9c5-3afb8b8d043f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_94528d4e-25ce-4504-82cd-a3b476e29ace" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_4c56cb15-4c32-44bf-bbde-bcd663a54383" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_94528d4e-25ce-4504-82cd-a3b476e29ace" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_f00b0db1-3a64-4113-94ce-6dc5cec24b9c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_9aa56261-731b-41e7-87b9-220a9efa123d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_f00b0db1-3a64-4113-94ce-6dc5cec24b9c" xlink:to="loc_us-gaap_LiabilitiesCurrent_9aa56261-731b-41e7-87b9-220a9efa123d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_9784630b-bc31-4ff0-b4c5-eee763fc4364" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_f00b0db1-3a64-4113-94ce-6dc5cec24b9c" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_9784630b-bc31-4ff0-b4c5-eee763fc4364" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_0e36187b-1d6b-48c5-88b0-3126cd942d1b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_f00b0db1-3a64-4113-94ce-6dc5cec24b9c" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_0e36187b-1d6b-48c5-88b0-3126cd942d1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable_e911f775-5166-426e-82aa-5f3f764603d6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermNotesPayable"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_f00b0db1-3a64-4113-94ce-6dc5cec24b9c" xlink:to="loc_us-gaap_LongTermNotesPayable_e911f775-5166-426e-82aa-5f3f764603d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_2b0482e0-dad7-4e41-90df-513a348145e5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_f00b0db1-3a64-4113-94ce-6dc5cec24b9c" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_2b0482e0-dad7-4e41-90df-513a348145e5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical" xlink:type="simple" xlink:href="rdnt-20200930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited" xlink:type="simple" xlink:href="rdnt-20200930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_bf9ac9fc-f5af-42dd-8c62-f8520479584a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_ca11bf0b-ce13-4cdc-8c4c-8a553712563e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_bf9ac9fc-f5af-42dd-8c62-f8520479584a" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_ca11bf0b-ce13-4cdc-8c4c-8a553712563e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_a88ec5a1-927a-484a-9b73-d9488884b12d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_bf9ac9fc-f5af-42dd-8c62-f8520479584a" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_a88ec5a1-927a-484a-9b73-d9488884b12d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_f655065f-207f-49ab-830a-183cc5f515c9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_bf9ac9fc-f5af-42dd-8c62-f8520479584a" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_f655065f-207f-49ab-830a-183cc5f515c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_8d9b8eed-94a3-4b1d-a840-7a19342d377b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_bf9ac9fc-f5af-42dd-8c62-f8520479584a" xlink:to="loc_us-gaap_SeveranceCosts1_8d9b8eed-94a3-4b1d-a840-7a19342d377b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e1ac6d2d-c516-4bbb-9094-591782fc94e1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_e0f41824-cc91-4c22-a24a-4bce1f6054ac" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_e1ac6d2d-c516-4bbb-9094-591782fc94e1" xlink:to="loc_us-gaap_ProfitLoss_e0f41824-cc91-4c22-a24a-4bce1f6054ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_b8f764ce-fcf4-4d9f-ad9a-59197507ab58" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_e1ac6d2d-c516-4bbb-9094-591782fc94e1" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_b8f764ce-fcf4-4d9f-ad9a-59197507ab58" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_abb4aded-de06-4520-820b-162e54a73fd7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_97c9208f-6128-4a61-827d-617ddc9212bb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_abb4aded-de06-4520-820b-162e54a73fd7" xlink:to="loc_us-gaap_OperatingExpenses_97c9208f-6128-4a61-827d-617ddc9212bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueNotFromContractWithCustomer_719c6c05-e130-4ff6-a02b-26ef50bfda25" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueNotFromContractWithCustomer"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_abb4aded-de06-4520-820b-162e54a73fd7" xlink:to="loc_us-gaap_RevenueNotFromContractWithCustomer_719c6c05-e130-4ff6-a02b-26ef50bfda25" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_677d4e0a-133b-431b-ba53-9d2b68bb3c83" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_abb4aded-de06-4520-820b-162e54a73fd7" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_677d4e0a-133b-431b-ba53-9d2b68bb3c83" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_dc51ff40-c534-41a6-a156-ee9e097562e3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_5aaf0274-5bba-4786-84aa-f68147d986fa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_dc51ff40-c534-41a6-a156-ee9e097562e3" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_5aaf0274-5bba-4786-84aa-f68147d986fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_ef1cc5e8-4997-44f6-a2ac-b186d9ea7b26" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_dc51ff40-c534-41a6-a156-ee9e097562e3" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_ef1cc5e8-4997-44f6-a2ac-b186d9ea7b26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_41780324-f259-4955-b616-10d2970a7f87" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_b945fa9e-d0c4-4748-bda5-1a6097e8f3d0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_41780324-f259-4955-b616-10d2970a7f87" xlink:to="loc_us-gaap_InterestExpenseDebt_b945fa9e-d0c4-4748-bda5-1a6097e8f3d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_760d212f-4bfe-47cc-9c0e-ba511e4de6d7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_41780324-f259-4955-b616-10d2970a7f87" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_760d212f-4bfe-47cc-9c0e-ba511e4de6d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1_d6d8f86b-8450-461a-b646-d3521fe40458" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_41780324-f259-4955-b616-10d2970a7f87" xlink:to="loc_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1_d6d8f86b-8450-461a-b646-d3521fe40458" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_5c3e35c8-24db-4613-9051-fbf82d285baa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_41780324-f259-4955-b616-10d2970a7f87" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_5c3e35c8-24db-4613-9051-fbf82d285baa" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited" xlink:type="simple" xlink:href="rdnt-20200930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_323d585e-47f4-425c-8a23-dce31c577355" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_cc1e5ba6-c581-4747-a9c6-b5a4253228f7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_323d585e-47f4-425c-8a23-dce31c577355" xlink:to="loc_us-gaap_ProfitLoss_cc1e5ba6-c581-4747-a9c6-b5a4253228f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2d00dbdf-cdd6-48db-8cc9-cb798b312d52" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_323d585e-47f4-425c-8a23-dce31c577355" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2d00dbdf-cdd6-48db-8cc9-cb798b312d52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_424fa379-bb39-4bb0-8c40-94fa30770688" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_323d585e-47f4-425c-8a23-dce31c577355" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_424fa379-bb39-4bb0-8c40-94fa30770688" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_24f605ad-7f79-42b6-99b3-5cdc66c8067c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_323d585e-47f4-425c-8a23-dce31c577355" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_24f605ad-7f79-42b6-99b3-5cdc66c8067c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_e6679f38-0959-42b6-ba7e-fafd254ed075" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_3dc4fdb7-1c5e-45cc-a435-c4366ce98555" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_e6679f38-0959-42b6-ba7e-fafd254ed075" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_3dc4fdb7-1c5e-45cc-a435-c4366ce98555" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_e663c381-21e7-4201-99b3-be5ba010e403" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_e6679f38-0959-42b6-ba7e-fafd254ed075" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_e663c381-21e7-4201-99b3-be5ba010e403" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited" xlink:type="simple" xlink:href="rdnt-20200930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" xlink:type="simple" xlink:href="rdnt-20200930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b2c6e383-4ff4-4714-ad71-dda6c3445c32" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7346de7f-182c-40be-b819-fa2081e77641" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b2c6e383-4ff4-4714-ad71-dda6c3445c32" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7346de7f-182c-40be-b819-fa2081e77641" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_61f52d89-ba51-4b29-8bb8-8677149f3485" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b2c6e383-4ff4-4714-ad71-dda6c3445c32" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_61f52d89-ba51-4b29-8bb8-8677149f3485" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e7241c0d-cc31-40f2-835e-79ef94795ace" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b2c6e383-4ff4-4714-ad71-dda6c3445c32" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e7241c0d-cc31-40f2-835e-79ef94795ace" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8aeb65b1-ee47-4525-8891-e9a221c4ac81" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b2c6e383-4ff4-4714-ad71-dda6c3445c32" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8aeb65b1-ee47-4525-8891-e9a221c4ac81" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5e5d405c-ccfd-45c9-8263-a0fa1d396c6a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_f711e77d-8486-40ae-b8f2-88159bacc6e7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5e5d405c-ccfd-45c9-8263-a0fa1d396c6a" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_f711e77d-8486-40ae-b8f2-88159bacc6e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_3c04bb24-144c-45f5-822a-98f4c1b99d5e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5e5d405c-ccfd-45c9-8263-a0fa1d396c6a" xlink:to="loc_us-gaap_RepaymentsOfDebt_3c04bb24-144c-45f5-822a-98f4c1b99d5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_f2884530-4850-412f-9f19-cdc2628d20f5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5e5d405c-ccfd-45c9-8263-a0fa1d396c6a" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_f2884530-4850-412f-9f19-cdc2628d20f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProceedsFromGovernmentAssistance_12cc3a9a-7993-4234-a168-b0cb07afa275" xlink:href="rdnt-20200930.xsd#rdnt_ProceedsFromGovernmentAssistance"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5e5d405c-ccfd-45c9-8263-a0fa1d396c6a" xlink:to="loc_rdnt_ProceedsFromGovernmentAssistance_12cc3a9a-7993-4234-a168-b0cb07afa275" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_1311cb6a-f565-496b-ac81-f306f04d889b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5e5d405c-ccfd-45c9-8263-a0fa1d396c6a" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_1311cb6a-f565-496b-ac81-f306f04d889b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromContributedCapital_3c53a786-51e9-4d76-98de-2e2d16bcf688" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromContributedCapital"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5e5d405c-ccfd-45c9-8263-a0fa1d396c6a" xlink:to="loc_us-gaap_ProceedsFromContributedCapital_3c53a786-51e9-4d76-98de-2e2d16bcf688" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_92a2db4b-8f12-49b6-8ac8-265afb89ecf2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5e5d405c-ccfd-45c9-8263-a0fa1d396c6a" xlink:to="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_92a2db4b-8f12-49b6-8ac8-265afb89ecf2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_8885d229-aa6f-4285-af2a-fac6d9be63d6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5e5d405c-ccfd-45c9-8263-a0fa1d396c6a" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_8885d229-aa6f-4285-af2a-fac6d9be63d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities_abab8ec7-0b88-4577-a899-465a8bc6bfaf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5e5d405c-ccfd-45c9-8263-a0fa1d396c6a" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities_abab8ec7-0b88-4577-a899-465a8bc6bfaf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_93b0bdbb-1848-4c60-a67f-c91c47efadae" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5e5d405c-ccfd-45c9-8263-a0fa1d396c6a" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_93b0bdbb-1848-4c60-a67f-c91c47efadae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_d9255a98-c07a-4c66-9ec6-d08966dfe19a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5e5d405c-ccfd-45c9-8263-a0fa1d396c6a" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_d9255a98-c07a-4c66-9ec6-d08966dfe19a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b6db3b92-2c74-4bd1-a216-58e9ecdf6f9b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBuildings_8cb3213c-5acc-41f4-b830-5bae85f18490" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireBuildings"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b6db3b92-2c74-4bd1-a216-58e9ecdf6f9b" xlink:to="loc_us-gaap_PaymentsToAcquireBuildings_8cb3213c-5acc-41f4-b830-5bae85f18490" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_87d24cd8-6a73-4a8a-83e6-d72268139c86" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b6db3b92-2c74-4bd1-a216-58e9ecdf6f9b" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_87d24cd8-6a73-4a8a-83e6-d72268139c86" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment_7cb12a17-3366-436f-942b-c88196c0d21f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b6db3b92-2c74-4bd1-a216-58e9ecdf6f9b" xlink:to="loc_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment_7cb12a17-3366-436f-942b-c88196c0d21f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_1c2a2800-d477-4b43-9248-d7ddb5bbab05" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b6db3b92-2c74-4bd1-a216-58e9ecdf6f9b" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_1c2a2800-d477-4b43-9248-d7ddb5bbab05" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture_abb57d7a-9720-4a07-a582-1a297e4a08bc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromDivestitureOfInterestInJointVenture"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b6db3b92-2c74-4bd1-a216-58e9ecdf6f9b" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture_abb57d7a-9720-4a07-a582-1a297e4a08bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PaymentstoAcquireInterestinJointVentureAndContributionsToExistingJointVenture_0306cab2-d933-419f-8955-e9b75652c143" xlink:href="rdnt-20200930.xsd#rdnt_PaymentstoAcquireInterestinJointVentureAndContributionsToExistingJointVenture"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b6db3b92-2c74-4bd1-a216-58e9ecdf6f9b" xlink:to="loc_rdnt_PaymentstoAcquireInterestinJointVentureAndContributionsToExistingJointVenture_0306cab2-d933-419f-8955-e9b75652c143" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_fab6bd6f-3f1e-4d64-a174-0e798d2f220a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b6db3b92-2c74-4bd1-a216-58e9ecdf6f9b" xlink:to="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_fab6bd6f-3f1e-4d64-a174-0e798d2f220a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5a136cf2-0096-435f-b7b7-ffd93ab23385" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_2c4785e8-de90-4f54-a911-a3aa655187fc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5a136cf2-0096-435f-b7b7-ffd93ab23385" xlink:to="loc_us-gaap_ProfitLoss_2c4785e8-de90-4f54-a911-a3aa655187fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_d675bf00-caec-4e9b-b7b5-d09800e71f1b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5a136cf2-0096-435f-b7b7-ffd93ab23385" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_d675bf00-caec-4e9b-b7b5-d09800e71f1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingLeaseRightofUseAssetAmortization_d7adafc5-fdd1-4191-a6aa-c3f6d4d2e6ce" xlink:href="rdnt-20200930.xsd#rdnt_OperatingLeaseRightofUseAssetAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5a136cf2-0096-435f-b7b7-ffd93ab23385" xlink:to="loc_rdnt_OperatingLeaseRightofUseAssetAmortization_d7adafc5-fdd1-4191-a6aa-c3f6d4d2e6ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_39ab20a8-094f-44cc-888f-51b005f058bd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5a136cf2-0096-435f-b7b7-ffd93ab23385" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_39ab20a8-094f-44cc-888f-51b005f058bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_cd2bdd03-642a-487f-bc3c-fb662e9e73f4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5a136cf2-0096-435f-b7b7-ffd93ab23385" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_cd2bdd03-642a-487f-bc3c-fb662e9e73f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_7e3c0116-d941-4a4e-8c83-b7a51ddf9f56" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5a136cf2-0096-435f-b7b7-ffd93ab23385" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_7e3c0116-d941-4a4e-8c83-b7a51ddf9f56" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredHedgeGains_31fb624a-0c80-4614-8f1b-16056eb39d2a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfDeferredHedgeGains"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5a136cf2-0096-435f-b7b7-ffd93ab23385" xlink:to="loc_us-gaap_AmortizationOfDeferredHedgeGains_31fb624a-0c80-4614-8f1b-16056eb39d2a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_81a7e967-4779-4525-a288-aef282e4615f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5a136cf2-0096-435f-b7b7-ffd93ab23385" xlink:to="loc_us-gaap_ShareBasedCompensation_81a7e967-4779-4525-a288-aef282e4615f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IncreaseDecreaseInOtherNoncashItem_720a81d9-eab2-41a6-a5a1-ebb7fd67d35b" xlink:href="rdnt-20200930.xsd#rdnt_IncreaseDecreaseInOtherNoncashItem"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5a136cf2-0096-435f-b7b7-ffd93ab23385" xlink:to="loc_rdnt_IncreaseDecreaseInOtherNoncashItem_720a81d9-eab2-41a6-a5a1-ebb7fd67d35b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_ab135ba1-d4f2-4053-9c7a-58baf6b18081" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5a136cf2-0096-435f-b7b7-ffd93ab23385" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_ab135ba1-d4f2-4053-9c7a-58baf6b18081" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_ddaa82cf-63f5-4102-bcb9-3c721a6af3a7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5a136cf2-0096-435f-b7b7-ffd93ab23385" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_ddaa82cf-63f5-4102-bcb9-3c721a6af3a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_15919f4e-0819-4697-96a9-7b4dcea38698" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5a136cf2-0096-435f-b7b7-ffd93ab23385" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_15919f4e-0819-4697-96a9-7b4dcea38698" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_169a6c3e-950f-45d8-b62c-2061d175ae62" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5a136cf2-0096-435f-b7b7-ffd93ab23385" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_169a6c3e-950f-45d8-b62c-2061d175ae62" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_66549287-f8f8-49d1-9ba5-b5615fbcfd23" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5a136cf2-0096-435f-b7b7-ffd93ab23385" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_66549287-f8f8-49d1-9ba5-b5615fbcfd23" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IncreaseDecreaseinOperatingLeaseLiability_9d78cfd2-68bd-45b8-b9b2-12675fd355b1" xlink:href="rdnt-20200930.xsd#rdnt_IncreaseDecreaseinOperatingLeaseLiability"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5a136cf2-0096-435f-b7b7-ffd93ab23385" xlink:to="loc_rdnt_IncreaseDecreaseinOperatingLeaseLiability_9d78cfd2-68bd-45b8-b9b2-12675fd355b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_05d411f7-5819-4157-b365-2292211a947c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5a136cf2-0096-435f-b7b7-ffd93ab23385" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_05d411f7-5819-4157-b365-2292211a947c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_91cef9ec-fd89-4646-9aff-b6f7e376c5b8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5a136cf2-0096-435f-b7b7-ffd93ab23385" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_91cef9ec-fd89-4646-9aff-b6f7e376c5b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives_5044fce1-0464-4fe7-9791-1e3db9b696b7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <link:calculationArc order="18" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5a136cf2-0096-435f-b7b7-ffd93ab23385" xlink:to="loc_us-gaap_UnrealizedGainLossOnDerivatives_5044fce1-0464-4fe7-9791-1e3db9b696b7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATION" xlink:type="simple" xlink:href="rdnt-20200930.xsd#NATUREOFBUSINESSANDBASISOFPRESENTATION"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATION" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20200930.xsd#NATUREOFBUSINESSDetailsNarrative"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="rdnt-20200930.xsd#SIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="rdnt-20200930.xsd#SIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="simple" xlink:href="rdnt-20200930.xsd#SIGNIFICANTACCOUNTINGPOLICIESTables"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsRevenue" xlink:type="simple" xlink:href="rdnt-20200930.xsd#SIGNIFICANTACCOUNTINGPOLICIESDetailsRevenue"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsRevenue" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20200930.xsd#SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGoodwill" xlink:type="simple" xlink:href="rdnt-20200930.xsd#SIGNIFICANTACCOUNTINGPOLICIESDetailsGoodwill"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGoodwill" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGainonDerivative" xlink:type="simple" xlink:href="rdnt-20200930.xsd#SIGNIFICANTACCOUNTINGPOLICIESDetailsGainonDerivative"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGainonDerivative" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsFairValueMeasurements" xlink:type="simple" xlink:href="rdnt-20200930.xsd#SUMMARYOFACCOUNTINGPOLICIESDetailsFairValueMeasurements"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsFairValueMeasurements" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsEarningsPerShare" xlink:type="simple" xlink:href="rdnt-20200930.xsd#SUMMARYOFACCOUNTINGPOLICIESDetailsEarningsPerShare"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsEarningsPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0bb251c5-d7b3-43b5-b3d7-de794aa579c7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_aadf9a58-de08-43c3-8094-91b12258b9af" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0bb251c5-d7b3-43b5-b3d7-de794aa579c7" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_aadf9a58-de08-43c3-8094-91b12258b9af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_912239bc-d660-4a58-91ec-bb0bd9f4c3db" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesRestrictedStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0bb251c5-d7b3-43b5-b3d7-de794aa579c7" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_912239bc-d660-4a58-91ec-bb0bd9f4c3db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_01fa5939-2933-4815-a9bb-f052a9a4cb66" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0bb251c5-d7b3-43b5-b3d7-de794aa579c7" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_01fa5939-2933-4815-a9bb-f052a9a4cb66" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsInvestmentinJointVentures" xlink:type="simple" xlink:href="rdnt-20200930.xsd#SUMMARYOFACCOUNTINGPOLICIESDetailsInvestmentinJointVentures"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsInvestmentinJointVentures" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures" xlink:type="simple" xlink:href="rdnt-20200930.xsd#SUMMARYOFACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost_fc5f5b61-086f-412a-b9ca-a102c9e49726" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets_aa889ec6-c1b9-4a7b-ba47-e788e4ce9f2f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EquityMethodInvestmentAggregateCost_fc5f5b61-086f-412a-b9ca-a102c9e49726" xlink:to="loc_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets_aa889ec6-c1b9-4a7b-ba47-e788e4ce9f2f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAssets_119f0168-8fbb-45c4-88a2-20037dd89366" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EquityMethodInvestmentAggregateCost_fc5f5b61-086f-412a-b9ca-a102c9e49726" xlink:to="loc_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAssets_119f0168-8fbb-45c4-88a2-20037dd89366" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities_5a71549d-fa53-472e-a33a-8f0fe69d74eb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EquityMethodInvestmentAggregateCost_fc5f5b61-086f-412a-b9ca-a102c9e49726" xlink:to="loc_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities_5a71549d-fa53-472e-a33a-8f0fe69d74eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationLiabilities_2dd45cd3-ba2c-41c7-b1cb-7a43f7620b26" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentSummarizedFinancialInformationLiabilities"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EquityMethodInvestmentAggregateCost_fc5f5b61-086f-412a-b9ca-a102c9e49726" xlink:to="loc_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationLiabilities_2dd45cd3-ba2c-41c7-b1cb-7a43f7620b26" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/RECENTACCOUNTINGANDREPORTINGSTANDARDS" xlink:type="simple" xlink:href="rdnt-20200930.xsd#RECENTACCOUNTINGANDREPORTINGSTANDARDS"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/RECENTACCOUNTINGANDREPORTINGSTANDARDS" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONS" xlink:type="simple" xlink:href="rdnt-20200930.xsd#FACILITYACQUISITIONSANDDISPOSITIONS"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONS" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONSDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20200930.xsd#FACILITYACQUISITIONSANDDISPOSITIONSDetailsNarrative"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONSDetailsNarrative" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLE" xlink:type="simple" xlink:href="rdnt-20200930.xsd#CREDITFACILITYANDNOTESPAYABLE"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLE" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLETables" xlink:type="simple" xlink:href="rdnt-20200930.xsd#CREDITFACILITYANDNOTESPAYABLETables"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLETables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt" xlink:type="simple" xlink:href="rdnt-20200930.xsd#CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities_32d6466d-8ae6-45f1-814a-6f711fbce307" xlink:href="rdnt-20200930.xsd#rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_223e806e-8fad-4588-bcbf-dc80b2ad8a35" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities_32d6466d-8ae6-45f1-814a-6f711fbce307" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_223e806e-8fad-4588-bcbf-dc80b2ad8a35" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_41635d10-cab1-4c3a-9d83-bffa09e6989d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities_32d6466d-8ae6-45f1-814a-6f711fbce307" xlink:to="loc_us-gaap_LongTermDebt_41635d10-cab1-4c3a-9d83-bffa09e6989d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermLoansPayable_98e88f64-29f2-4008-8077-47dd68b3d989" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermLoansPayable"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities_32d6466d-8ae6-45f1-814a-6f711fbce307" xlink:to="loc_us-gaap_LongTermLoansPayable_98e88f64-29f2-4008-8077-47dd68b3d989" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20200930.xsd#CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsTermLoans" xlink:type="simple" xlink:href="rdnt-20200930.xsd#CREDITFACILITYANDNOTESPAYABLEDetailsTermLoans"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsTermLoans" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio" xlink:type="simple" xlink:href="rdnt-20200930.xsd#CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument" xlink:type="simple" xlink:href="rdnt-20200930.xsd#CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATION" xlink:type="simple" xlink:href="rdnt-20200930.xsd#STOCKBASEDCOMPENSATION"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATION" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables" xlink:type="simple" xlink:href="rdnt-20200930.xsd#STOCKBASEDCOMPENSATIONTables"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20200930.xsd#STOCKBASEDCOMPENSATIONDetailsNarrative"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants" xlink:type="simple" xlink:href="rdnt-20200930.xsd#STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs" xlink:type="simple" xlink:href="rdnt-20200930.xsd#STOCKBASEDCOMPENSATIONDetailsRSUs"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/SUBSEQUENTEVENTS" xlink:type="simple" xlink:href="rdnt-20200930.xsd#SUBSEQUENTEVENTS"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/SUBSEQUENTEVENTS" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/SUBSEQUENTEVENTSDetails" xlink:type="simple" xlink:href="rdnt-20200930.xsd#SUBSEQUENTEVENTSDetails"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/SUBSEQUENTEVENTSDetails" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>rdnt-20200930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:57afb805-d064-496f-ad72-af37e545924d,g:a8620cad-346c-45d4-8ba0-be03bf014f2b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.radnet.com/role/CoverPage" xlink:type="simple" xlink:href="rdnt-20200930.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CoverPage" xlink:type="extended" id="i332312070dbe47bb860c293f54b8a79b_CoverPage"/>
  <link:roleRef roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited" xlink:type="simple" xlink:href="rdnt-20200930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited" xlink:type="extended" id="ia9986166d9104e0bb9a359d1ae3335c3_CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited"/>
  <link:roleRef roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical" xlink:type="simple" xlink:href="rdnt-20200930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical" xlink:type="extended" id="ifce6dfcd64db4a098a59f4f5f8080f5a_CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"/>
  <link:roleRef roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited" xlink:type="simple" xlink:href="rdnt-20200930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited" xlink:type="extended" id="i46bacfea71aa4a3d97626095751692a4_CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_7be81e2e-ab58-4596-b699-c85afb52d29f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_4d379372-455f-4c64-bfdc-4398e70fd03b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7be81e2e-ab58-4596-b699-c85afb52d29f" xlink:to="loc_us-gaap_RevenuesAbstract_4d379372-455f-4c64-bfdc-4398e70fd03b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ae8ea000-2be8-4819-aaf2-ddaf30cf23fd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_4d379372-455f-4c64-bfdc-4398e70fd03b" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ae8ea000-2be8-4819-aaf2-ddaf30cf23fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueNotFromContractWithCustomer_cd9f2036-01ca-46d5-9677-b785e6013e0f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueNotFromContractWithCustomer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_4d379372-455f-4c64-bfdc-4398e70fd03b" xlink:to="loc_us-gaap_RevenueNotFromContractWithCustomer_cd9f2036-01ca-46d5-9677-b785e6013e0f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_f5f3fe4a-1d07-45e3-bb7e-1c0b5c636789" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7be81e2e-ab58-4596-b699-c85afb52d29f" xlink:to="loc_us-gaap_OperatingExpensesAbstract_f5f3fe4a-1d07-45e3-bb7e-1c0b5c636789" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_989b552a-2593-4a1b-ae30-97e72d7dc1c3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_f5f3fe4a-1d07-45e3-bb7e-1c0b5c636789" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_989b552a-2593-4a1b-ae30-97e72d7dc1c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_3e8304de-f261-4ee7-b913-6fdee741674f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_f5f3fe4a-1d07-45e3-bb7e-1c0b5c636789" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_3e8304de-f261-4ee7-b913-6fdee741674f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_949860d6-79b8-4fdf-bcd5-2b769f19ca12" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_f5f3fe4a-1d07-45e3-bb7e-1c0b5c636789" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_949860d6-79b8-4fdf-bcd5-2b769f19ca12" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_2cae1f3e-eca4-4d6b-bf75-4f2060cfb1a0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_f5f3fe4a-1d07-45e3-bb7e-1c0b5c636789" xlink:to="loc_us-gaap_SeveranceCosts1_2cae1f3e-eca4-4d6b-bf75-4f2060cfb1a0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_dc28764c-8b2b-4cf7-a8c1-2bf52c35169e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7be81e2e-ab58-4596-b699-c85afb52d29f" xlink:to="loc_us-gaap_OperatingExpenses_dc28764c-8b2b-4cf7-a8c1-2bf52c35169e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_bfd76cf2-83cc-417d-8dfc-9aa7c184ec9f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7be81e2e-ab58-4596-b699-c85afb52d29f" xlink:to="loc_us-gaap_OperatingIncomeLoss_bfd76cf2-83cc-417d-8dfc-9aa7c184ec9f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpensesAbstract_9a634313-c6c6-49cc-af27-4714a2c74eed" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7be81e2e-ab58-4596-b699-c85afb52d29f" xlink:to="loc_us-gaap_OtherExpensesAbstract_9a634313-c6c6-49cc-af27-4714a2c74eed" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_87e20cb0-0b42-4b9d-b0c3-5873b85f8667" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherExpensesAbstract_9a634313-c6c6-49cc-af27-4714a2c74eed" xlink:to="loc_us-gaap_InterestExpenseDebt_87e20cb0-0b42-4b9d-b0c3-5873b85f8667" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_0ae0719a-9e28-41d3-9e11-da3d34108dd0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherExpensesAbstract_9a634313-c6c6-49cc-af27-4714a2c74eed" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_0ae0719a-9e28-41d3-9e11-da3d34108dd0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1_fad8f308-accf-4144-bd9f-523053f3df1a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherExpensesAbstract_9a634313-c6c6-49cc-af27-4714a2c74eed" xlink:to="loc_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1_fad8f308-accf-4144-bd9f-523053f3df1a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_99c42b43-a5c4-466f-a1b6-ce863e3ed0ec" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherExpensesAbstract_9a634313-c6c6-49cc-af27-4714a2c74eed" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_99c42b43-a5c4-466f-a1b6-ce863e3ed0ec" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_7a27e9ed-f4cd-46f3-909a-e388cc20887c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherExpensesAbstract_9a634313-c6c6-49cc-af27-4714a2c74eed" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_7a27e9ed-f4cd-46f3-909a-e388cc20887c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_d290bb5f-093d-448b-9107-2010c72510ab" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7be81e2e-ab58-4596-b699-c85afb52d29f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_d290bb5f-093d-448b-9107-2010c72510ab" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_ae70f733-af26-4236-84eb-c9df4e51e594" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7be81e2e-ab58-4596-b699-c85afb52d29f" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_ae70f733-af26-4236-84eb-c9df4e51e594" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_78248ec0-66ae-435f-b642-a86326451109" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7be81e2e-ab58-4596-b699-c85afb52d29f" xlink:to="loc_us-gaap_ProfitLoss_78248ec0-66ae-435f-b642-a86326451109" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_46fb8df9-5d37-400a-ac29-33d17622a3e9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7be81e2e-ab58-4596-b699-c85afb52d29f" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_46fb8df9-5d37-400a-ac29-33d17622a3e9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_9b1ce352-46e7-4ada-86f2-3475c8d93563" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7be81e2e-ab58-4596-b699-c85afb52d29f" xlink:to="loc_us-gaap_NetIncomeLoss_9b1ce352-46e7-4ada-86f2-3475c8d93563" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_56abcb79-b022-4413-bf35-d16c9d86a766" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7be81e2e-ab58-4596-b699-c85afb52d29f" xlink:to="loc_us-gaap_EarningsPerShareBasic_56abcb79-b022-4413-bf35-d16c9d86a766" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_78aca75b-2c80-4e31-9b6a-2ed259be98d1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7be81e2e-ab58-4596-b699-c85afb52d29f" xlink:to="loc_us-gaap_EarningsPerShareDiluted_78aca75b-2c80-4e31-9b6a-2ed259be98d1" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_93328b14-366e-463e-b20c-6557d065622f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7be81e2e-ab58-4596-b699-c85afb52d29f" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_93328b14-366e-463e-b20c-6557d065622f" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6f02549c-d1f2-445e-a0cd-f4b1b7186e6c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_93328b14-366e-463e-b20c-6557d065622f" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6f02549c-d1f2-445e-a0cd-f4b1b7186e6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_53adb4e1-663b-420b-9d43-9c9f7faec4af" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_93328b14-366e-463e-b20c-6557d065622f" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_53adb4e1-663b-420b-9d43-9c9f7faec4af" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_23f98579-acbb-46d8-9887-abc9886ac973" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_7be81e2e-ab58-4596-b699-c85afb52d29f" xlink:to="loc_us-gaap_StatementTable_23f98579-acbb-46d8-9887-abc9886ac973" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_c8779ee9-3f90-455f-8e59-92fb8ea4b03e" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_23f98579-acbb-46d8-9887-abc9886ac973" xlink:to="loc_srt_ProductOrServiceAxis_c8779ee9-3f90-455f-8e59-92fb8ea4b03e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c8779ee9-3f90-455f-8e59-92fb8ea4b03e_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_c8779ee9-3f90-455f-8e59-92fb8ea4b03e" xlink:to="loc_srt_ProductsAndServicesDomain_c8779ee9-3f90-455f-8e59-92fb8ea4b03e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_27f86ffb-45c2-4766-84eb-9e00634a9c20" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_c8779ee9-3f90-455f-8e59-92fb8ea4b03e" xlink:to="loc_srt_ProductsAndServicesDomain_27f86ffb-45c2-4766-84eb-9e00634a9c20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCarePatientServiceMember_4833cc1c-3cab-482f-97c0-73f9b1c0b6f4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HealthCarePatientServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_27f86ffb-45c2-4766-84eb-9e00634a9c20" xlink:to="loc_us-gaap_HealthCarePatientServiceMember_4833cc1c-3cab-482f-97c0-73f9b1c0b6f4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CapitationArrangementsMember_479e0db6-145f-4e0b-8512-7a6ae02f4361" xlink:href="rdnt-20200930.xsd#rdnt_CapitationArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_27f86ffb-45c2-4766-84eb-9e00634a9c20" xlink:to="loc_rdnt_CapitationArrangementsMember_479e0db6-145f-4e0b-8512-7a6ae02f4361" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited" xlink:type="simple" xlink:href="rdnt-20200930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited" xlink:type="extended" id="i56bb06be64ec407a8c04a07f7495a309_CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited"/>
  <link:roleRef roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited" xlink:type="simple" xlink:href="rdnt-20200930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited" xlink:type="extended" id="i7b5fa075076a467e8e008385b00bbd3f_CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_eab2d9e9-ce01-4268-85ca-ea422f4640f4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0067892a-31e5-4442-aa83-e836a2b69bce" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_eab2d9e9-ce01-4268-85ca-ea422f4640f4" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0067892a-31e5-4442-aa83-e836a2b69bce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_bea6138d-fdfa-4601-9174-949baeb548e6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0067892a-31e5-4442-aa83-e836a2b69bce" xlink:to="loc_us-gaap_SharesOutstanding_bea6138d-fdfa-4601-9174-949baeb548e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_362b63c2-e295-471f-80e0-33ed1a14a09d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0067892a-31e5-4442-aa83-e836a2b69bce" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_362b63c2-e295-471f-80e0-33ed1a14a09d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_ffb5f5f9-ff66-4513-b465-fb360e530917" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0067892a-31e5-4442-aa83-e836a2b69bce" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_ffb5f5f9-ff66-4513-b465-fb360e530917" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue_348a5ad4-6c37-4ba5-a564-1dc330ba3f3b" xlink:href="rdnt-20200930.xsd#rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0067892a-31e5-4442-aa83-e836a2b69bce" xlink:to="loc_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue_348a5ad4-6c37-4ba5-a564-1dc330ba3f3b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_a9710d7d-bd81-4cca-888a-12b29c178124" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0067892a-31e5-4442-aa83-e836a2b69bce" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_a9710d7d-bd81-4cca-888a-12b29c178124" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_ae75e065-e646-4ef2-964f-084e5636f01f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0067892a-31e5-4442-aa83-e836a2b69bce" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_ae75e065-e646-4ef2-964f-084e5636f01f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_fcc99cf3-5fd1-4384-9180-bba35f139473" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0067892a-31e5-4442-aa83-e836a2b69bce" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_fcc99cf3-5fd1-4384-9180-bba35f139473" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_b3e5d5e9-abae-48b9-83ca-8ba82b639b6d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0067892a-31e5-4442-aa83-e836a2b69bce" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_b3e5d5e9-abae-48b9-83ca-8ba82b639b6d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_3debe9e8-7ff7-4afa-9969-89374ec01eab" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0067892a-31e5-4442-aa83-e836a2b69bce" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_3debe9e8-7ff7-4afa-9969-89374ec01eab" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_d75c050b-a252-439c-b08b-86e70dcf19c6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0067892a-31e5-4442-aa83-e836a2b69bce" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_d75c050b-a252-439c-b08b-86e70dcf19c6" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_9efb9816-6b91-4d07-b0a5-5528ca965957" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0067892a-31e5-4442-aa83-e836a2b69bce" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_9efb9816-6b91-4d07-b0a5-5528ca965957" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_b2331204-743d-41a3-a3ec-282e72460de6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0067892a-31e5-4442-aa83-e836a2b69bce" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_b2331204-743d-41a3-a3ec-282e72460de6" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_e0c0e758-2406-4fbe-b030-9a0badc35082" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0067892a-31e5-4442-aa83-e836a2b69bce" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_e0c0e758-2406-4fbe-b030-9a0badc35082" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures_949f7ebd-9ac3-4621-9a76-df4f9d3d64d3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0067892a-31e5-4442-aa83-e836a2b69bce" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures_949f7ebd-9ac3-4621-9a76-df4f9d3d64d3" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_a29dd1c6-cc34-4e61-b3c2-c77d64ddfd06" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0067892a-31e5-4442-aa83-e836a2b69bce" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_a29dd1c6-cc34-4e61-b3c2-c77d64ddfd06" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_30168062-cf9e-430e-82ab-f315a7b2a065" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0067892a-31e5-4442-aa83-e836a2b69bce" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_30168062-cf9e-430e-82ab-f315a7b2a065" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContributionsFromNoncontrollingInterests_1ebb58d9-8b8d-49c0-8aa1-d5e3f8169944" xlink:href="rdnt-20200930.xsd#rdnt_ContributionsFromNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0067892a-31e5-4442-aa83-e836a2b69bce" xlink:to="loc_rdnt_ContributionsFromNoncontrollingInterests_1ebb58d9-8b8d-49c0-8aa1-d5e3f8169944" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_StockIssuedDuringPeriodSharesIssuedForReturnOfCapital_f5ad36b7-acd3-48d8-9459-9651e9ccf639" xlink:href="rdnt-20200930.xsd#rdnt_StockIssuedDuringPeriodSharesIssuedForReturnOfCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0067892a-31e5-4442-aa83-e836a2b69bce" xlink:to="loc_rdnt_StockIssuedDuringPeriodSharesIssuedForReturnOfCapital_f5ad36b7-acd3-48d8-9459-9651e9ccf639" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_StockIssuedDuringPeriodValueIssuedForReturnOfCapital_44419eea-a026-4769-8188-953135f97f89" xlink:href="rdnt-20200930.xsd#rdnt_StockIssuedDuringPeriodValueIssuedForReturnOfCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0067892a-31e5-4442-aa83-e836a2b69bce" xlink:to="loc_rdnt_StockIssuedDuringPeriodValueIssuedForReturnOfCapital_44419eea-a026-4769-8188-953135f97f89" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_c518b3b4-4589-46b9-9cff-95d06883e8ee" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0067892a-31e5-4442-aa83-e836a2b69bce" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_c518b3b4-4589-46b9-9cff-95d06883e8ee" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_41cda3de-6d63-4a5d-a7cf-ef40c28574c8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0067892a-31e5-4442-aa83-e836a2b69bce" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_41cda3de-6d63-4a5d-a7cf-ef40c28574c8" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_755a9f66-935e-4e85-8d27-18cf48af7751" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0067892a-31e5-4442-aa83-e836a2b69bce" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_755a9f66-935e-4e85-8d27-18cf48af7751" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther_f0a98542-739b-473b-a48f-beb356fd77dc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0067892a-31e5-4442-aa83-e836a2b69bce" xlink:to="loc_us-gaap_StockholdersEquityOther_f0a98542-739b-473b-a48f-beb356fd77dc" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_386e90af-c2df-4d72-8b84-4f87624621a5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0067892a-31e5-4442-aa83-e836a2b69bce" xlink:to="loc_us-gaap_ProfitLoss_386e90af-c2df-4d72-8b84-4f87624621a5" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_8f79690c-dade-4d8d-b8dc-766987063fb6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_67751890-bddb-4fe5-b492-122a1ffcac11" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_bc9f58b7-5b9b-4516-9b16-673589c6b0cc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_eab2d9e9-ce01-4268-85ca-ea422f4640f4" xlink:to="loc_us-gaap_StatementTable_bc9f58b7-5b9b-4516-9b16-673589c6b0cc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_e6c54e73-3f24-49af-b358-449200aa17fd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_bc9f58b7-5b9b-4516-9b16-673589c6b0cc" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_e6c54e73-3f24-49af-b358-449200aa17fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e6c54e73-3f24-49af-b358-449200aa17fd_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e6c54e73-3f24-49af-b358-449200aa17fd" xlink:to="loc_us-gaap_EquityComponentDomain_e6c54e73-3f24-49af-b358-449200aa17fd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_5ff1ec2a-3b4a-4c2b-b325-30e76aae868a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e6c54e73-3f24-49af-b358-449200aa17fd" xlink:to="loc_us-gaap_EquityComponentDomain_5ff1ec2a-3b4a-4c2b-b325-30e76aae868a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_StockholdersEquityDeficitMember_0e04afe5-91c4-4f62-a487-fcfebc758226" xlink:href="rdnt-20200930.xsd#rdnt_StockholdersEquityDeficitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_5ff1ec2a-3b4a-4c2b-b325-30e76aae868a" xlink:to="loc_rdnt_StockholdersEquityDeficitMember_0e04afe5-91c4-4f62-a487-fcfebc758226" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_46266c4d-51c9-40bb-83f4-1cfeea3fae87" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_StockholdersEquityDeficitMember_0e04afe5-91c4-4f62-a487-fcfebc758226" xlink:to="loc_us-gaap_CommonStockMember_46266c4d-51c9-40bb-83f4-1cfeea3fae87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_58694fa0-194d-4dad-ae82-7cfd13227861" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_StockholdersEquityDeficitMember_0e04afe5-91c4-4f62-a487-fcfebc758226" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_58694fa0-194d-4dad-ae82-7cfd13227861" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_fc675ed0-d65c-43ad-85f7-64321c0e2c78" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_StockholdersEquityDeficitMember_0e04afe5-91c4-4f62-a487-fcfebc758226" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_fc675ed0-d65c-43ad-85f7-64321c0e2c78" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_96856ac1-e00a-4c2d-bd20-4201848e139a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_StockholdersEquityDeficitMember_0e04afe5-91c4-4f62-a487-fcfebc758226" xlink:to="loc_us-gaap_RetainedEarningsMember_96856ac1-e00a-4c2d-bd20-4201848e139a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_97a821c9-d71a-416c-872f-f1790d753882" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_5ff1ec2a-3b4a-4c2b-b325-30e76aae868a" xlink:to="loc_us-gaap_NoncontrollingInterestMember_97a821c9-d71a-416c-872f-f1790d753882" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_095ddf93-944f-4391-bd90-ab8a6dc62b09" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_bc9f58b7-5b9b-4516-9b16-673589c6b0cc" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_095ddf93-944f-4391-bd90-ab8a6dc62b09" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_095ddf93-944f-4391-bd90-ab8a6dc62b09_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_095ddf93-944f-4391-bd90-ab8a6dc62b09" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_095ddf93-944f-4391-bd90-ab8a6dc62b09_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9ea91a6d-314e-4885-9dea-90c55c846cf9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_095ddf93-944f-4391-bd90-ab8a6dc62b09" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9ea91a6d-314e-4885-9dea-90c55c846cf9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthInc.Member_0bf01dd1-c645-40d3-b74c-37eff0793c56" xlink:href="rdnt-20200930.xsd#rdnt_DeepHealthInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9ea91a6d-314e-4885-9dea-90c55c846cf9" xlink:to="loc_rdnt_DeepHealthInc.Member_0bf01dd1-c645-40d3-b74c-37eff0793c56" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" xlink:type="simple" xlink:href="rdnt-20200930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" xlink:type="extended" id="i01952ee05ef54939b6d9cd0e980971c7_CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_0350ae88-cf23-446c-b069-c327e7aa5eb0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquipmentAcquiredAndLeaseholdImprovements_2f05243d-431d-4cdc-bc92-2f058a843ca5" xlink:href="rdnt-20200930.xsd#rdnt_EquipmentAcquiredAndLeaseholdImprovements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0350ae88-cf23-446c-b069-c327e7aa5eb0" xlink:to="loc_rdnt_EquipmentAcquiredAndLeaseholdImprovements_2f05243d-431d-4cdc-bc92-2f058a843ca5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_f88980f9-2174-4a37-bf5e-cee2492a824e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0350ae88-cf23-446c-b069-c327e7aa5eb0" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_f88980f9-2174-4a37-bf5e-cee2492a824e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_75bcb21b-0f28-4953-b978-d922c4486631" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0350ae88-cf23-446c-b069-c327e7aa5eb0" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_75bcb21b-0f28-4953-b978-d922c4486631" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_a47f5973-4551-4424-b195-451c5c0e8df9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0350ae88-cf23-446c-b069-c327e7aa5eb0" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_a47f5973-4551-4424-b195-451c5c0e8df9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_ee0ea4e4-64a1-4fd8-9025-67090291bd88" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0350ae88-cf23-446c-b069-c327e7aa5eb0" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_ee0ea4e4-64a1-4fd8-9025-67090291bd88" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_be6bb110-fc10-4031-a376-8ddf65078b14" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0350ae88-cf23-446c-b069-c327e7aa5eb0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_be6bb110-fc10-4031-a376-8ddf65078b14" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_5cda5997-1541-4fdb-9915-ba02cd1d8cc0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_0350ae88-cf23-446c-b069-c327e7aa5eb0" xlink:to="loc_us-gaap_StatementTable_5cda5997-1541-4fdb-9915-ba02cd1d8cc0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis_98778c7e-206d-47dc-92ce-0ff638265c51" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_5cda5997-1541-4fdb-9915-ba02cd1d8cc0" xlink:to="loc_us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis_98778c7e-206d-47dc-92ce-0ff638265c51" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassificationOfVariableInterestEntityDomain_98778c7e-206d-47dc-92ce-0ff638265c51_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassificationOfVariableInterestEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis_98778c7e-206d-47dc-92ce-0ff638265c51" xlink:to="loc_us-gaap_ClassificationOfVariableInterestEntityDomain_98778c7e-206d-47dc-92ce-0ff638265c51_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassificationOfVariableInterestEntityDomain_6bba3da5-478c-40b1-9e99-dc7e4a1bba2c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassificationOfVariableInterestEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis_98778c7e-206d-47dc-92ce-0ff638265c51" xlink:to="loc_us-gaap_ClassificationOfVariableInterestEntityDomain_6bba3da5-478c-40b1-9e99-dc7e4a1bba2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_4c5028a3-04b3-4a7a-9f4c-0f0ff21d7b01" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassificationOfVariableInterestEntityDomain_6bba3da5-478c-40b1-9e99-dc7e4a1bba2c" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_4c5028a3-04b3-4a7a-9f4c-0f0ff21d7b01" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e6fc0f73-8a6e-4f66-aba3-4940dbf29922" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_5cda5997-1541-4fdb-9915-ba02cd1d8cc0" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e6fc0f73-8a6e-4f66-aba3-4940dbf29922" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e6fc0f73-8a6e-4f66-aba3-4940dbf29922_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e6fc0f73-8a6e-4f66-aba3-4940dbf29922" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e6fc0f73-8a6e-4f66-aba3-4940dbf29922_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_caec8693-db2e-4eec-b873-a2d06cad5c19" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e6fc0f73-8a6e-4f66-aba3-4940dbf29922" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_caec8693-db2e-4eec-b873-a2d06cad5c19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthInc.Member_51062550-595a-4906-8ce3-85078f7bdd9c" xlink:href="rdnt-20200930.xsd#rdnt_DeepHealthInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_caec8693-db2e-4eec-b873-a2d06cad5c19" xlink:to="loc_rdnt_DeepHealthInc.Member_51062550-595a-4906-8ce3-85078f7bdd9c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NulogixMember_2dc5e355-d6c1-45f0-ba46-5557187f01ca" xlink:href="rdnt-20200930.xsd#rdnt_NulogixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_caec8693-db2e-4eec-b873-a2d06cad5c19" xlink:to="loc_rdnt_NulogixMember_2dc5e355-d6c1-45f0-ba46-5557187f01ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_VenturaCountyImagingGroupLLCMember_44831020-8730-429b-a42b-c12e8ff017d1" xlink:href="rdnt-20200930.xsd#rdnt_VenturaCountyImagingGroupLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_caec8693-db2e-4eec-b873-a2d06cad5c19" xlink:to="loc_rdnt_VenturaCountyImagingGroupLLCMember_44831020-8730-429b-a42b-c12e8ff017d1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HudsonValleyRadiologyAssociatesMember_0a57b790-cce6-4ebd-ae2d-0806e96d6790" xlink:href="rdnt-20200930.xsd#rdnt_HudsonValleyRadiologyAssociatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_caec8693-db2e-4eec-b873-a2d06cad5c19" xlink:to="loc_rdnt_HudsonValleyRadiologyAssociatesMember_0a57b790-cce6-4ebd-ae2d-0806e96d6790" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATION" xlink:type="simple" xlink:href="rdnt-20200930.xsd#NATUREOFBUSINESSANDBASISOFPRESENTATION"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATION" xlink:type="extended" id="ibbd1bb8e816141628630fe5eb5fc2e54_NATUREOFBUSINESSANDBASISOFPRESENTATION"/>
  <link:roleRef roleURI="http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20200930.xsd#NATUREOFBUSINESSDetailsNarrative"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative" xlink:type="extended" id="ide661986b2444df8987d833a6938288f_NATUREOFBUSINESSDetailsNarrative">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_d4f0a0b1-24f7-4f51-ac7a-b04efb19190d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberOfCenters_2db14ffc-af27-497e-90c1-e344b8f31cd6" xlink:href="rdnt-20200930.xsd#rdnt_NumberOfCenters"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d4f0a0b1-24f7-4f51-ac7a-b04efb19190d" xlink:to="loc_rdnt_NumberOfCenters_2db14ffc-af27-497e-90c1-e344b8f31cd6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_cfc30021-44a0-4c7f-b819-846d35d8ffd5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d4f0a0b1-24f7-4f51-ac7a-b04efb19190d" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_cfc30021-44a0-4c7f-b819-846d35d8ffd5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues_6c5d2aec-704c-4167-b055-fc653480a446" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d4f0a0b1-24f7-4f51-ac7a-b04efb19190d" xlink:to="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues_6c5d2aec-704c-4167-b055-fc653480a446" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense_b37a7ab1-c5bd-4149-8cf2-4c4d9b01e616" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d4f0a0b1-24f7-4f51-ac7a-b04efb19190d" xlink:to="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense_b37a7ab1-c5bd-4149-8cf2-4c4d9b01e616" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax_6d794d71-613f-4474-a2e1-9ec550c4cc14" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d4f0a0b1-24f7-4f51-ac7a-b04efb19190d" xlink:to="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax_6d794d71-613f-4474-a2e1-9ec550c4cc14" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_bc1468e8-cd7d-407d-a440-a68e1d42b2a4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d4f0a0b1-24f7-4f51-ac7a-b04efb19190d" xlink:to="loc_us-gaap_Assets_bc1468e8-cd7d-407d-a440-a68e1d42b2a4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_03c3b6f6-65d2-4216-81d3-ed2ee4915268" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d4f0a0b1-24f7-4f51-ac7a-b04efb19190d" xlink:to="loc_us-gaap_Liabilities_03c3b6f6-65d2-4216-81d3-ed2ee4915268" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_263adb48-01f7-4290-a241-8002099637c3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d4f0a0b1-24f7-4f51-ac7a-b04efb19190d" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_263adb48-01f7-4290-a241-8002099637c3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_ec22dd06-48e6-4ae6-ad36-e5fe5e9d50d6" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_263adb48-01f7-4290-a241-8002099637c3" xlink:to="loc_srt_ConsolidatedEntitiesAxis_ec22dd06-48e6-4ae6-ad36-e5fe5e9d50d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_ec22dd06-48e6-4ae6-ad36-e5fe5e9d50d6_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_ec22dd06-48e6-4ae6-ad36-e5fe5e9d50d6" xlink:to="loc_srt_ConsolidatedEntitiesDomain_ec22dd06-48e6-4ae6-ad36-e5fe5e9d50d6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_3bbadf61-0474-4db8-beda-3a4879d95266" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_ec22dd06-48e6-4ae6-ad36-e5fe5e9d50d6" xlink:to="loc_srt_ConsolidatedEntitiesDomain_3bbadf61-0474-4db8-beda-3a4879d95266" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_0ab0bef8-a44e-4c39-9d43-456f7c8c05ef" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_3bbadf61-0474-4db8-beda-3a4879d95266" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_0ab0bef8-a44e-4c39-9d43-456f7c8c05ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_9a84efe4-125a-4f7d-b562-66720b6a758e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_263adb48-01f7-4290-a241-8002099637c3" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_9a84efe4-125a-4f7d-b562-66720b6a758e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_9a84efe4-125a-4f7d-b562-66720b6a758e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_9a84efe4-125a-4f7d-b562-66720b6a758e" xlink:to="loc_us-gaap_RelatedPartyDomain_9a84efe4-125a-4f7d-b562-66720b6a758e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_200e5432-1734-4fab-9d35-3cd7866731ca" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_9a84efe4-125a-4f7d-b562-66720b6a758e" xlink:to="loc_us-gaap_RelatedPartyDomain_200e5432-1734-4fab-9d35-3cd7866731ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember_4975a0f5-714a-4ab3-964a-90a01d0ffe57" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_200e5432-1734-4fab-9d35-3cd7866731ca" xlink:to="loc_srt_ChiefExecutiveOfficerMember_4975a0f5-714a-4ab3-964a-90a01d0ffe57" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BoardMemberMember_c740c9d1-8860-4805-bc8b-2db0fd15a8dd" xlink:href="rdnt-20200930.xsd#rdnt_BoardMemberMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_200e5432-1734-4fab-9d35-3cd7866731ca" xlink:to="loc_rdnt_BoardMemberMember_c740c9d1-8860-4805-bc8b-2db0fd15a8dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_8bb3b5ce-06d4-4602-8cd1-571362a2214b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_263adb48-01f7-4290-a241-8002099637c3" xlink:to="loc_dei_LegalEntityAxis_8bb3b5ce-06d4-4602-8cd1-571362a2214b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_8bb3b5ce-06d4-4602-8cd1-571362a2214b_default" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_8bb3b5ce-06d4-4602-8cd1-571362a2214b" xlink:to="loc_dei_EntityDomain_8bb3b5ce-06d4-4602-8cd1-571362a2214b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_a8a262c7-8c1d-4a30-b857-4e6964acfcba" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_8bb3b5ce-06d4-4602-8cd1-571362a2214b" xlink:to="loc_dei_EntityDomain_a8a262c7-8c1d-4a30-b857-4e6964acfcba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BeverlyRadiologyMedicalGroupIIIMember_d8bb83c8-8b92-424c-8839-b706eee957dc" xlink:href="rdnt-20200930.xsd#rdnt_BeverlyRadiologyMedicalGroupIIIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_a8a262c7-8c1d-4a30-b857-4e6964acfcba" xlink:to="loc_rdnt_BeverlyRadiologyMedicalGroupIIIMember_d8bb83c8-8b92-424c-8839-b706eee957dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ScriptSenderLlcMember_b147cf64-b113-4b70-86c7-9a6d3d713f6a" xlink:href="rdnt-20200930.xsd#rdnt_ScriptSenderLlcMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_a8a262c7-8c1d-4a30-b857-4e6964acfcba" xlink:to="loc_rdnt_ScriptSenderLlcMember_b147cf64-b113-4b70-86c7-9a6d3d713f6a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="rdnt-20200930.xsd#SIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended" id="i4891638511874c96b6b3676a4761ce8f_SIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="rdnt-20200930.xsd#SIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended" id="i343e5cc2775646f8b2b384fd3f4a97a7_SIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="simple" xlink:href="rdnt-20200930.xsd#SIGNIFICANTACCOUNTINGPOLICIESTables"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="extended" id="i8e4f140194be4ea6b7ad81625c1931d7_SIGNIFICANTACCOUNTINGPOLICIESTables"/>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsRevenue" xlink:type="simple" xlink:href="rdnt-20200930.xsd#SIGNIFICANTACCOUNTINGPOLICIESDetailsRevenue"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsRevenue" xlink:type="extended" id="i084bf0ab20ca438b828a25bad5338add_SIGNIFICANTACCOUNTINGPOLICIESDetailsRevenue">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_3a79a506-b031-4a4a-b6b7-3d5aaa7657d5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_209ef6d6-8b84-4aef-ad66-75f362bd5db1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_3a79a506-b031-4a4a-b6b7-3d5aaa7657d5" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_209ef6d6-8b84-4aef-ad66-75f362bd5db1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_ee544bd9-1165-467f-ac44-84e32597b86e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_3a79a506-b031-4a4a-b6b7-3d5aaa7657d5" xlink:to="loc_us-gaap_Revenues_ee544bd9-1165-467f-ac44-84e32597b86e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_cf936bab-e429-410c-ab6b-7b79de7a3df6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_3a79a506-b031-4a4a-b6b7-3d5aaa7657d5" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_cf936bab-e429-410c-ab6b-7b79de7a3df6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_c9b37bc8-ce71-420c-b437-9dec01247a38" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_cf936bab-e429-410c-ab6b-7b79de7a3df6" xlink:to="loc_srt_ProductOrServiceAxis_c9b37bc8-ce71-420c-b437-9dec01247a38" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c9b37bc8-ce71-420c-b437-9dec01247a38_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_c9b37bc8-ce71-420c-b437-9dec01247a38" xlink:to="loc_srt_ProductsAndServicesDomain_c9b37bc8-ce71-420c-b437-9dec01247a38_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ded51f86-044a-43ff-b465-7aa999ae66c0" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_c9b37bc8-ce71-420c-b437-9dec01247a38" xlink:to="loc_srt_ProductsAndServicesDomain_ded51f86-044a-43ff-b465-7aa999ae66c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CommercialInsurance1Member_1a6d750b-f761-4a97-9e73-140dfad14878" xlink:href="rdnt-20200930.xsd#rdnt_CommercialInsurance1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ded51f86-044a-43ff-b465-7aa999ae66c0" xlink:to="loc_rdnt_CommercialInsurance1Member_1a6d750b-f761-4a97-9e73-140dfad14878" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Medicare1Member_3ec63333-8ac0-4357-a9c5-9a0a19bb071b" xlink:href="rdnt-20200930.xsd#rdnt_Medicare1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ded51f86-044a-43ff-b465-7aa999ae66c0" xlink:to="loc_rdnt_Medicare1Member_3ec63333-8ac0-4357-a9c5-9a0a19bb071b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Medicaid1Member_84c3deaf-5f74-43ce-ab27-fbc5711ada69" xlink:href="rdnt-20200930.xsd#rdnt_Medicaid1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ded51f86-044a-43ff-b465-7aa999ae66c0" xlink:to="loc_rdnt_Medicaid1Member_84c3deaf-5f74-43ce-ab27-fbc5711ada69" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WorkersCompensationPersonalInjury1Member_51392a36-b81c-4b04-948b-a0a8dbe271bb" xlink:href="rdnt-20200930.xsd#rdnt_WorkersCompensationPersonalInjury1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ded51f86-044a-43ff-b465-7aa999ae66c0" xlink:to="loc_rdnt_WorkersCompensationPersonalInjury1Member_51392a36-b81c-4b04-948b-a0a8dbe271bb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HealthCarePatientServiceOtherMember_df76c842-8039-4dcd-a5fb-511050005202" xlink:href="rdnt-20200930.xsd#rdnt_HealthCarePatientServiceOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ded51f86-044a-43ff-b465-7aa999ae66c0" xlink:to="loc_rdnt_HealthCarePatientServiceOtherMember_df76c842-8039-4dcd-a5fb-511050005202" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HealthCareManagementServiceMember_38b577ed-4a6f-418c-bc54-3533f292db59" xlink:href="rdnt-20200930.xsd#rdnt_HealthCareManagementServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ded51f86-044a-43ff-b465-7aa999ae66c0" xlink:to="loc_rdnt_HealthCareManagementServiceMember_38b577ed-4a6f-418c-bc54-3533f292db59" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TeleradiologyandSoftwareMember_6efbde4c-e641-4702-a7c0-819cd9c4c8d3" xlink:href="rdnt-20200930.xsd#rdnt_TeleradiologyandSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ded51f86-044a-43ff-b465-7aa999ae66c0" xlink:to="loc_rdnt_TeleradiologyandSoftwareMember_6efbde4c-e641-4702-a7c0-819cd9c4c8d3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOtherMember_73afddfd-de3a-4028-8078-50b11e2fa814" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HealthCareOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ded51f86-044a-43ff-b465-7aa999ae66c0" xlink:to="loc_us-gaap_HealthCareOtherMember_73afddfd-de3a-4028-8078-50b11e2fa814" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCarePatientServiceMember_7ac9b3d4-bd52-4c7c-8216-73eab65fd6fa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HealthCarePatientServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ded51f86-044a-43ff-b465-7aa999ae66c0" xlink:to="loc_us-gaap_HealthCarePatientServiceMember_7ac9b3d4-bd52-4c7c-8216-73eab65fd6fa" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CapitationArrangementsMember_b9fade46-fd2d-4c66-acb5-1883b60dc69b" xlink:href="rdnt-20200930.xsd#rdnt_CapitationArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ded51f86-044a-43ff-b465-7aa999ae66c0" xlink:to="loc_rdnt_CapitationArrangementsMember_b9fade46-fd2d-4c66-acb5-1883b60dc69b" xlink:type="arc" order="9"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20200930.xsd#SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative" xlink:type="extended" id="if33b6854f5e84464b8273c2efa0c0113_SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AdvanceMedicarePayments_ba77dfeb-10ad-4d5b-81f4-af584d9ec0ae" xlink:href="rdnt-20200930.xsd#rdnt_AdvanceMedicarePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_rdnt_AdvanceMedicarePayments_ba77dfeb-10ad-4d5b-81f4-af584d9ec0ae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProceedsReceivedFromInsurance_bfe5a35c-b78e-4c09-a79f-64189e1cfa49" xlink:href="rdnt-20200930.xsd#rdnt_ProceedsReceivedFromInsurance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_rdnt_ProceedsReceivedFromInsurance_bfe5a35c-b78e-4c09-a79f-64189e1cfa49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueNotFromContractWithCustomer_09586d51-9d34-479e-a1b3-5d03d9fa388a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueNotFromContractWithCustomer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_us-gaap_RevenueNotFromContractWithCustomer_09586d51-9d34-479e-a1b3-5d03d9fa388a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_df84f69a-026c-4f93-bbce-b866324a4a14" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_df84f69a-026c-4f93-bbce-b866324a4a14" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SocialSecurityTaxEmployerDeferralCARESAct_3d92732f-01c5-473f-ae53-4c1fbbc298d0" xlink:href="rdnt-20200930.xsd#rdnt_SocialSecurityTaxEmployerDeferralCARESAct"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_rdnt_SocialSecurityTaxEmployerDeferralCARESAct_3d92732f-01c5-473f-ae53-4c1fbbc298d0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContractsReceivableFactoringReceivable_5e3fae92-a742-4e45-b23f-9c2bfd585128" xlink:href="rdnt-20200930.xsd#rdnt_ContractsReceivableFactoringReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_rdnt_ContractsReceivableFactoringReceivable_5e3fae92-a742-4e45-b23f-9c2bfd585128" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_8129e819-1326-42c9-aa10-97a7e8fbcf57" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_8129e819-1326-42c9-aa10-97a7e8fbcf57" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_0aaf2a07-ffeb-451c-a33b-a28d77398224" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_0aaf2a07-ffeb-451c-a33b-a28d77398224" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_16e8032e-a4a5-4c50-9c3a-65a919189b0f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_us-gaap_Goodwill_16e8032e-a4a5-4c50-9c3a-65a919189b0f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_5080978c-dfed-4481-bf6b-6db4a13a2624" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_5080978c-dfed-4481-bf6b-6db4a13a2624" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_a5247dfe-5e71-47d2-9c41-af2963211747" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_a5247dfe-5e71-47d2-9c41-af2963211747" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_241b3747-cdc9-4b5a-bb51-6560e98cca63" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_241b3747-cdc9-4b5a-bb51-6560e98cca63" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_b20d4389-faab-4648-9dc0-38a481874e3b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_b20d4389-faab-4648-9dc0-38a481874e3b" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_91219a13-ef76-4d7c-87b4-776419679995" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_91219a13-ef76-4d7c-87b4-776419679995" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_dece8a34-e34e-4cef-bae3-ec10a70acd34" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_dece8a34-e34e-4cef-bae3-ec10a70acd34" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNumberOfInstrumentsHeld_54643e2a-0912-4ed2-9582-9eeeba77bdf0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeAssetNumberOfInstrumentsHeld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_us-gaap_DerivativeAssetNumberOfInstrumentsHeld_54643e2a-0912-4ed2-9582-9eeeba77bdf0" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_5291dc12-8ccf-4fbf-b48d-f8aeea1f005d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_5291dc12-8ccf-4fbf-b48d-f8aeea1f005d" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeBasisSpreadOnVariableRate_c91f3174-135f-480c-84e9-ffbdadfbd6d1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeBasisSpreadOnVariableRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_us-gaap_DerivativeBasisSpreadOnVariableRate_c91f3174-135f-480c-84e9-ffbdadfbd6d1" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_0c6a4efa-9a98-4937-85d6-b7eb26d39dff" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_0c6a4efa-9a98-4937-85d6-b7eb26d39dff" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MonthlyAmortizationOfDeferredHedgeGains_3b0b1e18-6d05-443d-a03f-5a3136262e15" xlink:href="rdnt-20200930.xsd#rdnt_MonthlyAmortizationOfDeferredHedgeGains"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_rdnt_MonthlyAmortizationOfDeferredHedgeGains_3b0b1e18-6d05-443d-a03f-5a3136262e15" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized_67d1814d-f26c-4b32-95f1-fed12c634f11" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized_67d1814d-f26c-4b32-95f1-fed12c634f11" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_52396bb3-170a-4d9b-82e8-9b889eb327ba" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_us-gaap_LineOfCredit_52396bb3-170a-4d9b-82e8-9b889eb327ba" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_9ab786e1-4992-482e-9684-8e54707d1302" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_9ab786e1-4992-482e-9684-8e54707d1302" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_a806940a-9d5c-44ec-9d0c-da19fc1ea7af" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_a806940a-9d5c-44ec-9d0c-da19fc1ea7af" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment_86391ec5-76a3-4078-bb0e-212ddd74c470" xlink:href="rdnt-20200930.xsd#rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment_86391ec5-76a3-4078-bb0e-212ddd74c470" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired_5c9aaf5d-25b0-4885-9dfa-e16b1a50085e" xlink:href="rdnt-20200930.xsd#rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired_5c9aaf5d-25b0-4885-9dfa-e16b1a50085e" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution_eb399c94-388f-48e5-802d-8b9b8c9da9bc" xlink:href="rdnt-20200930.xsd#rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution_eb399c94-388f-48e5-802d-8b9b8c9da9bc" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost_0a2d887e-f02d-45ed-9b58-bcd7c352d779" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_us-gaap_EquityMethodInvestmentAggregateCost_0a2d887e-f02d-45ed-9b58-bcd7c352d779" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentSharesPurchased_dfe8b228-2f7d-4daa-9a47-210b8ea76913" xlink:href="rdnt-20200930.xsd#rdnt_EquityMethodInvestmentSharesPurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_rdnt_EquityMethodInvestmentSharesPurchased_dfe8b228-2f7d-4daa-9a47-210b8ea76913" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_be38473b-bc35-43fa-b05b-7ab1ff51dde4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_us-gaap_ShortTermBorrowings_be38473b-bc35-43fa-b05b-7ab1ff51dde4" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_db251e4a-1d37-44a4-8f53-8bd6b8bc5849" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_db251e4a-1d37-44a4-8f53-8bd6b8bc5849" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_40d969ac-6f31-4205-8545-716d9fc8d717" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToFundLongtermLoansToRelatedParties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_40d969ac-6f31-4205-8545-716d9fc8d717" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_cae0395a-f667-408f-961c-c274c1ef43ac" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_cae0395a-f667-408f-961c-c274c1ef43ac" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberofUnconsolidatedJointVentures_9a2899c2-1536-48f5-af31-ac1c56e2a097" xlink:href="rdnt-20200930.xsd#rdnt_NumberofUnconsolidatedJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_rdnt_NumberofUnconsolidatedJointVentures_9a2899c2-1536-48f5-af31-ac1c56e2a097" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityOwnershipPercentage_fef80db9-db1f-4775-bc01-4cfe590007ab" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableInterestEntityOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_us-gaap_VariableInterestEntityOwnershipPercentage_fef80db9-db1f-4775-bc01-4cfe590007ab" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_ef0310eb-9f75-4257-9053-4c8779ff6b10" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireInterestInJointVenture"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_ef0310eb-9f75-4257-9053-4c8779ff6b10" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_5a9f916e-8e22-4509-9bc4-d69e687aac69" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ManagementServiceFees_40206a54-9c35-45b0-9034-f0e4e1babc1d" xlink:href="rdnt-20200930.xsd#rdnt_ManagementServiceFees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_rdnt_ManagementServiceFees_40206a54-9c35-45b0-9034-f0e4e1babc1d" xlink:type="arc" order="37"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_09b557c3-8149-47d5-bc54-29f8d7d7f81d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_09b557c3-8149-47d5-bc54-29f8d7d7f81d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_e5d35193-90ec-4415-b62e-85a4f2427127" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_09b557c3-8149-47d5-bc54-29f8d7d7f81d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_e5d35193-90ec-4415-b62e-85a4f2427127" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_e5d35193-90ec-4415-b62e-85a4f2427127_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_e5d35193-90ec-4415-b62e-85a4f2427127" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_e5d35193-90ec-4415-b62e-85a4f2427127_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_56516de5-36ee-4caf-b1de-5da4d5a90428" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_e5d35193-90ec-4415-b62e-85a4f2427127" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_56516de5-36ee-4caf-b1de-5da4d5a90428" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_56197768-52f5-4533-8526-2ebcbf535d06" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_56516de5-36ee-4caf-b1de-5da4d5a90428" xlink:to="loc_us-gaap_InterestExpenseMember_56197768-52f5-4533-8526-2ebcbf535d06" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_c5f4b4e2-46e3-4c0c-813e-567a3540175c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_09b557c3-8149-47d5-bc54-29f8d7d7f81d" xlink:to="loc_us-gaap_DebtInstrumentAxis_c5f4b4e2-46e3-4c0c-813e-567a3540175c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c5f4b4e2-46e3-4c0c-813e-567a3540175c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_c5f4b4e2-46e3-4c0c-813e-567a3540175c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c5f4b4e2-46e3-4c0c-813e-567a3540175c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_14c57957-0394-480c-a3b8-18700721202a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_c5f4b4e2-46e3-4c0c-813e-567a3540175c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_14c57957-0394-480c-a3b8-18700721202a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementMember_36ab725d-9e1b-4154-9ae2-f5da938d90dc" xlink:href="rdnt-20200930.xsd#rdnt_FirstLienCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_14c57957-0394-480c-a3b8-18700721202a" xlink:to="loc_rdnt_FirstLienCreditAgreementMember_36ab725d-9e1b-4154-9ae2-f5da938d90dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PaycheckProtectionProgramLoansMember_69165e32-9933-405f-b30f-501a6b0aaccb" xlink:href="rdnt-20200930.xsd#rdnt_PaycheckProtectionProgramLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_14c57957-0394-480c-a3b8-18700721202a" xlink:to="loc_rdnt_PaycheckProtectionProgramLoansMember_69165e32-9933-405f-b30f-501a6b0aaccb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_819734c0-7d4f-4be4-975d-8873a2ae461c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_09b557c3-8149-47d5-bc54-29f8d7d7f81d" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_819734c0-7d4f-4be4-975d-8873a2ae461c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_819734c0-7d4f-4be4-975d-8873a2ae461c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_819734c0-7d4f-4be4-975d-8873a2ae461c" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_819734c0-7d4f-4be4-975d-8873a2ae461c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_42406087-22d7-4d27-97bd-8625de99b60d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_819734c0-7d4f-4be4-975d-8873a2ae461c" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_42406087-22d7-4d27-97bd-8625de99b60d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_e4bf1e60-a283-4718-9b1b-312f1ad571d1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_42406087-22d7-4d27-97bd-8625de99b60d" xlink:to="loc_us-gaap_LineOfCreditMember_e4bf1e60-a283-4718-9b1b-312f1ad571d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_d78e74e7-0e45-468a-8a85-c7dee4466058" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_09b557c3-8149-47d5-bc54-29f8d7d7f81d" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_d78e74e7-0e45-468a-8a85-c7dee4466058" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_d78e74e7-0e45-468a-8a85-c7dee4466058_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_d78e74e7-0e45-468a-8a85-c7dee4466058" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_d78e74e7-0e45-468a-8a85-c7dee4466058_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_c6734171-260d-42a5-b46e-a4615783e49d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_d78e74e7-0e45-468a-8a85-c7dee4466058" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_c6734171-260d-42a5-b46e-a4615783e49d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BarclaysMember_a74a1693-0361-48d5-9678-3d2d9e6d33cd" xlink:href="rdnt-20200930.xsd#rdnt_BarclaysMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_c6734171-260d-42a5-b46e-a4615783e49d" xlink:to="loc_rdnt_BarclaysMember_a74a1693-0361-48d5-9678-3d2d9e6d33cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_c945dbc1-156c-4fff-b52f-2143f6878835" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_09b557c3-8149-47d5-bc54-29f8d7d7f81d" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_c945dbc1-156c-4fff-b52f-2143f6878835" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_c945dbc1-156c-4fff-b52f-2143f6878835_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_c945dbc1-156c-4fff-b52f-2143f6878835" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_c945dbc1-156c-4fff-b52f-2143f6878835_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_27b063ec-2505-432a-bdd5-bb2f8c140521" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_c945dbc1-156c-4fff-b52f-2143f6878835" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_27b063ec-2505-432a-bdd5-bb2f8c140521" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_COVID19PandemicMember_14da5540-44e3-4b74-87db-521a2f4bbef4" xlink:href="rdnt-20200930.xsd#rdnt_COVID19PandemicMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_27b063ec-2505-432a-bdd5-bb2f8c140521" xlink:to="loc_rdnt_COVID19PandemicMember_14da5540-44e3-4b74-87db-521a2f4bbef4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_f4d0d5fa-b7a8-418c-9d7a-39729bc7d5fc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_09b557c3-8149-47d5-bc54-29f8d7d7f81d" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_f4d0d5fa-b7a8-418c-9d7a-39729bc7d5fc" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_f4d0d5fa-b7a8-418c-9d7a-39729bc7d5fc_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_f4d0d5fa-b7a8-418c-9d7a-39729bc7d5fc" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_f4d0d5fa-b7a8-418c-9d7a-39729bc7d5fc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_e1001ba2-7212-4d36-a441-b76a0daacfea" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_f4d0d5fa-b7a8-418c-9d7a-39729bc7d5fc" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_e1001ba2-7212-4d36-a441-b76a0daacfea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_b351459c-d282-49f1-8c1d-8bbae86a3d3a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_e1001ba2-7212-4d36-a441-b76a0daacfea" xlink:to="loc_us-gaap_CommercialPaperMember_b351459c-d282-49f1-8c1d-8bbae86a3d3a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_2380ed49-46f8-42dd-9a6d-d7e1d429fcba" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_09b557c3-8149-47d5-bc54-29f8d7d7f81d" xlink:to="loc_srt_CounterpartyNameAxis_2380ed49-46f8-42dd-9a6d-d7e1d429fcba" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2380ed49-46f8-42dd-9a6d-d7e1d429fcba_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_2380ed49-46f8-42dd-9a6d-d7e1d429fcba" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2380ed49-46f8-42dd-9a6d-d7e1d429fcba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2b5fe721-7ba5-40f3-9c42-a429effec1b1" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_2380ed49-46f8-42dd-9a6d-d7e1d429fcba" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2b5fe721-7ba5-40f3-9c42-a429effec1b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DignityHealthMember_cb29ee55-fc4b-465d-a2f7-63478365cdb0" xlink:href="rdnt-20200930.xsd#rdnt_DignityHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2b5fe721-7ba5-40f3-9c42-a429effec1b1" xlink:to="loc_rdnt_DignityHealthMember_cb29ee55-fc4b-465d-a2f7-63478365cdb0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_f7d6a8b7-0d2d-4641-91d7-48bcae9e266e" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_09b557c3-8149-47d5-bc54-29f8d7d7f81d" xlink:to="loc_dei_LegalEntityAxis_f7d6a8b7-0d2d-4641-91d7-48bcae9e266e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_f7d6a8b7-0d2d-4641-91d7-48bcae9e266e_default" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_f7d6a8b7-0d2d-4641-91d7-48bcae9e266e" xlink:to="loc_dei_EntityDomain_f7d6a8b7-0d2d-4641-91d7-48bcae9e266e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_25f79581-7b39-4be3-b507-ba0920ce1422" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_f7d6a8b7-0d2d-4641-91d7-48bcae9e266e" xlink:to="loc_dei_EntityDomain_25f79581-7b39-4be3-b507-ba0920ce1422" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GlendaleAdvancedImagingMember_9fdcb289-7261-431b-a871-569cdb1ddafa" xlink:href="rdnt-20200930.xsd#rdnt_GlendaleAdvancedImagingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_25f79581-7b39-4be3-b507-ba0920ce1422" xlink:to="loc_rdnt_GlendaleAdvancedImagingMember_9fdcb289-7261-431b-a871-569cdb1ddafa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_dffe2814-333c-400b-99a1-fd31ac56934f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_09b557c3-8149-47d5-bc54-29f8d7d7f81d" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_dffe2814-333c-400b-99a1-fd31ac56934f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_dffe2814-333c-400b-99a1-fd31ac56934f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_dffe2814-333c-400b-99a1-fd31ac56934f" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_dffe2814-333c-400b-99a1-fd31ac56934f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_1ae7ef44-2c95-446a-bb8d-7faa48fa971d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_dffe2814-333c-400b-99a1-fd31ac56934f" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_1ae7ef44-2c95-446a-bb8d-7faa48fa971d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_JointVentureMember_900a8feb-3ac1-4d96-afff-0da68629a383" xlink:href="rdnt-20200930.xsd#rdnt_JointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_1ae7ef44-2c95-446a-bb8d-7faa48fa971d" xlink:to="loc_rdnt_JointVentureMember_900a8feb-3ac1-4d96-afff-0da68629a383" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_91c9f79c-8bbb-4323-82df-94f52431a5be" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_09b557c3-8149-47d5-bc54-29f8d7d7f81d" xlink:to="loc_us-gaap_CreditFacilityAxis_91c9f79c-8bbb-4323-82df-94f52431a5be" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_91c9f79c-8bbb-4323-82df-94f52431a5be_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_91c9f79c-8bbb-4323-82df-94f52431a5be" xlink:to="loc_us-gaap_CreditFacilityDomain_91c9f79c-8bbb-4323-82df-94f52431a5be_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_0c6ff73a-f5ee-40eb-aa45-19d579240147" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_91c9f79c-8bbb-4323-82df-94f52431a5be" xlink:to="loc_us-gaap_CreditFacilityDomain_0c6ff73a-f5ee-40eb-aa45-19d579240147" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_c956d5a2-4743-4a10-bc35-27fbe3065fe8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_0c6ff73a-f5ee-40eb-aa45-19d579240147" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_c956d5a2-4743-4a10-bc35-27fbe3065fe8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_68ef8327-9f5c-4283-938d-86bb71395407" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_09b557c3-8149-47d5-bc54-29f8d7d7f81d" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_68ef8327-9f5c-4283-938d-86bb71395407" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_68ef8327-9f5c-4283-938d-86bb71395407_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_68ef8327-9f5c-4283-938d-86bb71395407" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_68ef8327-9f5c-4283-938d-86bb71395407_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_7db03425-866a-46ce-a5f5-e314eec3834f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_68ef8327-9f5c-4283-938d-86bb71395407" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_7db03425-866a-46ce-a5f5-e314eec3834f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Caps2016Member_00c45fa1-ebe4-4f50-897d-140b0952b01a" xlink:href="rdnt-20200930.xsd#rdnt_Caps2016Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7db03425-866a-46ce-a5f5-e314eec3834f" xlink:to="loc_rdnt_Caps2016Member_00c45fa1-ebe4-4f50-897d-140b0952b01a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_267f1267-4436-483b-8def-78b5f42f6476" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7db03425-866a-46ce-a5f5-e314eec3834f" xlink:to="loc_us-gaap_InterestRateSwapMember_267f1267-4436-483b-8def-78b5f42f6476" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_271e1f13-aff9-4258-842d-c625dfa0778f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_09b557c3-8149-47d5-bc54-29f8d7d7f81d" xlink:to="loc_us-gaap_VariableRateAxis_271e1f13-aff9-4258-842d-c625dfa0778f" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_271e1f13-aff9-4258-842d-c625dfa0778f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_271e1f13-aff9-4258-842d-c625dfa0778f" xlink:to="loc_us-gaap_VariableRateDomain_271e1f13-aff9-4258-842d-c625dfa0778f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_43b373f5-fdc9-4f40-99dd-2095bd5bf171" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_271e1f13-aff9-4258-842d-c625dfa0778f" xlink:to="loc_us-gaap_VariableRateDomain_43b373f5-fdc9-4f40-99dd-2095bd5bf171" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_ad0d6ff5-9c08-4708-bc97-641ebc3efe89" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_43b373f5-fdc9-4f40-99dd-2095bd5bf171" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_ad0d6ff5-9c08-4708-bc97-641ebc3efe89" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_c527c853-9866-498f-85c4-ddc6a46a7136" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_09b557c3-8149-47d5-bc54-29f8d7d7f81d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_c527c853-9866-498f-85c4-ddc6a46a7136" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c527c853-9866-498f-85c4-ddc6a46a7136_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_c527c853-9866-498f-85c4-ddc6a46a7136" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c527c853-9866-498f-85c4-ddc6a46a7136_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8c2ecbd7-0a78-49a5-9abb-d458ce145460" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_c527c853-9866-498f-85c4-ddc6a46a7136" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8c2ecbd7-0a78-49a5-9abb-d458ce145460" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PropertyAndEquipmentMember_d1b919ba-101f-44bc-b5c5-1b40d2c285ac" xlink:href="rdnt-20200930.xsd#rdnt_PropertyAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8c2ecbd7-0a78-49a5-9abb-d458ce145460" xlink:to="loc_rdnt_PropertyAndEquipmentMember_d1b919ba-101f-44bc-b5c5-1b40d2c285ac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_3dfa927d-3443-44ec-885e-c44b24e7dff2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8c2ecbd7-0a78-49a5-9abb-d458ce145460" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_3dfa927d-3443-44ec-885e-c44b24e7dff2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesFinancingTransactionAxis_f7089a09-c3b8-4f20-a789-78e4f14f02bc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SecuritiesFinancingTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_09b557c3-8149-47d5-bc54-29f8d7d7f81d" xlink:to="loc_us-gaap_SecuritiesFinancingTransactionAxis_f7089a09-c3b8-4f20-a789-78e4f14f02bc" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_f7089a09-c3b8-4f20-a789-78e4f14f02bc_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SecuritiesFinancingTransactionTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionAxis_f7089a09-c3b8-4f20-a789-78e4f14f02bc" xlink:to="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_f7089a09-c3b8-4f20-a789-78e4f14f02bc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_63d17bf7-b6ca-4895-a2f1-0487727ff199" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SecuritiesFinancingTransactionTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionAxis_f7089a09-c3b8-4f20-a789-78e4f14f02bc" xlink:to="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_63d17bf7-b6ca-4895-a2f1-0487727ff199" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Caps2016Member_e66e29e7-7621-420e-9dda-20eb09c934e5" xlink:href="rdnt-20200930.xsd#rdnt_Caps2016Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_63d17bf7-b6ca-4895-a2f1-0487727ff199" xlink:to="loc_rdnt_Caps2016Member_e66e29e7-7621-420e-9dda-20eb09c934e5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A2019SWAPSMember_8401fbcb-577d-4580-9fab-0e2808830694" xlink:href="rdnt-20200930.xsd#rdnt_A2019SWAPSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_63d17bf7-b6ca-4895-a2f1-0487727ff199" xlink:to="loc_rdnt_A2019SWAPSMember_8401fbcb-577d-4580-9fab-0e2808830694" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A2019SWAPS1Member_a7b5b208-9207-4d54-909e-d001728af0a6" xlink:href="rdnt-20200930.xsd#rdnt_A2019SWAPS1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_63d17bf7-b6ca-4895-a2f1-0487727ff199" xlink:to="loc_rdnt_A2019SWAPS1Member_a7b5b208-9207-4d54-909e-d001728af0a6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditDerivativesByContractTypeAxis_3825c6fc-0ff6-48df-abe0-93995e61d0db" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditDerivativesByContractTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_09b557c3-8149-47d5-bc54-29f8d7d7f81d" xlink:to="loc_us-gaap_CreditDerivativesByContractTypeAxis_3825c6fc-0ff6-48df-abe0-93995e61d0db" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditDerivativesContractTypeDomain_3825c6fc-0ff6-48df-abe0-93995e61d0db_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditDerivativesContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditDerivativesByContractTypeAxis_3825c6fc-0ff6-48df-abe0-93995e61d0db" xlink:to="loc_us-gaap_CreditDerivativesContractTypeDomain_3825c6fc-0ff6-48df-abe0-93995e61d0db_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditDerivativesContractTypeDomain_3eb94d14-e45b-441f-9ea1-a9a325c14111" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditDerivativesContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditDerivativesByContractTypeAxis_3825c6fc-0ff6-48df-abe0-93995e61d0db" xlink:to="loc_us-gaap_CreditDerivativesContractTypeDomain_3eb94d14-e45b-441f-9ea1-a9a325c14111" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_September2020CapMember_5e031f29-82ec-4d33-99e1-28f23be33ed5" xlink:href="rdnt-20200930.xsd#rdnt_September2020CapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditDerivativesContractTypeDomain_3eb94d14-e45b-441f-9ea1-a9a325c14111" xlink:to="loc_rdnt_September2020CapMember_5e031f29-82ec-4d33-99e1-28f23be33ed5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_October2020CapMember_2b992026-1db1-49ca-914c-4d3593aebbe3" xlink:href="rdnt-20200930.xsd#rdnt_October2020CapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditDerivativesContractTypeDomain_3eb94d14-e45b-441f-9ea1-a9a325c14111" xlink:to="loc_rdnt_October2020CapMember_2b992026-1db1-49ca-914c-4d3593aebbe3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_October2023Member_c571753f-e92f-44d6-a956-16afeeeac041" xlink:href="rdnt-20200930.xsd#rdnt_October2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditDerivativesContractTypeDomain_3eb94d14-e45b-441f-9ea1-a9a325c14111" xlink:to="loc_rdnt_October2023Member_c571753f-e92f-44d6-a956-16afeeeac041" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_October2025Member_7bc47835-9b40-4313-88a9-eaf671214aca" xlink:href="rdnt-20200930.xsd#rdnt_October2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditDerivativesContractTypeDomain_3eb94d14-e45b-441f-9ea1-a9a325c14111" xlink:to="loc_rdnt_October2025Member_7bc47835-9b40-4313-88a9-eaf671214aca" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_abc1cf02-32d5-4c52-8dc0-074a70023d44" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_09b557c3-8149-47d5-bc54-29f8d7d7f81d" xlink:to="loc_us-gaap_PlanNameAxis_abc1cf02-32d5-4c52-8dc0-074a70023d44" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_abc1cf02-32d5-4c52-8dc0-074a70023d44_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_abc1cf02-32d5-4c52-8dc0-074a70023d44" xlink:to="loc_us-gaap_PlanNameDomain_abc1cf02-32d5-4c52-8dc0-074a70023d44_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_8001dc25-1b8a-4008-adb3-c1b895695f3c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_abc1cf02-32d5-4c52-8dc0-074a70023d44" xlink:to="loc_us-gaap_PlanNameDomain_8001dc25-1b8a-4008-adb3-c1b895695f3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedPlanMember_bb83dc9f-2c35-4830-9c7a-2dfc53acb535" xlink:href="rdnt-20200930.xsd#rdnt_RestatedPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_8001dc25-1b8a-4008-adb3-c1b895695f3c" xlink:to="loc_rdnt_RestatedPlanMember_bb83dc9f-2c35-4830-9c7a-2dfc53acb535" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3464b7df-f097-4135-8d72-64c9035a3c84" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_09b557c3-8149-47d5-bc54-29f8d7d7f81d" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3464b7df-f097-4135-8d72-64c9035a3c84" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_3464b7df-f097-4135-8d72-64c9035a3c84_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3464b7df-f097-4135-8d72-64c9035a3c84" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_3464b7df-f097-4135-8d72-64c9035a3c84_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_1b9ea42b-a57b-47e1-ab00-3ae7ee042ed0" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3464b7df-f097-4135-8d72-64c9035a3c84" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_1b9ea42b-a57b-47e1-ab00-3ae7ee042ed0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthIncMember_90c7b3af-9e10-4f73-be27-12966d934544" xlink:href="rdnt-20200930.xsd#rdnt_DeepHealthIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_1b9ea42b-a57b-47e1-ab00-3ae7ee042ed0" xlink:to="loc_rdnt_DeepHealthIncMember_90c7b3af-9e10-4f73-be27-12966d934544" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicVisionMember_d4aed9cc-7784-4bbd-aefa-116f1792346d" xlink:href="rdnt-20200930.xsd#rdnt_MedicVisionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_1b9ea42b-a57b-47e1-ab00-3ae7ee042ed0" xlink:to="loc_rdnt_MedicVisionMember_d4aed9cc-7784-4bbd-aefa-116f1792346d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TurnerImagingMember_71ceaeb3-3064-43a0-bcb6-dc26fda13638" xlink:href="rdnt-20200930.xsd#rdnt_TurnerImagingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_1b9ea42b-a57b-47e1-ab00-3ae7ee042ed0" xlink:to="loc_rdnt_TurnerImagingMember_71ceaeb3-3064-43a0-bcb6-dc26fda13638" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WhiteRabbit.aiInc.Member_71ec5669-6971-4a98-841f-ffb3749b47b9" xlink:href="rdnt-20200930.xsd#rdnt_WhiteRabbit.aiInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_1b9ea42b-a57b-47e1-ab00-3ae7ee042ed0" xlink:to="loc_rdnt_WhiteRabbit.aiInc.Member_71ec5669-6971-4a98-841f-ffb3749b47b9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SantaMonicaImagingGroupLLCMember_84ea1978-04ad-4e9b-a487-a16cec37b44e" xlink:href="rdnt-20200930.xsd#rdnt_SantaMonicaImagingGroupLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_1b9ea42b-a57b-47e1-ab00-3ae7ee042ed0" xlink:to="loc_rdnt_SantaMonicaImagingGroupLLCMember_84ea1978-04ad-4e9b-a487-a16cec37b44e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_71a83108-9fb9-437c-b18c-3c7af1f91d99" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_09b557c3-8149-47d5-bc54-29f8d7d7f81d" xlink:to="loc_srt_RangeAxis_71a83108-9fb9-437c-b18c-3c7af1f91d99" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_71a83108-9fb9-437c-b18c-3c7af1f91d99_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_71a83108-9fb9-437c-b18c-3c7af1f91d99" xlink:to="loc_srt_RangeMember_71a83108-9fb9-437c-b18c-3c7af1f91d99_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7b59a605-6ae7-4502-94e2-f24ef4601c72" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_71a83108-9fb9-437c-b18c-3c7af1f91d99" xlink:to="loc_srt_RangeMember_7b59a605-6ae7-4502-94e2-f24ef4601c72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_05a701bb-9941-4f3e-ab3c-0463a992c200" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_7b59a605-6ae7-4502-94e2-f24ef4601c72" xlink:to="loc_srt_MinimumMember_05a701bb-9941-4f3e-ab3c-0463a992c200" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_acf0f434-e06c-4927-9a12-9b7686c69a24" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_7b59a605-6ae7-4502-94e2-f24ef4601c72" xlink:to="loc_srt_MaximumMember_acf0f434-e06c-4927-9a12-9b7686c69a24" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGoodwill" xlink:type="simple" xlink:href="rdnt-20200930.xsd#SIGNIFICANTACCOUNTINGPOLICIESDetailsGoodwill"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGoodwill" xlink:type="extended" id="i061df54cbeb64e24b1fd20f1f482d0cd_SIGNIFICANTACCOUNTINGPOLICIESDetailsGoodwill">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_c4d843a9-0618-4a4d-83a1-50c9ace498bf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_9182b9f3-6973-4214-a0ff-7e417149a1d2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_c4d843a9-0618-4a4d-83a1-50c9ace498bf" xlink:to="loc_us-gaap_GoodwillRollForward_9182b9f3-6973-4214-a0ff-7e417149a1d2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b1d54ca6-e154-451e-b23b-08da83bbc202" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_9182b9f3-6973-4214-a0ff-7e417149a1d2" xlink:to="loc_us-gaap_Goodwill_b1d54ca6-e154-451e-b23b-08da83bbc202" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_2b3cc900-15b5-4453-919b-de1b82f06b5d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_9182b9f3-6973-4214-a0ff-7e417149a1d2" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_2b3cc900-15b5-4453-919b-de1b82f06b5d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_400b52cf-1a78-46e3-a044-ed6b11a53011" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_a879e016-b469-4ade-8c35-5df68788e05b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_c4d843a9-0618-4a4d-83a1-50c9ace498bf" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_a879e016-b469-4ade-8c35-5df68788e05b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_489641f5-9dc5-48d9-8a7a-2be3a0610e9c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_a879e016-b469-4ade-8c35-5df68788e05b" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_489641f5-9dc5-48d9-8a7a-2be3a0610e9c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_489641f5-9dc5-48d9-8a7a-2be3a0610e9c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_489641f5-9dc5-48d9-8a7a-2be3a0610e9c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_489641f5-9dc5-48d9-8a7a-2be3a0610e9c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5f654fd7-d4b0-4f8f-8c38-d98fb6611959" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_489641f5-9dc5-48d9-8a7a-2be3a0610e9c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5f654fd7-d4b0-4f8f-8c38-d98fb6611959" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OlneyOpenMRILLCMember_e9db4548-d67a-4276-b090-01a3ac23637f" xlink:href="rdnt-20200930.xsd#rdnt_OlneyOpenMRILLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5f654fd7-d4b0-4f8f-8c38-d98fb6611959" xlink:to="loc_rdnt_OlneyOpenMRILLCMember_e9db4548-d67a-4276-b090-01a3ac23637f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MRIatWoodbridgeLLCMember_aa28d043-2e67-4e33-a729-1b008cf24f83" xlink:href="rdnt-20200930.xsd#rdnt_MRIatWoodbridgeLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5f654fd7-d4b0-4f8f-8c38-d98fb6611959" xlink:to="loc_rdnt_MRIatWoodbridgeLLCMember_aa28d043-2e67-4e33-a729-1b008cf24f83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthInc.Member_34f8ab14-2aba-43ea-8d20-9640e4a396fa" xlink:href="rdnt-20200930.xsd#rdnt_DeepHealthInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5f654fd7-d4b0-4f8f-8c38-d98fb6611959" xlink:to="loc_rdnt_DeepHealthInc.Member_34f8ab14-2aba-43ea-8d20-9640e4a396fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AZTechMember_af113a3b-d64a-4bed-9e7b-b81b9103a3ed" xlink:href="rdnt-20200930.xsd#rdnt_AZTechMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5f654fd7-d4b0-4f8f-8c38-d98fb6611959" xlink:to="loc_rdnt_AZTechMember_af113a3b-d64a-4bed-9e7b-b81b9103a3ed" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGainonDerivative" xlink:type="simple" xlink:href="rdnt-20200930.xsd#SIGNIFICANTACCOUNTINGPOLICIESDetailsGainonDerivative"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGainonDerivative" xlink:type="extended" id="i93db87e226c64e58a2d1384235e2e82a_SIGNIFICANTACCOUNTINGPOLICIESDetailsGainonDerivative">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsLineItems_0bbd80c7-e6b1-47df-ab47-f0b7adbbd508" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OffsettingAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1_3675b1a0-aa46-46a0-b59a-f9570448788d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0bbd80c7-e6b1-47df-ab47-f0b7adbbd508" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1_3675b1a0-aa46-46a0-b59a-f9570448788d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_418f3d89-7216-44d9-b4f7-f28bc33b446c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0bbd80c7-e6b1-47df-ab47-f0b7adbbd508" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_418f3d89-7216-44d9-b4f7-f28bc33b446c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_c23e361e-258f-4bc1-9902-79d63e630686" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0bbd80c7-e6b1-47df-ab47-f0b7adbbd508" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_c23e361e-258f-4bc1-9902-79d63e630686" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1_bd4dce36-336d-43a4-bef8-981d51a27466" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_d0ab3947-1f3a-4581-9e05-f52db13206aa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0bbd80c7-e6b1-47df-ab47-f0b7adbbd508" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_d0ab3947-1f3a-4581-9e05-f52db13206aa" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsTable_e84234a8-e46a-4316-952f-7da126188ee9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OffsettingAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0bbd80c7-e6b1-47df-ab47-f0b7adbbd508" xlink:to="loc_us-gaap_OffsettingAssetsTable_e84234a8-e46a-4316-952f-7da126188ee9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_e640460a-ffea-4668-a948-97d3c1038b8a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OffsettingAssetsTable_e84234a8-e46a-4316-952f-7da126188ee9" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_e640460a-ffea-4668-a948-97d3c1038b8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e640460a-ffea-4668-a948-97d3c1038b8a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e640460a-ffea-4668-a948-97d3c1038b8a" xlink:to="loc_us-gaap_EquityComponentDomain_e640460a-ffea-4668-a948-97d3c1038b8a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ab90dba3-0b61-4493-b5ac-4fba5c31667c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e640460a-ffea-4668-a948-97d3c1038b8a" xlink:to="loc_us-gaap_EquityComponentDomain_ab90dba3-0b61-4493-b5ac-4fba5c31667c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_76fe5d74-da65-452d-9070-0f44ecc20475" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ab90dba3-0b61-4493-b5ac-4fba5c31667c" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_76fe5d74-da65-452d-9070-0f44ecc20475" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_513158e1-7e5c-4482-ba11-47adb0d8ee93" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OffsettingAssetsTable_e84234a8-e46a-4316-952f-7da126188ee9" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_513158e1-7e5c-4482-ba11-47adb0d8ee93" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_513158e1-7e5c-4482-ba11-47adb0d8ee93_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_513158e1-7e5c-4482-ba11-47adb0d8ee93" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_513158e1-7e5c-4482-ba11-47adb0d8ee93_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_5c2fab3a-f432-481d-b2f3-5f1edc335b8b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_513158e1-7e5c-4482-ba11-47adb0d8ee93" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_5c2fab3a-f432-481d-b2f3-5f1edc335b8b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_fc881cfb-4917-444c-9fb4-0bf7a7c6a3b0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5c2fab3a-f432-481d-b2f3-5f1edc335b8b" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_fc881cfb-4917-444c-9fb4-0bf7a7c6a3b0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_a830e0b9-68b1-4a96-ab2b-f80ccb9b899a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5c2fab3a-f432-481d-b2f3-5f1edc335b8b" xlink:to="loc_us-gaap_InterestExpenseMember_a830e0b9-68b1-4a96-ab2b-f80ccb9b899a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_a1aad85b-1cbb-41dd-81a8-e555615860e8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OffsettingAssetsTable_e84234a8-e46a-4316-952f-7da126188ee9" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_a1aad85b-1cbb-41dd-81a8-e555615860e8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_a1aad85b-1cbb-41dd-81a8-e555615860e8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_a1aad85b-1cbb-41dd-81a8-e555615860e8" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_a1aad85b-1cbb-41dd-81a8-e555615860e8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8e5e98d5-b483-49c5-a44f-114d049d3efc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_a1aad85b-1cbb-41dd-81a8-e555615860e8" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8e5e98d5-b483-49c5-a44f-114d049d3efc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_d0453baf-0824-4c24-acea-aaa31141a6f7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8e5e98d5-b483-49c5-a44f-114d049d3efc" xlink:to="loc_us-gaap_InterestRateCapMember_d0453baf-0824-4c24-acea-aaa31141a6f7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_4c2d42af-66f6-4b80-8e13-e573f5f37798" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8e5e98d5-b483-49c5-a44f-114d049d3efc" xlink:to="loc_us-gaap_InterestRateSwapMember_4c2d42af-66f6-4b80-8e13-e573f5f37798" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsFairValueMeasurements" xlink:type="simple" xlink:href="rdnt-20200930.xsd#SUMMARYOFACCOUNTINGPOLICIESDetailsFairValueMeasurements"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsFairValueMeasurements" xlink:type="extended" id="ib5cfa5aaa4df46c1bbe15fec3df6eb02_SUMMARYOFACCOUNTINGPOLICIESDetailsFairValueMeasurements">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_4fb15017-f274-47d8-9aab-2bb33834111a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesFairValueDisclosure_38c128f5-f2e4-4493-91f1-040e17ffff42" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedLiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_4fb15017-f274-47d8-9aab-2bb33834111a" xlink:to="loc_us-gaap_AccruedLiabilitiesFairValueDisclosure_38c128f5-f2e4-4493-91f1-040e17ffff42" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_243dcc61-f9dc-4e63-8298-58033783db1d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_4fb15017-f274-47d8-9aab-2bb33834111a" xlink:to="loc_us-gaap_DebtInstrumentFairValue_243dcc61-f9dc-4e63-8298-58033783db1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_fa30263b-315e-4e1a-9884-c2f919af1549" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_4fb15017-f274-47d8-9aab-2bb33834111a" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_fa30263b-315e-4e1a-9884-c2f919af1549" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_850f3add-8f55-4e1e-9672-eb7f7f5e38a8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_fa30263b-315e-4e1a-9884-c2f919af1549" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_850f3add-8f55-4e1e-9672-eb7f7f5e38a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_850f3add-8f55-4e1e-9672-eb7f7f5e38a8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_850f3add-8f55-4e1e-9672-eb7f7f5e38a8" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_850f3add-8f55-4e1e-9672-eb7f7f5e38a8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b2c46a4f-e94c-4b53-8027-652045db4a8f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_850f3add-8f55-4e1e-9672-eb7f7f5e38a8" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b2c46a4f-e94c-4b53-8027-652045db4a8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_1a4e9ad5-9598-4ce3-8c01-98394960d651" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b2c46a4f-e94c-4b53-8027-652045db4a8f" xlink:to="loc_us-gaap_InterestRateCapMember_1a4e9ad5-9598-4ce3-8c01-98394960d651" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_fcfb7430-c061-438a-aded-991d62abfe63" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b2c46a4f-e94c-4b53-8027-652045db4a8f" xlink:to="loc_us-gaap_InterestRateSwapMember_fcfb7430-c061-438a-aded-991d62abfe63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_6dabf53a-b143-4c7e-94ae-d651f9447170" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_fa30263b-315e-4e1a-9884-c2f919af1549" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_6dabf53a-b143-4c7e-94ae-d651f9447170" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_6dabf53a-b143-4c7e-94ae-d651f9447170_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_6dabf53a-b143-4c7e-94ae-d651f9447170" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_6dabf53a-b143-4c7e-94ae-d651f9447170_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_67ef71f0-0017-4f16-b71b-e5e3519e9635" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_6dabf53a-b143-4c7e-94ae-d651f9447170" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_67ef71f0-0017-4f16-b71b-e5e3519e9635" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_cac62fd6-a846-403e-838f-4219982b503b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_67ef71f0-0017-4f16-b71b-e5e3519e9635" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_cac62fd6-a846-403e-838f-4219982b503b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_77f78860-362d-4062-88b2-8ccf702f9b31" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_67ef71f0-0017-4f16-b71b-e5e3519e9635" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_77f78860-362d-4062-88b2-8ccf702f9b31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f1302f85-10bf-4d3e-8af2-ed494ad8bc9b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_fa30263b-315e-4e1a-9884-c2f919af1549" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f1302f85-10bf-4d3e-8af2-ed494ad8bc9b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f1302f85-10bf-4d3e-8af2-ed494ad8bc9b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f1302f85-10bf-4d3e-8af2-ed494ad8bc9b" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f1302f85-10bf-4d3e-8af2-ed494ad8bc9b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5aa5a787-9051-4588-afc9-88175ed6a92a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f1302f85-10bf-4d3e-8af2-ed494ad8bc9b" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5aa5a787-9051-4588-afc9-88175ed6a92a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_40fc329b-bf75-4a0d-a683-16c716601847" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5aa5a787-9051-4588-afc9-88175ed6a92a" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_40fc329b-bf75-4a0d-a683-16c716601847" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_f866599b-8c07-489c-93c2-e3d2ba2516d5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5aa5a787-9051-4588-afc9-88175ed6a92a" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_f866599b-8c07-489c-93c2-e3d2ba2516d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_16b55450-06f8-437a-89ac-5153c868fd4c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5aa5a787-9051-4588-afc9-88175ed6a92a" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_16b55450-06f8-437a-89ac-5153c868fd4c" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsEarningsPerShare" xlink:type="simple" xlink:href="rdnt-20200930.xsd#SUMMARYOFACCOUNTINGPOLICIESDetailsEarningsPerShare"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsEarningsPerShare" xlink:type="extended" id="iff192f23720549f6bb0ee548eba9d289_SUMMARYOFACCOUNTINGPOLICIESDetailsEarningsPerShare">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_c24db88a-0f9c-4dc0-bfa0-076a8b586b17" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_65db0cb1-58fc-4fc3-a212-a1f5dedd9f0e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_c24db88a-0f9c-4dc0-bfa0-076a8b586b17" xlink:to="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_65db0cb1-58fc-4fc3-a212-a1f5dedd9f0e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_51a55ad4-449e-4a20-b23f-4e21bf4aa5d7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_65db0cb1-58fc-4fc3-a212-a1f5dedd9f0e" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_51a55ad4-449e-4a20-b23f-4e21bf4aa5d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_0fcb846b-8dab-409c-8c6f-5672f6d1c690" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_c24db88a-0f9c-4dc0-bfa0-076a8b586b17" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_0fcb846b-8dab-409c-8c6f-5672f6d1c690" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_daae44f1-8df1-4cf3-87a0-9887c106471e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_0fcb846b-8dab-409c-8c6f-5672f6d1c690" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_daae44f1-8df1-4cf3-87a0-9887c106471e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_daae44f1-8df1-4cf3-87a0-9887c106471e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_daae44f1-8df1-4cf3-87a0-9887c106471e" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_daae44f1-8df1-4cf3-87a0-9887c106471e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_01dca9e0-902f-4c7d-ba83-95a92f203ccd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_daae44f1-8df1-4cf3-87a0-9887c106471e" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_01dca9e0-902f-4c7d-ba83-95a92f203ccd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_750978af-bd30-4147-8c8f-f00715c288c7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_01dca9e0-902f-4c7d-ba83-95a92f203ccd" xlink:to="loc_us-gaap_RestrictedStockMember_750978af-bd30-4147-8c8f-f00715c288c7" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsInvestmentinJointVentures" xlink:type="simple" xlink:href="rdnt-20200930.xsd#SUMMARYOFACCOUNTINGPOLICIESDetailsInvestmentinJointVentures"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsInvestmentinJointVentures" xlink:type="extended" id="i4e5ab492eda04bebade5e3aa9bedf9c0_SUMMARYOFACCOUNTINGPOLICIESDetailsInvestmentinJointVentures"/>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures" xlink:type="simple" xlink:href="rdnt-20200930.xsd#SUMMARYOFACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures" xlink:type="extended" id="i8a07f403d46243f38bbc2bcf72db79b8_SUMMARYOFACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"/>
  <link:roleRef roleURI="http://www.radnet.com/role/RECENTACCOUNTINGANDREPORTINGSTANDARDS" xlink:type="simple" xlink:href="rdnt-20200930.xsd#RECENTACCOUNTINGANDREPORTINGSTANDARDS"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/RECENTACCOUNTINGANDREPORTINGSTANDARDS" xlink:type="extended" id="i3e11ac2108a54452983839710ee50432_RECENTACCOUNTINGANDREPORTINGSTANDARDS"/>
  <link:roleRef roleURI="http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONS" xlink:type="simple" xlink:href="rdnt-20200930.xsd#FACILITYACQUISITIONSANDDISPOSITIONS"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONS" xlink:type="extended" id="i3c4492905f8d49c2821c7ea4f65596cd_FACILITYACQUISITIONSANDDISPOSITIONS"/>
  <link:roleRef roleURI="http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONSDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20200930.xsd#FACILITYACQUISITIONSANDDISPOSITIONSDetailsNarrative"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONSDetailsNarrative" xlink:type="extended" id="i7af22a1b73b740df8e880f80f82b1daa_FACILITYACQUISITIONSANDDISPOSITIONSDetailsNarrative">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_91246272-c8fd-4ab0-89ac-4d441cee7b96" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfBusinessesAcquired_7db10d2a-1cf3-4e31-baf0-7eb9e0826b5c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NumberOfBusinessesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_91246272-c8fd-4ab0-89ac-4d441cee7b96" xlink:to="loc_us-gaap_NumberOfBusinessesAcquired_7db10d2a-1cf3-4e31-baf0-7eb9e0826b5c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_521db2db-e242-4668-aa4a-3a277f144592" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_91246272-c8fd-4ab0-89ac-4d441cee7b96" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_521db2db-e242-4668-aa4a-3a277f144592" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_74ca21fe-b1fa-4ec9-83dd-b65633231143" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_91246272-c8fd-4ab0-89ac-4d441cee7b96" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_74ca21fe-b1fa-4ec9-83dd-b65633231143" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_a19106e8-9a68-4589-80e3-43660c916c43" xlink:href="rdnt-20200930.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_91246272-c8fd-4ab0-89ac-4d441cee7b96" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_a19106e8-9a68-4589-80e3-43660c916c43" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther_6498afae-d7f7-464a-a99e-a91c72732fa5" xlink:href="rdnt-20200930.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_91246272-c8fd-4ab0-89ac-4d441cee7b96" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther_6498afae-d7f7-464a-a99e-a91c72732fa5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_fd67f64b-fb06-43eb-a87e-06d67626b214" xlink:href="rdnt-20200930.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_91246272-c8fd-4ab0-89ac-4d441cee7b96" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_fd67f64b-fb06-43eb-a87e-06d67626b214" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_66e813dc-4485-4f6f-9c06-34eda9246279" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_91246272-c8fd-4ab0-89ac-4d441cee7b96" xlink:to="loc_us-gaap_Goodwill_66e813dc-4485-4f6f-9c06-34eda9246279" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_5e7ffb56-3ddd-49d9-9499-5f0bfaa361f4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_91246272-c8fd-4ab0-89ac-4d441cee7b96" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_5e7ffb56-3ddd-49d9-9499-5f0bfaa361f4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_10cac9c7-3443-4981-809d-33c12abf9667" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_91246272-c8fd-4ab0-89ac-4d441cee7b96" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_10cac9c7-3443-4981-809d-33c12abf9667" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution_9f2122ac-565e-4331-9ae2-b4e83457fdcd" xlink:href="rdnt-20200930.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_91246272-c8fd-4ab0-89ac-4d441cee7b96" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution_9f2122ac-565e-4331-9ae2-b4e83457fdcd" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution_10e8a149-d59f-4955-961c-2066b36fd631" xlink:href="rdnt-20200930.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_91246272-c8fd-4ab0-89ac-4d441cee7b96" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution_10e8a149-d59f-4955-961c-2066b36fd631" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm_81a53a15-8166-4449-bf91-787873e1f3ea" xlink:href="rdnt-20200930.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_91246272-c8fd-4ab0-89ac-4d441cee7b96" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm_81a53a15-8166-4449-bf91-787873e1f3ea" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution_db7fcfb2-9212-403b-b04b-94d4c1d550aa" xlink:href="rdnt-20200930.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_91246272-c8fd-4ab0-89ac-4d441cee7b96" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution_db7fcfb2-9212-403b-b04b-94d4c1d550aa" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution_882fba8f-83dd-4e61-9f6e-3b1673d074c5" xlink:href="rdnt-20200930.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_91246272-c8fd-4ab0-89ac-4d441cee7b96" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution_882fba8f-83dd-4e61-9f6e-3b1673d074c5" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards_42130d62-d78c-4d18-8ae9-44c71a76efd3" xlink:href="rdnt-20200930.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_91246272-c8fd-4ab0-89ac-4d441cee7b96" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards_42130d62-d78c-4d18-8ae9-44c71a76efd3" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure_9fc5ac97-d3b7-46d3-9cff-e2ac54b30965" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_91246272-c8fd-4ab0-89ac-4d441cee7b96" xlink:to="loc_us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure_9fc5ac97-d3b7-46d3-9cff-e2ac54b30965" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_3f6abfe1-dd63-411b-a3ac-17fb2369ee5d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_91246272-c8fd-4ab0-89ac-4d441cee7b96" xlink:to="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_3f6abfe1-dd63-411b-a3ac-17fb2369ee5d" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares_b8009d13-790b-450d-8afc-de237d041003" xlink:href="rdnt-20200930.xsd#rdnt_BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_91246272-c8fd-4ab0-89ac-4d441cee7b96" xlink:to="loc_rdnt_BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares_b8009d13-790b-450d-8afc-de237d041003" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares_b328f9b7-51ef-434d-89d3-af0bd02bbb46" xlink:href="rdnt-20200930.xsd#rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_91246272-c8fd-4ab0-89ac-4d441cee7b96" xlink:to="loc_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares_b328f9b7-51ef-434d-89d3-af0bd02bbb46" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares_618e1d7d-ea21-4bcb-ab50-f44e0f867101" xlink:href="rdnt-20200930.xsd#rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_91246272-c8fd-4ab0-89ac-4d441cee7b96" xlink:to="loc_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares_618e1d7d-ea21-4bcb-ab50-f44e0f867101" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_f15daf93-5cc4-47df-8e96-2f4cb0d16067" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_91246272-c8fd-4ab0-89ac-4d441cee7b96" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_f15daf93-5cc4-47df-8e96-2f4cb0d16067" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_e6ae82dc-adc9-45cb-93e8-4ddd2ef55970" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_91246272-c8fd-4ab0-89ac-4d441cee7b96" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_e6ae82dc-adc9-45cb-93e8-4ddd2ef55970" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_c180c6a4-0e31-41ed-a58e-5c776488b3d9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_91246272-c8fd-4ab0-89ac-4d441cee7b96" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_c180c6a4-0e31-41ed-a58e-5c776488b3d9" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFinanceLeaseLiabilities_0641d8ca-4666-47eb-a89f-0984293da596" xlink:href="rdnt-20200930.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFinanceLeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_91246272-c8fd-4ab0-89ac-4d441cee7b96" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFinanceLeaseLiabilities_0641d8ca-4666-47eb-a89f-0984293da596" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture_f6b64a63-75c2-4676-a10e-d56dd3fd554c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromDivestitureOfInterestInJointVenture"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_91246272-c8fd-4ab0-89ac-4d441cee7b96" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture_f6b64a63-75c2-4676-a10e-d56dd3fd554c" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0d1125fc-2613-4a76-b5ce-7b1f25b29983" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_91246272-c8fd-4ab0-89ac-4d441cee7b96" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0d1125fc-2613-4a76-b5ce-7b1f25b29983" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_32044fa2-34cf-4f4a-a62a-be93f70a27b3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0d1125fc-2613-4a76-b5ce-7b1f25b29983" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_32044fa2-34cf-4f4a-a62a-be93f70a27b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_32044fa2-34cf-4f4a-a62a-be93f70a27b3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_32044fa2-34cf-4f4a-a62a-be93f70a27b3" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_32044fa2-34cf-4f4a-a62a-be93f70a27b3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_02e6d87e-13c5-432b-a3ca-70fbbfd62c9a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_32044fa2-34cf-4f4a-a62a-be93f70a27b3" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_02e6d87e-13c5-432b-a3ca-70fbbfd62c9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthIncMember_5928a8f2-463c-4564-bf41-3ffce14f9373" xlink:href="rdnt-20200930.xsd#rdnt_DeepHealthIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_02e6d87e-13c5-432b-a3ca-70fbbfd62c9a" xlink:to="loc_rdnt_DeepHealthIncMember_5928a8f2-463c-4564-bf41-3ffce14f9373" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AssetAcquisitionAxis_6912a104-1072-430c-b2e9-8811ab472387" xlink:href="rdnt-20200930.xsd#rdnt_AssetAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0d1125fc-2613-4a76-b5ce-7b1f25b29983" xlink:to="loc_rdnt_AssetAcquisitionAxis_6912a104-1072-430c-b2e9-8811ab472387" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AssetAcquisitionDomain_6912a104-1072-430c-b2e9-8811ab472387_default" xlink:href="rdnt-20200930.xsd#rdnt_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_rdnt_AssetAcquisitionAxis_6912a104-1072-430c-b2e9-8811ab472387" xlink:to="loc_rdnt_AssetAcquisitionDomain_6912a104-1072-430c-b2e9-8811ab472387_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AssetAcquisitionDomain_c4578a22-c342-464d-9882-3d938436013d" xlink:href="rdnt-20200930.xsd#rdnt_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_rdnt_AssetAcquisitionAxis_6912a104-1072-430c-b2e9-8811ab472387" xlink:to="loc_rdnt_AssetAcquisitionDomain_c4578a22-c342-464d-9882-3d938436013d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AZTechMember_95273eb7-afda-4ac3-961f-d6559696ae14" xlink:href="rdnt-20200930.xsd#rdnt_AZTechMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_AssetAcquisitionDomain_c4578a22-c342-464d-9882-3d938436013d" xlink:to="loc_rdnt_AZTechMember_95273eb7-afda-4ac3-961f-d6559696ae14" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MRIatWoodbridgeLLCMember_d8aaca80-f09f-4064-aceb-769ed54c06cd" xlink:href="rdnt-20200930.xsd#rdnt_MRIatWoodbridgeLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_AssetAcquisitionDomain_c4578a22-c342-464d-9882-3d938436013d" xlink:to="loc_rdnt_MRIatWoodbridgeLLCMember_d8aaca80-f09f-4064-aceb-769ed54c06cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OlneyOpenMRILLCMember_95bd682a-ae47-400c-b804-e149d71512a1" xlink:href="rdnt-20200930.xsd#rdnt_OlneyOpenMRILLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_AssetAcquisitionDomain_c4578a22-c342-464d-9882-3d938436013d" xlink:to="loc_rdnt_OlneyOpenMRILLCMember_95bd682a-ae47-400c-b804-e149d71512a1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_1124195b-e79c-4c9b-800e-093798534dc7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0d1125fc-2613-4a76-b5ce-7b1f25b29983" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_1124195b-e79c-4c9b-800e-093798534dc7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_1124195b-e79c-4c9b-800e-093798534dc7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_1124195b-e79c-4c9b-800e-093798534dc7" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_1124195b-e79c-4c9b-800e-093798534dc7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_40ec5491-226a-4753-ad79-63e1bcc24a5b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_1124195b-e79c-4c9b-800e-093798534dc7" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_40ec5491-226a-4753-ad79-63e1bcc24a5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ImagingOnCallMember_f56e22a2-b52f-4316-848e-733a9dd2a493" xlink:href="rdnt-20200930.xsd#rdnt_ImagingOnCallMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_40ec5491-226a-4753-ad79-63e1bcc24a5b" xlink:to="loc_rdnt_ImagingOnCallMember_f56e22a2-b52f-4316-848e-733a9dd2a493" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLE" xlink:type="simple" xlink:href="rdnt-20200930.xsd#CREDITFACILITYANDNOTESPAYABLE"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLE" xlink:type="extended" id="id9e7fba18edd4080a3daaecca8e7edfb_CREDITFACILITYANDNOTESPAYABLE"/>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLETables" xlink:type="simple" xlink:href="rdnt-20200930.xsd#CREDITFACILITYANDNOTESPAYABLETables"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLETables" xlink:type="extended" id="i264389e1246a46e1a0e31178cfd3a797_CREDITFACILITYANDNOTESPAYABLETables"/>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt" xlink:type="simple" xlink:href="rdnt-20200930.xsd#CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt" xlink:type="extended" id="ic6a451a0a85548dbbcb45348f0a0a28f_CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_c828e204-8609-42ed-9120-d90cc35bdcd0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_ebe5ca9d-d7b5-4554-90c2-9e6bafc58455" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c828e204-8609-42ed-9120-d90cc35bdcd0" xlink:to="loc_us-gaap_LongTermDebt_ebe5ca9d-d7b5-4554-90c2-9e6bafc58455" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_4b89bdc0-e599-4d50-8020-0ba8ea0fc337" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c828e204-8609-42ed-9120-d90cc35bdcd0" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_4b89bdc0-e599-4d50-8020-0ba8ea0fc337" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermLoansPayable_87d9b784-dd68-4c72-a250-6b88211549d0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermLoansPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c828e204-8609-42ed-9120-d90cc35bdcd0" xlink:to="loc_us-gaap_LongTermLoansPayable_87d9b784-dd68-4c72-a250-6b88211549d0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities_19c26690-ddc5-4bd1-ae41-57634deaa762" xlink:href="rdnt-20200930.xsd#rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c828e204-8609-42ed-9120-d90cc35bdcd0" xlink:to="loc_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities_19c26690-ddc5-4bd1-ae41-57634deaa762" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsCurrentMaturities_2de3ff72-5802-4dce-8a84-2ae304052295" xlink:href="rdnt-20200930.xsd#rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsCurrentMaturities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c828e204-8609-42ed-9120-d90cc35bdcd0" xlink:to="loc_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsCurrentMaturities_2de3ff72-5802-4dce-8a84-2ae304052295" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsExcludingCurrentMaturities_f201ab6d-dfae-4f59-aa84-f72d6590726b" xlink:href="rdnt-20200930.xsd#rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsExcludingCurrentMaturities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c828e204-8609-42ed-9120-d90cc35bdcd0" xlink:to="loc_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsExcludingCurrentMaturities_f201ab6d-dfae-4f59-aa84-f72d6590726b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c3278128-58c3-4186-860c-49252977019b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c828e204-8609-42ed-9120-d90cc35bdcd0" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c3278128-58c3-4186-860c-49252977019b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_969e8dfe-2a13-4393-aa96-baf8bb3b57e7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c828e204-8609-42ed-9120-d90cc35bdcd0" xlink:to="loc_us-gaap_DebtInstrumentTable_969e8dfe-2a13-4393-aa96-baf8bb3b57e7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_8421b68f-3f7e-42cc-a1bb-67d770ef6351" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_969e8dfe-2a13-4393-aa96-baf8bb3b57e7" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_8421b68f-3f7e-42cc-a1bb-67d770ef6351" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8421b68f-3f7e-42cc-a1bb-67d770ef6351_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8421b68f-3f7e-42cc-a1bb-67d770ef6351" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8421b68f-3f7e-42cc-a1bb-67d770ef6351_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8efb58a9-d9be-4360-b2e9-f42845c6868c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8421b68f-3f7e-42cc-a1bb-67d770ef6351" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8efb58a9-d9be-4360-b2e9-f42845c6868c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TermLoanMember_cf53561c-5fa8-42f0-b7d7-76f379cf5605" xlink:href="rdnt-20200930.xsd#rdnt_TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8efb58a9-d9be-4360-b2e9-f42845c6868c" xlink:to="loc_rdnt_TermLoanMember_cf53561c-5fa8-42f0-b7d7-76f379cf5605" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_b0287f9b-5815-4a4f-93e9-750ccf8ccfd7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8efb58a9-d9be-4360-b2e9-f42845c6868c" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_b0287f9b-5815-4a4f-93e9-750ccf8ccfd7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_f26f79c1-1e10-4a35-92ba-a5d264eb7c96" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_969e8dfe-2a13-4393-aa96-baf8bb3b57e7" xlink:to="loc_us-gaap_DebtInstrumentAxis_f26f79c1-1e10-4a35-92ba-a5d264eb7c96" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f26f79c1-1e10-4a35-92ba-a5d264eb7c96_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_f26f79c1-1e10-4a35-92ba-a5d264eb7c96" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f26f79c1-1e10-4a35-92ba-a5d264eb7c96_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_092a86c4-b83e-43f1-8100-62d7d34bbd23" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_f26f79c1-1e10-4a35-92ba-a5d264eb7c96" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_092a86c4-b83e-43f1-8100-62d7d34bbd23" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienTermLoanMember_eb4acd38-0ef3-4724-9ebb-ba0101978fee" xlink:href="rdnt-20200930.xsd#rdnt_FirstLienTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_092a86c4-b83e-43f1-8100-62d7d34bbd23" xlink:to="loc_rdnt_FirstLienTermLoanMember_eb4acd38-0ef3-4724-9ebb-ba0101978fee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedAgreementMember_897c95ce-fcac-4478-8262-a97aab8cb78f" xlink:href="rdnt-20200930.xsd#rdnt_RestatedAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_092a86c4-b83e-43f1-8100-62d7d34bbd23" xlink:to="loc_rdnt_RestatedAgreementMember_897c95ce-fcac-4478-8262-a97aab8cb78f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PaycheckProtectionProgramLoansMember_94f9a81e-c125-46f1-a9b6-bad7cf092fee" xlink:href="rdnt-20200930.xsd#rdnt_PaycheckProtectionProgramLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_092a86c4-b83e-43f1-8100-62d7d34bbd23" xlink:to="loc_rdnt_PaycheckProtectionProgramLoansMember_94f9a81e-c125-46f1-a9b6-bad7cf092fee" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20200930.xsd#CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative" xlink:type="extended" id="id731f60bbc8143bf970b88a4a0f343e2_CREDITFACILITYANDNOTESPAYABLEDetailsNarrative">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_3e516c43-0c0a-48a3-9a3a-2654b21bf400" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_ef742759-0603-4683-a49b-d35284346107" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e516c43-0c0a-48a3-9a3a-2654b21bf400" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_ef742759-0603-4683-a49b-d35284346107" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_e8799081-6edf-4e60-a755-e969bf7897e9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e516c43-0c0a-48a3-9a3a-2654b21bf400" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_e8799081-6edf-4e60-a755-e969bf7897e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_07791085-fd32-45f9-a0b1-639a13e1b144" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e516c43-0c0a-48a3-9a3a-2654b21bf400" xlink:to="loc_us-gaap_LineOfCredit_07791085-fd32-45f9-a0b1-639a13e1b144" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_966fee13-1cb3-4c5b-9002-3356704b2694" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e516c43-0c0a-48a3-9a3a-2654b21bf400" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_966fee13-1cb3-4c5b-9002-3356704b2694" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_e2a0df88-e3db-44c9-9ade-3b0339d87f2e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e516c43-0c0a-48a3-9a3a-2654b21bf400" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_e2a0df88-e3db-44c9-9ade-3b0339d87f2e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_0dadd0ac-4f89-40bc-bb13-4eb63f98882a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e516c43-0c0a-48a3-9a3a-2654b21bf400" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_0dadd0ac-4f89-40bc-bb13-4eb63f98882a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_bfc7cc7d-e029-4716-9952-612fd0e7f0b2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e516c43-0c0a-48a3-9a3a-2654b21bf400" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_bfc7cc7d-e029-4716-9952-612fd0e7f0b2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_aa0e6d7e-4b0b-48d2-9d12-7b5f2f70c4ee" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e516c43-0c0a-48a3-9a3a-2654b21bf400" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_aa0e6d7e-4b0b-48d2-9d12-7b5f2f70c4ee" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_2f08e4d2-bf13-405a-b32d-0f52d36e3936" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e516c43-0c0a-48a3-9a3a-2654b21bf400" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_2f08e4d2-bf13-405a-b32d-0f52d36e3936" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_298562b8-968a-4d5f-b607-059ec74ae0a7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e516c43-0c0a-48a3-9a3a-2654b21bf400" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_298562b8-968a-4d5f-b607-059ec74ae0a7" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentPeriodicPaymentPercent_7c37ce21-a0ff-440a-8616-dfed409f0f79" xlink:href="rdnt-20200930.xsd#rdnt_DebtInstrumentPeriodicPaymentPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e516c43-0c0a-48a3-9a3a-2654b21bf400" xlink:to="loc_rdnt_DebtInstrumentPeriodicPaymentPercent_7c37ce21-a0ff-440a-8616-dfed409f0f79" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease_087c59a7-984c-43a4-85a6-3f9792b876ef" xlink:href="rdnt-20200930.xsd#rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e516c43-0c0a-48a3-9a3a-2654b21bf400" xlink:to="loc_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease_087c59a7-984c-43a4-85a6-3f9792b876ef" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_b38f4620-4825-4981-8954-d0ff7a8f3e05" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e516c43-0c0a-48a3-9a3a-2654b21bf400" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_b38f4620-4825-4981-8954-d0ff7a8f3e05" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_12d246b0-d15f-4465-8635-bf07304fd063" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e516c43-0c0a-48a3-9a3a-2654b21bf400" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_12d246b0-d15f-4465-8635-bf07304fd063" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity_956082a4-f3ef-48ff-861e-d66e0060b3cc" xlink:href="rdnt-20200930.xsd#rdnt_LineofCreditFacilityIncreaseBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e516c43-0c0a-48a3-9a3a-2654b21bf400" xlink:to="loc_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity_956082a4-f3ef-48ff-861e-d66e0060b3cc" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_757c2203-0b0e-4bda-b11f-e387a693eca8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e516c43-0c0a-48a3-9a3a-2654b21bf400" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_757c2203-0b0e-4bda-b11f-e387a693eca8" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountCurrent_30f822ae-ca54-41e5-a6ff-ef3fdcbbb831" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e516c43-0c0a-48a3-9a3a-2654b21bf400" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountCurrent_30f822ae-ca54-41e5-a6ff-ef3fdcbbb831" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredCharges_92b437ee-bc43-4f0c-be74-80f831ae9f2a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfDeferredCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e516c43-0c0a-48a3-9a3a-2654b21bf400" xlink:to="loc_us-gaap_AmortizationOfDeferredCharges_92b437ee-bc43-4f0c-be74-80f831ae9f2a" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_6eb06406-7c9c-42b9-9e4d-5979985589cb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e516c43-0c0a-48a3-9a3a-2654b21bf400" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_6eb06406-7c9c-42b9-9e4d-5979985589cb" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_44786cc1-261b-4cc0-9f03-7afc34d3a6e3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e516c43-0c0a-48a3-9a3a-2654b21bf400" xlink:to="loc_us-gaap_DebtInstrumentTerm_44786cc1-261b-4cc0-9f03-7afc34d3a6e3" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentNumberofLoansReceived_9a6330ff-fdcc-48a1-9517-c1c429058cf4" xlink:href="rdnt-20200930.xsd#rdnt_DebtInstrumentNumberofLoansReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e516c43-0c0a-48a3-9a3a-2654b21bf400" xlink:to="loc_rdnt_DebtInstrumentNumberofLoansReceived_9a6330ff-fdcc-48a1-9517-c1c429058cf4" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_60cc0524-1824-4819-be75-3662b2826dde" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e516c43-0c0a-48a3-9a3a-2654b21bf400" xlink:to="loc_us-gaap_DebtInstrumentTable_60cc0524-1824-4819-be75-3662b2826dde" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_1f7e8f18-3a0e-4589-bc32-8ee1d72233d8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_60cc0524-1824-4819-be75-3662b2826dde" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_1f7e8f18-3a0e-4589-bc32-8ee1d72233d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_1f7e8f18-3a0e-4589-bc32-8ee1d72233d8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_1f7e8f18-3a0e-4589-bc32-8ee1d72233d8" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_1f7e8f18-3a0e-4589-bc32-8ee1d72233d8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_ca19f81f-5de1-43f1-b9db-37757b7fabbf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_1f7e8f18-3a0e-4589-bc32-8ee1d72233d8" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_ca19f81f-5de1-43f1-b9db-37757b7fabbf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_COVID19PandemicMember_b2b106b9-d2ce-4707-90b1-137bad7f562d" xlink:href="rdnt-20200930.xsd#rdnt_COVID19PandemicMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_ca19f81f-5de1-43f1-b9db-37757b7fabbf" xlink:to="loc_rdnt_COVID19PandemicMember_b2b106b9-d2ce-4707-90b1-137bad7f562d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_5c6166f1-7b03-4397-a8e8-08e56a206141" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_60cc0524-1824-4819-be75-3662b2826dde" xlink:to="loc_us-gaap_VariableRateAxis_5c6166f1-7b03-4397-a8e8-08e56a206141" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_5c6166f1-7b03-4397-a8e8-08e56a206141_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_5c6166f1-7b03-4397-a8e8-08e56a206141" xlink:to="loc_us-gaap_VariableRateDomain_5c6166f1-7b03-4397-a8e8-08e56a206141_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_d34b236c-f642-46be-b470-6ee396d9671d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_5c6166f1-7b03-4397-a8e8-08e56a206141" xlink:to="loc_us-gaap_VariableRateDomain_d34b236c-f642-46be-b470-6ee396d9671d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember_ff277473-8b2f-437f-ae49-6922e3b39a04" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EurodollarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_d34b236c-f642-46be-b470-6ee396d9671d" xlink:to="loc_us-gaap_EurodollarMember_ff277473-8b2f-437f-ae49-6922e3b39a04" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_2760a6ac-6636-46f8-8958-906a629cd9b1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_d34b236c-f642-46be-b470-6ee396d9671d" xlink:to="loc_us-gaap_BaseRateMember_2760a6ac-6636-46f8-8958-906a629cd9b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioAxis_d3f1ae14-3e4a-4e98-afb9-4070c8db3b5c" xlink:href="rdnt-20200930.xsd#rdnt_LeverageRatioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_60cc0524-1824-4819-be75-3662b2826dde" xlink:to="loc_rdnt_LeverageRatioAxis_d3f1ae14-3e4a-4e98-afb9-4070c8db3b5c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_d3f1ae14-3e4a-4e98-afb9-4070c8db3b5c_default" xlink:href="rdnt-20200930.xsd#rdnt_LeverageRatioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_rdnt_LeverageRatioAxis_d3f1ae14-3e4a-4e98-afb9-4070c8db3b5c" xlink:to="loc_rdnt_LeverageRatioDomain_d3f1ae14-3e4a-4e98-afb9-4070c8db3b5c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_091623a6-f096-46a5-9dc1-6255263f7fb9" xlink:href="rdnt-20200930.xsd#rdnt_LeverageRatioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_rdnt_LeverageRatioAxis_d3f1ae14-3e4a-4e98-afb9-4070c8db3b5c" xlink:to="loc_rdnt_LeverageRatioDomain_091623a6-f096-46a5-9dc1-6255263f7fb9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioThreeMember_b338a95a-c3fc-4b1a-9627-c562659ac330" xlink:href="rdnt-20200930.xsd#rdnt_LeverageRatioThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_091623a6-f096-46a5-9dc1-6255263f7fb9" xlink:to="loc_rdnt_LeverageRatioThreeMember_b338a95a-c3fc-4b1a-9627-c562659ac330" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIIIMember_4250b806-a2d2-40d7-8a20-9e1d995f34f7" xlink:href="rdnt-20200930.xsd#rdnt_PricingLevelIIIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_091623a6-f096-46a5-9dc1-6255263f7fb9" xlink:to="loc_rdnt_PricingLevelIIIMember_4250b806-a2d2-40d7-8a20-9e1d995f34f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_9bd56799-3783-484f-897a-3320cafad3e9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_60cc0524-1824-4819-be75-3662b2826dde" xlink:to="loc_us-gaap_DebtInstrumentAxis_9bd56799-3783-484f-897a-3320cafad3e9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9bd56799-3783-484f-897a-3320cafad3e9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_9bd56799-3783-484f-897a-3320cafad3e9" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9bd56799-3783-484f-897a-3320cafad3e9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_55db966f-b5d8-43f9-bb24-9c348565412e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_9bd56799-3783-484f-897a-3320cafad3e9" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_55db966f-b5d8-43f9-bb24-9c348565412e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienTermLoanMember_3f5696cc-b142-44b8-9012-bca812659299" xlink:href="rdnt-20200930.xsd#rdnt_FirstLienTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_55db966f-b5d8-43f9-bb24-9c348565412e" xlink:to="loc_rdnt_FirstLienTermLoanMember_3f5696cc-b142-44b8-9012-bca812659299" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedAgreementMember_abc01169-ec01-46b3-b759-0a7ecd28f6c3" xlink:href="rdnt-20200930.xsd#rdnt_RestatedAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_55db966f-b5d8-43f9-bb24-9c348565412e" xlink:to="loc_rdnt_RestatedAgreementMember_abc01169-ec01-46b3-b759-0a7ecd28f6c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementMember_3b5a6094-702a-4ce4-8194-f0f940909c40" xlink:href="rdnt-20200930.xsd#rdnt_FirstLienCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_55db966f-b5d8-43f9-bb24-9c348565412e" xlink:to="loc_rdnt_FirstLienCreditAgreementMember_3b5a6094-702a-4ce4-8194-f0f940909c40" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementEighthAmendmentMember_786f2195-889d-403b-a293-f83e7e3f83b8" xlink:href="rdnt-20200930.xsd#rdnt_FirstLienCreditAgreementEighthAmendmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_55db966f-b5d8-43f9-bb24-9c348565412e" xlink:to="loc_rdnt_FirstLienCreditAgreementEighthAmendmentMember_786f2195-889d-403b-a293-f83e7e3f83b8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember_6aef1cf8-8913-4b01-97e1-6ca58814d167" xlink:href="rdnt-20200930.xsd#rdnt_FirstLienCreditAgreementSixthAmendmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_55db966f-b5d8-43f9-bb24-9c348565412e" xlink:to="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember_6aef1cf8-8913-4b01-97e1-6ca58814d167" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PaycheckProtectionProgramLoansMember_749f6bad-a262-47a7-8d00-e3d0d12a7eb4" xlink:href="rdnt-20200930.xsd#rdnt_PaycheckProtectionProgramLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_55db966f-b5d8-43f9-bb24-9c348565412e" xlink:to="loc_rdnt_PaycheckProtectionProgramLoansMember_749f6bad-a262-47a7-8d00-e3d0d12a7eb4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_618279d9-b441-48e8-a5e3-556cd6755ad2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_60cc0524-1824-4819-be75-3662b2826dde" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_618279d9-b441-48e8-a5e3-556cd6755ad2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_618279d9-b441-48e8-a5e3-556cd6755ad2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_618279d9-b441-48e8-a5e3-556cd6755ad2" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_618279d9-b441-48e8-a5e3-556cd6755ad2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_da62dbb1-9a42-4975-aa31-7850bb055a51" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_618279d9-b441-48e8-a5e3-556cd6755ad2" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_da62dbb1-9a42-4975-aa31-7850bb055a51" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BarclaysMember_0c5c0a32-552f-4c11-a984-72a658328f93" xlink:href="rdnt-20200930.xsd#rdnt_BarclaysMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_da62dbb1-9a42-4975-aa31-7850bb055a51" xlink:to="loc_rdnt_BarclaysMember_0c5c0a32-552f-4c11-a984-72a658328f93" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SunTrustMember_7ef5c0d1-db50-401b-bb54-62e51ef9b594" xlink:href="rdnt-20200930.xsd#rdnt_SunTrustMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_da62dbb1-9a42-4975-aa31-7850bb055a51" xlink:to="loc_rdnt_SunTrustMember_7ef5c0d1-db50-401b-bb54-62e51ef9b594" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_e73cbbc8-123f-4249-bb53-c9058166bff2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_60cc0524-1824-4819-be75-3662b2826dde" xlink:to="loc_us-gaap_CreditFacilityAxis_e73cbbc8-123f-4249-bb53-c9058166bff2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_e73cbbc8-123f-4249-bb53-c9058166bff2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_e73cbbc8-123f-4249-bb53-c9058166bff2" xlink:to="loc_us-gaap_CreditFacilityDomain_e73cbbc8-123f-4249-bb53-c9058166bff2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_9d0f7aca-cb3a-477b-8988-8de03f31313a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_e73cbbc8-123f-4249-bb53-c9058166bff2" xlink:to="loc_us-gaap_CreditFacilityDomain_9d0f7aca-cb3a-477b-8988-8de03f31313a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_700c59b2-6bfe-484b-9eef-1147542c2f45" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_9d0f7aca-cb3a-477b-8988-8de03f31313a" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_700c59b2-6bfe-484b-9eef-1147542c2f45" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_740e606a-147f-41e1-842d-226c90df2c7d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_60cc0524-1824-4819-be75-3662b2826dde" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_740e606a-147f-41e1-842d-226c90df2c7d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_740e606a-147f-41e1-842d-226c90df2c7d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_740e606a-147f-41e1-842d-226c90df2c7d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_740e606a-147f-41e1-842d-226c90df2c7d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_59ef52f7-234b-4794-83b6-3a9462098c40" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_740e606a-147f-41e1-842d-226c90df2c7d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_59ef52f7-234b-4794-83b6-3a9462098c40" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TermLoanMember_5da3cba6-f34d-4cf8-befa-c36d9b5ce708" xlink:href="rdnt-20200930.xsd#rdnt_TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_59ef52f7-234b-4794-83b6-3a9462098c40" xlink:to="loc_rdnt_TermLoanMember_5da3cba6-f34d-4cf8-befa-c36d9b5ce708" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienTermLoansAMember_029eeed5-1ae2-42ce-a464-1b0fb545a6a7" xlink:href="rdnt-20200930.xsd#rdnt_FirstLienTermLoansAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_59ef52f7-234b-4794-83b6-3a9462098c40" xlink:to="loc_rdnt_FirstLienTermLoansAMember_029eeed5-1ae2-42ce-a464-1b0fb545a6a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_cdd1a4cf-5125-487b-8ef7-cc67ca58fbed" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_59ef52f7-234b-4794-83b6-3a9462098c40" xlink:to="loc_us-gaap_LineOfCreditMember_cdd1a4cf-5125-487b-8ef7-cc67ca58fbed" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_c08c039d-69e4-4cc1-a7e8-0b7e358461f7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_59ef52f7-234b-4794-83b6-3a9462098c40" xlink:to="loc_us-gaap_LetterOfCreditMember_c08c039d-69e4-4cc1-a7e8-0b7e358461f7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember_ecfafcb8-16fc-43f5-9772-21397a501678" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MediumTermNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_59ef52f7-234b-4794-83b6-3a9462098c40" xlink:to="loc_us-gaap_MediumTermNotesMember_ecfafcb8-16fc-43f5-9772-21397a501678" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementSeventhAmendmentMember_7e9a98b1-1c85-4d80-b8c4-3e8f0abb4a09" xlink:href="rdnt-20200930.xsd#rdnt_FirstLienCreditAgreementSeventhAmendmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_59ef52f7-234b-4794-83b6-3a9462098c40" xlink:to="loc_rdnt_FirstLienCreditAgreementSeventhAmendmentMember_7e9a98b1-1c85-4d80-b8c4-3e8f0abb4a09" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsTermLoans" xlink:type="simple" xlink:href="rdnt-20200930.xsd#CREDITFACILITYANDNOTESPAYABLEDetailsTermLoans"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsTermLoans" xlink:type="extended" id="i87314b4d5c764f8aaf975a49d911c822_CREDITFACILITYANDNOTESPAYABLEDetailsTermLoans">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_74bff9b9-0252-4352-9910-a71e92beb86e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_613c081d-d7b8-4ba5-bcba-3c9a0de44684" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_74bff9b9-0252-4352-9910-a71e92beb86e" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_613c081d-d7b8-4ba5-bcba-3c9a0de44684" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_d370672f-e642-497a-a28d-36296511f127" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_74bff9b9-0252-4352-9910-a71e92beb86e" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_d370672f-e642-497a-a28d-36296511f127" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_46d4d1eb-d4c1-420f-a0fe-96d757a0aac4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_74bff9b9-0252-4352-9910-a71e92beb86e" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_46d4d1eb-d4c1-420f-a0fe-96d757a0aac4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_f310db50-54f9-409c-badc-69e626fffcf7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_74bff9b9-0252-4352-9910-a71e92beb86e" xlink:to="loc_us-gaap_DebtInstrumentTable_f310db50-54f9-409c-badc-69e626fffcf7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_8249f60d-444d-4c31-acbc-c6f5b9ecca33" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f310db50-54f9-409c-badc-69e626fffcf7" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_8249f60d-444d-4c31-acbc-c6f5b9ecca33" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8249f60d-444d-4c31-acbc-c6f5b9ecca33_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8249f60d-444d-4c31-acbc-c6f5b9ecca33" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8249f60d-444d-4c31-acbc-c6f5b9ecca33_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_124af8d6-ddd9-4a7f-90be-0f773a7fd8a8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8249f60d-444d-4c31-acbc-c6f5b9ecca33" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_124af8d6-ddd9-4a7f-90be-0f773a7fd8a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TermLoanMember_85085211-ebf9-4a2f-82b0-fcb4921f1c34" xlink:href="rdnt-20200930.xsd#rdnt_TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_124af8d6-ddd9-4a7f-90be-0f773a7fd8a8" xlink:to="loc_rdnt_TermLoanMember_85085211-ebf9-4a2f-82b0-fcb4921f1c34" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_60e26460-2b1c-485a-bde0-d569352e1a47" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f310db50-54f9-409c-badc-69e626fffcf7" xlink:to="loc_us-gaap_DebtInstrumentAxis_60e26460-2b1c-485a-bde0-d569352e1a47" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_60e26460-2b1c-485a-bde0-d569352e1a47_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_60e26460-2b1c-485a-bde0-d569352e1a47" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_60e26460-2b1c-485a-bde0-d569352e1a47_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_75020e28-5d48-421a-bed0-c27dcce329a2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_60e26460-2b1c-485a-bde0-d569352e1a47" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_75020e28-5d48-421a-bed0-c27dcce329a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienTermLoanMember_86307544-8fc1-4963-a818-96d46fdd369a" xlink:href="rdnt-20200930.xsd#rdnt_FirstLienTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_75020e28-5d48-421a-bed0-c27dcce329a2" xlink:to="loc_rdnt_FirstLienTermLoanMember_86307544-8fc1-4963-a818-96d46fdd369a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedAgreementMember_9728eda1-0411-4cfc-9ee1-b479a8eff947" xlink:href="rdnt-20200930.xsd#rdnt_RestatedAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_75020e28-5d48-421a-bed0-c27dcce329a2" xlink:to="loc_rdnt_RestatedAgreementMember_9728eda1-0411-4cfc-9ee1-b479a8eff947" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio" xlink:type="simple" xlink:href="rdnt-20200930.xsd#CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio" xlink:type="extended" id="i5fcedc9eafa94656b12b554b577d5d95_CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_1cdad959-4523-4f92-be9e-5ec242578782" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_9a7c1b74-5166-45a7-8f97-83c256fdcf3a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1cdad959-4523-4f92-be9e-5ec242578782" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_9a7c1b74-5166-45a7-8f97-83c256fdcf3a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_890b2ba9-12c2-4902-9926-27a8024008b7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1cdad959-4523-4f92-be9e-5ec242578782" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_890b2ba9-12c2-4902-9926-27a8024008b7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_669ddc30-db8b-4a08-8b60-e66e40872675" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_890b2ba9-12c2-4902-9926-27a8024008b7" xlink:to="loc_us-gaap_DebtInstrumentAxis_669ddc30-db8b-4a08-8b60-e66e40872675" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_669ddc30-db8b-4a08-8b60-e66e40872675_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_669ddc30-db8b-4a08-8b60-e66e40872675" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_669ddc30-db8b-4a08-8b60-e66e40872675_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c069ec69-fe79-418c-9090-08e25489fdf9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_669ddc30-db8b-4a08-8b60-e66e40872675" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c069ec69-fe79-418c-9090-08e25489fdf9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementMember_4ddddc84-0768-427a-b9a6-8480208ec8f1" xlink:href="rdnt-20200930.xsd#rdnt_FirstLienCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c069ec69-fe79-418c-9090-08e25489fdf9" xlink:to="loc_rdnt_FirstLienCreditAgreementMember_4ddddc84-0768-427a-b9a6-8480208ec8f1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_f3df757b-eea1-4b10-8c52-b6e00aa8356d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_890b2ba9-12c2-4902-9926-27a8024008b7" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_f3df757b-eea1-4b10-8c52-b6e00aa8356d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f3df757b-eea1-4b10-8c52-b6e00aa8356d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f3df757b-eea1-4b10-8c52-b6e00aa8356d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f3df757b-eea1-4b10-8c52-b6e00aa8356d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_57c306be-f7c3-458c-932f-748f4ac6a76b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f3df757b-eea1-4b10-8c52-b6e00aa8356d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_57c306be-f7c3-458c-932f-748f4ac6a76b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_afe36209-54d3-471a-a5a7-c93512502ca6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_57c306be-f7c3-458c-932f-748f4ac6a76b" xlink:to="loc_us-gaap_LineOfCreditMember_afe36209-54d3-471a-a5a7-c93512502ca6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_4b6800cd-8ff5-45ac-ae1b-29a0de3a9aa5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_890b2ba9-12c2-4902-9926-27a8024008b7" xlink:to="loc_us-gaap_VariableRateAxis_4b6800cd-8ff5-45ac-ae1b-29a0de3a9aa5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_4b6800cd-8ff5-45ac-ae1b-29a0de3a9aa5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_4b6800cd-8ff5-45ac-ae1b-29a0de3a9aa5" xlink:to="loc_us-gaap_VariableRateDomain_4b6800cd-8ff5-45ac-ae1b-29a0de3a9aa5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_7612a4e4-4d94-451f-a2c5-eb513694b11d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_4b6800cd-8ff5-45ac-ae1b-29a0de3a9aa5" xlink:to="loc_us-gaap_VariableRateDomain_7612a4e4-4d94-451f-a2c5-eb513694b11d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember_4173fb8c-5130-4062-8beb-6e62cdb2708c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EurodollarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_7612a4e4-4d94-451f-a2c5-eb513694b11d" xlink:to="loc_us-gaap_EurodollarMember_4173fb8c-5130-4062-8beb-6e62cdb2708c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_06c54564-c9c8-46ef-90a2-58cb7666dd11" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_7612a4e4-4d94-451f-a2c5-eb513694b11d" xlink:to="loc_us-gaap_BaseRateMember_06c54564-c9c8-46ef-90a2-58cb7666dd11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioAxis_1f82eb05-9239-45b6-82b3-3c8b06c35cfe" xlink:href="rdnt-20200930.xsd#rdnt_LeverageRatioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_890b2ba9-12c2-4902-9926-27a8024008b7" xlink:to="loc_rdnt_LeverageRatioAxis_1f82eb05-9239-45b6-82b3-3c8b06c35cfe" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_1f82eb05-9239-45b6-82b3-3c8b06c35cfe_default" xlink:href="rdnt-20200930.xsd#rdnt_LeverageRatioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_rdnt_LeverageRatioAxis_1f82eb05-9239-45b6-82b3-3c8b06c35cfe" xlink:to="loc_rdnt_LeverageRatioDomain_1f82eb05-9239-45b6-82b3-3c8b06c35cfe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_8bbcc3f6-60c7-436e-b46d-9c26dd0a18e5" xlink:href="rdnt-20200930.xsd#rdnt_LeverageRatioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_rdnt_LeverageRatioAxis_1f82eb05-9239-45b6-82b3-3c8b06c35cfe" xlink:to="loc_rdnt_LeverageRatioDomain_8bbcc3f6-60c7-436e-b46d-9c26dd0a18e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioOneMember_9fe6e0f0-6f07-46f2-b743-398670fd8b41" xlink:href="rdnt-20200930.xsd#rdnt_LeverageRatioOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_8bbcc3f6-60c7-436e-b46d-9c26dd0a18e5" xlink:to="loc_rdnt_LeverageRatioOneMember_9fe6e0f0-6f07-46f2-b743-398670fd8b41" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioTwoMember_51db5632-4a74-442e-8f16-d00b252e36e0" xlink:href="rdnt-20200930.xsd#rdnt_LeverageRatioTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_8bbcc3f6-60c7-436e-b46d-9c26dd0a18e5" xlink:to="loc_rdnt_LeverageRatioTwoMember_51db5632-4a74-442e-8f16-d00b252e36e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioThreeMember_2a628657-ea02-40c5-b668-dcda5a10ad56" xlink:href="rdnt-20200930.xsd#rdnt_LeverageRatioThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_8bbcc3f6-60c7-436e-b46d-9c26dd0a18e5" xlink:to="loc_rdnt_LeverageRatioThreeMember_2a628657-ea02-40c5-b668-dcda5a10ad56" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioFourMember_971470ec-8270-4020-aa20-6eb8f2c078d3" xlink:href="rdnt-20200930.xsd#rdnt_LeverageRatioFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_8bbcc3f6-60c7-436e-b46d-9c26dd0a18e5" xlink:to="loc_rdnt_LeverageRatioFourMember_971470ec-8270-4020-aa20-6eb8f2c078d3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_c1e1726d-1bfe-4176-992c-23270808f279" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_890b2ba9-12c2-4902-9926-27a8024008b7" xlink:to="loc_us-gaap_CreditFacilityAxis_c1e1726d-1bfe-4176-992c-23270808f279" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_c1e1726d-1bfe-4176-992c-23270808f279_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_c1e1726d-1bfe-4176-992c-23270808f279" xlink:to="loc_us-gaap_CreditFacilityDomain_c1e1726d-1bfe-4176-992c-23270808f279_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_2b42c8c3-8e48-4e10-a421-d2b76973caf5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_c1e1726d-1bfe-4176-992c-23270808f279" xlink:to="loc_us-gaap_CreditFacilityDomain_2b42c8c3-8e48-4e10-a421-d2b76973caf5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_08b9a6af-969a-4071-8dff-97b43d949163" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_2b42c8c3-8e48-4e10-a421-d2b76973caf5" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_08b9a6af-969a-4071-8dff-97b43d949163" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument" xlink:type="simple" xlink:href="rdnt-20200930.xsd#CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument" xlink:type="extended" id="icee7a1b1cfb247248bf2913e18b45af6_CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_bcde458f-a304-4878-a2f4-12b7a611b634" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum_e4de029a-462c-4864-83dd-5f404a7ec4d0" xlink:href="rdnt-20200930.xsd#rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bcde458f-a304-4878-a2f4-12b7a611b634" xlink:to="loc_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum_e4de029a-462c-4864-83dd-5f404a7ec4d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentCovenantLeverageRatioMaximum_a532a1c3-8df4-476f-a30c-4f33cd5e0377" xlink:href="rdnt-20200930.xsd#rdnt_DebtInstrumentCovenantLeverageRatioMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bcde458f-a304-4878-a2f4-12b7a611b634" xlink:to="loc_rdnt_DebtInstrumentCovenantLeverageRatioMaximum_a532a1c3-8df4-476f-a30c-4f33cd5e0377" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_e8195d13-4d7f-4373-a4de-d89ba121514e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bcde458f-a304-4878-a2f4-12b7a611b634" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_e8195d13-4d7f-4373-a4de-d89ba121514e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_018876b1-a05c-4cde-850b-643e99bcc0a2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bcde458f-a304-4878-a2f4-12b7a611b634" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_018876b1-a05c-4cde-850b-643e99bcc0a2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_248ebb82-fca9-4969-a584-b3e7e0ebad8c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bcde458f-a304-4878-a2f4-12b7a611b634" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_248ebb82-fca9-4969-a584-b3e7e0ebad8c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_e70dec25-fb2a-4ded-97ea-5f50e26f0bdf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bcde458f-a304-4878-a2f4-12b7a611b634" xlink:to="loc_us-gaap_DebtInstrumentTable_e70dec25-fb2a-4ded-97ea-5f50e26f0bdf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioAxis_beea9bd4-fb31-43ec-8e1f-e3c3255bbb82" xlink:href="rdnt-20200930.xsd#rdnt_LeverageRatioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e70dec25-fb2a-4ded-97ea-5f50e26f0bdf" xlink:to="loc_rdnt_LeverageRatioAxis_beea9bd4-fb31-43ec-8e1f-e3c3255bbb82" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_beea9bd4-fb31-43ec-8e1f-e3c3255bbb82_default" xlink:href="rdnt-20200930.xsd#rdnt_LeverageRatioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_rdnt_LeverageRatioAxis_beea9bd4-fb31-43ec-8e1f-e3c3255bbb82" xlink:to="loc_rdnt_LeverageRatioDomain_beea9bd4-fb31-43ec-8e1f-e3c3255bbb82_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_42ba1702-d37b-4549-883e-07fe5108cc03" xlink:href="rdnt-20200930.xsd#rdnt_LeverageRatioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_rdnt_LeverageRatioAxis_beea9bd4-fb31-43ec-8e1f-e3c3255bbb82" xlink:to="loc_rdnt_LeverageRatioDomain_42ba1702-d37b-4549-883e-07fe5108cc03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIMember_70d2c486-e473-4737-8e86-16c3cd9e8fa3" xlink:href="rdnt-20200930.xsd#rdnt_PricingLevelIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_42ba1702-d37b-4549-883e-07fe5108cc03" xlink:to="loc_rdnt_PricingLevelIMember_70d2c486-e473-4737-8e86-16c3cd9e8fa3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIIMember_f49edfc6-878b-4ce4-bf21-6c2a2c2c730b" xlink:href="rdnt-20200930.xsd#rdnt_PricingLevelIIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_42ba1702-d37b-4549-883e-07fe5108cc03" xlink:to="loc_rdnt_PricingLevelIIMember_f49edfc6-878b-4ce4-bf21-6c2a2c2c730b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIIIMember_f39fa118-94c7-4caf-9001-2e245aca6b1a" xlink:href="rdnt-20200930.xsd#rdnt_PricingLevelIIIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_42ba1702-d37b-4549-883e-07fe5108cc03" xlink:to="loc_rdnt_PricingLevelIIIMember_f39fa118-94c7-4caf-9001-2e245aca6b1a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIVMember_53fa77a2-d051-4a1c-8f49-07ce722120e3" xlink:href="rdnt-20200930.xsd#rdnt_PricingLevelIVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_42ba1702-d37b-4549-883e-07fe5108cc03" xlink:to="loc_rdnt_PricingLevelIVMember_53fa77a2-d051-4a1c-8f49-07ce722120e3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelVMember_f77c71fa-aad4-4afc-8c43-4abc1fd7b52b" xlink:href="rdnt-20200930.xsd#rdnt_PricingLevelVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_42ba1702-d37b-4549-883e-07fe5108cc03" xlink:to="loc_rdnt_PricingLevelVMember_f77c71fa-aad4-4afc-8c43-4abc1fd7b52b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_58a34415-d901-4eb1-b35c-271a85c0cf7a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e70dec25-fb2a-4ded-97ea-5f50e26f0bdf" xlink:to="loc_us-gaap_VariableRateAxis_58a34415-d901-4eb1-b35c-271a85c0cf7a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_58a34415-d901-4eb1-b35c-271a85c0cf7a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_58a34415-d901-4eb1-b35c-271a85c0cf7a" xlink:to="loc_us-gaap_VariableRateDomain_58a34415-d901-4eb1-b35c-271a85c0cf7a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_4bc03ee6-db38-4faf-a043-29b465ef2d5b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_58a34415-d901-4eb1-b35c-271a85c0cf7a" xlink:to="loc_us-gaap_VariableRateDomain_4bc03ee6-db38-4faf-a043-29b465ef2d5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember_8dc611fa-4d1b-4b3b-914f-325d9ef73cea" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EurodollarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_4bc03ee6-db38-4faf-a043-29b465ef2d5b" xlink:to="loc_us-gaap_EurodollarMember_8dc611fa-4d1b-4b3b-914f-325d9ef73cea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_eebefc6e-f64b-419c-af37-43919b0d86ff" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_4bc03ee6-db38-4faf-a043-29b465ef2d5b" xlink:to="loc_us-gaap_BaseRateMember_eebefc6e-f64b-419c-af37-43919b0d86ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_f18df39f-d0a8-4bb0-8555-4b43a0653c6f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e70dec25-fb2a-4ded-97ea-5f50e26f0bdf" xlink:to="loc_us-gaap_DebtInstrumentAxis_f18df39f-d0a8-4bb0-8555-4b43a0653c6f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f18df39f-d0a8-4bb0-8555-4b43a0653c6f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_f18df39f-d0a8-4bb0-8555-4b43a0653c6f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f18df39f-d0a8-4bb0-8555-4b43a0653c6f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_fe019b40-cad4-4c1b-8e58-bf673d3961f5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_f18df39f-d0a8-4bb0-8555-4b43a0653c6f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_fe019b40-cad4-4c1b-8e58-bf673d3961f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedAgreementMember_d3133812-0c6a-4115-bee6-34568dadf00e" xlink:href="rdnt-20200930.xsd#rdnt_RestatedAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fe019b40-cad4-4c1b-8e58-bf673d3961f5" xlink:to="loc_rdnt_RestatedAgreementMember_d3133812-0c6a-4115-bee6-34568dadf00e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_cd1e4d94-11a9-4c74-9a6f-76093ecd3261" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e70dec25-fb2a-4ded-97ea-5f50e26f0bdf" xlink:to="loc_us-gaap_CreditFacilityAxis_cd1e4d94-11a9-4c74-9a6f-76093ecd3261" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_cd1e4d94-11a9-4c74-9a6f-76093ecd3261_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_cd1e4d94-11a9-4c74-9a6f-76093ecd3261" xlink:to="loc_us-gaap_CreditFacilityDomain_cd1e4d94-11a9-4c74-9a6f-76093ecd3261_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_812e9ce0-6099-4765-8d11-5aaed70b75f9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_cd1e4d94-11a9-4c74-9a6f-76093ecd3261" xlink:to="loc_us-gaap_CreditFacilityDomain_812e9ce0-6099-4765-8d11-5aaed70b75f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_8e028af6-5135-4152-99f1-305118f412bf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_812e9ce0-6099-4765-8d11-5aaed70b75f9" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_8e028af6-5135-4152-99f1-305118f412bf" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATION" xlink:type="simple" xlink:href="rdnt-20200930.xsd#STOCKBASEDCOMPENSATION"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATION" xlink:type="extended" id="i0129a338c5da46f9a7baddbe231f6b4e_STOCKBASEDCOMPENSATION"/>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables" xlink:type="simple" xlink:href="rdnt-20200930.xsd#STOCKBASEDCOMPENSATIONTables"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables" xlink:type="extended" id="i444c04fd0e234b05ae68a9a83e085ac4_STOCKBASEDCOMPENSATIONTables"/>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20200930.xsd#STOCKBASEDCOMPENSATIONDetailsNarrative"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative" xlink:type="extended" id="i80141a0163e94a92a133452ed74d5ca7_STOCKBASEDCOMPENSATIONDetailsNarrative">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_519acb76-1f60-4bf1-9dc9-02ca2cae185f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_eb4e69f4-ae3b-44af-857b-5f99cd373e90" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_519acb76-1f60-4bf1-9dc9-02ca2cae185f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_eb4e69f4-ae3b-44af-857b-5f99cd373e90" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_e1f45dd4-3bd8-4b84-a2e6-427bf6b3f1e0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_519acb76-1f60-4bf1-9dc9-02ca2cae185f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_e1f45dd4-3bd8-4b84-a2e6-427bf6b3f1e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_1ebc930c-101f-4be6-ac5d-a047c4d6e7df" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_519acb76-1f60-4bf1-9dc9-02ca2cae185f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_1ebc930c-101f-4be6-ac5d-a047c4d6e7df" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_72f15ed1-0a23-42fb-ac28-7d5f97615246" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_519acb76-1f60-4bf1-9dc9-02ca2cae185f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_72f15ed1-0a23-42fb-ac28-7d5f97615246" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0d0f81e1-eb21-44d1-9f35-e9819342d3c8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_519acb76-1f60-4bf1-9dc9-02ca2cae185f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0d0f81e1-eb21-44d1-9f35-e9819342d3c8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_644a25af-a8ae-47e9-8616-69ece5653216" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_519acb76-1f60-4bf1-9dc9-02ca2cae185f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_644a25af-a8ae-47e9-8616-69ece5653216" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_79f472d8-68d8-446b-ab36-8dee870afe68" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_519acb76-1f60-4bf1-9dc9-02ca2cae185f" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_79f472d8-68d8-446b-ab36-8dee870afe68" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dc555b44-81f0-4667-90c0-8558e8012349" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_519acb76-1f60-4bf1-9dc9-02ca2cae185f" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dc555b44-81f0-4667-90c0-8558e8012349" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_e87de1d0-0c3b-4165-a2b5-dc8dfe715b46" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_519acb76-1f60-4bf1-9dc9-02ca2cae185f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_e87de1d0-0c3b-4165-a2b5-dc8dfe715b46" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_90fef1bc-b26b-4862-b562-f6b7f75c671a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_519acb76-1f60-4bf1-9dc9-02ca2cae185f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_90fef1bc-b26b-4862-b562-f6b7f75c671a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AwardsIssuedToDate_908bd11d-6d58-46fb-8e01-63bc0df65285" xlink:href="rdnt-20200930.xsd#rdnt_AwardsIssuedToDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_519acb76-1f60-4bf1-9dc9-02ca2cae185f" xlink:to="loc_rdnt_AwardsIssuedToDate_908bd11d-6d58-46fb-8e01-63bc0df65285" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_43cfbbf0-38af-4b73-b247-2a5907c8ee74" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_519acb76-1f60-4bf1-9dc9-02ca2cae185f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_43cfbbf0-38af-4b73-b247-2a5907c8ee74" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_280766cf-ccba-40c6-8bb2-dea1fe7c2fd8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_519acb76-1f60-4bf1-9dc9-02ca2cae185f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_280766cf-ccba-40c6-8bb2-dea1fe7c2fd8" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_4431a9c1-edc9-4d0a-b784-2eab9807bb72" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_519acb76-1f60-4bf1-9dc9-02ca2cae185f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_4431a9c1-edc9-4d0a-b784-2eab9807bb72" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance_e76cb903-a629-463f-8b02-af4e809d4bcb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_519acb76-1f60-4bf1-9dc9-02ca2cae185f" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance_e76cb903-a629-463f-8b02-af4e809d4bcb" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0c4fd2e6-ed9d-4bf7-a8fa-54edd4eb3888" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_519acb76-1f60-4bf1-9dc9-02ca2cae185f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0c4fd2e6-ed9d-4bf7-a8fa-54edd4eb3888" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_828e3c8e-6f7f-473e-a64f-8d46106a75c9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0c4fd2e6-ed9d-4bf7-a8fa-54edd4eb3888" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_828e3c8e-6f7f-473e-a64f-8d46106a75c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_828e3c8e-6f7f-473e-a64f-8d46106a75c9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_828e3c8e-6f7f-473e-a64f-8d46106a75c9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_828e3c8e-6f7f-473e-a64f-8d46106a75c9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5a036467-ccf8-43fc-8772-b7d66ea1f989" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_828e3c8e-6f7f-473e-a64f-8d46106a75c9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5a036467-ccf8-43fc-8772-b7d66ea1f989" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthIncMember_a6f25cef-d6f4-4416-93e8-a4c2b354fa54" xlink:href="rdnt-20200930.xsd#rdnt_DeepHealthIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5a036467-ccf8-43fc-8772-b7d66ea1f989" xlink:to="loc_rdnt_DeepHealthIncMember_a6f25cef-d6f4-4416-93e8-a4c2b354fa54" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_99048de6-3901-4187-b6ef-4be92b068139" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0c4fd2e6-ed9d-4bf7-a8fa-54edd4eb3888" xlink:to="loc_us-gaap_PlanNameAxis_99048de6-3901-4187-b6ef-4be92b068139" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_99048de6-3901-4187-b6ef-4be92b068139_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_99048de6-3901-4187-b6ef-4be92b068139" xlink:to="loc_us-gaap_PlanNameDomain_99048de6-3901-4187-b6ef-4be92b068139_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_207dedad-4af2-4d76-b774-73b947aea80d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_99048de6-3901-4187-b6ef-4be92b068139" xlink:to="loc_us-gaap_PlanNameDomain_207dedad-4af2-4d76-b774-73b947aea80d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedPlanMember_e9832eac-a55e-4747-a264-048d0bdccc5c" xlink:href="rdnt-20200930.xsd#rdnt_RestatedPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_207dedad-4af2-4d76-b774-73b947aea80d" xlink:to="loc_rdnt_RestatedPlanMember_e9832eac-a55e-4747-a264-048d0bdccc5c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_09594458-a078-4067-b963-3f3dfb1cc263" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0c4fd2e6-ed9d-4bf7-a8fa-54edd4eb3888" xlink:to="loc_us-gaap_AwardTypeAxis_09594458-a078-4067-b963-3f3dfb1cc263" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_09594458-a078-4067-b963-3f3dfb1cc263_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_09594458-a078-4067-b963-3f3dfb1cc263" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_09594458-a078-4067-b963-3f3dfb1cc263_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c9e90166-a6f6-4cba-9a1a-4fa8c4532f28" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_09594458-a078-4067-b963-3f3dfb1cc263" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c9e90166-a6f6-4cba-9a1a-4fa8c4532f28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_46f3b38a-525c-47ab-8654-88653a670bcd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c9e90166-a6f6-4cba-9a1a-4fa8c4532f28" xlink:to="loc_us-gaap_StockOptionMember_46f3b38a-525c-47ab-8654-88653a670bcd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_df5307cb-18df-4a59-8577-689b18d951df" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c9e90166-a6f6-4cba-9a1a-4fa8c4532f28" xlink:to="loc_us-gaap_RestrictedStockMember_df5307cb-18df-4a59-8577-689b18d951df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FutureServiceMember_945c61b6-18cf-4957-8da9-b342963c4ebc" xlink:href="rdnt-20200930.xsd#rdnt_FutureServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c9e90166-a6f6-4cba-9a1a-4fa8c4532f28" xlink:to="loc_rdnt_FutureServiceMember_945c61b6-18cf-4957-8da9-b342963c4ebc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cf48d69e-a53b-432c-af29-bf7db006e380" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0c4fd2e6-ed9d-4bf7-a8fa-54edd4eb3888" xlink:to="loc_srt_RangeAxis_cf48d69e-a53b-432c-af29-bf7db006e380" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cf48d69e-a53b-432c-af29-bf7db006e380_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_cf48d69e-a53b-432c-af29-bf7db006e380" xlink:to="loc_srt_RangeMember_cf48d69e-a53b-432c-af29-bf7db006e380_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_aa408e1f-924d-462d-942d-0d5fbce2a4e2" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_cf48d69e-a53b-432c-af29-bf7db006e380" xlink:to="loc_srt_RangeMember_aa408e1f-924d-462d-942d-0d5fbce2a4e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b6766ea3-af5f-40bd-8a4b-90b8f691cf11" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_aa408e1f-924d-462d-942d-0d5fbce2a4e2" xlink:to="loc_srt_MinimumMember_b6766ea3-af5f-40bd-8a4b-90b8f691cf11" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_25dfd513-b40f-49ec-865b-f4fa90af4d32" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_aa408e1f-924d-462d-942d-0d5fbce2a4e2" xlink:to="loc_srt_MaximumMember_25dfd513-b40f-49ec-865b-f4fa90af4d32" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants" xlink:type="simple" xlink:href="rdnt-20200930.xsd#STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants" xlink:type="extended" id="i7e0df4b31e1d4c99be99144fb7357b74_STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90ff4f25-817e-44bf-97da-4bd7dbcf70e7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_757d4913-e018-45f5-990c-90b795694660" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90ff4f25-817e-44bf-97da-4bd7dbcf70e7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_757d4913-e018-45f5-990c-90b795694660" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4253baf6-decc-4932-95e1-f9309afba26d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_757d4913-e018-45f5-990c-90b795694660" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4253baf6-decc-4932-95e1-f9309afba26d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_350a3120-133d-4d49-a285-89cc82daa716" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_757d4913-e018-45f5-990c-90b795694660" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_350a3120-133d-4d49-a285-89cc82daa716" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_5dba68c4-bca1-41d1-a5e3-0a57ef253322" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_757d4913-e018-45f5-990c-90b795694660" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_5dba68c4-bca1-41d1-a5e3-0a57ef253322" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0e33d616-b0a8-4ba2-a926-1499339b811f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_9ba67b41-7fd2-4606-834f-d6768a7ea801" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_757d4913-e018-45f5-990c-90b795694660" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_9ba67b41-7fd2-4606-834f-d6768a7ea801" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1afc894b-e022-4a0a-9c11-591a2ab4d23a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90ff4f25-817e-44bf-97da-4bd7dbcf70e7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1afc894b-e022-4a0a-9c11-591a2ab4d23a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_a9651ef4-d864-47bb-b4f8-0242e1a298ad" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1afc894b-e022-4a0a-9c11-591a2ab4d23a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_a9651ef4-d864-47bb-b4f8-0242e1a298ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_cdec4002-0fbc-4db9-a9cc-4110732a5229" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1afc894b-e022-4a0a-9c11-591a2ab4d23a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_cdec4002-0fbc-4db9-a9cc-4110732a5229" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_e42f1373-2060-42d3-884c-a61fa0ebeee4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_b999f413-4111-422e-b933-2434eaa56fd3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1afc894b-e022-4a0a-9c11-591a2ab4d23a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_b999f413-4111-422e-b933-2434eaa56fd3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WeightedAverageRemainingContractualLife_6d6ddc72-4d3b-42d3-9663-448de3f7e2e2" xlink:href="rdnt-20200930.xsd#rdnt_WeightedAverageRemainingContractualLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90ff4f25-817e-44bf-97da-4bd7dbcf70e7" xlink:to="loc_rdnt_WeightedAverageRemainingContractualLife_6d6ddc72-4d3b-42d3-9663-448de3f7e2e2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_3e841da8-8afa-40e8-9d59-b97ce7315986" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_WeightedAverageRemainingContractualLife_6d6ddc72-4d3b-42d3-9663-448de3f7e2e2" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_3e841da8-8afa-40e8-9d59-b97ce7315986" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_e2b69781-3b19-4eda-a821-1b1fbdf88496" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_WeightedAverageRemainingContractualLife_6d6ddc72-4d3b-42d3-9663-448de3f7e2e2" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_e2b69781-3b19-4eda-a821-1b1fbdf88496" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AggregateIntrinsicValue_149912d0-18b2-4a13-9990-1788237264c0" xlink:href="rdnt-20200930.xsd#rdnt_AggregateIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90ff4f25-817e-44bf-97da-4bd7dbcf70e7" xlink:to="loc_rdnt_AggregateIntrinsicValue_149912d0-18b2-4a13-9990-1788237264c0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_d16ea896-6ff1-4a12-886a-b41a7072016f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_AggregateIntrinsicValue_149912d0-18b2-4a13-9990-1788237264c0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_d16ea896-6ff1-4a12-886a-b41a7072016f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_9fa885d6-885f-4a7a-8b1f-34da8ae8b160" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_AggregateIntrinsicValue_149912d0-18b2-4a13-9990-1788237264c0" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_9fa885d6-885f-4a7a-8b1f-34da8ae8b160" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0a7af896-8cd0-4608-bc24-607b8c74fe3f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90ff4f25-817e-44bf-97da-4bd7dbcf70e7" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0a7af896-8cd0-4608-bc24-607b8c74fe3f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_f9a66748-d966-4ad8-b0fa-d31bd30ab96a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0a7af896-8cd0-4608-bc24-607b8c74fe3f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_f9a66748-d966-4ad8-b0fa-d31bd30ab96a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f9a66748-d966-4ad8-b0fa-d31bd30ab96a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f9a66748-d966-4ad8-b0fa-d31bd30ab96a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f9a66748-d966-4ad8-b0fa-d31bd30ab96a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_73e4de67-7894-4bc2-ba69-08dbd56ee415" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f9a66748-d966-4ad8-b0fa-d31bd30ab96a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_73e4de67-7894-4bc2-ba69-08dbd56ee415" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthInc.Member_df514d30-8e4f-4e92-8115-87e377cf908e" xlink:href="rdnt-20200930.xsd#rdnt_DeepHealthInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_73e4de67-7894-4bc2-ba69-08dbd56ee415" xlink:to="loc_rdnt_DeepHealthInc.Member_df514d30-8e4f-4e92-8115-87e377cf908e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_2723c8c7-fcdd-47c0-a49a-ea1209ca346f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0a7af896-8cd0-4608-bc24-607b8c74fe3f" xlink:to="loc_us-gaap_AwardTypeAxis_2723c8c7-fcdd-47c0-a49a-ea1209ca346f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2723c8c7-fcdd-47c0-a49a-ea1209ca346f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_2723c8c7-fcdd-47c0-a49a-ea1209ca346f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2723c8c7-fcdd-47c0-a49a-ea1209ca346f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3b795b62-a5e7-43f0-aded-62ca81d4382e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_2723c8c7-fcdd-47c0-a49a-ea1209ca346f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3b795b62-a5e7-43f0-aded-62ca81d4382e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_78f06794-f71b-4e2e-b6eb-d1e3eaf0f9bc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3b795b62-a5e7-43f0-aded-62ca81d4382e" xlink:to="loc_us-gaap_StockOptionMember_78f06794-f71b-4e2e-b6eb-d1e3eaf0f9bc" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs" xlink:type="simple" xlink:href="rdnt-20200930.xsd#STOCKBASEDCOMPENSATIONDetailsRSUs"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs" xlink:type="extended" id="iaaebc36be8c34aedadc79730cae4d93f_STOCKBASEDCOMPENSATIONDetailsRSUs">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9bfb894a-a670-4ba2-8eef-b1b5f83e4d46" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_72d03470-4f4f-4af0-a19d-30b4c70ce761" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9bfb894a-a670-4ba2-8eef-b1b5f83e4d46" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_72d03470-4f4f-4af0-a19d-30b4c70ce761" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_f28a3e90-f897-4f12-a593-06156dc9f1f3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_72d03470-4f4f-4af0-a19d-30b4c70ce761" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_f28a3e90-f897-4f12-a593-06156dc9f1f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_165457b5-84c0-4fb7-a9d9-4eebc4f26aac" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_72d03470-4f4f-4af0-a19d-30b4c70ce761" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_165457b5-84c0-4fb7-a9d9-4eebc4f26aac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_4a2f915a-790b-42d0-bab4-adb1345b8e84" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_72d03470-4f4f-4af0-a19d-30b4c70ce761" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_4a2f915a-790b-42d0-bab4-adb1345b8e84" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_5c0ffcaf-d58a-4bb6-bece-8cba9ae47fd5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_55d52b14-7cf3-4a25-8a47-0e00a98ecb91" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9bfb894a-a670-4ba2-8eef-b1b5f83e4d46" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_55d52b14-7cf3-4a25-8a47-0e00a98ecb91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_484b4e4b-de36-473c-886a-4f0a1ca251d6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9bfb894a-a670-4ba2-8eef-b1b5f83e4d46" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_484b4e4b-de36-473c-886a-4f0a1ca251d6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_dee5d8c3-2bc0-4d70-bcd0-9f7e04a68b6e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_484b4e4b-de36-473c-886a-4f0a1ca251d6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_dee5d8c3-2bc0-4d70-bcd0-9f7e04a68b6e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_4f84171b-382d-4ce1-9daa-4f2738427b3d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_484b4e4b-de36-473c-886a-4f0a1ca251d6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_4f84171b-382d-4ce1-9daa-4f2738427b3d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_1596c024-2ca6-4239-a6c6-2dfc98c7369e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_484b4e4b-de36-473c-886a-4f0a1ca251d6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_1596c024-2ca6-4239-a6c6-2dfc98c7369e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_e50f1bba-4111-44f2-b180-c181c480f2ae" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_60fc68e8-e80e-4e44-b60c-2c5cf294b0bc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9bfb894a-a670-4ba2-8eef-b1b5f83e4d46" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_60fc68e8-e80e-4e44-b60c-2c5cf294b0bc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6657edf6-f404-44e7-8abe-7cb10987fbf3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_60fc68e8-e80e-4e44-b60c-2c5cf294b0bc" xlink:to="loc_us-gaap_AwardTypeAxis_6657edf6-f404-44e7-8abe-7cb10987fbf3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6657edf6-f404-44e7-8abe-7cb10987fbf3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_6657edf6-f404-44e7-8abe-7cb10987fbf3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6657edf6-f404-44e7-8abe-7cb10987fbf3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_03a7946f-1464-42bc-adae-b6ffd0048714" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_6657edf6-f404-44e7-8abe-7cb10987fbf3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_03a7946f-1464-42bc-adae-b6ffd0048714" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_488b17b6-9e96-4fd7-b06e-424a1379b83c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_03a7946f-1464-42bc-adae-b6ffd0048714" xlink:to="loc_us-gaap_RestrictedStockMember_488b17b6-9e96-4fd7-b06e-424a1379b83c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUBSEQUENTEVENTS" xlink:type="simple" xlink:href="rdnt-20200930.xsd#SUBSEQUENTEVENTS"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SUBSEQUENTEVENTS" xlink:type="extended" id="i175690d6597c432fb10cb6a14247b4d4_SUBSEQUENTEVENTS"/>
  <link:roleRef roleURI="http://www.radnet.com/role/SUBSEQUENTEVENTSDetails" xlink:type="simple" xlink:href="rdnt-20200930.xsd#SUBSEQUENTEVENTSDetails"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SUBSEQUENTEVENTSDetails" xlink:type="extended" id="i4981ea71b97d4749ba1e0a05584d9fe4_SUBSEQUENTEVENTSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_d58becb8-a208-48d0-b26d-5e18edb91009" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberOfAssetsAcquired_e6900dc8-d504-478e-b66a-28dcfd818616" xlink:href="rdnt-20200930.xsd#rdnt_NumberOfAssetsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_d58becb8-a208-48d0-b26d-5e18edb91009" xlink:to="loc_rdnt_NumberOfAssetsAcquired_e6900dc8-d504-478e-b66a-28dcfd818616" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_dff00c29-2286-4f69-a53c-661bd31bc11b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_d58becb8-a208-48d0-b26d-5e18edb91009" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_dff00c29-2286-4f69-a53c-661bd31bc11b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_b466a008-7987-49c7-b73a-30bd217e9a90" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_d58becb8-a208-48d0-b26d-5e18edb91009" xlink:to="loc_us-gaap_SubsequentEventTable_b466a008-7987-49c7-b73a-30bd217e9a90" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_6987e132-df90-485b-b107-0e132d25a555" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_b466a008-7987-49c7-b73a-30bd217e9a90" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_6987e132-df90-485b-b107-0e132d25a555" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_6987e132-df90-485b-b107-0e132d25a555_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_6987e132-df90-485b-b107-0e132d25a555" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_6987e132-df90-485b-b107-0e132d25a555_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_0732e26d-56ba-4f2d-9fee-9c23b9686c4a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_6987e132-df90-485b-b107-0e132d25a555" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_0732e26d-56ba-4f2d-9fee-9c23b9686c4a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_5af1d10f-3c21-4fb0-a89d-14a73e626c38" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_0732e26d-56ba-4f2d-9fee-9c23b9686c4a" xlink:to="loc_us-gaap_SubsequentEventMember_5af1d10f-3c21-4fb0-a89d-14a73e626c38" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis_d33e7358-cf0c-4f52-864e-98f8f44f250a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_b466a008-7987-49c7-b73a-30bd217e9a90" xlink:to="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis_d33e7358-cf0c-4f52-864e-98f8f44f250a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationDomain_d33e7358-cf0c-4f52-864e-98f8f44f250a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis_d33e7358-cf0c-4f52-864e-98f8f44f250a" xlink:to="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationDomain_d33e7358-cf0c-4f52-864e-98f8f44f250a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationDomain_8a92a63c-6d50-44d3-9c80-2a3eafa865b2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis_d33e7358-cf0c-4f52-864e-98f8f44f250a" xlink:to="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationDomain_8a92a63c-6d50-44d3-9c80-2a3eafa865b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInMajorityOwnedSubsidiariesMember_9f4ceedc-fae5-4b19-8126-ab6da630601e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsInMajorityOwnedSubsidiariesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationDomain_8a92a63c-6d50-44d3-9c80-2a3eafa865b2" xlink:to="loc_us-gaap_InvestmentsInMajorityOwnedSubsidiariesMember_9f4ceedc-fae5-4b19-8126-ab6da630601e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_d9284529-4803-4536-a217-72b96fe742be" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_b466a008-7987-49c7-b73a-30bd217e9a90" xlink:to="loc_dei_LegalEntityAxis_d9284529-4803-4536-a217-72b96fe742be" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_d9284529-4803-4536-a217-72b96fe742be_default" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_d9284529-4803-4536-a217-72b96fe742be" xlink:to="loc_dei_EntityDomain_d9284529-4803-4536-a217-72b96fe742be_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_cd18f756-2fed-4bf4-9730-9429196dd3e0" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_d9284529-4803-4536-a217-72b96fe742be" xlink:to="loc_dei_EntityDomain_cd18f756-2fed-4bf4-9730-9429196dd3e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SimiValleyHospitalAndHealthServicesMember_5f9f5d18-34ff-48ec-b2cb-60b6e852aaaa" xlink:href="rdnt-20200930.xsd#rdnt_SimiValleyHospitalAndHealthServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_cd18f756-2fed-4bf4-9730-9429196dd3e0" xlink:to="loc_rdnt_SimiValleyHospitalAndHealthServicesMember_5f9f5d18-34ff-48ec-b2cb-60b6e852aaaa" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>rdnt-20200930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:57afb805-d064-496f-ad72-af37e545924d,g:a8620cad-346c-45d4-8ba0-be03bf014f2b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c02954d4-e1ee-4243-bb0c-cf8c96c34b8d_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_eab95c28-61c7-40f4-8815-d24cd0d4959d_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance, value</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_584627c9-712d-466e-8055-b21afa1aa7a7_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance, value</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ImagingOnCallMember_9831e025-2924-4852-94ca-8423c8183be3_terseLabel_en-US" xlink:label="lab_rdnt_ImagingOnCallMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Imaging On Call</link:label>
    <link:label id="lab_rdnt_ImagingOnCallMember_label_en-US" xlink:label="lab_rdnt_ImagingOnCallMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Imaging On Call [Member]</link:label>
    <link:label id="lab_rdnt_ImagingOnCallMember_documentation_en-US" xlink:label="lab_rdnt_ImagingOnCallMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Imaging On Call [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ImagingOnCallMember" xlink:href="rdnt-20200930.xsd#rdnt_ImagingOnCallMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ImagingOnCallMember" xlink:to="lab_rdnt_ImagingOnCallMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_FirstLienCreditAgreementSeventhAmendmentMember_dd22122d-92b9-4ca3-b43b-d04e1c20861b_terseLabel_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementSeventhAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement Seventh Amendment</link:label>
    <link:label id="lab_rdnt_FirstLienCreditAgreementSeventhAmendmentMember_label_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementSeventhAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement Seventh Amendment [Member]</link:label>
    <link:label id="lab_rdnt_FirstLienCreditAgreementSeventhAmendmentMember_documentation_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementSeventhAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement Seventh Amendment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementSeventhAmendmentMember" xlink:href="rdnt-20200930.xsd#rdnt_FirstLienCreditAgreementSeventhAmendmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_FirstLienCreditAgreementSeventhAmendmentMember" xlink:to="lab_rdnt_FirstLienCreditAgreementSeventhAmendmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_3cdb8b52-838b-4987-b11c-a992832df109_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional deferred finance costs on revolving loan amendment</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PricingLevelIIMember_9f31f1a4-6ab5-4624-92d7-73d363509564_terseLabel_en-US" xlink:label="lab_rdnt_PricingLevelIIMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level II</link:label>
    <link:label id="lab_rdnt_PricingLevelIIMember_label_en-US" xlink:label="lab_rdnt_PricingLevelIIMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level II [Member]</link:label>
    <link:label id="lab_rdnt_PricingLevelIIMember_documentation_en-US" xlink:label="lab_rdnt_PricingLevelIIMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level II [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIIMember" xlink:href="rdnt-20200930.xsd#rdnt_PricingLevelIIMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PricingLevelIIMember" xlink:to="lab_rdnt_PricingLevelIIMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_6d485f8e-6342-4796-bc77-6026628d1da8_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVESTMENTS IN JOINT VENTURES</link:label>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentPolicyTextBlock" xlink:to="lab_us-gaap_InvestmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_d7d96e51-1737-40be-a002-ce416ced772c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PaymentstoAcquireInterestinJointVentureAndContributionsToExistingJointVenture_abd4aaed-b160-4c57-ad33-9d8a6fe230b7_negatedLabel_en-US" xlink:label="lab_rdnt_PaymentstoAcquireInterestinJointVentureAndContributionsToExistingJointVenture" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity contributions in existing and purchase of interest in joint ventures</link:label>
    <link:label id="lab_rdnt_PaymentstoAcquireInterestinJointVentureAndContributionsToExistingJointVenture_label_en-US" xlink:label="lab_rdnt_PaymentstoAcquireInterestinJointVentureAndContributionsToExistingJointVenture" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Interest in Joint Venture And Contributions To Existing Joint Venture</link:label>
    <link:label id="lab_rdnt_PaymentstoAcquireInterestinJointVentureAndContributionsToExistingJointVenture_documentation_en-US" xlink:label="lab_rdnt_PaymentstoAcquireInterestinJointVentureAndContributionsToExistingJointVenture" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Interest in Joint Venture And Contributions To Existing Joint Venture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PaymentstoAcquireInterestinJointVentureAndContributionsToExistingJointVenture" xlink:href="rdnt-20200930.xsd#rdnt_PaymentstoAcquireInterestinJointVentureAndContributionsToExistingJointVenture"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PaymentstoAcquireInterestinJointVentureAndContributionsToExistingJointVenture" xlink:to="lab_rdnt_PaymentstoAcquireInterestinJointVentureAndContributionsToExistingJointVenture" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_4afd9b6b-a491-4851-b903-0c569d495eb3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_e974eb03-7b50-489a-a8fb-6dd52b1dab44_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total credit facilities outstanding</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_d1bb6a35-6eaf-4ed1-9666-827052b81c65_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LEASES</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_e8ff9e01-a080-40cc-9a96-aecdfe8abecf_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_a65b234f-f317-4cd6-ab07-002172a14643_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_dd4b7783-2edd-4d76-92b9-e470037c329f_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_40891156-7628-4691-a811-3605f22f6f4c_terseLabel_en-US" xlink:label="lab_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures [Roll Forward]</link:label>
    <link:label id="lab_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_label_en-US" xlink:label="lab_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures [Roll Forward]</link:label>
    <link:label id="lab_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_documentation_en-US" xlink:label="lab_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward" xlink:href="rdnt-20200930.xsd#rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward" xlink:to="lab_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_3e34dd8c-2fa4-4dbc-948e-66e652697491_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassificationOfVariableInterestEntityDomain_8af0c70d-4a2c-4262-ab35-8bb7d4734a1b_terseLabel_en-US" xlink:label="lab_us-gaap_ClassificationOfVariableInterestEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassificationOfVariableInterestEntityDomain_label_en-US" xlink:label="lab_us-gaap_ClassificationOfVariableInterestEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassificationOfVariableInterestEntityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassificationOfVariableInterestEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassificationOfVariableInterestEntityDomain" xlink:to="lab_us-gaap_ClassificationOfVariableInterestEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_16047e47-f2cd-4378-8b1c-202309e3322d_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill acquired through acquisitions</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayableCurrent_3f35f354-8443-407e-b0b5-ad8f5ebb0be9_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of notes payable</link:label>
    <link:label id="lab_us-gaap_NotesPayableCurrent_label_en-US" xlink:label="lab_us-gaap_NotesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NotesPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableCurrent" xlink:to="lab_us-gaap_NotesPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9231196d-c321-452f-9b17-b7ea35d79d6a_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_bb18f09e-6787-4bae-b063-33aa461146a7_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets_abbcaeaf-c1f6-4eee-8241-a6617228468e_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Current Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_f916c059-8a78-432e-bd92-8ac30fb254f1_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on revolving credit facility</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:to="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_7447e80f-114f-4785-8525-e2008b26358e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSA's granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution_dc301a59-6ac9-45c6-b2f4-156f9b401836_terseLabel_en-US" xlink:label="lab_rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial ownership percentage after dilution</link:label>
    <link:label id="lab_rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution_label_en-US" xlink:label="lab_rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Initial Ownership Percentage After Dilution</link:label>
    <link:label id="lab_rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution_documentation_en-US" xlink:label="lab_rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Initial Ownership Percentage After Dilution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution" xlink:href="rdnt-20200930.xsd#rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution" xlink:to="lab_rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_7ad71f55-6168-4cfb-92a3-b21e13dc49e5_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RECENT ACCOUNTING AND REPORTING STANDARDS</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_0d039c81-eb9a-44bb-946b-52bacb61871d_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSA's vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_d1c5ee4b-c8cd-46f8-9fb1-34f58b16d438_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_250b605b-fa44-4248-8394-f5d9b992abfc_verboseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total service revenue</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8d84760b-1513-42a1-b5b2-700611f87e90_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ebdd7b2a-6501-4749-a082-b1615de4baff_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of common shares used in calculating diluted net income per share (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_a2371439-d6a8-4956-9d7f-bc51a6409f7b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_6f047c2d-b373-4973-8d21-cd2be0e04728_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain" xlink:to="lab_us-gaap_ShortTermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_50bb14b2-11ec-4ba9-8d8a-0f0ed5115290_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditDerivativesContractTypeDomain_deb048b2-b2ad-4e71-afd8-906ca4e391d7_terseLabel_en-US" xlink:label="lab_us-gaap_CreditDerivativesContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Derivatives Contract Type [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditDerivativesContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_CreditDerivativesContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Derivatives Contract Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditDerivativesContractTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditDerivativesContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditDerivativesContractTypeDomain" xlink:to="lab_us-gaap_CreditDerivativesContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1308390c-5e46-4e40-99b8-b709292820a7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_11fffb19-7809-4c32-b43a-760394b73920_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Begining Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_40c52352-3e15-4e08-832a-c40ea791dcd9_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BeverlyRadiologyMedicalGroupIIIMember_8f59073d-b25f-4c43-aa9e-1798e285d7dd_terseLabel_en-US" xlink:label="lab_rdnt_BeverlyRadiologyMedicalGroupIIIMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beverly Radiology Medical Group III</link:label>
    <link:label id="lab_rdnt_BeverlyRadiologyMedicalGroupIIIMember_label_en-US" xlink:label="lab_rdnt_BeverlyRadiologyMedicalGroupIIIMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beverly Radiology Medical Group III [Member]</link:label>
    <link:label id="lab_rdnt_BeverlyRadiologyMedicalGroupIIIMember_documentation_en-US" xlink:label="lab_rdnt_BeverlyRadiologyMedicalGroupIIIMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beverly Radiology Medical Group III [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BeverlyRadiologyMedicalGroupIIIMember" xlink:href="rdnt-20200930.xsd#rdnt_BeverlyRadiologyMedicalGroupIIIMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BeverlyRadiologyMedicalGroupIIIMember" xlink:to="lab_rdnt_BeverlyRadiologyMedicalGroupIIIMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_3868c243-88fe-43e2-b939-e03bfc037cb3_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_478d577c-86df-476b-987f-c811c0dbb34c_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MediumTermNotesMember_a5588b7a-95a7-4313-be03-5a425786a789_terseLabel_en-US" xlink:label="lab_us-gaap_MediumTermNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medium-term Notes</link:label>
    <link:label id="lab_us-gaap_MediumTermNotesMember_label_en-US" xlink:label="lab_us-gaap_MediumTermNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medium-term Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MediumTermNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MediumTermNotesMember" xlink:to="lab_us-gaap_MediumTermNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_e39a9cd6-e917-47a8-9873-d9dd6511e677_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EQUITY INVESTMENTS AT FAIR VALUE</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:to="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_2c97fd49-d0ef-43d4-bafd-69aa873fc734_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR)</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b0d956d3-0c85-4912-a11b-beb0726486ce_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_85fa9936-9a88-43c8-850a-72a51c76e825_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread on variable rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_8d2a1fbe-c2fb-42b9-bc9b-83908160ea2c_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_374f7bf2-5118-469c-b42d-8c1aee1eb5a4_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BRMG and NY Groups accounts receivable</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_143b85bd-0364-46b9-955f-2fe0809c4083_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_8684693e-b11b-4016-8c77-8e51e32d3243_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_70c558ae-eab3-4caf-b87b-363a8bb2a283_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_IncreaseDecreaseinOperatingLeaseLiability_1a78d52a-e98b-4279-933f-dd20befdffef_negatedTerseLabel_en-US" xlink:label="lab_rdnt_IncreaseDecreaseinOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liability</link:label>
    <link:label id="lab_rdnt_IncreaseDecreaseinOperatingLeaseLiability_label_en-US" xlink:label="lab_rdnt_IncreaseDecreaseinOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase Decrease in Operating Lease Liability</link:label>
    <link:label id="lab_rdnt_IncreaseDecreaseinOperatingLeaseLiability_documentation_en-US" xlink:label="lab_rdnt_IncreaseDecreaseinOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase Decrease in Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IncreaseDecreaseinOperatingLeaseLiability" xlink:href="rdnt-20200930.xsd#rdnt_IncreaseDecreaseinOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_IncreaseDecreaseinOperatingLeaseLiability" xlink:to="lab_rdnt_IncreaseDecreaseinOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_bad1d855-8fe9-4396-83b8-6754de1a878a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_3fdd3859-2c84-47b0-8981-a72fe9fb35d3_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_6350fd08-d421-480f-97ec-695f925d6fc2_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_241b3456-9b89-4d67-9c95-e56034abd3a2_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_TermLoanMember_657de101-9987-4b12-9d38-e666b67904bc_terseLabel_en-US" xlink:label="lab_rdnt_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan</link:label>
    <link:label id="lab_rdnt_TermLoanMember_label_en-US" xlink:label="lab_rdnt_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TermLoanMember" xlink:href="rdnt-20200930.xsd#rdnt_TermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_TermLoanMember" xlink:to="lab_rdnt_TermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityOwnershipPercentage_a21f2584-ee6c-4f6f-bda5-a9dcafe9cc63_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable interest entity, ownership percentage</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableInterestEntityOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:to="lab_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_b6ed2dfe-8158-498a-bfdf-0ab699e8e6d9_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_cd3e7955-7647-4851-8f2e-e6881e1faf25_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_b2c6956a-ee8c-4dc9-be9c-77a85e38e01a_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CURRENT LIABILITIES</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_d633ac3c-cb26-4e6d-a689-ed00fe4dd25b_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_4a309493-bbf5-4700-a897-31faa298b664_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current finance lease liability</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_85e9da6f-e701-4f21-a1f6-7b5cbae59949_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_Medicaid1Member_0daf147c-8ed8-42bd-92e6-c4943679deb3_terseLabel_en-US" xlink:label="lab_rdnt_Medicaid1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid</link:label>
    <link:label id="lab_rdnt_Medicaid1Member_label_en-US" xlink:label="lab_rdnt_Medicaid1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid1 [Member]</link:label>
    <link:label id="lab_rdnt_Medicaid1Member_documentation_en-US" xlink:label="lab_rdnt_Medicaid1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Medicaid1Member" xlink:href="rdnt-20200930.xsd#rdnt_Medicaid1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_Medicaid1Member" xlink:to="lab_rdnt_Medicaid1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetNumberOfInstrumentsHeld_3361a83f-8181-4386-b197-cbac57071008_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetNumberOfInstrumentsHeld" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of forward interest rate cap agreements</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetNumberOfInstrumentsHeld_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetNumberOfInstrumentsHeld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Number of Instruments Held</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNumberOfInstrumentsHeld" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeAssetNumberOfInstrumentsHeld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetNumberOfInstrumentsHeld" xlink:to="lab_us-gaap_DerivativeAssetNumberOfInstrumentsHeld" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DueToAffiliateCurrent_16f07842-f532-4d13-94c1-9910e1483f6d_terseLabel_en-US" xlink:label="lab_us-gaap_DueToAffiliateCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due to affiliates</link:label>
    <link:label id="lab_us-gaap_DueToAffiliateCurrent_label_en-US" xlink:label="lab_us-gaap_DueToAffiliateCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due to Affiliate, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToAffiliateCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DueToAffiliateCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DueToAffiliateCurrent" xlink:to="lab_us-gaap_DueToAffiliateCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_OlneyOpenMRILLCMember_7cbc4162-5d4c-48a8-830e-bbdfa15e2138_terseLabel_en-US" xlink:label="lab_rdnt_OlneyOpenMRILLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Olney Open MRI, LLC</link:label>
    <link:label id="lab_rdnt_OlneyOpenMRILLCMember_label_en-US" xlink:label="lab_rdnt_OlneyOpenMRILLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Olney Open MRI, LLC [Member]</link:label>
    <link:label id="lab_rdnt_OlneyOpenMRILLCMember_documentation_en-US" xlink:label="lab_rdnt_OlneyOpenMRILLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Olney Open MRI, LLC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OlneyOpenMRILLCMember" xlink:href="rdnt-20200930.xsd#rdnt_OlneyOpenMRILLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_OlneyOpenMRILLCMember" xlink:to="lab_rdnt_OlneyOpenMRILLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_afcee03b-27f7-45c9-b1ae-11596416cb54_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Separately Recognized Transactions [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Separately Recognized Transactions [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:to="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DeepHealthInc.Member_11d62ab6-a777-4756-b9fb-7fcfddf57a3e_terseLabel_en-US" xlink:label="lab_rdnt_DeepHealthInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DeepHealth, Inc.</link:label>
    <link:label id="lab_rdnt_DeepHealthInc.Member_label_en-US" xlink:label="lab_rdnt_DeepHealthInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DeepHealth, Inc. [Member]</link:label>
    <link:label id="lab_rdnt_DeepHealthInc.Member_documentation_en-US" xlink:label="lab_rdnt_DeepHealthInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DeepHealth, Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthInc.Member" xlink:href="rdnt-20200930.xsd#rdnt_DeepHealthInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DeepHealthInc.Member" xlink:to="lab_rdnt_DeepHealthInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_RestatedAgreementMember_0b505093-cf34-40d0-aa7d-cadfcc090fae_terseLabel_en-US" xlink:label="lab_rdnt_RestatedAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SunTrust Term Loan Agreement collateralized by NJIN's tangible and intangible assets</link:label>
    <link:label id="lab_rdnt_RestatedAgreementMember_15929044-4f6f-4c26-b15b-8484c8ff1f64_verboseLabel_en-US" xlink:label="lab_rdnt_RestatedAgreementMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restated Agreement</link:label>
    <link:label id="lab_rdnt_RestatedAgreementMember_label_en-US" xlink:label="lab_rdnt_RestatedAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restated Agreement [Member]</link:label>
    <link:label id="lab_rdnt_RestatedAgreementMember_documentation_en-US" xlink:label="lab_rdnt_RestatedAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restated Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedAgreementMember" xlink:href="rdnt-20200930.xsd#rdnt_RestatedAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_RestatedAgreementMember" xlink:to="lab_rdnt_RestatedAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_704e007f-c059-41b3-b328-97941c12f9bf_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discounts on First Lien Term Loans</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_06e7020d-a535-4b22-bec8-0a3c01ea8b25_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discounts on term loans</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d2b407d6-3ab4-4b4a-817d-07ab1824f3b9_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EFFECT OF EXCHANGE RATE CHANGES ON CASH</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_ffcc63f5-da2c-4432-affb-9881e899a77d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options cancelled (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_706d41d6-8524-456a-92a2-1b30efecda78_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit facility, remaining borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_ebc826ce-0ce9-4645-aaf2-c8519ed53142_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of cash flow hedge, net of taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_7e87d457-9b72-40eb-a228-bf13d2c7380d_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of cash flow hedge, net of taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_122100f8-d161-414f-9cb0-5149f3e9f3c9_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_ac6bd460-c5d1-40a0-9a08-8d95c341bee7_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_13788c7d-df83-4a34-9fa2-2ffd957bc696_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH AND CASH EQUIVALENTS, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0c7423c3-3913-4eb7-bc89-1238b6fcc774_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH AND CASH EQUIVALENTS, end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_ec4fa0a3-f1a4-4ac3-a10f-e46bb1291aa9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentAggregateCost_ee1fb0e9-60be-4dc1-81c2-7a540146473a_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentAggregateCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate cost</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentAggregateCost_2fa78c23-1fa7-4e02-804a-0c20d72f83b6_totalLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentAggregateCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net assets</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentAggregateCost_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentAggregateCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Aggregate Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentAggregateCost" xlink:to="lab_us-gaap_EquityMethodInvestmentAggregateCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_81ef9c78-2541-443c-8651-5ce49e392217_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_21c9b0f8-0661-4393-a4ba-d6f115a2b5ef_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable shares (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_1a06511c-3d65-4a41-80e4-30791cfb36e3_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable at the end (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment_83d8fadc-9321-4f40-8b36-4ab9ffbd9bbb_terseLabel_en-US" xlink:label="lab_rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option to purchase additional equity method investment</link:label>
    <link:label id="lab_rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment_label_en-US" xlink:label="lab_rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments, Option To Purchase Additional Equity Method Investment</link:label>
    <link:label id="lab_rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment_documentation_en-US" xlink:label="lab_rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments, Option To Purchase Additional Equity Method Investment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment" xlink:href="rdnt-20200930.xsd#rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment" xlink:to="lab_rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_StockholdersEquityDeficitMember_d542193b-858d-4a8c-bd4a-f02893c4a419_terseLabel_en-US" xlink:label="lab_rdnt_StockholdersEquityDeficitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Radnet, Inc.'s Equity</link:label>
    <link:label id="lab_rdnt_StockholdersEquityDeficitMember_label_en-US" xlink:label="lab_rdnt_StockholdersEquityDeficitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Radnet, Inc.'s Equity [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_StockholdersEquityDeficitMember" xlink:href="rdnt-20200930.xsd#rdnt_StockholdersEquityDeficitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_StockholdersEquityDeficitMember" xlink:to="lab_rdnt_StockholdersEquityDeficitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_MonthlyAmortizationOfDeferredHedgeGains_60a8f693-437f-4c47-a010-348f0338a43a_terseLabel_en-US" xlink:label="lab_rdnt_MonthlyAmortizationOfDeferredHedgeGains" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Monthly amortization of deferred hedge gains</link:label>
    <link:label id="lab_rdnt_MonthlyAmortizationOfDeferredHedgeGains_label_en-US" xlink:label="lab_rdnt_MonthlyAmortizationOfDeferredHedgeGains" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Monthly Amortization Of Deferred Hedge Gains</link:label>
    <link:label id="lab_rdnt_MonthlyAmortizationOfDeferredHedgeGains_documentation_en-US" xlink:label="lab_rdnt_MonthlyAmortizationOfDeferredHedgeGains" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Monthly Amortization Of Deferred Hedge Gains</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MonthlyAmortizationOfDeferredHedgeGains" xlink:href="rdnt-20200930.xsd#rdnt_MonthlyAmortizationOfDeferredHedgeGains"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_MonthlyAmortizationOfDeferredHedgeGains" xlink:to="lab_rdnt_MonthlyAmortizationOfDeferredHedgeGains" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LeverageRatioTwoMember_8e82e126-7ceb-42a4-a0f8-c43b041c6f6d_terseLabel_en-US" xlink:label="lab_rdnt_LeverageRatioTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">&gt; 4.00x but &#8804; 5.50x</link:label>
    <link:label id="lab_rdnt_LeverageRatioTwoMember_label_en-US" xlink:label="lab_rdnt_LeverageRatioTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Two [Member]</link:label>
    <link:label id="lab_rdnt_LeverageRatioTwoMember_documentation_en-US" xlink:label="lab_rdnt_LeverageRatioTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioTwoMember" xlink:href="rdnt-20200930.xsd#rdnt_LeverageRatioTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LeverageRatioTwoMember" xlink:to="lab_rdnt_LeverageRatioTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_AZTechMember_a0967b82-cf1c-455b-936a-d98e7c132666_terseLabel_en-US" xlink:label="lab_rdnt_AZTechMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AZ Tech Radiology &amp; Open MRI, LLC</link:label>
    <link:label id="lab_rdnt_AZTechMember_label_en-US" xlink:label="lab_rdnt_AZTechMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AZ Tech [Member]</link:label>
    <link:label id="lab_rdnt_AZTechMember_documentation_en-US" xlink:label="lab_rdnt_AZTechMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AZ Tech Radiology &amp; Open MRI, LLC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AZTechMember" xlink:href="rdnt-20200930.xsd#rdnt_AZTechMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_AZTechMember" xlink:to="lab_rdnt_AZTechMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease_6fe0348f-27ff-4332-941c-c1a326a45880_terseLabel_en-US" xlink:label="lab_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Periodic payment amortization increase</link:label>
    <link:label id="lab_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease_label_en-US" xlink:label="lab_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment Terms, Amortization Increase</link:label>
    <link:label id="lab_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease_documentation_en-US" xlink:label="lab_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment Terms, Amortization Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease" xlink:href="rdnt-20200930.xsd#rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease" xlink:to="lab_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_a8011ae5-d893-44a0-89ac-c4b31bf8b2fd_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_b3cd9049-04a1-498b-9992-dc7de878714f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based payment award, award vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_A2019SWAPSMember_6df872ad-2f68-4808-9042-5378eb13d5e2_terseLabel_en-US" xlink:label="lab_rdnt_A2019SWAPSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 SWAPS</link:label>
    <link:label id="lab_rdnt_A2019SWAPSMember_label_en-US" xlink:label="lab_rdnt_A2019SWAPSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 SWAPS [Member]</link:label>
    <link:label id="lab_rdnt_A2019SWAPSMember_documentation_en-US" xlink:label="lab_rdnt_A2019SWAPSMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 SWAPS [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A2019SWAPSMember" xlink:href="rdnt-20200930.xsd#rdnt_A2019SWAPSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_A2019SWAPSMember" xlink:to="lab_rdnt_A2019SWAPSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_35530185-73b3-4500-936a-320a6ee049f3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LeverageRatioAxis_d661a2ea-f04b-49ad-ae47-547283f5752b_terseLabel_en-US" xlink:label="lab_rdnt_LeverageRatioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio [Axis]</link:label>
    <link:label id="lab_rdnt_LeverageRatioAxis_label_en-US" xlink:label="lab_rdnt_LeverageRatioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio [Axis]</link:label>
    <link:label id="lab_rdnt_LeverageRatioAxis_documentation_en-US" xlink:label="lab_rdnt_LeverageRatioAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioAxis" xlink:href="rdnt-20200930.xsd#rdnt_LeverageRatioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LeverageRatioAxis" xlink:to="lab_rdnt_LeverageRatioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_VenturaCountyImagingGroupLLCMember_c0d42529-aacc-4a06-ae3b-2cd36fc0221f_terseLabel_en-US" xlink:label="lab_rdnt_VenturaCountyImagingGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ventura County Imaging Group, LLC</link:label>
    <link:label id="lab_rdnt_VenturaCountyImagingGroupLLCMember_label_en-US" xlink:label="lab_rdnt_VenturaCountyImagingGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ventura County Imaging Group, LLC [Member]</link:label>
    <link:label id="lab_rdnt_VenturaCountyImagingGroupLLCMember_documentation_en-US" xlink:label="lab_rdnt_VenturaCountyImagingGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ventura County Imaging Group, LLC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_VenturaCountyImagingGroupLLCMember" xlink:href="rdnt-20200930.xsd#rdnt_VenturaCountyImagingGroupLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_VenturaCountyImagingGroupLLCMember" xlink:to="lab_rdnt_VenturaCountyImagingGroupLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_37e98907-a303-4d6f-9949-91bccf3c6284_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_d00d16e5-1cb7-4ce4-b903-8f5a872d2fb3_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under the equity compensation plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsAbstract_af0ce5fb-dc70-4f4d-8826-20de6706006c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OTHER ASSETS</link:label>
    <link:label id="lab_us-gaap_OtherAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_OtherAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsAbstract" xlink:to="lab_us-gaap_OtherAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_SantaMonicaImagingGroupLLCMember_d4482e59-3766-4e2a-a07a-4e24d0ba2efa_terseLabel_en-US" xlink:label="lab_rdnt_SantaMonicaImagingGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Santa Monica Imaging Group, LLC</link:label>
    <link:label id="lab_rdnt_SantaMonicaImagingGroupLLCMember_label_en-US" xlink:label="lab_rdnt_SantaMonicaImagingGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Santa Monica Imaging Group, LLC [Member]</link:label>
    <link:label id="lab_rdnt_SantaMonicaImagingGroupLLCMember_documentation_en-US" xlink:label="lab_rdnt_SantaMonicaImagingGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Santa Monica Imaging Group, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SantaMonicaImagingGroupLLCMember" xlink:href="rdnt-20200930.xsd#rdnt_SantaMonicaImagingGroupLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_SantaMonicaImagingGroupLLCMember" xlink:to="lab_rdnt_SantaMonicaImagingGroupLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_4f9d2900-9b27-4590-aeb3-36459b1fbcd4_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_8dfe33e3-3ffe-4d1a-b20c-54c5d59ed0fd_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_93469bf0-c3ff-41f9-bb1e-b7d83b832d45_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis" xlink:to="lab_us-gaap_ShortTermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c1e4b81a-4ee5-41cd-a215-3c2d8fae70e6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average fair value, vested (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8cc640c0-4078-4041-93de-e8e6bcdae899_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_abe3c382-41e5-433d-9a7f-a6a4a1690c5d_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Promissory Note</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnDerivatives_d5ce17b4-7073-4d23-9fc1-f314d6e58bdd_negatedLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnDerivatives" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash change in fair value of interest rate hedge</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnDerivatives_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnDerivatives" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Derivatives</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnDerivatives" xlink:to="lab_us-gaap_UnrealizedGainLossOnDerivatives" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_92748135-3c71-4cd6-b3fd-8ac073e0fe35_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME FROM OPERATIONS</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsExcludingCurrentMaturities_fb4ae203-e729-4c54-b2cd-a857ffe98a1c_terseLabel_en-US" xlink:label="lab_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsExcludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term portion debt obligations</link:label>
    <link:label id="lab_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsExcludingCurrentMaturities_label_en-US" xlink:label="lab_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsExcludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Short-term Debt and Capital Lease Obligations, Excluding Current Maturities</link:label>
    <link:label id="lab_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsExcludingCurrentMaturities_documentation_en-US" xlink:label="lab_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsExcludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Short-term Debt and Capital Lease Obligations, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsExcludingCurrentMaturities" xlink:href="rdnt-20200930.xsd#rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsExcludingCurrentMaturities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsExcludingCurrentMaturities" xlink:to="lab_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsExcludingCurrentMaturities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLocationDomain_9662690a-96e4-4048-b3c1-41b3d258a698_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Location [Domain]</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLocationDomain_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_ae5418c0-930c-4859-bc89-b91d1c7a08e1_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_fa97afe4-5684-4333-90f2-a786b02770af_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_33e0141e-05ed-4925-96d4-cf33c269ef00_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_461e467d-e2f7-42e4-bef7-ee24c8db1f63_verboseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill acquired</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_AssetAcquisitionAxis_d5e4504f-2636-4f1e-99a1-d1125f827623_terseLabel_en-US" xlink:label="lab_rdnt_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:label id="lab_rdnt_AssetAcquisitionAxis_label_en-US" xlink:label="lab_rdnt_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:label id="lab_rdnt_AssetAcquisitionAxis_documentation_en-US" xlink:label="lab_rdnt_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AssetAcquisitionAxis" xlink:href="rdnt-20200930.xsd#rdnt_AssetAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_AssetAcquisitionAxis" xlink:to="lab_rdnt_AssetAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_79ba6a81-4536-4e45-87a8-aa064ffc9246_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_34bbe250-ba06-48a7-b90a-2ea2fc0135f6_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total service revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a61e3375-6427-4c2a-9585-0f2d7e6a3dcc_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service fee revenue, net of contractual allowances and discounts</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution_6fde6bdb-1166-4793-b915-4770aa3fb01f_terseLabel_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of shares issued after execution</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution_label_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Shares Issued After Execution</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution_documentation_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Shares Issued After Execution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution" xlink:href="rdnt-20200930.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution" xlink:to="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_KeyFinancialDataForJointVenturesAbstract_87db54bb-481a-4fc8-aa32-2ff3c086438d_terseLabel_en-US" xlink:label="lab_rdnt_KeyFinancialDataForJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Data:</link:label>
    <link:label id="lab_rdnt_KeyFinancialDataForJointVenturesAbstract_label_en-US" xlink:label="lab_rdnt_KeyFinancialDataForJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Key financial data for joint ventures</link:label>
    <link:label id="lab_rdnt_KeyFinancialDataForJointVenturesAbstract_documentation_en-US" xlink:label="lab_rdnt_KeyFinancialDataForJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Key financial data for joint ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_KeyFinancialDataForJointVenturesAbstract" xlink:href="rdnt-20200930.xsd#rdnt_KeyFinancialDataForJointVenturesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_KeyFinancialDataForJointVenturesAbstract" xlink:to="lab_rdnt_KeyFinancialDataForJointVenturesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_5de8cce8-3c88-453e-9f9f-27e472d8c38c_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_d6be83f3-231f-4592-b2d6-2dcdf946e697_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net income (loss) per share attributable to RadNet, Inc.'s common stockholders (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_5e769507-7533-4ad3-8b4b-cdc47dde93bc_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Begining Balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_d513e8fb-942c-46d8-8a00-06f5f2081b28_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_TurnerImagingMember_422bdab7-8a10-47e4-adf6-8b6b5250bb3e_terseLabel_en-US" xlink:label="lab_rdnt_TurnerImagingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Turner Imaging</link:label>
    <link:label id="lab_rdnt_TurnerImagingMember_label_en-US" xlink:label="lab_rdnt_TurnerImagingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Turner Imaging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TurnerImagingMember" xlink:href="rdnt-20200930.xsd#rdnt_TurnerImagingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_TurnerImagingMember" xlink:to="lab_rdnt_TurnerImagingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_7f0b97d8-a9a2-4870-9cc3-5d3577120baf_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EARNINGS PER SHARE</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_d9e21768-8872-4fea-b5ff-988da45cacfd_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMPREHENSIVE INCOME (LOSS) ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ContractsReceivableFactoringReceivable_1572c5b0-7d6d-45a4-a2a4-39197b96d007_terseLabel_en-US" xlink:label="lab_rdnt_ContractsReceivableFactoringReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contracts receivable, factoring receivable</link:label>
    <link:label id="lab_rdnt_ContractsReceivableFactoringReceivable_label_en-US" xlink:label="lab_rdnt_ContractsReceivableFactoringReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contracts Receivable, Factoring Receivable</link:label>
    <link:label id="lab_rdnt_ContractsReceivableFactoringReceivable_documentation_en-US" xlink:label="lab_rdnt_ContractsReceivableFactoringReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contracts Receivable, Factoring Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContractsReceivableFactoringReceivable" xlink:href="rdnt-20200930.xsd#rdnt_ContractsReceivableFactoringReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ContractsReceivableFactoringReceivable" xlink:to="lab_rdnt_ContractsReceivableFactoringReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_b989d212-819e-49ba-8b45-ed0f1598b278_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_56c64e6d-5d72-4b31-98b4-e518e06b3de7_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_55554878-6a8e-4a4c-aafd-41c613641b8d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense_e9d3faac-893e-470e-89d3-dbd3a129640d_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BRMG and NY Groups operating expenses</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Measure of Activity, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense" xlink:to="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_StockIssuedDuringPeriodSharesIssuedForReturnOfCapital_b3ca7f30-5412-453c-89c5-7743c6c2ef28_terseLabel_en-US" xlink:label="lab_rdnt_StockIssuedDuringPeriodSharesIssuedForReturnOfCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock for purchase of Nulogix (in shares)</link:label>
    <link:label id="lab_rdnt_StockIssuedDuringPeriodSharesIssuedForReturnOfCapital_label_en-US" xlink:label="lab_rdnt_StockIssuedDuringPeriodSharesIssuedForReturnOfCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Issued for Return of Capital</link:label>
    <link:label id="lab_rdnt_StockIssuedDuringPeriodSharesIssuedForReturnOfCapital_documentation_en-US" xlink:label="lab_rdnt_StockIssuedDuringPeriodSharesIssuedForReturnOfCapital" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Issued for Return of Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_StockIssuedDuringPeriodSharesIssuedForReturnOfCapital" xlink:href="rdnt-20200930.xsd#rdnt_StockIssuedDuringPeriodSharesIssuedForReturnOfCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_StockIssuedDuringPeriodSharesIssuedForReturnOfCapital" xlink:to="lab_rdnt_StockIssuedDuringPeriodSharesIssuedForReturnOfCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_6bd47dea-1d6e-4a3c-98e8-8ed51f621b01_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable at the end</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_b3ce1dfa-2c8d-4f77-a0f6-a84434b4ecf0_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_3f16fec7-df33-4833-b133-df9000796f7a_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_October2023Member_deeac7ab-c920-449c-83a6-3856410dd9b0_terseLabel_en-US" xlink:label="lab_rdnt_October2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2023</link:label>
    <link:label id="lab_rdnt_October2023Member_label_en-US" xlink:label="lab_rdnt_October2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2023 [Member]</link:label>
    <link:label id="lab_rdnt_October2023Member_documentation_en-US" xlink:label="lab_rdnt_October2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_October2023Member" xlink:href="rdnt-20200930.xsd#rdnt_October2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_October2023Member" xlink:to="lab_rdnt_October2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7abf5e8c-e1d1-4bb1-adef-bd9d5009b64f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_b7cd1c34-de88-411a-a2a1-e586043ffaab_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME (LOSS) BEFORE INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_3e4e54c8-b454-4bb6-ad54-e8169c5c35ab_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock - shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_43df7e3e-8d5e-473e-af01-ad5e9c296b9e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_b4641f19-79aa-43e0-a1ac-0e87c6506820_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution_49d90aa7-04d3-43b7-80a8-ea78157efdf8_terseLabel_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued after execution (in shares)</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution_label_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Maximum Number of Shares Issued After Execution</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution_documentation_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Maximum Number of Shares Issued After Execution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution" xlink:href="rdnt-20200930.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution" xlink:to="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_bab81cbd-64be-481b-9405-5fb04b23a388_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseMember_af7e160e-4a2e-4246-a08c-001bc2434826_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity and Interest Expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseMember_label_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseMember" xlink:to="lab_us-gaap_InterestExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ScriptSenderLlcMember_45f81594-f701-4daf-bb63-743377156eec_terseLabel_en-US" xlink:label="lab_rdnt_ScriptSenderLlcMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ScriptSender LLC</link:label>
    <link:label id="lab_rdnt_ScriptSenderLlcMember_label_en-US" xlink:label="lab_rdnt_ScriptSenderLlcMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ScriptSender LLC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ScriptSenderLlcMember" xlink:href="rdnt-20200930.xsd#rdnt_ScriptSenderLlcMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ScriptSenderLlcMember" xlink:to="lab_rdnt_ScriptSenderLlcMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_FutureServiceMember_c8461857-9e7e-4c30-a9a2-602cf65521a6_terseLabel_en-US" xlink:label="lab_rdnt_FutureServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future Service</link:label>
    <link:label id="lab_rdnt_FutureServiceMember_label_en-US" xlink:label="lab_rdnt_FutureServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future Service [Member]</link:label>
    <link:label id="lab_rdnt_FutureServiceMember_documentation_en-US" xlink:label="lab_rdnt_FutureServiceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future Services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FutureServiceMember" xlink:href="rdnt-20200930.xsd#rdnt_FutureServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_FutureServiceMember" xlink:to="lab_rdnt_FutureServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_StockIssuedDuringPeriodValueIssuedForReturnOfCapital_3e18b3fe-99c1-4244-8264-5d024e07fcf1_negatedTerseLabel_en-US" xlink:label="lab_rdnt_StockIssuedDuringPeriodValueIssuedForReturnOfCapital" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock for purchase of Nulogix</link:label>
    <link:label id="lab_rdnt_StockIssuedDuringPeriodValueIssuedForReturnOfCapital_label_en-US" xlink:label="lab_rdnt_StockIssuedDuringPeriodValueIssuedForReturnOfCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Issued for Return of Capital</link:label>
    <link:label id="lab_rdnt_StockIssuedDuringPeriodValueIssuedForReturnOfCapital_documentation_en-US" xlink:label="lab_rdnt_StockIssuedDuringPeriodValueIssuedForReturnOfCapital" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Issued for Return of Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_StockIssuedDuringPeriodValueIssuedForReturnOfCapital" xlink:href="rdnt-20200930.xsd#rdnt_StockIssuedDuringPeriodValueIssuedForReturnOfCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_StockIssuedDuringPeriodValueIssuedForReturnOfCapital" xlink:to="lab_rdnt_StockIssuedDuringPeriodValueIssuedForReturnOfCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_87c1258b-a137-4b2c-9e70-41cde88e0faa_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:to="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_fdb50d5e-6d08-4f18-a829-cc6c761bbafc_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in earnings of joint ventures</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_ec24ed08-e86d-45ea-990a-1f72f39602e7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in earnings in these joint ventures</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_2c3ab25b-e3bc-4a84-9f4c-00f86e39a006_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards_03442e4c-86ab-4bc5-824f-434e94ca9369_terseLabel_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of replacement awards attributable to pre-combination</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards_label_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Replacement Awards</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards_documentation_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Replacement Awards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards" xlink:href="rdnt-20200930.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards" xlink:to="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HealthCareOtherMember_d9c1ad6e-590b-4a0c-856b-beac03934d41_terseLabel_en-US" xlink:label="lab_us-gaap_HealthCareOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_HealthCareOtherMember_label_en-US" xlink:label="lab_us-gaap_HealthCareOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOtherMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HealthCareOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HealthCareOtherMember" xlink:to="lab_us-gaap_HealthCareOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PricingLevelIIIMember_1f9b1967-936d-432e-9a5f-f163c024fe3b_terseLabel_en-US" xlink:label="lab_rdnt_PricingLevelIIIMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level III</link:label>
    <link:label id="lab_rdnt_PricingLevelIIIMember_label_en-US" xlink:label="lab_rdnt_PricingLevelIIIMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level III [Member]</link:label>
    <link:label id="lab_rdnt_PricingLevelIIIMember_documentation_en-US" xlink:label="lab_rdnt_PricingLevelIIIMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level III [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIIIMember" xlink:href="rdnt-20200930.xsd#rdnt_PricingLevelIIIMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PricingLevelIIIMember" xlink:to="lab_rdnt_PricingLevelIIIMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_997e8e26-059b-4bc4-b524-448b4b14e97e_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfDeferredHedgeGains_61ec5d03-a7d2-4d20-a6ca-47fee84ff0b0_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfDeferredHedgeGains" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of cash flow hedge</link:label>
    <link:label id="lab_us-gaap_AmortizationOfDeferredHedgeGains_label_en-US" xlink:label="lab_us-gaap_AmortizationOfDeferredHedgeGains" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Deferred Hedge Gains</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredHedgeGains" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfDeferredHedgeGains"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfDeferredHedgeGains" xlink:to="lab_us-gaap_AmortizationOfDeferredHedgeGains" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_4bbaf33c-ff7b-4e75-9592-5c451be3962b_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity_8849a9b6-4cd4-4856-8dbf-adcdcf08856c_terseLabel_en-US" xlink:label="lab_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit facility, increase borrowing capacity</link:label>
    <link:label id="lab_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity_label_en-US" xlink:label="lab_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Increase Borrowing Capacity</link:label>
    <link:label id="lab_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity_documentation_en-US" xlink:label="lab_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Increase Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity" xlink:href="rdnt-20200930.xsd#rdnt_LineofCreditFacilityIncreaseBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity" xlink:to="lab_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_35ff0fe8-006e-4ee3-bfae-7cce15af80c7_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other expenses</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_e390ac27-0be9-4ece-b59a-9056803a946e_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in-capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ScheduleOfLeverageRatioTableTextBlock_223f45f8-1875-4ac4-9f48-3627bbdd4ca9_terseLabel_en-US" xlink:label="lab_rdnt_ScheduleOfLeverageRatioTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of leverage ratio</link:label>
    <link:label id="lab_rdnt_ScheduleOfLeverageRatioTableTextBlock_label_en-US" xlink:label="lab_rdnt_ScheduleOfLeverageRatioTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Leverage Ratio [Table Text Block]</link:label>
    <link:label id="lab_rdnt_ScheduleOfLeverageRatioTableTextBlock_documentation_en-US" xlink:label="lab_rdnt_ScheduleOfLeverageRatioTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Leverage Ratio [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ScheduleOfLeverageRatioTableTextBlock" xlink:href="rdnt-20200930.xsd#rdnt_ScheduleOfLeverageRatioTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ScheduleOfLeverageRatioTableTextBlock" xlink:to="lab_rdnt_ScheduleOfLeverageRatioTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_705eb12c-d25c-4701-a0a9-a56a4d5363b3_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a70ebb88-f6b3-4c29-8ca4-a07f081db94c_verboseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advance for future software subscription fees</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_69ac7017-975b-4ac7-b3a2-bb0086867f7b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock upon exercise of options (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_084c96ae-d040-4b03-ab52-74593c253ef7_netLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_ee432cdf-53a0-46fa-a5b2-b48af5b79b2a_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_dec76b47-23aa-4aba-b48c-038e84ed8b4d_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_a073ef54-c9a9-448e-84ec-87f6c714cd86_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_2c15e671-e798-4875-9241-b19f01519598_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Separately Recognized Transactions [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Separately Recognized Transactions [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:to="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_aec20681-cc15-4579-950b-78c2be8706a6_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less comprehensive income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution_8ede5355-6df4-45ad-aea0-1ee40485d259_terseLabel_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of shares issued at execution</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution_label_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Shares Issued At Execution</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution_documentation_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Shares Issued At Execution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution" xlink:href="rdnt-20200930.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution" xlink:to="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_6c3db67a-79cd-444a-b09b-0f98fa1b8e99_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_e8011b28-5bb3-4dd5-a7a2-b3bccaf69b27_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DERIVATIVE INSTRUMENTS</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_cb5afd9f-4a7c-4ed4-aa8a-9fade37d635c_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of credit outstanding</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_3275f04b-db53-401b-bcfc-1dfa4842956e_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_ddd00192-ef7a-46bc-8a70-c7e05481def9_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Current</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_6abaa3f6-a97b-4b51-9b6d-6673454443c6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_2d5182ec-6d1d-4a0a-bfce-3eaf7a83375b_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements and Changes in Accounting Principles [Abstract]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements and Changes in Accounting Principles [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0832cea6-3297-4072-b59b-a8705924ba84_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET INCREASE IN CASH AND CASH EQUIVALENTS</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_4d8b673a-af2d-423b-9163-dee3d4e62e00_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in earnings of joint ventures</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments, Net of Dividends or Distributions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_0a7eb3d0-66f3-43ab-a9b0-419f6ed0143b_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LONG-TERM LIABILITIES</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss_a7c4f5cc-d54b-488a-8ffe-eeb7c0497e23_verboseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Summarized Financial Information, Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss" xlink:to="lab_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_TeleradiologyandSoftwareMember_2a8685d5-2aa6-4df0-9701-8ed5ba9cd6ff_terseLabel_en-US" xlink:label="lab_rdnt_TeleradiologyandSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Teleradiology and Software revenue</link:label>
    <link:label id="lab_rdnt_TeleradiologyandSoftwareMember_label_en-US" xlink:label="lab_rdnt_TeleradiologyandSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Teleradiology and Software [Member]</link:label>
    <link:label id="lab_rdnt_TeleradiologyandSoftwareMember_documentation_en-US" xlink:label="lab_rdnt_TeleradiologyandSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Teleradiology and Software [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TeleradiologyandSoftwareMember" xlink:href="rdnt-20200930.xsd#rdnt_TeleradiologyandSoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_TeleradiologyandSoftwareMember" xlink:to="lab_rdnt_TeleradiologyandSoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares_818a7263-3260-48cd-95de-ef573a53fc9b_terseLabel_en-US" xlink:label="lab_rdnt_BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration, milestone one, shares issued (in shares)</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares_label_en-US" xlink:label="lab_rdnt_BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Contingent Consideration Arrangements, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares_documentation_en-US" xlink:label="lab_rdnt_BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Contingent Consideration Arrangements, Milestone One, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares" xlink:href="rdnt-20200930.xsd#rdnt_BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares" xlink:to="lab_rdnt_BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_abd5dd01-c5c4-45b7-b0a1-64f14cb56e51_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET INCOME (LOSS) ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_b986a5d9-c97e-4931-8ef0-6128fefeeaa9_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) attributable to RadNet, Inc.'s common stockholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_96f3c114-7de7-413f-be28-31e85bf0c287_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_84d84593-b752-4963-9d6d-48deefc56ec7_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CURRENT ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_bdb312d0-da65-4c84-bd01-cefb1c652866_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACCOUNTS RECEIVABLE</link:label>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:to="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_JointVentureMember_1d44977e-db21-4c78-ac9d-ca678a5f6fab_terseLabel_en-US" xlink:label="lab_rdnt_JointVentureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint Venture</link:label>
    <link:label id="lab_rdnt_JointVentureMember_label_en-US" xlink:label="lab_rdnt_JointVentureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint Venture [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_JointVentureMember" xlink:href="rdnt-20200930.xsd#rdnt_JointVentureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_JointVentureMember" xlink:to="lab_rdnt_JointVentureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBuildings_b65a9819-8176-411f-af18-3b6371696035_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBuildings" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of imaging facilities and other acquisitions</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBuildings_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBuildings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Buildings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBuildings" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireBuildings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBuildings" xlink:to="lab_us-gaap_PaymentsToAcquireBuildings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_962a97dd-c294-43d6-836d-5bb394b0e124_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0efaee3f-6172-43ac-a60a-6734af70a5ea_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_23da3d26-33e5-46c9-8441-f1d262c328e4_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of loss recognized in income on derivative (current period ineffective portion)</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ebaddbe6-85da-4e4b-b882-0857b7447b51_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_42b755c3-5c73-4ed4-ad81-567c04548a2a_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET INCOME (LOSS)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_01f36afb-10a5-4be1-89c8-e32cf1b3b7cd_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET INCOME (LOSS)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_f0ba8fa5-5d59-4e2b-a98a-2625792ee682_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_09acf56a-0d86-4a0d-b375-297fcdc01ea3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisition, percentage of voting interests acquired</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_069b2979-2b6a-43d4-9a72-720961b3900d_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_SunTrustMember_07283fd3-06e6-45fe-99ea-517eaad796a4_terseLabel_en-US" xlink:label="lab_rdnt_SunTrustMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SunTrust</link:label>
    <link:label id="lab_rdnt_SunTrustMember_label_en-US" xlink:label="lab_rdnt_SunTrustMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SunTrust [Member]</link:label>
    <link:label id="lab_rdnt_SunTrustMember_documentation_en-US" xlink:label="lab_rdnt_SunTrustMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SunTrust [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SunTrustMember" xlink:href="rdnt-20200930.xsd#rdnt_SunTrustMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_SunTrustMember" xlink:to="lab_rdnt_SunTrustMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_878bb747-8516-48d9-9cdf-a9b8a41ec26a_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_cc1332eb-b1cb-4bb0-ad34-5a2201ecefe7_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments at fair value</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_0f88a433-1e5c-4b6c-9c35-3f2c42732e36_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LeverageRatioDomain_e3d9b39f-2b6e-4f54-ab3d-0bb77c30eb0b_terseLabel_en-US" xlink:label="lab_rdnt_LeverageRatioDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio [Domain]</link:label>
    <link:label id="lab_rdnt_LeverageRatioDomain_label_en-US" xlink:label="lab_rdnt_LeverageRatioDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio [Domain]</link:label>
    <link:label id="lab_rdnt_LeverageRatioDomain_documentation_en-US" xlink:label="lab_rdnt_LeverageRatioDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Leverage Ratio [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain" xlink:href="rdnt-20200930.xsd#rdnt_LeverageRatioDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LeverageRatioDomain" xlink:to="lab_rdnt_LeverageRatioDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LetterOfCreditMember_dbe395dd-5066-4340-ae3e-a782d5dcf660_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LeverageRatioFourMember_ce64816c-7e94-4262-8627-8fa5faf69d7f_terseLabel_en-US" xlink:label="lab_rdnt_LeverageRatioFourMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">&#8804; 3.50x</link:label>
    <link:label id="lab_rdnt_LeverageRatioFourMember_label_en-US" xlink:label="lab_rdnt_LeverageRatioFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Four [Member]</link:label>
    <link:label id="lab_rdnt_LeverageRatioFourMember_documentation_en-US" xlink:label="lab_rdnt_LeverageRatioFourMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Four [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioFourMember" xlink:href="rdnt-20200930.xsd#rdnt_LeverageRatioFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LeverageRatioFourMember" xlink:to="lab_rdnt_LeverageRatioFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_8ed6b58e-2e9f-4dc0-93f1-050e449c0aba_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 swaps - Interest Rate Contracts</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_29af1585-0787-4515-b495-9687de694fc6_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfDeferredCharges_45db35da-c521-4bd2-97f0-ed41e001f36d_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfDeferredCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of deferred issuance costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfDeferredCharges_label_en-US" xlink:label="lab_us-gaap_AmortizationOfDeferredCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Deferred Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfDeferredCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfDeferredCharges" xlink:to="lab_us-gaap_AmortizationOfDeferredCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_ddb4675f-dd05-43a3-b2f8-5507cac5363d_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock for purchase of membership interest in HVRA (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_06a823ab-8092-482b-b25d-d3d9760bd843_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuritiesFinancingTransactionAxis_13552495-2604-4fd6-82bb-b7be2e179094_terseLabel_en-US" xlink:label="lab_us-gaap_SecuritiesFinancingTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities Financing Transaction [Axis]</link:label>
    <link:label id="lab_us-gaap_SecuritiesFinancingTransactionAxis_label_en-US" xlink:label="lab_us-gaap_SecuritiesFinancingTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities Financing Transaction [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesFinancingTransactionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SecuritiesFinancingTransactionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionAxis" xlink:to="lab_us-gaap_SecuritiesFinancingTransactionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_GlendaleAdvancedImagingMember_ae56ca33-3994-463d-bddb-c7c0a9a876c5_terseLabel_en-US" xlink:label="lab_rdnt_GlendaleAdvancedImagingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Glendale Advanced Imaging</link:label>
    <link:label id="lab_rdnt_GlendaleAdvancedImagingMember_label_en-US" xlink:label="lab_rdnt_GlendaleAdvancedImagingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Glendale Advanced Imaging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GlendaleAdvancedImagingMember" xlink:href="rdnt-20200930.xsd#rdnt_GlendaleAdvancedImagingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_GlendaleAdvancedImagingMember" xlink:to="lab_rdnt_GlendaleAdvancedImagingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_AwardsIssuedToDate_6b03b5bf-e922-43d6-8e5b-9fad96e84bc1_terseLabel_en-US" xlink:label="lab_rdnt_AwardsIssuedToDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards issued to date (in shares)</link:label>
    <link:label id="lab_rdnt_AwardsIssuedToDate_label_en-US" xlink:label="lab_rdnt_AwardsIssuedToDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards issued to date</link:label>
    <link:label id="lab_rdnt_AwardsIssuedToDate_documentation_en-US" xlink:label="lab_rdnt_AwardsIssuedToDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards issued to date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AwardsIssuedToDate" xlink:href="rdnt-20200930.xsd#rdnt_AwardsIssuedToDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_AwardsIssuedToDate" xlink:to="lab_rdnt_AwardsIssuedToDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermBorrowings_3edd3d85-e81b-4724-b041-ca89be7f14d9_verboseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible promissory note</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowings_label_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermBorrowings" xlink:to="lab_us-gaap_ShortTermBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_b5dceb54-c1ee-436d-a74c-69c19b326da3_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis_31996c41-7d79-43ea-a61c-e032e91bd414_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entities [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis" xlink:to="lab_us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_3f7a5296-b23f-4ba6-be27-a3a0cd531d1e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OPERATING EXPENSES</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance_7de7a973-8cd0-4a26-afba-6c52fe35d447_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares available for future issuance, options, warrants, shares of restricted stock and other bonus awards (in shares)</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Common Stock Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance" xlink:to="lab_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_a8d0c100-32a6-40d6-947b-9e4f1f0400c2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_8b31dbac-8177-421a-b351-4f75ff9ced01_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_WeightedAverageRemainingContractualLife_2640d327-552e-4af8-aaf1-958e2e09a3d3_terseLabel_en-US" xlink:label="lab_rdnt_WeightedAverageRemainingContractualLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Contractual Life</link:label>
    <link:label id="lab_rdnt_WeightedAverageRemainingContractualLife_label_en-US" xlink:label="lab_rdnt_WeightedAverageRemainingContractualLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Contractual Life</link:label>
    <link:label id="lab_rdnt_WeightedAverageRemainingContractualLife_documentation_en-US" xlink:label="lab_rdnt_WeightedAverageRemainingContractualLife" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Contractual Life abstract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WeightedAverageRemainingContractualLife" xlink:href="rdnt-20200930.xsd#rdnt_WeightedAverageRemainingContractualLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_WeightedAverageRemainingContractualLife" xlink:to="lab_rdnt_WeightedAverageRemainingContractualLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_ead6491c-9b76-4530-b8a7-50c44515e971_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeiture of restricted stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Forfeited</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_SimiValleyHospitalAndHealthServicesMember_ff4f8a4e-11d9-42ce-9dcf-4d262abc9b61_terseLabel_en-US" xlink:label="lab_rdnt_SimiValleyHospitalAndHealthServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Simi Valley Hospital and Health Services</link:label>
    <link:label id="lab_rdnt_SimiValleyHospitalAndHealthServicesMember_label_en-US" xlink:label="lab_rdnt_SimiValleyHospitalAndHealthServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Simi Valley Hospital and Health Services [Member]</link:label>
    <link:label id="lab_rdnt_SimiValleyHospitalAndHealthServicesMember_documentation_en-US" xlink:label="lab_rdnt_SimiValleyHospitalAndHealthServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Simi Valley Hospital and Health Services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SimiValleyHospitalAndHealthServicesMember" xlink:href="rdnt-20200930.xsd#rdnt_SimiValleyHospitalAndHealthServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_SimiValleyHospitalAndHealthServicesMember" xlink:to="lab_rdnt_SimiValleyHospitalAndHealthServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_e6badef2-2189-4308-a03f-76b4dc607bd4_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EQUITY</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_be2ea774-9493-4e5d-8514-2a6c18006cb3_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OffsettingAssetsLineItems_fe64616a-c122-4e84-b96f-20519ec0f693_terseLabel_en-US" xlink:label="lab_us-gaap_OffsettingAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offsetting Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_OffsettingAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_OffsettingAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offsetting Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OffsettingAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OffsettingAssetsLineItems" xlink:to="lab_us-gaap_OffsettingAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c696f87d-bf99-49f7-be75-236b53e0eced_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_9aa8cb40-fdc2-486a-9dda-b8c1863a02d7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of fair value of assets and liabilities</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_162836c9-ec16-40a9-9d1d-d0a6e920643e_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUBSEQUENT EVENTS</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_b192e28d-e1c5-4846-88ac-407a40da8e3d_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">REVENUE</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_20d51023-2157-4a04-8e62-8a40b9a4ba18_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sales of Business, Affiliate and Productive Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:to="lab_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_66db5e30-8321-4ff0-9679-613d9dd64a35_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of notes payable, line of credit and capital lease obligations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeveranceCosts1_bacf6f18-4a69-44a8-9229-fecfa99fe194_terseLabel_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance costs</link:label>
    <link:label id="lab_us-gaap_SeveranceCosts1_label_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeveranceCosts1" xlink:to="lab_us-gaap_SeveranceCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BoardMemberMember_9398afb3-88be-4d62-a57e-782e068d5188_terseLabel_en-US" xlink:label="lab_rdnt_BoardMemberMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Board Member</link:label>
    <link:label id="lab_rdnt_BoardMemberMember_label_en-US" xlink:label="lab_rdnt_BoardMemberMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Board Member [Member]</link:label>
    <link:label id="lab_rdnt_BoardMemberMember_documentation_en-US" xlink:label="lab_rdnt_BoardMemberMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Board Member [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BoardMemberMember" xlink:href="rdnt-20200930.xsd#rdnt_BoardMemberMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BoardMemberMember" xlink:to="lab_rdnt_BoardMemberMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_Caps2016Member_1658ecea-bdc8-4f6e-9568-019416f2258f_terseLabel_en-US" xlink:label="lab_rdnt_Caps2016Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 Caps</link:label>
    <link:label id="lab_rdnt_Caps2016Member_label_en-US" xlink:label="lab_rdnt_Caps2016Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 Caps [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Caps2016Member" xlink:href="rdnt-20200930.xsd#rdnt_Caps2016Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_Caps2016Member" xlink:to="lab_rdnt_Caps2016Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_89544c37-43fc-47f7-9cbf-8fd03065da10_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_2985a21a-530f-4af2-b7e1-75fe4724bf0f_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income) expenses</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_287896f3-234c-4b04-9122-a5e60fc3e289_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLocationAxis_24311c49-140b-4269-83ac-8dbdd971a470_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Location [Axis]</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLocationAxis_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_e02a36ff-52c8-4944-b695-98858db29382_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_8f54bcb9-4046-4197-98ec-912e3f6d01cc_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Remaining Contractual Term (Years)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_35fbdcc3-c4e7-4a32-bc81-cb82e79371ce_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9005d570-9973-4d00-97bc-8162c61ac965_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherExpensesAbstract_3fb976f8-65c2-45d9-b4ff-999c45d7abf7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OTHER INCOME AND EXPENSES</link:label>
    <link:label id="lab_us-gaap_OtherExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OtherExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherExpensesAbstract" xlink:to="lab_us-gaap_OtherExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_c8fb4ecf-f7c0-4f4a-9be2-3ae968f96cd8_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_29cefbd6-6de6-41fd-b680-237d40e6a1cc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_4a7ae76b-b331-4eb8-9a2e-ce5c2e23d28f_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_b3e0edfa-b115-4d32-92f1-fa6b538b00b9_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_c1ac3d78-e8ca-4aa2-a958-e5d2a8a65d3d_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of deferred financing costs and loan discount</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_8096fae6-abf9-464e-91b0-0db21468f6d6_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_8b836e74-8ca1-46ed-9ae4-e6e101d954fb_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_c0da3c31-c924-4705-bf13-77ca5e39b944_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WEIGHTED AVERAGE SHARES OUTSTANDING</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_f8de2bf8-4e2c-4fcc-8abb-069999f63a84_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateCapMember_6fe56e03-aa5b-40e1-bc2c-5a83d627f5e1_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 caps - Interest Rate Contracts</link:label>
    <link:label id="lab_us-gaap_InterestRateCapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateCapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCapMember" xlink:to="lab_us-gaap_InterestRateCapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_a0e4a334-a10d-4614-98c2-e3413c7be232_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_15aa7b1e-1fd6-45f4-8cd3-4c8f94eefb0e_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_c1145410-69f8-48c0-81ff-ccebdcabd075_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PPE estimated useful lives</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_77b03f85-9a08-43c6-a359-9a530dcc39cb_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Primary Beneficiary</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Primary Beneficiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:to="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_AggregateIntrinsicValue_2935f039-bff9-47f2-91a2-bb23e43f02c4_terseLabel_en-US" xlink:label="lab_rdnt_AggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value</link:label>
    <link:label id="lab_rdnt_AggregateIntrinsicValue_label_en-US" xlink:label="lab_rdnt_AggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value</link:label>
    <link:label id="lab_rdnt_AggregateIntrinsicValue_documentation_en-US" xlink:label="lab_rdnt_AggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AggregateIntrinsicValue" xlink:href="rdnt-20200930.xsd#rdnt_AggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_AggregateIntrinsicValue" xlink:to="lab_rdnt_AggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_04b9dcbe-43fb-48bf-b194-dc2ddbeba30b_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM INVESTING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuritiesFinancingTransactionTypeDomain_c4634c8b-f855-4d19-809a-50bf90621144_terseLabel_en-US" xlink:label="lab_us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities Financing Transaction [Domain]</link:label>
    <link:label id="lab_us-gaap_SecuritiesFinancingTransactionTypeDomain_label_en-US" xlink:label="lab_us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities Financing Transaction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SecuritiesFinancingTransactionTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:to="lab_us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_18d87d1a-9733-42df-bca9-7d3f3bfb55b0_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_b2879420-9cb6-4f40-a9f1-88dd258c9c00_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_NumberOfCenters_d2a23788-470d-41c6-9c9b-22b88118c74d_terseLabel_en-US" xlink:label="lab_rdnt_NumberOfCenters" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of centers</link:label>
    <link:label id="lab_rdnt_NumberOfCenters_label_en-US" xlink:label="lab_rdnt_NumberOfCenters" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Centers</link:label>
    <link:label id="lab_rdnt_NumberOfCenters_documentation_en-US" xlink:label="lab_rdnt_NumberOfCenters" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Centers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberOfCenters" xlink:href="rdnt-20200930.xsd#rdnt_NumberOfCenters"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_NumberOfCenters" xlink:to="lab_rdnt_NumberOfCenters" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_ddaaafc9-c441-4d83-812b-dc646bd2dbf9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of RSA activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_5ec38f0a-29fd-4909-b895-ee04a4ac7573_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ProceedsFromGovernmentAssistance_d1436bd2-5d9e-4f10-a41b-de3dc1e34854_terseLabel_en-US" xlink:label="lab_rdnt_ProceedsFromGovernmentAssistance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Payment Protection Program</link:label>
    <link:label id="lab_rdnt_ProceedsFromGovernmentAssistance_label_en-US" xlink:label="lab_rdnt_ProceedsFromGovernmentAssistance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Government Assistance</link:label>
    <link:label id="lab_rdnt_ProceedsFromGovernmentAssistance_documentation_en-US" xlink:label="lab_rdnt_ProceedsFromGovernmentAssistance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Government Assistance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProceedsFromGovernmentAssistance" xlink:href="rdnt-20200930.xsd#rdnt_ProceedsFromGovernmentAssistance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ProceedsFromGovernmentAssistance" xlink:to="lab_rdnt_ProceedsFromGovernmentAssistance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized_cea3d0b8-4b87-4495-b8ea-cfffc5eaacb0_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium liability for 2016 Caps</link:label>
    <link:label id="lab_us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized_label_en-US" xlink:label="lab_us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Guarantee Insurance Contracts, Unearned Premium Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized" xlink:to="lab_us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_245a5168-0b3a-47d6-a949-6f2315942449_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_8fb83044-4bd9-424d-b517-91b65bef7bc3_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_85c22d83-3bbb-40fd-9491-f96dd1df857f_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PricingLevelIMember_b17b17dd-5c1d-46e2-8c37-eb0bf62154b7_terseLabel_en-US" xlink:label="lab_rdnt_PricingLevelIMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level I</link:label>
    <link:label id="lab_rdnt_PricingLevelIMember_label_en-US" xlink:label="lab_rdnt_PricingLevelIMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level I [Member]</link:label>
    <link:label id="lab_rdnt_PricingLevelIMember_documentation_en-US" xlink:label="lab_rdnt_PricingLevelIMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level I [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIMember" xlink:href="rdnt-20200930.xsd#rdnt_PricingLevelIMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PricingLevelIMember" xlink:to="lab_rdnt_PricingLevelIMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_f546f649-4521-4679-8d36-2e0153b6df48_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationDomain_539f7f36-6618-4a2e-a1d0-b7c44e42cd37_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advances to Affiliates Categorization [Domain]</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationDomain_label_en-US" xlink:label="lab_us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advances to Affiliates Categorization [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationDomain" xlink:to="lab_us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_66becdec-03ec-4ae4-b0e3-2467b6941296_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">REVENUES</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_e9fedc5e-28a2-48a6-a0ac-5db413f681c9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Face Value</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_ea7072db-7c85-476a-9fe5-da3d3fd8abb6_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument face value</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_918bcb11-a101-4be3-a88e-ade03468e0be_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_66814ff5-9a64-4cd2-8573-775ff0b40ec0_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net income per share attributable to RadNet, Inc.'s common stockholders (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_1886c8bd-a05d-402d-88b5-1ec6d3e485e2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense)</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_7f60b046-f90d-4af0-8ccb-da292b90326a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity interest issued, value assigned</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Value Assigned</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:to="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_6d091953-1fb8-4969-8e33-5fbf77c77ae3_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_FirstLienTermLoanMember_a1c3a069-cc24-4b75-a1c0-fa4dd4969f1d_terseLabel_en-US" xlink:label="lab_rdnt_FirstLienTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Term Loan</link:label>
    <link:label id="lab_rdnt_FirstLienTermLoanMember_label_en-US" xlink:label="lab_rdnt_FirstLienTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienTermLoanMember" xlink:href="rdnt-20200930.xsd#rdnt_FirstLienTermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_FirstLienTermLoanMember" xlink:to="lab_rdnt_FirstLienTermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ManagementServiceFees_72c1eb8c-2797-40b8-8003-38ece32ae9ad_terseLabel_en-US" xlink:label="lab_rdnt_ManagementServiceFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management service fees</link:label>
    <link:label id="lab_rdnt_ManagementServiceFees_label_en-US" xlink:label="lab_rdnt_ManagementServiceFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management service fees</link:label>
    <link:label id="lab_rdnt_ManagementServiceFees_documentation_en-US" xlink:label="lab_rdnt_ManagementServiceFees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management service fees.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ManagementServiceFees" xlink:href="rdnt-20200930.xsd#rdnt_ManagementServiceFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ManagementServiceFees" xlink:to="lab_rdnt_ManagementServiceFees" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_f0ec9d99-cadc-4f9d-80da-1dc771904323_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_734f7cf8-f062-448f-a30c-819e9e6e4a7b_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_776ea0d4-3122-42fc-af30-438cdffafbc0_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested restricted stock subject to service vesting</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted, Other Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:to="lab_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_b0c3f28e-830f-4488-9ed2-c00926e3bfc0_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nulogix return of capital</link:label>
    <link:label id="lab_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_label_en-US" xlink:label="lab_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Equity Method Investment, Distribution, Return of Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" xlink:to="lab_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_15ed15e2-9fd7-43e2-9a97-476c9135dce5_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock issued upon conversion (in shares)</link:label>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_label_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock, Shares Issued upon Conversion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:to="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_642ac786-a148-4237-83bd-cd0d6739d788_terseLabel_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities acquired</link:label>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_label_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Operating Lease Liabilities</link:label>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_documentation_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Operating Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" xlink:href="rdnt-20200930.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" xlink:to="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_NumberofUnconsolidatedJointVentures_1823dc81-369a-455f-894f-98e7269f0208_terseLabel_en-US" xlink:label="lab_rdnt_NumberofUnconsolidatedJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of unconsolidated joint ventures</link:label>
    <link:label id="lab_rdnt_NumberofUnconsolidatedJointVentures_label_en-US" xlink:label="lab_rdnt_NumberofUnconsolidatedJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Unconsolidated Joint Ventures</link:label>
    <link:label id="lab_rdnt_NumberofUnconsolidatedJointVentures_documentation_en-US" xlink:label="lab_rdnt_NumberofUnconsolidatedJointVentures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Unconsolidated Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberofUnconsolidatedJointVentures" xlink:href="rdnt-20200930.xsd#rdnt_NumberofUnconsolidatedJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_NumberofUnconsolidatedJointVentures" xlink:to="lab_rdnt_NumberofUnconsolidatedJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_7a68f9a8-772f-4b9d-b670-2874091e4992_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_755a618b-ccdf-493a-a3db-868d7b8956de_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PPP loans, maturity term</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockOptionMember_93461f40-6487-424e-812a-43d70bfbad8d_terseLabel_en-US" xlink:label="lab_us-gaap_StockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Option</link:label>
    <link:label id="lab_us-gaap_StockOptionMember_label_en-US" xlink:label="lab_us-gaap_StockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockOptionMember" xlink:to="lab_us-gaap_StockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_4def45b7-9852-4184-b845-27868f9300ec_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_IncreaseDecreaseInOtherNoncashItem_48eec005-2406-475a-a3f7-27c245c1ea90_negatedTerseLabel_en-US" xlink:label="lab_rdnt_IncreaseDecreaseInOtherNoncashItem" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-cash items included in cost of operations</link:label>
    <link:label id="lab_rdnt_IncreaseDecreaseInOtherNoncashItem_label_en-US" xlink:label="lab_rdnt_IncreaseDecreaseInOtherNoncashItem" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase Decrease In Other Noncash Item</link:label>
    <link:label id="lab_rdnt_IncreaseDecreaseInOtherNoncashItem_documentation_en-US" xlink:label="lab_rdnt_IncreaseDecreaseInOtherNoncashItem" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase Decrease In Other Noncash Item</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IncreaseDecreaseInOtherNoncashItem" xlink:href="rdnt-20200930.xsd#rdnt_IncreaseDecreaseInOtherNoncashItem"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_IncreaseDecreaseInOtherNoncashItem" xlink:to="lab_rdnt_IncreaseDecreaseInOtherNoncashItem" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_e446b766-6bf7-47e6-8712-56cdf6103870_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_b9ce12a5-217e-4da2-9df6-829229a2254b_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term finance lease liability</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_def623c4-6a4d-41d4-81ed-0c721601ea3d_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net (loss) income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions_258a7ee9-db17-4ffc-bdc1-907dd8624fc4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions from joint ventures</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Equity Method Investment, Distribution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:to="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_a5d689fe-662f-4ed6-abc4-eefba7d5fc51_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of options activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_cad323aa-06a2-46f0-a368-4ba61b8189a1_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash (used in) provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_e78d6cbd-a2c2-4f9e-862f-fd2327d2e633_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_EquipmentAcquiredAndLeaseholdImprovements_39eecdec-9649-4a54-8e14-73498c1bd654_terseLabel_en-US" xlink:label="lab_rdnt_EquipmentAcquiredAndLeaseholdImprovements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment acquired and leasehold improvements</link:label>
    <link:label id="lab_rdnt_EquipmentAcquiredAndLeaseholdImprovements_label_en-US" xlink:label="lab_rdnt_EquipmentAcquiredAndLeaseholdImprovements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment acquired and leasehold improvements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquipmentAcquiredAndLeaseholdImprovements" xlink:href="rdnt-20200930.xsd#rdnt_EquipmentAcquiredAndLeaseholdImprovements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_EquipmentAcquiredAndLeaseholdImprovements" xlink:to="lab_rdnt_EquipmentAcquiredAndLeaseholdImprovements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_9e8e5d37-c94d-4310-b89d-26948b93f3a3_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate value exercisable</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_0f1572ae-0c80-4f8e-bf21-5c8dd97f31e5_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment_56fe35a3-e9c1-4897-973a-da7c1a99afbc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Other Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_e8e366c7-e272-4b88-96c4-1fdfcf8a498e_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in joint ventures</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_c50deb4c-b5f5-4b6d-8bb0-71df4910b2cf_periodStartLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_4860717c-3c72-4a39-8241-1a6d7906446c_periodEndLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_98c58ad0-4278-42bb-b096-1e6e27d280fd_verboseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total value of Radnet joint venture interests</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_label_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:to="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_9d340bdb-9369-493c-ad54-f25ffda2bf5d_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Provision for) benefit from income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_ea7012ae-c335-40ff-8097-8efa7cf57afa_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueNotFromContractWithCustomer_1c085574-bdbe-4a1e-b355-d57eab19c5fd_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueNotFromContractWithCustomer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provider relief funding</link:label>
    <link:label id="lab_us-gaap_RevenueNotFromContractWithCustomer_label_en-US" xlink:label="lab_us-gaap_RevenueNotFromContractWithCustomer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Not from Contract with Customer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueNotFromContractWithCustomer" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueNotFromContractWithCustomer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueNotFromContractWithCustomer" xlink:to="lab_us-gaap_RevenueNotFromContractWithCustomer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_eb5ff8b3-804e-4a4c-9dcc-ff4f8371fd44_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCK-BASED COMPENSATION</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesFairValueDisclosure_a83659dc-774d-4f7b-8866-8ff5ed750b5e_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Contracts</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedLiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_AccruedLiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_a0f4bf73-9326-47ac-828e-4415292cd417_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock for acquisition</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BarclaysMember_c955f81c-5bfe-4a77-acef-b16f2f4ea819_terseLabel_en-US" xlink:label="lab_rdnt_BarclaysMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Barclays</link:label>
    <link:label id="lab_rdnt_BarclaysMember_label_en-US" xlink:label="lab_rdnt_BarclaysMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Barclays [Member]</link:label>
    <link:label id="lab_rdnt_BarclaysMember_documentation_en-US" xlink:label="lab_rdnt_BarclaysMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Barclays [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BarclaysMember" xlink:href="rdnt-20200930.xsd#rdnt_BarclaysMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BarclaysMember" xlink:to="lab_rdnt_BarclaysMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1_a5db1131-7f3b-490b-8200-17bedadcde9b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash change in fair value of interest rate hedge</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Fair Value of Hedged Item in Interest Rate Fair Value Hedge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1" xlink:to="lab_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_cbdf09f9-030b-4696-9923-8dc4d48e6eb2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemAxis_25ad4350-2cc0-4a53-9829-0d3da2b22c4f_terseLabel_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Axis]</link:label>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemAxis_label_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis" xlink:to="lab_us-gaap_UnusualOrInfrequentItemAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution_3d1387ca-1d60-41f0-bf85-e34a522185ce_terseLabel_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued at execution (in shares)</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution_label_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares At Execution</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution_documentation_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares At Execution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution" xlink:href="rdnt-20200930.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution" xlink:to="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_a354f66b-eee9-45df-b1db-d8b7bdac1a5a_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ContributionsFromNoncontrollingInterests_8552794c-4eb0-412e-8e8c-5c3b19a4dbf9_terseLabel_en-US" xlink:label="lab_rdnt_ContributionsFromNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contribution from noncontrolling partner</link:label>
    <link:label id="lab_rdnt_ContributionsFromNoncontrollingInterests_label_en-US" xlink:label="lab_rdnt_ContributionsFromNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions from noncontrolling interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContributionsFromNoncontrollingInterests" xlink:href="rdnt-20200930.xsd#rdnt_ContributionsFromNoncontrollingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ContributionsFromNoncontrollingInterests" xlink:to="lab_rdnt_ContributionsFromNoncontrollingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_cb227045-6976-497a-86c7-20d5a908757a_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unused capacity, commitment fee percentage</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Unused Capacity, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_81a5bfa3-ce8b-4b67-94fb-4cf731c5f949_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_a687dcba-7ca0-444f-9200-22f9d528e9ec_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_9325da4a-785e-4b37-a843-e4ce960aea52_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable at the end (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_77960dc7-0a87-45a0-b18d-e3ff012528a4_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_9e0da7cc-15c3-476f-ab25-322eaeaf7727_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_3e7adff9-2b43-4cc9-8779-83498424a118_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_032f0b0d-5d87-4b84-82dc-df65c9482417_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_89a2fa2a-3020-4452-a000-e556e5099854_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_34796c6a-a2b9-4de4-9da3-50b78f3fcafc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions paid to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1_fcc471f8-5f8d-4b9a-b728-f200293d6859_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative instrument, beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1_63d0497a-ef72-4bb7-9c10-c3eac1ade507_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative instrument, ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Adjusted Balance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_857103eb-b721-4d40-b9da-5cee70c4668d_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PROPERTY AND EQUIPMENT</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_92feffa5-d888-4a2c-8b51-d72e9a45a6a3_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets, net of current portion</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a0280230-846e-4fbf-9788-a694886292f9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average fair value, granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_fb72222b-9a17-41e7-bea8-3ba00c51b921_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Carrying Value</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares_cffa0e16-c282-439c-9cf2-dab400565b0e_terseLabel_en-US" xlink:label="lab_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration, milestone three, shares issued (in shares)</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares_label_en-US" xlink:label="lab_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Contingent Consideration Arrangements, Milestone Three, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares_documentation_en-US" xlink:label="lab_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Contingent Consideration Arrangements, Milestone Three, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares" xlink:href="rdnt-20200930.xsd#rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares" xlink:to="lab_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_64a8c05e-0cc8-4fcd-8944-9a19c6de44b1_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DeepHealthIncMember_e86ff635-95ae-4dc4-bf9a-ceca4c1aaca0_terseLabel_en-US" xlink:label="lab_rdnt_DeepHealthIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DeepHealth Inc.</link:label>
    <link:label id="lab_rdnt_DeepHealthIncMember_label_en-US" xlink:label="lab_rdnt_DeepHealthIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deep Health Inc [Member]</link:label>
    <link:label id="lab_rdnt_DeepHealthIncMember_documentation_en-US" xlink:label="lab_rdnt_DeepHealthIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deep Health, Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthIncMember" xlink:href="rdnt-20200930.xsd#rdnt_DeepHealthIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DeepHealthIncMember" xlink:to="lab_rdnt_DeepHealthIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_NulogixMember_2fdffee1-aafc-4526-8973-e117bdda3677_terseLabel_en-US" xlink:label="lab_rdnt_NulogixMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nulogix</link:label>
    <link:label id="lab_rdnt_NulogixMember_label_en-US" xlink:label="lab_rdnt_NulogixMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nulogix [Member]</link:label>
    <link:label id="lab_rdnt_NulogixMember_documentation_en-US" xlink:label="lab_rdnt_NulogixMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nulogix</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NulogixMember" xlink:href="rdnt-20200930.xsd#rdnt_NulogixMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_NulogixMember" xlink:to="lab_rdnt_NulogixMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromContributedCapital_7c689bcd-83cf-4ca0-9ddf-b8a0ae2317ef_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromContributedCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contribution from noncontrolling partner</link:label>
    <link:label id="lab_us-gaap_ProceedsFromContributedCapital_label_en-US" xlink:label="lab_us-gaap_ProceedsFromContributedCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Contributed Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromContributedCapital" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromContributedCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromContributedCapital" xlink:to="lab_us-gaap_ProceedsFromContributedCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_d2953347-5f54-4b9a-9128-5c951aefabc3_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_a421f748-247e-4b1c-8d75-f9c25e8446af_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum_f5129c35-bac9-4860-8686-2a50170bfa33_terseLabel_en-US" xlink:label="lab_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage ratio, greater than</link:label>
    <link:label id="lab_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum_label_en-US" xlink:label="lab_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Liquidity Ratio Required, Minimum</link:label>
    <link:label id="lab_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum_documentation_en-US" xlink:label="lab_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Liquidity Ratio Required, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum" xlink:href="rdnt-20200930.xsd#rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum" xlink:to="lab_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_fb8f839f-de3a-4c72-8586-f1e63f2847d4_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BUSINESS COMBINATION</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsPolicy" xlink:to="lab_us-gaap_BusinessCombinationsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_e59a2982-2d02-4488-9412-df7867291b61_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_9f6e12b6-5471-47fa-b8fa-42d6c4de983e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from debt issuance, net of issuing costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_de837b9c-0af4-44ba-b215-7d5b1469585b_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM OPERATING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_9b724db1-5a47-4939-ad2d-bb5b50b95c76_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_63556cbb-5c4f-458b-b244-ed9028205b6b_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSA's outstanding, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_89feb66c-cb27-4c36-b214-f65b088c0da4_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSA's outstanding, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_adb775c5-fe8e-43dc-839c-eaead963af39_verboseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in joint ventures</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:to="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_Medicare1Member_42713850-cbfb-4cc5-98fc-17b7a4ef0d19_terseLabel_en-US" xlink:label="lab_rdnt_Medicare1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare</link:label>
    <link:label id="lab_rdnt_Medicare1Member_label_en-US" xlink:label="lab_rdnt_Medicare1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare1 [Member]</link:label>
    <link:label id="lab_rdnt_Medicare1Member_documentation_en-US" xlink:label="lab_rdnt_Medicare1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Medicare1Member" xlink:href="rdnt-20200930.xsd#rdnt_Medicare1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_Medicare1Member" xlink:to="lab_rdnt_Medicare1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingCostsAndExpenses_8ec45baf-0f13-4232-a8a4-105e9c6569e2_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of operations, excluding depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_OperatingCostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingCostsAndExpenses" xlink:to="lab_us-gaap_OperatingCostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures_f7c122c0-a8f1-48e4-b74a-eca72d17d607_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeiture of restricted stock</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Restricted Stock Award, Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditDerivativesByContractTypeAxis_0da936a9-14fe-4f6d-b1b4-d39add24a779_terseLabel_en-US" xlink:label="lab_us-gaap_CreditDerivativesByContractTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Derivatives Contract Type [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditDerivativesByContractTypeAxis_label_en-US" xlink:label="lab_us-gaap_CreditDerivativesByContractTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Derivatives Contract Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditDerivativesByContractTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditDerivativesByContractTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditDerivativesByContractTypeAxis" xlink:to="lab_us-gaap_CreditDerivativesByContractTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_FirstLienCreditAgreementMember_5415de0e-cdbf-47e6-aa4b-7894bbbb67c9_terseLabel_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement</link:label>
    <link:label id="lab_rdnt_FirstLienCreditAgreementMember_label_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementMember" xlink:href="rdnt-20200930.xsd#rdnt_FirstLienCreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_FirstLienCreditAgreementMember" xlink:to="lab_rdnt_FirstLienCreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_ecd851b7-d11a-44e4-a0b5-32f6b1b39cf0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_b1c2a06a-3746-4ef8-97b5-59de91eb5150_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on term loan debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebt" xlink:to="lab_us-gaap_RepaymentsOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LeverageRatioOneMember_4a0cfc16-2d0b-4a67-bf1b-ccccd4fc3977_terseLabel_en-US" xlink:label="lab_rdnt_LeverageRatioOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">&gt; 5.50x</link:label>
    <link:label id="lab_rdnt_LeverageRatioOneMember_label_en-US" xlink:label="lab_rdnt_LeverageRatioOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio One [Member]</link:label>
    <link:label id="lab_rdnt_LeverageRatioOneMember_documentation_en-US" xlink:label="lab_rdnt_LeverageRatioOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioOneMember" xlink:href="rdnt-20200930.xsd#rdnt_LeverageRatioOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LeverageRatioOneMember" xlink:to="lab_rdnt_LeverageRatioOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_a0ac6a3e-155b-4558-8d89-38a741175249_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_4add5529-20fe-42ca-aa0e-b7df14c7b137_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_45297aea-9682-4bfa-8a69-6c928a36e561_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_1217c62b-4e97-40d9-b192-5bd1a9718d6d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_3b63d5f8-ec39-4b20-a0b1-368a6a9282d3_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_3cad905b-ffcc-4042-ba45-2421fc4d9919_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_September2020CapMember_7ccaf6ad-39e3-4f9d-8ad0-f008f22d137f_terseLabel_en-US" xlink:label="lab_rdnt_September2020CapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">September 2020</link:label>
    <link:label id="lab_rdnt_September2020CapMember_label_en-US" xlink:label="lab_rdnt_September2020CapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">September 2020 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_September2020CapMember" xlink:href="rdnt-20200930.xsd#rdnt_September2020CapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_September2020CapMember" xlink:to="lab_rdnt_September2020CapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DebtInstrumentPeriodicPaymentPercent_77b9ff18-d164-4ca3-ae9a-0ed5d2f0aac3_terseLabel_en-US" xlink:label="lab_rdnt_DebtInstrumentPeriodicPaymentPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Periodic payment, percent</link:label>
    <link:label id="lab_rdnt_DebtInstrumentPeriodicPaymentPercent_label_en-US" xlink:label="lab_rdnt_DebtInstrumentPeriodicPaymentPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Percent</link:label>
    <link:label id="lab_rdnt_DebtInstrumentPeriodicPaymentPercent_documentation_en-US" xlink:label="lab_rdnt_DebtInstrumentPeriodicPaymentPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentPeriodicPaymentPercent" xlink:href="rdnt-20200930.xsd#rdnt_DebtInstrumentPeriodicPaymentPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DebtInstrumentPeriodicPaymentPercent" xlink:to="lab_rdnt_DebtInstrumentPeriodicPaymentPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_44172845-1a19-4c4a-a104-51e267be3c9f_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMPREHENSIVE INCOME (LOSS)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_27f16033-e55c-4343-87b7-e02725d3057a_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable, accrued expenses and other</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_594f4826-07e1-4950-888d-cf0ade932036_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate value outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_6339012a-3c1c-44c5-a6ee-6f07b58cba40_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_c8c1cc5c-d65d-4403-8482-3e96578244ce_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired_9e0fc28b-c253-476a-b7b7-63b523d876df_terseLabel_en-US" xlink:label="lab_rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership percentage diluted</link:label>
    <link:label id="lab_rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired_label_en-US" xlink:label="lab_rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments, Ownership Interest Percentage Acquired</link:label>
    <link:label id="lab_rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired_documentation_en-US" xlink:label="lab_rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments, Ownership Interest Percentage Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired" xlink:href="rdnt-20200930.xsd#rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired" xlink:to="lab_rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_COVID19PandemicMember_cbca384e-a41d-4421-851a-d5c012ad57c4_terseLabel_en-US" xlink:label="lab_rdnt_COVID19PandemicMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19 Pandemic</link:label>
    <link:label id="lab_rdnt_COVID19PandemicMember_label_en-US" xlink:label="lab_rdnt_COVID19PandemicMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19 Pandemic [Member]</link:label>
    <link:label id="lab_rdnt_COVID19PandemicMember_documentation_en-US" xlink:label="lab_rdnt_COVID19PandemicMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19 Pandemic [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_COVID19PandemicMember" xlink:href="rdnt-20200930.xsd#rdnt_COVID19PandemicMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_COVID19PandemicMember" xlink:to="lab_rdnt_COVID19PandemicMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_523bd694-4aa4-464a-b53d-7edb34d18062_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm_50826682-fad8-442c-8004-d0365c3d4e17_terseLabel_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued after acquisition, term</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm_label_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares Issued After Acquisition Term</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm_documentation_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares Issued After Acquisition Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm" xlink:href="rdnt-20200930.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm" xlink:to="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_78a36359-7132-4420-8d4e-08bd8838922d_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DEFERRED REVENUE</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_d285946a-a24a-45f7-957a-66b7f8ff47a2_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PaycheckProtectionProgramLoansMember_c500b8bf-96b3-4cdf-9dc9-986b36870bd6_terseLabel_en-US" xlink:label="lab_rdnt_PaycheckProtectionProgramLoansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Paycheck Protection Program loans at 1% due April 2022</link:label>
    <link:label id="lab_rdnt_PaycheckProtectionProgramLoansMember_01e75e2b-3887-4142-b0d2-591d2a32b179_verboseLabel_en-US" xlink:label="lab_rdnt_PaycheckProtectionProgramLoansMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Paycheck Protection Program Loans</link:label>
    <link:label id="lab_rdnt_PaycheckProtectionProgramLoansMember_label_en-US" xlink:label="lab_rdnt_PaycheckProtectionProgramLoansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Paycheck Protection Program Loans [Member]</link:label>
    <link:label id="lab_rdnt_PaycheckProtectionProgramLoansMember_documentation_en-US" xlink:label="lab_rdnt_PaycheckProtectionProgramLoansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Paycheck Protection Program Loans [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PaycheckProtectionProgramLoansMember" xlink:href="rdnt-20200930.xsd#rdnt_PaycheckProtectionProgramLoansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PaycheckProtectionProgramLoansMember" xlink:to="lab_rdnt_PaycheckProtectionProgramLoansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_WorkersCompensationPersonalInjury1Member_cadc38f1-9116-4188-9aed-ce181686b3a6_terseLabel_en-US" xlink:label="lab_rdnt_WorkersCompensationPersonalInjury1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Workers' compensation/personal injury</link:label>
    <link:label id="lab_rdnt_WorkersCompensationPersonalInjury1Member_label_en-US" xlink:label="lab_rdnt_WorkersCompensationPersonalInjury1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Workers' Compensation/Personal Injury1 [Member]</link:label>
    <link:label id="lab_rdnt_WorkersCompensationPersonalInjury1Member_documentation_en-US" xlink:label="lab_rdnt_WorkersCompensationPersonalInjury1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Workers' Compensation/Personal Injury1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WorkersCompensationPersonalInjury1Member" xlink:href="rdnt-20200930.xsd#rdnt_WorkersCompensationPersonalInjury1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_WorkersCompensationPersonalInjury1Member" xlink:to="lab_rdnt_WorkersCompensationPersonalInjury1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_ab842725-ab63-40a6-b79a-d0f95d201105_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership percentage</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DebtInstrumentNumberofLoansReceived_56079072-42fa-4186-bdba-2d8a2833b48a_terseLabel_en-US" xlink:label="lab_rdnt_DebtInstrumentNumberofLoansReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of PPP loans received</link:label>
    <link:label id="lab_rdnt_DebtInstrumentNumberofLoansReceived_label_en-US" xlink:label="lab_rdnt_DebtInstrumentNumberofLoansReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Number of Loans Received</link:label>
    <link:label id="lab_rdnt_DebtInstrumentNumberofLoansReceived_documentation_en-US" xlink:label="lab_rdnt_DebtInstrumentNumberofLoansReceived" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Number of Loans Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentNumberofLoansReceived" xlink:href="rdnt-20200930.xsd#rdnt_DebtInstrumentNumberofLoansReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DebtInstrumentNumberofLoansReceived" xlink:to="lab_rdnt_DebtInstrumentNumberofLoansReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_6f9ed80e-2013-4ecc-bf2a-0e654822b7b9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NATURE OF BUSINESS AND BASIS OF PRESENTATION</link:label>
    <link:label id="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Description and Basis of Presentation [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_7553dbe9-629e-4553-b546-842361dfa0bf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of goodwill and other intangible assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities_a9dde45c-dfdb-4420-8e3f-7d604dc6e18a_totalLabel_en-US" xlink:label="lab_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt obligations</link:label>
    <link:label id="lab_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities_label_en-US" xlink:label="lab_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Short-term Debt and Capital Lease Obligations, Including Current Maturities</link:label>
    <link:label id="lab_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities_documentation_en-US" xlink:label="lab_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Short-term Debt and Capital Lease Obligations, Including Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities" xlink:href="rdnt-20200930.xsd#rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities" xlink:to="lab_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_5a2e372d-cb4c-4fc6-a25e-ad086183c31b_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_c15746fa-665b-4f44-a00c-59c4df30b2c4_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis" xlink:to="lab_us-gaap_LineOfCreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_7deadab9-a037-42b5-a008-7599ec6b2198_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock - shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_EquityContributionsInJointVentures_8ee344ca-bf73-4136-9811-6fbfd89c4a5f_terseLabel_en-US" xlink:label="lab_rdnt_EquityContributionsInJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity contributions in existing joint ventures</link:label>
    <link:label id="lab_rdnt_EquityContributionsInJointVentures_label_en-US" xlink:label="lab_rdnt_EquityContributionsInJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Contributions In Joint Ventures</link:label>
    <link:label id="lab_rdnt_EquityContributionsInJointVentures_documentation_en-US" xlink:label="lab_rdnt_EquityContributionsInJointVentures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Contributions In Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityContributionsInJointVentures" xlink:href="rdnt-20200930.xsd#rdnt_EquityContributionsInJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_EquityContributionsInJointVentures" xlink:to="lab_rdnt_EquityContributionsInJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock_0fef43c1-ba81-408c-8454-b84574779df2_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EQUITY BASED COMPENSATION</link:label>
    <link:label id="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Related Costs, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:to="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_5637325e-248d-48f7-9ab3-e39d7312e4e1_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_39655a68-f4d3-4ad5-9e63-2b22187eafbe_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares_60af8a1c-f9ec-46e9-a4d7-b468a0c228f9_terseLabel_en-US" xlink:label="lab_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration, milestone two, shares issued (in shares)</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares_label_en-US" xlink:label="lab_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Contingent Consideration Arrangements, Milestone Two, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares_documentation_en-US" xlink:label="lab_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Contingent Consideration Arrangements, Milestone Two, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares" xlink:href="rdnt-20200930.xsd#rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares" xlink:to="lab_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_e8bcce23-a504-4bfd-b360-e695b69f9431_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSA's unvested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_4e51a1b9-5afb-4eff-8332-a61473c17c12_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_e5d16ee7-d704-406a-a616-a3598ff6c136_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemDomain_09fd1c26-1b79-427f-a257-a09f81731f31_terseLabel_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Domain]</link:label>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemDomain_label_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain" xlink:to="lab_us-gaap_UnusualOrInfrequentItemDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_FirstLienCreditAgreementEighthAmendmentMember_13955c52-a685-42eb-8264-c07b839a4755_terseLabel_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementEighthAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement Eighth Amendment</link:label>
    <link:label id="lab_rdnt_FirstLienCreditAgreementEighthAmendmentMember_label_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementEighthAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement Eighth Amendment [Member]</link:label>
    <link:label id="lab_rdnt_FirstLienCreditAgreementEighthAmendmentMember_documentation_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementEighthAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement Eighth Amendment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementEighthAmendmentMember" xlink:href="rdnt-20200930.xsd#rdnt_FirstLienCreditAgreementEighthAmendmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_FirstLienCreditAgreementEighthAmendmentMember" xlink:to="lab_rdnt_FirstLienCreditAgreementEighthAmendmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_3e9b228f-0988-410a-a67d-2323f6840c91_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_61af120b-4645-4878-97dc-ae3dd666f60b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current operating lease liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_eb6f759e-3f23-4968-a810-42327817bad1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax_ab05dd8c-19fc-4c95-b97c-dd289bab9c9e_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management services provided to BRMG and NY Groups</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Measure of Activity, Income or Loss before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax" xlink:to="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_399af173-36c1-41a0-8425-c34114354791_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from revolving credit facility</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_be3e394e-630b-4309-9953-591a73f988e8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions paid to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_label_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToMinorityShareholders" xlink:to="lab_us-gaap_PaymentsToMinorityShareholders" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_October2025Member_b067e407-eb19-4f9b-a6b4-ec364e1466b4_terseLabel_en-US" xlink:label="lab_rdnt_October2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2025</link:label>
    <link:label id="lab_rdnt_October2025Member_label_en-US" xlink:label="lab_rdnt_October2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2025 [Member]</link:label>
    <link:label id="lab_rdnt_October2025Member_documentation_en-US" xlink:label="lab_rdnt_October2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_October2025Member" xlink:href="rdnt-20200930.xsd#rdnt_October2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_October2025Member" xlink:to="lab_rdnt_October2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_09bbedf1-167c-4442-b943-ea98b493679a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_2abd073c-d396-4d1b-bb08-e7ecdc2c63c3_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_d5f1de2c-79d8-4e6c-9f6d-1cdd23e8581e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:to="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BaseRateMember_89054daa-9c9c-4455-8080-48fb0ae3a0a6_terseLabel_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate</link:label>
    <link:label id="lab_us-gaap_BaseRateMember_label_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BaseRateMember" xlink:to="lab_us-gaap_BaseRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_f1aa4fba-2604-41d9-b49f-4d8cfe79d100_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_dd0dd986-4ff9-4374-96de-85341ebfbb0e_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RECENT ACCOUNTING AND REPORTING STANDARDS</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements and Changes in Accounting Principles [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets_45da2036-f036-496e-9049-f4c120170cf6_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Summarized Financial Information, Current Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets" xlink:to="lab_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_f48f105c-2135-4907-b259-df05ddc28a90_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_7367dfb3-9eba-4277-aabc-66443082e064_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_68ee6898-0f4b-4ed4-afeb-040fd946cc9f_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment fee percentage</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ProceedsReceivedFromInsurance_61677924-9a1c-4e7c-b761-e32f81456c1f_terseLabel_en-US" xlink:label="lab_rdnt_ProceedsReceivedFromInsurance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advance insurance carrier payments</link:label>
    <link:label id="lab_rdnt_ProceedsReceivedFromInsurance_label_en-US" xlink:label="lab_rdnt_ProceedsReceivedFromInsurance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds Received From Insurance</link:label>
    <link:label id="lab_rdnt_ProceedsReceivedFromInsurance_documentation_en-US" xlink:label="lab_rdnt_ProceedsReceivedFromInsurance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds Received From Insurance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProceedsReceivedFromInsurance" xlink:href="rdnt-20200930.xsd#rdnt_ProceedsReceivedFromInsurance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ProceedsReceivedFromInsurance" xlink:to="lab_rdnt_ProceedsReceivedFromInsurance" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_MedicVisionMember_73c8b28b-4f04-4411-b255-ff6bbe6a5936_terseLabel_en-US" xlink:label="lab_rdnt_MedicVisionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medic Vision</link:label>
    <link:label id="lab_rdnt_MedicVisionMember_label_en-US" xlink:label="lab_rdnt_MedicVisionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medic Vision [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicVisionMember" xlink:href="rdnt-20200930.xsd#rdnt_MedicVisionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_MedicVisionMember" xlink:to="lab_rdnt_MedicVisionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_2a2c5795-3434-4488-9067-28746ac28b1b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of derivative instruments on comprehensive income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3ea5238e-35b7-4eb5-aab9-03d642323deb_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_2db37060-7382-442d-9dae-1467aa506056_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under the equity compensation plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_12b02ff0-bf4f-44fc-bb38-791d9f3f67b5_terseLabel_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use asset required</link:label>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_label_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Right Of Use Asset</link:label>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_documentation_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Right Of Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" xlink:href="rdnt-20200930.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" xlink:to="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e7732eb0-8d3d-4f15-81e2-c292e2812c2e_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM FINANCING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_93a45a41-3c80-4b22-bff8-8ded12b46bc6_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0b03e688-0aa1-47de-abbc-a8ceebc928fe_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_084bbe3b-6489-447f-8763-00eb3b825680_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable, accrued expenses and other</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_HealthCareManagementServiceMember_a53d9c01-c078-47d6-8a8a-6508e83f83a3_terseLabel_en-US" xlink:label="lab_rdnt_HealthCareManagementServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management fee revenue</link:label>
    <link:label id="lab_rdnt_HealthCareManagementServiceMember_label_en-US" xlink:label="lab_rdnt_HealthCareManagementServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care, Management Service [Member]</link:label>
    <link:label id="lab_rdnt_HealthCareManagementServiceMember_documentation_en-US" xlink:label="lab_rdnt_HealthCareManagementServiceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care, Management Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HealthCareManagementServiceMember" xlink:href="rdnt-20200930.xsd#rdnt_HealthCareManagementServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_HealthCareManagementServiceMember" xlink:to="lab_rdnt_HealthCareManagementServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_0efcac6f-adcd-4cd5-a84b-1d106886a5e5_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermLoansPayable_389693a8-6e1f-4766-8188-dd8e9c7a0338_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermLoansPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment note payable at 4.6%, due through 2020, collateralized by medical equipment</link:label>
    <link:label id="lab_us-gaap_LongTermLoansPayable_label_en-US" xlink:label="lab_us-gaap_LongTermLoansPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermLoansPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermLoansPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermLoansPayable" xlink:to="lab_us-gaap_LongTermLoansPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_TotalBookValueOfOtherJointVenturePartnerInterests_09cb67ec-0041-4e99-9f37-96b008d6d5e8_terseLabel_en-US" xlink:label="lab_rdnt_TotalBookValueOfOtherJointVenturePartnerInterests" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total book value of other joint venture partner interests</link:label>
    <link:label id="lab_rdnt_TotalBookValueOfOtherJointVenturePartnerInterests_label_en-US" xlink:label="lab_rdnt_TotalBookValueOfOtherJointVenturePartnerInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total book value of other joint venture partner interests</link:label>
    <link:label id="lab_rdnt_TotalBookValueOfOtherJointVenturePartnerInterests_documentation_en-US" xlink:label="lab_rdnt_TotalBookValueOfOtherJointVenturePartnerInterests" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total book value of other joint venture partner interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TotalBookValueOfOtherJointVenturePartnerInterests" xlink:href="rdnt-20200930.xsd#rdnt_TotalBookValueOfOtherJointVenturePartnerInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_TotalBookValueOfOtherJointVenturePartnerInterests" xlink:to="lab_rdnt_TotalBookValueOfOtherJointVenturePartnerInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7e13f00c-0157-481c-a793-19e7be5645e1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepositsAssets_03bafe95-cb9b-454c-8f3a-ca28078a7341_terseLabel_en-US" xlink:label="lab_us-gaap_DepositsAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deposits and other</link:label>
    <link:label id="lab_us-gaap_DepositsAssets_label_en-US" xlink:label="lab_us-gaap_DepositsAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deposits Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DepositsAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepositsAssets" xlink:to="lab_us-gaap_DepositsAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets_7dbd84f1-28c3-432e-8d42-44637a78cbfe_totalLabel_en-US" xlink:label="lab_rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total property, equipment and right-of-use assets</link:label>
    <link:label id="lab_rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets_label_en-US" xlink:label="lab_rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property Plant and Equipment Net Including Right of Use Assets</link:label>
    <link:label id="lab_rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets_documentation_en-US" xlink:label="lab_rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property Plant and Equipment Net Including Right of Use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets" xlink:href="rdnt-20200930.xsd#rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets" xlink:to="lab_rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets_3dbe94de-7815-4541-b880-fa742c285493_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on sale and disposal of equipment and other</link:label>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets_label_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnDispositionOfAssets" xlink:to="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_e3213828-0259-4976-8f4a-ea669e5faf17_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Not Primary Beneficiary</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Not Primary Beneficiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:to="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HealthCarePatientServiceMember_4fd7d02d-f93f-4629-8174-c2c35a93f1f1_verboseLabel_en-US" xlink:label="lab_us-gaap_HealthCarePatientServiceMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service fee revenue</link:label>
    <link:label id="lab_us-gaap_HealthCarePatientServiceMember_1d817fab-e3f0-4050-bc72-e1e0b93a84f7_terseLabel_en-US" xlink:label="lab_us-gaap_HealthCarePatientServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service fee revenue</link:label>
    <link:label id="lab_us-gaap_HealthCarePatientServiceMember_label_en-US" xlink:label="lab_us-gaap_HealthCarePatientServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care, Patient Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCarePatientServiceMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HealthCarePatientServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HealthCarePatientServiceMember" xlink:to="lab_us-gaap_HealthCarePatientServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_27b101a5-293f-45b5-9c31-2529c0e391ec_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional amounts</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:to="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_bbdbe439-ad26-42cf-a7ab-1dd95109dbb6_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_118d6880-54bc-4301-bfd1-8be0a9621809_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized expense weighted average period</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities_f4e1afec-638c-47ba-9e5f-ecf13ba24bba_negatedLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Summarized Financial Information, Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities" xlink:to="lab_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_8228ca43-8d8b-4967-9147-1dea9f33d0c0_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_5b26bc0d-d159-4e72-ae35-8a371e2b11fe_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_SocialSecurityTaxEmployerDeferralCARESAct_a697f51b-e3b9-42f4-bc28-015c3e41ffd2_terseLabel_en-US" xlink:label="lab_rdnt_SocialSecurityTaxEmployerDeferralCARESAct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred social security taxes</link:label>
    <link:label id="lab_rdnt_SocialSecurityTaxEmployerDeferralCARESAct_label_en-US" xlink:label="lab_rdnt_SocialSecurityTaxEmployerDeferralCARESAct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Social Security Tax, Employer, Deferral, CARES Act</link:label>
    <link:label id="lab_rdnt_SocialSecurityTaxEmployerDeferralCARESAct_documentation_en-US" xlink:label="lab_rdnt_SocialSecurityTaxEmployerDeferralCARESAct" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Social Security Tax, Employer, Deferral, CARES Act</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SocialSecurityTaxEmployerDeferralCARESAct" xlink:href="rdnt-20200930.xsd#rdnt_SocialSecurityTaxEmployerDeferralCARESAct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_SocialSecurityTaxEmployerDeferralCARESAct" xlink:to="lab_rdnt_SocialSecurityTaxEmployerDeferralCARESAct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_1cba6970-39a4-4635-bd79-7eab82c7519a_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock for acquisition (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFinanceLeaseLiabilities_ebc9ac2d-972c-436a-92fa-983b148b73c8_terseLabel_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFinanceLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease liabilities acquired</link:label>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFinanceLeaseLiabilities_label_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFinanceLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Finance Lease Liabilities</link:label>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFinanceLeaseLiabilities_documentation_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFinanceLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Finance Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFinanceLeaseLiabilities" xlink:href="rdnt-20200930.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFinanceLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFinanceLeaseLiabilities" xlink:to="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFinanceLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_0207f3f9-5e40-46f9-b7d7-b0486598e547_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_f92c5522-e973-45d8-a8e6-5f41d2005049_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate, stated percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_bbbd6ead-740b-4222-9d0c-8f7e45e51b84_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate, stated percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue_3efbbf75-e38e-43c8-ad8c-6b41c2e693ef_terseLabel_en-US" xlink:label="lab_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock upon exercise of options</link:label>
    <link:label id="lab_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue_label_en-US" xlink:label="lab_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-based Payment Award, Options, Grants In Period, Gross, Value</link:label>
    <link:label id="lab_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue_documentation_en-US" xlink:label="lab_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-based Payment Award, Options, Grants In Period, Gross, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" xlink:href="rdnt-20200930.xsd#rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" xlink:to="lab_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_82dc06ae-bbe7-4b5b-8aa3-26303de277d8_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ChiefExecutiveOfficerMember_1ab03220-60af-4fdd-b886-9bad8c0d4523_terseLabel_en-US" xlink:label="lab_srt_ChiefExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chief Executive Officer</link:label>
    <link:label id="lab_srt_ChiefExecutiveOfficerMember_label_en-US" xlink:label="lab_srt_ChiefExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chief Executive Officer [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ChiefExecutiveOfficerMember" xlink:to="lab_srt_ChiefExecutiveOfficerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_60f2cd59-d46c-42ab-8ba6-6f348f5681b9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_79b5c119-8379-401b-9ea6-c54524f0103a_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional shares issuable upon exercise of stock options and warrants (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_d9eca29f-0887-4b25-aac7-5f919e1f1af0_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_EquityMethodInvestmentSharesPurchased_592e325e-bd44-40e3-82d7-416f2f8ff690_terseLabel_en-US" xlink:label="lab_rdnt_EquityMethodInvestmentSharesPurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares purchased (in shares)</link:label>
    <link:label id="lab_rdnt_EquityMethodInvestmentSharesPurchased_label_en-US" xlink:label="lab_rdnt_EquityMethodInvestmentSharesPurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Shares Purchased</link:label>
    <link:label id="lab_rdnt_EquityMethodInvestmentSharesPurchased_documentation_en-US" xlink:label="lab_rdnt_EquityMethodInvestmentSharesPurchased" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Shares Purchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentSharesPurchased" xlink:href="rdnt-20200930.xsd#rdnt_EquityMethodInvestmentSharesPurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_EquityMethodInvestmentSharesPurchased" xlink:to="lab_rdnt_EquityMethodInvestmentSharesPurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_HealthCarePatientServiceOtherMember_5eea1898-d904-4d2e-af44-83502aae64d2_terseLabel_en-US" xlink:label="lab_rdnt_HealthCarePatientServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other patient revenue</link:label>
    <link:label id="lab_rdnt_HealthCarePatientServiceOtherMember_label_en-US" xlink:label="lab_rdnt_HealthCarePatientServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care, Patient Service Other [Member]</link:label>
    <link:label id="lab_rdnt_HealthCarePatientServiceOtherMember_documentation_en-US" xlink:label="lab_rdnt_HealthCarePatientServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care, Patient Service Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HealthCarePatientServiceOtherMember" xlink:href="rdnt-20200930.xsd#rdnt_HealthCarePatientServiceOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_HealthCarePatientServiceOtherMember" xlink:to="lab_rdnt_HealthCarePatientServiceOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_RestatedPlanMember_3caedecb-e6dd-48c4-bccb-9d737ed5aa0e_terseLabel_en-US" xlink:label="lab_rdnt_RestatedPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restated Plan</link:label>
    <link:label id="lab_rdnt_RestatedPlanMember_label_en-US" xlink:label="lab_rdnt_RestatedPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restated Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedPlanMember" xlink:href="rdnt-20200930.xsd#rdnt_RestatedPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_RestatedPlanMember" xlink:to="lab_rdnt_RestatedPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_52dbb311-9cad-4b01-9422-dfacc97419e5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of loss reclassified from accumulated OCI into income (prior period effective portion)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_WhiteRabbit.aiInc.Member_43e3e1ab-67cc-4e8e-a71e-616202a5e17c_terseLabel_en-US" xlink:label="lab_rdnt_WhiteRabbit.aiInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WhiteRabbit.ai Inc.</link:label>
    <link:label id="lab_rdnt_WhiteRabbit.aiInc.Member_label_en-US" xlink:label="lab_rdnt_WhiteRabbit.aiInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WhiteRabbit.ai Inc. [Member]</link:label>
    <link:label id="lab_rdnt_WhiteRabbit.aiInc.Member_documentation_en-US" xlink:label="lab_rdnt_WhiteRabbit.aiInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WhiteRabbit.ai Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WhiteRabbit.aiInc.Member" xlink:href="rdnt-20200930.xsd#rdnt_WhiteRabbit.aiInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_WhiteRabbit.aiInc.Member" xlink:to="lab_rdnt_WhiteRabbit.aiInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_576c3572-ee8d-4ce3-ad1c-daeccdf3d21f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_a6c46a2c-a663-4b46-ba85-f82414c3a477_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DebtInstrumentCovenantLeverageRatioMaximum_c4c5624d-bac7-4ade-83fe-8466aac22906_terseLabel_en-US" xlink:label="lab_rdnt_DebtInstrumentCovenantLeverageRatioMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage ratio, less than</link:label>
    <link:label id="lab_rdnt_DebtInstrumentCovenantLeverageRatioMaximum_label_en-US" xlink:label="lab_rdnt_DebtInstrumentCovenantLeverageRatioMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Leverage Ratio, Maximum</link:label>
    <link:label id="lab_rdnt_DebtInstrumentCovenantLeverageRatioMaximum_documentation_en-US" xlink:label="lab_rdnt_DebtInstrumentCovenantLeverageRatioMaximum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Leverage Ratio, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentCovenantLeverageRatioMaximum" xlink:href="rdnt-20200930.xsd#rdnt_DebtInstrumentCovenantLeverageRatioMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DebtInstrumentCovenantLeverageRatioMaximum" xlink:to="lab_rdnt_DebtInstrumentCovenantLeverageRatioMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_3e68f28e-fb78-4881-a02b-cf441d98ee23_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationRevenue_3dada496-8899-4864-8f0e-ab1e76013c5e_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenue</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationRevenue_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Summarized Financial Information, Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentSummarizedFinancialInformationRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationRevenue" xlink:to="lab_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_48e4c922-282e-435d-b18f-d22a9315fb16_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based payment award, expiration period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_ff92bbfc-e816-4439-80a2-6d9b21d135a8_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_c8d55e53-c508-4718-b545-d22136a1e1b5_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy_268cd8ae-8bdb-4989-94f1-9e4bf509d035_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GOODWILL AND INDEFINITE LIVED INTANGIBLES</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Intangible Assets, Indefinite-Lived, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfBusinessesAcquired_a6fe8832-f9b8-4aaf-a354-ad4d98ea28fa_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfBusinessesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of businesses acquired</link:label>
    <link:label id="lab_us-gaap_NumberOfBusinessesAcquired_label_en-US" xlink:label="lab_us-gaap_NumberOfBusinessesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Businesses Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfBusinessesAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NumberOfBusinessesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfBusinessesAcquired" xlink:to="lab_us-gaap_NumberOfBusinessesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_8512495c-55e3-49f9-9229-d1595694a22f_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of equipment</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_1a48c09e-a3c0-4c35-b2d8-775fb3992dcd_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_f12ee51d-e236-4fa1-a240-d5fb8521b497_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of loss recognized in income on derivative (current period ineffective portion)</link:label>
    <link:label id="lab_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_label_en-US" xlink:label="lab_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Fair Value Hedges Recognized in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings" xlink:to="lab_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities_290ef335-a6cd-4afc-b0a7-af5d00a5c356_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal payments on notes and leases payable</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of Long-term Debt, Long-term Lease Obligation, and Capital Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_9866ff55-5101-4a41-b962-6be117db6397_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SIGNIFICANT ACCOUNTING POLICIES</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DignityHealthMember_4c226264-3860-4a63-b923-4197ef3e91ee_terseLabel_en-US" xlink:label="lab_rdnt_DignityHealthMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dignity Health</link:label>
    <link:label id="lab_rdnt_DignityHealthMember_label_en-US" xlink:label="lab_rdnt_DignityHealthMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dignity Health [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DignityHealthMember" xlink:href="rdnt-20200930.xsd#rdnt_DignityHealthMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DignityHealthMember" xlink:to="lab_rdnt_DignityHealthMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInMajorityOwnedSubsidiariesMember_5f34a182-5cdf-46e4-bd35-877bcb8ccdd5_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInMajorityOwnedSubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Majority-owned Subsidiaries</link:label>
    <link:label id="lab_us-gaap_InvestmentsInMajorityOwnedSubsidiariesMember_label_en-US" xlink:label="lab_us-gaap_InvestmentsInMajorityOwnedSubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Majority-owned Subsidiaries [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInMajorityOwnedSubsidiariesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsInMajorityOwnedSubsidiariesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInMajorityOwnedSubsidiariesMember" xlink:to="lab_us-gaap_InvestmentsInMajorityOwnedSubsidiariesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_a0e77b81-aa04-4e82-be55-c737151f34b5_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_ae85fae4-c06b-4496-a1c6-6d18e05c2a79_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_d880f1dc-98f2-494d-8d4c-a33398a4be8b_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock - shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_c37dc992-fe17-4fa2-8980-8f180184b29c_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_3a24e9d2-32a2-40ba-a51a-e4d2a0a13229_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock - par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayableOtherPayablesMember_ed8f07da-2b4f-437a-938b-1dc0bd884d30_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment Notes Payable</link:label>
    <link:label id="lab_us-gaap_NotesPayableOtherPayablesMember_label_en-US" xlink:label="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Other Payables [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableOtherPayablesMember" xlink:to="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_154824db-a70e-4b2c-91f8-8b0600ad518f_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_da2d54bf-e324-4a3e-ac30-a56561203944_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Term Loans and SunTrust Term Loan</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_ac729b9a-8715-4bfe-8499-7f97e48e92a1_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average fair value, beginning balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_221ab4c3-5944-40e2-939e-f02907dfee9b_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average fair value, ending balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther_b434f8cd-57b5-41a9-bde7-fae5a9f2db85_terseLabel_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets acquired</link:label>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther_label_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets, Other</link:label>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther_documentation_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" xlink:href="rdnt-20200930.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" xlink:to="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_08b76a17-3768-4f9a-8278-828d3c4eb103_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_c3d21906-fd18-4067-ad10-a958e13ebb27_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_ec8c4521-e6c6-4587-b6f1-f17acdc8c3bb_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_51c05aad-8ab9-4670-b633-8c79d8dddf58_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:to="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationLiabilities_92b9ea8c-ed24-4374-a850-33b70e0e5b18_negatedLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent liabilities</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationLiabilities_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Summarized Financial Information, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentSummarizedFinancialInformationLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationLiabilities" xlink:to="lab_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_October2020CapMember_3ed46379-2e14-4265-bc2f-b03d473004ec_terseLabel_en-US" xlink:label="lab_rdnt_October2020CapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2020</link:label>
    <link:label id="lab_rdnt_October2020CapMember_label_en-US" xlink:label="lab_rdnt_October2020CapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2020 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_October2020CapMember" xlink:href="rdnt-20200930.xsd#rdnt_October2020CapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_October2020CapMember" xlink:to="lab_rdnt_October2020CapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_169a69ce-ea9c-41aa-a116-274d30462e01_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenue_1ad91e6c-0137-45b8-a722-8521d9625686_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_DeferredRevenue_label_en-US" xlink:label="lab_us-gaap_DeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenue" xlink:to="lab_us-gaap_DeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_6d59d2ba-e7b5-4933-a1f6-3f2c6f68d056_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_b65c40ba-ef2c-48e6-9315-ba894db29514_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_0459a6cc-fc51-455e-87cf-137df97a3c5d_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PricingLevelIVMember_d58ee101-3851-406b-ba21-181897d88eec_terseLabel_en-US" xlink:label="lab_rdnt_PricingLevelIVMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level IV</link:label>
    <link:label id="lab_rdnt_PricingLevelIVMember_label_en-US" xlink:label="lab_rdnt_PricingLevelIVMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level IV [Member]</link:label>
    <link:label id="lab_rdnt_PricingLevelIVMember_documentation_en-US" xlink:label="lab_rdnt_PricingLevelIVMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level IV [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIVMember" xlink:href="rdnt-20200930.xsd#rdnt_PricingLevelIVMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PricingLevelIVMember" xlink:to="lab_rdnt_PricingLevelIVMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_29eebf98-37fc-4332-9fe8-9301a8904dd2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of first lien credit agreement</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_d497e6b7-0473-412d-9f5f-c6ae59ac271a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisition, closing costs</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Transaction Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:to="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_2d93338e-9ae8-43f5-b547-a285b8bbfaef_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_a8629ae2-a1f3-4506-b58f-f72adda98d94_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesAxis" xlink:to="lab_srt_ConsolidatedEntitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_e731fbfa-2711-497e-b2b4-0fbc3acf07c8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Periodic payment, principal</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Principal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:to="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_ced9a8da-9c68-45ac-9f93-40c821cb62cf_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_7908c386-78e7-409c-a58c-c3a78ba8f7ce_terseLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BRMG and NY Groups accounts payable</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PropertyAndEquipmentMember_95588054-a275-4ea8-a1d6-ba5701bd4e02_terseLabel_en-US" xlink:label="lab_rdnt_PropertyAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts returned to property and equipment</link:label>
    <link:label id="lab_rdnt_PropertyAndEquipmentMember_label_en-US" xlink:label="lab_rdnt_PropertyAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Propery and equipment, net [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PropertyAndEquipmentMember" xlink:href="rdnt-20200930.xsd#rdnt_PropertyAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PropertyAndEquipmentMember" xlink:to="lab_rdnt_PropertyAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_NumberOfAssetsAcquired_a41198be-e3ac-4be1-93e4-e391d08d38ca_terseLabel_en-US" xlink:label="lab_rdnt_NumberOfAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of assets acquired</link:label>
    <link:label id="lab_rdnt_NumberOfAssetsAcquired_label_en-US" xlink:label="lab_rdnt_NumberOfAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Assets Acquired</link:label>
    <link:label id="lab_rdnt_NumberOfAssetsAcquired_documentation_en-US" xlink:label="lab_rdnt_NumberOfAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberOfAssetsAcquired" xlink:href="rdnt-20200930.xsd#rdnt_NumberOfAssetsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_NumberOfAssetsAcquired" xlink:to="lab_rdnt_NumberOfAssetsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_25a36147-4e82-4eb6-ace2-b744e6b2b07a_terseLabel_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RECLASSIFICATION</link:label>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_label_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_450e8fe3-d6dc-4ec7-94a0-0ab9d3e7794d_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock - $0.0001 par value, 200,000,000 shares authorized; 51,596,098 and 50,314,328 shares issued and outstanding at September 30, 2020 and December 31, 2019, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_6b8ac3ab-841c-4794-b16c-a4c47247bf78_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_b1da6944-739e-4a95-9967-6c5d44bb1374_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_1c88c291-e8ea-411a-9561-3ca459917bc7_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of common stock upon exercise of options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_d4310e14-5d6f-4b69-a860-835d467e3e3b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_1cac5b45-7f79-4771-87c1-94aa40d728cb_terseLabel_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FACILITY ACQUISITIONS AND DISPOSITIONS</link:label>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mergers, Acquisitions and Dispositions Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:to="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_5137d563-ec47-4079-bd9c-e513e328f2b7_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_CommercialInsurance1Member_9ee8fb6b-28fd-4a7f-ae45-c65f6860e6b8_terseLabel_en-US" xlink:label="lab_rdnt_CommercialInsurance1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial insurance</link:label>
    <link:label id="lab_rdnt_CommercialInsurance1Member_label_en-US" xlink:label="lab_rdnt_CommercialInsurance1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Insurance1 [Member]</link:label>
    <link:label id="lab_rdnt_CommercialInsurance1Member_documentation_en-US" xlink:label="lab_rdnt_CommercialInsurance1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Insurance1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CommercialInsurance1Member" xlink:href="rdnt-20200930.xsd#rdnt_CommercialInsurance1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_CommercialInsurance1Member" xlink:to="lab_rdnt_CommercialInsurance1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_HudsonValleyRadiologyAssociatesMember_8a92cc23-6481-4039-8890-eab39d8fca5b_terseLabel_en-US" xlink:label="lab_rdnt_HudsonValleyRadiologyAssociatesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hudson Valley Radiology Associates</link:label>
    <link:label id="lab_rdnt_HudsonValleyRadiologyAssociatesMember_label_en-US" xlink:label="lab_rdnt_HudsonValleyRadiologyAssociatesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hudson Valley Radiology Associates [Member]</link:label>
    <link:label id="lab_rdnt_HudsonValleyRadiologyAssociatesMember_documentation_en-US" xlink:label="lab_rdnt_HudsonValleyRadiologyAssociatesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hudson Valley Radiology Associates [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HudsonValleyRadiologyAssociatesMember" xlink:href="rdnt-20200930.xsd#rdnt_HudsonValleyRadiologyAssociatesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_HudsonValleyRadiologyAssociatesMember" xlink:to="lab_rdnt_HudsonValleyRadiologyAssociatesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis_2aa71005-788c-4836-8bbc-21392691a184_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advances to Affiliates Categorization [Axis]</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis_label_en-US" xlink:label="lab_us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advances to Affiliates Categorization [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis" xlink:to="lab_us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_AdvanceMedicarePayments_a2eeb789-a51c-469a-934c-863f6791e15d_terseLabel_en-US" xlink:label="lab_rdnt_AdvanceMedicarePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advance medicare payments</link:label>
    <link:label id="lab_rdnt_AdvanceMedicarePayments_label_en-US" xlink:label="lab_rdnt_AdvanceMedicarePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advance Medicare Payments</link:label>
    <link:label id="lab_rdnt_AdvanceMedicarePayments_documentation_en-US" xlink:label="lab_rdnt_AdvanceMedicarePayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advance Medicare Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AdvanceMedicarePayments" xlink:href="rdnt-20200930.xsd#rdnt_AdvanceMedicarePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_AdvanceMedicarePayments" xlink:to="lab_rdnt_AdvanceMedicarePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_36faf0b1-7031-4517-8d11-1d99b26541f5_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock_643f9a3e-1ee9-4965-83f9-1e4fd5ad290f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CREDIT FACILITY AND NOTES PAYABLE</link:label>
    <link:label id="lab_us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Capital Leases Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock" xlink:to="lab_us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_MRIatWoodbridgeLLCMember_eb0237cf-bc40-43d2-a082-bc96ba7a5836_terseLabel_en-US" xlink:label="lab_rdnt_MRIatWoodbridgeLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MRI at Woodbridge, LLC</link:label>
    <link:label id="lab_rdnt_MRIatWoodbridgeLLCMember_label_en-US" xlink:label="lab_rdnt_MRIatWoodbridgeLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MRI at Woodbridge, LLC [Member]</link:label>
    <link:label id="lab_rdnt_MRIatWoodbridgeLLCMember_documentation_en-US" xlink:label="lab_rdnt_MRIatWoodbridgeLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MRI at Woodbridge, LLC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MRIatWoodbridgeLLCMember" xlink:href="rdnt-20200930.xsd#rdnt_MRIatWoodbridgeLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_MRIatWoodbridgeLLCMember" xlink:to="lab_rdnt_MRIatWoodbridgeLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityOther_00c243e7-66df-4b07-9aee-8bb661f85ab4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityOther_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityOther" xlink:to="lab_us-gaap_StockholdersEquityOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_db70bebe-56d0-4da5-b4e0-61b07a774cec_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d587fe4b-9aa2-4596-a782-13eb963b1f8e_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of common shares outstanding during the period (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_fde8b6a3-3c93-4c83-a1fb-acdcd1df2f97_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_eeb27ee7-0557-4270-b8ad-46b31ec508e1_terseLabel_en-US" xlink:label="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customer [Line Items]</link:label>
    <link:label id="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_label_en-US" xlink:label="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customer [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_1103dcf0-3951-46ff-8852-32566c06d3ea_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0908c174-6dc9-4891-a2b7-522be8db010f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LeverageRatioThreeMember_d919bb84-07a4-42ff-a35a-c890b030c1da_terseLabel_en-US" xlink:label="lab_rdnt_LeverageRatioThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">&gt;3.50x but &#8804; 4.00x</link:label>
    <link:label id="lab_rdnt_LeverageRatioThreeMember_label_en-US" xlink:label="lab_rdnt_LeverageRatioThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Three [Member]</link:label>
    <link:label id="lab_rdnt_LeverageRatioThreeMember_documentation_en-US" xlink:label="lab_rdnt_LeverageRatioThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Three [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioThreeMember" xlink:href="rdnt-20200930.xsd#rdnt_LeverageRatioThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LeverageRatioThreeMember" xlink:to="lab_rdnt_LeverageRatioThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OffsettingAssetsTable_9f989b94-72fe-49b6-8ca5-9d186f43b19c_terseLabel_en-US" xlink:label="lab_us-gaap_OffsettingAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offsetting Assets [Table]</link:label>
    <link:label id="lab_us-gaap_OffsettingAssetsTable_label_en-US" xlink:label="lab_us-gaap_OffsettingAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offsetting Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OffsettingAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OffsettingAssetsTable" xlink:to="lab_us-gaap_OffsettingAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock_dd23254a-5d38-4f5c-9a2c-cf206e60797b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service Fee Revenue</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Principal Transactions Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock" xlink:to="lab_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_FirstLienCreditAgreementSixthAmendmentMember_ee7c0cda-3183-41d3-a172-2887b35b05d3_terseLabel_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementSixthAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement, Sixth Amendment</link:label>
    <link:label id="lab_rdnt_FirstLienCreditAgreementSixthAmendmentMember_label_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementSixthAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement Sixth Amendment [Member]</link:label>
    <link:label id="lab_rdnt_FirstLienCreditAgreementSixthAmendmentMember_documentation_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementSixthAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement Sixth Amendment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember" xlink:href="rdnt-20200930.xsd#rdnt_FirstLienCreditAgreementSixthAmendmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember" xlink:to="lab_rdnt_FirstLienCreditAgreementSixthAmendmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_096ad1d9-bc75-491f-8853-6a046d7dac09_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to acquire equity method investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_19786edc-3c60-4416-8be6-cafac4e368c4_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total RadNet, Inc.'s stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountCurrent_9819ffce-ca03-4760-b103-7ba30be1c4c0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt discount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountCurrent_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermNotesPayable_a8287866-4bc7-40c9-8681-d173e3252fb6_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes payable, net of current portion</link:label>
    <link:label id="lab_us-gaap_LongTermNotesPayable_label_en-US" xlink:label="lab_us-gaap_LongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermNotesPayable" xlink:to="lab_us-gaap_LongTermNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock_be4106bc-ae73-42cd-8c20-84e05c6f3f29_terseLabel_en-US" xlink:label="lab_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint venture investment and financial information</link:label>
    <link:label id="lab_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock_label_en-US" xlink:label="lab_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint Venture Investment And Financial Information [Table Text Block]</link:label>
    <link:label id="lab_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock_documentation_en-US" xlink:label="lab_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint Venture Investment And Financial Information</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock" xlink:href="rdnt-20200930.xsd#rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock" xlink:to="lab_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets_6b5a5763-c182-42f1-812e-44bb77767a7b_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost in excess of book value of acquired joint venture interests and other</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Underlying Equity in Net Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets" xlink:to="lab_us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_b8db2ff2-6aac-4657-8291-7edc08550171_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSA's forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireInterestInJointVenture_cbfada22-5abc-434a-852a-099fca4e716b_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to acquire additional interest in subsidiaries</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInterestInJointVenture_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Interest in Joint Venture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireInterestInJointVenture"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:to="lab_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsCurrentMaturities_68840c0a-ce77-4df3-ac2d-877711abcdd0_negatedLabel_en-US" xlink:label="lab_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsCurrentMaturities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: current portion</link:label>
    <link:label id="lab_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsCurrentMaturities_label_en-US" xlink:label="lab_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Short-term Debt and Capital Lease Obligations, Current Maturities</link:label>
    <link:label id="lab_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsCurrentMaturities_documentation_en-US" xlink:label="lab_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Short-term Debt and Capital Lease Obligations, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsCurrentMaturities" xlink:href="rdnt-20200930.xsd#rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsCurrentMaturities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsCurrentMaturities" xlink:to="lab_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsCurrentMaturities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_4fe38817-3807-4ca0-87ca-3173abf5ca99_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of noncontrolling interests, net of taxes</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase from Sale of Parent Equity Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:to="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_3e7472b6-aca0-40fc-9c36-173f516319a8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FAIR VALUE MEASUREMENTS</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_3bb0fd85-4776-408b-a49d-7bd9342cb8c5_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_OperatingLeaseRightofUseAssetAmortization_61ea2ffd-b2cc-4a43-b132-2b9c925a6c5a_terseLabel_en-US" xlink:label="lab_rdnt_OperatingLeaseRightofUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of operating lease right-of-use assets</link:label>
    <link:label id="lab_rdnt_OperatingLeaseRightofUseAssetAmortization_label_en-US" xlink:label="lab_rdnt_OperatingLeaseRightofUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Right of Use Asset Amortization</link:label>
    <link:label id="lab_rdnt_OperatingLeaseRightofUseAssetAmortization_documentation_en-US" xlink:label="lab_rdnt_OperatingLeaseRightofUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Right of Use Asset Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingLeaseRightofUseAssetAmortization" xlink:href="rdnt-20200930.xsd#rdnt_OperatingLeaseRightofUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_OperatingLeaseRightofUseAssetAmortization" xlink:to="lab_rdnt_OperatingLeaseRightofUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DueFromRelatedPartiesCurrent_ea28b00d-9d85-4c6b-adbc-4785627478c8_terseLabel_en-US" xlink:label="lab_us-gaap_DueFromRelatedPartiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due from affiliates</link:label>
    <link:label id="lab_us-gaap_DueFromRelatedPartiesCurrent_label_en-US" xlink:label="lab_us-gaap_DueFromRelatedPartiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due from Related Parties, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueFromRelatedPartiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DueFromRelatedPartiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DueFromRelatedPartiesCurrent" xlink:to="lab_us-gaap_DueFromRelatedPartiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract_6327776d-e977-4ef5-9126-e96813460cdf_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PROPERTY, EQUIPMENT AND RIGHT-OF-USE ASSETS</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net, Including and Excluding Capital Leased Asset [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_AssetAcquisitionDomain_0c090064-e238-44f3-99a2-c77a87b72851_terseLabel_en-US" xlink:label="lab_rdnt_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Domain]</link:label>
    <link:label id="lab_rdnt_AssetAcquisitionDomain_label_en-US" xlink:label="lab_rdnt_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Domain]</link:label>
    <link:label id="lab_rdnt_AssetAcquisitionDomain_documentation_en-US" xlink:label="lab_rdnt_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Asset Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AssetAcquisitionDomain" xlink:href="rdnt-20200930.xsd#rdnt_AssetAcquisitionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_AssetAcquisitionDomain" xlink:to="lab_rdnt_AssetAcquisitionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture_b96e4ccf-3dde-4815-93f0-b142fab18c3c_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from the sale of equity interests in a joint venture</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Interest in Joint Venture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromDivestitureOfInterestInJointVenture"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_aabe7843-f814-434d-b634-e43cf1f71820_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss, net of taxes</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:to="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_d1a08105-44da-4030-817b-4e2cd85144bc_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_a56a0fa7-7ca1-4f2e-81b7-4a4628c988ff_verboseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_dfd68f06-ce3b-4876-ac39-efdc05da5843_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in cumulative foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_015e5142-62f7-4279-b19e-2a503319603c_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock for purchase of membership interest in HVRA</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_26c30ef3-4e56-40d9-9565-fc211c092c30_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid during the period for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EurodollarMember_a7fb09ef-d655-483a-9737-09f24f52a471_terseLabel_en-US" xlink:label="lab_us-gaap_EurodollarMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eurodollar</link:label>
    <link:label id="lab_us-gaap_EurodollarMember_label_en-US" xlink:label="lab_us-gaap_EurodollarMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eurodollar [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EurodollarMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EurodollarMember" xlink:to="lab_us-gaap_EurodollarMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_f401d4d6-ed8c-405c-bf28-8161c79bb61d_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_13f57f2f-cecb-4f60-abd3-0d5549811165_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_FirstLienTermLoansAMember_665ea159-ac38-41b1-87b1-8260245b0be6_terseLabel_en-US" xlink:label="lab_rdnt_FirstLienTermLoansAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FirstLienTermLoansAMember</link:label>
    <link:label id="lab_rdnt_FirstLienTermLoansAMember_label_en-US" xlink:label="lab_rdnt_FirstLienTermLoansAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FirstLienTermLoansAMember</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienTermLoansAMember" xlink:href="rdnt-20200930.xsd#rdnt_FirstLienTermLoansAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_FirstLienTermLoansAMember" xlink:to="lab_rdnt_FirstLienTermLoansAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_72bfac51-e6cc-44c3-9da6-02d285f5f1ad_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ebf3df29-3c6f-41a6-93e1-3d351d963e1f_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares for which the exercise price exceeds average market price of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_d05ba111-cb41-441b-bfa7-17b2ee5634be_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested restricted stock subject only to service vesting (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares, Restricted Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesRestrictedStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_e5847a1e-ce35-4a9e-86f8-331d1f311f27_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PricingLevelVMember_df70bf8d-ba40-40c0-91b0-9d95b7a9f264_terseLabel_en-US" xlink:label="lab_rdnt_PricingLevelVMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level V</link:label>
    <link:label id="lab_rdnt_PricingLevelVMember_label_en-US" xlink:label="lab_rdnt_PricingLevelVMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level V [Member]</link:label>
    <link:label id="lab_rdnt_PricingLevelVMember_documentation_en-US" xlink:label="lab_rdnt_PricingLevelVMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level V [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelVMember" xlink:href="rdnt-20200930.xsd#rdnt_PricingLevelVMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PricingLevelVMember" xlink:to="lab_rdnt_PricingLevelVMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_12356657-81b1-4575-8f19-f40b8b3ad80e_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Book value of RadNet joint venture interests</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_2d243bb6-e5ec-41de-bab8-8d276e3ff367_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1a9058f2-178b-4998-a1b4-15be7d87e5cc_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMPREHENSIVE INCOME (LOSS)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_1103a177-ad72-47a7-9cd4-c45d9ddb76cd_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_7bddcf8c-3dc7-40e1-ba57-9a64df5cc5dd_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to fund loan to related parties</link:label>
    <link:label id="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_label_en-US" xlink:label="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Fund Long-term Loans to Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToFundLongtermLoansToRelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:to="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeBasisSpreadOnVariableRate_23e4f276-8f2e-44a9-a59f-c05892c7fd5f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeBasisSpreadOnVariableRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread on variable rate</link:label>
    <link:label id="lab_us-gaap_DerivativeBasisSpreadOnVariableRate_label_en-US" xlink:label="lab_us-gaap_DerivativeBasisSpreadOnVariableRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeBasisSpreadOnVariableRate" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeBasisSpreadOnVariableRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeBasisSpreadOnVariableRate" xlink:to="lab_us-gaap_DerivativeBasisSpreadOnVariableRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_3592e4ac-57ed-440e-a799-22d6e72c6c19_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_ed19b404-8a43-469e-ae79-30f5e9f800ce_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_CapitationArrangementsMember_68996ac9-40dd-4247-8539-6c3d597507c4_verboseLabel_en-US" xlink:label="lab_rdnt_CapitationArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue under capitation arrangements</link:label>
    <link:label id="lab_rdnt_CapitationArrangementsMember_af690660-f8c0-4b60-959e-0edd1b39b62e_terseLabel_en-US" xlink:label="lab_rdnt_CapitationArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue under capitation arrangements</link:label>
    <link:label id="lab_rdnt_CapitationArrangementsMember_label_en-US" xlink:label="lab_rdnt_CapitationArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitation Arrangements [Member]</link:label>
    <link:label id="lab_rdnt_CapitationArrangementsMember_documentation_en-US" xlink:label="lab_rdnt_CapitationArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitation Arrangements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CapitationArrangementsMember" xlink:href="rdnt-20200930.xsd#rdnt_CapitationArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_CapitationArrangementsMember" xlink:to="lab_rdnt_CapitationArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_89426dc3-581c-40ff-bd6d-9f6d091e68af_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred financing costs, net of accumulated amortization</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredChargesPolicyTextBlock_c170601b-2304-4320-bc08-f70ca761702a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredChargesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DEFERRED FINANCING COSTS</link:label>
    <link:label id="lab_us-gaap_DeferredChargesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DeferredChargesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Charges, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredChargesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredChargesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredChargesPolicyTextBlock" xlink:to="lab_us-gaap_DeferredChargesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_5c9be310-9e5a-4b7b-ad84-fc653233c874_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsGross" xlink:to="lab_us-gaap_DeferredFinanceCostsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_0026ade9-e373-4996-8b14-39584a64fd94_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesDomain" xlink:to="lab_srt_ConsolidatedEntitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_A2019SWAPS1Member_c6672821-90cb-44bb-977a-49c619d343ba_terseLabel_en-US" xlink:label="lab_rdnt_A2019SWAPS1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 SWAPS1</link:label>
    <link:label id="lab_rdnt_A2019SWAPS1Member_label_en-US" xlink:label="lab_rdnt_A2019SWAPS1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 SWAPS1 [Member]</link:label>
    <link:label id="lab_rdnt_A2019SWAPS1Member_documentation_en-US" xlink:label="lab_rdnt_A2019SWAPS1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 SWAPS1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A2019SWAPS1Member" xlink:href="rdnt-20200930.xsd#rdnt_A2019SWAPS1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_A2019SWAPS1Member" xlink:to="lab_rdnt_A2019SWAPS1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_43971236-504b-4d0e-b658-8dd6b3f2dc60_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure_ab54fc1f-4c84-4d7b-8fe6-b9e54eed1eed_terseLabel_en-US" xlink:label="lab_us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration, fair value</link:label>
    <link:label id="lab_us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Issued in Business Combination, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure" xlink:to="lab_us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues_a3d587c3-738d-4ea1-acff-80fd0b323804_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BRMG and NY Groups revenues</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Measure of Activity, Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues" xlink:to="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAssets_9ac3e154-2d1c-458c-93f3-c8edb87f688f_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent assets</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAssets_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Summarized Financial Information, Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAssets" xlink:to="lab_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_2a3ba07b-3878-4648-bfa9-52aeef51ccaf_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNoncurrentNet_a62a1f9d-3256-41f9-857b-fdc358b1b3cb_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred financing costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNoncurrentNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Noncurrent, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>rdnt-20200930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:57afb805-d064-496f-ad72-af37e545924d,g:a8620cad-346c-45d4-8ba0-be03bf014f2b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.radnet.com/role/CoverPage" xlink:type="simple" xlink:href="rdnt-20200930.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_fe1bea6b-1398-412e-a38f-c1005f2360a8" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_1f0d8ab6-3104-49bc-9f84-ab50f70d7cb7" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fe1bea6b-1398-412e-a38f-c1005f2360a8" xlink:to="loc_dei_DocumentType_1f0d8ab6-3104-49bc-9f84-ab50f70d7cb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_f4be2e3a-ac7d-4085-bdcf-e88a58c26d1d" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fe1bea6b-1398-412e-a38f-c1005f2360a8" xlink:to="loc_dei_DocumentQuarterlyReport_f4be2e3a-ac7d-4085-bdcf-e88a58c26d1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_ce8a2df6-ca52-4c9a-be93-b1e715324bd5" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fe1bea6b-1398-412e-a38f-c1005f2360a8" xlink:to="loc_dei_DocumentPeriodEndDate_ce8a2df6-ca52-4c9a-be93-b1e715324bd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_313012d2-6d38-47dc-82f1-e0ea51836787" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fe1bea6b-1398-412e-a38f-c1005f2360a8" xlink:to="loc_dei_DocumentTransitionReport_313012d2-6d38-47dc-82f1-e0ea51836787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_4aec6935-dcd2-42f3-8589-d464e5c0ae9a" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fe1bea6b-1398-412e-a38f-c1005f2360a8" xlink:to="loc_dei_EntityFileNumber_4aec6935-dcd2-42f3-8589-d464e5c0ae9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_506d462b-0a58-469a-935f-92f494fe2f92" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fe1bea6b-1398-412e-a38f-c1005f2360a8" xlink:to="loc_dei_EntityRegistrantName_506d462b-0a58-469a-935f-92f494fe2f92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_75b772b2-4fee-4894-ac64-3ab9367d27b1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fe1bea6b-1398-412e-a38f-c1005f2360a8" xlink:to="loc_dei_EntityIncorporationStateCountryCode_75b772b2-4fee-4894-ac64-3ab9367d27b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_1515df17-2326-4b8f-ad75-8a2c7e49eb0b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fe1bea6b-1398-412e-a38f-c1005f2360a8" xlink:to="loc_dei_EntityTaxIdentificationNumber_1515df17-2326-4b8f-ad75-8a2c7e49eb0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_01cb64a4-bf42-42d5-99ba-17779c7f4110" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fe1bea6b-1398-412e-a38f-c1005f2360a8" xlink:to="loc_dei_EntityAddressAddressLine1_01cb64a4-bf42-42d5-99ba-17779c7f4110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_bb2a6726-4d3f-4211-9f4f-38a47881c4d2" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fe1bea6b-1398-412e-a38f-c1005f2360a8" xlink:to="loc_dei_EntityAddressCityOrTown_bb2a6726-4d3f-4211-9f4f-38a47881c4d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_680992bf-2a2a-4aac-bb9c-1db056f05609" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fe1bea6b-1398-412e-a38f-c1005f2360a8" xlink:to="loc_dei_EntityAddressStateOrProvince_680992bf-2a2a-4aac-bb9c-1db056f05609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_22fff5d4-1302-4723-8449-e79a22a087a7" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fe1bea6b-1398-412e-a38f-c1005f2360a8" xlink:to="loc_dei_EntityAddressPostalZipCode_22fff5d4-1302-4723-8449-e79a22a087a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_ade70842-915f-401d-9733-39e8e47e6274" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fe1bea6b-1398-412e-a38f-c1005f2360a8" xlink:to="loc_dei_CityAreaCode_ade70842-915f-401d-9733-39e8e47e6274" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_cf2faf83-3280-41e7-a07e-aae42d60e6ee" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fe1bea6b-1398-412e-a38f-c1005f2360a8" xlink:to="loc_dei_LocalPhoneNumber_cf2faf83-3280-41e7-a07e-aae42d60e6ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_ff91b942-2ccb-49a5-a730-48cae8b95632" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fe1bea6b-1398-412e-a38f-c1005f2360a8" xlink:to="loc_dei_EntityCurrentReportingStatus_ff91b942-2ccb-49a5-a730-48cae8b95632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_25cfe75d-375a-4b30-852c-2974b50d4367" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fe1bea6b-1398-412e-a38f-c1005f2360a8" xlink:to="loc_dei_EntityInteractiveDataCurrent_25cfe75d-375a-4b30-852c-2974b50d4367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_d92d8ab7-2715-4e66-b73e-b1e038e9e12a" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fe1bea6b-1398-412e-a38f-c1005f2360a8" xlink:to="loc_dei_EntityFilerCategory_d92d8ab7-2715-4e66-b73e-b1e038e9e12a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_d995c9da-6ec0-487c-b11d-80210a3c36b4" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fe1bea6b-1398-412e-a38f-c1005f2360a8" xlink:to="loc_dei_EntitySmallBusiness_d995c9da-6ec0-487c-b11d-80210a3c36b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_5ad1d051-eee2-493d-9c6f-03472cbc2f19" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fe1bea6b-1398-412e-a38f-c1005f2360a8" xlink:to="loc_dei_EntityEmergingGrowthCompany_5ad1d051-eee2-493d-9c6f-03472cbc2f19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_0bd6d168-7013-4b4f-bc60-ba9251ef4a02" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fe1bea6b-1398-412e-a38f-c1005f2360a8" xlink:to="loc_dei_EntityShellCompany_0bd6d168-7013-4b4f-bc60-ba9251ef4a02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_ba992187-0668-41d1-b0fe-ccd6920615ef" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fe1bea6b-1398-412e-a38f-c1005f2360a8" xlink:to="loc_dei_Security12bTitle_ba992187-0668-41d1-b0fe-ccd6920615ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_e9ecfb57-3d28-4402-ad23-45e811dfc8fd" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fe1bea6b-1398-412e-a38f-c1005f2360a8" xlink:to="loc_dei_TradingSymbol_e9ecfb57-3d28-4402-ad23-45e811dfc8fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_24914ae2-b6b0-4850-97fe-8414276baced" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fe1bea6b-1398-412e-a38f-c1005f2360a8" xlink:to="loc_dei_SecurityExchangeName_24914ae2-b6b0-4850-97fe-8414276baced" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_749b71a7-887e-4040-8bce-a694dc57b8c8" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fe1bea6b-1398-412e-a38f-c1005f2360a8" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_749b71a7-887e-4040-8bce-a694dc57b8c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_252bec2a-8bb6-491c-9f08-a209fb3d5117" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fe1bea6b-1398-412e-a38f-c1005f2360a8" xlink:to="loc_dei_EntityCentralIndexKey_252bec2a-8bb6-491c-9f08-a209fb3d5117" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_632c256f-5250-465a-9e8a-24d0562a5e99" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fe1bea6b-1398-412e-a38f-c1005f2360a8" xlink:to="loc_dei_AmendmentFlag_632c256f-5250-465a-9e8a-24d0562a5e99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_2000b9df-9e49-4bb7-a75b-a89330987dac" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fe1bea6b-1398-412e-a38f-c1005f2360a8" xlink:to="loc_dei_CurrentFiscalYearEndDate_2000b9df-9e49-4bb7-a75b-a89330987dac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_5a1bffd0-8a67-4322-873d-c18e468c5403" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fe1bea6b-1398-412e-a38f-c1005f2360a8" xlink:to="loc_dei_DocumentFiscalPeriodFocus_5a1bffd0-8a67-4322-873d-c18e468c5403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_3bb60216-2e22-45bf-bed6-9bd5b5a85c85" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fe1bea6b-1398-412e-a38f-c1005f2360a8" xlink:to="loc_dei_DocumentFiscalYearFocus_3bb60216-2e22-45bf-bed6-9bd5b5a85c85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited" xlink:type="simple" xlink:href="rdnt-20200930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_8b221a19-1592-4399-aae6-350617ab799c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_714ffb7e-509d-492d-8201-ed95238d5110" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_8b221a19-1592-4399-aae6-350617ab799c" xlink:to="loc_us-gaap_AssetsAbstract_714ffb7e-509d-492d-8201-ed95238d5110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_d8afe17a-b354-4a79-adfe-c91d49fe351a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_714ffb7e-509d-492d-8201-ed95238d5110" xlink:to="loc_us-gaap_AssetsCurrentAbstract_d8afe17a-b354-4a79-adfe-c91d49fe351a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_99db3502-27cd-4858-b2c7-98780e2bb6e3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d8afe17a-b354-4a79-adfe-c91d49fe351a" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_99db3502-27cd-4858-b2c7-98780e2bb6e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_b5ef46bf-39f2-4d12-921a-2155ec8cd212" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d8afe17a-b354-4a79-adfe-c91d49fe351a" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_b5ef46bf-39f2-4d12-921a-2155ec8cd212" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueFromRelatedPartiesCurrent_1afdc516-8e6d-4c8c-842e-8407d6c56e71" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DueFromRelatedPartiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d8afe17a-b354-4a79-adfe-c91d49fe351a" xlink:to="loc_us-gaap_DueFromRelatedPartiesCurrent_1afdc516-8e6d-4c8c-842e-8407d6c56e71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_5cb89ad6-54f8-40a8-9b52-0615a86d2001" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d8afe17a-b354-4a79-adfe-c91d49fe351a" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_5cb89ad6-54f8-40a8-9b52-0615a86d2001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_645dcef3-c63a-4ad5-8801-3f1431226b9a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d8afe17a-b354-4a79-adfe-c91d49fe351a" xlink:to="loc_us-gaap_AssetsCurrent_645dcef3-c63a-4ad5-8801-3f1431226b9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract_5cad40eb-c05b-45dd-9648-4b3b59fcfdba" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_714ffb7e-509d-492d-8201-ed95238d5110" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract_5cad40eb-c05b-45dd-9648-4b3b59fcfdba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_e62ae6f1-3ae5-4b7a-a6b5-198ce1552e4d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract_5cad40eb-c05b-45dd-9648-4b3b59fcfdba" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_e62ae6f1-3ae5-4b7a-a6b5-198ce1552e4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_fcec0059-aa63-4927-b498-a9fcc5f651f5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract_5cad40eb-c05b-45dd-9648-4b3b59fcfdba" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_fcec0059-aa63-4927-b498-a9fcc5f651f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets_63961cb9-9f55-4bd0-aac1-b5014ebc92ce" xlink:href="rdnt-20200930.xsd#rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract_5cad40eb-c05b-45dd-9648-4b3b59fcfdba" xlink:to="loc_rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets_63961cb9-9f55-4bd0-aac1-b5014ebc92ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsAbstract_bf546e02-bac3-4c24-8ae3-db5c7b08f67b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_714ffb7e-509d-492d-8201-ed95238d5110" xlink:to="loc_us-gaap_OtherAssetsAbstract_bf546e02-bac3-4c24-8ae3-db5c7b08f67b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_9cf40cf1-58b6-4158-994f-adcc5f57f82e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_bf546e02-bac3-4c24-8ae3-db5c7b08f67b" xlink:to="loc_us-gaap_Goodwill_9cf40cf1-58b6-4158-994f-adcc5f57f82e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_bb420a52-dbbe-4f2a-987d-0ffa6b7e8079" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_bf546e02-bac3-4c24-8ae3-db5c7b08f67b" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_bb420a52-dbbe-4f2a-987d-0ffa6b7e8079" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_b7b644f2-d0a0-488b-8e1a-79990b116092" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_bf546e02-bac3-4c24-8ae3-db5c7b08f67b" xlink:to="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_b7b644f2-d0a0-488b-8e1a-79990b116092" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_c4f7fb45-1693-4607-b8b2-ea0af4ab4e7a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_bf546e02-bac3-4c24-8ae3-db5c7b08f67b" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_c4f7fb45-1693-4607-b8b2-ea0af4ab4e7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_19541467-697a-48e5-a02a-bb79f11805bf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_bf546e02-bac3-4c24-8ae3-db5c7b08f67b" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_19541467-697a-48e5-a02a-bb79f11805bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsAssets_b413c75c-6f3b-4864-8893-8fb3b91f7ae0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DepositsAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_bf546e02-bac3-4c24-8ae3-db5c7b08f67b" xlink:to="loc_us-gaap_DepositsAssets_b413c75c-6f3b-4864-8893-8fb3b91f7ae0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_da1349da-4474-46a2-8493-e0d3105e03ee" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_714ffb7e-509d-492d-8201-ed95238d5110" xlink:to="loc_us-gaap_Assets_da1349da-4474-46a2-8493-e0d3105e03ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b9513393-e9ab-4c5d-84e9-adac6ec776dc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_8b221a19-1592-4399-aae6-350617ab799c" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b9513393-e9ab-4c5d-84e9-adac6ec776dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_8f753d2b-1a16-489e-8b18-d76947eb8eb2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b9513393-e9ab-4c5d-84e9-adac6ec776dc" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_8f753d2b-1a16-489e-8b18-d76947eb8eb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_12b1e981-2498-4cf6-9c9d-97359c1b50da" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_8f753d2b-1a16-489e-8b18-d76947eb8eb2" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_12b1e981-2498-4cf6-9c9d-97359c1b50da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToAffiliateCurrent_f63cf4df-8d22-4c5c-91a3-ccc2eb98d43c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DueToAffiliateCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_8f753d2b-1a16-489e-8b18-d76947eb8eb2" xlink:to="loc_us-gaap_DueToAffiliateCurrent_f63cf4df-8d22-4c5c-91a3-ccc2eb98d43c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenue_07647a81-c824-41b4-8ec7-b1bcf90b9305" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredRevenue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_8f753d2b-1a16-489e-8b18-d76947eb8eb2" xlink:to="loc_us-gaap_DeferredRevenue_07647a81-c824-41b4-8ec7-b1bcf90b9305" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_57afa0f6-3ca6-4646-bc4f-2118ff99ae75" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_8f753d2b-1a16-489e-8b18-d76947eb8eb2" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_57afa0f6-3ca6-4646-bc4f-2118ff99ae75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_390a7cff-c992-4013-a5f4-df71b74d7b6f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_8f753d2b-1a16-489e-8b18-d76947eb8eb2" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_390a7cff-c992-4013-a5f4-df71b74d7b6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent_6e467f74-899f-421d-ae32-ed05de67ed9e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NotesPayableCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_8f753d2b-1a16-489e-8b18-d76947eb8eb2" xlink:to="loc_us-gaap_NotesPayableCurrent_6e467f74-899f-421d-ae32-ed05de67ed9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_a3b581c3-805d-40f3-b695-67b9bdbd8980" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b9513393-e9ab-4c5d-84e9-adac6ec776dc" xlink:to="loc_us-gaap_LiabilitiesCurrent_a3b581c3-805d-40f3-b695-67b9bdbd8980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_6e04921d-717c-4b89-82d7-a1a3bd58db34" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b9513393-e9ab-4c5d-84e9-adac6ec776dc" xlink:to="loc_us-gaap_LiabilitiesNoncurrentAbstract_6e04921d-717c-4b89-82d7-a1a3bd58db34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_2662715a-bc9f-4c84-8f42-833980501272" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_6e04921d-717c-4b89-82d7-a1a3bd58db34" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_2662715a-bc9f-4c84-8f42-833980501272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_fe837332-aa37-4385-a136-18ebed37ae89" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_6e04921d-717c-4b89-82d7-a1a3bd58db34" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_fe837332-aa37-4385-a136-18ebed37ae89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable_d10ffaed-1418-4e4c-94b9-e643fb6cc7fd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermNotesPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_6e04921d-717c-4b89-82d7-a1a3bd58db34" xlink:to="loc_us-gaap_LongTermNotesPayable_d10ffaed-1418-4e4c-94b9-e643fb6cc7fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_a3095c71-801a-4a68-b3cf-50a75c7500bb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_6e04921d-717c-4b89-82d7-a1a3bd58db34" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_a3095c71-801a-4a68-b3cf-50a75c7500bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_67d9193d-9fd1-47b5-ab00-2ec661d64652" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_6e04921d-717c-4b89-82d7-a1a3bd58db34" xlink:to="loc_us-gaap_Liabilities_67d9193d-9fd1-47b5-ab00-2ec661d64652" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_aa52a009-fad1-49be-969d-2fa684dcd516" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b9513393-e9ab-4c5d-84e9-adac6ec776dc" xlink:to="loc_us-gaap_StockholdersEquityAbstract_aa52a009-fad1-49be-969d-2fa684dcd516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_fe4ba465-0fe0-44f1-b08a-2309786a742a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_aa52a009-fad1-49be-969d-2fa684dcd516" xlink:to="loc_us-gaap_CommonStockValue_fe4ba465-0fe0-44f1-b08a-2309786a742a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_46f0d46d-2158-4693-9281-664a0016b624" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_aa52a009-fad1-49be-969d-2fa684dcd516" xlink:to="loc_us-gaap_AdditionalPaidInCapital_46f0d46d-2158-4693-9281-664a0016b624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c22004ed-21f2-4f91-a357-3fee10e6501a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_aa52a009-fad1-49be-969d-2fa684dcd516" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c22004ed-21f2-4f91-a357-3fee10e6501a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_777c768f-c197-431a-9980-ecd297c14870" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_aa52a009-fad1-49be-969d-2fa684dcd516" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_777c768f-c197-431a-9980-ecd297c14870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_398664e5-142c-416e-99f5-28e7dc2c08b6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_aa52a009-fad1-49be-969d-2fa684dcd516" xlink:to="loc_us-gaap_StockholdersEquity_398664e5-142c-416e-99f5-28e7dc2c08b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_79aefd43-3667-4b1c-9545-a00b06cc342f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_aa52a009-fad1-49be-969d-2fa684dcd516" xlink:to="loc_us-gaap_MinorityInterest_79aefd43-3667-4b1c-9545-a00b06cc342f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3fe9af96-df37-4db9-be29-d243e4c9c278" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b9513393-e9ab-4c5d-84e9-adac6ec776dc" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3fe9af96-df37-4db9-be29-d243e4c9c278" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_6ae6eb85-c8e5-4400-86f3-03ce1e27fca7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b9513393-e9ab-4c5d-84e9-adac6ec776dc" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_6ae6eb85-c8e5-4400-86f3-03ce1e27fca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical" xlink:type="simple" xlink:href="rdnt-20200930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_649e3ec6-40f4-4dc9-8edb-64f3622d9dea" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_c98fa63c-b69d-42fe-b7a3-10699b6b111c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_649e3ec6-40f4-4dc9-8edb-64f3622d9dea" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_c98fa63c-b69d-42fe-b7a3-10699b6b111c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_f70c08f9-13e0-417d-9ea5-23fe3b49fd49" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_649e3ec6-40f4-4dc9-8edb-64f3622d9dea" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_f70c08f9-13e0-417d-9ea5-23fe3b49fd49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_9515c569-2550-449b-a004-0988ea168225" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_649e3ec6-40f4-4dc9-8edb-64f3622d9dea" xlink:to="loc_us-gaap_CommonStockSharesIssued_9515c569-2550-449b-a004-0988ea168225" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_ba953f11-4c00-46cb-be48-82310a30b9c3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_649e3ec6-40f4-4dc9-8edb-64f3622d9dea" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_ba953f11-4c00-46cb-be48-82310a30b9c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited" xlink:type="simple" xlink:href="rdnt-20200930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_31901a46-71a0-47fb-a1ac-6232b0bff71b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_23f98579-acbb-46d8-9887-abc9886ac973" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_31901a46-71a0-47fb-a1ac-6232b0bff71b" xlink:to="loc_us-gaap_StatementTable_23f98579-acbb-46d8-9887-abc9886ac973" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_c8779ee9-3f90-455f-8e59-92fb8ea4b03e" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_23f98579-acbb-46d8-9887-abc9886ac973" xlink:to="loc_srt_ProductOrServiceAxis_c8779ee9-3f90-455f-8e59-92fb8ea4b03e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_27f86ffb-45c2-4766-84eb-9e00634a9c20" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_c8779ee9-3f90-455f-8e59-92fb8ea4b03e" xlink:to="loc_srt_ProductsAndServicesDomain_27f86ffb-45c2-4766-84eb-9e00634a9c20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCarePatientServiceMember_4833cc1c-3cab-482f-97c0-73f9b1c0b6f4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HealthCarePatientServiceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_27f86ffb-45c2-4766-84eb-9e00634a9c20" xlink:to="loc_us-gaap_HealthCarePatientServiceMember_4833cc1c-3cab-482f-97c0-73f9b1c0b6f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CapitationArrangementsMember_479e0db6-145f-4e0b-8512-7a6ae02f4361" xlink:href="rdnt-20200930.xsd#rdnt_CapitationArrangementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_27f86ffb-45c2-4766-84eb-9e00634a9c20" xlink:to="loc_rdnt_CapitationArrangementsMember_479e0db6-145f-4e0b-8512-7a6ae02f4361" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_7be81e2e-ab58-4596-b699-c85afb52d29f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_23f98579-acbb-46d8-9887-abc9886ac973" xlink:to="loc_us-gaap_StatementLineItems_7be81e2e-ab58-4596-b699-c85afb52d29f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_4d379372-455f-4c64-bfdc-4398e70fd03b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7be81e2e-ab58-4596-b699-c85afb52d29f" xlink:to="loc_us-gaap_RevenuesAbstract_4d379372-455f-4c64-bfdc-4398e70fd03b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ae8ea000-2be8-4819-aaf2-ddaf30cf23fd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_4d379372-455f-4c64-bfdc-4398e70fd03b" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ae8ea000-2be8-4819-aaf2-ddaf30cf23fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueNotFromContractWithCustomer_cd9f2036-01ca-46d5-9677-b785e6013e0f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueNotFromContractWithCustomer"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_4d379372-455f-4c64-bfdc-4398e70fd03b" xlink:to="loc_us-gaap_RevenueNotFromContractWithCustomer_cd9f2036-01ca-46d5-9677-b785e6013e0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_f5f3fe4a-1d07-45e3-bb7e-1c0b5c636789" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7be81e2e-ab58-4596-b699-c85afb52d29f" xlink:to="loc_us-gaap_OperatingExpensesAbstract_f5f3fe4a-1d07-45e3-bb7e-1c0b5c636789" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_989b552a-2593-4a1b-ae30-97e72d7dc1c3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_f5f3fe4a-1d07-45e3-bb7e-1c0b5c636789" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_989b552a-2593-4a1b-ae30-97e72d7dc1c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_3e8304de-f261-4ee7-b913-6fdee741674f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_f5f3fe4a-1d07-45e3-bb7e-1c0b5c636789" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_3e8304de-f261-4ee7-b913-6fdee741674f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_949860d6-79b8-4fdf-bcd5-2b769f19ca12" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_f5f3fe4a-1d07-45e3-bb7e-1c0b5c636789" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_949860d6-79b8-4fdf-bcd5-2b769f19ca12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_2cae1f3e-eca4-4d6b-bf75-4f2060cfb1a0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_f5f3fe4a-1d07-45e3-bb7e-1c0b5c636789" xlink:to="loc_us-gaap_SeveranceCosts1_2cae1f3e-eca4-4d6b-bf75-4f2060cfb1a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_dc28764c-8b2b-4cf7-a8c1-2bf52c35169e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7be81e2e-ab58-4596-b699-c85afb52d29f" xlink:to="loc_us-gaap_OperatingExpenses_dc28764c-8b2b-4cf7-a8c1-2bf52c35169e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_bfd76cf2-83cc-417d-8dfc-9aa7c184ec9f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7be81e2e-ab58-4596-b699-c85afb52d29f" xlink:to="loc_us-gaap_OperatingIncomeLoss_bfd76cf2-83cc-417d-8dfc-9aa7c184ec9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpensesAbstract_9a634313-c6c6-49cc-af27-4714a2c74eed" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherExpensesAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7be81e2e-ab58-4596-b699-c85afb52d29f" xlink:to="loc_us-gaap_OtherExpensesAbstract_9a634313-c6c6-49cc-af27-4714a2c74eed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_87e20cb0-0b42-4b9d-b0c3-5873b85f8667" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherExpensesAbstract_9a634313-c6c6-49cc-af27-4714a2c74eed" xlink:to="loc_us-gaap_InterestExpenseDebt_87e20cb0-0b42-4b9d-b0c3-5873b85f8667" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_0ae0719a-9e28-41d3-9e11-da3d34108dd0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherExpensesAbstract_9a634313-c6c6-49cc-af27-4714a2c74eed" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_0ae0719a-9e28-41d3-9e11-da3d34108dd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1_fad8f308-accf-4144-bd9f-523053f3df1a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherExpensesAbstract_9a634313-c6c6-49cc-af27-4714a2c74eed" xlink:to="loc_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1_fad8f308-accf-4144-bd9f-523053f3df1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_99c42b43-a5c4-466f-a1b6-ce863e3ed0ec" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherExpensesAbstract_9a634313-c6c6-49cc-af27-4714a2c74eed" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_99c42b43-a5c4-466f-a1b6-ce863e3ed0ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_7a27e9ed-f4cd-46f3-909a-e388cc20887c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherExpensesAbstract_9a634313-c6c6-49cc-af27-4714a2c74eed" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_7a27e9ed-f4cd-46f3-909a-e388cc20887c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_d290bb5f-093d-448b-9107-2010c72510ab" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7be81e2e-ab58-4596-b699-c85afb52d29f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_d290bb5f-093d-448b-9107-2010c72510ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_ae70f733-af26-4236-84eb-c9df4e51e594" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7be81e2e-ab58-4596-b699-c85afb52d29f" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_ae70f733-af26-4236-84eb-c9df4e51e594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_78248ec0-66ae-435f-b642-a86326451109" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7be81e2e-ab58-4596-b699-c85afb52d29f" xlink:to="loc_us-gaap_ProfitLoss_78248ec0-66ae-435f-b642-a86326451109" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_46fb8df9-5d37-400a-ac29-33d17622a3e9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7be81e2e-ab58-4596-b699-c85afb52d29f" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_46fb8df9-5d37-400a-ac29-33d17622a3e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_9b1ce352-46e7-4ada-86f2-3475c8d93563" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7be81e2e-ab58-4596-b699-c85afb52d29f" xlink:to="loc_us-gaap_NetIncomeLoss_9b1ce352-46e7-4ada-86f2-3475c8d93563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_56abcb79-b022-4413-bf35-d16c9d86a766" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7be81e2e-ab58-4596-b699-c85afb52d29f" xlink:to="loc_us-gaap_EarningsPerShareBasic_56abcb79-b022-4413-bf35-d16c9d86a766" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_78aca75b-2c80-4e31-9b6a-2ed259be98d1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7be81e2e-ab58-4596-b699-c85afb52d29f" xlink:to="loc_us-gaap_EarningsPerShareDiluted_78aca75b-2c80-4e31-9b6a-2ed259be98d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_93328b14-366e-463e-b20c-6557d065622f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7be81e2e-ab58-4596-b699-c85afb52d29f" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_93328b14-366e-463e-b20c-6557d065622f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6f02549c-d1f2-445e-a0cd-f4b1b7186e6c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_93328b14-366e-463e-b20c-6557d065622f" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6f02549c-d1f2-445e-a0cd-f4b1b7186e6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_53adb4e1-663b-420b-9d43-9c9f7faec4af" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_93328b14-366e-463e-b20c-6557d065622f" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_53adb4e1-663b-420b-9d43-9c9f7faec4af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited" xlink:type="simple" xlink:href="rdnt-20200930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1fe46ad0-7b27-443d-8ee3-08e4fc6ef95a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_7e7bd6e5-a5d3-4840-90b0-ef18a6b5ee90" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1fe46ad0-7b27-443d-8ee3-08e4fc6ef95a" xlink:to="loc_us-gaap_ProfitLoss_7e7bd6e5-a5d3-4840-90b0-ef18a6b5ee90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_ed410a9d-2729-43a7-bd4a-475d8a0c63c2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1fe46ad0-7b27-443d-8ee3-08e4fc6ef95a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_ed410a9d-2729-43a7-bd4a-475d8a0c63c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_7ac12afd-a734-4fd4-bde5-7fee27d78151" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1fe46ad0-7b27-443d-8ee3-08e4fc6ef95a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_7ac12afd-a734-4fd4-bde5-7fee27d78151" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_761db0d5-2228-4509-8f01-429b9bba0ff3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1fe46ad0-7b27-443d-8ee3-08e4fc6ef95a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_761db0d5-2228-4509-8f01-429b9bba0ff3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_01d8376a-2c9d-4be9-88e2-303a81703f37" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1fe46ad0-7b27-443d-8ee3-08e4fc6ef95a" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_01d8376a-2c9d-4be9-88e2-303a81703f37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_89c52cca-645b-45f4-8662-ab236b8a8948" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1fe46ad0-7b27-443d-8ee3-08e4fc6ef95a" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_89c52cca-645b-45f4-8662-ab236b8a8948" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_cc2ff862-e64d-43d6-a4aa-886d71d16dba" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1fe46ad0-7b27-443d-8ee3-08e4fc6ef95a" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_cc2ff862-e64d-43d6-a4aa-886d71d16dba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited" xlink:type="simple" xlink:href="rdnt-20200930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_d2310825-bf75-4aaa-a024-330a3554fd9e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_bc9f58b7-5b9b-4516-9b16-673589c6b0cc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_d2310825-bf75-4aaa-a024-330a3554fd9e" xlink:to="loc_us-gaap_StatementTable_bc9f58b7-5b9b-4516-9b16-673589c6b0cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_e6c54e73-3f24-49af-b358-449200aa17fd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_bc9f58b7-5b9b-4516-9b16-673589c6b0cc" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_e6c54e73-3f24-49af-b358-449200aa17fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_5ff1ec2a-3b4a-4c2b-b325-30e76aae868a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e6c54e73-3f24-49af-b358-449200aa17fd" xlink:to="loc_us-gaap_EquityComponentDomain_5ff1ec2a-3b4a-4c2b-b325-30e76aae868a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_StockholdersEquityDeficitMember_0e04afe5-91c4-4f62-a487-fcfebc758226" xlink:href="rdnt-20200930.xsd#rdnt_StockholdersEquityDeficitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_5ff1ec2a-3b4a-4c2b-b325-30e76aae868a" xlink:to="loc_rdnt_StockholdersEquityDeficitMember_0e04afe5-91c4-4f62-a487-fcfebc758226" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_46266c4d-51c9-40bb-83f4-1cfeea3fae87" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_StockholdersEquityDeficitMember_0e04afe5-91c4-4f62-a487-fcfebc758226" xlink:to="loc_us-gaap_CommonStockMember_46266c4d-51c9-40bb-83f4-1cfeea3fae87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_58694fa0-194d-4dad-ae82-7cfd13227861" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_StockholdersEquityDeficitMember_0e04afe5-91c4-4f62-a487-fcfebc758226" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_58694fa0-194d-4dad-ae82-7cfd13227861" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_fc675ed0-d65c-43ad-85f7-64321c0e2c78" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_StockholdersEquityDeficitMember_0e04afe5-91c4-4f62-a487-fcfebc758226" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_fc675ed0-d65c-43ad-85f7-64321c0e2c78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_96856ac1-e00a-4c2d-bd20-4201848e139a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_StockholdersEquityDeficitMember_0e04afe5-91c4-4f62-a487-fcfebc758226" xlink:to="loc_us-gaap_RetainedEarningsMember_96856ac1-e00a-4c2d-bd20-4201848e139a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_97a821c9-d71a-416c-872f-f1790d753882" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_5ff1ec2a-3b4a-4c2b-b325-30e76aae868a" xlink:to="loc_us-gaap_NoncontrollingInterestMember_97a821c9-d71a-416c-872f-f1790d753882" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_095ddf93-944f-4391-bd90-ab8a6dc62b09" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_bc9f58b7-5b9b-4516-9b16-673589c6b0cc" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_095ddf93-944f-4391-bd90-ab8a6dc62b09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9ea91a6d-314e-4885-9dea-90c55c846cf9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_095ddf93-944f-4391-bd90-ab8a6dc62b09" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9ea91a6d-314e-4885-9dea-90c55c846cf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthInc.Member_0bf01dd1-c645-40d3-b74c-37eff0793c56" xlink:href="rdnt-20200930.xsd#rdnt_DeepHealthInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9ea91a6d-314e-4885-9dea-90c55c846cf9" xlink:to="loc_rdnt_DeepHealthInc.Member_0bf01dd1-c645-40d3-b74c-37eff0793c56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_eab2d9e9-ce01-4268-85ca-ea422f4640f4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_bc9f58b7-5b9b-4516-9b16-673589c6b0cc" xlink:to="loc_us-gaap_StatementLineItems_eab2d9e9-ce01-4268-85ca-ea422f4640f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0067892a-31e5-4442-aa83-e836a2b69bce" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_eab2d9e9-ce01-4268-85ca-ea422f4640f4" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0067892a-31e5-4442-aa83-e836a2b69bce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_bea6138d-fdfa-4601-9174-949baeb548e6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0067892a-31e5-4442-aa83-e836a2b69bce" xlink:to="loc_us-gaap_SharesOutstanding_bea6138d-fdfa-4601-9174-949baeb548e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_362b63c2-e295-471f-80e0-33ed1a14a09d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0067892a-31e5-4442-aa83-e836a2b69bce" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_362b63c2-e295-471f-80e0-33ed1a14a09d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_ffb5f5f9-ff66-4513-b465-fb360e530917" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0067892a-31e5-4442-aa83-e836a2b69bce" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_ffb5f5f9-ff66-4513-b465-fb360e530917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue_348a5ad4-6c37-4ba5-a564-1dc330ba3f3b" xlink:href="rdnt-20200930.xsd#rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0067892a-31e5-4442-aa83-e836a2b69bce" xlink:to="loc_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue_348a5ad4-6c37-4ba5-a564-1dc330ba3f3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_a9710d7d-bd81-4cca-888a-12b29c178124" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0067892a-31e5-4442-aa83-e836a2b69bce" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_a9710d7d-bd81-4cca-888a-12b29c178124" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_ae75e065-e646-4ef2-964f-084e5636f01f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0067892a-31e5-4442-aa83-e836a2b69bce" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_ae75e065-e646-4ef2-964f-084e5636f01f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_fcc99cf3-5fd1-4384-9180-bba35f139473" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0067892a-31e5-4442-aa83-e836a2b69bce" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_fcc99cf3-5fd1-4384-9180-bba35f139473" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_b3e5d5e9-abae-48b9-83ca-8ba82b639b6d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0067892a-31e5-4442-aa83-e836a2b69bce" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_b3e5d5e9-abae-48b9-83ca-8ba82b639b6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_3debe9e8-7ff7-4afa-9969-89374ec01eab" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0067892a-31e5-4442-aa83-e836a2b69bce" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_3debe9e8-7ff7-4afa-9969-89374ec01eab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_d75c050b-a252-439c-b08b-86e70dcf19c6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0067892a-31e5-4442-aa83-e836a2b69bce" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_d75c050b-a252-439c-b08b-86e70dcf19c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_9efb9816-6b91-4d07-b0a5-5528ca965957" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0067892a-31e5-4442-aa83-e836a2b69bce" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_9efb9816-6b91-4d07-b0a5-5528ca965957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_b2331204-743d-41a3-a3ec-282e72460de6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0067892a-31e5-4442-aa83-e836a2b69bce" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_b2331204-743d-41a3-a3ec-282e72460de6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_e0c0e758-2406-4fbe-b030-9a0badc35082" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0067892a-31e5-4442-aa83-e836a2b69bce" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_e0c0e758-2406-4fbe-b030-9a0badc35082" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures_949f7ebd-9ac3-4621-9a76-df4f9d3d64d3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0067892a-31e5-4442-aa83-e836a2b69bce" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures_949f7ebd-9ac3-4621-9a76-df4f9d3d64d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_a29dd1c6-cc34-4e61-b3c2-c77d64ddfd06" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0067892a-31e5-4442-aa83-e836a2b69bce" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_a29dd1c6-cc34-4e61-b3c2-c77d64ddfd06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_30168062-cf9e-430e-82ab-f315a7b2a065" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0067892a-31e5-4442-aa83-e836a2b69bce" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_30168062-cf9e-430e-82ab-f315a7b2a065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContributionsFromNoncontrollingInterests_1ebb58d9-8b8d-49c0-8aa1-d5e3f8169944" xlink:href="rdnt-20200930.xsd#rdnt_ContributionsFromNoncontrollingInterests"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0067892a-31e5-4442-aa83-e836a2b69bce" xlink:to="loc_rdnt_ContributionsFromNoncontrollingInterests_1ebb58d9-8b8d-49c0-8aa1-d5e3f8169944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_StockIssuedDuringPeriodSharesIssuedForReturnOfCapital_f5ad36b7-acd3-48d8-9459-9651e9ccf639" xlink:href="rdnt-20200930.xsd#rdnt_StockIssuedDuringPeriodSharesIssuedForReturnOfCapital"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0067892a-31e5-4442-aa83-e836a2b69bce" xlink:to="loc_rdnt_StockIssuedDuringPeriodSharesIssuedForReturnOfCapital_f5ad36b7-acd3-48d8-9459-9651e9ccf639" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_StockIssuedDuringPeriodValueIssuedForReturnOfCapital_44419eea-a026-4769-8188-953135f97f89" xlink:href="rdnt-20200930.xsd#rdnt_StockIssuedDuringPeriodValueIssuedForReturnOfCapital"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0067892a-31e5-4442-aa83-e836a2b69bce" xlink:to="loc_rdnt_StockIssuedDuringPeriodValueIssuedForReturnOfCapital_44419eea-a026-4769-8188-953135f97f89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_c518b3b4-4589-46b9-9cff-95d06883e8ee" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0067892a-31e5-4442-aa83-e836a2b69bce" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_c518b3b4-4589-46b9-9cff-95d06883e8ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_41cda3de-6d63-4a5d-a7cf-ef40c28574c8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0067892a-31e5-4442-aa83-e836a2b69bce" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_41cda3de-6d63-4a5d-a7cf-ef40c28574c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_755a9f66-935e-4e85-8d27-18cf48af7751" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0067892a-31e5-4442-aa83-e836a2b69bce" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_755a9f66-935e-4e85-8d27-18cf48af7751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther_f0a98542-739b-473b-a48f-beb356fd77dc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityOther"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0067892a-31e5-4442-aa83-e836a2b69bce" xlink:to="loc_us-gaap_StockholdersEquityOther_f0a98542-739b-473b-a48f-beb356fd77dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_386e90af-c2df-4d72-8b84-4f87624621a5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0067892a-31e5-4442-aa83-e836a2b69bce" xlink:to="loc_us-gaap_ProfitLoss_386e90af-c2df-4d72-8b84-4f87624621a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_8f79690c-dade-4d8d-b8dc-766987063fb6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0067892a-31e5-4442-aa83-e836a2b69bce" xlink:to="loc_us-gaap_SharesOutstanding_8f79690c-dade-4d8d-b8dc-766987063fb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_67751890-bddb-4fe5-b492-122a1ffcac11" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0067892a-31e5-4442-aa83-e836a2b69bce" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_67751890-bddb-4fe5-b492-122a1ffcac11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" xlink:type="simple" xlink:href="rdnt-20200930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_d209602c-5d3b-4806-9cdf-aff15e464221" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_792709e8-2d02-451f-a0ce-b94277332305" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d209602c-5d3b-4806-9cdf-aff15e464221" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_792709e8-2d02-451f-a0ce-b94277332305" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_bd27ee88-df64-4d20-9913-0c99655a2f86" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_792709e8-2d02-451f-a0ce-b94277332305" xlink:to="loc_us-gaap_ProfitLoss_bd27ee88-df64-4d20-9913-0c99655a2f86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ee784db2-6171-45ab-adbb-7305e76c89a0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_792709e8-2d02-451f-a0ce-b94277332305" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ee784db2-6171-45ab-adbb-7305e76c89a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_5d4a9ce6-66c6-4e58-a557-62e123346ebe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ee784db2-6171-45ab-adbb-7305e76c89a0" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_5d4a9ce6-66c6-4e58-a557-62e123346ebe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingLeaseRightofUseAssetAmortization_d541dff3-5360-4c81-ac5c-ee3789ed9c5a" xlink:href="rdnt-20200930.xsd#rdnt_OperatingLeaseRightofUseAssetAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ee784db2-6171-45ab-adbb-7305e76c89a0" xlink:to="loc_rdnt_OperatingLeaseRightofUseAssetAmortization_d541dff3-5360-4c81-ac5c-ee3789ed9c5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_92126521-7d49-47a8-9a3c-43d13d3434a2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ee784db2-6171-45ab-adbb-7305e76c89a0" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_92126521-7d49-47a8-9a3c-43d13d3434a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_be10f49d-f832-4956-aec0-8e4d5e012c4a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ee784db2-6171-45ab-adbb-7305e76c89a0" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_be10f49d-f832-4956-aec0-8e4d5e012c4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_811e1108-dfb5-4a1e-88c4-cae576fbf0e4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ee784db2-6171-45ab-adbb-7305e76c89a0" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_811e1108-dfb5-4a1e-88c4-cae576fbf0e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredHedgeGains_f32bbfa5-bb35-41e3-a497-0a0f7157cada" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfDeferredHedgeGains"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ee784db2-6171-45ab-adbb-7305e76c89a0" xlink:to="loc_us-gaap_AmortizationOfDeferredHedgeGains_f32bbfa5-bb35-41e3-a497-0a0f7157cada" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives_f84e8ddd-2df2-4110-b6f5-8a5d61dd5aad" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ee784db2-6171-45ab-adbb-7305e76c89a0" xlink:to="loc_us-gaap_UnrealizedGainLossOnDerivatives_f84e8ddd-2df2-4110-b6f5-8a5d61dd5aad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_ec3a99fa-f0fc-46cd-a55b-e5ba6b880e2b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ee784db2-6171-45ab-adbb-7305e76c89a0" xlink:to="loc_us-gaap_ShareBasedCompensation_ec3a99fa-f0fc-46cd-a55b-e5ba6b880e2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IncreaseDecreaseInOtherNoncashItem_999bbecd-a5f4-42f5-a6ce-230b2eb6f983" xlink:href="rdnt-20200930.xsd#rdnt_IncreaseDecreaseInOtherNoncashItem"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ee784db2-6171-45ab-adbb-7305e76c89a0" xlink:to="loc_rdnt_IncreaseDecreaseInOtherNoncashItem_999bbecd-a5f4-42f5-a6ce-230b2eb6f983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_b96336e0-cdc2-4537-aa11-9e69b97c4daa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ee784db2-6171-45ab-adbb-7305e76c89a0" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_b96336e0-cdc2-4537-aa11-9e69b97c4daa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_60709c82-5eb6-4160-a744-ae32a446eaa1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_792709e8-2d02-451f-a0ce-b94277332305" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_60709c82-5eb6-4160-a744-ae32a446eaa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_2103161a-e6f5-4a50-ad14-c8b5adfb4d5d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_60709c82-5eb6-4160-a744-ae32a446eaa1" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_2103161a-e6f5-4a50-ad14-c8b5adfb4d5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_d0658ebf-ffb6-4e53-8748-8298236cc33a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_60709c82-5eb6-4160-a744-ae32a446eaa1" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_d0658ebf-ffb6-4e53-8748-8298236cc33a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_a26e9b18-2e1f-4835-8e93-acd2345e81c0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_60709c82-5eb6-4160-a744-ae32a446eaa1" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_a26e9b18-2e1f-4835-8e93-acd2345e81c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_7d4a25b1-2341-4878-ab41-ab399486d6ef" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_60709c82-5eb6-4160-a744-ae32a446eaa1" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_7d4a25b1-2341-4878-ab41-ab399486d6ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IncreaseDecreaseinOperatingLeaseLiability_80f7cfac-3bce-4fe2-af09-e020d18cf4f1" xlink:href="rdnt-20200930.xsd#rdnt_IncreaseDecreaseinOperatingLeaseLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_60709c82-5eb6-4160-a744-ae32a446eaa1" xlink:to="loc_rdnt_IncreaseDecreaseinOperatingLeaseLiability_80f7cfac-3bce-4fe2-af09-e020d18cf4f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_d9baf4b8-7c92-4c6e-b6b9-09d23837a218" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_60709c82-5eb6-4160-a744-ae32a446eaa1" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_d9baf4b8-7c92-4c6e-b6b9-09d23837a218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_54f222f0-838d-4a51-900a-edbc9bf51c45" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_60709c82-5eb6-4160-a744-ae32a446eaa1" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_54f222f0-838d-4a51-900a-edbc9bf51c45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d6c9b2c3-981d-4709-9a25-e14181cf5d14" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_792709e8-2d02-451f-a0ce-b94277332305" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d6c9b2c3-981d-4709-9a25-e14181cf5d14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_99b457f3-7ea7-472e-9f73-1926716f44b6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d209602c-5d3b-4806-9cdf-aff15e464221" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_99b457f3-7ea7-472e-9f73-1926716f44b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBuildings_726c4ab2-8d36-4832-b718-903ed003384f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireBuildings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_99b457f3-7ea7-472e-9f73-1926716f44b6" xlink:to="loc_us-gaap_PaymentsToAcquireBuildings_726c4ab2-8d36-4832-b718-903ed003384f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_b734b608-3d5d-4ddb-b17f-37e528f9a366" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_99b457f3-7ea7-472e-9f73-1926716f44b6" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_b734b608-3d5d-4ddb-b17f-37e528f9a366" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment_9053df8b-b09a-49e7-89d6-8f730da6148e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_99b457f3-7ea7-472e-9f73-1926716f44b6" xlink:to="loc_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment_9053df8b-b09a-49e7-89d6-8f730da6148e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_4d0f941e-86f1-47fa-b38c-08786bbba757" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_99b457f3-7ea7-472e-9f73-1926716f44b6" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_4d0f941e-86f1-47fa-b38c-08786bbba757" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture_35164d84-be2a-49cd-a628-b8abb6252148" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromDivestitureOfInterestInJointVenture"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_99b457f3-7ea7-472e-9f73-1926716f44b6" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture_35164d84-be2a-49cd-a628-b8abb6252148" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_e39901c8-b88d-4b5c-9d00-2e5c8a1428cc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_99b457f3-7ea7-472e-9f73-1926716f44b6" xlink:to="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_e39901c8-b88d-4b5c-9d00-2e5c8a1428cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PaymentstoAcquireInterestinJointVentureAndContributionsToExistingJointVenture_0edaa62b-1dcd-4b59-82e5-3ce93bebb9b1" xlink:href="rdnt-20200930.xsd#rdnt_PaymentstoAcquireInterestinJointVentureAndContributionsToExistingJointVenture"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_99b457f3-7ea7-472e-9f73-1926716f44b6" xlink:to="loc_rdnt_PaymentstoAcquireInterestinJointVentureAndContributionsToExistingJointVenture_0edaa62b-1dcd-4b59-82e5-3ce93bebb9b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0a3f10ff-e6f2-4e67-b4cc-8806a147f8a7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_99b457f3-7ea7-472e-9f73-1926716f44b6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0a3f10ff-e6f2-4e67-b4cc-8806a147f8a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_07877a64-34e0-495f-bc55-19b560a8a078" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d209602c-5d3b-4806-9cdf-aff15e464221" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_07877a64-34e0-495f-bc55-19b560a8a078" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities_7d8cea39-298d-41e3-a7bb-197de903e912" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_07877a64-34e0-495f-bc55-19b560a8a078" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities_7d8cea39-298d-41e3-a7bb-197de903e912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_8b297fbe-4999-4bc5-9fe9-34e9818e329b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_07877a64-34e0-495f-bc55-19b560a8a078" xlink:to="loc_us-gaap_RepaymentsOfDebt_8b297fbe-4999-4bc5-9fe9-34e9818e329b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_a1b6948a-335e-4718-a6b1-1c758beac7e7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_07877a64-34e0-495f-bc55-19b560a8a078" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_a1b6948a-335e-4718-a6b1-1c758beac7e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_3e659275-5ec0-4a29-a0e1-134e89ddefb2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_07877a64-34e0-495f-bc55-19b560a8a078" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_3e659275-5ec0-4a29-a0e1-134e89ddefb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProceedsFromGovernmentAssistance_5e32e94b-4a38-4b91-aaff-43e03fbe093f" xlink:href="rdnt-20200930.xsd#rdnt_ProceedsFromGovernmentAssistance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_07877a64-34e0-495f-bc55-19b560a8a078" xlink:to="loc_rdnt_ProceedsFromGovernmentAssistance_5e32e94b-4a38-4b91-aaff-43e03fbe093f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_923fb851-ef7f-4072-bff1-6c5883611e47" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_07877a64-34e0-495f-bc55-19b560a8a078" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_923fb851-ef7f-4072-bff1-6c5883611e47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_445da92c-138a-479d-8248-9c2435f4959a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_07877a64-34e0-495f-bc55-19b560a8a078" xlink:to="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_445da92c-138a-479d-8248-9c2435f4959a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromContributedCapital_ad972fee-6f50-40eb-8805-9fa705321def" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromContributedCapital"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_07877a64-34e0-495f-bc55-19b560a8a078" xlink:to="loc_us-gaap_ProceedsFromContributedCapital_ad972fee-6f50-40eb-8805-9fa705321def" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_de613fa5-b544-4131-89a1-aa68f70711a8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_07877a64-34e0-495f-bc55-19b560a8a078" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_de613fa5-b544-4131-89a1-aa68f70711a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_3c854acf-12fb-4f66-abc4-a8cb12906775" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_07877a64-34e0-495f-bc55-19b560a8a078" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_3c854acf-12fb-4f66-abc4-a8cb12906775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_aa43dec4-6928-4c6a-a76c-bbdad9564af4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_07877a64-34e0-495f-bc55-19b560a8a078" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_aa43dec4-6928-4c6a-a76c-bbdad9564af4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e4dbc2d2-84d5-4d7b-b317-f594ab1f2078" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_07877a64-34e0-495f-bc55-19b560a8a078" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e4dbc2d2-84d5-4d7b-b317-f594ab1f2078" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_056ed570-5c82-49d8-b56a-69f2a9565e15" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d209602c-5d3b-4806-9cdf-aff15e464221" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_056ed570-5c82-49d8-b56a-69f2a9565e15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2cecfaf0-de53-4194-bd24-7ad6cbb55721" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d209602c-5d3b-4806-9cdf-aff15e464221" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2cecfaf0-de53-4194-bd24-7ad6cbb55721" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7ff71490-9100-49b4-a37b-e08fd21e9d3b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d209602c-5d3b-4806-9cdf-aff15e464221" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7ff71490-9100-49b4-a37b-e08fd21e9d3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_999d6df1-77aa-402b-941a-d5254c3d0591" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d209602c-5d3b-4806-9cdf-aff15e464221" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_999d6df1-77aa-402b-941a-d5254c3d0591" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_5ac40352-4999-451e-a542-3f35d626901f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d209602c-5d3b-4806-9cdf-aff15e464221" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_5ac40352-4999-451e-a542-3f35d626901f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_0c67c78b-1096-4459-8b64-efef98345008" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_5ac40352-4999-451e-a542-3f35d626901f" xlink:to="loc_us-gaap_InterestPaidNet_0c67c78b-1096-4459-8b64-efef98345008" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_5cda5997-1541-4fdb-9915-ba02cd1d8cc0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_5ac40352-4999-451e-a542-3f35d626901f" xlink:to="loc_us-gaap_StatementTable_5cda5997-1541-4fdb-9915-ba02cd1d8cc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis_98778c7e-206d-47dc-92ce-0ff638265c51" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_5cda5997-1541-4fdb-9915-ba02cd1d8cc0" xlink:to="loc_us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis_98778c7e-206d-47dc-92ce-0ff638265c51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassificationOfVariableInterestEntityDomain_6bba3da5-478c-40b1-9e99-dc7e4a1bba2c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassificationOfVariableInterestEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis_98778c7e-206d-47dc-92ce-0ff638265c51" xlink:to="loc_us-gaap_ClassificationOfVariableInterestEntityDomain_6bba3da5-478c-40b1-9e99-dc7e4a1bba2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_4c5028a3-04b3-4a7a-9f4c-0f0ff21d7b01" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassificationOfVariableInterestEntityDomain_6bba3da5-478c-40b1-9e99-dc7e4a1bba2c" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_4c5028a3-04b3-4a7a-9f4c-0f0ff21d7b01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e6fc0f73-8a6e-4f66-aba3-4940dbf29922" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_5cda5997-1541-4fdb-9915-ba02cd1d8cc0" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e6fc0f73-8a6e-4f66-aba3-4940dbf29922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_caec8693-db2e-4eec-b873-a2d06cad5c19" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e6fc0f73-8a6e-4f66-aba3-4940dbf29922" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_caec8693-db2e-4eec-b873-a2d06cad5c19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthInc.Member_51062550-595a-4906-8ce3-85078f7bdd9c" xlink:href="rdnt-20200930.xsd#rdnt_DeepHealthInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_caec8693-db2e-4eec-b873-a2d06cad5c19" xlink:to="loc_rdnt_DeepHealthInc.Member_51062550-595a-4906-8ce3-85078f7bdd9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NulogixMember_2dc5e355-d6c1-45f0-ba46-5557187f01ca" xlink:href="rdnt-20200930.xsd#rdnt_NulogixMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_caec8693-db2e-4eec-b873-a2d06cad5c19" xlink:to="loc_rdnt_NulogixMember_2dc5e355-d6c1-45f0-ba46-5557187f01ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_VenturaCountyImagingGroupLLCMember_44831020-8730-429b-a42b-c12e8ff017d1" xlink:href="rdnt-20200930.xsd#rdnt_VenturaCountyImagingGroupLLCMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_caec8693-db2e-4eec-b873-a2d06cad5c19" xlink:to="loc_rdnt_VenturaCountyImagingGroupLLCMember_44831020-8730-429b-a42b-c12e8ff017d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HudsonValleyRadiologyAssociatesMember_0a57b790-cce6-4ebd-ae2d-0806e96d6790" xlink:href="rdnt-20200930.xsd#rdnt_HudsonValleyRadiologyAssociatesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_caec8693-db2e-4eec-b873-a2d06cad5c19" xlink:to="loc_rdnt_HudsonValleyRadiologyAssociatesMember_0a57b790-cce6-4ebd-ae2d-0806e96d6790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_0350ae88-cf23-446c-b069-c327e7aa5eb0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_5cda5997-1541-4fdb-9915-ba02cd1d8cc0" xlink:to="loc_us-gaap_StatementLineItems_0350ae88-cf23-446c-b069-c327e7aa5eb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquipmentAcquiredAndLeaseholdImprovements_2f05243d-431d-4cdc-bc92-2f058a843ca5" xlink:href="rdnt-20200930.xsd#rdnt_EquipmentAcquiredAndLeaseholdImprovements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_0350ae88-cf23-446c-b069-c327e7aa5eb0" xlink:to="loc_rdnt_EquipmentAcquiredAndLeaseholdImprovements_2f05243d-431d-4cdc-bc92-2f058a843ca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_f88980f9-2174-4a37-bf5e-cee2492a824e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_0350ae88-cf23-446c-b069-c327e7aa5eb0" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_f88980f9-2174-4a37-bf5e-cee2492a824e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_75bcb21b-0f28-4953-b978-d922c4486631" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_0350ae88-cf23-446c-b069-c327e7aa5eb0" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_75bcb21b-0f28-4953-b978-d922c4486631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_a47f5973-4551-4424-b195-451c5c0e8df9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_0350ae88-cf23-446c-b069-c327e7aa5eb0" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_a47f5973-4551-4424-b195-451c5c0e8df9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_ee0ea4e4-64a1-4fd8-9025-67090291bd88" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_0350ae88-cf23-446c-b069-c327e7aa5eb0" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_ee0ea4e4-64a1-4fd8-9025-67090291bd88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_be6bb110-fc10-4031-a376-8ddf65078b14" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_0350ae88-cf23-446c-b069-c327e7aa5eb0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_be6bb110-fc10-4031-a376-8ddf65078b14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATION" xlink:type="simple" xlink:href="rdnt-20200930.xsd#NATUREOFBUSINESSANDBASISOFPRESENTATION"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8e3af337-b8d3-4043-b55b-c9284fb81843" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_359f8e79-7d6f-4fc4-9466-3e7f46e880cc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8e3af337-b8d3-4043-b55b-c9284fb81843" xlink:to="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_359f8e79-7d6f-4fc4-9466-3e7f46e880cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20200930.xsd#NATUREOFBUSINESSDetailsNarrative"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1efd524d-4b62-4674-af78-88d21c80e9d1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_263adb48-01f7-4290-a241-8002099637c3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1efd524d-4b62-4674-af78-88d21c80e9d1" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_263adb48-01f7-4290-a241-8002099637c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_ec22dd06-48e6-4ae6-ad36-e5fe5e9d50d6" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_263adb48-01f7-4290-a241-8002099637c3" xlink:to="loc_srt_ConsolidatedEntitiesAxis_ec22dd06-48e6-4ae6-ad36-e5fe5e9d50d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_3bbadf61-0474-4db8-beda-3a4879d95266" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_ec22dd06-48e6-4ae6-ad36-e5fe5e9d50d6" xlink:to="loc_srt_ConsolidatedEntitiesDomain_3bbadf61-0474-4db8-beda-3a4879d95266" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_0ab0bef8-a44e-4c39-9d43-456f7c8c05ef" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_3bbadf61-0474-4db8-beda-3a4879d95266" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_0ab0bef8-a44e-4c39-9d43-456f7c8c05ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_9a84efe4-125a-4f7d-b562-66720b6a758e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_263adb48-01f7-4290-a241-8002099637c3" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_9a84efe4-125a-4f7d-b562-66720b6a758e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_200e5432-1734-4fab-9d35-3cd7866731ca" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_9a84efe4-125a-4f7d-b562-66720b6a758e" xlink:to="loc_us-gaap_RelatedPartyDomain_200e5432-1734-4fab-9d35-3cd7866731ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember_4975a0f5-714a-4ab3-964a-90a01d0ffe57" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_200e5432-1734-4fab-9d35-3cd7866731ca" xlink:to="loc_srt_ChiefExecutiveOfficerMember_4975a0f5-714a-4ab3-964a-90a01d0ffe57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BoardMemberMember_c740c9d1-8860-4805-bc8b-2db0fd15a8dd" xlink:href="rdnt-20200930.xsd#rdnt_BoardMemberMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_200e5432-1734-4fab-9d35-3cd7866731ca" xlink:to="loc_rdnt_BoardMemberMember_c740c9d1-8860-4805-bc8b-2db0fd15a8dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_8bb3b5ce-06d4-4602-8cd1-571362a2214b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_263adb48-01f7-4290-a241-8002099637c3" xlink:to="loc_dei_LegalEntityAxis_8bb3b5ce-06d4-4602-8cd1-571362a2214b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_a8a262c7-8c1d-4a30-b857-4e6964acfcba" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_8bb3b5ce-06d4-4602-8cd1-571362a2214b" xlink:to="loc_dei_EntityDomain_a8a262c7-8c1d-4a30-b857-4e6964acfcba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BeverlyRadiologyMedicalGroupIIIMember_d8bb83c8-8b92-424c-8839-b706eee957dc" xlink:href="rdnt-20200930.xsd#rdnt_BeverlyRadiologyMedicalGroupIIIMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_a8a262c7-8c1d-4a30-b857-4e6964acfcba" xlink:to="loc_rdnt_BeverlyRadiologyMedicalGroupIIIMember_d8bb83c8-8b92-424c-8839-b706eee957dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ScriptSenderLlcMember_b147cf64-b113-4b70-86c7-9a6d3d713f6a" xlink:href="rdnt-20200930.xsd#rdnt_ScriptSenderLlcMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_a8a262c7-8c1d-4a30-b857-4e6964acfcba" xlink:to="loc_rdnt_ScriptSenderLlcMember_b147cf64-b113-4b70-86c7-9a6d3d713f6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_d4f0a0b1-24f7-4f51-ac7a-b04efb19190d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_263adb48-01f7-4290-a241-8002099637c3" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_d4f0a0b1-24f7-4f51-ac7a-b04efb19190d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberOfCenters_2db14ffc-af27-497e-90c1-e344b8f31cd6" xlink:href="rdnt-20200930.xsd#rdnt_NumberOfCenters"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d4f0a0b1-24f7-4f51-ac7a-b04efb19190d" xlink:to="loc_rdnt_NumberOfCenters_2db14ffc-af27-497e-90c1-e344b8f31cd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_cfc30021-44a0-4c7f-b819-846d35d8ffd5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d4f0a0b1-24f7-4f51-ac7a-b04efb19190d" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_cfc30021-44a0-4c7f-b819-846d35d8ffd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues_6c5d2aec-704c-4167-b055-fc653480a446" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d4f0a0b1-24f7-4f51-ac7a-b04efb19190d" xlink:to="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues_6c5d2aec-704c-4167-b055-fc653480a446" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense_b37a7ab1-c5bd-4149-8cf2-4c4d9b01e616" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d4f0a0b1-24f7-4f51-ac7a-b04efb19190d" xlink:to="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense_b37a7ab1-c5bd-4149-8cf2-4c4d9b01e616" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax_6d794d71-613f-4474-a2e1-9ec550c4cc14" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d4f0a0b1-24f7-4f51-ac7a-b04efb19190d" xlink:to="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax_6d794d71-613f-4474-a2e1-9ec550c4cc14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_bc1468e8-cd7d-407d-a440-a68e1d42b2a4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d4f0a0b1-24f7-4f51-ac7a-b04efb19190d" xlink:to="loc_us-gaap_Assets_bc1468e8-cd7d-407d-a440-a68e1d42b2a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_03c3b6f6-65d2-4216-81d3-ed2ee4915268" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d4f0a0b1-24f7-4f51-ac7a-b04efb19190d" xlink:to="loc_us-gaap_Liabilities_03c3b6f6-65d2-4216-81d3-ed2ee4915268" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="rdnt-20200930.xsd#SIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_533c93ef-45ee-4637-bbe6-22ed2876974a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_1931b7c6-eeee-42b8-b5bf-0ce604476a9b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_533c93ef-45ee-4637-bbe6-22ed2876974a" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_1931b7c6-eeee-42b8-b5bf-0ce604476a9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="rdnt-20200930.xsd#SIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_6d09fa8e-b9ba-483b-8285-2aa8a7c4b4c4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_3c2e5257-b15a-4957-a3e0-0103e9be85db" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6d09fa8e-b9ba-483b-8285-2aa8a7c4b4c4" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_3c2e5257-b15a-4957-a3e0-0103e9be85db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_688f465c-7f8f-470a-a337-e5c2ec092de3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6d09fa8e-b9ba-483b-8285-2aa8a7c4b4c4" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_688f465c-7f8f-470a-a337-e5c2ec092de3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock_2f07b7a6-b02f-4922-9239-73e59369ee36" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6d09fa8e-b9ba-483b-8285-2aa8a7c4b4c4" xlink:to="loc_us-gaap_ReceivablesPolicyTextBlock_2f07b7a6-b02f-4922-9239-73e59369ee36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_2f1ebb83-07d1-43a6-aa8e-5b43ddf9ac60" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6d09fa8e-b9ba-483b-8285-2aa8a7c4b4c4" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_2f1ebb83-07d1-43a6-aa8e-5b43ddf9ac60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredChargesPolicyTextBlock_f2425c26-8286-437b-ac2f-b857cf331a8a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredChargesPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6d09fa8e-b9ba-483b-8285-2aa8a7c4b4c4" xlink:to="loc_us-gaap_DeferredChargesPolicyTextBlock_f2425c26-8286-437b-ac2f-b857cf331a8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_28a5e8fb-c00d-47e6-822b-9a3e33e1969d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6d09fa8e-b9ba-483b-8285-2aa8a7c4b4c4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_28a5e8fb-c00d-47e6-822b-9a3e33e1969d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy_8e6d4160-5908-403e-a258-d6be0e3eee05" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6d09fa8e-b9ba-483b-8285-2aa8a7c4b4c4" xlink:to="loc_us-gaap_BusinessCombinationsPolicy_8e6d4160-5908-403e-a258-d6be0e3eee05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy_b888df16-126e-4df9-9826-290dfcb58d72" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6d09fa8e-b9ba-483b-8285-2aa8a7c4b4c4" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy_b888df16-126e-4df9-9826-290dfcb58d72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_c1cdc1b9-bff9-4059-babd-4a4da3b02b8c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6d09fa8e-b9ba-483b-8285-2aa8a7c4b4c4" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_c1cdc1b9-bff9-4059-babd-4a4da3b02b8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_5c726102-f62e-4eba-ba0e-c2b45f0a8cfd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6d09fa8e-b9ba-483b-8285-2aa8a7c4b4c4" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_5c726102-f62e-4eba-ba0e-c2b45f0a8cfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock_f3943e76-b6b2-475f-a383-6d212acff140" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6d09fa8e-b9ba-483b-8285-2aa8a7c4b4c4" xlink:to="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock_f3943e76-b6b2-475f-a383-6d212acff140" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_6b3dec3d-d9fd-4b82-8335-97e845016dc0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6d09fa8e-b9ba-483b-8285-2aa8a7c4b4c4" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_6b3dec3d-d9fd-4b82-8335-97e845016dc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_a56542d5-154c-4d89-bfb3-999606c8ec41" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6d09fa8e-b9ba-483b-8285-2aa8a7c4b4c4" xlink:to="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_a56542d5-154c-4d89-bfb3-999606c8ec41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_463a8dbc-f472-48a4-8bcb-b5494f6545ac" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6d09fa8e-b9ba-483b-8285-2aa8a7c4b4c4" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_463a8dbc-f472-48a4-8bcb-b5494f6545ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_0ac9a463-2e18-40dc-ac25-4575126ff38a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6d09fa8e-b9ba-483b-8285-2aa8a7c4b4c4" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_0ac9a463-2e18-40dc-ac25-4575126ff38a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_5830ff20-6fcb-4451-9dda-d3114d3699cd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6d09fa8e-b9ba-483b-8285-2aa8a7c4b4c4" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_5830ff20-6fcb-4451-9dda-d3114d3699cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy_cae35bdb-22e4-448d-a1ab-a30fbe188046" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6d09fa8e-b9ba-483b-8285-2aa8a7c4b4c4" xlink:to="loc_us-gaap_EquityMethodInvestmentsPolicy_cae35bdb-22e4-448d-a1ab-a30fbe188046" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock_a72614e3-b2b6-4db4-af8c-3f1ea641c398" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6d09fa8e-b9ba-483b-8285-2aa8a7c4b4c4" xlink:to="loc_us-gaap_InvestmentPolicyTextBlock_a72614e3-b2b6-4db4-af8c-3f1ea641c398" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_c6a77b7d-351e-4237-8ad9-95ce4cca1969" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6d09fa8e-b9ba-483b-8285-2aa8a7c4b4c4" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_c6a77b7d-351e-4237-8ad9-95ce4cca1969" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="simple" xlink:href="rdnt-20200930.xsd#SIGNIFICANTACCOUNTINGPOLICIESTables"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_a1c145db-a8b3-4695-bccd-e1fbf85ebc55" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock_6589ae7e-9689-413c-9766-f3a42ed332a1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a1c145db-a8b3-4695-bccd-e1fbf85ebc55" xlink:to="loc_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock_6589ae7e-9689-413c-9766-f3a42ed332a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_e8c9b8b3-54dc-410a-8730-fbaf68b248d6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a1c145db-a8b3-4695-bccd-e1fbf85ebc55" xlink:to="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_e8c9b8b3-54dc-410a-8730-fbaf68b248d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_c8f76029-cce7-423f-8573-9f448b48a8d4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a1c145db-a8b3-4695-bccd-e1fbf85ebc55" xlink:to="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_c8f76029-cce7-423f-8573-9f448b48a8d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_022c87f2-3073-4585-9dfd-10c49d73b211" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a1c145db-a8b3-4695-bccd-e1fbf85ebc55" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_022c87f2-3073-4585-9dfd-10c49d73b211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_fd63c5fd-8da0-4a69-bb7c-b191da4afcb0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a1c145db-a8b3-4695-bccd-e1fbf85ebc55" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_fd63c5fd-8da0-4a69-bb7c-b191da4afcb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock_f5534863-b23f-4e6d-a42d-e63697e836af" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a1c145db-a8b3-4695-bccd-e1fbf85ebc55" xlink:to="loc_us-gaap_EquityMethodInvestmentsTextBlock_f5534863-b23f-4e6d-a42d-e63697e836af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock_cc721f6d-a85f-4eff-b675-41a442ea1d2f" xlink:href="rdnt-20200930.xsd#rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a1c145db-a8b3-4695-bccd-e1fbf85ebc55" xlink:to="loc_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock_cc721f6d-a85f-4eff-b675-41a442ea1d2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsRevenue" xlink:type="simple" xlink:href="rdnt-20200930.xsd#SIGNIFICANTACCOUNTINGPOLICIESDetailsRevenue"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsRevenue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_364befbc-0675-4b8e-8ab2-07badf0dd1a6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_cf936bab-e429-410c-ab6b-7b79de7a3df6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_364befbc-0675-4b8e-8ab2-07badf0dd1a6" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_cf936bab-e429-410c-ab6b-7b79de7a3df6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_c9b37bc8-ce71-420c-b437-9dec01247a38" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_cf936bab-e429-410c-ab6b-7b79de7a3df6" xlink:to="loc_srt_ProductOrServiceAxis_c9b37bc8-ce71-420c-b437-9dec01247a38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ded51f86-044a-43ff-b465-7aa999ae66c0" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_c9b37bc8-ce71-420c-b437-9dec01247a38" xlink:to="loc_srt_ProductsAndServicesDomain_ded51f86-044a-43ff-b465-7aa999ae66c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CommercialInsurance1Member_1a6d750b-f761-4a97-9e73-140dfad14878" xlink:href="rdnt-20200930.xsd#rdnt_CommercialInsurance1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ded51f86-044a-43ff-b465-7aa999ae66c0" xlink:to="loc_rdnt_CommercialInsurance1Member_1a6d750b-f761-4a97-9e73-140dfad14878" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Medicare1Member_3ec63333-8ac0-4357-a9c5-9a0a19bb071b" xlink:href="rdnt-20200930.xsd#rdnt_Medicare1Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ded51f86-044a-43ff-b465-7aa999ae66c0" xlink:to="loc_rdnt_Medicare1Member_3ec63333-8ac0-4357-a9c5-9a0a19bb071b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Medicaid1Member_84c3deaf-5f74-43ce-ab27-fbc5711ada69" xlink:href="rdnt-20200930.xsd#rdnt_Medicaid1Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ded51f86-044a-43ff-b465-7aa999ae66c0" xlink:to="loc_rdnt_Medicaid1Member_84c3deaf-5f74-43ce-ab27-fbc5711ada69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WorkersCompensationPersonalInjury1Member_51392a36-b81c-4b04-948b-a0a8dbe271bb" xlink:href="rdnt-20200930.xsd#rdnt_WorkersCompensationPersonalInjury1Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ded51f86-044a-43ff-b465-7aa999ae66c0" xlink:to="loc_rdnt_WorkersCompensationPersonalInjury1Member_51392a36-b81c-4b04-948b-a0a8dbe271bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HealthCarePatientServiceOtherMember_df76c842-8039-4dcd-a5fb-511050005202" xlink:href="rdnt-20200930.xsd#rdnt_HealthCarePatientServiceOtherMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ded51f86-044a-43ff-b465-7aa999ae66c0" xlink:to="loc_rdnt_HealthCarePatientServiceOtherMember_df76c842-8039-4dcd-a5fb-511050005202" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HealthCareManagementServiceMember_38b577ed-4a6f-418c-bc54-3533f292db59" xlink:href="rdnt-20200930.xsd#rdnt_HealthCareManagementServiceMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ded51f86-044a-43ff-b465-7aa999ae66c0" xlink:to="loc_rdnt_HealthCareManagementServiceMember_38b577ed-4a6f-418c-bc54-3533f292db59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TeleradiologyandSoftwareMember_6efbde4c-e641-4702-a7c0-819cd9c4c8d3" xlink:href="rdnt-20200930.xsd#rdnt_TeleradiologyandSoftwareMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ded51f86-044a-43ff-b465-7aa999ae66c0" xlink:to="loc_rdnt_TeleradiologyandSoftwareMember_6efbde4c-e641-4702-a7c0-819cd9c4c8d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOtherMember_73afddfd-de3a-4028-8078-50b11e2fa814" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HealthCareOtherMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ded51f86-044a-43ff-b465-7aa999ae66c0" xlink:to="loc_us-gaap_HealthCareOtherMember_73afddfd-de3a-4028-8078-50b11e2fa814" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCarePatientServiceMember_7ac9b3d4-bd52-4c7c-8216-73eab65fd6fa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HealthCarePatientServiceMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ded51f86-044a-43ff-b465-7aa999ae66c0" xlink:to="loc_us-gaap_HealthCarePatientServiceMember_7ac9b3d4-bd52-4c7c-8216-73eab65fd6fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CapitationArrangementsMember_b9fade46-fd2d-4c66-acb5-1883b60dc69b" xlink:href="rdnt-20200930.xsd#rdnt_CapitationArrangementsMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ded51f86-044a-43ff-b465-7aa999ae66c0" xlink:to="loc_rdnt_CapitationArrangementsMember_b9fade46-fd2d-4c66-acb5-1883b60dc69b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_3a79a506-b031-4a4a-b6b7-3d5aaa7657d5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_cf936bab-e429-410c-ab6b-7b79de7a3df6" xlink:to="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_3a79a506-b031-4a4a-b6b7-3d5aaa7657d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_209ef6d6-8b84-4aef-ad66-75f362bd5db1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_3a79a506-b031-4a4a-b6b7-3d5aaa7657d5" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_209ef6d6-8b84-4aef-ad66-75f362bd5db1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_ee544bd9-1165-467f-ac44-84e32597b86e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_3a79a506-b031-4a4a-b6b7-3d5aaa7657d5" xlink:to="loc_us-gaap_Revenues_ee544bd9-1165-467f-ac44-84e32597b86e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20200930.xsd#SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_6ae9e0e8-50f0-4425-b660-f4e55edeb1e9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_09b557c3-8149-47d5-bc54-29f8d7d7f81d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6ae9e0e8-50f0-4425-b660-f4e55edeb1e9" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_09b557c3-8149-47d5-bc54-29f8d7d7f81d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_e5d35193-90ec-4415-b62e-85a4f2427127" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_09b557c3-8149-47d5-bc54-29f8d7d7f81d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_e5d35193-90ec-4415-b62e-85a4f2427127" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_56516de5-36ee-4caf-b1de-5da4d5a90428" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_e5d35193-90ec-4415-b62e-85a4f2427127" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_56516de5-36ee-4caf-b1de-5da4d5a90428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_56197768-52f5-4533-8526-2ebcbf535d06" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_56516de5-36ee-4caf-b1de-5da4d5a90428" xlink:to="loc_us-gaap_InterestExpenseMember_56197768-52f5-4533-8526-2ebcbf535d06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_c5f4b4e2-46e3-4c0c-813e-567a3540175c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_09b557c3-8149-47d5-bc54-29f8d7d7f81d" xlink:to="loc_us-gaap_DebtInstrumentAxis_c5f4b4e2-46e3-4c0c-813e-567a3540175c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_14c57957-0394-480c-a3b8-18700721202a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_c5f4b4e2-46e3-4c0c-813e-567a3540175c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_14c57957-0394-480c-a3b8-18700721202a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementMember_36ab725d-9e1b-4154-9ae2-f5da938d90dc" xlink:href="rdnt-20200930.xsd#rdnt_FirstLienCreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_14c57957-0394-480c-a3b8-18700721202a" xlink:to="loc_rdnt_FirstLienCreditAgreementMember_36ab725d-9e1b-4154-9ae2-f5da938d90dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PaycheckProtectionProgramLoansMember_69165e32-9933-405f-b30f-501a6b0aaccb" xlink:href="rdnt-20200930.xsd#rdnt_PaycheckProtectionProgramLoansMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_14c57957-0394-480c-a3b8-18700721202a" xlink:to="loc_rdnt_PaycheckProtectionProgramLoansMember_69165e32-9933-405f-b30f-501a6b0aaccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_819734c0-7d4f-4be4-975d-8873a2ae461c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_09b557c3-8149-47d5-bc54-29f8d7d7f81d" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_819734c0-7d4f-4be4-975d-8873a2ae461c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_42406087-22d7-4d27-97bd-8625de99b60d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_819734c0-7d4f-4be4-975d-8873a2ae461c" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_42406087-22d7-4d27-97bd-8625de99b60d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_e4bf1e60-a283-4718-9b1b-312f1ad571d1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_42406087-22d7-4d27-97bd-8625de99b60d" xlink:to="loc_us-gaap_LineOfCreditMember_e4bf1e60-a283-4718-9b1b-312f1ad571d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_d78e74e7-0e45-468a-8a85-c7dee4466058" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_09b557c3-8149-47d5-bc54-29f8d7d7f81d" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_d78e74e7-0e45-468a-8a85-c7dee4466058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_c6734171-260d-42a5-b46e-a4615783e49d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_d78e74e7-0e45-468a-8a85-c7dee4466058" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_c6734171-260d-42a5-b46e-a4615783e49d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BarclaysMember_a74a1693-0361-48d5-9678-3d2d9e6d33cd" xlink:href="rdnt-20200930.xsd#rdnt_BarclaysMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_c6734171-260d-42a5-b46e-a4615783e49d" xlink:to="loc_rdnt_BarclaysMember_a74a1693-0361-48d5-9678-3d2d9e6d33cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_c945dbc1-156c-4fff-b52f-2143f6878835" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_09b557c3-8149-47d5-bc54-29f8d7d7f81d" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_c945dbc1-156c-4fff-b52f-2143f6878835" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_27b063ec-2505-432a-bdd5-bb2f8c140521" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_c945dbc1-156c-4fff-b52f-2143f6878835" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_27b063ec-2505-432a-bdd5-bb2f8c140521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_COVID19PandemicMember_14da5540-44e3-4b74-87db-521a2f4bbef4" xlink:href="rdnt-20200930.xsd#rdnt_COVID19PandemicMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_27b063ec-2505-432a-bdd5-bb2f8c140521" xlink:to="loc_rdnt_COVID19PandemicMember_14da5540-44e3-4b74-87db-521a2f4bbef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_f4d0d5fa-b7a8-418c-9d7a-39729bc7d5fc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_09b557c3-8149-47d5-bc54-29f8d7d7f81d" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_f4d0d5fa-b7a8-418c-9d7a-39729bc7d5fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_e1001ba2-7212-4d36-a441-b76a0daacfea" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_f4d0d5fa-b7a8-418c-9d7a-39729bc7d5fc" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_e1001ba2-7212-4d36-a441-b76a0daacfea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_b351459c-d282-49f1-8c1d-8bbae86a3d3a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_e1001ba2-7212-4d36-a441-b76a0daacfea" xlink:to="loc_us-gaap_CommercialPaperMember_b351459c-d282-49f1-8c1d-8bbae86a3d3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_2380ed49-46f8-42dd-9a6d-d7e1d429fcba" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_09b557c3-8149-47d5-bc54-29f8d7d7f81d" xlink:to="loc_srt_CounterpartyNameAxis_2380ed49-46f8-42dd-9a6d-d7e1d429fcba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2b5fe721-7ba5-40f3-9c42-a429effec1b1" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_2380ed49-46f8-42dd-9a6d-d7e1d429fcba" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2b5fe721-7ba5-40f3-9c42-a429effec1b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DignityHealthMember_cb29ee55-fc4b-465d-a2f7-63478365cdb0" xlink:href="rdnt-20200930.xsd#rdnt_DignityHealthMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2b5fe721-7ba5-40f3-9c42-a429effec1b1" xlink:to="loc_rdnt_DignityHealthMember_cb29ee55-fc4b-465d-a2f7-63478365cdb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_f7d6a8b7-0d2d-4641-91d7-48bcae9e266e" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_09b557c3-8149-47d5-bc54-29f8d7d7f81d" xlink:to="loc_dei_LegalEntityAxis_f7d6a8b7-0d2d-4641-91d7-48bcae9e266e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_25f79581-7b39-4be3-b507-ba0920ce1422" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_f7d6a8b7-0d2d-4641-91d7-48bcae9e266e" xlink:to="loc_dei_EntityDomain_25f79581-7b39-4be3-b507-ba0920ce1422" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GlendaleAdvancedImagingMember_9fdcb289-7261-431b-a871-569cdb1ddafa" xlink:href="rdnt-20200930.xsd#rdnt_GlendaleAdvancedImagingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_25f79581-7b39-4be3-b507-ba0920ce1422" xlink:to="loc_rdnt_GlendaleAdvancedImagingMember_9fdcb289-7261-431b-a871-569cdb1ddafa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_dffe2814-333c-400b-99a1-fd31ac56934f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_09b557c3-8149-47d5-bc54-29f8d7d7f81d" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_dffe2814-333c-400b-99a1-fd31ac56934f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_1ae7ef44-2c95-446a-bb8d-7faa48fa971d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_dffe2814-333c-400b-99a1-fd31ac56934f" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_1ae7ef44-2c95-446a-bb8d-7faa48fa971d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_JointVentureMember_900a8feb-3ac1-4d96-afff-0da68629a383" xlink:href="rdnt-20200930.xsd#rdnt_JointVentureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_1ae7ef44-2c95-446a-bb8d-7faa48fa971d" xlink:to="loc_rdnt_JointVentureMember_900a8feb-3ac1-4d96-afff-0da68629a383" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_91c9f79c-8bbb-4323-82df-94f52431a5be" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_09b557c3-8149-47d5-bc54-29f8d7d7f81d" xlink:to="loc_us-gaap_CreditFacilityAxis_91c9f79c-8bbb-4323-82df-94f52431a5be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_0c6ff73a-f5ee-40eb-aa45-19d579240147" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_91c9f79c-8bbb-4323-82df-94f52431a5be" xlink:to="loc_us-gaap_CreditFacilityDomain_0c6ff73a-f5ee-40eb-aa45-19d579240147" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_c956d5a2-4743-4a10-bc35-27fbe3065fe8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_0c6ff73a-f5ee-40eb-aa45-19d579240147" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_c956d5a2-4743-4a10-bc35-27fbe3065fe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_68ef8327-9f5c-4283-938d-86bb71395407" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_09b557c3-8149-47d5-bc54-29f8d7d7f81d" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_68ef8327-9f5c-4283-938d-86bb71395407" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_7db03425-866a-46ce-a5f5-e314eec3834f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_68ef8327-9f5c-4283-938d-86bb71395407" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_7db03425-866a-46ce-a5f5-e314eec3834f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Caps2016Member_00c45fa1-ebe4-4f50-897d-140b0952b01a" xlink:href="rdnt-20200930.xsd#rdnt_Caps2016Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7db03425-866a-46ce-a5f5-e314eec3834f" xlink:to="loc_rdnt_Caps2016Member_00c45fa1-ebe4-4f50-897d-140b0952b01a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_267f1267-4436-483b-8def-78b5f42f6476" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7db03425-866a-46ce-a5f5-e314eec3834f" xlink:to="loc_us-gaap_InterestRateSwapMember_267f1267-4436-483b-8def-78b5f42f6476" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_271e1f13-aff9-4258-842d-c625dfa0778f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_09b557c3-8149-47d5-bc54-29f8d7d7f81d" xlink:to="loc_us-gaap_VariableRateAxis_271e1f13-aff9-4258-842d-c625dfa0778f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_43b373f5-fdc9-4f40-99dd-2095bd5bf171" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_271e1f13-aff9-4258-842d-c625dfa0778f" xlink:to="loc_us-gaap_VariableRateDomain_43b373f5-fdc9-4f40-99dd-2095bd5bf171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_ad0d6ff5-9c08-4708-bc97-641ebc3efe89" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_43b373f5-fdc9-4f40-99dd-2095bd5bf171" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_ad0d6ff5-9c08-4708-bc97-641ebc3efe89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_c527c853-9866-498f-85c4-ddc6a46a7136" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_09b557c3-8149-47d5-bc54-29f8d7d7f81d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_c527c853-9866-498f-85c4-ddc6a46a7136" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8c2ecbd7-0a78-49a5-9abb-d458ce145460" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_c527c853-9866-498f-85c4-ddc6a46a7136" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8c2ecbd7-0a78-49a5-9abb-d458ce145460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PropertyAndEquipmentMember_d1b919ba-101f-44bc-b5c5-1b40d2c285ac" xlink:href="rdnt-20200930.xsd#rdnt_PropertyAndEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8c2ecbd7-0a78-49a5-9abb-d458ce145460" xlink:to="loc_rdnt_PropertyAndEquipmentMember_d1b919ba-101f-44bc-b5c5-1b40d2c285ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_3dfa927d-3443-44ec-885e-c44b24e7dff2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8c2ecbd7-0a78-49a5-9abb-d458ce145460" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_3dfa927d-3443-44ec-885e-c44b24e7dff2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesFinancingTransactionAxis_f7089a09-c3b8-4f20-a789-78e4f14f02bc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SecuritiesFinancingTransactionAxis"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_09b557c3-8149-47d5-bc54-29f8d7d7f81d" xlink:to="loc_us-gaap_SecuritiesFinancingTransactionAxis_f7089a09-c3b8-4f20-a789-78e4f14f02bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_63d17bf7-b6ca-4895-a2f1-0487727ff199" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SecuritiesFinancingTransactionTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionAxis_f7089a09-c3b8-4f20-a789-78e4f14f02bc" xlink:to="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_63d17bf7-b6ca-4895-a2f1-0487727ff199" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Caps2016Member_e66e29e7-7621-420e-9dda-20eb09c934e5" xlink:href="rdnt-20200930.xsd#rdnt_Caps2016Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_63d17bf7-b6ca-4895-a2f1-0487727ff199" xlink:to="loc_rdnt_Caps2016Member_e66e29e7-7621-420e-9dda-20eb09c934e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A2019SWAPSMember_8401fbcb-577d-4580-9fab-0e2808830694" xlink:href="rdnt-20200930.xsd#rdnt_A2019SWAPSMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_63d17bf7-b6ca-4895-a2f1-0487727ff199" xlink:to="loc_rdnt_A2019SWAPSMember_8401fbcb-577d-4580-9fab-0e2808830694" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A2019SWAPS1Member_a7b5b208-9207-4d54-909e-d001728af0a6" xlink:href="rdnt-20200930.xsd#rdnt_A2019SWAPS1Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_63d17bf7-b6ca-4895-a2f1-0487727ff199" xlink:to="loc_rdnt_A2019SWAPS1Member_a7b5b208-9207-4d54-909e-d001728af0a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditDerivativesByContractTypeAxis_3825c6fc-0ff6-48df-abe0-93995e61d0db" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditDerivativesByContractTypeAxis"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_09b557c3-8149-47d5-bc54-29f8d7d7f81d" xlink:to="loc_us-gaap_CreditDerivativesByContractTypeAxis_3825c6fc-0ff6-48df-abe0-93995e61d0db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditDerivativesContractTypeDomain_3eb94d14-e45b-441f-9ea1-a9a325c14111" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditDerivativesContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditDerivativesByContractTypeAxis_3825c6fc-0ff6-48df-abe0-93995e61d0db" xlink:to="loc_us-gaap_CreditDerivativesContractTypeDomain_3eb94d14-e45b-441f-9ea1-a9a325c14111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_September2020CapMember_5e031f29-82ec-4d33-99e1-28f23be33ed5" xlink:href="rdnt-20200930.xsd#rdnt_September2020CapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditDerivativesContractTypeDomain_3eb94d14-e45b-441f-9ea1-a9a325c14111" xlink:to="loc_rdnt_September2020CapMember_5e031f29-82ec-4d33-99e1-28f23be33ed5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_October2020CapMember_2b992026-1db1-49ca-914c-4d3593aebbe3" xlink:href="rdnt-20200930.xsd#rdnt_October2020CapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditDerivativesContractTypeDomain_3eb94d14-e45b-441f-9ea1-a9a325c14111" xlink:to="loc_rdnt_October2020CapMember_2b992026-1db1-49ca-914c-4d3593aebbe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_October2023Member_c571753f-e92f-44d6-a956-16afeeeac041" xlink:href="rdnt-20200930.xsd#rdnt_October2023Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditDerivativesContractTypeDomain_3eb94d14-e45b-441f-9ea1-a9a325c14111" xlink:to="loc_rdnt_October2023Member_c571753f-e92f-44d6-a956-16afeeeac041" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_October2025Member_7bc47835-9b40-4313-88a9-eaf671214aca" xlink:href="rdnt-20200930.xsd#rdnt_October2025Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditDerivativesContractTypeDomain_3eb94d14-e45b-441f-9ea1-a9a325c14111" xlink:to="loc_rdnt_October2025Member_7bc47835-9b40-4313-88a9-eaf671214aca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_abc1cf02-32d5-4c52-8dc0-074a70023d44" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_09b557c3-8149-47d5-bc54-29f8d7d7f81d" xlink:to="loc_us-gaap_PlanNameAxis_abc1cf02-32d5-4c52-8dc0-074a70023d44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_8001dc25-1b8a-4008-adb3-c1b895695f3c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_abc1cf02-32d5-4c52-8dc0-074a70023d44" xlink:to="loc_us-gaap_PlanNameDomain_8001dc25-1b8a-4008-adb3-c1b895695f3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedPlanMember_bb83dc9f-2c35-4830-9c7a-2dfc53acb535" xlink:href="rdnt-20200930.xsd#rdnt_RestatedPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_8001dc25-1b8a-4008-adb3-c1b895695f3c" xlink:to="loc_rdnt_RestatedPlanMember_bb83dc9f-2c35-4830-9c7a-2dfc53acb535" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3464b7df-f097-4135-8d72-64c9035a3c84" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_09b557c3-8149-47d5-bc54-29f8d7d7f81d" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3464b7df-f097-4135-8d72-64c9035a3c84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_1b9ea42b-a57b-47e1-ab00-3ae7ee042ed0" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3464b7df-f097-4135-8d72-64c9035a3c84" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_1b9ea42b-a57b-47e1-ab00-3ae7ee042ed0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthIncMember_90c7b3af-9e10-4f73-be27-12966d934544" xlink:href="rdnt-20200930.xsd#rdnt_DeepHealthIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_1b9ea42b-a57b-47e1-ab00-3ae7ee042ed0" xlink:to="loc_rdnt_DeepHealthIncMember_90c7b3af-9e10-4f73-be27-12966d934544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicVisionMember_d4aed9cc-7784-4bbd-aefa-116f1792346d" xlink:href="rdnt-20200930.xsd#rdnt_MedicVisionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_1b9ea42b-a57b-47e1-ab00-3ae7ee042ed0" xlink:to="loc_rdnt_MedicVisionMember_d4aed9cc-7784-4bbd-aefa-116f1792346d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TurnerImagingMember_71ceaeb3-3064-43a0-bcb6-dc26fda13638" xlink:href="rdnt-20200930.xsd#rdnt_TurnerImagingMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_1b9ea42b-a57b-47e1-ab00-3ae7ee042ed0" xlink:to="loc_rdnt_TurnerImagingMember_71ceaeb3-3064-43a0-bcb6-dc26fda13638" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WhiteRabbit.aiInc.Member_71ec5669-6971-4a98-841f-ffb3749b47b9" xlink:href="rdnt-20200930.xsd#rdnt_WhiteRabbit.aiInc.Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_1b9ea42b-a57b-47e1-ab00-3ae7ee042ed0" xlink:to="loc_rdnt_WhiteRabbit.aiInc.Member_71ec5669-6971-4a98-841f-ffb3749b47b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SantaMonicaImagingGroupLLCMember_84ea1978-04ad-4e9b-a487-a16cec37b44e" xlink:href="rdnt-20200930.xsd#rdnt_SantaMonicaImagingGroupLLCMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_1b9ea42b-a57b-47e1-ab00-3ae7ee042ed0" xlink:to="loc_rdnt_SantaMonicaImagingGroupLLCMember_84ea1978-04ad-4e9b-a487-a16cec37b44e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_71a83108-9fb9-437c-b18c-3c7af1f91d99" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_09b557c3-8149-47d5-bc54-29f8d7d7f81d" xlink:to="loc_srt_RangeAxis_71a83108-9fb9-437c-b18c-3c7af1f91d99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7b59a605-6ae7-4502-94e2-f24ef4601c72" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_71a83108-9fb9-437c-b18c-3c7af1f91d99" xlink:to="loc_srt_RangeMember_7b59a605-6ae7-4502-94e2-f24ef4601c72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_05a701bb-9941-4f3e-ab3c-0463a992c200" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_7b59a605-6ae7-4502-94e2-f24ef4601c72" xlink:to="loc_srt_MinimumMember_05a701bb-9941-4f3e-ab3c-0463a992c200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_acf0f434-e06c-4927-9a12-9b7686c69a24" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_7b59a605-6ae7-4502-94e2-f24ef4601c72" xlink:to="loc_srt_MaximumMember_acf0f434-e06c-4927-9a12-9b7686c69a24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_09b557c3-8149-47d5-bc54-29f8d7d7f81d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AdvanceMedicarePayments_ba77dfeb-10ad-4d5b-81f4-af584d9ec0ae" xlink:href="rdnt-20200930.xsd#rdnt_AdvanceMedicarePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_rdnt_AdvanceMedicarePayments_ba77dfeb-10ad-4d5b-81f4-af584d9ec0ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProceedsReceivedFromInsurance_bfe5a35c-b78e-4c09-a79f-64189e1cfa49" xlink:href="rdnt-20200930.xsd#rdnt_ProceedsReceivedFromInsurance"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_rdnt_ProceedsReceivedFromInsurance_bfe5a35c-b78e-4c09-a79f-64189e1cfa49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueNotFromContractWithCustomer_09586d51-9d34-479e-a1b3-5d03d9fa388a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueNotFromContractWithCustomer"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_us-gaap_RevenueNotFromContractWithCustomer_09586d51-9d34-479e-a1b3-5d03d9fa388a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_df84f69a-026c-4f93-bbce-b866324a4a14" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_df84f69a-026c-4f93-bbce-b866324a4a14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SocialSecurityTaxEmployerDeferralCARESAct_3d92732f-01c5-473f-ae53-4c1fbbc298d0" xlink:href="rdnt-20200930.xsd#rdnt_SocialSecurityTaxEmployerDeferralCARESAct"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_rdnt_SocialSecurityTaxEmployerDeferralCARESAct_3d92732f-01c5-473f-ae53-4c1fbbc298d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContractsReceivableFactoringReceivable_5e3fae92-a742-4e45-b23f-9c2bfd585128" xlink:href="rdnt-20200930.xsd#rdnt_ContractsReceivableFactoringReceivable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_rdnt_ContractsReceivableFactoringReceivable_5e3fae92-a742-4e45-b23f-9c2bfd585128" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_8129e819-1326-42c9-aa10-97a7e8fbcf57" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_8129e819-1326-42c9-aa10-97a7e8fbcf57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_0aaf2a07-ffeb-451c-a33b-a28d77398224" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_0aaf2a07-ffeb-451c-a33b-a28d77398224" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_16e8032e-a4a5-4c50-9c3a-65a919189b0f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_us-gaap_Goodwill_16e8032e-a4a5-4c50-9c3a-65a919189b0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_5080978c-dfed-4481-bf6b-6db4a13a2624" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_5080978c-dfed-4481-bf6b-6db4a13a2624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_a5247dfe-5e71-47d2-9c41-af2963211747" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_a5247dfe-5e71-47d2-9c41-af2963211747" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_241b3747-cdc9-4b5a-bb51-6560e98cca63" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_241b3747-cdc9-4b5a-bb51-6560e98cca63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_b20d4389-faab-4648-9dc0-38a481874e3b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_b20d4389-faab-4648-9dc0-38a481874e3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_91219a13-ef76-4d7c-87b4-776419679995" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_91219a13-ef76-4d7c-87b4-776419679995" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_dece8a34-e34e-4cef-bae3-ec10a70acd34" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_dece8a34-e34e-4cef-bae3-ec10a70acd34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNumberOfInstrumentsHeld_54643e2a-0912-4ed2-9582-9eeeba77bdf0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeAssetNumberOfInstrumentsHeld"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_us-gaap_DerivativeAssetNumberOfInstrumentsHeld_54643e2a-0912-4ed2-9582-9eeeba77bdf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_5291dc12-8ccf-4fbf-b48d-f8aeea1f005d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_5291dc12-8ccf-4fbf-b48d-f8aeea1f005d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeBasisSpreadOnVariableRate_c91f3174-135f-480c-84e9-ffbdadfbd6d1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeBasisSpreadOnVariableRate"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_us-gaap_DerivativeBasisSpreadOnVariableRate_c91f3174-135f-480c-84e9-ffbdadfbd6d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_0c6a4efa-9a98-4937-85d6-b7eb26d39dff" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_0c6a4efa-9a98-4937-85d6-b7eb26d39dff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MonthlyAmortizationOfDeferredHedgeGains_3b0b1e18-6d05-443d-a03f-5a3136262e15" xlink:href="rdnt-20200930.xsd#rdnt_MonthlyAmortizationOfDeferredHedgeGains"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_rdnt_MonthlyAmortizationOfDeferredHedgeGains_3b0b1e18-6d05-443d-a03f-5a3136262e15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized_67d1814d-f26c-4b32-95f1-fed12c634f11" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized_67d1814d-f26c-4b32-95f1-fed12c634f11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_52396bb3-170a-4d9b-82e8-9b889eb327ba" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_us-gaap_LineOfCredit_52396bb3-170a-4d9b-82e8-9b889eb327ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_9ab786e1-4992-482e-9684-8e54707d1302" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_9ab786e1-4992-482e-9684-8e54707d1302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_a806940a-9d5c-44ec-9d0c-da19fc1ea7af" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_a806940a-9d5c-44ec-9d0c-da19fc1ea7af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment_86391ec5-76a3-4078-bb0e-212ddd74c470" xlink:href="rdnt-20200930.xsd#rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment_86391ec5-76a3-4078-bb0e-212ddd74c470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired_5c9aaf5d-25b0-4885-9dfa-e16b1a50085e" xlink:href="rdnt-20200930.xsd#rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired_5c9aaf5d-25b0-4885-9dfa-e16b1a50085e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution_eb399c94-388f-48e5-802d-8b9b8c9da9bc" xlink:href="rdnt-20200930.xsd#rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution_eb399c94-388f-48e5-802d-8b9b8c9da9bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost_0a2d887e-f02d-45ed-9b58-bcd7c352d779" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_us-gaap_EquityMethodInvestmentAggregateCost_0a2d887e-f02d-45ed-9b58-bcd7c352d779" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentSharesPurchased_dfe8b228-2f7d-4daa-9a47-210b8ea76913" xlink:href="rdnt-20200930.xsd#rdnt_EquityMethodInvestmentSharesPurchased"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_rdnt_EquityMethodInvestmentSharesPurchased_dfe8b228-2f7d-4daa-9a47-210b8ea76913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_be38473b-bc35-43fa-b05b-7ab1ff51dde4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_us-gaap_ShortTermBorrowings_be38473b-bc35-43fa-b05b-7ab1ff51dde4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_db251e4a-1d37-44a4-8f53-8bd6b8bc5849" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_db251e4a-1d37-44a4-8f53-8bd6b8bc5849" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_40d969ac-6f31-4205-8545-716d9fc8d717" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToFundLongtermLoansToRelatedParties"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_40d969ac-6f31-4205-8545-716d9fc8d717" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_cae0395a-f667-408f-961c-c274c1ef43ac" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_cae0395a-f667-408f-961c-c274c1ef43ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberofUnconsolidatedJointVentures_9a2899c2-1536-48f5-af31-ac1c56e2a097" xlink:href="rdnt-20200930.xsd#rdnt_NumberofUnconsolidatedJointVentures"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_rdnt_NumberofUnconsolidatedJointVentures_9a2899c2-1536-48f5-af31-ac1c56e2a097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityOwnershipPercentage_fef80db9-db1f-4775-bc01-4cfe590007ab" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableInterestEntityOwnershipPercentage"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_us-gaap_VariableInterestEntityOwnershipPercentage_fef80db9-db1f-4775-bc01-4cfe590007ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_ef0310eb-9f75-4257-9053-4c8779ff6b10" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireInterestInJointVenture"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_ef0310eb-9f75-4257-9053-4c8779ff6b10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_5a9f916e-8e22-4509-9bc4-d69e687aac69" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ManagementServiceFees_40206a54-9c35-45b0-9034-f0e4e1babc1d" xlink:href="rdnt-20200930.xsd#rdnt_ManagementServiceFees"/>
    <link:presentationArc order="38" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a3fd9824-e4ae-4792-a199-daa0be7e6b64" xlink:to="loc_rdnt_ManagementServiceFees_40206a54-9c35-45b0-9034-f0e4e1babc1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGoodwill" xlink:type="simple" xlink:href="rdnt-20200930.xsd#SIGNIFICANTACCOUNTINGPOLICIESDetailsGoodwill"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGoodwill" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_6b52d79d-2b3d-4965-a630-71b8b5f55b49" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_a879e016-b469-4ade-8c35-5df68788e05b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6b52d79d-2b3d-4965-a630-71b8b5f55b49" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_a879e016-b469-4ade-8c35-5df68788e05b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_489641f5-9dc5-48d9-8a7a-2be3a0610e9c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_a879e016-b469-4ade-8c35-5df68788e05b" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_489641f5-9dc5-48d9-8a7a-2be3a0610e9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5f654fd7-d4b0-4f8f-8c38-d98fb6611959" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_489641f5-9dc5-48d9-8a7a-2be3a0610e9c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5f654fd7-d4b0-4f8f-8c38-d98fb6611959" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OlneyOpenMRILLCMember_e9db4548-d67a-4276-b090-01a3ac23637f" xlink:href="rdnt-20200930.xsd#rdnt_OlneyOpenMRILLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5f654fd7-d4b0-4f8f-8c38-d98fb6611959" xlink:to="loc_rdnt_OlneyOpenMRILLCMember_e9db4548-d67a-4276-b090-01a3ac23637f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MRIatWoodbridgeLLCMember_aa28d043-2e67-4e33-a729-1b008cf24f83" xlink:href="rdnt-20200930.xsd#rdnt_MRIatWoodbridgeLLCMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5f654fd7-d4b0-4f8f-8c38-d98fb6611959" xlink:to="loc_rdnt_MRIatWoodbridgeLLCMember_aa28d043-2e67-4e33-a729-1b008cf24f83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthInc.Member_34f8ab14-2aba-43ea-8d20-9640e4a396fa" xlink:href="rdnt-20200930.xsd#rdnt_DeepHealthInc.Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5f654fd7-d4b0-4f8f-8c38-d98fb6611959" xlink:to="loc_rdnt_DeepHealthInc.Member_34f8ab14-2aba-43ea-8d20-9640e4a396fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AZTechMember_af113a3b-d64a-4bed-9e7b-b81b9103a3ed" xlink:href="rdnt-20200930.xsd#rdnt_AZTechMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5f654fd7-d4b0-4f8f-8c38-d98fb6611959" xlink:to="loc_rdnt_AZTechMember_af113a3b-d64a-4bed-9e7b-b81b9103a3ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_c4d843a9-0618-4a4d-83a1-50c9ace498bf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_a879e016-b469-4ade-8c35-5df68788e05b" xlink:to="loc_us-gaap_GoodwillLineItems_c4d843a9-0618-4a4d-83a1-50c9ace498bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_9182b9f3-6973-4214-a0ff-7e417149a1d2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_c4d843a9-0618-4a4d-83a1-50c9ace498bf" xlink:to="loc_us-gaap_GoodwillRollForward_9182b9f3-6973-4214-a0ff-7e417149a1d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b1d54ca6-e154-451e-b23b-08da83bbc202" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_9182b9f3-6973-4214-a0ff-7e417149a1d2" xlink:to="loc_us-gaap_Goodwill_b1d54ca6-e154-451e-b23b-08da83bbc202" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_2b3cc900-15b5-4453-919b-de1b82f06b5d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_9182b9f3-6973-4214-a0ff-7e417149a1d2" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_2b3cc900-15b5-4453-919b-de1b82f06b5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_400b52cf-1a78-46e3-a044-ed6b11a53011" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_9182b9f3-6973-4214-a0ff-7e417149a1d2" xlink:to="loc_us-gaap_Goodwill_400b52cf-1a78-46e3-a044-ed6b11a53011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGainonDerivative" xlink:type="simple" xlink:href="rdnt-20200930.xsd#SIGNIFICANTACCOUNTINGPOLICIESDetailsGainonDerivative"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGainonDerivative" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_851eb534-05e8-488b-8c56-74424f5b348d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsTable_e84234a8-e46a-4316-952f-7da126188ee9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OffsettingAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_851eb534-05e8-488b-8c56-74424f5b348d" xlink:to="loc_us-gaap_OffsettingAssetsTable_e84234a8-e46a-4316-952f-7da126188ee9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_e640460a-ffea-4668-a948-97d3c1038b8a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsTable_e84234a8-e46a-4316-952f-7da126188ee9" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_e640460a-ffea-4668-a948-97d3c1038b8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ab90dba3-0b61-4493-b5ac-4fba5c31667c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e640460a-ffea-4668-a948-97d3c1038b8a" xlink:to="loc_us-gaap_EquityComponentDomain_ab90dba3-0b61-4493-b5ac-4fba5c31667c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_76fe5d74-da65-452d-9070-0f44ecc20475" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ab90dba3-0b61-4493-b5ac-4fba5c31667c" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_76fe5d74-da65-452d-9070-0f44ecc20475" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_513158e1-7e5c-4482-ba11-47adb0d8ee93" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsTable_e84234a8-e46a-4316-952f-7da126188ee9" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_513158e1-7e5c-4482-ba11-47adb0d8ee93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_5c2fab3a-f432-481d-b2f3-5f1edc335b8b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_513158e1-7e5c-4482-ba11-47adb0d8ee93" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_5c2fab3a-f432-481d-b2f3-5f1edc335b8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_fc881cfb-4917-444c-9fb4-0bf7a7c6a3b0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5c2fab3a-f432-481d-b2f3-5f1edc335b8b" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_fc881cfb-4917-444c-9fb4-0bf7a7c6a3b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_a830e0b9-68b1-4a96-ab2b-f80ccb9b899a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5c2fab3a-f432-481d-b2f3-5f1edc335b8b" xlink:to="loc_us-gaap_InterestExpenseMember_a830e0b9-68b1-4a96-ab2b-f80ccb9b899a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_a1aad85b-1cbb-41dd-81a8-e555615860e8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsTable_e84234a8-e46a-4316-952f-7da126188ee9" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_a1aad85b-1cbb-41dd-81a8-e555615860e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8e5e98d5-b483-49c5-a44f-114d049d3efc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_a1aad85b-1cbb-41dd-81a8-e555615860e8" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8e5e98d5-b483-49c5-a44f-114d049d3efc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_d0453baf-0824-4c24-acea-aaa31141a6f7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8e5e98d5-b483-49c5-a44f-114d049d3efc" xlink:to="loc_us-gaap_InterestRateCapMember_d0453baf-0824-4c24-acea-aaa31141a6f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_4c2d42af-66f6-4b80-8e13-e573f5f37798" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8e5e98d5-b483-49c5-a44f-114d049d3efc" xlink:to="loc_us-gaap_InterestRateSwapMember_4c2d42af-66f6-4b80-8e13-e573f5f37798" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsLineItems_0bbd80c7-e6b1-47df-ab47-f0b7adbbd508" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OffsettingAssetsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsTable_e84234a8-e46a-4316-952f-7da126188ee9" xlink:to="loc_us-gaap_OffsettingAssetsLineItems_0bbd80c7-e6b1-47df-ab47-f0b7adbbd508" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1_3675b1a0-aa46-46a0-b59a-f9570448788d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0bbd80c7-e6b1-47df-ab47-f0b7adbbd508" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1_3675b1a0-aa46-46a0-b59a-f9570448788d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_418f3d89-7216-44d9-b4f7-f28bc33b446c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0bbd80c7-e6b1-47df-ab47-f0b7adbbd508" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_418f3d89-7216-44d9-b4f7-f28bc33b446c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_c23e361e-258f-4bc1-9902-79d63e630686" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0bbd80c7-e6b1-47df-ab47-f0b7adbbd508" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_c23e361e-258f-4bc1-9902-79d63e630686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1_bd4dce36-336d-43a4-bef8-981d51a27466" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0bbd80c7-e6b1-47df-ab47-f0b7adbbd508" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1_bd4dce36-336d-43a4-bef8-981d51a27466" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_d0ab3947-1f3a-4581-9e05-f52db13206aa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0bbd80c7-e6b1-47df-ab47-f0b7adbbd508" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_d0ab3947-1f3a-4581-9e05-f52db13206aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsFairValueMeasurements" xlink:type="simple" xlink:href="rdnt-20200930.xsd#SUMMARYOFACCOUNTINGPOLICIESDetailsFairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsFairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_b6132ef6-78d8-4776-ad4d-304c58e0ab58" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_fa30263b-315e-4e1a-9884-c2f919af1549" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b6132ef6-78d8-4776-ad4d-304c58e0ab58" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_fa30263b-315e-4e1a-9884-c2f919af1549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_850f3add-8f55-4e1e-9672-eb7f7f5e38a8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_fa30263b-315e-4e1a-9884-c2f919af1549" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_850f3add-8f55-4e1e-9672-eb7f7f5e38a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b2c46a4f-e94c-4b53-8027-652045db4a8f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_850f3add-8f55-4e1e-9672-eb7f7f5e38a8" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b2c46a4f-e94c-4b53-8027-652045db4a8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_1a4e9ad5-9598-4ce3-8c01-98394960d651" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b2c46a4f-e94c-4b53-8027-652045db4a8f" xlink:to="loc_us-gaap_InterestRateCapMember_1a4e9ad5-9598-4ce3-8c01-98394960d651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_fcfb7430-c061-438a-aded-991d62abfe63" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b2c46a4f-e94c-4b53-8027-652045db4a8f" xlink:to="loc_us-gaap_InterestRateSwapMember_fcfb7430-c061-438a-aded-991d62abfe63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_6dabf53a-b143-4c7e-94ae-d651f9447170" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_fa30263b-315e-4e1a-9884-c2f919af1549" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_6dabf53a-b143-4c7e-94ae-d651f9447170" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_67ef71f0-0017-4f16-b71b-e5e3519e9635" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_6dabf53a-b143-4c7e-94ae-d651f9447170" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_67ef71f0-0017-4f16-b71b-e5e3519e9635" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_cac62fd6-a846-403e-838f-4219982b503b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_67ef71f0-0017-4f16-b71b-e5e3519e9635" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_cac62fd6-a846-403e-838f-4219982b503b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_77f78860-362d-4062-88b2-8ccf702f9b31" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_67ef71f0-0017-4f16-b71b-e5e3519e9635" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_77f78860-362d-4062-88b2-8ccf702f9b31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f1302f85-10bf-4d3e-8af2-ed494ad8bc9b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_fa30263b-315e-4e1a-9884-c2f919af1549" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f1302f85-10bf-4d3e-8af2-ed494ad8bc9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5aa5a787-9051-4588-afc9-88175ed6a92a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f1302f85-10bf-4d3e-8af2-ed494ad8bc9b" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5aa5a787-9051-4588-afc9-88175ed6a92a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_40fc329b-bf75-4a0d-a683-16c716601847" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5aa5a787-9051-4588-afc9-88175ed6a92a" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_40fc329b-bf75-4a0d-a683-16c716601847" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_f866599b-8c07-489c-93c2-e3d2ba2516d5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5aa5a787-9051-4588-afc9-88175ed6a92a" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_f866599b-8c07-489c-93c2-e3d2ba2516d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_16b55450-06f8-437a-89ac-5153c868fd4c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5aa5a787-9051-4588-afc9-88175ed6a92a" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_16b55450-06f8-437a-89ac-5153c868fd4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_4fb15017-f274-47d8-9aab-2bb33834111a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_fa30263b-315e-4e1a-9884-c2f919af1549" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_4fb15017-f274-47d8-9aab-2bb33834111a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesFairValueDisclosure_38c128f5-f2e4-4493-91f1-040e17ffff42" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedLiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_4fb15017-f274-47d8-9aab-2bb33834111a" xlink:to="loc_us-gaap_AccruedLiabilitiesFairValueDisclosure_38c128f5-f2e4-4493-91f1-040e17ffff42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_243dcc61-f9dc-4e63-8298-58033783db1d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_4fb15017-f274-47d8-9aab-2bb33834111a" xlink:to="loc_us-gaap_DebtInstrumentFairValue_243dcc61-f9dc-4e63-8298-58033783db1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsEarningsPerShare" xlink:type="simple" xlink:href="rdnt-20200930.xsd#SUMMARYOFACCOUNTINGPOLICIESDetailsEarningsPerShare"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsEarningsPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_61007ee3-99b0-49b9-b01d-655669353f2e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_44080cef-0bde-4207-9ea8-6206204f363f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_61007ee3-99b0-49b9-b01d-655669353f2e" xlink:to="loc_us-gaap_NetIncomeLoss_44080cef-0bde-4207-9ea8-6206204f363f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_943f9ec7-fb85-45dc-8840-ace369a65506" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_61007ee3-99b0-49b9-b01d-655669353f2e" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_943f9ec7-fb85-45dc-8840-ace369a65506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_85e88367-cc19-467c-8ecf-151eb9dd131f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_943f9ec7-fb85-45dc-8840-ace369a65506" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_85e88367-cc19-467c-8ecf-151eb9dd131f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_e7ed075a-88b7-4152-8170-667eddc7199d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_943f9ec7-fb85-45dc-8840-ace369a65506" xlink:to="loc_us-gaap_EarningsPerShareBasic_e7ed075a-88b7-4152-8170-667eddc7199d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_f4433737-67b5-4027-9abe-d8a29ec9cbff" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesRestrictedStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_943f9ec7-fb85-45dc-8840-ace369a65506" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_f4433737-67b5-4027-9abe-d8a29ec9cbff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_923b5207-11f6-42e0-b819-ecb53c5683ed" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_943f9ec7-fb85-45dc-8840-ace369a65506" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_923b5207-11f6-42e0-b819-ecb53c5683ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_edca4354-a940-4429-ade3-5e3c937af0f5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_943f9ec7-fb85-45dc-8840-ace369a65506" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_edca4354-a940-4429-ade3-5e3c937af0f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_a03bf732-bca2-47f2-a939-3027014ad125" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_943f9ec7-fb85-45dc-8840-ace369a65506" xlink:to="loc_us-gaap_EarningsPerShareDiluted_a03bf732-bca2-47f2-a939-3027014ad125" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_0fcb846b-8dab-409c-8c6f-5672f6d1c690" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_61007ee3-99b0-49b9-b01d-655669353f2e" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_0fcb846b-8dab-409c-8c6f-5672f6d1c690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_daae44f1-8df1-4cf3-87a0-9887c106471e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_0fcb846b-8dab-409c-8c6f-5672f6d1c690" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_daae44f1-8df1-4cf3-87a0-9887c106471e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_01dca9e0-902f-4c7d-ba83-95a92f203ccd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_daae44f1-8df1-4cf3-87a0-9887c106471e" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_01dca9e0-902f-4c7d-ba83-95a92f203ccd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_750978af-bd30-4147-8c8f-f00715c288c7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_01dca9e0-902f-4c7d-ba83-95a92f203ccd" xlink:to="loc_us-gaap_RestrictedStockMember_750978af-bd30-4147-8c8f-f00715c288c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_c24db88a-0f9c-4dc0-bfa0-076a8b586b17" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_0fcb846b-8dab-409c-8c6f-5672f6d1c690" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_c24db88a-0f9c-4dc0-bfa0-076a8b586b17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_65db0cb1-58fc-4fc3-a212-a1f5dedd9f0e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_c24db88a-0f9c-4dc0-bfa0-076a8b586b17" xlink:to="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_65db0cb1-58fc-4fc3-a212-a1f5dedd9f0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_51a55ad4-449e-4a20-b23f-4e21bf4aa5d7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_65db0cb1-58fc-4fc3-a212-a1f5dedd9f0e" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_51a55ad4-449e-4a20-b23f-4e21bf4aa5d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsInvestmentinJointVentures" xlink:type="simple" xlink:href="rdnt-20200930.xsd#SUMMARYOFACCOUNTINGPOLICIESDetailsInvestmentinJointVentures"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsInvestmentinJointVentures" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_45e04588-468d-434b-9d60-6e6fe7532613" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_cab58629-b93d-44ad-ab2d-da18430dcc8c" xlink:href="rdnt-20200930.xsd#rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_45e04588-468d-434b-9d60-6e6fe7532613" xlink:to="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_cab58629-b93d-44ad-ab2d-da18430dcc8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_942dd213-7a5e-4993-9341-c2db21af881b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_cab58629-b93d-44ad-ab2d-da18430dcc8c" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_942dd213-7a5e-4993-9341-c2db21af881b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_d494cee1-500e-4e37-9dd0-4794c7ca9ffc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_cab58629-b93d-44ad-ab2d-da18430dcc8c" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_d494cee1-500e-4e37-9dd0-4794c7ca9ffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_afc399c0-ee08-4bf3-a5d2-a17b4e42dfc2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_cab58629-b93d-44ad-ab2d-da18430dcc8c" xlink:to="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_afc399c0-ee08-4bf3-a5d2-a17b4e42dfc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityContributionsInJointVentures_4d483dc8-c31c-40a6-858a-8f8c99041c39" xlink:href="rdnt-20200930.xsd#rdnt_EquityContributionsInJointVentures"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_cab58629-b93d-44ad-ab2d-da18430dcc8c" xlink:to="loc_rdnt_EquityContributionsInJointVentures_4d483dc8-c31c-40a6-858a-8f8c99041c39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_6379b5f5-9cdc-4e7c-afd2-bd1d65c6e271" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_cab58629-b93d-44ad-ab2d-da18430dcc8c" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_6379b5f5-9cdc-4e7c-afd2-bd1d65c6e271" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures" xlink:type="simple" xlink:href="rdnt-20200930.xsd#SUMMARYOFACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_ed378fcc-18d1-4fd9-8c02-cb16b4ee822b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_KeyFinancialDataForJointVenturesAbstract_5948ad8d-5bcb-4bf7-b1b7-2b450186614b" xlink:href="rdnt-20200930.xsd#rdnt_KeyFinancialDataForJointVenturesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ed378fcc-18d1-4fd9-8c02-cb16b4ee822b" xlink:to="loc_rdnt_KeyFinancialDataForJointVenturesAbstract_5948ad8d-5bcb-4bf7-b1b7-2b450186614b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets_5eb09f1e-e08c-4666-b625-f67b6b38804c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_KeyFinancialDataForJointVenturesAbstract_5948ad8d-5bcb-4bf7-b1b7-2b450186614b" xlink:to="loc_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets_5eb09f1e-e08c-4666-b625-f67b6b38804c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAssets_f6fd9062-c1aa-4bf4-812d-58718fda21fb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_KeyFinancialDataForJointVenturesAbstract_5948ad8d-5bcb-4bf7-b1b7-2b450186614b" xlink:to="loc_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAssets_f6fd9062-c1aa-4bf4-812d-58718fda21fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities_d5048ab8-e8e6-4532-8330-da8547dfbf12" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_KeyFinancialDataForJointVenturesAbstract_5948ad8d-5bcb-4bf7-b1b7-2b450186614b" xlink:to="loc_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities_d5048ab8-e8e6-4532-8330-da8547dfbf12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationLiabilities_2403a56c-69ec-4505-9ebf-1b231564394e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentSummarizedFinancialInformationLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_KeyFinancialDataForJointVenturesAbstract_5948ad8d-5bcb-4bf7-b1b7-2b450186614b" xlink:to="loc_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationLiabilities_2403a56c-69ec-4505-9ebf-1b231564394e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost_e1513bac-24bc-4178-80e2-97cbf5c27075" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_KeyFinancialDataForJointVenturesAbstract_5948ad8d-5bcb-4bf7-b1b7-2b450186614b" xlink:to="loc_us-gaap_EquityMethodInvestmentAggregateCost_e1513bac-24bc-4178-80e2-97cbf5c27075" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_ae400a37-72d6-4b34-99f0-c773a54711d8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_KeyFinancialDataForJointVenturesAbstract_5948ad8d-5bcb-4bf7-b1b7-2b450186614b" xlink:to="loc_us-gaap_EquityMethodInvestments_ae400a37-72d6-4b34-99f0-c773a54711d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets_f801d574-067d-43d7-aab2-43aa58a103bd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_KeyFinancialDataForJointVenturesAbstract_5948ad8d-5bcb-4bf7-b1b7-2b450186614b" xlink:to="loc_us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets_f801d574-067d-43d7-aab2-43aa58a103bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_eff2594f-2606-4c95-b41c-b2b07e8c210c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_KeyFinancialDataForJointVenturesAbstract_5948ad8d-5bcb-4bf7-b1b7-2b450186614b" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_eff2594f-2606-4c95-b41c-b2b07e8c210c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TotalBookValueOfOtherJointVenturePartnerInterests_2a5331b8-062b-40ee-ae4c-f66d3c360170" xlink:href="rdnt-20200930.xsd#rdnt_TotalBookValueOfOtherJointVenturePartnerInterests"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_KeyFinancialDataForJointVenturesAbstract_5948ad8d-5bcb-4bf7-b1b7-2b450186614b" xlink:to="loc_rdnt_TotalBookValueOfOtherJointVenturePartnerInterests_2a5331b8-062b-40ee-ae4c-f66d3c360170" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationRevenue_97ada34e-1f79-4a67-9654-d05c5e2b85c4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentSummarizedFinancialInformationRevenue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_KeyFinancialDataForJointVenturesAbstract_5948ad8d-5bcb-4bf7-b1b7-2b450186614b" xlink:to="loc_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationRevenue_97ada34e-1f79-4a67-9654-d05c5e2b85c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss_983bb9d2-191c-40ca-98d3-48b3d9ab40e8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_KeyFinancialDataForJointVenturesAbstract_5948ad8d-5bcb-4bf7-b1b7-2b450186614b" xlink:to="loc_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss_983bb9d2-191c-40ca-98d3-48b3d9ab40e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/RECENTACCOUNTINGANDREPORTINGSTANDARDS" xlink:type="simple" xlink:href="rdnt-20200930.xsd#RECENTACCOUNTINGANDREPORTINGSTANDARDS"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/RECENTACCOUNTINGANDREPORTINGSTANDARDS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_4d409af6-176b-4c8b-ac6b-b3e065f0717c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_f708f93c-4bb0-434a-9db3-8ef636aab0d2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_4d409af6-176b-4c8b-ac6b-b3e065f0717c" xlink:to="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_f708f93c-4bb0-434a-9db3-8ef636aab0d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONS" xlink:type="simple" xlink:href="rdnt-20200930.xsd#FACILITYACQUISITIONSANDDISPOSITIONS"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_effa946f-08cb-4e71-bb11-c20f23a91767" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_92dd922e-8e44-485d-a7ce-3ec1d5f990f6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_effa946f-08cb-4e71-bb11-c20f23a91767" xlink:to="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_92dd922e-8e44-485d-a7ce-3ec1d5f990f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONSDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20200930.xsd#FACILITYACQUISITIONSANDDISPOSITIONSDetailsNarrative"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONSDetailsNarrative" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_1f7f3ec9-76df-4c06-9fba-42634a899db7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0d1125fc-2613-4a76-b5ce-7b1f25b29983" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_1f7f3ec9-76df-4c06-9fba-42634a899db7" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0d1125fc-2613-4a76-b5ce-7b1f25b29983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_32044fa2-34cf-4f4a-a62a-be93f70a27b3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0d1125fc-2613-4a76-b5ce-7b1f25b29983" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_32044fa2-34cf-4f4a-a62a-be93f70a27b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_02e6d87e-13c5-432b-a3ca-70fbbfd62c9a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_32044fa2-34cf-4f4a-a62a-be93f70a27b3" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_02e6d87e-13c5-432b-a3ca-70fbbfd62c9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthIncMember_5928a8f2-463c-4564-bf41-3ffce14f9373" xlink:href="rdnt-20200930.xsd#rdnt_DeepHealthIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_02e6d87e-13c5-432b-a3ca-70fbbfd62c9a" xlink:to="loc_rdnt_DeepHealthIncMember_5928a8f2-463c-4564-bf41-3ffce14f9373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AssetAcquisitionAxis_6912a104-1072-430c-b2e9-8811ab472387" xlink:href="rdnt-20200930.xsd#rdnt_AssetAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0d1125fc-2613-4a76-b5ce-7b1f25b29983" xlink:to="loc_rdnt_AssetAcquisitionAxis_6912a104-1072-430c-b2e9-8811ab472387" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AssetAcquisitionDomain_c4578a22-c342-464d-9882-3d938436013d" xlink:href="rdnt-20200930.xsd#rdnt_AssetAcquisitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_AssetAcquisitionAxis_6912a104-1072-430c-b2e9-8811ab472387" xlink:to="loc_rdnt_AssetAcquisitionDomain_c4578a22-c342-464d-9882-3d938436013d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AZTechMember_95273eb7-afda-4ac3-961f-d6559696ae14" xlink:href="rdnt-20200930.xsd#rdnt_AZTechMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_AssetAcquisitionDomain_c4578a22-c342-464d-9882-3d938436013d" xlink:to="loc_rdnt_AZTechMember_95273eb7-afda-4ac3-961f-d6559696ae14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MRIatWoodbridgeLLCMember_d8aaca80-f09f-4064-aceb-769ed54c06cd" xlink:href="rdnt-20200930.xsd#rdnt_MRIatWoodbridgeLLCMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_AssetAcquisitionDomain_c4578a22-c342-464d-9882-3d938436013d" xlink:to="loc_rdnt_MRIatWoodbridgeLLCMember_d8aaca80-f09f-4064-aceb-769ed54c06cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OlneyOpenMRILLCMember_95bd682a-ae47-400c-b804-e149d71512a1" xlink:href="rdnt-20200930.xsd#rdnt_OlneyOpenMRILLCMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_AssetAcquisitionDomain_c4578a22-c342-464d-9882-3d938436013d" xlink:to="loc_rdnt_OlneyOpenMRILLCMember_95bd682a-ae47-400c-b804-e149d71512a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_1124195b-e79c-4c9b-800e-093798534dc7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0d1125fc-2613-4a76-b5ce-7b1f25b29983" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_1124195b-e79c-4c9b-800e-093798534dc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_40ec5491-226a-4753-ad79-63e1bcc24a5b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_1124195b-e79c-4c9b-800e-093798534dc7" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_40ec5491-226a-4753-ad79-63e1bcc24a5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ImagingOnCallMember_f56e22a2-b52f-4316-848e-733a9dd2a493" xlink:href="rdnt-20200930.xsd#rdnt_ImagingOnCallMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_40ec5491-226a-4753-ad79-63e1bcc24a5b" xlink:to="loc_rdnt_ImagingOnCallMember_f56e22a2-b52f-4316-848e-733a9dd2a493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_91246272-c8fd-4ab0-89ac-4d441cee7b96" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0d1125fc-2613-4a76-b5ce-7b1f25b29983" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_91246272-c8fd-4ab0-89ac-4d441cee7b96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfBusinessesAcquired_7db10d2a-1cf3-4e31-baf0-7eb9e0826b5c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NumberOfBusinessesAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_91246272-c8fd-4ab0-89ac-4d441cee7b96" xlink:to="loc_us-gaap_NumberOfBusinessesAcquired_7db10d2a-1cf3-4e31-baf0-7eb9e0826b5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_521db2db-e242-4668-aa4a-3a277f144592" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_91246272-c8fd-4ab0-89ac-4d441cee7b96" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_521db2db-e242-4668-aa4a-3a277f144592" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_74ca21fe-b1fa-4ec9-83dd-b65633231143" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_91246272-c8fd-4ab0-89ac-4d441cee7b96" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_74ca21fe-b1fa-4ec9-83dd-b65633231143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_a19106e8-9a68-4589-80e3-43660c916c43" xlink:href="rdnt-20200930.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_91246272-c8fd-4ab0-89ac-4d441cee7b96" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_a19106e8-9a68-4589-80e3-43660c916c43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther_6498afae-d7f7-464a-a99e-a91c72732fa5" xlink:href="rdnt-20200930.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_91246272-c8fd-4ab0-89ac-4d441cee7b96" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther_6498afae-d7f7-464a-a99e-a91c72732fa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_fd67f64b-fb06-43eb-a87e-06d67626b214" xlink:href="rdnt-20200930.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_91246272-c8fd-4ab0-89ac-4d441cee7b96" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_fd67f64b-fb06-43eb-a87e-06d67626b214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_66e813dc-4485-4f6f-9c06-34eda9246279" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_91246272-c8fd-4ab0-89ac-4d441cee7b96" xlink:to="loc_us-gaap_Goodwill_66e813dc-4485-4f6f-9c06-34eda9246279" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_5e7ffb56-3ddd-49d9-9499-5f0bfaa361f4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_91246272-c8fd-4ab0-89ac-4d441cee7b96" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_5e7ffb56-3ddd-49d9-9499-5f0bfaa361f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_10cac9c7-3443-4981-809d-33c12abf9667" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_91246272-c8fd-4ab0-89ac-4d441cee7b96" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_10cac9c7-3443-4981-809d-33c12abf9667" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution_9f2122ac-565e-4331-9ae2-b4e83457fdcd" xlink:href="rdnt-20200930.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_91246272-c8fd-4ab0-89ac-4d441cee7b96" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution_9f2122ac-565e-4331-9ae2-b4e83457fdcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution_10e8a149-d59f-4955-961c-2066b36fd631" xlink:href="rdnt-20200930.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_91246272-c8fd-4ab0-89ac-4d441cee7b96" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution_10e8a149-d59f-4955-961c-2066b36fd631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm_81a53a15-8166-4449-bf91-787873e1f3ea" xlink:href="rdnt-20200930.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_91246272-c8fd-4ab0-89ac-4d441cee7b96" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm_81a53a15-8166-4449-bf91-787873e1f3ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution_db7fcfb2-9212-403b-b04b-94d4c1d550aa" xlink:href="rdnt-20200930.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_91246272-c8fd-4ab0-89ac-4d441cee7b96" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution_db7fcfb2-9212-403b-b04b-94d4c1d550aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution_882fba8f-83dd-4e61-9f6e-3b1673d074c5" xlink:href="rdnt-20200930.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_91246272-c8fd-4ab0-89ac-4d441cee7b96" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution_882fba8f-83dd-4e61-9f6e-3b1673d074c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards_42130d62-d78c-4d18-8ae9-44c71a76efd3" xlink:href="rdnt-20200930.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_91246272-c8fd-4ab0-89ac-4d441cee7b96" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards_42130d62-d78c-4d18-8ae9-44c71a76efd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure_9fc5ac97-d3b7-46d3-9cff-e2ac54b30965" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_91246272-c8fd-4ab0-89ac-4d441cee7b96" xlink:to="loc_us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure_9fc5ac97-d3b7-46d3-9cff-e2ac54b30965" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_3f6abfe1-dd63-411b-a3ac-17fb2369ee5d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_91246272-c8fd-4ab0-89ac-4d441cee7b96" xlink:to="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_3f6abfe1-dd63-411b-a3ac-17fb2369ee5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares_b8009d13-790b-450d-8afc-de237d041003" xlink:href="rdnt-20200930.xsd#rdnt_BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_91246272-c8fd-4ab0-89ac-4d441cee7b96" xlink:to="loc_rdnt_BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares_b8009d13-790b-450d-8afc-de237d041003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares_b328f9b7-51ef-434d-89d3-af0bd02bbb46" xlink:href="rdnt-20200930.xsd#rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_91246272-c8fd-4ab0-89ac-4d441cee7b96" xlink:to="loc_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares_b328f9b7-51ef-434d-89d3-af0bd02bbb46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares_618e1d7d-ea21-4bcb-ab50-f44e0f867101" xlink:href="rdnt-20200930.xsd#rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_91246272-c8fd-4ab0-89ac-4d441cee7b96" xlink:to="loc_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares_618e1d7d-ea21-4bcb-ab50-f44e0f867101" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_f15daf93-5cc4-47df-8e96-2f4cb0d16067" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_91246272-c8fd-4ab0-89ac-4d441cee7b96" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_f15daf93-5cc4-47df-8e96-2f4cb0d16067" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_e6ae82dc-adc9-45cb-93e8-4ddd2ef55970" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_91246272-c8fd-4ab0-89ac-4d441cee7b96" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_e6ae82dc-adc9-45cb-93e8-4ddd2ef55970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_c180c6a4-0e31-41ed-a58e-5c776488b3d9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_91246272-c8fd-4ab0-89ac-4d441cee7b96" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_c180c6a4-0e31-41ed-a58e-5c776488b3d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFinanceLeaseLiabilities_0641d8ca-4666-47eb-a89f-0984293da596" xlink:href="rdnt-20200930.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFinanceLeaseLiabilities"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_91246272-c8fd-4ab0-89ac-4d441cee7b96" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFinanceLeaseLiabilities_0641d8ca-4666-47eb-a89f-0984293da596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture_f6b64a63-75c2-4676-a10e-d56dd3fd554c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromDivestitureOfInterestInJointVenture"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_91246272-c8fd-4ab0-89ac-4d441cee7b96" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture_f6b64a63-75c2-4676-a10e-d56dd3fd554c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLE" xlink:type="simple" xlink:href="rdnt-20200930.xsd#CREDITFACILITYANDNOTESPAYABLE"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_51bceffb-6c15-4050-90f1-16e4c1247660" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock_ebeff4a4-5e50-4bc9-a911-857650a35169" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_51bceffb-6c15-4050-90f1-16e4c1247660" xlink:to="loc_us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock_ebeff4a4-5e50-4bc9-a911-857650a35169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLETables" xlink:type="simple" xlink:href="rdnt-20200930.xsd#CREDITFACILITYANDNOTESPAYABLETables"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_a1172460-058f-4290-82c8-2322c59419b5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_670def24-84d6-4d68-8b8d-ff250c488ccf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_a1172460-058f-4290-82c8-2322c59419b5" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_670def24-84d6-4d68-8b8d-ff250c488ccf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_9d76702d-1484-46c9-9442-81e4cb5b82d5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_a1172460-058f-4290-82c8-2322c59419b5" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_9d76702d-1484-46c9-9442-81e4cb5b82d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ScheduleOfLeverageRatioTableTextBlock_26849441-b349-461c-baee-c790ed13cbc4" xlink:href="rdnt-20200930.xsd#rdnt_ScheduleOfLeverageRatioTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_a1172460-058f-4290-82c8-2322c59419b5" xlink:to="loc_rdnt_ScheduleOfLeverageRatioTableTextBlock_26849441-b349-461c-baee-c790ed13cbc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt" xlink:type="simple" xlink:href="rdnt-20200930.xsd#CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_51014b65-27be-4353-8144-25bd35a13424" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_969e8dfe-2a13-4393-aa96-baf8bb3b57e7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_51014b65-27be-4353-8144-25bd35a13424" xlink:to="loc_us-gaap_DebtInstrumentTable_969e8dfe-2a13-4393-aa96-baf8bb3b57e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_8421b68f-3f7e-42cc-a1bb-67d770ef6351" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_969e8dfe-2a13-4393-aa96-baf8bb3b57e7" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_8421b68f-3f7e-42cc-a1bb-67d770ef6351" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8efb58a9-d9be-4360-b2e9-f42845c6868c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8421b68f-3f7e-42cc-a1bb-67d770ef6351" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8efb58a9-d9be-4360-b2e9-f42845c6868c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TermLoanMember_cf53561c-5fa8-42f0-b7d7-76f379cf5605" xlink:href="rdnt-20200930.xsd#rdnt_TermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8efb58a9-d9be-4360-b2e9-f42845c6868c" xlink:to="loc_rdnt_TermLoanMember_cf53561c-5fa8-42f0-b7d7-76f379cf5605" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_b0287f9b-5815-4a4f-93e9-750ccf8ccfd7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8efb58a9-d9be-4360-b2e9-f42845c6868c" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_b0287f9b-5815-4a4f-93e9-750ccf8ccfd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_f26f79c1-1e10-4a35-92ba-a5d264eb7c96" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_969e8dfe-2a13-4393-aa96-baf8bb3b57e7" xlink:to="loc_us-gaap_DebtInstrumentAxis_f26f79c1-1e10-4a35-92ba-a5d264eb7c96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_092a86c4-b83e-43f1-8100-62d7d34bbd23" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_f26f79c1-1e10-4a35-92ba-a5d264eb7c96" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_092a86c4-b83e-43f1-8100-62d7d34bbd23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienTermLoanMember_eb4acd38-0ef3-4724-9ebb-ba0101978fee" xlink:href="rdnt-20200930.xsd#rdnt_FirstLienTermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_092a86c4-b83e-43f1-8100-62d7d34bbd23" xlink:to="loc_rdnt_FirstLienTermLoanMember_eb4acd38-0ef3-4724-9ebb-ba0101978fee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedAgreementMember_897c95ce-fcac-4478-8262-a97aab8cb78f" xlink:href="rdnt-20200930.xsd#rdnt_RestatedAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_092a86c4-b83e-43f1-8100-62d7d34bbd23" xlink:to="loc_rdnt_RestatedAgreementMember_897c95ce-fcac-4478-8262-a97aab8cb78f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PaycheckProtectionProgramLoansMember_94f9a81e-c125-46f1-a9b6-bad7cf092fee" xlink:href="rdnt-20200930.xsd#rdnt_PaycheckProtectionProgramLoansMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_092a86c4-b83e-43f1-8100-62d7d34bbd23" xlink:to="loc_rdnt_PaycheckProtectionProgramLoansMember_94f9a81e-c125-46f1-a9b6-bad7cf092fee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_c828e204-8609-42ed-9120-d90cc35bdcd0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_969e8dfe-2a13-4393-aa96-baf8bb3b57e7" xlink:to="loc_us-gaap_DebtInstrumentLineItems_c828e204-8609-42ed-9120-d90cc35bdcd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_ebe5ca9d-d7b5-4554-90c2-9e6bafc58455" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c828e204-8609-42ed-9120-d90cc35bdcd0" xlink:to="loc_us-gaap_LongTermDebt_ebe5ca9d-d7b5-4554-90c2-9e6bafc58455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_4b89bdc0-e599-4d50-8020-0ba8ea0fc337" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c828e204-8609-42ed-9120-d90cc35bdcd0" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_4b89bdc0-e599-4d50-8020-0ba8ea0fc337" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermLoansPayable_87d9b784-dd68-4c72-a250-6b88211549d0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermLoansPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c828e204-8609-42ed-9120-d90cc35bdcd0" xlink:to="loc_us-gaap_LongTermLoansPayable_87d9b784-dd68-4c72-a250-6b88211549d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities_19c26690-ddc5-4bd1-ae41-57634deaa762" xlink:href="rdnt-20200930.xsd#rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c828e204-8609-42ed-9120-d90cc35bdcd0" xlink:to="loc_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities_19c26690-ddc5-4bd1-ae41-57634deaa762" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsCurrentMaturities_2de3ff72-5802-4dce-8a84-2ae304052295" xlink:href="rdnt-20200930.xsd#rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsCurrentMaturities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c828e204-8609-42ed-9120-d90cc35bdcd0" xlink:to="loc_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsCurrentMaturities_2de3ff72-5802-4dce-8a84-2ae304052295" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsExcludingCurrentMaturities_f201ab6d-dfae-4f59-aa84-f72d6590726b" xlink:href="rdnt-20200930.xsd#rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsExcludingCurrentMaturities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c828e204-8609-42ed-9120-d90cc35bdcd0" xlink:to="loc_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsExcludingCurrentMaturities_f201ab6d-dfae-4f59-aa84-f72d6590726b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c3278128-58c3-4186-860c-49252977019b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c828e204-8609-42ed-9120-d90cc35bdcd0" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c3278128-58c3-4186-860c-49252977019b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20200930.xsd#CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_2a9886c3-5a99-419c-b7ac-d912d337edfa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_60cc0524-1824-4819-be75-3662b2826dde" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2a9886c3-5a99-419c-b7ac-d912d337edfa" xlink:to="loc_us-gaap_DebtInstrumentTable_60cc0524-1824-4819-be75-3662b2826dde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_1f7e8f18-3a0e-4589-bc32-8ee1d72233d8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_60cc0524-1824-4819-be75-3662b2826dde" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_1f7e8f18-3a0e-4589-bc32-8ee1d72233d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_ca19f81f-5de1-43f1-b9db-37757b7fabbf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_1f7e8f18-3a0e-4589-bc32-8ee1d72233d8" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_ca19f81f-5de1-43f1-b9db-37757b7fabbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_COVID19PandemicMember_b2b106b9-d2ce-4707-90b1-137bad7f562d" xlink:href="rdnt-20200930.xsd#rdnt_COVID19PandemicMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_ca19f81f-5de1-43f1-b9db-37757b7fabbf" xlink:to="loc_rdnt_COVID19PandemicMember_b2b106b9-d2ce-4707-90b1-137bad7f562d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_5c6166f1-7b03-4397-a8e8-08e56a206141" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_60cc0524-1824-4819-be75-3662b2826dde" xlink:to="loc_us-gaap_VariableRateAxis_5c6166f1-7b03-4397-a8e8-08e56a206141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_d34b236c-f642-46be-b470-6ee396d9671d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_5c6166f1-7b03-4397-a8e8-08e56a206141" xlink:to="loc_us-gaap_VariableRateDomain_d34b236c-f642-46be-b470-6ee396d9671d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember_ff277473-8b2f-437f-ae49-6922e3b39a04" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EurodollarMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_d34b236c-f642-46be-b470-6ee396d9671d" xlink:to="loc_us-gaap_EurodollarMember_ff277473-8b2f-437f-ae49-6922e3b39a04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_2760a6ac-6636-46f8-8958-906a629cd9b1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_d34b236c-f642-46be-b470-6ee396d9671d" xlink:to="loc_us-gaap_BaseRateMember_2760a6ac-6636-46f8-8958-906a629cd9b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioAxis_d3f1ae14-3e4a-4e98-afb9-4070c8db3b5c" xlink:href="rdnt-20200930.xsd#rdnt_LeverageRatioAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_60cc0524-1824-4819-be75-3662b2826dde" xlink:to="loc_rdnt_LeverageRatioAxis_d3f1ae14-3e4a-4e98-afb9-4070c8db3b5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_091623a6-f096-46a5-9dc1-6255263f7fb9" xlink:href="rdnt-20200930.xsd#rdnt_LeverageRatioDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioAxis_d3f1ae14-3e4a-4e98-afb9-4070c8db3b5c" xlink:to="loc_rdnt_LeverageRatioDomain_091623a6-f096-46a5-9dc1-6255263f7fb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioThreeMember_b338a95a-c3fc-4b1a-9627-c562659ac330" xlink:href="rdnt-20200930.xsd#rdnt_LeverageRatioThreeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_091623a6-f096-46a5-9dc1-6255263f7fb9" xlink:to="loc_rdnt_LeverageRatioThreeMember_b338a95a-c3fc-4b1a-9627-c562659ac330" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIIIMember_4250b806-a2d2-40d7-8a20-9e1d995f34f7" xlink:href="rdnt-20200930.xsd#rdnt_PricingLevelIIIMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_091623a6-f096-46a5-9dc1-6255263f7fb9" xlink:to="loc_rdnt_PricingLevelIIIMember_4250b806-a2d2-40d7-8a20-9e1d995f34f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_9bd56799-3783-484f-897a-3320cafad3e9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_60cc0524-1824-4819-be75-3662b2826dde" xlink:to="loc_us-gaap_DebtInstrumentAxis_9bd56799-3783-484f-897a-3320cafad3e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_55db966f-b5d8-43f9-bb24-9c348565412e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_9bd56799-3783-484f-897a-3320cafad3e9" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_55db966f-b5d8-43f9-bb24-9c348565412e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienTermLoanMember_3f5696cc-b142-44b8-9012-bca812659299" xlink:href="rdnt-20200930.xsd#rdnt_FirstLienTermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_55db966f-b5d8-43f9-bb24-9c348565412e" xlink:to="loc_rdnt_FirstLienTermLoanMember_3f5696cc-b142-44b8-9012-bca812659299" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedAgreementMember_abc01169-ec01-46b3-b759-0a7ecd28f6c3" xlink:href="rdnt-20200930.xsd#rdnt_RestatedAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_55db966f-b5d8-43f9-bb24-9c348565412e" xlink:to="loc_rdnt_RestatedAgreementMember_abc01169-ec01-46b3-b759-0a7ecd28f6c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementMember_3b5a6094-702a-4ce4-8194-f0f940909c40" xlink:href="rdnt-20200930.xsd#rdnt_FirstLienCreditAgreementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_55db966f-b5d8-43f9-bb24-9c348565412e" xlink:to="loc_rdnt_FirstLienCreditAgreementMember_3b5a6094-702a-4ce4-8194-f0f940909c40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementEighthAmendmentMember_786f2195-889d-403b-a293-f83e7e3f83b8" xlink:href="rdnt-20200930.xsd#rdnt_FirstLienCreditAgreementEighthAmendmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_55db966f-b5d8-43f9-bb24-9c348565412e" xlink:to="loc_rdnt_FirstLienCreditAgreementEighthAmendmentMember_786f2195-889d-403b-a293-f83e7e3f83b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember_6aef1cf8-8913-4b01-97e1-6ca58814d167" xlink:href="rdnt-20200930.xsd#rdnt_FirstLienCreditAgreementSixthAmendmentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_55db966f-b5d8-43f9-bb24-9c348565412e" xlink:to="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember_6aef1cf8-8913-4b01-97e1-6ca58814d167" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PaycheckProtectionProgramLoansMember_749f6bad-a262-47a7-8d00-e3d0d12a7eb4" xlink:href="rdnt-20200930.xsd#rdnt_PaycheckProtectionProgramLoansMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_55db966f-b5d8-43f9-bb24-9c348565412e" xlink:to="loc_rdnt_PaycheckProtectionProgramLoansMember_749f6bad-a262-47a7-8d00-e3d0d12a7eb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_618279d9-b441-48e8-a5e3-556cd6755ad2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_60cc0524-1824-4819-be75-3662b2826dde" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_618279d9-b441-48e8-a5e3-556cd6755ad2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_da62dbb1-9a42-4975-aa31-7850bb055a51" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_618279d9-b441-48e8-a5e3-556cd6755ad2" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_da62dbb1-9a42-4975-aa31-7850bb055a51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BarclaysMember_0c5c0a32-552f-4c11-a984-72a658328f93" xlink:href="rdnt-20200930.xsd#rdnt_BarclaysMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_da62dbb1-9a42-4975-aa31-7850bb055a51" xlink:to="loc_rdnt_BarclaysMember_0c5c0a32-552f-4c11-a984-72a658328f93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SunTrustMember_7ef5c0d1-db50-401b-bb54-62e51ef9b594" xlink:href="rdnt-20200930.xsd#rdnt_SunTrustMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_da62dbb1-9a42-4975-aa31-7850bb055a51" xlink:to="loc_rdnt_SunTrustMember_7ef5c0d1-db50-401b-bb54-62e51ef9b594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_e73cbbc8-123f-4249-bb53-c9058166bff2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_60cc0524-1824-4819-be75-3662b2826dde" xlink:to="loc_us-gaap_CreditFacilityAxis_e73cbbc8-123f-4249-bb53-c9058166bff2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_9d0f7aca-cb3a-477b-8988-8de03f31313a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_e73cbbc8-123f-4249-bb53-c9058166bff2" xlink:to="loc_us-gaap_CreditFacilityDomain_9d0f7aca-cb3a-477b-8988-8de03f31313a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_700c59b2-6bfe-484b-9eef-1147542c2f45" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_9d0f7aca-cb3a-477b-8988-8de03f31313a" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_700c59b2-6bfe-484b-9eef-1147542c2f45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_740e606a-147f-41e1-842d-226c90df2c7d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_60cc0524-1824-4819-be75-3662b2826dde" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_740e606a-147f-41e1-842d-226c90df2c7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_59ef52f7-234b-4794-83b6-3a9462098c40" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_740e606a-147f-41e1-842d-226c90df2c7d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_59ef52f7-234b-4794-83b6-3a9462098c40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TermLoanMember_5da3cba6-f34d-4cf8-befa-c36d9b5ce708" xlink:href="rdnt-20200930.xsd#rdnt_TermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_59ef52f7-234b-4794-83b6-3a9462098c40" xlink:to="loc_rdnt_TermLoanMember_5da3cba6-f34d-4cf8-befa-c36d9b5ce708" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienTermLoansAMember_029eeed5-1ae2-42ce-a464-1b0fb545a6a7" xlink:href="rdnt-20200930.xsd#rdnt_FirstLienTermLoansAMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_59ef52f7-234b-4794-83b6-3a9462098c40" xlink:to="loc_rdnt_FirstLienTermLoansAMember_029eeed5-1ae2-42ce-a464-1b0fb545a6a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_cdd1a4cf-5125-487b-8ef7-cc67ca58fbed" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_59ef52f7-234b-4794-83b6-3a9462098c40" xlink:to="loc_us-gaap_LineOfCreditMember_cdd1a4cf-5125-487b-8ef7-cc67ca58fbed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_c08c039d-69e4-4cc1-a7e8-0b7e358461f7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_59ef52f7-234b-4794-83b6-3a9462098c40" xlink:to="loc_us-gaap_LetterOfCreditMember_c08c039d-69e4-4cc1-a7e8-0b7e358461f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember_ecfafcb8-16fc-43f5-9772-21397a501678" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MediumTermNotesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_59ef52f7-234b-4794-83b6-3a9462098c40" xlink:to="loc_us-gaap_MediumTermNotesMember_ecfafcb8-16fc-43f5-9772-21397a501678" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementSeventhAmendmentMember_7e9a98b1-1c85-4d80-b8c4-3e8f0abb4a09" xlink:href="rdnt-20200930.xsd#rdnt_FirstLienCreditAgreementSeventhAmendmentMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_59ef52f7-234b-4794-83b6-3a9462098c40" xlink:to="loc_rdnt_FirstLienCreditAgreementSeventhAmendmentMember_7e9a98b1-1c85-4d80-b8c4-3e8f0abb4a09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_3e516c43-0c0a-48a3-9a3a-2654b21bf400" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_60cc0524-1824-4819-be75-3662b2826dde" xlink:to="loc_us-gaap_DebtInstrumentLineItems_3e516c43-0c0a-48a3-9a3a-2654b21bf400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_ef742759-0603-4683-a49b-d35284346107" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e516c43-0c0a-48a3-9a3a-2654b21bf400" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_ef742759-0603-4683-a49b-d35284346107" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_e8799081-6edf-4e60-a755-e969bf7897e9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e516c43-0c0a-48a3-9a3a-2654b21bf400" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_e8799081-6edf-4e60-a755-e969bf7897e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_07791085-fd32-45f9-a0b1-639a13e1b144" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e516c43-0c0a-48a3-9a3a-2654b21bf400" xlink:to="loc_us-gaap_LineOfCredit_07791085-fd32-45f9-a0b1-639a13e1b144" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_966fee13-1cb3-4c5b-9002-3356704b2694" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e516c43-0c0a-48a3-9a3a-2654b21bf400" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_966fee13-1cb3-4c5b-9002-3356704b2694" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_e2a0df88-e3db-44c9-9ade-3b0339d87f2e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e516c43-0c0a-48a3-9a3a-2654b21bf400" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_e2a0df88-e3db-44c9-9ade-3b0339d87f2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_0dadd0ac-4f89-40bc-bb13-4eb63f98882a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e516c43-0c0a-48a3-9a3a-2654b21bf400" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_0dadd0ac-4f89-40bc-bb13-4eb63f98882a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_bfc7cc7d-e029-4716-9952-612fd0e7f0b2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e516c43-0c0a-48a3-9a3a-2654b21bf400" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_bfc7cc7d-e029-4716-9952-612fd0e7f0b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_aa0e6d7e-4b0b-48d2-9d12-7b5f2f70c4ee" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e516c43-0c0a-48a3-9a3a-2654b21bf400" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_aa0e6d7e-4b0b-48d2-9d12-7b5f2f70c4ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_2f08e4d2-bf13-405a-b32d-0f52d36e3936" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e516c43-0c0a-48a3-9a3a-2654b21bf400" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_2f08e4d2-bf13-405a-b32d-0f52d36e3936" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_298562b8-968a-4d5f-b607-059ec74ae0a7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e516c43-0c0a-48a3-9a3a-2654b21bf400" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_298562b8-968a-4d5f-b607-059ec74ae0a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentPeriodicPaymentPercent_7c37ce21-a0ff-440a-8616-dfed409f0f79" xlink:href="rdnt-20200930.xsd#rdnt_DebtInstrumentPeriodicPaymentPercent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e516c43-0c0a-48a3-9a3a-2654b21bf400" xlink:to="loc_rdnt_DebtInstrumentPeriodicPaymentPercent_7c37ce21-a0ff-440a-8616-dfed409f0f79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease_087c59a7-984c-43a4-85a6-3f9792b876ef" xlink:href="rdnt-20200930.xsd#rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e516c43-0c0a-48a3-9a3a-2654b21bf400" xlink:to="loc_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease_087c59a7-984c-43a4-85a6-3f9792b876ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_b38f4620-4825-4981-8954-d0ff7a8f3e05" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e516c43-0c0a-48a3-9a3a-2654b21bf400" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_b38f4620-4825-4981-8954-d0ff7a8f3e05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_12d246b0-d15f-4465-8635-bf07304fd063" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e516c43-0c0a-48a3-9a3a-2654b21bf400" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_12d246b0-d15f-4465-8635-bf07304fd063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity_956082a4-f3ef-48ff-861e-d66e0060b3cc" xlink:href="rdnt-20200930.xsd#rdnt_LineofCreditFacilityIncreaseBorrowingCapacity"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e516c43-0c0a-48a3-9a3a-2654b21bf400" xlink:to="loc_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity_956082a4-f3ef-48ff-861e-d66e0060b3cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_757c2203-0b0e-4bda-b11f-e387a693eca8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e516c43-0c0a-48a3-9a3a-2654b21bf400" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_757c2203-0b0e-4bda-b11f-e387a693eca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountCurrent_30f822ae-ca54-41e5-a6ff-ef3fdcbbb831" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountCurrent"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e516c43-0c0a-48a3-9a3a-2654b21bf400" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountCurrent_30f822ae-ca54-41e5-a6ff-ef3fdcbbb831" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredCharges_92b437ee-bc43-4f0c-be74-80f831ae9f2a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfDeferredCharges"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e516c43-0c0a-48a3-9a3a-2654b21bf400" xlink:to="loc_us-gaap_AmortizationOfDeferredCharges_92b437ee-bc43-4f0c-be74-80f831ae9f2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_6eb06406-7c9c-42b9-9e4d-5979985589cb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e516c43-0c0a-48a3-9a3a-2654b21bf400" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_6eb06406-7c9c-42b9-9e4d-5979985589cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_44786cc1-261b-4cc0-9f03-7afc34d3a6e3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e516c43-0c0a-48a3-9a3a-2654b21bf400" xlink:to="loc_us-gaap_DebtInstrumentTerm_44786cc1-261b-4cc0-9f03-7afc34d3a6e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentNumberofLoansReceived_9a6330ff-fdcc-48a1-9517-c1c429058cf4" xlink:href="rdnt-20200930.xsd#rdnt_DebtInstrumentNumberofLoansReceived"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e516c43-0c0a-48a3-9a3a-2654b21bf400" xlink:to="loc_rdnt_DebtInstrumentNumberofLoansReceived_9a6330ff-fdcc-48a1-9517-c1c429058cf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsTermLoans" xlink:type="simple" xlink:href="rdnt-20200930.xsd#CREDITFACILITYANDNOTESPAYABLEDetailsTermLoans"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsTermLoans" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_f79e21a3-54cb-48f2-9ea3-befb5609084d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_f310db50-54f9-409c-badc-69e626fffcf7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f79e21a3-54cb-48f2-9ea3-befb5609084d" xlink:to="loc_us-gaap_DebtInstrumentTable_f310db50-54f9-409c-badc-69e626fffcf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_8249f60d-444d-4c31-acbc-c6f5b9ecca33" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f310db50-54f9-409c-badc-69e626fffcf7" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_8249f60d-444d-4c31-acbc-c6f5b9ecca33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_124af8d6-ddd9-4a7f-90be-0f773a7fd8a8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8249f60d-444d-4c31-acbc-c6f5b9ecca33" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_124af8d6-ddd9-4a7f-90be-0f773a7fd8a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TermLoanMember_85085211-ebf9-4a2f-82b0-fcb4921f1c34" xlink:href="rdnt-20200930.xsd#rdnt_TermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_124af8d6-ddd9-4a7f-90be-0f773a7fd8a8" xlink:to="loc_rdnt_TermLoanMember_85085211-ebf9-4a2f-82b0-fcb4921f1c34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_60e26460-2b1c-485a-bde0-d569352e1a47" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f310db50-54f9-409c-badc-69e626fffcf7" xlink:to="loc_us-gaap_DebtInstrumentAxis_60e26460-2b1c-485a-bde0-d569352e1a47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_75020e28-5d48-421a-bed0-c27dcce329a2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_60e26460-2b1c-485a-bde0-d569352e1a47" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_75020e28-5d48-421a-bed0-c27dcce329a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienTermLoanMember_86307544-8fc1-4963-a818-96d46fdd369a" xlink:href="rdnt-20200930.xsd#rdnt_FirstLienTermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_75020e28-5d48-421a-bed0-c27dcce329a2" xlink:to="loc_rdnt_FirstLienTermLoanMember_86307544-8fc1-4963-a818-96d46fdd369a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedAgreementMember_9728eda1-0411-4cfc-9ee1-b479a8eff947" xlink:href="rdnt-20200930.xsd#rdnt_RestatedAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_75020e28-5d48-421a-bed0-c27dcce329a2" xlink:to="loc_rdnt_RestatedAgreementMember_9728eda1-0411-4cfc-9ee1-b479a8eff947" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_74bff9b9-0252-4352-9910-a71e92beb86e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f310db50-54f9-409c-badc-69e626fffcf7" xlink:to="loc_us-gaap_DebtInstrumentLineItems_74bff9b9-0252-4352-9910-a71e92beb86e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_613c081d-d7b8-4ba5-bcba-3c9a0de44684" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_74bff9b9-0252-4352-9910-a71e92beb86e" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_613c081d-d7b8-4ba5-bcba-3c9a0de44684" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_d370672f-e642-497a-a28d-36296511f127" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_74bff9b9-0252-4352-9910-a71e92beb86e" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_d370672f-e642-497a-a28d-36296511f127" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_46d4d1eb-d4c1-420f-a0fe-96d757a0aac4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_74bff9b9-0252-4352-9910-a71e92beb86e" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_46d4d1eb-d4c1-420f-a0fe-96d757a0aac4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio" xlink:type="simple" xlink:href="rdnt-20200930.xsd#CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_a37c2c2e-bb06-48de-916a-fae7b7811619" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_890b2ba9-12c2-4902-9926-27a8024008b7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_a37c2c2e-bb06-48de-916a-fae7b7811619" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_890b2ba9-12c2-4902-9926-27a8024008b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_669ddc30-db8b-4a08-8b60-e66e40872675" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_890b2ba9-12c2-4902-9926-27a8024008b7" xlink:to="loc_us-gaap_DebtInstrumentAxis_669ddc30-db8b-4a08-8b60-e66e40872675" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c069ec69-fe79-418c-9090-08e25489fdf9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_669ddc30-db8b-4a08-8b60-e66e40872675" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c069ec69-fe79-418c-9090-08e25489fdf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementMember_4ddddc84-0768-427a-b9a6-8480208ec8f1" xlink:href="rdnt-20200930.xsd#rdnt_FirstLienCreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c069ec69-fe79-418c-9090-08e25489fdf9" xlink:to="loc_rdnt_FirstLienCreditAgreementMember_4ddddc84-0768-427a-b9a6-8480208ec8f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_f3df757b-eea1-4b10-8c52-b6e00aa8356d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_890b2ba9-12c2-4902-9926-27a8024008b7" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_f3df757b-eea1-4b10-8c52-b6e00aa8356d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_57c306be-f7c3-458c-932f-748f4ac6a76b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f3df757b-eea1-4b10-8c52-b6e00aa8356d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_57c306be-f7c3-458c-932f-748f4ac6a76b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_afe36209-54d3-471a-a5a7-c93512502ca6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_57c306be-f7c3-458c-932f-748f4ac6a76b" xlink:to="loc_us-gaap_LineOfCreditMember_afe36209-54d3-471a-a5a7-c93512502ca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_4b6800cd-8ff5-45ac-ae1b-29a0de3a9aa5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_890b2ba9-12c2-4902-9926-27a8024008b7" xlink:to="loc_us-gaap_VariableRateAxis_4b6800cd-8ff5-45ac-ae1b-29a0de3a9aa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_7612a4e4-4d94-451f-a2c5-eb513694b11d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_4b6800cd-8ff5-45ac-ae1b-29a0de3a9aa5" xlink:to="loc_us-gaap_VariableRateDomain_7612a4e4-4d94-451f-a2c5-eb513694b11d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember_4173fb8c-5130-4062-8beb-6e62cdb2708c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EurodollarMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_7612a4e4-4d94-451f-a2c5-eb513694b11d" xlink:to="loc_us-gaap_EurodollarMember_4173fb8c-5130-4062-8beb-6e62cdb2708c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_06c54564-c9c8-46ef-90a2-58cb7666dd11" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_7612a4e4-4d94-451f-a2c5-eb513694b11d" xlink:to="loc_us-gaap_BaseRateMember_06c54564-c9c8-46ef-90a2-58cb7666dd11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioAxis_1f82eb05-9239-45b6-82b3-3c8b06c35cfe" xlink:href="rdnt-20200930.xsd#rdnt_LeverageRatioAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_890b2ba9-12c2-4902-9926-27a8024008b7" xlink:to="loc_rdnt_LeverageRatioAxis_1f82eb05-9239-45b6-82b3-3c8b06c35cfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_8bbcc3f6-60c7-436e-b46d-9c26dd0a18e5" xlink:href="rdnt-20200930.xsd#rdnt_LeverageRatioDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioAxis_1f82eb05-9239-45b6-82b3-3c8b06c35cfe" xlink:to="loc_rdnt_LeverageRatioDomain_8bbcc3f6-60c7-436e-b46d-9c26dd0a18e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioOneMember_9fe6e0f0-6f07-46f2-b743-398670fd8b41" xlink:href="rdnt-20200930.xsd#rdnt_LeverageRatioOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_8bbcc3f6-60c7-436e-b46d-9c26dd0a18e5" xlink:to="loc_rdnt_LeverageRatioOneMember_9fe6e0f0-6f07-46f2-b743-398670fd8b41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioTwoMember_51db5632-4a74-442e-8f16-d00b252e36e0" xlink:href="rdnt-20200930.xsd#rdnt_LeverageRatioTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_8bbcc3f6-60c7-436e-b46d-9c26dd0a18e5" xlink:to="loc_rdnt_LeverageRatioTwoMember_51db5632-4a74-442e-8f16-d00b252e36e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioThreeMember_2a628657-ea02-40c5-b668-dcda5a10ad56" xlink:href="rdnt-20200930.xsd#rdnt_LeverageRatioThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_8bbcc3f6-60c7-436e-b46d-9c26dd0a18e5" xlink:to="loc_rdnt_LeverageRatioThreeMember_2a628657-ea02-40c5-b668-dcda5a10ad56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioFourMember_971470ec-8270-4020-aa20-6eb8f2c078d3" xlink:href="rdnt-20200930.xsd#rdnt_LeverageRatioFourMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_8bbcc3f6-60c7-436e-b46d-9c26dd0a18e5" xlink:to="loc_rdnt_LeverageRatioFourMember_971470ec-8270-4020-aa20-6eb8f2c078d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_c1e1726d-1bfe-4176-992c-23270808f279" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_890b2ba9-12c2-4902-9926-27a8024008b7" xlink:to="loc_us-gaap_CreditFacilityAxis_c1e1726d-1bfe-4176-992c-23270808f279" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_2b42c8c3-8e48-4e10-a421-d2b76973caf5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_c1e1726d-1bfe-4176-992c-23270808f279" xlink:to="loc_us-gaap_CreditFacilityDomain_2b42c8c3-8e48-4e10-a421-d2b76973caf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_08b9a6af-969a-4071-8dff-97b43d949163" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_2b42c8c3-8e48-4e10-a421-d2b76973caf5" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_08b9a6af-969a-4071-8dff-97b43d949163" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_1cdad959-4523-4f92-be9e-5ec242578782" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_890b2ba9-12c2-4902-9926-27a8024008b7" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_1cdad959-4523-4f92-be9e-5ec242578782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_9a7c1b74-5166-45a7-8f97-83c256fdcf3a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1cdad959-4523-4f92-be9e-5ec242578782" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_9a7c1b74-5166-45a7-8f97-83c256fdcf3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument" xlink:type="simple" xlink:href="rdnt-20200930.xsd#CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_e88a01cd-619c-4028-b827-8818af65aea4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_e70dec25-fb2a-4ded-97ea-5f50e26f0bdf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e88a01cd-619c-4028-b827-8818af65aea4" xlink:to="loc_us-gaap_DebtInstrumentTable_e70dec25-fb2a-4ded-97ea-5f50e26f0bdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioAxis_beea9bd4-fb31-43ec-8e1f-e3c3255bbb82" xlink:href="rdnt-20200930.xsd#rdnt_LeverageRatioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e70dec25-fb2a-4ded-97ea-5f50e26f0bdf" xlink:to="loc_rdnt_LeverageRatioAxis_beea9bd4-fb31-43ec-8e1f-e3c3255bbb82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_42ba1702-d37b-4549-883e-07fe5108cc03" xlink:href="rdnt-20200930.xsd#rdnt_LeverageRatioDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioAxis_beea9bd4-fb31-43ec-8e1f-e3c3255bbb82" xlink:to="loc_rdnt_LeverageRatioDomain_42ba1702-d37b-4549-883e-07fe5108cc03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIMember_70d2c486-e473-4737-8e86-16c3cd9e8fa3" xlink:href="rdnt-20200930.xsd#rdnt_PricingLevelIMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_42ba1702-d37b-4549-883e-07fe5108cc03" xlink:to="loc_rdnt_PricingLevelIMember_70d2c486-e473-4737-8e86-16c3cd9e8fa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIIMember_f49edfc6-878b-4ce4-bf21-6c2a2c2c730b" xlink:href="rdnt-20200930.xsd#rdnt_PricingLevelIIMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_42ba1702-d37b-4549-883e-07fe5108cc03" xlink:to="loc_rdnt_PricingLevelIIMember_f49edfc6-878b-4ce4-bf21-6c2a2c2c730b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIIIMember_f39fa118-94c7-4caf-9001-2e245aca6b1a" xlink:href="rdnt-20200930.xsd#rdnt_PricingLevelIIIMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_42ba1702-d37b-4549-883e-07fe5108cc03" xlink:to="loc_rdnt_PricingLevelIIIMember_f39fa118-94c7-4caf-9001-2e245aca6b1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIVMember_53fa77a2-d051-4a1c-8f49-07ce722120e3" xlink:href="rdnt-20200930.xsd#rdnt_PricingLevelIVMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_42ba1702-d37b-4549-883e-07fe5108cc03" xlink:to="loc_rdnt_PricingLevelIVMember_53fa77a2-d051-4a1c-8f49-07ce722120e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelVMember_f77c71fa-aad4-4afc-8c43-4abc1fd7b52b" xlink:href="rdnt-20200930.xsd#rdnt_PricingLevelVMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_42ba1702-d37b-4549-883e-07fe5108cc03" xlink:to="loc_rdnt_PricingLevelVMember_f77c71fa-aad4-4afc-8c43-4abc1fd7b52b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_58a34415-d901-4eb1-b35c-271a85c0cf7a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e70dec25-fb2a-4ded-97ea-5f50e26f0bdf" xlink:to="loc_us-gaap_VariableRateAxis_58a34415-d901-4eb1-b35c-271a85c0cf7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_4bc03ee6-db38-4faf-a043-29b465ef2d5b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_58a34415-d901-4eb1-b35c-271a85c0cf7a" xlink:to="loc_us-gaap_VariableRateDomain_4bc03ee6-db38-4faf-a043-29b465ef2d5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember_8dc611fa-4d1b-4b3b-914f-325d9ef73cea" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EurodollarMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_4bc03ee6-db38-4faf-a043-29b465ef2d5b" xlink:to="loc_us-gaap_EurodollarMember_8dc611fa-4d1b-4b3b-914f-325d9ef73cea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_eebefc6e-f64b-419c-af37-43919b0d86ff" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_4bc03ee6-db38-4faf-a043-29b465ef2d5b" xlink:to="loc_us-gaap_BaseRateMember_eebefc6e-f64b-419c-af37-43919b0d86ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_f18df39f-d0a8-4bb0-8555-4b43a0653c6f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e70dec25-fb2a-4ded-97ea-5f50e26f0bdf" xlink:to="loc_us-gaap_DebtInstrumentAxis_f18df39f-d0a8-4bb0-8555-4b43a0653c6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_fe019b40-cad4-4c1b-8e58-bf673d3961f5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_f18df39f-d0a8-4bb0-8555-4b43a0653c6f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_fe019b40-cad4-4c1b-8e58-bf673d3961f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedAgreementMember_d3133812-0c6a-4115-bee6-34568dadf00e" xlink:href="rdnt-20200930.xsd#rdnt_RestatedAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fe019b40-cad4-4c1b-8e58-bf673d3961f5" xlink:to="loc_rdnt_RestatedAgreementMember_d3133812-0c6a-4115-bee6-34568dadf00e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_cd1e4d94-11a9-4c74-9a6f-76093ecd3261" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e70dec25-fb2a-4ded-97ea-5f50e26f0bdf" xlink:to="loc_us-gaap_CreditFacilityAxis_cd1e4d94-11a9-4c74-9a6f-76093ecd3261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_812e9ce0-6099-4765-8d11-5aaed70b75f9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_cd1e4d94-11a9-4c74-9a6f-76093ecd3261" xlink:to="loc_us-gaap_CreditFacilityDomain_812e9ce0-6099-4765-8d11-5aaed70b75f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_8e028af6-5135-4152-99f1-305118f412bf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_812e9ce0-6099-4765-8d11-5aaed70b75f9" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_8e028af6-5135-4152-99f1-305118f412bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_bcde458f-a304-4878-a2f4-12b7a611b634" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e70dec25-fb2a-4ded-97ea-5f50e26f0bdf" xlink:to="loc_us-gaap_DebtInstrumentLineItems_bcde458f-a304-4878-a2f4-12b7a611b634" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum_e4de029a-462c-4864-83dd-5f404a7ec4d0" xlink:href="rdnt-20200930.xsd#rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bcde458f-a304-4878-a2f4-12b7a611b634" xlink:to="loc_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum_e4de029a-462c-4864-83dd-5f404a7ec4d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentCovenantLeverageRatioMaximum_a532a1c3-8df4-476f-a30c-4f33cd5e0377" xlink:href="rdnt-20200930.xsd#rdnt_DebtInstrumentCovenantLeverageRatioMaximum"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bcde458f-a304-4878-a2f4-12b7a611b634" xlink:to="loc_rdnt_DebtInstrumentCovenantLeverageRatioMaximum_a532a1c3-8df4-476f-a30c-4f33cd5e0377" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_e8195d13-4d7f-4373-a4de-d89ba121514e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bcde458f-a304-4878-a2f4-12b7a611b634" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_e8195d13-4d7f-4373-a4de-d89ba121514e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_018876b1-a05c-4cde-850b-643e99bcc0a2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bcde458f-a304-4878-a2f4-12b7a611b634" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_018876b1-a05c-4cde-850b-643e99bcc0a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_248ebb82-fca9-4969-a584-b3e7e0ebad8c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bcde458f-a304-4878-a2f4-12b7a611b634" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_248ebb82-fca9-4969-a584-b3e7e0ebad8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATION" xlink:type="simple" xlink:href="rdnt-20200930.xsd#STOCKBASEDCOMPENSATION"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_759fbedc-66ff-4f3f-840e-0f07b8ed1483" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_fbf26ee4-6b87-4710-a3b9-4f718bd81303" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_759fbedc-66ff-4f3f-840e-0f07b8ed1483" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_fbf26ee4-6b87-4710-a3b9-4f718bd81303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables" xlink:type="simple" xlink:href="rdnt-20200930.xsd#STOCKBASEDCOMPENSATIONTables"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ac345550-337a-4d3b-be06-34cf0ad2b6fd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_e3b5c9a0-2d33-4de0-8753-9da83a04c273" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ac345550-337a-4d3b-be06-34cf0ad2b6fd" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_e3b5c9a0-2d33-4de0-8753-9da83a04c273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_60b2758f-40f3-4cb4-aae0-f48971e9160c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ac345550-337a-4d3b-be06-34cf0ad2b6fd" xlink:to="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_60b2758f-40f3-4cb4-aae0-f48971e9160c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20200930.xsd#STOCKBASEDCOMPENSATIONDetailsNarrative"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_11f5324e-71a5-44fd-8e80-a9fb3542a18a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0c4fd2e6-ed9d-4bf7-a8fa-54edd4eb3888" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_11f5324e-71a5-44fd-8e80-a9fb3542a18a" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0c4fd2e6-ed9d-4bf7-a8fa-54edd4eb3888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_828e3c8e-6f7f-473e-a64f-8d46106a75c9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0c4fd2e6-ed9d-4bf7-a8fa-54edd4eb3888" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_828e3c8e-6f7f-473e-a64f-8d46106a75c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5a036467-ccf8-43fc-8772-b7d66ea1f989" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_828e3c8e-6f7f-473e-a64f-8d46106a75c9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5a036467-ccf8-43fc-8772-b7d66ea1f989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthIncMember_a6f25cef-d6f4-4416-93e8-a4c2b354fa54" xlink:href="rdnt-20200930.xsd#rdnt_DeepHealthIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5a036467-ccf8-43fc-8772-b7d66ea1f989" xlink:to="loc_rdnt_DeepHealthIncMember_a6f25cef-d6f4-4416-93e8-a4c2b354fa54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_99048de6-3901-4187-b6ef-4be92b068139" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0c4fd2e6-ed9d-4bf7-a8fa-54edd4eb3888" xlink:to="loc_us-gaap_PlanNameAxis_99048de6-3901-4187-b6ef-4be92b068139" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_207dedad-4af2-4d76-b774-73b947aea80d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_99048de6-3901-4187-b6ef-4be92b068139" xlink:to="loc_us-gaap_PlanNameDomain_207dedad-4af2-4d76-b774-73b947aea80d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedPlanMember_e9832eac-a55e-4747-a264-048d0bdccc5c" xlink:href="rdnt-20200930.xsd#rdnt_RestatedPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_207dedad-4af2-4d76-b774-73b947aea80d" xlink:to="loc_rdnt_RestatedPlanMember_e9832eac-a55e-4747-a264-048d0bdccc5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_09594458-a078-4067-b963-3f3dfb1cc263" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0c4fd2e6-ed9d-4bf7-a8fa-54edd4eb3888" xlink:to="loc_us-gaap_AwardTypeAxis_09594458-a078-4067-b963-3f3dfb1cc263" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c9e90166-a6f6-4cba-9a1a-4fa8c4532f28" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_09594458-a078-4067-b963-3f3dfb1cc263" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c9e90166-a6f6-4cba-9a1a-4fa8c4532f28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_46f3b38a-525c-47ab-8654-88653a670bcd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c9e90166-a6f6-4cba-9a1a-4fa8c4532f28" xlink:to="loc_us-gaap_StockOptionMember_46f3b38a-525c-47ab-8654-88653a670bcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_df5307cb-18df-4a59-8577-689b18d951df" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c9e90166-a6f6-4cba-9a1a-4fa8c4532f28" xlink:to="loc_us-gaap_RestrictedStockMember_df5307cb-18df-4a59-8577-689b18d951df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FutureServiceMember_945c61b6-18cf-4957-8da9-b342963c4ebc" xlink:href="rdnt-20200930.xsd#rdnt_FutureServiceMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c9e90166-a6f6-4cba-9a1a-4fa8c4532f28" xlink:to="loc_rdnt_FutureServiceMember_945c61b6-18cf-4957-8da9-b342963c4ebc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cf48d69e-a53b-432c-af29-bf7db006e380" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0c4fd2e6-ed9d-4bf7-a8fa-54edd4eb3888" xlink:to="loc_srt_RangeAxis_cf48d69e-a53b-432c-af29-bf7db006e380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_aa408e1f-924d-462d-942d-0d5fbce2a4e2" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_cf48d69e-a53b-432c-af29-bf7db006e380" xlink:to="loc_srt_RangeMember_aa408e1f-924d-462d-942d-0d5fbce2a4e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b6766ea3-af5f-40bd-8a4b-90b8f691cf11" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_aa408e1f-924d-462d-942d-0d5fbce2a4e2" xlink:to="loc_srt_MinimumMember_b6766ea3-af5f-40bd-8a4b-90b8f691cf11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_25dfd513-b40f-49ec-865b-f4fa90af4d32" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_aa408e1f-924d-462d-942d-0d5fbce2a4e2" xlink:to="loc_srt_MaximumMember_25dfd513-b40f-49ec-865b-f4fa90af4d32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_519acb76-1f60-4bf1-9dc9-02ca2cae185f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0c4fd2e6-ed9d-4bf7-a8fa-54edd4eb3888" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_519acb76-1f60-4bf1-9dc9-02ca2cae185f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_eb4e69f4-ae3b-44af-857b-5f99cd373e90" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_519acb76-1f60-4bf1-9dc9-02ca2cae185f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_eb4e69f4-ae3b-44af-857b-5f99cd373e90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_e1f45dd4-3bd8-4b84-a2e6-427bf6b3f1e0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_519acb76-1f60-4bf1-9dc9-02ca2cae185f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_e1f45dd4-3bd8-4b84-a2e6-427bf6b3f1e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_1ebc930c-101f-4be6-ac5d-a047c4d6e7df" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_519acb76-1f60-4bf1-9dc9-02ca2cae185f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_1ebc930c-101f-4be6-ac5d-a047c4d6e7df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_72f15ed1-0a23-42fb-ac28-7d5f97615246" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_519acb76-1f60-4bf1-9dc9-02ca2cae185f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_72f15ed1-0a23-42fb-ac28-7d5f97615246" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0d0f81e1-eb21-44d1-9f35-e9819342d3c8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_519acb76-1f60-4bf1-9dc9-02ca2cae185f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0d0f81e1-eb21-44d1-9f35-e9819342d3c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_644a25af-a8ae-47e9-8616-69ece5653216" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_519acb76-1f60-4bf1-9dc9-02ca2cae185f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_644a25af-a8ae-47e9-8616-69ece5653216" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_79f472d8-68d8-446b-ab36-8dee870afe68" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_519acb76-1f60-4bf1-9dc9-02ca2cae185f" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_79f472d8-68d8-446b-ab36-8dee870afe68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dc555b44-81f0-4667-90c0-8558e8012349" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_519acb76-1f60-4bf1-9dc9-02ca2cae185f" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dc555b44-81f0-4667-90c0-8558e8012349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_e87de1d0-0c3b-4165-a2b5-dc8dfe715b46" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_519acb76-1f60-4bf1-9dc9-02ca2cae185f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_e87de1d0-0c3b-4165-a2b5-dc8dfe715b46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_90fef1bc-b26b-4862-b562-f6b7f75c671a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_519acb76-1f60-4bf1-9dc9-02ca2cae185f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_90fef1bc-b26b-4862-b562-f6b7f75c671a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AwardsIssuedToDate_908bd11d-6d58-46fb-8e01-63bc0df65285" xlink:href="rdnt-20200930.xsd#rdnt_AwardsIssuedToDate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_519acb76-1f60-4bf1-9dc9-02ca2cae185f" xlink:to="loc_rdnt_AwardsIssuedToDate_908bd11d-6d58-46fb-8e01-63bc0df65285" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_43cfbbf0-38af-4b73-b247-2a5907c8ee74" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_519acb76-1f60-4bf1-9dc9-02ca2cae185f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_43cfbbf0-38af-4b73-b247-2a5907c8ee74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_280766cf-ccba-40c6-8bb2-dea1fe7c2fd8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_519acb76-1f60-4bf1-9dc9-02ca2cae185f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_280766cf-ccba-40c6-8bb2-dea1fe7c2fd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_4431a9c1-edc9-4d0a-b784-2eab9807bb72" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_519acb76-1f60-4bf1-9dc9-02ca2cae185f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_4431a9c1-edc9-4d0a-b784-2eab9807bb72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance_e76cb903-a629-463f-8b02-af4e809d4bcb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_519acb76-1f60-4bf1-9dc9-02ca2cae185f" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance_e76cb903-a629-463f-8b02-af4e809d4bcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants" xlink:type="simple" xlink:href="rdnt-20200930.xsd#STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9c16478e-6a9b-453c-832e-6451d92c43c4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0a7af896-8cd0-4608-bc24-607b8c74fe3f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9c16478e-6a9b-453c-832e-6451d92c43c4" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0a7af896-8cd0-4608-bc24-607b8c74fe3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_f9a66748-d966-4ad8-b0fa-d31bd30ab96a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0a7af896-8cd0-4608-bc24-607b8c74fe3f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_f9a66748-d966-4ad8-b0fa-d31bd30ab96a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_73e4de67-7894-4bc2-ba69-08dbd56ee415" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f9a66748-d966-4ad8-b0fa-d31bd30ab96a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_73e4de67-7894-4bc2-ba69-08dbd56ee415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthInc.Member_df514d30-8e4f-4e92-8115-87e377cf908e" xlink:href="rdnt-20200930.xsd#rdnt_DeepHealthInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_73e4de67-7894-4bc2-ba69-08dbd56ee415" xlink:to="loc_rdnt_DeepHealthInc.Member_df514d30-8e4f-4e92-8115-87e377cf908e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_2723c8c7-fcdd-47c0-a49a-ea1209ca346f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0a7af896-8cd0-4608-bc24-607b8c74fe3f" xlink:to="loc_us-gaap_AwardTypeAxis_2723c8c7-fcdd-47c0-a49a-ea1209ca346f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3b795b62-a5e7-43f0-aded-62ca81d4382e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_2723c8c7-fcdd-47c0-a49a-ea1209ca346f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3b795b62-a5e7-43f0-aded-62ca81d4382e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_78f06794-f71b-4e2e-b6eb-d1e3eaf0f9bc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3b795b62-a5e7-43f0-aded-62ca81d4382e" xlink:to="loc_us-gaap_StockOptionMember_78f06794-f71b-4e2e-b6eb-d1e3eaf0f9bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90ff4f25-817e-44bf-97da-4bd7dbcf70e7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0a7af896-8cd0-4608-bc24-607b8c74fe3f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90ff4f25-817e-44bf-97da-4bd7dbcf70e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_757d4913-e018-45f5-990c-90b795694660" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90ff4f25-817e-44bf-97da-4bd7dbcf70e7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_757d4913-e018-45f5-990c-90b795694660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4253baf6-decc-4932-95e1-f9309afba26d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_757d4913-e018-45f5-990c-90b795694660" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4253baf6-decc-4932-95e1-f9309afba26d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_350a3120-133d-4d49-a285-89cc82daa716" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_757d4913-e018-45f5-990c-90b795694660" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_350a3120-133d-4d49-a285-89cc82daa716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_5dba68c4-bca1-41d1-a5e3-0a57ef253322" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_757d4913-e018-45f5-990c-90b795694660" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_5dba68c4-bca1-41d1-a5e3-0a57ef253322" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0e33d616-b0a8-4ba2-a926-1499339b811f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_757d4913-e018-45f5-990c-90b795694660" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0e33d616-b0a8-4ba2-a926-1499339b811f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_9ba67b41-7fd2-4606-834f-d6768a7ea801" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_757d4913-e018-45f5-990c-90b795694660" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_9ba67b41-7fd2-4606-834f-d6768a7ea801" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1afc894b-e022-4a0a-9c11-591a2ab4d23a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90ff4f25-817e-44bf-97da-4bd7dbcf70e7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1afc894b-e022-4a0a-9c11-591a2ab4d23a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_a9651ef4-d864-47bb-b4f8-0242e1a298ad" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1afc894b-e022-4a0a-9c11-591a2ab4d23a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_a9651ef4-d864-47bb-b4f8-0242e1a298ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_cdec4002-0fbc-4db9-a9cc-4110732a5229" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1afc894b-e022-4a0a-9c11-591a2ab4d23a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_cdec4002-0fbc-4db9-a9cc-4110732a5229" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_e42f1373-2060-42d3-884c-a61fa0ebeee4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1afc894b-e022-4a0a-9c11-591a2ab4d23a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_e42f1373-2060-42d3-884c-a61fa0ebeee4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_b999f413-4111-422e-b933-2434eaa56fd3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1afc894b-e022-4a0a-9c11-591a2ab4d23a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_b999f413-4111-422e-b933-2434eaa56fd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WeightedAverageRemainingContractualLife_6d6ddc72-4d3b-42d3-9663-448de3f7e2e2" xlink:href="rdnt-20200930.xsd#rdnt_WeightedAverageRemainingContractualLife"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90ff4f25-817e-44bf-97da-4bd7dbcf70e7" xlink:to="loc_rdnt_WeightedAverageRemainingContractualLife_6d6ddc72-4d3b-42d3-9663-448de3f7e2e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_3e841da8-8afa-40e8-9d59-b97ce7315986" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_WeightedAverageRemainingContractualLife_6d6ddc72-4d3b-42d3-9663-448de3f7e2e2" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_3e841da8-8afa-40e8-9d59-b97ce7315986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_e2b69781-3b19-4eda-a821-1b1fbdf88496" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_WeightedAverageRemainingContractualLife_6d6ddc72-4d3b-42d3-9663-448de3f7e2e2" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_e2b69781-3b19-4eda-a821-1b1fbdf88496" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AggregateIntrinsicValue_149912d0-18b2-4a13-9990-1788237264c0" xlink:href="rdnt-20200930.xsd#rdnt_AggregateIntrinsicValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90ff4f25-817e-44bf-97da-4bd7dbcf70e7" xlink:to="loc_rdnt_AggregateIntrinsicValue_149912d0-18b2-4a13-9990-1788237264c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_d16ea896-6ff1-4a12-886a-b41a7072016f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_AggregateIntrinsicValue_149912d0-18b2-4a13-9990-1788237264c0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_d16ea896-6ff1-4a12-886a-b41a7072016f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_9fa885d6-885f-4a7a-8b1f-34da8ae8b160" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_AggregateIntrinsicValue_149912d0-18b2-4a13-9990-1788237264c0" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_9fa885d6-885f-4a7a-8b1f-34da8ae8b160" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs" xlink:type="simple" xlink:href="rdnt-20200930.xsd#STOCKBASEDCOMPENSATIONDetailsRSUs"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c7dd620e-bedc-4f7e-8021-8a5b84207edc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_60fc68e8-e80e-4e44-b60c-2c5cf294b0bc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c7dd620e-bedc-4f7e-8021-8a5b84207edc" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_60fc68e8-e80e-4e44-b60c-2c5cf294b0bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6657edf6-f404-44e7-8abe-7cb10987fbf3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_60fc68e8-e80e-4e44-b60c-2c5cf294b0bc" xlink:to="loc_us-gaap_AwardTypeAxis_6657edf6-f404-44e7-8abe-7cb10987fbf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_03a7946f-1464-42bc-adae-b6ffd0048714" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_6657edf6-f404-44e7-8abe-7cb10987fbf3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_03a7946f-1464-42bc-adae-b6ffd0048714" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_488b17b6-9e96-4fd7-b06e-424a1379b83c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_03a7946f-1464-42bc-adae-b6ffd0048714" xlink:to="loc_us-gaap_RestrictedStockMember_488b17b6-9e96-4fd7-b06e-424a1379b83c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9bfb894a-a670-4ba2-8eef-b1b5f83e4d46" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_60fc68e8-e80e-4e44-b60c-2c5cf294b0bc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9bfb894a-a670-4ba2-8eef-b1b5f83e4d46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_72d03470-4f4f-4af0-a19d-30b4c70ce761" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9bfb894a-a670-4ba2-8eef-b1b5f83e4d46" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_72d03470-4f4f-4af0-a19d-30b4c70ce761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_f28a3e90-f897-4f12-a593-06156dc9f1f3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_72d03470-4f4f-4af0-a19d-30b4c70ce761" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_f28a3e90-f897-4f12-a593-06156dc9f1f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_165457b5-84c0-4fb7-a9d9-4eebc4f26aac" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_72d03470-4f4f-4af0-a19d-30b4c70ce761" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_165457b5-84c0-4fb7-a9d9-4eebc4f26aac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_4a2f915a-790b-42d0-bab4-adb1345b8e84" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_72d03470-4f4f-4af0-a19d-30b4c70ce761" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_4a2f915a-790b-42d0-bab4-adb1345b8e84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_5c0ffcaf-d58a-4bb6-bece-8cba9ae47fd5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_72d03470-4f4f-4af0-a19d-30b4c70ce761" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_5c0ffcaf-d58a-4bb6-bece-8cba9ae47fd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_55d52b14-7cf3-4a25-8a47-0e00a98ecb91" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9bfb894a-a670-4ba2-8eef-b1b5f83e4d46" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_55d52b14-7cf3-4a25-8a47-0e00a98ecb91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_484b4e4b-de36-473c-886a-4f0a1ca251d6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9bfb894a-a670-4ba2-8eef-b1b5f83e4d46" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_484b4e4b-de36-473c-886a-4f0a1ca251d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_dee5d8c3-2bc0-4d70-bcd0-9f7e04a68b6e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_484b4e4b-de36-473c-886a-4f0a1ca251d6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_dee5d8c3-2bc0-4d70-bcd0-9f7e04a68b6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_4f84171b-382d-4ce1-9daa-4f2738427b3d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_484b4e4b-de36-473c-886a-4f0a1ca251d6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_4f84171b-382d-4ce1-9daa-4f2738427b3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_1596c024-2ca6-4239-a6c6-2dfc98c7369e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_484b4e4b-de36-473c-886a-4f0a1ca251d6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_1596c024-2ca6-4239-a6c6-2dfc98c7369e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_e50f1bba-4111-44f2-b180-c181c480f2ae" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_484b4e4b-de36-473c-886a-4f0a1ca251d6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_e50f1bba-4111-44f2-b180-c181c480f2ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUBSEQUENTEVENTS" xlink:type="simple" xlink:href="rdnt-20200930.xsd#SUBSEQUENTEVENTS"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUBSEQUENTEVENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_62f63730-4cb2-495b-9329-c0d2bec0ab32" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_678ac24f-7e6e-40a0-ab4d-4bd583eef356" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_62f63730-4cb2-495b-9329-c0d2bec0ab32" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_678ac24f-7e6e-40a0-ab4d-4bd583eef356" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUBSEQUENTEVENTSDetails" xlink:type="simple" xlink:href="rdnt-20200930.xsd#SUBSEQUENTEVENTSDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUBSEQUENTEVENTSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_ec30800a-a8d8-42e1-896b-4702ce865f2e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_b466a008-7987-49c7-b73a-30bd217e9a90" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_ec30800a-a8d8-42e1-896b-4702ce865f2e" xlink:to="loc_us-gaap_SubsequentEventTable_b466a008-7987-49c7-b73a-30bd217e9a90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_6987e132-df90-485b-b107-0e132d25a555" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_b466a008-7987-49c7-b73a-30bd217e9a90" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_6987e132-df90-485b-b107-0e132d25a555" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_0732e26d-56ba-4f2d-9fee-9c23b9686c4a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_6987e132-df90-485b-b107-0e132d25a555" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_0732e26d-56ba-4f2d-9fee-9c23b9686c4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_5af1d10f-3c21-4fb0-a89d-14a73e626c38" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_0732e26d-56ba-4f2d-9fee-9c23b9686c4a" xlink:to="loc_us-gaap_SubsequentEventMember_5af1d10f-3c21-4fb0-a89d-14a73e626c38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis_d33e7358-cf0c-4f52-864e-98f8f44f250a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_b466a008-7987-49c7-b73a-30bd217e9a90" xlink:to="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis_d33e7358-cf0c-4f52-864e-98f8f44f250a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationDomain_8a92a63c-6d50-44d3-9c80-2a3eafa865b2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis_d33e7358-cf0c-4f52-864e-98f8f44f250a" xlink:to="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationDomain_8a92a63c-6d50-44d3-9c80-2a3eafa865b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInMajorityOwnedSubsidiariesMember_9f4ceedc-fae5-4b19-8126-ab6da630601e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsInMajorityOwnedSubsidiariesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationDomain_8a92a63c-6d50-44d3-9c80-2a3eafa865b2" xlink:to="loc_us-gaap_InvestmentsInMajorityOwnedSubsidiariesMember_9f4ceedc-fae5-4b19-8126-ab6da630601e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_d9284529-4803-4536-a217-72b96fe742be" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_b466a008-7987-49c7-b73a-30bd217e9a90" xlink:to="loc_dei_LegalEntityAxis_d9284529-4803-4536-a217-72b96fe742be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_cd18f756-2fed-4bf4-9730-9429196dd3e0" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_d9284529-4803-4536-a217-72b96fe742be" xlink:to="loc_dei_EntityDomain_cd18f756-2fed-4bf4-9730-9429196dd3e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SimiValleyHospitalAndHealthServicesMember_5f9f5d18-34ff-48ec-b2cb-60b6e852aaaa" xlink:href="rdnt-20200930.xsd#rdnt_SimiValleyHospitalAndHealthServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_cd18f756-2fed-4bf4-9730-9429196dd3e0" xlink:to="loc_rdnt_SimiValleyHospitalAndHealthServicesMember_5f9f5d18-34ff-48ec-b2cb-60b6e852aaaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_d58becb8-a208-48d0-b26d-5e18edb91009" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_b466a008-7987-49c7-b73a-30bd217e9a90" xlink:to="loc_us-gaap_SubsequentEventLineItems_d58becb8-a208-48d0-b26d-5e18edb91009" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberOfAssetsAcquired_e6900dc8-d504-478e-b66a-28dcfd818616" xlink:href="rdnt-20200930.xsd#rdnt_NumberOfAssetsAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_d58becb8-a208-48d0-b26d-5e18edb91009" xlink:to="loc_rdnt_NumberOfAssetsAcquired_e6900dc8-d504-478e-b66a-28dcfd818616" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_dff00c29-2286-4f69-a53c-661bd31bc11b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_d58becb8-a208-48d0-b26d-5e18edb91009" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_dff00c29-2286-4f69-a53c-661bd31bc11b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>rdnt-20200930_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:rdnt="http://www.radnet.com/20200930"
  xmlns:srt="http://fasb.org/srt/2019-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="rdnt-20200930.xsd" xlink:type="simple"/>
    <context id="i7d337e311ea047289cd379605dc1a780_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i60bc3d6fa03048149fc05435bef6c409_I20201105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <instant>2020-11-05</instant>
        </period>
    </context>
    <context id="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4a9fe0209e954a06aca8cad30d601c73_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia0096f14793b40c99c3a08b6a4ac8010_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ibe98f272e55f41dd878edf32fc7653a3_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0ee478ac62b2402380d60e1df30d2970_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i058de6765e1e47449153067fb1e94bc6_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CapitationArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia03c585e05f349bd894ed447f40ca3fc_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CapitationArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ife4b7517ca2542439322f6bb062453a3_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CapitationArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i202db1f71dbd487f9b8bf67552d7ead3_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CapitationArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i4ae3d85b0b824473a80ccd4a4708aba0_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i3ae0e1753b584266bd033c7378cf877e_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i94f2d48724ea46b3aa0a89c46fcb12f8_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i6d04f49cdfcc40eb9852bb1986ae7007_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ibb96d5b718234c88935d8f52fbbbf3f6_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">rdnt:StockholdersEquityDeficitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i91203f5108484c309c7a4260b22ee742_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i2376698dad8742228ddb9d35b6913ee4_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i8c20b6a988b44e36a260b09593425753_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5fd6699fb85d4180a93c8a06313ec3e6_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4961d9edd85f4cd7b2f81b0166beb6fa_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i09bf6bb1e62e463c8657ba3f07a2376b_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7c7faff739fa454eacddcea55ed701ca_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">rdnt:StockholdersEquityDeficitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i555980525511438faed4ba009d6f37b0_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i90d9b7dfff1842639dab833ff5ec3886_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ief71dd6a90be46dd80cc9cdc74b1b643_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia6a10831dcf34a89b6122ba9bb78bea5_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ie6c25823a7a04a639911e6f404f10a57_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i9b82209eab2648ec9c1833dbc1c0b1db_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i69ba183096574a37a4b5b0ca97c5a51f_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i693f4b2418da466e9e6ad9dad2ab2b32_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">rdnt:StockholdersEquityDeficitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ie0c660ddab0648f28f0f4288a933f163_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i03b809d756f245699c9daa49222191fe_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="if75788edb86f41d092529d110d74bf6b_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i89e4fdcc70e84e32bb0c67373df7c420_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i04d33784ad9449e99e9c45a3134d5d9c_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i15c0b6b3069e42be8f76b29a49821089_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">rdnt:StockholdersEquityDeficitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i46b89b31f76140d281b073abfb16009e_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i77ea6f08b3b34bc687923c35ae708d67_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i9f84ecccfa2c445b87e09865cedb5674_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ide24663efeeb41099f7c5f224f6bc5d7_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i4e3e0e81d2f34922abfd07a4e2eaad7b_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">rdnt:StockholdersEquityDeficitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="id0e02291004444ac9e7381725f9d033f_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i42768d703fd64d3cb22b5badf8ab7fa5_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i8831da9d7f5d4f6fb802e218f7740494_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ic034acb0117040d6afe7d976972fa479_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i0747908eb36543a89df88a2d9e1cd35b_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i8e1094d35d014fd3a95b14bc592059f5_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="ie0f76e06105741279da7c3328d1d487a_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="idd2c608cacd0477aa45970e7d954f191_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">rdnt:StockholdersEquityDeficitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i3d9baeb9e126447b98c2cf732d7b12b4_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i799130036d73414da02bb032ba102c39_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="id4d77a0476814e54bf880ea51ec53067_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i07e00b3689c84e6a9310fc4102bb4b43_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i73519d6ef869432190c131a957d0509a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic04fc01f723141e58a3d30372eb006ea_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3b58c81a32474a7dad91e48ea01781b6_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">rdnt:StockholdersEquityDeficitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="icfb4354e13e748e5a050d331bc69d1a3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if7d38396af1648f3a9c78d6c8c94147c_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3743b37848a340a097d285381b700385_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7fda9262fb95476a816ecc3cad434f3c_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i77d674128a5b4732a239eb275df36879_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6912bfccd4a448a292e8ea776b60d181_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">rdnt:StockholdersEquityDeficitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="idfbed43c89ad4ebfa5f48f8e5bb8a6f9_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id643d75beaf84a40a839ec6515ad926a_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i04b4ca98d99646caa1edf8c9b4cb072e_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3e1e45a341fa4faa80a854e436e843dc_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i6fd92e65f41647c28809f9a7ea4bfa83_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i705ee60e173d4b72997f9e6d827ceed9_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="icb755bfe39e64168aac8fb85840caa13_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i8702613a07bc43e49e4a5a9dc8474851_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">rdnt:StockholdersEquityDeficitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i990f6dad8c174377a290cf37479ca637_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i9799a383a2814cafbb89d610347f767d_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i040549d733b84e41865f935d6710183a_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ia0d67703fcc549f58c3bb54805e151a1_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i4644861e9ece4360bab418f1b9fef51a_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">rdnt:StockholdersEquityDeficitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="id349387901e24032a2736f786cf5a404_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i2a16c2751a89418ca779969dd77a5344_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i34391a7bab5d4dc58cabd25c59a6d33e_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="if4d28a9eeb2a4c71935db70483100dcc_D20200601-20200601">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-06-01</endDate>
        </period>
    </context>
    <context id="i6ef5f4569a454da5b5b38254fa362064_I20200601">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-01</instant>
        </period>
    </context>
    <context id="ibdf5ae03b0ed462b8db002f00aaa9eb3_D20190801-20190801">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:NulogixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-01</startDate>
            <endDate>2019-08-01</endDate>
        </period>
    </context>
    <context id="i9c76df6e41e74111ace2b21a4181efad_I20190801">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:NulogixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-01</instant>
        </period>
    </context>
    <context id="i03857062bad24956a20685e95d06b5f4_I20180412">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <instant>2018-04-12</instant>
        </period>
    </context>
    <context id="id84f65c6811e410281f7a3f3cee987b2_I20190301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:VenturaCountyImagingGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-01</instant>
        </period>
    </context>
    <context id="i09d00c2072a64166aae3435ab4296e8b_D20190227-20190227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HudsonValleyRadiologyAssociatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableInterestEntitiesByClassificationOfEntityAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-02-27</startDate>
            <endDate>2019-02-27</endDate>
        </period>
    </context>
    <context id="iada1780824384c7aa307e03c01df38f3_I20190227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HudsonValleyRadiologyAssociatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableInterestEntitiesByClassificationOfEntityAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-02-27</instant>
        </period>
    </context>
    <context id="ic0ea34f7e0b34c6cb8b791288d9c8ac5_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:BeverlyRadiologyMedicalGroupIIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i6a57a87a6da342959e454a8c3d0ad301_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">rdnt:BoardMemberMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:BeverlyRadiologyMedicalGroupIIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i47fc5bf332c0415ca58f64dd07a99d47_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i4a3dff9af20d4d0898edd8b68ba20037_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie01b35e6814e4aa2a06cc5668ed2166b_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:ScriptSenderLlcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i24364a0cec3f4ac4a7f4537560711888_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CommercialInsurance1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if8be3197ba81441aab9f7bdfa36dd45b_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CommercialInsurance1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ic05adfe570c7418c8583caa2e3756087_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CommercialInsurance1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if079f62201f649a19398e263e6bb723c_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CommercialInsurance1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ic506a388c6254f67851aedb7d7e51a7c_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicare1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9d59877f74b84a14b84be572617b45e4_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicare1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="iaa7ae55f8352482ab21ec0d1d7641820_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicare1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i82a5ccc725d2482e9b6e4b8be5a837c2_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicare1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="id2804457ff9c4979ab5dea362493dfa8_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicaid1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ibbd32a5208b04ee3af351b7e413a9606_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicaid1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="icb0bcbdd5fb649f5a3eba1e57ea2bbdb_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicaid1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i510758bcd5d0485a8ea0f178b65d230b_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicaid1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ic1ccd693101546e9948d833ef3206f25_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:WorkersCompensationPersonalInjury1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6fc9ace2676a462f9ebb5cde7964d542_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:WorkersCompensationPersonalInjury1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ia51cd72af487490cb9a1c49464f21473_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:WorkersCompensationPersonalInjury1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3f5a0223f69441b2ac8a10d4c658efa4_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:WorkersCompensationPersonalInjury1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i959dcd70aa414905a86891687e922d26_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCarePatientServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i36a7f7a656c54a7a93f09e843a05e4dc_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCarePatientServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i1f798c18497b4449804b907ac22474ac_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCarePatientServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1d5a8b020d4846f2be96b5b9d725d28a_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCarePatientServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i2de4a1d7e34f4c979e8ee54471682d8a_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCareManagementServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i467bef824abe4dc791d4fb7875ad8839_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCareManagementServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ib0daed54cf994635a1e3a709aa285693_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCareManagementServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id54012c7cfa84d7182be4c74e1c06f71_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCareManagementServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i35e7f0afe7a540a99ebbf34af2e3756a_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:TeleradiologyandSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i63e61bbfa0be4d13b84f9d661bb940ba_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:TeleradiologyandSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i9c1f6bb93c3c4ac6aba73e2eb120728c_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:TeleradiologyandSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i521d126ad2134cb19713cd8598e5062b_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:TeleradiologyandSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i6d60555cdf4c455083bcb664a31aa0e9_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4b1f63bb36be4d77bc8acab605869faa_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i5744e3fc1fd54fb286b8e45bdced2585_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1d13380e9b574e229bc4acfa7bd99b00_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i1da458a1f30e42a280a85b687626d8c9_D20200401-20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="i9f412c4a4bc94dc6bdf4cf62ede09d62_D20200501-20200531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-01</startDate>
            <endDate>2020-05-31</endDate>
        </period>
    </context>
    <context id="icd0727e676b44495b92424a21cfd803d_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:PaycheckProtectionProgramLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i03664eb4b82e43e8b82d1e6f730f020d_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ie19ca44258f54d33b5e7d6546bae1a8d_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rdnt:PropertyAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1e5c92bdeee343cfa400ee011058ca0f_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rdnt:PropertyAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9851e7fbb9b4406b9d2a6222679efb4d_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie6887d928dca440bbe9351ea5442a009_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i812d1f3338f848fbb0cae71405a11682_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:OlneyOpenMRILLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1b47417b06a54e549d7dc88a99fac34c_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MRIatWoodbridgeLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib71e54b77f294940bda2035bdb641b80_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AZTechMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i027fbe622cb740e796aa36dc1f00b42e_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rdnt:RestatedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ib32f550e8d5d42f69af46e7e6c5dedd0_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i73cdb78ce3cb47cf9c32f71cc3b685a7_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i658e0bcb8f99489086788f33b3dd88c1_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:Caps2016Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i91802bf2d66e48f8b03dbae52a216767_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditDerivativesByContractTypeAxis">rdnt:September2020CapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:Caps2016Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="idc736fa25bf945e0a7f00b0f62403cd4_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditDerivativesByContractTypeAxis">rdnt:October2020CapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:Caps2016Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i4052e92e79fc4969969e1b1a1bdef340_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">rdnt:Caps2016Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i6a7deb3c96cc42bcaa935bd270ffd41b_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i2ae781a9e9de432895fcc55db7b0b610_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9e0459768a414e26a0829c4867e4d0d0_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i1f380d5dd68c48e19e7b1642f1ddc90a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i042c5a0cd0164e16bee1a9405ebde456_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1b5787978e97447bb1142eeeaa5ad186_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ib707578bfbd243ac8417cc2b7cbfd5e7_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i5dc9976fcf3a4031bb4bd9fd7345be68_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditDerivativesByContractTypeAxis">rdnt:October2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i91b5b54bcf7a4da796a36d934ff39258_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditDerivativesByContractTypeAxis">rdnt:October2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ia060340684bb4943a12a873d70c71339_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i62e737b9da50433792d2421c47ccf0cc_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ifcd8f19b217b413699a01d86bc9952fd_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPS1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i3910f866882c4e5bb053c720b008b7b3_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPS1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i77a7a48de64144dbbdb67e5d5e1fd55d_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i57991304d22244b4afe63c7cf8852d25_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0cef0dd9679a4974b78ae9d5a40855d5_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i59e1973e89c2415998dcf8ff7e0ecc39_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if3da5fe50e89470eab1ee1a1f974a635_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie82dec00a8604d95a2968bee33120c7b_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i431f25720da34567b5a173bf4a73fe62_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i889543454acf49acbccb8ebd9c38f86a_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia396b2b61c8e4b9abc54299a4a1c0633_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia385deaca17344c6a8f1436288ae4840_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i01ce6999cc2b4bf9b84083975db56a53_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i0b463d8a36cc4c62adba03e5d8291e67_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i0c840428ea464162be7bc72c9f034b71_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i9c5e95d255df47498c382ead963f4c96_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="if0824895d6334dfe9da358f2324b7091_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i0f6dd49d77474e6fb6ccf417ecec63d2_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i48d3b990dba24f0cb0d02544b0cf7fa6_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i4387d0038f9941debbb302baf4924da2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id5fd69436b804acfb68af2e47702c383_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i59307cb2dd2b47f9a6120f81576277c0_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i00f4787a196b415f81d3165cb90e703b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i67bcd77704ee456ab79b13a06de53338_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ifa429bfca5a2467c87c67ff821d458bd_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6e9fd1b586d44e85871ade2eab7bb3ed_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ided14c36476d4cab94bd8241ae0fc540_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3feb945275b44b0fb63b73ab2bc8752d_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i89984b2070bb46b08c4541ec8ad418d4_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ic4a7827c18a1422ea8ef8558bf7be6c6_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i3612bace1a1a42f99fbd311811c270f5_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i032df92579e74d6c8afec1017d9cb9c5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9e87b2da11c74056a77487fc8c5830e4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6a05e3ae8a634224aa7d2a7d85315360_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i66da6813d35d464786a99b7d5141ed64_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i505d1abebd8447a787b012d89a5eacb7_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i1abfe8394b234eb5bbad4195a9ec0e60_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0cbd1734b449470db208d75670176435_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i601cf4edf4274dc1b781ef5ce684831c_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="id452ca96882e4a38a4bc8cd85bf9878b_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic0b2de2326bf4699aba943152bce409a_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i2ace966e50834326892e2ead3a754d4f_I20170324">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:MedicVisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-03-24</instant>
        </period>
    </context>
    <context id="i918ce2e8fa4a4e8e9a15abd08285dd07_D20170324-20170324">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:MedicVisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-03-24</startDate>
            <endDate>2017-03-24</endDate>
        </period>
    </context>
    <context id="ib5e9eca7800545f5913ba28234bb8765_D20180301-20180301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:MedicVisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-03-01</startDate>
            <endDate>2018-03-01</endDate>
        </period>
    </context>
    <context id="i9a31e32cd3854ea7a79489c93300ee4d_I20180301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:MedicVisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-03-01</instant>
        </period>
    </context>
    <context id="iaad66b5ea72843f5b39b9301e19778be_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:MedicVisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i936ffb40dcb9477e990698614800d7df_D20180201-20180201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:TurnerImagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-02-01</startDate>
            <endDate>2018-02-01</endDate>
        </period>
    </context>
    <context id="ic4d616de0e5248008f9d7307398420b2_I20190101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:TurnerImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-01-01</instant>
        </period>
    </context>
    <context id="i9f1bfde7a34b4cdcbac1a70f78d72a80_I20191011">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:TurnerImagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-11</instant>
        </period>
    </context>
    <context id="id8efe47b9b214f68a5239a62a1642eb8_D20191105-20191105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:WhiteRabbit.aiInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-05</startDate>
            <endDate>2019-11-05</endDate>
        </period>
    </context>
    <context id="ic70d35efa82941bba6027c1e3fda60f0_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:WhiteRabbit.aiInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="icab535e9b02f4e88a0372c47d217e396_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:DignityHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">rdnt:JointVentureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:GlendaleAdvancedImagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="id982434e749e47d18d3f11f2943eee32_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:DignityHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">rdnt:JointVentureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:GlendaleAdvancedImagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i01a109385ece4d30a97550263c32b101_D20200801-20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:SantaMonicaImagingGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="i6a8c4e00f17d4b9db8412be7b503be4e_I20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:SantaMonicaImagingGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="i162b6e4a9b024569bbd2a742fbb7e2df_D20200831-20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="rdnt:AssetAcquisitionAxis">rdnt:AZTechMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-31</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="i88ab08c169fd45579b828ee84aa3fbe2_I20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="rdnt:AssetAcquisitionAxis">rdnt:AZTechMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="i91654ea5e0e647c0ba9d259407ee064a_D20200601-20200601">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-06-01</endDate>
        </period>
    </context>
    <context id="i8973a0068cd845ef97762ff48f7c1a82_I20200601">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-01</instant>
        </period>
    </context>
    <context id="if82d035b351345f5a975f117243ce1cd_D20200302-20200302">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="rdnt:AssetAcquisitionAxis">rdnt:MRIatWoodbridgeLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-02</startDate>
            <endDate>2020-03-02</endDate>
        </period>
    </context>
    <context id="icc8791aabe8a4ca798528207f763624d_I20200302">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="rdnt:AssetAcquisitionAxis">rdnt:MRIatWoodbridgeLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-02</instant>
        </period>
    </context>
    <context id="ib5716180cf92431199e9568b6e00f780_D20200102-20200102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="rdnt:AssetAcquisitionAxis">rdnt:OlneyOpenMRILLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-02</startDate>
            <endDate>2020-01-02</endDate>
        </period>
    </context>
    <context id="i6cbda2807f6f4c2388609f72bced8aa2_I20200102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="rdnt:AssetAcquisitionAxis">rdnt:OlneyOpenMRILLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-02</instant>
        </period>
    </context>
    <context id="i6e52cfe398fa4efabaa39a7aee14b01c_D20200601-20200601">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">rdnt:ImagingOnCallMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-06-01</endDate>
        </period>
    </context>
    <context id="i2afc665ece974620b3ccc8ebbf0e35c7_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i2fe2d4283d9e45e4ad2946e8fa2b5dad_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i71fd7722d0aa4607b2773ebefd280d93_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="if476d02b586946bfaa11a0d8851b0dc2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i21f621247677495cadc7f88b6433f851_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:PaycheckProtectionProgramLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="id5ca3ff1c3f84af0b0834ea2b962f872_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:PaycheckProtectionProgramLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ic35d04f7e5d145f491a377cf89ff8da0_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ia9a34455b88e496f99f11135df67cea7_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i0a84159a6d674db38efa7bbccb1be3e3_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:FirstLienTermLoansAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i2b01a556be2b4c8ab3308ab426b040ab_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementEighthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="iaf61ff95dda14ecdb11e6615b7e7633a_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i42e0febe792a4db09dfe882d336f96bd_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="iafc255d1386a4de3bf178436d2562022_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:SunTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ib9d01a93b2904f61b4796d8a81410b9e_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:SunTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i843b248c0d484e4c80e2fdd2f502195c_D20160701-20160701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-07-01</startDate>
            <endDate>2016-07-01</endDate>
        </period>
    </context>
    <context id="i1b15ecede84f41abb4d034630198d257_D20160701-20160701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-07-01</startDate>
            <endDate>2016-07-01</endDate>
        </period>
    </context>
    <context id="i9aab2f0d56d34189a074316bda4c4b67_D20160701-20160701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-07-01</startDate>
            <endDate>2016-07-01</endDate>
        </period>
    </context>
    <context id="ic02a9a741f3842eea3e3a5a7eb322904_D20160701-20160701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-07-01</startDate>
            <endDate>2016-07-01</endDate>
        </period>
    </context>
    <context id="i0b849e478e084b868c575f20c8653b78_D20160701-20160701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-07-01</startDate>
            <endDate>2016-07-01</endDate>
        </period>
    </context>
    <context id="i8684bb7afe064ac9983fbd954121786d_D20160701-20160701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-07-01</startDate>
            <endDate>2016-07-01</endDate>
        </period>
    </context>
    <context id="ib1a02d97b28646ba996e0c7e95b82bdd_D20160701-20160701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-07-01</startDate>
            <endDate>2016-07-01</endDate>
        </period>
    </context>
    <context id="i437bbb2e361f476fa45f34fff448bb87_D20160701-20160701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-07-01</startDate>
            <endDate>2016-07-01</endDate>
        </period>
    </context>
    <context id="i82c3ce35d9e9413e9de0e1feba63291d_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i6eb5d73b46ce44f6be703ba3df195553_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="icbbf618e1bfe4a609b2387b2599710eb_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i36ad65e4b32d4d83a34c87cef93670a7_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i88ef47c29fec45228c446b6058e13c36_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia5c31aa95d9342c4ba31e43e8ecb8e1f_I20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-31</instant>
        </period>
    </context>
    <context id="icb9718af7bcb4577b02afe00cd03dadd_D20180831-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-31</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="i640e0341ae9546acb37a3b43ce1eba05_D20180831-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-31</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="i5c9e317de1694916936baac47457baad_D20180831-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-31</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="i5ffaf7ff24bc4ca493fd2b08c7ff3a25_I20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-31</instant>
        </period>
    </context>
    <context id="i2f5089184ad64416acfb6e9f45e20056_D20180831-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-31</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="i0e66507e91084592ad6ec96e2082905e_D20180831-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-31</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="ie2a7f7080321422c81221d552960c25c_D20180831-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-31</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="i26e31c72794a4556a79b247236f494e6_I20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-31</instant>
        </period>
    </context>
    <context id="i5f63a8341b184981a270daf0995422d2_D20180831-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-31</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="i5a2cdf61ca404c6b9eaecf77fe17e670_D20180831-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-31</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="i213ea2bff4394c6288e6955b70cfbd38_D20180831-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-31</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="i0b253bd7f2ce411085bd510025d25d34_I20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-31</instant>
        </period>
    </context>
    <context id="i0d4647b913524ddf926d5badbccce1c9_D20180831-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-31</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="i0e02d8d2117c46f3b37af31ddd457d1b_D20180831-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-31</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="i0a4736e633334391ba86255660511b78_D20180831-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-31</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="id619046e0cd648adbb423bb179acab8e_I20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-31</instant>
        </period>
    </context>
    <context id="iae42d0b5f76b4c879b3f0f43f04b1aed_D20180831-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-31</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="ic7de0702b16e423a8f2781f8ef6aa693_D20180831-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-31</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="ia9129b65b01747c292ade5e736c79ab6_D20180831-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-31</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="i3a832ef6cbe04ce4bb0e0da41889582d_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if922a8b092874f639caee5acc1fd1a61_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:SunTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="id655214ccff949e495e113e479f89eba_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:SunTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="if5fdeeaa617f45bc8b5b2de98d538da7_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i34109ecc091e412a9dbd8651e8bb4f2e_I20170822">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-08-22</instant>
        </period>
    </context>
    <context id="i978f7eac6654400d951615a49c92ee12_I20190418">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-18</instant>
        </period>
    </context>
    <context id="i8cca9d99b9324bd1b781038f68dc4e2f_I20190418">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:FirstLienCreditAgreementSeventhAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-18</instant>
        </period>
    </context>
    <context id="ib5b7a6ac8167458194c44af4ba48c5bd_D20190418-20190418">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:FirstLienCreditAgreementSeventhAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-18</startDate>
            <endDate>2019-04-18</endDate>
        </period>
    </context>
    <context id="i965d7b0c650248aeb676ce27ef4835ab_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:PaycheckProtectionProgramLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib55973caf29b407cacf26e47cab62a42_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rdnt:RestatedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if47fff6cbf3149a0a1f38edce2abc129_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rdnt:RestatedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3d158c180c134e64a61a649a0dff7314_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="iaab629f0885047bfac5042b54e4cf7b0_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4b5d964821bf467daf58020889b187c2_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i656e4333bc494b37a20f965c8618f1d0_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ifb572eb0a62c470bb17e387648d4f17f_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic88e676c8ae54e949cbc0e057a2855a7_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i1e4ebdf884e14af1b77318c2bc533fa7_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="icff8e20d84f241cd8104a1116305268a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8741d0f710974ec5a70b0b546a43e7fb_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iced7ee1846d8433483d7f50dbea0a847_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="icfc15acb74684a52b57e605b24afd3db_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i24073316903a4b80852ce62f50a13e5f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id598685e49ce4cde89846d1481b70e13_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic62bac0609a645d1a910b8ba6cb946fb_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:FutureServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8bcd128fbffd44eca246f153070892ca_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rdnt:RestatedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic97e88dc3d0b400f82757dbc8ca7b075_I20201101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentsInAndAdvancesToAffiliatesCategorizationAxis">us-gaap:InvestmentsInMajorityOwnedSubsidiariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-01</instant>
        </period>
    </context>
    <context id="i1f2ef1f8cedb41f48a20163cf23ac25f_I20201101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentsInAndAdvancesToAffiliatesCategorizationAxis">us-gaap:InvestmentsInMajorityOwnedSubsidiariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:SimiValleyHospitalAndHealthServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-01</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="center">
        <measure>rdnt:Center</measure>
    </unit>
    <unit id="numberofagreement">
        <measure>rdnt:numberOfAgreement</measure>
    </unit>
    <unit id="joint_venture">
        <measure>rdnt:joint_venture</measure>
    </unit>
    <unit id="loan">
        <measure>rdnt:loan</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80L2ZyYWc6NjkxMmEyMDg1OGEwNDM2OWFmNTgzOTgwNGMyYjFkNTIvdGFibGU6YmUwYzM0OTViNWM2NGVhNGFjYWI1MzA5NWE1OGFiNmMvdGFibGVyYW5nZTpiZTBjMzQ5NWI1YzY0ZWE0YWNhYjUzMDk1YTU4YWI2Y18xLTEtMS0xLTA_ece6089e-27d7-4059-9077-c1e9a763b9d4">0000790526</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80L2ZyYWc6NjkxMmEyMDg1OGEwNDM2OWFmNTgzOTgwNGMyYjFkNTIvdGFibGU6YmUwYzM0OTViNWM2NGVhNGFjYWI1MzA5NWE1OGFiNmMvdGFibGVyYW5nZTpiZTBjMzQ5NWI1YzY0ZWE0YWNhYjUzMDk1YTU4YWI2Y18yLTEtMS0xLTA_3c426677-05e7-4e3d-8a1f-adad7a40fa13">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80L2ZyYWc6NjkxMmEyMDg1OGEwNDM2OWFmNTgzOTgwNGMyYjFkNTIvdGFibGU6YmUwYzM0OTViNWM2NGVhNGFjYWI1MzA5NWE1OGFiNmMvdGFibGVyYW5nZTpiZTBjMzQ5NWI1YzY0ZWE0YWNhYjUzMDk1YTU4YWI2Y18zLTEtMS0xLTA_64193899-1025-4ba7-8b2b-3dedefed8d8c">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80L2ZyYWc6NjkxMmEyMDg1OGEwNDM2OWFmNTgzOTgwNGMyYjFkNTIvdGFibGU6YmUwYzM0OTViNWM2NGVhNGFjYWI1MzA5NWE1OGFiNmMvdGFibGVyYW5nZTpiZTBjMzQ5NWI1YzY0ZWE0YWNhYjUzMDk1YTU4YWI2Y180LTEtMS0xLTA_a6773483-7631-4c67-81ed-ae3f59489d42">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80L2ZyYWc6NjkxMmEyMDg1OGEwNDM2OWFmNTgzOTgwNGMyYjFkNTIvdGFibGU6YmUwYzM0OTViNWM2NGVhNGFjYWI1MzA5NWE1OGFiNmMvdGFibGVyYW5nZTpiZTBjMzQ5NWI1YzY0ZWE0YWNhYjUzMDk1YTU4YWI2Y181LTEtMS0xLTA_5dca5a91-6c89-4973-b50d-df709aaa9c88">2020</dei:DocumentFiscalYearFocus>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ib32f550e8d5d42f69af46e7e6c5dedd0_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMTY2Mzg_7bbe4cad-8aac-4d51-9911-a759df597876">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="ib32f550e8d5d42f69af46e7e6c5dedd0_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMTY2NTg_8014eae6-0e25-46ab-80ed-ec3b42b893fd">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <dei:DocumentType
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xL2ZyYWc6NDU4OTU2OGJlZDFkNDIxZTkwYmQ2ZTRmYzZmYmFjZjgvdGV4dHJlZ2lvbjo0NTg5NTY4YmVkMWQ0MjFlOTBiZDZlNGZjNmZiYWNmOF8yMTc2_7da13e44-9ead-41f6-be52-6d2adabc89ee">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xL2ZyYWc6NDU4OTU2OGJlZDFkNDIxZTkwYmQ2ZTRmYzZmYmFjZjgvdGV4dHJlZ2lvbjo0NTg5NTY4YmVkMWQ0MjFlOTBiZDZlNGZjNmZiYWNmOF8yMTgx_f01004cf-7118-4bcd-aeff-3f31fce2aea2">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xL2ZyYWc6NDU4OTU2OGJlZDFkNDIxZTkwYmQ2ZTRmYzZmYmFjZjgvdGV4dHJlZ2lvbjo0NTg5NTY4YmVkMWQ0MjFlOTBiZDZlNGZjNmZiYWNmOF8yMjM_13177161-1f90-491c-89db-2a4ed0d417b8">2020-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xL2ZyYWc6NDU4OTU2OGJlZDFkNDIxZTkwYmQ2ZTRmYzZmYmFjZjgvdGV4dHJlZ2lvbjo0NTg5NTY4YmVkMWQ0MjFlOTBiZDZlNGZjNmZiYWNmOF8yMTgy_d2236016-db19-420f-a455-f92551ff2595">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xL2ZyYWc6NDU4OTU2OGJlZDFkNDIxZTkwYmQ2ZTRmYzZmYmFjZjgvdGV4dHJlZ2lvbjo0NTg5NTY4YmVkMWQ0MjFlOTBiZDZlNGZjNmZiYWNmOF8yMTc3_e319d1aa-3131-4ec2-b4f6-ba6b1b0e451e">001-33307</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xL2ZyYWc6NDU4OTU2OGJlZDFkNDIxZTkwYmQ2ZTRmYzZmYmFjZjgvdGV4dHJlZ2lvbjo0NTg5NTY4YmVkMWQ0MjFlOTBiZDZlNGZjNmZiYWNmOF8yMTgz_27641702-962b-443e-943f-c23e22a05e75">RadNet, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xL2ZyYWc6NDU4OTU2OGJlZDFkNDIxZTkwYmQ2ZTRmYzZmYmFjZjgvdGFibGU6YjdhMGI4YWE3YjE5NGQyZTlmZGJjYWVkMDFjYzI4MjYvdGFibGVyYW5nZTpiN2EwYjhhYTdiMTk0ZDJlOWZkYmNhZWQwMWNjMjgyNl8wLTAtMS0xLTA_c03f8aca-8de6-4ab3-92dd-f4286c1be23d">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xL2ZyYWc6NDU4OTU2OGJlZDFkNDIxZTkwYmQ2ZTRmYzZmYmFjZjgvdGFibGU6YjdhMGI4YWE3YjE5NGQyZTlmZGJjYWVkMDFjYzI4MjYvdGFibGVyYW5nZTpiN2EwYjhhYTdiMTk0ZDJlOWZkYmNhZWQwMWNjMjgyNl8wLTItMS0xLTA_d47a68c1-36b7-4d06-a560-af0dbdd1ccdc">13-3326724</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xL2ZyYWc6NDU4OTU2OGJlZDFkNDIxZTkwYmQ2ZTRmYzZmYmFjZjgvdGFibGU6YjdhMGI4YWE3YjE5NGQyZTlmZGJjYWVkMDFjYzI4MjYvdGFibGVyYW5nZTpiN2EwYjhhYTdiMTk0ZDJlOWZkYmNhZWQwMWNjMjgyNl8zLTAtMS0xLTA_f89828d5-44bf-49bb-b87e-aea228ef7c04">1510 Cotner Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xL2ZyYWc6NDU4OTU2OGJlZDFkNDIxZTkwYmQ2ZTRmYzZmYmFjZjgvdGFibGU6YjdhMGI4YWE3YjE5NGQyZTlmZGJjYWVkMDFjYzI4MjYvdGFibGVyYW5nZTpiN2EwYjhhYTdiMTk0ZDJlOWZkYmNhZWQwMWNjMjgyNl80LTAtMS0xLTA_c95c52eb-f312-4a15-a238-ec38804990e2">Los Angeles,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xL2ZyYWc6NDU4OTU2OGJlZDFkNDIxZTkwYmQ2ZTRmYzZmYmFjZjgvdGFibGU6YjdhMGI4YWE3YjE5NGQyZTlmZGJjYWVkMDFjYzI4MjYvdGFibGVyYW5nZTpiN2EwYjhhYTdiMTk0ZDJlOWZkYmNhZWQwMWNjMjgyNl80LTEtMS0xLTA_3f0cc4c8-bbb8-4159-8f1b-1da1972d2db8">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xL2ZyYWc6NDU4OTU2OGJlZDFkNDIxZTkwYmQ2ZTRmYzZmYmFjZjgvdGFibGU6YjdhMGI4YWE3YjE5NGQyZTlmZGJjYWVkMDFjYzI4MjYvdGFibGVyYW5nZTpiN2EwYjhhYTdiMTk0ZDJlOWZkYmNhZWQwMWNjMjgyNl80LTItMS0xLTA_165051f6-5ac8-4370-877d-2ba2badafca9">90025</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xL2ZyYWc6NDU4OTU2OGJlZDFkNDIxZTkwYmQ2ZTRmYzZmYmFjZjgvdGV4dHJlZ2lvbjo0NTg5NTY4YmVkMWQ0MjFlOTBiZDZlNGZjNmZiYWNmOF8yMTg0_ad299a2d-7736-462c-bb84-bbc187585d13">310</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xL2ZyYWc6NDU4OTU2OGJlZDFkNDIxZTkwYmQ2ZTRmYzZmYmFjZjgvdGV4dHJlZ2lvbjo0NTg5NTY4YmVkMWQ0MjFlOTBiZDZlNGZjNmZiYWNmOF8yMTc4_0be551ff-2ded-4ecf-9b47-621af6c8bbce">478-7808</dei:LocalPhoneNumber>
    <dei:EntityCurrentReportingStatus
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xL2ZyYWc6NDU4OTU2OGJlZDFkNDIxZTkwYmQ2ZTRmYzZmYmFjZjgvdGV4dHJlZ2lvbjo0NTg5NTY4YmVkMWQ0MjFlOTBiZDZlNGZjNmZiYWNmOF8yMTg1_7b0c4840-3ea2-4556-86a6-7f3672f49599">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xL2ZyYWc6NDU4OTU2OGJlZDFkNDIxZTkwYmQ2ZTRmYzZmYmFjZjgvdGV4dHJlZ2lvbjo0NTg5NTY4YmVkMWQ0MjFlOTBiZDZlNGZjNmZiYWNmOF8yMTc5_c455263e-04af-452b-bc33-8ae10d411e0b">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xL2ZyYWc6NDU4OTU2OGJlZDFkNDIxZTkwYmQ2ZTRmYzZmYmFjZjgvdGFibGU6ODliOWY1ZDlkZjAxNGJmYzljYjkyZTAyZDg2MTlhMTIvdGFibGVyYW5nZTo4OWI5ZjVkOWRmMDE0YmZjOWNiOTJlMDJkODYxOWExMl8wLTItMS0xLTA_6999d642-d5f3-42e7-851d-c88066282f8c">Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xL2ZyYWc6NDU4OTU2OGJlZDFkNDIxZTkwYmQ2ZTRmYzZmYmFjZjgvdGFibGU6ODliOWY1ZDlkZjAxNGJmYzljYjkyZTAyZDg2MTlhMTIvdGFibGVyYW5nZTo4OWI5ZjVkOWRmMDE0YmZjOWNiOTJlMDJkODYxOWExMl8xLTMtMS0xLTA_b1483c75-c593-4735-b2cb-6232b28be048">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xL2ZyYWc6NDU4OTU2OGJlZDFkNDIxZTkwYmQ2ZTRmYzZmYmFjZjgvdGFibGU6ODliOWY1ZDlkZjAxNGJmYzljYjkyZTAyZDg2MTlhMTIvdGFibGVyYW5nZTo4OWI5ZjVkOWRmMDE0YmZjOWNiOTJlMDJkODYxOWExMl8yLTEtMS0xLTA_530a3d55-fdb8-4259-862d-0912b0900633">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xL2ZyYWc6NDU4OTU2OGJlZDFkNDIxZTkwYmQ2ZTRmYzZmYmFjZjgvdGV4dHJlZ2lvbjo0NTg5NTY4YmVkMWQ0MjFlOTBiZDZlNGZjNmZiYWNmOF8yMTgw_c5b8f839-972d-4755-8499-b1acbf054609">false</dei:EntityShellCompany>
    <dei:Security12bTitle
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xL2ZyYWc6NDU4OTU2OGJlZDFkNDIxZTkwYmQ2ZTRmYzZmYmFjZjgvdGFibGU6NjA5ODkzNWYzMTcxNGE1NWIxYTA5ZjhmOTE2MGZiMjIvdGFibGVyYW5nZTo2MDk4OTM1ZjMxNzE0YTU1YjFhMDlmOGY5MTYwZmIyMl8xLTAtMS0xLTA_4c79e57f-1cdb-43bd-9c37-6e7eb3d16ec4">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xL2ZyYWc6NDU4OTU2OGJlZDFkNDIxZTkwYmQ2ZTRmYzZmYmFjZjgvdGFibGU6NjA5ODkzNWYzMTcxNGE1NWIxYTA5ZjhmOTE2MGZiMjIvdGFibGVyYW5nZTo2MDk4OTM1ZjMxNzE0YTU1YjFhMDlmOGY5MTYwZmIyMl8xLTItMS0xLTA_103aa28b-67aa-4cd1-94be-581d7857b280">RDNT</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xL2ZyYWc6NDU4OTU2OGJlZDFkNDIxZTkwYmQ2ZTRmYzZmYmFjZjgvdGFibGU6NjA5ODkzNWYzMTcxNGE1NWIxYTA5ZjhmOTE2MGZiMjIvdGFibGVyYW5nZTo2MDk4OTM1ZjMxNzE0YTU1YjFhMDlmOGY5MTYwZmIyMl8xLTQtMS0xLTA_1a0c78f5-66b9-4f14-b4ae-3de7f275347e">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i60bc3d6fa03048149fc05435bef6c409_I20201105"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xL2ZyYWc6NDU4OTU2OGJlZDFkNDIxZTkwYmQ2ZTRmYzZmYmFjZjgvdGV4dHJlZ2lvbjo0NTg5NTY4YmVkMWQ0MjFlOTBiZDZlNGZjNmZiYWNmOF8yMTY3_1d5709a0-986c-44c5-a40c-818d2cd48cf6"
      unitRef="shares">51636099</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfNC0xLTEtMS0w_5f353ba9-8514-467a-9f4d-ec4fe6e85e70"
      unitRef="usd">89739000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfNC0zLTEtMS0w_ca770016-e80f-419a-b5d0-f50536d51baa"
      unitRef="usd">40165000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfNS0xLTEtMS0w_24a05d98-7e44-41ca-9d26-20d95110a39b"
      unitRef="usd">137411000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfNS0zLTEtMS0w_849fae01-4fc9-4788-a322-241aaaab0585"
      unitRef="usd">154763000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:DueFromRelatedPartiesCurrent
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfNi0xLTEtMS0w_edd410bc-7851-4d3f-a8bf-58e411a726dc"
      unitRef="usd">424000</us-gaap:DueFromRelatedPartiesCurrent>
    <us-gaap:DueFromRelatedPartiesCurrent
      contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfNi0zLTEtMS0w_e78fbfe1-76a3-4e37-b0b7-773d3ef84246"
      unitRef="usd">1242000</us-gaap:DueFromRelatedPartiesCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfNy0xLTEtMS0w_0fd86245-5f2d-45dc-9300-e119ec31b965"
      unitRef="usd">31482000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfNy0zLTEtMS0w_cb2d87d9-4f38-451a-865b-8b69b675fc82"
      unitRef="usd">45004000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfOS0xLTEtMS0w_d288acbd-0a02-4250-a453-651751bdf10e"
      unitRef="usd">259056000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfOS0zLTEtMS0w_a3b791c2-1d32-4798-aa28-c577641ebf29"
      unitRef="usd">241174000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMTEtMS0xLTEtMA_301219ff-63c8-4734-bfd9-66e7a0e91707"
      unitRef="usd">361950000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMTEtMy0xLTEtMA_11dabb61-2f58-4708-bba1-31715eb9aafc"
      unitRef="usd">367795000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMTItMS0xLTEtMA_c2219aa9-9b26-4133-878e-adb50f18876c"
      unitRef="usd">451613000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMTItMy0xLTEtMA_70dbc591-5687-4b7a-b416-16f5ad39aa2d"
      unitRef="usd">445477000</us-gaap:OperatingLeaseRightOfUseAsset>
    <rdnt:PropertyPlantandEquipmentNetIncludingRightofUseAssets
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMTMtMS0xLTEtMA_81e75e78-4d72-4686-a22e-398f570752cf"
      unitRef="usd">813563000</rdnt:PropertyPlantandEquipmentNetIncludingRightofUseAssets>
    <rdnt:PropertyPlantandEquipmentNetIncludingRightofUseAssets
      contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMTMtMy0xLTEtMA_3db50396-74e7-455b-a59a-afee069dc35a"
      unitRef="usd">813272000</rdnt:PropertyPlantandEquipmentNetIncludingRightofUseAssets>
    <us-gaap:Goodwill
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMTUtMS0xLTEtMA_30d16c41-4c1a-4a7f-b4c2-2839f915d93c"
      unitRef="usd">470685000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMTUtMy0xLTEtMA_da99798a-ce81-4c90-9b36-20783c9cf975"
      unitRef="usd">441973000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMTYtMS0xLTEtMA_a0f821a7-2c65-4ccb-b00b-580293ac35ab"
      unitRef="usd">57152000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMTYtMy0xLTEtMA_0c1da3ce-fad1-48d2-8289-372f34381227"
      unitRef="usd">42994000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:DeferredFinanceCostsNoncurrentNet
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMTctMS0xLTEtMA_ccafbb7a-6c7d-4906-a2f7-a4eefa8d32d2"
      unitRef="usd">1944000</us-gaap:DeferredFinanceCostsNoncurrentNet>
    <us-gaap:DeferredFinanceCostsNoncurrentNet
      contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMTctMy0xLTEtMA_cc56835b-31cd-4c76-9ebd-9a448c228644"
      unitRef="usd">1559000</us-gaap:DeferredFinanceCostsNoncurrentNet>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMTgtMS0xLTEtMA_34fb13bd-ced8-40af-891d-050f7e346332"
      unitRef="usd">35571000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMTgtMy0xLTEtMA_803c5ef4-fcde-41bf-9be0-f36edaf671d7"
      unitRef="usd">34470000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMTktMS0xLTEtMA_ee3f49f7-3336-4266-83b9-4e1576de1aeb"
      unitRef="usd">42188000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMTktMy0xLTEtMA_00c5c341-2620-4bed-9e85-5243cc8a286e"
      unitRef="usd">34548000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DepositsAssets
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMjAtMS0xLTEtMA_0c67edc3-30e1-4978-bc2c-20b1f366d60b"
      unitRef="usd">37707000</us-gaap:DepositsAssets>
    <us-gaap:DepositsAssets
      contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMjAtMy0xLTEtMA_dc2d846a-5741-48d8-80fa-9ca354f87a21"
      unitRef="usd">36996000</us-gaap:DepositsAssets>
    <us-gaap:Assets
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMjEtMS0xLTEtMA_2d5dd518-129c-4b7e-a057-a3a52dfc3a50"
      unitRef="usd">1717866000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMjEtMy0xLTEtMA_3bfa8545-e735-49dc-9bf7-ed13d9ea414b"
      unitRef="usd">1646986000</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMjQtMS0xLTEtMA_82b6fec2-7c33-4774-a5d8-2ca55fc7b550"
      unitRef="usd">205701000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMjQtMy0xLTEtMA_8ffd0560-e4c3-4431-8df2-323ff4587e16"
      unitRef="usd">207585000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:DueToAffiliateCurrent
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMjUtMS0xLTEtMA_490e2b01-5bd0-47b4-816c-b599733b42a1"
      unitRef="usd">12287000</us-gaap:DueToAffiliateCurrent>
    <us-gaap:DueToAffiliateCurrent
      contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMjUtMy0xLTEtMA_9f376949-5622-4111-8b0c-05b9f2dcbd9f"
      unitRef="usd">14347000</us-gaap:DueToAffiliateCurrent>
    <us-gaap:DeferredRevenue
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMjYtMS0xLTEtMA_b8a6e4ae-299a-4216-b4a9-6efa4db0d35f"
      unitRef="usd">45846000</us-gaap:DeferredRevenue>
    <us-gaap:DeferredRevenue
      contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMjYtMy0xLTEtMA_ec692343-c9e8-4ea7-9662-9a2d5cb4de18"
      unitRef="usd">1316000</us-gaap:DeferredRevenue>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMjctMS0xLTEtMA_b05546b3-f15f-4aaf-a282-2671aeec584f"
      unitRef="usd">3041000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMjctMy0xLTEtMA_8eea5c4c-095f-4099-b42c-4d7354d7dfcf"
      unitRef="usd">3283000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMjgtMS0xLTEtMA_4cbf253b-ab11-4f69-8a6c-cb215a7ca813"
      unitRef="usd">67449000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMjgtMy0xLTEtMA_1a99202f-25ba-4659-92be-aabda04d249b"
      unitRef="usd">61206000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMjktMS0xLTEtMA_9b366fab-b732-407b-819b-2440c0143bf0"
      unitRef="usd">39463000</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMjktMy0xLTEtMA_5a6c51fe-0a76-43f8-87bf-0b0f200cdfc6"
      unitRef="usd">39691000</us-gaap:NotesPayableCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMzAtMS0xLTEtMA_ab121f88-311c-42f3-b16a-173a046cc998"
      unitRef="usd">373787000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMzAtMy0xLTEtMA_69fbe095-190b-45a2-9271-810697319a8a"
      unitRef="usd">327428000</us-gaap:LiabilitiesCurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMzItMS0xLTEtMA_ac7ace82-d27d-4c44-be3b-acb2720244d4"
      unitRef="usd">1108000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMzItMy0xLTEtMA_332a9f0e-f7d8-4918-9075-2d13414ab982"
      unitRef="usd">3264000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMzMtMS0xLTEtMA_379b6616-5b09-4068-a6ca-10ed480d9d37"
      unitRef="usd">428233000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMzMtMy0xLTEtMA_4387cfc0-71e2-41eb-824c-5b0c7411cca4"
      unitRef="usd">420922000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LongTermNotesPayable
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMzQtMS0xLTEtMA_627ada95-050b-4c0c-8a73-6a1a427de53e"
      unitRef="usd">627179000</us-gaap:LongTermNotesPayable>
    <us-gaap:LongTermNotesPayable
      contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMzQtMy0xLTEtMA_940f869b-0ec3-43fd-83ff-e2c7f2d08675"
      unitRef="usd">652704000</us-gaap:LongTermNotesPayable>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMzUtMS0xLTEtMA_2eff0916-1ed0-4baa-995a-5fde15949ffa"
      unitRef="usd">41438000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMzUtMy0xLTEtMA_47b0b307-9a47-4076-8aa6-081e36d6a1f9"
      unitRef="usd">9529000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMzYtMS0xLTEtMA_72e7a110-1cb7-41ec-8991-a2e051e4c622"
      unitRef="usd">1471745000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMzYtMy0xLTEtMA_45bfd864-aa9c-4879-b1d8-ac8851b2e381"
      unitRef="usd">1413847000</us-gaap:Liabilities>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjgzNmUxZTI5ZTlmNDRiMDg5ZjdlNmU2NzM5ZTUzMDc0XzE2NDkyNjc0NDE4NTE_1cf549c9-b986-45ec-89b0-779e266bccc2"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjgzNmUxZTI5ZTlmNDRiMDg5ZjdlNmU2NzM5ZTUzMDc0XzE2NDkyNjc0NDE4NTE_d7b11d97-9e19-4101-b3f5-93b69f46513f"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjgzNmUxZTI5ZTlmNDRiMDg5ZjdlNmU2NzM5ZTUzMDc0XzE2NDkyNjc0NDE4NjU_a0fd9169-e8a5-4a58-b663-d50e155f35ae"
      unitRef="shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjgzNmUxZTI5ZTlmNDRiMDg5ZjdlNmU2NzM5ZTUzMDc0XzE2NDkyNjc0NDE4NjU_a16e6018-41d2-4a55-b8c2-1926dc9adc51"
      unitRef="shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjgzNmUxZTI5ZTlmNDRiMDg5ZjdlNmU2NzM5ZTUzMDc0XzE2NDkyNjc0NDE4Nzg_f1ce8da0-ee7a-417c-ae21-c98e6522a249"
      unitRef="shares">51596098</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjgzNmUxZTI5ZTlmNDRiMDg5ZjdlNmU2NzM5ZTUzMDc0XzE2NDkyNjc0NDE4Nzg_f6167a0a-93aa-44fc-80f5-6fa143ba9e45"
      unitRef="shares">51596098</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjgzNmUxZTI5ZTlmNDRiMDg5ZjdlNmU2NzM5ZTUzMDc0XzE2NDkyNjc0NDE4OTE_5bd94392-321a-4fb8-8c73-71a913882030"
      unitRef="shares">50314328</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjgzNmUxZTI5ZTlmNDRiMDg5ZjdlNmU2NzM5ZTUzMDc0XzE2NDkyNjc0NDE4OTE_d9d0399c-d436-4e4a-abea-10fbfada97e5"
      unitRef="shares">50314328</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMzgtMS0xLTEtMA_a87cebd9-842a-45a3-b9bf-0f0b5d7b4555"
      unitRef="usd">5000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMzgtMy0xLTEtMA_10310590-4ef0-4e51-98d2-5615c8238e53"
      unitRef="usd">5000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMzktMS0xLTEtMA_50e1214d-ca20-49b1-b3b4-bb24fb0a8d1a"
      unitRef="usd">306079000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfMzktMy0xLTEtMA_97dd333e-7149-471e-8db3-d36ecb0a776e"
      unitRef="usd">262865000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfNDAtMS0xLTEtMA_d239722e-b850-4c38-a0c4-8732283ba591"
      unitRef="usd">-24923000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfNDAtMy0xLTEtMA_a52298ab-4ada-400f-99da-8f60dc4655c0"
      unitRef="usd">-8026000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfNDEtMS0xLTEtMA_d3e606ff-5b66-4e14-b75f-1759e12e7edd"
      unitRef="usd">-123956000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfNDEtMy0xLTEtMA_7de832d0-805e-4d02-b399-ba620708b865"
      unitRef="usd">-103159000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfNDItMS0xLTEtMA_de0a55ee-143e-4486-9623-d9cb70bd945a"
      unitRef="usd">157205000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfNDItMy0xLTEtMA_69602399-05df-4059-b5b9-b9876f98e75c"
      unitRef="usd">151685000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfNDMtMS0xLTEtMA_fa0a360e-15d9-4011-a34c-ef4ab58e75f8"
      unitRef="usd">88916000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfNDMtMy0xLTEtMA_e4dff2e5-c371-4592-b7a1-2163ebe40716"
      unitRef="usd">81454000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfNDQtMS0xLTEtMA_57cc05f3-b212-4f1c-ba5b-5ea05fa6f0b4"
      unitRef="usd">246121000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfNDQtMy0xLTEtMA_91851a4d-44fd-4d29-b249-3d3f4536b09f"
      unitRef="usd">233139000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfNDUtMS0xLTEtMA_c12045e4-db0a-4e33-8610-59782eef2117"
      unitRef="usd">1717866000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8xNi9mcmFnOjA1YWUxYmM0MjE5ZjRiNzdhMzAwODJiODc0NmFiODI5L3RhYmxlOjNlZjEwOTNkZGU2MDQ2M2VhNjU5MDgwNjE3NDU4MWM0L3RhYmxlcmFuZ2U6M2VmMTA5M2RkZTYwNDYzZWE2NTkwODA2MTc0NTgxYzRfNDUtMy0xLTEtMA_b5070292-36e5-489c-ae33-860a27807e1e"
      unitRef="usd">1646986000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4a9fe0209e954a06aca8cad30d601c73_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMy0xLTEtMS0w_bf7c07a4-ea88-4e61-adf2-a35dc43f2b12"
      unitRef="usd">256730000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia0096f14793b40c99c3a08b6a4ac8010_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMy0zLTEtMS0w_6b3b181f-379f-4d50-b43d-4de3e1000707"
      unitRef="usd">261908000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibe98f272e55f41dd878edf32fc7653a3_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMy01LTEtMS0w_3c971745-2afe-457c-b74a-f38450e2f7ab"
      unitRef="usd">660760000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0ee478ac62b2402380d60e1df30d2970_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMy03LTEtMS0w_3fa174eb-b945-4301-8fbf-c22044cea28f"
      unitRef="usd">762751000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i058de6765e1e47449153067fb1e94bc6_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfNC0xLTEtMS0w_dfa3ff63-2d21-40be-9ae6-5dffa017ce3c"
      unitRef="usd">35046000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia03c585e05f349bd894ed447f40ca3fc_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfNC0zLTEtMS0w_005451df-c13b-44da-8577-4c24dd46fc06"
      unitRef="usd">30784000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ife4b7517ca2542439322f6bb062453a3_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfNC01LTEtMS0w_42ec0ae6-cb2e-4037-891a-73067a333fb1"
      unitRef="usd">103145000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i202db1f71dbd487f9b8bf67552d7ead3_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfNC03LTEtMS0w_0af072d2-bf4a-48b5-ad87-6ecb7706ce81"
      unitRef="usd">90587000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfNS0xLTEtMS0w_e613f6ae-321f-43ab-969e-1a75edc8aa9f"
      unitRef="usd">291776000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfNS0zLTEtMS0w_5ad7a3be-7a76-42aa-9d3b-ab64423a2533"
      unitRef="usd">292692000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfNS01LTEtMS0w_ac3800f8-0651-4f57-a3fc-14c7162bcbe4"
      unitRef="usd">763905000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfNS03LTEtMS0w_e00a046e-2cde-4666-bb5b-27d445f7a02c"
      unitRef="usd">853338000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueNotFromContractWithCustomer
      contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfNi0xLTEtMS0w_8fa5796e-0ad9-4c80-8dac-9fa817cdf381"
      unitRef="usd">221000</us-gaap:RevenueNotFromContractWithCustomer>
    <us-gaap:RevenueNotFromContractWithCustomer
      contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfNi0zLTEtMS0w_8d539efe-46a4-43ad-b08f-f5aef1e2e828"
      unitRef="usd">0</us-gaap:RevenueNotFromContractWithCustomer>
    <us-gaap:RevenueNotFromContractWithCustomer
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfNi01LTEtMS0w_8589f83e-b5d6-4ade-9db5-42a25e1fd899"
      unitRef="usd">25696000</us-gaap:RevenueNotFromContractWithCustomer>
    <us-gaap:RevenueNotFromContractWithCustomer
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfNi03LTEtMS0w_de286ba6-2464-4c38-8ad8-f29bcb7954d2"
      unitRef="usd">0</us-gaap:RevenueNotFromContractWithCustomer>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfOC0xLTEtMS0w_8b79b9d0-639c-49ca-8fbf-8e6bca787e0e"
      unitRef="usd">246462000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfOC0zLTEtMS0w_0416bc00-e27b-4563-b131-e17903403878"
      unitRef="usd">254383000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfOC01LTEtMS0w_288f5480-df2d-4555-b3e7-20392e33a4c0"
      unitRef="usd">708095000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfOC03LTEtMS0w_62d263d5-a1de-4bf8-82af-800961e2fd10"
      unitRef="usd">743997000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfOS0xLTEtMS0w_816665b0-fe25-4c58-973b-7830c8262965"
      unitRef="usd">21247000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfOS0zLTEtMS0w_90d7f1b0-30f6-4b5a-8cad-972f3340758b"
      unitRef="usd">20490000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfOS01LTEtMS0w_3ec21319-1072-4263-9357-3298bfb4bf1c"
      unitRef="usd">64536000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfOS03LTEtMS0w_2556e07d-6691-452b-aab4-e840b8527034"
      unitRef="usd">60193000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTAtMS0xLTEtMA_6319ee86-6c10-4105-ab16-9a93eaba4715"
      unitRef="usd">-342000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTAtMy0xLTEtMA_d37c67d8-b147-4ac6-9b80-6ff54b5d814a"
      unitRef="usd">-917000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTAtNS0xLTEtMA_271bf9b2-b88d-4b11-885c-8377878c1852"
      unitRef="usd">-543000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTAtNy0xLTEtMA_30e525f3-67b4-462c-93b0-f6cab5276daf"
      unitRef="usd">-1990000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:SeveranceCosts1
      contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTEtMS0xLTEtMA_d516c725-ea83-4258-be78-39ec2c9e4667"
      unitRef="usd">571000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTEtMy0xLTEtMA_9ee31284-65b3-4dfc-b832-90effa54477b"
      unitRef="usd">52000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTEtNS0xLTEtMA_59287cc2-f6f9-49a8-a439-49024ee73fd3"
      unitRef="usd">1647000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTEtNy0xLTEtMA_fcdb29c0-efe3-4ef5-ba74-e4b20dd98b29"
      unitRef="usd">1054000</us-gaap:SeveranceCosts1>
    <us-gaap:OperatingExpenses
      contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTItMS0xLTEtMA_a04da6d6-300f-46ce-b572-2a0c36adff1e"
      unitRef="usd">268622000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTItMy0xLTEtMA_974b8585-9c9a-4652-be1a-86ac9b84afae"
      unitRef="usd">275842000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTItNS0xLTEtMA_661c27a7-aa60-47c7-8201-78db7f11b7d6"
      unitRef="usd">774821000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTItNy0xLTEtMA_17f02b40-ac82-4b62-a2e4-7956358c2e60"
      unitRef="usd">807234000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTMtMS0xLTEtMA_a57c9582-b0e9-462f-9bc9-79b2c26fa153"
      unitRef="usd">23375000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTMtMy0xLTEtMA_7de55257-35f7-4a5e-90af-af1ad4311b67"
      unitRef="usd">16850000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTMtNS0xLTEtMA_125dc9bc-7228-45be-922f-dafb725be285"
      unitRef="usd">14780000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTMtNy0xLTEtMA_0346588e-a6ab-44b7-a798-d67c4e9573a7"
      unitRef="usd">46104000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpenseDebt
      contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTYtMS0xLTEtMA_1e238834-e3df-4eb3-a36a-e2ef950a6df9"
      unitRef="usd">11061000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTYtMy0xLTEtMA_a3bfd9ef-26ae-47e1-93ac-1fd6202b63e6"
      unitRef="usd">11895000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTYtNS0xLTEtMA_13ed0a78-e993-4d71-ac9e-c3a7f11270f0"
      unitRef="usd">33443000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTYtNy0xLTEtMA_715d5131-1984-4764-b93c-01c9a5d17a5d"
      unitRef="usd">36589000</us-gaap:InterestExpenseDebt>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTctMS0xLTEtMA_2257e000-2c46-41dd-aaf9-96df105a7414"
      unitRef="usd">2276000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTctMy0xLTEtMA_8e810eba-8154-4a73-a506-28310e9bee50"
      unitRef="usd">1955000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTctNS0xLTEtMA_151f10d1-7751-4396-b21c-0bb91028ffab"
      unitRef="usd">5176000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTctNy0xLTEtMA_97ad5160-c775-4c6a-8b84-8389ab0566b9"
      unitRef="usd">6072000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1
      contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTgtMS0xLTEtMA_707b291d-9c1a-4e43-894a-f89546d6d142"
      unitRef="usd">-679000</us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1>
    <us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1
      contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTgtMy0xLTEtMA_8786e49e-8676-47b2-8bfd-6d7ce2bc6468"
      unitRef="usd">0</us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1>
    <us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTgtNS0xLTEtMA_b2bab0a0-0e3c-47cf-a3b6-0b9af138480b"
      unitRef="usd">-4523000</us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1>
    <us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTgtNy0xLTEtMA_123b3c8d-530d-4b82-83de-539f0564243c"
      unitRef="usd">0</us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTktMS0xLTEtMA_18c9bbac-4e7f-4b9e-b05b-b5596f102841"
      unitRef="usd">139000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTktMy0xLTEtMA_7ddebe63-0d71-43ec-af4a-f454a5e2b7a2"
      unitRef="usd">-2000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTktNS0xLTEtMA_455b8503-9e17-41c6-8016-e9c03fac582b"
      unitRef="usd">247000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMTktNy0xLTEtMA_1947c2df-e2a4-426c-80fd-8102298d8532"
      unitRef="usd">-1271000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjAtMS0xLTEtMA_7a3eba80-a35c-4a31-9198-916bc636d24f"
      unitRef="usd">-9325000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjAtMy0xLTEtMA_757cb3e9-3f63-4e5b-bcc7-d52d0c22b8e5"
      unitRef="usd">-9942000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjAtNS0xLTEtMA_3d5cfaf3-636a-4c8e-9925-1aa9628bc408"
      unitRef="usd">-32543000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjAtNy0xLTEtMA_ec96d7da-09c7-46ce-9a89-1ab9247d490a"
      unitRef="usd">-31788000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjEtMS0xLTEtMA_f67fc565-ec2e-466b-9252-24c1a634bfc1"
      unitRef="usd">14050000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjEtMy0xLTEtMA_d0bfb3a8-c3d1-4d20-bce7-e37c620a158b"
      unitRef="usd">6908000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjEtNS0xLTEtMA_f85e8ac5-1efd-4fea-b96e-482397d4cfb8"
      unitRef="usd">-17763000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjEtNy0xLTEtMA_b8d3ec2d-e375-49f0-a9b5-528746a21d02"
      unitRef="usd">14316000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjItMS0xLTEtMA_8ed2e573-259a-4c95-b777-a20fa3689af5"
      unitRef="usd">3825000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjItMy0xLTEtMA_db94617e-efc9-43db-82c0-ac71db079dca"
      unitRef="usd">1816000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjItNS0xLTEtMA_e42bf3b2-118e-4655-b172-585910a7d431"
      unitRef="usd">-5029000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjItNy0xLTEtMA_6456f652-16ce-411c-a778-3069d4a56393"
      unitRef="usd">3556000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjMtMS0xLTEtMA_d4e2d3e9-03c5-4d7a-889e-c8bb3e5780c1"
      unitRef="usd">10225000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjMtMy0xLTEtMA_16efd2e6-3ffe-4fe4-a795-c771c6f58c08"
      unitRef="usd">5092000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjMtNS0xLTEtMA_c8b52fb1-563c-43ca-a5fa-2d51809a800f"
      unitRef="usd">-12734000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjMtNy0xLTEtMA_2a9b76bf-8182-46b9-9e09-850a43e9a65d"
      unitRef="usd">10760000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjQtMS0xLTEtMA_f9f1024e-6236-4e44-8713-c42c46bfd0f4"
      unitRef="usd">4069000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjQtMy0xLTEtMA_52598eec-4c6b-4409-ab86-5716744340c8"
      unitRef="usd">1897000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjQtNS0xLTEtMA_71f30af9-fc6b-4d62-8a02-04a32708493c"
      unitRef="usd">8063000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjQtNy0xLTEtMA_7d987a0b-85c4-4e9b-ab9d-27f027a7bd06"
      unitRef="usd">6400000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjUtMS0xLTEtMA_014bf2e0-e508-4597-bf31-7c0a42f49bc1"
      unitRef="usd">6156000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjUtMy0xLTEtMA_159d80ba-38d4-4787-987d-97e3b6b46bb6"
      unitRef="usd">3195000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjUtNS0xLTEtMA_4416fedb-1495-492f-8f02-96f2f28f1e65"
      unitRef="usd">-20797000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjUtNy0xLTEtMA_a66c4737-1f86-4e95-b7a4-9885d3daee7e"
      unitRef="usd">4360000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjctMS0xLTEtMA_74e5e306-a7d7-448d-a800-5d53a7d8b6c1"
      unitRef="usdPerShare">0.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjctMy0xLTEtMA_83979e64-7c50-44ab-934f-0a791b5fb475"
      unitRef="usdPerShare">0.06</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjctNS0xLTEtMA_4796f212-f4ba-45c7-bb85-682144204fc5"
      unitRef="usdPerShare">-0.41</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjctNy0xLTEtMA_6386cd3e-a9ef-4ce1-96e8-8141ff729ed7"
      unitRef="usdPerShare">0.09</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjktMS0xLTEtMA_8933812f-32cc-4927-bcd5-a6d2bd93097d"
      unitRef="usdPerShare">0.12</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjktMy0xLTEtMA_c067caa6-dcf2-4558-a8fc-663556df9670"
      unitRef="usdPerShare">0.06</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjktNS0xLTEtMA_a5039b3b-b306-4680-840f-19ac611f28db"
      unitRef="usdPerShare">-0.41</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMjktNy0xLTEtMA_0b05b82e-253d-44dc-8191-9996c0f05dc4"
      unitRef="usdPerShare">0.09</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMzEtMS0xLTEtMA_00e42a2f-60de-4a39-9d05-ec99e6d3214b"
      unitRef="shares">51358603</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMzEtMy0xLTEtMA_347064ee-95b1-4ce0-9669-935e85cbf922"
      unitRef="shares">49807460</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMzEtNS0xLTEtMA_b9b4425e-5d3e-480c-aeb9-6b5882ee8ed8"
      unitRef="shares">50746380</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMzEtNy0xLTEtMA_598e2aba-4b1c-4090-b2ea-fc4615603baf"
      unitRef="shares">49597138</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMzItMS0xLTEtMA_10b5a331-afa2-4cbb-bb55-12c501f6fb4f"
      unitRef="shares">51955815</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMzItMy0xLTEtMA_171e71c5-1881-461c-a749-8a19cfc05f4e"
      unitRef="shares">50360360</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMzItNS0xLTEtMA_e7494d89-4f16-42b9-ac00-ae402f43f029"
      unitRef="shares">50746380</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yMi9mcmFnOmQ4ODgxNGEyZmFkOTRjYWNiY2MyNzBhZTNmYTZkMWFiL3RhYmxlOmU0YTgxNTVlMTE5YTRjOTU4M2QzMjc4ODQyYTY4NjVkL3RhYmxlcmFuZ2U6ZTRhODE1NWUxMTlhNGM5NTgzZDMyNzg4NDJhNjg2NWRfMzItNy0xLTEtMA_15fb4d85-de88-4d3e-b9b0-71200bd09738"
      unitRef="shares">50113306</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss
      contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yNS9mcmFnOjhkYmIzODA2YzViMzRhMjk5NzE1Y2UyNGYxMjIwZWQ2L3RhYmxlOmMzYmFiNmUyMDI2OTRhYjI4NzQyNWMwYjc1MWE0NDZmL3RhYmxlcmFuZ2U6YzNiYWI2ZTIwMjY5NGFiMjg3NDI1YzBiNzUxYTQ0NmZfMi0xLTEtMS0w_1ee845fc-bcc9-484f-ba28-f9b6893b2bad"
      unitRef="usd">10225000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yNS9mcmFnOjhkYmIzODA2YzViMzRhMjk5NzE1Y2UyNGYxMjIwZWQ2L3RhYmxlOmMzYmFiNmUyMDI2OTRhYjI4NzQyNWMwYjc1MWE0NDZmL3RhYmxlcmFuZ2U6YzNiYWI2ZTIwMjY5NGFiMjg3NDI1YzBiNzUxYTQ0NmZfMi0zLTEtMS0w_c2acc063-f58a-445e-ab12-98615d2f4b18"
      unitRef="usd">5092000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yNS9mcmFnOjhkYmIzODA2YzViMzRhMjk5NzE1Y2UyNGYxMjIwZWQ2L3RhYmxlOmMzYmFiNmUyMDI2OTRhYjI4NzQyNWMwYjc1MWE0NDZmL3RhYmxlcmFuZ2U6YzNiYWI2ZTIwMjY5NGFiMjg3NDI1YzBiNzUxYTQ0NmZfMi01LTEtMS0w_60aa02b8-eb25-425c-813d-f2c2ffacb072"
      unitRef="usd">-12734000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yNS9mcmFnOjhkYmIzODA2YzViMzRhMjk5NzE1Y2UyNGYxMjIwZWQ2L3RhYmxlOmMzYmFiNmUyMDI2OTRhYjI4NzQyNWMwYjc1MWE0NDZmL3RhYmxlcmFuZ2U6YzNiYWI2ZTIwMjY5NGFiMjg3NDI1YzBiNzUxYTQ0NmZfMi03LTEtMS0w_5fd06429-463f-4f8f-8b70-6b16b32763a8"
      unitRef="usd">10760000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yNS9mcmFnOjhkYmIzODA2YzViMzRhMjk5NzE1Y2UyNGYxMjIwZWQ2L3RhYmxlOmMzYmFiNmUyMDI2OTRhYjI4NzQyNWMwYjc1MWE0NDZmL3RhYmxlcmFuZ2U6YzNiYWI2ZTIwMjY5NGFiMjg3NDI1YzBiNzUxYTQ0NmZfMy0xLTEtMS0w_10d4c400-6a6f-4931-813e-0396b6930123"
      unitRef="usd">11000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yNS9mcmFnOjhkYmIzODA2YzViMzRhMjk5NzE1Y2UyNGYxMjIwZWQ2L3RhYmxlOmMzYmFiNmUyMDI2OTRhYjI4NzQyNWMwYjc1MWE0NDZmL3RhYmxlcmFuZ2U6YzNiYWI2ZTIwMjY5NGFiMjg3NDI1YzBiNzUxYTQ0NmZfMy0zLTEtMS0w_43106a0b-8d88-4973-80c8-19b456d95603"
      unitRef="usd">-23000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yNS9mcmFnOjhkYmIzODA2YzViMzRhMjk5NzE1Y2UyNGYxMjIwZWQ2L3RhYmxlOmMzYmFiNmUyMDI2OTRhYjI4NzQyNWMwYjc1MWE0NDZmL3RhYmxlcmFuZ2U6YzNiYWI2ZTIwMjY5NGFiMjg3NDI1YzBiNzUxYTQ0NmZfMy01LTEtMS0w_5cc25002-957b-4032-884a-12954a2c6863"
      unitRef="usd">6000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yNS9mcmFnOjhkYmIzODA2YzViMzRhMjk5NzE1Y2UyNGYxMjIwZWQ2L3RhYmxlOmMzYmFiNmUyMDI2OTRhYjI4NzQyNWMwYjc1MWE0NDZmL3RhYmxlcmFuZ2U6YzNiYWI2ZTIwMjY5NGFiMjg3NDI1YzBiNzUxYTQ0NmZfMy03LTEtMS0w_ce473d23-d0fd-4735-bfd0-e219c5482f50"
      unitRef="usd">-28000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yNS9mcmFnOjhkYmIzODA2YzViMzRhMjk5NzE1Y2UyNGYxMjIwZWQ2L3RhYmxlOmMzYmFiNmUyMDI2OTRhYjI4NzQyNWMwYjc1MWE0NDZmL3RhYmxlcmFuZ2U6YzNiYWI2ZTIwMjY5NGFiMjg3NDI1YzBiNzUxYTQ0NmZfNC0xLTEtMS0w_9c9c2c7b-f2d3-48d2-9dbd-36c5cf366866"
      unitRef="usd">195000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yNS9mcmFnOjhkYmIzODA2YzViMzRhMjk5NzE1Y2UyNGYxMjIwZWQ2L3RhYmxlOmMzYmFiNmUyMDI2OTRhYjI4NzQyNWMwYjc1MWE0NDZmL3RhYmxlcmFuZ2U6YzNiYWI2ZTIwMjY5NGFiMjg3NDI1YzBiNzUxYTQ0NmZfNC0zLTEtMS0w_ef235ad4-267f-4a4a-bae9-23041b48f274"
      unitRef="usd">-5283000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yNS9mcmFnOjhkYmIzODA2YzViMzRhMjk5NzE1Y2UyNGYxMjIwZWQ2L3RhYmxlOmMzYmFiNmUyMDI2OTRhYjI4NzQyNWMwYjc1MWE0NDZmL3RhYmxlcmFuZ2U6YzNiYWI2ZTIwMjY5NGFiMjg3NDI1YzBiNzUxYTQ0NmZfNC01LTEtMS0w_75783a3c-134f-4b45-935d-3508ca6695e4"
      unitRef="usd">-18764000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yNS9mcmFnOjhkYmIzODA2YzViMzRhMjk5NzE1Y2UyNGYxMjIwZWQ2L3RhYmxlOmMzYmFiNmUyMDI2OTRhYjI4NzQyNWMwYjc1MWE0NDZmL3RhYmxlcmFuZ2U6YzNiYWI2ZTIwMjY5NGFiMjg3NDI1YzBiNzUxYTQ0NmZfNC03LTEtMS0w_8fb1e305-b7f9-41e7-a178-c354566f1120"
      unitRef="usd">-14481000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yNS9mcmFnOjhkYmIzODA2YzViMzRhMjk5NzE1Y2UyNGYxMjIwZWQ2L3RhYmxlOmMzYmFiNmUyMDI2OTRhYjI4NzQyNWMwYjc1MWE0NDZmL3RhYmxlcmFuZ2U6YzNiYWI2ZTIwMjY5NGFiMjg3NDI1YzBiNzUxYTQ0NmZfNS0xLTEtMS0w_29dcc640-62dd-4d0c-b7cc-2cfd922f8024"
      unitRef="usd">-969000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yNS9mcmFnOjhkYmIzODA2YzViMzRhMjk5NzE1Y2UyNGYxMjIwZWQ2L3RhYmxlOmMzYmFiNmUyMDI2OTRhYjI4NzQyNWMwYjc1MWE0NDZmL3RhYmxlcmFuZ2U6YzNiYWI2ZTIwMjY5NGFiMjg3NDI1YzBiNzUxYTQ0NmZfNS0zLTEtMS0w_a0d614cd-cc2a-4964-a2d1-fd1a0b9725b7"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yNS9mcmFnOjhkYmIzODA2YzViMzRhMjk5NzE1Y2UyNGYxMjIwZWQ2L3RhYmxlOmMzYmFiNmUyMDI2OTRhYjI4NzQyNWMwYjc1MWE0NDZmL3RhYmxlcmFuZ2U6YzNiYWI2ZTIwMjY5NGFiMjg3NDI1YzBiNzUxYTQ0NmZfNS01LTEtMS0w_c9f976db-1c80-4e46-982b-7142dfb8bb4d"
      unitRef="usd">-1861000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yNS9mcmFnOjhkYmIzODA2YzViMzRhMjk5NzE1Y2UyNGYxMjIwZWQ2L3RhYmxlOmMzYmFiNmUyMDI2OTRhYjI4NzQyNWMwYjc1MWE0NDZmL3RhYmxlcmFuZ2U6YzNiYWI2ZTIwMjY5NGFiMjg3NDI1YzBiNzUxYTQ0NmZfNS03LTEtMS0w_49ddf1a2-ea1b-47f4-931a-5ec4d0358f1c"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yNS9mcmFnOjhkYmIzODA2YzViMzRhMjk5NzE1Y2UyNGYxMjIwZWQ2L3RhYmxlOmMzYmFiNmUyMDI2OTRhYjI4NzQyNWMwYjc1MWE0NDZmL3RhYmxlcmFuZ2U6YzNiYWI2ZTIwMjY5NGFiMjg3NDI1YzBiNzUxYTQ0NmZfNi0xLTEtMS0w_d85a4c79-e6d5-409c-b804-675a7e22df42"
      unitRef="usd">11400000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yNS9mcmFnOjhkYmIzODA2YzViMzRhMjk5NzE1Y2UyNGYxMjIwZWQ2L3RhYmxlOmMzYmFiNmUyMDI2OTRhYjI4NzQyNWMwYjc1MWE0NDZmL3RhYmxlcmFuZ2U6YzNiYWI2ZTIwMjY5NGFiMjg3NDI1YzBiNzUxYTQ0NmZfNi0zLTEtMS0w_55025a09-7716-426c-affc-a58e7a02acea"
      unitRef="usd">-214000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yNS9mcmFnOjhkYmIzODA2YzViMzRhMjk5NzE1Y2UyNGYxMjIwZWQ2L3RhYmxlOmMzYmFiNmUyMDI2OTRhYjI4NzQyNWMwYjc1MWE0NDZmL3RhYmxlcmFuZ2U6YzNiYWI2ZTIwMjY5NGFiMjg3NDI1YzBiNzUxYTQ0NmZfNi01LTEtMS0w_67355c6c-be6a-4ac3-bae1-fb5f7806d1ce"
      unitRef="usd">-29631000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yNS9mcmFnOjhkYmIzODA2YzViMzRhMjk5NzE1Y2UyNGYxMjIwZWQ2L3RhYmxlOmMzYmFiNmUyMDI2OTRhYjI4NzQyNWMwYjc1MWE0NDZmL3RhYmxlcmFuZ2U6YzNiYWI2ZTIwMjY5NGFiMjg3NDI1YzBiNzUxYTQ0NmZfNi03LTEtMS0w_2a424c08-f0ad-4cba-b7e7-7c2494512b19"
      unitRef="usd">-3749000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yNS9mcmFnOjhkYmIzODA2YzViMzRhMjk5NzE1Y2UyNGYxMjIwZWQ2L3RhYmxlOmMzYmFiNmUyMDI2OTRhYjI4NzQyNWMwYjc1MWE0NDZmL3RhYmxlcmFuZ2U6YzNiYWI2ZTIwMjY5NGFiMjg3NDI1YzBiNzUxYTQ0NmZfNy0xLTEtMS0w_07d0559e-9458-47fc-801d-2f3e4f74bd61"
      unitRef="usd">4069000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yNS9mcmFnOjhkYmIzODA2YzViMzRhMjk5NzE1Y2UyNGYxMjIwZWQ2L3RhYmxlOmMzYmFiNmUyMDI2OTRhYjI4NzQyNWMwYjc1MWE0NDZmL3RhYmxlcmFuZ2U6YzNiYWI2ZTIwMjY5NGFiMjg3NDI1YzBiNzUxYTQ0NmZfNy0zLTEtMS0w_282e2baa-6117-4962-be07-599d1edc17b9"
      unitRef="usd">1897000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yNS9mcmFnOjhkYmIzODA2YzViMzRhMjk5NzE1Y2UyNGYxMjIwZWQ2L3RhYmxlOmMzYmFiNmUyMDI2OTRhYjI4NzQyNWMwYjc1MWE0NDZmL3RhYmxlcmFuZ2U6YzNiYWI2ZTIwMjY5NGFiMjg3NDI1YzBiNzUxYTQ0NmZfNy01LTEtMS0w_f0c1a53e-c3c3-44e7-b56f-b35732ea9c59"
      unitRef="usd">8063000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yNS9mcmFnOjhkYmIzODA2YzViMzRhMjk5NzE1Y2UyNGYxMjIwZWQ2L3RhYmxlOmMzYmFiNmUyMDI2OTRhYjI4NzQyNWMwYjc1MWE0NDZmL3RhYmxlcmFuZ2U6YzNiYWI2ZTIwMjY5NGFiMjg3NDI1YzBiNzUxYTQ0NmZfNy03LTEtMS0w_894cdfe9-fda1-48d6-a6ff-1d4ecefb3948"
      unitRef="usd">6400000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yNS9mcmFnOjhkYmIzODA2YzViMzRhMjk5NzE1Y2UyNGYxMjIwZWQ2L3RhYmxlOmMzYmFiNmUyMDI2OTRhYjI4NzQyNWMwYjc1MWE0NDZmL3RhYmxlcmFuZ2U6YzNiYWI2ZTIwMjY5NGFiMjg3NDI1YzBiNzUxYTQ0NmZfOS0xLTEtMS0w_4ee4ef1f-659f-4793-a983-1ff44d9a1d83"
      unitRef="usd">7331000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yNS9mcmFnOjhkYmIzODA2YzViMzRhMjk5NzE1Y2UyNGYxMjIwZWQ2L3RhYmxlOmMzYmFiNmUyMDI2OTRhYjI4NzQyNWMwYjc1MWE0NDZmL3RhYmxlcmFuZ2U6YzNiYWI2ZTIwMjY5NGFiMjg3NDI1YzBiNzUxYTQ0NmZfOS0zLTEtMS0w_a522dc44-3aa9-469e-9b35-bd67d30a2d31"
      unitRef="usd">-2111000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yNS9mcmFnOjhkYmIzODA2YzViMzRhMjk5NzE1Y2UyNGYxMjIwZWQ2L3RhYmxlOmMzYmFiNmUyMDI2OTRhYjI4NzQyNWMwYjc1MWE0NDZmL3RhYmxlcmFuZ2U6YzNiYWI2ZTIwMjY5NGFiMjg3NDI1YzBiNzUxYTQ0NmZfOS01LTEtMS0w_73e77fcb-c7b7-4720-99f5-400f04a77b29"
      unitRef="usd">-37694000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yNS9mcmFnOjhkYmIzODA2YzViMzRhMjk5NzE1Y2UyNGYxMjIwZWQ2L3RhYmxlOmMzYmFiNmUyMDI2OTRhYjI4NzQyNWMwYjc1MWE0NDZmL3RhYmxlcmFuZ2U6YzNiYWI2ZTIwMjY5NGFiMjg3NDI1YzBiNzUxYTQ0NmZfOS03LTEtMS0w_95247d53-9a4f-4a19-ae4b-c594a5458a68"
      unitRef="usd">-10149000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:SharesOutstanding
      contextRef="i4ae3d85b0b824473a80ccd4a4708aba0_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMi0xLTEtMS0w_361f7021-6d71-4bb8-8962-3ef4ffab9494"
      unitRef="shares">51554760</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4ae3d85b0b824473a80ccd4a4708aba0_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMi0zLTEtMS0w_57736c72-2ad4-4fcd-b89f-70843ef2a41e"
      unitRef="usd">5000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3ae0e1753b584266bd033c7378cf877e_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMi01LTEtMS0w_d2899dac-76cf-49ad-be24-94e4a28e93ed"
      unitRef="usd">304012000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i94f2d48724ea46b3aa0a89c46fcb12f8_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMi03LTEtMS0w_85468d08-a223-403c-9236-1524a0048324"
      unitRef="usd">-26098000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6d04f49cdfcc40eb9852bb1986ae7007_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMi05LTEtMS0w_3281fefb-c4ca-4215-9929-4d33d97a4166"
      unitRef="usd">-130111000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibb96d5b718234c88935d8f52fbbbf3f6_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMi0xMS0xLTEtMA_47bbee85-bf2c-4e38-b396-42c80d68d0c7"
      unitRef="usd">147808000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i91203f5108484c309c7a4260b22ee742_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMi0xMy0xLTEtMA_fd5538c5-e5f1-4b59-88bf-2fec2b787b55"
      unitRef="usd">85448000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2376698dad8742228ddb9d35b6913ee4_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMi0xNS0xLTEtMA_989c372d-5eb6-45b6-b630-fa3303f78995"
      unitRef="usd">233256000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i8c20b6a988b44e36a260b09593425753_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfNS0xLTEtMS0w_1a047034-2192-4277-b6a1-49292829059b"
      unitRef="shares">37000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfNS0xNS0xLTEtMA_dd7ba91a-70a7-4883-8e37-8ae16a86d2e9"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i5fd6699fb85d4180a93c8a06313ec3e6_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfNi0xLTEtMS01MDA_8d98dced-faa3-43ce-b3c7-414494393dbe"
      unitRef="shares">4338</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i4961d9edd85f4cd7b2f81b0166beb6fa_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfNi0xNS0xLTEtNTA1_e52eaf1c-bda0-4d95-8de5-2f41ff439711"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i09bf6bb1e62e463c8657ba3f07a2376b_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfNi01LTEtMS0w_65b895f1-282c-48fa-a030-8aece1da1155"
      unitRef="usd">2067000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i7c7faff739fa454eacddcea55ed701ca_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfNi0xMS0xLTEtMA_bc555cec-7944-4949-94c7-4c3f3bf8a4a9"
      unitRef="usd">2067000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfNi0xNS0xLTEtMA_11a6f9f4-2635-4d99-acf4-74b1dc2c811c"
      unitRef="usd">2067000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i555980525511438faed4ba009d6f37b0_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMTItMTMtMS0xLTA_76c8628c-3f00-44a2-afaf-83c68bd7a21b"
      unitRef="usd">601000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMTItMTUtMS0xLTA_01e858f7-8c5e-4e01-827f-c80b9a9281d3"
      unitRef="usd">601000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="i90d9b7dfff1842639dab833ff5ec3886_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMTUtNy0xLTEtMA_8c60086b-6a25-4a10-ab47-906f065f0876"
      unitRef="usd">11000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="i7c7faff739fa454eacddcea55ed701ca_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMTUtMTEtMS0xLTA_3bf42d59-d9ee-4e8a-9a12-ab25c2811736"
      unitRef="usd">11000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMTUtMTUtMS0xLTA_2cf30451-2459-4e5e-9908-aeef86df210a"
      unitRef="usd">11000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i90d9b7dfff1842639dab833ff5ec3886_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMTYtNy0xLTEtMA_0797c19b-012d-4af7-b620-3774b2ac6c01"
      unitRef="usd">195000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i7c7faff739fa454eacddcea55ed701ca_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMTYtMTEtMS0xLTA_772491c1-bb7b-4d6f-aed4-d24ba6dad1c9"
      unitRef="usd">195000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMTYtMTUtMS0xLTA_c1013b6c-a9b1-496a-9652-caf2b5711502"
      unitRef="usd">195000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i90d9b7dfff1842639dab833ff5ec3886_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMTctNy0xLTEtMA_adb54dda-2c7d-4ee6-b313-85c6561377e4"
      unitRef="usd">-969000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i7c7faff739fa454eacddcea55ed701ca_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMTctMTEtMS0xLTA_c51dde4a-6a18-4d16-a6d2-fd35548b4b8f"
      unitRef="usd">-969000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMTctMTUtMS0xLTA_e5197ecb-fdf5-46b1-9760-b00efd036295"
      unitRef="usd">-969000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:StockholdersEquityOther
      contextRef="ief71dd6a90be46dd80cc9cdc74b1b643_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMTgtOS0xLTEtMA_82ff8e61-918b-4bb0-9467-fbb1fdd0c09c"
      unitRef="usd">1000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i7c7faff739fa454eacddcea55ed701ca_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMTgtMTEtMS0xLTA_21538563-3557-4fbb-9222-a505d8903aa4"
      unitRef="usd">1000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMTgtMTUtMS0xLTA_c05aaef5-d216-48a5-9d42-015f7852d30d"
      unitRef="usd">1000</us-gaap:StockholdersEquityOther>
    <us-gaap:ProfitLoss
      contextRef="ief71dd6a90be46dd80cc9cdc74b1b643_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMTktOS0xLTEtMA_ccd77e50-a958-48f5-b0e2-b49ed008e28f"
      unitRef="usd">6156000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i7c7faff739fa454eacddcea55ed701ca_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMTktMTEtMS0xLTA_5ae4e6a8-c8df-4184-8fba-4751197e37b1"
      unitRef="usd">6156000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i555980525511438faed4ba009d6f37b0_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMTktMTMtMS0xLTA_e5138e8e-0edd-4b71-a012-fa471f5798d8"
      unitRef="usd">4069000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMTktMTUtMS0xLTA_2e69c766-5ba7-408a-b8a4-1354576bfdc5"
      unitRef="usd">10225000</us-gaap:ProfitLoss>
    <us-gaap:SharesOutstanding
      contextRef="ia6a10831dcf34a89b6122ba9bb78bea5_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMjAtMS0xLTEtMA_518fc2cd-714e-4820-83e7-a626d07cc8ad"
      unitRef="shares">51596098</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia6a10831dcf34a89b6122ba9bb78bea5_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMjAtMy0xLTEtMA_6f3c65cb-6877-4ace-a460-4943739ab930"
      unitRef="usd">5000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie6c25823a7a04a639911e6f404f10a57_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMjAtNS0xLTEtMA_7ea2975f-5e47-489f-83bf-7e18839fdfad"
      unitRef="usd">306079000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9b82209eab2648ec9c1833dbc1c0b1db_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMjAtNy0xLTEtMA_61df93ae-2012-4f5b-a3b5-6263333c8d38"
      unitRef="usd">-24923000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i69ba183096574a37a4b5b0ca97c5a51f_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMjAtOS0xLTEtMA_40a641f1-bfd6-48e8-88f5-658990835c05"
      unitRef="usd">-123956000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i693f4b2418da466e9e6ad9dad2ab2b32_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMjAtMTEtMS0xLTA_415fa0d0-32ea-4262-81c2-eb0b084e14d3"
      unitRef="usd">157205000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie0c660ddab0648f28f0f4288a933f163_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMjAtMTMtMS0xLTA_4581fd15-6bb6-47a5-be3c-f55b93e1697d"
      unitRef="usd">88916000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMjAtMTUtMS0xLTA_e4dba09e-81bd-4b1e-9ae6-8b2231d5f574"
      unitRef="usd">246121000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="i03b809d756f245699c9daa49222191fe_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMjItMS0xLTEtMA_c1a83963-ca5d-4c62-aea2-36b3a5fb44b5"
      unitRef="shares">50127234</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i03b809d756f245699c9daa49222191fe_I20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMjItMy0xLTEtMA_7cc03034-adc9-4f7d-85af-7717111b7054"
      unitRef="usd">5000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if75788edb86f41d092529d110d74bf6b_I20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMjItNS0xLTEtMA_70935b5f-ac46-41c7-84d1-60d27a4e1a3e"
      unitRef="usd">257607000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i89e4fdcc70e84e32bb0c67373df7c420_I20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMjItNy0xLTEtMA_399d2c56-559a-4284-962d-fdd9e3a7f133"
      unitRef="usd">-6942000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i04d33784ad9449e99e9c45a3134d5d9c_I20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMjItOS0xLTEtMA_65244594-3356-48eb-a837-7fa85da0b267"
      unitRef="usd">-116752000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i15c0b6b3069e42be8f76b29a49821089_I20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMjItMTEtMS0xLTA_45e0d667-1c29-4a0b-a662-421cad327837"
      unitRef="usd">133918000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i46b89b31f76140d281b073abfb16009e_I20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMjItMTMtMS0xLTA_1b666555-e950-4319-b55b-0bd80adae366"
      unitRef="usd">78512000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i77ea6f08b3b34bc687923c35ae708d67_I20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMjItMTUtMS0xLTA_e38e7d0a-b3b4-48af-8ba6-f0a69e7436de"
      unitRef="usd">212430000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i9f84ecccfa2c445b87e09865cedb5674_D20190701-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMjQtMS0xLTEtMA_b32725bc-c225-424b-a134-ea69ba4da9ee"
      unitRef="shares">25000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMjQtMTUtMS0xLTA_47bea64f-fdbc-4087-b429-fdc997b30df4"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ide24663efeeb41099f7c5f224f6bc5d7_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMjUtNS0xLTEtMA_abb51d5b-ae20-4b52-a1e8-034c95a66efe"
      unitRef="usd">1356000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i4e3e0e81d2f34922abfd07a4e2eaad7b_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMjUtMTEtMS0xLTA_3549bfd5-1500-4179-a31e-8942075fe0e4"
      unitRef="usd">1356000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMjUtMTUtMS0xLTA_c826f7fb-0d0a-4dca-ad07-6fc6aeee2d17"
      unitRef="usd">1356000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="i9f84ecccfa2c445b87e09865cedb5674_D20190701-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMjYtMS0xLTEtMA_4cba6037-c6b8-4ae3-9488-d9173f845690"
      unitRef="shares">101902</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="ide24663efeeb41099f7c5f224f6bc5d7_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMjYtNS0xLTEtMA_7fbceb0f-085a-4f32-b9ff-6719b9b15c4a"
      unitRef="usd">1500000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="i4e3e0e81d2f34922abfd07a4e2eaad7b_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMjYtMTEtMS0xLTA_0f64aeb1-4663-4a62-99ca-528304c0204b"
      unitRef="usd">1500000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMjYtMTUtMS0xLTA_f1924214-eb82-4e5f-b039-c4fd52bdfa2b"
      unitRef="usd">1500000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="id0e02291004444ac9e7381725f9d033f_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMzItNy0xLTEtMA_a188df8f-1d7c-4407-b84f-5cbac8063baf"
      unitRef="usd">-23000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="i4e3e0e81d2f34922abfd07a4e2eaad7b_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMzItMTEtMS0xLTA_44c443de-68ea-4721-9207-7e14ff80c0cc"
      unitRef="usd">-23000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMzItMTUtMS0xLTA_93dacc1e-6d62-4986-84e6-0cf06b20801a"
      unitRef="usd">-23000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="id0e02291004444ac9e7381725f9d033f_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMzMtNy0xLTEtMA_1dfdb44d-c6ba-45b2-98f2-e7ade08a5536"
      unitRef="usd">-5283000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i4e3e0e81d2f34922abfd07a4e2eaad7b_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMzMtMTEtMS0xLTA_cd1ef074-5b02-4172-81b4-67c5e772376e"
      unitRef="usd">-5283000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMzMtMTUtMS0xLTA_c04a18d1-669d-4f6e-ae9e-3ffbd577bb04"
      unitRef="usd">-5283000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:StockholdersEquityOther
      contextRef="id0e02291004444ac9e7381725f9d033f_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMzQtNy0xLTEtMA_d13d18a1-74b0-40d0-9577-8e72f23836c4"
      unitRef="usd">2000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i42768d703fd64d3cb22b5badf8ab7fa5_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMzQtOS0xLTEtMA_dd74dc15-f444-4543-8120-0f3df5bdf60c"
      unitRef="usd">-2000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMzQtMTUtMS0xLTA_a7cd5d72-35d3-4477-88a7-da9f4496b04a"
      unitRef="usd">0</us-gaap:StockholdersEquityOther>
    <us-gaap:ProfitLoss
      contextRef="i42768d703fd64d3cb22b5badf8ab7fa5_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMzUtOS0xLTEtMA_3017148f-cbdf-40df-bb77-82c0012e657b"
      unitRef="usd">3195000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i4e3e0e81d2f34922abfd07a4e2eaad7b_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMzUtMTEtMS0xLTA_0dd6ab2d-9315-4d39-8a5e-3d1d757352fe"
      unitRef="usd">3195000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i8831da9d7f5d4f6fb802e218f7740494_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMzUtMTMtMS0xLTA_bc5fad7e-95f3-4f53-a64a-b29f961e19a0"
      unitRef="usd">1897000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMzUtMTUtMS0xLTA_75324686-5430-456a-92c2-55ebdc25f9b5"
      unitRef="usd">5092000</us-gaap:ProfitLoss>
    <us-gaap:SharesOutstanding
      contextRef="ic034acb0117040d6afe7d976972fa479_I20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMzYtMS0xLTEtMA_1238e860-9def-4079-a825-67fa60e491c4"
      unitRef="shares">50254136</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic034acb0117040d6afe7d976972fa479_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMzYtMy0xLTEtMA_30c9aee5-9522-4981-b017-e558a51b39eb"
      unitRef="usd">5000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0747908eb36543a89df88a2d9e1cd35b_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMzYtNS0xLTEtMA_5306cc59-16c0-48a8-8fc9-7430e35dbb1c"
      unitRef="usd">260463000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8e1094d35d014fd3a95b14bc592059f5_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMzYtNy0xLTEtMA_f3cde724-2b6f-42b5-bebf-f43e8b3b1027"
      unitRef="usd">-12250000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie0f76e06105741279da7c3328d1d487a_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMzYtOS0xLTEtMA_b7d5b08e-9c99-4069-b0f7-898992573183"
      unitRef="usd">-113555000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idd2c608cacd0477aa45970e7d954f191_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMzYtMTEtMS0xLTA_5c6975a3-1f53-489c-a682-a289434f9379"
      unitRef="usd">134663000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3d9baeb9e126447b98c2cf732d7b12b4_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMzYtMTMtMS0xLTA_2672f534-370b-4b13-8f20-941b8c67d9bd"
      unitRef="usd">80409000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i799130036d73414da02bb032ba102c39_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8yOC9mcmFnOmNkMTg3NTVlYzUwMzRlNjBhMjc0MDA3MDNhOWQ2MTc4L3RhYmxlOjI5MmY3ZmQwYWExYjQwNzA5NmUzMTBjMzA1OWM1NGU4L3RhYmxlcmFuZ2U6MjkyZjdmZDBhYTFiNDA3MDk2ZTMxMGMzMDU5YzU0ZThfMzYtMTUtMS0xLTA_f92407f1-4262-47d2-8aea-a95a20b855fd"
      unitRef="usd">215072000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="id4d77a0476814e54bf880ea51ec53067_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMi0xLTEtMS0w_2839a5a6-d47b-4249-8e41-3b7caf937ec9"
      unitRef="shares">50314328</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id4d77a0476814e54bf880ea51ec53067_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMi0zLTEtMS0w_3a4f6a99-9cd3-4424-bb0a-36f193835dad"
      unitRef="usd">5000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i07e00b3689c84e6a9310fc4102bb4b43_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMi01LTEtMS0w_ab2fbc0b-4303-4931-a78c-6f57fb231a13"
      unitRef="usd">262865000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i73519d6ef869432190c131a957d0509a_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMi03LTEtMS0w_03b6751d-7e21-4b27-b7f3-ef7de139c266"
      unitRef="usd">-8026000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic04fc01f723141e58a3d30372eb006ea_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMi05LTEtMS0w_48aa1b67-94cf-41c6-979a-a3d7316c1ea5"
      unitRef="usd">-103159000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3b58c81a32474a7dad91e48ea01781b6_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMi0xMS0xLTEtMA_513becae-8403-4d9f-96c6-15e44302c0b1"
      unitRef="usd">151685000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icfb4354e13e748e5a050d331bc69d1a3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMi0xMy0xLTEtMA_868db6d7-72a2-4937-b312-28badfba9127"
      unitRef="usd">81454000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMi0xNS0xLTEtMA_1a6f9bee-8834-481c-b445-bfefa714cdef"
      unitRef="usd">233139000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="if7d38396af1648f3a9c78d6c8c94147c_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfNS0xLTEtMS0w_9ef0179a-8246-4747-810d-ca0fbb64b5eb"
      unitRef="shares">453817</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfNS0xNS0xLTEtMA_eb7fa7da-d337-411e-8a65-fb3c258d85de"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i3743b37848a340a097d285381b700385_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfNi0xLTEtMS0zMTkw_8629753e-9538-42da-844c-9e3c55e37cdf"
      unitRef="shares">4338</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i7fda9262fb95476a816ecc3cad434f3c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfNi0xNS0xLTEtMzE5Mw_c11815f5-ed87-4918-99ff-2716cef0ccb1"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i77d674128a5b4732a239eb275df36879_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfNi01LTEtMS0w_6e31dcc6-129b-4e09-8c3e-86d1f1727abb"
      unitRef="usd">10203000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i6912bfccd4a448a292e8ea776b60d181_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfNi0xMS0xLTEtMA_78efe909-0ea8-442d-a812-d1b5b0558213"
      unitRef="usd">10203000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfNi0xNS0xLTEtMA_87748de5-eb9e-4985-b970-5479a2c16145"
      unitRef="usd">10203000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="if7d38396af1648f3a9c78d6c8c94147c_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfOC0xLTEtMS0w_955dbbd9-8d67-4e91-abeb-4b2b94f22624"
      unitRef="shares">823615</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i77d674128a5b4732a239eb275df36879_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfOC01LTEtMS0w_47bdc091-a7e3-45eb-910a-81a72c43618a"
      unitRef="usd">33011000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i6912bfccd4a448a292e8ea776b60d181_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfOC0xMS0xLTEtMA_036f400c-2dbe-446e-be67-a74bc0d5b9d4"
      unitRef="usd">33011000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfOC0xNS0xLTEtMA_a2a17bb0-9789-49c5-af61-f02d13dbb37b"
      unitRef="usd">33011000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="idfbed43c89ad4ebfa5f48f8e5bb8a6f9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMTItMTMtMS0xLTA_08385c1e-d0ec-4cdc-b4ac-d7536eeb1510"
      unitRef="usd">601000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMTItMTUtMS0xLTA_33acd66f-1d2a-4fc1-9bd9-c409f0f5661b"
      unitRef="usd">601000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="id643d75beaf84a40a839ec6515ad926a_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMTUtNy0xLTEtMA_d397b0d8-2d92-4f82-8105-134f93b34581"
      unitRef="usd">6000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="i6912bfccd4a448a292e8ea776b60d181_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMTUtMTEtMS0xLTA_5809c63b-8e33-48c3-b674-528b2e743e53"
      unitRef="usd">6000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMTUtMTUtMS0xLTA_fc2f7c4a-ca92-4bb0-bd7e-10986392cb57"
      unitRef="usd">6000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="id643d75beaf84a40a839ec6515ad926a_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMTYtNy0xLTEtMA_4caa1237-a966-4dbc-bdb5-0a78d99c4cf3"
      unitRef="usd">-18764000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i6912bfccd4a448a292e8ea776b60d181_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMTYtMTEtMS0xLTA_8fb48740-3308-427e-bed9-a4d988fc0555"
      unitRef="usd">-18764000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMTYtMTUtMS0xLTA_ba3532c1-dcb4-4e2a-8053-bf926e22c8c3"
      unitRef="usd">-18764000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="id643d75beaf84a40a839ec6515ad926a_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMTctNy0xLTEtMA_166d3469-7b6f-4a05-86a4-cbf9cb5296f6"
      unitRef="usd">-1861000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i6912bfccd4a448a292e8ea776b60d181_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMTctMTEtMS0xLTA_e0634d48-2827-4d7e-843a-eacde09b734d"
      unitRef="usd">-1861000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMTctMTUtMS0xLTA_b49eb5b6-4148-4f4e-8e69-00e120fa9188"
      unitRef="usd">-1861000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:ProfitLoss
      contextRef="i04b4ca98d99646caa1edf8c9b4cb072e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMTktOS0xLTEtMA_843ebf79-d626-4d29-8b2b-8c220daca91b"
      unitRef="usd">-20797000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i6912bfccd4a448a292e8ea776b60d181_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMTktMTEtMS0xLTA_3fc15a02-128e-4c1f-ba9b-2af9c889c5f8"
      unitRef="usd">-20797000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="idfbed43c89ad4ebfa5f48f8e5bb8a6f9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMTktMTMtMS0xLTA_c494931c-c345-4d96-9d5b-a14f9b53e5cc"
      unitRef="usd">8063000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMTktMTUtMS0xLTA_85944d0b-e3c5-4d29-9f79-b7c8db610686"
      unitRef="usd">-12734000</us-gaap:ProfitLoss>
    <us-gaap:SharesOutstanding
      contextRef="ia6a10831dcf34a89b6122ba9bb78bea5_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjAtMS0xLTEtMA_de49ea27-861a-4270-acd5-c78d8de0ec1a"
      unitRef="shares">51596098</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia6a10831dcf34a89b6122ba9bb78bea5_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjAtMy0xLTEtMA_bb24b695-fdf5-44af-a8aa-ad10f3ade48f"
      unitRef="usd">5000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie6c25823a7a04a639911e6f404f10a57_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjAtNS0xLTEtMA_396b1200-aaf6-4adb-8941-62b4963ae176"
      unitRef="usd">306079000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9b82209eab2648ec9c1833dbc1c0b1db_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjAtNy0xLTEtMA_1dae844a-e2e4-428b-bd95-74471d994361"
      unitRef="usd">-24923000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i69ba183096574a37a4b5b0ca97c5a51f_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjAtOS0xLTEtMA_ed68b5dc-b491-42ce-8aa2-91dc4887de61"
      unitRef="usd">-123956000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i693f4b2418da466e9e6ad9dad2ab2b32_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjAtMTEtMS0xLTA_aad732f9-b629-4712-a692-97b75bf432a9"
      unitRef="usd">157205000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie0c660ddab0648f28f0f4288a933f163_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjAtMTMtMS0xLTA_79649471-242b-4a5b-98c6-cc645c623f43"
      unitRef="usd">88916000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjAtMTUtMS0xLTA_41fedeee-1e14-4563-8f07-d442b7886705"
      unitRef="usd">246121000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="i3e1e45a341fa4faa80a854e436e843dc_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjItMS0xLTEtMA_c940d892-bbbf-49e3-b92e-2cdb2e04b162"
      unitRef="shares">48977485</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3e1e45a341fa4faa80a854e436e843dc_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjItMy0xLTEtMA_1f367f65-a246-4ff8-b881-e00209dfa188"
      unitRef="usd">5000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6fd92e65f41647c28809f9a7ea4bfa83_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjItNS0xLTEtMA_62241e25-7487-4acf-aa97-52c6799e469c"
      unitRef="usd">242835000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i705ee60e173d4b72997f9e6d827ceed9_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjItNy0xLTEtMA_a4b4bf39-418e-4849-a74b-a0eb2f17bb46"
      unitRef="usd">2259000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icb755bfe39e64168aac8fb85840caa13_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjItOS0xLTEtMA_0bee8621-c642-4ac5-b0b9-787aa5a6bc12"
      unitRef="usd">-117915000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8702613a07bc43e49e4a5a9dc8474851_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjItMTEtMS0xLTA_ad5de01e-3cbb-4d4a-ab0e-4849731621d3"
      unitRef="usd">127184000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i990f6dad8c174377a290cf37479ca637_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjItMTMtMS0xLTA_d33adfae-ad89-4ab7-8ec4-0e66291c92fe"
      unitRef="usd">73069000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9799a383a2814cafbb89d610347f767d_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjItMTUtMS0xLTA_39d5d21d-3f4c-46b3-bb8d-fb7f6d255d1e"
      unitRef="usd">200253000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i040549d733b84e41865f935d6710183a_D20190101-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjMtMS0xLTEtMA_07a2005b-f5d7-4b23-806e-5aa25f74bf4d"
      unitRef="shares">10000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <rdnt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue
      contextRef="ia0d67703fcc549f58c3bb54805e151a1_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjMtNS0xLTEtMA_83ea1a3d-ec9b-426d-b953-41e5a3973b10"
      unitRef="usd">50000</rdnt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue>
    <rdnt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue
      contextRef="i4644861e9ece4360bab418f1b9fef51a_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjMtMTEtMS0xLTA_38e9ea3e-cc19-49a0-bf3c-c62cbadfd2fc"
      unitRef="usd">50000</rdnt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue>
    <rdnt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjMtMTUtMS0xLTA_e22a8fc9-2aa5-4e68-a9e1-72e822e11558"
      unitRef="usd">50000</rdnt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i040549d733b84e41865f935d6710183a_D20190101-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjQtMS0xLTEtMA_063a5bc6-1932-48c8-80c3-6473612b1d82"
      unitRef="shares">726042</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjQtMTUtMS0xLTA_75ff0d5d-9d1f-4510-8c5c-ef75928cd49d"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ia0d67703fcc549f58c3bb54805e151a1_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjUtNS0xLTEtMA_aaed3148-4337-4613-942f-05025ebfb3f0"
      unitRef="usd">6993000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i4644861e9ece4360bab418f1b9fef51a_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjUtMTEtMS0xLTA_13c0c5f9-a933-4489-aed7-cdedd59d74d6"
      unitRef="usd">6993000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjUtMTUtMS0xLTA_8eb2cb66-d10b-47e2-8f7b-0212532c8ac5"
      unitRef="usd">6993000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="i040549d733b84e41865f935d6710183a_D20190101-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjctMS0xLTEtMA_21a139c1-af97-446c-8d76-c8e3456f5ce0"
      unitRef="shares">440207</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="ia0d67703fcc549f58c3bb54805e151a1_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjctNS0xLTEtMA_2a355522-abca-4cdd-a671-e05d8d0e8477"
      unitRef="usd">6000000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i4644861e9ece4360bab418f1b9fef51a_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjctMTEtMS0xLTA_4399e86b-1ed8-4510-91e2-37aa2818d9a4"
      unitRef="usd">6000000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjctMTUtMS0xLTA_731675eb-6e5c-4fac-a0cb-11904bf0d233"
      unitRef="usd">6000000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited
      contextRef="i040549d733b84e41865f935d6710183a_D20190101-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjgtMS0xLTEtMA_c19d98c3-11ad-434c-8fa2-89d3034db147"
      unitRef="shares">1500</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="ia0d67703fcc549f58c3bb54805e151a1_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjgtNS0xLTEtMA_2505198e-153e-44f7-8255-e358b7090388"
      unitRef="usd">5000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="i4644861e9ece4360bab418f1b9fef51a_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjgtMTEtMS0xLTA_b797f87b-461b-45e9-9491-45eedd5b2dd8"
      unitRef="usd">5000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjgtMTUtMS0xLTA_a7ff8d5c-af09-4115-8fd9-fecaf6aae7e7"
      unitRef="usd">5000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest
      contextRef="ia0d67703fcc549f58c3bb54805e151a1_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjktNS0xLTEtMA_eebd5265-2931-4b7a-8e53-8327f90d2bb9"
      unitRef="usd">3090000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest
      contextRef="i4644861e9ece4360bab418f1b9fef51a_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjktMTEtMS0xLTA_d41b7fa5-1610-4818-a8e0-d4cef33dee24"
      unitRef="usd">3090000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest
      contextRef="id349387901e24032a2736f786cf5a404_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjktMTMtMS0xLTA_702a91ff-e477-4c9d-b925-ec89545064df"
      unitRef="usd">2008000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMjktMTUtMS0xLTA_fbb7bd9e-b6b0-4a44-9cb7-5d7a4a4e43c1"
      unitRef="usd">5098000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="id349387901e24032a2736f786cf5a404_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMzItMTMtMS0xLTA_4d8444a6-3e2c-45ec-bd42-58e3a333eeaa"
      unitRef="usd">1818000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMzItMTUtMS0xLTA_ee5cc559-6d16-4de6-9a64-9cda1fffc81f"
      unitRef="usd">1818000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <rdnt:ContributionsFromNoncontrollingInterests
      contextRef="id349387901e24032a2736f786cf5a404_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMzMtMTMtMS0xLTA_2495f7ff-c8b3-48fa-b930-b46662b4a7eb"
      unitRef="usd">750000</rdnt:ContributionsFromNoncontrollingInterests>
    <rdnt:ContributionsFromNoncontrollingInterests
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMzMtMTUtMS0xLTA_0441d09c-0e4f-4836-a5df-3083f2853dbf"
      unitRef="usd">750000</rdnt:ContributionsFromNoncontrollingInterests>
    <rdnt:StockIssuedDuringPeriodSharesIssuedForReturnOfCapital
      contextRef="i040549d733b84e41865f935d6710183a_D20190101-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMzUtMS0xLTEtNzM3_74ed00b7-a87a-484c-9b9a-a2114e88dc0b"
      unitRef="shares">101902</rdnt:StockIssuedDuringPeriodSharesIssuedForReturnOfCapital>
    <rdnt:StockIssuedDuringPeriodValueIssuedForReturnOfCapital
      contextRef="ia0d67703fcc549f58c3bb54805e151a1_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMzUtNS0xLTEtNzM3_809ad8f2-db1a-4ef4-8f5e-29feacc0b3e0"
      unitRef="usd">-1500000</rdnt:StockIssuedDuringPeriodValueIssuedForReturnOfCapital>
    <rdnt:StockIssuedDuringPeriodValueIssuedForReturnOfCapital
      contextRef="i4644861e9ece4360bab418f1b9fef51a_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMzUtMTEtMS0xLTczNw_af666c4a-ccea-46d6-b66c-ce1a2a155a72"
      unitRef="usd">-1500000</rdnt:StockIssuedDuringPeriodValueIssuedForReturnOfCapital>
    <rdnt:StockIssuedDuringPeriodValueIssuedForReturnOfCapital
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMzUtMTUtMS0xLTczNw_d67fc421-4b28-45f0-b997-8c489da87795"
      unitRef="usd">-1500000</rdnt:StockIssuedDuringPeriodValueIssuedForReturnOfCapital>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="i2a16c2751a89418ca779969dd77a5344_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMzQtNy0xLTEtMA_25e71b15-ba4a-4ec3-b78e-3c82d7a2a1a7"
      unitRef="usd">-28000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="i4644861e9ece4360bab418f1b9fef51a_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMzQtMTEtMS0xLTA_5a49b6bc-f3f6-4501-9e94-0df21e550cac"
      unitRef="usd">-28000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMzQtMTUtMS0xLTA_8c855121-d868-45bc-bedc-03effcdd3e6d"
      unitRef="usd">-28000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i2a16c2751a89418ca779969dd77a5344_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMzUtNy0xLTEtMA_42ee1956-5b91-4318-a7f9-a95c925d21db"
      unitRef="usd">-14481000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i4644861e9ece4360bab418f1b9fef51a_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMzUtMTEtMS0xLTA_dd47fd6a-e2eb-4adf-b6f4-a19156bf5669"
      unitRef="usd">-14481000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMzUtMTUtMS0xLTA_f2437781-600a-4e62-a231-d8a503886579"
      unitRef="usd">-14481000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:ProfitLoss
      contextRef="i34391a7bab5d4dc58cabd25c59a6d33e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMzYtOS0xLTEtMA_c603efd1-8ad0-49ba-a7fd-820002b7508b"
      unitRef="usd">4360000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i4644861e9ece4360bab418f1b9fef51a_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMzYtMTEtMS0xLTA_80dfd6d5-fc19-461b-bee8-eff639e09820"
      unitRef="usd">4360000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="id349387901e24032a2736f786cf5a404_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMzYtMTMtMS0xLTA_f0c4fcd8-0c94-4295-bac5-1308d69a4cd4"
      unitRef="usd">6400000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMzYtMTUtMS0xLTA_b6f5e7da-622d-4ad3-9b4a-9c292af8ed06"
      unitRef="usd">10760000</us-gaap:ProfitLoss>
    <us-gaap:SharesOutstanding
      contextRef="ic034acb0117040d6afe7d976972fa479_I20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMzctMS0xLTEtMA_f2195a07-10b1-4042-bc1f-82509eb9952f"
      unitRef="shares">50254136</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic034acb0117040d6afe7d976972fa479_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMzctMy0xLTEtMA_b6599ea1-2e38-4c35-9af8-07423996fe86"
      unitRef="usd">5000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0747908eb36543a89df88a2d9e1cd35b_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMzctNS0xLTEtMA_26708b4a-a600-4439-8b25-fb43f0802b5c"
      unitRef="usd">260463000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8e1094d35d014fd3a95b14bc592059f5_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMzctNy0xLTEtMA_82cb4840-2e60-46b2-a1dc-4fe8a5bb9dc4"
      unitRef="usd">-12250000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie0f76e06105741279da7c3328d1d487a_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMzctOS0xLTEtMA_5ab9e0fa-5c8a-4ba9-a4ad-bf5359e87f2d"
      unitRef="usd">-113555000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idd2c608cacd0477aa45970e7d954f191_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMzctMTEtMS0xLTA_723deec5-5a91-46c9-9bdc-722861006661"
      unitRef="usd">134663000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3d9baeb9e126447b98c2cf732d7b12b4_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMzctMTMtMS0xLTA_61fdf170-63e2-486b-bc33-ce3b87afcb03"
      unitRef="usd">80409000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i799130036d73414da02bb032ba102c39_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zMS9mcmFnOjQzODZiMmU3M2ExNzQzMDVhZmM1NjNhOTEzNmI3YmNjL3RhYmxlOmY2NmQzMmE0OGQyZDRkNTliOTg5Mzk2YmM5NzQ1MTEzL3RhYmxlcmFuZ2U6ZjY2ZDMyYTQ4ZDJkNGQ1OWI5ODkzOTZiYzk3NDUxMTNfMzctMTUtMS0xLTA_25057c1a-9468-49f5-83e3-6955eb4183c6"
      unitRef="usd">215072000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMy0xLTEtMS0w_69a77182-e352-4f57-9161-066e32c45ac5"
      unitRef="usd">-12734000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMy0zLTEtMS0w_5b34f3ab-49f9-4b01-80ee-bc71fd4a320a"
      unitRef="usd">10760000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfNS0xLTEtMS0w_7bb81ab4-1ec1-43a0-a3fb-13e95756b879"
      unitRef="usd">64536000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfNS0zLTEtMS0w_a95f8ec9-3325-4360-8de9-6b5e00a124ea"
      unitRef="usd">60193000</us-gaap:DepreciationDepletionAndAmortization>
    <rdnt:OperatingLeaseRightofUseAssetAmortization
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfNi0xLTEtMS0w_ab751fd4-768d-486b-b8fd-542efaffe32e"
      unitRef="usd">50769000</rdnt:OperatingLeaseRightofUseAssetAmortization>
    <rdnt:OperatingLeaseRightofUseAssetAmortization
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfNi0zLTEtMS0w_0136ee01-e237-416a-a591-01ca3646a8c3"
      unitRef="usd">49948000</rdnt:OperatingLeaseRightofUseAssetAmortization>
    <us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfNy0xLTEtMS0w_882752ef-b30b-480d-bc5f-e99968c6fac8"
      unitRef="usd">-530000</us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions>
    <us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfNy0zLTEtMS0w_811e24c3-0ecf-4bd4-967a-e477513fac25"
      unitRef="usd">2148000</us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfOS0xLTEtMS0w_62c6dd1f-dc32-4c0a-a06e-614aaa88b486"
      unitRef="usd">3266000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfOS0zLTEtMS0w_f7b4fd5a-652e-4ee6-a4f8-f5ccc06098b1"
      unitRef="usd">3103000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMTAtMS0xLTEtMA_d7bc7f30-627a-4122-8b40-99fb4f8edf54"
      unitRef="usd">-543000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMTAtMy0xLTEtMA_ab395f23-d9ab-40a9-bf28-bb62584dc86c"
      unitRef="usd">-1990000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:AmortizationOfDeferredHedgeGains
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMTEtMS0xLTEtMA_00a2cf0c-585a-40e5-8c0a-ec5b85d85019"
      unitRef="usd">2204000</us-gaap:AmortizationOfDeferredHedgeGains>
    <us-gaap:AmortizationOfDeferredHedgeGains
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMTEtMy0xLTEtMA_7030ec83-7dd3-449f-8d23-573c62e2d8bb"
      unitRef="usd">0</us-gaap:AmortizationOfDeferredHedgeGains>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMTItMS0xLTEtMA_2d8098ba-5df5-46c7-afad-0b12e3a4c7a4"
      unitRef="usd">-4523000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMTItMy0xLTEtMA_3ef1777a-123d-48f0-9f15-2fb02dade425"
      unitRef="usd">0</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:ShareBasedCompensation
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMTMtMS0xLTEtMA_e48786d3-9905-4bbb-8818-cb8bc2ce55cb"
      unitRef="usd">10144000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMTMtMy0xLTEtMA_bf41de8d-5a0e-46de-b817-83c89cab3566"
      unitRef="usd">6963000</us-gaap:ShareBasedCompensation>
    <rdnt:IncreaseDecreaseInOtherNoncashItem
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMTQtMS0xLTEtMA_25a8c6c4-0f9f-4cae-9c4b-55516ac4d84c"
      unitRef="usd">0</rdnt:IncreaseDecreaseInOtherNoncashItem>
    <rdnt:IncreaseDecreaseInOtherNoncashItem
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMTQtMy0xLTEtMA_29f10235-d574-4ebf-a9c7-6f64c2adbaac"
      unitRef="usd">559000</rdnt:IncreaseDecreaseInOtherNoncashItem>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMTUtMS0xLTEtMA_b405381b-21db-4a54-939c-be10c1ae16a1"
      unitRef="usd">-145000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMTUtMy0xLTEtMA_03b04b55-1fe3-4614-9057-cf42de56d24a"
      unitRef="usd">-1749000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMTctMS0xLTEtMA_1d65bdd0-8abb-47a0-8e9c-84027dadbdea"
      unitRef="usd">-17380000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMTctMy0xLTEtMA_50c4ccb5-b6d4-4526-a847-81c2f3d4c66b"
      unitRef="usd">3467000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMTgtMS0xLTEtMA_974a37a5-6d4b-4ecb-8f99-ed71193278a1"
      unitRef="usd">-13522000</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMTgtMy0xLTEtMA_84033711-aa32-4375-a7d8-95e80746db94"
      unitRef="usd">1569000</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMTktMS0xLTEtMA_492812b9-0587-476b-b6bb-be28d2016152"
      unitRef="usd">700000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMTktMy0xLTEtMA_7259c005-6f36-475a-b5cf-28090c9f0a20"
      unitRef="usd">5770000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMjAtMS0xLTEtMA_134249c8-fb5b-4600-b771-27fec69245a2"
      unitRef="usd">7640000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMjAtMy0xLTEtMA_e13e90ed-d98c-4923-a894-924d45d0e4c9"
      unitRef="usd">4230000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <rdnt:IncreaseDecreaseinOperatingLeaseLiability
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMjEtMS0xLTEtMA_05bc311c-0ff0-45d0-80fa-8560b49dc1e8"
      unitRef="usd">43351000</rdnt:IncreaseDecreaseinOperatingLeaseLiability>
    <rdnt:IncreaseDecreaseinOperatingLeaseLiability
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMjEtMy0xLTEtMA_0d05b0d1-797c-4127-baf6-6b4e5653bfc3"
      unitRef="usd">49721000</rdnt:IncreaseDecreaseinOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMjItMS0xLTEtMA_88343077-5007-4690-b069-f188e0f1354b"
      unitRef="usd">44530000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMjItMy0xLTEtMA_3e0d0965-01fe-485b-8c7c-39a8d7de54a8"
      unitRef="usd">-490000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMjMtMS0xLTEtMA_3afb419a-96f3-4bad-b4d3-c60f05cde695"
      unitRef="usd">22966000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMjMtMy0xLTEtMA_be45dbf5-beff-452a-a97f-21224325241c"
      unitRef="usd">19349000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMjQtMS0xLTEtMA_ab176ccd-2608-4944-894a-30831278439e"
      unitRef="usd">170343000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMjQtMy0xLTEtMA_03a9d0a7-431a-4054-a5f9-8a3b41cc5459"
      unitRef="usd">82603000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireBuildings
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMjYtMS0xLTEtMA_0b2b089e-b450-4724-b32a-ff0215eaea4d"
      unitRef="usd">10125000</us-gaap:PaymentsToAcquireBuildings>
    <us-gaap:PaymentsToAcquireBuildings
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMjYtMy0xLTEtMA_71f35349-bf55-4176-a850-8934c95baaa5"
      unitRef="usd">27150000</us-gaap:PaymentsToAcquireBuildings>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMjctMS0xLTEtMA_c4fd638f-2029-43b4-acf3-8bca6263d3e5"
      unitRef="usd">0</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMjctMy0xLTEtMA_0470b081-30f5-46cc-93ca-29430ac9f19f"
      unitRef="usd">143000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMjgtMS0xLTEtMA_7042848c-3f55-46be-9861-32ffcabb763e"
      unitRef="usd">77303000</us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMjgtMy0xLTEtMA_1ee0001b-6a54-4bc9-938b-d46723ced11a"
      unitRef="usd">68269000</us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMjktMS0xLTEtMA_bb44cb05-8ccf-4b8f-b660-080405ff625b"
      unitRef="usd">779000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMjktMy0xLTEtMA_4ca7bcc0-a7fc-4f60-a715-78ea602a81fd"
      unitRef="usd">760000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromDivestitureOfInterestInJointVenture
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMzAtMS0xLTEtMA_b226d7a1-3d3f-4235-b994-833506e9ba48"
      unitRef="usd">0</us-gaap:ProceedsFromDivestitureOfInterestInJointVenture>
    <us-gaap:ProceedsFromDivestitureOfInterestInJointVenture
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMzAtMy0xLTEtMA_c2541a04-42df-41d5-9a8e-9ea4bb6d8b8a"
      unitRef="usd">132000</us-gaap:ProceedsFromDivestitureOfInterestInJointVenture>
    <us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMzEtMS0xLTEtMA_adaae8ae-10eb-41f9-b109-9586afcaf1d1"
      unitRef="usd">0</us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital>
    <us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMzEtMy0xLTEtMA_3d02847a-11d3-4f59-a7ca-54707efac2f0"
      unitRef="usd">792000</us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital>
    <rdnt:PaymentstoAcquireInterestinJointVentureAndContributionsToExistingJointVenture
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMzItMS0xLTEtMA_3760a546-40a9-4640-adae-422369c77563"
      unitRef="usd">1631000</rdnt:PaymentstoAcquireInterestinJointVentureAndContributionsToExistingJointVenture>
    <rdnt:PaymentstoAcquireInterestinJointVentureAndContributionsToExistingJointVenture
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMzItMy0xLTEtMA_af5e3238-6691-4bcc-968b-632e0b7022a0"
      unitRef="usd">103000</rdnt:PaymentstoAcquireInterestinJointVentureAndContributionsToExistingJointVenture>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMzMtMS0xLTEtMA_416a9827-30d8-45d7-8a7f-17d06ddbe035"
      unitRef="usd">-88280000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMzMtMy0xLTEtMA_c05f368d-6281-4349-8b9d-fe88f572bb1c"
      unitRef="usd">-93981000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMzUtMS0xLTEtMA_5e35c614-cd83-4196-aefb-c6e16f2227d5"
      unitRef="usd">2704000</us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities>
    <us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMzUtMy0xLTEtMA_c9be21c6-bfe6-4143-adbd-1e5dea4d60ea"
      unitRef="usd">4778000</us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities>
    <us-gaap:RepaymentsOfDebt
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMzYtMS0xLTEtMA_36de482c-14ab-4c29-906f-5fcd89d61894"
      unitRef="usd">32472000</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMzYtMy0xLTEtMA_84952f91-ee07-44ed-8a10-8d5da145e93d"
      unitRef="usd">29918000</us-gaap:RepaymentsOfDebt>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMzctMS0xLTEtNzUw_7a6fc05b-a997-404c-8f7d-30ff186c9db7"
      unitRef="usd">741000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMzctMy0xLTEtNzUw_55db0abf-688b-4014-9534-0aac47aefcb0"
      unitRef="usd">0</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMzctMS0xLTEtMA_5bf9ca87-8a35-4ae6-b405-8161ce9ffbe9"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMzctMy0xLTEtMA_c6c40593-23a1-45d4-85a2-3bf4c2ed9bd6"
      unitRef="usd">97144000</us-gaap:ProceedsFromIssuanceOfDebt>
    <rdnt:ProceedsFromGovernmentAssistance
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMzgtMS0xLTEtMA_1a472b0f-def2-4123-98ce-de1d9d06ccb1"
      unitRef="usd">4023000</rdnt:ProceedsFromGovernmentAssistance>
    <rdnt:ProceedsFromGovernmentAssistance
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMzgtMy0xLTEtMA_ca8c9899-1129-40d9-a8ab-48e60109c019"
      unitRef="usd">0</rdnt:ProceedsFromGovernmentAssistance>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMzktMS0xLTEtMA_7b092b2f-fbd7-483c-94e9-4a19a079d29a"
      unitRef="usd">601000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfMzktMy0xLTEtMA_43cbbaf2-85f3-4ed6-8e88-681c4cf0f396"
      unitRef="usd">1818000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfNDAtMS0xLTEtMA_6cd7dd6b-7c2d-472e-a8a7-71c29fd9ebb3"
      unitRef="usd">0</us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets>
    <us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfNDAtMy0xLTEtMA_0e98684e-6a61-4c33-809b-476442fd203a"
      unitRef="usd">5275000</us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets>
    <us-gaap:ProceedsFromContributedCapital
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfNDEtMS0xLTEtMA_41a4eae2-ab25-4352-b956-7a6835f4a4e1"
      unitRef="usd">0</us-gaap:ProceedsFromContributedCapital>
    <us-gaap:ProceedsFromContributedCapital
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfNDEtMy0xLTEtMA_406a21a9-eb17-4e2c-9dcd-6ba7c1d7698e"
      unitRef="usd">750000</us-gaap:ProceedsFromContributedCapital>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfNDItMS0xLTEtMA_38efee3e-56c9-438b-ba6b-943a4f11a3ac"
      unitRef="usd">250900000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfNDItMy0xLTEtMA_983911d9-8266-4b3a-831e-6c460acdeabd"
      unitRef="usd">251200000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfNDQtMS0xLTEtMA_ce890b51-019f-47a0-98b7-7b1e9e8ce50c"
      unitRef="usd">250900000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfNDQtMy0xLTEtMA_a8c8ad88-3717-4fbf-abe5-f76f1e535bf4"
      unitRef="usd">279200000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfNDUtMS0xLTEtMA_30d7d8e9-fad8-4cfe-a518-bd977cd14d00"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfNDUtMy0xLTEtMA_c7a6949b-ecfd-40b9-9ba3-c2d4e867be71"
      unitRef="usd">50000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfNDYtMS0xLTEtMA_f029f79e-0656-4f8a-9a45-71d9a8b4d5db"
      unitRef="usd">-32495000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfNDYtMy0xLTEtMA_5b8a4a62-2adf-45f9-ac0e-0c6cfa9e0447"
      unitRef="usd">38705000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfNDctMS0xLTEtMA_ccb010f3-937e-4225-87f5-ae79795030e1"
      unitRef="usd">6000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfNDctMy0xLTEtMA_f3171b87-652e-4f18-baad-8ff47618875f"
      unitRef="usd">-28000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfNDgtMS0xLTEtMA_88b259fe-6caa-4beb-bd93-5ba1f5feb27f"
      unitRef="usd">49574000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfNDgtMy0xLTEtMA_e6baeace-408d-4290-83ad-b3656cb8283a"
      unitRef="usd">27299000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfNDktMS0xLTEtMA_bd0f19d6-ea94-438a-abf2-ff940c832155"
      unitRef="usd">40165000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i9799a383a2814cafbb89d610347f767d_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfNDktMy0xLTEtMA_4f863037-c3a3-4e81-9ffd-f7497c94ef8d"
      unitRef="usd">10389000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfNTAtMS0xLTEtMA_f1581002-97d5-477f-ba52-67f0f47900dc"
      unitRef="usd">89739000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i799130036d73414da02bb032ba102c39_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfNTAtMy0xLTEtMA_0262a5eb-b01c-4730-95b6-316102c50dd7"
      unitRef="usd">37688000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfNTMtMS0xLTEtMA_d4f6181a-cdf4-4d59-8d15-500fd65f1385"
      unitRef="usd">31210000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RhYmxlOmVjNjQ4NzA0YWJiZTQxZWVhOTA1NzEwODUwMGUxMzkxL3RhYmxlcmFuZ2U6ZWM2NDg3MDRhYmJlNDFlZWE5MDU3MTA4NTAwZTEzOTFfNTMtMy0xLTEtMA_8b65202c-4abc-46d3-aec6-c75ab36d53e2"
      unitRef="usd">36058000</us-gaap:InterestPaidNet>
    <rdnt:EquipmentAcquiredAndLeaseholdImprovements
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RleHRyZWdpb246MzY1ZDNlNDkwYjg0NDcwMzhkNzYyYzRkM2E5MTIwNDhfNDMz_516951df-43b4-4fe4-a806-f67ae4ab5312"
      unitRef="usd">28100000</rdnt:EquipmentAcquiredAndLeaseholdImprovements>
    <rdnt:EquipmentAcquiredAndLeaseholdImprovements
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RleHRyZWdpb246MzY1ZDNlNDkwYjg0NDcwMzhkNzYyYzRkM2E5MTIwNDhfNDQw_c39766e1-7c62-4cdd-87c9-2947f2ffaad0"
      unitRef="usd">14100000</rdnt:EquipmentAcquiredAndLeaseholdImprovements>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="if4d28a9eeb2a4c71935db70483100dcc_D20200601-20200601"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RleHRyZWdpb246MzY1ZDNlNDkwYjg0NDcwMzhkNzYyYzRkM2E5MTIwNDhfNzY3_26f99d4e-a140-4433-9de2-c8e4f4189a73"
      unitRef="shares">823615</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
      contextRef="i6ef5f4569a454da5b5b38254fa362064_I20200601"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RleHRyZWdpb246MzY1ZDNlNDkwYjg0NDcwMzhkNzYyYzRkM2E5MTIwNDhfODk2_8f518295-bbdb-4b0c-a199-2d73a37792dc"
      unitRef="usd">13900000</us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="ibdf5ae03b0ed462b8db002f00aaa9eb3_D20190801-20190801"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RleHRyZWdpb246MzY1ZDNlNDkwYjg0NDcwMzhkNzYyYzRkM2E5MTIwNDhfMjE5OTAyMzI1ODk2Mg_6cfac5cb-4f20-4472-96d6-a3b209d232f4"
      unitRef="usd">1500000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i9c76df6e41e74111ace2b21a4181efad_I20190801"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RleHRyZWdpb246MzY1ZDNlNDkwYjg0NDcwMzhkNzYyYzRkM2E5MTIwNDhfMjE5OTAyMzI1ODk3Nw_03354130-080d-4e98-a02d-7fa31d91c294"
      unitRef="number">0.75</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i03857062bad24956a20685e95d06b5f4_I20180412"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RleHRyZWdpb246MzY1ZDNlNDkwYjg0NDcwMzhkNzYyYzRkM2E5MTIwNDhfMjE5OTAyMzI1OTAxOA_c2676a9c-d507-41d8-bb8a-e03f0ca552a8"
      unitRef="number">0.25</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="id84f65c6811e410281f7a3f3cee987b2_I20190301"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RleHRyZWdpb246MzY1ZDNlNDkwYjg0NDcwMzhkNzYyYzRkM2E5MTIwNDhfMTA5MA_310f1c30-02f4-48bb-a37f-29612eba9392"
      unitRef="usd">4300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="i09d00c2072a64166aae3435ab4296e8b_D20190227-20190227"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RleHRyZWdpb246MzY1ZDNlNDkwYjg0NDcwMzhkNzYyYzRkM2E5MTIwNDhfMTIxNA_da3af1fa-d9cf-4b93-8413-fb393c9c03a8"
      unitRef="shares">440207</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
      contextRef="iada1780824384c7aa307e03c01df38f3_I20190227"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl8zNC9mcmFnOjM2NWQzZTQ5MGI4NDQ3MDM4ZDc2MmM0ZDNhOTEyMDQ4L3RleHRyZWdpb246MzY1ZDNlNDkwYjg0NDcwMzhkNzYyYzRkM2E5MTIwNDhfMTUxOA_fb530c47-f480-48d3-8a9b-89b66147b81e"
      unitRef="usd">6000000.0</us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80MC9mcmFnOjBiOGNlMjE4ODI5NzQ5OGQ5MmY5NTNiNDc2MzY5OWQ2L3RleHRyZWdpb246MGI4Y2UyMTg4Mjk3NDk4ZDkyZjk1M2I0NzYzNjk5ZDZfOTA2NA_a50c1f8f-93f6-4457-bff8-a751b1aa9663">NATURE OF BUSINESS AND BASIS OF PRESENTATION&lt;div style="margin-top:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are a national provider of freestanding, fixed-site outpatient diagnostic imaging services with operations in seven U.S. states. At September&#160;30, 2020, we operated, directly or indirectly through joint ventures with hospitals, 334 centers located in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Our centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Our services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. The vast majority of our centers offer multi-modality imaging services. Our multi-modality strategy diversifies revenue streams, reduces exposure to reimbursement changes and provides patients and referring physicians the convenience of a single location to serve the needs of multiple procedures. In addition to our imaging services, we design and develop software applications, Artificial Intelligence tools and other computerized systems for the diagnostic imaging industry. Our operations comprise a single segment for financial reporting purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements include the accounts of RadNet, Inc as well as its subsidiaries in which RadNet has a controlling financial interest. The consolidated financial statements also include certain variable interest entities in which we are the primary beneficiary (as described in more detail below). All material intercompany transactions and balances have been eliminated upon consolidation.  All of these affiliated entities are referred to collectively as &#x201c;RadNet&#x201d;, &#x201c;we&#x201d;, &#x201c;us&#x201d;, &#x201c;our&#x201d; or the &#x201c;Company&#x201d; in this report.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounting regulations stipulate that generally any entity with a) insufficient equity to finance its activities without additional subordinated financial support provided by any parties, or b) equity holders that, as a group, lack the characteristics which evidence a controlling financial interest, is considered a Variable Interest Entity (&#x201c;VIE&#x201d;). We consolidate all VIEs in which we are the primary beneficiary. We determine whether we are the primary beneficiary of a VIE through a qualitative analysis that identifies which variable interest holder has the controlling financial interest in the VIE. The variable interest holder who has both of the following has the controlling financial interest and is the primary beneficiary: (1) the power to direct the activities of the VIE that most significantly impact the VIE&#x2019;s economic performance and (2) the obligation to absorb losses of, or the right to receive benefits from, the VIE that could potentially be significant to the VIE. In performing our analysis, we consider all relevant facts and circumstances, including: the design and activities of the VIE, the terms of the contracts the VIE has entered into, the nature of the VIE&#x2019;s variable interests issued and how they were negotiated with or marketed to potential investors, and which parties participated significantly in the design or redesign of the entity.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;VIEs that we consolidate as the primary beneficiary consist of professional corporations which are owned or controlled by individuals within our senior management, namely Howard G. Berger, M.D., our President and Chief Executive Officer, and John V. Crues, III, M.D., RadNet's Medical Director, both of whom are members of our Board of Directors.  Dr. Berger owns, indirectly, 99% of the equity interests in Beverly Radiology Medical Group III (BRMG) and a controlling interest in two professional corporations in New York City.  BRMG is responsible for the professional medical services at nearly all of our facilities located in California.  Dr. Crues owns six professional corporations which provide medical services in Delaware, Maryland, New Jersey and New York.  Additionally, Dr. Crues is a 1% owner of BRMG.  These VIEs are collectively referred to as the consolidated medical group ("the Group").&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;RadNet provides non-medical, technical and administrative services to the Group for which it receives a management fee, pursuant to the related management agreements. Through the management agreements we have exclusive authority over all non-medical decision making related to the ongoing business operations and we determine the annual budget. The Group has insignificant operating assets and liabilities, and de minimis equity. Through management agreements with us, substantially all cash flows of the Group after expenses, including professional salaries, are transferred to us. We consolidate the revenue and expenses, assets and liabilities of the Group.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Group on a combined basis recognized $38.3 million and $40.6 million of revenue, net of management services fees to RadNet, for the three months ended September&#160;30, 2020 and 2019, respectively and $38.3 million and $40.6 million of operating expenses for the three months ended September&#160;30, 2020 and 2019, respectively.  RadNet recognized $169.0 million and $154.5 million of total billed net service fee revenue for the three months ended September&#160;30, 2020, and 2019, respectively, for management services provided to the Group relating primarily to the technical portion of billed revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Group on a combined basis recognized $104.8 million and $116.9 million of revenue, net of management services fees to RadNet, for the nine months ended September&#160;30, 2020 and 2019, respectively and $104.8 million and $116.9 million of operating expenses for the nine months ended September&#160;30, 2020 and 2019, respectively.  RadNet recognized $433.3 million &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and $456.1 million of total billed net service fee revenue for the nine months ended September&#160;30, 2020, and 2019, respectively, for management services provided to the Group relating primarily to the technical portion of billed revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The cash flows of the Group are included in the accompanying condensed consolidated statements of cash flows. All intercompany balances and transactions have been eliminated in consolidation. In our condensed consolidated balance sheets at September&#160;30, 2020 and December&#160;31, 2019, we have included approximately $84.5 million and $100.3 million, respectively, of accounts receivable and approximately $10.7 million and $7.0 million of accounts payable and accrued liabilities related to the Group, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The creditors of the Group do not have recourse to our general credit and there are no other arrangements that could expose us to losses on their behalf. However, RadNet may be required to provide financial support to cover any operating expenses in excess of operating revenues.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We also own a 49% economic interest in ScriptSender, LLC, which provides secure data transmission services of medical information. Through a management agreement, RadNet provides management and accounting services and receives an agreed upon fee. ScriptSender, LLC is dependent on the Company to finance its own activities, and as such we determined that it is a VIE but we are not a primary beneficiary since we do not have the power to direct the activities of the entity that most significantly impact the entity&#x2019;s economic performance.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At all of our centers not serviced by the Group we have entered into long-term contracts (typically up to 40 years) with independent radiology groups to provide physician services at those centers. These radiology practices provide professional services, including supervision and interpretation of diagnostic imaging procedures, in our diagnostic imaging centers. The radiology practices maintain full control over the provision of professional services. Under these arrangements, in addition to obtaining technical fees for the use of our diagnostic imaging equipment and the provision of technical services, we provide management services and receive a fee based on the value of the services we provide.  We own the diagnostic imaging equipment and, therefore, receive 100% of the technical reimbursements associated with imaging procedures. The radiology practice groups retain the professional reimbursements associated with imaging procedures after deducting management service fees paid to us and we have no economic controlling interest in these radiology practices as such, the financial results of these practices are not consolidated in our financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X and, therefore, do not include all information and footnotes necessary for conformity with U.S. generally accepted accounting principles for complete financial statements; however, in the opinion of our management, all adjustments consisting of normal recurring adjustments necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods ended September&#160;30, 2020 and 2019 have been made. The results of operations for any interim period are not necessarily indicative of the results for a full year. These interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes thereto contained in our annual report on Form 10-K for the year ended December&#160;31, 2019.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <rdnt:NumberOfCenters
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80MC9mcmFnOjBiOGNlMjE4ODI5NzQ5OGQ5MmY5NTNiNDc2MzY5OWQ2L3RleHRyZWdpb246MGI4Y2UyMTg4Mjk3NDk4ZDkyZjk1M2I0NzYzNjk5ZDZfMjcw_273a801f-d01f-4f3a-8c9b-ac9770cdc125"
      unitRef="center">334</rdnt:NumberOfCenters>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="ic0ea34f7e0b34c6cb8b791288d9c8ac5_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80MC9mcmFnOjBiOGNlMjE4ODI5NzQ5OGQ5MmY5NTNiNDc2MzY5OWQ2L3RleHRyZWdpb246MGI4Y2UyMTg4Mjk3NDk4ZDkyZjk1M2I0NzYzNjk5ZDZfMzU2Mw_a614c427-532e-460d-8d63-2cf282f39f06"
      unitRef="number">0.99</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i6a57a87a6da342959e454a8c3d0ad301_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80MC9mcmFnOjBiOGNlMjE4ODI5NzQ5OGQ5MmY5NTNiNDc2MzY5OWQ2L3RleHRyZWdpb246MGI4Y2UyMTg4Mjk3NDk4ZDkyZjk1M2I0NzYzNjk5ZDZfMzk4Mw_4ab3c313-596f-4aba-9c32-6677664a9797"
      unitRef="number">0.01</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues
      contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80MC9mcmFnOjBiOGNlMjE4ODI5NzQ5OGQ5MmY5NTNiNDc2MzY5OWQ2L3RleHRyZWdpb246MGI4Y2UyMTg4Mjk3NDk4ZDkyZjk1M2I0NzYzNjk5ZDZfNDc5NA_22f5706b-d409-4aa1-9329-04f0d9c7822b"
      unitRef="usd">38300000</us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues>
    <us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues
      contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80MC9mcmFnOjBiOGNlMjE4ODI5NzQ5OGQ5MmY5NTNiNDc2MzY5OWQ2L3RleHRyZWdpb246MGI4Y2UyMTg4Mjk3NDk4ZDkyZjk1M2I0NzYzNjk5ZDZfNDgwMQ_ce7ea826-23e5-477e-865b-2331b943dc8b"
      unitRef="usd">40600000</us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues>
    <us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityExpense
      contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80MC9mcmFnOjBiOGNlMjE4ODI5NzQ5OGQ5MmY5NTNiNDc2MzY5OWQ2L3RleHRyZWdpb246MGI4Y2UyMTg4Mjk3NDk4ZDkyZjk1M2I0NzYzNjk5ZDZfNDkxNA_b5940aff-f8e3-4ca8-8a42-848857161b25"
      unitRef="usd">38300000</us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityExpense>
    <us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityExpense
      contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80MC9mcmFnOjBiOGNlMjE4ODI5NzQ5OGQ5MmY5NTNiNDc2MzY5OWQ2L3RleHRyZWdpb246MGI4Y2UyMTg4Mjk3NDk4ZDkyZjk1M2I0NzYzNjk5ZDZfNDkyMQ_031bba07-d32b-4fe2-af06-0369ccc9231d"
      unitRef="usd">40600000</us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityExpense>
    <us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax
      contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80MC9mcmFnOjBiOGNlMjE4ODI5NzQ5OGQ5MmY5NTNiNDc2MzY5OWQ2L3RleHRyZWdpb246MGI4Y2UyMTg4Mjk3NDk4ZDkyZjk1M2I0NzYzNjk5ZDZfNTAxNw_e05d3d10-e749-4d18-a300-b4dd0b8e829a"
      unitRef="usd">169000000.0</us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax>
    <us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax
      contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80MC9mcmFnOjBiOGNlMjE4ODI5NzQ5OGQ5MmY5NTNiNDc2MzY5OWQ2L3RleHRyZWdpb246MGI4Y2UyMTg4Mjk3NDk4ZDkyZjk1M2I0NzYzNjk5ZDZfNTAyNA_d07c39f1-9643-428d-9198-2302272fa980"
      unitRef="usd">154500000</us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax>
    <us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80MC9mcmFnOjBiOGNlMjE4ODI5NzQ5OGQ5MmY5NTNiNDc2MzY5OWQ2L3RleHRyZWdpb246MGI4Y2UyMTg4Mjk3NDk4ZDkyZjk1M2I0NzYzNjk5ZDZfNTI3MQ_1fee2352-abcd-4696-812a-67167221e4a1"
      unitRef="usd">104800000</us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues>
    <us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80MC9mcmFnOjBiOGNlMjE4ODI5NzQ5OGQ5MmY5NTNiNDc2MzY5OWQ2L3RleHRyZWdpb246MGI4Y2UyMTg4Mjk3NDk4ZDkyZjk1M2I0NzYzNjk5ZDZfNTI3OA_6a23629e-6921-45ed-a667-d27bae984071"
      unitRef="usd">116900000</us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues>
    <us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityExpense
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80MC9mcmFnOjBiOGNlMjE4ODI5NzQ5OGQ5MmY5NTNiNDc2MzY5OWQ2L3RleHRyZWdpb246MGI4Y2UyMTg4Mjk3NDk4ZDkyZjk1M2I0NzYzNjk5ZDZfNTM4OQ_6d87e2e7-67bb-41ba-9cc0-1d5cf74d5fae"
      unitRef="usd">104800000</us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityExpense>
    <us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityExpense
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80MC9mcmFnOjBiOGNlMjE4ODI5NzQ5OGQ5MmY5NTNiNDc2MzY5OWQ2L3RleHRyZWdpb246MGI4Y2UyMTg4Mjk3NDk4ZDkyZjk1M2I0NzYzNjk5ZDZfNTM5Ng_c1081b85-b88b-4022-8b96-341ebf450539"
      unitRef="usd">116900000</us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityExpense>
    <us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80MC9mcmFnOjBiOGNlMjE4ODI5NzQ5OGQ5MmY5NTNiNDc2MzY5OWQ2L3RleHRyZWdpb246MGI4Y2UyMTg4Mjk3NDk4ZDkyZjk1M2I0NzYzNjk5ZDZfNTQ5MA_69070ae7-bfc1-41df-a51c-c94f0cab138e"
      unitRef="usd">433300000</us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax>
    <us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80MC9mcmFnOjBiOGNlMjE4ODI5NzQ5OGQ5MmY5NTNiNDc2MzY5OWQ2L3RleHRyZWdpb246MGI4Y2UyMTg4Mjk3NDk4ZDkyZjk1M2I0NzYzNjk5ZDZfNTQ5Nw_0e7da238-e01a-497a-b0f5-21c2e14471ba"
      unitRef="usd">456100000</us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax>
    <us-gaap:Assets
      contextRef="i47fc5bf332c0415ca58f64dd07a99d47_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80MC9mcmFnOjBiOGNlMjE4ODI5NzQ5OGQ5MmY5NTNiNDc2MzY5OWQ2L3RleHRyZWdpb246MGI4Y2UyMTg4Mjk3NDk4ZDkyZjk1M2I0NzYzNjk5ZDZfNTk4Mw_89313dba-2cd3-4b68-b733-19269de82227"
      unitRef="usd">84500000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i4a3dff9af20d4d0898edd8b68ba20037_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80MC9mcmFnOjBiOGNlMjE4ODI5NzQ5OGQ5MmY5NTNiNDc2MzY5OWQ2L3RleHRyZWdpb246MGI4Y2UyMTg4Mjk3NDk4ZDkyZjk1M2I0NzYzNjk5ZDZfNTk5MA_07b98322-7fcb-4e2f-b644-387934523ae7"
      unitRef="usd">100300000</us-gaap:Assets>
    <us-gaap:Liabilities
      contextRef="i47fc5bf332c0415ca58f64dd07a99d47_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80MC9mcmFnOjBiOGNlMjE4ODI5NzQ5OGQ5MmY5NTNiNDc2MzY5OWQ2L3RleHRyZWdpb246MGI4Y2UyMTg4Mjk3NDk4ZDkyZjk1M2I0NzYzNjk5ZDZfNjA0OQ_e4b0858c-25ea-40db-b31d-a62724e105ea"
      unitRef="usd">10700000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i4a3dff9af20d4d0898edd8b68ba20037_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80MC9mcmFnOjBiOGNlMjE4ODI5NzQ5OGQ5MmY5NTNiNDc2MzY5OWQ2L3RleHRyZWdpb246MGI4Y2UyMTg4Mjk3NDk4ZDkyZjk1M2I0NzYzNjk5ZDZfNjA1Ng_3fa4928e-74b2-4324-8977-582b60a45170"
      unitRef="usd">7000000.0</us-gaap:Liabilities>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="ie01b35e6814e4aa2a06cc5668ed2166b_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80MC9mcmFnOjBiOGNlMjE4ODI5NzQ5OGQ5MmY5NTNiNDc2MzY5OWQ2L3RleHRyZWdpb246MGI4Y2UyMTg4Mjk3NDk4ZDkyZjk1M2I0NzYzNjk5ZDZfNjQzNQ_fe5a378e-81e1-402e-b02c-09c9e37f9361"
      unitRef="number">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMzAxMDg_512490a0-33a0-4b88-9ec8-50df8899b8f0">SIGNIFICANT ACCOUNTING POLICIES&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the period covered in this report, there have been no material changes to the significant accounting policies we use and have explained, in our annual report on Form 10-K for the fiscal year ended December&#160;31, 2019. The information below is intended only to supplement the disclosure in our annual report on Form 10-K for the fiscal year ended December&#160;31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;REVENUES  - Our revenues generally relate to net patient fees&#160;received from various payors and patients themselves under contracts in which our performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period when our obligations to provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payor (Medicare, Medicaid, managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed care health plans and commercial insurance companies) the third-party payors. The payment arrangements with third-party payors for the services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As it relates to the Group, this service fee revenue includes payments for both the professional medical interpretation revenue recognized by them as well as the payment for all other aspects related to our providing the imaging services, for which we earn management fees. As it relates to others centers, this service fee revenue is earned through providing the use of our diagnostic imaging equipment and the provision of technical services as well as providing administration services such as clerical and administrative personnel, bookkeeping and accounting services, billing and collection, provision of medical and office supplies, secretarial, reception and transcription services, maintenance of medical records, and advertising, marketing and promotional activities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our revenues are based upon the estimated amounts we expect to be entitled to receive from patients and third-party payors. Estimates of contractual allowances under managed care and commercial insurance plans are based upon the payment terms specified in the related contractual agreements. Revenues related to uninsured patients and copayment and deductible amounts for patients who have health care coverage may have discounts applied (uninsured discounts and contractual discounts). We also record estimated implicit price concessions (based primarily on historical collection experience) related to uninsured accounts to record self-pay revenues at the estimated amounts we expect to collect.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under capitation arrangements with various health plans, we earn a per-enrollee amount each month for making available diagnostic imaging services to all plan enrollees under the capitation arrangement. Revenue under capitation arrangements is recognized in the period in which we are obligated to provide services to plan enrollees under contracts with various health plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our total service revenues during the three and nine  months ended September&#160;30, 2020 and 2019 are presented in the table below based on an allocation of the estimated transaction price with the patient between the primary patient classification of insurance coverage (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.830%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.734%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.734%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.734%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.738%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial insurance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;412,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;475,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Workers' compensation/personal injury&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other patient revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Management fee revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Teleradiology and Software revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service fee revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;261,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;660,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;762,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue under capitation arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total service revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;763,905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;853,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;COVID-19 PANDEMIC AND CARES ACT FUNDING -  On March 11, 2020 the World Health Organization (WHO) designated COVID-19 as a global pandemic.  Patient volumes and the related revenues for our services were significantly impacted during the latter portion of the first quarter through the middle of the third quarter of 2020 as a result of federal, state and local government mandated restrictions requiring many people to remain at home and forced the closure of or limitations on certain businesses, as well as suspended elective procedures by health care facilities.  Many of these restrictions have been eased or completely lifted across the states the Company operates in however, we are unable to predict the future impact of the pandemic on our operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;During the nine months ended September 30, 2020, we received $39.4 million of accelerated Medicare payments, $5.0 million from Blue Cross, $25.7 million from the general distribution and $4.0 million from the Paycheck Protection Program established through the Coronavirus Aid, Relief and Economic Security (&#x201c;CARES&#x201d;) Act.  The accelerated Medicare payments are recorded under the caption &#x201c; Deferred Revenue&#x201c;  in our condensed consolidated balance sheet and will be repaid beginning in 2021.  The general distribution funds were accounted for as government grants and recognized as other revenue, once reasonable assurance that the applicable terms and conditions required to retain the funds were met, under the caption &#x201c;Provider relief funding&#x201d; in our condensed Consolidated Statements of Operations&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;During the three months ended September 30, 2020, the Department of Health and Human Services significantly changed the measurement of Provider Relief Funds that providers are able to retain.  We received approximately $0.2 million in &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;funding and based on our assessment of the likelihood of meeting the applicable terms and conditions of the general distribution we continue to recognized the funds received as other revenue.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The CARES Act also providers for a payment deferral of the employer portion of Social Security tax incurred during the pandemic, allowing half of such payroll taxes to be deferred until December 2021 and the remaining half until December 2022.  At September 30, 2020, the Company had deferred $10.8 million of Social Security taxes.  These payment deferrals are recorded as payroll tax liability under the caption &#x201c;Accounts payable, accrued expenses and other&#x201d; in our condensed consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;We believe the extent of the COVID-19 pandemic&#x2019;s impact on our operating results and financial condition has been and will continue to be driven by many factors, most of which are beyond our control and ability to forecast.  Such factors include, but are not limited to, the scope and duration of stay-at-home practices, business closures  and restrictions, suspensions of elective procedures and continued decline in procedure volumes for an indeterminable length of time and incremental expenses required for supplies and personal protective equipment.  Because of these uncertainties, we cannot estimate the length or impact of the pandemic on our business.  If we incur declines in cash flows and results of operations, such declines could have an impact on the inputs and assumptions used in significant accounting estimates, including implicit prices concessions related to uninsured patient  accounts, and potential impairment of goodwill and long-lived assets.  During the third quarter of 2020, procedure volumes increased and have had a positive impact on our patient revenue.  However, the impact of COVID-19 in future periods may vary and could adversely impact our results of operations.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;RECLASSIFICATION &#x2013;We have reclassified certain amounts previously classified as held for sale related to property and equipment and goodwill to conform to our 2020 presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ACCOUNTS RECEIVABLE - Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. Services are generally provided pursuant to one-year contracts with healthcare providers. We continuously monitor collections from our payors and maintain an allowance for bad debts based upon specific payor collection issues that we have identified and our historical experience.  In regards to the credit loss standard, we have concluded that the historical credit loss experienced across our receivable portfolio is materially similar to any current expected credit losses estimated under the Current Expected Credit Loss ("CECL") model.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2018 and 2019 we entered into factoring agreements with various institutions and sold certain accounts receivable under non-recourse agreements in exchange for notes receivables from the buyers. These transactions are accounted for as a reduction in accounts receivable as the agreements transfer effective control over and risk related to the receivables to the buyers. Proceeds on notes receivables are reflected as operating activities on our statement of cash flows and on our balance sheet as prepaid expenses and other current assets for the current portion and deposits and other for the long term portion. At September&#160;30, 2020 we have&#160;$20.4 million remaining to be collected on these agreements. We do not utilize factoring arrangements as an integral part of our financing for working capital.  To employ the CECL model for the notes receivable, we assess the party's ability to pay upfront at the inception of the notes receivable and subsequently by reviewing their financial statements annually and reassessing any insolvency risk on a periodic basis.  In the event of a significant past due balance, as the sold receivables were already revalued and recorded at net realizable value, we can mitigate the expected credit loss by offsetting any collections from the underlying factored receivables and not remitting that to the counter party.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;DEFERRED REVENUE - As noted above, in April of 2020, we received approximately $39.4 million in advanced Medicare payments from the Centers for Medicare and Medicaid Services ("CMS") as part of the expanded Accelerated and Advance Payment Program under the Coronavirus Aid, Relief, and Economic Security (CARES) Act.  As these payments are required to be repaid to CMS beginning 120 days after their receipt through offsets from new Medicare claims over a three month period, we have recorded amounts received to deferred revenue which will be amortized as Medicare reimbursements are earned.  In addition, in May of 2020 we received $5.0 million in advance payments from an insurance carrier with similar repayment terms as the CMS.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;DEFERRED FINANCING COSTS - Costs of financing are deferred and amortized using the effective interest rate method. Deferred financing costs, net of accumulated amortization, were $1.9 million and $1.6 million, as of September&#160;30, 2020 and December&#160;31, 2019, respectively and related to our Barclays line of credit.  See Note 5, Credit Facilities and Notes Payable for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;PROPERTY AND EQUIPMENT - Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation of property and equipment is performed using the straight-line method over the estimated useful lives of the assets acquired, which range from 3 to 15 years. Leasehold improvements are amortized at the lesser of lease term or their estimated useful lives, which range from 3 to 15 years. Maintenance and repairs are charged to expense as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;BUSINESS COMBINATION  -  When the qualifications for business combination accounting treatment are met, it requires us to recognize separately from goodwill the assets acquired and the liabilities assumed at their acquisition date fair values. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities assumed. While we use our best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, we record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to our consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;GOODWILL AND INDEFINITE LIVED INTANGIBLES - Goodwill at September&#160;30, 2020 totaled $470.7 million.  Indefinite lived intangible assets at September&#160;30, 2020 were $11.3 million.  Goodwill and Indefinite Lived Intangibles are recorded as a result of business combinations. When we determine the carrying value of reporting unit exceeds its fair value an impairment charge would be recognized and should not exceed the total amount of goodwill allocated to that reporting unit.  We tested goodwill and indefinite lived intangibles for impairment on October 1, 2019, noting no impairment.  In addition to the annual impairment test, we regularly assess if an event has occurred which would require interim impairment testing.  We considered the current and expected future economic and market conditions surrounding the novel strain of coronavirus ("COVID-19") pandemic and did not identify an indication of goodwill impairment being more likely than not through September&#160;30, 2020.  Activity in goodwill for the nine months ended September&#160;30, 2020 is provided below (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;441,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired through the acquisition of Olney Open MRI, LLC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired through the acquisition of MRI at Woodbridge, LLC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired through the acquisition of DeepHealth, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired through the acquisition of AZ-Tech Radiology &amp;amp; Open MRI, LLC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;470,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;INCOME TAXES -  Income tax expense is computed using an asset and liability method and using expected annual effective tax rates. Under this method, deferred income tax assets and liabilities result from temporary differences in the financial reporting bases and the income tax reporting bases of assets and liabilities. The measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefit that, based on available evidence, is not expected to be realized. When it appears more likely than not that deferred taxes will not be realized, a valuation allowance is recorded to reduce the deferred tax asset to its estimated realizable value. For net deferred tax assets we consider estimates of future taxable income in determining whether our net deferred tax assets are more likely than not to be realized. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recorded an income tax expense of $3.8 million, or an effective tax rate of 27.2%, for the three months ended September 30, 2020 compared to an income tax expense of $1.8 million, or an effective tax rate of 26.3% for the three months ended September 30, 2019. We recorded an income tax benefit of $5.0 million, or an effective tax rate of 28.3%, for the nine months ended September 30, 2020 compared to an income tax expense of $3.6 million , or an effective tax rate of 24.8% for the nine months ended September 30, 2019.The income tax rates for the three and nine months ended September&#160;30, 2020 diverge from the federal statutory rate due to (i) noncontrolling interests due to the controlled partnerships; (ii) effects of state income taxes; and (iii) excess tax benefits attributable to share-based compensation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We believe no significant changes in the unrecognized tax benefits will occur within the next 12 months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 27, 2020, the President of the United States signed into law the Coronavirus Aid, Relief, and Economic Security Act ("CARES Act"). The CARES Act, among other things, includes certain income tax provisions for individuals and corporations; however, these benefits do not impact the Company&#x2019;s current tax provision.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;LEASES - We determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (&#x201c;ROU&#x201d;) assets, current operating lease liabilities, and long term operating lease liability in our consolidated balance sheets. Finance leases are included in property and equipment, current finance lease liability, and long-term finance lease liability in our consolidated balance sheets.&#160;&#160;ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. We use the implicit rate when readily determinable.  We include options to extend a lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term.  For a contract in which we are a lessee that contains fixed &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;payments for both lease and non-lease components, we have elected to account for the components as a single lease component, as permitted. For finance leases, interest expense on the lease liability is recognized using the effective interest method and amortization of the ROU asset is recognized on a straight-line basis over the shorter of the estimated useful life of the asset or the lease term.  &lt;/span&gt;&lt;span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ROU assets are&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; tested for impairment if circumstances suggest that the carrying amount may not be recoverable.  Our ROU assets consist of facility and equipment assets on operating leases.  No events have occurred such as fire, flood, or other acts which have impaired the integrity of our ROU assets in 2020.  Our facility leases require us to maintain insurance policies which would cover major damage to our facilities.  We maintain business interruption insurance to cover loss of business due to a facility becoming non-operational under certain circumstances.  Our equipment leases are covered by warranty and service contracts which cover repairs and provide regular maintenance to keep the equipment in functioning order.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;EQUITY BASED COMPENSATION &#x2013; We have one long-term incentive plan that we adopted in 2006 and which we first amended and restated as of April 20, 2015, and again on March 9, 2017 (the &#x201c;Restated Plan&#x201d;). The Restated Plan was approved by our stockholders at our annual stockholders meeting on June 8, 2017. We have reserved 14,000,000 shares of common stock for issuance under the Restated Plan which can be issued in the form of options, stock awards, stock appreciation rights, stock units, and cash awards.  Stock options generally vest over &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMTY2Mzg_7bbe4cad-8aac-4d51-9911-a759df597876"&gt;three&lt;/span&gt; to five years and expire &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMTY2NTg_8014eae6-0e25-46ab-80ed-ec3b42b893fd"&gt;five&lt;/span&gt; to ten years from date of grant.  We determine the compensation expense for each stock option award using the Black Scholes, or similar valuation model.  Those models require that our management make certain estimates concerning risk free interest rates and volatility in the trading price of our common stock. The compensation expense recognized for all equity-based awards is recognized over the awards&#x2019; service periods. Equity-based compensation is classified in operating expenses within the same line item as the majority of the cash compensation paid to employees.  In connection with our acquisition of DeepHealth Inc. on June 1, 2020, we assumed the DeepHealth, Inc. 2017 Stock Incentive Plan, including outstanding options awards that can be exercised for our common stock.  No additional awards will be granted under the DeepHealth, Inc. 2017 Equity Incentive Plan.  See Note 4, Facility Acquisitions and Note 6, Stock-Based Compensation, for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;COMPREHENSIVE INCOME (LOSS) - ASC 220 establishes rules for reporting and displaying comprehensive income or loss and its components. Our unrealized gains or losses on foreign currency translation adjustments, interest rate cap and swap agreements are included in comprehensive loss and are included in the consolidated statements of comprehensive income (loss) for the three and nine months ended September&#160;30, 2020 and 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;COMMITMENTS AND CONTINGENCIES - We are party to various legal proceedings, claims, and regulatory, tax or government inquiries and investigations that arise in the ordinary course of business. With respect to these matters, we evaluate the developments on a regular basis and accrue a liability when we believe a loss is probable and the amount can be reasonably estimated. Based on current information, we do not believe that reasonably possible or probable losses associated with pending legal proceedings would either individually or in the aggregate, have a material adverse effect on our business and consolidated financial statements. However, the outcome of these matters is inherently uncertain. Therefore, if one or more of these matters were resolved against us for amounts in excess of management's expectations, our results of operations and financial condition, including in a particular reporting period in which any such outcome becomes probable and estimable, could be materially adversely affected.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;DERIVATIVE INSTRUMENTS&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2016 CAPS&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the fourth quarter of 2016, we entered into two forward interest rate cap agreements ("2016 Caps"). The 2016 Caps will mature in September and October 2020. The 2016 Caps had notional amounts of $150,000,000 and $350,000,000, respectively. Under these arrangements, the Company purchased a cap on 3 month LIBOR at 2.0%. We incurred a $5.3 million premium to enter into the 2016 Caps which is being accrued over the life of the agreements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At inception, we designated our 2016 Caps as cash flow hedges of floating-rate borrowings. In accordance with accounting guidance, derivatives that have been designated and qualify as cash flow hedging instruments are reported at fair value. The gain or loss of the hedge (i.e. change in fair value) is reported as a component of comprehensive loss in the consolidated statement of equity since such hedge has been determined to be effective.  See Fair Value Measurements section below for the fair value of the 2016 Caps at September&#160;30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive loss of the 2016 Caps is as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.512%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.108%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the three months ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Account&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;July 1, 2020 Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of comprehensive gain recognized on derivative net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020 Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated Other Comprehensive Loss, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,409)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,214)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities and Equity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.512%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.108%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the nine months ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Account&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 1, 2020 Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of comprehensive gain recognized on derivative net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020 Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated Other Comprehensive Loss, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,877)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,214)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities and Equity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2019 SWAPS&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the second quarter of 2019, we entered into four forward interest rate agreements ("2019 Swaps").  The 2019 Swaps have total notional amounts of $500,000,000, consisting of two agreements of $50,000,000 each and two agreements of  $200,000,000 each.   The 2019 Swaps will secure a constant interest rate associated with portions of our variable rate bank debt and have an effective date of October 13, 2020. They will mature in October 2023 for the smaller notional and October 2025 for the larger notional. Under these arrangements, we arranged the 2019 Swaps with locked in 1 month LIBOR rates at 1.96% for the $100,000,000 notional and at 2.05%  for the $400,000,000 notional.  As of the effective date, we will be liable for premium payments if interest rates decline below arranged rates, but will receive interest payments if rates remain above the arranged rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At inception, we designated our 2019 Swaps as cash flow hedges of floating-rate borrowings. In accordance with accounting guidance, derivatives that have been designated and qualify as cash flow hedging instruments are reported at fair value. The gain or loss on the effective portion of the hedge (i.e. change in fair value) is reported as a component of comprehensive loss in the consolidated statement of equity.  The remaining gain or loss, if any, is recognized currently in earnings.  As a result of the economic impact of the coronavirus pandemic, which precipitated a reduction in interest rates , the cash flows for both our $400,000,000 notional interest rate swap contract locked in at 2.05% due October 2025 and our $100,000,000 notional interest rate swap contract locked in at 1.96% do not match the cash flows for our First Lien Term Loans and so we have determined that they are not currently effective as cash flow hedges. Accordingly, all changes in their fair value after April 1, 2020 for the $400,000,000 notional and after July 1, 2020 for the $100,000,000 notional will be recognized in earnings.&#160;As of July 1, 2020, the total change in fair value relating to swaps included in other comprehensive income was approximately $24.4 million, net of taxes.  This amount will be amortized to interest expense through October 2025 at approximately $0.4 million per month.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive loss of the 2019 swaps which remain ineffective is as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.660%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.229%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.217%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.528%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.528%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the three months ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Account&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;July 1, 2020 Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of comprehensive loss recognized on derivative net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of loss reclassified out of accumulated OCI into income (prior period effective portion), net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020 Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated Other Comprehensive Loss, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,406)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,437)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities and Equity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.052%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.886%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.561%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.561%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.561%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.561%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.561%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the nine months ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Account&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 1, 2020 Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of comprehensive loss recognized on derivative net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of loss reclassified out of accumulated OCI into income (prior period effective portion), net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020 Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated Other Comprehensive Loss, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,870)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,428)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,437)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities and Equity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A tabular presentation of the effect of derivative instruments on our statement of operations of the 2019 Swaps for the Swaps that became ineffective during the third quarter is as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.345%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.027%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.109%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.109%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.109%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.114%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the three months ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Ineffective interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of loss recognized in income on derivative (current period ineffective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of  loss recognized in Income on derivative (current period ineffective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of loss reclassified from accumulated OCI into income (prior period effective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of gain (Loss) reclassified from accumulated OCI into income (prior period effective portion)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(679)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income (expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,312)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity and Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.345%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.027%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.109%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.109%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.109%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.114%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the nine months ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Ineffective interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of loss recognized in income on derivative (current period ineffective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of  loss recognized in Income on derivative (current period ineffective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of loss reclassified from accumulated OCI into income (prior period effective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of gain (Loss) reclassified from accumulated OCI into income (prior period effective portion)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,523)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income (expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,204)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity and Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:40.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Fair Value Measurements section below for the fair value of the 2016 caps and 2019 swaps at September&#160;30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;FAIR VALUE MEASUREMENTS &#x2013; Assets and liabilities subject to fair value measurements are required to be disclosed within a fair value hierarchy. The fair value hierarchy ranks the quality and reliability of inputs used to determine fair value. Accordingly, assets and liabilities carried at, or permitted to be carried at, fair value are classified within the fair value hierarchy in one of the following categories based on the lowest level input that is significant to a fair value measurement:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;1&#x2014;Fair value is determined by using unadjusted quoted prices that are available in active markets for identical assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;2&#x2014;Fair value is determined by using inputs other than Level&#160;1 quoted prices that are directly or indirectly observable. Inputs can include quoted prices for similar assets and liabilities in active markets or quoted prices for identical assets and liabilities in inactive markets. Related inputs can also include those used in valuation or other pricing models such as interest rates and yield curves that can be corroborated by observable market data.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;3&#x2014;Fair value is determined by using inputs that are unobservable and not corroborated by market data. Use of these inputs involves significant and subjective judgment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Derivatives:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tables below summarize the estimated fair values of certain of our financial assets that are subject to fair value measurements, and the classification of these assets on our condensed consolidated balance sheets, as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current and long term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2016 caps - Interest Rate Contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 swaps - Interest Rate Contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current and long term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2016 caps - Interest Rate Contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 swaps - Interest Rate Contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of these contracts was determined using Level 2 inputs. More specifically, the fair value was determined by calculating the value of the difference between the fixed interest rate of the interest rate swaps and the counterparty&#x2019;s forward LIBOR curve. The forward LIBOR curve is readily available in the public markets or can be derived from information available in the public markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Long Term Debt:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the estimated fair value compared to our face value of our long-term debt as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.225%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.651%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Face Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;First Lien Term Loans and SunTrust Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;663,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;663,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;673,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.225%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.651%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Face Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;First Lien Term Loans and SunTrust Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;708,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;708,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2020 and at December&#160;31, 2019 our Barclays revolving credit facility had no balance outstanding. Our SunTrust revolving credit facility relating to our consolidated subsidiary NJIN, had no principal amount outstanding at September&#160;30, 2020 and at December&#160;31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of our long-term debt, which is discussed in Note 5, was determined using Level 2 inputs primarily related to comparable market prices.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We consider the carrying amounts of cash and cash equivalents, receivables, other current assets, current liabilities and other notes payables to approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization or payment. Additionally, we consider the carrying amount of our finance lease obligations to approximate their fair value because the weighted average interest rate used to formulate the carrying amounts approximates current market rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;EARNINGS PER SHARE - Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.538%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.175%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.541%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.175%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.541%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.175%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.541%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.182%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" rowspan="2" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) attributable to RadNet, Inc.'s common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,797)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares outstanding during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,358,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,807,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,746,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,597,138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic net income (loss) per share attributable to RadNet, Inc.'s common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares outstanding during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,358,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,807,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,746,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,597,138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add nonvested restricted stock subject only to service vesting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add additional shares issuable upon exercise of stock options and warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;476,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;324,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares used in calculating diluted net income per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,955,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,360,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,746,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,113,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted net income (loss) per share attributable to RadNet, Inc.'s common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and non vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested restricted stock subject to service vesting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;331,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares issuable upon the exercise of stock options:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;933,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;EQUITY INVESTMENTS AT FAIR VALUE&#x2013;Accounting guidance requires entities to measure equity investments at fair value, with any changes in fair value recognized in net income. If there is no readily determinable fair value, the guidance allows entities the ability to measure investments at cost, adjusted for observable price changes and impairments, with changes recognized in net income. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2020, we have three equity investments for which a fair value is not readily determinable and therefore the total amounts invested are recognized at cost as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medic Vision Imaging Solutions Ltd., based in Israel, specializes in software packages that provide compliant radiation dose structured reporting and enhanced images from reduced dose CT scans.  On March 24, 2017, we acquired an initial 12.5% equity interest in Medic Vision for $1.0 million. We also received an option to exercise warrants to acquire up to an additional 12.5% equity interest for $1.4 million within one year from the initial share purchase date, if exercised in full. On March 1, 2018 we exercised our warrant in part and acquired an additional 1.96% for $0.2 million. Our initial equity interest has been diluted to 12.25% and our total equity investment stands at 14.21%.  In accordance with accounting guidance&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; as we exercise no significant influence over Medic Vision&#x2019;s operations, the investment is recorded at its cost of $1.2 million, given that the fair value is not readily determinable. No observable price changes or impairment in our investment was identified as of September&#160;30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Turner Imaging Systems, based in Utah, develops and markets portable X-ray imaging systems that provide a user the ability to acquire X-ray images wherever and whenever they are needed. On February 1, 2018, we purchased 2.1 million preferred shares in Turner Imaging Systems for $2.0 million. On January 1, 2019 we funded a convertible promissory note in the amount of $0.1 million that converted to additional 80,000 shares December 21, 2019.  No observable price changes impairment in our investment was identified as of September&#160;30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;WhiteRabbit.ai Inc., based in California, is currently developing an artificial intelligence suite which aims to improve the speed and accuracy of cancer detection in radiology and improve patient care. On November 5, 2019 we acquired an equity interest in the company for $1.0 million and also loaned the company $2.5 million, the principal of which is due November 2022.  To leverage their artificial intelligence expertise, we entered into a software subscription service contract to assist our radiology work flow and advanced them $4.0 million for future software subscription fees that is recorded as a prepaid expense in Prepaid and Other Current assets in our consolidated balance sheets.  No observable price changes or impairment in our investment or the loan receivable was identified as of September&#160;30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;INVESTMENT IN JOINT VENTURES &#x2013; We have &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; unconsolidated joint ventures with ownership interests ranging from 35% to 55%. These joint ventures represent partnerships with hospitals, health systems or radiology practices and were formed for the purpose of owning and operating diagnostic imaging centers. Professional services at the joint venture diagnostic imaging centers are performed by contracted radiology practices or a radiology practice that participates in the joint venture.&#160;Our investment in these joint ventures is accounted for under the equity method, since RadNet does not have a controlling financial interest in such ventures. We evaluate our investment in joint ventures, including cost in excess of book value (equity method goodwill) for impairment whenever indicators of impairment exist. No indicators of impairment existed as of September&#160;30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Joint venture investment contribution&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the month of August 2020, we made additional cash contributions to our Santa Monica Imaging Group, LLC partnership in the amount of $1.6 million in support of its expanded operations.  We maintain our 35% economic interest in the partnership.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Joint venture investment and financial information&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of our investment in joint ventures during the nine months ended September 30, 2020 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity in earnings in these joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distribution of earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,706)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity contributions in existing joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We charged management service fees from the centers underlying these joint ventures of approximately $2.7 million and $1.8 million for the three months ended September&#160;30, 2020 and 2019, respectively, and $8.6 million and $7.8 million for the nine months ended September&#160;30, 2020 and 2019, respectively.  We eliminate any unrealized portion of our management service fees with our equity in earnings of joint ventures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of key balance sheet data for these joint ventures as of September&#160;30, 2020 and December&#160;31, 2019 and income statement data for the nine months ended September 30, 2020 and 2019 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance Sheet Data:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,487)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,217)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,751)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,872)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Book value of RadNet joint venture interests&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost in excess of book value of acquired joint venture interests and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total value of Radnet joint venture interests&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total book value of other joint venture partner interests&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income statement data for the nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:RevenueRecognitionPolicyTextBlock
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMzAwODQ_11573ce6-265f-479f-908e-c25cfa3f4dce">REVENUES  - Our revenues generally relate to net patient fees&#160;received from various payors and patients themselves under contracts in which our performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period when our obligations to provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payor (Medicare, Medicaid, managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed care health plans and commercial insurance companies) the third-party payors. The payment arrangements with third-party payors for the services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As it relates to the Group, this service fee revenue includes payments for both the professional medical interpretation revenue recognized by them as well as the payment for all other aspects related to our providing the imaging services, for which we earn management fees. As it relates to others centers, this service fee revenue is earned through providing the use of our diagnostic imaging equipment and the provision of technical services as well as providing administration services such as clerical and administrative personnel, bookkeeping and accounting services, billing and collection, provision of medical and office supplies, secretarial, reception and transcription services, maintenance of medical records, and advertising, marketing and promotional activities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our revenues are based upon the estimated amounts we expect to be entitled to receive from patients and third-party payors. Estimates of contractual allowances under managed care and commercial insurance plans are based upon the payment terms specified in the related contractual agreements. Revenues related to uninsured patients and copayment and deductible amounts for patients who have health care coverage may have discounts applied (uninsured discounts and contractual discounts). We also record estimated implicit price concessions (based primarily on historical collection experience) related to uninsured accounts to record self-pay revenues at the estimated amounts we expect to collect.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under capitation arrangements with various health plans, we earn a per-enrollee amount each month for making available diagnostic imaging services to all plan enrollees under the capitation arrangement. Revenue under capitation arrangements is recognized in the period in which we are obligated to provide services to plan enrollees under contracts with various health plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our total service revenues during the three and nine  months ended September&#160;30, 2020 and 2019 are presented in the table below based on an allocation of the estimated transaction price with the patient between the primary patient classification of insurance coverage (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.830%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.734%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.734%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.734%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.738%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial insurance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;412,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;475,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Workers' compensation/personal injury&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other patient revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Management fee revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Teleradiology and Software revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service fee revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;261,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;660,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;762,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue under capitation arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total service revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;763,905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;853,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;COVID-19 PANDEMIC AND CARES ACT FUNDING -  On March 11, 2020 the World Health Organization (WHO) designated COVID-19 as a global pandemic.  Patient volumes and the related revenues for our services were significantly impacted during the latter portion of the first quarter through the middle of the third quarter of 2020 as a result of federal, state and local government mandated restrictions requiring many people to remain at home and forced the closure of or limitations on certain businesses, as well as suspended elective procedures by health care facilities.  Many of these restrictions have been eased or completely lifted across the states the Company operates in however, we are unable to predict the future impact of the pandemic on our operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;During the nine months ended September 30, 2020, we received $39.4 million of accelerated Medicare payments, $5.0 million from Blue Cross, $25.7 million from the general distribution and $4.0 million from the Paycheck Protection Program established through the Coronavirus Aid, Relief and Economic Security (&#x201c;CARES&#x201d;) Act.  The accelerated Medicare payments are recorded under the caption &#x201c; Deferred Revenue&#x201c;  in our condensed consolidated balance sheet and will be repaid beginning in 2021.  The general distribution funds were accounted for as government grants and recognized as other revenue, once reasonable assurance that the applicable terms and conditions required to retain the funds were met, under the caption &#x201c;Provider relief funding&#x201d; in our condensed Consolidated Statements of Operations&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;During the three months ended September 30, 2020, the Department of Health and Human Services significantly changed the measurement of Provider Relief Funds that providers are able to retain.  We received approximately $0.2 million in &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;funding and based on our assessment of the likelihood of meeting the applicable terms and conditions of the general distribution we continue to recognized the funds received as other revenue.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The CARES Act also providers for a payment deferral of the employer portion of Social Security tax incurred during the pandemic, allowing half of such payroll taxes to be deferred until December 2021 and the remaining half until December 2022.  At September 30, 2020, the Company had deferred $10.8 million of Social Security taxes.  These payment deferrals are recorded as payroll tax liability under the caption &#x201c;Accounts payable, accrued expenses and other&#x201d; in our condensed consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;We believe the extent of the COVID-19 pandemic&#x2019;s impact on our operating results and financial condition has been and will continue to be driven by many factors, most of which are beyond our control and ability to forecast.  Such factors include, but are not limited to, the scope and duration of stay-at-home practices, business closures  and restrictions, suspensions of elective procedures and continued decline in procedure volumes for an indeterminable length of time and incremental expenses required for supplies and personal protective equipment.  Because of these uncertainties, we cannot estimate the length or impact of the pandemic on our business.  If we incur declines in cash flows and results of operations, such declines could have an impact on the inputs and assumptions used in significant accounting estimates, including implicit prices concessions related to uninsured patient  accounts, and potential impairment of goodwill and long-lived assets.  During the third quarter of 2020, procedure volumes increased and have had a positive impact on our patient revenue.  However, the impact of COVID-19 in future periods may vary and could adversely impact our results of operations.</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:ScheduleOfPrincipalTransactionsRevenueTextBlock
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMzAwNjU_23b2d368-6b72-46b9-8089-3dfd347431ab">&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our total service revenues during the three and nine  months ended September&#160;30, 2020 and 2019 are presented in the table below based on an allocation of the estimated transaction price with the patient between the primary patient classification of insurance coverage (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.830%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.734%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.734%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.734%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.738%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial insurance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;412,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;475,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Workers' compensation/personal injury&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other patient revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Management fee revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Teleradiology and Software revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service fee revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;261,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;660,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;762,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue under capitation arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total service revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;763,905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;853,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfPrincipalTransactionsRevenueTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i24364a0cec3f4ac4a7f4537560711888_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfMi0xLTEtMS0w_749345bf-7d95-499b-aea6-8acaa922c565"
      unitRef="usd">160524000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if8be3197ba81441aab9f7bdfa36dd45b_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfMi0zLTEtMS0w_06bad616-2c34-4064-a06f-706baec605a7"
      unitRef="usd">163152000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic05adfe570c7418c8583caa2e3756087_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfMi01LTEtMS0w_18439939-65c7-4a1b-a473-90b8c40d6960"
      unitRef="usd">412415000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if079f62201f649a19398e263e6bb723c_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfMi03LTEtMS0w_43fb14e2-5876-4595-9070-e0e115d05dca"
      unitRef="usd">475064000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic506a388c6254f67851aedb7d7e51a7c_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfMy0xLTEtMS0w_00186e8a-3278-4742-ab2e-c2a8a962cdbd"
      unitRef="usd">62704000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9d59877f74b84a14b84be572617b45e4_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfMy0zLTEtMS0w_9c060b45-cb81-4468-bcb2-7ebc4ea47410"
      unitRef="usd">61599000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaa7ae55f8352482ab21ec0d1d7641820_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfMy01LTEtMS0w_b58bd8e1-59fd-463f-aeb4-7d0b11ee2246"
      unitRef="usd">154847000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i82a5ccc725d2482e9b6e4b8be5a837c2_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfMy03LTEtMS0w_2d308bf0-d610-432e-b94e-51b911dbbd60"
      unitRef="usd">175825000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id2804457ff9c4979ab5dea362493dfa8_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfNC0xLTEtMS0w_81e11255-bb43-4de0-b687-eb6471b35d2c"
      unitRef="usd">7098000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibbd32a5208b04ee3af351b7e413a9606_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfNC0zLTEtMS0w_01d363a8-8487-4ac6-908a-5009b06523ed"
      unitRef="usd">7128000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icb0bcbdd5fb649f5a3eba1e57ea2bbdb_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfNC01LTEtMS0w_5784b2b8-be85-4285-8e0a-42823a34850e"
      unitRef="usd">18072000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i510758bcd5d0485a8ea0f178b65d230b_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfNC03LTEtMS0w_e05f593e-4c53-44ad-9f6e-b8079265ba1e"
      unitRef="usd">21564000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic1ccd693101546e9948d833ef3206f25_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfNS0xLTEtMS0w_354f24c2-e3ea-414c-9a16-e70afda953eb"
      unitRef="usd">7183000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6fc9ace2676a462f9ebb5cde7964d542_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfNS0zLTEtMS0w_5c28aaee-57db-4559-b4d2-dd8ace51c6ec"
      unitRef="usd">10865000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia51cd72af487490cb9a1c49464f21473_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfNS01LTEtMS0w_f6e5c1bc-e72e-4dbb-839b-b37ff97e4b2d"
      unitRef="usd">25705000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3f5a0223f69441b2ac8a10d4c658efa4_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfNS03LTEtMS0w_bb2b0ba3-1b5d-4afe-8e86-e3e2f6ad712b"
      unitRef="usd">32950000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i959dcd70aa414905a86891687e922d26_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfNi0xLTEtMS0w_868ce93b-09d6-41fa-88a9-b926ad13690d"
      unitRef="usd">8328000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i36a7f7a656c54a7a93f09e843a05e4dc_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfNi0zLTEtMS0w_e4bb6cc2-eb77-448c-b200-5d4acb4071bb"
      unitRef="usd">6085000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1f798c18497b4449804b907ac22474ac_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfNi01LTEtMS0w_a07cd7c3-debe-44d3-80d4-cdb57f46a104"
      unitRef="usd">17211000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1d5a8b020d4846f2be96b5b9d725d28a_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfNi03LTEtMS0w_4c6ac13d-7cd3-45be-b38c-620d87280dd0"
      unitRef="usd">17947000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2de4a1d7e34f4c979e8ee54471682d8a_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfNy0xLTEtMS0w_9b77ca64-667e-4b46-9cce-6404c2830fa6"
      unitRef="usd">2675000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i467bef824abe4dc791d4fb7875ad8839_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfNy0zLTEtMS0w_676d0506-b5a1-4533-bf2b-b25f3711de6e"
      unitRef="usd">1792000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib0daed54cf994635a1e3a709aa285693_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfNy01LTEtMS0w_53c4f0e4-37c3-4aaa-b31a-95568daacf9c"
      unitRef="usd">8574000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id54012c7cfa84d7182be4c74e1c06f71_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfNy03LTEtMS0w_b26224cb-b814-4987-8561-978c16369afb"
      unitRef="usd">5662000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i35e7f0afe7a540a99ebbf34af2e3756a_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfOC0xLTEtMS0w_7295d326-351a-4dbb-b628-f30e947264b8"
      unitRef="usd">2349000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i63e61bbfa0be4d13b84f9d661bb940ba_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfOC0zLTEtMS0w_1be2b034-3f8a-4d7e-b8cd-1a056eb6f0a5"
      unitRef="usd">4412000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9c1f6bb93c3c4ac6aba73e2eb120728c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfOC01LTEtMS0w_c2f75451-6d1d-4809-a09b-df2e331c6a75"
      unitRef="usd">8319000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i521d126ad2134cb19713cd8598e5062b_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfOC03LTEtMS0w_6a1b7f73-8c15-4c2b-8b68-06dc07fbc23b"
      unitRef="usd">12861000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6d60555cdf4c455083bcb664a31aa0e9_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfOS0xLTEtMS0w_f32baa9e-015d-4fad-a19d-a4c72db0fd54"
      unitRef="usd">5869000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4b1f63bb36be4d77bc8acab605869faa_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfOS0zLTEtMS0w_f650691f-b29c-41fe-9f80-8b4a0c03eb9d"
      unitRef="usd">6875000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5744e3fc1fd54fb286b8e45bdced2585_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfOS01LTEtMS0w_b6612280-7a84-48b2-b0fe-8de09a93c80a"
      unitRef="usd">15617000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1d13380e9b574e229bc4acfa7bd99b00_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfOS03LTEtMS0w_593f170e-4d0a-4e01-b56e-0144e03a6942"
      unitRef="usd">20878000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4a9fe0209e954a06aca8cad30d601c73_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfMTAtMS0xLTEtMA_0b5d3e1b-c9b7-4d92-a5d1-9b8af6627503"
      unitRef="usd">256730000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia0096f14793b40c99c3a08b6a4ac8010_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfMTAtMy0xLTEtMA_9124e623-3d9b-43ae-8298-e67a0ebe2657"
      unitRef="usd">261908000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibe98f272e55f41dd878edf32fc7653a3_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfMTAtNS0xLTEtMA_8dd1f625-6a66-48aa-ac9b-5abe5f2337f8"
      unitRef="usd">660760000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0ee478ac62b2402380d60e1df30d2970_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfMTAtNy0xLTEtMA_9c47e0b1-d897-47b2-8bda-5951a9bf6e85"
      unitRef="usd">762751000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i058de6765e1e47449153067fb1e94bc6_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfMTEtMS0xLTEtMA_e10a3c08-ed64-44a2-95c4-17f3407a8498"
      unitRef="usd">35046000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia03c585e05f349bd894ed447f40ca3fc_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfMTEtMy0xLTEtMA_b995b6c3-6720-4e76-b2e0-94bfe3ca29da"
      unitRef="usd">30784000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ife4b7517ca2542439322f6bb062453a3_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfMTEtNS0xLTEtMA_241d695d-b60a-4a96-b0b6-27a3f085518c"
      unitRef="usd">103145000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i202db1f71dbd487f9b8bf67552d7ead3_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfMTEtNy0xLTEtMA_0e3d3a2a-b982-4fdf-981a-a738ae168e51"
      unitRef="usd">90587000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:Revenues
      contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfMTItMS0xLTEtMA_2bb274c8-fbc6-4919-955e-67c2ce85f0e8"
      unitRef="usd">291776000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfMTItMy0xLTEtMA_a27114fd-b589-4940-b312-f589c19b731e"
      unitRef="usd">292692000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfMTItNS0xLTEtMA_1ddef44d-b899-4a20-abe6-169c94fa18c8"
      unitRef="usd">763905000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjkyNzVlZDliYzY5MjRlNDg5Mzk0MjRiNmJiNjJiNWQyL3RhYmxlcmFuZ2U6OTI3NWVkOWJjNjkyNGU0ODkzOTQyNGI2YmI2MmI1ZDJfMTItNy0xLTEtMA_a74153ef-f5aa-44e8-b7fa-8da39f00e23e"
      unitRef="usd">853338000</us-gaap:Revenues>
    <rdnt:AdvanceMedicarePayments
      contextRef="i1da458a1f30e42a280a85b687626d8c9_D20200401-20200430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjE5OTAyMzMwNDIwOA_85b786b1-cb4a-4fa7-8946-fb06e62daf36"
      unitRef="usd">39400000</rdnt:AdvanceMedicarePayments>
    <rdnt:ProceedsReceivedFromInsurance
      contextRef="i9f412c4a4bc94dc6bdf4cf62ede09d62_D20200501-20200531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjE5OTAyMzMwNDI1MQ_71b5e3f7-772d-40ab-9513-05f6981cc8fa"
      unitRef="usd">5000000.0</rdnt:ProceedsReceivedFromInsurance>
    <us-gaap:RevenueNotFromContractWithCustomer
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjE5OTAyMzMwNDI4OQ_35ca4f68-1233-4a41-b0ec-d35d0df2f243"
      unitRef="usd">25700000</us-gaap:RevenueNotFromContractWithCustomer>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="icd0727e676b44495b92424a21cfd803d_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjE5OTAyMzMwNDMwNw_bf55d90a-c502-4cbb-92d8-f316a5a03cc4"
      unitRef="usd">4000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:RevenueNotFromContractWithCustomer
      contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjE5OTAyMzMwNDEzNg_309274a4-e247-4d98-9fad-4dc5b4cd15db"
      unitRef="usd">200000</us-gaap:RevenueNotFromContractWithCustomer>
    <rdnt:SocialSecurityTaxEmployerDeferralCARESAct
      contextRef="i03664eb4b82e43e8b82d1e6f730f020d_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjE5OTAyMzMwNzg3NA_6202d977-6f82-4041-a214-4771fc90d7ba"
      unitRef="usd">10800000</rdnt:SocialSecurityTaxEmployerDeferralCARESAct>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMzAwODU_cc51f6f4-6cdc-4bcb-ba3b-ddce8f4b4348">RECLASSIFICATION &#x2013;We have reclassified certain amounts previously classified as held for sale related to property and equipment and goodwill to conform to our 2020 presentation.</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:ReceivablesPolicyTextBlock
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMzAxMDE_d44661a5-3283-4079-926d-115d200d2776">ACCOUNTS RECEIVABLE - Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. Services are generally provided pursuant to one-year contracts with healthcare providers. We continuously monitor collections from our payors and maintain an allowance for bad debts based upon specific payor collection issues that we have identified and our historical experience.  In regards to the credit loss standard, we have concluded that the historical credit loss experienced across our receivable portfolio is materially similar to any current expected credit losses estimated under the Current Expected Credit Loss ("CECL") model.</us-gaap:ReceivablesPolicyTextBlock>
    <rdnt:ContractsReceivableFactoringReceivable
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfNzAyMQ_11e74568-dfd1-43ef-aac9-4297568e9bc9"
      unitRef="usd">20400000</rdnt:ContractsReceivableFactoringReceivable>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMzAwNzA_4b25cc81-d691-4a3c-ab56-6b471dea3823">DEFERRED REVENUE - As noted above, in April of 2020, we received approximately $39.4 million in advanced Medicare payments from the Centers for Medicare and Medicaid Services ("CMS") as part of the expanded Accelerated and Advance Payment Program under the Coronavirus Aid, Relief, and Economic Security (CARES) Act.  As these payments are required to be repaid to CMS beginning 120 days after their receipt through offsets from new Medicare claims over a three month period, we have recorded amounts received to deferred revenue which will be amortized as Medicare reimbursements are earned.  In addition, in May of 2020 we received $5.0 million in advance payments from an insurance carrier with similar repayment terms as the CMS.</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <rdnt:AdvanceMedicarePayments
      contextRef="i1da458a1f30e42a280a85b687626d8c9_D20200401-20200430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfNzk4MQ_85b786b1-cb4a-4fa7-8946-fb06e62daf36"
      unitRef="usd">39400000</rdnt:AdvanceMedicarePayments>
    <rdnt:ProceedsReceivedFromInsurance
      contextRef="i9f412c4a4bc94dc6bdf4cf62ede09d62_D20200501-20200531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfODUyNg_71b5e3f7-772d-40ab-9513-05f6981cc8fa"
      unitRef="usd">5000000.0</rdnt:ProceedsReceivedFromInsurance>
    <us-gaap:DeferredChargesPolicyTextBlock
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMzAwNzg_72b2bd65-42c1-4e95-8075-34c797c1799a">DEFERRED FINANCING COSTS - Costs of financing are deferred and amortized using the effective interest rate method. Deferred financing costs, net of accumulated amortization, were $1.9 million and $1.6 million, as of September&#160;30, 2020 and December&#160;31, 2019, respectively and related to our Barclays line of credit.  See Note 5, Credit Facilities and Notes Payable for more information.</us-gaap:DeferredChargesPolicyTextBlock>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfODc5NQ_33b98e8a-7bea-4b28-9145-9f46addae7bf"
      unitRef="usd">1900000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfODgwMg_37231beb-608c-47fe-a475-f25f20775250"
      unitRef="usd">1600000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMzAxMDM_c89df241-34c9-4dc7-a6f2-0f91e0ada578">PROPERTY AND EQUIPMENT - Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation of property and equipment is performed using the straight-line method over the estimated useful lives of the assets acquired, which range from 3 to 15 years. Leasehold improvements are amortized at the lesser of lease term or their estimated useful lives, which range from 3 to 15 years. Maintenance and repairs are charged to expense as incurred.</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ie19ca44258f54d33b5e7d6546bae1a8d_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfOTQyNQ_f5244de6-4f32-475f-b398-51fe7bd729b0">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i1e5c92bdeee343cfa400ee011058ca0f_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfOTQzMQ_8c097f2c-e7b2-42e7-bceb-543452c8b2bd">P15Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i9851e7fbb9b4406b9d2a6222679efb4d_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfOTU1MA_dbea741d-fefa-4a71-b189-6b4eac46edfb">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ie6887d928dca440bbe9351ea5442a009_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfOTU1Ng_484faceb-8f08-4f5a-b261-4ee53dbb4fe8">P15Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:BusinessCombinationsPolicy
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMzAxMTQ_3dd52393-e9e6-4fb4-9988-1274e33ea264">BUSINESS COMBINATION  -  When the qualifications for business combination accounting treatment are met, it requires us to recognize separately from goodwill the assets acquired and the liabilities assumed at their acquisition date fair values. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities assumed. While we use our best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, we record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to our consolidated statements of operations.</us-gaap:BusinessCombinationsPolicy>
    <us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMzAwOTM_1e12bc2a-8228-4767-b071-94a71ef3d3a8">&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;GOODWILL AND INDEFINITE LIVED INTANGIBLES - Goodwill at September&#160;30, 2020 totaled $470.7 million.  Indefinite lived intangible assets at September&#160;30, 2020 were $11.3 million.  Goodwill and Indefinite Lived Intangibles are recorded as a result of business combinations. When we determine the carrying value of reporting unit exceeds its fair value an impairment charge would be recognized and should not exceed the total amount of goodwill allocated to that reporting unit.  We tested goodwill and indefinite lived intangibles for impairment on October 1, 2019, noting no impairment.  In addition to the annual impairment test, we regularly assess if an event has occurred which would require interim impairment testing.  We considered the current and expected future economic and market conditions surrounding the novel strain of coronavirus ("COVID-19") pandemic and did not identify an indication of goodwill impairment being more likely than not through September&#160;30, 2020.  Activity in goodwill for the nine months ended September&#160;30, 2020 is provided below (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;441,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired through the acquisition of Olney Open MRI, LLC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired through the acquisition of MRI at Woodbridge, LLC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired through the acquisition of DeepHealth, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired through the acquisition of AZ-Tech Radiology &amp;amp; Open MRI, LLC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;470,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy>
    <us-gaap:Goodwill
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMTA3Njg_4cc4a8f0-93da-4a6d-96d9-66133c41c18b"
      unitRef="usd">470700000</us-gaap:Goodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMTA4MTk_36aa7966-d02d-40d9-8819-329f2d8bdf4f"
      unitRef="usd">11300000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMzAwNzY_d48c4690-a36f-481e-98ad-e01803b1c5fd">Activity in goodwill for the nine months ended September&#160;30, 2020 is provided below (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;441,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired through the acquisition of Olney Open MRI, LLC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired through the acquisition of MRI at Woodbridge, LLC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired through the acquisition of DeepHealth, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired through the acquisition of AZ-Tech Radiology &amp;amp; Open MRI, LLC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;470,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <us-gaap:Goodwill
      contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjIzNmE0NWEzMDNhYjQwYzA4NWNhZGU4NTZiZTcwM2VkL3RhYmxlcmFuZ2U6MjM2YTQ1YTMwM2FiNDBjMDg1Y2FkZTg1NmJlNzAzZWRfMC0xLTEtMS0w_5c137729-dc6e-4d64-869f-e9ee2febdbde"
      unitRef="usd">441973000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i812d1f3338f848fbb0cae71405a11682_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjIzNmE0NWEzMDNhYjQwYzA4NWNhZGU4NTZiZTcwM2VkL3RhYmxlcmFuZ2U6MjM2YTQ1YTMwM2FiNDBjMDg1Y2FkZTg1NmJlNzAzZWRfMS0xLTEtMS0w_071cec59-9adb-4c9f-aa6a-9e767ecc539e"
      unitRef="usd">601000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i1b47417b06a54e549d7dc88a99fac34c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjIzNmE0NWEzMDNhYjQwYzA4NWNhZGU4NTZiZTcwM2VkL3RhYmxlcmFuZ2U6MjM2YTQ1YTMwM2FiNDBjMDg1Y2FkZTg1NmJlNzAzZWRfMi0xLTEtMS0w_1fb4a4a8-afdf-420b-8456-2f7e980de6ad"
      unitRef="usd">1833000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i7fda9262fb95476a816ecc3cad434f3c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjIzNmE0NWEzMDNhYjQwYzA4NWNhZGU4NTZiZTcwM2VkL3RhYmxlcmFuZ2U6MjM2YTQ1YTMwM2FiNDBjMDg1Y2FkZTg1NmJlNzAzZWRfMy0xLTEtMS0w_f209bc65-4a3d-4c00-9912-e51761164eb1"
      unitRef="usd">23396000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ib71e54b77f294940bda2035bdb641b80_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjIzNmE0NWEzMDNhYjQwYzA4NWNhZGU4NTZiZTcwM2VkL3RhYmxlcmFuZ2U6MjM2YTQ1YTMwM2FiNDBjMDg1Y2FkZTg1NmJlNzAzZWRfNC0xLTEtMS0yNzQ_2c4458fc-7ee6-4136-9b3d-bb5f9d8a760a"
      unitRef="usd">2882000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:Goodwill
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjIzNmE0NWEzMDNhYjQwYzA4NWNhZGU4NTZiZTcwM2VkL3RhYmxlcmFuZ2U6MjM2YTQ1YTMwM2FiNDBjMDg1Y2FkZTg1NmJlNzAzZWRfMTMtMS0xLTEtMA_6e7ca319-6307-4734-9606-f258adfaa846"
      unitRef="usd">470685000</us-gaap:Goodwill>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMzAwOTk_215fb02f-4681-4dad-9087-87e3c80787e5">&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;INCOME TAXES -  Income tax expense is computed using an asset and liability method and using expected annual effective tax rates. Under this method, deferred income tax assets and liabilities result from temporary differences in the financial reporting bases and the income tax reporting bases of assets and liabilities. The measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefit that, based on available evidence, is not expected to be realized. When it appears more likely than not that deferred taxes will not be realized, a valuation allowance is recorded to reduce the deferred tax asset to its estimated realizable value. For net deferred tax assets we consider estimates of future taxable income in determining whether our net deferred tax assets are more likely than not to be realized. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recorded an income tax expense of $3.8 million, or an effective tax rate of 27.2%, for the three months ended September 30, 2020 compared to an income tax expense of $1.8 million, or an effective tax rate of 26.3% for the three months ended September 30, 2019. We recorded an income tax benefit of $5.0 million, or an effective tax rate of 28.3%, for the nine months ended September 30, 2020 compared to an income tax expense of $3.6 million , or an effective tax rate of 24.8% for the nine months ended September 30, 2019.The income tax rates for the three and nine months ended September&#160;30, 2020 diverge from the federal statutory rate due to (i) noncontrolling interests due to the controlled partnerships; (ii) effects of state income taxes; and (iii) excess tax benefits attributable to share-based compensation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We believe no significant changes in the unrecognized tax benefits will occur within the next 12 months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 27, 2020, the President of the United States signed into law the Coronavirus Aid, Relief, and Economic Security Act ("CARES Act"). The CARES Act, among other things, includes certain income tax provisions for individuals and corporations; however, these benefits do not impact the Company&#x2019;s current tax provision.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMTI1NjY_466ef77b-fe20-4f62-8454-f9b457e5f1c4"
      unitRef="usd">3800000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMTI1OTg_17072476-1ebc-4eb2-8b25-7cfcacb90cbb"
      unitRef="number">0.272</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMTI2NTA_eb29a957-8ea0-4597-8450-bce4092fc375"
      unitRef="usd">1800000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMTI2ODI_fadcdb90-5828-4a7c-90e4-46ff75ce2651"
      unitRef="number">0.263</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMTI3MzQ_16f1142b-957d-4638-b215-b77f7eca1653"
      unitRef="usd">-5000000.0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMTI3NjY_c07c2812-4193-49eb-9b19-e11d1b6fc301"
      unitRef="number">0.283</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMTI4MTg_db5ce7ec-adf4-44c6-ad8f-13adb744279b"
      unitRef="usd">3600000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMTI4NTE_70f4546a-8bd1-41f0-ba9a-4f1f03022da1"
      unitRef="number">0.248</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMzAwODY_1ca83f9b-55bb-4845-8a54-901416f9e188">LEASES - We determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (&#x201c;ROU&#x201d;) assets, current operating lease liabilities, and long term operating lease liability in our consolidated balance sheets. Finance leases are included in property and equipment, current finance lease liability, and long-term finance lease liability in our consolidated balance sheets.&#160;&#160;ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. We use the implicit rate when readily determinable.  We include options to extend a lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term.  For a contract in which we are a lessee that contains fixed &lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;payments for both lease and non-lease components, we have elected to account for the components as a single lease component, as permitted. For finance leases, interest expense on the lease liability is recognized using the effective interest method and amortization of the ROU asset is recognized on a straight-line basis over the shorter of the estimated useful life of the asset or the lease term.  &lt;/span&gt;&lt;span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ROU assets are&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; tested for impairment if circumstances suggest that the carrying amount may not be recoverable.  Our ROU assets consist of facility and equipment assets on operating leases.  No events have occurred such as fire, flood, or other acts which have impaired the integrity of our ROU assets in 2020.  Our facility leases require us to maintain insurance policies which would cover major damage to our facilities.  We maintain business interruption insurance to cover loss of business due to a facility becoming non-operational under certain circumstances.  Our equipment leases are covered by warranty and service contracts which cover repairs and provide regular maintenance to keep the equipment in functioning order.&lt;/span&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:CompensationRelatedCostsPolicyTextBlock
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMzAwNjY_21c18807-1d7f-4798-a425-f5f0ee4540e4">EQUITY BASED COMPENSATION &#x2013; We have one long-term incentive plan that we adopted in 2006 and which we first amended and restated as of April 20, 2015, and again on March 9, 2017 (the &#x201c;Restated Plan&#x201d;). The Restated Plan was approved by our stockholders at our annual stockholders meeting on June 8, 2017. We have reserved 14,000,000 shares of common stock for issuance under the Restated Plan which can be issued in the form of options, stock awards, stock appreciation rights, stock units, and cash awards.  Stock options generally vest over &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMTY2Mzg_7bbe4cad-8aac-4d51-9911-a759df597876"&gt;three&lt;/span&gt; to five years and expire &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMTY2NTg_8014eae6-0e25-46ab-80ed-ec3b42b893fd"&gt;five&lt;/span&gt; to ten years from date of grant.  We determine the compensation expense for each stock option award using the Black Scholes, or similar valuation model.  Those models require that our management make certain estimates concerning risk free interest rates and volatility in the trading price of our common stock. The compensation expense recognized for all equity-based awards is recognized over the awards&#x2019; service periods. Equity-based compensation is classified in operating expenses within the same line item as the majority of the cash compensation paid to employees.  In connection with our acquisition of DeepHealth Inc. on June 1, 2020, we assumed the DeepHealth, Inc. 2017 Stock Incentive Plan, including outstanding options awards that can be exercised for our common stock.  No additional awards will be granted under the DeepHealth, Inc. 2017 Equity Incentive Plan.  See Note 4, Facility Acquisitions and Note 6, Stock-Based Compensation, for more information.</us-gaap:CompensationRelatedCostsPolicyTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i027fbe622cb740e796aa36dc1f00b42e_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMTYzMDQ_24016147-e26d-46b8-9ae8-dce3d0958d11"
      unitRef="shares">14000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i73cdb78ce3cb47cf9c32f71cc3b685a7_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMTY2NDQ_e3594fff-204d-4088-8d77-992371e3fe6d">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i73cdb78ce3cb47cf9c32f71cc3b685a7_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMTY2NjQ_bb4d0088-3737-409b-94f6-929ec4dab1c7">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMzAwODc_ce20e728-b3c2-41a7-be62-1655a2d16069">COMPREHENSIVE INCOME (LOSS) - ASC 220 establishes rules for reporting and displaying comprehensive income or loss and its components. Our unrealized gains or losses on foreign currency translation adjustments, interest rate cap and swap agreements are included in comprehensive loss and are included in the consolidated statements of comprehensive income (loss) for the three and nine months ended September&#160;30, 2020 and 2019</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMzAxMDc_4c10446d-b582-408c-91bf-b46069cd5168">COMMITMENTS AND CONTINGENCIES - We are party to various legal proceedings, claims, and regulatory, tax or government inquiries and investigations that arise in the ordinary course of business. With respect to these matters, we evaluate the developments on a regular basis and accrue a liability when we believe a loss is probable and the amount can be reasonably estimated. Based on current information, we do not believe that reasonably possible or probable losses associated with pending legal proceedings would either individually or in the aggregate, have a material adverse effect on our business and consolidated financial statements. However, the outcome of these matters is inherently uncertain. Therefore, if one or more of these matters were resolved against us for amounts in excess of management's expectations, our results of operations and financial condition, including in a particular reporting period in which any such outcome becomes probable and estimable, could be materially adversely affected.</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMzAwODA_70b49a30-f8ab-422b-a7e8-44ca7e9abd9d">&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;DERIVATIVE INSTRUMENTS&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2016 CAPS&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the fourth quarter of 2016, we entered into two forward interest rate cap agreements ("2016 Caps"). The 2016 Caps will mature in September and October 2020. The 2016 Caps had notional amounts of $150,000,000 and $350,000,000, respectively. Under these arrangements, the Company purchased a cap on 3 month LIBOR at 2.0%. We incurred a $5.3 million premium to enter into the 2016 Caps which is being accrued over the life of the agreements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At inception, we designated our 2016 Caps as cash flow hedges of floating-rate borrowings. In accordance with accounting guidance, derivatives that have been designated and qualify as cash flow hedging instruments are reported at fair value. The gain or loss of the hedge (i.e. change in fair value) is reported as a component of comprehensive loss in the consolidated statement of equity since such hedge has been determined to be effective.  See Fair Value Measurements section below for the fair value of the 2016 Caps at September&#160;30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive loss of the 2016 Caps is as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.512%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.108%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the three months ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Account&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;July 1, 2020 Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of comprehensive gain recognized on derivative net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020 Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated Other Comprehensive Loss, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,409)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,214)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities and Equity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.512%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.108%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the nine months ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Account&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 1, 2020 Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of comprehensive gain recognized on derivative net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020 Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated Other Comprehensive Loss, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,877)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,214)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities and Equity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2019 SWAPS&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the second quarter of 2019, we entered into four forward interest rate agreements ("2019 Swaps").  The 2019 Swaps have total notional amounts of $500,000,000, consisting of two agreements of $50,000,000 each and two agreements of  $200,000,000 each.   The 2019 Swaps will secure a constant interest rate associated with portions of our variable rate bank debt and have an effective date of October 13, 2020. They will mature in October 2023 for the smaller notional and October 2025 for the larger notional. Under these arrangements, we arranged the 2019 Swaps with locked in 1 month LIBOR rates at 1.96% for the $100,000,000 notional and at 2.05%  for the $400,000,000 notional.  As of the effective date, we will be liable for premium payments if interest rates decline below arranged rates, but will receive interest payments if rates remain above the arranged rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At inception, we designated our 2019 Swaps as cash flow hedges of floating-rate borrowings. In accordance with accounting guidance, derivatives that have been designated and qualify as cash flow hedging instruments are reported at fair value. The gain or loss on the effective portion of the hedge (i.e. change in fair value) is reported as a component of comprehensive loss in the consolidated statement of equity.  The remaining gain or loss, if any, is recognized currently in earnings.  As a result of the economic impact of the coronavirus pandemic, which precipitated a reduction in interest rates , the cash flows for both our $400,000,000 notional interest rate swap contract locked in at 2.05% due October 2025 and our $100,000,000 notional interest rate swap contract locked in at 1.96% do not match the cash flows for our First Lien Term Loans and so we have determined that they are not currently effective as cash flow hedges. Accordingly, all changes in their fair value after April 1, 2020 for the $400,000,000 notional and after July 1, 2020 for the $100,000,000 notional will be recognized in earnings.&#160;As of July 1, 2020, the total change in fair value relating to swaps included in other comprehensive income was approximately $24.4 million, net of taxes.  This amount will be amortized to interest expense through October 2025 at approximately $0.4 million per month.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive loss of the 2019 swaps which remain ineffective is as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.660%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.229%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.217%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.528%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.528%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the three months ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Account&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;July 1, 2020 Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of comprehensive loss recognized on derivative net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of loss reclassified out of accumulated OCI into income (prior period effective portion), net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020 Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated Other Comprehensive Loss, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,406)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,437)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities and Equity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.052%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.886%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.561%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.561%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.561%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.561%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.561%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the nine months ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Account&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 1, 2020 Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of comprehensive loss recognized on derivative net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of loss reclassified out of accumulated OCI into income (prior period effective portion), net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020 Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated Other Comprehensive Loss, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,870)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,428)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,437)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities and Equity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A tabular presentation of the effect of derivative instruments on our statement of operations of the 2019 Swaps for the Swaps that became ineffective during the third quarter is as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.345%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.027%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.109%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.109%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.109%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.114%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the three months ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Ineffective interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of loss recognized in income on derivative (current period ineffective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of  loss recognized in Income on derivative (current period ineffective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of loss reclassified from accumulated OCI into income (prior period effective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of gain (Loss) reclassified from accumulated OCI into income (prior period effective portion)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(679)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income (expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,312)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity and Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:DerivativeAssetNumberOfInstrumentsHeld
      contextRef="i658e0bcb8f99489086788f33b3dd88c1_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMTY0OTI2NzQ5NDI1Mg_0ed97b0f-78f3-4f40-b3f9-305cebe87396"
      unitRef="numberofagreement">2</us-gaap:DerivativeAssetNumberOfInstrumentsHeld>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i91802bf2d66e48f8b03dbae52a216767_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMTg5NzM_e5ee2b0c-d0b4-456f-9e63-b25b9307912e"
      unitRef="usd">150000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="idc736fa25bf945e0a7f00b0f62403cd4_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMTg5ODA_facc8c68-2250-40ad-a335-9caae719fa51"
      unitRef="usd">350000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeBasisSpreadOnVariableRate
      contextRef="i4052e92e79fc4969969e1b1a1bdef340_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMTkwNzI_45d5e20d-a568-4ae3-a629-51a5b2ec625d"
      unitRef="number">0.020</us-gaap:DerivativeBasisSpreadOnVariableRate>
    <us-gaap:FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized
      contextRef="i658e0bcb8f99489086788f33b3dd88c1_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMTkwOTA_6c7cebed-a334-4b15-b0c7-2eaad47f6178"
      unitRef="usd">5300000</us-gaap:FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized>
    <us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMzAxMTM_55cc9c5f-4627-4440-b2ad-1bf698376a2c">A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive loss of the 2016 Caps is as follows (amounts in thousands):&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.512%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.108%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the three months ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Account&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;July 1, 2020 Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of comprehensive gain recognized on derivative net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020 Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated Other Comprehensive Loss, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,409)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,214)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities and Equity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.512%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.108%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the nine months ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Account&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 1, 2020 Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of comprehensive gain recognized on derivative net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020 Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated Other Comprehensive Loss, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,877)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,214)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities and Equity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive loss of the 2019 swaps which remain ineffective is as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.660%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.229%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.217%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.528%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.528%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the three months ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Account&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;July 1, 2020 Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of comprehensive loss recognized on derivative net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of loss reclassified out of accumulated OCI into income (prior period effective portion), net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020 Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated Other Comprehensive Loss, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,406)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,437)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities and Equity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.052%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.886%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.561%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.561%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.561%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.561%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.561%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the nine months ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Account&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 1, 2020 Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of comprehensive loss recognized on derivative net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of loss reclassified out of accumulated OCI into income (prior period effective portion), net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020 Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated Other Comprehensive Loss, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,870)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,428)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,437)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities and Equity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A tabular presentation of the effect of derivative instruments on our statement of operations of the 2019 Swaps for the Swaps that became ineffective during the third quarter is as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.345%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.027%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.109%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.109%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.109%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.114%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the three months ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Ineffective interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of loss recognized in income on derivative (current period ineffective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of  loss recognized in Income on derivative (current period ineffective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of loss reclassified from accumulated OCI into income (prior period effective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of gain (Loss) reclassified from accumulated OCI into income (prior period effective portion)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(679)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income (expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,312)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity and Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1
      contextRef="i6a7deb3c96cc42bcaa935bd270ffd41b_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmRmYzIxMzUxMzE4NDQ4ODdhNTNkYTQ1OWI3ZmZjZWFhL3RhYmxlcmFuZ2U6ZGZjMjEzNTEzMTg0NDg4N2E1M2RhNDU5YjdmZmNlYWFfMi0yLTEtMS0w_62705f99-c54c-4ac2-88a1-22911d02a8c8"
      unitRef="usd">-1409000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i2ae781a9e9de432895fcc55db7b0b610_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmRmYzIxMzUxMzE4NDQ4ODdhNTNkYTQ1OWI3ZmZjZWFhL3RhYmxlcmFuZ2U6ZGZjMjEzNTEzMTg0NDg4N2E1M2RhNDU5YjdmZmNlYWFfMi00LTEtMS0w_b4d3a814-4ce1-420f-8ba1-b7560c7a1911"
      unitRef="usd">195000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1
      contextRef="i9e0459768a414e26a0829c4867e4d0d0_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmRmYzIxMzUxMzE4NDQ4ODdhNTNkYTQ1OWI3ZmZjZWFhL3RhYmxlcmFuZ2U6ZGZjMjEzNTEzMTg0NDg4N2E1M2RhNDU5YjdmZmNlYWFfMi02LTEtMS0w_80f39cb0-c64a-4381-a8e1-d1581a29c907"
      unitRef="usd">-1214000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1
      contextRef="i1f380d5dd68c48e19e7b1642f1ddc90a_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjgxYzk4NTA3Y2ExNDRlZTQ5MTkxY2FmYTFjOWQ3Y2U2L3RhYmxlcmFuZ2U6ODFjOTg1MDdjYTE0NGVlNDkxOTFjYWZhMWM5ZDdjZTZfMi0yLTEtMS0w_f7ed630f-50ae-4979-815b-af6ffa77c40f"
      unitRef="usd">-1877000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i042c5a0cd0164e16bee1a9405ebde456_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjgxYzk4NTA3Y2ExNDRlZTQ5MTkxY2FmYTFjOWQ3Y2U2L3RhYmxlcmFuZ2U6ODFjOTg1MDdjYTE0NGVlNDkxOTFjYWZhMWM5ZDdjZTZfMi00LTEtMS0w_6668d130-f074-4c7e-817f-90a21b1fd029"
      unitRef="usd">663000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1
      contextRef="i9e0459768a414e26a0829c4867e4d0d0_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjgxYzk4NTA3Y2ExNDRlZTQ5MTkxY2FmYTFjOWQ3Y2U2L3RhYmxlcmFuZ2U6ODFjOTg1MDdjYTE0NGVlNDkxOTFjYWZhMWM5ZDdjZTZfMi02LTEtMS0w_0ee3276c-99e5-4ca1-9bb3-6f5f1a0ce0ff"
      unitRef="usd">-1214000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1>
    <us-gaap:DerivativeAssetNumberOfInstrumentsHeld
      contextRef="i1b5787978e97447bb1142eeeaa5ad186_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMTY0OTI2NzQ5NDI2MQ_f8cbe8cf-ebb5-474d-b637-d7067ad00bc5"
      unitRef="numberofagreement">4</us-gaap:DerivativeAssetNumberOfInstrumentsHeld>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="ib707578bfbd243ac8417cc2b7cbfd5e7_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjAwNDk_61647e11-1777-4f58-9734-d4e1c8d097da"
      unitRef="usd">500000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i5dc9976fcf3a4031bb4bd9fd7345be68_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjAwODU_d8cb9032-ec01-43cc-8366-6edb322d63b2"
      unitRef="usd">50000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i91b5b54bcf7a4da796a36d934ff39258_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjAxMTY_9b01ed96-7838-4eb1-9fee-a1654347cc54"
      unitRef="usd">200000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeBasisSpreadOnVariableRate
      contextRef="ia060340684bb4943a12a873d70c71339_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjA0NzQ_05fe54af-ce36-4bff-97ca-cbbd55b2d33a"
      unitRef="number">0.0196</us-gaap:DerivativeBasisSpreadOnVariableRate>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i62e737b9da50433792d2421c47ccf0cc_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjA0ODU_0d898c97-8b64-48a1-b40a-8c43eb1d3302"
      unitRef="usd">100000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeBasisSpreadOnVariableRate
      contextRef="ifcd8f19b217b413699a01d86bc9952fd_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjA1MDQ_ac5a360a-3390-4de3-894c-3f388b5feb5e"
      unitRef="number">0.0205</us-gaap:DerivativeBasisSpreadOnVariableRate>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i3910f866882c4e5bb053c720b008b7b3_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjA1MTY_efde62ce-dbac-4601-ab83-d5e80aeeea12"
      unitRef="usd">400000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i3910f866882c4e5bb053c720b008b7b3_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjEzNDk_efde62ce-dbac-4601-ab83-d5e80aeeea12"
      unitRef="usd">400000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeBasisSpreadOnVariableRate
      contextRef="ifcd8f19b217b413699a01d86bc9952fd_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjE0MDI_ac5a360a-3390-4de3-894c-3f388b5feb5e"
      unitRef="number">0.0205</us-gaap:DerivativeBasisSpreadOnVariableRate>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i62e737b9da50433792d2421c47ccf0cc_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjc0ODc3OTA5OTYxNg_0d898c97-8b64-48a1-b40a-8c43eb1d3302"
      unitRef="usd">100000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeBasisSpreadOnVariableRate
      contextRef="ia060340684bb4943a12a873d70c71339_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjc0ODc3OTA5OTYzMw_05fe54af-ce36-4bff-97ca-cbbd55b2d33a"
      unitRef="number">0.0196</us-gaap:DerivativeBasisSpreadOnVariableRate>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i3910f866882c4e5bb053c720b008b7b3_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjc0ODc3OTA5OTY1OA_efde62ce-dbac-4601-ab83-d5e80aeeea12"
      unitRef="usd">400000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i62e737b9da50433792d2421c47ccf0cc_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjc0ODc3OTA5OTcxMA_0d898c97-8b64-48a1-b40a-8c43eb1d3302"
      unitRef="usd">100000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings
      contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjE4MDg_0425efbf-b478-4151-a032-b744aed93b57"
      unitRef="usd">24400000</us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings>
    <rdnt:MonthlyAmortizationOfDeferredHedgeGains
      contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjE5MDE_438eeb22-06d6-4357-b6a1-561cb9cdc36c"
      unitRef="usd">400000</rdnt:MonthlyAmortizationOfDeferredHedgeGains>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1
      contextRef="i77a7a48de64144dbbdb67e5d5e1fd55d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmQ3M2NjZWQwNTZiZTQ1NzM5OGQ3YTRiMjNhM2Q1ZWIxL3RhYmxlcmFuZ2U6ZDczY2NlZDA1NmJlNDU3Mzk4ZDdhNGIyM2EzZDVlYjFfMi0yLTEtMS0w_4021d72f-6cd0-4688-9d75-cb06bb7eda77"
      unitRef="usd">-24406000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i57991304d22244b4afe63c7cf8852d25_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmQ3M2NjZWQwNTZiZTQ1NzM5OGQ3YTRiMjNhM2Q1ZWIxL3RhYmxlcmFuZ2U6ZDczY2NlZDA1NmJlNDU3Mzk4ZDdhNGIyM2EzZDVlYjFfMi00LTEtMS0w_74b8ab5a-48b4-47f1-8392-796cd3254964"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i57991304d22244b4afe63c7cf8852d25_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmQ3M2NjZWQwNTZiZTQ1NzM5OGQ3YTRiMjNhM2Q1ZWIxL3RhYmxlcmFuZ2U6ZDczY2NlZDA1NmJlNDU3Mzk4ZDdhNGIyM2EzZDVlYjFfMi02LTEtMS0w_0d8a0b4b-5154-4b1d-8a31-670d4e433d05"
      unitRef="usd">-969000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1
      contextRef="i0cef0dd9679a4974b78ae9d5a40855d5_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmQ3M2NjZWQwNTZiZTQ1NzM5OGQ3YTRiMjNhM2Q1ZWIxL3RhYmxlcmFuZ2U6ZDczY2NlZDA1NmJlNDU3Mzk4ZDdhNGIyM2EzZDVlYjFfMi04LTEtMS0w_d62ebc58-be46-47bf-955d-38224194cdaa"
      unitRef="usd">-23437000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1
      contextRef="i59e1973e89c2415998dcf8ff7e0ecc39_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmIyNzM0MGM5YjRiMjQ0Yzk5YTk2MDI2ZTRiZGJlOWI5L3RhYmxlcmFuZ2U6YjI3MzQwYzliNGIyNDRjOTlhOTYwMjZlNGJkYmU5YjlfMi0yLTEtMS0w_6469c34c-5bcc-4892-b5ae-5a82597174ca"
      unitRef="usd">-5870000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="if3da5fe50e89470eab1ee1a1f974a635_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmIyNzM0MGM5YjRiMjQ0Yzk5YTk2MDI2ZTRiZGJlOWI5L3RhYmxlcmFuZ2U6YjI3MzQwYzliNGIyNDRjOTlhOTYwMjZlNGJkYmU5YjlfMi00LTEtMS0w_630577bf-290f-4286-a9f5-3c16da050287"
      unitRef="usd">-19428000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="if3da5fe50e89470eab1ee1a1f974a635_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmIyNzM0MGM5YjRiMjQ0Yzk5YTk2MDI2ZTRiZGJlOWI5L3RhYmxlcmFuZ2U6YjI3MzQwYzliNGIyNDRjOTlhOTYwMjZlNGJkYmU5YjlfMi02LTEtMS0w_334a3d90-83d8-4ef8-bef9-0f7642fddbe4"
      unitRef="usd">-1861000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1
      contextRef="i0cef0dd9679a4974b78ae9d5a40855d5_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmIyNzM0MGM5YjRiMjQ0Yzk5YTk2MDI2ZTRiZGJlOWI5L3RhYmxlcmFuZ2U6YjI3MzQwYzliNGIyNDRjOTlhOTYwMjZlNGJkYmU5YjlfMi04LTEtMS0w_20132c76-b8e3-4f07-ae24-b3bc82557980"
      unitRef="usd">-23437000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ie82dec00a8604d95a2968bee33120c7b_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjQ4ZTY1MTEzMDYxZjRkMTVhN2Q4MjUzYTc4ZDk3NmNkL3RhYmxlcmFuZ2U6NDhlNjUxMTMwNjFmNGQxNWE3ZDgyNTNhNzhkOTc2Y2RfMi0yLTEtMS0w_adb0c28c-6f83-460d-99cb-6f10a17013b2"
      unitRef="usd">679000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i431f25720da34567b5a173bf4a73fe62_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjQ4ZTY1MTEzMDYxZjRkMTVhN2Q4MjUzYTc4ZDk3NmNkL3RhYmxlcmFuZ2U6NDhlNjUxMTMwNjFmNGQxNWE3ZDgyNTNhNzhkOTc2Y2RfMi02LTEtMS0w_8be53258-6248-4e98-a3f8-30694adc24cb"
      unitRef="usd">1312000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i889543454acf49acbccb8ebd9c38f86a_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjAyNzU0MzBmZmQzMzRhNTNhYzIxYjE1NTMyOTFkZDJiL3RhYmxlcmFuZ2U6MDI3NTQzMGZmZDMzNGE1M2FjMjFiMTU1MzI5MWRkMmJfMi0yLTEtMS02NjU_cb2c6e4d-2cea-4a25-afa6-8aaa606ed7d4"
      unitRef="usd">4523000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="ia396b2b61c8e4b9abc54299a4a1c0633_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjAyNzU0MzBmZmQzMzRhNTNhYzIxYjE1NTMyOTFkZDJiL3RhYmxlcmFuZ2U6MDI3NTQzMGZmZDMzNGE1M2FjMjFiMTU1MzI5MWRkMmJfMi02LTEtMS02Njk_930e5e2b-4e16-4e2c-a1c5-a2ce21dcd5b7"
      unitRef="usd">2204000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMzAwNzM_98af7f22-3473-4bb7-b70b-aec23f4f0353">&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;FAIR VALUE MEASUREMENTS &#x2013; Assets and liabilities subject to fair value measurements are required to be disclosed within a fair value hierarchy. The fair value hierarchy ranks the quality and reliability of inputs used to determine fair value. Accordingly, assets and liabilities carried at, or permitted to be carried at, fair value are classified within the fair value hierarchy in one of the following categories based on the lowest level input that is significant to a fair value measurement:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;1&#x2014;Fair value is determined by using unadjusted quoted prices that are available in active markets for identical assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;2&#x2014;Fair value is determined by using inputs other than Level&#160;1 quoted prices that are directly or indirectly observable. Inputs can include quoted prices for similar assets and liabilities in active markets or quoted prices for identical assets and liabilities in inactive markets. Related inputs can also include those used in valuation or other pricing models such as interest rates and yield curves that can be corroborated by observable market data.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;3&#x2014;Fair value is determined by using inputs that are unobservable and not corroborated by market data. Use of these inputs involves significant and subjective judgment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Derivatives:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tables below summarize the estimated fair values of certain of our financial assets that are subject to fair value measurements, and the classification of these assets on our condensed consolidated balance sheets, as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current and long term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2016 caps - Interest Rate Contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 swaps - Interest Rate Contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current and long term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2016 caps - Interest Rate Contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 swaps - Interest Rate Contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of these contracts was determined using Level 2 inputs. More specifically, the fair value was determined by calculating the value of the difference between the fixed interest rate of the interest rate swaps and the counterparty&#x2019;s forward LIBOR curve. The forward LIBOR curve is readily available in the public markets or can be derived from information available in the public markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Long Term Debt:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the estimated fair value compared to our face value of our long-term debt as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.225%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.651%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Face Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;First Lien Term Loans and SunTrust Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;663,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;663,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;673,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.225%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.651%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Face Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;First Lien Term Loans and SunTrust Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;708,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;708,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2020 and at December&#160;31, 2019 our Barclays revolving credit facility had no balance outstanding. Our SunTrust revolving credit facility relating to our consolidated subsidiary NJIN, had no principal amount outstanding at September&#160;30, 2020 and at December&#160;31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of our long-term debt, which is discussed in Note 5, was determined using Level 2 inputs primarily related to comparable market prices.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We consider the carrying amounts of cash and cash equivalents, receivables, other current assets, current liabilities and other notes payables to approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization or payment. Additionally, we consider the carrying amount of our finance lease obligations to approximate their fair value because the weighted average interest rate used to formulate the carrying amounts approximates current market rates.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueByBalanceSheetGroupingTextBlock
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMzAwODE_b5720022-69a2-4163-89c5-df52d77c4cf4">The tables below summarize the estimated fair values of certain of our financial assets that are subject to fair value measurements, and the classification of these assets on our condensed consolidated balance sheets, as follows (in thousands):&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current and long term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2016 caps - Interest Rate Contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 swaps - Interest Rate Contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current and long term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2016 caps - Interest Rate Contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 swaps - Interest Rate Contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the estimated fair value compared to our face value of our long-term debt as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.225%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.651%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Face Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;First Lien Term Loans and SunTrust Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;663,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;663,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;673,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.225%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.651%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Face Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;First Lien Term Loans and SunTrust Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;708,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;708,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
    <us-gaap:AccruedLiabilitiesFairValueDisclosure
      contextRef="ia385deaca17344c6a8f1436288ae4840_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjI1ZGE0ZTdlYmUxNjRmNmE4ZTZlMDVlMDA2YTJiZjQ4L3RhYmxlcmFuZ2U6MjVkYTRlN2ViZTE2NGY2YThlNmUwNWUwMDZhMmJmNDhfMy0xLTEtMS0w_7a7e5ab0-198d-48bc-8ea7-3a48bfa55c4d"
      unitRef="usd">0</us-gaap:AccruedLiabilitiesFairValueDisclosure>
    <us-gaap:AccruedLiabilitiesFairValueDisclosure
      contextRef="i01ce6999cc2b4bf9b84083975db56a53_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjI1ZGE0ZTdlYmUxNjRmNmE4ZTZlMDVlMDA2YTJiZjQ4L3RhYmxlcmFuZ2U6MjVkYTRlN2ViZTE2NGY2YThlNmUwNWUwMDZhMmJmNDhfMy0zLTEtMS0w_44f56c43-36ae-4ee6-9ea4-138584a81192"
      unitRef="usd">182000</us-gaap:AccruedLiabilitiesFairValueDisclosure>
    <us-gaap:AccruedLiabilitiesFairValueDisclosure
      contextRef="i0b463d8a36cc4c62adba03e5d8291e67_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjI1ZGE0ZTdlYmUxNjRmNmE4ZTZlMDVlMDA2YTJiZjQ4L3RhYmxlcmFuZ2U6MjVkYTRlN2ViZTE2NGY2YThlNmUwNWUwMDZhMmJmNDhfMy01LTEtMS0w_8ced4af4-c406-4403-a6a1-953714379694"
      unitRef="usd">0</us-gaap:AccruedLiabilitiesFairValueDisclosure>
    <us-gaap:AccruedLiabilitiesFairValueDisclosure
      contextRef="i0c840428ea464162be7bc72c9f034b71_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjI1ZGE0ZTdlYmUxNjRmNmE4ZTZlMDVlMDA2YTJiZjQ4L3RhYmxlcmFuZ2U6MjVkYTRlN2ViZTE2NGY2YThlNmUwNWUwMDZhMmJmNDhfMy03LTEtMS0w_9e5d73ad-01c5-4632-8ac9-e18186c18b99"
      unitRef="usd">182000</us-gaap:AccruedLiabilitiesFairValueDisclosure>
    <us-gaap:AccruedLiabilitiesFairValueDisclosure
      contextRef="i9c5e95d255df47498c382ead963f4c96_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjI1ZGE0ZTdlYmUxNjRmNmE4ZTZlMDVlMDA2YTJiZjQ4L3RhYmxlcmFuZ2U6MjVkYTRlN2ViZTE2NGY2YThlNmUwNWUwMDZhMmJmNDhfNC0xLTEtMS0w_200e5b0c-7e60-4e23-a58e-542a33ba5f3c"
      unitRef="usd">0</us-gaap:AccruedLiabilitiesFairValueDisclosure>
    <us-gaap:AccruedLiabilitiesFairValueDisclosure
      contextRef="if0824895d6334dfe9da358f2324b7091_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjI1ZGE0ZTdlYmUxNjRmNmE4ZTZlMDVlMDA2YTJiZjQ4L3RhYmxlcmFuZ2U6MjVkYTRlN2ViZTE2NGY2YThlNmUwNWUwMDZhMmJmNDhfNC0zLTEtMS0w_c8b6489b-f8cc-47e3-a760-1fcbba43f30c"
      unitRef="usd">39983000</us-gaap:AccruedLiabilitiesFairValueDisclosure>
    <us-gaap:AccruedLiabilitiesFairValueDisclosure
      contextRef="i0f6dd49d77474e6fb6ccf417ecec63d2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjI1ZGE0ZTdlYmUxNjRmNmE4ZTZlMDVlMDA2YTJiZjQ4L3RhYmxlcmFuZ2U6MjVkYTRlN2ViZTE2NGY2YThlNmUwNWUwMDZhMmJmNDhfNC01LTEtMS0w_6631c192-dbf2-44a8-9103-ad441209a242"
      unitRef="usd">0</us-gaap:AccruedLiabilitiesFairValueDisclosure>
    <us-gaap:AccruedLiabilitiesFairValueDisclosure
      contextRef="i48d3b990dba24f0cb0d02544b0cf7fa6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjI1ZGE0ZTdlYmUxNjRmNmE4ZTZlMDVlMDA2YTJiZjQ4L3RhYmxlcmFuZ2U6MjVkYTRlN2ViZTE2NGY2YThlNmUwNWUwMDZhMmJmNDhfNC03LTEtMS0w_3ebbc569-6434-47f7-8a7d-78d64654dd7c"
      unitRef="usd">39983000</us-gaap:AccruedLiabilitiesFairValueDisclosure>
    <us-gaap:AccruedLiabilitiesFairValueDisclosure
      contextRef="i4387d0038f9941debbb302baf4924da2_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmMxNDZkNjk5MzI3NDQ3ZGZhN2M5MzkzYjVjZDg3YTJmL3RhYmxlcmFuZ2U6YzE0NmQ2OTkzMjc0NDdkZmE3YzkzOTNiNWNkODdhMmZfMy0xLTEtMS0w_6dc96fd2-6a53-49e7-ae9a-82eb0f3e9d84"
      unitRef="usd">0</us-gaap:AccruedLiabilitiesFairValueDisclosure>
    <us-gaap:AccruedLiabilitiesFairValueDisclosure
      contextRef="id5fd69436b804acfb68af2e47702c383_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmMxNDZkNjk5MzI3NDQ3ZGZhN2M5MzkzYjVjZDg3YTJmL3RhYmxlcmFuZ2U6YzE0NmQ2OTkzMjc0NDdkZmE3YzkzOTNiNWNkODdhMmZfMy0zLTEtMS0w_88e624a7-eff7-4af8-927f-93258fe2eed6"
      unitRef="usd">1081000</us-gaap:AccruedLiabilitiesFairValueDisclosure>
    <us-gaap:AccruedLiabilitiesFairValueDisclosure
      contextRef="i59307cb2dd2b47f9a6120f81576277c0_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmMxNDZkNjk5MzI3NDQ3ZGZhN2M5MzkzYjVjZDg3YTJmL3RhYmxlcmFuZ2U6YzE0NmQ2OTkzMjc0NDdkZmE3YzkzOTNiNWNkODdhMmZfMy01LTEtMS0w_a0712184-8efa-4fe2-b971-610f2343178c"
      unitRef="usd">0</us-gaap:AccruedLiabilitiesFairValueDisclosure>
    <us-gaap:AccruedLiabilitiesFairValueDisclosure
      contextRef="i00f4787a196b415f81d3165cb90e703b_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmMxNDZkNjk5MzI3NDQ3ZGZhN2M5MzkzYjVjZDg3YTJmL3RhYmxlcmFuZ2U6YzE0NmQ2OTkzMjc0NDdkZmE3YzkzOTNiNWNkODdhMmZfMy03LTEtMS0w_7ea91455-0218-4c99-bcc0-d47de85f82e2"
      unitRef="usd">1081000</us-gaap:AccruedLiabilitiesFairValueDisclosure>
    <us-gaap:AccruedLiabilitiesFairValueDisclosure
      contextRef="i67bcd77704ee456ab79b13a06de53338_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmMxNDZkNjk5MzI3NDQ3ZGZhN2M5MzkzYjVjZDg3YTJmL3RhYmxlcmFuZ2U6YzE0NmQ2OTkzMjc0NDdkZmE3YzkzOTNiNWNkODdhMmZfNC0xLTEtMS0w_7d8691a4-a8cb-4540-88d2-671e4d651f27"
      unitRef="usd">0</us-gaap:AccruedLiabilitiesFairValueDisclosure>
    <us-gaap:AccruedLiabilitiesFairValueDisclosure
      contextRef="ifa429bfca5a2467c87c67ff821d458bd_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmMxNDZkNjk5MzI3NDQ3ZGZhN2M5MzkzYjVjZDg3YTJmL3RhYmxlcmFuZ2U6YzE0NmQ2OTkzMjc0NDdkZmE3YzkzOTNiNWNkODdhMmZfNC0zLTEtMS0w_f8aa5d6a-09e9-40a1-b0e4-2473ef5dd9d0"
      unitRef="usd">9477000</us-gaap:AccruedLiabilitiesFairValueDisclosure>
    <us-gaap:AccruedLiabilitiesFairValueDisclosure
      contextRef="i6e9fd1b586d44e85871ade2eab7bb3ed_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmMxNDZkNjk5MzI3NDQ3ZGZhN2M5MzkzYjVjZDg3YTJmL3RhYmxlcmFuZ2U6YzE0NmQ2OTkzMjc0NDdkZmE3YzkzOTNiNWNkODdhMmZfNC01LTEtMS0w_86018a33-f27d-46fb-b17d-1c46cfbe1cf8"
      unitRef="usd">0</us-gaap:AccruedLiabilitiesFairValueDisclosure>
    <us-gaap:AccruedLiabilitiesFairValueDisclosure
      contextRef="ided14c36476d4cab94bd8241ae0fc540_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmMxNDZkNjk5MzI3NDQ3ZGZhN2M5MzkzYjVjZDg3YTJmL3RhYmxlcmFuZ2U6YzE0NmQ2OTkzMjc0NDdkZmE3YzkzOTNiNWNkODdhMmZfNC03LTEtMS0w_b29074ee-cf88-4d05-8fe1-048a8c13b53a"
      unitRef="usd">9477000</us-gaap:AccruedLiabilitiesFairValueDisclosure>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i3feb945275b44b0fb63b73ab2bc8752d_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjc2NzliODhiMmIyNzQxNmRhYjY5MTE0NTEyMzlhZTg4L3RhYmxlcmFuZ2U6NzY3OWI4OGIyYjI3NDE2ZGFiNjkxMTQ1MTIzOWFlODhfMi0xLTEtMS0w_8d648de9-79a9-49ee-bed9-ccee813e3420"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i89984b2070bb46b08c4541ec8ad418d4_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjc2NzliODhiMmIyNzQxNmRhYjY5MTE0NTEyMzlhZTg4L3RhYmxlcmFuZ2U6NzY3OWI4OGIyYjI3NDE2ZGFiNjkxMTQ1MTIzOWFlODhfMi0zLTEtMS0w_0a9aecf3-3b17-4d46-bc78-6a0782f7020d"
      unitRef="usd">663140000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ic4a7827c18a1422ea8ef8558bf7be6c6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjc2NzliODhiMmIyNzQxNmRhYjY5MTE0NTEyMzlhZTg4L3RhYmxlcmFuZ2U6NzY3OWI4OGIyYjI3NDE2ZGFiNjkxMTQ1MTIzOWFlODhfMi01LTEtMS0w_b418e1ed-1dce-45a6-af3d-6034d4d6a433"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i3612bace1a1a42f99fbd311811c270f5_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjc2NzliODhiMmIyNzQxNmRhYjY5MTE0NTEyMzlhZTg4L3RhYmxlcmFuZ2U6NzY3OWI4OGIyYjI3NDE2ZGFiNjkxMTQ1MTIzOWFlODhfMi03LTEtMS0w_1213ea59-a1c1-4dae-afd0-62b93622705d"
      unitRef="usd">663140000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjc2NzliODhiMmIyNzQxNmRhYjY5MTE0NTEyMzlhZTg4L3RhYmxlcmFuZ2U6NzY3OWI4OGIyYjI3NDE2ZGFiNjkxMTQ1MTIzOWFlODhfMi05LTEtMS0w_cddceed9-9be3-49d4-8827-1bc4acf09b1d"
      unitRef="usd">673227000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i032df92579e74d6c8afec1017d9cb9c5_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjlhYjA1MTJjOTcyYTQyZTg4YTljMTdjZGRhZmVlMWJjL3RhYmxlcmFuZ2U6OWFiMDUxMmM5NzJhNDJlODhhOWMxN2NkZGFmZWUxYmNfMi0xLTEtMS0w_3603a9f9-26b6-4e5f-8981-d0fbc8ca2186"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i9e87b2da11c74056a77487fc8c5830e4_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjlhYjA1MTJjOTcyYTQyZTg4YTljMTdjZGRhZmVlMWJjL3RhYmxlcmFuZ2U6OWFiMDUxMmM5NzJhNDJlODhhOWMxN2NkZGFmZWUxYmNfMi0zLTEtMS0w_fdea8d67-ff25-405a-8825-825ade6e2971"
      unitRef="usd">708948000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i6a05e3ae8a634224aa7d2a7d85315360_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjlhYjA1MTJjOTcyYTQyZTg4YTljMTdjZGRhZmVlMWJjL3RhYmxlcmFuZ2U6OWFiMDUxMmM5NzJhNDJlODhhOWMxN2NkZGFmZWUxYmNfMi01LTEtMS0w_415ffc15-48db-45d6-b202-bcee8033158f"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i66da6813d35d464786a99b7d5141ed64_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjlhYjA1MTJjOTcyYTQyZTg4YTljMTdjZGRhZmVlMWJjL3RhYmxlcmFuZ2U6OWFiMDUxMmM5NzJhNDJlODhhOWMxN2NkZGFmZWUxYmNfMi03LTEtMS0w_8dd60e27-2839-4bf7-bd34-66126789d050"
      unitRef="usd">708948000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjlhYjA1MTJjOTcyYTQyZTg4YTljMTdjZGRhZmVlMWJjL3RhYmxlcmFuZ2U6OWFiMDUxMmM5NzJhNDJlODhhOWMxN2NkZGFmZWUxYmNfMi05LTEtMS0w_49d68e62-00bf-4c39-96d0-f63acdc88f29"
      unitRef="usd">705699000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:LineOfCredit
      contextRef="i505d1abebd8447a787b012d89a5eacb7_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjQ1ODk_ce915ed4-5066-48a2-9d85-91d3e27ef2ea"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i1abfe8394b234eb5bbad4195a9ec0e60_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjQ1ODk_d37250a6-14b6-40fd-a41d-319131f9dbb0"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjQ3MDI_b2908313-4f0b-4d88-9973-76fff55a7ccc"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjQ3MDI_ed2e6f78-cc1c-454b-8c60-3a1507f99766"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMzAwODk_92668d0b-27d3-488f-b7f8-3d6b63272786">EARNINGS PER SHARE - Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.538%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.175%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.541%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.175%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.541%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.175%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.541%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.182%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" rowspan="2" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) attributable to RadNet, Inc.'s common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,797)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares outstanding during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,358,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,807,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,746,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,597,138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic net income (loss) per share attributable to RadNet, Inc.'s common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares outstanding during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,358,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,807,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,746,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,597,138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add nonvested restricted stock subject only to service vesting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add additional shares issuable upon exercise of stock options and warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;476,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;324,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares used in calculating diluted net income per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,955,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,360,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,746,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,113,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted net income (loss) per share attributable to RadNet, Inc.'s common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and non vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested restricted stock subject to service vesting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;331,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares issuable upon the exercise of stock options:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;933,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMzAwOTY_27312cb2-2e9e-487f-b2ec-1fe85e2fe11f">Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.538%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.175%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.541%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.175%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.541%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.175%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.541%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.182%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" rowspan="2" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) attributable to RadNet, Inc.'s common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,797)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares outstanding during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,358,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,807,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,746,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,597,138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic net income (loss) per share attributable to RadNet, Inc.'s common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares outstanding during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,358,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,807,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,746,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,597,138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add nonvested restricted stock subject only to service vesting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add additional shares issuable upon exercise of stock options and warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;476,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;324,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares used in calculating diluted net income per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,955,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,360,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,746,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,113,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted net income (loss) per share attributable to RadNet, Inc.'s common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and non vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested restricted stock subject to service vesting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;331,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares issuable upon the exercise of stock options:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;933,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfMi0xLTEtMS0w_aab4274d-f5d0-43ea-a7fc-bb640e83b4e5"
      unitRef="usd">6156000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfMi0zLTEtMS0w_cef91780-76f2-48da-aac5-b84ed329848e"
      unitRef="usd">3195000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfMi01LTEtMS0w_3dcd7c3c-88c8-4377-9592-3ceb36d5b771"
      unitRef="usd">-20797000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfMi03LTEtMS0w_01a1c9f0-83fe-4c49-a16a-8becef50066f"
      unitRef="usd">4360000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfNS0xLTEtMS0w_5afd4340-a201-4b81-933a-e0db5866bb4d"
      unitRef="shares">51358603</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfNS0zLTEtMS0w_1bb35a89-a95a-4687-a103-8a83aaad91a0"
      unitRef="shares">49807460</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfNS01LTEtMS0w_2de0a369-8ab7-42e8-a88c-6a036d0f78b7"
      unitRef="shares">50746380</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfNS03LTEtMS0w_a2a8489e-ce03-4a23-becc-628c6c5e8cc3"
      unitRef="shares">49597138</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfNi0xLTEtMS0w_ffcfa344-d756-473a-8550-584c132ef8ac"
      unitRef="usdPerShare">0.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfNi0zLTEtMS0w_844445c3-151c-46f0-91ee-f442b36cf857"
      unitRef="usdPerShare">0.06</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfNi01LTEtMS0w_b7fb826d-b44a-400d-bd58-ca72c53741dc"
      unitRef="usdPerShare">-0.41</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfNi03LTEtMS0w_f8321951-7722-4578-8b36-385a9f36dab4"
      unitRef="usdPerShare">0.09</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfOS0xLTEtMS0w_19f6e0fa-1502-4de8-a4e7-4c30a018f8ef"
      unitRef="shares">51358603</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfOS0zLTEtMS0w_14f24c32-95cc-456b-8af6-6cd1cb688e5c"
      unitRef="shares">49807460</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfOS01LTEtMS0w_c5ef5584-25ca-42b3-9ed3-6424627e2cf7"
      unitRef="shares">50746380</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfOS03LTEtMS0w_20b81c60-36a7-46f6-803b-390c0d30b0f3"
      unitRef="shares">49597138</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesRestrictedStock
      contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfMTAtMS0xLTEtMA_9ab109c6-f576-4992-9d7e-dfcf4888a3ba"
      unitRef="shares">120605</us-gaap:WeightedAverageNumberOfSharesRestrictedStock>
    <us-gaap:WeightedAverageNumberOfSharesRestrictedStock
      contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfMTAtMy0xLTEtMA_86daffc6-a35f-4524-a5df-c1c8392db5b1"
      unitRef="shares">200567</us-gaap:WeightedAverageNumberOfSharesRestrictedStock>
    <us-gaap:WeightedAverageNumberOfSharesRestrictedStock
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfMTAtNS0xLTEtMA_735b0cfc-3960-4a64-8e7b-a2dcfb5209d4"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:WeightedAverageNumberOfSharesRestrictedStock
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfMTAtNy0xLTEtMA_9c5e1e52-0d79-41e3-935e-6c7659ee5cf2"
      unitRef="shares">191375</us-gaap:WeightedAverageNumberOfSharesRestrictedStock>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants
      contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfMTEtMS0xLTEtMA_5127393a-2e51-4476-adf9-0eaef7b5f8eb"
      unitRef="shares">476607</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants
      contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfMTEtMy0xLTEtMA_c37f3fab-a0a1-4574-9884-ac707a1af144"
      unitRef="shares">352333</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfMTEtNS0xLTEtMA_4dcdec81-2bf0-4d05-a6fd-704416e5a4a3"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfMTEtNy0xLTEtMA_558b662f-ba6d-499a-a974-6ddcc18cb44d"
      unitRef="shares">324793</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfMTItMS0xLTEtMA_e4523f25-8267-401f-bb25-3018913c2109"
      unitRef="shares">51955815</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfMTItMy0xLTEtMA_fa78b836-74d9-4452-8270-ca657b05c95f"
      unitRef="shares">50360360</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfMTItNS0xLTEtMA_490c9097-eac8-4a3b-87ac-d81a80006783"
      unitRef="shares">50746380</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfMTItNy0xLTEtMA_7725edfd-8676-4197-bfc2-064c881444b4"
      unitRef="shares">50113306</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfMTMtMS0xLTEtMA_5e282904-1b35-4574-96d0-3fb63531948b"
      unitRef="usdPerShare">0.12</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfMTMtMy0xLTEtMA_30aaef04-c432-4232-965f-5690682fac13"
      unitRef="usdPerShare">0.06</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfMTMtNS0xLTEtMA_1a2cf55b-4625-4026-bb72-1eb02b64e3b8"
      unitRef="usdPerShare">-0.41</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfMTMtNy0xLTEtMA_58a8ce36-8438-423c-beda-7d08a9bd6af5"
      unitRef="usdPerShare">0.09</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i0cbd1734b449470db208d75670176435_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfMTUtMS0xLTEtMjg2MA_57098a07-cc2e-4d96-ada3-95a1e685c418"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i601cf4edf4274dc1b781ef5ce684831c_D20190701-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfMTUtMy0xLTEtMjg2MA_c699466b-81cb-43cf-a786-db9bbd41eff3"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="id452ca96882e4a38a4bc8cd85bf9878b_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfMTUtNS0xLTEtMjg2MA_45dea0f4-4467-4510-b8eb-ae3f7d82b251"
      unitRef="shares">331659</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ic0b2de2326bf4699aba943152bce409a_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfMTUtNy0xLTEtMjg2MA_7c5e569d-9a65-4a3d-a171-c2a293f7dfe4"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfMTYtMS0xLTEtMTE2Mw_be0a6c45-8f10-470e-877a-d14655247ca1"
      unitRef="shares">48948</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfMTYtMy0xLTEtMTE2Ng_304efb0f-a225-4b98-a781-c620237fa23d"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfMTYtNS0xLTEtMTE2OQ_30f838f3-c656-4297-b011-81d057e77961"
      unitRef="shares">933370</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmViMjliYzM5NGNmYTRhZmJhODQyYzQzNjA1MTM1YjJhL3RhYmxlcmFuZ2U6ZWIyOWJjMzk0Y2ZhNGFmYmE4NDJjNDM2MDUxMzViMmFfMTYtNy0xLTEtMTE2OQ_0e24607a-d647-410e-99ba-204bd4f81549"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:EquityMethodInvestmentsPolicy
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMzAwNjg_3fd31538-c36f-4560-a45d-f806f91085f1">EQUITY INVESTMENTS AT FAIR VALUE&#x2013;Accounting guidance requires entities to measure equity investments at fair value, with any changes in fair value recognized in net income. If there is no readily determinable fair value, the guidance allows entities the ability to measure investments at cost, adjusted for observable price changes and impairments, with changes recognized in net income.</us-gaap:EquityMethodInvestmentsPolicy>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i2ace966e50834326892e2ead3a754d4f_I20170324"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjY2MTM_83b1578a-315f-40da-92fc-52a88c5d4d2a"
      unitRef="number">0.125</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i918ce2e8fa4a4e8e9a15abd08285dd07_D20170324-20170324"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjY2NTI_a302c4a3-8926-465a-b09f-5bc7ab16aa03"
      unitRef="usd">1000000.0</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i2ace966e50834326892e2ead3a754d4f_I20170324"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjY3MzU_a96e5b83-6f5c-4e16-bf27-33f6b3dc89ab"
      unitRef="number">0.125</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <rdnt:EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment
      contextRef="i2ace966e50834326892e2ead3a754d4f_I20170324"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjY3NTg_deb1a1d6-669c-4718-93e1-e13e7d5b526f"
      unitRef="usd">1400000</rdnt:EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment>
    <rdnt:EquityMethodInvestmentsOwnershipInterestPercentageAcquired
      contextRef="ib5e9eca7800545f5913ba28234bb8765_D20180301-20180301"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjY5MTQ_c0711009-9096-4a4f-b3ad-a1a279ada9f9"
      unitRef="number">0.0196</rdnt:EquityMethodInvestmentsOwnershipInterestPercentageAcquired>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="ib5e9eca7800545f5913ba28234bb8765_D20180301-20180301"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjY5MjE_f3daff03-fbd5-4ed7-b006-5d4470370f81"
      unitRef="usd">200000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <rdnt:EquityMethodInvestmentInitialOwnershipPercentageAfterDilution
      contextRef="ib5e9eca7800545f5913ba28234bb8765_D20180301-20180301"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjY5NzM_b7688d51-8bcf-465a-8d8e-e6ede66c73b3"
      unitRef="number">0.1225</rdnt:EquityMethodInvestmentInitialOwnershipPercentageAfterDilution>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i9a31e32cd3854ea7a79489c93300ee4d_I20180301"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjcwMTg_5b8e0afe-918f-4762-917a-a41cad0ffb68"
      unitRef="number">0.1421</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentAggregateCost
      contextRef="iaad66b5ea72843f5b39b9301e19778be_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjcxNzY_012f0ebf-305d-40eb-aeb9-396882c7c69a"
      unitRef="usd">1200000</us-gaap:EquityMethodInvestmentAggregateCost>
    <rdnt:EquityMethodInvestmentSharesPurchased
      contextRef="i936ffb40dcb9477e990698614800d7df_D20180201-20180201"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjc1Mjg_d4e9d68d-bdf6-4efc-87f7-6cf079707519"
      unitRef="shares">2100000</rdnt:EquityMethodInvestmentSharesPurchased>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i936ffb40dcb9477e990698614800d7df_D20180201-20180201"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjc1Nzg_fc129543-dd52-4987-bfe9-c5fd8df2aac6"
      unitRef="usd">2000000.0</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:ShortTermBorrowings
      contextRef="ic4d616de0e5248008f9d7307398420b2_I20190101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjc2NTg_0196580e-5368-4ccd-bf65-128c2f4a0651"
      unitRef="usd">100000</us-gaap:ShortTermBorrowings>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="i9f1bfde7a34b4cdcbac1a70f78d72a80_I20191011"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjc2OTA_19a312ff-2ee4-4921-ac4a-12135fdbd9e7"
      unitRef="shares">80000</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="id8efe47b9b214f68a5239a62a1642eb8_D20191105-20191105"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjgwNzI_59ad9c7e-27cf-4da6-8a59-a2e1aa11ef26"
      unitRef="usd">1000000.0</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToFundLongtermLoansToRelatedParties
      contextRef="id8efe47b9b214f68a5239a62a1642eb8_D20191105-20191105"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjgxMDM_bfce4b36-cd5f-4a71-bd07-4fb1b899dcb7"
      unitRef="usd">2500000</us-gaap:PaymentsToFundLongtermLoansToRelatedParties>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ic70d35efa82941bba6027c1e3fda60f0_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjgzMTU_f5326225-b6bc-4b40-8b6e-d443c7c717e9"
      unitRef="usd">4000000.0</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:InvestmentPolicyTextBlock
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMzAwNzQ_c6626745-462f-47cb-9075-36460019eb74">&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;INVESTMENT IN JOINT VENTURES &#x2013; We have &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; unconsolidated joint ventures with ownership interests ranging from 35% to 55%. These joint ventures represent partnerships with hospitals, health systems or radiology practices and were formed for the purpose of owning and operating diagnostic imaging centers. Professional services at the joint venture diagnostic imaging centers are performed by contracted radiology practices or a radiology practice that participates in the joint venture.&#160;Our investment in these joint ventures is accounted for under the equity method, since RadNet does not have a controlling financial interest in such ventures. We evaluate our investment in joint ventures, including cost in excess of book value (equity method goodwill) for impairment whenever indicators of impairment exist. No indicators of impairment existed as of September&#160;30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Joint venture investment contribution&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the month of August 2020, we made additional cash contributions to our Santa Monica Imaging Group, LLC partnership in the amount of $1.6 million in support of its expanded operations.  We maintain our 35% economic interest in the partnership.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Joint venture investment and financial information&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of our investment in joint ventures during the nine months ended September 30, 2020 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity in earnings in these joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distribution of earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,706)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity contributions in existing joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We charged management service fees from the centers underlying these joint ventures of approximately $2.7 million and $1.8 million for the three months ended September&#160;30, 2020 and 2019, respectively, and $8.6 million and $7.8 million for the nine months ended September&#160;30, 2020 and 2019, respectively.  We eliminate any unrealized portion of our management service fees with our equity in earnings of joint ventures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of key balance sheet data for these joint ventures as of September&#160;30, 2020 and December&#160;31, 2019 and income statement data for the nine months ended September 30, 2020 and 2019 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance Sheet Data:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,487)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,217)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,751)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,872)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Book value of RadNet joint venture interests&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost in excess of book value of acquired joint venture interests and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total value of Radnet joint venture interests&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total book value of other joint venture partner interests&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income statement data for the nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:InvestmentPolicyTextBlock>
    <rdnt:NumberofUnconsolidatedJointVentures
      contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjg1ODY_a96fb1e6-0691-465a-a97b-993649ba98a5"
      unitRef="joint_venture">12</rdnt:NumberofUnconsolidatedJointVentures>
    <us-gaap:VariableInterestEntityOwnershipPercentage
      contextRef="icab535e9b02f4e88a0372c47d217e396_D20190101-20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjg2NTc_049bb281-e7a5-435e-b969-2e068e6e8229"
      unitRef="number">0.35</us-gaap:VariableInterestEntityOwnershipPercentage>
    <us-gaap:VariableInterestEntityOwnershipPercentage
      contextRef="id982434e749e47d18d3f11f2943eee32_D20190101-20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjg2NjM_3349f1a4-42aa-4eb3-9b81-442adf950dbb"
      unitRef="number">0.55</us-gaap:VariableInterestEntityOwnershipPercentage>
    <us-gaap:PaymentsToAcquireInterestInJointVenture
      contextRef="i01a109385ece4d30a97550263c32b101_D20200801-20200831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjE5OTAyMzI4Njg2OQ_bffd2e8d-ea1e-46ac-b83f-0e50a85a8ba9"
      unitRef="usd">1600000</us-gaap:PaymentsToAcquireInterestInJointVenture>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i6a8c4e00f17d4b9db8412be7b503be4e_I20200831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjE5OTAyMzI4NjkzMA_70ca573b-da4d-4c80-97a8-abbb4537bbf3"
      unitRef="number">0.35</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentsTextBlock
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMzAwNjk_eb841f2e-900e-42de-a5cb-03ec22f0222b">&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of our investment in joint ventures during the nine months ended September 30, 2020 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity in earnings in these joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distribution of earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,706)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity contributions in existing joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsTextBlock>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjNiZDEwNzRkMjEwNjQzYTU4OGY0ZjUwMDczNDE4YTgwL3RhYmxlcmFuZ2U6M2JkMTA3NGQyMTA2NDNhNTg4ZjRmNTAwNzM0MThhODBfMC0xLTEtMS0w_a92a2df4-02af-49ad-b681-b75e1e9bfa52"
      unitRef="usd">34470000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjNiZDEwNzRkMjEwNjQzYTU4OGY0ZjUwMDczNDE4YTgwL3RhYmxlcmFuZ2U6M2JkMTA3NGQyMTA2NDNhNTg4ZjRmNTAwNzM0MThhODBfMS0xLTEtMS0w_d86a0dac-719f-449c-8d7d-ef0d2769ec42"
      unitRef="usd">5176000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentDividendsOrDistributions
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjNiZDEwNzRkMjEwNjQzYTU4OGY0ZjUwMDczNDE4YTgwL3RhYmxlcmFuZ2U6M2JkMTA3NGQyMTA2NDNhNTg4ZjRmNTAwNzM0MThhODBfMi0xLTEtMS0w_fe158c35-dc07-41e4-a570-8d46e3dd90ad"
      unitRef="usd">5706000</us-gaap:EquityMethodInvestmentDividendsOrDistributions>
    <rdnt:EquityContributionsInJointVentures
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjNiZDEwNzRkMjEwNjQzYTU4OGY0ZjUwMDczNDE4YTgwL3RhYmxlcmFuZ2U6M2JkMTA3NGQyMTA2NDNhNTg4ZjRmNTAwNzM0MThhODBfNi0xLTEtMS0w_517ab8ed-80ca-416e-a15f-a6d79d2659b2"
      unitRef="usd">1631000</rdnt:EquityContributionsInJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjNiZDEwNzRkMjEwNjQzYTU4OGY0ZjUwMDczNDE4YTgwL3RhYmxlcmFuZ2U6M2JkMTA3NGQyMTA2NDNhNTg4ZjRmNTAwNzM0MThhODBfNy0xLTEtMS0w_8f23bfc9-e95e-4a05-ac3e-51d64e9ff18f"
      unitRef="usd">35571000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <rdnt:ManagementServiceFees
      contextRef="i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjk2NTY_d7994e5c-d7e6-4204-8ecf-f87e1747e6c6"
      unitRef="usd">2700000</rdnt:ManagementServiceFees>
    <rdnt:ManagementServiceFees
      contextRef="i975f6d0073ce4e638e3da21090fb2f39_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjk2NjM_5b3176ba-a5dd-4b02-8deb-d72d247492c0"
      unitRef="usd">1800000</rdnt:ManagementServiceFees>
    <rdnt:ManagementServiceFees
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjk3MjI_bb8248bf-c23b-4a5f-bb6e-fbf5313fad5c"
      unitRef="usd">8600000</rdnt:ManagementServiceFees>
    <rdnt:ManagementServiceFees
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMjk3Mjk_446ad0a0-5090-455f-8b16-9437259eed23"
      unitRef="usd">7800000</rdnt:ManagementServiceFees>
    <rdnt:JointVentureInvestmentAndFinancialInformationTableTextBlock
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMTY0OTI2NzQ5MTQyNw_45d6fd78-cc38-4530-a460-1adccbf74251">&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of key balance sheet data for these joint ventures as of September&#160;30, 2020 and December&#160;31, 2019 and income statement data for the nine months ended September 30, 2020 and 2019 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance Sheet Data:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,487)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,217)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,751)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,872)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Book value of RadNet joint venture interests&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost in excess of book value of acquired joint venture interests and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total value of Radnet joint venture interests&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total book value of other joint venture partner interests&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income statement data for the nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</rdnt:JointVentureInvestmentAndFinancialInformationTableTextBlock>
    <us-gaap:EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmZmZDI3OTUyYmJmNDRjYTJiMGZhYjgwOGIyMzI1N2IyL3RhYmxlcmFuZ2U6ZmZkMjc5NTJiYmY0NGNhMmIwZmFiODA4YjIzMjU3YjJfMS0xLTEtMS0w_7ffede8f-28b2-4b46-86fc-27dbdecaa564"
      unitRef="usd">26618000</us-gaap:EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets>
    <us-gaap:EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets
      contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmZmZDI3OTUyYmJmNDRjYTJiMGZhYjgwOGIyMzI1N2IyL3RhYmxlcmFuZ2U6ZmZkMjc5NTJiYmY0NGNhMmIwZmFiODA4YjIzMjU3YjJfMS0zLTEtMS0w_812d46f7-c1c5-4601-a6f1-967fc13ee7fc"
      unitRef="usd">27427000</us-gaap:EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets>
    <us-gaap:EquityMethodInvestmentSummarizedFinancialInformationAssets
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmZmZDI3OTUyYmJmNDRjYTJiMGZhYjgwOGIyMzI1N2IyL3RhYmxlcmFuZ2U6ZmZkMjc5NTJiYmY0NGNhMmIwZmFiODA4YjIzMjU3YjJfMi0xLTEtMS0w_b649e66b-1708-4117-8a39-8c5b1f954796"
      unitRef="usd">70576000</us-gaap:EquityMethodInvestmentSummarizedFinancialInformationAssets>
    <us-gaap:EquityMethodInvestmentSummarizedFinancialInformationAssets
      contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmZmZDI3OTUyYmJmNDRjYTJiMGZhYjgwOGIyMzI1N2IyL3RhYmxlcmFuZ2U6ZmZkMjc5NTJiYmY0NGNhMmIwZmFiODA4YjIzMjU3YjJfMi0zLTEtMS0w_fa0b3756-1542-4f1a-87b1-2ec6945e8029"
      unitRef="usd">61037000</us-gaap:EquityMethodInvestmentSummarizedFinancialInformationAssets>
    <us-gaap:EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmZmZDI3OTUyYmJmNDRjYTJiMGZhYjgwOGIyMzI1N2IyL3RhYmxlcmFuZ2U6ZmZkMjc5NTJiYmY0NGNhMmIwZmFiODA4YjIzMjU3YjJfMy0xLTEtMS0w_bf6cecd2-6c96-43e4-89ac-c71fd34a9109"
      unitRef="usd">10487000</us-gaap:EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities>
    <us-gaap:EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities
      contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmZmZDI3OTUyYmJmNDRjYTJiMGZhYjgwOGIyMzI1N2IyL3RhYmxlcmFuZ2U6ZmZkMjc5NTJiYmY0NGNhMmIwZmFiODA4YjIzMjU3YjJfMy0zLTEtMS0w_5a757bf1-a83a-4295-9f30-c5a536ea30fe"
      unitRef="usd">9217000</us-gaap:EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities>
    <us-gaap:EquityMethodInvestmentSummarizedFinancialInformationLiabilities
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmZmZDI3OTUyYmJmNDRjYTJiMGZhYjgwOGIyMzI1N2IyL3RhYmxlcmFuZ2U6ZmZkMjc5NTJiYmY0NGNhMmIwZmFiODA4YjIzMjU3YjJfNC0xLTEtMS0w_abcf0462-277a-49e3-af65-2e6fa150c699"
      unitRef="usd">22751000</us-gaap:EquityMethodInvestmentSummarizedFinancialInformationLiabilities>
    <us-gaap:EquityMethodInvestmentSummarizedFinancialInformationLiabilities
      contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmZmZDI3OTUyYmJmNDRjYTJiMGZhYjgwOGIyMzI1N2IyL3RhYmxlcmFuZ2U6ZmZkMjc5NTJiYmY0NGNhMmIwZmFiODA4YjIzMjU3YjJfNC0zLTEtMS0w_ba4ad2bb-9f85-416e-910c-648164acc1ae"
      unitRef="usd">18872000</us-gaap:EquityMethodInvestmentSummarizedFinancialInformationLiabilities>
    <us-gaap:EquityMethodInvestmentAggregateCost
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmZmZDI3OTUyYmJmNDRjYTJiMGZhYjgwOGIyMzI1N2IyL3RhYmxlcmFuZ2U6ZmZkMjc5NTJiYmY0NGNhMmIwZmFiODA4YjIzMjU3YjJfNS0xLTEtMS0w_01a6a06e-e947-43ed-8d29-043d9008e1cb"
      unitRef="usd">63956000</us-gaap:EquityMethodInvestmentAggregateCost>
    <us-gaap:EquityMethodInvestmentAggregateCost
      contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmZmZDI3OTUyYmJmNDRjYTJiMGZhYjgwOGIyMzI1N2IyL3RhYmxlcmFuZ2U6ZmZkMjc5NTJiYmY0NGNhMmIwZmFiODA4YjIzMjU3YjJfNS0zLTEtMS0w_3ba7a77b-86b0-4c29-9e1d-3ebbe1bae0dc"
      unitRef="usd">60375000</us-gaap:EquityMethodInvestmentAggregateCost>
    <us-gaap:EquityMethodInvestments
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmZmZDI3OTUyYmJmNDRjYTJiMGZhYjgwOGIyMzI1N2IyL3RhYmxlcmFuZ2U6ZmZkMjc5NTJiYmY0NGNhMmIwZmFiODA4YjIzMjU3YjJfNy0xLTEtMS0w_700e07e3-bf03-49d4-9881-a3af0adcf7d6"
      unitRef="usd">29121000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmZmZDI3OTUyYmJmNDRjYTJiMGZhYjgwOGIyMzI1N2IyL3RhYmxlcmFuZ2U6ZmZkMjc5NTJiYmY0NGNhMmIwZmFiODA4YjIzMjU3YjJfNy0zLTEtMS0w_1f0cea5e-4af2-4cc1-a68b-860d1d69f35a"
      unitRef="usd">28001000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentUnderlyingEquityInNetAssets
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmZmZDI3OTUyYmJmNDRjYTJiMGZhYjgwOGIyMzI1N2IyL3RhYmxlcmFuZ2U6ZmZkMjc5NTJiYmY0NGNhMmIwZmFiODA4YjIzMjU3YjJfOC0xLTEtMS0w_3b5b3134-5f60-48ff-bb70-713871532e7b"
      unitRef="usd">6450000</us-gaap:EquityMethodInvestmentUnderlyingEquityInNetAssets>
    <us-gaap:EquityMethodInvestmentUnderlyingEquityInNetAssets
      contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmZmZDI3OTUyYmJmNDRjYTJiMGZhYjgwOGIyMzI1N2IyL3RhYmxlcmFuZ2U6ZmZkMjc5NTJiYmY0NGNhMmIwZmFiODA4YjIzMjU3YjJfOC0zLTEtMS0w_9dcf7954-3f3d-43f2-a01c-77e4b0d821ef"
      unitRef="usd">6469000</us-gaap:EquityMethodInvestmentUnderlyingEquityInNetAssets>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmZmZDI3OTUyYmJmNDRjYTJiMGZhYjgwOGIyMzI1N2IyL3RhYmxlcmFuZ2U6ZmZkMjc5NTJiYmY0NGNhMmIwZmFiODA4YjIzMjU3YjJfOS0xLTEtMS0w_69e23675-41c6-4698-ae8d-d92532c8c818"
      unitRef="usd">35571000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmZmZDI3OTUyYmJmNDRjYTJiMGZhYjgwOGIyMzI1N2IyL3RhYmxlcmFuZ2U6ZmZkMjc5NTJiYmY0NGNhMmIwZmFiODA4YjIzMjU3YjJfOS0zLTEtMS0w_0bc9d949-6523-4d08-a3c1-98255885426b"
      unitRef="usd">34470000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <rdnt:TotalBookValueOfOtherJointVenturePartnerInterests
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmZmZDI3OTUyYmJmNDRjYTJiMGZhYjgwOGIyMzI1N2IyL3RhYmxlcmFuZ2U6ZmZkMjc5NTJiYmY0NGNhMmIwZmFiODA4YjIzMjU3YjJfMTEtMS0xLTEtMA_47872d6e-6188-4641-a766-559bf9a9877e"
      unitRef="usd">34835000</rdnt:TotalBookValueOfOtherJointVenturePartnerInterests>
    <rdnt:TotalBookValueOfOtherJointVenturePartnerInterests
      contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOmZmZDI3OTUyYmJmNDRjYTJiMGZhYjgwOGIyMzI1N2IyL3RhYmxlcmFuZ2U6ZmZkMjc5NTJiYmY0NGNhMmIwZmFiODA4YjIzMjU3YjJfMTEtMy0xLTEtMA_33aad731-e979-467c-b000-3d8243beb9e6"
      unitRef="usd">32374000</rdnt:TotalBookValueOfOtherJointVenturePartnerInterests>
    <us-gaap:EquityMethodInvestmentSummarizedFinancialInformationRevenue
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjliZjM5ZjFjNWU0ZDQ2ZTRhNDExYzU3YjE1MmFiZDcxL3RhYmxlcmFuZ2U6OWJmMzlmMWM1ZTRkNDZlNGE0MTFjNTdiMTUyYWJkNzFfMS0xLTEtMS0w_98fb453d-c617-4d79-998a-91dcc45c4f53"
      unitRef="usd">78988000</us-gaap:EquityMethodInvestmentSummarizedFinancialInformationRevenue>
    <us-gaap:EquityMethodInvestmentSummarizedFinancialInformationRevenue
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjliZjM5ZjFjNWU0ZDQ2ZTRhNDExYzU3YjE1MmFiZDcxL3RhYmxlcmFuZ2U6OWJmMzlmMWM1ZTRkNDZlNGE0MTFjNTdiMTUyYWJkNzFfMS0zLTEtMS0w_3f017519-fcad-4d5d-92d3-664d916b341f"
      unitRef="usd">80115000</us-gaap:EquityMethodInvestmentSummarizedFinancialInformationRevenue>
    <us-gaap:EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjliZjM5ZjFjNWU0ZDQ2ZTRhNDExYzU3YjE1MmFiZDcxL3RhYmxlcmFuZ2U6OWJmMzlmMWM1ZTRkNDZlNGE0MTFjNTdiMTUyYWJkNzFfMi0xLTEtMS0w_abb4e8dc-2bcd-4894-9447-cf581505c36a"
      unitRef="usd">13651000</us-gaap:EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss>
    <us-gaap:EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
      contextRef="i223c6ad5b1224e548d10402b1be744d9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RhYmxlOjliZjM5ZjFjNWU0ZDQ2ZTRhNDExYzU3YjE1MmFiZDcxL3RhYmxlcmFuZ2U6OWJmMzlmMWM1ZTRkNDZlNGE0MTFjNTdiMTUyYWJkNzFfMi0zLTEtMS0w_5ef1e269-96ba-4ff8-a66a-02e064122a48"
      unitRef="usd">13718000</us-gaap:EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss>
    <us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80OS9mcmFnOjQyN2NmNjUzZDg3ZDRkZjVhNGJhMmQzNjA5M2YxNGQ5L3RleHRyZWdpb246NDI3Y2Y2NTNkODdkNGRmNWE0YmEyZDM2MDkzZjE0ZDlfNDI5Mg_7f89e230-48d9-40aa-a8b8-42980a02ca03">RECENT ACCOUNTING AND REPORTING STANDARDS&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting standards adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the FASB issued ASU No. 2016-13 ("ASU 2016-13), &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments - Credit Losses.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  ASU 2016-13 replaces the incurred loss methodology previously utilized for valuing financial instruments with an expected loss methodology that is referred to as the current expected credit loss (CECL) methodology.  We prospectively adopted the standard on January 1, 2020 and the adoption did not have a material impact to the condensed consolidated financial statements, resulting in no adjustments to our prior year earnings.  See the Accounts Receivable section to Note 2 for further information on our allowances for credit losses.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASU No. 2018-15 (&#x201c;ASU 2018-15&#x201d;),&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles-Goodwill and Other-Internal-Use Software.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;ASU 2018-15 aligns the requirements for deferring implementation costs incurred in a cloud computing arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. This ASU is effective in the first quarter of 2020 with early adoption permitted and can be applied either retrospectively or prospectively to all implementation costs incurred after the date of adoption. The adoption of this standard did not have a material impact on our condensed consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the FASB issued ASU 2020-03 ("ASU 2020-03"),&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Codification Improvements to Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The amendments in this update represent changes to clarify or improve the codification and correct unintended application. ASU 2020-03 was effective immediately upon issuance and its adoption did not have a material impact on our financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASU No. 2018-13 ("ASU 2018-13"),&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Disclosure Framework &#x2013; Changes to the Disclosure Requirements for Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. This standard removes, modifies and adds certain disclosures related to recurring and nonrecurring fair value measurements. We adopted ASC 2018-13 effective January 1, 2020 and it had no effect on our disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting standards not yet adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued ASU 2019-12 ("ASU 2019-12"), &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740).  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASU 2019-12 removes certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. It also clarifies and simplifies other areas of the standard. ASU 2019-12 will be effective beginning in the first quarter of 2021. Early adoption is permitted. Certain amendments in this update must be applied on a prospective basis, certain amendments must be applied on a retrospective basis, and certain amendments must be applied on a modified retrospective basis through a cumulative-effect adjustment to retained earnings/(deficit) in the period of adoption. We are currently evaluating the impact this ASU will have on our financial statements and related disclosures as well as the timing of adoption.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2020, the FASB issued ASU 2020-01 ("ASU 2020-01"), &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments&#x2014;Equity Securities (Topic 321), Investments&#x2014;Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815), &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;clarifying the interaction between accounting standards related to equity securities, equity method investments, and certain derivatives. ASU 2020-01 is effective for fiscal years beginning after December 15, 2020. We do not expect the adoption of this guidance will have a material impact on our financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the FASB issued ASU 2020-04 ("ASU 2020-04"),&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848), Facilitation of the Effects of Reference Rate Reform on Financial Reporting&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. ASU 2020-04 provides optional expedients and exceptions for applying generally accepted accounting principles to certain contract modifications and hedging relationships that reference London Inter-bank Offered Rate (LIBOR) or another reference rate expected to be discontinued. The guidance is effective upon issuance and generally can be applied through December 31, 2022. We are currently evaluating the potential impact of ASU 2020-04 on our financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80OS9mcmFnOjQyN2NmNjUzZDg3ZDRkZjVhNGJhMmQzNjA5M2YxNGQ5L3RleHRyZWdpb246NDI3Y2Y2NTNkODdkNGRmNWE0YmEyZDM2MDkzZjE0ZDlfNDI5Mw_85c6488a-be7f-4a44-ab24-100ca5f814e1">RECENT ACCOUNTING AND REPORTING STANDARDS&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting standards adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the FASB issued ASU No. 2016-13 ("ASU 2016-13), &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments - Credit Losses.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  ASU 2016-13 replaces the incurred loss methodology previously utilized for valuing financial instruments with an expected loss methodology that is referred to as the current expected credit loss (CECL) methodology.  We prospectively adopted the standard on January 1, 2020 and the adoption did not have a material impact to the condensed consolidated financial statements, resulting in no adjustments to our prior year earnings.  See the Accounts Receivable section to Note 2 for further information on our allowances for credit losses.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASU No. 2018-15 (&#x201c;ASU 2018-15&#x201d;),&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles-Goodwill and Other-Internal-Use Software.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;ASU 2018-15 aligns the requirements for deferring implementation costs incurred in a cloud computing arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. This ASU is effective in the first quarter of 2020 with early adoption permitted and can be applied either retrospectively or prospectively to all implementation costs incurred after the date of adoption. The adoption of this standard did not have a material impact on our condensed consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the FASB issued ASU 2020-03 ("ASU 2020-03"),&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Codification Improvements to Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The amendments in this update represent changes to clarify or improve the codification and correct unintended application. ASU 2020-03 was effective immediately upon issuance and its adoption did not have a material impact on our financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASU No. 2018-13 ("ASU 2018-13"),&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Disclosure Framework &#x2013; Changes to the Disclosure Requirements for Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. This standard removes, modifies and adds certain disclosures related to recurring and nonrecurring fair value measurements. We adopted ASC 2018-13 effective January 1, 2020 and it had no effect on our disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting standards not yet adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued ASU 2019-12 ("ASU 2019-12"), &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740).  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASU 2019-12 removes certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. It also clarifies and simplifies other areas of the standard. ASU 2019-12 will be effective beginning in the first quarter of 2021. Early adoption is permitted. Certain amendments in this update must be applied on a prospective basis, certain amendments must be applied on a retrospective basis, and certain amendments must be applied on a modified retrospective basis through a cumulative-effect adjustment to retained earnings/(deficit) in the period of adoption. We are currently evaluating the impact this ASU will have on our financial statements and related disclosures as well as the timing of adoption.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2020, the FASB issued ASU 2020-01 ("ASU 2020-01"), &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments&#x2014;Equity Securities (Topic 321), Investments&#x2014;Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815), &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;clarifying the interaction between accounting standards related to equity securities, equity method investments, and certain derivatives. ASU 2020-01 is effective for fiscal years beginning after December 15, 2020. We do not expect the adoption of this guidance will have a material impact on our financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the FASB issued ASU 2020-04 ("ASU 2020-04"),&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848), Facilitation of the Effects of Reference Rate Reform on Financial Reporting&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. ASU 2020-04 provides optional expedients and exceptions for applying generally accepted accounting principles to certain contract modifications and hedging relationships that reference London Inter-bank Offered Rate (LIBOR) or another reference rate expected to be discontinued. The guidance is effective upon issuance and generally can be applied through December 31, 2022. We are currently evaluating the potential impact of ASU 2020-04 on our financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMzU0Mw_3aa25ea7-9268-4484-8e89-cf2b83c379d1">FACILITY ACQUISITIONS AND DISPOSITIONS&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Acquisitions:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 31, 2020 we completed our acquisition of certain assets of AZ-Tech Radiology &amp;amp; Open MRI, LLC, consisting of eight multi-modality imaging centers located in the Phoenix, Arizona area for purchase consideration of $5.5 million.  We made a preliminary fair value determination of the acquired assets and assumed liabilities and approximately $2.5 million in property and equipment, $7.6 million in right-of-use assets, $0.1 million in other assets, $7.6 million in operating lease liabilities, and $2.9 million in goodwill were recorded.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 1, 2020, we completed our acquisition of all the equity interests of DeepHealth Inc., ("DeepHealth") an artificial intelligence and machine learning company in an all stock purchase.  As initial purchase consideration, we issued 915,132 shares at $16.93 per share (823,615 issued at execution, with up to 91,517 shares to be issued 18 months after acquisition subject to adjustment for any indemnification claims).  The transaction was accounted for as an acquisition of a business and total purchase consideration determined to be approximately $34.6 million including i) 823,615 shares issued on the date of closing with fair value of $13.9 million, ii) a liability of 91,517 shares with a fair value of $1.5 million to be issued 18 months after acquisition subject to adjustment for any indemnification claims and will be marked to market in subsequent periods, iii) replacement awards attributable to pre-combination service issued to DeepHealth option holders with allocated fair value of $2.0 million, iv) acquisition date fair value of contingent consideration of $17.0 million and v) $0.1 million in closing costs reimbursed to the seller.  The fair values of replacement awards attributable to pre-combination service and contingent consideration are recorded in additional paid in capital upon closing of the transaction. For the contingent consideration, there are three arrangements that will be settled in a fixed number of shares upon achievement of three individual specific milestones which are mutually exclusive of each other, with 390,789, 586,184, and 195,393 shares, respectively, issuable for each milestone arrangement. The fair value of the contingent consideration was estimated at the date of acquisition based on our share price and estimated probability of the achievement of the respective milestones.  We preliminarily recorded $0.1 million in current assets, $3.5 million in deferred tax liabilities, $14.8 million in intangible assets, primarily in-process research and development ("IPR&amp;amp;D'), and $23.4 million in goodwill. The goodwill is primarily attributable to expected post-acquisition synergies from integrating DeepHealth&#x2019;s assembled workforce and IPR&amp;amp;D technologies. The fair values of the identifiable intangible assets related to IPR&amp;amp;D were determined by the income method and the assets will not be amortized until completion. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 2, 2020 our consolidated subsidiary New Jersey Imaging Networks ("NJIN") completed the acquisition of certain assets of MRI at Woodbridge, LLC consisting of a single multi-modality imaging center located in Avenel, New Jersey for cash consideration of $2.6 million.  NJIN made a fair value determination of the acquired assets and assumed liabilities and approximately $0.5 million in property and equipment, $1.1 million in right-of-use assets, $0.3 million in intangible assets, $1.1 million in operating lease liabilities, $0.1 million in finance lease liabilities, and $1.8 million in goodwill were recorded.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;On January 2, 2020 we completed our acquisition of certain assets of Olney Open MRI, LLC, consisting of a single multi-modality imaging center located in Columbia, Maryland for cash consideration of $1.8 million.  We have made a fair value determination of the acquired assets and assumed liabilities and approximately $0.8 million in property and equipment, $1.3 million in right-of-use assets, $0.3 million in intangible assets, $1.3 million in operating lease liabilities and $0.6 million  in goodwill were recorded.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Dispositions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 1, 2020 we completed our sale of certain assets of our Imaging On Call subsidiary to RadVantage P.C. (an unrelated corporation) for approximately $1.0 thousand.  With this transaction, we have exited the teleradiology business.&lt;/span&gt;&lt;/div&gt;</us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="i162b6e4a9b024569bbd2a742fbb7e2df_D20200831-20200831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMjE5OTAyMzI2MDU0Mw_e4d2b8d0-be59-4f82-8d44-0c4b8954a4d2"
      unitRef="center">8</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i162b6e4a9b024569bbd2a742fbb7e2df_D20200831-20200831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMjc0ODc3OTA3MzgzOQ_d9ca8ed1-4f43-48f2-ace7-099785e60c1b"
      unitRef="usd">5500000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i88ab08c169fd45579b828ee84aa3fbe2_I20200831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMjc0ODc3OTA3NDI0Mw_4432e8b6-8a66-4f19-b0ab-967640ce2f25"
      unitRef="usd">2500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="i88ab08c169fd45579b828ee84aa3fbe2_I20200831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMjc0ODc3OTA3NDI1MA_c9da0d12-093a-431d-bdab-545b7d8ae146"
      unitRef="usd">7600000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther
      contextRef="i88ab08c169fd45579b828ee84aa3fbe2_I20200831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMjc0ODc3OTA3NDM5Mg_6e561829-1337-44f9-acc7-ee9d15bf3546"
      unitRef="usd">100000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="i88ab08c169fd45579b828ee84aa3fbe2_I20200831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMjc0ODc3OTA3NDI3Mw_e67070d8-827f-4872-a43c-504275ebdc34"
      unitRef="usd">7600000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:Goodwill
      contextRef="i88ab08c169fd45579b828ee84aa3fbe2_I20200831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMjc0ODc3OTA3NDI3Nw_7d8729bd-2f55-4f6b-92e7-87b6745e1af9"
      unitRef="usd">2900000</us-gaap:Goodwill>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="i91654ea5e0e647c0ba9d259407ee064a_D20200601-20200601"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMzA2_9c437481-77c1-4a0d-8ce9-6fdd5cd6faf6"
      unitRef="shares">915132</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i8973a0068cd845ef97762ff48f7c1a82_I20200601"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMzE5_f87fc610-549d-415a-8b54-65aa71e38c72"
      unitRef="usdPerShare">16.93</us-gaap:CommonStockParOrStatedValuePerShare>
    <rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution
      contextRef="i91654ea5e0e647c0ba9d259407ee064a_D20200601-20200601"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMzMz_34a032e6-2a0e-46e1-aa2b-9d6799552d27"
      unitRef="shares">823615</rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution>
    <rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution
      contextRef="i91654ea5e0e647c0ba9d259407ee064a_D20200601-20200601"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMzY4_e75d492c-8d76-4af2-abc2-c52124cffded"
      unitRef="shares">91517</rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution>
    <rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm
      contextRef="i91654ea5e0e647c0ba9d259407ee064a_D20200601-20200601"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMzkx_7bae248b-49bf-466b-b3d2-56ad13866fb5">P18M</rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i91654ea5e0e647c0ba9d259407ee064a_D20200601-20200601"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfNTk4_64fcb1d8-06ea-43d3-86ae-d97f0e6a86ce"
      unitRef="usd">34600000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution
      contextRef="i91654ea5e0e647c0ba9d259407ee064a_D20200601-20200601"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfNjE0_34a032e6-2a0e-46e1-aa2b-9d6799552d27"
      unitRef="shares">823615</rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution>
    <rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution
      contextRef="i91654ea5e0e647c0ba9d259407ee064a_D20200601-20200601"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfNjcz_c694fc78-5919-4fa2-b201-804f992b8a90"
      unitRef="usd">13900000</rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution>
    <rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution
      contextRef="i91654ea5e0e647c0ba9d259407ee064a_D20200601-20200601"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfNjk2_e75d492c-8d76-4af2-abc2-c52124cffded"
      unitRef="shares">91517</rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution>
    <rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution
      contextRef="i91654ea5e0e647c0ba9d259407ee064a_D20200601-20200601"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfNzI3_5fd105e3-1849-470f-978e-947986647767"
      unitRef="usd">1500000</rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution>
    <rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm
      contextRef="i91654ea5e0e647c0ba9d259407ee064a_D20200601-20200601"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfNzQz_7bae248b-49bf-466b-b3d2-56ad13866fb5">P18M</rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm>
    <rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards
      contextRef="i91654ea5e0e647c0ba9d259407ee064a_D20200601-20200601"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfOTk4_247dca6d-4d5a-4d40-a737-c158a3602369"
      unitRef="usd">2000000.0</rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards>
    <us-gaap:EquityIssuedInBusinessCombinationFairValueDisclosure
      contextRef="i8973a0068cd845ef97762ff48f7c1a82_I20200601"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMTA2NQ_cc952993-b671-4118-a516-55d740b40032"
      unitRef="usd">17000000.0</us-gaap:EquityIssuedInBusinessCombinationFairValueDisclosure>
    <us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
      contextRef="i8973a0068cd845ef97762ff48f7c1a82_I20200601"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMTA3NQ_8f52ab6c-6e4c-48f5-824c-e82f38375bc8"
      unitRef="usd">100000</us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts>
    <rdnt:BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares
      contextRef="i91654ea5e0e647c0ba9d259407ee064a_D20200601-20200601"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMTUyMw_b59bb3f0-bd29-46d7-a0df-7659c4adbc83"
      unitRef="shares">390789</rdnt:BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares>
    <rdnt:BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares
      contextRef="i91654ea5e0e647c0ba9d259407ee064a_D20200601-20200601"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMTUyNw_9b6edb8c-e376-4472-bf26-c75343b3f3f1"
      unitRef="shares">586184</rdnt:BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares>
    <rdnt:BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares
      contextRef="i91654ea5e0e647c0ba9d259407ee064a_D20200601-20200601"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMTUzNQ_67f2b1d9-b305-40b4-aec0-0fa8beb70d84"
      unitRef="shares">195393</rdnt:BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets
      contextRef="i8973a0068cd845ef97762ff48f7c1a82_I20200601"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMTgxNg_54cfaf94-8cf4-409b-b44b-8bd822e6266c"
      unitRef="usd">100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i8973a0068cd845ef97762ff48f7c1a82_I20200601"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMTgzOA_a765954f-433d-41d8-b9e9-d006c02be522"
      unitRef="usd">3500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i8973a0068cd845ef97762ff48f7c1a82_I20200601"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMTg3MA_3d9a5d27-0e4f-4d7f-8101-9e66fda11e3a"
      unitRef="usd">14800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:Goodwill
      contextRef="i8973a0068cd845ef97762ff48f7c1a82_I20200601"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMTk1Ng_7f5b87a3-800c-489e-9a53-c7c69ed45484"
      unitRef="usd">23400000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="if82d035b351345f5a975f117243ce1cd_D20200302-20200302"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMjU1MQ_774ffb70-a349-45ba-bd15-9ede7f3742c3"
      unitRef="usd">2600000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="icc8791aabe8a4ca798528207f763624d_I20200302"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMjY1OA_2ad68bb6-5a4a-480b-a473-abfc4976b0a5"
      unitRef="usd">500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="icc8791aabe8a4ca798528207f763624d_I20200302"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMjY4OA_16fc645a-4182-438e-a61d-ce7a25639868"
      unitRef="usd">1100000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="icc8791aabe8a4ca798528207f763624d_I20200302"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMjcxNQ_77143b2b-1019-410d-9a49-c440e48e78f8"
      unitRef="usd">300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="icc8791aabe8a4ca798528207f763624d_I20200302"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMjc0MA_b2e468ed-ef44-42c1-bbbd-482e1f489530"
      unitRef="usd">1100000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFinanceLeaseLiabilities
      contextRef="icc8791aabe8a4ca798528207f763624d_I20200302"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMjc3NQ_2f608064-b46f-425b-b2d8-8ef42cd4cb76"
      unitRef="usd">100000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFinanceLeaseLiabilities>
    <us-gaap:Goodwill
      contextRef="icc8791aabe8a4ca798528207f763624d_I20200302"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMjgxMg_880010ce-a5d5-4e38-b5ee-958e292dde75"
      unitRef="usd">1800000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ib5716180cf92431199e9568b6e00f780_D20200102-20200102"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMzA0Mw_3252d3ed-d08f-4346-b412-ebd623e15c62"
      unitRef="usd">1800000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i6cbda2807f6f4c2388609f72bced8aa2_I20200102"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMzE1Mw_8b2c1062-c3c4-4190-938c-22689990c497"
      unitRef="usd">800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="i6cbda2807f6f4c2388609f72bced8aa2_I20200102"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMzE4Mw_b72fcaf2-ef04-4853-8bae-8b049a569ba7"
      unitRef="usd">1300000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i6cbda2807f6f4c2388609f72bced8aa2_I20200102"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMzIxMA_8215fb83-261b-462d-815c-cfb9c33e19f8"
      unitRef="usd">300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="i6cbda2807f6f4c2388609f72bced8aa2_I20200102"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMzIzNQ_92b62de1-2dbc-4e86-8378-aa036f019324"
      unitRef="usd">1300000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:Goodwill
      contextRef="i6cbda2807f6f4c2388609f72bced8aa2_I20200102"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMzI3Mw_75e083d7-fd15-4bc0-8319-bfc4dd187b47"
      unitRef="usd">600000</us-gaap:Goodwill>
    <us-gaap:ProceedsFromDivestitureOfInterestInJointVenture
      contextRef="i6e52cfe398fa4efabaa39a7aee14b01c_D20200601-20200601"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81Mi9mcmFnOmRiNDAwODUwZGJlMjQ5MzE5NmY0YjUzMzcyMzcwNWY3L3RleHRyZWdpb246ZGI0MDA4NTBkYmUyNDkzMTk2ZjRiNTMzNzIzNzA1ZjdfMzQ3Mg_18651465-a360-4ed3-ba6e-bf0430de0066"
      unitRef="usd">1000.0</us-gaap:ProceedsFromDivestitureOfInterestInJointVenture>
    <us-gaap:DebtAndCapitalLeasesDisclosuresTextBlock
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMTAxMDM_4c2628b6-b15d-4618-b5c7-4d5615033dd7">CREDIT FACILITIES AND NOTES PAYABLE&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2020 and December&#160;31, 2019 our debt obligations consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.953%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.273%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.840%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="12" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;First Lien Term Loans collateralized by RadNet's tangible and intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;620,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;649,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounts on First Lien Term Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,669)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,579)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SunTrust Term Loan Agreement collateralized by NJIN's tangible and intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Paycheck Protection Program loans at 1% due April 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment note payable at 4.6%, due through 2020, collateralized by medical equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;666,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;692,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39,463)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39,691)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long term portion debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;627,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;652,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Included in our condensed consolidated balance sheets at September&#160;30, 2020 are $620.7 million of First Lien Term Loans and $52.5 million of SunTrust Term Loan debt for a combined total of $673.2 million of total term loan debt (exclusive of unamortized discounts of  $10.7 million) in thousands: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.748%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.794%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.794%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.796%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Face Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;First Lien Term Loans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;620,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,669)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;610,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SunTrust Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Term Loans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;673,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,669)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;662,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We had no balance under our $195.0 million Barclays Revolving Credit Facility at September&#160;30, 2020 and have reserved $6.3 million for certain letters of credit. The remaining $188.7 million of our Barclays Revolving Credit Facility was available to draw upon as of September&#160;30, 2020.  We had no balance under our $30.0 million SunTrust Revolving Credit Facility related to our consolidated subsidiary NJIN at September&#160;30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Senior Secured Credit Facilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Barclays Credit Facilities:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September&#160;30, 2020, (a) our Barclays credit facilities were comprised of one tranche of term loans (&#x201c;First Lien Term Loans&#x201d;) and a revolving credit facility of $195.0 million (the &#x201c;Barclays Revolving Credit Facility&#x201d;) and (b) our SunTrust credit facilities, which relate to our consolidated subsidiary NJIN, were comprised of one term loan (the "SunTrust Term Loan") and a revolving credit facility of $30.0 million (the "SunTrust Revolving Credit Facility").&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2020, we were in compliance with all covenants under our credit facilities.  Deferred financing costs at September&#160;30, 2020, net of accumulated amortization, was $1.9 million and is specifically related to our Barclays Revolving Credit Facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our First Lien Term Loans bear interest at either an Adjusted Eurodollar Rate or a Base Rate, plus an applicable margin according to the following schedule:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:89.181%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.850%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.342%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.508%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;First Lien Leverage Ratio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Eurodollar Rate Spread&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Base Rate Spread&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&amp;gt; 5.50x&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.50%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&amp;gt; 4.00x but &#x2264; 5.50x&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.75%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.75%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&amp;gt;3.50x but &#x2264; 4.00x&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.50%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2264; 3.50x&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September&#160;30, 2020 the effective Adjusted Eurodollar Rate and the Base Rate for the First Lien Term Loans was 1.00% and 3.25%, respectively and the applicable margin for Adjusted Eurodollar Rate and Base Rate borrowings was 3.75% and 2.75%, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The First Lien Credit Agreement provides for quarterly payments of principal under the First Lien Term Loans in the amount of approximately $9.7 million.  The  First Lien Term Loans will mature on July 21, 2023 unless otherwise accelerated under the terms of the First Lien Credit Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;SunTrust Credit Facilities:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our SunTrust Term Loan bears interest at either an Adjusted Eurodollar Rate or a Base Rate, plus an applicable margin according to the following schedule:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:93.859%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.713%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.099%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.099%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pricing Level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Leverage Ratio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Applicable Margin for Eurodollar Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Applicable Margin for Base Rate Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Applicable Margin for Letter of Credit Fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Applicable Percentage for Commitment Fee&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;I&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than or equal to 3.00:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.75%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.75%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.45%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;II&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than 3.00:1.00 but greater than or equal to 2.50:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.25%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.40%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;III&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt;padding-right:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than 2.50:1.00 but greater than or equal to&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt;padding-right:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.00%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.35%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IV&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than 2.00:1.00 but greater than or equal to 1.50:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.75%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.30%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;V&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than 1.50:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.50%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.30%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The loans and other obligations outstanding under the SunTrust Restated Credit Agreement currently bear applicable margin and fees based on Pricing Level III described above.  The loans outstanding under the SunTrust Restated Credit Agreement currently bear interest based on a three month Eurodollar election of 2.00%, plus the applicable margin.  &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:31.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The scheduled amortization of the SunTrust Term Loan began December 31, 2018 with quarterly payments of $0.8 million, representing annual amortization equal to 5.00% of the original principal amount of the SunTrust Term Loan. At scheduled intervals, the quarterly amortization increases by $0.4 million, with the remaining balance to be paid at maturity.  The SunTrust Term Loan will mature on August 1, 2023 unless otherwise accelerated under the terms of the SunTrust credit facility.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:31.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Revolving Credit Facilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Barclays Revolving Credit Facility&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revolving loans borrowed under the Barclays Revolving Credit Facility bear interest at either an Adjusted Eurodollar Rate or a Base Rate plus an applicable margin.  Rates of the applicable margin for borrowing under the Revolving Credit Facility also change depending on our leverage ratio and are the same rates as noted in the schedule above for First Lien Term Loans. As of September&#160;30, 2020, the effective interest rate payable on revolving loans was 6.00%.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Letters of credit issued under the Barclays Revolving Credit Facility, letter of credit fees accrue at the applicable margin of Adjusted Eurodollar Rate, currently 3.75% , and fronting fees accrue at 0.25% per annum, in each case on the average aggregate daily maximum amount available to be drawn under all letters of credit issued under the First Lien Credit Agreement. In addition, a commitment fee of 0.50% per annum accrues on the unused revolver commitments under the Revolving Credit Facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Barclays Revolving Credit Facility will terminate on the earliest to occur of July 1, 2023 or its earlier termination to specific events of default pursuant to the First Lien Credit Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Barclays Revolving Credit Facility was amended in August 2020 to add $57.5 million of revolving commitments and extend the maximum borrowing capacity to $195.0 million.  Total issue costs added in relation to the eighth amendment amounted to approximately $0.7 million and was capitalized as deferred financing costs and will be amortized over the remaining term of the agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;SunTrust Revolving Credit Facility&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our SunTrust Revolving Credit Facility is available to NJIN for funding requirements, with an available borrowing limit of $30.0 million.  Revolving loan borrowed under the SunTrust Revolving Credit Facility bear interest at either an Adjusted Eurodollar Rate or a Base Rate plus an applicable margin.  Rates of the applicable margin for borrowing under the Revolving Credit Facility also change depending on our leverage ration and are the same rates noted in the schedule above for the SunTrust Term Loan. The SunTrust Revolving Credit Facility terminates on August 31, 2023 unless all amounts outstanding otherwise have been declared or have automatically become due and payable (whether by acceleration or otherwise). NJIN has not borrowed against the revolving credit line.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Recent Amendments to credit facilities:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Barclays Credit Facilities:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 28, 2020, RadNet, Inc. entered into Amendment No. 8, Consent and Incremental Joinder Agreement to Credit and Guaranty Agreement "the Eighth Amendment".  The Eighth Amendment amends the First Lien Credit Agreement to add $57.5 million of revolving commitments to the Barclays Revolving Credit Facility extending the maximum borrowing capacity under the revolving credit facility to $195.0 million while leaving the maturity date of July 1, 2023 unchanged.  Total issue costs added in relation to the Eighth Amendment amounted to approximately $0.7 million and was capitalized as deferred financing costs and will be amortized over the remaining term of the agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 18, 2019 we entered into the following two amendments to the First Lien Credit Agreement: (i) Amendment No. 6, Consent and Incremental Joinder Agreement to Credit and Guaranty Agreement (the &#x201c;Sixth Amendment&#x201d;); and (ii) Amendment No. 7 to Credit and Guaranty Agreement (the &#x201c;Seventh Amendment&#x201d;).  The Sixth Amendment amended the First Lien Credit Agreement to issue $100.0 million in incremental First Lien Term Loans and to add an additional $20.0 million of revolving commitments to the Barclay's Revolving Credit Facility.  The Seventh Amendment amended the First Lien Credit Agreement to extend the maturity date of the Barclays Revolving Credit Facility by an additional two years to July 1, 2023, unless sooner terminated in accordance with the terms of the First Lien Credit Agreement.  Total issue costs added in relation to the Sixth and Seventh amendments in 2019 amounted to approximately $4.4 million. Of this amount, $2.1 million was identified and capitalized as discount on debt, $0.7 million was capitalized as deferred financing costs, and $1.6 million was expensed. Amounts capitalized will be amortized over the remaining term of the agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Paycheck Protection Program&lt;/span&gt;&lt;/div&gt;The Paycheck Protection Program (PPP) includes funds available for loans to small business and Medicare providers to support operations during the COVID-19 pandemic. The funds are administered by the Small Business Administration (SBA), through approved lenders and do not require collateral or personal guarantees.  We received our loans based on being a Medicare provider. The terms and conditions for participation require entities to certify that economic uncertainty related to the COVID-19 pandemic makes the loan necessary to support their current operations, and that they will use the funds to retain workers (e.g., by paying salaries, providing paid sick/medical leave and health insurance benefits) and pay certain debts (mortgage obligations) and expenses (e.g. rent, utilities, telephone).  The loans have a 1.0% fixed interest rate and are due in 2 years. Initial repayments have been deferred for six months.  The loans are eligible for forgiveness subject to salary limitations and employee retention levels. Certain of our consolidated subsidiaries received four loans totaling $4.0 million.  We have accounted for the funds received as debt and recorded a liability for the full amount of proceeds received.  Interest will be accrued over the term of the loans.  If we meet the eligibility requirements for forgiveness the amounts forgiven will be recognized in the income statement as a gain on loan extinguishment in accordance with accounting guidance.</us-gaap:DebtAndCapitalLeasesDisclosuresTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMTAwOTk_fde67d44-14e8-4696-8eca-1cc655d75d95">&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2020 and December&#160;31, 2019 our debt obligations consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.953%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.273%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.840%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="12" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;First Lien Term Loans collateralized by RadNet's tangible and intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;620,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;649,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounts on First Lien Term Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,669)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,579)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SunTrust Term Loan Agreement collateralized by NJIN's tangible and intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Paycheck Protection Program loans at 1% due April 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment note payable at 4.6%, due through 2020, collateralized by medical equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;666,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;692,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39,463)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39,691)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long term portion debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;627,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;652,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:LongTermDebt
      contextRef="i2afc665ece974620b3ccc8ebbf0e35c7_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOjU1MzNmYWMwMWI4NDQ1NWY5MGM0ZjVmMjA5ZWY2NWNjL3RhYmxlcmFuZ2U6NTUzM2ZhYzAxYjg0NDU1ZjkwYzRmNWYyMDllZjY1Y2NfMi0xLTEtMS0w_b04fd261-7707-41af-900e-4771ba0d8183"
      unitRef="usd">620727000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i2fe2d4283d9e45e4ad2946e8fa2b5dad_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOjU1MzNmYWMwMWI4NDQ1NWY5MGM0ZjVmMjA5ZWY2NWNjL3RhYmxlcmFuZ2U6NTUzM2ZhYzAxYjg0NDU1ZjkwYzRmNWYyMDllZjY1Y2NfMi0zLTEtMS0w_a66e80d9-0844-4419-a64e-0c827af13d38"
      unitRef="usd">649824000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i2afc665ece974620b3ccc8ebbf0e35c7_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOjU1MzNmYWMwMWI4NDQ1NWY5MGM0ZjVmMjA5ZWY2NWNjL3RhYmxlcmFuZ2U6NTUzM2ZhYzAxYjg0NDU1ZjkwYzRmNWYyMDllZjY1Y2NfMy0xLTEtMS0w_10e2e41c-4181-44e3-8096-f9482bfd69bf"
      unitRef="usd">10669000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i2fe2d4283d9e45e4ad2946e8fa2b5dad_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOjU1MzNmYWMwMWI4NDQ1NWY5MGM0ZjVmMjA5ZWY2NWNjL3RhYmxlcmFuZ2U6NTUzM2ZhYzAxYjg0NDU1ZjkwYzRmNWYyMDllZjY1Y2NfMy0zLTEtMS0w_f1636cf4-8219-4205-8606-6b2cd121b24f"
      unitRef="usd">13579000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:LongTermDebt
      contextRef="i71fd7722d0aa4607b2773ebefd280d93_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOjU1MzNmYWMwMWI4NDQ1NWY5MGM0ZjVmMjA5ZWY2NWNjL3RhYmxlcmFuZ2U6NTUzM2ZhYzAxYjg0NDU1ZjkwYzRmNWYyMDllZjY1Y2NfNC0xLTEtMS0w_f7dc9d13-45c3-4601-9d4b-c9f7cba6b693"
      unitRef="usd">52500000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="if476d02b586946bfaa11a0d8851b0dc2_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOjU1MzNmYWMwMWI4NDQ1NWY5MGM0ZjVmMjA5ZWY2NWNjL3RhYmxlcmFuZ2U6NTUzM2ZhYzAxYjg0NDU1ZjkwYzRmNWYyMDllZjY1Y2NfNC0zLTEtMS0w_6fd0dd92-3d0f-47fb-8a06-9a7e62ffa589"
      unitRef="usd">55875000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i21f621247677495cadc7f88b6433f851_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOjU1MzNmYWMwMWI4NDQ1NWY5MGM0ZjVmMjA5ZWY2NWNjL3RhYmxlcmFuZ2U6NTUzM2ZhYzAxYjg0NDU1ZjkwYzRmNWYyMDllZjY1Y2NfNS0wLTEtMS0wL3RleHRyZWdpb246NTJhYTJiMzM5ZmRjNDQ3N2ExZmRlZmYzMzQ2ZGY3ZmNfMTIwOTQ2Mjc5MDU1OTY_eddaad40-49d4-4767-a292-7603579c8194"
      unitRef="number">0.01</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="id5ca3ff1c3f84af0b0834ea2b962f872_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOjU1MzNmYWMwMWI4NDQ1NWY5MGM0ZjVmMjA5ZWY2NWNjL3RhYmxlcmFuZ2U6NTUzM2ZhYzAxYjg0NDU1ZjkwYzRmNWYyMDllZjY1Y2NfNS0xLTEtMS0w_45d8cd93-391a-4a2c-aec0-4afcc86a19e2"
      unitRef="usd">4037000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic35d04f7e5d145f491a377cf89ff8da0_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOjU1MzNmYWMwMWI4NDQ1NWY5MGM0ZjVmMjA5ZWY2NWNjL3RhYmxlcmFuZ2U6NTUzM2ZhYzAxYjg0NDU1ZjkwYzRmNWYyMDllZjY1Y2NfNy0wLTEtMS0wL3RleHRyZWdpb246Nzg4NzA2MWJlOWZhNGM2NjkxN2M1MDdmODE5N2NmODZfMTIwOTQ2Mjc5MDU2Mjk_84aab597-bbc7-4ac0-a68e-302ddaa6bed2"
      unitRef="number">0.046</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermLoansPayable
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOjU1MzNmYWMwMWI4NDQ1NWY5MGM0ZjVmMjA5ZWY2NWNjL3RhYmxlcmFuZ2U6NTUzM2ZhYzAxYjg0NDU1ZjkwYzRmNWYyMDllZjY1Y2NfNy0xLTEtMS0w_d69941d5-290b-41e8-a4ac-0e37b327541b"
      unitRef="usd">47000</us-gaap:LongTermLoansPayable>
    <us-gaap:LongTermLoansPayable
      contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOjU1MzNmYWMwMWI4NDQ1NWY5MGM0ZjVmMjA5ZWY2NWNjL3RhYmxlcmFuZ2U6NTUzM2ZhYzAxYjg0NDU1ZjkwYzRmNWYyMDllZjY1Y2NfNy0zLTEtMS0w_2f360ed8-f05b-4acb-be50-81f39de7ebda"
      unitRef="usd">275000</us-gaap:LongTermLoansPayable>
    <rdnt:LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOjU1MzNmYWMwMWI4NDQ1NWY5MGM0ZjVmMjA5ZWY2NWNjL3RhYmxlcmFuZ2U6NTUzM2ZhYzAxYjg0NDU1ZjkwYzRmNWYyMDllZjY1Y2NfOC0xLTEtMS0w_94154eb1-14b7-4ba5-87d7-98b016b032f5"
      unitRef="usd">666642000</rdnt:LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities>
    <rdnt:LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities
      contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOjU1MzNmYWMwMWI4NDQ1NWY5MGM0ZjVmMjA5ZWY2NWNjL3RhYmxlcmFuZ2U6NTUzM2ZhYzAxYjg0NDU1ZjkwYzRmNWYyMDllZjY1Y2NfOC0zLTEtMS0w_aefb3df0-9f80-48db-9105-aeb58d10ca40"
      unitRef="usd">692395000</rdnt:LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities>
    <rdnt:LongtermDebtShorttermDebtandCapitalLeaseObligationsCurrentMaturities
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOjU1MzNmYWMwMWI4NDQ1NWY5MGM0ZjVmMjA5ZWY2NWNjL3RhYmxlcmFuZ2U6NTUzM2ZhYzAxYjg0NDU1ZjkwYzRmNWYyMDllZjY1Y2NfOS0xLTEtMS0w_3a2ac04d-d633-4c13-bee3-7d461866786a"
      unitRef="usd">39463000</rdnt:LongtermDebtShorttermDebtandCapitalLeaseObligationsCurrentMaturities>
    <rdnt:LongtermDebtShorttermDebtandCapitalLeaseObligationsCurrentMaturities
      contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOjU1MzNmYWMwMWI4NDQ1NWY5MGM0ZjVmMjA5ZWY2NWNjL3RhYmxlcmFuZ2U6NTUzM2ZhYzAxYjg0NDU1ZjkwYzRmNWYyMDllZjY1Y2NfOS0zLTEtMS0w_15a54079-1704-4727-ad7b-232cd1aea9a2"
      unitRef="usd">39691000</rdnt:LongtermDebtShorttermDebtandCapitalLeaseObligationsCurrentMaturities>
    <rdnt:LongtermDebtShorttermDebtandCapitalLeaseObligationsExcludingCurrentMaturities
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOjU1MzNmYWMwMWI4NDQ1NWY5MGM0ZjVmMjA5ZWY2NWNjL3RhYmxlcmFuZ2U6NTUzM2ZhYzAxYjg0NDU1ZjkwYzRmNWYyMDllZjY1Y2NfMTAtMS0xLTEtMA_e81e2224-f9e9-46cf-9bd2-12a4d39ba464"
      unitRef="usd">627179000</rdnt:LongtermDebtShorttermDebtandCapitalLeaseObligationsExcludingCurrentMaturities>
    <rdnt:LongtermDebtShorttermDebtandCapitalLeaseObligationsExcludingCurrentMaturities
      contextRef="i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOjU1MzNmYWMwMWI4NDQ1NWY5MGM0ZjVmMjA5ZWY2NWNjL3RhYmxlcmFuZ2U6NTUzM2ZhYzAxYjg0NDU1ZjkwYzRmNWYyMDllZjY1Y2NfMTAtMy0xLTEtMA_2d8c9fcb-28d3-40b9-9d59-3a45fe192be0"
      unitRef="usd">652704000</rdnt:LongtermDebtShorttermDebtandCapitalLeaseObligationsExcludingCurrentMaturities>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMTIwOTQ2Mjc5NTQ1OTc_6594dc1c-68e1-49e9-a0e8-4b40d40d48b4">&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Included in our condensed consolidated balance sheets at September&#160;30, 2020 are $620.7 million of First Lien Term Loans and $52.5 million of SunTrust Term Loan debt for a combined total of $673.2 million of total term loan debt (exclusive of unamortized discounts of  $10.7 million) in thousands: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.748%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.794%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.794%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.796%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Face Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;First Lien Term Loans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;620,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,669)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;610,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SunTrust Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Term Loans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;673,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,669)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;662,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i2afc665ece974620b3ccc8ebbf0e35c7_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMjE5OTAyMzMwMTMzNQ_d2b34795-378e-447a-a448-c6144f69d9d1"
      unitRef="usd">620700000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i71fd7722d0aa4607b2773ebefd280d93_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMjE5OTAyMzMwMTM2OA_baeb50b2-80b9-4a9a-81e1-cb35eea40c98"
      unitRef="usd">52500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ia9a34455b88e496f99f11135df67cea7_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMjE5OTAyMzMwMTQyMw_73dadce3-c8f2-433c-adc8-0c324ac06fb1"
      unitRef="usd">673200000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i0a84159a6d674db38efa7bbccb1be3e3_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMjE5OTAyMzMwMTQ5MQ_62629c21-6714-4a75-8d4c-8cd8cc364886"
      unitRef="usd">10700000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i2afc665ece974620b3ccc8ebbf0e35c7_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmUyNDEwM2ExOTUzOTQ1MmU5MWI5NDJhNTcyM2Q1MTRjL3RhYmxlcmFuZ2U6ZTI0MTAzYTE5NTM5NDUyZTkxYjk0MmE1NzIzZDUxNGNfMS0xLTEtMS0xNzU1_bbb8f098-bf0f-4540-bb18-9225124ed63b"
      unitRef="usd">620727000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet
      contextRef="i2afc665ece974620b3ccc8ebbf0e35c7_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmUyNDEwM2ExOTUzOTQ1MmU5MWI5NDJhNTcyM2Q1MTRjL3RhYmxlcmFuZ2U6ZTI0MTAzYTE5NTM5NDUyZTkxYjk0MmE1NzIzZDUxNGNfMS0zLTEtMS0xNzU1_4c6c3cc1-4d8a-49e7-8046-a72772868eaf"
      unitRef="usd">10669000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i2afc665ece974620b3ccc8ebbf0e35c7_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmUyNDEwM2ExOTUzOTQ1MmU5MWI5NDJhNTcyM2Q1MTRjL3RhYmxlcmFuZ2U6ZTI0MTAzYTE5NTM5NDUyZTkxYjk0MmE1NzIzZDUxNGNfMS01LTEtMS0xNzU1_cf8742cf-f4ff-4551-baec-c71a12958113"
      unitRef="usd">610058000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i71fd7722d0aa4607b2773ebefd280d93_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmUyNDEwM2ExOTUzOTQ1MmU5MWI5NDJhNTcyM2Q1MTRjL3RhYmxlcmFuZ2U6ZTI0MTAzYTE5NTM5NDUyZTkxYjk0MmE1NzIzZDUxNGNfMi0xLTEtMS0xNzU1_174bbb40-dab3-428d-b38a-5706cd8bd3ad"
      unitRef="usd">52500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet
      contextRef="i71fd7722d0aa4607b2773ebefd280d93_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmUyNDEwM2ExOTUzOTQ1MmU5MWI5NDJhNTcyM2Q1MTRjL3RhYmxlcmFuZ2U6ZTI0MTAzYTE5NTM5NDUyZTkxYjk0MmE1NzIzZDUxNGNfMi0zLTEtMS0xNzU1_423e001c-99f4-4af2-b962-4e2b356b83b6"
      unitRef="usd">0</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i71fd7722d0aa4607b2773ebefd280d93_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmUyNDEwM2ExOTUzOTQ1MmU5MWI5NDJhNTcyM2Q1MTRjL3RhYmxlcmFuZ2U6ZTI0MTAzYTE5NTM5NDUyZTkxYjk0MmE1NzIzZDUxNGNfMi01LTEtMS0xNzU1_2ff0186e-33fd-4150-b09d-694539fd6461"
      unitRef="usd">52500000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ia9a34455b88e496f99f11135df67cea7_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmUyNDEwM2ExOTUzOTQ1MmU5MWI5NDJhNTcyM2Q1MTRjL3RhYmxlcmFuZ2U6ZTI0MTAzYTE5NTM5NDUyZTkxYjk0MmE1NzIzZDUxNGNfMy0xLTEtMS0xNzU1_e6d8b119-ce36-4edf-8ff0-a142a99fff00"
      unitRef="usd">673227000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet
      contextRef="ia9a34455b88e496f99f11135df67cea7_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmUyNDEwM2ExOTUzOTQ1MmU5MWI5NDJhNTcyM2Q1MTRjL3RhYmxlcmFuZ2U6ZTI0MTAzYTE5NTM5NDUyZTkxYjk0MmE1NzIzZDUxNGNfMy0zLTEtMS0xNzU1_9badcd65-198e-435b-a83e-a99df9a234bc"
      unitRef="usd">10669000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ia9a34455b88e496f99f11135df67cea7_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmUyNDEwM2ExOTUzOTQ1MmU5MWI5NDJhNTcyM2Q1MTRjL3RhYmxlcmFuZ2U6ZTI0MTAzYTE5NTM5NDUyZTkxYjk0MmE1NzIzZDUxNGNfMy01LTEtMS0xNzU1_02919b8f-38ef-4efc-96f7-b97c297d6b0f"
      unitRef="usd">662558000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LineOfCredit
      contextRef="i505d1abebd8447a787b012d89a5eacb7_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMjE5OTAyMzMwMTUyMA_ce915ed4-5066-48a2-9d85-91d3e27ef2ea"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i1abfe8394b234eb5bbad4195a9ec0e60_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMjE5OTAyMzMwMTUyMA_d37250a6-14b6-40fd-a41d-319131f9dbb0"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i2b01a556be2b4c8ab3308ab426b040ab_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMjE5OTAyMzMwMTU0Mg_c1927e52-0cbd-4fc6-94db-913922b29452"
      unitRef="usd">195000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="iaf61ff95dda14ecdb11e6615b7e7633a_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMjE5OTAyMzMwMTYyMA_69f54b30-4726-4f1f-a6aa-df31bb53bdf7"
      unitRef="usd">6300000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="i42e0febe792a4db09dfe882d336f96bd_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMjE5OTAyMzMwMTY2OQ_2de1aa67-7a45-4c85-9f39-582b0f92066d"
      unitRef="usd">188700000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:LineOfCredit
      contextRef="iafc255d1386a4de3bf178436d2562022_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMjE5OTAyMzMwMTc2MQ_3ad43d87-4254-4b9c-b29c-a97718dc37dc"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ib9d01a93b2904f61b4796d8a81410b9e_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMjE5OTAyMzMwMTc4Mw_51da22f1-0fb4-454f-94ca-890e4b34f6d9"
      unitRef="usd">30000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i2b01a556be2b4c8ab3308ab426b040ab_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMzA4_c1927e52-0cbd-4fc6-94db-913922b29452"
      unitRef="usd">195000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ib9d01a93b2904f61b4796d8a81410b9e_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfNzE3_51da22f1-0fb4-454f-94ca-890e4b34f6d9"
      unitRef="usd">30000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="iaf61ff95dda14ecdb11e6615b7e7633a_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMTAxMw_5a169cae-3897-44d7-9663-1f867187dbdc"
      unitRef="usd">1900000</us-gaap:DeferredFinanceCostsNet>
    <rdnt:ScheduleOfLeverageRatioTableTextBlock
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMTAxMDU_331f653f-9875-407c-9b7f-0b9dba746026">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our First Lien Term Loans bear interest at either an Adjusted Eurodollar Rate or a Base Rate, plus an applicable margin according to the following schedule:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:89.181%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.850%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.342%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.508%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;First Lien Leverage Ratio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Eurodollar Rate Spread&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Base Rate Spread&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&amp;gt; 5.50x&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.50%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&amp;gt; 4.00x but &#x2264; 5.50x&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.75%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.75%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&amp;gt;3.50x but &#x2264; 4.00x&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.50%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2264; 3.50x&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our SunTrust Term Loan bears interest at either an Adjusted Eurodollar Rate or a Base Rate, plus an applicable margin according to the following schedule:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:93.859%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.713%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.099%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.099%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pricing Level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Leverage Ratio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Applicable Margin for Eurodollar Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Applicable Margin for Base Rate Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Applicable Margin for Letter of Credit Fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Applicable Percentage for Commitment Fee&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;I&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than or equal to 3.00:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.75%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.75%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.45%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;II&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than 3.00:1.00 but greater than or equal to 2.50:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.25%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.40%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;III&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt;padding-right:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than 2.50:1.00 but greater than or equal to&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt;padding-right:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.00%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.35%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IV&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than 2.00:1.00 but greater than or equal to 1.50:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.75%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.30%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;V&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than 1.50:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.50%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.30%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</rdnt:ScheduleOfLeverageRatioTableTextBlock>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i843b248c0d484e4c80e2fdd2f502195c_D20160701-20160701"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOjNmYmE5ZjYwZWRjYzQ4NDM4N2UwZTRjZmE2MzE4YzBhL3RhYmxlcmFuZ2U6M2ZiYTlmNjBlZGNjNDg0Mzg3ZTBlNGNmYTYzMThjMGFfMS0xLTEtMS0w_17b2a799-27c7-43fd-ab5f-cf7d7a6faee3"
      unitRef="number">0.0450</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i1b15ecede84f41abb4d034630198d257_D20160701-20160701"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOjNmYmE5ZjYwZWRjYzQ4NDM4N2UwZTRjZmE2MzE4YzBhL3RhYmxlcmFuZ2U6M2ZiYTlmNjBlZGNjNDg0Mzg3ZTBlNGNmYTYzMThjMGFfMS0yLTEtMS0w_9a50e751-a6fc-4b2f-a346-fe6c680a0e61"
      unitRef="number">0.0350</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i9aab2f0d56d34189a074316bda4c4b67_D20160701-20160701"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOjNmYmE5ZjYwZWRjYzQ4NDM4N2UwZTRjZmE2MzE4YzBhL3RhYmxlcmFuZ2U6M2ZiYTlmNjBlZGNjNDg0Mzg3ZTBlNGNmYTYzMThjMGFfMi0xLTEtMS0w_af662e66-3f31-4cbc-bdcd-2144aa463e7f"
      unitRef="number">0.0375</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ic02a9a741f3842eea3e3a5a7eb322904_D20160701-20160701"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOjNmYmE5ZjYwZWRjYzQ4NDM4N2UwZTRjZmE2MzE4YzBhL3RhYmxlcmFuZ2U6M2ZiYTlmNjBlZGNjNDg0Mzg3ZTBlNGNmYTYzMThjMGFfMi0yLTEtMS0w_a8b55502-cb5e-4391-929e-16fae0e9ec21"
      unitRef="number">0.0275</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i0b849e478e084b868c575f20c8653b78_D20160701-20160701"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOjNmYmE5ZjYwZWRjYzQ4NDM4N2UwZTRjZmE2MzE4YzBhL3RhYmxlcmFuZ2U6M2ZiYTlmNjBlZGNjNDg0Mzg3ZTBlNGNmYTYzMThjMGFfMy0xLTEtMS0w_9bf57efc-46c3-4783-9a0e-d5f301a2b177"
      unitRef="number">0.0350</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i8684bb7afe064ac9983fbd954121786d_D20160701-20160701"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOjNmYmE5ZjYwZWRjYzQ4NDM4N2UwZTRjZmE2MzE4YzBhL3RhYmxlcmFuZ2U6M2ZiYTlmNjBlZGNjNDg0Mzg3ZTBlNGNmYTYzMThjMGFfMy0yLTEtMS0w_0a52f936-cd83-40c2-9874-0b4c3367ff9a"
      unitRef="number">0.0250</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ib1a02d97b28646ba996e0c7e95b82bdd_D20160701-20160701"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOjNmYmE5ZjYwZWRjYzQ4NDM4N2UwZTRjZmE2MzE4YzBhL3RhYmxlcmFuZ2U6M2ZiYTlmNjBlZGNjNDg0Mzg3ZTBlNGNmYTYzMThjMGFfNC0xLTEtMS0w_c9e11312-a338-4863-b333-cc19174aedaa"
      unitRef="number">0.0325</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i437bbb2e361f476fa45f34fff448bb87_D20160701-20160701"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOjNmYmE5ZjYwZWRjYzQ4NDM4N2UwZTRjZmE2MzE4YzBhL3RhYmxlcmFuZ2U6M2ZiYTlmNjBlZGNjNDg0Mzg3ZTBlNGNmYTYzMThjMGFfNC0yLTEtMS0w_6aac9446-7c14-431a-b6cb-0464464ed95c"
      unitRef="number">0.0225</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="i82c3ce35d9e9413e9de0e1feba63291d_I20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfNDg4Mw_dd98d292-91dd-476f-b623-bfeac401bf16"
      unitRef="number">0.0100</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="i6eb5d73b46ce44f6be703ba3df195553_I20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfNDg5MA_f0d64618-9a92-4276-80e4-6fa9d8f36aaa"
      unitRef="number">0.0325</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="icbbf618e1bfe4a609b2387b2599710eb_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfNDk5MQ_a9c70cc3-f9dd-4967-ad1d-8234c1f73d07"
      unitRef="number">0.0375</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i36ad65e4b32d4d83a34c87cef93670a7_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfNDk5OA_c2acbfab-8165-4b73-aff2-8e1c88028f3b"
      unitRef="number">0.0275</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="i88ef47c29fec45228c446b6058e13c36_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMjE5OTAyMzMwNDE5Ng_1ebeaf77-b1df-49e3-9439-8a3fc2e9f6f2"
      unitRef="usd">9700000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum
      contextRef="ia5c31aa95d9342c4ba31e43e8ecb8e1f_I20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmI5NDhmMjIwMDhmZDQ2MjU5MTJiNzU0NjJkMDcwNGMzL3RhYmxlcmFuZ2U6Yjk0OGYyMjAwOGZkNDYyNTkxMmI3NTQ2MmQwNzA0YzNfMS0xLTEtMS0zMDMxL3RleHRyZWdpb246NmJiOTRiMzUyYjQ1NDE0MTkxNWJkYjJiODI0ZTA4MmVfMTY0OTI2NzQ0MTcwNg_f9625a03-eb52-4c90-a331-b325e5d29d64"
      unitRef="number">3.00</rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="icb9718af7bcb4577b02afe00cd03dadd_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmI5NDhmMjIwMDhmZDQ2MjU5MTJiNzU0NjJkMDcwNGMzL3RhYmxlcmFuZ2U6Yjk0OGYyMjAwOGZkNDYyNTkxMmI3NTQ2MmQwNzA0YzNfMS0yLTEtMS0zMDU4L3RleHRyZWdpb246MDJmYTQ1NzA1YTk0NDFhNzgxNGJhZjIwZDczY2UxYTBfMTY0OTI2NzQ0MTY5Nw_ca3eab2d-1fd1-4692-93af-ca58747ae244"
      unitRef="number">0.0275</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i640e0341ae9546acb37a3b43ce1eba05_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmI5NDhmMjIwMDhmZDQ2MjU5MTJiNzU0NjJkMDcwNGMzL3RhYmxlcmFuZ2U6Yjk0OGYyMjAwOGZkNDYyNTkxMmI3NTQ2MmQwNzA0YzNfMS0zLTEtMS0zMDU1L3RleHRyZWdpb246Nzk2MmZmMDNkNTgzNGQ2YThkYzRhZDU4YmIyZGU0NmVfMTY0OTI2NzQ0MTY4OQ_aa82a150-d5d3-4ea9-b6bc-dff04d49b0bd"
      unitRef="number">0.0175</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i5c9e317de1694916936baac47457baad_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmI5NDhmMjIwMDhmZDQ2MjU5MTJiNzU0NjJkMDcwNGMzL3RhYmxlcmFuZ2U6Yjk0OGYyMjAwOGZkNDYyNTkxMmI3NTQ2MmQwNzA0YzNfMS00LTEtMS0zMDY0L3RleHRyZWdpb246ZDdkODZmN2M5MTA3NDIyNmFmYzk5YjNiYTIyMjYxN2JfMTY0OTI2NzQ0MTY5Nw_5b11239a-b6f2-4056-840f-afb1d434b563"
      unitRef="number">0.0275</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="i5c9e317de1694916936baac47457baad_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmI5NDhmMjIwMDhmZDQ2MjU5MTJiNzU0NjJkMDcwNGMzL3RhYmxlcmFuZ2U6Yjk0OGYyMjAwOGZkNDYyNTkxMmI3NTQ2MmQwNzA0YzNfMS01LTEtMS0zMDYxL3RleHRyZWdpb246MTc3MDRjMjg3NWY2NDdiNzk1YmRiMWMzMTVhNjdjODlfMTY0OTI2NzQ0MTY4OQ_ba960594-88a8-4bf4-9556-0cb0b594dd5a"
      unitRef="number">0.0045</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <rdnt:DebtInstrumentCovenantLeverageRatioMaximum
      contextRef="i5ffaf7ff24bc4ca493fd2b08c7ff3a25_I20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmI5NDhmMjIwMDhmZDQ2MjU5MTJiNzU0NjJkMDcwNGMzL3RhYmxlcmFuZ2U6Yjk0OGYyMjAwOGZkNDYyNTkxMmI3NTQ2MmQwNzA0YzNfMi0xLTEtMS0zMDM0L3RleHRyZWdpb246MDA0NzFiNzhiOWYxNDk5NThjZmU5MTliNjM1YjYyNmJfMTY0OTI2NzQ0MTczNw_bf2875b6-2dd3-48a6-91ca-40f695723b61"
      unitRef="number">3.00</rdnt:DebtInstrumentCovenantLeverageRatioMaximum>
    <rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum
      contextRef="i5ffaf7ff24bc4ca493fd2b08c7ff3a25_I20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmI5NDhmMjIwMDhmZDQ2MjU5MTJiNzU0NjJkMDcwNGMzL3RhYmxlcmFuZ2U6Yjk0OGYyMjAwOGZkNDYyNTkxMmI3NTQ2MmQwNzA0YzNfMi0xLTEtMS0zMDM0L3RleHRyZWdpb246MDA0NzFiNzhiOWYxNDk5NThjZmU5MTliNjM1YjYyNmJfMTY0OTI2NzQ0MTczMA_b7cfc392-211f-4102-8336-2f8d2fced6e2"
      unitRef="number">2.50</rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i2f5089184ad64416acfb6e9f45e20056_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmI5NDhmMjIwMDhmZDQ2MjU5MTJiNzU0NjJkMDcwNGMzL3RhYmxlcmFuZ2U6Yjk0OGYyMjAwOGZkNDYyNTkxMmI3NTQ2MmQwNzA0YzNfMi0yLTEtMS0zMDc2L3RleHRyZWdpb246NGU1MTFmZmRjNjNlNDMwOWFmODg2Y2VjODA5NWVhZDdfMTY0OTI2NzQ0MTY4OQ_b7ddcf8b-0704-47cf-bf7f-6690c9980073"
      unitRef="number">0.0225</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i0e66507e91084592ad6ec96e2082905e_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmI5NDhmMjIwMDhmZDQ2MjU5MTJiNzU0NjJkMDcwNGMzL3RhYmxlcmFuZ2U6Yjk0OGYyMjAwOGZkNDYyNTkxMmI3NTQ2MmQwNzA0YzNfMi0zLTEtMS0zMDcwL3RleHRyZWdpb246YzkyZGVmMTZlN2RiNDdjODllNzZhNTk5YzRmOTI5MThfMTY0OTI2NzQ0MTY4OQ_544e8427-e2e3-4d10-835d-785e50bf591e"
      unitRef="number">0.0125</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="ie2a7f7080321422c81221d552960c25c_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmI5NDhmMjIwMDhmZDQ2MjU5MTJiNzU0NjJkMDcwNGMzL3RhYmxlcmFuZ2U6Yjk0OGYyMjAwOGZkNDYyNTkxMmI3NTQ2MmQwNzA0YzNfMi00LTEtMS0zMDczL3RleHRyZWdpb246NTFjOGMwNDg5NDE2NDJlNGFiNTU5NGFjZTYyNGI0ZjVfMTY0OTI2NzQ0MTY5Nw_1d0c4faa-0194-4d2c-86e4-cdf7c6889a98"
      unitRef="number">0.0225</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="ie2a7f7080321422c81221d552960c25c_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmI5NDhmMjIwMDhmZDQ2MjU5MTJiNzU0NjJkMDcwNGMzL3RhYmxlcmFuZ2U6Yjk0OGYyMjAwOGZkNDYyNTkxMmI3NTQ2MmQwNzA0YzNfMi01LTEtMS0zMDY3L3RleHRyZWdpb246NTIyYjdiMmZkMDdhNGVkYWEwMDlhZWQ4MjU3Y2I2ZjNfMTY0OTI2NzQ0MTY4OQ_12e66f6d-c286-4e60-85d0-0401d6634b5f"
      unitRef="number">0.0040</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <rdnt:DebtInstrumentCovenantLeverageRatioMaximum
      contextRef="i26e31c72794a4556a79b247236f494e6_I20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmI5NDhmMjIwMDhmZDQ2MjU5MTJiNzU0NjJkMDcwNGMzL3RhYmxlcmFuZ2U6Yjk0OGYyMjAwOGZkNDYyNTkxMmI3NTQ2MmQwNzA0YzNfMy0xLTEtMS0zMDQwL3RleHRyZWdpb246MjA2ODAzNTQ4OWEyNGY0ZGE4ZjNjNDkxZjFhMzcwNTFfMTY0OTI2NzQ0MTc0Nw_6771ebe2-aefa-4b06-ae94-5fb9c7864bce"
      unitRef="number">2.50</rdnt:DebtInstrumentCovenantLeverageRatioMaximum>
    <rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum
      contextRef="i26e31c72794a4556a79b247236f494e6_I20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmI5NDhmMjIwMDhmZDQ2MjU5MTJiNzU0NjJkMDcwNGMzL3RhYmxlcmFuZ2U6Yjk0OGYyMjAwOGZkNDYyNTkxMmI3NTQ2MmQwNzA0YzNfMy0xLTEtMS0zMDQwL3RleHRyZWdpb246MjA2ODAzNTQ4OWEyNGY0ZGE4ZjNjNDkxZjFhMzcwNTFfMTY0OTI2NzQ0MTczOA_cb4a9dfa-088b-4e87-9b25-5518e05c0795"
      unitRef="number">2.00</rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i5f63a8341b184981a270daf0995422d2_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmI5NDhmMjIwMDhmZDQ2MjU5MTJiNzU0NjJkMDcwNGMzL3RhYmxlcmFuZ2U6Yjk0OGYyMjAwOGZkNDYyNTkxMmI3NTQ2MmQwNzA0YzNfMy0yLTEtMS0zMDg4L3RleHRyZWdpb246NzU2YjFkZGVjZDJkNGU3ZWE1ZWFkMzM3NzU4NmY2MjhfMTY0OTI2NzQ0MTY4OQ_bce5eb7f-a520-43ad-8784-68f6d466b21c"
      unitRef="number">0.0200</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i5a2cdf61ca404c6b9eaecf77fe17e670_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmI5NDhmMjIwMDhmZDQ2MjU5MTJiNzU0NjJkMDcwNGMzL3RhYmxlcmFuZ2U6Yjk0OGYyMjAwOGZkNDYyNTkxMmI3NTQ2MmQwNzA0YzNfMy0zLTEtMS0zMDk3L3RleHRyZWdpb246NjcwODJhOTg5YWY3NDE5OTgxODczNjg0OGQzM2ZjZDFfMTY0OTI2NzQ0MTY4OQ_097966c6-9a93-47a4-a76d-cca73161b93b"
      unitRef="number">0.0100</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i213ea2bff4394c6288e6955b70cfbd38_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmI5NDhmMjIwMDhmZDQ2MjU5MTJiNzU0NjJkMDcwNGMzL3RhYmxlcmFuZ2U6Yjk0OGYyMjAwOGZkNDYyNTkxMmI3NTQ2MmQwNzA0YzNfMy00LTEtMS0zMTAwL3RleHRyZWdpb246YTgyNjkwNzQ4NjliNGQzOTg3ZGRlM2NlZWNhMjBkNGZfMTY0OTI2NzQ0MTY5Nw_e0371de2-937a-461c-ba26-cf5e9bdf4539"
      unitRef="number">0.0200</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="i213ea2bff4394c6288e6955b70cfbd38_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmI5NDhmMjIwMDhmZDQ2MjU5MTJiNzU0NjJkMDcwNGMzL3RhYmxlcmFuZ2U6Yjk0OGYyMjAwOGZkNDYyNTkxMmI3NTQ2MmQwNzA0YzNfMy01LTEtMS0zMDgyL3RleHRyZWdpb246MDI1Nzk5MWQ3YjFkNDk3Yzg3M2UwN2UwYjVlOGJiN2NfMTY0OTI2NzQ0MTY5Nw_fc8c8d97-b69a-4424-ba7f-732fb20ab463"
      unitRef="number">0.0035</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <rdnt:DebtInstrumentCovenantLeverageRatioMaximum
      contextRef="i0b253bd7f2ce411085bd510025d25d34_I20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmI5NDhmMjIwMDhmZDQ2MjU5MTJiNzU0NjJkMDcwNGMzL3RhYmxlcmFuZ2U6Yjk0OGYyMjAwOGZkNDYyNTkxMmI3NTQ2MmQwNzA0YzNfNC0xLTEtMS0zMDM3L3RleHRyZWdpb246ZDM3MWExMTk4ZmIzNDRlN2EzZDY2NjQ3MzhiMWZjZDVfMTY0OTI2NzQ0MTczNw_e28f4de4-0221-417f-947e-2587dc785c7f"
      unitRef="number">2.00</rdnt:DebtInstrumentCovenantLeverageRatioMaximum>
    <rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum
      contextRef="i0b253bd7f2ce411085bd510025d25d34_I20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmI5NDhmMjIwMDhmZDQ2MjU5MTJiNzU0NjJkMDcwNGMzL3RhYmxlcmFuZ2U6Yjk0OGYyMjAwOGZkNDYyNTkxMmI3NTQ2MmQwNzA0YzNfNC0xLTEtMS0zMDM3L3RleHRyZWdpb246ZDM3MWExMTk4ZmIzNDRlN2EzZDY2NjQ3MzhiMWZjZDVfMTY0OTI2NzQ0MTczMA_401bdd6c-f8ad-457b-8c2f-60269068de23"
      unitRef="number">1.50</rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i0d4647b913524ddf926d5badbccce1c9_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmI5NDhmMjIwMDhmZDQ2MjU5MTJiNzU0NjJkMDcwNGMzL3RhYmxlcmFuZ2U6Yjk0OGYyMjAwOGZkNDYyNTkxMmI3NTQ2MmQwNzA0YzNfNC0yLTEtMS0zMDkxL3RleHRyZWdpb246ZmE0YjRjZmFhZmUyNGY5YzgzZWU0NjI0ZGFiNWE5YWFfMTY0OTI2NzQ0MTY4OQ_39c33df9-5d6b-48a0-ac5b-29b9e49c3d61"
      unitRef="number">0.0175</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i0e02d8d2117c46f3b37af31ddd457d1b_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmI5NDhmMjIwMDhmZDQ2MjU5MTJiNzU0NjJkMDcwNGMzL3RhYmxlcmFuZ2U6Yjk0OGYyMjAwOGZkNDYyNTkxMmI3NTQ2MmQwNzA0YzNfNC0zLTEtMS0zMTA2L3RleHRyZWdpb246YjJmMTYzZGFmNmEyNGFiYWI4ZTkyY2FiMTQ3NmU1YmZfMTY0OTI2NzQ0MTY4OQ_b88ae1d1-2d01-400f-a937-1a0ddc4af1ca"
      unitRef="number">0.0075</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i0a4736e633334391ba86255660511b78_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmI5NDhmMjIwMDhmZDQ2MjU5MTJiNzU0NjJkMDcwNGMzL3RhYmxlcmFuZ2U6Yjk0OGYyMjAwOGZkNDYyNTkxMmI3NTQ2MmQwNzA0YzNfNC00LTEtMS0zMTA5L3RleHRyZWdpb246NWE0Y2ZkYjI0OGQzNGEzNWEyOWI5YjUyMzg1MWVhZGNfMTY0OTI2NzQ0MTY4OQ_d8109db9-a528-45a5-ac9f-27b116bcd69e"
      unitRef="number">0.0175</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="i0a4736e633334391ba86255660511b78_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmI5NDhmMjIwMDhmZDQ2MjU5MTJiNzU0NjJkMDcwNGMzL3RhYmxlcmFuZ2U6Yjk0OGYyMjAwOGZkNDYyNTkxMmI3NTQ2MmQwNzA0YzNfNC01LTEtMS0zMDc5L3RleHRyZWdpb246ZmI1OGMzY2JlYWY5NDBkNTkyYmFiYzk4MWU1ODNmNmFfMTY0OTI2NzQ0MTY4OQ_bae33007-5c74-4de8-aa9a-6a0e7ef62eea"
      unitRef="number">0.0030</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <rdnt:DebtInstrumentCovenantLeverageRatioMaximum
      contextRef="id619046e0cd648adbb423bb179acab8e_I20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmI5NDhmMjIwMDhmZDQ2MjU5MTJiNzU0NjJkMDcwNGMzL3RhYmxlcmFuZ2U6Yjk0OGYyMjAwOGZkNDYyNTkxMmI3NTQ2MmQwNzA0YzNfNS0xLTEtMS0zMDUyL3RleHRyZWdpb246YjhmNGFjODM3ODVjNDJjNzk4N2FiNGExMWM5MmEyZDlfMTY0OTI2NzQ0MTY5MQ_45090367-23fb-46a3-a462-95e2399ccbb2"
      unitRef="number">1.50</rdnt:DebtInstrumentCovenantLeverageRatioMaximum>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="iae42d0b5f76b4c879b3f0f43f04b1aed_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmI5NDhmMjIwMDhmZDQ2MjU5MTJiNzU0NjJkMDcwNGMzL3RhYmxlcmFuZ2U6Yjk0OGYyMjAwOGZkNDYyNTkxMmI3NTQ2MmQwNzA0YzNfNS0yLTEtMS0zMDk0L3RleHRyZWdpb246OTEyYmM0NGVkNDgwNDQxOWIyYjUwNjA5NjVlNmU2ODZfMTY0OTI2NzQ0MTY4OQ_9dedfec1-d23d-4245-8781-261bc65d7340"
      unitRef="number">0.0150</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ic7de0702b16e423a8f2781f8ef6aa693_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmI5NDhmMjIwMDhmZDQ2MjU5MTJiNzU0NjJkMDcwNGMzL3RhYmxlcmFuZ2U6Yjk0OGYyMjAwOGZkNDYyNTkxMmI3NTQ2MmQwNzA0YzNfNS0zLTEtMS0zMTAzL3RleHRyZWdpb246YmYwZjQyMzg0YjAxNGFmNzg2MjNjMmUyZTU1ZTk3YzVfMTY0OTI2NzQ0MTY4OQ_de7f24c3-6531-4098-94d3-140e1fd5aa12"
      unitRef="number">0.0050</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="ia9129b65b01747c292ade5e736c79ab6_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmI5NDhmMjIwMDhmZDQ2MjU5MTJiNzU0NjJkMDcwNGMzL3RhYmxlcmFuZ2U6Yjk0OGYyMjAwOGZkNDYyNTkxMmI3NTQ2MmQwNzA0YzNfNS00LTEtMS0zMTEyL3RleHRyZWdpb246ZGI4OGRjNzU2MGFmNDM5NzkyYTA5Y2RjNTVhZTAxMTRfMTY0OTI2NzQ0MTY4OQ_9a0c9b30-ffbb-43ab-8f78-12944e65cbb2"
      unitRef="number">0.0150</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="ia9129b65b01747c292ade5e736c79ab6_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RhYmxlOmI5NDhmMjIwMDhmZDQ2MjU5MTJiNzU0NjJkMDcwNGMzL3RhYmxlcmFuZ2U6Yjk0OGYyMjAwOGZkNDYyNTkxMmI3NTQ2MmQwNzA0YzNfNS01LTEtMS0zMDg1L3RleHRyZWdpb246NjZiYzNmMTRkMjk1NDA3ZThjYzQ4NGU1MDkzMGE0Y2NfMTY0OTI2NzQ0MTY5Nw_13476861-b073-4aa6-9b90-723de842f457"
      unitRef="number">0.0030</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i3a832ef6cbe04ce4bb0e0da41889582d_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMjE5OTAyMzI4MjA0OA_d735acef-b3ce-412b-b81b-9579d3f60b60"
      unitRef="number">0.0200</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="if922a8b092874f639caee5acc1fd1a61_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMjE5OTAyMzMwNDU4Ng_655c00c6-2a50-4a04-a639-675761e44d7e"
      unitRef="usd">800000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <rdnt:DebtInstrumentPeriodicPaymentPercent
      contextRef="if922a8b092874f639caee5acc1fd1a61_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMjE5OTAyMzMwNDU3MQ_431ea55e-9f4c-44ec-b964-93e380735850"
      unitRef="number">0.0500</rdnt:DebtInstrumentPeriodicPaymentPercent>
    <rdnt:DebtInstrumentPeriodicPaymentTermsAmortizationIncrease
      contextRef="id655214ccff949e495e113e479f89eba_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMjE5OTAyMzMwNDYwNA_215cad6d-091f-47f1-90f0-f487fee8e761"
      unitRef="usd">400000</rdnt:DebtInstrumentPeriodicPaymentTermsAmortizationIncrease>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="iaf61ff95dda14ecdb11e6615b7e7633a_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMzI5ODUzNDkxMjQxOA_713207f6-4d46-4d44-b314-d7101fc3e8a4"
      unitRef="number">0.0600</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="icbbf618e1bfe4a609b2387b2599710eb_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMzI5ODUzNDkxMjYwMw_a9c70cc3-f9dd-4967-ad1d-8234c1f73d07"
      unitRef="number">0.0375</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="if5fdeeaa617f45bc8b5b2de98d538da7_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMzI5ODUzNDkxMjYzNw_2455857a-c428-4e64-8d8c-45d0ba3ecc65"
      unitRef="number">0.0025</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="if5fdeeaa617f45bc8b5b2de98d538da7_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMzI5ODUzNDkxMjgzOQ_2810d711-c6cf-4660-9a26-6a6d6d28e17f"
      unitRef="number">0.0050</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <rdnt:LineofCreditFacilityIncreaseBorrowingCapacity
      contextRef="i2b01a556be2b4c8ab3308ab426b040ab_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMzI5ODUzNDkxNTEwMA_55612a07-02e2-4010-8ef5-56cc9d2366e7"
      unitRef="usd">57500000</rdnt:LineofCreditFacilityIncreaseBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i2b01a556be2b4c8ab3308ab426b040ab_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMzI5ODUzNDkxNTE3NA_c1927e52-0cbd-4fc6-94db-913922b29452"
      unitRef="usd">195000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="i2b01a556be2b4c8ab3308ab426b040ab_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMzI5ODUzNDkxNTI2Ng_8930bab3-7fee-42b4-9d06-0f5f04adadff"
      unitRef="usd">700000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ib9d01a93b2904f61b4796d8a81410b9e_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMzI5ODUzNDkxOTUxMQ_51da22f1-0fb4-454f-94ca-890e4b34f6d9"
      unitRef="usd">30000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <rdnt:LineofCreditFacilityIncreaseBorrowingCapacity
      contextRef="i2b01a556be2b4c8ab3308ab426b040ab_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMjE5OTAyMzI4MjM2OA_55612a07-02e2-4010-8ef5-56cc9d2366e7"
      unitRef="usd">57500000</rdnt:LineofCreditFacilityIncreaseBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i2b01a556be2b4c8ab3308ab426b040ab_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMjE5OTAyMzI4MjUxOQ_c1927e52-0cbd-4fc6-94db-913922b29452"
      unitRef="usd">195000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="i2b01a556be2b4c8ab3308ab426b040ab_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMjE5OTAyMzI4MjY2OQ_8930bab3-7fee-42b4-9d06-0f5f04adadff"
      unitRef="usd">700000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:LineOfCredit
      contextRef="i34109ecc091e412a9dbd8651e8bb4f2e_I20170822"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMjE5OTAyMzI4MzI3Mg_d737b96f-58ab-42ea-ac84-7ee28b64c744"
      unitRef="usd">100000000.0</us-gaap:LineOfCredit>
    <rdnt:LineofCreditFacilityIncreaseBorrowingCapacity
      contextRef="i978f7eac6654400d951615a49c92ee12_I20190418"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMjE5OTAyMzI4MzMzOA_a6f0e736-fee4-47cb-920a-06296807602f"
      unitRef="usd">20000000.0</rdnt:LineofCreditFacilityIncreaseBorrowingCapacity>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="i8cca9d99b9324bd1b781038f68dc4e2f_I20190418"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMjE5OTAyMzI4Mzc2Ng_9c2ca9da-7ab6-41ca-8aeb-ce29a2e1520e"
      unitRef="usd">4400000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:DebtInstrumentUnamortizedDiscountCurrent
      contextRef="i8cca9d99b9324bd1b781038f68dc4e2f_I20190418"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMjE5OTAyMzI4Mzc4Nw_e1ea3946-3ae5-4122-9444-12c15cd68812"
      unitRef="usd">2100000</us-gaap:DebtInstrumentUnamortizedDiscountCurrent>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i8cca9d99b9324bd1b781038f68dc4e2f_I20190418"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMjE5OTAyMzI4Mzg0Mw_959db7c4-eb5a-4cd0-a7c6-75f1551c2b6a"
      unitRef="usd">700000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:AmortizationOfDeferredCharges
      contextRef="ib5b7a6ac8167458194c44af4ba48c5bd_D20190418-20190418"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMjE5OTAyMzI4Mzg5Ng_3190007c-3690-4ef1-b179-a10ee7b4e0d6"
      unitRef="usd">1600000</us-gaap:AmortizationOfDeferredCharges>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="icd0727e676b44495b92424a21cfd803d_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMjE5OTAyMzI3MTQxOQ_3c2d6232-3f78-409b-836f-f8d161aa9c6b"
      unitRef="number">0.010</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentTerm
      contextRef="i965d7b0c650248aeb676ce27ef4835ab_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMjE5OTAyMzI3MTQ1OA_6caa1905-3e82-4b6b-be68-88efacda9ee5">P2Y</us-gaap:DebtInstrumentTerm>
    <rdnt:DebtInstrumentNumberofLoansReceived
      contextRef="i965d7b0c650248aeb676ce27ef4835ab_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMjE5OTAyMzI3MTY2OA_b493ec2f-f73c-491d-a499-e081c1a71c30"
      unitRef="loan">4</rdnt:DebtInstrumentNumberofLoansReceived>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="icd0727e676b44495b92424a21cfd803d_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl81NS9mcmFnOjAwNzkxYTk0YjZmYzRmZTdhYWM5ZjZkYjJhOTFjMTQzL3RleHRyZWdpb246MDA3OTFhOTRiNmZjNGZlN2FhYzlmNmRiMmE5MWMxNDNfMjE5OTAyMzI3MTY4Nw_bf55d90a-c502-4cbb-92d8-f316a5a03cc4"
      unitRef="usd">4000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RleHRyZWdpb246NjYzNDIxNWY0ZWM0NGI4OTg5ZDVkMDk4MGZhYmM4MTdfMzM0Nw_52697d85-c6c4-43b7-a258-1938b2414788">STOCK-BASED COMPENSATIONStock Incentive Plans&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have one long-term equity incentive plan which we refer to as the 2006 Equity Incentive Plan, which we first amended and restated as of April 20, 2015 and again on March 9, 2017 (the "Restated Plan&#x201d;). The Restated Plan was approved by our stockholders at our annual stockholders meeting on June 8, 2017. We have reserved for issuance under the Restated Plan 14,000,000 shares of common stock. We can issue options (incentive and non-qualified), stock awards, stock appreciation rights, stock units and cash awards under the Restated Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain options granted under the Restated Plan to employees are intended to qualify as incentive stock options under existing tax regulations. Stock options generally vest over 3 to 5 years and expire 5 to 10 years from the date of grant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2020, we had outstanding options to acquire 527,899 shares of our common stock, of which options to acquire 298,863 shares were exercisable. The following summarizes all of our option transactions for the nine months ended September&#160;30, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.973%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Outstanding Options&lt;br/&gt;Under the 2006 Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Exercise price&lt;br/&gt;Per Common Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual Life&lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;478,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;527,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.59&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,419,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;298,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.85&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,353,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Aggregate intrinsic value in the table above represents the total pretax intrinsic value (the difference between our closing stock price on September&#160;30, 2020 and the exercise price, multiplied by the number of in-the-money options as applicable) that would have been received by the holder had all holders exercised their options on September&#160;30, 2020. No options were exercised during the nine months ended September&#160;30, 2020.  As of September&#160;30, 2020, total unrecognized stock-based compensation expense related to non-vested employee awards was $0.7 million which is expected to be recognized over a weighted average period of approximately 1.68 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:174%"&gt;DeepHealth Options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the second quarter of fiscal 2020, in connection with the completion of the DeepHealth acquisition, we granted&#160;412,434&#160;options at a grant date fair value of $16.93&#160;per share unit to DeepHealth employees in replacement of their stock options that were outstanding as of the closing date.  As of September&#160;30, 2020, total unrecognized stock based compensation expense related to non-vested DeepHealth options was approximately $4.3 million which is expected to be recognized over a weighted average period of approximately 2.53 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.836%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.506%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.587%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.587%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.587%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.587%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.713%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Outstanding Options&lt;br/&gt;Under the Deep Health Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Exercise price&lt;br/&gt;Per Common Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual Life&lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted, June 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;412,434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,963)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;405,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.65&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,223,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.65&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;371,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Stock Awards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Restated Plan permits the award of restricted stock awards (&#x201c;RSA&#x2019;s&#x201d;). As of September&#160;30, 2020, we have issued a total of 6,551,872 RSA&#x2019;s of which 331,659 were unvested at September&#160;30, 2020. The following summarizes all unvested RSA&#x2019;s activities during the nine months ended September&#160;30, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;RSA's&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSA's unvested at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;387,934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;457,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(513,871)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSA's unvested at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;331,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.11&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We determine the fair value of all RSA&#x2019;s based on the closing price of our common stock on the award date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other stock bonus awards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Restated Plan also permits the award of stock bonuses not subject to any future service period. These awards are valued and expensed based on the closing price of our common stock on the date of award. During the nine months ended September&#160;30, 2020 awards totaling 26,078 shares were granted.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Plan summary&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In summary, of the 14,000,000 shares of common stock reserved for issuance under the Restated Plan, at September&#160;30, 2020, we had issued 15,384,316 total shares between options, RSA&#x2019;s and other stock awards. With options canceled and RSA&#x2019;s forfeited amounting to 3,281,040 and 61,703 shares, respectively, there remain 1,958,427 shares available under the Restated Plan for future issuance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The DeepHealth options were issued outside of the Restated Plan and are a direct result of our acquisition and not included in the share count of the Restated Plan.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i027fbe622cb740e796aa36dc1f00b42e_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RleHRyZWdpb246NjYzNDIxNWY0ZWM0NGI4OTg5ZDVkMDk4MGZhYmM4MTdfNDIy_5f8e318f-7622-4dc2-b132-df8b54eb7362"
      unitRef="shares">14000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ib55973caf29b407cacf26e47cab62a42_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RleHRyZWdpb246NjYzNDIxNWY0ZWM0NGI4OTg5ZDVkMDk4MGZhYmM4MTdfNzgx_8a0de3f8-81b3-439a-97ba-309505f3aec6">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="if47fff6cbf3149a0a1f38edce2abc129_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RleHRyZWdpb246NjYzNDIxNWY0ZWM0NGI4OTg5ZDVkMDk4MGZhYmM4MTdfNzg3_b7bf8c58-0824-444e-b815-ecb8808920f2">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="ib55973caf29b407cacf26e47cab62a42_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RleHRyZWdpb246NjYzNDIxNWY0ZWM0NGI4OTg5ZDVkMDk4MGZhYmM4MTdfODA3_f7518132-06bc-4043-b8c9-ce49da188bdb">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="if47fff6cbf3149a0a1f38edce2abc129_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RleHRyZWdpb246NjYzNDIxNWY0ZWM0NGI4OTg5ZDVkMDk4MGZhYmM4MTdfODEz_e2865cfa-67fc-4c46-8fd4-4e9be81a0746">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i3d158c180c134e64a61a649a0dff7314_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RleHRyZWdpb246NjYzNDIxNWY0ZWM0NGI4OTg5ZDVkMDk4MGZhYmM4MTdfODk0_db11e330-2764-439f-88dd-a53955ac31e9"
      unitRef="shares">527899</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i3d158c180c134e64a61a649a0dff7314_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RleHRyZWdpb246NjYzNDIxNWY0ZWM0NGI4OTg5ZDVkMDk4MGZhYmM4MTdfOTUz_ada91c4b-bb21-44e0-b069-ade7479658d0"
      unitRef="shares">298863</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RleHRyZWdpb246NjYzNDIxNWY0ZWM0NGI4OTg5ZDVkMDk4MGZhYmM4MTdfMzM0OQ_0e8cdf64-8a3c-4080-b9a3-6bbe51e5c718">The following summarizes all of our option transactions for the nine months ended September&#160;30, 2020:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.973%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Outstanding Options&lt;br/&gt;Under the 2006 Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Exercise price&lt;br/&gt;Per Common Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual Life&lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;478,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;527,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.59&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,419,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;298,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.85&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,353,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.836%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.506%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.587%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.587%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.587%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.587%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.713%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Outstanding Options&lt;br/&gt;Under the Deep Health Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Exercise price&lt;br/&gt;Per Common Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual Life&lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted, June 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;412,434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,963)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;405,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.65&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,223,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.65&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;371,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="iaab629f0885047bfac5042b54e4cf7b0_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RhYmxlOmUyZTE1ZWI2NWZjYjRlMzg4MzliYWQwNTBmZjM5ZTZkL3RhYmxlcmFuZ2U6ZTJlMTVlYjY1ZmNiNGUzODgzOWJhZDA1MGZmMzllNmRfMS0yLTEtMS0w_3b11629b-ee23-4ebd-9f4e-46302798e01d"
      unitRef="shares">478951</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="iaab629f0885047bfac5042b54e4cf7b0_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RhYmxlOmUyZTE1ZWI2NWZjYjRlMzg4MzliYWQwNTBmZjM5ZTZkL3RhYmxlcmFuZ2U6ZTJlMTVlYjY1ZmNiNGUzODgzOWJhZDA1MGZmMzllNmRfMS00LTEtMS0w_4f52061f-b3e0-446e-939c-886de5526c1a"
      unitRef="usdPerShare">8.21</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i4b5d964821bf467daf58020889b187c2_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RhYmxlOmUyZTE1ZWI2NWZjYjRlMzg4MzliYWQwNTBmZjM5ZTZkL3RhYmxlcmFuZ2U6ZTJlMTVlYjY1ZmNiNGUzODgzOWJhZDA1MGZmMzllNmRfMi0yLTEtMS0w_384fcc27-dd13-43a6-8c95-5d0935c900c3"
      unitRef="shares">48948</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i4b5d964821bf467daf58020889b187c2_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RhYmxlOmUyZTE1ZWI2NWZjYjRlMzg4MzliYWQwNTBmZjM5ZTZkL3RhYmxlcmFuZ2U6ZTJlMTVlYjY1ZmNiNGUzODgzOWJhZDA1MGZmMzllNmRfMi00LTEtMS0w_ab93a480-110a-42ff-afc5-518b0dd5c0b7"
      unitRef="usdPerShare">20.43</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i3d158c180c134e64a61a649a0dff7314_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RhYmxlOmUyZTE1ZWI2NWZjYjRlMzg4MzliYWQwNTBmZjM5ZTZkL3RhYmxlcmFuZ2U6ZTJlMTVlYjY1ZmNiNGUzODgzOWJhZDA1MGZmMzllNmRfNS0yLTEtMS0w_d1a81745-431f-4a9c-a7e9-4e56a48c7c19"
      unitRef="shares">527899</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i3d158c180c134e64a61a649a0dff7314_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RhYmxlOmUyZTE1ZWI2NWZjYjRlMzg4MzliYWQwNTBmZjM5ZTZkL3RhYmxlcmFuZ2U6ZTJlMTVlYjY1ZmNiNGUzODgzOWJhZDA1MGZmMzllNmRfNS00LTEtMS0w_3ef9a32f-645a-4d70-b2e2-62f50de778fa"
      unitRef="usdPerShare">9.34</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i4b5d964821bf467daf58020889b187c2_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RhYmxlOmUyZTE1ZWI2NWZjYjRlMzg4MzliYWQwNTBmZjM5ZTZkL3RhYmxlcmFuZ2U6ZTJlMTVlYjY1ZmNiNGUzODgzOWJhZDA1MGZmMzllNmRfNS02LTEtMS0w_4c8c9982-21d3-4f82-974c-59f6a6b91aae">P6Y7M2D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i3d158c180c134e64a61a649a0dff7314_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RhYmxlOmUyZTE1ZWI2NWZjYjRlMzg4MzliYWQwNTBmZjM5ZTZkL3RhYmxlcmFuZ2U6ZTJlMTVlYjY1ZmNiNGUzODgzOWJhZDA1MGZmMzllNmRfNS04LTEtMS0w_b3f2b534-3741-421a-bb1c-c4c210313d25"
      unitRef="usd">3419956000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i3d158c180c134e64a61a649a0dff7314_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RhYmxlOmUyZTE1ZWI2NWZjYjRlMzg4MzliYWQwNTBmZjM5ZTZkL3RhYmxlcmFuZ2U6ZTJlMTVlYjY1ZmNiNGUzODgzOWJhZDA1MGZmMzllNmRfNi0yLTEtMS0w_844b3585-8c95-41f8-9649-4f84bcf19379"
      unitRef="shares">298863</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i3d158c180c134e64a61a649a0dff7314_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RhYmxlOmUyZTE1ZWI2NWZjYjRlMzg4MzliYWQwNTBmZjM5ZTZkL3RhYmxlcmFuZ2U6ZTJlMTVlYjY1ZmNiNGUzODgzOWJhZDA1MGZmMzllNmRfNi00LTEtMS0w_a8857e76-81b9-49c3-b9ca-9d4a16a25615"
      unitRef="usdPerShare">7.48</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
      contextRef="i4b5d964821bf467daf58020889b187c2_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RhYmxlOmUyZTE1ZWI2NWZjYjRlMzg4MzliYWQwNTBmZjM5ZTZkL3RhYmxlcmFuZ2U6ZTJlMTVlYjY1ZmNiNGUzODgzOWJhZDA1MGZmMzllNmRfNi02LTEtMS0w_2b809666-c793-48eb-be2d-1996d199e436">P5Y10M6D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="i3d158c180c134e64a61a649a0dff7314_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RhYmxlOmUyZTE1ZWI2NWZjYjRlMzg4MzliYWQwNTBmZjM5ZTZkL3RhYmxlcmFuZ2U6ZTJlMTVlYjY1ZmNiNGUzODgzOWJhZDA1MGZmMzllNmRfNi04LTEtMS0w_c0aadbf9-6efa-4853-9537-31e0f2f7b894"
      unitRef="usd">2353438000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i4b5d964821bf467daf58020889b187c2_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RleHRyZWdpb246NjYzNDIxNWY0ZWM0NGI4OTg5ZDVkMDk4MGZhYmM4MTdfMTM4OQ_19011ff6-b720-4e31-a1e0-3dd6fa62c1d0"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="i949cafed8cd44d929d2f3beaa3acf0d8_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RleHRyZWdpb246NjYzNDIxNWY0ZWM0NGI4OTg5ZDVkMDk4MGZhYmM4MTdfMTU1MQ_5048312d-ef11-4a27-a215-2485c790d285"
      unitRef="usd">700000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RleHRyZWdpb246NjYzNDIxNWY0ZWM0NGI4OTg5ZDVkMDk4MGZhYmM4MTdfMTYzNw_e2f88608-c420-43bf-a31b-3900833ce21a">P1Y8M4D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i656e4333bc494b37a20f965c8618f1d0_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RleHRyZWdpb246NjYzNDIxNWY0ZWM0NGI4OTg5ZDVkMDk4MGZhYmM4MTdfMTc3OA_eeaec566-5ad1-4898-80ca-45e3e5752acf"
      unitRef="shares">412434</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ifb572eb0a62c470bb17e387648d4f17f_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RleHRyZWdpb246NjYzNDIxNWY0ZWM0NGI4OTg5ZDVkMDk4MGZhYmM4MTdfMTgxOQ_912a60c9-91a8-45a1-a047-ee07e3d8a0b7"
      unitRef="usdPerShare">16.93</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="ic88e676c8ae54e949cbc0e057a2855a7_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RleHRyZWdpb246NjYzNDIxNWY0ZWM0NGI4OTg5ZDVkMDk4MGZhYmM4MTdfMjA2Nw_11211331-4b41-4be6-a380-7f291a5950aa"
      unitRef="usd">4300000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i1e4ebdf884e14af1b77318c2bc533fa7_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RleHRyZWdpb246NjYzNDIxNWY0ZWM0NGI4OTg5ZDVkMDk4MGZhYmM4MTdfMjE1MA_0dc3f0b6-fe9c-4774-a3c1-921f87d31454">P2Y6M10D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="icff8e20d84f241cd8104a1116305268a_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RhYmxlOmY4OTBhY2YxZGFjNDQ1YmI5MDgyNTczMjIyMWE1ODU1L3RhYmxlcmFuZ2U6Zjg5MGFjZjFkYWM0NDViYjkwODI1NzMyMjIxYTU4NTVfMS0yLTEtMS0w_c6227968-8cfe-4686-88ca-bad9e39d9c9e"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i8741d0f710974ec5a70b0b546a43e7fb_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RhYmxlOmY4OTBhY2YxZGFjNDQ1YmI5MDgyNTczMjIyMWE1ODU1L3RhYmxlcmFuZ2U6Zjg5MGFjZjFkYWM0NDViYjkwODI1NzMyMjIxYTU4NTVfMi0yLTEtMS0w_4d552b85-a420-444d-940f-2bbc5a07617a"
      unitRef="shares">412434</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i8741d0f710974ec5a70b0b546a43e7fb_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RhYmxlOmY4OTBhY2YxZGFjNDQ1YmI5MDgyNTczMjIyMWE1ODU1L3RhYmxlcmFuZ2U6Zjg5MGFjZjFkYWM0NDViYjkwODI1NzMyMjIxYTU4NTVfMy0yLTEtMS0w_73fbd1a0-556c-469b-b33c-362a423d927c"
      unitRef="shares">6963</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="iced7ee1846d8433483d7f50dbea0a847_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RhYmxlOmY4OTBhY2YxZGFjNDQ1YmI5MDgyNTczMjIyMWE1ODU1L3RhYmxlcmFuZ2U6Zjg5MGFjZjFkYWM0NDViYjkwODI1NzMyMjIxYTU4NTVfNC0yLTEtMS0w_18047243-eb2d-4b9e-9d7e-8c13066c19c4"
      unitRef="shares">405471</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i8741d0f710974ec5a70b0b546a43e7fb_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RhYmxlOmY4OTBhY2YxZGFjNDQ1YmI5MDgyNTczMjIyMWE1ODU1L3RhYmxlcmFuZ2U6Zjg5MGFjZjFkYWM0NDViYjkwODI1NzMyMjIxYTU4NTVfNC02LTEtMS0w_0c64641e-3155-4fc1-8bb7-a26c77f8ffd4">P8Y7M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="iced7ee1846d8433483d7f50dbea0a847_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RhYmxlOmY4OTBhY2YxZGFjNDQ1YmI5MDgyNTczMjIyMWE1ODU1L3RhYmxlcmFuZ2U6Zjg5MGFjZjFkYWM0NDViYjkwODI1NzMyMjIxYTU4NTVfNC04LTEtMS0w_9f01eb71-74e8-403c-a8c2-bfb04df025e1"
      unitRef="usd">6223980000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="iced7ee1846d8433483d7f50dbea0a847_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RhYmxlOmY4OTBhY2YxZGFjNDQ1YmI5MDgyNTczMjIyMWE1ODU1L3RhYmxlcmFuZ2U6Zjg5MGFjZjFkYWM0NDViYjkwODI1NzMyMjIxYTU4NTVfNS0yLTEtMS0w_f942ecee-4d13-4d60-92f7-6eb48445d63c"
      unitRef="shares">24211</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
      contextRef="i8741d0f710974ec5a70b0b546a43e7fb_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RhYmxlOmY4OTBhY2YxZGFjNDQ1YmI5MDgyNTczMjIyMWE1ODU1L3RhYmxlcmFuZ2U6Zjg5MGFjZjFkYWM0NDViYjkwODI1NzMyMjIxYTU4NTVfNS02LTEtMS0w_99e25334-1175-4cdc-9dd1-3e494c3656fa">P8Y7M24D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="iced7ee1846d8433483d7f50dbea0a847_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RhYmxlOmY4OTBhY2YxZGFjNDQ1YmI5MDgyNTczMjIyMWE1ODU1L3RhYmxlcmFuZ2U6Zjg5MGFjZjFkYWM0NDViYjkwODI1NzMyMjIxYTU4NTVfNS04LTEtMS0w_29f9a19d-a01b-45d2-bb8e-72bdc2f22550"
      unitRef="usd">371639000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <rdnt:AwardsIssuedToDate
      contextRef="icfc15acb74684a52b57e605b24afd3db_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RleHRyZWdpb246NjYzNDIxNWY0ZWM0NGI4OTg5ZDVkMDk4MGZhYmM4MTdfMjI5MA_07729ceb-c09f-40c8-9f78-bd59fb93fc01"
      unitRef="shares">6551872</rdnt:AwardsIssuedToDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="icfc15acb74684a52b57e605b24afd3db_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RleHRyZWdpb246NjYzNDIxNWY0ZWM0NGI4OTg5ZDVkMDk4MGZhYmM4MTdfMjMwOA_faa8f1fa-036c-4128-9202-e7d46c71e9cb"
      unitRef="shares">331659</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RleHRyZWdpb246NjYzNDIxNWY0ZWM0NGI4OTg5ZDVkMDk4MGZhYmM4MTdfMzM1Mg_fb7e70f1-64d7-4960-a0bf-23151bd43395">The following summarizes all unvested RSA&#x2019;s activities during the nine months ended September&#160;30, 2020:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;RSA's&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSA's unvested at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;387,934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;457,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(513,871)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSA's unvested at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;331,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.11&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="i24073316903a4b80852ce62f50a13e5f_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RhYmxlOmEzZmFjMDA4ZWY3ODQwODY4ZGRjNWZlZDc2MmFmYTkxL3RhYmxlcmFuZ2U6YTNmYWMwMDhlZjc4NDA4NjhkZGM1ZmVkNzYyYWZhOTFfMS0xLTEtMS0w_fe3bd0fe-630c-478d-8bbe-dcf91aa795f8"
      unitRef="shares">387934</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i24073316903a4b80852ce62f50a13e5f_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RhYmxlOmEzZmFjMDA4ZWY3ODQwODY4ZGRjNWZlZDc2MmFmYTkxL3RhYmxlcmFuZ2U6YTNmYWMwMDhlZjc4NDA4NjhkZGM1ZmVkNzYyYWZhOTFfMS01LTEtMS0w_b796a1e5-c551-4164-981c-2cf31dd9eb92"
      unitRef="usdPerShare">11.61</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="id598685e49ce4cde89846d1481b70e13_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RhYmxlOmEzZmFjMDA4ZWY3ODQwODY4ZGRjNWZlZDc2MmFmYTkxL3RhYmxlcmFuZ2U6YTNmYWMwMDhlZjc4NDA4NjhkZGM1ZmVkNzYyYWZhOTFfMy0xLTEtMS0w_46be57a3-599e-42a6-8f4b-f631395dcdb1"
      unitRef="shares">457596</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="id598685e49ce4cde89846d1481b70e13_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RhYmxlOmEzZmFjMDA4ZWY3ODQwODY4ZGRjNWZlZDc2MmFmYTkxL3RhYmxlcmFuZ2U6YTNmYWMwMDhlZjc4NDA4NjhkZGM1ZmVkNzYyYWZhOTFfMy01LTEtMS0w_52bb503f-d697-4fd1-8a34-eaeed52fc7c2"
      unitRef="usdPerShare">19.66</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="id598685e49ce4cde89846d1481b70e13_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RhYmxlOmEzZmFjMDA4ZWY3ODQwODY4ZGRjNWZlZDc2MmFmYTkxL3RhYmxlcmFuZ2U6YTNmYWMwMDhlZjc4NDA4NjhkZGM1ZmVkNzYyYWZhOTFfNC0xLTEtMS0w_eaa9debe-de52-4681-807f-7c945865a77a"
      unitRef="shares">513871</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="id598685e49ce4cde89846d1481b70e13_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RhYmxlOmEzZmFjMDA4ZWY3ODQwODY4ZGRjNWZlZDc2MmFmYTkxL3RhYmxlcmFuZ2U6YTNmYWMwMDhlZjc4NDA4NjhkZGM1ZmVkNzYyYWZhOTFfNC01LTEtMS0w_d00fea39-37a9-46f1-bc64-c0db080a9910"
      unitRef="usdPerShare">15.47</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="icfc15acb74684a52b57e605b24afd3db_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RhYmxlOmEzZmFjMDA4ZWY3ODQwODY4ZGRjNWZlZDc2MmFmYTkxL3RhYmxlcmFuZ2U6YTNmYWMwMDhlZjc4NDA4NjhkZGM1ZmVkNzYyYWZhOTFfNi0xLTEtMS0w_5102b564-8e67-4d13-8bee-78847c325384"
      unitRef="shares">331659</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
      contextRef="id598685e49ce4cde89846d1481b70e13_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RhYmxlOmEzZmFjMDA4ZWY3ODQwODY4ZGRjNWZlZDc2MmFmYTkxL3RhYmxlcmFuZ2U6YTNmYWMwMDhlZjc4NDA4NjhkZGM1ZmVkNzYyYWZhOTFfNi0zLTEtMS0w_5f887e63-9b97-462b-afbc-436af0725264">P1Y1M9D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="icfc15acb74684a52b57e605b24afd3db_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RhYmxlOmEzZmFjMDA4ZWY3ODQwODY4ZGRjNWZlZDc2MmFmYTkxL3RhYmxlcmFuZ2U6YTNmYWMwMDhlZjc4NDA4NjhkZGM1ZmVkNzYyYWZhOTFfNi01LTEtMS0w_f1b7de60-13db-40f2-a04d-850602d56e26"
      unitRef="usdPerShare">16.67</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="ic62bac0609a645d1a910b8ba6cb946fb_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RleHRyZWdpb246NjYzNDIxNWY0ZWM0NGI4OTg5ZDVkMDk4MGZhYmM4MTdfMjgwNA_96f0217b-92dc-45aa-b84d-f27aee52d0af"
      unitRef="shares">26078</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i027fbe622cb740e796aa36dc1f00b42e_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RleHRyZWdpb246NjYzNDIxNWY0ZWM0NGI4OTg5ZDVkMDk4MGZhYmM4MTdfMjg2MA_5f8e318f-7622-4dc2-b132-df8b54eb7362"
      unitRef="shares">14000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <rdnt:AwardsIssuedToDate
      contextRef="i027fbe622cb740e796aa36dc1f00b42e_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RleHRyZWdpb246NjYzNDIxNWY0ZWM0NGI4OTg5ZDVkMDk4MGZhYmM4MTdfMjk1NA_ccf3d29b-0337-4f9e-844e-fa9209bc5b33"
      unitRef="shares">15384316</rdnt:AwardsIssuedToDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="i8bcd128fbffd44eca246f153070892ca_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RleHRyZWdpb246NjYzNDIxNWY0ZWM0NGI4OTg5ZDVkMDk4MGZhYmM4MTdfMzA3Mg_f47e8ba8-ebba-424f-b6d4-08ce26ab5711"
      unitRef="shares">3281040</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i8bcd128fbffd44eca246f153070892ca_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RleHRyZWdpb246NjYzNDIxNWY0ZWM0NGI4OTg5ZDVkMDk4MGZhYmM4MTdfMzA3OQ_593ab79b-4e67-4a15-b712-0e160d939f58"
      unitRef="shares">61703</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance
      contextRef="i027fbe622cb740e796aa36dc1f00b42e_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82MS9mcmFnOjY2MzQyMTVmNGVjNDRiODk4OWQ1ZDA5ODBmYWJjODE3L3RleHRyZWdpb246NjYzNDIxNWY0ZWM0NGI4OTg5ZDVkMDk4MGZhYmM4MTdfMzExNw_4165eae9-c4ea-4375-8a97-4a18d040a240"
      unitRef="shares">1958427</us-gaap:DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="i7d337e311ea047289cd379605dc1a780_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82NC9mcmFnOjJkYmIxMWQwN2I5MDRmMDI5NjhiZmM2ZmFkNTZhZDNiL3RleHRyZWdpb246MmRiYjExZDA3YjkwNGYwMjk2OGJmYzZmYWQ1NmFkM2JfODY3_d12d1ee5-032c-41b9-add7-7bc98fa4771c">SUBSEQUENT EVENTS&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Formation of majority owned subsidiary&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 1, 2020 we formed in conjunction with Simi Valley Hospital and Health Services ("Simi Adventist") the Simi Valley Imaging Group, LLC (&#x201c;SVIG&#x201d;), consisting of three multi-modality imaging centers located in Simi Valley, CA.  RadNet will hold a 60% economic interest in SVIG and Simi Adventist will have the remaining  40% interest.&lt;/span&gt;&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
    <rdnt:NumberOfAssetsAcquired
      contextRef="ic97e88dc3d0b400f82757dbc8ca7b075_I20201101"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82NC9mcmFnOjJkYmIxMWQwN2I5MDRmMDI5NjhiZmM2ZmFkNTZhZDNiL3RleHRyZWdpb246MmRiYjExZDA3YjkwNGYwMjk2OGJmYzZmYWQ1NmFkM2JfMTY0OTI2NzQ0ODc1NA_310b88b4-fc0a-4270-b71e-fcc40f638c99"
      unitRef="center">3</rdnt:NumberOfAssetsAcquired>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="ic97e88dc3d0b400f82757dbc8ca7b075_I20201101"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82NC9mcmFnOjJkYmIxMWQwN2I5MDRmMDI5NjhiZmM2ZmFkNTZhZDNiL3RleHRyZWdpb246MmRiYjExZDA3YjkwNGYwMjk2OGJmYzZmYWQ1NmFkM2JfMjc0ODc3OTA3NjM0NA_77cc7f47-e3bc-4714-b955-97ae137e67d4"
      unitRef="number">0.60</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="i1f2ef1f8cedb41f48a20163cf23ac25f_I20201101"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl82NC9mcmFnOjJkYmIxMWQwN2I5MDRmMDI5NjhiZmM2ZmFkNTZhZDNiL3RleHRyZWdpb246MmRiYjExZDA3YjkwNGYwMjk2OGJmYzZmYWQ1NmFkM2JfMjc0ODc3OTA3NjQxOQ_04bd8f46-0434-4740-936c-175b1c763be2"
      unitRef="number">0.40</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140489891140360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Nov. 05, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33307<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">RadNet, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">13-3326724<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1510 Cotner Avenue<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Los Angeles,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">90025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">310<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">478-7808<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">RDNT<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,636,099<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000790526<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 13<br> -Subsection a-13<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1-<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140489887999832">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>CURRENT ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 89,739<span></span>
</td>
<td class="nump">$ 40,165<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">137,411<span></span>
</td>
<td class="nump">154,763<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueFromRelatedPartiesCurrent', window );">Due from affiliates</a></td>
<td class="nump">424<span></span>
</td>
<td class="nump">1,242<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">31,482<span></span>
</td>
<td class="nump">45,004<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">259,056<span></span>
</td>
<td class="nump">241,174<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract', window );"><strong>PROPERTY, EQUIPMENT AND RIGHT-OF-USE ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">361,950<span></span>
</td>
<td class="nump">367,795<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">451,613<span></span>
</td>
<td class="nump">445,477<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets', window );">Total property, equipment and right-of-use assets</a></td>
<td class="nump">813,563<span></span>
</td>
<td class="nump">813,272<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsAbstract', window );"><strong>OTHER ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">470,685<span></span>
</td>
<td class="nump">441,973<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets</a></td>
<td class="nump">57,152<span></span>
</td>
<td class="nump">42,994<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNoncurrentNet', window );">Deferred financing costs</a></td>
<td class="nump">1,944<span></span>
</td>
<td class="nump">1,559<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investment in joint ventures</a></td>
<td class="nump">35,571<span></span>
</td>
<td class="nump">34,470<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax assets, net of current portion</a></td>
<td class="nump">42,188<span></span>
</td>
<td class="nump">34,548<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepositsAssets', window );">Deposits and other</a></td>
<td class="nump">37,707<span></span>
</td>
<td class="nump">36,996<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">1,717,866<span></span>
</td>
<td class="nump">1,646,986<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>CURRENT LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable, accrued expenses and other</a></td>
<td class="nump">205,701<span></span>
</td>
<td class="nump">207,585<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToAffiliateCurrent', window );">Due to affiliates</a></td>
<td class="nump">12,287<span></span>
</td>
<td class="nump">14,347<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Deferred revenue</a></td>
<td class="nump">45,846<span></span>
</td>
<td class="nump">1,316<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Current finance lease liability</a></td>
<td class="nump">3,041<span></span>
</td>
<td class="nump">3,283<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current operating lease liability</a></td>
<td class="nump">67,449<span></span>
</td>
<td class="nump">61,206<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">Current portion of notes payable</a></td>
<td class="nump">39,463<span></span>
</td>
<td class="nump">39,691<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">373,787<span></span>
</td>
<td class="nump">327,428<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>LONG-TERM LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Long-term finance lease liability</a></td>
<td class="nump">1,108<span></span>
</td>
<td class="nump">3,264<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liability</a></td>
<td class="nump">428,233<span></span>
</td>
<td class="nump">420,922<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermNotesPayable', window );">Notes payable, net of current portion</a></td>
<td class="nump">627,179<span></span>
</td>
<td class="nump">652,704<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="nump">41,438<span></span>
</td>
<td class="nump">9,529<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">1,471,745<span></span>
</td>
<td class="nump">1,413,847<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock - $0.0001 par value, 200,000,000 shares authorized; 51,596,098 and 50,314,328 shares issued and outstanding at September 30, 2020 and December 31, 2019, respectively</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in-capital</a></td>
<td class="nump">306,079<span></span>
</td>
<td class="nump">262,865<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(24,923)<span></span>
</td>
<td class="num">(8,026)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(123,956)<span></span>
</td>
<td class="num">(103,159)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total RadNet, Inc.'s stockholders' equity</a></td>
<td class="nump">157,205<span></span>
</td>
<td class="nump">151,685<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">88,916<span></span>
</td>
<td class="nump">81,454<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity</a></td>
<td class="nump">246,121<span></span>
</td>
<td class="nump">233,139<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and equity</a></td>
<td class="nump">$ 1,717,866<span></span>
</td>
<td class="nump">$ 1,646,986<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Property Plant and Equipment Net Including Right of Use Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130549-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118952595&amp;loc=d3e4428-111522<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=118952595&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6801-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNoncurrentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs classified as noncurrent. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28555-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNoncurrentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueFromRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of receivables to be collected from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth, at the financial statement date. which are usually due within one year (or one business cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueFromRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToAffiliateCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payable due to an entity that is affiliated with the reporting entity by means of direct or indirect ownership. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6488278&amp;loc=d3e603758-122996<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToAffiliateCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=77989000&amp;loc=SL49117168-202975<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4590271-111686<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140489884920888">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock - par value (in dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock - shares authorized (in shares)</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock - shares issued (in shares)</a></td>
<td class="nump">51,596,098<span></span>
</td>
<td class="nump">50,314,328<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock - shares outstanding (in shares)</a></td>
<td class="nump">51,596,098<span></span>
</td>
<td class="nump">50,314,328<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140489887373624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>REVENUE</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total service revenue</a></td>
<td class="nump">$ 291,776<span></span>
</td>
<td class="nump">$ 292,692<span></span>
</td>
<td class="nump">$ 763,905<span></span>
</td>
<td class="nump">$ 853,338<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueNotFromContractWithCustomer', window );">Provider relief funding</a></td>
<td class="nump">221<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">25,696<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>OPERATING EXPENSES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Cost of operations, excluding depreciation and amortization</a></td>
<td class="nump">246,462<span></span>
</td>
<td class="nump">254,383<span></span>
</td>
<td class="nump">708,095<span></span>
</td>
<td class="nump">743,997<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">21,247<span></span>
</td>
<td class="nump">20,490<span></span>
</td>
<td class="nump">64,536<span></span>
</td>
<td class="nump">60,193<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">Loss on sale and disposal of equipment and other</a></td>
<td class="nump">342<span></span>
</td>
<td class="nump">917<span></span>
</td>
<td class="nump">543<span></span>
</td>
<td class="nump">1,990<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance costs</a></td>
<td class="nump">571<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="nump">1,647<span></span>
</td>
<td class="nump">1,054<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">268,622<span></span>
</td>
<td class="nump">275,842<span></span>
</td>
<td class="nump">774,821<span></span>
</td>
<td class="nump">807,234<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">INCOME FROM OPERATIONS</a></td>
<td class="nump">23,375<span></span>
</td>
<td class="nump">16,850<span></span>
</td>
<td class="nump">14,780<span></span>
</td>
<td class="nump">46,104<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherExpensesAbstract', window );"><strong>OTHER INCOME AND EXPENSES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="nump">11,061<span></span>
</td>
<td class="nump">11,895<span></span>
</td>
<td class="nump">33,443<span></span>
</td>
<td class="nump">36,589<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in earnings of joint ventures</a></td>
<td class="num">(2,276)<span></span>
</td>
<td class="num">(1,955)<span></span>
</td>
<td class="num">(5,176)<span></span>
</td>
<td class="num">(6,072)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1', window );">Non-cash change in fair value of interest rate hedge</a></td>
<td class="nump">679<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,523<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (income) expenses</a></td>
<td class="num">(139)<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="num">(247)<span></span>
</td>
<td class="nump">1,271<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other expenses</a></td>
<td class="nump">9,325<span></span>
</td>
<td class="nump">9,942<span></span>
</td>
<td class="nump">32,543<span></span>
</td>
<td class="nump">31,788<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">INCOME (LOSS) BEFORE INCOME TAXES</a></td>
<td class="nump">14,050<span></span>
</td>
<td class="nump">6,908<span></span>
</td>
<td class="num">(17,763)<span></span>
</td>
<td class="nump">14,316<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">(Provision for) benefit from income taxes</a></td>
<td class="num">(3,825)<span></span>
</td>
<td class="num">(1,816)<span></span>
</td>
<td class="nump">5,029<span></span>
</td>
<td class="num">(3,556)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">NET INCOME (LOSS)</a></td>
<td class="nump">10,225<span></span>
</td>
<td class="nump">5,092<span></span>
</td>
<td class="num">(12,734)<span></span>
</td>
<td class="nump">10,760<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="nump">4,069<span></span>
</td>
<td class="nump">1,897<span></span>
</td>
<td class="nump">8,063<span></span>
</td>
<td class="nump">6,400<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">NET INCOME (LOSS) ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</a></td>
<td class="nump">$ 6,156<span></span>
</td>
<td class="nump">$ 3,195<span></span>
</td>
<td class="num">$ (20,797)<span></span>
</td>
<td class="nump">$ 4,360<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS (in dollars per share)</a></td>
<td class="nump">$ 0.12<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="num">$ (0.41)<span></span>
</td>
<td class="nump">$ 0.09<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS (in dollars per share)</a></td>
<td class="nump">$ 0.12<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="num">$ (0.41)<span></span>
</td>
<td class="nump">$ 0.09<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>WEIGHTED AVERAGE SHARES OUTSTANDING</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">51,358,603<span></span>
</td>
<td class="nump">49,807,460<span></span>
</td>
<td class="nump">50,746,380<span></span>
</td>
<td class="nump">49,597,138<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">51,955,815<span></span>
</td>
<td class="nump">50,360,360<span></span>
</td>
<td class="nump">50,746,380<span></span>
</td>
<td class="nump">50,113,306<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthCarePatientServiceMember', window );">Service fee revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>REVENUE</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total service revenue</a></td>
<td class="nump">$ 256,730<span></span>
</td>
<td class="nump">$ 261,908<span></span>
</td>
<td class="nump">$ 660,760<span></span>
</td>
<td class="nump">$ 762,751<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_CapitationArrangementsMember', window );">Revenue under capitation arrangements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>REVENUE</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total service revenue</a></td>
<td class="nump">$ 35,046<span></span>
</td>
<td class="nump">$ 30,784<span></span>
</td>
<td class="nump">$ 103,145<span></span>
</td>
<td class="nump">$ 90,587<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1337-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=117327953&amp;loc=d3e4984-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=SL5780133-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=117327953&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1252-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2443-110228<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109238882&amp;loc=d3e38679-109324<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) included in earnings related to the fair value of the hedged item in an interest rate fair value hedge, offset by the gain (loss) on the hedging instrument to the extent that the fair value hedge is determined to be effective.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5618551-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591551-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591551-111686<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3000-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591552-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130543-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueNotFromContractWithCustomer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue that is not accounted for under Topic 606.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueNotFromContractWithCustomer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1448-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthCarePatientServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthCarePatientServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_CapitationArrangementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_CapitationArrangementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140489887377592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">NET INCOME (LOSS)</a></td>
<td class="nump">$ 10,225<span></span>
</td>
<td class="nump">$ 5,092<span></span>
</td>
<td class="num">$ (12,734)<span></span>
</td>
<td class="nump">$ 10,760<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="nump">11<span></span>
</td>
<td class="num">(23)<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="num">(28)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Change in fair value of cash flow hedge, net of taxes</a></td>
<td class="nump">195<span></span>
</td>
<td class="num">(5,283)<span></span>
</td>
<td class="num">(18,764)<span></span>
</td>
<td class="num">(14,481)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Amount of loss reclassified from accumulated OCI into income (prior period effective portion)</a></td>
<td class="nump">969<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,861<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">COMPREHENSIVE INCOME (LOSS)</a></td>
<td class="nump">11,400<span></span>
</td>
<td class="num">(214)<span></span>
</td>
<td class="num">(29,631)<span></span>
</td>
<td class="num">(3,749)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Less comprehensive income attributable to noncontrolling interests</a></td>
<td class="nump">4,069<span></span>
</td>
<td class="nump">1,897<span></span>
</td>
<td class="nump">8,063<span></span>
</td>
<td class="nump">6,400<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">COMPREHENSIVE INCOME (LOSS) ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</a></td>
<td class="nump">$ 7,331<span></span>
</td>
<td class="num">$ (2,111)<span></span>
</td>
<td class="num">$ (37,694)<span></span>
</td>
<td class="num">$ (10,149)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e557-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591552-111686<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4613674-111683<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b,c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591551-111686<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3000-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591552-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140489897134648">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>DeepHealth, Inc.</div></th>
<th class="th"><div>Total Radnet, Inc.'s Equity</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th">
<div>Common Stock </div>
<div>DeepHealth, Inc.</div>
</th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss)</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th"><div>Noncontrolling Interests</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,977,485<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance, value at Dec. 31, 2018</a></td>
<td class="nump">$ 200,253<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 127,184<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 242,835<span></span>
</td>
<td class="nump">$ 2,259<span></span>
</td>
<td class="num">$ (117,915)<span></span>
</td>
<td class="nump">$ 73,069<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Issuance of common stock upon exercise of options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue', window );">Issuance of common stock upon exercise of options</a></td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under the equity compensation plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">726,042<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under the equity compensation plan</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">6,993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Issuance of common stock for acquisition (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">440,207<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Issuance of common stock for acquisition</a></td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited', window );">Forfeiture of restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures', window );">Forfeiture of restricted stock</a></td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest', window );">Sale of noncontrolling interests, net of taxes</a></td>
<td class="nump">5,098<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,090<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,090<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,008<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromRedemptions', window );">Purchase of noncontrolling interests</a></td>
<td class="num">(1,818)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,818)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_ContributionsFromNoncontrollingInterests', window );">Contribution from noncontrolling partner</a></td>
<td class="nump">750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_StockIssuedDuringPeriodSharesIssuedForReturnOfCapital', window );">Issuance of common stock for purchase of Nulogix (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101,902<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_StockIssuedDuringPeriodValueIssuedForReturnOfCapital', window );">Issuance of common stock for purchase of Nulogix</a></td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent', window );">Change in cumulative foreign currency translation adjustment</a></td>
<td class="num">(28)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(28)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(28)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Change in fair value of cash flow hedge, net of taxes</a></td>
<td class="num">(14,481)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,481)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,481)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Amount of loss reclassified from accumulated OCI into income (prior period effective portion)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (loss) income</a></td>
<td class="nump">10,760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,360<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,360<span></span>
</td>
<td class="nump">6,400<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,254,136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance, value at Sep. 30, 2019</a></td>
<td class="nump">215,072<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">134,663<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">260,463<span></span>
</td>
<td class="num">(12,250)<span></span>
</td>
<td class="num">(113,555)<span></span>
</td>
<td class="nump">80,409<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Jun. 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,127,234<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance, value at Jun. 30, 2019</a></td>
<td class="nump">212,430<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133,918<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">257,607<span></span>
</td>
<td class="num">(6,942)<span></span>
</td>
<td class="num">(116,752)<span></span>
</td>
<td class="nump">78,512<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under the equity compensation plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under the equity compensation plan</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">1,356<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,356<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,356<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Issuance of common stock for purchase of membership interest in HVRA (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101,902<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Issuance of common stock for purchase of membership interest in HVRA</a></td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent', window );">Change in cumulative foreign currency translation adjustment</a></td>
<td class="num">(23)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Change in fair value of cash flow hedge, net of taxes</a></td>
<td class="num">(5,283)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,283)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,283)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Amount of loss reclassified from accumulated OCI into income (prior period effective portion)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (loss) income</a></td>
<td class="nump">5,092<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,195<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,195<span></span>
</td>
<td class="nump">1,897<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,254,136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance, value at Sep. 30, 2019</a></td>
<td class="nump">215,072<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">134,663<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">260,463<span></span>
</td>
<td class="num">(12,250)<span></span>
</td>
<td class="num">(113,555)<span></span>
</td>
<td class="nump">80,409<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,314,328<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance, value at Dec. 31, 2019</a></td>
<td class="nump">233,139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">151,685<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">262,865<span></span>
</td>
<td class="num">(8,026)<span></span>
</td>
<td class="num">(103,159)<span></span>
</td>
<td class="nump">81,454<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under the equity compensation plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">453,817<span></span>
</td>
<td class="nump">4,338<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under the equity compensation plan</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">10,203<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,203<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,203<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Issuance of common stock for acquisition (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">823,615<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Issuance of common stock for acquisition</a></td>
<td class="nump">33,011<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,011<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,011<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions paid to noncontrolling interests</a></td>
<td class="num">(601)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(601)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent', window );">Change in cumulative foreign currency translation adjustment</a></td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Change in fair value of cash flow hedge, net of taxes</a></td>
<td class="num">(18,764)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18,764)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18,764)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Amount of loss reclassified from accumulated OCI into income (prior period effective portion)</a></td>
<td class="nump">1,861<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,861<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,861<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (loss) income</a></td>
<td class="num">(12,734)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20,797)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20,797)<span></span>
</td>
<td class="nump">8,063<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,596,098<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance, value at Sep. 30, 2020</a></td>
<td class="nump">246,121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">157,205<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">306,079<span></span>
</td>
<td class="num">(24,923)<span></span>
</td>
<td class="num">(123,956)<span></span>
</td>
<td class="nump">88,916<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,554,760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance, value at Jun. 30, 2020</a></td>
<td class="nump">233,256<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">147,808<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">304,012<span></span>
</td>
<td class="num">(26,098)<span></span>
</td>
<td class="num">(130,111)<span></span>
</td>
<td class="nump">85,448<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under the equity compensation plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,000<span></span>
</td>
<td class="nump">4,338<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under the equity compensation plan</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">2,067<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,067<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,067<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions paid to noncontrolling interests</a></td>
<td class="num">(601)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(601)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent', window );">Change in cumulative foreign currency translation adjustment</a></td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Change in fair value of cash flow hedge, net of taxes</a></td>
<td class="nump">195<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">195<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">195<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Amount of loss reclassified from accumulated OCI into income (prior period effective portion)</a></td>
<td class="nump">969<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">969<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">969<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (loss) income</a></td>
<td class="nump">10,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,156<span></span>
</td>
<td class="nump">4,069<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,596,098<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance, value at Sep. 30, 2020</a></td>
<td class="nump">$ 246,121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 157,205<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 306,079<span></span>
</td>
<td class="num">$ (24,923)<span></span>
</td>
<td class="num">$ (123,956)<span></span>
</td>
<td class="nump">$ 88,916<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ContributionsFromNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ContributionsFromNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-based Payment Award, Options, Grants In Period, Gross, Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_StockIssuedDuringPeriodSharesIssuedForReturnOfCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Shares, Issued for Return of Capital</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_StockIssuedDuringPeriodSharesIssuedForReturnOfCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_StockIssuedDuringPeriodValueIssuedForReturnOfCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Value, Issued for Return of Capital</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_StockIssuedDuringPeriodValueIssuedForReturnOfCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118258462&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=118258462&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116855982&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromRedemptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569655-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4616395-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromRedemptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in noncontrolling interest from sale of a portion of the parent's controlling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569655-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, on foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591551-111686<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3000-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591552-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares related to Restricted Stock Award forfeited during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock related to Restricted Stock Awards forfeited during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4590271-111686<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140489891432664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (loss) income</a></td>
<td class="num">$ (12,734)<span></span>
</td>
<td class="nump">$ 10,760<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net (loss) income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">64,536<span></span>
</td>
<td class="nump">60,193<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_OperatingLeaseRightofUseAssetAmortization', window );">Amortization of operating lease right-of-use assets</a></td>
<td class="nump">50,769<span></span>
</td>
<td class="nump">49,948<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions', window );">Equity in earnings of joint ventures</a></td>
<td class="nump">530<span></span>
</td>
<td class="num">(2,148)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of deferred financing costs and loan discount</a></td>
<td class="nump">3,266<span></span>
</td>
<td class="nump">3,103<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">Loss on sale and disposal of equipment and other</a></td>
<td class="nump">543<span></span>
</td>
<td class="nump">1,990<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDeferredHedgeGains', window );">Amortization of cash flow hedge</a></td>
<td class="nump">2,204<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnDerivatives', window );">Non-cash change in fair value of interest rate hedge</a></td>
<td class="nump">4,523<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">10,144<span></span>
</td>
<td class="nump">6,963<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_IncreaseDecreaseInOtherNoncashItem', window );">Other non-cash items included in cost of operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(559)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in fair value of contingent consideration</a></td>
<td class="num">(145)<span></span>
</td>
<td class="num">(1,749)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract', window );"><strong>Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">17,380<span></span>
</td>
<td class="num">(3,467)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets', window );">Other current assets</a></td>
<td class="nump">13,522<span></span>
</td>
<td class="num">(1,569)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="num">(700)<span></span>
</td>
<td class="num">(5,770)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes', window );">Deferred taxes</a></td>
<td class="num">(7,640)<span></span>
</td>
<td class="num">(4,230)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_IncreaseDecreaseinOperatingLeaseLiability', window );">Operating lease liability</a></td>
<td class="num">(43,351)<span></span>
</td>
<td class="num">(49,721)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenue</a></td>
<td class="nump">44,530<span></span>
</td>
<td class="num">(490)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable, accrued expenses and other</a></td>
<td class="nump">22,966<span></span>
</td>
<td class="nump">19,349<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">170,343<span></span>
</td>
<td class="nump">82,603<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBuildings', window );">Purchase of imaging facilities and other acquisitions</a></td>
<td class="num">(10,125)<span></span>
</td>
<td class="num">(27,150)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Equity investments at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(143)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(77,303)<span></span>
</td>
<td class="num">(68,269)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from sale of equipment</a></td>
<td class="nump">779<span></span>
</td>
<td class="nump">760<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture', window );">Proceeds from the sale of equity interests in a joint venture</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">132<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital', window );">Nulogix return of capital</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">792<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_PaymentstoAcquireInterestinJointVentureAndContributionsToExistingJointVenture', window );">Equity contributions in existing and purchase of interest in joint ventures</a></td>
<td class="num">(1,631)<span></span>
</td>
<td class="num">(103)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(88,280)<span></span>
</td>
<td class="num">(93,981)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities', window );">Principal payments on notes and leases payable</a></td>
<td class="num">(2,704)<span></span>
</td>
<td class="num">(4,778)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Payments on term loan debt</a></td>
<td class="num">(32,472)<span></span>
</td>
<td class="num">(29,918)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Additional deferred finance costs on revolving loan amendment</a></td>
<td class="num">(741)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from debt issuance, net of issuing costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">97,144<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_ProceedsFromGovernmentAssistance', window );">Proceeds from Payment Protection Program</a></td>
<td class="nump">4,023<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToMinorityShareholders', window );">Distributions paid to noncontrolling interests</a></td>
<td class="num">(601)<span></span>
</td>
<td class="num">(1,818)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets', window );">Proceeds from sale of noncontrolling interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,275<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromContributedCapital', window );">Contribution from noncontrolling partner</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">750<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Proceeds from revolving credit facility</a></td>
<td class="nump">250,900<span></span>
</td>
<td class="nump">251,200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Payments on revolving credit facility</a></td>
<td class="num">(250,900)<span></span>
</td>
<td class="num">(279,200)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Proceeds from issuance of common stock upon exercise of options</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash (used in) provided by financing activities</a></td>
<td class="num">(32,495)<span></span>
</td>
<td class="nump">38,705<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">EFFECT OF EXCHANGE RATE CHANGES ON CASH</a></td>
<td class="nump">6<span></span>
</td>
<td class="num">(28)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">NET INCREASE IN CASH AND CASH EQUIVALENTS</a></td>
<td class="nump">49,574<span></span>
</td>
<td class="nump">27,299<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">CASH AND CASH EQUIVALENTS, beginning of period</a></td>
<td class="nump">40,165<span></span>
</td>
<td class="nump">10,389<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">CASH AND CASH EQUIVALENTS, end of period</a></td>
<td class="nump">89,739<span></span>
</td>
<td class="nump">37,688<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid during the period for interest</a></td>
<td class="nump">31,210<span></span>
</td>
<td class="nump">36,058<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_EquipmentAcquiredAndLeaseholdImprovements', window );">Equipment acquired and leasehold improvements</a></td>
<td class="nump">$ 28,100<span></span>
</td>
<td class="nump">$ 14,100<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_EquipmentAcquiredAndLeaseholdImprovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_EquipmentAcquiredAndLeaseholdImprovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_IncreaseDecreaseInOtherNoncashItem">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase Decrease In Other Noncash Item</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_IncreaseDecreaseInOtherNoncashItem</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_IncreaseDecreaseinOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase Decrease in Operating Lease Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_IncreaseDecreaseinOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_OperatingLeaseRightofUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease Right of Use Asset Amortization</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_OperatingLeaseRightofUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_PaymentstoAcquireInterestinJointVentureAndContributionsToExistingJointVenture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments to Acquire Interest in Joint Venture And Contributions To Existing Joint Venture</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_PaymentstoAcquireInterestinJointVentureAndContributionsToExistingJointVenture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ProceedsFromGovernmentAssistance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Government Assistance</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ProceedsFromGovernmentAssistance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDeferredHedgeGains">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense charged against earnings by an Entity to record deferred gains and losses on hedge instruments. Examples include gain on economic hedges, amortization of gain on designated fair value hedge and so forth.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDeferredHedgeGains</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2443-110228<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the undistributed income (or loss) of equity method investments, net of dividends or other distributions received from unconsolidated subsidiaries, certain corporate joint ventures, and certain noncontrolled corporations; such investments are accounted for under the equity method of accounting. This element excludes distributions that constitute a return of investment, which are classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBuildings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for acquisition of buildings (properties) whether for investment or use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBuildings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of all investments (debt, security, other) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from the acquisition of or improvements to long-lived, physical assets used to produce goods and services and not intended for resale, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromContributedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received by a corporation from a shareholder during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromContributedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of an investment interest in a joint venture that the reporting entity has not previously accounted for using consolidation or the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfInterestInJointVenture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of distribution received from equity method investee for return of investment, classified as investing activities. Excludes distribution for return on investment, classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=SL94080555-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate cash proceeds received from a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591551-111686<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3000-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591552-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for debt, mandatory redeemable security, and principal payment for finance lease obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a),(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140489880410088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NATURE OF BUSINESS AND BASIS OF PRESENTATION<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">NATURE OF BUSINESS AND BASIS OF PRESENTATION</a></td>
<td class="text">NATURE OF BUSINESS AND BASIS OF PRESENTATION<div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a national provider of freestanding, fixed-site outpatient diagnostic imaging services with operations in seven U.S. states. At September&#160;30, 2020, we operated, directly or indirectly through joint ventures with hospitals, 334 centers located in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Our centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Our services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. The vast majority of our centers offer multi-modality imaging services. Our multi-modality strategy diversifies revenue streams, reduces exposure to reimbursement changes and provides patients and referring physicians the convenience of a single location to serve the needs of multiple procedures. In addition to our imaging services, we design and develop software applications, Artificial Intelligence tools and other computerized systems for the diagnostic imaging industry. Our operations comprise a single segment for financial reporting purposes.</span></div><div style="text-align:right;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the accounts of RadNet, Inc as well as its subsidiaries in which RadNet has a controlling financial interest. The consolidated financial statements also include certain variable interest entities in which we are the primary beneficiary (as described in more detail below). All material intercompany transactions and balances have been eliminated upon consolidation.  All of these affiliated entities are referred to collectively as &#8220;RadNet&#8221;, &#8220;we&#8221;, &#8220;us&#8221;, &#8220;our&#8221; or the &#8220;Company&#8221; in this report.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounting regulations stipulate that generally any entity with a) insufficient equity to finance its activities without additional subordinated financial support provided by any parties, or b) equity holders that, as a group, lack the characteristics which evidence a controlling financial interest, is considered a Variable Interest Entity (&#8220;VIE&#8221;). We consolidate all VIEs in which we are the primary beneficiary. We determine whether we are the primary beneficiary of a VIE through a qualitative analysis that identifies which variable interest holder has the controlling financial interest in the VIE. The variable interest holder who has both of the following has the controlling financial interest and is the primary beneficiary: (1) the power to direct the activities of the VIE that most significantly impact the VIE&#8217;s economic performance and (2) the obligation to absorb losses of, or the right to receive benefits from, the VIE that could potentially be significant to the VIE. In performing our analysis, we consider all relevant facts and circumstances, including: the design and activities of the VIE, the terms of the contracts the VIE has entered into, the nature of the VIE&#8217;s variable interests issued and how they were negotiated with or marketed to potential investors, and which parties participated significantly in the design or redesign of the entity.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIEs that we consolidate as the primary beneficiary consist of professional corporations which are owned or controlled by individuals within our senior management, namely Howard G. Berger, M.D., our President and Chief Executive Officer, and John V. Crues, III, M.D., RadNet's Medical Director, both of whom are members of our Board of Directors.  Dr. Berger owns, indirectly, 99% of the equity interests in Beverly Radiology Medical Group III (BRMG) and a controlling interest in two professional corporations in New York City.  BRMG is responsible for the professional medical services at nearly all of our facilities located in California.  Dr. Crues owns six professional corporations which provide medical services in Delaware, Maryland, New Jersey and New York.  Additionally, Dr. Crues is a 1% owner of BRMG.  These VIEs are collectively referred to as the consolidated medical group ("the Group").</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RadNet provides non-medical, technical and administrative services to the Group for which it receives a management fee, pursuant to the related management agreements. Through the management agreements we have exclusive authority over all non-medical decision making related to the ongoing business operations and we determine the annual budget. The Group has insignificant operating assets and liabilities, and de minimis equity. Through management agreements with us, substantially all cash flows of the Group after expenses, including professional salaries, are transferred to us. We consolidate the revenue and expenses, assets and liabilities of the Group.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Group on a combined basis recognized $38.3 million and $40.6 million of revenue, net of management services fees to RadNet, for the three months ended September&#160;30, 2020 and 2019, respectively and $38.3 million and $40.6 million of operating expenses for the three months ended September&#160;30, 2020 and 2019, respectively.  RadNet recognized $169.0 million and $154.5 million of total billed net service fee revenue for the three months ended September&#160;30, 2020, and 2019, respectively, for management services provided to the Group relating primarily to the technical portion of billed revenue.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Group on a combined basis recognized $104.8 million and $116.9 million of revenue, net of management services fees to RadNet, for the nine months ended September&#160;30, 2020 and 2019, respectively and $104.8 million and $116.9 million of operating expenses for the nine months ended September&#160;30, 2020 and 2019, respectively.  RadNet recognized $433.3 million </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $456.1 million of total billed net service fee revenue for the nine months ended September&#160;30, 2020, and 2019, respectively, for management services provided to the Group relating primarily to the technical portion of billed revenue.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cash flows of the Group are included in the accompanying condensed consolidated statements of cash flows. All intercompany balances and transactions have been eliminated in consolidation. In our condensed consolidated balance sheets at September&#160;30, 2020 and December&#160;31, 2019, we have included approximately $84.5 million and $100.3 million, respectively, of accounts receivable and approximately $10.7 million and $7.0 million of accounts payable and accrued liabilities related to the Group, respectively.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The creditors of the Group do not have recourse to our general credit and there are no other arrangements that could expose us to losses on their behalf. However, RadNet may be required to provide financial support to cover any operating expenses in excess of operating revenues.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also own a 49% economic interest in ScriptSender, LLC, which provides secure data transmission services of medical information. Through a management agreement, RadNet provides management and accounting services and receives an agreed upon fee. ScriptSender, LLC is dependent on the Company to finance its own activities, and as such we determined that it is a VIE but we are not a primary beneficiary since we do not have the power to direct the activities of the entity that most significantly impact the entity&#8217;s economic performance.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At all of our centers not serviced by the Group we have entered into long-term contracts (typically up to 40 years) with independent radiology groups to provide physician services at those centers. These radiology practices provide professional services, including supervision and interpretation of diagnostic imaging procedures, in our diagnostic imaging centers. The radiology practices maintain full control over the provision of professional services. Under these arrangements, in addition to obtaining technical fees for the use of our diagnostic imaging equipment and the provision of technical services, we provide management services and receive a fee based on the value of the services we provide.  We own the diagnostic imaging equipment and, therefore, receive 100% of the technical reimbursements associated with imaging procedures. The radiology practice groups retain the professional reimbursements associated with imaging procedures after deducting management service fees paid to us and we have no economic controlling interest in these radiology practices as such, the financial results of these practices are not consolidated in our financial statements.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X and, therefore, do not include all information and footnotes necessary for conformity with U.S. generally accepted accounting principles for complete financial statements; however, in the opinion of our management, all adjustments consisting of normal recurring adjustments necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods ended September&#160;30, 2020 and 2019 have been made. The results of operations for any interim period are not necessarily indicative of the results for a full year. These interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes thereto contained in our annual report on Form 10-K for the year ended December&#160;31, 2019.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity.  Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140489880337688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text">SIGNIFICANT ACCOUNTING POLICIES<div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the period covered in this report, there have been no material changes to the significant accounting policies we use and have explained, in our annual report on Form 10-K for the fiscal year ended December&#160;31, 2019. The information below is intended only to supplement the disclosure in our annual report on Form 10-K for the fiscal year ended December&#160;31, 2019.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">REVENUES  - Our revenues generally relate to net patient fees&#160;received from various payors and patients themselves under contracts in which our performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period when our obligations to provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payor (Medicare, Medicaid, managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed care health plans and commercial insurance companies) the third-party payors. The payment arrangements with third-party payors for the services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As it relates to the Group, this service fee revenue includes payments for both the professional medical interpretation revenue recognized by them as well as the payment for all other aspects related to our providing the imaging services, for which we earn management fees. As it relates to others centers, this service fee revenue is earned through providing the use of our diagnostic imaging equipment and the provision of technical services as well as providing administration services such as clerical and administrative personnel, bookkeeping and accounting services, billing and collection, provision of medical and office supplies, secretarial, reception and transcription services, maintenance of medical records, and advertising, marketing and promotional activities.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues are based upon the estimated amounts we expect to be entitled to receive from patients and third-party payors. Estimates of contractual allowances under managed care and commercial insurance plans are based upon the payment terms specified in the related contractual agreements. Revenues related to uninsured patients and copayment and deductible amounts for patients who have health care coverage may have discounts applied (uninsured discounts and contractual discounts). We also record estimated implicit price concessions (based primarily on historical collection experience) related to uninsured accounts to record self-pay revenues at the estimated amounts we expect to collect.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under capitation arrangements with various health plans, we earn a per-enrollee amount each month for making available diagnostic imaging services to all plan enrollees under the capitation arrangement. Revenue under capitation arrangements is recognized in the period in which we are obligated to provide services to plan enrollees under contracts with various health plans.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our total service revenues during the three and nine  months ended September&#160;30, 2020 and 2019 are presented in the table below based on an allocation of the estimated transaction price with the patient between the primary patient classification of insurance coverage (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.830%"><tr><td style="width:1.0%"/><td style="width:49.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.734%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.734%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.734%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.738%"/><td style="width:0.1%"/></tr><tr style="height:21pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial insurance</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,524&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,152&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412,415&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475,064&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,704&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154,847&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175,825&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,098&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,128&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,072&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,564&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Workers' compensation/personal injury</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,865&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,950&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other patient revenue</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,328&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,085&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,211&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,947&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management fee revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,675&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,792&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,574&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,662&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Teleradiology and Software revenue</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,349&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,412&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,319&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,861&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,869&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,617&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,878&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service fee revenue</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256,730&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261,908&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">660,760&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">762,751&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue under capitation arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,784&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,587&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total service revenue</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291,776&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292,692&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">763,905&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">853,338&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">COVID-19 PANDEMIC AND CARES ACT FUNDING -  On March 11, 2020 the World Health Organization (WHO) designated COVID-19 as a global pandemic.  Patient volumes and the related revenues for our services were significantly impacted during the latter portion of the first quarter through the middle of the third quarter of 2020 as a result of federal, state and local government mandated restrictions requiring many people to remain at home and forced the closure of or limitations on certain businesses, as well as suspended elective procedures by health care facilities.  Many of these restrictions have been eased or completely lifted across the states the Company operates in however, we are unable to predict the future impact of the pandemic on our operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the nine months ended September 30, 2020, we received $39.4 million of accelerated Medicare payments, $5.0 million from Blue Cross, $25.7 million from the general distribution and $4.0 million from the Paycheck Protection Program established through the Coronavirus Aid, Relief and Economic Security (&#8220;CARES&#8221;) Act.  The accelerated Medicare payments are recorded under the caption &#8220; Deferred Revenue&#8220;  in our condensed consolidated balance sheet and will be repaid beginning in 2021.  The general distribution funds were accounted for as government grants and recognized as other revenue, once reasonable assurance that the applicable terms and conditions required to retain the funds were met, under the caption &#8220;Provider relief funding&#8221; in our condensed Consolidated Statements of Operations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the three months ended September 30, 2020, the Department of Health and Human Services significantly changed the measurement of Provider Relief Funds that providers are able to retain.  We received approximately $0.2 million in </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">funding and based on our assessment of the likelihood of meeting the applicable terms and conditions of the general distribution we continue to recognized the funds received as other revenue.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The CARES Act also providers for a payment deferral of the employer portion of Social Security tax incurred during the pandemic, allowing half of such payroll taxes to be deferred until December 2021 and the remaining half until December 2022.  At September 30, 2020, the Company had deferred $10.8 million of Social Security taxes.  These payment deferrals are recorded as payroll tax liability under the caption &#8220;Accounts payable, accrued expenses and other&#8221; in our condensed consolidated balance sheet.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We believe the extent of the COVID-19 pandemic&#8217;s impact on our operating results and financial condition has been and will continue to be driven by many factors, most of which are beyond our control and ability to forecast.  Such factors include, but are not limited to, the scope and duration of stay-at-home practices, business closures  and restrictions, suspensions of elective procedures and continued decline in procedure volumes for an indeterminable length of time and incremental expenses required for supplies and personal protective equipment.  Because of these uncertainties, we cannot estimate the length or impact of the pandemic on our business.  If we incur declines in cash flows and results of operations, such declines could have an impact on the inputs and assumptions used in significant accounting estimates, including implicit prices concessions related to uninsured patient  accounts, and potential impairment of goodwill and long-lived assets.  During the third quarter of 2020, procedure volumes increased and have had a positive impact on our patient revenue.  However, the impact of COVID-19 in future periods may vary and could adversely impact our results of operations.  </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RECLASSIFICATION &#8211;We have reclassified certain amounts previously classified as held for sale related to property and equipment and goodwill to conform to our 2020 presentation.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ACCOUNTS RECEIVABLE - Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. Services are generally provided pursuant to one-year contracts with healthcare providers. We continuously monitor collections from our payors and maintain an allowance for bad debts based upon specific payor collection issues that we have identified and our historical experience.  In regards to the credit loss standard, we have concluded that the historical credit loss experienced across our receivable portfolio is materially similar to any current expected credit losses estimated under the Current Expected Credit Loss ("CECL") model.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2018 and 2019 we entered into factoring agreements with various institutions and sold certain accounts receivable under non-recourse agreements in exchange for notes receivables from the buyers. These transactions are accounted for as a reduction in accounts receivable as the agreements transfer effective control over and risk related to the receivables to the buyers. Proceeds on notes receivables are reflected as operating activities on our statement of cash flows and on our balance sheet as prepaid expenses and other current assets for the current portion and deposits and other for the long term portion. At September&#160;30, 2020 we have&#160;$20.4 million remaining to be collected on these agreements. We do not utilize factoring arrangements as an integral part of our financing for working capital.  To employ the CECL model for the notes receivable, we assess the party's ability to pay upfront at the inception of the notes receivable and subsequently by reviewing their financial statements annually and reassessing any insolvency risk on a periodic basis.  In the event of a significant past due balance, as the sold receivables were already revalued and recorded at net realizable value, we can mitigate the expected credit loss by offsetting any collections from the underlying factored receivables and not remitting that to the counter party.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DEFERRED REVENUE - As noted above, in April of 2020, we received approximately $39.4 million in advanced Medicare payments from the Centers for Medicare and Medicaid Services ("CMS") as part of the expanded Accelerated and Advance Payment Program under the Coronavirus Aid, Relief, and Economic Security (CARES) Act.  As these payments are required to be repaid to CMS beginning 120 days after their receipt through offsets from new Medicare claims over a three month period, we have recorded amounts received to deferred revenue which will be amortized as Medicare reimbursements are earned.  In addition, in May of 2020 we received $5.0 million in advance payments from an insurance carrier with similar repayment terms as the CMS.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DEFERRED FINANCING COSTS - Costs of financing are deferred and amortized using the effective interest rate method. Deferred financing costs, net of accumulated amortization, were $1.9 million and $1.6 million, as of September&#160;30, 2020 and December&#160;31, 2019, respectively and related to our Barclays line of credit.  See Note 5, Credit Facilities and Notes Payable for more information.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PROPERTY AND EQUIPMENT - Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation of property and equipment is performed using the straight-line method over the estimated useful lives of the assets acquired, which range from 3 to 15 years. Leasehold improvements are amortized at the lesser of lease term or their estimated useful lives, which range from 3 to 15 years. Maintenance and repairs are charged to expense as incurred.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BUSINESS COMBINATION  -  When the qualifications for business combination accounting treatment are met, it requires us to recognize separately from goodwill the assets acquired and the liabilities assumed at their acquisition date fair values. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities assumed. While we use our best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, we record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to our consolidated statements of operations.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GOODWILL AND INDEFINITE LIVED INTANGIBLES - Goodwill at September&#160;30, 2020 totaled $470.7 million.  Indefinite lived intangible assets at September&#160;30, 2020 were $11.3 million.  Goodwill and Indefinite Lived Intangibles are recorded as a result of business combinations. When we determine the carrying value of reporting unit exceeds its fair value an impairment charge would be recognized and should not exceed the total amount of goodwill allocated to that reporting unit.  We tested goodwill and indefinite lived intangibles for impairment on October 1, 2019, noting no impairment.  In addition to the annual impairment test, we regularly assess if an event has occurred which would require interim impairment testing.  We considered the current and expected future economic and market conditions surrounding the novel strain of coronavirus ("COVID-19") pandemic and did not identify an indication of goodwill impairment being more likely than not through September&#160;30, 2020.  Activity in goodwill for the nine months ended September&#160;30, 2020 is provided below (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:87.186%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">441,973&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired through the acquisition of Olney Open MRI, LLC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired through the acquisition of MRI at Woodbridge, LLC</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,833&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired through the acquisition of DeepHealth, Inc.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,396&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired through the acquisition of AZ-Tech Radiology &amp; Open MRI, LLC</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,882&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470,685&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">INCOME TAXES -  Income tax expense is computed using an asset and liability method and using expected annual effective tax rates. Under this method, deferred income tax assets and liabilities result from temporary differences in the financial reporting bases and the income tax reporting bases of assets and liabilities. The measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefit that, based on available evidence, is not expected to be realized. When it appears more likely than not that deferred taxes will not be realized, a valuation allowance is recorded to reduce the deferred tax asset to its estimated realizable value. For net deferred tax assets we consider estimates of future taxable income in determining whether our net deferred tax assets are more likely than not to be realized. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded an income tax expense of $3.8 million, or an effective tax rate of 27.2%, for the three months ended September 30, 2020 compared to an income tax expense of $1.8 million, or an effective tax rate of 26.3% for the three months ended September 30, 2019. We recorded an income tax benefit of $5.0 million, or an effective tax rate of 28.3%, for the nine months ended September 30, 2020 compared to an income tax expense of $3.6 million , or an effective tax rate of 24.8% for the nine months ended September 30, 2019.The income tax rates for the three and nine months ended September&#160;30, 2020 diverge from the federal statutory rate due to (i) noncontrolling interests due to the controlled partnerships; (ii) effects of state income taxes; and (iii) excess tax benefits attributable to share-based compensation.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe no significant changes in the unrecognized tax benefits will occur within the next 12 months.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 27, 2020, the President of the United States signed into law the Coronavirus Aid, Relief, and Economic Security Act ("CARES Act"). The CARES Act, among other things, includes certain income tax provisions for individuals and corporations; however, these benefits do not impact the Company&#8217;s current tax provision.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LEASES - We determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (&#8220;ROU&#8221;) assets, current operating lease liabilities, and long term operating lease liability in our consolidated balance sheets. Finance leases are included in property and equipment, current finance lease liability, and long-term finance lease liability in our consolidated balance sheets.&#160;&#160;ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. We use the implicit rate when readily determinable.  We include options to extend a lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term.  For a contract in which we are a lessee that contains fixed </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">payments for both lease and non-lease components, we have elected to account for the components as a single lease component, as permitted. For finance leases, interest expense on the lease liability is recognized using the effective interest method and amortization of the ROU asset is recognized on a straight-line basis over the shorter of the estimated useful life of the asset or the lease term.  </span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ROU assets are</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> tested for impairment if circumstances suggest that the carrying amount may not be recoverable.  Our ROU assets consist of facility and equipment assets on operating leases.  No events have occurred such as fire, flood, or other acts which have impaired the integrity of our ROU assets in 2020.  Our facility leases require us to maintain insurance policies which would cover major damage to our facilities.  We maintain business interruption insurance to cover loss of business due to a facility becoming non-operational under certain circumstances.  Our equipment leases are covered by warranty and service contracts which cover repairs and provide regular maintenance to keep the equipment in functioning order.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EQUITY BASED COMPENSATION &#8211; We have one long-term incentive plan that we adopted in 2006 and which we first amended and restated as of April 20, 2015, and again on March 9, 2017 (the &#8220;Restated Plan&#8221;). The Restated Plan was approved by our stockholders at our annual stockholders meeting on June 8, 2017. We have reserved 14,000,000 shares of common stock for issuance under the Restated Plan which can be issued in the form of options, stock awards, stock appreciation rights, stock units, and cash awards.  Stock options generally vest over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMTY2Mzg_7bbe4cad-8aac-4d51-9911-a759df597876">three</span> to five years and expire <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMTY2NTg_8014eae6-0e25-46ab-80ed-ec3b42b893fd">five</span> to ten years from date of grant.  We determine the compensation expense for each stock option award using the Black Scholes, or similar valuation model.  Those models require that our management make certain estimates concerning risk free interest rates and volatility in the trading price of our common stock. The compensation expense recognized for all equity-based awards is recognized over the awards&#8217; service periods. Equity-based compensation is classified in operating expenses within the same line item as the majority of the cash compensation paid to employees.  In connection with our acquisition of DeepHealth Inc. on June 1, 2020, we assumed the DeepHealth, Inc. 2017 Stock Incentive Plan, including outstanding options awards that can be exercised for our common stock.  No additional awards will be granted under the DeepHealth, Inc. 2017 Equity Incentive Plan.  See Note 4, Facility Acquisitions and Note 6, Stock-Based Compensation, for more information.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COMPREHENSIVE INCOME (LOSS) - ASC 220 establishes rules for reporting and displaying comprehensive income or loss and its components. Our unrealized gains or losses on foreign currency translation adjustments, interest rate cap and swap agreements are included in comprehensive loss and are included in the consolidated statements of comprehensive income (loss) for the three and nine months ended September&#160;30, 2020 and 2019.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COMMITMENTS AND CONTINGENCIES - We are party to various legal proceedings, claims, and regulatory, tax or government inquiries and investigations that arise in the ordinary course of business. With respect to these matters, we evaluate the developments on a regular basis and accrue a liability when we believe a loss is probable and the amount can be reasonably estimated. Based on current information, we do not believe that reasonably possible or probable losses associated with pending legal proceedings would either individually or in the aggregate, have a material adverse effect on our business and consolidated financial statements. However, the outcome of these matters is inherently uncertain. Therefore, if one or more of these matters were resolved against us for amounts in excess of management's expectations, our results of operations and financial condition, including in a particular reporting period in which any such outcome becomes probable and estimable, could be materially adversely affected.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DERIVATIVE INSTRUMENTS</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2016 CAPS</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2016, we entered into two forward interest rate cap agreements ("2016 Caps"). The 2016 Caps will mature in September and October 2020. The 2016 Caps had notional amounts of $150,000,000 and $350,000,000, respectively. Under these arrangements, the Company purchased a cap on 3 month LIBOR at 2.0%. We incurred a $5.3 million premium to enter into the 2016 Caps which is being accrued over the life of the agreements.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At inception, we designated our 2016 Caps as cash flow hedges of floating-rate borrowings. In accordance with accounting guidance, derivatives that have been designated and qualify as cash flow hedging instruments are reported at fair value. The gain or loss of the hedge (i.e. change in fair value) is reported as a component of comprehensive loss in the consolidated statement of equity since such hedge has been determined to be effective.  See Fair Value Measurements section below for the fair value of the 2016 Caps at September&#160;30, 2020.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive loss of the 2016 Caps is as follows (amounts in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:42.512%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.108%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.650%"/><td style="width:0.1%"/></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Account</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">July 1, 2020 Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of comprehensive gain recognized on derivative net of taxes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020 Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Other Comprehensive Loss, net of taxes</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,409)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,214)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities and Equity</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:42.512%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.108%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.650%"/><td style="width:0.1%"/></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the nine months ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Account</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1, 2020 Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of comprehensive gain recognized on derivative net of taxes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020 Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Other Comprehensive Loss, net of taxes</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,877)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">663&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,214)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities and Equity</span></td></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2019 SWAPS</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2019, we entered into four forward interest rate agreements ("2019 Swaps").  The 2019 Swaps have total notional amounts of $500,000,000, consisting of two agreements of $50,000,000 each and two agreements of  $200,000,000 each.   The 2019 Swaps will secure a constant interest rate associated with portions of our variable rate bank debt and have an effective date of October 13, 2020. They will mature in October 2023 for the smaller notional and October 2025 for the larger notional. Under these arrangements, we arranged the 2019 Swaps with locked in 1 month LIBOR rates at 1.96% for the $100,000,000 notional and at 2.05%  for the $400,000,000 notional.  As of the effective date, we will be liable for premium payments if interest rates decline below arranged rates, but will receive interest payments if rates remain above the arranged rates.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At inception, we designated our 2019 Swaps as cash flow hedges of floating-rate borrowings. In accordance with accounting guidance, derivatives that have been designated and qualify as cash flow hedging instruments are reported at fair value. The gain or loss on the effective portion of the hedge (i.e. change in fair value) is reported as a component of comprehensive loss in the consolidated statement of equity.  The remaining gain or loss, if any, is recognized currently in earnings.  As a result of the economic impact of the coronavirus pandemic, which precipitated a reduction in interest rates , the cash flows for both our $400,000,000 notional interest rate swap contract locked in at 2.05% due October 2025 and our $100,000,000 notional interest rate swap contract locked in at 1.96% do not match the cash flows for our First Lien Term Loans and so we have determined that they are not currently effective as cash flow hedges. Accordingly, all changes in their fair value after April 1, 2020 for the $400,000,000 notional and after July 1, 2020 for the $100,000,000 notional will be recognized in earnings.&#160;As of July 1, 2020, the total change in fair value relating to swaps included in other comprehensive income was approximately $24.4 million, net of taxes.  This amount will be amortized to interest expense through October 2025 at approximately $0.4 million per month.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive loss of the 2019 swaps which remain ineffective is as follows (amounts in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.660%"><tr><td style="width:1.0%"/><td style="width:36.624%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.229%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.217%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.528%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.528%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.534%"/><td style="width:0.1%"/></tr><tr><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Account</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">July 1, 2020 Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of comprehensive loss recognized on derivative net of taxes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of loss reclassified out of accumulated OCI into income (prior period effective portion), net of taxes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020 Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Other Comprehensive Loss, net of taxes</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,406)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">969&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,437)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities and Equity</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.052%"><tr><td style="width:1.0%"/><td style="width:35.886%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.561%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.561%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.561%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.561%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.706%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.561%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.709%"/><td style="width:0.1%"/></tr><tr><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the nine months ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Account</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1, 2020 Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of comprehensive loss recognized on derivative net of taxes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of loss reclassified out of accumulated OCI into income (prior period effective portion), net of taxes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020 Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Other Comprehensive Loss, net of taxes</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,870)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,428)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,861&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,437)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities and Equity</span></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A tabular presentation of the effect of derivative instruments on our statement of operations of the 2019 Swaps for the Swaps that became ineffective during the third quarter is as follows (amounts in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.345%"><tr><td style="width:1.0%"/><td style="width:23.027%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.109%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.109%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.109%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.114%"/><td style="width:0.1%"/></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ineffective interest rate swap</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of loss recognized in income on derivative (current period ineffective portion)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of  loss recognized in Income on derivative (current period ineffective portion)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of loss reclassified from accumulated OCI into income (prior period effective portion)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of gain (Loss) reclassified from accumulated OCI into income (prior period effective portion)</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(679)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense)</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,312)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity and Interest Expense</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.345%"><tr><td style="width:1.0%"/><td style="width:23.027%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.109%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.109%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.109%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.114%"/><td style="width:0.1%"/></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the nine months ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ineffective interest rate swap</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of loss recognized in income on derivative (current period ineffective portion)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of  loss recognized in Income on derivative (current period ineffective portion)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of loss reclassified from accumulated OCI into income (prior period effective portion)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of gain (Loss) reclassified from accumulated OCI into income (prior period effective portion)</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,523)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense)</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,204)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity and Interest Expense</span></td></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Fair Value Measurements section below for the fair value of the 2016 caps and 2019 swaps at September&#160;30, 2020.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FAIR VALUE MEASUREMENTS &#8211; Assets and liabilities subject to fair value measurements are required to be disclosed within a fair value hierarchy. The fair value hierarchy ranks the quality and reliability of inputs used to determine fair value. Accordingly, assets and liabilities carried at, or permitted to be carried at, fair value are classified within the fair value hierarchy in one of the following categories based on the lowest level input that is significant to a fair value measurement:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;1&#8212;Fair value is determined by using unadjusted quoted prices that are available in active markets for identical assets and liabilities.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;2&#8212;Fair value is determined by using inputs other than Level&#160;1 quoted prices that are directly or indirectly observable. Inputs can include quoted prices for similar assets and liabilities in active markets or quoted prices for identical assets and liabilities in inactive markets. Related inputs can also include those used in valuation or other pricing models such as interest rates and yield curves that can be corroborated by observable market data.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;3&#8212;Fair value is determined by using inputs that are unobservable and not corroborated by market data. Use of these inputs involves significant and subjective judgment.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Derivatives:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below summarize the estimated fair values of certain of our financial assets that are subject to fair value measurements, and the classification of these assets on our condensed consolidated balance sheets, as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:49.779%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.632%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 30, 2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current and long term liabilities</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2016 caps - Interest Rate Contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 swaps - Interest Rate Contracts</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,983&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,983&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:49.779%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.632%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2019</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current and long term liabilities</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2016 caps - Interest Rate Contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,081&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,081&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 swaps - Interest Rate Contracts</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,477&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,477&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of these contracts was determined using Level 2 inputs. More specifically, the fair value was determined by calculating the value of the difference between the fixed interest rate of the interest rate swaps and the counterparty&#8217;s forward LIBOR curve. The forward LIBOR curve is readily available in the public markets or can be derived from information available in the public markets.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Long Term Debt:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the estimated fair value compared to our face value of our long-term debt as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:37.225%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.651%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 30, 2020</span></td></tr><tr style="height:21pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Face Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Lien Term Loans and SunTrust Term Loan</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">663,140&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">663,140&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">673,227&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:37.225%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.651%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2019</span></td></tr><tr style="height:21pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Face Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Lien Term Loans and SunTrust Term Loan</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">708,948&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">708,948&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705,699&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2020 and at December&#160;31, 2019 our Barclays revolving credit facility had no balance outstanding. Our SunTrust revolving credit facility relating to our consolidated subsidiary NJIN, had no principal amount outstanding at September&#160;30, 2020 and at December&#160;31, 2019.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of our long-term debt, which is discussed in Note 5, was determined using Level 2 inputs primarily related to comparable market prices.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider the carrying amounts of cash and cash equivalents, receivables, other current assets, current liabilities and other notes payables to approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization or payment. Additionally, we consider the carrying amount of our finance lease obligations to approximate their fair value because the weighted average interest rate used to formulate the carrying amounts approximates current market rates.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EARNINGS PER SHARE - Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.538%"><tr><td style="width:1.0%"/><td style="width:51.570%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.175%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.541%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.175%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.541%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.175%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.541%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.182%"/><td style="width:0.1%"/></tr><tr style="height:21pt"><td colspan="3" rowspan="2" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="9" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to RadNet, Inc.'s common stockholders</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,156&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,195&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,797)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,360&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,358,603&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,807,460&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,746,380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,597,138&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net income (loss) per share attributable to RadNet, Inc.'s common stockholders</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.12&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.06&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.41)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.09&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,358,603&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,807,460&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,746,380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,597,138&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add nonvested restricted stock subject only to service vesting</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,605&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,567&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191,375&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add additional shares issuable upon exercise of stock options and warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">476,607&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352,333&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324,793&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares used in calculating diluted net income per share</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,955,815&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,360,360&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,746,380&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,113,306&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net income (loss) per share attributable to RadNet, Inc.'s common stockholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.12&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.06&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.41)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.09&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and non vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested restricted stock subject to service vesting</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331,659&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issuable upon the exercise of stock options:</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,948&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">933,370&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EQUITY INVESTMENTS AT FAIR VALUE&#8211;Accounting guidance requires entities to measure equity investments at fair value, with any changes in fair value recognized in net income. If there is no readily determinable fair value, the guidance allows entities the ability to measure investments at cost, adjusted for observable price changes and impairments, with changes recognized in net income. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2020, we have three equity investments for which a fair value is not readily determinable and therefore the total amounts invested are recognized at cost as follows:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medic Vision Imaging Solutions Ltd., based in Israel, specializes in software packages that provide compliant radiation dose structured reporting and enhanced images from reduced dose CT scans.  On March 24, 2017, we acquired an initial 12.5% equity interest in Medic Vision for $1.0 million. We also received an option to exercise warrants to acquire up to an additional 12.5% equity interest for $1.4 million within one year from the initial share purchase date, if exercised in full. On March 1, 2018 we exercised our warrant in part and acquired an additional 1.96% for $0.2 million. Our initial equity interest has been diluted to 12.25% and our total equity investment stands at 14.21%.  In accordance with accounting guidance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as we exercise no significant influence over Medic Vision&#8217;s operations, the investment is recorded at its cost of $1.2 million, given that the fair value is not readily determinable. No observable price changes or impairment in our investment was identified as of September&#160;30, 2020.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Turner Imaging Systems, based in Utah, develops and markets portable X-ray imaging systems that provide a user the ability to acquire X-ray images wherever and whenever they are needed. On February 1, 2018, we purchased 2.1 million preferred shares in Turner Imaging Systems for $2.0 million. On January 1, 2019 we funded a convertible promissory note in the amount of $0.1 million that converted to additional 80,000 shares December 21, 2019.  No observable price changes impairment in our investment was identified as of September&#160;30, 2020.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WhiteRabbit.ai Inc., based in California, is currently developing an artificial intelligence suite which aims to improve the speed and accuracy of cancer detection in radiology and improve patient care. On November 5, 2019 we acquired an equity interest in the company for $1.0 million and also loaned the company $2.5 million, the principal of which is due November 2022.  To leverage their artificial intelligence expertise, we entered into a software subscription service contract to assist our radiology work flow and advanced them $4.0 million for future software subscription fees that is recorded as a prepaid expense in Prepaid and Other Current assets in our consolidated balance sheets.  No observable price changes or impairment in our investment or the loan receivable was identified as of September&#160;30, 2020.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">INVESTMENT IN JOINT VENTURES &#8211; We have </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> unconsolidated joint ventures with ownership interests ranging from 35% to 55%. These joint ventures represent partnerships with hospitals, health systems or radiology practices and were formed for the purpose of owning and operating diagnostic imaging centers. Professional services at the joint venture diagnostic imaging centers are performed by contracted radiology practices or a radiology practice that participates in the joint venture.&#160;Our investment in these joint ventures is accounted for under the equity method, since RadNet does not have a controlling financial interest in such ventures. We evaluate our investment in joint ventures, including cost in excess of book value (equity method goodwill) for impairment whenever indicators of impairment exist. No indicators of impairment existed as of September&#160;30, 2020.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Joint venture investment contribution</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the month of August 2020, we made additional cash contributions to our Santa Monica Imaging Group, LLC partnership in the amount of $1.6 million in support of its expanded operations.  We maintain our 35% economic interest in the partnership.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Joint venture investment and financial information</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of our investment in joint ventures during the nine months ended September 30, 2020 (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:87.186%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,470&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings in these joint ventures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,176&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution of earnings</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,706)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity contributions in existing joint ventures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,631&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2020</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,571&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We charged management service fees from the centers underlying these joint ventures of approximately $2.7 million and $1.8 million for the three months ended September&#160;30, 2020 and 2019, respectively, and $8.6 million and $7.8 million for the nine months ended September&#160;30, 2020 and 2019, respectively.  We eliminate any unrealized portion of our management service fees with our equity in earnings of joint ventures.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of key balance sheet data for these joint ventures as of September&#160;30, 2020 and December&#160;31, 2019 and income statement data for the nine months ended September 30, 2020 and 2019 (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance Sheet Data:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,618&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,427&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,576&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,037&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,487)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,217)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,751)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,872)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net assets</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,956&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,375&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Book value of RadNet joint venture interests</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,121&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,001&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost in excess of book value of acquired joint venture interests and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,450&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,469&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total value of Radnet joint venture interests</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,571&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,470&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total book value of other joint venture partner interests</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,835&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,374&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income statement data for the nine months ended September 30,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,988&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,115&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,651&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,718&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140489881803176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RECENT ACCOUNTING AND REPORTING STANDARDS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>New Accounting Pronouncements and Changes in Accounting Principles [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">RECENT ACCOUNTING AND REPORTING STANDARDS</a></td>
<td class="text">RECENT ACCOUNTING AND REPORTING STANDARDS<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting standards adopted</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASU No. 2016-13 ("ASU 2016-13), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  ASU 2016-13 replaces the incurred loss methodology previously utilized for valuing financial instruments with an expected loss methodology that is referred to as the current expected credit loss (CECL) methodology.  We prospectively adopted the standard on January 1, 2020 and the adoption did not have a material impact to the condensed consolidated financial statements, resulting in no adjustments to our prior year earnings.  See the Accounts Receivable section to Note 2 for further information on our allowances for credit losses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU No. 2018-15 (&#8220;ASU 2018-15&#8221;),&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles-Goodwill and Other-Internal-Use Software.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;ASU 2018-15 aligns the requirements for deferring implementation costs incurred in a cloud computing arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. This ASU is effective in the first quarter of 2020 with early adoption permitted and can be applied either retrospectively or prospectively to all implementation costs incurred after the date of adoption. The adoption of this standard did not have a material impact on our condensed consolidated balance sheet.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU 2020-03 ("ASU 2020-03"),&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Codification Improvements to Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The amendments in this update represent changes to clarify or improve the codification and correct unintended application. ASU 2020-03 was effective immediately upon issuance and its adoption did not have a material impact on our financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU No. 2018-13 ("ASU 2018-13"),&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disclosure Framework &#8211; Changes to the Disclosure Requirements for Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This standard removes, modifies and adds certain disclosures related to recurring and nonrecurring fair value measurements. We adopted ASC 2018-13 effective January 1, 2020 and it had no effect on our disclosures.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting standards not yet adopted</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12 ("ASU 2019-12"), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740).  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASU 2019-12 removes certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. It also clarifies and simplifies other areas of the standard. ASU 2019-12 will be effective beginning in the first quarter of 2021. Early adoption is permitted. Certain amendments in this update must be applied on a prospective basis, certain amendments must be applied on a retrospective basis, and certain amendments must be applied on a modified retrospective basis through a cumulative-effect adjustment to retained earnings/(deficit) in the period of adoption. We are currently evaluating the impact this ASU will have on our financial statements and related disclosures as well as the timing of adoption.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the FASB issued ASU 2020-01 ("ASU 2020-01"), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments&#8212;Equity Securities (Topic 321), Investments&#8212;Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">clarifying the interaction between accounting standards related to equity securities, equity method investments, and certain derivatives. ASU 2020-01 is effective for fiscal years beginning after December 15, 2020. We do not expect the adoption of this guidance will have a material impact on our financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU 2020-04 ("ASU 2020-04"),&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848), Facilitation of the Effects of Reference Rate Reform on Financial Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. ASU 2020-04 provides optional expedients and exceptions for applying generally accepted accounting principles to certain contract modifications and hedging relationships that reference London Inter-bank Offered Rate (LIBOR) or another reference rate expected to be discontinued. The guidance is effective upon issuance and generally can be applied through December 31, 2022. We are currently evaluating the potential impact of ASU 2020-04 on our financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140489880197944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FACILITY ACQUISITIONS AND DISPOSITIONS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock', window );">FACILITY ACQUISITIONS AND DISPOSITIONS</a></td>
<td class="text">FACILITY ACQUISITIONS AND DISPOSITIONS<div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions:</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 31, 2020 we completed our acquisition of certain assets of AZ-Tech Radiology &amp; Open MRI, LLC, consisting of eight multi-modality imaging centers located in the Phoenix, Arizona area for purchase consideration of $5.5 million.  We made a preliminary fair value determination of the acquired assets and assumed liabilities and approximately $2.5 million in property and equipment, $7.6 million in right-of-use assets, $0.1 million in other assets, $7.6 million in operating lease liabilities, and $2.9 million in goodwill were recorded.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 1, 2020, we completed our acquisition of all the equity interests of DeepHealth Inc., ("DeepHealth") an artificial intelligence and machine learning company in an all stock purchase.  As initial purchase consideration, we issued 915,132 shares at $16.93 per share (823,615 issued at execution, with up to 91,517 shares to be issued 18 months after acquisition subject to adjustment for any indemnification claims).  The transaction was accounted for as an acquisition of a business and total purchase consideration determined to be approximately $34.6 million including i) 823,615 shares issued on the date of closing with fair value of $13.9 million, ii) a liability of 91,517 shares with a fair value of $1.5 million to be issued 18 months after acquisition subject to adjustment for any indemnification claims and will be marked to market in subsequent periods, iii) replacement awards attributable to pre-combination service issued to DeepHealth option holders with allocated fair value of $2.0 million, iv) acquisition date fair value of contingent consideration of $17.0 million and v) $0.1 million in closing costs reimbursed to the seller.  The fair values of replacement awards attributable to pre-combination service and contingent consideration are recorded in additional paid in capital upon closing of the transaction. For the contingent consideration, there are three arrangements that will be settled in a fixed number of shares upon achievement of three individual specific milestones which are mutually exclusive of each other, with 390,789, 586,184, and 195,393 shares, respectively, issuable for each milestone arrangement. The fair value of the contingent consideration was estimated at the date of acquisition based on our share price and estimated probability of the achievement of the respective milestones.  We preliminarily recorded $0.1 million in current assets, $3.5 million in deferred tax liabilities, $14.8 million in intangible assets, primarily in-process research and development ("IPR&amp;D'), and $23.4 million in goodwill. The goodwill is primarily attributable to expected post-acquisition synergies from integrating DeepHealth&#8217;s assembled workforce and IPR&amp;D technologies. The fair values of the identifiable intangible assets related to IPR&amp;D were determined by the income method and the assets will not be amortized until completion. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 2, 2020 our consolidated subsidiary New Jersey Imaging Networks ("NJIN") completed the acquisition of certain assets of MRI at Woodbridge, LLC consisting of a single multi-modality imaging center located in Avenel, New Jersey for cash consideration of $2.6 million.  NJIN made a fair value determination of the acquired assets and assumed liabilities and approximately $0.5 million in property and equipment, $1.1 million in right-of-use assets, $0.3 million in intangible assets, $1.1 million in operating lease liabilities, $0.1 million in finance lease liabilities, and $1.8 million in goodwill were recorded.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On January 2, 2020 we completed our acquisition of certain assets of Olney Open MRI, LLC, consisting of a single multi-modality imaging center located in Columbia, Maryland for cash consideration of $1.8 million.  We have made a fair value determination of the acquired assets and assumed liabilities and approximately $0.8 million in property and equipment, $1.3 million in right-of-use assets, $0.3 million in intangible assets, $1.3 million in operating lease liabilities and $0.6 million  in goodwill were recorded.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dispositions:</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 1, 2020 we completed our sale of certain assets of our Imaging On Call subsidiary to RadVantage P.C. (an unrelated corporation) for approximately $1.0 thousand.  With this transaction, we have exited the teleradiology business.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures.  This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2122178<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140489881776088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CREDIT FACILITY AND NOTES PAYABLE<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock', window );">CREDIT FACILITY AND NOTES PAYABLE</a></td>
<td class="text">CREDIT FACILITIES AND NOTES PAYABLE<div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2020 and December&#160;31, 2019 our debt obligations consisted of the following (in thousands):</span></div><div style="margin-bottom:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.953%"><tr><td style="width:1.0%"/><td style="width:74.273%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.840%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.841%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="12" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Lien Term Loans collateralized by RadNet's tangible and intangible assets</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">620,727&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">649,824&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounts on First Lien Term Loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,669)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,579)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SunTrust Term Loan Agreement collateralized by NJIN's tangible and intangible assets</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,500&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,875&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paycheck Protection Program loans at 1% due April 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,037&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment note payable at 4.6%, due through 2020, collateralized by medical equipment</span></div></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt obligations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666,642&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">692,395&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,463)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,691)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long term portion debt obligations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">627,179&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">652,704&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in our condensed consolidated balance sheets at September&#160;30, 2020 are $620.7 million of First Lien Term Loans and $52.5 million of SunTrust Term Loan debt for a combined total of $673.2 million of total term loan debt (exclusive of unamortized discounts of  $10.7 million) in thousands: </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:61.748%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.794%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.794%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.796%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Face Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Discount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Carrying<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Lien Term Loans</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">620,727&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,669)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610,058&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SunTrust Term Loan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,500&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,500&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Term Loans</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">673,227&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,669)</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662,558&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had no balance under our $195.0 million Barclays Revolving Credit Facility at September&#160;30, 2020 and have reserved $6.3 million for certain letters of credit. The remaining $188.7 million of our Barclays Revolving Credit Facility was available to draw upon as of September&#160;30, 2020.  We had no balance under our $30.0 million SunTrust Revolving Credit Facility related to our consolidated subsidiary NJIN at September&#160;30, 2020.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Senior Secured Credit Facilities</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Barclays Credit Facilities:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2020, (a) our Barclays credit facilities were comprised of one tranche of term loans (&#8220;First Lien Term Loans&#8221;) and a revolving credit facility of $195.0 million (the &#8220;Barclays Revolving Credit Facility&#8221;) and (b) our SunTrust credit facilities, which relate to our consolidated subsidiary NJIN, were comprised of one term loan (the "SunTrust Term Loan") and a revolving credit facility of $30.0 million (the "SunTrust Revolving Credit Facility").</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2020, we were in compliance with all covenants under our credit facilities.  Deferred financing costs at September&#160;30, 2020, net of accumulated amortization, was $1.9 million and is specifically related to our Barclays Revolving Credit Facility.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our First Lien Term Loans bear interest at either an Adjusted Eurodollar Rate or a Base Rate, plus an applicable margin according to the following schedule:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:89.181%"><tr><td style="width:1.0%"/><td style="width:31.850%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.342%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.508%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">First Lien Leverage Ratio</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Eurodollar Rate Spread</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Base Rate Spread</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&gt; 5.50x</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.50%</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.50%</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&gt; 4.00x but &#8804; 5.50x</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.75%</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.75%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&gt;3.50x but &#8804; 4.00x</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.50%</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.50%</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8804; 3.50x</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.25%</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25%</span></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2020 the effective Adjusted Eurodollar Rate and the Base Rate for the First Lien Term Loans was 1.00% and 3.25%, respectively and the applicable margin for Adjusted Eurodollar Rate and Base Rate borrowings was 3.75% and 2.75%, respectively. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The First Lien Credit Agreement provides for quarterly payments of principal under the First Lien Term Loans in the amount of approximately $9.7 million.  The  First Lien Term Loans will mature on July 21, 2023 unless otherwise accelerated under the terms of the First Lien Credit Agreement.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">SunTrust Credit Facilities:</span></div><div style="margin-top:1pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our SunTrust Term Loan bears interest at either an Adjusted Eurodollar Rate or a Base Rate, plus an applicable margin according to the following schedule:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:93.859%"><tr><td style="width:1.0%"/><td style="width:8.713%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.576%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.099%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.099%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.347%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pricing Level</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Leverage Ratio</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Applicable Margin for Eurodollar Loans</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Applicable Margin for Base Rate Loans</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Applicable Margin for Letter of Credit Fees</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Applicable Percentage for Commitment Fee</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than or equal to 3.00:1.00</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.75%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.75%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.45%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">II</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 3.00:1.00 but greater than or equal to 2.50:1.00</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.25%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.40%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">III</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt;padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 2.50:1.00 but greater than or equal to</span></div><div style="margin-top:2.9pt;padding-left:4.5pt;padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00:1.00</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.00%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.35%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IV</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 2.00:1.00 but greater than or equal to 1.50:1.00</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.75%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.30%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">V</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 1.50:1.00</span></div></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.30%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The loans and other obligations outstanding under the SunTrust Restated Credit Agreement currently bear applicable margin and fees based on Pricing Level III described above.  The loans outstanding under the SunTrust Restated Credit Agreement currently bear interest based on a three month Eurodollar election of 2.00%, plus the applicable margin.  </span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:31.5pt"><span><br/></span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The scheduled amortization of the SunTrust Term Loan began December 31, 2018 with quarterly payments of $0.8 million, representing annual amortization equal to 5.00% of the original principal amount of the SunTrust Term Loan. At scheduled intervals, the quarterly amortization increases by $0.4 million, with the remaining balance to be paid at maturity.  The SunTrust Term Loan will mature on August 1, 2023 unless otherwise accelerated under the terms of the SunTrust credit facility.</span></div><div><span><br/></span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:31.5pt"><span><br/></span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Revolving Credit Facilities</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Barclays Revolving Credit Facility</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revolving loans borrowed under the Barclays Revolving Credit Facility bear interest at either an Adjusted Eurodollar Rate or a Base Rate plus an applicable margin.  Rates of the applicable margin for borrowing under the Revolving Credit Facility also change depending on our leverage ratio and are the same rates as noted in the schedule above for First Lien Term Loans. As of September&#160;30, 2020, the effective interest rate payable on revolving loans was 6.00%.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Letters of credit issued under the Barclays Revolving Credit Facility, letter of credit fees accrue at the applicable margin of Adjusted Eurodollar Rate, currently 3.75% , and fronting fees accrue at 0.25% per annum, in each case on the average aggregate daily maximum amount available to be drawn under all letters of credit issued under the First Lien Credit Agreement. In addition, a commitment fee of 0.50% per annum accrues on the unused revolver commitments under the Revolving Credit Facility.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Barclays Revolving Credit Facility will terminate on the earliest to occur of July 1, 2023 or its earlier termination to specific events of default pursuant to the First Lien Credit Agreement.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Barclays Revolving Credit Facility was amended in August 2020 to add $57.5 million of revolving commitments and extend the maximum borrowing capacity to $195.0 million.  Total issue costs added in relation to the eighth amendment amounted to approximately $0.7 million and was capitalized as deferred financing costs and will be amortized over the remaining term of the agreement.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">SunTrust Revolving Credit Facility</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our SunTrust Revolving Credit Facility is available to NJIN for funding requirements, with an available borrowing limit of $30.0 million.  Revolving loan borrowed under the SunTrust Revolving Credit Facility bear interest at either an Adjusted Eurodollar Rate or a Base Rate plus an applicable margin.  Rates of the applicable margin for borrowing under the Revolving Credit Facility also change depending on our leverage ration and are the same rates noted in the schedule above for the SunTrust Term Loan. The SunTrust Revolving Credit Facility terminates on August 31, 2023 unless all amounts outstanding otherwise have been declared or have automatically become due and payable (whether by acceleration or otherwise). NJIN has not borrowed against the revolving credit line.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Recent Amendments to credit facilities:</span></div><div style="margin-top:10pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Barclays Credit Facilities:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 28, 2020, RadNet, Inc. entered into Amendment No. 8, Consent and Incremental Joinder Agreement to Credit and Guaranty Agreement "the Eighth Amendment".  The Eighth Amendment amends the First Lien Credit Agreement to add $57.5 million of revolving commitments to the Barclays Revolving Credit Facility extending the maximum borrowing capacity under the revolving credit facility to $195.0 million while leaving the maturity date of July 1, 2023 unchanged.  Total issue costs added in relation to the Eighth Amendment amounted to approximately $0.7 million and was capitalized as deferred financing costs and will be amortized over the remaining term of the agreement.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 18, 2019 we entered into the following two amendments to the First Lien Credit Agreement: (i) Amendment No. 6, Consent and Incremental Joinder Agreement to Credit and Guaranty Agreement (the &#8220;Sixth Amendment&#8221;); and (ii) Amendment No. 7 to Credit and Guaranty Agreement (the &#8220;Seventh Amendment&#8221;).  The Sixth Amendment amended the First Lien Credit Agreement to issue $100.0 million in incremental First Lien Term Loans and to add an additional $20.0 million of revolving commitments to the Barclay's Revolving Credit Facility.  The Seventh Amendment amended the First Lien Credit Agreement to extend the maturity date of the Barclays Revolving Credit Facility by an additional two years to July 1, 2023, unless sooner terminated in accordance with the terms of the First Lien Credit Agreement.  Total issue costs added in relation to the Sixth and Seventh amendments in 2019 amounted to approximately $4.4 million. Of this amount, $2.1 million was identified and capitalized as discount on debt, $0.7 million was capitalized as deferred financing costs, and $1.6 million was expensed. Amounts capitalized will be amortized over the remaining term of the agreement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:10pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Paycheck Protection Program</span></div>The Paycheck Protection Program (PPP) includes funds available for loans to small business and Medicare providers to support operations during the COVID-19 pandemic. The funds are administered by the Small Business Administration (SBA), through approved lenders and do not require collateral or personal guarantees.  We received our loans based on being a Medicare provider. The terms and conditions for participation require entities to certify that economic uncertainty related to the COVID-19 pandemic makes the loan necessary to support their current operations, and that they will use the funds to retain workers (e.g., by paying salaries, providing paid sick/medical leave and health insurance benefits) and pay certain debts (mortgage obligations) and expenses (e.g. rent, utilities, telephone).  The loans have a 1.0% fixed interest rate and are due in 2 years. Initial repayments have been deferred for six months.  The loans are eligible for forgiveness subject to salary limitations and employee retention levels. Certain of our consolidated subsidiaries received four loans totaling $4.0 million.  We have accounted for the funds received as debt and recorded a liability for the full amount of proceeds received.  Interest will be accrued over the term of the loans.  If we meet the eligibility requirements for forgiveness the amounts forgiven will be recognized in the income statement as a gain on loan extinguishment in accordance with accounting guidance.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for debt and capital lease obligations can be reported. Information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants. Also includes descriptions and amounts of capital leasing arrangements that consist of direct financing, sales type and leveraged leases. Disclosure may include the effect on the balance sheet and the income statement resulting from a change in lease classification for leases that at inception would have been classified differently had guidance been in effect at the inception of the original lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -URI http://asc.fasb.org/topic&amp;trid=2208923<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140489880360648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">STOCK-BASED COMPENSATION</a></td>
<td class="text">STOCK-BASED COMPENSATIONStock Incentive Plans<div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have one long-term equity incentive plan which we refer to as the 2006 Equity Incentive Plan, which we first amended and restated as of April 20, 2015 and again on March 9, 2017 (the "Restated Plan&#8221;). The Restated Plan was approved by our stockholders at our annual stockholders meeting on June 8, 2017. We have reserved for issuance under the Restated Plan 14,000,000 shares of common stock. We can issue options (incentive and non-qualified), stock awards, stock appreciation rights, stock units and cash awards under the Restated Plan.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Options</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain options granted under the Restated Plan to employees are intended to qualify as incentive stock options under existing tax regulations. Stock options generally vest over 3 to 5 years and expire 5 to 10 years from the date of grant.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2020, we had outstanding options to acquire 527,899 shares of our common stock, of which options to acquire 298,863 shares were exercisable. The following summarizes all of our option transactions for the nine months ended September&#160;30, 2020:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:48.973%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.650%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outstanding Options<br/>Under the 2006 Plan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise price<br/>Per Common Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining<br/>Contractual Life<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2019</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478,951&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.21&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,948&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, September 30, 2020</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">527,899&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.34&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.59</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,419,956&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at September 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298,863&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.85</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,353,438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aggregate intrinsic value in the table above represents the total pretax intrinsic value (the difference between our closing stock price on September&#160;30, 2020 and the exercise price, multiplied by the number of in-the-money options as applicable) that would have been received by the holder had all holders exercised their options on September&#160;30, 2020. No options were exercised during the nine months ended September&#160;30, 2020.  As of September&#160;30, 2020, total unrecognized stock-based compensation expense related to non-vested employee awards was $0.7 million which is expected to be recognized over a weighted average period of approximately 1.68 years.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:174%">DeepHealth Options</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of fiscal 2020, in connection with the completion of the DeepHealth acquisition, we granted&#160;412,434&#160;options at a grant date fair value of $16.93&#160;per share unit to DeepHealth employees in replacement of their stock options that were outstanding as of the closing date.  As of September&#160;30, 2020, total unrecognized stock based compensation expense related to non-vested DeepHealth options was approximately $4.3 million which is expected to be recognized over a weighted average period of approximately 2.53 years.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.836%"><tr><td style="width:1.0%"/><td style="width:48.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.711%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.711%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.711%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.713%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outstanding Options<br/>Under the Deep Health Plan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise price<br/>Per Common Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining<br/>Contractual Life<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2019</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted, June 1, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412,434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,963)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, September 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405,471&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.65</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,223,980&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at September 30, 2020</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,211&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.65</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371,639&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Awards</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Restated Plan permits the award of restricted stock awards (&#8220;RSA&#8217;s&#8221;). As of September&#160;30, 2020, we have issued a total of 6,551,872 RSA&#8217;s of which 331,659 were unvested at September&#160;30, 2020. The following summarizes all unvested RSA&#8217;s activities during the nine months ended September&#160;30, 2020:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">RSA's</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Remaining<br/>Contractual<br/>Term (Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSA's unvested at December 31, 2019</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387,934&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.61&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes during the period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">457,596&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.66&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(513,871)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSA's unvested at September 30, 2020</span></td><td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331,659&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.11</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.67&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine the fair value of all RSA&#8217;s based on the closing price of our common stock on the award date.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other stock bonus awards</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Restated Plan also permits the award of stock bonuses not subject to any future service period. These awards are valued and expensed based on the closing price of our common stock on the date of award. During the nine months ended September&#160;30, 2020 awards totaling 26,078 shares were granted.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Plan summary</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In summary, of the 14,000,000 shares of common stock reserved for issuance under the Restated Plan, at September&#160;30, 2020, we had issued 15,384,316 total shares between options, RSA&#8217;s and other stock awards. With options canceled and RSA&#8217;s forfeited amounting to 3,281,040 and 61,703 shares, respectively, there remain 1,958,427 shares available under the Restated Plan for future issuance.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The DeepHealth options were issued outside of the Restated Plan and are a direct result of our acquisition and not included in the share count of the Restated Plan.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140489881764456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text">SUBSEQUENT EVENTS<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Formation of majority owned subsidiary</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2020 we formed in conjunction with Simi Valley Hospital and Health Services ("Simi Adventist") the Simi Valley Imaging Group, LLC (&#8220;SVIG&#8221;), consisting of three multi-modality imaging centers located in Simi Valley, CA.  RadNet will hold a 60% economic interest in SVIG and Simi Adventist will have the remaining  40% interest.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140489887236168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">REVENUES</a></td>
<td class="text">REVENUES  - Our revenues generally relate to net patient fees&#160;received from various payors and patients themselves under contracts in which our performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period when our obligations to provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payor (Medicare, Medicaid, managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed care health plans and commercial insurance companies) the third-party payors. The payment arrangements with third-party payors for the services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.<div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As it relates to the Group, this service fee revenue includes payments for both the professional medical interpretation revenue recognized by them as well as the payment for all other aspects related to our providing the imaging services, for which we earn management fees. As it relates to others centers, this service fee revenue is earned through providing the use of our diagnostic imaging equipment and the provision of technical services as well as providing administration services such as clerical and administrative personnel, bookkeeping and accounting services, billing and collection, provision of medical and office supplies, secretarial, reception and transcription services, maintenance of medical records, and advertising, marketing and promotional activities.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues are based upon the estimated amounts we expect to be entitled to receive from patients and third-party payors. Estimates of contractual allowances under managed care and commercial insurance plans are based upon the payment terms specified in the related contractual agreements. Revenues related to uninsured patients and copayment and deductible amounts for patients who have health care coverage may have discounts applied (uninsured discounts and contractual discounts). We also record estimated implicit price concessions (based primarily on historical collection experience) related to uninsured accounts to record self-pay revenues at the estimated amounts we expect to collect.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under capitation arrangements with various health plans, we earn a per-enrollee amount each month for making available diagnostic imaging services to all plan enrollees under the capitation arrangement. Revenue under capitation arrangements is recognized in the period in which we are obligated to provide services to plan enrollees under contracts with various health plans.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our total service revenues during the three and nine  months ended September&#160;30, 2020 and 2019 are presented in the table below based on an allocation of the estimated transaction price with the patient between the primary patient classification of insurance coverage (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.830%"><tr><td style="width:1.0%"/><td style="width:49.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.734%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.734%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.734%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.738%"/><td style="width:0.1%"/></tr><tr style="height:21pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial insurance</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,524&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,152&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412,415&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475,064&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,704&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154,847&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175,825&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,098&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,128&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,072&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,564&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Workers' compensation/personal injury</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,865&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,950&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other patient revenue</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,328&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,085&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,211&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,947&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management fee revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,675&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,792&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,574&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,662&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Teleradiology and Software revenue</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,349&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,412&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,319&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,861&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,869&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,617&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,878&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service fee revenue</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256,730&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261,908&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">660,760&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">762,751&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue under capitation arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,784&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,587&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total service revenue</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291,776&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292,692&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">763,905&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">853,338&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">COVID-19 PANDEMIC AND CARES ACT FUNDING -  On March 11, 2020 the World Health Organization (WHO) designated COVID-19 as a global pandemic.  Patient volumes and the related revenues for our services were significantly impacted during the latter portion of the first quarter through the middle of the third quarter of 2020 as a result of federal, state and local government mandated restrictions requiring many people to remain at home and forced the closure of or limitations on certain businesses, as well as suspended elective procedures by health care facilities.  Many of these restrictions have been eased or completely lifted across the states the Company operates in however, we are unable to predict the future impact of the pandemic on our operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the nine months ended September 30, 2020, we received $39.4 million of accelerated Medicare payments, $5.0 million from Blue Cross, $25.7 million from the general distribution and $4.0 million from the Paycheck Protection Program established through the Coronavirus Aid, Relief and Economic Security (&#8220;CARES&#8221;) Act.  The accelerated Medicare payments are recorded under the caption &#8220; Deferred Revenue&#8220;  in our condensed consolidated balance sheet and will be repaid beginning in 2021.  The general distribution funds were accounted for as government grants and recognized as other revenue, once reasonable assurance that the applicable terms and conditions required to retain the funds were met, under the caption &#8220;Provider relief funding&#8221; in our condensed Consolidated Statements of Operations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the three months ended September 30, 2020, the Department of Health and Human Services significantly changed the measurement of Provider Relief Funds that providers are able to retain.  We received approximately $0.2 million in </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">funding and based on our assessment of the likelihood of meeting the applicable terms and conditions of the general distribution we continue to recognized the funds received as other revenue.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The CARES Act also providers for a payment deferral of the employer portion of Social Security tax incurred during the pandemic, allowing half of such payroll taxes to be deferred until December 2021 and the remaining half until December 2022.  At September 30, 2020, the Company had deferred $10.8 million of Social Security taxes.  These payment deferrals are recorded as payroll tax liability under the caption &#8220;Accounts payable, accrued expenses and other&#8221; in our condensed consolidated balance sheet.</span></div>We believe the extent of the COVID-19 pandemic&#8217;s impact on our operating results and financial condition has been and will continue to be driven by many factors, most of which are beyond our control and ability to forecast.  Such factors include, but are not limited to, the scope and duration of stay-at-home practices, business closures  and restrictions, suspensions of elective procedures and continued decline in procedure volumes for an indeterminable length of time and incremental expenses required for supplies and personal protective equipment.  Because of these uncertainties, we cannot estimate the length or impact of the pandemic on our business.  If we incur declines in cash flows and results of operations, such declines could have an impact on the inputs and assumptions used in significant accounting estimates, including implicit prices concessions related to uninsured patient  accounts, and potential impairment of goodwill and long-lived assets.  During the third quarter of 2020, procedure volumes increased and have had a positive impact on our patient revenue.  However, the impact of COVID-19 in future periods may vary and could adversely impact our results of operations.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">RECLASSIFICATION</a></td>
<td class="text">RECLASSIFICATION &#8211;We have reclassified certain amounts previously classified as held for sale related to property and equipment and goodwill to conform to our 2020 presentation.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">ACCOUNTS RECEIVABLE</a></td>
<td class="text">ACCOUNTS RECEIVABLE - Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. Services are generally provided pursuant to one-year contracts with healthcare providers. We continuously monitor collections from our payors and maintain an allowance for bad debts based upon specific payor collection issues that we have identified and our historical experience.  In regards to the credit loss standard, we have concluded that the historical credit loss experienced across our receivable portfolio is materially similar to any current expected credit losses estimated under the Current Expected Credit Loss ("CECL") model.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">DEFERRED REVENUE</a></td>
<td class="text">DEFERRED REVENUE - As noted above, in April of 2020, we received approximately $39.4 million in advanced Medicare payments from the Centers for Medicare and Medicaid Services ("CMS") as part of the expanded Accelerated and Advance Payment Program under the Coronavirus Aid, Relief, and Economic Security (CARES) Act.  As these payments are required to be repaid to CMS beginning 120 days after their receipt through offsets from new Medicare claims over a three month period, we have recorded amounts received to deferred revenue which will be amortized as Medicare reimbursements are earned.  In addition, in May of 2020 we received $5.0 million in advance payments from an insurance carrier with similar repayment terms as the CMS.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredChargesPolicyTextBlock', window );">DEFERRED FINANCING COSTS</a></td>
<td class="text">DEFERRED FINANCING COSTS - Costs of financing are deferred and amortized using the effective interest rate method. Deferred financing costs, net of accumulated amortization, were $1.9 million and $1.6 million, as of September&#160;30, 2020 and December&#160;31, 2019, respectively and related to our Barclays line of credit.  See Note 5, Credit Facilities and Notes Payable for more information.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">PROPERTY AND EQUIPMENT</a></td>
<td class="text">PROPERTY AND EQUIPMENT - Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation of property and equipment is performed using the straight-line method over the estimated useful lives of the assets acquired, which range from 3 to 15 years. Leasehold improvements are amortized at the lesser of lease term or their estimated useful lives, which range from 3 to 15 years. Maintenance and repairs are charged to expense as incurred.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsPolicy', window );">BUSINESS COMBINATION</a></td>
<td class="text">BUSINESS COMBINATION  -  When the qualifications for business combination accounting treatment are met, it requires us to recognize separately from goodwill the assets acquired and the liabilities assumed at their acquisition date fair values. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities assumed. While we use our best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, we record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to our consolidated statements of operations.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy', window );">GOODWILL AND INDEFINITE LIVED INTANGIBLES</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GOODWILL AND INDEFINITE LIVED INTANGIBLES - Goodwill at September&#160;30, 2020 totaled $470.7 million.  Indefinite lived intangible assets at September&#160;30, 2020 were $11.3 million.  Goodwill and Indefinite Lived Intangibles are recorded as a result of business combinations. When we determine the carrying value of reporting unit exceeds its fair value an impairment charge would be recognized and should not exceed the total amount of goodwill allocated to that reporting unit.  We tested goodwill and indefinite lived intangibles for impairment on October 1, 2019, noting no impairment.  In addition to the annual impairment test, we regularly assess if an event has occurred which would require interim impairment testing.  We considered the current and expected future economic and market conditions surrounding the novel strain of coronavirus ("COVID-19") pandemic and did not identify an indication of goodwill impairment being more likely than not through September&#160;30, 2020.  Activity in goodwill for the nine months ended September&#160;30, 2020 is provided below (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:87.186%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">441,973&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired through the acquisition of Olney Open MRI, LLC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired through the acquisition of MRI at Woodbridge, LLC</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,833&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired through the acquisition of DeepHealth, Inc.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,396&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired through the acquisition of AZ-Tech Radiology &amp; Open MRI, LLC</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,882&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470,685&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">INCOME TAXES</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">INCOME TAXES -  Income tax expense is computed using an asset and liability method and using expected annual effective tax rates. Under this method, deferred income tax assets and liabilities result from temporary differences in the financial reporting bases and the income tax reporting bases of assets and liabilities. The measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefit that, based on available evidence, is not expected to be realized. When it appears more likely than not that deferred taxes will not be realized, a valuation allowance is recorded to reduce the deferred tax asset to its estimated realizable value. For net deferred tax assets we consider estimates of future taxable income in determining whether our net deferred tax assets are more likely than not to be realized. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded an income tax expense of $3.8 million, or an effective tax rate of 27.2%, for the three months ended September 30, 2020 compared to an income tax expense of $1.8 million, or an effective tax rate of 26.3% for the three months ended September 30, 2019. We recorded an income tax benefit of $5.0 million, or an effective tax rate of 28.3%, for the nine months ended September 30, 2020 compared to an income tax expense of $3.6 million , or an effective tax rate of 24.8% for the nine months ended September 30, 2019.The income tax rates for the three and nine months ended September&#160;30, 2020 diverge from the federal statutory rate due to (i) noncontrolling interests due to the controlled partnerships; (ii) effects of state income taxes; and (iii) excess tax benefits attributable to share-based compensation.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe no significant changes in the unrecognized tax benefits will occur within the next 12 months.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 27, 2020, the President of the United States signed into law the Coronavirus Aid, Relief, and Economic Security Act ("CARES Act"). The CARES Act, among other things, includes certain income tax provisions for individuals and corporations; however, these benefits do not impact the Company&#8217;s current tax provision.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">LEASES</a></td>
<td class="text">LEASES - We determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (&#8220;ROU&#8221;) assets, current operating lease liabilities, and long term operating lease liability in our consolidated balance sheets. Finance leases are included in property and equipment, current finance lease liability, and long-term finance lease liability in our consolidated balance sheets.&#160;&#160;ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. We use the implicit rate when readily determinable.  We include options to extend a lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term.  For a contract in which we are a lessee that contains fixed <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">payments for both lease and non-lease components, we have elected to account for the components as a single lease component, as permitted. For finance leases, interest expense on the lease liability is recognized using the effective interest method and amortization of the ROU asset is recognized on a straight-line basis over the shorter of the estimated useful life of the asset or the lease term.  </span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ROU assets are</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> tested for impairment if circumstances suggest that the carrying amount may not be recoverable.  Our ROU assets consist of facility and equipment assets on operating leases.  No events have occurred such as fire, flood, or other acts which have impaired the integrity of our ROU assets in 2020.  Our facility leases require us to maintain insurance policies which would cover major damage to our facilities.  We maintain business interruption insurance to cover loss of business due to a facility becoming non-operational under certain circumstances.  Our equipment leases are covered by warranty and service contracts which cover repairs and provide regular maintenance to keep the equipment in functioning order.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationRelatedCostsPolicyTextBlock', window );">EQUITY BASED COMPENSATION</a></td>
<td class="text">EQUITY BASED COMPENSATION &#8211; We have one long-term incentive plan that we adopted in 2006 and which we first amended and restated as of April 20, 2015, and again on March 9, 2017 (the &#8220;Restated Plan&#8221;). The Restated Plan was approved by our stockholders at our annual stockholders meeting on June 8, 2017. We have reserved 14,000,000 shares of common stock for issuance under the Restated Plan which can be issued in the form of options, stock awards, stock appreciation rights, stock units, and cash awards.  Stock options generally vest over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMTY2Mzg_7bbe4cad-8aac-4d51-9911-a759df597876">three</span> to five years and expire <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZmYzBiNTk3MDViZjRjZmY5MzZmNjE5MjkzYjFhMzA2L3NlYzpmZmMwYjU5NzA1YmY0Y2ZmOTM2ZjYxOTI5M2IxYTMwNl80My9mcmFnOjg0MWYyZmEzYjczMjRjYTk4YjlhNWU4MTg4OGZkNTVhL3RleHRyZWdpb246ODQxZjJmYTNiNzMyNGNhOThiOWE1ZTgxODg4ZmQ1NWFfMTY2NTg_8014eae6-0e25-46ab-80ed-ec3b42b893fd">five</span> to ten years from date of grant.  We determine the compensation expense for each stock option award using the Black Scholes, or similar valuation model.  Those models require that our management make certain estimates concerning risk free interest rates and volatility in the trading price of our common stock. The compensation expense recognized for all equity-based awards is recognized over the awards&#8217; service periods. Equity-based compensation is classified in operating expenses within the same line item as the majority of the cash compensation paid to employees.  In connection with our acquisition of DeepHealth Inc. on June 1, 2020, we assumed the DeepHealth, Inc. 2017 Stock Incentive Plan, including outstanding options awards that can be exercised for our common stock.  No additional awards will be granted under the DeepHealth, Inc. 2017 Equity Incentive Plan.  See Note 4, Facility Acquisitions and Note 6, Stock-Based Compensation, for more information.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">COMPREHENSIVE INCOME (LOSS)</a></td>
<td class="text">COMPREHENSIVE INCOME (LOSS) - ASC 220 establishes rules for reporting and displaying comprehensive income or loss and its components. Our unrealized gains or losses on foreign currency translation adjustments, interest rate cap and swap agreements are included in comprehensive loss and are included in the consolidated statements of comprehensive income (loss) for the three and nine months ended September&#160;30, 2020 and 2019<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text">COMMITMENTS AND CONTINGENCIES - We are party to various legal proceedings, claims, and regulatory, tax or government inquiries and investigations that arise in the ordinary course of business. With respect to these matters, we evaluate the developments on a regular basis and accrue a liability when we believe a loss is probable and the amount can be reasonably estimated. Based on current information, we do not believe that reasonably possible or probable losses associated with pending legal proceedings would either individually or in the aggregate, have a material adverse effect on our business and consolidated financial statements. However, the outcome of these matters is inherently uncertain. Therefore, if one or more of these matters were resolved against us for amounts in excess of management's expectations, our results of operations and financial condition, including in a particular reporting period in which any such outcome becomes probable and estimable, could be materially adversely affected.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">DERIVATIVE INSTRUMENTS</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DERIVATIVE INSTRUMENTS</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2016 CAPS</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2016, we entered into two forward interest rate cap agreements ("2016 Caps"). The 2016 Caps will mature in September and October 2020. The 2016 Caps had notional amounts of $150,000,000 and $350,000,000, respectively. Under these arrangements, the Company purchased a cap on 3 month LIBOR at 2.0%. We incurred a $5.3 million premium to enter into the 2016 Caps which is being accrued over the life of the agreements.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At inception, we designated our 2016 Caps as cash flow hedges of floating-rate borrowings. In accordance with accounting guidance, derivatives that have been designated and qualify as cash flow hedging instruments are reported at fair value. The gain or loss of the hedge (i.e. change in fair value) is reported as a component of comprehensive loss in the consolidated statement of equity since such hedge has been determined to be effective.  See Fair Value Measurements section below for the fair value of the 2016 Caps at September&#160;30, 2020.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive loss of the 2016 Caps is as follows (amounts in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:42.512%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.108%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.650%"/><td style="width:0.1%"/></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Account</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">July 1, 2020 Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of comprehensive gain recognized on derivative net of taxes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020 Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Other Comprehensive Loss, net of taxes</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,409)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,214)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities and Equity</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:42.512%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.108%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.650%"/><td style="width:0.1%"/></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the nine months ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Account</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1, 2020 Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of comprehensive gain recognized on derivative net of taxes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020 Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Other Comprehensive Loss, net of taxes</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,877)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">663&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,214)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities and Equity</span></td></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2019 SWAPS</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2019, we entered into four forward interest rate agreements ("2019 Swaps").  The 2019 Swaps have total notional amounts of $500,000,000, consisting of two agreements of $50,000,000 each and two agreements of  $200,000,000 each.   The 2019 Swaps will secure a constant interest rate associated with portions of our variable rate bank debt and have an effective date of October 13, 2020. They will mature in October 2023 for the smaller notional and October 2025 for the larger notional. Under these arrangements, we arranged the 2019 Swaps with locked in 1 month LIBOR rates at 1.96% for the $100,000,000 notional and at 2.05%  for the $400,000,000 notional.  As of the effective date, we will be liable for premium payments if interest rates decline below arranged rates, but will receive interest payments if rates remain above the arranged rates.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At inception, we designated our 2019 Swaps as cash flow hedges of floating-rate borrowings. In accordance with accounting guidance, derivatives that have been designated and qualify as cash flow hedging instruments are reported at fair value. The gain or loss on the effective portion of the hedge (i.e. change in fair value) is reported as a component of comprehensive loss in the consolidated statement of equity.  The remaining gain or loss, if any, is recognized currently in earnings.  As a result of the economic impact of the coronavirus pandemic, which precipitated a reduction in interest rates , the cash flows for both our $400,000,000 notional interest rate swap contract locked in at 2.05% due October 2025 and our $100,000,000 notional interest rate swap contract locked in at 1.96% do not match the cash flows for our First Lien Term Loans and so we have determined that they are not currently effective as cash flow hedges. Accordingly, all changes in their fair value after April 1, 2020 for the $400,000,000 notional and after July 1, 2020 for the $100,000,000 notional will be recognized in earnings.&#160;As of July 1, 2020, the total change in fair value relating to swaps included in other comprehensive income was approximately $24.4 million, net of taxes.  This amount will be amortized to interest expense through October 2025 at approximately $0.4 million per month.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive loss of the 2019 swaps which remain ineffective is as follows (amounts in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.660%"><tr><td style="width:1.0%"/><td style="width:36.624%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.229%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.217%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.528%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.528%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.534%"/><td style="width:0.1%"/></tr><tr><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Account</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">July 1, 2020 Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of comprehensive loss recognized on derivative net of taxes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of loss reclassified out of accumulated OCI into income (prior period effective portion), net of taxes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020 Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Other Comprehensive Loss, net of taxes</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,406)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">969&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,437)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities and Equity</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.052%"><tr><td style="width:1.0%"/><td style="width:35.886%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.561%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.561%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.561%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.561%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.706%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.561%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.709%"/><td style="width:0.1%"/></tr><tr><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the nine months ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Account</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1, 2020 Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of comprehensive loss recognized on derivative net of taxes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of loss reclassified out of accumulated OCI into income (prior period effective portion), net of taxes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020 Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Other Comprehensive Loss, net of taxes</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,870)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,428)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,861&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,437)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities and Equity</span></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A tabular presentation of the effect of derivative instruments on our statement of operations of the 2019 Swaps for the Swaps that became ineffective during the third quarter is as follows (amounts in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.345%"><tr><td style="width:1.0%"/><td style="width:23.027%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.109%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.109%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.109%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.114%"/><td style="width:0.1%"/></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ineffective interest rate swap</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of loss recognized in income on derivative (current period ineffective portion)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of  loss recognized in Income on derivative (current period ineffective portion)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of loss reclassified from accumulated OCI into income (prior period effective portion)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of gain (Loss) reclassified from accumulated OCI into income (prior period effective portion)</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(679)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense)</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,312)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity and Interest Expense</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">FAIR VALUE MEASUREMENTS</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FAIR VALUE MEASUREMENTS &#8211; Assets and liabilities subject to fair value measurements are required to be disclosed within a fair value hierarchy. The fair value hierarchy ranks the quality and reliability of inputs used to determine fair value. Accordingly, assets and liabilities carried at, or permitted to be carried at, fair value are classified within the fair value hierarchy in one of the following categories based on the lowest level input that is significant to a fair value measurement:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;1&#8212;Fair value is determined by using unadjusted quoted prices that are available in active markets for identical assets and liabilities.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;2&#8212;Fair value is determined by using inputs other than Level&#160;1 quoted prices that are directly or indirectly observable. Inputs can include quoted prices for similar assets and liabilities in active markets or quoted prices for identical assets and liabilities in inactive markets. Related inputs can also include those used in valuation or other pricing models such as interest rates and yield curves that can be corroborated by observable market data.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;3&#8212;Fair value is determined by using inputs that are unobservable and not corroborated by market data. Use of these inputs involves significant and subjective judgment.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Derivatives:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below summarize the estimated fair values of certain of our financial assets that are subject to fair value measurements, and the classification of these assets on our condensed consolidated balance sheets, as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:49.779%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.632%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 30, 2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current and long term liabilities</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2016 caps - Interest Rate Contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 swaps - Interest Rate Contracts</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,983&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,983&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:49.779%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.632%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2019</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current and long term liabilities</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2016 caps - Interest Rate Contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,081&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,081&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 swaps - Interest Rate Contracts</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,477&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,477&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of these contracts was determined using Level 2 inputs. More specifically, the fair value was determined by calculating the value of the difference between the fixed interest rate of the interest rate swaps and the counterparty&#8217;s forward LIBOR curve. The forward LIBOR curve is readily available in the public markets or can be derived from information available in the public markets.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Long Term Debt:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the estimated fair value compared to our face value of our long-term debt as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:37.225%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.651%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 30, 2020</span></td></tr><tr style="height:21pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Face Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Lien Term Loans and SunTrust Term Loan</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">663,140&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">663,140&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">673,227&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:37.225%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.651%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2019</span></td></tr><tr style="height:21pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Face Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Lien Term Loans and SunTrust Term Loan</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">708,948&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">708,948&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705,699&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2020 and at December&#160;31, 2019 our Barclays revolving credit facility had no balance outstanding. Our SunTrust revolving credit facility relating to our consolidated subsidiary NJIN, had no principal amount outstanding at September&#160;30, 2020 and at December&#160;31, 2019.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of our long-term debt, which is discussed in Note 5, was determined using Level 2 inputs primarily related to comparable market prices.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider the carrying amounts of cash and cash equivalents, receivables, other current assets, current liabilities and other notes payables to approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization or payment. Additionally, we consider the carrying amount of our finance lease obligations to approximate their fair value because the weighted average interest rate used to formulate the carrying amounts approximates current market rates.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">EARNINGS PER SHARE</a></td>
<td class="text">EARNINGS PER SHARE - Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.538%"><tr><td style="width:1.0%"/><td style="width:51.570%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.175%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.541%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.175%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.541%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.175%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.541%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.182%"/><td style="width:0.1%"/></tr><tr style="height:21pt"><td colspan="3" rowspan="2" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="9" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to RadNet, Inc.'s common stockholders</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,156&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,195&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,797)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,360&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,358,603&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,807,460&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,746,380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,597,138&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net income (loss) per share attributable to RadNet, Inc.'s common stockholders</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.12&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.06&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.41)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.09&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,358,603&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,807,460&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,746,380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,597,138&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add nonvested restricted stock subject only to service vesting</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,605&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,567&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191,375&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add additional shares issuable upon exercise of stock options and warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">476,607&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352,333&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324,793&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares used in calculating diluted net income per share</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,955,815&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,360,360&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,746,380&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,113,306&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net income (loss) per share attributable to RadNet, Inc.'s common stockholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.12&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.06&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.41)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.09&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and non vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested restricted stock subject to service vesting</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331,659&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issuable upon the exercise of stock options:</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,948&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">933,370&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsPolicy', window );">EQUITY INVESTMENTS AT FAIR VALUE</a></td>
<td class="text">EQUITY INVESTMENTS AT FAIR VALUE&#8211;Accounting guidance requires entities to measure equity investments at fair value, with any changes in fair value recognized in net income. If there is no readily determinable fair value, the guidance allows entities the ability to measure investments at cost, adjusted for observable price changes and impairments, with changes recognized in net income.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">INVESTMENTS IN JOINT VENTURES</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">INVESTMENT IN JOINT VENTURES &#8211; We have </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> unconsolidated joint ventures with ownership interests ranging from 35% to 55%. These joint ventures represent partnerships with hospitals, health systems or radiology practices and were formed for the purpose of owning and operating diagnostic imaging centers. Professional services at the joint venture diagnostic imaging centers are performed by contracted radiology practices or a radiology practice that participates in the joint venture.&#160;Our investment in these joint ventures is accounted for under the equity method, since RadNet does not have a controlling financial interest in such ventures. We evaluate our investment in joint ventures, including cost in excess of book value (equity method goodwill) for impairment whenever indicators of impairment exist. No indicators of impairment existed as of September&#160;30, 2020.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Joint venture investment contribution</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the month of August 2020, we made additional cash contributions to our Santa Monica Imaging Group, LLC partnership in the amount of $1.6 million in support of its expanded operations.  We maintain our 35% economic interest in the partnership.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Joint venture investment and financial information</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of our investment in joint ventures during the nine months ended September 30, 2020 (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:87.186%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,470&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings in these joint ventures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,176&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution of earnings</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,706)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity contributions in existing joint ventures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,631&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2020</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,571&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We charged management service fees from the centers underlying these joint ventures of approximately $2.7 million and $1.8 million for the three months ended September&#160;30, 2020 and 2019, respectively, and $8.6 million and $7.8 million for the nine months ended September&#160;30, 2020 and 2019, respectively.  We eliminate any unrealized portion of our management service fees with our equity in earnings of joint ventures.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of key balance sheet data for these joint ventures as of September&#160;30, 2020 and December&#160;31, 2019 and income statement data for the nine months ended September 30, 2020 and 2019 (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance Sheet Data:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,618&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,427&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,576&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,037&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,487)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,217)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,751)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,872)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net assets</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,956&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,375&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Book value of RadNet joint venture interests</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,121&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,001&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost in excess of book value of acquired joint venture interests and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,450&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,469&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total value of Radnet joint venture interests</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,571&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,470&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total book value of other joint venture partner interests</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,835&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,374&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income statement data for the nine months ended September 30,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,988&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,115&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,651&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,718&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">RECENT ACCOUNTING AND REPORTING STANDARDS</a></td>
<td class="text">RECENT ACCOUNTING AND REPORTING STANDARDS<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting standards adopted</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASU No. 2016-13 ("ASU 2016-13), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  ASU 2016-13 replaces the incurred loss methodology previously utilized for valuing financial instruments with an expected loss methodology that is referred to as the current expected credit loss (CECL) methodology.  We prospectively adopted the standard on January 1, 2020 and the adoption did not have a material impact to the condensed consolidated financial statements, resulting in no adjustments to our prior year earnings.  See the Accounts Receivable section to Note 2 for further information on our allowances for credit losses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU No. 2018-15 (&#8220;ASU 2018-15&#8221;),&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles-Goodwill and Other-Internal-Use Software.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;ASU 2018-15 aligns the requirements for deferring implementation costs incurred in a cloud computing arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. This ASU is effective in the first quarter of 2020 with early adoption permitted and can be applied either retrospectively or prospectively to all implementation costs incurred after the date of adoption. The adoption of this standard did not have a material impact on our condensed consolidated balance sheet.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU 2020-03 ("ASU 2020-03"),&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Codification Improvements to Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The amendments in this update represent changes to clarify or improve the codification and correct unintended application. ASU 2020-03 was effective immediately upon issuance and its adoption did not have a material impact on our financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU No. 2018-13 ("ASU 2018-13"),&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disclosure Framework &#8211; Changes to the Disclosure Requirements for Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This standard removes, modifies and adds certain disclosures related to recurring and nonrecurring fair value measurements. We adopted ASC 2018-13 effective January 1, 2020 and it had no effect on our disclosures.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting standards not yet adopted</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12 ("ASU 2019-12"), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740).  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASU 2019-12 removes certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. It also clarifies and simplifies other areas of the standard. ASU 2019-12 will be effective beginning in the first quarter of 2021. Early adoption is permitted. Certain amendments in this update must be applied on a prospective basis, certain amendments must be applied on a retrospective basis, and certain amendments must be applied on a modified retrospective basis through a cumulative-effect adjustment to retained earnings/(deficit) in the period of adoption. We are currently evaluating the impact this ASU will have on our financial statements and related disclosures as well as the timing of adoption.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the FASB issued ASU 2020-01 ("ASU 2020-01"), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments&#8212;Equity Securities (Topic 321), Investments&#8212;Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">clarifying the interaction between accounting standards related to equity securities, equity method investments, and certain derivatives. ASU 2020-01 is effective for fiscal years beginning after December 15, 2020. We do not expect the adoption of this guidance will have a material impact on our financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU 2020-04 ("ASU 2020-04"),&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848), Facilitation of the Effects of Reference Rate Reform on Financial Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. ASU 2020-04 provides optional expedients and exceptions for applying generally accepted accounting principles to certain contract modifications and hedging relationships that reference London Inter-bank Offered Rate (LIBOR) or another reference rate expected to be discontinued. The guidance is effective upon issuance and generally can be applied through December 31, 2022. We are currently evaluating the potential impact of ASU 2020-04 on our financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (a)-(d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6909625&amp;loc=d3e227-128457<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6052-115624<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6049-115624<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationRelatedCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18726-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationRelatedCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI http://asc.fasb.org/topic&amp;trid=2134417<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredChargesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for deferral and amortization of significant deferred charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredChargesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=d3e41638-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5579245-113959<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=d3e41675-113959<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(n))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=SL94080555-108585<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for indefinite-lived intangible assets (that is, those intangible assets not subject to amortization). This accounting policy also may address how the entity assesses whether events and circumstances continue to support an indefinite useful life and how the entity assesses and measures impairment of such assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32847-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116657188&amp;loc=SL116659661-227067<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32840-109319<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=116821951&amp;loc=d3e32247-109318<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=116821951&amp;loc=d3e32280-109318<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65884525&amp;loc=d3e40913-109327<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassifications that affects the comparability of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6359566&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, basis of assets, depreciation and depletion methods used, including composite deprecation, estimated useful lives, capitalization policy, accounting treatment for costs incurred for repairs and maintenance, capitalized interest and the method it is calculated, disposals and impairments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118936363&amp;loc=d3e5033-111524<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10178-111534<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10149-111534<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140489884845288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock', window );">Service Fee Revenue</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our total service revenues during the three and nine  months ended September&#160;30, 2020 and 2019 are presented in the table below based on an allocation of the estimated transaction price with the patient between the primary patient classification of insurance coverage (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.830%"><tr><td style="width:1.0%"/><td style="width:49.343%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.734%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.734%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.734%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.738%"/><td style="width:0.1%"/></tr><tr style="height:21pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial insurance</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,524&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,152&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412,415&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475,064&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,704&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154,847&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175,825&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,098&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,128&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,072&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,564&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Workers' compensation/personal injury</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,865&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,950&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other patient revenue</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,328&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,085&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,211&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,947&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management fee revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,675&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,792&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,574&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,662&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Teleradiology and Software revenue</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,349&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,412&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,319&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,861&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,869&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,617&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,878&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service fee revenue</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256,730&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261,908&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">660,760&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">762,751&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue under capitation arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,784&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,587&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total service revenue</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291,776&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292,692&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">763,905&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">853,338&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Schedule of goodwill and other intangible assets</a></td>
<td class="text">Activity in goodwill for the nine months ended September&#160;30, 2020 is provided below (in thousands):<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:87.186%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">441,973&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired through the acquisition of Olney Open MRI, LLC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired through the acquisition of MRI at Woodbridge, LLC</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,833&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired through the acquisition of DeepHealth, Inc.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,396&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired through the acquisition of AZ-Tech Radiology &amp; Open MRI, LLC</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,882&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470,685&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Effect of derivative instruments on comprehensive income</a></td>
<td class="text">A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive loss of the 2016 Caps is as follows (amounts in thousands):<div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:42.512%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.108%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.650%"/><td style="width:0.1%"/></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Account</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">July 1, 2020 Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of comprehensive gain recognized on derivative net of taxes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020 Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Other Comprehensive Loss, net of taxes</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,409)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,214)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities and Equity</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:42.512%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.108%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.650%"/><td style="width:0.1%"/></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the nine months ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Account</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1, 2020 Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of comprehensive gain recognized on derivative net of taxes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020 Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Other Comprehensive Loss, net of taxes</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,877)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">663&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,214)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities and Equity</span></td></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive loss of the 2019 swaps which remain ineffective is as follows (amounts in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.660%"><tr><td style="width:1.0%"/><td style="width:36.624%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.229%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.217%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.528%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.528%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.534%"/><td style="width:0.1%"/></tr><tr><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Account</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">July 1, 2020 Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of comprehensive loss recognized on derivative net of taxes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of loss reclassified out of accumulated OCI into income (prior period effective portion), net of taxes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020 Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Other Comprehensive Loss, net of taxes</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,406)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">969&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,437)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities and Equity</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.052%"><tr><td style="width:1.0%"/><td style="width:35.886%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.561%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.561%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.561%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.561%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.706%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.561%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.709%"/><td style="width:0.1%"/></tr><tr><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the nine months ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Account</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1, 2020 Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of comprehensive loss recognized on derivative net of taxes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of loss reclassified out of accumulated OCI into income (prior period effective portion), net of taxes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020 Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Other Comprehensive Loss, net of taxes</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,870)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,428)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,861&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,437)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities and Equity</span></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A tabular presentation of the effect of derivative instruments on our statement of operations of the 2019 Swaps for the Swaps that became ineffective during the third quarter is as follows (amounts in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.345%"><tr><td style="width:1.0%"/><td style="width:23.027%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.109%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.109%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.109%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.114%"/><td style="width:0.1%"/></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ineffective interest rate swap</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of loss recognized in income on derivative (current period ineffective portion)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of  loss recognized in Income on derivative (current period ineffective portion)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of loss reclassified from accumulated OCI into income (prior period effective portion)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of gain (Loss) reclassified from accumulated OCI into income (prior period effective portion)</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(679)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense)</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,312)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity and Interest Expense</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock', window );">Schedule of fair value of assets and liabilities</a></td>
<td class="text">The tables below summarize the estimated fair values of certain of our financial assets that are subject to fair value measurements, and the classification of these assets on our condensed consolidated balance sheets, as follows (in thousands):<div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:49.779%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.632%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 30, 2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current and long term liabilities</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2016 caps - Interest Rate Contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 swaps - Interest Rate Contracts</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,983&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,983&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:49.779%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.632%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2019</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current and long term liabilities</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2016 caps - Interest Rate Contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,081&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,081&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 swaps - Interest Rate Contracts</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,477&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,477&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the estimated fair value compared to our face value of our long-term debt as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:37.225%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.651%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 30, 2020</span></td></tr><tr style="height:21pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Face Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Lien Term Loans and SunTrust Term Loan</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">663,140&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">663,140&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">673,227&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:37.225%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.651%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2019</span></td></tr><tr style="height:21pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Face Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Lien Term Loans and SunTrust Term Loan</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">708,948&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">708,948&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705,699&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Earnings per share</a></td>
<td class="text">Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.538%"><tr><td style="width:1.0%"/><td style="width:51.570%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.175%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.541%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.175%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.541%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.175%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.541%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.182%"/><td style="width:0.1%"/></tr><tr style="height:21pt"><td colspan="3" rowspan="2" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="9" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to RadNet, Inc.'s common stockholders</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,156&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,195&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,797)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,360&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,358,603&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,807,460&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,746,380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,597,138&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net income (loss) per share attributable to RadNet, Inc.'s common stockholders</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.12&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.06&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.41)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.09&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,358,603&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,807,460&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,746,380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,597,138&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add nonvested restricted stock subject only to service vesting</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,605&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,567&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191,375&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add additional shares issuable upon exercise of stock options and warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">476,607&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352,333&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324,793&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares used in calculating diluted net income per share</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,955,815&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,360,360&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,746,380&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,113,306&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net income (loss) per share attributable to RadNet, Inc.'s common stockholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.12&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.06&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.41)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.09&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and non vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested restricted stock subject to service vesting</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331,659&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issuable upon the exercise of stock options:</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,948&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">933,370&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsTextBlock', window );">Investment in joint ventures</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of our investment in joint ventures during the nine months ended September 30, 2020 (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:87.186%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,470&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings in these joint ventures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,176&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution of earnings</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,706)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity contributions in existing joint ventures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,631&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2020</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,571&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock', window );">Joint venture investment and financial information</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of key balance sheet data for these joint ventures as of September&#160;30, 2020 and December&#160;31, 2019 and income statement data for the nine months ended September 30, 2020 and 2019 (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance Sheet Data:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,618&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,427&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,576&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,037&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,487)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,217)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,751)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,872)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net assets</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,956&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,375&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Book value of RadNet joint venture interests</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,121&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,001&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost in excess of book value of acquired joint venture interests and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,450&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,469&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total value of Radnet joint venture interests</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,571&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,470&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total book value of other joint venture partner interests</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,835&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,374&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income statement data for the nine months ended September 30,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,988&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,115&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,651&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,718&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Joint Venture Investment And Financial Information</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118260190&amp;loc=d3e13467-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByBalanceSheetGroupingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of revenue by reporting categories or types of financial instruments, including derivatives but excluding dividends and interests, from trading for own account by broker dealers.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=35711157&amp;loc=d3e42567-110969<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140489880282520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CREDIT FACILITY AND NOTES PAYABLE (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of notes payable, line of credit and capital lease obligations</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2020 and December&#160;31, 2019 our debt obligations consisted of the following (in thousands):</span></div><div style="margin-bottom:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.953%"><tr><td style="width:1.0%"/><td style="width:74.273%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.840%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.841%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="12" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Lien Term Loans collateralized by RadNet's tangible and intangible assets</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">620,727&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">649,824&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounts on First Lien Term Loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,669)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,579)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SunTrust Term Loan Agreement collateralized by NJIN's tangible and intangible assets</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,500&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,875&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paycheck Protection Program loans at 1% due April 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,037&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment note payable at 4.6%, due through 2020, collateralized by medical equipment</span></div></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt obligations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666,642&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">692,395&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,463)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,691)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long term portion debt obligations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">627,179&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">652,704&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of first lien credit agreement</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in our condensed consolidated balance sheets at September&#160;30, 2020 are $620.7 million of First Lien Term Loans and $52.5 million of SunTrust Term Loan debt for a combined total of $673.2 million of total term loan debt (exclusive of unamortized discounts of  $10.7 million) in thousands: </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:61.748%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.794%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.794%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.796%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Face Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Discount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Carrying<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Lien Term Loans</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">620,727&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,669)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610,058&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SunTrust Term Loan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,500&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,500&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Term Loans</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">673,227&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,669)</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662,558&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_ScheduleOfLeverageRatioTableTextBlock', window );">Schedule of leverage ratio</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our First Lien Term Loans bear interest at either an Adjusted Eurodollar Rate or a Base Rate, plus an applicable margin according to the following schedule:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:89.181%"><tr><td style="width:1.0%"/><td style="width:31.850%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.342%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.508%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">First Lien Leverage Ratio</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Eurodollar Rate Spread</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Base Rate Spread</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&gt; 5.50x</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.50%</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.50%</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&gt; 4.00x but &#8804; 5.50x</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.75%</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.75%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&gt;3.50x but &#8804; 4.00x</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.50%</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.50%</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8804; 3.50x</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.25%</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25%</span></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our SunTrust Term Loan bears interest at either an Adjusted Eurodollar Rate or a Base Rate, plus an applicable margin according to the following schedule:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:93.859%"><tr><td style="width:1.0%"/><td style="width:8.713%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.576%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.099%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.099%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.347%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pricing Level</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Leverage Ratio</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Applicable Margin for Eurodollar Loans</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Applicable Margin for Base Rate Loans</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Applicable Margin for Letter of Credit Fees</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Applicable Percentage for Commitment Fee</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than or equal to 3.00:1.00</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.75%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.75%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.45%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">II</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 3.00:1.00 but greater than or equal to 2.50:1.00</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.25%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.40%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">III</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt;padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 2.50:1.00 but greater than or equal to</span></div><div style="margin-top:2.9pt;padding-left:4.5pt;padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00:1.00</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.00%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.35%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IV</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 2.00:1.00 but greater than or equal to 1.50:1.00</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.75%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.30%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">V</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 1.50:1.00</span></div></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.30%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ScheduleOfLeverageRatioTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Leverage Ratio [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ScheduleOfLeverageRatioTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28541-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21506-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(e),(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28551-108399<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21521-112644<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21538-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140489880291640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of options activity</a></td>
<td class="text">The following summarizes all of our option transactions for the nine months ended September&#160;30, 2020:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:48.973%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.650%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outstanding Options<br/>Under the 2006 Plan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise price<br/>Per Common Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining<br/>Contractual Life<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2019</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478,951&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.21&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,948&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, September 30, 2020</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">527,899&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.34&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.59</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,419,956&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at September 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298,863&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.85</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,353,438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.836%"><tr><td style="width:1.0%"/><td style="width:48.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.711%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.711%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.711%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.713%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outstanding Options<br/>Under the Deep Health Plan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise price<br/>Per Common Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining<br/>Contractual Life<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2019</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted, June 1, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412,434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,963)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, September 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405,471&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.65</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,223,980&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at September 30, 2020</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,211&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.65</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371,639&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock', window );">Schedule of RSA activity</a></td>
<td class="text">The following summarizes all unvested RSA&#8217;s activities during the nine months ended September&#160;30, 2020:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">RSA's</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Remaining<br/>Contractual<br/>Term (Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSA's unvested at December 31, 2019</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387,934&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.61&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes during the period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">457,596&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.66&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(513,871)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSA's unvested at September 30, 2020</span></td><td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331,659&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.11</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.67&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140489890950440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NATURE OF BUSINESS (Details Narrative)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>Center</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>Center</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Apr. 12, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_NumberOfCenters', window );">Number of centers | Center</a></td>
<td class="nump">334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues', window );">BRMG and NY Groups revenues</a></td>
<td class="nump">$ 38,300<span></span>
</td>
<td class="nump">$ 40,600<span></span>
</td>
<td class="nump">$ 104,800<span></span>
</td>
<td class="nump">$ 116,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense', window );">BRMG and NY Groups operating expenses</a></td>
<td class="nump">38,300<span></span>
</td>
<td class="nump">40,600<span></span>
</td>
<td class="nump">104,800<span></span>
</td>
<td class="nump">116,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax', window );">Management services provided to BRMG and NY Groups</a></td>
<td class="nump">169,000<span></span>
</td>
<td class="nump">$ 154,500<span></span>
</td>
<td class="nump">433,300<span></span>
</td>
<td class="nump">$ 456,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">BRMG and NY Groups accounts receivable</a></td>
<td class="nump">1,717,866<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,717,866<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,646,986<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">BRMG and NY Groups accounts payable</a></td>
<td class="nump">$ 1,471,745<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,471,745<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,413,847<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=rdnt_ScriptSenderLlcMember', window );">ScriptSender LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership percentage</a></td>
<td class="nump">49.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_ChiefExecutiveOfficerMember', window );">Chief Executive Officer | Beverly Radiology Medical Group III</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership percentage</a></td>
<td class="nump">99.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=rdnt_BoardMemberMember', window );">Board Member | Beverly Radiology Medical Group III</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership percentage</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember', window );">Variable Interest Entity, Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">BRMG and NY Groups accounts receivable</a></td>
<td class="nump">$ 84,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 84,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">BRMG and NY Groups accounts payable</a></td>
<td class="nump">$ 10,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_NumberOfCenters">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Centers</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_NumberOfCenters</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense between the reporting entity and the Variable Interest Entity (VIE).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph d<br> -URI http://asc.fasb.org/extlink&amp;oid=118582676&amp;loc=d3e5747-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the amount of pre-tax income (loss) derived by the reporting entity from the Variable Interest Entity (VIE).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph d<br> -URI http://asc.fasb.org/extlink&amp;oid=118582676&amp;loc=d3e5747-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income between the reporting entity and the Variable Interest Entity (VIE).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph d<br> -URI http://asc.fasb.org/extlink&amp;oid=118582676&amp;loc=d3e5747-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=rdnt_ScriptSenderLlcMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=rdnt_ScriptSenderLlcMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=rdnt_BeverlyRadiologyMedicalGroupIIIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=rdnt_BeverlyRadiologyMedicalGroupIIIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=rdnt_BoardMemberMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=rdnt_BoardMemberMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140489887435448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details - Revenue) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue, net of contractual allowances and discounts</a></td>
<td class="nump">$ 291,776<span></span>
</td>
<td class="nump">$ 292,692<span></span>
</td>
<td class="nump">$ 763,905<span></span>
</td>
<td class="nump">$ 853,338<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total service revenue</a></td>
<td class="nump">291,776<span></span>
</td>
<td class="nump">292,692<span></span>
</td>
<td class="nump">763,905<span></span>
</td>
<td class="nump">853,338<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_CommercialInsurance1Member', window );">Commercial insurance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue, net of contractual allowances and discounts</a></td>
<td class="nump">160,524<span></span>
</td>
<td class="nump">163,152<span></span>
</td>
<td class="nump">412,415<span></span>
</td>
<td class="nump">475,064<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_Medicare1Member', window );">Medicare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue, net of contractual allowances and discounts</a></td>
<td class="nump">62,704<span></span>
</td>
<td class="nump">61,599<span></span>
</td>
<td class="nump">154,847<span></span>
</td>
<td class="nump">175,825<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_Medicaid1Member', window );">Medicaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue, net of contractual allowances and discounts</a></td>
<td class="nump">7,098<span></span>
</td>
<td class="nump">7,128<span></span>
</td>
<td class="nump">18,072<span></span>
</td>
<td class="nump">21,564<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_WorkersCompensationPersonalInjury1Member', window );">Workers' compensation/personal injury</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue, net of contractual allowances and discounts</a></td>
<td class="nump">7,183<span></span>
</td>
<td class="nump">10,865<span></span>
</td>
<td class="nump">25,705<span></span>
</td>
<td class="nump">32,950<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_HealthCarePatientServiceOtherMember', window );">Other patient revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue, net of contractual allowances and discounts</a></td>
<td class="nump">8,328<span></span>
</td>
<td class="nump">6,085<span></span>
</td>
<td class="nump">17,211<span></span>
</td>
<td class="nump">17,947<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_HealthCareManagementServiceMember', window );">Management fee revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue, net of contractual allowances and discounts</a></td>
<td class="nump">2,675<span></span>
</td>
<td class="nump">1,792<span></span>
</td>
<td class="nump">8,574<span></span>
</td>
<td class="nump">5,662<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_TeleradiologyandSoftwareMember', window );">Teleradiology and Software revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue, net of contractual allowances and discounts</a></td>
<td class="nump">2,349<span></span>
</td>
<td class="nump">4,412<span></span>
</td>
<td class="nump">8,319<span></span>
</td>
<td class="nump">12,861<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthCareOtherMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue, net of contractual allowances and discounts</a></td>
<td class="nump">5,869<span></span>
</td>
<td class="nump">6,875<span></span>
</td>
<td class="nump">15,617<span></span>
</td>
<td class="nump">20,878<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthCarePatientServiceMember', window );">Service fee revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue, net of contractual allowances and discounts</a></td>
<td class="nump">256,730<span></span>
</td>
<td class="nump">261,908<span></span>
</td>
<td class="nump">660,760<span></span>
</td>
<td class="nump">762,751<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_CapitationArrangementsMember', window );">Revenue under capitation arrangements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue, net of contractual allowances and discounts</a></td>
<td class="nump">$ 35,046<span></span>
</td>
<td class="nump">$ 30,784<span></span>
</td>
<td class="nump">$ 103,145<span></span>
</td>
<td class="nump">$ 90,587<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130543-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_CommercialInsurance1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_CommercialInsurance1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_Medicare1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_Medicare1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_Medicaid1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_Medicaid1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_WorkersCompensationPersonalInjury1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_WorkersCompensationPersonalInjury1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_HealthCarePatientServiceOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_HealthCarePatientServiceOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_HealthCareManagementServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_HealthCareManagementServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_TeleradiologyandSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_TeleradiologyandSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthCareOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthCareOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthCarePatientServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthCarePatientServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_CapitationArrangementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_CapitationArrangementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140489799096264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF ACCOUNTING POLICIES (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Nov. 05, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 01, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 01, 2018 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 24, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>numberOfAgreement </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>numberOfAgreement </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>joint_venture</div>
</th>
<th class="th">
<div>Oct. 11, 2019 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 01, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Apr. 12, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueNotFromContractWithCustomer', window );">Provider relief funding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 221,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,696,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_ContractsReceivableFactoringReceivable', window );">Contracts receivable, factoring receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Deferred financing costs, net of accumulated amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">470,685,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">470,685,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">441,973,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,825,000<span></span>
</td>
<td class="nump">$ 1,816,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (5,029,000)<span></span>
</td>
<td class="nump">$ 3,556,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27.20%<span></span>
</td>
<td class="nump">26.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28.30%<span></span>
</td>
<td class="nump">24.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings', window );">Amount of loss recognized in income on derivative (current period ineffective portion)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_MonthlyAmortizationOfDeferredHedgeGains', window );">Monthly amortization of deferred hedge gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Total credit facilities outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentAggregateCost', window );">Aggregate cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63,956,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63,956,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,375,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Advance for future software subscription fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,482,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,482,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45,004,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_NumberofUnconsolidatedJointVentures', window );">Number of unconsolidated joint ventures | joint_venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_ManagementServiceFees', window );">Management service fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,700,000<span></span>
</td>
<td class="nump">$ 1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,600,000<span></span>
</td>
<td class="nump">$ 7,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_MedicVisionMember', window );">Medic Vision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.21%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Payments to acquire equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment', window );">Option to purchase additional equity method investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired', window );">Ownership percentage diluted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.96%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution', window );">Initial ownership percentage after dilution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentAggregateCost', window );">Aggregate cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_TurnerImagingMember', window );">Turner Imaging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Payments to acquire equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_EquityMethodInvestmentSharesPurchased', window );">Number of shares purchased (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Preferred stock issued upon conversion (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_WhiteRabbit.aiInc.Member', window );">WhiteRabbit.ai Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Payments to acquire equity method investments</a></td>
<td class="nump">$ 1,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToFundLongtermLoansToRelatedParties', window );">Payments to fund loan to related parties</a></td>
<td class="nump">$ 2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Advance for future software subscription fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_SantaMonicaImagingGroupLLCMember', window );">Santa Monica Imaging Group, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInterestInJointVenture', window );">Payments to acquire additional interest in subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=rdnt_RestatedPlanMember', window );">Restated Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Shares authorized (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=rdnt_RestatedPlanMember', window );">Restated Plan | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=rdnt_RestatedPlanMember', window );">Restated Plan | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_Caps2016Member', window );">2016 Caps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNumberOfInstrumentsHeld', window );">Number of forward interest rate cap agreements | numberOfAgreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized', window );">Premium liability for 2016 Caps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_Caps2016Member', window );">2016 Caps | September 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_Caps2016Member', window );">2016 Caps | October 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 350,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 350,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPSMember', window );">2019 SWAPS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNumberOfInstrumentsHeld', window );">Number of forward interest rate cap agreements | numberOfAgreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPSMember', window );">2019 SWAPS | October 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPSMember', window );">2019 SWAPS | October 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=rdnt_PropertyAndEquipmentMember', window );">Amounts returned to property and equipment | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">PPE estimated useful lives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=rdnt_PropertyAndEquipmentMember', window );">Amounts returned to property and equipment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">PPE estimated useful lives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">PPE estimated useful lives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">PPE estimated useful lives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=rdnt_Caps2016Member', window );">2016 Caps | London Interbank Offered Rate (LIBOR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeBasisSpreadOnVariableRate', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">2019 swaps - Interest Rate Contracts | 2019 SWAPS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">2019 swaps - Interest Rate Contracts | 2019 SWAPS1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">2019 swaps - Interest Rate Contracts | London Interbank Offered Rate (LIBOR) | 2019 SWAPS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeBasisSpreadOnVariableRate', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.96%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">2019 swaps - Interest Rate Contracts | London Interbank Offered Rate (LIBOR) | 2019 SWAPS1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeBasisSpreadOnVariableRate', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.05%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Deferred financing costs, net of accumulated amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=rdnt_DignityHealthMember', window );">Dignity Health | Glendale Advanced Imaging | Joint Venture | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityOwnershipPercentage', window );">Variable interest entity, ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=rdnt_DignityHealthMember', window );">Dignity Health | Glendale Advanced Imaging | Joint Venture | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityOwnershipPercentage', window );">Variable interest entity, ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember', window );">Promissory Note | Turner Imaging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Convertible promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemAxis=rdnt_COVID19PandemicMember', window );">COVID-19 Pandemic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_AdvanceMedicarePayments', window );">Advance medicare payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 39,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_ProceedsReceivedFromInsurance', window );">Advance insurance carrier payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_SocialSecurityTaxEmployerDeferralCARESAct', window );">Deferred social security taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementMember', window );">First Lien Credit Agreement | Line of Credit | Barclays | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Total credit facilities outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_PaycheckProtectionProgramLoansMember', window );">Paycheck Protection Program loans at 1% due April 2022 | COVID-19 Pandemic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_AdvanceMedicarePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Advance Medicare Payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_AdvanceMedicarePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ContractsReceivableFactoringReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contracts Receivable, Factoring Receivable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ContractsReceivableFactoringReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Initial Ownership Percentage After Dilution</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_EquityMethodInvestmentSharesPurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Shares Purchased</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_EquityMethodInvestmentSharesPurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investments, Option To Purchase Additional Equity Method Investment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investments, Ownership Interest Percentage Acquired</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ManagementServiceFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Management service fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ManagementServiceFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_MonthlyAmortizationOfDeferredHedgeGains">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Monthly Amortization Of Deferred Hedge Gains</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_MonthlyAmortizationOfDeferredHedgeGains</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_NumberofUnconsolidatedJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Unconsolidated Joint Ventures</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_NumberofUnconsolidatedJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ProceedsReceivedFromInsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds Received From Insurance</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ProceedsReceivedFromInsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_SocialSecurityTaxEmployerDeferralCARESAct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Social Security Tax, Employer, Deferral, CARES Act</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_SocialSecurityTaxEmployerDeferralCARESAct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for each share of convertible preferred stock that is converted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21506-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNumberOfInstrumentsHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of derivative instruments of a particular derivative asset or group of derivative assets held by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5579245-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5580258-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNumberOfInstrumentsHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeBasisSpreadOnVariableRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage points added to the reference rate to compute the variable rate on the interest rate derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeBasisSpreadOnVariableRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentAggregateCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the aggregate cost of investments accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentAggregateCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unearned premium revenue under contracts issued by an insurance entity that provide protection to the holder of a financial obligation from a financial loss in the event of a default.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total amount of gain (loss) derived from fair value hedges recognized in earnings in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=77989000&amp;loc=SL49117168-202975<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109238882&amp;loc=d3e38679-109324<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInterestInJointVenture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the investment in or advances to an entity in which the reporting entity shares control of the entity with another party or group.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInterestInJointVenture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToFundLongtermLoansToRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with extending a long-term loan to a related party. Alternate caption: Payments for Advances to Affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToFundLongtermLoansToRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueNotFromContractWithCustomer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue that is not accounted for under Topic 606.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueNotFromContractWithCustomer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118582676&amp;loc=SL6759159-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_MedicVisionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_MedicVisionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_TurnerImagingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_TurnerImagingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_WhiteRabbit.aiInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_WhiteRabbit.aiInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_SantaMonicaImagingGroupLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_SantaMonicaImagingGroupLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=rdnt_RestatedPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=rdnt_RestatedPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_Caps2016Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuritiesFinancingTransactionAxis=rdnt_Caps2016Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditDerivativesByContractTypeAxis=rdnt_September2020CapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditDerivativesByContractTypeAxis=rdnt_September2020CapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditDerivativesByContractTypeAxis=rdnt_October2020CapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditDerivativesByContractTypeAxis=rdnt_October2020CapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditDerivativesByContractTypeAxis=rdnt_October2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditDerivativesByContractTypeAxis=rdnt_October2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditDerivativesByContractTypeAxis=rdnt_October2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditDerivativesByContractTypeAxis=rdnt_October2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=rdnt_PropertyAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=rdnt_PropertyAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=rdnt_Caps2016Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=rdnt_Caps2016Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPS1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPS1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=rdnt_DignityHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=rdnt_DignityHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=rdnt_GlendaleAdvancedImagingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=rdnt_GlendaleAdvancedImagingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis=rdnt_JointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis=rdnt_JointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualOrInfrequentItemAxis=rdnt_COVID19PandemicMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualOrInfrequentItemAxis=rdnt_COVID19PandemicMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=rdnt_BarclaysMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=rdnt_BarclaysMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_PaycheckProtectionProgramLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_PaycheckProtectionProgramLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140489887973368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details - Goodwill)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">$ 441,973<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">470,685<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_OlneyOpenMRILLCMember', window );">Olney Open MRI, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired through acquisitions</a></td>
<td class="nump">601<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_MRIatWoodbridgeLLCMember', window );">MRI at Woodbridge, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired through acquisitions</a></td>
<td class="nump">1,833<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthInc.Member', window );">DeepHealth, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired through acquisitions</a></td>
<td class="nump">23,396<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_AZTechMember', window );">AZ Tech Radiology &amp; Open MRI, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired through acquisitions</a></td>
<td class="nump">$ 2,882<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=77989000&amp;loc=SL49117168-202975<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_OlneyOpenMRILLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_OlneyOpenMRILLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_MRIatWoodbridgeLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_MRIatWoodbridgeLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_AZTechMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_AZTechMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140489888079448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details - Gain on Derivative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Change in fair value of cash flow hedge, net of taxes</a></td>
<td class="nump">$ 195<span></span>
</td>
<td class="num">$ (5,283)<span></span>
</td>
<td class="num">$ (18,764)<span></span>
</td>
<td class="num">$ (14,481)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Amount of loss reclassified from accumulated OCI into income (prior period effective portion)</a></td>
<td class="nump">969<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">1,861<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember', window );">2016 caps - Interest Rate Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Change in fair value of cash flow hedge, net of taxes</a></td>
<td class="nump">195<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">663<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">2019 swaps - Interest Rate Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Change in fair value of cash flow hedge, net of taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19,428)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Amount of loss reclassified from accumulated OCI into income (prior period effective portion)</a></td>
<td class="nump">969<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,861<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember', window );">Other income (expense) | 2019 swaps - Interest Rate Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Amount of loss recognized in income on derivative (current period ineffective portion)</a></td>
<td class="nump">679<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,523<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember', window );">Equity and Interest Expense | 2019 swaps - Interest Rate Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Amount of loss reclassified from accumulated OCI into income (prior period effective portion)</a></td>
<td class="num">(1,312)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,204)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Accumulated Other Comprehensive Loss, net of taxes | 2016 caps - Interest Rate Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1', window );">Derivative instrument, beginning balance</a></td>
<td class="num">(1,409)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,877)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1', window );">Derivative instrument, ending balance</a></td>
<td class="num">(1,214)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,214)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Accumulated Other Comprehensive Loss, net of taxes | 2019 swaps - Interest Rate Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1', window );">Derivative instrument, beginning balance</a></td>
<td class="num">(24,406)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,870)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1', window );">Derivative instrument, ending balance</a></td>
<td class="num">$ (23,437)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (23,437)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OffsettingAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OffsettingAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity including the portion attributable to noncontrolling interests, after the cumulative effect adjustment of a new accounting principle applied in the period of adoption.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140489887858552">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUMMARY OF ACCOUNTING POLICIES (Details - Fair Value Measurements) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">First Lien Term Loans and SunTrust Term Loan</a></td>
<td class="nump">$ 673,227<span></span>
</td>
<td class="nump">$ 705,699<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">First Lien Term Loans and SunTrust Term Loan</a></td>
<td class="nump">663,140<span></span>
</td>
<td class="nump">708,948<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Fair Value, Inputs, Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">First Lien Term Loans and SunTrust Term Loan</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Fair Value, Inputs, Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">First Lien Term Loans and SunTrust Term Loan</a></td>
<td class="nump">663,140<span></span>
</td>
<td class="nump">708,948<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Fair Value, Inputs, Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">First Lien Term Loans and SunTrust Term Loan</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember', window );">2016 caps - Interest Rate Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesFairValueDisclosure', window );">Interest Rate Contracts</a></td>
<td class="nump">182<span></span>
</td>
<td class="nump">1,081<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember', window );">2016 caps - Interest Rate Contracts | Fair Value, Inputs, Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesFairValueDisclosure', window );">Interest Rate Contracts</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember', window );">2016 caps - Interest Rate Contracts | Fair Value, Inputs, Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesFairValueDisclosure', window );">Interest Rate Contracts</a></td>
<td class="nump">182<span></span>
</td>
<td class="nump">1,081<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember', window );">2016 caps - Interest Rate Contracts | Fair Value, Inputs, Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesFairValueDisclosure', window );">Interest Rate Contracts</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">2019 swaps - Interest Rate Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesFairValueDisclosure', window );">Interest Rate Contracts</a></td>
<td class="nump">39,983<span></span>
</td>
<td class="nump">9,477<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">2019 swaps - Interest Rate Contracts | Fair Value, Inputs, Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesFairValueDisclosure', window );">Interest Rate Contracts</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">2019 swaps - Interest Rate Contracts | Fair Value, Inputs, Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesFairValueDisclosure', window );">Interest Rate Contracts</a></td>
<td class="nump">39,983<span></span>
</td>
<td class="nump">9,477<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">2019 swaps - Interest Rate Contracts | Fair Value, Inputs, Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesFairValueDisclosure', window );">Interest Rate Contracts</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=118260190&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140489882359240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF ACCOUNTING POLICIES (Details - Earnings Per Share) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) attributable to RadNet, Inc.'s common stockholders</a></td>
<td class="nump">$ 6,156<span></span>
</td>
<td class="nump">$ 3,195<span></span>
</td>
<td class="num">$ (20,797)<span></span>
</td>
<td class="nump">$ 4,360<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of common shares outstanding during the period (in shares)</a></td>
<td class="nump">51,358,603<span></span>
</td>
<td class="nump">49,807,460<span></span>
</td>
<td class="nump">50,746,380<span></span>
</td>
<td class="nump">49,597,138<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income (loss) per share attributable to RadNet, Inc.'s common stockholders (in dollars per share)</a></td>
<td class="nump">$ 0.12<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="num">$ (0.41)<span></span>
</td>
<td class="nump">$ 0.09<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesRestrictedStock', window );">Nonvested restricted stock subject only to service vesting (in shares)</a></td>
<td class="nump">120,605<span></span>
</td>
<td class="nump">200,567<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">191,375<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants', window );">Additional shares issuable upon exercise of stock options and warrants (in shares)</a></td>
<td class="nump">476,607<span></span>
</td>
<td class="nump">352,333<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">324,793<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average number of common shares used in calculating diluted net income per share (in shares)</a></td>
<td class="nump">51,955,815<span></span>
</td>
<td class="nump">50,360,360<span></span>
</td>
<td class="nump">50,746,380<span></span>
</td>
<td class="nump">50,113,306<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income per share attributable to RadNet, Inc.'s common stockholders (in dollars per share)</a></td>
<td class="nump">$ 0.12<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="num">$ (0.41)<span></span>
</td>
<td class="nump">$ 0.09<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract', window );"><strong>Nonvested restricted stock subject to service vesting</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Weighted average shares for which the exercise price exceeds average market price of common stock (in shares)</a></td>
<td class="nump">48,948<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">933,370<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract', window );"><strong>Nonvested restricted stock subject to service vesting</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Weighted average shares for which the exercise price exceeds average market price of common stock (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">331,659<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1337-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=117327953&amp;loc=d3e4984-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=SL5780133-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=117327953&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1252-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1448-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesRestrictedStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of restricted stock determined by relating the portion of time within a reporting period that restricted shares have been outstanding to the total time in that period. Restricted shares are subject to sales, contractual, regulatory or other restrictions that prevent or inhibit the holder from freely disposing of them before the restriction ends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e2646-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesRestrictedStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140489887150296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF ACCOUNTING POLICIES (Details - Investment in Joint Ventures) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward', window );"><strong>Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,470<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in earnings in these joint ventures</a></td>
<td class="nump">$ 2,276<span></span>
</td>
<td class="nump">$ 1,955<span></span>
</td>
<td class="nump">5,176<span></span>
</td>
<td class="nump">$ 6,072<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentDividendsOrDistributions', window );">Distributions from joint ventures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,706)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_EquityContributionsInJointVentures', window );">Equity contributions in existing joint ventures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,631<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Ending balance</a></td>
<td class="nump">$ 35,571<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,571<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_EquityContributionsInJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Contributions In Joint Ventures</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_EquityContributionsInJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentDividendsOrDistributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of distribution received from equity method investee for return on investment, classified as operating activities. Excludes distribution for return of investment, classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=SL94080555-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentDividendsOrDistributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140489891005992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF ACCOUNTING POLICIES (Details - Key Financial Data on Joint Ventures) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_KeyFinancialDataForJointVenturesAbstract', window );"><strong>Balance Sheet Data:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets', window );">Current assets</a></td>
<td class="nump">$ 26,618<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27,427<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAssets', window );">Noncurrent assets</a></td>
<td class="nump">70,576<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61,037<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities', window );">Current liabilities</a></td>
<td class="num">(10,487)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,217)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationLiabilities', window );">Noncurrent liabilities</a></td>
<td class="num">(22,751)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18,872)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentAggregateCost', window );">Total net assets</a></td>
<td class="nump">63,956<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,375<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Book value of RadNet joint venture interests</a></td>
<td class="nump">29,121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets', window );">Cost in excess of book value of acquired joint venture interests and other</a></td>
<td class="nump">6,450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,469<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Total value of Radnet joint venture interests</a></td>
<td class="nump">35,571<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,470<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_TotalBookValueOfOtherJointVenturePartnerInterests', window );">Total book value of other joint venture partner interests</a></td>
<td class="nump">34,835<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32,374<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationRevenue', window );">Net revenue</a></td>
<td class="nump">78,988<span></span>
</td>
<td class="nump">$ 80,115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 13,651<span></span>
</td>
<td class="nump">$ 13,718<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_KeyFinancialDataForJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Key financial data for joint ventures</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_KeyFinancialDataForJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_TotalBookValueOfOtherJointVenturePartnerInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total book value of other joint venture partner interests</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_TotalBookValueOfOtherJointVenturePartnerInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentAggregateCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the aggregate cost of investments accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentAggregateCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets reported by an equity method investment of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33912-111571<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current assets reported by an equity method investment of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33912-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current liabilities reported by an equity method investment of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33912-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities reported by an equity method investment of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33912-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentSummarizedFinancialInformationLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) reported by an equity method investment of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33912-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue from sale of product and rendering of service reported by equity method investee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentSummarizedFinancialInformationRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the entity's ownership percentage in the investee multiplied by the investee's total equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140489882560776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FACILITY ACQUISITIONS AND DISPOSITIONS (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Aug. 31, 2020 </div>
<div>USD ($) </div>
<div>Center</div>
</th>
<th class="th">
<div>Jun. 01, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 02, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 02, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 470,685,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 441,973,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock - par value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture', window );">Proceeds from the sale of equity interests in a joint venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 132,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=rdnt_ImagingOnCallMember', window );">Imaging On Call</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture', window );">Proceeds from the sale of equity interests in a joint venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_AssetAcquisitionAxis=rdnt_AZTechMember', window );">AZ Tech Radiology &amp; Open MRI, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of businesses acquired | Center</a></td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Purchase consideration</a></td>
<td class="nump">$ 5,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Fixed assets acquired</a></td>
<td class="nump">2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right-of-use asset required</a></td>
<td class="nump">7,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther', window );">Other assets acquired</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Operating lease liabilities acquired</a></td>
<td class="nump">7,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill acquired</a></td>
<td class="nump">$ 2,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_AssetAcquisitionAxis=rdnt_MRIatWoodbridgeLLCMember', window );">MRI at Woodbridge, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Purchase consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Fixed assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right-of-use asset required</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Operating lease liabilities acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFinanceLeaseLiabilities', window );">Finance lease liabilities acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_AssetAcquisitionAxis=rdnt_OlneyOpenMRILLCMember', window );">Olney Open MRI, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Purchase consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Fixed assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right-of-use asset required</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Operating lease liabilities acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthIncMember', window );">DeepHealth Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Purchase consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Shares issued (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">915,132<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock - par value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16.93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution', window );">Shares issued at execution (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">823,615<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution', window );">Shares issued after execution (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">91,517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm', window );">Shares issued after acquisition, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution', window );">Fair value of shares issued at execution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution', window );">Fair value of shares issued after execution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards', window );">Fair value of replacement awards attributable to pre-combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure', window );">Contingent consideration, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts', window );">Business acquisition, closing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares', window );">Contingent consideration, milestone one, shares issued (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">390,789<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares', window );">Contingent consideration, milestone two, shares issued (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">586,184<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares', window );">Contingent consideration, milestone three, shares issued (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">195,393<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets', window );">Current assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liabilities acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Contingent Consideration Arrangements, Milestone One, Equity Interest Issued or Issuable, Number of Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Contingent Consideration Arrangements, Milestone Three, Equity Interest Issued or Issuable, Number of Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Contingent Consideration Arrangements, Milestone Two, Equity Interest Issued or Issuable, Number of Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Replacement Awards</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Shares Issued After Execution</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Shares Issued At Execution</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Equity Interest Issued or Issuable, Maximum Number of Shares Issued After Execution</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Equity Interest Issued or Issuable, Number of Shares At Execution</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Equity Interest Issued or Issuable, Number of Shares Issued After Acquisition Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets, Other</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFinanceLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Finance Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFinanceLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Operating Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Right Of Use Asset</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116821951&amp;loc=d3e31917-109318<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=116868840&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=116868840&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of equity issued in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=77989000&amp;loc=SL49117168-202975<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfBusinessesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of businesses acquired by the entity during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfBusinessesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of an investment interest in a joint venture that the reporting entity has not previously accounted for using consolidation or the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfInterestInJointVenture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=rdnt_ImagingOnCallMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=rdnt_ImagingOnCallMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_AssetAcquisitionAxis=rdnt_AZTechMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_AssetAcquisitionAxis=rdnt_AZTechMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_AssetAcquisitionAxis=rdnt_MRIatWoodbridgeLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_AssetAcquisitionAxis=rdnt_MRIatWoodbridgeLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_AssetAcquisitionAxis=rdnt_OlneyOpenMRILLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_AssetAcquisitionAxis=rdnt_OlneyOpenMRILLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140489897290296">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CREDIT FACILITY AND NOTES PAYABLE (Details - Schedule of debt) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermLoansPayable', window );">Equipment note payable at 4.6%, due through 2020, collateralized by medical equipment</a></td>
<td class="nump">$ 47<span></span>
</td>
<td class="nump">$ 275<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities', window );">Total debt obligations</a></td>
<td class="nump">666,642<span></span>
</td>
<td class="nump">692,395<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsCurrentMaturities', window );">Less: current portion</a></td>
<td class="num">(39,463)<span></span>
</td>
<td class="num">(39,691)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsExcludingCurrentMaturities', window );">Long term portion debt obligations</a></td>
<td class="nump">$ 627,179<span></span>
</td>
<td class="nump">652,704<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_PaycheckProtectionProgramLoansMember', window );">Paycheck Protection Program loans at 1% due April 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=rdnt_TermLoanMember', window );">Term Loan | First Lien Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt</a></td>
<td class="nump">$ 620,727<span></span>
</td>
<td class="nump">649,824<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Discounts on First Lien Term Loans</a></td>
<td class="num">(10,669)<span></span>
</td>
<td class="num">(13,579)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=rdnt_TermLoanMember', window );">Term Loan | SunTrust Term Loan Agreement collateralized by NJIN's tangible and intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt</a></td>
<td class="nump">52,500<span></span>
</td>
<td class="nump">$ 55,875<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=rdnt_TermLoanMember', window );">Term Loan | Paycheck Protection Program loans at 1% due April 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt</a></td>
<td class="nump">$ 4,037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember', window );">Equipment Notes Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="nump">4.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsCurrentMaturities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-term Debt, Short-term Debt and Capital Lease Obligations, Current Maturities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsCurrentMaturities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsExcludingCurrentMaturities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-term Debt, Short-term Debt and Capital Lease Obligations, Excluding Current Maturities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsExcludingCurrentMaturities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-term Debt, Short-term Debt and Capital Lease Obligations, Including Current Maturities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermLoansPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermLoansPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_PaycheckProtectionProgramLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_PaycheckProtectionProgramLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=rdnt_TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=rdnt_TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_FirstLienTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140489807013416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CREDIT FACILITY AND NOTES PAYABLE (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Apr. 18, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Aug. 31, 2018</div></th>
<th class="th"><div>Jul. 01, 2016</div></th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>loan</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 22, 2017 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Total credit facilities outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Deferred financing costs, net of accumulated amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=rdnt_TermLoanMember', window );">Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument face value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">673,227,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=rdnt_FirstLienTermLoansAMember', window );">FirstLienTermLoansAMember</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Discounts on term loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=rdnt_FirstLienCreditAgreementSeventhAmendmentMember', window );">First Lien Credit Agreement Seventh Amendment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Deferred financing costs, net of accumulated amortization</a></td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Debt issuance costs</a></td>
<td class="nump">4,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountCurrent', window );">Debt discount</a></td>
<td class="nump">2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDeferredCharges', window );">Amortization of deferred issuance costs</a></td>
<td class="nump">1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letters of credit outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Deferred financing costs, net of accumulated amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=rdnt_BarclaysMember', window );">Barclays | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Line of credit facility, remaining borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 188,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=rdnt_BarclaysMember', window );">Barclays | Revolving Credit Facility | Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Unused capacity, commitment fee percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=rdnt_SunTrustMember', window );">SunTrust | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Periodic payment, principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_DebtInstrumentPeriodicPaymentPercent', window );">Periodic payment, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease', window );">Periodic payment amortization increase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=rdnt_SunTrustMember', window );">SunTrust | Revolving Credit Facility | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienTermLoanMember', window );">First Lien Term Loan | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument face value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">620,727,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Discounts on term loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,669,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,579,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienTermLoanMember', window );">First Lien Term Loan | Barclays | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Periodic payment, principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember', window );">Restated Agreement | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument face value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementMember', window );">First Lien Credit Agreement | Barclays | Revolving Credit Facility | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Total credit facilities outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementMember', window );">First Lien Credit Agreement | SunTrust | Revolving Credit Facility | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Total credit facilities outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementEighthAmendmentMember', window );">First Lien Credit Agreement Eighth Amendment | Barclays | Revolving Credit Facility | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">195,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity', window );">Line of credit facility, increase borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementSixthAmendmentMember', window );">First Lien Credit Agreement, Sixth Amendment | Medium-term Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Total credit facilities outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementSixthAmendmentMember', window );">First Lien Credit Agreement, Sixth Amendment | Revolving Credit Facility | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity', window );">Line of credit facility, increase borrowing capacity</a></td>
<td class="nump">$ 20,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_PaycheckProtectionProgramLoansMember', window );">Paycheck Protection Program Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIIIMember', window );">Pricing Level III | Restated Agreement | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Unused capacity, commitment fee percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.35%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableRateAxis=us-gaap_EurodollarMember', window );">Eurodollar | First Lien Credit Agreement, Sixth Amendment | Revolving Credit Facility | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableRateAxis=us-gaap_EurodollarMember', window );">Eurodollar | &gt;3.50x but &#8804; 4.00x | First Lien Credit Agreement | Revolving Credit Facility | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableRateAxis=us-gaap_EurodollarMember', window );">Eurodollar | &gt;3.50x but &#8804; 4.00x | First Lien Credit Agreement, Sixth Amendment | Revolving Credit Facility | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableRateAxis=us-gaap_EurodollarMember', window );">Eurodollar | Pricing Level III | Restated Agreement | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember', window );">Base Rate | First Lien Credit Agreement, Sixth Amendment | Revolving Credit Facility | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember', window );">Base Rate | &gt;3.50x but &#8804; 4.00x | First Lien Credit Agreement | Revolving Credit Facility | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember', window );">Base Rate | &gt;3.50x but &#8804; 4.00x | First Lien Credit Agreement, Sixth Amendment | Revolving Credit Facility | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember', window );">Base Rate | Pricing Level III | Restated Agreement | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemAxis=rdnt_COVID19PandemicMember', window );">COVID-19 Pandemic | Paycheck Protection Program Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument face value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">PPP loans, maturity term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_DebtInstrumentNumberofLoansReceived', window );">Number of PPP loans received | loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_DebtInstrumentNumberofLoansReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Number of Loans Received</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_DebtInstrumentNumberofLoansReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_DebtInstrumentPeriodicPaymentPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Periodic Payment, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_DebtInstrumentPeriodicPaymentPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Periodic Payment Terms, Amortization Increase</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line of Credit Facility, Increase Borrowing Capacity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LineofCreditFacilityIncreaseBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDeferredCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of amortization of deferred charges applied against earnings during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDeferredCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments applied to principal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPaymentPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of debt discount to be amortized within one year or within the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=rdnt_TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=rdnt_TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=rdnt_FirstLienTermLoansAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=rdnt_FirstLienTermLoansAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=rdnt_FirstLienCreditAgreementSeventhAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=rdnt_FirstLienCreditAgreementSeventhAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=rdnt_BarclaysMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=rdnt_BarclaysMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=rdnt_SunTrustMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=rdnt_SunTrustMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_FirstLienTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementEighthAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementEighthAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementSixthAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementSixthAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_PaycheckProtectionProgramLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_PaycheckProtectionProgramLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIIIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_PricingLevelIIIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_EurodollarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_EurodollarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_LeverageRatioThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_LeverageRatioThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualOrInfrequentItemAxis=rdnt_COVID19PandemicMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualOrInfrequentItemAxis=rdnt_COVID19PandemicMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140489891425800">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CREDIT FACILITY AND NOTES PAYABLE (Details - Term Loans) - Term Loan<br></strong></div></th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face Value</a></td>
<td class="nump">$ 673,227,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet', window );">Discount</a></td>
<td class="num">(10,669,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total Carrying Value</a></td>
<td class="nump">662,558,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=rdnt_TermLoanMember', window );">First Lien Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face Value</a></td>
<td class="nump">620,727,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet', window );">Discount</a></td>
<td class="num">(10,669,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total Carrying Value</a></td>
<td class="nump">610,058,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=rdnt_TermLoanMember', window );">Restated Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face Value</a></td>
<td class="nump">52,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet', window );">Discount</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total Carrying Value</a></td>
<td class="nump">$ 52,500,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount (premium).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28555-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28567-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28541-108399<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=rdnt_TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=rdnt_TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_FirstLienTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140489882360536">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CREDIT FACILITY AND NOTES PAYABLE (Details - Margin Spread Based on Leverage Ratio) - First Lien Credit Agreement - Line of Credit - Revolving Credit Facility<br></strong></div></th>
<th class="th"><div>Jul. 01, 2016</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementMember', window );">Eurodollar | &gt; 5.50x</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">4.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementMember', window );">Eurodollar | &gt; 4.00x but &#8804; 5.50x</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">3.75%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementMember', window );">Eurodollar | &gt;3.50x but &#8804; 4.00x</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">3.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementMember', window );">Eurodollar | &#8804; 3.50x</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">3.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementMember', window );">Base Rate | &gt; 5.50x</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">3.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementMember', window );">Base Rate | &gt; 4.00x but &#8804; 5.50x</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">2.75%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementMember', window );">Base Rate | &gt;3.50x but &#8804; 4.00x</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">2.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementMember', window );">Base Rate | &#8804; 3.50x</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">2.25%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_EurodollarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_EurodollarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_LeverageRatioOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_LeverageRatioOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_LeverageRatioTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_LeverageRatioTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_LeverageRatioThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_LeverageRatioThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_LeverageRatioFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_LeverageRatioFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140489810879336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CREDIT FACILITY AND NOTES PAYABLE (Details - Margin Spread Based on Leverage Ratio, Debt Instrument) - Restated Agreement<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2018</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIMember', window );">Pricing Level I</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum', window );">Leverage ratio, greater than</a></td>
<td class="nump">3.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIMember', window );">Pricing Level I | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Unused capacity, commitment fee percentage</a></td>
<td class="nump">0.45%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIMember', window );">Pricing Level I | Eurodollar | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIMember', window );">Pricing Level I | Base Rate | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIIMember', window );">Pricing Level II</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum', window );">Leverage ratio, greater than</a></td>
<td class="nump">2.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_DebtInstrumentCovenantLeverageRatioMaximum', window );">Leverage ratio, less than</a></td>
<td class="nump">3.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIIMember', window );">Pricing Level II | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="nump">2.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Unused capacity, commitment fee percentage</a></td>
<td class="nump">0.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIIMember', window );">Pricing Level II | Eurodollar | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">2.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIIMember', window );">Pricing Level II | Base Rate | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">1.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIIIMember', window );">Pricing Level III</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum', window );">Leverage ratio, greater than</a></td>
<td class="nump">2.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_DebtInstrumentCovenantLeverageRatioMaximum', window );">Leverage ratio, less than</a></td>
<td class="nump">2.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIIIMember', window );">Pricing Level III | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Unused capacity, commitment fee percentage</a></td>
<td class="nump">0.35%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIIIMember', window );">Pricing Level III | Eurodollar | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIIIMember', window );">Pricing Level III | Base Rate | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIVMember', window );">Pricing Level IV</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum', window );">Leverage ratio, greater than</a></td>
<td class="nump">1.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_DebtInstrumentCovenantLeverageRatioMaximum', window );">Leverage ratio, less than</a></td>
<td class="nump">2.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIVMember', window );">Pricing Level IV | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Unused capacity, commitment fee percentage</a></td>
<td class="nump">0.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIVMember', window );">Pricing Level IV | Eurodollar | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIVMember', window );">Pricing Level IV | Base Rate | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelVMember', window );">Pricing Level V</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_DebtInstrumentCovenantLeverageRatioMaximum', window );">Leverage ratio, less than</a></td>
<td class="nump">1.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelVMember', window );">Pricing Level V | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Unused capacity, commitment fee percentage</a></td>
<td class="nump">0.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelVMember', window );">Pricing Level V | Eurodollar | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelVMember', window );">Pricing Level V | Base Rate | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_DebtInstrumentCovenantLeverageRatioMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Leverage Ratio, Maximum</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_DebtInstrumentCovenantLeverageRatioMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Liquidity Ratio Required, Minimum</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_PricingLevelIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_EurodollarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_EurodollarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_PricingLevelIIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIIIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_PricingLevelIIIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_PricingLevelIVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_PricingLevelVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140489882369704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION (Details Narrative) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized stock-based compensation expense</a></td>
<td class="nump">$ 0.7<span></span>
</td>
<td class="nump">$ 0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized expense weighted average period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 8 months 4 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember', window );">Equity Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding (in shares)</a></td>
<td class="nump">527,899<span></span>
</td>
<td class="nump">527,899<span></span>
</td>
<td class="nump">478,951<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable shares (in shares)</a></td>
<td class="nump">298,863<span></span>
</td>
<td class="nump">298,863<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,948<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_AwardsIssuedToDate', window );">Awards issued to date (in shares)</a></td>
<td class="nump">6,551,872<span></span>
</td>
<td class="nump">6,551,872<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">RSA's unvested (in shares)</a></td>
<td class="nump">331,659<span></span>
</td>
<td class="nump">331,659<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=rdnt_FutureServiceMember', window );">Future Service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,078<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=rdnt_RestatedPlanMember', window );">Restated Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Shares authorized (in shares)</a></td>
<td class="nump">14,000,000<span></span>
</td>
<td class="nump">14,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_AwardsIssuedToDate', window );">Awards issued to date (in shares)</a></td>
<td class="nump">15,384,316<span></span>
</td>
<td class="nump">15,384,316<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Options cancelled (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,281,040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">RSA's forfeited (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61,703<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance', window );">Shares available for future issuance, options, warrants, shares of restricted stock and other bonus awards (in shares)</a></td>
<td class="nump">1,958,427<span></span>
</td>
<td class="nump">1,958,427<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=rdnt_RestatedPlanMember', window );">Restated Plan | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=rdnt_RestatedPlanMember', window );">Restated Plan | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthIncMember', window );">DeepHealth Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized stock-based compensation expense</a></td>
<td class="nump">$ 4.3<span></span>
</td>
<td class="nump">$ 4.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized expense weighted average period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 6 months 10 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Options granted (in dollars per share)</a></td>
<td class="nump">$ 16.93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthIncMember', window );">DeepHealth Inc. | Equity Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted (in shares)</a></td>
<td class="nump">412,434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_AwardsIssuedToDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Awards issued to date</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_AwardsIssuedToDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common shares reserved for future issuance related to deferred compensation arrangements with individuals.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=rdnt_FutureServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=rdnt_FutureServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=rdnt_RestatedPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=rdnt_RestatedPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140489810959528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION (Details-Outstanding options and warrants) - Equity Option<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Begining Balance (in shares)</a></td>
<td class="nump">478,951<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">48,948<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised (in shares)</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Ending Balance (in shares)</a></td>
<td class="nump">527,899<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable at the end (in shares)</a></td>
<td class="nump">298,863<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Begining Balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 8.21<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">20.43<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Ending Balance (in dollars per share) | $ / shares</a></td>
<td class="nump">9.34<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable at the end (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 7.48<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_WeightedAverageRemainingContractualLife', window );"><strong>Weighted Average Remaining Contractual Life</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Balance at end of period</a></td>
<td class="text">6 years 7 months 2 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Exercisable at the end</a></td>
<td class="text">5 years 10 months 6 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_AggregateIntrinsicValue', window );"><strong>Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate value outstanding | $</a></td>
<td class="nump">$ 3,419,956<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate value exercisable | $</a></td>
<td class="nump">$ 2,353,438<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthInc.Member', window );">DeepHealth, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Begining Balance (in shares)</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">412,434<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised (in shares)</a></td>
<td class="num">(6,963)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Ending Balance (in shares)</a></td>
<td class="nump">405,471<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable at the end (in shares)</a></td>
<td class="nump">24,211<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_WeightedAverageRemainingContractualLife', window );"><strong>Weighted Average Remaining Contractual Life</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Balance at end of period</a></td>
<td class="text">8 years 7 months 24 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Exercisable at the end</a></td>
<td class="text">8 years 7 months 24 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_AggregateIntrinsicValue', window );"><strong>Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate value outstanding | $</a></td>
<td class="nump">$ 6,223,980<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate value exercisable | $</a></td>
<td class="nump">$ 371,639<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_AggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate Intrinsic Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_AggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_WeightedAverageRemainingContractualLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Remaining Contractual Life abstract</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_WeightedAverageRemainingContractualLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140489887345240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION (Details - RSU's) - Restricted Stock<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">RSA's outstanding, beginning balance (in shares) | shares</a></td>
<td class="nump">387,934<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">RSA's granted (in shares) | shares</a></td>
<td class="nump">457,596<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">RSA's vested (in shares) | shares</a></td>
<td class="num">(513,871)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">RSA's outstanding, ending balance (in shares) | shares</a></td>
<td class="nump">331,659<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms', window );">Weighted-Average Remaining Contractual Term (Years)</a></td>
<td class="text">1 year 1 month 9 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted-average fair value, beginning balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 11.61<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average fair value, granted (in dollars per share) | $ / shares</a></td>
<td class="nump">19.66<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average fair value, vested (in dollars per share) | $ / shares</a></td>
<td class="nump">15.47<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted-average fair value, ending balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 16.67<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of equity instruments other than options outstanding, including both vested and non-vested instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140489887769880">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS (Details) - Subsequent Event - Investments in Majority-owned Subsidiaries<br></strong></div></th>
<th class="th">
<div>Nov. 01, 2020 </div>
<div>Center</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_NumberOfAssetsAcquired', window );">Number of assets acquired</a></td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Business acquisition, percentage of voting interests acquired</a></td>
<td class="nump">60.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Simi Valley Hospital and Health Services</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Business acquisition, percentage of voting interests acquired</a></td>
<td class="nump">40.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_NumberOfAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Assets Acquired</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_NumberOfAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis=us-gaap_InvestmentsInMajorityOwnedSubsidiariesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis=us-gaap_InvestmentsInMajorityOwnedSubsidiariesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=rdnt_SimiValleyHospitalAndHealthServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=rdnt_SimiValleyHospitalAndHealthServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R9999.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140489884537944">
<tr>
<th class="tl" colspan="1">Label</th>
<th class="tl"><strong>Element</strong></th>
<th class="th" colspan="1">Value</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthInc.Member', window );">DeepHealth, Inc. [Member]</a></td>
<td class="th" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned', window );">Business Acquisition, Equity Interest Issued or Issuable, Value Assigned</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned</td>
<td class="nump">$ 13,900,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
<td class="nump">823,615<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_NulogixMember', window );">Nulogix [Member]</a></td>
<td class="th" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity Method Investment, Ownership Percentage</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
<td class="nump">75.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Payments to Acquire Equity Method Investments</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
<td class="nump">$ 1,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_VenturaCountyImagingGroupLLCMember', window );">Ventura County Imaging Group, LLC [Member]</a></td>
<td class="th" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
<td class="nump">4,300,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_HudsonValleyRadiologyAssociatesMember', window );">Hudson Valley Radiology Associates [Member] | Variable Interest Entity, Not Primary Beneficiary [Member]</a></td>
<td class="th" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned', window );">Business Acquisition, Equity Interest Issued or Issuable, Value Assigned</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned</td>
<td class="nump">$ 6,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
<td class="nump">440,207<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=116868840&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_NulogixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_NulogixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_VenturaCountyImagingGroupLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_VenturaCountyImagingGroupLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_HudsonValleyRadiologyAssociatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_HudsonValleyRadiologyAssociatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>50
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M9CB^F4VFLV0Z(3A*;JZO)J,[G)R/KD>S\90DE]/I74*.[@6M,F8@.R9'<ZI
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M:)T@AZH[:STQLG3-:2$-MCHWS/$R F4#<'\II7F:V'[77&_#OU!+ P04
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MVNZ:QER^_\*QE'GRM)/QD]HL2($RH=YG,A=IJLWD>\V'DP!P-]@SBQ^ 4@[
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M\D.K?AA(MJM[T363T-G6CQG\WA"N / ^94R^#U2 YH=I^!]02P,$%     @
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M!/9_EL#0NOB&D T3&NSD"ZSRE3NG5]#=65T"\5A<"TB(P!""!X%^=G4!7;2
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MG6' ?<L3S,/Z\I@X1"CG&OL?5CA;X@(:4@9E>E<C -=#&.LN<0SB$&%,SUX
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MA%WP84*@9"2Y'=]_I*,NF>(7[.4E(U"H,P;4;RA'V# VH&3$/.SJK)FUEXR
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M+Q<BE-2G ,C?YTF2_[@IWHK>_?<"I_\#4$L#!!0    (  F#:5&"E)OKL D
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M)&$SDOIQAPD*TQ*T\VAWK812KX(\GD<L:5HJ["8P,76+2B *FQ'UD+.0TJA
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MWKP(UGPHV;%^E^J9E25+Z\,##2*:<P/X?L>@4&X_\!_H7L>[^3]02P,$%
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M:#CN[X0;J_3#FYH_W9L9[TW)?RZA/&5I =Z3(Z8?=$#[+>?S_P!02P,$%
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M[X2)BE9AN@1<E!G-5,3+-%[$49B6P#H691N#LJU65:%5F,YY/OUEDX ,T/,
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M.-)9-0Z;LSA)S "PK<5Y".J &P+ 02"4$6ED>I#4+G2$)($V54"Z?L/N!V(
M!7&4QYO:/E!-D"G#2M!-S]H7E0_M"S0<:#L #E_(/^O2P FPK;.2:9.\G!AD
M5]&HFR;(8)Z,P<,0/D>A+V)L2W8<[!F)9 9_ 'K*A&E1S!;F1"L>^6 /9?-$
MYD:M56-LH/=LBSLU-DU-!)Q4!Z(M#C=A>(D%!LOHV)B^3I[70%CFFC6%9^YX
M7%>EM*ZO!1@NJVS@+]""%>!ZEFB+/9;G\L9VE;%A+.I.)!P<(NP6-KWC;XWP
MAB6(@.;JW"WO?9G6MV"_N6BH3YJM$R87[U3C]0:-]9*5/KX?L0PKU#EC$;X
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M7C=3V,T)[;XCK!!NQ63-F?J,V& ,DC=C&1I.(,^^D-$'J[UJ-MJ6P>+4X(O
MM)8C1?E1H!8&$E(P\6< 8Y5Q:'BMV7=^R2'+!$=)<JM-.$T;YT?HS=&!V\L>
M"3*IBSH'X4@NG$,-4;9U;N?$?["^,85!<&>[NLI\S,C&M'*A#+]@5*LBOO7C
M]R)^ W;%\?$J3!8X!0548$WT'/!]=B=F6M8G$5'&B<N((,]ZY@#J0SO?X=!V
M0XW+DR1HM,PJG+OU7K6:C:$OTH_L4G,HN- 'Z-J3;V'A;PZ((IRAYMR=9M&Q
M\6WA/:21 &5/7J%B_H)&M!A#=+ G^?:T3"1JGR&#/&L^UR^E1[76+#-'ADNT
M!C\55J'6%"@@GNT=!FH18T"),GN&G &W!=L 5AC[!(P'G0.QIFABD+$#MD69
M88"04B$ %CNB%(;1NPRW7HEKF4GX35 *TP$)ZR@L8)>/2%<REXFT!F#\E#13
MFI5L'Y$H96(H(M@4QUFJW+IIH"]WEV%Y2?;6!KU9"=J)&66,+B/_G?D3B$U5
M&*8^9EB9( OB VDPPD0LGJ<=8TU@8D^40B903Q(DT>D2Y"8>7RP6(>R6A2+&
MU0W-6,V!TYC((8?RC#^V$7,!,ZLFBMI0;P&A$G)E$Z]*Q90L*?:($BE,$:'&
M66;Q)W#EW[#$#!X;:KK N4A\&$20V0?G"2<)8L.BF.@-C5RK@@*6(_8U8*%$
MDL2(,DNZ%,Y.-Y70*VK@]8:E;E5P@.!$$MILKI8CJT>[BEJXZVO!/1O XCCK
M)D,6)&\=((USHT:6H#R(8]AU2)>7B<CU0I=UR_6H0Q(<H2(B#M)<-HV.T@_D
M?E;$=/9U1M]SOAOJ-V.%<VK G*T5'*0ER03G6%)!@<=G#(8PL>/)4&2YT-8W
MHZ6.GBPFOJ]NQH^/5(WP-+V[)4'9:OWT2:H*@.,EN(*"3[P<$^O;8,(IJPJT
M'-RH$(-0B?!"F&C_L !EL'C)T-:S"?8\.#6%2623,2'_3P)-!'C#E$T\X@8F
MTX_CMS<3<)P?JQFFZO"T 2;*Q' NP\8T67VSA8B)41L0V,^TN?":F/Y( GY(
M/+#IBB,Y3MF1L6(OBPWJ#"12]O38:&>W 6:BI!^ AC98+1S?<)9:/5%N$[>;
M*B\J9"?$5:HOJ<YA+S987Y,-$E)5(ASY",&NC$OR(DVL6/;.E&JK&2BY0620
MNN _9]=(T\_JR4^)X$>25O<BT3$(""TVY%;H+<8LM="1:",OC.UBUR#1,$&W
M#/.Y30E&Z*B"ZD&/UV1L SLSB@_44W/G$/@!<N]=MXIUH)F#+.F@E;8 $R##
M.*\IN,&,,FB]),PIM@S:EFPU#%-30!P9R*T"&W?Q3V>O7,DK$_/*%;]R@U"<
MGUT!NYY=P%'-=4(H:#=;0Q>0W5*&1RJ%4&.3BB:;VJ9(ZN%BH-TR+BN7=@7+
MQF/T(VS#L*99>HEV&%"?]B>/4UNP0"0!JDO[KQ?.DYY5.YU;4\\+ 8L?L>\4
M8O2'4C3L+1QE:8YO>/#0M& \*KU8B/HUU@U7F*#2BXO/OI!BV]=!+(\,O/<H
M]O6<XCZ'VV,#=9'PZ:&38(TYE\HS\K\P3A\EU>JJV*CPNL]-0I=\[4.#U=(;
MJS!;'6$>&]^"LUVDDORWS7#4A>0[F1=.6/F6LUZUFUZ8QGD-;($*P[,WQT:.
MGZ\#*33/R&0$(DS V?*)UH_,(@6DE*)?YA3-S$LCW<4RQJH"S)UG.:6!.,0+
M;/*4B7_%' 8LQ QD=[Q_BAP$(Z=3S"H0^S\4OBV,R;!J [2,Z"[%]#&I8;'&
M]J=E_@(5Q643("]FIF9#+(TX]ZS\PD4$N,PMV8F-QJ"QJ[Q#%L8BIC3:,25G
MJ:V; JD+DC@N2%20/_(LQ!;63+$-6/6D"X7: L-)) U\\N9X38+EP@1[F%0B
MJIU75E*)' R!XZ1]TRACS *AE)3N$@?I4#0B6K+% FBX-'L\T$E4JX"2*-G1
MN1/-Z#JLE-#*$!)84@($86FU!4F7G \7S+W)N\G#P^3:E *"-3$NZ C1!P)9
M015D8[!%$V<!;D_'-FJA2Q17\^>0-,IAS,YNZ(K+-X@NCQ9C.6L 5,'[1] $
MY +GU@$ =(84%QI[44*<8<S+8_B2Y(T)67J:YWB0,C@5I:1(A\0EQX5P]EX<
MTL737(P0_@#0O5!A"T3)/-S!.PO."R ;$%HWI0VC,CT(KE*]=?@!RS->%Z9>
MT N1"0\X"\!1Z-K7' R@C5"8M(ZD:"7 ":^ +)30HUT[U_%ZABK0;9JK:XCA
MPCE[Z40Y[\.=36748MQ^S-K1R1YUD.2S5B;(Q1AV2XK<F!R(7;]P0A@84.W1
M]KOI[?CV"I-,5W>/3UCM>I45[!0X&<H%@X(-<N3LWJO"N$1.G5+1%)@R5)N&
M$=)5!MNW 68W;X1+!20;.)1?K:O$U [@ B$CBT3,JU9C9-%"T?A6HV\>D'C"
MV-'QW/1!?2^6[5 M%L!KA6BM)NMMF ,= 0U2A "5,8DC-+^UN@4AH'J!,<7>
MV?P,S71+4OZ>XTE<AI#EM0)G,!D>[NXG#T__0AF_R3]_F-Z_G]P^ ?KO3_A#
MN>1K2)HBX@*N2/2Q!BH<J"@.K4[WT8@GX'T-.SKA>L6%*=FMG2_66V'_PR4A
MA$^5>:R>N0?'?E$E"EUG&UL5\R.,F/T#8:6<C4(DYP[BO=6CHFQ03C?H,Z]0
MU8##"@Z*QTX>WY42^H#9<RX(#@L.\JK,B(WC@'T;@O=>P1:3!X8*& 2N^212
M$9N+G3Z.Q#;4VP^/T]O)XR/PU/NWP&#D1E^J3RNI5O@KJ&Y;G"!EB#:^E:UG
MP"#2SV+C(24HS])2 F4=J-Z/$(K1E%IX6A48[&>]0YMSKO3A:=CHKHF6$AUC
MJ,;B.,YY=,$Q1HQS@H*%IZ3' 5N_VM")._/]%] QX@S"W,@B< QPSUP_1J6G
MO'%CH^-02V(B)H[.[0%S@N:^MDNP.5<QL*HT/)"1C?++!J$.HE?HS@'C"8II
MX:,+GD;IP1X"6M=;DD0&=G.086C#@,9F_%TJJL"U ,KAX.'89<0#/R'@9VZL
M#B0&P&#1# M\)5K 71'6_C@$<FNT)NBEWZNB%*<J.XGS8RBPM3PP$0KBC-,\
MK-)Q,D.O#?7!5 &RMUYXUO3AKI#M4;TDR@9M??/;$<@^H)2_/X!3D(3Q-^1+
M=%6Q8"$@ ]29[35,U-(1HDMJZ8&BEM;S(V^_WMU=?YK>W)!.F-Z"CI[>3I\F
MZF;Z<8(/GL:WOT[?WE!/BF.XHXX857BA+=$=-%V*&VV0.9)+7&K%L4T,W*3+
M6/*CFDO>CWIVI();C8Z;[%<_7NK-?$,S3^W,ASD:OVSCF.1#+Q"%Y5;;@]22
MO,ES,N^9Y>!U;O3!1Q4L3A(%/7%T9)U0,%%IB?6R_ :W$&.CLUHY-S'7BKZ@
M&#M-QR%?*O61,L-:M)C+V$RD("SW8"*/%C@:1]1"S/'IPV"EX(>G4W4'#@V>
MB35A $!<(\V\@34ST[(E]T1YTR$XPLM8Q9^C#<3>;8Q%".(58BXIBR2_*-8O
MH4;T#EMZ\7I_9H#*!!-)J)MZ&1.,2.?.RY/@M3;N!,<3L?;9S]$"GX/5G]JB
M]!2T0L(F2<KJP[DJX A)<!R\(9O_H!!'S*<J(<6=Y'>\*D%[/MZ.9IHJ@]"$
MHR0S!@U""O187^2081KH!F%L![UQ-ZV-+[RDJC+VNW&H>G*_8O&MA()8ZQY8
MN5AEV&T%HT''XU4C\OQR%%_,8ZU!DNH=5AR D_(P#=3-S97J-UO?-PF\B;+D
M$[PSR^/Y4O,\K6#8^4YPKK7><+U" -0=-52[$W1&_>^;9/ROET\:"/C!%B#^
M0[C>_+2WRW8P'+;WT'KD9+!ZLQGTASV0RF#C3=33^'^36 ;P,'&)N6=C&<8D
MV395::UIC)*CK*VIQYTQJ?$AC[,\(OSK/"R<7QI_/HB[3M853A X5RUVT!CA
MOJ>010RSOM=K;/?)=\ GU(9&%?RFY,4&H9QPPY"^*Q7T%ML?XBG<^OI<(;%7
M5V+!]^"FXNEY%5'OZ0),0;0; =1 ^F\\N8RZ&=^<Z12D:TD2.?#JCFTIN$;.
MHM!67(BP%WR;Z 2&J]@Z!!J!J<+-!IV#4[(@+&NP8VP,J1._]*8#ZX&4DICX
M-ETB]>'&;N#MTMX.$8(#4,,YYV8_MM; OE<RF8^A<^MDLV=QHL_/TAB&TE1R
MID #1@WCH6Y7FL+#:-J<6H&\E*-HVL>M;QFD/A49!@*P7G5<B0CEQE!%'7 #
M15,&C?9? BMG7U0?Q4DZ"4N=AJ'U8ACZC<Y?O@<$[#<^C0=#R B#%QKZ!@Q#
M@"'X/GWS,C1T7-1%?0.&;F/XE^\  =#PM"=(B"[KF'QQ4\(<X,F-=T\RC N$
MR0*OR@P$'4$ZY]*8\_@"<UB2"TJX9)$#68494ZYLLBC1G/Q-=4[-Q3_!!# #
M8Z*04I;2WXV&,0@\C,.![/IZ!XRF-U>>F8*Y NQ4?<FBRZ_IKQ45@?GG!^Z]
MSDN.B/LU:_YB))O(NB-W3,:G^DNI6FU!;L,5GK<'?B77/:"%K"CC6GU(8UNS
MR#6$)N.8A-L_$DW&@CFPY$SQW-G%7C5=@"(??48210C_TM:*8&F(.,L>,=G^
M/C&NP? ##5!1#1E52G"W*P[XR14_<Q3;8DTR4U)&X16UV<(M8^76EFRHF\GX
MD4R$3[Y/P]:VE]5"-1!*( OTB<T@-4P!*&R9OC4! LE@HQE<'Z!RBM9EBTN,
M:9@2XH>[#[: F$5U8"'>G\!3U(&MB9'PVHFA.Z\V[D1%'!#5NYCC:B<V<CPN
MZ>!<^*^[I1V,EP3CB6$O@A#09#19KJ7.A%/^B%0J,J*;,?R,$VMFFS-UL4@"
M:Q^C>_.ZBQ%P\G7XV<S@Y4^H,]2),_K^@"Y\T _"+WG=URVY$1,VSC65**^L
MH41I3H'0>MM[,-G8G-LM!:%,+2'N3 Y9&,<TL[%#SM5<N0DLF>";7U$WR\#S
MHVQH?@">?V6(L^N.;FO/A'G!YDC((D12>.5@Y8LQ,.&);95^>2"](Z0,/&)C
MA53T.;>,O15[DDP^J4_?69%EJE](0.LOV%A62,UZ)K* PN-6*R/)[1U,O=F0
M\K_U^#TE@8^?WSNJ2[:-^/N]B2$'W 4B' 9 8V3L"VG$_=9Z$664>$TO^2_4
M95G*'1HF%:<3:WM+V-M5*]CA'#M"-D@,S/9+2@%M\"C*$@W+=UE>%P&D'B0S
M90V:U-N^)R)JZ/MJCLOSVOQLB]&+EAN_^TB*56:*"T\D6!:V/XI7.) \-3E&
M-\5P%&HOM@1**(KSJ%ICB11WW2^7N#=;%F7#;N)F8=38NC7<3TG4C\VEWI+D
M8[ DD!:F@[06#\P.M!>PWVW&82AI;+*!*%-DMXCQ)I9%DJ'/BVUI9 EPC1L1
M+)>/T3ZU\5&Q5@3!$.'D <O]*4W>A 57I)<)>'&>Q=:[><WK]M(D+TQ&F('1
MOV,U7[C&GE.)"/L=79^TF] &0XF^\FHCM4VV<R632:DJPH^>BH4:.M!G<#)K
M#A"FES;.#")5^AU%W-2.GG?OSL?3T.;"*7"XMV2PR&$>ED<R"AA.FS;C2PQ(
M]DO,L78G H".%S<PJ;M4)+6 4)4'Y0? .\H;E"Y]^A?U%@RJ:TRQW4]N'VNE
MJLK4JF)"PQD$:$RE7!&.[=-&SH9S$*ML>> ]=UPX;R0>=RB&:_8R3,UY:"JY
M%E+_T68'IB<7.2PI+&E,YQ%]-U#GN#ECAYE9[@$48Y&QB5O["G!=<"'),^.>
MB\2RZ#-F1ZG#IO3OO:I]9;I@ ))_K%+LY"5 &A8_J %SG+C5#9K-)O['3H?D
MY-9K+-?$*5EF%%A8&FFO1F0/6#[Y$&_PXF).VP1.U;N4\# 5Y#1MN WI_@OY
M:^-EJ,G4LE]A)%W,4"J+XQ<;X''@MT;7NG+89Q1@(DS1;5S@N2.Q/$Q^ WJ9
M?IR8V-WYS=WCXP56]SQ>*3@;KVD/&+\RP7@7U.)0<@%$M.,JAC5 O<+.@V?K
M[V7"HA3G+PM/AS&+H5_&(1"U)/TI+W E(/95@ LE%F^TXX1H(I:.RS9Y&HT,
MDRC<,$]N\8.K>=RWL.L@6T#WAXF[>RIW=73CYSC;Q1_UV4W=:@./ZOWT"8LB
M'KDK^HZNQ)O<TGUXY$9QR53.Y7>F?#712^ZMP,0-.X5<#Q0H[]:B#$.'Z*$!
MF%YK89Q2([!$->,4B<C=?(;R JUP;7 #\@@,C!R+T:CJU9/'P&.8XY0J$XD=
M%"CI2[Z/!PMS.0QH@GS/.LDV@MR44F0L)MDND.ML\HHL,&NI;"5-9J(!(9\F
MIPYFML;0"Y$*=WJ&IS4M&NJM,:^-K^69V 2SF/&NHXG277:J#2Q.R<0L=P (
M78.>Q<XN>V48]C^SOM\[,=&>.B:%[OQTO,,D-[@/ETLL]D;/@?M.W#6'TNT@
MUMI^YXOI 7)4?:S <J_Q(JM*9NM%_1SYCL+#)#U)\EPC'U/ &A61J0,ZF(-R
MJT I6+,IR@,8NI(6)*E,XS)JJ99PUS_]4$C8VC3FG.SL.-4Q5FNPH4)18*DX
MJJ2$3&3>_D4EG &GRPD9,V1MZ#VR8\JB^MG()%N]XGC7EA+242$%7D\>IA]!
MFY-\?GQZ^, B (1"7UV-[Q]-W>H"-@I$5&O!:?6#@X+W<DMM:J@MC@E+)R//
MSWB-<%.88)-]P+X80"X733K)A;LTB5DV'^LO8K-/:F]NDK.D:'*O:54N5;-U
MW(-Z=9K+\5"EM%<!7>^JW%1@;'"K$>T-Z+XC=8\WT[=W#V@IM!O-OQ@GE:WI
M$(/*-JF/3O$ZKJC/AM H2*PC@R@@+B0S:OHEG3/I>R9>8??8BV>Q,''W4W!3
MCUD!;_PRM>]JI>=+R4XD&;D(EQP*,)$!+F9&KS&?DWE"XL4KGEI6\9R+F &/
M\3-=&R;RW-V9X &#Y\$U6KM#4)A/P'6K_((/Y!,.J;BJ VEU)UO06>R(%=J2
M.H\;,$9:(]#4M6]>*'NCJRF8L ;$H>9EB?\U=4WMD*#:2FQ(H3@7LBY#81M&
MO0L)Y6HPX^URT>,[!.\C!4O>NXP=7BH7>9>VVDM67?&%;-H[WF,E)D ?>%,0
MR1V_L\LZP"+-%]XAU@XB.Q+7J[=3'&+M +28B&^1)=1U<>Y)7S_O_NZ[TDO2
M8@PV.$@Z<W^+R3&/;>*R#AZ133U@X.W;U,)1EO'(DF;V&W/!TM@K$^6[=*YJ
MR]W0A1BU:<];0;<YNE"M40\_MUO="W7C1Q,Q;L]$]>Y[TDP6'2%X+/E_,8P,
M!X,+U>]WOH41*K]X_.0IK )+7/9Z1K&*YZ!#B^(#1S76OK:"%;9U=25/6*QQ
MQ=)1[=-K>LI&PC1<@4<*TUN(1UM51?>KD45Y.*S=K(\[@(JT:($9'LT11FK-
MW-_DOIG(+4>%"=F@H4\&AL2#T\_48>CZ:VOYR+GD(FWQ5"=P>GJWK]<]3=YQ
M5\FNP5BA!C>#R+K.[[F8/Y:5N8%?4]Q;^V!N))##$H9-P:ME)ZQ5T^&<$04!
MVFJ,^BZY^JKEX;X&*"O]GC>T>V0H1>UK@M8@+["AZ!E'2*6DW1@*+N2\J!]D
M8=OK63'8[>;<UHUW ]"\YM9)^[8_)<]D[F'"KALV*VJ3O<BT,.C][VM;I'O'
MMW?9UM_/Z&!@71N@#W; .=!=L!<@%P<TH7P=MM#P87@5SI9>3>ZX?O.!7Q+H
M+D1AVY6B3'3=&UG M2[2/2(.) !N.S%M9@/IZB@S[0DT"L;8=(IC;,N9&+JM
MR1/3YWR<JU\\.XL(\=A!R$6K8WO!A=Y1E/,F!E)]PDCI31;:YE^;H?'M0TD,
M[.SM'NZX'/T=X;0&:7\,FRR3'5U/LU>P@/V.7MDN]7]QB-68"5^58RSRZ*V:
MM?5U.>GNK/+OYZP1'1"5/V'@E00?XR7N)I*6UX+D3BU53_;&T?B9C?>ZQL%V
MUS4.UBT29"RT6-EB.NQ,PS*Q_927J9&L4UQY>!.3:U;$F\E)"?V=;?21H%)Z
M=U@I $&ZK-S_*]8[ ?XR6]5-85YR%V=DU4%GW-W5E.U$$V\%YLAR$Y\Y$/X7
MP7^*9?Q*G;>[X"[T+^ C96':/\&G47]$7W6";F?P]_4>_@>>2 ^\E28>R#GX
M&=WV$#^VZ#;5;Y_)G\/G-=;V0I$^2[-59@0T_T7Z9::CD(I//8/TU T\_Q&,
M/TU/M;22SCVD$D]WF"Q0C<C.[;4+)IAZ2!SNS(]///W#$W^-JKFC^&^@Z1K8
M9-Z=WU >Z$]>9EJ/X-J4,Q!T?S"Z$.8PLXG*8Q8(.JWVA2%O[EB2N2:B&;]+
M#OU_ZO@O11W=H-?N?(T^VD&[V?TZ??QI0="(_%!S10_;-"=BHN_&TP?U<7SS
M8:+>3\:/'QXFG \QE0[CXY5^7G^H!\/:A_C(?0SR:UH2>:%DD/?V*@;YG4<K
M<>>.?8/]U)^YM9=\W-*VUMN$989A KH1CFZ HWL63#6L[][6_83CN^1K#] S
MI@(@6_QE[IGQOO:="KXBPI"=5_Q\=$LQ_[R4G!^K&+Y,IM3+C)+%M:)$^!J)
M)L%\+F^5U5E<NUK5U.H<.YL?U0V]W!)#ZIT;%1>^&S;;26U:E7)1@$:-2!>4
MR UYDK/67GED;'XG4=KLI!J:6N+H%T].=.HP3.T7PR2G;.JSP]3LZA2(]KXS
M*<XV?\VP1H7KRZ8\9\3="51E69^,;IB3^R].$,WA_N&=PUF^A1"6X_69\*<@
M6'3%#E#Y63&&%JR10MN[#UT;D"U?0PBXW7"ND\*[4*X6E$!8=C%>J0>RW<:;
M)+.//=79+..;7F8^ DUC)?A=H3G0SO<>J#VO*O5F-C?K["]>6_&#?Z^E3"<_
MN%9G#J_%'='[>S5?<G/KM8NQ_4A2J.2+?5CL\L^.XOT']8K)O=L!3.5;5KLK
MRIVTW>&WI6A@JRL.?W%"PKZNPO&%5\;R1?'6EMVS8<>G>A(-=PF?FN.5GRBX
M\GIO71F_3\].,UTZU?> BO3*4Z3.MVL-VP=_>_KL99-T1L%HV#GV:'RBI?4_
M?9M!<]@Z\N2[MPHNV&!PY,G3"5)U).155H8UUF2^-)A@AFJH]UAD8NY8Q#J+
M8%^Y[4T#; KCHLI$K,Q-"4;GN7;0VF^N<,5WW?:5-PX-8M<G*K=L4>&6;9HQ
M^2Y.<I!0$ROC\ LIFZ?B^YI:HZ+^:I;$D2_:12J206RLS..- T>G #F)=$1A
MT6L]*SVQLR]UBI-BI]9:)_6_'I*I3<*6J7(VZT^7 )[E:AX #/S@=/SWL4J?
M<K LW/,:"??QAVVZS1//^H-.T&X/_B O_WE0#IK#8-0=GG@V:/:"_FAT&J^2
M1CN$OW9/5*Y1D9%ER+="V4)LK@&R0CX#+L6[2.F6!*P%M="?GL(/)Q\&4*M9
M$<]CC(;=_N/T-C +@BT!>FWCW5KA5CYQS<>IK3:^*J8.Z3=P14+H5%2%6#SF
MXJP7"#+OE\N\J[F8D7QCAFVVVGT3QWH66/-3Y; I(4;G!_; >MR[)C X>GFF
MZS]+]D)F/)KO=I1;Y/F&(!=1/TQMS&KW?,L!TV5DU/CA_<PM733N"UYP.I;U
MFVV*>O1-1"W>?F5:VJ4_W!B;DF(%-TNN"F$]L?TZ#NL6D^DTV?MUX!?M&B??
MTL^IHW\FO\=5UQK&/41)726F3/;@5+WE7.^ED(8DAR?CA]OI[:^/ZG[RH!Y_
M&S_@58X3R>Y0<H-JWJFBK?[+@P<@IA6Q!7;W'B^3Y^)2[X%'9#[_V6AM;3#=
MDHWB/B<;<W?:$J1BT$TID(=\K[S\A<;V\9\SJW/\X8^;'9$(>S]U=JO+O4KO
M_:;EAW!^B]>3X4T=/Q2U_9F^!- ,0:N'OXX%FF+4H_!+,QB,!AB)Z0:=?A.;
M.Z97ZG;RM%>E[XYP_/3T,'W[X8DN^GZZ4P_C:Q@>X/C&#W3UVON[6_7X='?U
M3[_=W5Q/'AY!1)P\3@.FG*HG* ]_%[O7"CJ]8=!O=E1W% R;@Z +$/=@!]U^
MT!DV\6EO- A:G2$65(,MD1Y@S9W6'\)?L]%JTS]-Q.)YL]%M7?#?(W4]O?GP
M-+G^;X \$$[8O/3,76OFQQXH98C<8MPS^]OPTHGTS%<0X36BL$X/NWJ"7G^@
M6B-8>]"C:4,K]PS8U-Q"UUDC]]N^2VKD]UM,J#V(&Z *U1WT88F!ZO3:0:?3
M49UV%^BX\W)DF5" ;X"#94NWQ7A4X\@%\#?J]8)AJX=( U8A=O'P!Q];K4[0
M <JX/ISH/Y[\L"'GS>ORES>OXP+^%\%_>;:%_Y-S>PVRZ9<W:[R8X4HG2<'N
MP,]GK3/O*=YI]_/9N/7CN'WV&MYTPW]YLP%LO@_S)?;,)'H!KS8;@]X9=PN9
M/\IL@U-BG4:9K>GC"CP&G>, ^'Z1@;*6/W !O"":P/OEWP%02P,$%     @
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MOE'L9Z'.P3=;5ZIR, M*+URJD^KD3%M%/C&Y=OZ(S#3&F=\AB8-8JF9P\OR
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MIIW3F7],!4!K: />S[5VS0\RT'Y^O?HW4$L#!!0    (  F#:5&O0"91;0P
M '0I   9    >&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;-U:ZV_C-A+_5PB?
MMTT 09'E5Y)] -YLMDV1[@:;7(OB<!]HB;9YE467I.+D_OJ;&>IMV7'0 G>X
M+XDED3/#>?SF(;W;*OV[60EAV=,Z2<W[WLK:S>79F8E68LV-KS8BA2<+I=?<
MPJ5>GIF-%CRF3>OD+ R"R=F:R[3WX1W=N],?WJG,)C(5=YJ9;+WF^OFC2-3V
M?6_0*VY\D\N5Q1MG']YM^%+<"_OWS9V&J[.22BS7(C52I4R+Q?O>;'#Y<83K
M:<$O4FQ-[3?#D\R5^ATO;N+WO0 %$HF(+%+@\.]17(DD04(@QA\YS5[)$C?6
M?Q?4/]/9X2QS;L252GZ5L5V][YWW6"P6/$OL-[7]4>3G&2.]2"6&_K*M6SL<
M]5B4&:O6^6:08"U3]Y\_Y7JH;3@/]FP(\PTAR>T8D92?N.4?WFFU91I7 S7\
M04>EW2"<3-$H]U;#4PG[[(>K;]>?;A[8Y]G5S>W-PV]L]N43^_+UX?J>W<U^
MFWV\O7YW9H$-+CZ+<I(?'<EP#\D+]K-*[<JPZS06<7/_&8A7RA@6,GX,#Q*\
M%QN?#0./A4$8'* W+,\\)'K#/?0^B;EEGZ2)$F4R+=@_9G-C-?C'/P\0'Y7$
M1T1\]%<J]#4D;X#4#E$V,TPM&&C*BO5<Z%)=C*<Q^R2B_.X [PXNF,HT^"ZH
M0<T3N>08((9%\$<:*V(D95>"+50"02O3)3N1*=Q1F0%RYO2RQ:A!_[/4QK);
M*5+V(/2:W2I.M).$6Z%Y(O\-#.;/[!N/OPC[O6&6ITLY3P2)*M/JTAAA#>NS
M21AXTW"*OT87WGDX(N.I+(6G$-C=#$\&@3>97)S"CZ$WGL*/^RQ]T!!1U2HV
M6VHA &)LAWQ??KKY\K)TX] ;!P$;C[WSZ9C=\6= S>AW=J>5S7$'?BXU7[.$
MQ.*6#=ZP.!-LMM$R01N%;.0%PRG[[F_GX2!\RZ[_R.2&A$J!"-OP9TX,+1OY
MDS<>;;8KK;+EBDSL=0B_%K&,>,)$26LT92%(^* LW-XQ_60R\2:CD$TN0F]X
M,6:WPIA+P!^M<>]&:3K*R?#"&TV&I_1C<C$X!2V"<UC49[%FAS3:;^H-IA?X
M"]0U#4;L)HV2#, !%$JN")X7 ]###?1!E<B8HQO.><+32#""-])=EX-#!/?!
M1?PIX&.2H S@OMU.@3;LCT-_7%_:X1=T",AXC(- ZSG$8\PL:0[6]R?3H1_6
M*;A'I(:DW'XBGN"0!G(.+LE2OD8-H7WBRGN!VJ F^2FKQ]DE^\SA]+_P!"Q>
MN'QNP2NN]3-&9O=!ZT%31@+<A)_!^+SKR+DC%TZ87SIF3<+3H1?N$)[ >B#\
MJV K'H/CEK;+P+*:C-P?7(S]H-3;1ZZCA#\;]DT\JN01SW*EP6TMGEHFTC[O
M,S@8<<5!K5H8H1]!H?V)/RSIHMDBH2T4)"P1%JQ">HZ(ML\>5K@1RQ7DV!^<
MGS<=!R4]0K0M!V]ZY#*AV+2*Q9IO6;;!0F,/%/N'M3,,:LHI#;1? BT2"A+@
MG8=0%3@FFQL92ZBR",:Z%>G#O52"MNX%!#KL:G*0PE2*V'ETR69=-#UVPD^;
M.G2*9XN*ZE9 R$)< 0 :EVQ4"CK4H)$5!4L920#CZ)!A\+;3S>G9X.TIN00'
MC12Z:O)\=G'6\+X3S&\Y[9?-W6!T,G<G+&VT<T*/;5<R6N4F.L9"WCZEE)A"
M O=V [=WW.D;WM6BM??8O5-_;V&!$CNA(<Y0[D221V^E73&>)'#O4:0<4:YR
M\AU-^5 [+(1&[UM(6!V1_,KL0WN/I="H@$ \BK)UYB(@1U;*-QY%9G_@7Y2G
MI<1MF-F(2"XP*R8[P?.R!_CL*ZSK!MNYX!I+ U &/ 6Y!>@ A,8"(_Y71A75
M=:95C&E:0^$#/D&YY2.T$W3IL0VD"MS -Z#(B$ %FJ2EQ+XE4CI&D4#89E6&
M+5J<)>*R+MBM>(1*8$F$I=IA?$^]6\6ZN/'=T@+J^^/@"<J,<?"&#>DOW1[Y
M =R>9Q8CYCP8%0N'_G3\AH7T%Q<.Z6Y]G=OI2(6.8/YDF%,(B0+^[004.K%8
M+ 1U;_OUB4;&I=6Y, _@G6Z;H9<,0+@WM)/$\#"A;!PC<)&"XJY%D/)!02HA
MYDIKLI7CZ!2&2TAI38XN-]7$S5VP*E(W6CW*&! 4)?@CXQI<#B2%"A$?4Z "
M?$ 0;2!INZC;KP&J- 0&#U85&%(;H/\DH=/%X_<OJKRX(UE=D; $%&.QD8)@
M^RF#O2&U&>$09$B@D&0*PV$+N(;.# VYIMBK!$24,T73<4 !?H6Y'0GI:QV3
MJ\(&H]/\E\/S3DM"-HS-I!VALXKFSY6#U21RBNY>5KG:H56W5 >AA@N]"=%8
M>R=T! I&H7#]E5JOI26?@Y7LAOT &&')6J $6 !]!5:\"CPZ""XQD'(8V)!B
MTVP-T=6\;C\/_%'C^N:&N@['HB*+:++<QQTAI> >MKB'+>YAFWO0Y%YG7]%]
M@7UU^"!HLF]>MY\'_K!Y^%\:W(\Z_* 4LJWJX 53 />&-'7F=:KCELSCUAG;
MSYM4$3.2LNTB#&@TABJS!MIIBIT*"VI5"3RU55E:Z]5=6PI 0YFW(R:!WP(]
M'.=U,:,FO!Z :&R T4C+.98/<ZA4_)JX?Y5@)>:48G!LW"&@UC@@JX=X.:6$
M$"5?R2&G,P$Y60MT:=8_!8IV N$2_K9G0>>N8NO.)OW /R^2 ":K#;9<J47%
MH(W!#QN\2]<<D[OGHB@M06AX4.6F*NETR^IC,5 =D!3YR!,HK'%])6N#.Q"'
M4#%H]F>4?%1)3D>TC<ZOZ,! VCD.662,J8$2&95[#]U*;*6[6;;$YW\FW^UI
M(T"$?<5HHS/;WR!63YQ;NUJD(<@15/Y\<;L_>?KTO-1$=Z55EE UN0^,#!*C
M6 1 !IDL%AOAHEBY,5-2)%Y-B9?Z)BV(HN%KN@W20)V&@[>XJ) */W1 03)U
MED*'>J5F%5NJ4_/:@(_><C1-AC7C!&/)SU-X;90!/8W)7FE-+Y^(U*@03H*;
MZHQ&C-UV@.7[C.W54,^5MY[#7ZT<4+08!,U$[*&6!8=F.4)_47E1FMN)+P%;
MEZBDF$M@L.90GT)JR?&C,8"!*,893)HK!%O0G?'/KLX.5ILWX+,QW",,H5%@
M417!H9!J.R6Z8YKB&%F:(? [JPI=(V".<68'0L<,HQ"4$%0 9FVI1 C<1**7
M89,+[3)9G>KS J[ DR6(XA;JD@*"*>PI&F8&49/G@_QU%]MDVF30VQ<U[T$M
M?GW%1 UVY&/A'%E=#ZC0#JP_GC8GM[611TVSZ'WBR8J\?RM\IL*1B&^ *; $
MNLVQD)\//,E-BCE$G$M$,X-<-Z1??.&W<C*34SBO=%.%5C-5GTZC?'A8$$/:
M?&0/E_'>00BN1PO/!:N&R.HQ=Y\JI=&PJ,#2CIYIO^X;K=/^9;(U\Z39(N+A
M(G,XJ_%]@R:^)L^ZB/OEGLH&B01[[4RF_%;2ZLI91\CY_YNSTGU)ZZ6,M:_.
M>CA.HR6XF%K5,VR5/0BY+@::-715#M'8?BX$OB(!/$!O!]GH+L^L@FC)YW-S
M 1$MZ%47'KA(D2?;E2!+0H57EE8$!KKB<NH[QURY1%[Y$%]"H!B;1TUK6HHO
M7=']L UFLR*F#;KYSM3R\N!@_&L%7N=%_G<O.SU\\>4S09Y)9:VJ6+$ORF>P
MX0IZ(T(3./<-EK3X$##I)R7)EZIV W;G[''M#U 5 R0_UQ;T\*37#J9*/CUG
M]/9MAV/F)3A_)1;G4'D$_#O$)A@[#-I51.V?>.\ .P[DP7\2P1\K%J[49S&%
M?RLU9JD+R/A5*:%#J?^3*0%=E%X_#\[S#P*VHNF6S4F6W:HJSYDCLOXE.Y&G
M+=^>_*6^77^!<R^?ZEHOWM:\=:]KY(XDTU>2IP*H@T$.GTWN91%S1"0YI^H/
M@OK;&9FWLKEN]K_)SD.15U4J+.^'=5I'!N;W!]]\T"';.GC-,1O56"OJCFU#
MGUOG1)=\IM$N,*B'KE>D(Z-46JMJ7<2Z<6WUINIUX^=70('S"C13H;I: ,%Z
MBKH#\#"JYA<0KR@;5E^TW@,C^X,*V@ I9(QCF85$W "6;1PIOAW(O\_PFNCS
M"N1QO5U_X$\:N\73AC[?@!8XS_]U>G\&J0Y\4=/UL=99[4NXM=!+^MX/OSX"
MH=Q'<>7=\I/"F?N2KEKNOD=TXW,#.6,!6W&DVF/:?>/G+JS:T'=U<V6A=*&?
M*\$!QG !/%\HD#B_0 ;EAY8?_@-02P,$%     @ "8-I458Y5B9!"   RQ4
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MD[]$J_5/.ZML!8-!:P>M-3N#:3O-H#?HJF.2IN4D3>NHI!G?@'Y[I1Y&_^.
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M.T0<2!Q%MLD+D"%=U1ZF'89&'BL;E7,'VYY,C !4^(FIYJX_U2\>G5F$N ^
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M-"O-2*."N:=*(S6W;J1IIVJFLUJM]L$E3F(-8,8V22O-CU\;*"0!W'2V?4G
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MSWR9"%:<2Q4W@J;YL<@#%8+&^>4&(]GKE8!\OJ)4/-\H!=7IX/ _4$L#!!0
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MR=;B]R $4DSR FR"BGU*"Q*AD*O "I&T6,0*1G.4ED7.H:0K;]=2'2 CUTV
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M=HFW[@"GN:X$3!=&M%[3KGJ+TC'M?9KNJRKQTM7B98!N_CR9W0"6>Q(PO0$
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M'[CYH4C7U1>2W:9%D<;5QQ7?+=%,-.!_7Z3<=_4/XCO.=M_B>/P_4$L#!!0
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MA.]1%HLEW7W!^PFYRE](8Y[_PFZ/-5L09ES09&\L,TA(6ORCYST11P;2C][
MWAO858/.*P;.WL!Y;X3.WJ#SW@CNWB"?NE',/2=N@@0:]!G= 5-HZ4U=Y.SG
MUI(ODJI""0233XFT$X/@[N9FN/P=YI]A.![/[VY7L]M?8#&_GHUGTP#.)E@@
M$G/X!%/$4I(^<%A@!L$&,7PN1^^""9Q].(</8 !7@QQ("G<I$?Q"#LKKU89F
M'*41[QM")JS"&N$^N5&1G/U*<@[<T%1L.$S3"$<:^TFSO=]@;TBB2K;L%[9&
M=J/# &_;X)@78)NVJ<EG_&YSR]=-Y]]%G_YP]!,RG+)TG-R?\XJ_81C2+!6R
M)F!!8Q(2N?9_#-=<,+G[_VP(T"D#=/( G5<"W$J=)&E($PQG,>7\') 0C*PS
M@=8Q!D%AB2()NH!9&K8_<I#01(J/W#3AXX;&$6;:HBNB>GE4):1/ \]RO;[Q
M=+R2=9!C^>XI:%('?;+-KM\]A4WKL([CF27HA!RW),=M9'\T#&9CN)VN8'8[
MGM],X>QZ'@3GL)@N(?@R7$YAN%HM9Z.[U7!T/875');#B81?*'S[8P#2Z&9^
M"\%J/O[UR_QZ,ET&#6OFE6EYC6OV-5=F' %ZPDR^:2#-DK44#'I?KDZA$O*E
MQ864!54^4<;4G]A@V&)&: 1GY 5XKEO!(@?WB%#7<MR>9SJ55:P#.W[/[':.
MV"]64N-1P9Q>!3C5>73]KN7T].O9+8GK-A(W0IR$D-9*7A)2,/$#Q9_3&-$X
M1O*Z=*1EM$BN=S0MLVW9%39U(+.R<29UT">SW;$J-&I=^7H*>R6%O6:]H.D3
MYJKX9-U(KD)UF?,A^Z#U7[(U 9K&WQ1W'+,G$F)0>%5Z;]1;K[;HEFUZ9D4.
MQG68[-=<KR('D\99J,[PDF]1B*]:LO53B>+6 '1RK\G*MYRNJV?1+UGT&UD<
M1A%1/1R*RQ<ZYUE>=-E6%AA^QBPD'*LM79!+MPK/0>YFV"'&4"KX6XSZ]6W4
M]3RS0M6X#G-<VW$JVWS2.*/O8%03SNYT?4?/J&4>FBSSYZABQB5(,A>B.,QB
ME-=F1.),V1YIPT$4WJ!YG]>I4OJNV[.JM:M#FO(MY=2D4HO4:J46:5F.<R0:
MIXP>M:U6(Z.3)E+^4Z7<)_:&5&I1-:W4H'1BJ7?VBEI:]H%#N[&%>(=>UJ6R
MH4>P#IVCY7S??MB7O_SPA=V&A)N\%RB59LM4 O@YQ#CBI8W\L'V4JU\\/-I)
M^03>VA=.77]Z?J=77<4ZK+8;ZA!?"E2WMA>:7)W2>.B/K>8&>7E8MD#-NFEM
M#GVEU=Q8_O2J.+2.UG?VCO][5=2;.[-:$6]")AJ(XUB>ZU<KHLE50:%Q]&&?
M8/:0GZ@H 9/?7<6'6CE:GMH,\[.*ROC(NAQ;FO&).N7)#Q(.[HLCHAO$'HA\
MJ<?X7H8RVUV9)RM.78H;0;?YL<*:"D&3_'*#D113!9#/[RD5+S<J0'GV-?@'
M4$L#!!0    (  F#:5&)(=0[-P,  $H)   9    >&PO=V]R:W-H965T<R]S
M:&5E=#(V+GAM;*56VT[C,!#]%2OB 20@MR8IJ*W4&[M=+1>UP&JUV@>WF39>
M$KO83@M_O[:3AD)#0;LOK2]S9LX<CS-NK1E_$ F 1$]92D7;2J1<GMNVF"60
M87'*ED#5SISQ#$LUY0M;+#G@V("RU/8<)[0S3*C5:9FU&]YIL5RFA,(-1R+/
M,LR?>Y"R==MRK<W"F"P2J1?L3FN)%S !>;>\X6IF5UYBD@$5A%'$8=ZVNN[Y
ML*GMC<$]@;78&B.=R92Q!ST9Q6W+T80@A9G4'K#Z6T$?TE0[4C0>2Y]6%5(#
MM\<;[Q<F=Y7+% OHL_0'B672MIH6BF&.\U2.V?HKE/D$VM^,I<+\HG5IZUAH
ME@O)LA*L&&2$%O_XJ=1A"Z#\U .\$N"]!33> ?@EP/]LA$8):'PV0E "3.IV
MD;L1;H E[K0X6R.NK94W/3#J&[32BU!=)Q/)U2Y1.-F9W%U>=L<_T?4%ZO;[
MUW=7MZ.K+^CF^ONH/QI.T.$ )":I0"=H1%<@I"H1B0A%WQA1@WLURSF(([5_
M-QF@PX,C=*"W;Q.6"TQCT;*E8JECV;.24:]@Y+W#R$>7C,I$H"&-(:[!#_;C
MS_;@;:5.)9&WD:CG[74X@>4I\IUCY#F>4\.G_VFX>U:7SO]%'_YS]%=B^%6]
M^,:?_XZ_ERH0^IS5$:-NO,)T!D@RU)W/24JP!'&,)OE4D)A@3O2L*P2;E3L:
M]+I^T*\Q2U.DKOX:\_CW'IZ-BF?#\&R\P[,'"T(IH0OU&4DUO3KE"Q>A<:$_
MJ*N.WVA$2N553>2@BASLC3Q\S(E\UN( YIJ!$4HF( #],5FORJSK[D:P0\GS
MHK!B5!3<KI%[%@2OC0:%4;!E%+AO/0UW/85.Y-4+$%8"A'L%&! A.9GFNA$(
M-.<L^SCO0;C#]B2(G+">250QB3YS%#/U/7@AI _F25'4M?$QKVB'EQOZ;CVM
M9D6KN9\6C?<79J^Y6YA!$+EO3O@CJX*<O=4<,N +TY6%$B6GLKCWU6K5^+NF
MW[U9[[GG?;=F?: >"D5??W%?O#(N,5>W4* 4YBJ4<QHI'7G1N8N)9$O3FJ9,
MJD9GAHEZ[ #7!FI_SIC<3'2 ZOG4^0M02P,$%     @ "8-I44KTJEO2 P
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M?*6*W3MI_7=::QYPWNND<^ !D#V\<W#$YM:@R6RX/^P!P[U&AF_#\]WW-@\
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M=:I7VU39@52'JWF7<'I&F$][>\)'>/B#6.IPWX0S__MP3Q>MJ1QK*L<JO>"
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M61?J=4>+HBI:MT)CY5PU4_RX 6D6X'PBA&X[IGSN/I=6_P%02P,$%     @
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M':5_'<?VD-/IKV,BM'I;Z/EQ:%0*CMQC)8QQ8K3^-8+)#^Q^ %!+ P04
M"  )@VE1GXEV5(D#   A&@  #P   'AL+W=O<FMB;V]K+GAM;,6976^;,!1
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M;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ "8-I49&@+4'N    *P(  !$
M             ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @
M"8-I49E<G",0!@  G"<  !,              ( !S $  'AL+W1H96UE+W1H
M96UE,2YX;6Q02P$"% ,4    "  )@VE1B?VWJ1@%   ^%0  &
M    @($-"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @
M"8-I49Y+5M]Z!P  [AT  !@              ("!6PT  'AL+W=O<FMS:&5E
M=',O<VAE970R+GAM;%!+ 0(4 Q0    (  F#:5'Y(.?<GP(  .H&   8
M          " @0L5  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4
M    "  )@VE1/VG2_<<'  !](   &               @('@%P  >&PO=V]R
M:W-H965T<R]S:&5E=#0N>&UL4$L! A0#%     @ "8-I4;27)3U&!   / T
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M965T.2YX;6Q02P$"% ,4    "  )@VE1WXZO&4<(  !I%0  &0
M    @($9<P  >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    (
M  F#:5%D(0*-\P<  (H5   9              " @9=[  !X;"]W;W)K<VAE
M971S+W-H965T,3$N>&UL4$L! A0#%     @ "8-I4:] )E%M#   ="D  !D
M             ("!P8,  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"
M% ,4    "  )@VE15CE6)D$(  #+%0  &0              @(%ED   >&PO
M=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    (  F#:5&!.AGBPP(
M -<%   9              " @=V8  !X;"]W;W)K<VAE971S+W-H965T,30N
M>&UL4$L! A0#%     @ "8-I45TV7.0',0  !:   !D              ("!
MUYL  'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4    "  )@VE1
M5\TA2@4,  "O)P  &0              @($5S0  >&PO=V]R:W-H965T<R]S
M:&5E=#$V+GAM;%!+ 0(4 Q0    (  F#:5$A4675RP4  %@/   9
M      " @5'9  !X;"]W;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%
M  @ "8-I4:$OERNK P  ^0@  !D              ("!4]\  'AL+W=O<FMS
M:&5E=',O<VAE970Q."YX;6Q02P$"% ,4    "  )@VE1 7Q)+<,$   I%
M&0              @($UXP  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+
M 0(4 Q0    (  F#:5'W%L6L8 4  /<:   9              " @2_H  !X
M;"]W;W)K<VAE971S+W-H965T,C N>&UL4$L! A0#%     @ "8-I49;<D\SB
M#0  T5$  !D              ("!QNT  'AL+W=O<FMS:&5E=',O<VAE970R
M,2YX;6Q02P$"% ,4    "  )@VE1VU@28QL#   2"@  &0
M@('?^P  >&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    (  F#
M:5&V5QG3S@0  )$4   9              " @3'_  !X;"]W;W)K<VAE971S
M+W-H965T,C,N>&UL4$L! A0#%     @ "8-I44 ]O$)8!   I!D  !D
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M=#(X+GAM;%!+ 0(4 Q0    (  F#:5&J) A7- 0  )D.   9
M  " @0P= 0!X;"]W;W)K<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @
M"8-I4<#ZP5#^"   O#@  !D              ("!=R$! 'AL+W=O<FMS:&5E
M=',O<VAE970S,"YX;6Q02P$"% ,4    "  )@VE1/9W7;\,"   ?"0  &0
M            @(&L*@$ >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4
M Q0    (  F#:5$LTB)]/0,  (H.   9              " @:8M 0!X;"]W
M;W)K<VAE971S+W-H965T,S(N>&UL4$L! A0#%     @ "8-I45$\M1-4!0
M<B0  !D              ("!&C$! 'AL+W=O<FMS:&5E=',O<VAE970S,RYX
M;6Q02P$"% ,4    "  )@VE1P-%N;A0&  #?'P  &0              @(&E
M-@$ >&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    (  F#:5$$
M!%L#Y00  &P4   9              " @? \ 0!X;"]W;W)K<VAE971S+W-H
M965T,S4N>&UL4$L! A0#%     @ "8-I47C]V'VF P  -PL  !D
M     ("!#$(! 'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6Q02P$"% ,4
M"  )@VE1' :HW7 "   W!@  &0              @('I10$ >&PO=V]R:W-H
M965T<R]S:&5E=#,W+GAM;%!+ 0(4 Q0    (  F#:5%,<+RHPP,  #H-   9
M              " @9!( 0!X;"]W;W)K<VAE971S+W-H965T,S@N>&UL4$L!
M A0#%     @ "8-I45JNZ@E% @  @ L   T              ( !BDP! 'AL
M+W-T>6QE<RYX;6Q02P$"% ,4    "  )@VE1EXJ[',     3 @  "P
M        @ 'Z3@$ 7W)E;',O+G)E;'-02P$"% ,4    "  )@VE1GXEV5(D#
M   A&@  #P              @ 'C3P$ >&PO=V]R:V)O;VLN>&UL4$L! A0#
M%     @ "8-I4;>]PDN! 0  *1<  !H              ( !F5,! 'AL+U]R
M96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ "8-I46/6BA2; 0
ME!<  !,              ( !4E4! %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&
2     "X +@!Y#   'E<!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>296</ContextCount>
  <ElementCount>395</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>100</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>8</UnitCount>
  <MyReports>
    <Report instance="rdnt-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="rdnt-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="rdnt-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="rdnt-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="rdnt-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="rdnt-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="rdnt-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="rdnt-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - NATURE OF BUSINESS AND BASIS OF PRESENTATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATION</Role>
      <ShortName>NATURE OF BUSINESS AND BASIS OF PRESENTATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="rdnt-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2103102 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIES</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="rdnt-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2114103 - Disclosure - RECENT ACCOUNTING AND REPORTING STANDARDS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/RECENTACCOUNTINGANDREPORTINGSTANDARDS</Role>
      <ShortName>RECENT ACCOUNTING AND REPORTING STANDARDS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="rdnt-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2115104 - Disclosure - FACILITY ACQUISITIONS AND DISPOSITIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONS</Role>
      <ShortName>FACILITY ACQUISITIONS AND DISPOSITIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="rdnt-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2117105 - Disclosure - CREDIT FACILITY AND NOTES PAYABLE</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLE</Role>
      <ShortName>CREDIT FACILITY AND NOTES PAYABLE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="rdnt-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2124106 - Disclosure - STOCK-BASED COMPENSATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/STOCKBASEDCOMPENSATION</Role>
      <ShortName>STOCK-BASED COMPENSATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="rdnt-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2129107 - Disclosure - SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUBSEQUENTEVENTS</Role>
      <ShortName>SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="rdnt-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2204201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="rdnt-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2305301 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIES</ParentRole>
      <Position>16</Position>
    </Report>
    <Report instance="rdnt-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2318302 - Disclosure - CREDIT FACILITY AND NOTES PAYABLE (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLETables</Role>
      <ShortName>CREDIT FACILITY AND NOTES PAYABLE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLE</ParentRole>
      <Position>17</Position>
    </Report>
    <Report instance="rdnt-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2325303 - Disclosure - STOCK-BASED COMPENSATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables</Role>
      <ShortName>STOCK-BASED COMPENSATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.radnet.com/role/STOCKBASEDCOMPENSATION</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="rdnt-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2402401 - Disclosure - NATURE OF BUSINESS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative</Role>
      <ShortName>NATURE OF BUSINESS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATION</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="rdnt-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2406402 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details - Revenue)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsRevenue</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Details - Revenue)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="rdnt-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2407403 - Disclosure - SUMMARY OF ACCOUNTING POLICIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative</Role>
      <ShortName>SUMMARY OF ACCOUNTING POLICIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="rdnt-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2408404 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details - Goodwill)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGoodwill</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Details - Goodwill)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="rdnt-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2409405 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details - Gain on Derivative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGainonDerivative</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Details - Gain on Derivative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="rdnt-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2410406 - Disclosure - SUMMARY OF ACCOUNTING POLICIES (Details - Fair Value Measurements)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsFairValueMeasurements</Role>
      <ShortName>SUMMARY OF ACCOUNTING POLICIES (Details - Fair Value Measurements)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="rdnt-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2411407 - Disclosure - SUMMARY OF ACCOUNTING POLICIES (Details - Earnings Per Share)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsEarningsPerShare</Role>
      <ShortName>SUMMARY OF ACCOUNTING POLICIES (Details - Earnings Per Share)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="rdnt-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2412408 - Disclosure - SUMMARY OF ACCOUNTING POLICIES (Details - Investment in Joint Ventures)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsInvestmentinJointVentures</Role>
      <ShortName>SUMMARY OF ACCOUNTING POLICIES (Details - Investment in Joint Ventures)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="rdnt-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2413409 - Disclosure - SUMMARY OF ACCOUNTING POLICIES (Details - Key Financial Data on Joint Ventures)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures</Role>
      <ShortName>SUMMARY OF ACCOUNTING POLICIES (Details - Key Financial Data on Joint Ventures)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="rdnt-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2416410 - Disclosure - FACILITY ACQUISITIONS AND DISPOSITIONS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONSDetailsNarrative</Role>
      <ShortName>FACILITY ACQUISITIONS AND DISPOSITIONS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONS</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="rdnt-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2419411 - Disclosure - CREDIT FACILITY AND NOTES PAYABLE (Details - Schedule of debt)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt</Role>
      <ShortName>CREDIT FACILITY AND NOTES PAYABLE (Details - Schedule of debt)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLETables</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="rdnt-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2420412 - Disclosure - CREDIT FACILITY AND NOTES PAYABLE (Details Narrative)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative</Role>
      <ShortName>CREDIT FACILITY AND NOTES PAYABLE (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLETables</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="rdnt-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2421413 - Disclosure - CREDIT FACILITY AND NOTES PAYABLE (Details - Term Loans)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsTermLoans</Role>
      <ShortName>CREDIT FACILITY AND NOTES PAYABLE (Details - Term Loans)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLETables</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="rdnt-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2422414 - Disclosure - CREDIT FACILITY AND NOTES PAYABLE (Details - Margin Spread Based on Leverage Ratio)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio</Role>
      <ShortName>CREDIT FACILITY AND NOTES PAYABLE (Details - Margin Spread Based on Leverage Ratio)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLETables</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="rdnt-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2423415 - Disclosure - CREDIT FACILITY AND NOTES PAYABLE (Details - Margin Spread Based on Leverage Ratio, Debt Instrument)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument</Role>
      <ShortName>CREDIT FACILITY AND NOTES PAYABLE (Details - Margin Spread Based on Leverage Ratio, Debt Instrument)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLETables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="rdnt-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2426416 - Disclosure - STOCK-BASED COMPENSATION (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative</Role>
      <ShortName>STOCK-BASED COMPENSATION (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="rdnt-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2427417 - Disclosure - STOCK-BASED COMPENSATION (Details-Outstanding options and warrants)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants</Role>
      <ShortName>STOCK-BASED COMPENSATION (Details-Outstanding options and warrants)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="rdnt-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2428418 - Disclosure - STOCK-BASED COMPENSATION (Details - RSU's)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs</Role>
      <ShortName>STOCK-BASED COMPENSATION (Details - RSU's)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="rdnt-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2430419 - Disclosure - SUBSEQUENT EVENTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUBSEQUENTEVENTSDetails</Role>
      <ShortName>SUBSEQUENT EVENTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/SUBSEQUENTEVENTS</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="rdnt-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9999.htm</HtmlFileName>
      <LongName>Uncategorized Items - rdnt-20200930.htm</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/role/uncategorizedFacts</Role>
      <ShortName>Uncategorized Items - rdnt-20200930.htm</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="rdnt-20200930.htm">rdnt-20200930.htm</File>
    <File>q32020exhibit311.htm</File>
    <File>q32020exhibit312.htm</File>
    <File>q32020exhibit321.htm</File>
    <File>q32020exhibit322.htm</File>
    <File>rdnt-20200930.xsd</File>
    <File>rdnt-20200930_cal.xml</File>
    <File>rdnt-20200930_def.xml</File>
    <File>rdnt-20200930_lab.xml</File>
    <File>rdnt-20200930_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>56
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "rdnt-20200930.htm": {
   "axisCustom": 2,
   "axisStandard": 31,
   "contextCount": 296,
   "dts": {
    "calculationLink": {
     "local": [
      "rdnt-20200930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "rdnt-20200930_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml",
      "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "rdnt-20200930.htm"
     ]
    },
    "labelLink": {
     "local": [
      "rdnt-20200930_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "rdnt-20200930_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "rdnt-20200930.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd",
      "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-parts-codification-2019-01-31.xsd"
     ]
    }
   },
   "elementCount": 560,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2019-01-31": 2,
    "http://xbrl.sec.gov/dei/2019-01-31": 5,
    "total": 7
   },
   "keyCustom": 51,
   "keyStandard": 344,
   "memberCustom": 60,
   "memberStandard": 35,
   "nsprefix": "rdnt",
   "nsuri": "http://www.radnet.com/20200930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i7d337e311ea047289cd379605dc1a780_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://www.radnet.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i7d337e311ea047289cd379605dc1a780_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i7d337e311ea047289cd379605dc1a780_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2114103 - Disclosure - RECENT ACCOUNTING AND REPORTING STANDARDS",
     "role": "http://www.radnet.com/role/RECENTACCOUNTINGANDREPORTINGSTANDARDS",
     "shortName": "RECENT ACCOUNTING AND REPORTING STANDARDS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i7d337e311ea047289cd379605dc1a780_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i7d337e311ea047289cd379605dc1a780_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2115104 - Disclosure - FACILITY ACQUISITIONS AND DISPOSITIONS",
     "role": "http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONS",
     "shortName": "FACILITY ACQUISITIONS AND DISPOSITIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i7d337e311ea047289cd379605dc1a780_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i7d337e311ea047289cd379605dc1a780_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtAndCapitalLeasesDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2117105 - Disclosure - CREDIT FACILITY AND NOTES PAYABLE",
     "role": "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLE",
     "shortName": "CREDIT FACILITY AND NOTES PAYABLE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i7d337e311ea047289cd379605dc1a780_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtAndCapitalLeasesDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i7d337e311ea047289cd379605dc1a780_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2124106 - Disclosure - STOCK-BASED COMPENSATION",
     "role": "http://www.radnet.com/role/STOCKBASEDCOMPENSATION",
     "shortName": "STOCK-BASED COMPENSATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i7d337e311ea047289cd379605dc1a780_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i7d337e311ea047289cd379605dc1a780_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2129107 - Disclosure - SUBSEQUENT EVENTS",
     "role": "http://www.radnet.com/role/SUBSEQUENTEVENTS",
     "shortName": "SUBSEQUENT EVENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i7d337e311ea047289cd379605dc1a780_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i7d337e311ea047289cd379605dc1a780_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRecognitionPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2204201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "role": "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i7d337e311ea047289cd379605dc1a780_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRecognitionPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i7d337e311ea047289cd379605dc1a780_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfPrincipalTransactionsRevenueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2305301 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "role": "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i7d337e311ea047289cd379605dc1a780_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfPrincipalTransactionsRevenueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i7d337e311ea047289cd379605dc1a780_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2318302 - Disclosure - CREDIT FACILITY AND NOTES PAYABLE (Tables)",
     "role": "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLETables",
     "shortName": "CREDIT FACILITY AND NOTES PAYABLE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i7d337e311ea047289cd379605dc1a780_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i7d337e311ea047289cd379605dc1a780_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2325303 - Disclosure - STOCK-BASED COMPENSATION (Tables)",
     "role": "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables",
     "shortName": "STOCK-BASED COMPENSATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i7d337e311ea047289cd379605dc1a780_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i949cafed8cd44d929d2f3beaa3acf0d8_I20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:NumberOfCenters",
      "reportCount": 1,
      "unitRef": "center",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2402401 - Disclosure - NATURE OF BUSINESS (Details Narrative)",
     "role": "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative",
     "shortName": "NATURE OF BUSINESS (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i949cafed8cd44d929d2f3beaa3acf0d8_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited)",
     "role": "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i949cafed8cd44d929d2f3beaa3acf0d8_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406402 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details - Revenue)",
     "role": "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsRevenue",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Details - Revenue)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfPrincipalTransactionsRevenueTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueNotFromContractWithCustomer",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407403 - Disclosure - SUMMARY OF ACCOUNTING POLICIES (Details Narrative)",
     "role": "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative",
     "shortName": "SUMMARY OF ACCOUNTING POLICIES (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:IncomeTaxPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930",
      "decimals": "3",
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408404 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details - Goodwill)",
     "role": "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGoodwill",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Details - Goodwill)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i812d1f3338f848fbb0cae71405a11682_D20200101-20200930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409405 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details - Gain on Derivative)",
     "role": "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGainonDerivative",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Details - Gain on Derivative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i2ae781a9e9de432895fcc55db7b0b610_D20200701-20200930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i949cafed8cd44d929d2f3beaa3acf0d8_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410406 - Disclosure - SUMMARY OF ACCOUNTING POLICIES (Details - Fair Value Measurements)",
     "role": "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsFairValueMeasurements",
     "shortName": "SUMMARY OF ACCOUNTING POLICIES (Details - Fair Value Measurements)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i949cafed8cd44d929d2f3beaa3acf0d8_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411407 - Disclosure - SUMMARY OF ACCOUNTING POLICIES (Details - Earnings Per Share)",
     "role": "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsEarningsPerShare",
     "shortName": "SUMMARY OF ACCOUNTING POLICIES (Details - Earnings Per Share)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930",
      "decimals": "0",
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesRestrictedStock",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:EquityMethodInvestmentsTextBlock",
       "us-gaap:InvestmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i3ca1dfb7e9fe4481a03a08ec4ed83139_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412408 - Disclosure - SUMMARY OF ACCOUNTING POLICIES (Details - Investment in Joint Ventures)",
     "role": "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsInvestmentinJointVentures",
     "shortName": "SUMMARY OF ACCOUNTING POLICIES (Details - Investment in Joint Ventures)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:EquityMethodInvestmentsTextBlock",
       "us-gaap:InvestmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i7d337e311ea047289cd379605dc1a780_D20200101-20200930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentDividendsOrDistributions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "rdnt:JointVentureInvestmentAndFinancialInformationTableTextBlock",
       "us-gaap:InvestmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i949cafed8cd44d929d2f3beaa3acf0d8_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413409 - Disclosure - SUMMARY OF ACCOUNTING POLICIES (Details - Key Financial Data on Joint Ventures)",
     "role": "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures",
     "shortName": "SUMMARY OF ACCOUNTING POLICIES (Details - Key Financial Data on Joint Ventures)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "rdnt:JointVentureInvestmentAndFinancialInformationTableTextBlock",
       "us-gaap:InvestmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i949cafed8cd44d929d2f3beaa3acf0d8_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i949cafed8cd44d929d2f3beaa3acf0d8_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416410 - Disclosure - FACILITY ACQUISITIONS AND DISPOSITIONS (Details Narrative)",
     "role": "http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONSDetailsNarrative",
     "shortName": "FACILITY ACQUISITIONS AND DISPOSITIONS (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i6e52cfe398fa4efabaa39a7aee14b01c_D20200601-20200601",
      "decimals": "-2",
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromDivestitureOfInterestInJointVenture",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i949cafed8cd44d929d2f3beaa3acf0d8_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermLoansPayable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419411 - Disclosure - CREDIT FACILITY AND NOTES PAYABLE (Details - Schedule of debt)",
     "role": "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt",
     "shortName": "CREDIT FACILITY AND NOTES PAYABLE (Details - Schedule of debt)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i949cafed8cd44d929d2f3beaa3acf0d8_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermLoansPayable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i949cafed8cd44d929d2f3beaa3acf0d8_I20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)",
     "role": "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:CommonStockSharesAuthorized",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i949cafed8cd44d929d2f3beaa3acf0d8_I20200930",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:LineOfCredit",
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i949cafed8cd44d929d2f3beaa3acf0d8_I20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCredit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420412 - Disclosure - CREDIT FACILITY AND NOTES PAYABLE (Details Narrative)",
     "role": "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
     "shortName": "CREDIT FACILITY AND NOTES PAYABLE (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i0a84159a6d674db38efa7bbccb1be3e3_I20200930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentUnamortizedDiscount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "ia9a34455b88e496f99f11135df67cea7_I20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421413 - Disclosure - CREDIT FACILITY AND NOTES PAYABLE (Details - Term Loans)",
     "role": "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsTermLoans",
     "shortName": "CREDIT FACILITY AND NOTES PAYABLE (Details - Term Loans)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "ia9a34455b88e496f99f11135df67cea7_I20200930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "rdnt:ScheduleOfLeverageRatioTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i843b248c0d484e4c80e2fdd2f502195c_D20160701-20160701",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentBasisSpreadOnVariableRate1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2422414 - Disclosure - CREDIT FACILITY AND NOTES PAYABLE (Details - Margin Spread Based on Leverage Ratio)",
     "role": "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
     "shortName": "CREDIT FACILITY AND NOTES PAYABLE (Details - Margin Spread Based on Leverage Ratio)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "rdnt:ScheduleOfLeverageRatioTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i843b248c0d484e4c80e2fdd2f502195c_D20160701-20160701",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentBasisSpreadOnVariableRate1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "ia5c31aa95d9342c4ba31e43e8ecb8e1f_I20180831",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423415 - Disclosure - CREDIT FACILITY AND NOTES PAYABLE (Details - Margin Spread Based on Leverage Ratio, Debt Instrument)",
     "role": "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument",
     "shortName": "CREDIT FACILITY AND NOTES PAYABLE (Details - Margin Spread Based on Leverage Ratio, Debt Instrument)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "ia5c31aa95d9342c4ba31e43e8ecb8e1f_I20180831",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i949cafed8cd44d929d2f3beaa3acf0d8_I20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426416 - Disclosure - STOCK-BASED COMPENSATION (Details Narrative)",
     "role": "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
     "shortName": "STOCK-BASED COMPENSATION (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i7d337e311ea047289cd379605dc1a780_D20200101-20200930",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "iaab629f0885047bfac5042b54e4cf7b0_I20191231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2427417 - Disclosure - STOCK-BASED COMPENSATION (Details-Outstanding options and warrants)",
     "role": "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants",
     "shortName": "STOCK-BASED COMPENSATION (Details-Outstanding options and warrants)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "iaab629f0885047bfac5042b54e4cf7b0_I20191231",
      "decimals": "2",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i24073316903a4b80852ce62f50a13e5f_I20191231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428418 - Disclosure - STOCK-BASED COMPENSATION (Details - RSU's)",
     "role": "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs",
     "shortName": "STOCK-BASED COMPENSATION (Details - RSU's)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i24073316903a4b80852ce62f50a13e5f_I20191231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "ic97e88dc3d0b400f82757dbc8ca7b075_I20201101",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:NumberOfAssetsAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "center",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2430419 - Disclosure - SUBSEQUENT EVENTS (Details)",
     "role": "http://www.radnet.com/role/SUBSEQUENTEVENTSDetails",
     "shortName": "SUBSEQUENT EVENTS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "ic97e88dc3d0b400f82757dbc8ca7b075_I20201101",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:NumberOfAssetsAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "center",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)",
     "role": "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OperatingCostsAndExpenses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Unaudited)",
     "role": "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i3f6ab2013b9d4a8b8ac77b36b85c854d_D20200701-20200930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i3e1e45a341fa4faa80a854e436e843dc_I20181231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (Unaudited)",
     "role": "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited",
     "shortName": "CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i3e1e45a341fa4faa80a854e436e843dc_I20181231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i7d337e311ea047289cd379605dc1a780_D20200101-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)",
     "role": "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i7d337e311ea047289cd379605dc1a780_D20200101-20200930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "rdnt:OperatingLeaseRightofUseAssetAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i7d337e311ea047289cd379605dc1a780_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - NATURE OF BUSINESS AND BASIS OF PRESENTATION",
     "role": "http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATION",
     "shortName": "NATURE OF BUSINESS AND BASIS OF PRESENTATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i7d337e311ea047289cd379605dc1a780_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i7d337e311ea047289cd379605dc1a780_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2103102 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES",
     "role": "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIES",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i7d337e311ea047289cd379605dc1a780_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9999": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i6ef5f4569a454da5b5b38254fa362064_I20200601",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "",
     "isDefault": "false",
     "longName": "Uncategorized Items - rdnt-20200930.htm",
     "role": "http://xbrl.sec.gov/role/uncategorizedFacts",
     "shortName": "Uncategorized Items - rdnt-20200930.htm",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20200930.htm",
      "contextRef": "i6ef5f4569a454da5b5b38254fa362064_I20200601",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 100,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r374"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r375"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r376"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Current"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative",
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetails",
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r376"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r376"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r377"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r376"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r376"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r376"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r376"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative",
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetails",
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r372"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r373"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "rdnt_A2019SWAPS1Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2019 SWAPS1 [Member]",
        "label": "2019 SWAPS1 [Member]",
        "terseLabel": "2019 SWAPS1"
       }
      }
     },
     "localname": "A2019SWAPS1Member",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_A2019SWAPSMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2019 SWAPS [Member]",
        "label": "2019 SWAPS [Member]",
        "terseLabel": "2019 SWAPS"
       }
      }
     },
     "localname": "A2019SWAPSMember",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_AZTechMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "AZ Tech Radiology &amp; Open MRI, LLC [Member]",
        "label": "AZ Tech [Member]",
        "terseLabel": "AZ Tech Radiology &amp; Open MRI, LLC"
       }
      }
     },
     "localname": "AZTechMember",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONSDetailsNarrative",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGoodwill"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_AdvanceMedicarePayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Advance Medicare Payments",
        "label": "Advance Medicare Payments",
        "terseLabel": "Advance medicare payments"
       }
      }
     },
     "localname": "AdvanceMedicarePayments",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_AggregateIntrinsicValue": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate Intrinsic Value",
        "label": "Aggregate Intrinsic Value",
        "terseLabel": "Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "AggregateIntrinsicValue",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "stringItemType"
    },
    "rdnt_AssetAcquisitionAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Asset Acquisition [Axis]",
        "label": "Asset Acquisition [Axis]",
        "terseLabel": "Asset Acquisition [Axis]"
       }
      }
     },
     "localname": "AssetAcquisitionAxis",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "rdnt_AssetAcquisitionDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "[Domain] for Asset Acquisition [Axis]",
        "label": "Asset Acquisition [Domain]",
        "terseLabel": "Asset Acquisition [Domain]"
       }
      }
     },
     "localname": "AssetAcquisitionDomain",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_AwardsIssuedToDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Awards issued to date",
        "label": "Awards issued to date",
        "terseLabel": "Awards issued to date (in shares)"
       }
      }
     },
     "localname": "AwardsIssuedToDate",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "rdnt_BarclaysMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Barclays [Member]",
        "label": "Barclays [Member]",
        "terseLabel": "Barclays"
       }
      }
     },
     "localname": "BarclaysMember",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_BeverlyRadiologyMedicalGroupIIIMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Beverly Radiology Medical Group III [Member]",
        "label": "Beverly Radiology Medical Group III [Member]",
        "terseLabel": "Beverly Radiology Medical Group III"
       }
      }
     },
     "localname": "BeverlyRadiologyMedicalGroupIIIMember",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_BoardMemberMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Board Member [Member]",
        "label": "Board Member [Member]",
        "terseLabel": "Board Member"
       }
      }
     },
     "localname": "BoardMemberMember",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Acquisition, Contingent Consideration Arrangements, Milestone One, Equity Interest Issued or Issuable, Number of Shares",
        "label": "Business Acquisition, Contingent Consideration Arrangements, Equity Interest Issued or Issuable, Number of Shares",
        "terseLabel": "Contingent consideration, milestone one, shares issued (in shares)"
       }
      }
     },
     "localname": "BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Acquisition, Contingent Consideration Arrangements, Milestone Three, Equity Interest Issued or Issuable, Number of Shares",
        "label": "Business Acquisition, Contingent Consideration Arrangements, Milestone Three, Equity Interest Issued or Issuable, Number of Shares",
        "terseLabel": "Contingent consideration, milestone three, shares issued (in shares)"
       }
      }
     },
     "localname": "BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Acquisition, Contingent Consideration Arrangements, Milestone Two, Equity Interest Issued or Issuable, Number of Shares",
        "label": "Business Acquisition, Contingent Consideration Arrangements, Milestone Two, Equity Interest Issued or Issuable, Number of Shares",
        "terseLabel": "Contingent consideration, milestone two, shares issued (in shares)"
       }
      }
     },
     "localname": "BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Replacement Awards",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Replacement Awards",
        "terseLabel": "Fair value of replacement awards attributable to pre-combination"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Shares Issued After Execution",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Shares Issued After Execution",
        "terseLabel": "Fair value of shares issued after execution"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Shares Issued At Execution",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Shares Issued At Execution",
        "terseLabel": "Fair value of shares issued at execution"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Acquisition, Equity Interest Issued or Issuable, Maximum Number of Shares Issued After Execution",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Maximum Number of Shares Issued After Execution",
        "terseLabel": "Shares issued after execution (in shares)"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares At Execution",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares At Execution",
        "terseLabel": "Shares issued at execution (in shares)"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares Issued After Acquisition Term",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares Issued After Acquisition Term",
        "terseLabel": "Shares issued after acquisition, term"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets, Other",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets, Other",
        "terseLabel": "Other assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFinanceLeaseLiabilities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Finance Lease Liabilities",
        "label": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Finance Lease Liabilities",
        "terseLabel": "Finance lease liabilities acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFinanceLeaseLiabilities",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Operating Lease Liabilities",
        "label": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Operating Lease Liabilities",
        "terseLabel": "Operating lease liabilities acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Right Of Use Asset",
        "label": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Right Of Use Asset",
        "terseLabel": "Right-of-use asset required"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_COVID19PandemicMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "COVID-19 Pandemic [Member]",
        "label": "COVID-19 Pandemic [Member]",
        "terseLabel": "COVID-19 Pandemic"
       }
      }
     },
     "localname": "COVID19PandemicMember",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_CapitationArrangementsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Capitation Arrangements [Member]",
        "label": "Capitation Arrangements [Member]",
        "terseLabel": "Revenue under capitation arrangements",
        "verboseLabel": "Revenue under capitation arrangements"
       }
      }
     },
     "localname": "CapitationArrangementsMember",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsRevenue"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_Caps2016Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "2016 Caps [Member]",
        "terseLabel": "2016 Caps"
       }
      }
     },
     "localname": "Caps2016Member",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_CommercialInsurance1Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commercial Insurance1 [Member]",
        "label": "Commercial Insurance1 [Member]",
        "terseLabel": "Commercial insurance"
       }
      }
     },
     "localname": "CommercialInsurance1Member",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsRevenue"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ContractsReceivableFactoringReceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contracts Receivable, Factoring Receivable",
        "label": "Contracts Receivable, Factoring Receivable",
        "terseLabel": "Contracts receivable, factoring receivable"
       }
      }
     },
     "localname": "ContractsReceivableFactoringReceivable",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_ContributionsFromNoncontrollingInterests": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "label": "Contributions from noncontrolling interests",
        "terseLabel": "Contribution from noncontrolling partner"
       }
      }
     },
     "localname": "ContributionsFromNoncontrollingInterests",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_DebtInstrumentCovenantLeverageRatioMaximum": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Leverage Ratio, Maximum",
        "label": "Debt Instrument, Covenant, Leverage Ratio, Maximum",
        "terseLabel": "Leverage ratio, less than"
       }
      }
     },
     "localname": "DebtInstrumentCovenantLeverageRatioMaximum",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument"
     ],
     "xbrltype": "pureItemType"
    },
    "rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Liquidity Ratio Required, Minimum",
        "label": "Debt Instrument, Covenant, Liquidity Ratio Required, Minimum",
        "terseLabel": "Leverage ratio, greater than"
       }
      }
     },
     "localname": "DebtInstrumentCovenantLiquidityRatioRequiredMinimum",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument"
     ],
     "xbrltype": "pureItemType"
    },
    "rdnt_DebtInstrumentNumberofLoansReceived": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Instrument, Number of Loans Received",
        "label": "Debt Instrument, Number of Loans Received",
        "terseLabel": "Number of PPP loans received"
       }
      }
     },
     "localname": "DebtInstrumentNumberofLoansReceived",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "integerItemType"
    },
    "rdnt_DebtInstrumentPeriodicPaymentPercent": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Instrument, Periodic Payment, Percent",
        "label": "Debt Instrument, Periodic Payment, Percent",
        "terseLabel": "Periodic payment, percent"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPaymentPercent",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Instrument, Periodic Payment Terms, Amortization Increase",
        "label": "Debt Instrument, Periodic Payment Terms, Amortization Increase",
        "terseLabel": "Periodic payment amortization increase"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPaymentTermsAmortizationIncrease",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_DeepHealthInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "DeepHealth, Inc. [Member]",
        "label": "DeepHealth, Inc. [Member]",
        "terseLabel": "DeepHealth, Inc."
       }
      }
     },
     "localname": "DeepHealthInc.Member",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited",
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGoodwill",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_DeepHealthIncMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Deep Health, Inc. [Member]",
        "label": "Deep Health Inc [Member]",
        "terseLabel": "DeepHealth Inc."
       }
      }
     },
     "localname": "DeepHealthIncMember",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONSDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_DignityHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Dignity Health [Member]",
        "terseLabel": "Dignity Health"
       }
      }
     },
     "localname": "DignityHealthMember",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_EquipmentAcquiredAndLeaseholdImprovements": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "label": "Equipment acquired and leasehold improvements",
        "terseLabel": "Equipment acquired and leasehold improvements"
       }
      }
     },
     "localname": "EquipmentAcquiredAndLeaseholdImprovements",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_EquityContributionsInJointVentures": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Contributions In Joint Ventures",
        "label": "Equity Contributions In Joint Ventures",
        "terseLabel": "Equity contributions in existing joint ventures"
       }
      }
     },
     "localname": "EquityContributionsInJointVentures",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsInvestmentinJointVentures"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Method Investment, Initial Ownership Percentage After Dilution",
        "label": "Equity Method Investment, Initial Ownership Percentage After Dilution",
        "terseLabel": "Initial ownership percentage after dilution"
       }
      }
     },
     "localname": "EquityMethodInvestmentInitialOwnershipPercentageAfterDilution",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "rdnt_EquityMethodInvestmentSharesPurchased": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Method Investment, Shares Purchased",
        "label": "Equity Method Investment, Shares Purchased",
        "terseLabel": "Number of shares purchased (in shares)"
       }
      }
     },
     "localname": "EquityMethodInvestmentSharesPurchased",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Method Investments, Option To Purchase Additional Equity Method Investment",
        "label": "Equity Method Investments, Option To Purchase Additional Equity Method Investment",
        "terseLabel": "Option to purchase additional equity method investment"
       }
      }
     },
     "localname": "EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Method Investments, Ownership Interest Percentage Acquired",
        "label": "Equity Method Investments, Ownership Interest Percentage Acquired",
        "terseLabel": "Ownership percentage diluted"
       }
      }
     },
     "localname": "EquityMethodInvestmentsOwnershipInterestPercentageAcquired",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "rdnt_FirstLienCreditAgreementEighthAmendmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "First Lien Credit Agreement Eighth Amendment",
        "label": "First Lien Credit Agreement Eighth Amendment [Member]",
        "terseLabel": "First Lien Credit Agreement Eighth Amendment"
       }
      }
     },
     "localname": "FirstLienCreditAgreementEighthAmendmentMember",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_FirstLienCreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "First Lien Credit Agreement [Member]",
        "terseLabel": "First Lien Credit Agreement"
       }
      }
     },
     "localname": "FirstLienCreditAgreementMember",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_FirstLienCreditAgreementSeventhAmendmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "First Lien Credit Agreement Seventh Amendment [Member]",
        "label": "First Lien Credit Agreement Seventh Amendment [Member]",
        "terseLabel": "First Lien Credit Agreement Seventh Amendment"
       }
      }
     },
     "localname": "FirstLienCreditAgreementSeventhAmendmentMember",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_FirstLienCreditAgreementSixthAmendmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "First Lien Credit Agreement Sixth Amendment [Member]",
        "label": "First Lien Credit Agreement Sixth Amendment [Member]",
        "terseLabel": "First Lien Credit Agreement, Sixth Amendment"
       }
      }
     },
     "localname": "FirstLienCreditAgreementSixthAmendmentMember",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_FirstLienTermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "First Lien Term Loan [Member]",
        "terseLabel": "First Lien Term Loan"
       }
      }
     },
     "localname": "FirstLienTermLoanMember",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsTermLoans"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_FirstLienTermLoansAMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "FirstLienTermLoansAMember",
        "terseLabel": "FirstLienTermLoansAMember"
       }
      }
     },
     "localname": "FirstLienTermLoansAMember",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_FutureServiceMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Future Services [Member]",
        "label": "Future Service [Member]",
        "terseLabel": "Future Service"
       }
      }
     },
     "localname": "FutureServiceMember",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_GlendaleAdvancedImagingMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Glendale Advanced Imaging [Member]",
        "terseLabel": "Glendale Advanced Imaging"
       }
      }
     },
     "localname": "GlendaleAdvancedImagingMember",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_HealthCareManagementServiceMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Health Care, Management Service [Member]",
        "label": "Health Care, Management Service [Member]",
        "terseLabel": "Management fee revenue"
       }
      }
     },
     "localname": "HealthCareManagementServiceMember",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsRevenue"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_HealthCarePatientServiceOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Health Care, Patient Service Other [Member]",
        "label": "Health Care, Patient Service Other [Member]",
        "terseLabel": "Other patient revenue"
       }
      }
     },
     "localname": "HealthCarePatientServiceOtherMember",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsRevenue"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_HudsonValleyRadiologyAssociatesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Hudson Valley Radiology Associates [Member]",
        "label": "Hudson Valley Radiology Associates [Member]",
        "terseLabel": "Hudson Valley Radiology Associates"
       }
      }
     },
     "localname": "HudsonValleyRadiologyAssociatesMember",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ImagingOnCallMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Imaging On Call [Member]",
        "label": "Imaging On Call [Member]",
        "terseLabel": "Imaging On Call"
       }
      }
     },
     "localname": "ImagingOnCallMember",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_IncreaseDecreaseInOtherNoncashItem": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Increase Decrease In Other Noncash Item",
        "label": "Increase Decrease In Other Noncash Item",
        "negatedTerseLabel": "Other non-cash items included in cost of operations"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncashItem",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_IncreaseDecreaseinOperatingLeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Increase Decrease in Operating Lease Liability",
        "label": "Increase Decrease in Operating Lease Liability",
        "negatedTerseLabel": "Operating lease liability"
       }
      }
     },
     "localname": "IncreaseDecreaseinOperatingLeaseLiability",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures",
        "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures [Roll Forward]",
        "terseLabel": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures [Roll Forward]"
       }
      }
     },
     "localname": "InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsInvestmentinJointVentures"
     ],
     "xbrltype": "stringItemType"
    },
    "rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Joint Venture Investment And Financial Information",
        "label": "Joint Venture Investment And Financial Information [Table Text Block]",
        "terseLabel": "Joint venture investment and financial information"
       }
      }
     },
     "localname": "JointVentureInvestmentAndFinancialInformationTableTextBlock",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "rdnt_JointVentureMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Joint Venture [Member]",
        "terseLabel": "Joint Venture"
       }
      }
     },
     "localname": "JointVentureMember",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_KeyFinancialDataForJointVenturesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Key financial data for joint ventures",
        "label": "Key financial data for joint ventures",
        "terseLabel": "Balance Sheet Data:"
       }
      }
     },
     "localname": "KeyFinancialDataForJointVenturesAbstract",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "stringItemType"
    },
    "rdnt_LeverageRatioAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Leverage Ratio [Axis]",
        "label": "Leverage Ratio [Axis]",
        "terseLabel": "Leverage Ratio [Axis]"
       }
      }
     },
     "localname": "LeverageRatioAxis",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "rdnt_LeverageRatioDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "[Domain] for Leverage Ratio [Axis]",
        "label": "Leverage Ratio [Domain]",
        "terseLabel": "Leverage Ratio [Domain]"
       }
      }
     },
     "localname": "LeverageRatioDomain",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_LeverageRatioFourMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Leverage Ratio Four [Member]",
        "label": "Leverage Ratio Four [Member]",
        "terseLabel": "\u2264 3.50x"
       }
      }
     },
     "localname": "LeverageRatioFourMember",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_LeverageRatioOneMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Leverage Ratio One [Member]",
        "label": "Leverage Ratio One [Member]",
        "terseLabel": "> 5.50x"
       }
      }
     },
     "localname": "LeverageRatioOneMember",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_LeverageRatioThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Leverage Ratio Three [Member]",
        "label": "Leverage Ratio Three [Member]",
        "terseLabel": ">3.50x but \u2264 4.00x"
       }
      }
     },
     "localname": "LeverageRatioThreeMember",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_LeverageRatioTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Leverage Ratio Two [Member]",
        "label": "Leverage Ratio Two [Member]",
        "terseLabel": "> 4.00x but \u2264 5.50x"
       }
      }
     },
     "localname": "LeverageRatioTwoMember",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_LineofCreditFacilityIncreaseBorrowingCapacity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line of Credit Facility, Increase Borrowing Capacity",
        "label": "Line of Credit Facility, Increase Borrowing Capacity",
        "terseLabel": "Line of credit facility, increase borrowing capacity"
       }
      }
     },
     "localname": "LineofCreditFacilityIncreaseBorrowingCapacity",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsCurrentMaturities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Long-term Debt, Short-term Debt and Capital Lease Obligations, Current Maturities",
        "label": "Long-term Debt, Short-term Debt and Capital Lease Obligations, Current Maturities",
        "negatedLabel": "Less: current portion"
       }
      }
     },
     "localname": "LongtermDebtShorttermDebtandCapitalLeaseObligationsCurrentMaturities",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsExcludingCurrentMaturities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Long-term Debt, Short-term Debt and Capital Lease Obligations, Excluding Current Maturities",
        "label": "Long-term Debt, Short-term Debt and Capital Lease Obligations, Excluding Current Maturities",
        "terseLabel": "Long term portion debt obligations"
       }
      }
     },
     "localname": "LongtermDebtShorttermDebtandCapitalLeaseObligationsExcludingCurrentMaturities",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Long-term Debt, Short-term Debt and Capital Lease Obligations, Including Current Maturities",
        "label": "Long-term Debt, Short-term Debt and Capital Lease Obligations, Including Current Maturities",
        "totalLabel": "Total debt obligations"
       }
      }
     },
     "localname": "LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_MRIatWoodbridgeLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "MRI at Woodbridge, LLC [Member]",
        "label": "MRI at Woodbridge, LLC [Member]",
        "terseLabel": "MRI at Woodbridge, LLC"
       }
      }
     },
     "localname": "MRIatWoodbridgeLLCMember",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONSDetailsNarrative",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGoodwill"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ManagementServiceFees": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Management service fees.",
        "label": "Management service fees",
        "terseLabel": "Management service fees"
       }
      }
     },
     "localname": "ManagementServiceFees",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_MedicVisionMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Medic Vision [Member]",
        "terseLabel": "Medic Vision"
       }
      }
     },
     "localname": "MedicVisionMember",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_Medicaid1Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Medicaid1 [Member]",
        "label": "Medicaid1 [Member]",
        "terseLabel": "Medicaid"
       }
      }
     },
     "localname": "Medicaid1Member",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsRevenue"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_Medicare1Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Medicare1 [Member]",
        "label": "Medicare1 [Member]",
        "terseLabel": "Medicare"
       }
      }
     },
     "localname": "Medicare1Member",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsRevenue"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_MonthlyAmortizationOfDeferredHedgeGains": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Monthly Amortization Of Deferred Hedge Gains",
        "label": "Monthly Amortization Of Deferred Hedge Gains",
        "terseLabel": "Monthly amortization of deferred hedge gains"
       }
      }
     },
     "localname": "MonthlyAmortizationOfDeferredHedgeGains",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_NulogixMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Nulogix",
        "label": "Nulogix [Member]",
        "terseLabel": "Nulogix"
       }
      }
     },
     "localname": "NulogixMember",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_NumberOfAssetsAcquired": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number Of Assets Acquired",
        "label": "Number Of Assets Acquired",
        "terseLabel": "Number of assets acquired"
       }
      }
     },
     "localname": "NumberOfAssetsAcquired",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "rdnt_NumberOfCenters": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number Of Centers",
        "label": "Number Of Centers",
        "terseLabel": "Number of centers"
       }
      }
     },
     "localname": "NumberOfCenters",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "integerItemType"
    },
    "rdnt_NumberofUnconsolidatedJointVentures": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of Unconsolidated Joint Ventures",
        "label": "Number of Unconsolidated Joint Ventures",
        "terseLabel": "Number of unconsolidated joint ventures"
       }
      }
     },
     "localname": "NumberofUnconsolidatedJointVentures",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "integerItemType"
    },
    "rdnt_October2020CapMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "October 2020 [Member]",
        "terseLabel": "October 2020"
       }
      }
     },
     "localname": "October2020CapMember",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_October2023Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "October 2023 [Member]",
        "label": "October 2023 [Member]",
        "terseLabel": "October 2023"
       }
      }
     },
     "localname": "October2023Member",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_October2025Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "October 2025 [Member]",
        "label": "October 2025 [Member]",
        "terseLabel": "October 2025"
       }
      }
     },
     "localname": "October2025Member",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_OlneyOpenMRILLCMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Olney Open MRI, LLC [Member]",
        "label": "Olney Open MRI, LLC [Member]",
        "terseLabel": "Olney Open MRI, LLC"
       }
      }
     },
     "localname": "OlneyOpenMRILLCMember",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONSDetailsNarrative",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGoodwill"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_OperatingLeaseRightofUseAssetAmortization": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Operating Lease Right of Use Asset Amortization",
        "label": "Operating Lease Right of Use Asset Amortization",
        "terseLabel": "Amortization of operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightofUseAssetAmortization",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_PaycheckProtectionProgramLoansMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Paycheck Protection Program Loans [Member]",
        "label": "Paycheck Protection Program Loans [Member]",
        "terseLabel": "Paycheck Protection Program loans at 1% due April 2022",
        "verboseLabel": "Paycheck Protection Program Loans"
       }
      }
     },
     "localname": "PaycheckProtectionProgramLoansMember",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt",
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_PaymentstoAcquireInterestinJointVentureAndContributionsToExistingJointVenture": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Payments to Acquire Interest in Joint Venture And Contributions To Existing Joint Venture",
        "label": "Payments to Acquire Interest in Joint Venture And Contributions To Existing Joint Venture",
        "negatedLabel": "Equity contributions in existing and purchase of interest in joint ventures"
       }
      }
     },
     "localname": "PaymentstoAcquireInterestinJointVentureAndContributionsToExistingJointVenture",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_PricingLevelIIIMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Pricing Level III [Member]",
        "label": "Pricing Level III [Member]",
        "terseLabel": "Pricing Level III"
       }
      }
     },
     "localname": "PricingLevelIIIMember",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_PricingLevelIIMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Pricing Level II [Member]",
        "label": "Pricing Level II [Member]",
        "terseLabel": "Pricing Level II"
       }
      }
     },
     "localname": "PricingLevelIIMember",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_PricingLevelIMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Pricing Level I [Member]",
        "label": "Pricing Level I [Member]",
        "terseLabel": "Pricing Level I"
       }
      }
     },
     "localname": "PricingLevelIMember",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_PricingLevelIVMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Pricing Level IV [Member]",
        "label": "Pricing Level IV [Member]",
        "terseLabel": "Pricing Level IV"
       }
      }
     },
     "localname": "PricingLevelIVMember",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_PricingLevelVMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Pricing Level V [Member]",
        "label": "Pricing Level V [Member]",
        "terseLabel": "Pricing Level V"
       }
      }
     },
     "localname": "PricingLevelVMember",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ProceedsFromGovernmentAssistance": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Proceeds From Government Assistance",
        "label": "Proceeds From Government Assistance",
        "terseLabel": "Proceeds from Payment Protection Program"
       }
      }
     },
     "localname": "ProceedsFromGovernmentAssistance",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_ProceedsReceivedFromInsurance": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Proceeds Received From Insurance",
        "label": "Proceeds Received From Insurance",
        "terseLabel": "Advance insurance carrier payments"
       }
      }
     },
     "localname": "ProceedsReceivedFromInsurance",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_PropertyAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Propery and equipment, net [Member]",
        "terseLabel": "Amounts returned to property and equipment"
       }
      }
     },
     "localname": "PropertyAndEquipmentMember",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Property Plant and Equipment Net Including Right of Use Assets",
        "label": "Property Plant and Equipment Net Including Right of Use Assets",
        "totalLabel": "Total property, equipment and right-of-use assets"
       }
      }
     },
     "localname": "PropertyPlantandEquipmentNetIncludingRightofUseAssets",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_RestatedAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Restated Agreement [Member]",
        "label": "Restated Agreement [Member]",
        "terseLabel": "SunTrust Term Loan Agreement collateralized by NJIN's tangible and intangible assets",
        "verboseLabel": "Restated Agreement"
       }
      }
     },
     "localname": "RestatedAgreementMember",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsTermLoans"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_RestatedPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Restated Plan [Member]",
        "terseLabel": "Restated Plan"
       }
      }
     },
     "localname": "RestatedPlanMember",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_SantaMonicaImagingGroupLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Santa Monica Imaging Group, LLC",
        "label": "Santa Monica Imaging Group, LLC [Member]",
        "terseLabel": "Santa Monica Imaging Group, LLC"
       }
      }
     },
     "localname": "SantaMonicaImagingGroupLLCMember",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ScheduleOfLeverageRatioTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule Of Leverage Ratio [Table Text Block]",
        "label": "Schedule Of Leverage Ratio [Table Text Block]",
        "terseLabel": "Schedule of leverage ratio"
       }
      }
     },
     "localname": "ScheduleOfLeverageRatioTableTextBlock",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "rdnt_ScriptSenderLlcMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "ScriptSender LLC [Member]",
        "terseLabel": "ScriptSender LLC"
       }
      }
     },
     "localname": "ScriptSenderLlcMember",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_September2020CapMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "September 2020 [Member]",
        "terseLabel": "September 2020"
       }
      }
     },
     "localname": "September2020CapMember",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-based Payment Award, Options, Grants In Period, Gross, Value",
        "label": "Share-Based Compensation Arrangement By Share-based Payment Award, Options, Grants In Period, Gross, Value",
        "terseLabel": "Issuance of common stock upon exercise of options"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_SimiValleyHospitalAndHealthServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Simi Valley Hospital and Health Services",
        "label": "Simi Valley Hospital and Health Services [Member]",
        "terseLabel": "Simi Valley Hospital and Health Services"
       }
      }
     },
     "localname": "SimiValleyHospitalAndHealthServicesMember",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_SocialSecurityTaxEmployerDeferralCARESAct": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Social Security Tax, Employer, Deferral, CARES Act",
        "label": "Social Security Tax, Employer, Deferral, CARES Act",
        "terseLabel": "Deferred social security taxes"
       }
      }
     },
     "localname": "SocialSecurityTaxEmployerDeferralCARESAct",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_StockIssuedDuringPeriodSharesIssuedForReturnOfCapital": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Stock Issued During Period, Shares, Issued for Return of Capital",
        "label": "Stock Issued During Period, Shares, Issued for Return of Capital",
        "terseLabel": "Issuance of common stock for purchase of Nulogix (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesIssuedForReturnOfCapital",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "rdnt_StockIssuedDuringPeriodValueIssuedForReturnOfCapital": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Stock Issued During Period, Value, Issued for Return of Capital",
        "label": "Stock Issued During Period, Value, Issued for Return of Capital",
        "negatedTerseLabel": "Issuance of common stock for purchase of Nulogix"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueIssuedForReturnOfCapital",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_StockholdersEquityDeficitMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Total Radnet, Inc.'s Equity [Member]",
        "terseLabel": "Total Radnet, Inc.'s Equity"
       }
      }
     },
     "localname": "StockholdersEquityDeficitMember",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_SunTrustMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "SunTrust [Member]",
        "label": "SunTrust [Member]",
        "terseLabel": "SunTrust"
       }
      }
     },
     "localname": "SunTrustMember",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_TeleradiologyandSoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Teleradiology and Software [Member]",
        "label": "Teleradiology and Software [Member]",
        "terseLabel": "Teleradiology and Software revenue"
       }
      }
     },
     "localname": "TeleradiologyandSoftwareMember",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsRevenue"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_TermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Term Loan [Member]",
        "terseLabel": "Term Loan"
       }
      }
     },
     "localname": "TermLoanMember",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsTermLoans"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_TotalBookValueOfOtherJointVenturePartnerInterests": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total book value of other joint venture partner interests",
        "label": "Total book value of other joint venture partner interests",
        "terseLabel": "Total book value of other joint venture partner interests"
       }
      }
     },
     "localname": "TotalBookValueOfOtherJointVenturePartnerInterests",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_TurnerImagingMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Turner Imaging [Member]",
        "terseLabel": "Turner Imaging"
       }
      }
     },
     "localname": "TurnerImagingMember",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_VenturaCountyImagingGroupLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Ventura County Imaging Group, LLC [Member]",
        "label": "Ventura County Imaging Group, LLC [Member]",
        "terseLabel": "Ventura County Imaging Group, LLC"
       }
      }
     },
     "localname": "VenturaCountyImagingGroupLLCMember",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_WeightedAverageRemainingContractualLife": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted Average Remaining Contractual Life abstract",
        "label": "Weighted Average Remaining Contractual Life",
        "terseLabel": "Weighted Average Remaining Contractual Life"
       }
      }
     },
     "localname": "WeightedAverageRemainingContractualLife",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "stringItemType"
    },
    "rdnt_WhiteRabbit.aiInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "WhiteRabbit.ai Inc. [Member]",
        "label": "WhiteRabbit.ai Inc. [Member]",
        "terseLabel": "WhiteRabbit.ai Inc."
       }
      }
     },
     "localname": "WhiteRabbit.aiInc.Member",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_WorkersCompensationPersonalInjury1Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Workers' Compensation/Personal Injury1 [Member]",
        "label": "Workers' Compensation/Personal Injury1 [Member]",
        "terseLabel": "Workers' compensation/personal injury"
       }
      }
     },
     "localname": "WorkersCompensationPersonalInjury1Member",
     "nsuri": "http://www.radnet.com/20200930",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsRevenue"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ChiefExecutiveOfficerMember": {
     "auth_ref": [
      "r145"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Chief Executive Officer [Member]",
        "terseLabel": "Chief Executive Officer"
       }
      }
     },
     "localname": "ChiefExecutiveOfficerMember",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidatedEntitiesAxis": {
     "auth_ref": [
      "r371"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Consolidated Entities [Axis]",
        "terseLabel": "Consolidated Entities [Axis]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesAxis",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Consolidated Entities [Domain]",
        "terseLabel": "Consolidated Entities [Domain]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesDomain",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r53",
      "r113"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Investment, Name [Domain]",
        "terseLabel": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r144",
      "r193",
      "r195",
      "r363",
      "r364"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsRevenue"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsRevenue"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r155"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Investment, Name [Axis]",
        "terseLabel": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Accounts Payable and Accrued Liabilities, Current",
        "terseLabel": "Accounts payable, accrued expenses and other"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r6",
      "r22",
      "r146",
      "r147",
      "r194"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r41"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of accrued expenses.",
        "label": "Accrued Liabilities, Fair Value Disclosure",
        "terseLabel": "Interest Rate Contracts"
       }
      }
     },
     "localname": "AccruedLiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": {
     "auth_ref": [
      "r59",
      "r68",
      "r269"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Loss, net of taxes"
       }
      }
     },
     "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGainonDerivative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r57",
      "r58",
      "r59"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r56",
      "r59",
      "r61",
      "r270"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r23"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in-capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r201",
      "r203",
      "r231",
      "r232"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net (loss) income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AmortizationOfDeferredCharges": {
     "auth_ref": [
      "r74"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of amortization of deferred charges applied against earnings during the period.",
        "label": "Amortization of Deferred Charges",
        "terseLabel": "Amortization of deferred issuance costs"
       }
      }
     },
     "localname": "AmortizationOfDeferredCharges",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfDeferredHedgeGains": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of expense charged against earnings by an Entity to record deferred gains and losses on hedge instruments. Examples include gain on economic hedges, amortization of gain on designated fair value hedge and so forth.",
        "label": "Amortization of Deferred Hedge Gains",
        "verboseLabel": "Amortization of cash flow hedge"
       }
      }
     },
     "localname": "AmortizationOfDeferredHedgeGains",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r73",
      "r100",
      "r311"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs",
        "terseLabel": "Amortization of deferred financing costs and loan discount"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r130"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Weighted average shares for which the exercise price exceeds average market price of common stock (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r130"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r130"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r140",
      "r343",
      "r353"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "BRMG and NY Groups accounts receivable",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited",
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r8",
      "r9",
      "r49"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "CURRENT ASSETS"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r205",
      "r229"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BaseRateMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Minimum rate investor will accept.",
        "label": "Base Rate [Member]",
        "terseLabel": "Base Rate"
       }
      }
     },
     "localname": "BaseRateMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited",
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
      "http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONSDetailsNarrative",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGoodwill",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r248",
      "r249"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited",
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
      "http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONSDetailsNarrative",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGoodwill",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.",
        "label": "Business Acquisition, Transaction Costs",
        "terseLabel": "Business acquisition, closing costs"
       }
      }
     },
     "localname": "BusinessAcquisitionCostOfAcquiredEntityTransactionCosts",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned": {
     "auth_ref": [
      "r255"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity.",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Value Assigned",
        "terseLabel": "Equity interest issued, value assigned"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": {
     "auth_ref": [
      "r255"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares of equity interests issued or issuable to acquire entity.",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares",
        "terseLabel": "Shares issued (in shares)"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
      "http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONSDetailsNarrative",
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "auth_ref": [
      "r246"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "terseLabel": "Business acquisition, percentage of voting interests acquired"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r252",
      "r253",
      "r254"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Purchase consideration"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r99",
      "r256"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "terseLabel": "Change in fair value of contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets": {
     "auth_ref": [
      "r251"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets",
        "terseLabel": "Current assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "auth_ref": [
      "r236",
      "r251"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "terseLabel": "Deferred tax liabilities acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r250",
      "r251"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Intangible assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r250",
      "r251"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Fixed assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
      "http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis": {
     "auth_ref": [
      "r247"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosures related to transactions that are recognized separately from the acquisition of assets and assumptions of liabilities in the business combination by type of transaction.",
        "label": "Business Combination, Separately Recognized Transactions [Axis]",
        "terseLabel": "Business Combination, Separately Recognized Transactions [Axis]"
       }
      }
     },
     "localname": "BusinessCombinationSeparatelyRecognizedTransactionsAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain": {
     "auth_ref": [
      "r247"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of transaction that is recognized separately from the acquisition of assets and assumptions of liabilities in a business combination by transaction.",
        "label": "Business Combination, Separately Recognized Transactions [Domain]",
        "terseLabel": "Business Combination, Separately Recognized Transactions [Domain]"
       }
      }
     },
     "localname": "BusinessCombinationSeparatelyRecognizedTransactionsDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationsPolicy": {
     "auth_ref": [
      "r106",
      "r245"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.",
        "label": "Business Combinations Policy [Policy Text Block]",
        "terseLabel": "BUSINESS COMBINATION"
       }
      }
     },
     "localname": "BusinessCombinationsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": {
     "auth_ref": [
      "r4",
      "r120",
      "r134"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for the business description and basis of presentation concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity.  Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Business Description and Basis of Presentation [Text Block]",
        "terseLabel": "NATURE OF BUSINESS AND BASIS OF PRESENTATION"
       }
      }
     },
     "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSANDBASISOFPRESENTATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r5",
      "r31",
      "r102"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r96",
      "r102",
      "r104"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "CASH AND CASH EQUIVALENTS, end of period",
        "periodStartLabel": "CASH AND CASH EQUIVALENTS, beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r96",
      "r307"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "NET INCREASE IN CASH AND CASH EQUIVALENTS"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassificationOfVariableInterestEntityDomain": {
     "auth_ref": [
      "r271",
      "r272",
      "r274",
      "r276"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Categorization of Variable Interest Entities (VIE) for consolidation and (or) disclosure purposes, whether individually or in aggregate, by: (1) VIEs consolidated because the entity is the primary beneficiary, (2) VIEs not consolidated because the entity is not the primary beneficiary, and (3) VIEs or potential VIEs that are not consolidated because necessary information is not available. In general, a VIE is a corporation, partnership, trust, or any other legal structure used for business purposes that either (a) does not have equity investors with voting rights or (b) has equity investors that do not provide sufficient financial resources for the entity to support its activities. A VIE often holds financial assets, including loans or receivables, real estate or other property. A VIE may be essentially passive or it may engage in research and development or other activities on behalf of another company.",
        "label": "Variable Interest Entity, Classification [Domain]",
        "terseLabel": "Variable Interest Entity, Classification [Domain]"
       }
      }
     },
     "localname": "ClassificationOfVariableInterestEntityDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r177"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Promissory Note"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": {
     "auth_ref": [
      "r106",
      "r176",
      "r368",
      "r369"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.",
        "label": "Commitments and Contingencies, Policy [Policy Text Block]",
        "terseLabel": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock - par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical",
      "http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock - shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock - shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r20",
      "r184"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock - shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r20"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock - $0.0001 par value, 200,000,000 shares authorized; 51,596,098 and 50,314,328 shares issued and outstanding at September 30, 2020 and December 31, 2019, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationRelatedCostsPolicyTextBlock": {
     "auth_ref": [
      "r105",
      "r210"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.",
        "label": "Compensation Related Costs, Policy [Policy Text Block]",
        "terseLabel": "EQUITY BASED COMPENSATION"
       }
      }
     },
     "localname": "CompensationRelatedCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r63",
      "r65",
      "r66"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "COMPREHENSIVE INCOME (LOSS) ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r63",
      "r65",
      "r261",
      "r262",
      "r279"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "terseLabel": "Less comprehensive income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r63",
      "r65",
      "r260",
      "r279"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "COMPREHENSIVE INCOME (LOSS)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r79"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "COMPREHENSIVE INCOME (LOSS)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion": {
     "auth_ref": [
      "r18",
      "r19",
      "r185",
      "r186"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares issued for each share of convertible preferred stock that is converted.",
        "label": "Convertible Preferred Stock, Shares Issued upon Conversion",
        "terseLabel": "Preferred stock issued upon conversion (in shares)"
       }
      }
     },
     "localname": "ConvertiblePreferredStockSharesIssuedUponConversion",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CreditDerivativesByContractTypeAxis": {
     "auth_ref": [
      "r296"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by major type of contract of credit derivatives.",
        "label": "Credit Derivatives Contract Type [Axis]",
        "terseLabel": "Credit Derivatives Contract Type [Axis]"
       }
      }
     },
     "localname": "CreditDerivativesByContractTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditDerivativesContractTypeDomain": {
     "auth_ref": [
      "r296"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Represents major types of credit derivative contracts.",
        "label": "Credit Derivatives Contract Type [Domain]",
        "terseLabel": "Credit Derivatives Contract Type [Domain]"
       }
      }
     },
     "localname": "CreditDerivativesContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock": {
     "auth_ref": [
      "r183",
      "r314"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for debt and capital lease obligations can be reported. Information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants. Also includes descriptions and amounts of capital leasing arrangements that consist of direct financing, sales type and leveraged leases. Disclosure may include the effect on the balance sheet and the income statement resulting from a change in lease classification for leases that at inception would have been classified differently had guidance been in effect at the inception of the original lease.",
        "label": "Debt and Capital Leases Disclosures [Text Block]",
        "terseLabel": "CREDIT FACILITY AND NOTES PAYABLE"
       }
      }
     },
     "localname": "DebtAndCapitalLeasesDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r15",
      "r16",
      "r17",
      "r344",
      "r345",
      "r352"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsTermLoans",
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Basis spread on variable rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r17",
      "r179",
      "r345",
      "r352"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "terseLabel": "Total Carrying Value"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsTermLoans"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r310",
      "r313"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Face Value",
        "verboseLabel": "Debt instrument face value"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsTermLoans",
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r303"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "First Lien Term Loans and SunTrust Term Loan"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "auth_ref": [
      "r43",
      "r181",
      "r310"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "terseLabel": "Effective interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r43"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest rate, stated percentage",
        "verboseLabel": "Interest rate, stated percentage"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsTermLoans"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsTermLoans",
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentPeriodicPaymentPrincipal": {
     "auth_ref": [
      "r44"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of the required periodic payments applied to principal.",
        "label": "Debt Instrument, Periodic Payment, Principal",
        "terseLabel": "Periodic payment, principal"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPaymentPrincipal",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r44",
      "r114",
      "r185",
      "r187",
      "r188",
      "r189",
      "r309",
      "r310",
      "r313",
      "r351"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsTermLoans"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "PPP loans, maturity term"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r309",
      "r313"
     ],
     "calculation": {
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt": {
       "order": 1.0,
       "parentTag": "rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Debt Instrument, Unamortized Discount",
        "negatedLabel": "Discounts on First Lien Term Loans",
        "terseLabel": "Discounts on term loans"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountCurrent": {
     "auth_ref": [
      "r309",
      "r313"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of debt discount to be amortized within one year or within the normal operating cycle, if longer.",
        "label": "Debt Instrument, Unamortized Discount, Current",
        "terseLabel": "Debt discount"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet": {
     "auth_ref": [
      "r309",
      "r310",
      "r311",
      "r312",
      "r313"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount (premium).",
        "label": "Debt Instrument, Unamortized Discount (Premium), Net",
        "negatedLabel": "Discount"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountPremiumNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsTermLoans"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredChargesPolicyTextBlock": {
     "auth_ref": [
      "r35",
      "r106"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for deferral and amortization of significant deferred charges.",
        "label": "Deferred Charges, Policy [Policy Text Block]",
        "terseLabel": "DEFERRED FINANCING COSTS"
       }
      }
     },
     "localname": "DeferredChargesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of common shares reserved for future issuance related to deferred compensation arrangements with individuals.",
        "label": "Deferred Compensation Arrangement with Individual, Common Stock Reserved for Future Issuance",
        "terseLabel": "Shares available for future issuance, options, warrants, shares of restricted stock and other bonus awards (in shares)"
       }
      }
     },
     "localname": "DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_DeferredFinanceCostsGross": {
     "auth_ref": [
      "r311"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Gross",
        "terseLabel": "Debt issuance costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsGross",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "auth_ref": [
      "r35",
      "r311"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Net",
        "terseLabel": "Deferred financing costs, net of accumulated amortization"
       }
      }
     },
     "localname": "DeferredFinanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsNoncurrentNet": {
     "auth_ref": [
      "r35",
      "r311"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs classified as noncurrent. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Noncurrent, Net",
        "terseLabel": "Deferred financing costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsNoncurrentNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r241"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred tax assets, net of current portion"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenue": {
     "auth_ref": [
      "r28"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Deferred Revenue",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "DeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepositsAssets": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment in the future.",
        "label": "Deposits Assets",
        "terseLabel": "Deposits and other"
       }
      }
     },
     "localname": "DepositsAssets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r100",
      "r137"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization",
        "verboseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetNotionalAmount": {
     "auth_ref": [
      "r281",
      "r282",
      "r284"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payments on the derivative asset.",
        "label": "Derivative Asset, Notional Amount",
        "terseLabel": "Notional amounts"
       }
      }
     },
     "localname": "DerivativeAssetNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetNumberOfInstrumentsHeld": {
     "auth_ref": [
      "r282",
      "r284"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of derivative instruments of a particular derivative asset or group of derivative assets held by the entity.",
        "label": "Derivative Asset, Number of Instruments Held",
        "terseLabel": "Number of forward interest rate cap agreements"
       }
      }
     },
     "localname": "DerivativeAssetNumberOfInstrumentsHeld",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DerivativeBasisSpreadOnVariableRate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The percentage points added to the reference rate to compute the variable rate on the interest rate derivative.",
        "label": "Derivative, Basis Spread on Variable Rate",
        "terseLabel": "Basis spread on variable rate"
       }
      }
     },
     "localname": "DerivativeBasisSpreadOnVariableRate",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGainonDerivative",
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsFairValueMeasurements",
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "auth_ref": [
      "r288"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.",
        "label": "Derivative, Gain (Loss) on Derivative, Net",
        "terseLabel": "Amount of loss recognized in income on derivative (current period ineffective portion)"
       }
      }
     },
     "localname": "DerivativeGainLossOnDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGainonDerivative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r287",
      "r289",
      "r292",
      "r295"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGainonDerivative",
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsFairValueMeasurements",
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r106",
      "r119",
      "r280",
      "r283",
      "r285",
      "r286",
      "r297"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "DERIVATIVE INSTRUMENTS"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r233"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "STOCK-BASED COMPENSATION"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DueFromRelatedPartiesCurrent": {
     "auth_ref": [
      "r7",
      "r10",
      "r21",
      "r111",
      "r319"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate amount of receivables to be collected from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth, at the financial statement date. which are usually due within one year (or one business cycle).",
        "label": "Due from Related Parties, Current",
        "terseLabel": "Due from affiliates"
       }
      }
     },
     "localname": "DueFromRelatedPartiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DueToAffiliateCurrent": {
     "auth_ref": [
      "r13",
      "r112",
      "r319",
      "r365"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of payable due to an entity that is affiliated with the reporting entity by means of direct or indirect ownership. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Due to Affiliate, Current",
        "terseLabel": "Due to affiliates"
       }
      }
     },
     "localname": "DueToAffiliateCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r72",
      "r121",
      "r126",
      "r127",
      "r128",
      "r129",
      "r133",
      "r350",
      "r362"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic net income (loss) per share attributable to RadNet, Inc.'s common stockholders (in dollars per share)",
        "verboseLabel": "BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited",
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Earnings Per Share, Basic [Abstract]",
        "terseLabel": "BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS"
       }
      }
     },
     "localname": "EarningsPerShareBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r72",
      "r121",
      "r126",
      "r127",
      "r128",
      "r129",
      "r133",
      "r350",
      "r362"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS (in dollars per share)",
        "verboseLabel": "Diluted net income per share attributable to RadNet, Inc.'s common stockholders (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited",
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Earnings Per Share, Diluted, Other Disclosures [Abstract]",
        "terseLabel": "Nonvested restricted stock subject to service vesting"
       }
      }
     },
     "localname": "EarningsPerShareDilutedOtherDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r106",
      "r130",
      "r131",
      "r132"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "EARNINGS PER SHARE"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r307"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "EFFECT OF EXCHANGE RATE CHANGES ON CASH"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r117",
      "r237",
      "r238"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r228"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Unrecognized expense weighted average period"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "auth_ref": [
      "r228"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized stock-based compensation expense"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue from External Customer [Line Items]",
        "terseLabel": "Revenue from External Customer [Line Items]"
       }
      }
     },
     "localname": "EntityWideInformationRevenueFromExternalCustomerLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsRevenue"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r184"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGainonDerivative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure": {
     "auth_ref": [
      "r298"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of equity issued in a business combination.",
        "label": "Equity Issued in Business Combination, Fair Value Disclosure",
        "terseLabel": "Contingent consideration, fair value"
       }
      }
     },
     "localname": "EquityIssuedInBusinessCombinationFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentAggregateCost": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This element represents the aggregate cost of investments accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Aggregate Cost",
        "terseLabel": "Aggregate cost",
        "totalLabel": "Total net assets"
       }
      }
     },
     "localname": "EquityMethodInvestmentAggregateCost",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures",
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentDividendsOrDistributions": {
     "auth_ref": [
      "r70",
      "r95",
      "r100",
      "r360"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of distribution received from equity method investee for return on investment, classified as operating activities. Excludes distribution for return of investment, classified as investing activities.",
        "label": "Proceeds from Equity Method Investment, Distribution",
        "negatedTerseLabel": "Distributions from joint ventures"
       }
      }
     },
     "localname": "EquityMethodInvestmentDividendsOrDistributions",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsInvestmentinJointVentures"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r155"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Ownership Percentage",
        "terseLabel": "Ownership percentage"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAssets": {
     "auth_ref": [
      "r2",
      "r109",
      "r154",
      "r158",
      "r306"
     ],
     "calculation": {
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures": {
       "order": 2.0,
       "parentTag": "us-gaap_EquityMethodInvestmentAggregateCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of assets reported by an equity method investment of the entity.",
        "label": "Equity Method Investment, Summarized Financial Information, Assets",
        "terseLabel": "Noncurrent assets"
       }
      }
     },
     "localname": "EquityMethodInvestmentSummarizedFinancialInformationAssets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets": {
     "auth_ref": [
      "r2",
      "r109",
      "r154",
      "r158",
      "r306"
     ],
     "calculation": {
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures": {
       "order": 1.0,
       "parentTag": "us-gaap_EquityMethodInvestmentAggregateCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of current assets reported by an equity method investment of the entity.",
        "label": "Equity Method Investment, Summarized Financial Information, Current Assets",
        "terseLabel": "Current assets"
       }
      }
     },
     "localname": "EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities": {
     "auth_ref": [
      "r2",
      "r109",
      "r154",
      "r158",
      "r306"
     ],
     "calculation": {
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures": {
       "order": 3.0,
       "parentTag": "us-gaap_EquityMethodInvestmentAggregateCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of current liabilities reported by an equity method investment of the entity.",
        "label": "Equity Method Investment, Summarized Financial Information, Current Liabilities",
        "negatedLabel": "Current liabilities"
       }
      }
     },
     "localname": "EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentSummarizedFinancialInformationLiabilities": {
     "auth_ref": [
      "r2",
      "r109",
      "r154",
      "r158",
      "r306"
     ],
     "calculation": {
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures": {
       "order": 4.0,
       "parentTag": "us-gaap_EquityMethodInvestmentAggregateCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of liabilities reported by an equity method investment of the entity.",
        "label": "Equity Method Investment, Summarized Financial Information, Liabilities",
        "negatedLabel": "Noncurrent liabilities"
       }
      }
     },
     "localname": "EquityMethodInvestmentSummarizedFinancialInformationLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss": {
     "auth_ref": [
      "r2",
      "r109",
      "r154",
      "r158",
      "r306"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of net income (loss) reported by an equity method investment of the entity.",
        "label": "Equity Method Investment, Summarized Financial Information, Net Income (Loss)",
        "verboseLabel": "Net income"
       }
      }
     },
     "localname": "EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentSummarizedFinancialInformationRevenue": {
     "auth_ref": [
      "r2",
      "r158"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of revenue from sale of product and rendering of service reported by equity method investee.",
        "label": "Equity Method Investment, Summarized Financial Information, Revenue",
        "terseLabel": "Net revenue"
       }
      }
     },
     "localname": "EquityMethodInvestmentSummarizedFinancialInformationRevenue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets": {
     "auth_ref": [
      "r157"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This item represents the entity's ownership percentage in the investee multiplied by the investee's total equity.",
        "label": "Equity Method Investment, Underlying Equity in Net Assets",
        "terseLabel": "Cost in excess of book value of acquired joint venture interests and other"
       }
      }
     },
     "localname": "EquityMethodInvestmentUnderlyingEquityInNetAssets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r32",
      "r141",
      "r153"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Book value of RadNet joint venture interests"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentsPolicy": {
     "auth_ref": [
      "r32",
      "r95",
      "r106",
      "r156",
      "r306"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.",
        "label": "Equity Method Investments [Policy Text Block]",
        "terseLabel": "EQUITY INVESTMENTS AT FAIR VALUE"
       }
      }
     },
     "localname": "EquityMethodInvestmentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquityMethodInvestmentsTextBlock": {
     "auth_ref": [
      "r159"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.",
        "label": "Equity Method Investments [Table Text Block]",
        "verboseLabel": "Investment in joint ventures"
       }
      }
     },
     "localname": "EquityMethodInvestmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r303"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measured as an estimate of fair value.",
        "label": "Estimate of Fair Value Measurement [Member]",
        "terseLabel": "Estimate of Fair Value Measurement"
       }
      }
     },
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EurodollarMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Interest rate based on U.S. dollar denominated deposits at foreign banks or foreign branches of U.S. banks.",
        "label": "Eurodollar [Member]",
        "terseLabel": "Eurodollar"
       }
      }
     },
     "localname": "EurodollarMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r298",
      "r304",
      "r305"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTextBlock": {
     "auth_ref": [
      "r298",
      "r304"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]",
        "terseLabel": "Schedule of fair value of assets and liabilities"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r197",
      "r198",
      "r200",
      "r299",
      "r325"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "auth_ref": [
      "r298",
      "r301"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by measurement basis.",
        "label": "Measurement Basis [Axis]",
        "terseLabel": "Measurement Basis [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementBasisAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.",
        "label": "Fair Value Measurement [Domain]",
        "terseLabel": "Fair Value Measurement [Domain]"
       }
      }
     },
     "localname": "FairValueDisclosureItemAmountsDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r300"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "FAIR VALUE MEASUREMENTS"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r197",
      "r198",
      "r200",
      "r299",
      "r326"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r197",
      "r198",
      "r200",
      "r299",
      "r327"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r197",
      "r198",
      "r200",
      "r299",
      "r328"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r316"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "terseLabel": "Current finance lease liability"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r316"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "terseLabel": "Long-term finance lease liability"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of unearned premium revenue under contracts issued by an insurance entity that provide protection to the holder of a financial obligation from a financial loss in the event of a default.",
        "label": "Financial Guarantee Insurance Contracts, Unearned Premium Revenue",
        "terseLabel": "Premium liability for 2016 Caps"
       }
      }
     },
     "localname": "FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnDispositionOfAssets": {
     "auth_ref": [
      "r100",
      "r168",
      "r171"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property",
        "negatedLabel": "Loss on sale and disposal of equipment and other"
       }
      }
     },
     "localname": "GainLossOnDispositionOfAssets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings": {
     "auth_ref": [
      "r290"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total amount of gain (loss) derived from fair value hedges recognized in earnings in the period.",
        "label": "Gain (Loss) on Fair Value Hedges Recognized in Earnings",
        "terseLabel": "Amount of loss recognized in income on derivative (current period ineffective portion)"
       }
      }
     },
     "localname": "GainLossOnFairValueHedgesRecognizedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r160",
      "r161"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Goodwill, ending balance",
        "periodStartLabel": "Goodwill, beginning balance",
        "terseLabel": "Goodwill",
        "verboseLabel": "Goodwill acquired"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited",
      "http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONSDetailsNarrative",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGoodwill",
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r162"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill acquired through acquisitions"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGoodwill"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy": {
     "auth_ref": [
      "r106",
      "r167"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for indefinite-lived intangible assets (that is, those intangible assets not subject to amortization). This accounting policy also may address how the entity assesses whether events and circumstances continue to support an indefinite useful life and how the entity assesses and measures impairment of such assets.",
        "label": "Goodwill and Intangible Assets, Intangible Assets, Indefinite-Lived, Policy [Policy Text Block]",
        "terseLabel": "GOODWILL AND INDEFINITE LIVED INTANGIBLES"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGoodwill"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGoodwill"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HealthCareOtherMember": {
     "auth_ref": [
      "r195"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Service provided for maintenance, diagnosis and treatment of physical and mental health, classified as other.",
        "label": "Health Care, Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "HealthCareOtherMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsRevenue"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HealthCarePatientServiceMember": {
     "auth_ref": [
      "r195"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Service provided to patient for maintenance, diagnosis and treatment of physical and mental health. Excludes service to resident in health care facility.",
        "label": "Health Care, Patient Service [Member]",
        "terseLabel": "Service fee revenue",
        "verboseLabel": "Service fee revenue"
       }
      }
     },
     "localname": "HealthCarePatientServiceMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsRevenue"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "terseLabel": "INCOME (LOSS) BEFORE INCOME TAXES"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r70",
      "r100",
      "r138",
      "r153",
      "r348",
      "r360"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "negatedLabel": "Equity in earnings of joint ventures",
        "terseLabel": "Equity in earnings in these joint ventures"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited",
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsInvestmentinJointVentures"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This element represents the undistributed income (or loss) of equity method investments, net of dividends or other distributions received from unconsolidated subsidiaries, certain corporate joint ventures, and certain noncontrolled corporations; such investments are accounted for under the equity method of accounting. This element excludes distributions that constitute a return of investment, which are classified as investing activities.",
        "label": "Income (Loss) from Equity Method Investments, Net of Dividends or Distributions",
        "negatedLabel": "Equity in earnings of joint ventures"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r172"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGainonDerivative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGainonDerivative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r110",
      "r139",
      "r243"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "(Provision for) benefit from income taxes",
        "terseLabel": "Income tax expense"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited",
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r67",
      "r106",
      "r234",
      "r235",
      "r239",
      "r240",
      "r242",
      "r244",
      "r370"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "verboseLabel": "Accounts payable, accrued expenses and other"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.",
        "label": "Increase (Decrease) in Deferred Income Taxes",
        "negatedLabel": "Deferred taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Deferred Revenue",
        "verboseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1": {
     "auth_ref": [
      "r287",
      "r290"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) included in earnings related to the fair value of the hedged item in an interest rate fair value hedge, offset by the gain (loss) on the hedging instrument to the extent that the fair value hedge is determined to be effective.",
        "label": "Increase (Decrease) in Fair Value of Hedged Item in Interest Rate Fair Value Hedge",
        "negatedTerseLabel": "Non-cash change in fair value of interest rate hedge"
       }
      }
     },
     "localname": "IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherCurrentAssets": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in current assets classified as other.",
        "label": "Increase (Decrease) in Other Current Assets",
        "negatedLabel": "Other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherCurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "negatedLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants": {
     "auth_ref": [
      "r129"
     ],
     "calculation": {
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsEarningsPerShare": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants",
        "terseLabel": "Additional shares issuable upon exercise of stock options and warrants (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToCallOptionsAndWarrants",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r167"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Indefinite-lived intangible assets"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r165",
      "r166"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Other intangible assets"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r76",
      "r182"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseMember": {
     "auth_ref": [
      "r294"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing interest expense.",
        "label": "Interest Expense [Member]",
        "terseLabel": "Equity and Interest Expense"
       }
      }
     },
     "localname": "InterestExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGainonDerivative",
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r93",
      "r97",
      "r103"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid during the period for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateCapMember": {
     "auth_ref": [
      "r293"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contract in which the cap writer, in return for a premium, agrees to limit, or cap, the cap holder's risk associated with an increase in interest rates. If rates go above a specified interest-rate-level (the strike price or the cap rate), the cap holder is entitled to receive cash payments equal to the excess of the market rate over the strike price multiplied by the notional principal amount.",
        "label": "Interest Rate Cap [Member]",
        "terseLabel": "2016 caps - Interest Rate Contracts"
       }
      }
     },
     "localname": "InterestRateCapMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGainonDerivative",
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r293"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "2019 swaps - Interest Rate Contracts"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGainonDerivative",
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsFairValueMeasurements",
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "auth_ref": [
      "r156"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment in financial asset.",
        "label": "Investment, Policy [Policy Text Block]",
        "terseLabel": "INVESTMENTS IN JOINT VENTURES"
       }
      }
     },
     "localname": "InvestmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in equity method investee and investment in and advance to affiliate.",
        "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Investment in joint ventures",
        "verboseLabel": "Total value of Radnet joint venture interests"
       }
      }
     },
     "localname": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited",
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsInvestmentinJointVentures",
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis": {
     "auth_ref": [
      "r367"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by category of investments used to group investments in and advances to affiliates.",
        "label": "Investments in and Advances to Affiliates Categorization [Axis]",
        "terseLabel": "Investments in and Advances to Affiliates Categorization [Axis]"
       }
      }
     },
     "localname": "InvestmentsInAndAdvancesToAffiliatesCategorizationAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationDomain": {
     "auth_ref": [
      "r367"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Used to categorize investments in and advances of affiliate. Lists the categories for (1) Investments in majority owned subsidiaries, segregating subsidiaries consolidated; (2) other controlled companies; and (3) other affiliates.",
        "label": "Investments in and Advances to Affiliates Categorization [Domain]",
        "terseLabel": "Investments in and Advances to Affiliates Categorization [Domain]"
       }
      }
     },
     "localname": "InvestmentsInAndAdvancesToAffiliatesCategorizationDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentsInMajorityOwnedSubsidiariesMember": {
     "auth_ref": [
      "r366"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A category that identifies investments in majority owned subsidiaries. This member would be expected to be further segregated into consolidated subsidiaries.",
        "label": "Investments in Majority-owned Subsidiaries [Member]",
        "terseLabel": "Investments in Majority-owned Subsidiaries"
       }
      }
     },
     "localname": "InvestmentsInMajorityOwnedSubsidiariesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r169"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold Improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r317"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "LEASES"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LetterOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).",
        "label": "Letter of Credit [Member]",
        "terseLabel": "Letter of Credit"
       }
      }
     },
     "localname": "LetterOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
        "label": "Letters of Credit Outstanding, Amount",
        "terseLabel": "Letters of credit outstanding"
       }
      }
     },
     "localname": "LettersOfCreditOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "terseLabel": "BRMG and NY Groups accounts payable",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited",
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r27",
      "r347",
      "r358"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "CURRENT LIABILITIES"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities, Noncurrent [Abstract]",
        "terseLabel": "LONG-TERM LIABILITIES"
       }
      }
     },
     "localname": "LiabilitiesNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r17",
      "r345",
      "r352"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-term Line of Credit",
        "terseLabel": "Total credit facilities outstanding"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityAxis": {
     "auth_ref": [
      "r37",
      "r114"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit.",
        "label": "Lender Name [Axis]",
        "terseLabel": "Lender Name [Axis]"
       }
      }
     },
     "localname": "LineOfCreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.",
        "label": "Line of Credit Facility, Commitment Fee Percentage",
        "terseLabel": "Commitment fee percentage"
       }
      }
     },
     "localname": "LineOfCreditFacilityCommitmentFeePercentage",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityLenderDomain": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility.",
        "label": "Line of Credit Facility, Lender [Domain]",
        "terseLabel": "Line of Credit Facility, Lender [Domain]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLenderDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Line of Credit Facility [Line Items]",
        "terseLabel": "Line of Credit Facility [Line Items]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r37"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "auth_ref": [
      "r37"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).",
        "label": "Line of Credit Facility, Remaining Borrowing Capacity",
        "terseLabel": "Line of credit facility, remaining borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "auth_ref": [
      "r37",
      "r114"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Line of Credit Facility [Table]",
        "terseLabel": "Line of Credit Facility [Table]"
       }
      }
     },
     "localname": "LineOfCreditFacilityTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.",
        "label": "Line of Credit Facility, Unused Capacity, Commitment Fee Percentage",
        "terseLabel": "Unused capacity, commitment fee percentage"
       }
      }
     },
     "localname": "LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "London Interbank Offered Rate (LIBOR)"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r17",
      "r180",
      "r345",
      "r355"
     ],
     "calculation": {
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt": {
       "order": 2.0,
       "parentTag": "rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "terseLabel": "Debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermLoansPayable": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt": {
       "order": 3.0,
       "parentTag": "rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.",
        "label": "Loans Payable, Noncurrent",
        "terseLabel": "Equipment note payable at 4.6%, due through 2020, collateralized by medical equipment"
       }
      }
     },
     "localname": "LongTermLoansPayable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermNotesPayable": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.",
        "label": "Notes Payable, Noncurrent",
        "terseLabel": "Notes payable, net of current portion"
       }
      }
     },
     "localname": "LongTermNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsTermLoans",
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r44",
      "r178"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsTermLoans",
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MediumTermNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt instruments with maturities ranging from five to ten years.",
        "label": "Medium-term Notes [Member]",
        "terseLabel": "Medium-term Notes"
       }
      }
     },
     "localname": "MediumTermNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock": {
     "auth_ref": [
      "r3",
      "r257"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures.  This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.",
        "label": "Mergers, Acquisitions and Dispositions Disclosures [Text Block]",
        "terseLabel": "FACILITY ACQUISITIONS AND DISPOSITIONS"
       }
      }
     },
     "localname": "MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r48",
      "r346",
      "r357"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "auth_ref": [
      "r190"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.",
        "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedTerseLabel": "Distributions paid to noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromRedemptions": {
     "auth_ref": [
      "r190",
      "r263",
      "r264"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).",
        "label": "Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests",
        "negatedTerseLabel": "Purchase of noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromRedemptions",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash (used in) provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM FINANCING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM INVESTING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r96",
      "r98",
      "r101"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM OPERATING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r62",
      "r64",
      "r71",
      "r101",
      "r131",
      "r349",
      "r361"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income (loss) attributable to RadNet, Inc.'s common stockholders",
        "totalLabel": "NET INCOME (LOSS) ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited",
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r62",
      "r64",
      "r266",
      "r278"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "terseLabel": "Net income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "New Accounting Pronouncements and Changes in Accounting Principles [Abstract]",
        "terseLabel": "New Accounting Pronouncements and Changes in Accounting Principles [Abstract]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r122"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.",
        "label": "New Accounting Pronouncements and Changes in Accounting Principles [Text Block]",
        "terseLabel": "RECENT ACCOUNTING AND REPORTING STANDARDS"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/RECENTACCOUNTINGANDREPORTINGSTANDARDS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "RECENT ACCOUNTING AND REPORTING STANDARDS"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest": {
     "auth_ref": [
      "r191",
      "r263",
      "r268"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in noncontrolling interest from sale of a portion of the parent's controlling interest.",
        "label": "Noncontrolling Interest, Increase from Sale of Parent Equity Interest",
        "terseLabel": "Sale of noncontrolling interests, net of taxes"
       }
      }
     },
     "localname": "NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r258"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Noncontrolling Interests"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "negatedTotalLabel": "Total other expenses"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NotesPayableCurrent": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.",
        "label": "Notes Payable, Current",
        "terseLabel": "Current portion of notes payable"
       }
      }
     },
     "localname": "NotesPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NotesPayableOtherPayablesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A written promise to pay a note to a third party.",
        "label": "Notes Payable, Other Payables [Member]",
        "terseLabel": "Equipment Notes Payable"
       }
      }
     },
     "localname": "NotesPayableOtherPayablesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsScheduleofdebt"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfBusinessesAcquired": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of businesses acquired by the entity during the period.",
        "label": "Number of Businesses Acquired",
        "terseLabel": "Number of businesses acquired"
       }
      }
     },
     "localname": "NumberOfBusinessesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OffsettingAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Offsetting Assets [Line Items]",
        "terseLabel": "Offsetting Assets [Line Items]"
       }
      }
     },
     "localname": "OffsettingAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGainonDerivative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OffsettingAssetsTable": {
     "auth_ref": [
      "r51",
      "r52"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about derivative and financial assets that are subject to offsetting, including enforceable master netting arrangements.",
        "label": "Offsetting Assets [Table]",
        "terseLabel": "Offsetting Assets [Table]"
       }
      }
     },
     "localname": "OffsettingAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGainonDerivative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingCostsAndExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.",
        "label": "Operating Costs and Expenses",
        "terseLabel": "Cost of operations, excluding depreciation and amortization"
       }
      }
     },
     "localname": "OperatingCostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "OPERATING EXPENSES"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "INCOME FROM OPERATIONS"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r316"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current operating lease liability"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r316"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liability"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r315"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 2.0,
       "parentTag": "rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Other Assets [Abstract]",
        "terseLabel": "OTHER ASSETS"
       }
      }
     },
     "localname": "OtherAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent": {
     "auth_ref": [
      "r260",
      "r261",
      "r269"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, on foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent",
        "terseLabel": "Change in cumulative foreign currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by location in other comprehensive income.",
        "label": "Other Comprehensive Income Location [Axis]",
        "terseLabel": "Other Comprehensive Income Location [Axis]"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Location in other comprehensive income.",
        "label": "Other Comprehensive Income Location [Domain]",
        "terseLabel": "Other Comprehensive Income Location [Domain]"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax": {
     "auth_ref": [
      "r55",
      "r57"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax",
        "terseLabel": "Change in fair value of cash flow hedge, net of taxes",
        "verboseLabel": "Change in fair value of cash flow hedge, net of taxes"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited",
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGainonDerivative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": {
     "auth_ref": [
      "r57",
      "r60"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax",
        "negatedTerseLabel": "Amount of loss reclassified from accumulated OCI into income (prior period effective portion)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited",
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGainonDerivative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r54",
      "r308"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Other Expenses [Abstract]",
        "terseLabel": "OTHER INCOME AND EXPENSES"
       }
      }
     },
     "localname": "OtherExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "negatedLabel": "Other (income) expenses"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other nonoperating income (expense).",
        "label": "Other Nonoperating Income (Expense) [Member]",
        "terseLabel": "Other income (expense)"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGainonDerivative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payments of Debt Issuance Costs",
        "negatedTerseLabel": "Additional deferred finance costs on revolving loan amendment"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBuildings": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow for acquisition of buildings (properties) whether for investment or use.",
        "label": "Payments to Acquire Buildings",
        "negatedTerseLabel": "Purchase of imaging facilities and other acquisitions"
       }
      }
     },
     "localname": "PaymentsToAcquireBuildings",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireEquityMethodInvestments": {
     "auth_ref": [
      "r84"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.",
        "label": "Payments to Acquire Equity Method Investments",
        "terseLabel": "Payments to acquire equity method investments"
       }
      }
     },
     "localname": "PaymentsToAcquireEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInterestInJointVenture": {
     "auth_ref": [
      "r84"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the investment in or advances to an entity in which the reporting entity shares control of the entity with another party or group.",
        "label": "Payments to Acquire Interest in Joint Venture",
        "terseLabel": "Payments to acquire additional interest in subsidiaries"
       }
      }
     },
     "localname": "PaymentsToAcquireInterestInJointVenture",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInvestments": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.",
        "label": "Payments to Acquire Investments",
        "negatedLabel": "Equity investments at fair value"
       }
      }
     },
     "localname": "PaymentsToAcquireInvestments",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow from the acquisition of or improvements to long-lived, physical assets used to produce goods and services and not intended for resale, classified as other.",
        "label": "Payments to Acquire Other Property, Plant, and Equipment",
        "negatedTerseLabel": "Purchase of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquireOtherPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToFundLongtermLoansToRelatedParties": {
     "auth_ref": [
      "r83",
      "r318"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with extending a long-term loan to a related party. Alternate caption: Payments for Advances to Affiliates.",
        "label": "Payments to Fund Long-term Loans to Related Parties",
        "terseLabel": "Payments to fund loan to related parties"
       }
      }
     },
     "localname": "PaymentsToFundLongtermLoansToRelatedParties",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToMinorityShareholders": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.",
        "label": "Payments to Noncontrolling Interests",
        "negatedTerseLabel": "Distributions paid to noncontrolling interests"
       }
      }
     },
     "localname": "PaymentsToMinorityShareholders",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r205",
      "r229"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r302"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measured at fair value for financial reporting purposes.",
        "label": "Portion at Fair Value Measurement [Member]",
        "terseLabel": "Portion at Fair Value Measurement"
       }
      }
     },
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r8",
      "r29",
      "r30"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets",
        "verboseLabel": "Advance for future software subscription fees"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited",
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for reclassifications that affects the comparability of the financial statements.",
        "label": "Reclassification, Policy [Policy Text Block]",
        "terseLabel": "RECLASSIFICATION"
       }
      }
     },
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProceedsFromContributedCapital": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow associated with the amount received by a corporation from a shareholder during the period.",
        "label": "Proceeds from Contributed Capital",
        "terseLabel": "Contribution from noncontrolling partner"
       }
      }
     },
     "localname": "ProceedsFromContributedCapital",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfInterestInJointVenture": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from the sale of an investment interest in a joint venture that the reporting entity has not previously accounted for using consolidation or the equity method of accounting.",
        "label": "Proceeds from Divestiture of Interest in Joint Venture",
        "terseLabel": "Proceeds from the sale of equity interests in a joint venture"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfInterestInJointVenture",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
      "http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital": {
     "auth_ref": [
      "r80",
      "r95"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of distribution received from equity method investee for return of investment, classified as investing activities. Excludes distribution for return on investment, classified as operating activities.",
        "label": "Proceeds from Equity Method Investment, Distribution, Return of Capital",
        "terseLabel": "Nulogix return of capital"
       }
      }
     },
     "localname": "ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfDebt": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.",
        "label": "Proceeds from Issuance of Debt",
        "terseLabel": "Proceeds from debt issuance, net of issuing costs"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "auth_ref": [
      "r87",
      "r230"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.",
        "label": "Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised",
        "terseLabel": "Proceeds from issuance of common stock upon exercise of options"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLinesOfCredit": {
     "auth_ref": [
      "r88",
      "r115"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Proceeds from Lines of Credit",
        "terseLabel": "Proceeds from revolving credit facility"
       }
      }
     },
     "localname": "ProceedsFromLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.",
        "label": "Proceeds from Sale of Property, Plant, and Equipment",
        "terseLabel": "Proceeds from sale of equipment"
       }
      }
     },
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate cash proceeds received from a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.",
        "label": "Proceeds from Sales of Business, Affiliate and Productive Assets",
        "terseLabel": "Proceeds from sale of noncontrolling interest"
       }
      }
     },
     "localname": "ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r62",
      "r64",
      "r94",
      "r140",
      "r143",
      "r260",
      "r265",
      "r267",
      "r278",
      "r279"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net (loss) income",
        "totalLabel": "NET INCOME (LOSS)",
        "verboseLabel": "NET INCOME (LOSS)"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited",
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited",
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r34",
      "r170"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Property, Plant and Equipment, Type [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r11",
      "r12",
      "r170",
      "r359"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 1.0,
       "parentTag": "rdnt_PropertyPlantandEquipmentNetIncludingRightofUseAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Property, Plant and Equipment, Net, Including and Excluding Capital Leased Asset [Abstract]",
        "terseLabel": "PROPERTY, EQUIPMENT AND RIGHT-OF-USE ASSETS"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r33",
      "r106",
      "r170"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, basis of assets, depreciation and depletion methods used, including composite deprecation, estimated useful lives, capitalization policy, accounting treatment for costs incurred for repairs and maintenance, capitalized interest and the method it is calculated, disposals and impairments.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "PROPERTY AND EQUIPMENT"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r11",
      "r169"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Property, Plant and Equipment, Type [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "PPE estimated useful lives"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "auth_ref": [
      "r106",
      "r148",
      "r150",
      "r151",
      "r152"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.",
        "label": "Receivable [Policy Text Block]",
        "terseLabel": "ACCOUNTS RECEIVABLE"
       }
      }
     },
     "localname": "ReceivablesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r322"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r199",
      "r320",
      "r321",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfDebt": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.",
        "label": "Repayments of Debt",
        "negatedLabel": "Payments on term loan debt"
       }
      }
     },
     "localname": "RepaymentsOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLinesOfCredit": {
     "auth_ref": [
      "r90",
      "r115"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Repayments of Lines of Credit",
        "negatedLabel": "Payments on revolving credit facility"
       }
      }
     },
     "localname": "RepaymentsOfLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow for debt, mandatory redeemable security, and principal payment for finance lease obligation.",
        "label": "Repayment of Long-term Debt, Long-term Lease Obligation, and Capital Security",
        "negatedLabel": "Principal payments on notes and leases payable"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebtAndCapitalSecurities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r130"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted Stock"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs",
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r24",
      "r190",
      "r356"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r192",
      "r193"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Service fee revenue, net of contractual allowances and discounts",
        "verboseLabel": "Total service revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsRevenue"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r107",
      "r196"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "DEFERRED REVENUE"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueNotFromContractWithCustomer": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of revenue that is not accounted for under Topic 606.",
        "label": "Revenue Not from Contract with Customer",
        "terseLabel": "Provider relief funding"
       }
      }
     },
     "localname": "RevenueNotFromContractWithCustomer",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited",
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r107",
      "r108"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue [Policy Text Block]",
        "terseLabel": "REVENUES"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r69",
      "r135",
      "r136",
      "r142"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "verboseLabel": "Total service revenue"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsRevenue"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "REVENUE"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r130"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r248",
      "r249"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONSDetailsNarrative",
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r291"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.",
        "label": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Effect of derivative instruments on comprehensive income"
       }
      }
     },
     "localname": "ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r44",
      "r114",
      "r185",
      "r187",
      "r188",
      "r189",
      "r309",
      "r310",
      "r313",
      "r351"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of first lien credit agreement"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Schedule of notes payable, line of credit and capital lease obligations"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r131"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Earnings per share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable": {
     "auth_ref": [
      "r144"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular presentation of the description and amount of revenues from a product or service, or a group of similar products or similar services, reported from external customers during the period, if the information is not provided as part of the reportable operating segment information.",
        "label": "Revenue from External Customers by Products and Services [Table]",
        "terseLabel": "Revenue from External Customers by Products and Services [Table]"
       }
      }
     },
     "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsRevenue"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r163",
      "r164"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGoodwill"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": {
     "auth_ref": [
      "r163"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.",
        "label": "Schedule of Intangible Assets and Goodwill [Table Text Block]",
        "terseLabel": "Schedule of goodwill and other intangible assets"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [
      "r219"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units.",
        "label": "Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]",
        "terseLabel": "Schedule of RSA activity"
       }
      }
     },
     "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock": {
     "auth_ref": [
      "r342"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of revenue by reporting categories or types of financial instruments, including derivatives but excluding dividends and interests, from trading for own account by broker dealers.",
        "label": "Schedule of Principal Transactions Revenue [Table Text Block]",
        "terseLabel": "Service Fee Revenue"
       }
      }
     },
     "localname": "ScheduleOfPrincipalTransactionsRevenueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r34",
      "r170"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r205",
      "r229"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r211",
      "r223",
      "r225"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Schedule of options activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecuritiesFinancingTransactionAxis": {
     "auth_ref": [
      "r50",
      "r118",
      "r329"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of securities financing transactions, including, but not limited to those measured at fair value or cost.",
        "label": "Securities Financing Transaction [Axis]",
        "terseLabel": "Securities Financing Transaction [Axis]"
       }
      }
     },
     "localname": "SecuritiesFinancingTransactionAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SecuritiesFinancingTransactionTypeDomain": {
     "auth_ref": [
      "r329"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measurement of financing transaction securities held.",
        "label": "Securities Financing Transaction [Domain]",
        "terseLabel": "Securities Financing Transaction [Domain]"
       }
      }
     },
     "localname": "SecuritiesFinancingTransactionTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeveranceCosts1": {
     "auth_ref": [
      "r100",
      "r173",
      "r174",
      "r175"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.",
        "label": "Severance Costs",
        "terseLabel": "Severance costs"
       }
      }
     },
     "localname": "SeveranceCosts1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "verboseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r206"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Share-based payment award, award vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r217"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "terseLabel": "RSA's forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r221"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "RSA's granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r221"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted-average fair value, granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r220"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "terseLabel": "RSA's unvested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r220"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Weighted-average fair value, ending balance (in dollars per share)",
        "periodStartLabel": "Weighted-average fair value, beginning balance (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms": {
     "auth_ref": [
      "r226"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms",
        "terseLabel": "Weighted-Average Remaining Contractual Term (Years)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r222"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "RSA's vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r222"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted-average fair value, vested (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": {
     "auth_ref": [
      "r212",
      "r214"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number",
        "periodEndLabel": "RSA's outstanding, ending balance (in shares)",
        "periodStartLabel": "RSA's outstanding, beginning balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r208"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized",
        "verboseLabel": "Shares authorized (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r215"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "periodEndLabel": "Exercisable at the end (in shares)",
        "terseLabel": "Exercisable shares (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r215"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "periodEndLabel": "Exercisable at the end (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "auth_ref": [
      "r218"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period",
        "terseLabel": "Options cancelled (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "netLabel": "Options granted (in shares)",
        "terseLabel": "Issuance of common stock upon exercise of options (in shares)",
        "verboseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r224"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Options granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r229"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "periodEndLabel": "Aggregate value outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r213",
      "r229"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Ending Balance (in shares)",
        "periodStartLabel": "Begining Balance (in shares)",
        "terseLabel": "Options outstanding (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r212"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Ending Balance (in dollars per share)",
        "periodStartLabel": "Begining Balance (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r202",
      "r209"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "verboseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r207"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period",
        "terseLabel": "Share-based payment award, expiration period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r229"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value",
        "periodEndLabel": "Aggregate value exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r226"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Balance at end of period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r227"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Exercisable at the end"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermBorrowings": {
     "auth_ref": [
      "r14",
      "r344",
      "r354"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.",
        "label": "Short-term Debt",
        "verboseLabel": "Convertible promissory note"
       }
      }
     },
     "localname": "ShortTermBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "auth_ref": [
      "r38"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of short-term debt arrangement.",
        "label": "Short-term Debt, Type [Axis]",
        "terseLabel": "Short-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "ShortTermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "auth_ref": [
      "r36"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.",
        "label": "Short-term Debt, Type [Domain]",
        "terseLabel": "Short-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "ShortTermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r120"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r47",
      "r184"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited",
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGainonDerivative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited",
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited",
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
     "auth_ref": [
      "r19",
      "r20",
      "r190"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.",
        "label": "Stock Issued During Period, Shares, Acquisitions",
        "terseLabel": "Issuance of common stock for acquisition (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r46",
      "r184",
      "r185",
      "r190"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.",
        "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "terseLabel": "Issuance of common stock for purchase of membership interest in HVRA (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited": {
     "auth_ref": [
      "r19",
      "r20",
      "r184",
      "r190"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares related to Restricted Stock Award forfeited during the period.",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Forfeited",
        "negatedTerseLabel": "Forfeiture of restricted stock (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r19",
      "r20",
      "r184",
      "r190"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of common stock under the equity compensation plan (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r19",
      "r20",
      "r184",
      "r190",
      "r216"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedTerseLabel": "Options exercised (in shares)",
        "terseLabel": "Options exercised (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueAcquisitions": {
     "auth_ref": [
      "r47",
      "r184",
      "r190"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value of stock issued pursuant to acquisitions during the period.",
        "label": "Stock Issued During Period, Value, Acquisitions",
        "terseLabel": "Issuance of common stock for acquisition"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r47",
      "r184",
      "r190"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.",
        "label": "Stock Issued During Period, Value, Conversion of Convertible Securities",
        "terseLabel": "Issuance of common stock for purchase of membership interest in HVRA"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures": {
     "auth_ref": [
      "r19",
      "r20",
      "r184",
      "r190"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value of stock related to Restricted Stock Awards forfeited during the period.",
        "label": "Stock Issued During Period, Value, Restricted Stock Award, Forfeitures",
        "negatedLabel": "Forfeiture of restricted stock"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r19",
      "r20",
      "r190",
      "r204",
      "r224"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of common stock under the equity compensation plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option).",
        "label": "Equity Option [Member]",
        "terseLabel": "Equity Option"
       }
      }
     },
     "localname": "StockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r20",
      "r25",
      "r26",
      "r149"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total RadNet, Inc.'s stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "EQUITY"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r258",
      "r259",
      "r277"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance, value",
        "periodStartLabel": "Beginning balance, value",
        "totalLabel": "Total equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSunaudited",
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of stockholders' equity including the portion attributable to noncontrolling interests, after the cumulative effect adjustment of a new accounting principle applied in the period of adoption.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Adjusted Balance",
        "periodEndLabel": "Derivative instrument, ending balance",
        "periodStartLabel": "Derivative instrument, beginning balance"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetailsGainonDerivative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityOther": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.",
        "label": "Stockholders' Equity, Other",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "StockholdersEquityOther",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r323"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r323"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r323"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Subsequent Events [Abstract]",
        "terseLabel": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r324"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "SUBSEQUENT EVENTS"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUBSEQUENTEVENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UnrealizedGainLossOnDerivatives": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.",
        "label": "Unrealized Gain (Loss) on Derivatives",
        "negatedLabel": "Non-cash change in fair value of interest rate hedge"
       }
      }
     },
     "localname": "UnrealizedGainLossOnDerivatives",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnusualOrInfrequentItemAxis": {
     "auth_ref": [
      "r78"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by an event or transaction that is unusual in nature or infrequent in occurrence, or both.",
        "label": "Unusual or Infrequent Item, or Both [Axis]",
        "terseLabel": "Unusual or Infrequent Item, or Both [Axis]"
       }
      }
     },
     "localname": "UnusualOrInfrequentItemAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UnusualOrInfrequentItemDomain": {
     "auth_ref": [
      "r78"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Event or transaction that is unusual in nature or infrequent in occurrence, or both.",
        "label": "Unusual or Infrequent Item, or Both [Domain]",
        "terseLabel": "Unusual or Infrequent Item, or Both [Domain]"
       }
      }
     },
     "localname": "UnusualOrInfrequentItemDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis": {
     "auth_ref": [
      "r271",
      "r272",
      "r276"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by category of Variable Interest Entity (VIE).",
        "label": "Variable Interest Entities [Axis]",
        "terseLabel": "Variable Interest Entities [Axis]"
       }
      }
     },
     "localname": "VariableInterestEntitiesByClassificationOfEntityAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense": {
     "auth_ref": [
      "r275"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of expense between the reporting entity and the Variable Interest Entity (VIE).",
        "label": "Variable Interest Entity, Measure of Activity, Expense",
        "terseLabel": "BRMG and NY Groups operating expenses"
       }
      }
     },
     "localname": "VariableInterestEntityActivityBetweenVIEAndEntityExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax": {
     "auth_ref": [
      "r275"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Description of the amount of pre-tax income (loss) derived by the reporting entity from the Variable Interest Entity (VIE).",
        "label": "Variable Interest Entity, Measure of Activity, Income or Loss before Tax",
        "terseLabel": "Management services provided to BRMG and NY Groups"
       }
      }
     },
     "localname": "VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues": {
     "auth_ref": [
      "r275"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of income between the reporting entity and the Variable Interest Entity (VIE).",
        "label": "Variable Interest Entity, Measure of Activity, Revenues",
        "terseLabel": "BRMG and NY Groups revenues"
       }
      }
     },
     "localname": "VariableInterestEntityActivityBetweenVIEAndEntityRevenues",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Variable Interest Entities (VIE) in which the entity does not have a controlling financial interest (as defined) and of which it is therefore not the primary beneficiary. VIEs of which the entity is not the primary beneficiary because it does not have the power to direct the activities of the VIE that most significantly impact the VIE's economic performance and for which it does not have the obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE are not included in the consolidated financial statements of the entity.",
        "label": "Variable Interest Entity, Not Primary Beneficiary [Member]",
        "terseLabel": "Variable Interest Entity, Not Primary Beneficiary"
       }
      }
     },
     "localname": "VariableInterestEntityNotPrimaryBeneficiaryMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableInterestEntityOwnershipPercentage": {
     "auth_ref": [
      "r273"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly).",
        "label": "Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage",
        "terseLabel": "Variable interest entity, ownership percentage"
       }
      }
     },
     "localname": "VariableInterestEntityOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_VariableInterestEntityPrimaryBeneficiaryMember": {
     "auth_ref": [
      "r271"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Variable Interest Entities (VIE) in which the entity has a controlling financial interest (as defined) and of which it is therefore the primary beneficiary. A controlling financial interest is determined based on both: (a) the entity's power to direct activities of the VIE that most significantly impact the VIE's economic performance and (b) the entity's obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. VIEs of which the entity is the primary beneficiary are included in the consolidated financial statements of the entity.",
        "label": "Variable Interest Entity, Primary Beneficiary [Member]",
        "terseLabel": "Variable Interest Entity, Primary Beneficiary"
       }
      }
     },
     "localname": "VariableInterestEntityPrimaryBeneficiaryMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrument",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r125",
      "r129"
     ],
     "calculation": {
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsEarningsPerShare": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Weighted average number of common shares used in calculating diluted net income per share (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited",
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r123",
      "r129"
     ],
     "calculation": {
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsEarningsPerShare": {
       "order": 3.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Weighted average number of common shares outstanding during the period (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited",
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]",
        "terseLabel": "WEIGHTED AVERAGE SHARES OUTSTANDING"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesRestrictedStock": {
     "auth_ref": [
      "r124"
     ],
     "calculation": {
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsEarningsPerShare": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares of restricted stock determined by relating the portion of time within a reporting period that restricted shares have been outstanding to the total time in that period. Restricted shares are subject to sales, contractual, regulatory or other restrictions that prevent or inhibit the holder from freely disposing of them before the restriction ends.",
        "label": "Weighted Average Number of Shares, Restricted Stock",
        "terseLabel": "Nonvested restricted stock subject only to service vesting (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesRestrictedStock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 8
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(11))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3044-108585"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4297-108586"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=SL98516268-108586"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18726-107790"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h)(1)(i))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(m))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(n))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "http://asc.fasb.org/topic&trid=2122394"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1448-109256"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e2646-109256"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1505-109256"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1252-109256"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=SL5780133-109256"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1337-109256"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a)(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117327953&loc=d3e4984-109258"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8813-108599"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9031-108599"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=118952595&loc=d3e4647-111522"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=118952595&loc=d3e4428-111522"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=118952595&loc=d3e4531-111522"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=118936363&loc=d3e5033-111524"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33912-111571"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=77989000&loc=SL49117168-202975"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13854-109267"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2443-110228"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6031897-161870"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6031897-161870"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6036836-161870"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6036836-161870"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130543-203045"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130545-203045"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130549-203045"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118944142&loc=SL49130690-203046-203046"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116855982&loc=d3e4534-113899"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f(1))",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)-(4)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=SL79508275-113901"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=118258462&loc=d3e11149-113907"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=118258462&loc=d3e11178-113907"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116821951&loc=d3e32247-109318"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116821951&loc=d3e32280-109318"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116821951&loc=d3e31917-109318"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32698-109319"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32847-109319"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=109238882&loc=d3e38679-109324"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "30",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=65884525&loc=d3e40913-109327"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6909625&loc=d3e227-128457"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116868840&loc=d3e2207-128464"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116869197&loc=d3e4845-128472"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(4)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e7008-128479"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4613674-111683"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569655-111683"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4616395-111683"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=118582676&loc=d3e5710-111685"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=118582676&loc=d3e5728-111685"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=118582676&loc=SL6759159-111685"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=118582676&loc=SL6759159-111685"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "d",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=118582676&loc=d3e5747-111685"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=118582676&loc=d3e5747-111685"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116874947&loc=SL4590271-111686"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116874947&loc=SL4591551-111686"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116874947&loc=SL4591552-111686"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579240-113959"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579245-113959"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579245-113959"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579245-113959"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5580258-113959"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41620-113959"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41638-113959"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5708775-113959"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41675-113959"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/subtopic&trid=2122178"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=116690757&loc=d3e13220-108610"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13433-108611"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13467-108611"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13476-108611"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b,c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28541-108399"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28551-108399"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28555-108399"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28567-108399"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "840",
   "URI": "http://asc.fasb.org/topic&trid=2208923"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918666-209980"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "http://asc.fasb.org/topic&trid=2122745"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL6224234-111729"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=35711157&loc=d3e42567-110969"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=117419784&loc=SL117783719-158441"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=6488278&loc=d3e603758-122996"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-14(1)(a)(1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=50485924&loc=d3e611322-123010"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-14(1)(a))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=50485924&loc=d3e611322-123010"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "450",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "450",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491354&loc=d3e6052-115624"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=6590653&loc=d3e638233-123024"
  },
  "r372": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r373": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r374": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-13"
  },
  "r375": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1-"
  },
  "r376": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r377": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=49176635&loc=d3e9760-107771"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225877-175312"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e637-108580"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e681-108580"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669686-108580"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e689-108580"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL34724394-108580"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e557-108580"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116657188&loc=SL116659661-227067"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118951672&loc=d3e1436-108581"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=114868883&loc=SL114871943-224233"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "http://asc.fasb.org/topic&trid=2134417"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3179-108585"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3179-108585"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3179-108585"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6801-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3367-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3000-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21D",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=SL94080555-108585"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3521-108585"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>57
<FILENAME>0000790526-20-000007-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000790526-20-000007-xbrl.zip
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M<TV].DNOTDN!Y"M*C1'[)PA'2S::V@S*LO5 P;V! A@(]7QHN1';DV5'.G
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M9G>4[R<:<74IE;*FUU 9"_?Q- ?T96"FR%\)U3 4>;NA20 . ECW@]J9X#[
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M5L,1+'=WOF"LL<994A3-!;]B^C.0XG=KH$Q__,$":XG%U$9D3*YOA7[D8Y
MAG46(HECV.38HJ%0^8U2Z=Y]1<Z+"YNNH G1F>'!#<;M<<44+>[M$++$,\M&
M/3WDJ2^13UZ'E,_B<L9<$YW^#5!+ P04    "  )@VE1<<;^00L%  !K&0
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M,C R,# Y,S N:'1M[+UK5QM'TR[\??\*O3QK[R=9*[+[?'!R>R]BL,.]#3B
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M&*SWTAJU7<+^-=@_7H7=*.ZE\[[-F=!M%< 2-1*A+1,FS)A<<G'E*1>/)7]
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MC=\HV3NF+R]T<>0;W^AI+<W77]G%.-&3U[MKW_PVO?(1"B>.2:GDA4\BRX
M$F)FR8W?YIP(\[6W>4T^O^UM7GL#,@)/.5CT&14)%,D5,(=1T4N17-;RQ#T7
MDL_5&^ 4WHBVY-\O3^3 :A]W^7BI>D_=NMJTMMHPZ@_^H>A]=G[Y<0U[_6[5
MN^VR=S40UR[Q^'KOOR;Y"@AP$B2/7BM@!B(X8BB2)<-XM/+"GML'M.<7CXV'
MA6:,OR:ZV=E)IXK5:!.[@6Z1*CHZGH@8#D9/7@WZZ32.M@>[.'A?15P]J\C@
M3OC-'PB=T=$S>H^OB*S052]:C:_UV^-;;W'Y[BY[\@\<C7T(1W,-4"",3.;*
M>N(>+'H?BR(' PHB\93:07-_ 2A]6 )Z9T#+9,$= 2U-IP1H0.^RL *USHJG
MY*S#E(GT1VNT!#D#QK4H@#X8%;P&*$-4UD$T@N(-)J0KMA;)^Y+1%=Y.-)0O
M-?0?:>@= 9VBAC+M$AK21N2$K%*>:\F,S8&C5R&:1OO0$D8^>08GU>CFH,!P
M,=VGC-II9#I+Y4-RGABP4C:3+P698Z/=Y\RPG(WGI$@F6,UM!*&54-)+(;()
M@1FA&N\Y9ZJ7#^\TZ6(I\&QY"DDYFWUP(1NKM4@6*5YIM-.<J5X^O+^4V4 H
MBUC*@@)P@;B0M4&:X'1T6J49^,M&^"9O=3:)'D-&5&BD0YE <.99#B)+/P/?
MU @_((2,!I(.7 B%6KG$&1'OP /:,MPW ]O1"#U50 +F=&#!":) $AR+D316
M6>8@ +L8%37S9VHO)[9&98T)G;/^G].R/*S?/>GWBEF]'JS0[]U^;W?4C^^F
M;V^O#]>:*0W7 E+(:+4,VI75/2$Q*:.5UL7LK,6%@68UI:KX1.B\@BIM],9>
MLM,0F+S*HM 5,CN@3)  #)R/RN1(QBB[Q8$IQM/N::>L^]X>'>&@M!O@4;G:
M>]SHQ7[W'B+_>X&,'*S*RL>48U0,@W=:A,"],X"6WO#"0+:#(ZAZF-9AT*MZ
MA_? -.\%GQ"\(5=NN1-21>>\U,EE+7(((1.S;#P^=3!0^Z*C?B?A8#ANMH;Y
MTV7G'B7/!9-9<^:44U$R'RV0GV)!""32)1J/TJ395K]7'GS0[W1(B3;H%0QP
MV!24A+3&>)<@.<)$")<2A612!^.Y1%0/A]*LWH"+@@4#WKF@%$H#14:9UUXJ
MH8E>-6#H=IZX[NQC9)T3B;3/P>FDN&/@971 (DP"'24V82S^W@"]\YU_/QT2
M,Q@.5R/=>5CS[RN^:0WQ9#R]0\3NT2(*D?*&)X^)@M^L8K*!J#H/C%.<A<%D
M:) 0_>A0,A_*D#]'(U 9L@5&VP R,PO%^X4&03EO$?/LP;719LC92I]!:8JQ
M8TH106M,!&ALDI[.65 P>VRUUM[16]::<R5=!DPJE,5-R61I UL<;!\ZE)@]
MMIXE'VS*.?,R>BE]@N"DS%D31W-N 4G:3,;'9@\TE@G;1/$5"^1]B4^Q&'U,
MT:K @U$+&%[=_ZC:[%$% YPYR5/,4H'SP7 A O@0K OD?A]NM?S<A%;?/:(S
MI67\:*+03DBPP!209?6<J&]63&7.0-N%@69&\T)3@LD')\J:>PC"*(=D$SGY
MOQ0BCRSP%!8'IMG/"TT),N,#$$C,4P"I0%I000<6P=NH0?.\,) ]]+S0U/"1
M606AN$N@C$&/!A(1RR1(R8(4C<=GMO-"T_)/+!K#$O%]1H8O"Y=95L(Y\$3_
MN9&-1VFV\T)30HG)X"C0MMIDH;3Q/I(B@?)"".YYQO%FP 68O7L@@E?69$UI
MPBI;;9W#%)PINX&8%UKXQ#E+%%-E$Q8&FAD0O"G"Y#RJG&*T#)U"*0)1!6.E
ME2G;J 1;')AF2_"F"!E3);6!4\0:E/+HZ=^H-$@N5=+)QX6!["$)WA3QX9IB
M(Q,D,Z1;(J#+U@3AR2TYP9GSC<=G=@1OBB@I$YP/DA,X7+$DRKRIE1!RX(9X
MW>)0AX<G>%-$R5H$DYD+,LBR0]%9+V24NBQQ=,G8AT-I5F_ 9_++,<8,(BJE
M@[/(O#,Z$K72QJH&[/.;)ZX[^TT>"06%_1(S8E"<>4]$2V<A%)'BJ)-=/$!G
M,M$_&W")0B,Q:5[2\I0PE/Q)8A84"@1(-BP.N+.<Z)^1XC)D0GC.F*)_('JT
MTG$K=/9E4TM>'&SG9C)X1DHLK''),IF3H5@K!B&"#I"R@V SZ,4#^F$G@V>#
MJBL3P>"3S3J1KRU%&P0*3M&954SY!212LUBG,QML(Y-DD /CW#(*Y@QDM,E;
MXZW(H.PDY&X^I \X#CRM(7I+[Y\Y#-)H)<%Y,J,.1/+(8]G!L3#0S&@<>$HP
M.:10A)R=3J4639+@=> 4<6LOF/99+PY,LQ\'GMH49;8&F>%,6\6%]0ELE%*X
MQ,M67E@8R!YZ''A*^*0DHF$N0DQ,60N@2F&GXIBTRMSSQN,SVW'@:>6333X
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M94EJS."$5SP$,*RLMT69$WW,<YQOL$$P3XMTG?:J,6S'_:HW^NL]W?-T@)?
M=,>+,L;/=:W)Y'J3%I/OY8*WBP4$36+A Q-9H7/ I!51V22X1>G-S?%,.7_S
MP FK)R_Q$#KK=7^N0/ZB0PH#'5Q-[Z$7,4W9F?]^.JQZ.!R2UPY5KQXFW<43
M&)"&=LYW,/8/>]5'3%<*' VO=.[?!;<W8]B^MT=%19[U3\LN)+K_Z/R&Z*]5
MU)/1^1\(G='1-.ZU [W#BQN4KYM5K^J>=N=J<%=>F2C^GBD@[X22"JWRY"T3
M=TEFSC/94(F(4BSU8ZD?7]</.%M4_6 <.)$&IS&B2I*!MUHS8624(I!67$R1
MNLD4J9L__9@2O]@E]PZ;_1ZYU L]>C'HGYZ\?/GL_N=!W=WG0=UT<#?@HD+&
M,K=)!9^"4[Q.(:J9#*@F@W=+N*=/*]UTED"5E*\&%13JI[3Q(92E[DKD$"R*
M\5C>&,&YU=QQI<CA$$>KD1 ;5C>+2![L8?R:09^*^LD'5C\BZF6G+3<^)Z6U
M]<$)A^@4@,P!Q?RJWZPPNQ<=\MR4V2:-#(VRD07P26BOF$5D1DVJCIB)]S/S
M-UIZDZS=CLH:XLF8'E'@?/\*9>[NS\QTAKN=MQ((H+*\2VG,WEHC<E8NV\C!
M311J">!=M,M,9UPY.Y&8U$%J+LOD?>&6%'Q9"L@B\I@NM$LRT9Y\F#=POF;M
M-G<V8/2VWT]A4*5#?!"R*-M,W%&YKC;]GK''Z*SG  $=J C6.RV<8#9;(XU0
MDSPC2_SNH%M7(?D.W0K:<L,=B]F3.G'N/7IM'#%"5B9NV.72U@O=XLW#9KO3
MP_/M$^P12 ^B6/SNBL6GHU@FA@3"D2:9K**0SAGFLRV+49,#F'BM)7A?TRH^
M':TRJ$7,*'U968@9 M%Q#Q80N0ILO(>@(7QPK1J>](?0J:/:9QT8#NF"5VMU
MU3!=A+[;O6?0Z2PB+Q20HS%E=,M;900+,I(WPQ R0ZEC8S>%CN>MZ>>7??C:
MZJ.[R\Q7-ZK=\8XSG'J[CGY&D91P,GFDJ$!!$EZ9LFY8!)V@ ;D.?SCTI[A)
MT/*<K!44A  HPVP0UDH,F!.YW.0;4'=M'M O.T!*J?6[[DZ=%]W/)6DE$R71
M*>E\R "< TO.:1Y8B@THK_##H3]%W1<\&\$%R8"URNL(*=KL*#Y24F82@?G7
M_2]"\@K.J4/QW:M!?X3UM"M].AQ +1!?V[0^+]J9"!*9,X^$AH+,0ME\A>26
MO1'9V0;4,;H??![0.,R+*$2I$U/9HDY<Z:P\!VEMS,[G[!+,\<JVNV6PV"(Q
M&))00.A@7?;[XG-35!4\2*6T#LZA\J;D9>2<$VC9V(CP0X10\X(% Z>X]F"2
ML2H%Z3"##2'&P -*;#:E_2S.&*XV!!81& >M34 15'00I&3T5PD3F&(0YA^6
M;\Y1LUX='HV.5NECN@,MG)(I78!D0'.6DV>:?B(;GK/7*0%7&%/@'(WA.EBT
M1DJ8?R587&R40)8QH/4"R&\PGS(Z)Y*4Y,]-:$"E@*6:3DU-8ZE*S:4S) HH
M0^;6*6F2T(9NU(#(Z^%]Q,PRN'U%ZG=/>WN#T^'4;K>X4A]\(HKF91">8DW#
M@[+>) >.*\Z"G^/-ZG/+C);"=^?%:8KD3KG(DG(**4!@*')*(FLFN-?CU'1F
MDIJN_K"4PIG9WOKB)9'V  YQI\R87[GIM=^W>U-+]3]]X;_SK=_ H"KC4:7X
MU8WTT*>#?NIW.G /.]FO;7TQ=\\.>*/I=RP-X(&7=0$)G<J*0P@J,:F,9-P[
M(D-VJ95+K9Q'K?P=AO6OBZB3'B"(S)(V22KN/#"K)*< %514P2QU<JYT<J[5
MY,[.:XJF9^]#?Q&U,C(!'JSB63HE$$&B! T6@Q0EGEIJY5(KI^N\ECKYU9G
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M!\G,7T6D/YTS')UW2'B[5:]]A-7AT>B)-">C7S]4:73TA#/VOU?J=D]_&YY
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M,%&E:G>S_(S!-YUT%_,TGD0(M/+^N86I%F*J:P6MF+.1<&K!6(R!1:%!&>'
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M>B48&)/[02JIP6*OP#BE.+8D4(5KN&/:4HL7KEVS-.3ZL\4SR1OCUMR>D;Q
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MI]SSG6E0!FL7'>*1A3I2H@(MHP)1H9A",0V68@K%+(EB9L28%&-KYI4&%K$
M1JP&XQ "$U(,'AF-B.AEBC&%8@K%-%@**A2S+(J9+8:=0B&O./B@%+ L^EIM
M$4B<5@GKD99THO=B3%MT\1SVYE!,K27]J^[]D_[UO8_;_YN^7-[YJ1F^[_4O
M;[ &U,5+=>U'=!W;+N1N0:N',<DP[AZ'RC@W.$V?_26WA.T/QNGJ"215NIG<
M'_;]T)Q49V8XK@:Q&A^'4:ABKV_ZKI=>3R@:A]/T *-G5U;\=C0N/H^19S)+
M9F>#42\;_Z=A.#'CWL?P\Z>>'Q]?TLK,'UZ,'YK^B;&C08;QG7_2E&$EUT=C
M]FN^VYIH8O+S+=<2<1N9BU%3$0761%.+34++GX1O7?[1\=49\;/$:6"'P?P%
M)J8'_,F<?#)?1EO_NCX#TUS[9MR_';([!R;&'S8PDVF?B'LP-+5!$[C#,+\K
MW9-IS+U4Q\.\:OW7_4S4K9LK)W"\R"M>/S=3-MNWV?]1Y^F-#,]ZGEX[L[S3
MV:V.WCP_VMO=VSG<:Q_=B>BFW/V+@\YNNW/4WJW2=T<'K_9V=W*VZE$W_;/?
M[G2/JH.7^23VZ\/VK^E]>[^WKQ_F;OP#_F.O4W5_/7ASE$RS#K=[WC?GOI?<
MK+OO]?K:R*\OC7Q2^*(&U-4B4*_EZ1%.S-DH_'3YS<^^-SH[,5]^ZO7K&ZG_
MZ-M%.UWS@O>T?L8%SM1WL0-T<?D+5GQ6L^(W#LCD=YP]D^CN7Z-G^,[??>^R
M^EDBD@==]?N_XY0][KW>$GI=FBJY?N%AG\\D69^Q(O>[U]N+OQ!\6_&7X>#3
MM[%H,P\2W!XLWN[G7SV@OL]#39AM-8^E[G4\HIO<A%#MI_<=CZIV\AY\=13.
MDC^< LZ*HM8]SD;<@8QU'YE.>N6^ W-'#23RO1I(<Q32;_9 93WU/D=H[O/
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MDF3=OZ+@GHBS)T+IK?>7V0TB,. 9]@[@,7CVSGZ9R'HSF@&)(PF/[5]_JR1
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M=0*4]C)JS;A6L1)UVRB@$G4;4'JN)&DEZM80]5R/.R*0FD!!*1M )!4!HXW
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MF=]/L%:4*DH5I8I21:FB5%&J*%64FHS2TR:MYL.X+W$X"#@ZNF,$-\E(?2>
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M$=YU[>9NKTOW+Z'<=0G]-:+^;Y7KM!-G5\<@W<&1VK(7ZR7LQO1EV)/7P"I
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M>;*#V!A$@)A!#/DZ%QNAI$CX?-8Y/>ST&G;V[L-.'-B!/SQ?;[3G3][DE\;
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MIFFTP4B6N#>R%O!6"V%;;V8,7K Q43CLD8H2Y[QN$/"$CDAP:AES5B3F'TS
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MK-)<B>@^J".=7ED]>%+.NC/14"=%H>%=\<=)]'GS!Q$V[:*Z9Y"'F2]=;VR
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ML$X\KL,>?]JK05H'!XPY$[C53ENOE&/2:>&UX*$R^JHYH^\=XQ^!6K<+BOX
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M>:2UUR#)*86,,!0!KP(1/ BG<HT%BM>4N5SQ]Q\URM4H]Y11;@F0HY1Y:>%
M$$I!NP&9@&".J2,NJAS<74EQI);B?C.V3=./,;'$FX219BDB[GGNW2 MTBZ"
M@"<PEC*]>LW7F'PR_1JN\>"(NWAP'L+"6S_C"3WC)=BL_]KXO/VFT=IJ-[9;
M;W::6XT_/NQ\_OR/F0C4C7;[T_9?7]H;?WW8:K1W&I\V-N'RM7S]^O_]W(";
MFCNMQN?VSIO_]]\['S:W/GU^5']T_8S5><;2!V3AM#V% _+U^D#;L?NFBK>=
M27<*HT&1YG@8JUR.ZXO++[=:5\K'3TA.+-?J81T:> E)<;R;&^5FMHJ]W$E%
MO/MP9[J#1>S[4\\._*629.OSC+]#V!0XXQA9V%;$G2;(,&91Q,$)+:5S/+QZ
M+<@:$WI-8G9?<?)J7'E4C?BVPD=]P.]MT:\/^(H<\*G!GSC'A-6@(!IA$9=:
M@:J(&=)6,VMM,,1B4!7-FL9JC=]?7ZP/^$H?\'M:M.L#OB('?&KGIB%BRZ2!
M$^T4XC1J9+7VN?TZ RA/2CL%'!RO*2[7F*X/^/,^X/>TYM8'?$4.^-38:ZG5
M7)N(? 2^S2UER$4/!YQJ+[V(VGM6<'!AU!IA]RXW^8 '_$78Y3)U%YFX\Q&E
MTUS:.K:T]MK=WVLW3O9_6),,_5E-B1J\EP;OV7C2E'RRC',4E)"(*V:1%@(C
MH;DGC,8$^_7J-5XG]*DXZNI A!K2'A?2[FF$JB'M,2!M:E'2'/XG/$-$Y$IT
M,F%D2(PH<4Z!\?BDA<J0ANL(^1K2GB.DW1A!>@VFW=/N1F<"26MP>W!PFUK3
MG$I.4QF0X]PBV'_X*PB-O%74"Z8X"86\QDD=,UKCVO/"M3O VCVMC;6H]AAH
M-C4=)LTH,8(@I2A%7"B--(AHB&EA36(R6,<+4>UI-7!8H3#1F0DSF%+HC[*1
M[R%+#=2C?/*C? EF\,WM#U_:6YMU@&K]C#I M0Y0K0-4:^_W7478G=D 56*2
MC#A91 0&$3;D\!8>56Y(ABTF.NF8Z@#5%W/ ZP#5YW' 9P)4>:)PF"DRPN?&
M-M(A;9-$T@?BG=0Z"E\'J+Z8 UX'J#Z/ SXUJ7L1DQ":(RJ\1=E'B$P,#$E.
MN:0J4I_J -67<\#K -7G<<"G5F:*G29%+SII50X(D$ACYA SV./ L,.I#E#]
M?<=S(X0&K/;W."Q;C U/!YVBVUC9+V8X<D?1GS;ZO>YYCDZ%MWSO^-C(U\,4
M[V1NN&*5GB66K8JYX=-D4S^?%BV?:BB[?6&5]D:&L=+BL+%OK -MTDN4A)*(
M&Y-[**N(0O*):ZTM<_;5:T+Q&LBD#^0U6R%??WV\5]#84!_O>Q[O\\GQUC+8
ME.!X6R82XH)R9$5(R!.OF:'!@5R:J\+A-2$OEX5[/L?[#L]X?#7^Q[#S9Z_3
MK=KKU2?DUYV0UI0!*B8<]LF#^ XB/;>2(QV50Y8&GYR@&$2=3%&7VDS77.AY
M*\SU&;OG&9MR(>-%)%%0A(,RB)/(D&$B(NF5%"9&X1,%(=.0-:962<A\"5[Z
MK"[;2;_ML4N^,QR.BOS-HJ]K_!$'OE/V!2^UZ/Y)V5H[=U$]LX.!+;I&UI[Z
M55"=MWM^$',C==M]4\19E'BV,9.6V^Z_L=WN3KF)&[WPM=K"&N26 KFM64U:
M$*J881;1* CB'-1I&Y)!.-J8E!-)1_?J-7P-FO2]1>W:Z+_2I_T7:M+U:?^%
MIWTJTGBF$DL6] 1L20XUY\AH#=IU;H9LB4V$@]K !%UC[#D'Z=SA&;]9L:X/
MS*\[,#-Z-@\>$$S#-KD$>G;  EF9 E*8<R*CL-RR>^O9-8]:23V[/G*_\,A-
M>900VDE)$W)6ANS;L<@:8%0R!.^)]H[G8J>,\C5E5HE'O00O]:V#XT=#N*C3
M:\"X_:AK3XL@^4YWE.^=J<(T*;]T'P?V_3);GSH@_G[O]F:YKY<"=FH07 H$
MMV?5\L@%98D*I*E4B&,"<.C@(\-$&\)\ULJ*@'HCQ)HF+ZT-7 T/*ZC3U_#P
MR/ PE9$2*)%.,XD4B+R( U@ 4"B,O)5".2R\$:F(UF42/Z7^0C4\O+A _AH>
M'@@>9JT6!GN <H6BS5T5+7-(*^M1T,1J(#^I-'O(8/X:'IXI//S^J(8:'AX*
M'J;2@U)4Q) "TC)'SQ( "I<\15ARKS7AG.>",P /A+ U]G0J!+Z$P(?-RT:4
M7UG*^G)YE9=53&SI^3]1;O#[2EE7!%[C^U+XWIR+Z8A44X,Y(HZ)RLLK T8L
M.<D$(X9K]S#EK)<]#K_9_UO#6@UKOZF<=0UK=X2UJ=C*L+4Q :QYSBCB-%>C
MD"(A(0V6FB;K"7N8DM8UK-6PMH*PMM(EK6N NQO S9CMB*4^">$0EQ3D-DPE
M<DY11*+#U$D>F=/W+FM=8UN-;2N(;2M8UKI&M#LBVDPLE[;:1R:1YDQGD<TC
M%X-%*F!MC0O2)O$PI:U_%:Q=4]J:+E7:^BG4>JV?4=?/O0N0?[Z4:0>GNG&Y
MKHT]LX,P;,0?OCL*\#D-^L=% 5W?/SX9G=J""_33)&IPQKQ]#$MT"L\>YNL[
M@T9,*=?&.>N/NJ'AX(+>::>XK?,]_GFGXM2/F$=0/^.1GO$2XF];/Z\051>'
M6LK#C;T+1#'N.#=<X> HUKD+I,)$2<[$<N&S%W'0#W9XN"A:;LP@TN?H1X/.
M:2<.MRKL>PO0]V:*>CMI41+=*!"O%D27$D2_3%TB1P<T"Z,*&VVQ0M[3B$!!
MR*FNEB$C+(E2"\\)J-?_SW]I2NB_5BB?OR[7\?#'7F+B$X\A<:IX\,0I36(2
M'NB :T;\<F&Q];%?J6-_/G?LO32&RURPFGB'./,)6:4E"LXX%SAL>RY\61_[
MEW#L Q?46R.UII%;IBUW7ON@A4M&*^T>,-RU/ON_X^RWYED^%R%:G#CB/*?1
M"(*1T]$A&UE205-'!7GUFC&R)L5#=5>KS_YJGGV/'0V1,BI=XL 3K+.&,R*H
M\Y%C8Y>+9:U9_DH=^WF6K[R(0IJ C)4BQ[\'9(DBR%-+33[Y*?)59/DOPCYX
M5:FN;/>[MES7]2:\6Q1$J!P"Y91?8@C_+\P/KK'OUV/?[M3*T=ZBS;-]%[&5
MG@ND$T@[7.&(M%(6!<*E$)0K;T'DX7K-\(>J\;_,&5N5"D U=/SJW.%:8EHI
MU#B?HD;K8)]A'I/#"5F:0X^<T=E( A*3!*; 5+*4A0>3F&K8>-:P\0MSBFOL
M^!W8T9J1.'8^ G8DS71B !9"(DYS.B$F!&D2L%!1P=Z#Q&$86V/JH?J&U=CQ
M/+'C81..:Y%CI6#C? XV<*1<XJR92*X0)Z"H&.,L["MW@2=-!#=/4>3XB1$G
M=(8G77N>)Q-O1IKZRODKZX6M%_9I75DL[#^+//RR1FSF=9W>R%9%8B]_$SK?
M7_]/\:\2V-S@GZ\G(#?^<?S* I<ZO1![IW\R60@=OYC#TQD.WQH=P_W^ 72!
MA;#\_QUU3L^;\?2P'[:+\+=<DW7X'P!N?_XT66\W_OO3^=[7<.* !0*K_;%W
M]!Y8;ZO3NFB> QL^W&D?=G:^;I&]]L&/G<T#OG?\D;2^ AN]V#AK'8&ZG@(C
M@FGDF<P-LB1&EHN DL8R&8*U2.15(X* <A*K>M*OMSY^V6[O-K9;?V]];C>W
M6NW/C8UVX^W&]J?&WQL?OFP5G);\:\/[+-WD@IT'HTZP/1\;@PA[D*WVL/"%
MJ)2C#(^C'8X&L1&+_6ETIEO3L*>-9#N#QG?;'<6UQEGG]+!A>^<-?VA[!]GX
MWYOY'9[N^P<](+BB8NBTL,5Z8SMESP"\HS-L]/IPH06I[1SDO=,X..[T"O_!
M[(NR&V$R:-OM]L]FAPP_6M?IYL'.#']AW+X_/%UKV' T*L(L09IL]%T.J"Q>
M=C+(<97C:>3@YL[Q"0R@N+V:Z/C7:Z<UEF6J _.Z<>T!/[:#@TZOS&; \X)^
M'E\GG?]K13!@8YC=-I_CR6G,=7M*Z8SAM48^U; PL7%HOT?8@T&\DF+R.I\=
M=CS0R2QI%/M^>O7&Y]4OJ /NC<7NGO9/;7<2'MX9A\KFF/&9S:@V.8>/IWY!
M(W\^@PUHQ@#8^W=GF'6L[6-[D _PYW[6<7(<_H?3L+[6<+8JR[L]'-C876L,
M3T!U@OE<E(=RV$^G9WFY3D" M@?%H8'E.AGTOW="&9G?[=@>; CL1QFA'_K#
M"',=C/PIG*8<EWS2'Q3HD?<G]@[S6<S'I'A<$>0/EXWR=\6M;]I9C>H-UQN-
MG5ZC:0=  I1GNB&JH!OK"^R!?>O!$.$HPQ9?JU.6Y8@7=4KKHY$R"JP99U1J
M0R,%BF)6"0Z:QOYV?AEFE,^JDMNMM[?C1#MGO3@8'G9.0#WTN5KX09RHAHB^
M- 9UM$M!7]S7S!&AM$7 IH!!X6"1H<DC0:W67@0>:-&@=?URY=K_GN(#G'98
MY$R9<^2=P>+_W)0PN.C'(-K#CNMDN>511V.)L"Y@3;4( :O"J% 0 +J*$I!8
MPB+Y'WM>(%J[OU$2[C7BRX1$Y NDD%9[>]\R3#VW#,%QE(A+89'#)B'AO+*.
M2&LQ PI9OVPQ; !\=N&/]<;7S.6'63#PL?.]Q(@R:"!S^$E P;C55_ZR@I/&
MZ*3XU)OM(E;#R@H3#6M>?-FW!M;;:89D$A[Q2"1RB2K$6)*.!:^-=;>&E65A
MY&X;?BOT& 20'JY!BK*[1+O_GQ'P1F#@&Q."O?J&EXPLK-4^V _1$4N"1%(:
M(!)%-#(L$A0)BRH()ZA,&5GXM<A2"/+ =4"5;YQ'.Y@F)XXED#(3\:3:DD:P
MIZ!^=-($<PHI*XVZW?6I6$,*J49GH69Z67\T&.-3ON7$#DX+R6E6[+DS1#D1
M3?19S\:"BR0,8<Y231EW3BM9)#<1C5EI32_^N :K;B30,5)M5R=KBE@5#PPO
M&KE$L_UQWV-%",8&&6R W5F>D&,VQR5:JHP-UB23B=)<+E[TWTLCU3WWO19X
M'IP"CK;V$\M-S3%#R04!O"MD-RF6"(1A#EQ#X:1)KH5PN2C?5.#9 ;080] B
M.P,@:K@8>Y.,:9!O5A NMLOA7R'>;"2825%T X;ZLA$#KMEW2FH=!$':^50*
MR#KHB**,(4KI%7.LD'7H5<).YB&9MY0VD4L6ET911[FP>"U'(\8R$AGU@6G!
MHU56&:Z--XQA'",/A1!T$VG44N\2E.#/X%G[(/%&;%-$H,@")2A)X2]ED>7$
MVX!3<E(#)?!U>KDPU'^O-QK;($)XWQ^4=M'2&GO9RCLV@CV2]:IXXI\=H,:.
MOX4]:^V1AW/CR[-M<$9*R[;G7 6MDSJ^E--2=Q3S6O:_Q\&<;:(PHJM_#4$-
MC8/"0C9<JP3'R='KE+;A02B-D9W386F0[*>EF+RU04J ;*NHYBP)QXPS<.XB
M,4II%_-)O!Q=M11OO_J,;AP<#.(!2+QO8-0OF*W['ZV+W7U,:,+1)<2P"(CC
M(KO,&<2*+$.OO#39TG4#6U]K''2^QUYI:\VT<CL#^'JCU;_>-P$2X]0UD36+
M?B$Z3(CP#$B\DXW60-29#F^RWZ\_ _MX>S0 SC*UC)\/8:;#&9/XEU-[N 8+
M_#UV^R>E;P=F]RW"Z<P6[6*)_S\TL.>%+3L_8U@^8]Y&;G/KN\&BLVEL=9H^
M &9VEIT7&4"*=O2'L5=\@#O/"Y=%+P*?#X7^^#:ZP<@.SL<J9&$8'RN?X7H.
M?G54-Y/ ,3@.WAFN5#0&2Z,EX2#V!152)>71L91'[Z <W"#_E?D_8V-&>,GX
M09I'!_N!1Q.D#LB%!(IA3!YIE122/F%E%%:"@&)(UR^S]HFUXF004QQD8T'5
M?1'(^6IZ7]YT_@N(I=8DER"9UL7!?O*$&L$9"D%0Q(W._3NB05ZDH$.BUGJ9
M2>8FTSF@RGO;FP$5DS$EC7J%5)*)H AR*QE+_[@S'/;A4N!%690IX:WPLRXK
MM7@>))$AXBAH)B*=3% ,*V8TI]C10G\H CSO3$>?#P&OV\ G_^H/!OVS'+GY
MDDF&9ILHK*D4&D<DF-2(>P]XDZ1 A&I/$[=8BL+X< /*%&RNHHO2NG ;N^35
M+"@1ET)4-M==\H M-D<#X:1T4-1J7!(!T "Y:V+ FRG]_F>,CD5ENI+]; ^'
MHQB^G/1[Y87#68O#$XWGO1>-[+0W]DG6[6E*B((B#[!"";*>6Z 1P@!97#!1
MO7JM\1I(:I?)I&(]F]$7$F2#5K "^N=-<NIC":F78^MFQ-9*,N1T70F0'D_Z
MPX*._QS$W*KX>_S762><'HX#V&=NK *'\?06ZX8YR.+Z6V9$XFS0B(/?)  3
ML[! ,_\^G-0S/0')%#E0-[XAF\UQ?]KNF3T?OOKGO-@/,O_"&BY._]I)IO1H
MDRQUC9!UZV+/_\S<;)"O@C'9E1E+XW"04?"_.BEY[ 3(>,(E[E/*PI8DAAKF
MB&58[E,!BDMQ:(#NWV0$!?'G?_YI7U^UE5?37*6&O;H^H'3AH)38%[F+V"2I
MC<FMB)WE&L0_2QU5+/J@2T"'>V+8R'CL*0Q;>:-DXEP9N,MI!L<R:HVE]^G:
M,[%B:N+7P\YI_&2=ZYRNVT[1,6M&1WP#8P86U.O8M:R9^Q&PE=YIH9<7:F,9
M]@3:6P:L'%A56.>!?1X4UJ(AB+-Q'.;6.2[B$0#_0',LX]>&)[%P^&7O'SS;
M^O.BL7HVS@T*U;_DK3"0''\%*W)P/HY!+)YQ AN88=,#$A<27@N^+<!83$6\
M6<?B%8$VXPJL.5QS664A:."T7#GC*.% .U909JRDEDA.@2#*Y!U"L$#C/VIE
MX?&X^L%9ZV)[7Q@;C%<1497=",%*!!MCD*616$M(3%3>'&=34F2.L^GV;2^&
M.1I9??IX"\C[H=\[R):S#S !^.I3YO,Q_"<?U/BB2>1'<[.Y[Y('O&<2^9"#
M]:PBR 6L$$^...  (*"KK$]>]C--39B9)D"RZ_G."< >P%8)<X"2812G0 0L
M@8)$V 9:BF6CSZJ&\W68&7^<9#E^& N;5R% %5B<U8]IO.IPY(9^T"E#O\;E
M;S/MY8$6JLIPV,DF=I OI]AYUA]\:Z1N_ZRD\/"]C%6% 1TOI],J')B(R6IJ
M.''.2@R'C426X+3AA!_ $@]*#,C)80M6HS>,&[VPDT.?-X;#>#I\4[*AETS&
M%\WVE_TD&)6Y?(&3SB/0+#'23D84.&=>>454-*]>\YN0+G.\-,J1S-?05HKC
MH.@Y+\X0B/&DW**"8F&/,C.M=JT@KV+#&M5>97J,18QZ09) 344>8@8ED#:Z
MA9]N>!CADI^H3S\S\_=+4W0&[BI*LGC(/12KQTWVF7+N,K^G#0__JPMZ^TNC
MZ9SH<_%QWTM)I>(BMP3*KE_OD,%*(":YA)4$,5OQ15F<,.TQ8SI$%3BSS 0G
M8@@RP<8HGO1B8M#3=.A,\Y@:VZW&^YUM^.-O^/3ET];G1I7+E .$B[R3JYS)
MUR8)_^*\N<L<YJ@/_&W_.RSPZ'+[56])2 Z@#$0IKHG%S&(=/8]!,\),93JC
M[,;0G+*[=C]]Z<U"S_O\WK_+UPY?L#GL@.QL[N988Y!_HD18&E+&WUBCX/R!
MFLZ-LP;DUQQ_<XF;_-;(A='<CC8*4FI4I#0L8S_ZXQB;B>('K S82=9>BT#7
MY2*"O'4"I!_C,$T<]'V@2$4]5X$"PV5&+I9L8->2YI@)_&T'G<RFQO&D6SF%
M[[P.#9HG4MIJ^WT,E.BH)B@J"TP"]@$Y(PVB$4L=9=24@LS#KHH06SH\,!A-
M.>/ 0PQH<8'HP("E))!Y68R1T7JC'VNCCYK[C'&3B.6(4VL1CXXAXV#?.7P.
MR0@<G'OU6ERQT>N-]F$$>70!"D TA?]D&3''G%<K7B'$87]XDB.UAFN-PVB[
M\,TXUJ$_JS^=%._P52;L64[4S0I-E39;:(2CP4F_+.D)J#/."JQBH^!3Z-B#
M7A_D"C^)JBB-Y"#W_@?X4QP.2_]2I=,5 8OYP7.3N>$Q120%O*X:ESN?:(4Y
M5_&*F<# [14_5$$>64O-&NYIZ62_-)+U4G3>F1?"RRLO;P&H$%4<7K5DA8VX
M+(9:6N:."W/66F/8R1K!)QM:\;01^K&,"BI$&UO.J \*3,;O3@^4A[$6/3;J
M#4>@BH]?6Z1-Q1Q>!--8U!?@XOE!KN6LY>XH%&O:+Q\7?\!*%2J#Z_>_59%*
M?\P-N7'0[X<ST*K^44QL1D>9!+J " F\X[0_*)XT<T7\ :IZ$=UT\R6/&;;T
M>$+MM7&0ZDJ&_GZ.T&=VJMCUCBN"I9]!?-9V>9J.X<+#O*<;HP,8X#1]_-CF
MX*JIP]G;X>'<&A36]$S-GRVPC$:SWP/2F<2_O -!_V2M\>'#FUFXNU\H R:6
M@ ZK!>C5/# ,TJ$0F$KF&77 !2MU5X_57<T>,#9FS#*W>[-2^PNV 6V)G?;&
M>?-BF[> 9>Y\W'<I!1IU0-&2"/*[]<AIEA". ELMK 81/AN^+R?<3,Q!!72>
MY/"_ G].<[LZ.!O9Y#.-[UUO9$ ]MK +MC+ +"=72:M!?<,X$=#7'6CKFA/J
MHG(",Q?Y.)!7_U2<JD/JEZ23;Q>Y6#SV5BCF4+ \(.XU1D99C:QSC@NFG,O]
M8:X4H2/L8_\X2QT+'K09C+F>"RWEI;T>U%>?5669;U8P*5'O$M_Z+66$7K2!
M\>C;?LQHDVA$!F- 21HBLL([A%GTE"9,*77/PV#8SI'U1<&7+!"4 =U9 @>(
M/S[.<9!92?F)--P(HT%Q-SP+U)E*7LE%AC)/F,BAC;$(VOBC (3^:)BSK?[Q
MTT(S57Q1#JB965A1-A<N1CP)1"H*&<+:=>W),/XY_N-?XS)DG5ZQ L5-B_4*
MX9E5O(XQZUJP;(NLRK]5CZ^B>=8+,^5"<<7R-ZW6B9;7_HS7R;6_W?18@M<E
MX;=Z[$OH]_E7Y0LJ]9Q);!VK8NONTZ/DRO*Q*[< _^=>4WRBE7$OJQIWL_HC
MMH2&,<,3MWL;*76ZG6SF^#QRPT[HV$$G#C>&P[XOOMWH7>,L8$^3C9:U<(]:
MG;W-K;/6Q:=O("<">_QXL=O^ M?MXKVC+V?-37_1VMSBN^V#L\5:N$WZ_ENS
MO<%:[SZ>PW]I:[-UV()WP/R.6^WLRVOB9OOP<&?SK]1\4]7!_8S/]JVAEH;$
M$:8V(6YL0$YJ@IP2D43CDA44I$^^QN]?.WOU.A65&$36J5AQ'-H:1\HU8E4,
M^CJKWGV:%3VG\MZ70>R>?0&61+-<:O%#?SC,U;Q_%AM8H]8M4.OS#&H%+2T.
MUB-%#* 6-Q[IH **"0>JI '.!*@EUHBZ;%VY6^7NWP):-P#F4P"MS<YP8A[-
M\N,8NEY80_@_5A2CKD:ES4[.(P9M<6<PNW\U6"T%5IT9L$J1".V90,'GH%82
M.;)"84 L+B,+P6 ;,E@I?!FL_K&"PM4*%WO_G0]_KC+GO).K<+\"+F0K5"UX
MK@ZHSU0\>#.[8?/^N1K%ET'QUBR*"Z*LTS$@C;T%%)<1V5Q;V,J@3*!2& <B
M)UF3['(.\Y,7.5<:I^:-E)>-X,NRT/DF/>PD1[R,LNU[/)7J@L+GL'R+K)5;
MOZ5MG ^X0,\&XPWHH#;%H'W(?<(H0$)B+EK+K >E5%^3@U-;2%<2^,]G@%\G
MRESR!D4C(N(6"V0]BTB0('DT*1&=LG]^3:A[(_^#'[![\8U)YZ!)18.9KB%/
MTPG[M4A=&AS$7%VK9P]B68RRRM@KLJLFM9;'(9QEYOQYY7>]'$8)3,>>G SZ
M/^#0GL;N<CFI]VR/?OMJ6,W)=#^7LWT;7W3JZ3?::N_N@^QF>!0>!15S[U#,
MD8X^H:15)(K#EV4I(W5S=O)2):WNU]6ZWO%[[/A1<U\X1I1T%ED1 N(.4Z1#
M=$  -%"NN*$>Y["\R\WIY[(TBWX_13>AJT,PYD.!"R+)N[G6 ,0XR844O@-2
MK"U-//=5)6OBN2OQL.;1]KYSFG+M$O(@$X L /J?RRF^R27!"$LV"/_JM;XI
MIG/9';]G1]IZQ^^SX]_V.8?%QQ8C 0"-N( =UXY(9#A35)@8 V6O7JO;P,4-
M 5NW0HLRT#=V.[D ZVDL.MJ->H-8],\*1970RM&2P\BN$V_*%#RX(%YV*<.M
M\[+-+\F]+JAO5EF9*?7;"V_'@9O;T[C-HB;1BXV<;.]B& -M77S,G1W.6V?[
M7 29@M+(>Z:!2%ENQR@Q(C9X[Y+B5)!+6=J"$R&=-PG^\L%;;YGS(7!C $WH
M,\G2ODW0Y;=X/E_T(+=3L>-C>UG>OS'IISB[XT"YZJ=Q@<NB5E(1&)#+WY^6
MAW/V7;>+Z1RCPQ,([E18W26X4W&X\W&".]GU/]_TV)M_$XP]SF!O-Z"?&'F?
MHBWW<W$.-^%L_'FM7^E6,RR5^%\S1[TPQ4MI"L44?VZ@OF&&.,_O9M?EDUJ,
MFT.*7X+W8KXBSQTMA2_=%5%[&A[4TW!-Y?Q"9,JZQE4R>47'94FPY^%M@#?M
M;6ZSG?:7\]WC]\>MS7S/^T[SW=[A[M'!V<Z[[9S'1UIT^WS1VP!W?FL>>=&"
MZ_,8LT#?/-X^VSM^V]G9W(#W;L,8OK#=H_?SD8TJP=9&G1#5CN8B8A)IF?Y_
M]MZTJ:UD61?^*PJ?>\[MCJ#HFH?N_3J"-M@71TMXD-L!7X@:0:"!(PDS_/HW
M:RU-(#$:C(#5L3<&:6FI5E7FDT]F969Y1%5PL%K6"LG?O*5R19)YE_.G=AL>
M;S/AGNA]V=956%AAX:^O2ZFP\!=CX?ETYY70P&52R!.?.]!A@JQ,!!FIDB<L
M1O@'L%"M<#J_/[.D6/A 281+C5R-7M=?RVJKU, E)W,5<MT=N6:3!9WD)DKI
M$%%8(TZ(0MHR@[07CB0CN#+RS5N%5\12%:C<$Y.N#$J\>O5>4GY2J?=]U'M*
M3)+%CBDA$1$<G+1$+-+*$42CEX:+J''N>BC)"F8_34RJ9.![A=/:K?+XP]8]
M"Q->1[G9DM*/T2+^,UW#"JON@E6SZ:LN21]]H$AZ(Q%GD2-MK$=>D108MX;@
MW(8,KW ]CU5/4G[V0.&B2LV7G894:OZS:CZE),(JH5PBR&IF$:=&(),81EY8
MP62T#*?XYJU9H61)M/R5!4)^EH\\7W?I!?"1"J'NAU"-"YV&'"PAEQ11I0"A
M3&3(YB-@:93)$H'!=<H'3=,5)>;K:&X/454X9(GU>TF)2*7?]];O*0-QEMM
MG0/>H459( V^A4<2UEERZSVQP$"(7M%J_LR2)]'OU]:/I]D;VG:M&ZMDHVJ#
M?=D)V=K>7C_NV6%\UQL,*U"^"RC/IA-A8J7% ,71<)6C/P'I0 W"G 6#P?02
M[]Z\E6S%B)_>B*K2B2JT>]YH]V3TM$*[GT"[*05ESBJKE$-:.HRX!Z SD03$
MHG.1.!MQ\(!V>(6I^>,4EA3M1B1U/)"Q:/.R;.>!/=1;W&/F@1<TIGB(;WBB
M43ZD-T#YJEIV;^#OZ=E9O30^V^O@TAD:H_,9JT;OKZ31^Y/Q_2KP<B>K-[O#
MJS".6$6&7,(,<1,X,EH3!&N6L T^J9![F)@50A^J0=$SHO$5%"W3LST',EY!
MT1VA:$K 2<(^VJ)-6J) P'W.V->9C^- @C2)"0M0I%<P7B8H>LC.OL^!^KV[
M[B#5W,ZL/.,Q7$4'RU-TA_NQ_\KVLI\#D_HV:5=7OK_9!6)?9?S>&=BV9C>O
MF<M]PQA'(DF,N$ZY\9/"2!&F%1&,1I7CJ"M<_/0I.=4&]O(J]9-QDDJI'TRI
MIVS%9-_("(Y88@%Q!I3%8N*14I$[@&A*8BJ46IHE4NJ'C%/ESDQ+S53*+>O9
M*%7WX:)4U0[/J]OAJ=ITOR0PG]WIEB92)E7.//(2 61K9//IZ[#(0,^\]IKH
MQVG37>UT+Q<<5#BX%$2VPL%?B(-34HN=-P',')*",L0#!AQDGB"CJ1!:"TZE
M>^ #7:L]\&H/_-GZ%A<CGT50\Y)_<63[PRZ\^K-^QM7'>;P>&WO+.7@Q=O81
M_8VB;78APSF3X]\LP5MI*\OOK"7]5 KOYEAV*\-ZEPK+TJB63L;:+E=:T2 C
MDD1K<#$X059)B80P+AEKM%*Q,*V:/7!ZV>W4YGFX&14,OCX8?$1WHX+!7P.#
M9Q,89,S:H!A!T2@#,*@\<B!IB 5-.1@W9Z($&*0K3/'G!(.W./-LT=^C8Q6*
M0L(+;?='RL)IF1!PU!NT\C5_]F/;YA,]_AHW>B^4:>:#H\?$TX]8!T[5\?#J
MC\PU^7ZB\Q9FFIF7$SCS<W_BP!W9O8A</]I#9!,,]D_;/K%G@S=_7#RVH-5%
ME^;P\N-?^9 I/=I#EE(%*-3K%VO^9WD^7*LX*-HNS5AJ^_T,O?_52LEC)XS"
MPB7N4S),)DF BC)'+,-REPKPA8KS'\ !RH<'YY#-?_ZP;Q<MY=V.E;BD'B74
M>@I?KKQ1,G&NC#'1:08T.&J-I??IJL\1ICUF3(>H F>6F>!$#$$F0J+B25_Y
MN9M..JF.OZB.OU@.2K7Y,Z?#O+2#,E[YT1B/=1I&Z5CI)=>$7(S2CS]B]SA6
MV_K5=M8C'XOYV U&OI22_#*\SH,VC*<N=@[>'\ U>&?],]UI?MEOK&^<;I]G
MCW&#U,&+W%GWIY>]SJWO'SOU\W:G_KU.X#.'C?6==N/#!JXWX5[-T*IG3_;[
MQ\/&^?N+QV(8G1P7#$1=$H5X ,?3&&V1(<%[+CQ/(A_#J%>,KH[%J.#PE</A
MSYX96\'A4L+A3*%[PD0)8E#R-@ <BH ,#0Q)":M+I&.<@!NM\0HASZW0_4&*
M<)X%O2V/ OV9%.*7AMB+'O'%@/*R<U00R3+\\$]O\$+V1WX5-+<NM+ET/.K@
M$74>H%D;C@SG"ODD-!%8>";MF[>$K<@%;2Z??:E0A5XO%+V6G5)6Z/43Z#73
M1CPF$JD$[UHZBWA*&EDI+<(T8LEA[2W7!7JIGS]^\J%KHB9;MW.;LK=Z9;R]
M]30;IY?F;K+75HCOC5MXW+RY>H.NH.RX@.G'?;*Y.';Q9(VMYD:-U?[GOS0E
MY*_:?RYLH3\ 1;J('3#H->]!S&!I]S[U>UWXU1=[*3G'_-V^[>[%G(\^<PWP
M\-91.PZ:,(Z_VSU_^,2@L?5U#!J?SQJT ??\=KZSOL=VUK\<[AS\N]_X\'&_
MWOE\WCA8@\]MGS8^?!8  .WX_[Z<[7P/1XYRV5C?9-MTFS::C<.M]7#8^/"E
MT_B^@;<[&V<[ZW5:7S\\WSG8 %!I)[A6U/=V5=*YA"97-P>#.+866>UT/DM
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MQ+Q(TT9%4G87/+MO@UC[VDO#$]N/3XI*Y23.3&^MD)L2"OJQ:(Y5*DN6VU#
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MV-<KZI"Y->F0.>JR,SI\9GKD3-[Z:X56;D>1O_-C[ _B66USU!>E$8=YZ0>
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M/'!?966R,;(W;SFHS)P']M^/KD,O"L\?0L6(([FW4HB:)TZL<SQ@QB7#Q.A
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M V'PWGX^*;[1V3EH?,BMNM_O;Y^W.XU\L%@'QOF]?MI8!]0\R,T+UL#[W>2
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M!YX9I*#6I;SPN_N1&R<O8OMD[S/GC,>NY^DN2T!#!6&@!T8,)J?+;>[ZK@6
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M]*=N\O/#J>A+C-1CGYSMV<=? -#O??;]./93Q]>YC4E(ONGH4>BZ>N@S;@(
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M6\!87I44L0/*?*5@ ?!,1KQ/[FR&E!R3;9/P"'D(*)K5?C(!>GC;1:?A*47
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M,&H!3$)T6TU >_YG@N0LOPN8 #N4MMF:)6PT;K,P<L(*HD<=BA/@'%N&(<L
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M60D8W1%D3Q-"&0G6PJ#.Q,%Q@4ZSRRS!( _YFS' #P<!<KD8DE>!C"Z8Q@"
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M'K\H]LH2V&_*C%:M[8GND%@)YQVHB+A]5V6[2_R<\GA2-KT<#KZ)3L_:FV*
M_>=%+\L4Z^QKL=H-UNR&:@5'M7W&%T7%12L^;!@'1'(!9C5FSPRPBA@;CE6W
M0ORU9->BH3=3O4GKADFBZ0KV(8V+H2@#3[,K>37)98^"NBB[_(22<%KER>K!
M: 8)$&(6PY=[JDLEM>LK94^$;]J727(NVF@4Z9@/18MM\3[5P6/(56_*K[R]
M\*B8B$9Z/$VQ_24\#I]0?;EZ+[(A=B^D#N^38=UQ@?JT7LOFVHN;7?8%]QYB
M"_8QURQ5^7ZJ25&S7[6'0Y:TS2KM/Q-6CK'*'?:!Q/KVHIB2:+@R'&*?0_D!
M[/+;HAQHIJ'_;^T<N>:LE%Z1Q<69J&1_DE7Q!+.CL+$$D#JU^<0[U0VIC"3C
M]%K]3EL4DQ34<VK^(.LMO_494IOR^H!$/RVB@JF9E1R;D@\OB_P2I[* <IKQ
MVET/*SK0A&.3]@A;:O&\N-J)'A3OA4]@N6A;.O>UFQ-MB@@\ 7J5KI!*.^=#
M$"HY<0IV,D'*PRRA$0@:ZF3+>25H7[2V1\[#BI*7#%AU4L%SUT4IB$5^!24
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M)IP+4@CXC29;L!)O@22?$H8T=K+O>?DTZR0?FO4;I6VN;WM@&^YI81(&%S8
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M&FVF;W57$9E4> [N0C 1KU=GBQ^1%BC+0B->:EJJ%MU=1+LM;;Y9S=CD:2S
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MS6JK9EF=5%L5-A@Y3<Q9%RI@+E8O=2<\A$ZEJ:4\JT4ZE_;I8?OCP,,L3ZH
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M77A.^/8C6H'P3D1UU\E; 3XD#$^PBR"*5],+/,/+KX5&@@HF(?I:43;@O.:
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M\EJDC//,(J\T:NC-I9?5X'PM>*UHA=%R9?91=DO@#3J%</"$1ILT-??@YH^
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MPI ;3\%F#T#K/T;,#S#7%W0>IP.TYX'#$+T@H/AB=H>E5.'B^I]7GYDY !E
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M !8)!>6+K4G4I9NQL]S8970YH+;!GU'+XAU@$*LF>WAV 97-Y>2>^O71*P\
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M[:GG80I(JFB=[#=[8L>?0$L>E')(J&S_X9_A)F;*Z<X#LLIT&46&MS%>6<C
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M4<)&6>6"[)KXUF+5<Z=4[HA56]FN(K%6(>ZU!N%#*04W5(.\.N4NSX$@XZQ
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M7 !CHTK0^/EW2,>_+1.^#L!!^@:=6/LA^UO?!"QXSN#3HH[G(H=J&>+"/VX
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MQOW/Z!Z54F:+FA9G_<G?,_UK"]F*<C\UET:JY7YIJ3!"K [!,.&4I%7FA,=
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M-/!U"L,$Z,WTTS]_[E/-4E8R!@@:29:!Y<0I3K32\D1CZFWTI'8'Q(N/04/
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MZ6[IR? SCJ1XF_WA?Q^AI?_$+TLL66?;=/WC=K!_VG"L2QNI$I0/TG%(GLH
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M?U@QUF%QQ6[TUL<:7;QD=P9TYQ,^P/BR9YE7PC-%+-.Z] ]U!&=U1HS%_Q?
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MQHKR@XU&JYD%EDPBX#DC,D1<?8*B)$L)-%MM&-UZ[[PJ\G^I>P>,K]#WUJ=
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MMC9:]#&J:!R.X(.-FL?2G@3]H3V6+)7;B^4'^CN+&QZOI8C6%Z:*HS5/IL1
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M8[Y%KM++BS2KV4MGW+MD C@6O"8#6X%FWH!E9%>[0 QV%KM=\N[V_E.GQC#
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M2IR%0MNE@Y*4S@HLCI 74T4Y13;TAGB-UH<\;WU]51&9ED54^#M,./F"^2R
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M']ICJ7V]]AS>RQHLSS/3>G$"J\A_3S&Q9(N) 5,"U:;QVY%?6/92<)<+RSY
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MHK'N.=J18ABPC^7.8YT78$/.29'9'WUD&KAG/I)3@-:BYMY)ZYHDZQW/@<E
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MU4IBB'#&!IZM"2YI)0LM"BE:$ 2IBV3<GSTDWSY8+5-+AH#LYE&#([=6QA4
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M8\]WW3CDD/F>"U'@21A3-X(T$L0/>!3SD-@P@,&88V.$6N0+4 A=N'A78E\
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M5#+=-YOZ-OMLF\''1N65G(#6@@)626JW(K<R@-EBNR]8>V9U+?:ZX!ZH);\
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M.-[82*V2&)0B@TKFL@J,;;B2 =H&C-<MACU3X$GXVK@*#'"T(,IN\1R(.3O
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MYU9O> _D].H4=SMW6"OH&MUD=D\<SGW62M,MMUJ[)[1;>]YF:5:VOTB?RC#
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M.^;:UFQ5.:P[-NX(XRY9^5R1!F7GCO#;9>FN'CMP$<^MYMB+=;][++@(_""
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MA[K($=*=QLH6L]5S[L6KKH.9/CTLR&*93SGGCH+'@T)&!**0,HA)Y$ 6"2=
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M3->(M8R +H$RQVX_S#%*RS#_;:@M':YMX?NX4/\M27L,]C^"1Z_A_MOC?6S
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M3>QH\D,GOV=ZW81PG^J"^8=6#VST,Q&.>91J$0Q9Z9B_+X66H%*SRS9O/<U
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M5(K<NR_FTRE=9."[7!2>?E='_\"OA.7.:KP3W?=VS:@%F='K=,@S>P?;UY4
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MHT\5@YO=KY;9DLY,-Y''^73Z9;XPUT]D@D7,3<O%@ >FOK:$V)BG2@1AD(A
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MF5'%N/^*/(1"\ 9=1FRFP8ZF^@"W;P,M![&0&11"@T+JBX*K+L"VY!TW*W'
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M I..PV_K1APZZ-9"^R.AMC9WM0B1R^Y7RVQ)\Z2FB0A(%(8H@9&*4)$?2/P
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M@:F!I/=:=[^ RZOGF]]NGF^N'<--&TR+'?OT"W;/K&3:CAOI026^237_R6@
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M.]J,K>4CFW'LU4);?<M-$\GLTWN>P4WY\ED_\?+/-)MX@I(PI@3Z2)G6(+&
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M)JF5Z]ZCK&/C[::D8"OJN3[W@T^Q&<./9.)ZYOZ.<V;-YP.@Z9+I^Q1WT'?
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MA^<0;SN_SQZU5D_0XG'#^8;V.NYXBQUN=Y>UIJV74,18!EA 21,,$<8^)%Y
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M?AU&./DVG VB-<8!.()\H"B4RFB@E2..YX";M Q4[')E$)]_!R+XMX?PV$9
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M9[-/L+\3N]9%Q6/T1$M5FDIF2:S6G/C A0[66R>KS. [D.Y&2B[[Q7?G"F[
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M:M]ZX(3F6D<,%A2+CD@: K$"0U.&#( 7&653*\UVGY)^8-.]DK?/2=Q#X@U
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M%V,&S[\L&[A[+T4"Y%\[;LOM1T^\T9&$D-#8*RU]KG*UJBI7NV']SW* T0Y
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MP[@:)+?XS<W)MR'NY-88&PT@!'3IZY4B<1A1$9JS%I9K%545GVP?8GLV6P>
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MNO:M1>W4!QH@6^*E!"*C<,0E69*Q.IMH(U5U&JT^C\RVD+8/,':Z?=")EAK
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MVP80O9IF') J;<&2F$PJ\[A3*7W 6 U_R)+D@?LJB'S&P.EJ]X6J(6H/V3:
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M%-$ JM[XZ1@%-/L T\6HL4<1C!4T9TZ)SK@TI%2,N)0\28(QF81V+E8)(W]
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MPT#I+!4984I'(G.ICU4\$\ZDR-H::T65 L\G:.JWP>!1MJNN--(NN%8KCIM
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M5%BNHLZ1T)S+^5_*!!^$"!?.*= LT11JN"([T+;;;O.R^YAUK:(64;?A(%M
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M<UM)LMY?<?@]Y]:^1/B%VGIH2Z(LJ7MB_(*HE8*'!'0!4-VZO]Y9 ,$5) ^
M4S@%>:8G*%*@SLG*_"HKLW*;]L>S@3L*WFK*HAE+J>#BVS2>3O"$710U^?AO
M4[K9)5PHX37ZZ9E8#8+B8E%K,E B6,*EX\%T.6DZ-1G<A]!N0#O>MI8'$^+
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M ;#=5%;=6X0SG"3B+2CC<0<ZJ\!YYB$;$D+I361M%==P(S7#'H#UX+0_ZQO
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MM%62(K<A<MA;X&J(JR:G-C'X.87I^:2DRY]&9#O:&>4,6!5TKK?:R23>::*
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M>^[ C3RK"7X/[C5PFFQ0B$GSX'TP0!DO R)$,=<DAV")-%0IGW,5,V1' ^1
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M,,P3R,$+RVBF:-QW,H./H*735F)ZIJ73-CQK0%%LF,2F2&)** +,TV*<ER3
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MUB?J&2%[<'CH"Y9[H96E2J79L.2)!,NX149X5=*F.?!@/*Z,RY!?C#=M?O3
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M;+R<4=)$4FJRH,Q7,7&/+8]Z*Z%OE4>]C00:@--3';Q]B$E(@^XB)WB.&VW
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MQN\%#[ '#HZ#5C; +GR_KIL[NUK,%VX2406LSL>19IG*%"D05Z8AL^R1 <R
M1O_*:D4E$ZJI\^"IE0Q\O=G AA@,%[_ QGC[5YJ%\;PX;M<,()%D0Q.%Y!E%
M,Q%983.7D*RAE@L6>1@FOV+;E0SL3Q_WQM@/%RULC!)G/9W/KU)\<S6[,?U6
M7M'=DNKKE:*#I- G8K(,ZC"N9.PE"T91!<JFD*22G-$Z1\+6I':"MOI5H5U7
ML@U@]^WE]XOIS[2.^&[F]TTY]9*U\Z_3A;NX^WDI+OPX7?PS+3ZG,#V?E#N
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M2P$"% ,4    "  )@VE1$9. M[4(  !\0   %               @ $
M<3,R,#(P97AH:6)I=#,Q,2YH=&U02P$"% ,4    "  )@VE1R9*AL<P(  "-
M0@  %               @ 'G"   <3,R,#(P97AH:6)I=#,Q,BYH=&U02P$"
M% ,4    "  )@VE15UZ9?C %  "!&@  %               @ 'E$0  <3,R
M,#(P97AH:6)I=#,R,2YH=&U02P$"% ,4    "  )@VE1<<;^00L%  !K&0
M%               @ %'%P  <3,R,#(P97AH:6)I=#,R,BYH=&U02P$"% ,4
M    "  )@VE19]'^(JA_ @"36!T $0              @ &$'   <F1N="TR
M,#(P,#DS,"YH=&U02P$"% ,4    "  )@VE1HHHX5)H2  !NO0  $0
M        @ %;G ( <F1N="TR,#(P,#DS,"YX<V102P$"% ,4    "  )@VE1
M'Z,D6E8?   >-P$ %0              @ $DKP( <F1N="TR,#(P,#DS,%]C
M86PN>&UL4$L! A0#%     @ "8-I427E'*H4?0  \%D% !4
M ( !K<X" ')D;G0M,C R,# Y,S!?9&5F+GAM;%!+ 0(4 Q0    (  F#:5&W
M#KET9@\! &(:"P 5              "  ?1+ P!R9&YT+3(P,C P.3,P7VQA
M8BYX;6Q02P$"% ,4    "  )@VE1K6;%8%>E  #S8 < %0
M@ &-6P0 <F1N="TR,#(P,#DS,%]P<F4N>&UL4$L%!@     *  H D@(  !<!
$!0    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
